Citrus Sinensis ID: 038003
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 848 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.976 | 0.792 | 0.436 | 0.0 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.891 | 0.675 | 0.415 | 1e-168 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.859 | 0.661 | 0.373 | 1e-130 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.878 | 0.676 | 0.379 | 1e-127 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.847 | 0.630 | 0.373 | 1e-125 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.840 | 0.634 | 0.381 | 1e-121 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.959 | 0.811 | 0.354 | 1e-120 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.827 | 0.618 | 0.364 | 1e-118 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.943 | 0.828 | 0.349 | 1e-118 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.936 | 0.729 | 0.310 | 1e-113 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 719 bits (1856), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/974 (43%), Positives = 569/974 (58%), Gaps = 146/974 (14%)
Query: 4 EEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPC-SWFGISCNHAGSRVISITMS 62
EEA ALLKWK++ NQ +SS LSSW N S C SW+G++C+ +I + ++
Sbjct: 49 EEANALLKWKSTFTNQT-SSSKLSSW----VNPNTSSFCTSWYGVACSLGS--IIRLNLT 101
Query: 63 TLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPE 122
G+ GTF DF FSS P+L ++LS N F G I G SKL+Y DL NQL G IPPE
Sbjct: 102 NTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPE 161
Query: 123 IGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182
+G L+ L L+L N+L+G+IP EIG+L+ + ++A+ N L G IPSS GNL+ L LYL
Sbjct: 162 LGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYL 221
Query: 183 YKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP- 241
+ NSLSGSIPS IG L +L +L L N +G IP S GNL ++T++++F N LSG IPP
Sbjct: 222 FINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPE 281
Query: 242 -----------------------ILGNLKSLSALGLHINQLNGFIPP------------- 265
LGN+K+L+ L L++NQLNG IPP
Sbjct: 282 IGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEI 341
Query: 266 -----------SIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHS 314
S G L++L L+L +N L G +P I L+ L+L TN G +P +
Sbjct: 342 SENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDT 401
Query: 315 IER------------------------------VLLNQNNLSGKMYEAFGDHPNLTFLDL 344
I R V N+ SG + EAFG +P L F+DL
Sbjct: 402 ICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDL 461
Query: 345 SNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQ 404
SNNNF G++S NW KL FI+S N+I+G+IPP+I N +L LDLSSN I G++P
Sbjct: 462 SNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPES 521
Query: 405 LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNL 464
+ ++ ++KL LN N+LSG +P LT L+YLDLS+N+ SS IP ++ NL +L+Y+NL
Sbjct: 522 ISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNL 581
Query: 465 SNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRC 524
S N L IP KL L LDLS+N L EI Q ++ +LE+L+LSHNNLS IP
Sbjct: 582 SRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPS 641
Query: 525 FEEMRSLSCIDISYNELHGPIPNSTAFKDG---LMEGNKGL------------------- 562
F++M +L+ +D+S+N L GPIP++ AF++ EGNK L
Sbjct: 642 FKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSK 701
Query: 563 ----------------------------------KRVSQ-EEQSNSMNRLRLLSVLNFDG 587
KR Q EE ++S + LS+ +FDG
Sbjct: 702 KSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDG 761
Query: 588 KIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLS--GNMADHDE 645
K+ ++EIIKAT +FD K+ IG GG G VYKA+LP+ I+AVKK N S N + E
Sbjct: 762 KVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQE 820
Query: 646 FLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
FLNE+ AL EIRHRN VK GFC + ++FLV EY++RGSL ++L +D AK+L W +RI
Sbjct: 821 FLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRI 880
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765
NV+KGVA+ALSY+HHD P+I+HRDISS N+LL ++EA +SDFG AK + P SSNW+
Sbjct: 881 NVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAV 940
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKI 825
AGT+GY APE+AY M+ TEK DVYSFGVL EVIKG HP D S SS + + + I
Sbjct: 941 AGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSI 1000
Query: 826 LDPRLPTPSPSVMD 839
D RLP P+P + +
Sbjct: 1001 SDHRLPEPTPEIKE 1014
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 592 bits (1527), Expect = e-168, Method: Compositional matrix adjust.
Identities = 352/847 (41%), Positives = 484/847 (57%), Gaps = 91/847 (10%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+ + +L L L N G IP +IGN+ + L L N+L+G IP +G L L L
Sbjct: 241 TLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLS 300
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
L N L G IPP++G + + L L +N L GSIPSSLGNL NL +LYLY+N L+G IP
Sbjct: 301 LFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPP 360
Query: 194 IIGKLKSLLQLDLSENQFSGSIPLS------------------------LGNLSSLTMMS 229
+G ++S++ L L+ N+ +GSIP S LGN+ S+ +
Sbjct: 361 ELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLD 420
Query: 230 LFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPE 289
L N L+GS+P GN L +L L +N L+G IPP + N S L L L N GF PE
Sbjct: 421 LSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPE 480
Query: 290 EIGYLKSLSELELCTNLLRGVIPHSIE------RVLLNQNNLSGKMYEAFGDHPNLTFLD 343
+ + L + L N L G IP S+ R N +G ++EAFG +P+L F+D
Sbjct: 481 TVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFID 540
Query: 344 LSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPV 403
S+N F GEIS NW KL I+S NNI+G+IP +I N +L LDLS+N++ G++P
Sbjct: 541 FSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPE 600
Query: 404 QLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLN 463
+ L++L++L LN NQLSG VP LT L+ LDLS+N SS IP++ + LKLH +N
Sbjct: 601 AIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMN 660
Query: 464 LSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPR 523
LS N+ IP KL L++LDLSHN L EIP Q+ ++ SL+KL+LSHNNLS IP
Sbjct: 661 LSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPT 719
Query: 524 CFEEMRSLSCIDISYNELHGPIPNSTAFKDGL---MEGNKGL------------------ 562
FE M +L+ +DIS N+L GP+P++ F+ +E N GL
Sbjct: 720 TFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKP 779
Query: 563 ---------------------------------KRVSQEEQSNSMNRLRLLSVLNFDGKI 589
KR Q ++ +S+ + DGK
Sbjct: 780 KKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKF 839
Query: 590 MHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQL---LSGNMADHDEF 646
+++II++T++FD IG GG VY+A L I+AVK+ + + +S + EF
Sbjct: 840 KYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLHDTIDEEISKPVVKQ-EF 897
Query: 647 LNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRIN 706
LNEV AL EIRHRN VK GFC + H+FL+ EY+++GSL ++L +D AK L W +RIN
Sbjct: 898 LNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRIN 957
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA 766
V+KGVA+ALSY+HHD + I+HRDISS N+LLD+++ A +SDFG AK + SSNW+ A
Sbjct: 958 VVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVA 1017
Query: 767 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKIL 826
GT+GY APE AYTM+ TEK DVYSFGVL+ E+I G HP D S + SS + + I
Sbjct: 1018 GTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVS-SLSSSPGEALSLRSIS 1076
Query: 827 DPRLPTP 833
D R+ P
Sbjct: 1077 DERVLEP 1083
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1200), Expect = e-130, Method: Compositional matrix adjust.
Identities = 307/822 (37%), Positives = 422/822 (51%), Gaps = 93/822 (11%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
S + L + N+ G++P +IG L L L NQLSG +P EIG L +L ++
Sbjct: 188 SIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVI 247
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
L N+ G IP EI + ++ LAL N L G IP LG+L +L LYLY+N L+G+IP
Sbjct: 248 LWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPR 307
Query: 194 IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALG 253
IG L +++D SEN +G IPL LGN+ L ++ LF N L+G+IP L LK+LS L
Sbjct: 308 EIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLD 367
Query: 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP- 312
L IN L G IP L L +L L+ N L G +P ++G+ L L++ N L G IP
Sbjct: 368 LSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPS 427
Query: 313 ----HSIERVL-LNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFI 367
HS +L L NNLSG + L L L+ NN G N ++
Sbjct: 428 YLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIE 487
Query: 368 VSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPL 427
+ N GSIP ++GN LQ L L+ N G++P ++ MLS L L ++ N+L+G VP
Sbjct: 488 LGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPS 547
Query: 428 EFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSEL- 486
E + LQ LD+ N S ++P +G+L +L L LSNN LS IP L L+EL
Sbjct: 548 EIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQ 607
Query: 487 ------------------------DLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIP 522
+LS+N L EIPP++ N+ LE L L++NNLS IP
Sbjct: 608 MGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIP 667
Query: 523 RCFEEMRSLSCIDISYNE---------------------LHGP-----------IPNSTA 550
F + SL + SYN L GP P+ +
Sbjct: 668 SSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQST 727
Query: 551 FKDGLMEGNK--------------------------GLKRVSQEEQSNSMNRLRLLSVLN 584
K G M +K ++ V+ Q + + L
Sbjct: 728 GKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFP 787
Query: 585 FDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHD 644
++++ ATD+FDE F +G+G G+VYKA LP+G +AVKK S GN + D
Sbjct: 788 PKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVD 847
Query: 645 -EFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNR 703
F E+L L IRHRN VK HGFC + + L+ EY+ +GSL IL D + L W++
Sbjct: 848 NSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHD--PSCNLDWSK 905
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG-PHSSNW 762
R + G A L+YLHHDC P I HRDI S N+LLD FEAHV DFG+AK + PHS +
Sbjct: 906 RFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSM 965
Query: 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ AG++GY APE AYTM+ TEK D+YS+GV++ E++ G P
Sbjct: 966 SAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAP 1007
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1177), Expect = e-127, Method: Compositional matrix adjust.
Identities = 307/808 (37%), Positives = 437/808 (54%), Gaps = 63/808 (7%)
Query: 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQL 139
+L +L L N G IP +GN+S+L+ L L N +G IP EIGKL +++RLYL NQL
Sbjct: 236 NLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQL 295
Query: 140 HGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLK 199
G IP EIG L ++ N L G IP G++ NL +L+L++N L G IP +G+L
Sbjct: 296 TGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELT 355
Query: 200 SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQL 259
L +LDLS N+ +G+IP L L L + LF+N L G IPP++G + S L + N L
Sbjct: 356 LLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSL 415
Query: 260 NGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP------H 313
+G IP +L +L L +N L G +P ++ KSL++L L N L G +P
Sbjct: 416 SGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQ 475
Query: 314 SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNI 373
++ + L+QN LSG + G NL L L+NNNF GEI GN +K+ F +S N +
Sbjct: 476 NLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQL 535
Query: 374 SGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLT 433
+G IP ++G+ +Q LDLS N G I +L L L L L+ N+L+G +P FG LT
Sbjct: 536 TGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLT 595
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHY-LNLSNNQLSHKIPTEFEKLIHLSELDLSHNI 492
+L L L N LS +IP +G L L LN+S+N LS IP L L L L+ N
Sbjct: 596 RLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNK 655
Query: 493 LQEEIPPQVCNMGSLEKLNLSHNNLSDFIP--RCFEEMRSLS------CIDISYNELHGP 544
L EIP + N+ SL N+S+NNL +P F+ M S + + +
Sbjct: 656 LSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPL 715
Query: 545 IPNSTAFKDGLMEGNK-------------------------GLKR-----VSQEEQSNSM 574
+P+S + + L+ G++ +KR V+ E+Q+
Sbjct: 716 VPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQT--- 772
Query: 575 NRLRLLSVLNFDGK-IMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNS 633
+ ++ F K ++ ++ AT +F E +G+G G+VYKAE+ G+++AVKK NS
Sbjct: 773 -KPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNS 831
Query: 634 QLLSGNMADHD-EFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGD 692
+ G A D F E+ L +IRHRN VK +GFCY+ + L+ EY+ +GSL L
Sbjct: 832 R---GEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQR 888
Query: 693 DVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752
L WN R + G A L YLHHDC P I+HRDI S N+LLD F+AHV DFG+A
Sbjct: 889 GEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLA 948
Query: 753 KFVG-PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR------ 805
K + +S + + AG++GY APE AYTM+ TEK D+YSFGV++ E+I G P
Sbjct: 949 KLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQG 1008
Query: 806 -DFFSINFSSFSNMIIDVNKILDPRLPT 832
D + S NMI + ++ D RL T
Sbjct: 1009 GDLVNWVRRSIRNMIPTI-EMFDARLDT 1035
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1153), Expect = e-125, Method: Compositional matrix adjust.
Identities = 291/779 (37%), Positives = 434/779 (55%), Gaps = 60/779 (7%)
Query: 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQL 139
+L L L+ GN+P +G L KL+ L + + +SG IP ++G ++L L+L N L
Sbjct: 227 NLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSL 286
Query: 140 HGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLK 199
G+IP EIGQL+ +++L L N+L G IP +GN SNL ++ L N LSGSIPS IG+L
Sbjct: 287 SGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLS 346
Query: 200 SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQL 259
L + +S+N+FSGSIP ++ N SSL + L N +SG IP LG L L+ NQL
Sbjct: 347 FLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQL 406
Query: 260 NGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH------ 313
G IPP + + + L+ L L N L G +P + L++L++L L +N L G IP
Sbjct: 407 EGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCS 466
Query: 314 SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNI 373
S+ R+ L N ++G++ G + FLD S+N G++ G+ S+L +S N++
Sbjct: 467 SLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSL 526
Query: 374 SGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLT 433
GS+P + + LQVLD+S+N GKIP L L SLNKLIL+ N SG +P G +
Sbjct: 527 EGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCS 586
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHY-LNLSNNQLSHKIPTEFEKLIHLSELDLSHNI 492
LQ LDL +N+LS IP +G++ L LNLS+N+L+ KIP++ L LS LDLSHN+
Sbjct: 587 GLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNM 646
Query: 493 LQEEIPPQVCNMGSLEKLNLSHNNLSDFIP--RCFEEMRSLSCIDISYN-ELHGPIPNST 549
L+ ++ P + N+ +L LN+S+N+ S ++P + F R LS D+ N +L +S
Sbjct: 647 LEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLF---RQLSPQDLEGNKKLCSSTQDSC 702
Query: 550 --AFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNFDGKIMHEEIIKATDDFD----- 602
++ G G+ G +++ + + L VL G + +I+A + D
Sbjct: 703 FLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVA---VIRARRNIDNERDS 759
Query: 603 ----------------------------EKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQ 634
E IGKG G VY+A++ +G+++AVKK
Sbjct: 760 ELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPA 819
Query: 635 LLSGNMAD-----HDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARI 689
+++G + D F EV L IRH+N V+F G C+N L+ +Y+ GSL +
Sbjct: 820 MVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSL 879
Query: 690 LGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749
L + L W+ R ++ G A L+YLHHDCLP I+HRDI + N+L+ +FE +++DF
Sbjct: 880 L-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADF 938
Query: 750 GIAKFV--GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806
G+AK V G AG++GY APE Y+M+ TEK DVYS+GV+V EV+ G P D
Sbjct: 939 GLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPID 997
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1123), Expect = e-121, Method: Compositional matrix adjust.
Identities = 293/768 (38%), Positives = 414/768 (53%), Gaps = 55/768 (7%)
Query: 89 NLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIG 148
N F G IP IGNL+ L+ L L N L G IP EIG + L++LYL NQL+GTIP E+G
Sbjct: 263 NKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELG 322
Query: 149 QLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSE 208
+LS + ++ N L G IP L +S L +LYL++N L+G IP+ + KL++L +LDLS
Sbjct: 323 KLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSI 382
Query: 209 NQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIG 268
N +G IP NL+S+ + LF+NSLSG IP LG L + NQL+G IPP I
Sbjct: 383 NSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFIC 442
Query: 269 NLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVL------LNQ 322
S+L +L L +N ++G +P + KSL +L + N L G P + +++ L+Q
Sbjct: 443 QQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQ 502
Query: 323 NNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIG 382
N SG + G L L L+ N F + S L TF VS N+++G IP +I
Sbjct: 503 NRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIA 562
Query: 383 NSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLST 442
N LQ LDLS N +G +P +L L L L L+ N+ SG +P G+LT L L +
Sbjct: 563 NCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGG 622
Query: 443 NKLSSSIPKSIGNLLKLHY-LNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV 501
N S SIP +G L L +NLS N S +IP E L L L L++N L EIP
Sbjct: 623 NLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTF 682
Query: 502 CNMGSLEKLNLSHNNLSDFIP--RCFEEMRSLSCID---------ISYNELHGPIPNSTA 550
N+ SL N S+NNL+ +P + F+ M S + S + H P+ ++
Sbjct: 683 ENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISS 742
Query: 551 FKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNF------------------------- 585
K G +G + ++ L + V++F
Sbjct: 743 LKAG--SARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIY 800
Query: 586 ---DGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMAD 642
+ ++I++AT F + + +G+G G+VYKA +PSG +AVKK S N
Sbjct: 801 FVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNS 860
Query: 643 HDE---FLNEVLALKEIRHRNNVKFHGFCYN-GPHS-FLVCEYLDRGSLARILGDDVTAK 697
++ F E+L L +IRHRN V+ + FCY+ G +S L+ EY+ RGSL +L +
Sbjct: 861 NNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGG-KSH 919
Query: 698 ELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG- 756
+ W R + G A L+YLHHDC P IIHRDI S N+L+D NFEAHV DFG+AK +
Sbjct: 920 SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDM 979
Query: 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
P S + + AG++GY APE AYTM+ TEK D+YSFGV++ E++ G P
Sbjct: 980 PLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAP 1027
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1117), Expect = e-120, Method: Compositional matrix adjust.
Identities = 325/917 (35%), Positives = 452/917 (49%), Gaps = 103/917 (11%)
Query: 5 EAYALLKWKTSLQNQ-NLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMST 63
E ALL KTSL + +S LSSW + S C+W G++C+ + V S+ +S
Sbjct: 25 EFRALLSLKTSLTGAGDDKNSPLSSWKV------STSFCTWIGVTCDVSRRHVTSLDLSG 78
Query: 64 LGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEI 123
L L+GT S L NL+L+ NL G IP +I +LS L++L+L +N +G P EI
Sbjct: 79 LNLSGTLSP-DVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEI 137
Query: 124 GK-LNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182
L LR L + N L G +P + L+ + L L N G IP S G+ + L +
Sbjct: 138 SSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAV 197
Query: 183 YKNSLSGSIPSIIGKLKSLLQLDLSE-NQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP 241
N L G IP IG L +L +L + N F +P +GNLS L N L+G IPP
Sbjct: 198 SGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPP 257
Query: 242 ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELE 301
+G L+ L L L +N +G + +G LSSL+ + L NN G +P LK+L+ L
Sbjct: 258 EIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLN 317
Query: 302 LCTNLLRGVIPHSI------ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISF 355
L N L G IP I E + L +NN +G + + G++ L +DLS+N G +
Sbjct: 318 LFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPP 377
Query: 356 NWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLI 415
N + +KL T I N + GSIP +G L + + N + G IP L L L ++
Sbjct: 378 NMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVE 437
Query: 416 LNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPT 475
L N LSG +P+ G L + LS N+LS +P +IGN + L L N+ IP+
Sbjct: 438 LQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPS 497
Query: 476 EFEKLIHLSELDLSHNI------------------------LQEEIPPQVCNMGSLEKLN 511
E KL LS++D SHN+ L EIP ++ M L LN
Sbjct: 498 EVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLN 557
Query: 512 LSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAF-------------------- 551
LS N+L IP M+SL+ +D SYN L G +P + F
Sbjct: 558 LSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLG 617
Query: 552 --KDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNFDGKIMHEEIIKAT----------- 598
KDG+ +G G + S+ S SM L +L +L IIKA
Sbjct: 618 PCKDGVAKG--GHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRAW 675
Query: 599 ----------------DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMAD 642
D E IGKGG G VYK +P+GD+VAVK+ + + G+ D
Sbjct: 676 RLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRL-AAMSRGSSHD 734
Query: 643 HDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWN 702
H F E+ L IRHR+ V+ GFC N + LV EY+ GSL +L L W+
Sbjct: 735 HG-FNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK-KGGHLHWD 792
Query: 703 RRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN- 761
R + A L YLHHDC P I+HRD+ S N+LLDSNFEAHV+DFG+AKF+ ++
Sbjct: 793 TRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSE 852
Query: 762 -WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF--SINFSSFSNM 818
+ AG++GY APE AYT++ EK DVYSFGV++ E++ G P F ++ +
Sbjct: 853 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRK 912
Query: 819 IIDVN-----KILDPRL 830
+ D N K+LDPRL
Sbjct: 913 MTDSNKDSVLKVLDPRL 929
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1098), Expect = e-118, Method: Compositional matrix adjust.
Identities = 290/796 (36%), Positives = 416/796 (52%), Gaps = 94/796 (11%)
Query: 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQL 139
+L L L+ G++P+ +G LSKLQ L + S LSG IP E+G ++L L+L N L
Sbjct: 228 NLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDL 287
Query: 140 HGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLK 199
GT+P E+G+L ++K+ L NNLHG IP +G + +L + L N SG+IP G L
Sbjct: 288 SGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLS 347
Query: 200 SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQL 259
+L +L LS N +GSIP L N + L + N +SG IPP +G LK L+ N+L
Sbjct: 348 NLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKL 407
Query: 260 NGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP------H 313
G IP + +L+ L L N L G +P + L++L++L L +N + GVIP
Sbjct: 408 EGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCT 467
Query: 314 SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNI 373
S+ R+ L N ++G++ + G NL+FLDLS NN G + N +L +S N +
Sbjct: 468 SLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTL 527
Query: 374 SGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLT 433
G +P + + KLQVLD+SSN + GKIP L L SLN+LIL+ N +G +P G T
Sbjct: 528 QGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCT 587
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHY-LNLSNNQLSHKIPTEFEKLIHLSELDLSHNI 492
LQ LDLS+N +S +IP+ + ++ L LNLS N L IP L LS LD+SHN+
Sbjct: 588 NLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNM 647
Query: 493 LQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFK 552
L G L L+ + +L ++IS+N G +P+S F+
Sbjct: 648 LS----------GDLSALS---------------GLENLVSLNISHNRFSGYLPDSKVFR 682
Query: 553 D---GLMEGNKGLKR-------VSQEEQSNSM-----NRLRL-----------LSVLNFD 586
MEGN GL VS Q + +RLR+ L+VL
Sbjct: 683 QLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVL 742
Query: 587 GKIMHEEIIKATDDFD----------------------------EKFCIGKGGQGSVYKA 618
I +++I+ +D + E IGKG G VYKA
Sbjct: 743 AVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKA 802
Query: 619 ELPSGDIVAVKKF------NSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672
E+P+ +++AVKK N + + D F EV L IRH+N V+F G C+N
Sbjct: 803 EMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKN 862
Query: 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 732
L+ +Y+ GSL +L + LGW R +I G A L+YLHHDC+P I+HRDI
Sbjct: 863 TRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIK 922
Query: 733 SKNVLLDSNFEAHVSDFGIAKFV--GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYS 790
+ N+L+ +FE ++ DFG+AK V G + + AG++GY APE Y+M+ TEK DVYS
Sbjct: 923 ANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYS 982
Query: 791 FGVLVFEVIKGNHPRD 806
+GV+V EV+ G P D
Sbjct: 983 YGVVVLEVLTGKQPID 998
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1094), Expect = e-118, Method: Compositional matrix adjust.
Identities = 314/899 (34%), Positives = 457/899 (50%), Gaps = 99/899 (11%)
Query: 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITM 61
+N E AL+ K S N ++L W + CSW G+ C++ V+S+ +
Sbjct: 26 MNNEGKALMAIKGSFSNL---VNMLLDWD----DVHNSDLCSWRGVFCDNVSYSVVSLNL 78
Query: 62 STLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPP 121
S+L L G + +L +++L N G IP +IGN + L YLDL N L G IP
Sbjct: 79 SSLNLGGEISP-AIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPF 137
Query: 122 EIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIP------------- 168
I KL QL L L NQL G +P + Q+ + +L L N+L G I
Sbjct: 138 SISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLG 197
Query: 169 -----------SSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPL 217
S + L+ L + N+L+G+IP IG S LD+S NQ +G IP
Sbjct: 198 LRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPY 257
Query: 218 SLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLY 277
++G L T+ SL N L+G IP ++G +++L+ L L N+L G IPP +GNLS LY
Sbjct: 258 NIGFLQVATL-SLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLY 316
Query: 278 LYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHP 337
L+ N L G +P E+G + LS L+L N L G IP + GK+ + F
Sbjct: 317 LHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPEL-----------GKLEQLFE--- 362
Query: 338 NLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397
L+L+NN G I N + + L+ F V N +SGSIP N L L+LSSN+
Sbjct: 363 ----LNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNF 418
Query: 398 VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL 457
GKIPV+L + +L+KL L+ N SG +PL G L L L+LS N LS +P GNL
Sbjct: 419 KGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLR 478
Query: 458 KLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNL 517
+ +++S N LS IPTE +L +L+ L L++N L +IP Q+ N +L LN+S NNL
Sbjct: 479 SIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNL 538
Query: 518 SDFIP--RCFEEMRSLSCIDISY------NELHGPIPNSTAFKDGL-------------- 555
S +P + F S + Y + GP+P S F G
Sbjct: 539 SGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLCM 598
Query: 556 --------MEGNKGLKRVSQEEQSNSMNRLRLLSVLNFDGKI-MHEEIIKATDDFDEKFC 606
M+ K L+ S++ + L L +L+ D I ++I++ T++ +EKF
Sbjct: 599 IFLAVYKSMQQKKILQGSSKQAEG-----LTKLVILHMDMAIHTFDDIMRVTENLNEKFI 653
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IG G +VYK L S +A+K+ +Q + EF E+ + IRHRN V HG
Sbjct: 654 IGYGASSTVYKCALKSSRPIAIKRLYNQY----PHNLREFETELETIGSIRHRNIVSLHG 709
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
+ + + L +Y++ GSL +L + +L W R+ + G A L+YLHHDC P I
Sbjct: 710 YALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRI 769
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA-GTFGYAAPEIAYTMRATEK 785
IHRDI S N+LLD NFEAH+SDFGIAK + ++ + + GT GY PE A T R EK
Sbjct: 770 IHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVLGTIGYIDPEYARTSRINEK 829
Query: 786 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII---DVNKILDPRLPTPSPSVMDYG 841
D+YSFG+++ E++ G D N ++ +I+ D N +++ P + + MD G
Sbjct: 830 SDIYSFGIVLLELLTGKKAVD----NEANLHQLILSKADDNTVMEAVDPEVTVTCMDLG 884
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-113, Method: Compositional matrix adjust.
Identities = 308/993 (31%), Positives = 480/993 (48%), Gaps = 199/993 (20%)
Query: 27 SSWTLYPANATKISPCS--WFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANL 84
S+W N ++ +PC+ WFG+ C+ +G+ V ++ +S GL+G L L
Sbjct: 50 STWK---ENTSETTPCNNNWFGVICDLSGNVVETLNLSASGLSGQLGS-EIGELKSLVTL 105
Query: 85 NLSFNLFFGNIPLQIGNLSKLQYLDLGSNQ------------------------LSGLIP 120
+LS N F G +P +GN + L+YLDL +N LSGLIP
Sbjct: 106 DLSLNSFSGLLPSTLGNCTSLEYLDLSNNDFSGEVPDIFGSLQNLTFLYLDRNNLSGLIP 165
Query: 121 PEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSL--------- 171
+G L +L L + N L GTIP +G S ++ LAL +N L+GS+P+SL
Sbjct: 166 ASVGGLIELVDLRMSYNNLSGTIPELLGNCSKLEYLALNNNKLNGSLPASLYLLENLGEL 225
Query: 172 ---------------------------------------GNLSNLAVLYLYKNSLSGSIP 192
GN S+L L + K +L+G+IP
Sbjct: 226 FVSNNSLGGRLHFGSSNCKKLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIP 285
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSAL 252
S +G L+ + +DLS+N+ SG+IP LGN SSL + L +N L G IPP L LK L +L
Sbjct: 286 SSMGMLRKVSVIDLSDNRLSGNIPQELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQSL 345
Query: 253 GLHINQLNGFIPPSIGNLSSL------------------------RVLYLYNNGLYGFVP 288
L N+L+G IP I + SL + L L+NNG YG +P
Sbjct: 346 ELFFNKLSGEIPIGIWKIQSLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIP 405
Query: 289 EEIGYLKSLSELEL-------------C-----------TNLLRGVIPHSI------ERV 318
+G +SL E++L C +N L G IP SI ERV
Sbjct: 406 MSLGLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERV 465
Query: 319 LLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIP 378
L N LSG + E F + +L++++L +N+F G I + G+ L T +S N ++G IP
Sbjct: 466 RLEDNKLSGVLPE-FPESLSLSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIP 524
Query: 379 PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYL 438
P++GN L +L+LS N++ G +P QL + L + N L+G +P F S L L
Sbjct: 525 PELGNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTL 584
Query: 439 DLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS-ELDLSHNILQEEI 497
LS N +IP+ + L +L L ++ N KIP+ L L LDLS N+ EI
Sbjct: 585 VLSDNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEI 644
Query: 498 PPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIP-----NSTAFK 552
P + + +LE+LN+S+N L+ + + ++SL+ +D+SYN+ GPIP NS+ F
Sbjct: 645 PTTLGALINLERLNISNNKLTGPL-SVLQSLKSLNQVDVSYNQFTGPIPVNLLSNSSKFS 703
Query: 553 ---DGLMEGNKGLKRVSQEEQSNSMNRLRLLS---------------------------- 581
D ++ + + + ++E + +++L +
Sbjct: 704 GNPDLCIQASYSVSAIIRKEFKSCKGQVKLSTWKIALIAAGSSLSVLALLFALFLVLCRC 763
Query: 582 ---VLNFDGKIMHEE--------IIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKK 630
D I+ EE ++ ATD+ D+K+ IG+G G VY+A L SG+ AVKK
Sbjct: 764 KRGTKTEDANILAEEGLSLLLNKVLAATDNLDDKYIIGRGAHGVVYRASLGSGEEYAVKK 823
Query: 631 FNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL 690
+ + ++ + E+ + +RHRN ++ F ++ +Y+ GSL +L
Sbjct: 824 L---IFAEHIRANQNMKREIETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHDVL 880
Query: 691 --GDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748
G+ A L W+ R N+ G+++ L+YLHHDC P IIHRDI +N+L+DS+ E H+ D
Sbjct: 881 HRGNQGEAV-LDWSARFNIALGISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEPHIGD 939
Query: 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH----- 803
FG+A+ + + + GT GY APE AY +++ DVYS+GV++ E++ G
Sbjct: 940 FGLARILDDSTVSTATVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRALDRS 999
Query: 804 -PRDFFSINF-----SSFSNMIIDVNKILDPRL 830
P D +++ SS+ + I+DP+L
Sbjct: 1000 FPEDINIVSWVRSVLSSYEDEDDTAGPIVDPKL 1032
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 848 | ||||||
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.970 | 0.797 | 0.496 | 0.0 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.970 | 0.797 | 0.491 | 0.0 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.972 | 0.795 | 0.486 | 0.0 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.969 | 0.762 | 0.487 | 0.0 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.968 | 0.824 | 0.489 | 0.0 | |
| 255545702 | 1008 | receptor protein kinase, putative [Ricin | 0.978 | 0.823 | 0.481 | 0.0 | |
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.974 | 0.795 | 0.471 | 0.0 | |
| 186511602 | 1045 | Leucine-rich repeat-containing protein [ | 0.976 | 0.792 | 0.436 | 0.0 | |
| 7267528 | 1027 | receptor protein kinase-like protein [Ar | 0.976 | 0.806 | 0.435 | 0.0 | |
| 297813345 | 1019 | hypothetical protein ARALYDRAFT_489780 [ | 0.976 | 0.812 | 0.431 | 0.0 |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2079), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/971 (49%), Positives = 593/971 (61%), Gaps = 148/971 (15%)
Query: 3 NEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKIS---------PCSWFGISCNHAG 53
NEE ALLKWK +L NQNL LL W+L+P N T S PC WFGISC AG
Sbjct: 32 NEETQALLKWKATLLNQNL---LL--WSLHPNNITNSSAQPGTATRTPCKWFGISCK-AG 85
Query: 54 SRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSN 113
S VI I ++ LGL GT DFSFSSFP+LA +++ N G IP QIG LSKL+YLDL +N
Sbjct: 86 S-VIRINLTDLGLIGTLQDFSFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKYLDLSTN 144
Query: 114 QLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGN 173
Q SG IP EIG L L L+L NQL+G+IP EIGQL + L+L N L GSIP+SLGN
Sbjct: 145 QFSGRIPSEIGLLTNLEVLHLVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGSIPASLGN 204
Query: 174 LSNLAVLYL------------------------------------------------YKN 185
LSNL LYL Y N
Sbjct: 205 LSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYNN 264
Query: 186 SLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGN 245
LSG IP+ IG LK L L LS N SG IP+SLG+LS L + LF+N LSG IP +GN
Sbjct: 265 QLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGN 324
Query: 246 LKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTN 305
L+SL L + NQLNG IP S+GNL +L +LYL +N L +P EIG L L ELE+ TN
Sbjct: 325 LRSLVDLEISQNQLNGSIPTSLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTN 384
Query: 306 LLRGVIPH------------------------------SIERVLLNQNNLSGKMYEAFGD 335
L G +P S+ R L +N L+G + EAFG
Sbjct: 385 QLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISEAFGV 444
Query: 336 HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSN 395
PNL ++LSNN F GE+S NWG KL ++ NNI+GSIP D G S +L VL+LSSN
Sbjct: 445 CPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSN 504
Query: 396 HIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGN 455
H+VG+IP +L +SSL KLILN N+LSG +P E GSL L YLDLS N+L+ SIP+ +GN
Sbjct: 505 HLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGN 564
Query: 456 LLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHN 515
L L+YLNLSNN+LSH IP + KL HLS LDLSHN+L EIP Q+ + SLEKLNLSHN
Sbjct: 565 CLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHN 624
Query: 516 NLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKD---GLMEGNKGL---------- 562
NLS IP+ FE+M L +DISYN+L G IPNS AF++ +++GNKGL
Sbjct: 625 NLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPC 684
Query: 563 ---------------------------------------KRVSQEEQSNSMNRLRLLSVL 583
+R ++ E++ + L S+
Sbjct: 685 ENRSATKGTHKAVFIIIFSLLGALLILSAFIGISLISQGRRNAKMEKAGDVQTENLFSIS 744
Query: 584 NFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADH 643
FDG+ +E II+AT DFD +CIG+GG GSVYKAELPSG+IVAVKK + +MA
Sbjct: 745 TFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR--FDIDMAHQ 802
Query: 644 DEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNR 703
+F+NE+ AL EI+HRN VK GFC + HSFLV EYL+RGSL IL ++ AKE+GW
Sbjct: 803 KDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGT 862
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT 763
R+N+IKGVA+ALSYLHHDC+P I+HRDISS NVLLDS +EAHVSDFG AKF+ SSNW+
Sbjct: 863 RVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWS 922
Query: 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVN 823
AGT+GY APE+AYTM+ TEK DVYSFGVL EV++G HP D S +S + +
Sbjct: 923 TLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSASPGKDNVVLK 982
Query: 824 KILDPRLPTPS 834
+LDPRLP P+
Sbjct: 983 DVLDPRLPPPT 993
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 477/971 (49%), Positives = 590/971 (60%), Gaps = 148/971 (15%)
Query: 3 NEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKIS---------PCSWFGISCNHAG 53
NEE ALLKWK +L NQNL LL W+L+P N T S PC WFGISC AG
Sbjct: 32 NEETQALLKWKATLLNQNL---LL--WSLHPNNITNSSAQPGTATRTPCKWFGISCK-AG 85
Query: 54 SRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSN 113
S VI I ++ LGL GT DFSFSSFP+LA +++ N G IP QIG LSKL+YLDL +N
Sbjct: 86 S-VIRINLTDLGLIGTLQDFSFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKYLDLSTN 144
Query: 114 QLSGLIPPEIG------------------------------------------------K 125
Q SG IP EIG
Sbjct: 145 QFSGRIPSEIGLLTNLEVLHLVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGTIPASLGN 204
Query: 126 LNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKN 185
L+ L LYLD N+L G IPPE+G L+ + +L L NNL G IPS+LGNL +L +L LY N
Sbjct: 205 LSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYNN 264
Query: 186 SLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGN 245
LSG IP+ IG LK L L LS N SG IP+SLG+LS L + LF+N LSG IP +GN
Sbjct: 265 QLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGN 324
Query: 246 LKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTN 305
L+SL L + NQLNG IP +GNL +L +LYL +N L +P EIG L L ELE+ TN
Sbjct: 325 LRSLVDLEISQNQLNGSIPTLLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTN 384
Query: 306 LLRGVIPH------------------------------SIERVLLNQNNLSGKMYEAFGD 335
L G +P S+ R L N L+G + EAFG
Sbjct: 385 QLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQGNQLTGNISEAFGV 444
Query: 336 HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSN 395
PNL ++LSNN F GE+S NWG KL ++ NNI+GSIP D G S +L VL+LSSN
Sbjct: 445 CPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSN 504
Query: 396 HIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGN 455
H+VG+IP +L +SSL KLILN N+LSG +P E GSL L YLDLS N+L+ SIP+ +GN
Sbjct: 505 HLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGN 564
Query: 456 LLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHN 515
L L+YLNLSNN+LSH IP + KL HLS LDLSHN+L EIP Q+ + SLEKLNLSHN
Sbjct: 565 CLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHN 624
Query: 516 NLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKD---GLMEGNKGL---------- 562
NLS IP+ FE+M L +DISYN+L G IPNS AF++ +++GNKGL
Sbjct: 625 NLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPC 684
Query: 563 ---------------------------------------KRVSQEEQSNSMNRLRLLSVL 583
+R ++ E++ + L S+
Sbjct: 685 ENRSATKGTHKAVFIIIFSLLGALLILSAFIGISLISQGRRNAKMEKAGDVQTENLFSIS 744
Query: 584 NFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADH 643
FDG+ +E II+AT DFD +CIG+GG GSVYKAELPSG+IVAVKK + +MA
Sbjct: 745 TFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR--FDIDMAHQ 802
Query: 644 DEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNR 703
+F+NE+ AL EI+HRN VK GFC + HSFLV EYL+RGSL IL ++ AKE+GW
Sbjct: 803 KDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGT 862
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT 763
R+N+IKGV++ALSYLHHDC+P I+HRDISS NVLLDS +EAHVSDFG AKF+ SSNW+
Sbjct: 863 RVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWS 922
Query: 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVN 823
AGT+GY APE+AYTM+ TEK DVYSFGVL EV++G HP D S S + +
Sbjct: 923 TLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSDSPGKDNVVLK 982
Query: 824 KILDPRLPTPS 834
+LDPRLP P+
Sbjct: 983 DVLDPRLPPPT 993
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2032), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/976 (48%), Positives = 592/976 (60%), Gaps = 151/976 (15%)
Query: 3 NEEAYALLKWKTSLQNQNLNSSLLSSWTLYPAN--------ATKISPCSWFGISCNHAGS 54
NEE ALLKWK +L N N +SSLLS WTLYP N T++SPC W+GISCNHAGS
Sbjct: 32 NEETQALLKWKATLHNHN-HSSLLS-WTLYPNNFTNSSTHLGTEVSPCKWYGISCNHAGS 89
Query: 55 RVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQ 114
VI I ++ GL GT FSFSSFP+LA +++S N G IP QIG LSKL+YLDL NQ
Sbjct: 90 -VIRINLTESGLGGTLQAFSFSSFPNLAYVDISMNNLSGPIPPQIGLLSKLKYLDLSINQ 148
Query: 115 LSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNL 174
SG IPPEIG L L L+L NQL+G+IP EIGQL+ + +LAL N L GSIP+SLGNL
Sbjct: 149 FSGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEIGQLTSLYELALYTNQLEGSIPASLGNL 208
Query: 175 SNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234
SNLA LYLY+N LSGSIP +G L +L+QL N +G IP + GNL LT++ LFNNS
Sbjct: 209 SNLASLYLYENQLSGSIPPEMGNLTNLVQLYSDTNNLTGPIPSTFGNLKHLTVLYLFNNS 268
Query: 235 LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYL 294
LSG IPP +GNLKSL L L+ N L+G IP S+ +LS L +L+LY N L G +P+EIG L
Sbjct: 269 LSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNL 328
Query: 295 KSLSELELCTNLLRGVIPHS------IERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNN 348
KSL +LEL N L G IP S +E + L N LSG + G L L++ N
Sbjct: 329 KSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQEIGKLHKLVVLEIDTNQ 388
Query: 349 FCGEISFNWGNFSKLSTFIVSMNNISGSIPPD------------------------IGNS 384
G + L F VS N++SG IP +G+
Sbjct: 389 LFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNVSEVVGDC 448
Query: 385 PKLQVLDLS------------------------------------------------SNH 396
P L+ +DLS SNH
Sbjct: 449 PNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSSNH 508
Query: 397 IVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNL 456
+VG+IP ++ L+SL LILN NQLSG +P E GSL+ L+YLDLS N+L+ SIP+ +G+
Sbjct: 509 LVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDC 568
Query: 457 LKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNN 516
L LHYLNLSNN+LSH IP + KL HLS+LDLSHN+L IP Q+ + SLE L+LSHNN
Sbjct: 569 LDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLTGGIPAQIQGLESLEMLDLSHNN 628
Query: 517 LSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGLME---GN-------KGLKR-- 564
L FIP+ FE+M +LS +DISYN+L GPIP+S AF++ +E GN KGL+
Sbjct: 629 LCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCK 688
Query: 565 ----VSQEEQSNS-----------MNRLRLLSVL-------------------------- 583
V Q+ S + L LLS
Sbjct: 689 YGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAFIGIFLIAERRERTPEIEEGDVQNNLL 748
Query: 584 ---NFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNM 640
FDG+ M+EEIIKAT DFD +CIGKGG GSVYKAELPSG+IVAVKK + + +M
Sbjct: 749 SISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKKLHPSDM--DM 806
Query: 641 ADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELG 700
A+ +FLN+V A+ EI+HRN V+ GFC HSFLV EYL+RGSLA IL + AK+LG
Sbjct: 807 ANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSRE-EAKKLG 865
Query: 701 WNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760
W R+ +IKGVA+ALSY+HHDC P I+HRDISS N+LLDS +EAH+S+ G AK + SS
Sbjct: 866 WATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLLKVDSS 925
Query: 761 NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD-FFSINFSSFSNMI 819
N ++ AGT GY APE AYTM+ TEK DVYSFGV+ EVIKG HP D SI+ S N++
Sbjct: 926 NQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQILSISVSPEKNIV 985
Query: 820 IDVNKILDPRLPTPSP 835
+ +LDPRLP +P
Sbjct: 986 L--KDMLDPRLPPLTP 999
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2023), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/953 (48%), Positives = 577/953 (60%), Gaps = 131/953 (13%)
Query: 3 NEEAYALLKWKTSLQNQNLNSSLLSSWTLYPA----------NATKISPCSWFGISCNHA 52
NEE ALLKWK++L N N S L SWTLYP + T PC W+GISCNHA
Sbjct: 58 NEETQALLKWKSTLHNHN--HSFLLSWTLYPDPNNSTNSSTHHGTATGPCKWYGISCNHA 115
Query: 53 GSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGS 112
GS VI I ++ GL GT FSFSSFP+LA +++ N G IP QIG LSKL+YLDL +
Sbjct: 116 GS-VIRINLTESGLRGTLQAFSFSSFPNLAYVDVCINNLSGPIPPQIGLLSKLKYLDLST 174
Query: 113 NQLSGLIPPEIG---------------------------KLNQLRRLYLDMNQLHGTIPP 145
NQ SG IPPEIG L+ L LYL NQL G+IPP
Sbjct: 175 NQFSGGIPPEIGLLTNLEVLHLLALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPP 234
Query: 146 EIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLD 205
E+G L+ + ++ NNL G IPS+ GNL L LYL+ N LSG IP IG L SL +
Sbjct: 235 EMGNLANLVEIYSDTNNLTGLIPSTFGNLKRLTTLYLFNNQLSGHIPPEIGNLTSLQGIS 294
Query: 206 LSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPP 265
L N SG IP SLG+LS LT++ L+ N LSG IPP +GNLKSL L L NQLNG IP
Sbjct: 295 LYANNLSGPIPASLGDLSGLTLLHLYANQLSGPIPPEIGNLKSLVDLELSENQLNGSIPT 354
Query: 266 SIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI---------- 315
S+GNL++L +L+L +N L G+ P+EIG L L LE+ TN L G +P I
Sbjct: 355 SLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGICQGGSLVRFT 414
Query: 316 --------------------ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISF 355
R L N L+G + E GD PNL ++DLS N F GE+S
Sbjct: 415 VSDNLLSGPIPKSMKNCRNLTRALFGGNQLTGNISEVVGDCPNLEYIDLSYNRFHGELSH 474
Query: 356 NWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLI 415
NWG +L ++ N+I+GSIP D G S L +LDLSSNH+VG+IP ++ L+SL +L
Sbjct: 475 NWGRCPQLQRLEMAGNDITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLELK 534
Query: 416 LNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPT 475
LN NQLSG +P E GSL L +LDLS N+L+ SI +++G L LHYLNLSNN+LS++IP
Sbjct: 535 LNDNQLSGSIPPELGSLFSLAHLDLSANRLNGSITENLGACLNLHYLNLSNNKLSNRIPA 594
Query: 476 EFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCID 535
+ KL HLS+LDLSHN+L EIPPQ+ + SLE LNLSHNNLS FIP+ FEEMR LS ID
Sbjct: 595 QMGKLSHLSQLDLSHNLLSGEIPPQIEGLESLENLNLSHNNLSGFIPKAFEEMRGLSDID 654
Query: 536 ISYNELHGPIPNSTAFKDG---LMEGN-------KGLKRVSQEEQSNSMNRLR------- 578
ISYN+L GPIPNS AF+D L++GN KGL+ + + +
Sbjct: 655 ISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQPVKKGHKIVFI 714
Query: 579 --------LLSVLNFDGKIMHEEIIKATDDFDEK-------------------------- 604
L+ + F G + E K T + +E
Sbjct: 715 IVFPLLGALVLLFAFIGIFLIAERTKRTPEIEEGDVQNDLFSISTFDGRAMYEEIIKATK 774
Query: 605 -----FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR 659
+CIGKGG GSVYKAEL SG+IVAVKK + + +MA+ +F NEV AL EI+HR
Sbjct: 775 DFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYASDI--DMANQRDFFNEVRALTEIKHR 832
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
N VK GFC + HSFLV EYL+RGSLA +L + AK+LGW RIN+IKGVA+ALSY+H
Sbjct: 833 NIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSRE-EAKKLGWATRINIIKGVAHALSYMH 891
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT 779
HDC P I+HRDISS N+LLDS +E H+SDFG AK + SSN + AGTFGY APE AYT
Sbjct: 892 HDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSNQSALAGTFGYVAPEHAYT 951
Query: 780 MRATEKYDVYSFGVLVFEVIKGNHPRD-FFSINFSSFSNMIIDVNKILDPRLP 831
M+ TEK DVYSFGV+ EVIKG HP D S++ S I+ + +LDPRLP
Sbjct: 952 MKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSPEKENIV-LEDMLDPRLP 1003
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1962), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/939 (48%), Positives = 573/939 (61%), Gaps = 118/939 (12%)
Query: 3 NEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANAT--------KISPCSWFGISCNHAGS 54
NEE ALLKWK SLQN + +SSLLS W LYP N+T SPC C + S
Sbjct: 32 NEETQALLKWKASLQNHD-HSSLLS-WDLYPNNSTNSSTHLGTATSPCK-----CMNNLS 84
Query: 55 RVISITMSTLGLNGTFHDFSFSSF-----------PHLANLNLSFNLFFGNIPLQIGNLS 103
I + L + D S + F +L L+L N G+IP +IG L+
Sbjct: 85 GPIPPQIGLLS-ELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIGQLA 143
Query: 104 KLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNL 163
L L L +NQL G IP +G L+ L LYL NQL +IPPE+G L+ + ++ NNL
Sbjct: 144 SLYELALYTNQLEGSIPASLGNLSNLAYLYLYENQLSDSIPPEMGNLTNLVEIYSDTNNL 203
Query: 164 HGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLS 223
G IPS+ GNL L VLYL+ N LSG IP IG LKSL L L EN SG IP SLG+LS
Sbjct: 204 IGPIPSTFGNLKRLTVLYLFNNRLSGHIPPEIGNLKSLQGLSLYENNLSGPIPASLGDLS 263
Query: 224 SLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGL 283
LT++ L+ N LSG IP +GNLKSL L L NQLNG IP S+GNL++L L+L +N L
Sbjct: 264 GLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLETLFLRDNQL 323
Query: 284 YGFVPEEIGYLKSLSELELCTNLLRGVIPHSI---------------------------- 315
G++P+EIG L L LE+ TN L G +P I
Sbjct: 324 SGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCK 383
Query: 316 --ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNI 373
R L N L+G + E GD PNL ++++S N+F GE+S NWG + +L ++ NNI
Sbjct: 384 NLTRALFGGNQLTGNISEVVGDCPNLEYINVSYNSFHGELSHNWGRYPRLQRLEMAWNNI 443
Query: 374 SGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLT 433
+GSIP D G S L +LDLSSNH+ G+IP ++ ++SL KLILN NQLSG +P E GSL
Sbjct: 444 TGSIPEDFGISTDLTLLDLSSNHLFGEIPKKMGSVTSLWKLILNDNQLSGNIPPELGSLA 503
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNIL 493
L YLDLS N+L+ SIP+ +G+ L L+YLNLSNN+LSH IP + KL HLS+LDLSHN+L
Sbjct: 504 DLGYLDLSANRLNGSIPEHLGDCLGLNYLNLSNNKLSHGIPVQMGKLGHLSQLDLSHNLL 563
Query: 494 QEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKD 553
+IPPQ+ + SLE LNLSHNNLS FIP+ FEEM LS +DISYN+L GPIPNS AF+D
Sbjct: 564 TGDIPPQIEGLQSLENLNLSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSKAFRD 623
Query: 554 GLME---GNKGL----KR---------VSQEEQSNS------------------------ 573
+E GNKGL KR V Q+ S
Sbjct: 624 ATIEALKGNKGLCGNVKRLRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGI 683
Query: 574 ----MNRLR------------LLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYK 617
R R L S+ FDG+ M+EEIIKAT DFD +CIGKGG GSVYK
Sbjct: 684 FLIAARRERTPEIKEGEVQNDLFSISTFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYK 743
Query: 618 AELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677
AELPS +IVAVKK + MA+ +FLNE+ AL EI+HRN VK GFC + H FLV
Sbjct: 744 AELPSSNIVAVKKLHPS--DTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLV 801
Query: 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVL 737
EYL+RGSLA IL + AK+LGW R+N+IKGVA+AL+Y+HHDC P I+HRDISS N+L
Sbjct: 802 YEYLERGSLATILSRE-EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDISSNNIL 860
Query: 738 LDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFE 797
LDS +EAH+SDFG AK + SSN + AGTFGY APE+AYTM+ TEK DV+SFGV+ E
Sbjct: 861 LDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALE 920
Query: 798 VIKGNHPRD-FFSINFSSFSNMIIDVNKILDPRLPTPSP 835
VIKG HP D S++ S + I + +LDPRLP +P
Sbjct: 921 VIKGRHPGDQILSLSVSPEKDNIA-LEDMLDPRLPPLTP 958
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/949 (48%), Positives = 574/949 (60%), Gaps = 119/949 (12%)
Query: 4 EEAYALLKWKTSLQNQNLNSSLLSSWTLYPANAT----KISPCSWFGISCNHAGSRVISI 59
E+A +LLKW +L NQ ++ S W L P N+T K SPC+W G+SCN GS V+ I
Sbjct: 32 EQANSLLKWAATLHNQKYSNR--SPWPLLPENSTNPNAKTSPCTWLGLSCNRGGS-VVRI 88
Query: 60 TMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLI 119
++T GLNGT H+ SFS+FP L L+LS N IPL+I L KL +LDL SNQLSG+I
Sbjct: 89 NLTTSGLNGTLHELSFSAFPDLEFLDLSCNSLSSTIPLEITQLPKLIFLDLSSNQLSGVI 148
Query: 120 PPEIG------------------------KLNQLRRLYLDMNQLHGTIPPEIGQLSLIDK 155
PP+IG L +L L+L N+ G+IP E+G L + +
Sbjct: 149 PPDIGLLTNLNTLRLSANRLDGSIPSSVGNLTELAWLHLYDNRFSGSIPSEMGNLKNLVE 208
Query: 156 LALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSI 215
L + N L GSIPS+ G+L+ L L+LY N LSG IP +G LKSL L L N SG I
Sbjct: 209 LFMDTNLLTGSIPSTFGSLTKLVQLFLYNNQLSGHIPQELGDLKSLTSLSLFGNNLSGPI 268
Query: 216 PLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRV 275
P SLG L+SLT++ L+ N LSG+IP LGNL SLS L L N+L G IP S+GNLS L +
Sbjct: 269 PASLGGLTSLTILHLYQNQLSGTIPKELGNLNSLSNLELSENKLTGSIPASLGNLSRLEL 328
Query: 276 LYLYNNGLYGFVPEEI-----------------GYL-------KSLSELELCTNLLRGVI 311
L+L NN L G +PE+I GYL K L + N L G I
Sbjct: 329 LFLKNNQLSGPIPEQIANLSKLSLLQLQSNQLTGYLPQNICQSKVLQNFSVNDNRLEGPI 388
Query: 312 PHSIE------RVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLST 365
P S+ R+ L N G + E FG +P L F+D+ N F GEIS WG L T
Sbjct: 389 PKSMRDCKSLVRLHLEGNQFIGNISEDFGVYPYLQFVDIRYNKFHGEISSKWGMCPHLGT 448
Query: 366 FIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGV 425
++S NNISG IPP+IGN+ +LQ LD SSN +VG+IP +L L+SL ++ L NQLS GV
Sbjct: 449 LLISGNNISGIIPPEIGNAARLQGLDFSSNQLVGRIPKELGKLTSLVRVNLEDNQLSDGV 508
Query: 426 PLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSE 485
P EFGSLT L+ LDLS N+ + SIP +IGNL+KL+YLNLSNNQ S +IP + KL+HLS+
Sbjct: 509 PSEFGSLTDLESLDLSANRFNQSIPGNIGNLVKLNYLNLSNNQFSQEIPIQLGKLVHLSK 568
Query: 486 LDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPI 545
LDLS N L EIP ++ M SLE LNLS NNLS FIP +EM LS IDISYN+L GP+
Sbjct: 569 LDLSQNFLIGEIPSELSGMQSLEVLNLSRNNLSGFIPGDLKEMHGLSSIDISYNKLEGPV 628
Query: 546 PNSTAFKDGLME---GNKGL---------------------------------------- 562
P++ AF++ +E GNKGL
Sbjct: 629 PDNKAFQNSSIEAFQGNKGLCGHVQGLQPCKPSSTEQGSSIKFHKRLFLVISLPLFGAFL 688
Query: 563 ------------KRVSQ--EEQSNSMNRLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIG 608
KR + E + +S +L + +FDGK MH+EII+ATD F++ +CIG
Sbjct: 689 ILSFLGVLFFQSKRSKEALEAEKSSQESEEILLITSFDGKSMHDEIIEATDSFNDIYCIG 748
Query: 609 KGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFC 668
KGG GSVYKA+L SG VAVKK + Q EF +E+ AL EI+HRN VKF+GFC
Sbjct: 749 KGGCGSVYKAKLSSGSTVAVKKLH-QSHDAWKPYQKEFWSEIRALTEIKHRNIVKFYGFC 807
Query: 669 YNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIH 728
+SFLV E +++GSLA IL D+ AKEL W +R N+IKGVANALSY+HHDC P I+H
Sbjct: 808 SYSAYSFLVYECIEKGSLATILRDNEAAKELEWFKRANIIKGVANALSYMHHDCSPPIVH 867
Query: 729 RDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDV 788
RDISSKN+LLDS EA VSDFGIA+ + SS+ T AGTFGY APE+AY++ TEK DV
Sbjct: 868 RDISSKNILLDSENEARVSDFGIARILNLDSSHRTALAGTFGYMAPELAYSIVVTEKCDV 927
Query: 789 YSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSV 837
YSFGVL EVI G HP + S SS S + + I+D RLP PSP V
Sbjct: 928 YSFGVLALEVINGKHPGEIISSISSSSSTRKMLLENIVDLRLPFPSPEV 976
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/976 (47%), Positives = 582/976 (59%), Gaps = 150/976 (15%)
Query: 3 NEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANAT--------KISPCSWFGISCNHAGS 54
NEE ALLKWK SLQN N +SSLLS W LYP N+T SPC W+GISCNHAGS
Sbjct: 32 NEETQALLKWKASLQNHN-HSSLLS-WDLYPNNSTNSSTHLGTATSPCKWYGISCNHAGS 89
Query: 55 RVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQ 114
VI I ++ GLNGT DFSFSSFP+LA +++S N G IP QIG L +L+YLDL NQ
Sbjct: 90 -VIKINLTESGLNGTLMDFSFSSFPNLAYVDISMNNLSGPIPPQIGLLFELKYLDLSINQ 148
Query: 115 LSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNL 174
SG IP EIG L L L+L NQL+G+IP EIGQL+ + +LAL N L GSIP+SLGNL
Sbjct: 149 FSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIGQLASLYELALYTNQLEGSIPASLGNL 208
Query: 175 SNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234
SNLA LYLY+N LSGSIP +G L +L+++ + N +G IP + GNL LT++ LFNNS
Sbjct: 209 SNLASLYLYENQLSGSIPPEMGNLTNLVEIYSNNNNLTGPIPSTFGNLKRLTVLYLFNNS 268
Query: 235 LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYL 294
LSG IPP +GNLKSL L L+ N L+G IP S+ +LS L +L+LY N L G +P+EIG L
Sbjct: 269 LSGPIPPEIGNLKSLQELSLYENNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNL 328
Query: 295 KSLSELELCTNLLRGVIPHS------IERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNN 348
KSL +LEL N L G IP S +E + L N LSG + + G L L++ N
Sbjct: 329 KSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQ 388
Query: 349 FCGEISFNWGNFSKLSTFIVSMNNISGSIPPD------------------------IGNS 384
G + L F VS N++SG IP +G+
Sbjct: 389 LFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISEVVGDC 448
Query: 385 PKLQVLDLS------------------------------------------------SNH 396
P L+ +DLS SNH
Sbjct: 449 PNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLTLLDLSSNH 508
Query: 397 IVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNL 456
+VG+IP ++ L+SL LILN NQLSG +P E GSL+ L+YLDLS N+L+ SIP+ +G+
Sbjct: 509 LVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDC 568
Query: 457 LKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNN 516
L LHYLNLSNN+LSH IP + KL HLS+LDLSHN+L IPPQ+ + SLE L+LSHNN
Sbjct: 569 LDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLEMLDLSHNN 628
Query: 517 LSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGLMEGNKGLKR------------ 564
L FIP+ FE+M +LS +DISYN+L GPIP+S AF++ +E KG K
Sbjct: 629 LCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCK 688
Query: 565 ----VSQEEQSNSMNRL---------RLLSVLNFDGKIMHEEIIKATDDFDE-------- 603
V Q+ S + L+ + F G + E + T + +E
Sbjct: 689 YGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAERRERTPEIEEGDVQNDLF 748
Query: 604 -----------------------KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNM 640
+CIGKGG GSVYKAELPS +IVAVKK + M
Sbjct: 749 SISNFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLHPS--DTEM 806
Query: 641 ADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELG 700
A+ +FLNE+ AL EI+HRN VK GFC + H FLV EYL+RGSLA IL + AK+LG
Sbjct: 807 ANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSRE-EAKKLG 865
Query: 701 WNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760
W R+N+IKGVA+AL+Y+HHDC P I+HRD+SS N+LLDS +EAH+SDFG AK + SS
Sbjct: 866 WATRVNIIKGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSS 925
Query: 761 NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD-FFSINFSSFSNMI 819
N + AGTFGY APE+AYTM+ TEK DV+SFGV+ EVIKG HP D S++ S + I
Sbjct: 926 NQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNI 985
Query: 820 IDVNKILDPRLPTPSP 835
+ +LDPRLP +P
Sbjct: 986 A-LEDMLDPRLPPLTP 1000
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186511602|ref|NP_849538.2| Leucine-rich repeat-containing protein [Arabidopsis thaliana] gi|281185491|sp|Q8VZG8.3|Y4885_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At4g08850; Flags: Precursor gi|18086327|gb|AAL57627.1| AT4g08850/T32A17_160 [Arabidopsis thaliana] gi|224589610|gb|ACN59338.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332657282|gb|AEE82682.1| Leucine-rich repeat-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1856), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/974 (43%), Positives = 569/974 (58%), Gaps = 146/974 (14%)
Query: 4 EEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPC-SWFGISCNHAGSRVISITMS 62
EEA ALLKWK++ NQ +SS LSSW N S C SW+G++C+ +I + ++
Sbjct: 49 EEANALLKWKSTFTNQT-SSSKLSSW----VNPNTSSFCTSWYGVACSLGS--IIRLNLT 101
Query: 63 TLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPE 122
G+ GTF DF FSS P+L ++LS N F G I G SKL+Y DL NQL G IPPE
Sbjct: 102 NTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPE 161
Query: 123 IGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182
+G L+ L L+L N+L+G+IP EIG+L+ + ++A+ N L G IPSS GNL+ L LYL
Sbjct: 162 LGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYL 221
Query: 183 YKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP- 241
+ NSLSGSIPS IG L +L +L L N +G IP S GNL ++T++++F N LSG IPP
Sbjct: 222 FINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPE 281
Query: 242 -----------------------ILGNLKSLSALGLHINQLNGFIPP------------- 265
LGN+K+L+ L L++NQLNG IPP
Sbjct: 282 IGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEI 341
Query: 266 -----------SIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHS 314
S G L++L L+L +N L G +P I L+ L+L TN G +P +
Sbjct: 342 SENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDT 401
Query: 315 IER------------------------------VLLNQNNLSGKMYEAFGDHPNLTFLDL 344
I R V N+ SG + EAFG +P L F+DL
Sbjct: 402 ICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDL 461
Query: 345 SNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQ 404
SNNNF G++S NW KL FI+S N+I+G+IPP+I N +L LDLSSN I G++P
Sbjct: 462 SNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPES 521
Query: 405 LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNL 464
+ ++ ++KL LN N+LSG +P LT L+YLDLS+N+ SS IP ++ NL +L+Y+NL
Sbjct: 522 ISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNL 581
Query: 465 SNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRC 524
S N L IP KL L LDLS+N L EI Q ++ +LE+L+LSHNNLS IP
Sbjct: 582 SRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPS 641
Query: 525 FEEMRSLSCIDISYNELHGPIPNSTAFKDG---LMEGNKGL------------------- 562
F++M +L+ +D+S+N L GPIP++ AF++ EGNK L
Sbjct: 642 FKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSK 701
Query: 563 ----------------------------------KRVSQ-EEQSNSMNRLRLLSVLNFDG 587
KR Q EE ++S + LS+ +FDG
Sbjct: 702 KSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDG 761
Query: 588 KIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLS--GNMADHDE 645
K+ ++EIIKAT +FD K+ IG GG G VYKA+LP+ I+AVKK N S N + E
Sbjct: 762 KVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQE 820
Query: 646 FLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
FLNE+ AL EIRHRN VK GFC + ++FLV EY++RGSL ++L +D AK+L W +RI
Sbjct: 821 FLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRI 880
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765
NV+KGVA+ALSY+HHD P+I+HRDISS N+LL ++EA +SDFG AK + P SSNW+
Sbjct: 881 NVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAV 940
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKI 825
AGT+GY APE+AY M+ TEK DVYSFGVL EVIKG HP D S SS + + + I
Sbjct: 941 AGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSI 1000
Query: 826 LDPRLPTPSPSVMD 839
D RLP P+P + +
Sbjct: 1001 SDHRLPEPTPEIKE 1014
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7267528|emb|CAB78010.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|7321074|emb|CAB82121.1| receptor protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1856), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/974 (43%), Positives = 569/974 (58%), Gaps = 146/974 (14%)
Query: 4 EEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPC-SWFGISCNHAGSRVISITMS 62
EEA ALLKWK++ NQ +SS LSSW N S C SW+G++C+ +I + ++
Sbjct: 31 EEANALLKWKSTFTNQT-SSSKLSSW----VNPNTSSFCTSWYGVACSLGS--IIRLNLT 83
Query: 63 TLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPE 122
G+ GTF DF FSS P+L ++LS N F G I G SKL+Y DL NQL G IPPE
Sbjct: 84 NTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPE 143
Query: 123 IGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182
+G L+ L L+L N+L+G+IP EIG+L+ + ++A+ N L G IPSS GNL+ L LYL
Sbjct: 144 LGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYL 203
Query: 183 YKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP- 241
+ NSLSGSIPS IG L +L +L L N +G IP S GNL ++T++++F N LSG IPP
Sbjct: 204 FINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPE 263
Query: 242 -----------------------ILGNLKSLSALGLHINQLNGFIPP------------- 265
LGN+K+L+ L L++NQLNG IPP
Sbjct: 264 IGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEI 323
Query: 266 -----------SIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHS 314
S G L++L L+L +N L G +P I L+ L++ TN G +P +
Sbjct: 324 SENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQVDTNNFTGFLPDT 383
Query: 315 IER------------------------------VLLNQNNLSGKMYEAFGDHPNLTFLDL 344
I R V N+ SG + EAFG +P L F+DL
Sbjct: 384 ICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDL 443
Query: 345 SNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQ 404
SNNNF G++S NW KL FI+S N+I+G+IPP+I N +L LDLSSN I G++P
Sbjct: 444 SNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPES 503
Query: 405 LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNL 464
+ ++ ++KL LN N+LSG +P LT L+YLDLS+N+ SS IP ++ NL +L+Y+NL
Sbjct: 504 ISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNL 563
Query: 465 SNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRC 524
S N L IP KL L LDLS+N L EI Q ++ +LE+L+LSHNNLS IP
Sbjct: 564 SRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPS 623
Query: 525 FEEMRSLSCIDISYNELHGPIPNSTAFKDG---LMEGNKGL------------------- 562
F++M +L+ +D+S+N L GPIP++ AF++ EGNK L
Sbjct: 624 FKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSK 683
Query: 563 ----------------------------------KRVSQ-EEQSNSMNRLRLLSVLNFDG 587
KR Q EE ++S + LS+ +FDG
Sbjct: 684 KSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDG 743
Query: 588 KIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLS--GNMADHDE 645
K+ ++EIIKAT +FD K+ IG GG G VYKA+LP+ I+AVKK N S N + E
Sbjct: 744 KVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQE 802
Query: 646 FLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
FLNE+ AL EIRHRN VK GFC + ++FLV EY++RGSL ++L +D AK+L W +RI
Sbjct: 803 FLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRI 862
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765
NV+KGVA+ALSY+HHD P+I+HRDISS N+LL ++EA +SDFG AK + P SSNW+
Sbjct: 863 NVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAV 922
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKI 825
AGT+GY APE+AY M+ TEK DVYSFGVL EVIKG HP D S SS + + + I
Sbjct: 923 AGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSI 982
Query: 826 LDPRLPTPSPSVMD 839
D RLP P+P + +
Sbjct: 983 SDHRLPEPTPEIKE 996
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297813345|ref|XP_002874556.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] gi|297320393|gb|EFH50815.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1821), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/971 (43%), Positives = 560/971 (57%), Gaps = 143/971 (14%)
Query: 4 EEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPC-SWFGISCNHAGSRVISITMS 62
EEA ALLKWK++ NQ +SS LSSW N S C SW+G+SC ++ + ++
Sbjct: 26 EEANALLKWKSTFTNQT-SSSKLSSW----VNPNTSSFCTSWYGVSCLRGS--IVRLNLT 78
Query: 63 TLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPE 122
G+ GTF +F FSS P+L ++LS N F G I G SKL Y DL NQL G IPPE
Sbjct: 79 NTGIEGTFEEFPFSSLPNLTYVDLSMNRFSGTISPLWGRFSKLVYFDLSINQLVGEIPPE 138
Query: 123 IGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182
+G L+ L L+L N+L+G+IP EIG+L+ + ++A+ N L G IPSS GNL+ L LYL
Sbjct: 139 LGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTRLVNLYL 198
Query: 183 YKNSLSGSIPSIIGKLKSLLQLDLS------------------------ENQFSGSIPLS 218
+ NSLSG IPS IG L +L +L L ENQ SG IP
Sbjct: 199 FINSLSGPIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVSLLNMFENQLSGEIPPE 258
Query: 219 LGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNL-------- 270
+GN+++L +SL N L+G IP LGN+K+L+ L L++NQL+G IPP +G++
Sbjct: 259 IGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAILHLYLNQLSGSIPPELGDMEAMIDLEI 318
Query: 271 ----------------------------------------SSLRVLYLYNNGLYGFVPEE 290
+ L VL L N GF+P+
Sbjct: 319 SENKLTGPVPDSFGKLTVLEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDT 378
Query: 291 IGYLKSLSELELCTNLLRGVIPHSIE------RVLLNQNNLSGKMYEAFGDHPNLTFLDL 344
I L L L N G +P S+ RV N+ SG + +AFG +P L F+DL
Sbjct: 379 ICRSGKLENLTLDDNHFEGPVPKSLRNCKSLVRVRFKGNHFSGDISDAFGVYPTLNFIDL 438
Query: 345 SNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQ 404
SNNNF G++S NW +KL FI+S N+ISG+IPP+I N +L LDLS N I G++P
Sbjct: 439 SNNNFHGQLSANWEQSTKLVAFILSNNSISGAIPPEIWNMTQLNQLDLSFNRITGELPES 498
Query: 405 LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNL 464
+ ++ ++KL LN NQLSG +P LT L+YLDLS+N+ IP ++ NL +L+Y+NL
Sbjct: 499 ISNINRISKLQLNGNQLSGKIPSGIRLLTNLEYLDLSSNQFGFEIPATLNNLPRLYYMNL 558
Query: 465 SNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRC 524
S N L IP KL L LDLS+N L EI Q ++ +LE+L+LSHNNLS IP
Sbjct: 559 SRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFGSLQNLERLDLSHNNLSGQIPTS 618
Query: 525 FEEMRSLSCIDISYNELHGPIPNSTAFKDG---LMEGNKGL------------------- 562
F++M +L+ ID+S+N L GPIP++ AF++ +EGN L
Sbjct: 619 FKDMLALTHIDVSHNNLQGPIPDNAAFRNASPNALEGNNDLCGDNKALKPCSITSSKKSH 678
Query: 563 -------------------------------KRVSQ-EEQSNSMNRLRLLSVLNFDGKIM 590
KR Q EE S+S + LS+ +FDGK+
Sbjct: 679 KDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEENSDSESGGETLSIFSFDGKVR 738
Query: 591 HEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG--NMADHDEFLN 648
++EIIKAT +FD K+ IG GG G VYKA+LP+ I+AVKK N S N + EFLN
Sbjct: 739 YQEIIKATGEFDSKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSITNPSTKQEFLN 797
Query: 649 EVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVI 708
E+ AL EIRHRN VK GFC + ++FLV EY++RGSL ++L +D AK+L W +RINV+
Sbjct: 798 EIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVV 857
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT 768
KGVA+ALSY+HHD P+I+HRDISS N+LL ++EA +SDFG AK + P SSNW+ AGT
Sbjct: 858 KGVADALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGT 917
Query: 769 FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDP 828
+GY APE+AY M+ TEK DVYSFGVL EVIKG HP D S SS + + + I D
Sbjct: 918 YGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDTSLSLKTISDH 977
Query: 829 RLPTPSPSVMD 839
RLP P+P + +
Sbjct: 978 RLPEPTPEIKE 988
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 848 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.554 | 0.449 | 0.440 | 7.7e-172 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.553 | 0.418 | 0.421 | 2.7e-154 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.584 | 0.450 | 0.348 | 2.8e-122 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.640 | 0.434 | 0.347 | 3.1e-122 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.607 | 0.458 | 0.338 | 9.2e-122 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.633 | 0.470 | 0.354 | 9.2e-121 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.604 | 0.451 | 0.346 | 9.6e-121 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.593 | 0.503 | 0.359 | 4.2e-116 | |
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.656 | 0.510 | 0.334 | 6.6e-115 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.604 | 0.511 | 0.340 | 1.4e-114 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 939 (335.6 bits), Expect = 7.7e-172, Sum P(2) = 7.7e-172
Identities = 211/479 (44%), Positives = 277/479 (57%)
Query: 93 GNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSL 152
G IP GNL+KL L L N LSG IP EIG L LR L LD N L G IP G L
Sbjct: 204 GPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKN 263
Query: 153 IDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFS 212
+ L + N L G IP +GN++ L L L+ N L+G IPS +G +K+L L L NQ +
Sbjct: 264 VTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLN 323
Query: 213 GSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSS 272
GSIP LG + S+ + + N L+G +P G L +L L L NQL+G IPP I N +
Sbjct: 324 GSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTE 383
Query: 273 LRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIE------RVLLNQNNLS 326
L VL L N GF+P+ I L L L N G +P S+ RV N+ S
Sbjct: 384 LTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFS 443
Query: 327 GKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPK 386
G + EAFG +P L F+DLSNNNF G++S NW KL FI+S N+I+G+IPP+I N +
Sbjct: 444 GDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQ 503
Query: 387 LQVLDLSSNHIVGKIPVQLEMXXXXXXXXXXXXXXXGGVPLEFGSLTKLQYLDLSTNKLS 446
L LDLSSN I G++P + G +P LT L+YLDLS+N+ S
Sbjct: 504 LSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFS 563
Query: 447 SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGS 506
S IP ++ NL +L+Y+NLS N L IP KL L LDLS+N L EI Q ++ +
Sbjct: 564 SEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQN 623
Query: 507 LEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDG---LMEGNKGL 562
LE+L+LSHNNLS IP F++M +L+ +D+S+N L GPIP++ AF++ EGNK L
Sbjct: 624 LERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDL 682
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 898 (321.2 bits), Expect = 2.7e-154, Sum P(2) = 2.7e-154
Identities = 202/479 (42%), Positives = 275/479 (57%)
Query: 93 GNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSL 152
G+IP +GNL L L L N L+G IPP++G + + L L N+L G+IP +G L
Sbjct: 284 GSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKN 343
Query: 153 IDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFS 212
+ L L N L G IP LGN+ ++ L L N L+GSIPS G LK+L L L N +
Sbjct: 344 LTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLT 403
Query: 213 GSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSS 272
G IP LGN+ S+ + L N L+GS+P GN L +L L +N L+G IPP + N S
Sbjct: 404 GVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSH 463
Query: 273 LRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIE--RVLLNQ----NNLS 326
L L L N GF PE + + L + L N L G IP S+ + L+ N +
Sbjct: 464 LTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFT 523
Query: 327 GKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPK 386
G ++EAFG +P+L F+D S+N F GEIS NW KL I+S NNI+G+IP +I N +
Sbjct: 524 GDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQ 583
Query: 387 LQVLDLSSNHIVGKIPVQLEMXXXXXXXXXXXXXXXGGVPLEFGSLTKLQYLDLSTNKLS 446
L LDLS+N++ G++P + G VP LT L+ LDLS+N S
Sbjct: 584 LVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFS 643
Query: 447 SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGS 506
S IP++ + LKLH +NLS N+ IP KL L++LDLSHN L EIP Q+ ++ S
Sbjct: 644 SEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQS 702
Query: 507 LEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGL---MEGNKGL 562
L+KL+LSHNNLS IP FE M +L+ +DIS N+L GP+P++ F+ +E N GL
Sbjct: 703 LDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGL 761
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 718 (257.8 bits), Expect = 2.8e-122, Sum P(2) = 2.8e-122
Identities = 178/511 (34%), Positives = 257/511 (50%)
Query: 93 GNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSL 152
G+IP QIGNLS LQ L + SN L+G+IPP + KL QLR + N G IP EI
Sbjct: 153 GSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCES 212
Query: 153 IDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFS 212
+ L L N L GS+P L L NL L L++N LSG IP +G + L L L EN F+
Sbjct: 213 LKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFT 272
Query: 213 GSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSS 272
GSIP +G L+ + + L+ N L+G IP +GNL + + NQL GFIP G++ +
Sbjct: 273 GSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILN 332
Query: 273 LRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIE------RVLLNQNNLS 326
L++L+L+ N L G +P E+G L L +L+L N L G IP ++ + L N L
Sbjct: 333 LKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLE 392
Query: 327 GKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPK 386
GK+ G + N + LD+S N+ G I ++ F L + N +SG+IP D+
Sbjct: 393 GKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKS 452
Query: 387 LQVLDLSSNHIVGKIPVQLEMXXXXXXXXXXXXXXXGGVPLEFGSLTKLQYLDLSTNKLS 446
L L L N + G +P++L G + + G L L+ L L+ N +
Sbjct: 453 LTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFT 512
Query: 447 SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGS 506
IP IGNL K+ N+S+NQL+ IP E + + LDLS N I ++ +
Sbjct: 513 GEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVY 572
Query: 507 LEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIP----NSTAFKDGLMEGNKGL 562
LE L LS N L+ IP F ++ L + + N L IP T+ + L + L
Sbjct: 573 LEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNL 632
Query: 563 KRVSQEEQSNSMNRLRLLSVLNF-DGKIMHE 592
+ S+ L++L +L D K+ E
Sbjct: 633 SGTIPD----SLGNLQMLEILYLNDNKLSGE 659
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 758 (271.9 bits), Expect = 3.1e-122, Sum P(2) = 3.1e-122
Identities = 194/558 (34%), Positives = 287/558 (51%)
Query: 35 NATKISPCSWFGISCNHAGS-RVISITMSTLGLNGTFHDFSFSSFPHLAXXXXXXXXXXG 93
N+ I+ CSW G++C++ G RVI++ ++ LGL G+ + F F +L G
Sbjct: 51 NSDNINYCSWTGVTCDNTGLFRVIALNLTGLGLTGSISPW-FGRFDNLIHLDLSSNNLVG 109
Query: 94 NIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLI 153
IP + NL+ L+ L L SNQL+G IP ++G L +R L + N+L G IP +G L +
Sbjct: 110 PIPTALSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNL 169
Query: 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSG 213
LAL L G IPS LG L + L L N L G IP+ +G L +EN +G
Sbjct: 170 QMLALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNG 229
Query: 214 SIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSL 273
+IP LG L +L +++L NNSL+G IP LG + L L L NQL G IP S+ +L +L
Sbjct: 230 TIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNL 289
Query: 274 RVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI-------ERVLLNQNNLS 326
+ L L N L G +PEE + L +L L N L G +P SI E+++L+ LS
Sbjct: 290 QTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLS 349
Query: 327 GKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPK 386
G++ +L LDLSNN+ G I +L+ + N + G++ P I N
Sbjct: 350 GEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTN 409
Query: 387 LQVLDLSSNHIVGKIPVQLEMXXXXXXXXXXXXXXXGGVPLEFGSLTKLQYLDLSTNKLS 446
LQ L L N++ GK+P ++ G +P E G+ T L+ +D+ N
Sbjct: 410 LQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFE 469
Query: 447 SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGS 506
IP SIG L +L+ L+L N+L +P L+ LDL+ N L IP +
Sbjct: 470 GEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKG 529
Query: 507 LEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHG---PIPNSTAFKDGLMEGNKGLK 563
LE+L L +N+L +P +R+L+ I++S+N L+G P+ S+++ + N G +
Sbjct: 530 LEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNN-GFE 588
Query: 564 RVSQEEQSNSMN--RLRL 579
E NS N RLRL
Sbjct: 589 DEIPLELGNSQNLDRLRL 606
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 9.2e-122, Sum P(2) = 9.2e-122
Identities = 179/529 (33%), Positives = 263/529 (49%)
Query: 31 LYPANATKISPCSWFGISCNHAGSR-------VISITMSTLGLNGTFHDFSFSSFPHLAX 83
L+ N +PC+W G++C+ GS V S+ +S++ L+G S +L
Sbjct: 55 LHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSP-SIGGLVNLVY 113
Query: 84 XXXXXXXXXGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTI 143
G+IP +IGN SKL+ + L +NQ G IP EI KL+QLR + N+L G +
Sbjct: 114 LNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPL 173
Query: 144 PPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQ 203
P EIG L +++L NNL G +P SLGNL+ L +N SG+IP+ IGK +L
Sbjct: 174 PEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKL 233
Query: 204 LDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFI 263
L L++N SG +P +G L L + L+ N SG IP +GNL SL L L+ N L G I
Sbjct: 234 LGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPI 293
Query: 264 PPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERV----- 318
P IGN+ SL+ LYLY N L G +P+E+G L + E++ NLL G IP + ++
Sbjct: 294 PSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRL 353
Query: 319 -LLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSI 377
L QN L+G + NL LDLS N+ G I + N + + + N++SG I
Sbjct: 354 LYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVI 413
Query: 378 PPDIGNSPKLQVLDLSSNHIVGKIPVQLEMXXXXXXXXXXXXXXXGGVPLEFGSLTKLQY 437
P +G L V+D S N + GKIP + G +P L
Sbjct: 414 PQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQ 473
Query: 438 LDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEI 497
L + N+L+ P + L+ L + L N+ S +P E L L L+ N +
Sbjct: 474 LRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNL 533
Query: 498 PPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIP 546
P ++ + +L N+S N+L+ IP + L +D+S N G +P
Sbjct: 534 PNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLP 582
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 781 (280.0 bits), Expect = 9.2e-121, Sum P(2) = 9.2e-121
Identities = 194/547 (35%), Positives = 280/547 (51%)
Query: 30 TLYPANATKISPCS-WFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLAXXXXXX 88
+L+ N+ +PC+ W I+C+ G + I + ++ L + + +F L
Sbjct: 57 SLFNWNSIDNTPCNNWTFITCSSQGF-ITDIDIESVPLQLSLPK-NLPAFRSLQKLTISG 114
Query: 89 XXXXGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIG 148
G +P +G+ L+ LDL SN L G IP + KL L L L+ NQL G IPP+I
Sbjct: 115 ANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDIS 174
Query: 149 QLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNS-LSGSIPSIIGKLKSLLQLDLS 207
+ S + L L N L GSIP+ LG LS L V+ + N +SG IPS IG +L L L+
Sbjct: 175 KCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLA 234
Query: 208 ENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSI 267
E SG++P SLG L L +S++ +SG IP LGN L L L+ N L+G IP I
Sbjct: 235 ETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREI 294
Query: 268 GNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERV------LLN 321
G L+ L L+L+ N L G +PEEIG +L ++L NLL G IP SI R+ +++
Sbjct: 295 GQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMIS 354
Query: 322 QNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDI 381
N SG + + +L L L N G I G +KL+ F N + GSIPP +
Sbjct: 355 DNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGL 414
Query: 382 GNSPKLQVLDLSSNHIVGKIPVQLEMXXXXXXXXXXXXXXXGGVPLEFGSLTKLQYLDLS 441
+ LQ LDLS N + G IP L M G +P E G+ + L L L
Sbjct: 415 ADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLG 474
Query: 442 TNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV 501
N+++ IP IG+L K+++L+ S+N+L K+P E L +DLS+N L+ +P V
Sbjct: 475 FNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPV 534
Query: 502 CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGLMEGNKG 561
++ L+ L++S N S IP + SL+ + +S N G IP S GL + G
Sbjct: 535 SSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLG 594
Query: 562 LKRVSQE 568
+S E
Sbjct: 595 SNELSGE 601
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 9.6e-121, Sum P(2) = 9.6e-121
Identities = 181/522 (34%), Positives = 277/522 (53%)
Query: 35 NATKISPCSWFGISCNHAGSRVIS-ITMSTLGLNGTFHDFSFSSFPHLAXXXXXXXXXXG 93
N + PC W I+C+ + +++++ I + ++ L F + SSF L G
Sbjct: 62 NPSDSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPP-NISSFTSLQKLVISNTNLTG 120
Query: 94 NIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLI 153
I +IG+ S+L +DL SN L G IP +GKL L+ L L+ N L G IPPE+G +
Sbjct: 121 AISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSL 180
Query: 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNS-LSGSIPSIIGKLKSLLQLDLSENQFS 212
L + N L ++P LG +S L + NS LSG IP IG ++L L L+ + S
Sbjct: 181 KNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKIS 240
Query: 213 GSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSS 272
GS+P+SLG LS L +S+++ LSG IP LGN L L L+ N L+G +P +G L +
Sbjct: 241 GSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQN 300
Query: 273 LRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHS------IERVLLNQNNLS 326
L + L+ N L+G +PEEIG++KSL+ ++L N G IP S ++ ++L+ NN++
Sbjct: 301 LEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNIT 360
Query: 327 GKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPK 386
G + + L + N G I G +L+ F+ N + G+IP ++
Sbjct: 361 GSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQN 420
Query: 387 LQVLDLSSNHIVGKIPVQLEMXXXXXXXXXXXXXXXGGVPLEFGSLTKLQYLDLSTNKLS 446
LQ LDLS N++ G +P L G +PLE G+ T L L L N+++
Sbjct: 421 LQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRIT 480
Query: 447 SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGS 506
IPK IG L L +L+LS N LS +P E L L+LS+N LQ +P + ++
Sbjct: 481 GEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTK 540
Query: 507 LEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548
L+ L++S N+L+ IP + SL+ + +S N +G IP+S
Sbjct: 541 LQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSS 582
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 707 (253.9 bits), Expect = 4.2e-116, Sum P(2) = 4.2e-116
Identities = 185/515 (35%), Positives = 272/515 (52%)
Query: 58 SITMSTLGLNGTFHDFSFSSFPHLAXXXXXXXXXXGNIPLQIG-NLSKLQYLDLGSNQLS 116
S+++ +NG+ F + +L G+IP + NL L++L++ N LS
Sbjct: 93 SLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLS 152
Query: 117 GLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGS-IPSSLGNLS 175
IP G+ +L L L N L GTIP +G ++ + +L L +N S IPS LGNL+
Sbjct: 153 DTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLT 212
Query: 176 NLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL 235
L VL+L +L G IP + +L SL+ LDL+ NQ +GSIP + L ++ + LFNNS
Sbjct: 213 ELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLKTVEQIELFNNSF 272
Query: 236 SGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLK 295
SG +P +GN+ +L +N+L G IP ++ NL +L L L+ N L G +PE I K
Sbjct: 273 SGELPESMGNMTTLKRFDASMNKLTGKIPDNL-NLLNLESLNLFENMLEGPLPESITRSK 331
Query: 296 SLSELELCTNLLRGVIPHSI------ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF 349
+LSEL+L N L GV+P + + V L+ N SG++ L +L L +N+F
Sbjct: 332 TLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSF 391
Query: 350 CGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMXX 409
GEIS N G L+ +S N +SG IP P+L +L+LS N G IP +
Sbjct: 392 SGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAK 451
Query: 410 XXXXXXXXXXXXXGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQL 469
G +P E GSL + + + N S IP+S+ L +L L+LS NQL
Sbjct: 452 NLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLDLSKNQL 511
Query: 470 SHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMR 529
S +IP E +L+EL+L++N L EIP +V + L L+LS N S IP + ++
Sbjct: 512 SGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPLELQNLK 571
Query: 530 SLSCIDISYNELHGPIPNSTAFKDGLME--GNKGL 562
L+ +++SYN L G IP A K + GN GL
Sbjct: 572 -LNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGL 605
|
|
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 6.6e-115, Sum P(2) = 6.6e-115
Identities = 192/574 (33%), Positives = 282/574 (49%)
Query: 2 LNEEAYALLKWKTXXXXXXXXXXXXXXWTLYPANATKISPCSWFGISCNHAGSRVISITM 61
L+++ ALL WK+ W + SPC+W G+ CN G V I +
Sbjct: 25 LDQQGQALLSWKSQLNISGDAFSS---W-----HVADTSPCNWVGVKCNRRGE-VSEIQL 75
Query: 62 STLGLNGTFHDFSFSSFPHLAXXXXXXXXXXGNIPLQIGNLSKLQYLDLGSNQLSGLIPP 121
+ L G+ S S L G IP +IG+ ++L+ LDL N LSG IP
Sbjct: 76 KGMDLQGSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPV 135
Query: 122 EIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLY 181
EI +L +L+ L L+ N L G IP EIG LS + +L L N L G IP S+G L NL VL
Sbjct: 136 EIFRLKKLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLR 195
Query: 182 LYKN-SLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIP 240
N +L G +P IG ++L+ L L+E SG +P S+GNL + ++++ + LSG IP
Sbjct: 196 AGGNKNLRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIP 255
Query: 241 PILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSEL 300
+G L L L+ N ++G IP +IG L L+ L L+ N L G +P E+G L +
Sbjct: 256 DEIGYCTELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLI 315
Query: 301 ELCTNLLRGVIPHS------IERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEIS 354
+ NLL G IP S ++ + L+ N +SG + E + LT L++ NN GEI
Sbjct: 316 DFSENLLTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIP 375
Query: 355 FNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMXXXXXXX 414
N L+ F N ++G+IP + +LQ +DLS N + G IP ++
Sbjct: 376 SLMSNLRSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKL 435
Query: 415 XXXXXXXXGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIP 474
G +P + G+ T L L L+ N+L+ SIP IGNL L+++++S N+L IP
Sbjct: 436 LLLSNDLSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIP 495
Query: 475 TEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCI 534
L LDL N L + SL+ ++ S N LS +P + L+ +
Sbjct: 496 PAISGCESLEFLDLHTNSLSGSLLGTTLPK-SLKFIDFSDNALSSTLPPGIGLLTELTKL 554
Query: 535 DISYNELHGPIPNSTAFKDGLMEGNKGLKRVSQE 568
+++ N L G IP + L N G S E
Sbjct: 555 NLAKNRLSGEIPREISTCRSLQLLNLGENDFSGE 588
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 1.4e-114, Sum P(2) = 1.4e-114
Identities = 178/523 (34%), Positives = 258/523 (49%)
Query: 42 CSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLAXXXXXXXXXXGNIPLQIGN 101
CSW G++C+ + V S+ +S L L+GT + P L G IP QI N
Sbjct: 57 CSWTGVTCDVSLRHVTSLDLSGLNLSGTLSS-DVAHLPLLQNLSLAANQISGPIPPQISN 115
Query: 102 LSKLQYLDLGSNQLSGLIPPEIGK-LNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160
L +L++L+L +N +G P E+ L LR L L N L G +P + L+ + L L
Sbjct: 116 LYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGG 175
Query: 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSE-NQFSGSIPLSL 219
N G IP++ G L L + N L+G IP IG L +L +L + N F +P +
Sbjct: 176 NYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEI 235
Query: 220 GNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLY 279
GNLS L N L+G IPP +G L+ L L L +N G I +G +SSL+ + L
Sbjct: 236 GNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLS 295
Query: 280 NNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI------ERVLLNQNNLSGKMYEAF 333
NN G +P LK+L+ L L N L G IP I E + L +NN +G + +
Sbjct: 296 NNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKL 355
Query: 334 GDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLS 393
G++ L LDLS+N G + N + ++L T I N + GSIP +G L + +
Sbjct: 356 GENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMG 415
Query: 394 SNHIVGKIPVQLEMXXXXXXXXXXXXXXXGGVPLEFGSLT-KLQYLDLSTNKLSSSIPKS 452
N + G IP +L G +P+ G ++ L + LS N+LS S+P +
Sbjct: 416 ENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAA 475
Query: 453 IGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNL 512
IGNL + L L N+ S IP E +L LS+LD SHN+ I P++ L ++L
Sbjct: 476 IGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDL 535
Query: 513 SHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGL 555
S N LS IP M+ L+ +++S N L G IP + A L
Sbjct: 536 SRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSL 578
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00017830001 | SubName- Full=Chromosome chr17 scaffold_16, whole genome shotgun sequence; (846 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 848 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-117 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 378 bits (972), Expect = e-117
Identities = 281/883 (31%), Positives = 435/883 (49%), Gaps = 112/883 (12%)
Query: 4 EEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMST 63
EE LL +K+S+ + LS+W + C W GI+CN++ SRV+SI +S
Sbjct: 29 EELELLLSFKSSINDP---LKYLSNWN------SSADVCLWQGITCNNS-SRVVSIDLSG 78
Query: 64 LGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-----------------------G 100
++G F P++ +NLS N G IP I G
Sbjct: 79 KNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG 137
Query: 101 NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160
++ L+ LDL +N LSG IP +IG + L+ L L N L G IP + L+ ++ L L
Sbjct: 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS 197
Query: 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLG 220
N L G IP LG + +L +YL N+LSG IP IG L SL LDL N +G IP SLG
Sbjct: 198 NQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG 257
Query: 221 NLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYN 280
NL +L + L+ N LSG IPP + +L+ L +L L N L+G IP + L +L +L+L++
Sbjct: 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS 317
Query: 281 NGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIER-----VL-LNQNNLSGKMYEAFG 334
N G +P + L L L+L +N G IP ++ + VL L+ NNL+G++ E
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377
Query: 335 DHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSS 394
NL L L +N+ GEI + G L + N+ SG +P + P + LD+S+
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 395 NHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIG 454
N++ G+I + + SL L L N+ GG+P FGS +L+ LDLS N+ S ++P+ +G
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLG 496
Query: 455 NLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSH 514
+L +L L LS N+LS +IP E L LDLSHN L +IP M L +L+LS
Sbjct: 497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQ 556
Query: 515 NNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAF----------KDGLMEGNK--GL 562
N LS IP+ + SL ++IS+N LHG +P++ AF L G+ GL
Sbjct: 557 NQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL 616
Query: 563 ---KRVSQEEQ-----SNSMNRLRLLSVLNFD------------GKIMHEEIIKATDDFD 602
KRV + + ++ +L+++ F ++ +E+ FD
Sbjct: 617 PPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD 676
Query: 603 EKF-----------------CIGKGGQGSVYKAELPSGDI-VAVKKFNSQLLSGNMADHD 644
K I +G +G+ YK + + VK+ N D +
Sbjct: 677 SKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN---------DVN 727
Query: 645 EF-LNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNR 703
+E+ + +++H N VK G C + ++L+ EY++ +L+ +L + L W R
Sbjct: 728 SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWER 781
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT 763
R + G+A AL +LH C P+++ ++S + +++D E H+ G ++
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL----RLSLPGLLCTDTK 837
Query: 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806
F + Y APE T TEK D+Y FG+++ E++ G P D
Sbjct: 838 CFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 73/233 (31%), Positives = 106/233 (45%), Gaps = 15/233 (6%)
Query: 606 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+G G G+VYKA +G IVAVK S E+ L+ + H N V+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILK--KRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
+ H +LV EY + G L L L + + + L YLH +
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE-IAYTMRAT 783
IIHRD+ +N+LLD N ++DFG+AK + SS+ T F GT Y APE +
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 784 EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPS 836
K DV+S GV+++E++ G P F N + + + +IL P L P
Sbjct: 178 PKVDVWSLGVILYELLTGKPP--FSGEN---ILDQLQLIRRILGPPLEFDEPK 225
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 65/194 (33%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+GG G+VY A +G VA+K + S + +E L E+ LK++ H N VK +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL---EELLREIEILKKLNHPNIVKLY 57
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G + H +LV EY + GSL +L ++ +L + + ++ + L YLH +
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 726 IIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE-IAYTMRAT 783
IIHRD+ +N+LLDS N + ++DFG++K + S GT Y APE + +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 784 EKYDVYSFGVLVFE 797
EK D++S GV+++E
Sbjct: 173 EKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 18/231 (7%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G G VY A + +G +VA+K + + D + L E+ LK+++H N V+ +
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK---DRERILREIKILKKLKHPNIVRLY 63
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
+ +LV EY + G L +L E + ++ + +AL YLH
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHSKG--- 117
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
I+HRD+ +N+LLD + ++DFG+A+ + P T F GT Y APE+ +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGKGYGKA 176
Query: 786 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPS 836
D++S GV+++E++ G P F ++ KI P+ P P P
Sbjct: 177 VDIWSLGVILYELLTGKPP-------FPGDDQLLELFKKIGKPKPPFPPPE 220
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 45/220 (20%)
Query: 601 FDEKFCIGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNM-ADHDEFLNEVLALK 654
+K +G+G G VYK L G+ VAVK L G + +EFL E +K
Sbjct: 3 LGKK--LGEGAFGEVYKGTLKGDGEGTETKVAVKT----LKEGASEEEREEFLEEASIMK 56
Query: 655 EIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGV 711
++ H N V+ G C G ++V EY+ G L R G+ +T K+L + + +
Sbjct: 57 KLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL-----LQMALQI 111
Query: 712 ANALSYLH-HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS---------- 760
A + YL + +HRD++++N L+ N +SDFG+++ +
Sbjct: 112 AKGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 761 -NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W APE + T K DV+SFGVL++E+
Sbjct: 168 IKWM---------APESLKDGKFTSKSDVWSFGVLLWEIF 198
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 32/207 (15%)
Query: 607 IGKGGQGSVYKAEL----PSGDI-VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G+G G VYK +L + VAVK + +EFL E ++++ H N
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE---DASEQQIEEFLREARIMRKLDHPNV 63
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
VK G C ++V EY++ G L L +L + ++ +A + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN----------WTEFAGTFGY 771
IHRD++++N L+ N +SDFG+++ + W
Sbjct: 122 N---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-------- 170
Query: 772 AAPEIAYTMRATEKYDVYSFGVLVFEV 798
APE + T K DV+SFGVL++E+
Sbjct: 171 -APESLKEGKFTSKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 34/255 (13%)
Query: 606 CIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+G+G GSVY A +G+++AVK +L + + + E+ L ++H N V++
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 665 HGFCYNGPHSFL--VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN----ALSYL 718
+G + + L EY+ GSL+ +L + VI+ L+YL
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLL-------KKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 719 H-HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF----AGTFGYAA 773
H + I+HRDI N+L+DS+ ++DFG AK + E GT + A
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRL--GDIETGEGTGSVRGTPYWMA 171
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTP 833
PE+ D++S G V E+ G P +S N + + KI P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP-------WSELGNPMAALYKIGSSGEPPE 224
Query: 834 SPSVMDYGGCHFMLR 848
P + F+ +
Sbjct: 225 IPEHLSEEAKDFLRK 239
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 600 DFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
F+ IGKGG G VYKA +G VA+K + + ++ +NE+ LK+ +H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKIINEIQILKKCKH 56
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRIN------VIKGVA 712
N VK++G ++V E+ GSL +L N+ + V K +
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL--------KSTNQTLTESQIAYVCKELL 108
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
L YLH + IIHRDI + N+LL S+ E + DFG++ + + GT +
Sbjct: 109 KGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-NTMVGTPYWM 164
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
APE+ K D++S G+ E+ +G P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 607 IGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G+G G VYK L VAVK + +EFL E ++++ H N
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRKLDHPNI 63
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
VK G C +V EY+ G L L + KEL + ++ +A + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLESK 122
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN----------WTEFAGTFGY 771
IHRD++++N L+ N +SDFG+++ + W
Sbjct: 123 N---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-------- 171
Query: 772 AAPEIAYTMRATEKYDVYSFGVLVFEV 798
APE + T K DV+SFGVL++E+
Sbjct: 172 -APESLKEGKFTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 74/243 (30%), Positives = 108/243 (44%), Gaps = 29/243 (11%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
D + +G+G G VYK P+G I A+KK + + G+ + L E+ L+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCE 57
Query: 658 HRNNVKFHG-FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA---- 712
VK +G F G S +V EY+D GSLA +L E V+ +A
Sbjct: 58 SPYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKIPE-------PVLAYIARQIL 109
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
L YLH IIHRDI N+L++S E ++DFGI+K + F GT Y
Sbjct: 110 KGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYM 167
Query: 773 APE----IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDP 828
+PE +Y+ A D++S G+ + E G P F SF ++ + P
Sbjct: 168 SPERIQGESYSYAA----DIWSLGLTLLECALGKFP--FLPPGQPSFFELMQAICDGPPP 221
Query: 829 RLP 831
LP
Sbjct: 222 SLP 224
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 36/213 (16%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+G+G G VYK +L D VAVK + + + +FL E +K++ H N V
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVK---TLKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSL------ARILGDDVTAKELGWNRRINVIKGVANALS 716
+ G C +LV EY++ G L +R + L ++ +A +
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN-----------WTEF 765
YL +HRD++++N L+ + +SDFG+++ V W
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-- 174
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
APE T K DV+SFGVL++E+
Sbjct: 175 -------APESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 606 CIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
IG+G G VYK L +GD VA+K+ + + + + E+ LK ++H N VK+
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKHPNIVKY 64
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALSYLHHD 721
G +++ EY + GSL +I+ G + + V L+YLH
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGP------FPESLVAVYVYQVLQGLAYLHEQ 118
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR 781
+IHRDI + N+L + ++DFG+A + S + GT + APE+
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 782 ATEKYDVYSFGVLVFEVIKGNHP 804
A+ D++S G V E++ GN P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 68/230 (29%), Positives = 106/230 (46%), Gaps = 30/230 (13%)
Query: 588 KIMHEEIIKATDDFDEKFC----IGKGGQGSVYKA-ELPSGDIVAVKK--FNSQLLSGNM 640
K ++I+ D E + IG+G G VYKA + +G VA+KK Q
Sbjct: 5 KAALKDIVSE-GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI- 62
Query: 641 ADHDEFLNEVLALKEIRHRNNVKFHG-FCYNGPHSFLVCEYLDRGSLARIL-GDDVTAKE 698
+NE+L +K+ +H N V ++ + ++V EY+D GSL I+ + V E
Sbjct: 63 ------INEILIMKDCKHPNIVDYYDSYLVGD-ELWVVMEYMDGGSLTDIITQNFVRMNE 115
Query: 699 LGWNRRIN-VIKGVANALSYLH--HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755
+I V + V L YLH + +IHRDI S N+LL + ++DFG A +
Sbjct: 116 ----PQIAYVCREVLQGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
Query: 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805
S GT + APE+ K D++S G++ E+ +G P
Sbjct: 167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH---RNNV 662
IG+G G+VY+ +P+G +VA+K N L D + EV L ++R N
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVI-KGVANALSYLHHD 721
K++G GP +++ EY + GS+ R L E + I+VI + V AL Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAE----KYISVIIREVLVALKYIHKV 120
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR 781
+IHRDI + N+L+ + + DFG+A + +SS + F GT + APE+ +
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 782 ATE-KYDVYSFGVLVFEVIKGNHP 804
+ K D++S G+ ++E+ GN P
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 2e-23
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 21/222 (9%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKG G VY G + +K+ + L + + + ++ LNEV LK++ H N +K++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKE-------LGWNRRINVIKGVANALSYL 718
+V EY D G L++ + + L W ++ AL YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYL 119
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY 778
H I+HRDI +N+ L SN + DFGI+K + GT Y +PE+
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ 176
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 820
K D++S G +++E+ HP F N + I+
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP--FEGENLLELALKIL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (253), Expect = 4e-23
Identities = 69/242 (28%), Positives = 112/242 (46%), Gaps = 17/242 (7%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN-VKFH 665
+G+G G VY A +VA+K +L S + + FL E+ L + H N VK +
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
F + +LV EY+D GSL +L L + + ++ + +AL YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 726 IIHRDISSKNVLLDSN-FEAHVSDFGIAKFVGPHSSN------WTEFAGTFGYAAPEIAY 778
IIHRDI +N+LLD + + DFG+AK + S + GT GY APE+
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 779 TM---RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
+ A+ D++S G+ ++E++ G P + + ++ + I + SP
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 836 SV 837
S
Sbjct: 242 SN 243
|
Length = 384 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G+VY A ++ +G VA+K+ N Q + +NE+L ++E +H N V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKHPNIVNYL 82
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G ++V EYL GSL D VT + + V + AL +LH +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---Q 135
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
+IHRDI S N+LL + ++DFG + P S + GT + APE+ K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 786 YDVYSFGVLVFEVIKGNHP 804
D++S G++ E+++G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 600 DFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHD--EFLNEVLALKEI 656
D++ IGKG G+V K G I+ K+ + GNM + + + ++EV L+E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDY----GNMTEKEKQQLVSEVNILREL 56
Query: 657 RHRNNVKFHGFCYNGPHS--FLVCEYLDRGSLARILGDDVTAKELGWNRRI------NVI 708
+H N V+++ + + ++V EY + G LA+++ K + I ++
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI-----QKCKKERKYIEEEFIWRIL 111
Query: 709 KGVANALSYLHHDCLPS--IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA 766
+ AL H+ P ++HRD+ N+ LD+N + DFG+AK +G SS +
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 767 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
GT Y +PE M EK D++S G L++E+ + P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 600 DFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR 659
+ IGKG G V + G VAVK A FL E + +RH
Sbjct: 7 ELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDD---STAAQ--AFLAEASVMTTLRHP 60
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALS 716
N V+ G G ++V EY+ +GSL L G V +++ V +
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA----QQLGFALDVCEGME 116
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTF--GYAAP 774
YL + +HRD++++NVL+ + A VSDFG+AK ++ + +G + AP
Sbjct: 117 YLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAP 168
Query: 775 EIAYTMRATEKYDVYSFGVLVFEV 798
E + + K DV+SFG+L++E+
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG G G VY A L +G+++AVK+ Q E +E+ L+ ++H N VK++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT--IKEIADEMKVLELLKHPNLVKYY 65
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN----ALSYLHHD 721
G + ++ EY G+L +L E G +VI+ L+YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE----FAGTFGYAAPEIA 777
I+HRDI N+ LD N + DFG A + +++ E AGT Y APE+
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV- 174
Query: 778 YTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFS 813
T + + D++S G +V E+ G P F
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 63/204 (30%), Positives = 90/204 (44%), Gaps = 12/204 (5%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG G VY A LP+ + VA+K+ + L DE EV A+ + H N VK++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRID---LEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G +LV YL GSL I+ L V+K V L YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKF----VGPHSSNWTEFAGTFGYAAPEIAYTMR 781
IHRDI + N+LL + ++DFG++ F GT + APE+ +
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 782 A-TEKYDVYSFGVLVFEVIKGNHP 804
K D++SFG+ E+ G P
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 26/201 (12%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G V++ + VA+K L S ++ +F EV ALK +RH++ +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKI----LKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
C G +++ E +++GSL L + L I++ VA ++YL +
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ---NS 125
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVG-----PHSSN----WTEFAGTFGYAAPEIA 777
IHRD++++N+L+ + V+DFG+A+ + WT APE A
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT---------APEAA 176
Query: 778 YTMRATEKYDVYSFGVLVFEV 798
+ K DV+SFG+L++E+
Sbjct: 177 SHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 70/249 (28%), Positives = 110/249 (44%), Gaps = 40/249 (16%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
DD + +G G G V K P+G I+AVK L N A + L E+ L +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---RLEINEAIQKQILRELDILHKCN 57
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL-------GDDVTAKELGWNRRINVIKG 710
V F+G YN + EY+D GSL +IL + + K +
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK---------IAVA 108
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
V L+YLH IIHRD+ N+L++S + + DFG++ + +S F GT
Sbjct: 109 VLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFVGTSS 164
Query: 771 YAAPE----IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDV-NKI 825
Y APE Y++++ D++S G+ + E+ G P + + I ++ I
Sbjct: 165 YMAPERIQGNDYSVKS----DIWSLGLSLIELATGRFPYPPENDP----PDGIFELLQYI 216
Query: 826 LD---PRLP 831
++ PRLP
Sbjct: 217 VNEPPPRLP 225
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G V+ VAVK L G M + FL E +K++RH V+ +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT----LKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
C ++V EY+ +GSL L K+L + +++ +A ++YL +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAYTMRAT 783
IHRD++++N+L+ N ++DFG+A+ + +T G + APE A R T
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 784 EKYDVYSFGVLVFEVI-KGNHP 804
K DV+SFG+L+ E++ G P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-21
Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G+V+ A ++ +G VA+K+ N Q + +NE+L +KE+++ N V F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELIINEILVMKELKNPNIVNFL 82
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G F+V EYL GSL D VT + + V + AL +LH +
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN---Q 135
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
+IHRDI S NVLL + ++DFG + P S + GT + APE+ K
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 786 YDVYSFGVLVFEVIKGNHP 804
D++S G++ E+++G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 600 DFDEKFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
DF+ IGKG G V+K + + A+K+ + L N + +E ++E L ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQID--LSKMNRREREEAIDEARVLAKLDS 58
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANA 714
++++ + +V EY + G L ++L G + ++ W I ++ G
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLP-EDQVWRFFIQILLG---- 113
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L++LH I+HRDI S N+ LD+ + D G+AK + +++ GT Y +P
Sbjct: 114 LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806
E+ EK DV++ GV+++E G HP D
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 5e-21
Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADH-----DEFLNEVLALKEIRHRN 660
IG G GSVY SG+++AVK+ +S + D D E+ LKE++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
V++ G + H + EY+ GS+A +L ++ A E R N ++ + L+YLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVR--NFVRQILKGLNYLHN 124
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT------EFAGTFGYAAP 774
IIHRDI N+L+D+ +SDFGI+K + +S + G+ + AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
E+ T K D++S G LV E++ G HP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 5e-21
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G+VY A ++ +G VA+++ N Q + +NE+L ++E ++ N V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYL 83
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G ++V EYL GSL D VT + + V + AL +LH +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
+IHRDI S N+LL + ++DFG + P S + GT + APE+ K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 786 YDVYSFGVLVFEVIKGNHP 804
D++S G++ E+I+G P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 2e-20
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G+VY A ++ +G VA+K+ N Q + +NE+L ++E ++ N V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKNPNIVNYL 82
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G ++V EYL GSL D VT + + V + AL +LH +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---Q 135
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
+IHRDI S N+LL + ++DFG + P S + GT + APE+ K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 786 YDVYSFGVLVFEVIKGNHP 804
D++S G++ E+++G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 23/215 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADH--DEFLNEVLALKEIRHRNNVK 663
IG G G+VY A ++ + ++VA+KK + SG ++ + + EV L+++RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 664 FHGFCYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC 722
+ G CY H+ +LV EY GS + IL +V K L + G L+YLH
Sbjct: 80 YKG-CYLREHTAWLVMEYC-LGSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHE 135
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-- 780
IHRDI + N+LL ++DFG A V P +S F GT + APE+ M
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDE 188
Query: 781 -RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 814
+ K DV+S G+ E+ + P F++N S
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP--LFNMNAMS 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+ FD +G+G GSVYKA +G +VA+K + D E + E+ LK+
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCD 56
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGS---LARILGDDVTAKELGWNRRINVI-KGVAN 713
VK++G + ++V EY GS + +I +T +E I I
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEE------IAAILYQTLK 110
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
L YLH IHRDI + N+LL+ +A ++DFG++ + + GT + A
Sbjct: 111 GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMA 167
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805
PE+ + K D++S G+ E+ +G P
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 607 IGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G+G G V P GD VAVK N SG +F E+ L+ + H N
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH---SGEEQHRSDFEREIEILRTLDHENI 68
Query: 662 VKFHGFCY--NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
VK+ G C G L+ EYL GSL L ++ R + + + YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLG 126
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV----GPHSSNWTEFAGTFGYAAPE 775
IHRD++++N+L++S +SDFG+AK + + + F Y APE
Sbjct: 127 SQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 776 IAYTMRATEKYDVYSFGVLVFE 797
T + + DV+SFGV ++E
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G V+ + VA+K G M++ D+F+ E + ++ H N V+ +G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSE-DDFIEEAKVMMKLSHPNLVQLYG 66
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
C F+V EY+ G L L + W +++ V A+ YL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---F 121
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH---SSNWTEFAGTFGYAAPEIAYTMRAT 783
IHRD++++N L+ + VSDFG+A++V SS T+F +A PE+ R +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFS 179
Query: 784 EKYDVYSFGVLVFEVI-KGNHPRDFFS 809
K DV+SFGVL++EV +G P + FS
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF---LNEVLALK 654
+D++ IG G G VYKA ++ +G++VA+K + D+F E+ LK
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-------LEPGDDFEIIQQEISMLK 55
Query: 655 EIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA 714
E RH N V + G ++V EY GSL I VT L + V +
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKG 113
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L+YLH IHRDI N+LL + + ++DFG++ + + F GT + AP
Sbjct: 114 LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170
Query: 775 EIA---YTMRATEKYDVYSFGVLVFEVIKGNHPR 805
E+A K D+++ G+ E+ + P
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 591 HEE-------IIKATD---DFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN------S 633
HE+ ++ D D IG+G G V A + +G VAVKK +
Sbjct: 1 HEQFRAALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR 60
Query: 634 QLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDD 693
+LL NEV+ +++ +H N V+ + G ++V E+L+ G+L I
Sbjct: 61 ELL----------FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI---- 106
Query: 694 VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753
VT + + V V ALS+LH +IHRDI S ++LL S+ +SDFG
Sbjct: 107 VTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCA 163
Query: 754 FVGPHSSNWTEFAGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809
V GT + APE I+ TE D++S G++V E++ G P +F+
Sbjct: 164 QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPP--YFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 63/237 (26%), Positives = 109/237 (45%), Gaps = 25/237 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG---NMADHDEFLNEVLALKEIRHRNNV 662
IG+G G VYKA + +G+IVA+KK + S A L E+ LKE+ H N +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA-----LREIKLLKELNHPNII 61
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC 722
K + +LV E++D L +++ + L + + + + L++ H
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA 782
I+HRD+ +N+L+++ ++DFG+A+ G +T + T Y APE+ +
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 783 -TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVM 838
+ D++S G + E++ R F + I + KI L TP P V
Sbjct: 176 YSTPVDIWSVGCIFAELLSR---RPLF-----PGKSEIDQLFKIFR-TLGTPDPEVW 223
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G V++ + VAVK L G M D +FL E +K++RH ++ +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKT----LKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
C ++V E + GSL L + L + I++ VA+ ++YL +
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLE---AQNY 124
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAG-TFGYAAPEIAYTMRATEK 785
IHRD++++NVL+ N V+DFG+A+ + E A + APE A R + K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 786 YDVYSFGVLVFEVI 799
DV+SFG+L+ E++
Sbjct: 185 SDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 26/199 (13%)
Query: 610 GGQ-GSVYKAELPS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGF 667
GGQ G VY+ VAVK L M EFL E +KEI+H N V+ G
Sbjct: 16 GGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 668 CYNGPHSFLVCEYLDRGSLARILGD----DVTAKELGWNRRINVIKGVANALSYLHHDCL 723
C P +++ E++ G+L L + +V A L + + +++A+ YL
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYLEKK-- 123
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPE-IAYT 779
+ IHRD++++N L+ N V+DFG+++ + +T AG + APE +AY
Sbjct: 124 -NFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 780 MRATEKYDVYSFGVLVFEV 798
+ K DV++FGVL++E+
Sbjct: 181 KFSI-KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+ F CIGKG G VYKA + + +VA+K + L + ++ E+ L + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQCR 57
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLA-----RILGDDVTAKELGWNRRINVIKGVA 712
K++G G +++ EY GS L + A +++ V
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---------ILREVL 108
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
L YLH + IHRDI + N+LL + ++DFG++ + S F GT +
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWM 165
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805
APE+ EK D++S G+ E+ KG P
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 69/241 (28%), Positives = 102/241 (42%), Gaps = 40/241 (16%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IGKG G VYK L VAVK S L +FL E LK+ H N VK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 667 FCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
C ++V E + GSL L + +T K+L + + A + YL
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGMEYLESKN- 113
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT----FGYAAPEIAYT 779
IHRD++++N L+ N +SDFG+++ +T G + APE
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 780 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM-------IIDVNKILDPRLPT 832
R T + DV+S+G+L++E FS+ + + M I+ R+P
Sbjct: 170 GRYTSESDVWSYGILLWET---------FSLGDTPYPGMSNQQTRERIESGY----RMPA 216
Query: 833 P 833
P
Sbjct: 217 P 217
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G V A E +G VAVKK + + + NEV+ +++ H N V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G ++V E+L+ G+L D VT + + V V ALSYLH+
Sbjct: 86 NSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---G 138
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
+IHRDI S ++LL S+ +SDFG V GT + APE+ + +
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 786 YDVYSFGVLVFEVIKGNHP 804
D++S G++V E+I G P
Sbjct: 199 VDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+GKG GSVYK + L A+K+ + + + + ++ +NE+ L + H N + +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYK 65
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAK-----ELGWNRRINVIKGVANALSYLHH 720
+G +V EY G L++ + + + W I +++G L LH
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQALHE 121
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM 780
I+HRD+ S N+LL +N + D GI+K + + + T+ GT Y APE+
Sbjct: 122 Q---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQI-GTPHYMAPEVWKGR 176
Query: 781 RATEKYDVYSFGVLVFEVIKGNHP 804
+ K D++S G L++E+ P
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRN 660
+G+G G V K +G+IVA+KKF ++ DE L EV L+++RH N
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKE-------SEDDEDVKKTALREVKVLRQLRHEN 61
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARI------LGDDVTAKELGWNRRINVIKGVANA 714
V +LV EY++R L + L D + W + A
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAV-RSYIWQ--------LLQA 112
Query: 715 LSYLH-HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV-GPHSSNWTEFAGTFGYA 772
++Y H H+ IIHRDI +N+L+ + + DFG A+ + +S T++ T Y
Sbjct: 113 IAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168
Query: 773 APEIAYTMRATEKY----DVYSFGVLVFEVIKGN 802
APE+ + Y DV++ G ++ E++ G
Sbjct: 169 APEL---LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 607 IGKGGQGSVYKAEL--PSGDI--VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+G G G V + E G + VAVK S LS M D+FL E + + H N +
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM---DDFLKEAAIMHSLDHENLI 59
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC 722
+ +G P +V E GSL L D + + +AN + YL
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRYLE--- 114
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAYT 779
IHRD++++N+LL S+ + + DFG+ + + + ++ F + APE T
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 780 MRATEKYDVYSFGVLVFEV 798
+ DV+ FGV ++E+
Sbjct: 175 RTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 67/238 (28%), Positives = 114/238 (47%), Gaps = 30/238 (12%)
Query: 607 IGKGGQGSVYKA--ELPSGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
IG G G V + +LP VA+K + S +FL E + + H N +
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQ--RLDFLTEASIMGQFDHPNII 68
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC 722
+ G ++ EY++ GSL + L + + + +++G+A+ + YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG--YAAPE-IAYT 779
+HRD++++N+L++SN VSDFG+++ + + +T G + APE IAY
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY- 182
Query: 780 MRA-TEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKILDP--RLPTP 833
R T DV+SFG++++EV+ G P + SN DV K ++ RLP P
Sbjct: 183 -RKFTSASDVWSFGIVMWEVMSYGERP-------YWDMSNQ--DVIKAVEDGYRLPPP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 8e-18
Identities = 53/188 (28%), Positives = 96/188 (51%), Gaps = 16/188 (8%)
Query: 626 VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGS 685
VA+K + G+M++ DEF+ E + ++ H V+ +G C ++V EY+ G
Sbjct: 31 VAIK----MIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85
Query: 686 LARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH 745
L L + K ++ + + K V ++YL IHRD++++N L+D
Sbjct: 86 LLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVK 140
Query: 746 VSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-G 801
VSDFG++++V +T G+ ++ PE+ + + K DV++FGVL++EV G
Sbjct: 141 VSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198
Query: 802 NHPRDFFS 809
P + F+
Sbjct: 199 KMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 70/253 (27%), Positives = 104/253 (41%), Gaps = 35/253 (13%)
Query: 607 IGKGGQGSVYKAEL-PSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+G GG G V ++ A+K ++ +H +E L+E H VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEH--IFSEKEILEECNHPFIVKL 58
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGD-----DVTAKELGWNRRINVIKGVANALSYLH 719
+ + + +++ EY G L IL D + TA+ I V A YLH
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY--------IACVVLAFEYLH 110
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI--- 776
+ II+RD+ +N+LLDSN + DFG AK + WT F GT Y APEI
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILN 166
Query: 777 -AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
Y D +S G+L++E++ G P F M I N IL P
Sbjct: 167 KGYDFSV----DYWSLGILLYELLTGRPP---FGE--DDEDPMEI-YNDILKGNGKLEFP 216
Query: 836 SVMDYGGCHFMLR 848
+ +D + +
Sbjct: 217 NYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G+G G V+ VA+K L G M+ + FL E +K++RH V+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKT----LKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 68
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
P ++V EY+ +GSL L + K L + +++ +A+ ++Y+ +
Sbjct: 69 VVSEEP-IYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNY 123
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAYTMRAT 783
+HRD+ + N+L+ N V+DFG+A+ + + +T G + APE A R T
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 784 EKYDVYSFGVLVFEV-IKGNHP 804
K DV+SFG+L+ E+ KG P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 73/227 (32%), Positives = 112/227 (49%), Gaps = 27/227 (11%)
Query: 599 DDFDEKFC----IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADH--DEFLNEVL 651
DD +E F IG G G+VY A + ++VAVKK + SG + + + EV
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMS---YSGKQTNEKWQDIIKEVK 73
Query: 652 ALKEIRHRNNVKFHGFCYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG 710
L++++H N +++ G CY H+ +LV EY GS + +L +V K L + G
Sbjct: 74 FLQQLKHPNTIEYKG-CYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHG 129
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
L+YLH + IHRDI + N+LL + ++DFG A P +S F GT
Sbjct: 130 ALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPY 182
Query: 771 YAAPEIAYTMRATE---KYDVYSFGVLVFEVIKGNHPRDFFSINFSS 814
+ APE+ M + K DV+S G+ E+ + P F++N S
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMS 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 21/228 (9%)
Query: 607 IGKGGQGSVYKAEL--PSGDIVAVKKFN--SQLLSGNMADHDE----FLNEVLALKE-IR 657
+G G G VYK +++A+K+ N + + + D+ ++EV +KE +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWN----RRINVIKGVAN 713
H N V+++ ++V + ++ L + KE R N+ +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF---NSLKEKKQRFTEERIWNIFVQMVL 124
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
AL YLH + I+HRD++ N++L + + ++DFG+AK P S T GT Y+
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTILYSC 181
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIID 821
PEI EK DV++FG +++++ P F+S N S + I++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKIVE 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 71/246 (28%), Positives = 100/246 (40%), Gaps = 35/246 (14%)
Query: 607 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDE------FLNEVLALKEIRHR 659
IGKG G V + + + A+K N Q E LNE L+E+ H
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-------KCVEKGSVRNVLNERRILQELNHP 60
Query: 660 NNVKFH-GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIK----GVANA 714
V F + + +LV + L G L L V E +K + A
Sbjct: 61 FLVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSE-------EQVKFWICEIVLA 112
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L YLH IIHRDI N+LLD H++DF IA V P + T +GT GY AP
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-DTLTTSTSGTPGYMAP 168
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLP-TP 833
E+ + D +S GV +E ++G P + + + + I + D P T
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRP---YRGHSRTIRDQIRAKQETADVLYPATW 225
Query: 834 SPSVMD 839
S +D
Sbjct: 226 STEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 67/244 (27%), Positives = 116/244 (47%), Gaps = 29/244 (11%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IG G G V+ VA+K +S ++F+ E + ++ H V+ +G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-----EEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDD--VTAKELGWNRRINVIKGVANALSYLHHDCLP 724
C LV E+++ G L+ L ++E ++V +G+A YL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA----YLESSN-- 120
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH---SSNWTEFAGTFGYAAPEIAYTMR 781
+IHRD++++N L+ N VSDFG+ +FV SS T+F +++PE+ +
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP--VKWSSPEVFSFSK 177
Query: 782 ATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVN---KILDPRL-PTPSPS 836
+ K DV+SFGVL++EV +G P + N S+ S ++ +N ++ PRL
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYE----NRSN-SEVVETINAGFRLYKPRLASQSVYE 232
Query: 837 VMDY 840
+M +
Sbjct: 233 LMQH 236
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 63/238 (26%), Positives = 112/238 (47%), Gaps = 34/238 (14%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G V+ + + VA+K N G M++ D F+ E + ++ H V+ +G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEED-FIEEAKVMMKLSHPKLVQLYG 66
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
C ++V E+++ G L L +L + +++ + V + YL + S
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERN---SF 121
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG------YAAPEIAYTM 780
IHRD++++N L+ S VSDFG+ ++V E+ + G ++ PE+
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-----DEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 781 RATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSN-----MIIDVNKILDPRLPT 832
+ + K DV+SFGVL++EV +G P F SN MI ++ P+L +
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMP-------FEKKSNYEVVEMISRGFRLYRPKLAS 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G V A E SG VAVK + + + NEV+ +++ +H+N V+ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLR----KQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G +++ E+L G+L I V+ L + V + V AL YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDI----VSQTRLNEEQIATVCESVLQALCYLHSQ---G 137
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE-IAYTMRATE 784
+IHRDI S ++LL + +SDFG + GT + APE I+ T TE
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 785 KYDVYSFGVLVFEVIKGNHPRDFFS 809
D++S G++V E++ G P +FS
Sbjct: 198 -VDIWSLGIMVIEMVDGEPP--YFS 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 607 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G V A + SG +VAVKK + + + NEV+ +++ +H N V+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G ++V E+L+ G+L D VT + + V V ALS LH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---G 136
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
+IHRDI S ++LL + +SDFG V GT + APE+ + +
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 786 YDVYSFGVLVFEVIKGNHP 804
D++S G++V E++ G P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 67/242 (27%), Positives = 119/242 (49%), Gaps = 37/242 (15%)
Query: 607 IGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
IG G G V++ L VA+K D FL+E + + H N +
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---FLSEASIMGQFSHHNII 69
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGD---DVTAKELGWNRRINVIKGVANALSYLH 719
+ G + ++ EY++ G+L + L D + ++ +L + +++G+A + YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYLS 124
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV--GPHSSNWTEFAGTFG--YAAPE 775
+ +HRD++++N+L++SN E VSDFG+++ + P + +T G + APE
Sbjct: 125 D---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT-YTTSGGKIPIRWTAPE 180
Query: 776 -IAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKILDP--RLP 831
IAY + T DV+SFG++++EV+ G P + SN +V K ++ RLP
Sbjct: 181 AIAYR-KFTSASDVWSFGIVMWEVMSFGERP-------YWDMSNH--EVMKAINDGFRLP 230
Query: 832 TP 833
P
Sbjct: 231 AP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 4e-17
Identities = 67/236 (28%), Positives = 100/236 (42%), Gaps = 30/236 (12%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+GKG G V + +G + A+K +++ +H L E L I H VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH--TLTERNILSRINHPFIVKL 58
Query: 665 HGFCYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH-HDC 722
H + + +LV EY G L L + E R + AL YLH
Sbjct: 59 H-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE-ERARFY--AAEIVLALEYLHSLG- 113
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI----AY 778
II+RD+ +N+LLD++ ++DFG+AK + S F GT Y APE+ Y
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
D +S GVL++E++ G P F++ + KIL L P
Sbjct: 171 GKAV----DWWSLGVLLYEMLTGKPP--FYA------EDRKEIYEKILKDPLRFPE 214
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 63/222 (28%), Positives = 109/222 (49%), Gaps = 33/222 (14%)
Query: 607 IGKGGQGSVYKAEL----PSGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G G V+ AE P+ D +VAVK L +A +F E L ++H +
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKA----LKDPTLAARKDFQREAELLTNLQHEH 68
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL------------GDDVTAK-ELGWNRRINV 707
VKF+G C +G +V EY+ G L + L G AK ELG ++ +++
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 708 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAG 767
+A+ + YL +HRD++++N L+ +N + DFG+++ V +S+++ G
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYRVGG 183
Query: 768 ----TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHP 804
+ PE + T + DV+SFGV+++E+ G P
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 23/215 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADH--DEFLNEVLALKEIRHRNNVK 663
IG G G+VY A ++ + ++VA+KK + SG ++ + + EV L+++RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 664 FHGFCYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC 722
+ G CY H+ +LV EY GS + +L +V K L V G L+YLH
Sbjct: 80 YRG-CYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSH- 134
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA 782
++IHRD+ + N+LL + DFG A + P + F GT + APE+ M
Sbjct: 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDE 188
Query: 783 TE---KYDVYSFGVLVFEVIKGNHPRDFFSINFSS 814
+ K DV+S G+ E+ + P F++N S
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP--LFNMNAMS 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 607 IGKGGQGSVYKAEL----PSGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G G V+ E P D +VAVK + N A +F E L +H N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKE--TASNDA-RKDFEREAELLTNFQHEN 69
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL-----------GDDVTAKELGWNRRINVIK 709
VKF+G C G +V EY++ G L + L D EL ++ + +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 710 GVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT- 768
+A+ + YL +HRD++++N L+ + + DFG+++ V +++++ G
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV--YTTDYYRVGGHT 184
Query: 769 ---FGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ PE + T + DV+SFGV+++E+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 69/215 (32%), Positives = 111/215 (51%), Gaps = 23/215 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADH--DEFLNEVLALKEIRHRNNVK 663
IG G G+VY A ++ + ++VA+KK + SG ++ + + EV L+ I+H N+++
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 664 FHGFCYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC 722
+ G CY H+ +LV EY GS + +L +V K L + G L+YLH
Sbjct: 90 YKG-CYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSH- 144
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA 782
++IHRDI + N+LL + ++DFG A P +S F GT + APE+ M
Sbjct: 145 --NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDE 198
Query: 783 TE---KYDVYSFGVLVFEVIKGNHPRDFFSINFSS 814
+ K DV+S G+ E+ + P F++N S
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPP--LFNMNAMS 231
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKF----NSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+GKG G+VY G ++AVK+ ++ L + ++++ EV LK ++H N V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEK--EYEKLQEEVDLLKSLKHVNIV 65
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC 722
++ G C + + E++ GS++ IL E + + K + + ++YLH++C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC 122
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV------GPHSSNWTEFAGTFGYAAPEI 776
++HRDI NV+L N + DFG A+ + G HS+ GT + APE+
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
K D++S G VFE+ G P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (199), Expect = 2e-16
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 606 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLALKEIRHRN 660
+G+G G VYKA + +G+IVA+KK +L + + + L E+ LKE++H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDN----EEEGIPSTALREISLLKELKHPN 59
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA----NALS 716
VK + +LV EY D L + L D L N+IK + L+
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPL----SPNLIKSIMYQLLRGLA 112
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
Y H I+HRD+ +N+L++ + ++DFG+A+ G +T T Y APEI
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 777 AYTMRATEKY----DVYSFGVLVFEVIKG 801
+ Y D++S G + E+I G
Sbjct: 170 LLGSK---HYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-16
Identities = 44/93 (47%), Positives = 59/93 (63%)
Query: 152 LIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQF 211
ID L L + L G IP+ + L +L + L NS+ G+IP +G + SL LDLS N F
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 212 SGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILG 244
+GSIP SLG L+SL +++L NSLSG +P LG
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 52/155 (33%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISC---NHAGSRVIS 58
L EE AL K+SL L W P + P W G C + G I
Sbjct: 370 LLEEVSALQTLKSSLG---LPLRF--GWNGDPC-VPQQHP--WSGADCQFDSTKGKWFID 421
Query: 59 -ITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSG 117
+ + GL G + S HL ++NLS N GNIP +G+++ L+ LDL N +G
Sbjct: 422 GLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480
Query: 118 LIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSL 152
IP +G+L LR L L+ N L G +P +G L
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G+G GSV K L + ++ K + N + L E+ K + VK++G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALK--TITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 667 FCYNGPHSFL--VCEYLDRGSLARILGDDVTAKELGWNRRIN------VIKGVANALSYL 718
+ S + EY + GSL I K RI + + V LSYL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYK-----KVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA-KFVGPHSSNWTEFAGTFGYAAPE-- 775
H IIHRDI N+LL + + DFG++ + V +S F GT Y APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYMAPERI 175
Query: 776 --IAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
Y++ + DV+S G+ + EV + P
Sbjct: 176 QGKPYSITS----DVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 62/196 (31%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IGKG G V + G+ VAVK N A FL E + ++RH N V+ G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK------NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 667 FCYNGPHS-FLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANALSYLHHDC 722
++V EY+ +GSL R G V LG + + V A+ YL +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEAN- 121
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA 782
+ +HRD++++NVL+ + A VSDFG+ K SS + APE +
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 176
Query: 783 TEKYDVYSFGVLVFEV 798
+ K DV+SFG+L++E+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 607 IGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN---- 661
I KG G V+ A+ S GDI A+K + +++VL ++I +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ-----VDQVLTERDILSQAQSPYV 55
Query: 662 VKFHGFCYNGPHS-FLVCEYLDRGSLARILG-----DDVTAKELGWNRRINVIKGVANAL 715
VK + + + G + +LV EYL G LA +L D+ A+ I + AL
Sbjct: 56 VKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLAL 106
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF--------VGPHSSNWTEFAG 767
YLH + IIHRD+ N+L+DSN ++DFG++K + G
Sbjct: 107 EYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 768 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
T Y APE+ ++ D +S G +++E + G P
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 67/244 (27%), Positives = 117/244 (47%), Gaps = 39/244 (15%)
Query: 607 IGKGGQGSVYKAEL-PSG---DIVAVKKFNSQLLSGNMADHD--EFLNEVLALKEIRHRN 660
IG G G V + L G VA+K L + +FL+E + + H N
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKT-----LKSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDD---VTAKELGWNRRINVIKGVANALSY 717
+ G ++ E+++ G+L L + T +L + +++G+A + Y
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKY 121
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG-----YA 772
L + +HRD++++N+L++SN VSDFG+++F+ +S+ T + G +
Sbjct: 122 LSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 773 APE-IAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKI-LDPR 829
APE IAY + T DV+S+G++++EV+ G P + SN + +N I D R
Sbjct: 179 APEAIAYR-KFTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDV-INAIEQDYR 229
Query: 830 LPTP 833
LP P
Sbjct: 230 LPPP 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G V+KA + +G+ VA+KK + L G + + + L E+ AL+ +H VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN--QALREIKALQACQHPYVVKLL 65
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI--NVIKGVANALSYLHHDCL 723
+G LV EY+ L+ +L D+ + ++KGVA Y+H +
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVA----YMHAN-- 118
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAK-FVGPHSSNWTEFAGTFGYAAPEIAYTMRA 782
I+HRD+ N+L+ ++ ++DFG+A+ F ++ T Y APE+ Y R
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 783 -TEKYDVYSFGVLVFEVIKG 801
D+++ G + E++ G
Sbjct: 178 YDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 597 ATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADH-DEFLNEVLALK 654
T F+ IG+G G VYKA +G +VA+K + + D +E E L+
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK------IMDIIEDEEEEIKEEYNILR 57
Query: 655 EI-RHRNNVKFHGFCYNGPHS------FLVCEYLDRGSLARILGDDVTAKELGWNRRIN- 706
+ H N F+G +LV E GS+ D+ +R+
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT-----DLVKGLRKKGKRLKE 112
Query: 707 -----VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN 761
+++ L+YLH + +IHRDI +N+LL N E + DFG++ +
Sbjct: 113 EWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169
Query: 762 WTEFAGTFGYAAPE-IA--------YTMRATEKYDVYSFGVLVFEVIKGNHP 804
F GT + APE IA Y R+ DV+S G+ E+ G P
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARS----DVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 38/227 (16%)
Query: 604 KFCIGKGGQGSVYKAE----LPSGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
K+ +G+G G V+ AE LP D +VAVK L + + +F E L ++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQDFQREAELLTVLQ 65
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL------------GDDVTAKELGWNRRI 705
H++ V+F+G C G +V EY+ G L R L G+DV +L + +
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 706 NVIKGVANALSY---LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762
+ +A+ + Y LH +HRD++++N L+ + DFG+++ + +S+++
Sbjct: 126 AIASQIASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDY 177
Query: 763 TEFAG----TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHP 804
G + PE + T + D++SFGV+++E+ G P
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 607 IGKGGQGSVYKA--ELPSGDI--VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+G G GSV K + SG VAVK A EFL E + ++ H V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ---EHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGD--DVTAKELGWNRRINVIKGVANALSYLHH 720
+ G C G LV E G L + L ++ +L + VA ++YL
Sbjct: 60 RLIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE- 112
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG-----YAAPE 775
+HRD++++NVLL + +A +SDFG+++ +G S + A T G + APE
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPE 168
Query: 776 IAYTMRATEKYDVYSFGVLVFEV 798
+ + K DV+S+GV ++E
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEA 191
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G V+ VAVK L G M+ + FL E +K++RH V+ +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKT----LKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYA 68
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
P ++V EY+ +GSL L D + L +++ VA ++Y+ +
Sbjct: 69 VVSEEP-IYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNY 123
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAYTMRAT 783
IHRD+ S N+L+ ++DFG+A+ + + +T G + APE A R T
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 784 EKYDVYSFGVLVFEVI-KGNHP 804
K DV+SFG+L+ E++ KG P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G+G G V+ VA+K L G M + FL E +K++RH V +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKT----LKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYA 68
Query: 667 FCYNGPHSFLVCEYLDRGSLARIL--GDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
P ++V E++ +GSL L GD K L + +++ +A+ ++Y+
Sbjct: 69 VVSEEP-IYIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIER---M 121
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAYTMR 781
+ IHRD+ + N+L+ N ++DFG+A+ + + +T G + APE A R
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 782 ATEKYDVYSFGVLVFEVI-KGNHP 804
T K DV+SFG+L+ E++ KG P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 38/89 (42%), Positives = 57/89 (64%)
Query: 108 LDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSI 167
L L + L G IP +I KL L+ + L N + G IPP +G ++ ++ L L +N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 168 PSSLGNLSNLAVLYLYKNSLSGSIPSIIG 196
P SLG L++L +L L NSLSG +P+ +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN-EVLALKEIRHRNNVKF 664
+G G GSVY+ L GD AVK+ + + + L E+ L +++H N V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKE---LGWNRRINVIKGVANALSYLHHD 721
G + ++ E + GSLA++L + E + R+I + G L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI--LLG----LEYLHDR 121
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR 781
+ +HRDI N+L+D+N ++DFG+AK V S F G+ + APE+ +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA-KSFKGSPYWMAPEV---IA 174
Query: 782 ATEKY----DVYSFGVLVFEVIKGNHP 804
Y D++S G V E+ G P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-15
Identities = 39/89 (43%), Positives = 57/89 (64%)
Query: 132 LYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSI 191
L LD L G IP +I +L + + L N++ G+IP SLG++++L VL L NS +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 192 PSIIGKLKSLLQLDLSENQFSGSIPLSLG 220
P +G+L SL L+L+ N SG +P +LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-15
Identities = 38/82 (46%), Positives = 54/82 (65%)
Query: 187 LSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNL 246
L G IP+ I KL+ L ++LS N G+IP SLG+++SL ++ L NS +GSIP LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 247 KSLSALGLHINQLNGFIPPSIG 268
SL L L+ N L+G +P ++G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G G GSV K + +P+G ++A K + + + L E+ + E R V F+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKK---VVHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA----LSYL--- 718
G N + + E++D GSL RI K+ G + ++ +A A L+YL
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIY------KKGG-PIPVEILGKIAVAVVEGLTYLYNV 122
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY 778
H I+HRDI N+L++S + + DFG++ + +S F GT Y +PE
Sbjct: 123 HR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGEL--INSIADTFVGTSTYMSPERIQ 175
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807
+ T K DV+S G+ + E+ G P F
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVK-----KFNSQLLSGNMADHDEFLN-EVLALKEIRHR 659
IGKG G VY A + +G+++AVK + D + L E+ LK++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 660 NNVKFHGFCYNGPHSF-LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN----A 714
N V++ GF + EY+ GS+ L +E +++
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTEQVLEG 120
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW------TEFAGT 768
L+YLH I+HRD+ + N+L+D++ +SDFGI+K S + G+
Sbjct: 121 LAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK----KSDDIYDNDQNMSMQGS 173
Query: 769 FGYAAPEIAYTMRA--TEKYDVYSFGVLVFEVIKGNHP 804
+ APE+ ++ + K D++S G +V E+ G P
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR-----N 660
I KG GSVY A+ +GD A+K L +M ++ N V A + I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIK----VLKKSDMIAKNQVTN-VKAERAIMMIQGESPY 58
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELG-----WNRRINVIKGVANAL 715
K + + + +LV EYL+ G A ++ K LG W + I V +
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAK--QYIAEVVLGV 110
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
LH IIHRDI +N+L+D ++DFG+++ G + +F GT Y APE
Sbjct: 111 EDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-NGLENK---KFVGTPDYLAPE 163
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ + D +S G ++FE + G P
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 35/211 (16%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLALKEIRHRNN 661
IG+G G VYKA +G++VA+KK + + + F + E+ L+++RH N
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME------NEKEGFPITAIREIKLLQKLRHPNI 60
Query: 662 VKFHGFCYNGPHS--FLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVA---- 712
V+ + ++V EY+D L +L T + IK
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQ---------IKCYMKQLL 110
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA-KFVGPHSSNWTEFAGTFGY 771
L YLH + I+HRDI N+L++++ ++DFG+A + +S+++T T Y
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 772 AAPEIAY-TMRATEKYDVYSFGVLVFEVIKG 801
PE+ R + D++S G ++ E+ G
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKF---NSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+G+G G V K + +G IVA+KKF + +A + E+ LK++RH N V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA-----MREIRMLKQLRHENLV 63
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKE--LGWNRRINVIKGVANALSYLHH 720
+LV E++D L DD+ L +R + + + + H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM 780
+IIHRDI +N+L+ + + DFG A+ + +T++ T Y APE+ +
Sbjct: 119 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL---L 172
Query: 781 RATEKY----DVYSFGVLVFEVIKGN 802
KY D+++ G LV E++ G
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G VY+A + SG+IVA+KK + L E+ L +RH N V+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLRHPNIVELK 72
Query: 666 GFCYNGPHS---FLVCEYLDRGSLARILGDDVTA-------KELGWNRRINVIKGVANAL 715
G H FLV EY ++ LA +L D++ K L + +++G L
Sbjct: 73 EVVV-GKHLDSIFLVMEYCEQ-DLASLL-DNMPTPFSESQVKCL----MLQLLRG----L 121
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
YLH + IIHRD+ N+LL ++DFG+A+ G + T T Y APE
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPE 178
Query: 776 IAYTMRA-TEKYDVYSFGVLVFEVIKGN 802
+ T D+++ G ++ E++
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 66/266 (24%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLALKEIRHRNN 661
IG G G V A +G VA+KK + N+ D L E+ L+ +RH N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS------NVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 662 VKFHG-FCYNGPHSF----LVCEYLDRGSLARIL--GDDVTAKELGWNRRI--NVIKGVA 712
+ P F +V E ++ L +++ +T + + +++G
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHI---QYFLYQILRG-- 115
Query: 713 NALSYLHHDCLPS--IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS---NWTEFAG 767
L YLH S +IHRD+ N+L++SN + + DFG+A+ V P TE+
Sbjct: 116 --LKYLH-----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 768 TFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVI------KGNHPRDFFSINFSSFSN 817
T Y APE+ + ++ +Y D++S G + E++ G D N
Sbjct: 169 TRWYRAPEL---LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL--------N 217
Query: 818 MIIDVNKILDPRLPTPSPSVMDYGGC 843
+I++V L TPS + +
Sbjct: 218 LIVEV-------LGTPSEEDLKFITS 236
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 30/213 (14%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IG+G G+V + E +G VAVK + + FL E + ++ H+N V+ G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA------QAFLEETAVMTKLHHKNLVRLLG 66
Query: 667 -FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIK------GVANALSYLH 719
+NG + +V E + +G+L L A ++VI+ VA + YL
Sbjct: 67 VILHNGLY--IVMELMSKGNLVNFLRTRGRAL-------VSVIQLLQFSLDVAEGMEYLE 117
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT 779
L +HRD++++N+L+ + A VSDFG+A+ VG + ++ + APE
Sbjct: 118 SKKL---VHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKH 171
Query: 780 MRATEKYDVYSFGVLVFEVIK-GNHPRDFFSIN 811
+ + K DV+S+GVL++EV G P S+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK 204
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMAD--HDEFLNEVLALKEIRHRNNVK 663
IG G G+VYK P+G + A+K ++ GN D + E+ L+++ H N VK
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALK-----VIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 664 FHGFCYNGPHSFLVCEYLDRGSL--ARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
H + ++ E++D GSL I + A +V + + + ++YLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA---------DVARQILSGIAYLHRR 187
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR 781
I+HRDI N+L++S ++DFG+++ + GT Y +PE T
Sbjct: 188 ---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 782 ATEKY-----DVYSFGVLVFEVIKGNHP 804
Y D++S GV + E G P
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
DDF+ +G G G V SG A+K + ++++ +H LNE L+ I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH--VLNEKRILQSI 58
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRRINV 707
RH V +G + + +LV EY+ G L + + V A +
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ--------- 109
Query: 708 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAG 767
V AL YLH I++RD+ +N+LLDS+ ++DFG AK V + +T G
Sbjct: 110 ---VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT-LCG 160
Query: 768 TFGYAAPEI----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811
T Y APEI Y D ++ G+L++E++ G P FF N
Sbjct: 161 TPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP--FFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL-KEI 656
DDF IG+G +V A E + A+K + + L E L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLN 59
Query: 657 RHRNNVKFHGFCYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA--- 712
H +K + + + + + V EY G L + + ++ G + + A
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI------RKYG-SLDEKCTRFYAAEI 111
Query: 713 -NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE------- 764
AL YLH IIHRD+ +N+LLD + ++DFG AK + P+SS +
Sbjct: 112 LLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 765 -------------FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
F GT Y +PE+ A + D+++ G ++++++ G P
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 606 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFL-NEVLALKEIRHRNNVK 663
+G+G G VY ++ +G +AVK+ S L E+ LK ++H V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLAR------ILGDDVTAKELGWNRRINVIKGVANALSY 717
++G + + EY+ GS+ L + VT K + R+I ++GV Y
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK---YTRQI--LEGVE----Y 119
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK---FVGPHSSNWTEFAGTFGYAAP 774
LH + I+HRDI N+L DS + DFG +K + + GT + +P
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
E+ K DV+S G V E++ P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 607 IGKGGQGSVYKAE-LPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G G G+VYK +P G+ VA+K + + A+ E L+E + + H +
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKAN-KEILDEAYVMASVDHPHV 71
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKE-LGWNRRINVIKGVANALSY 717
V+ G C L+ + + G L + D++ ++ L W +I A +SY
Sbjct: 72 VRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSY 124
Query: 718 L--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT--FGYAA 773
L ++HRD++++NVL+ + ++DFG+AK + + G + A
Sbjct: 125 LEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVI 799
E T K DV+S+GV V+E++
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-14
Identities = 38/91 (41%), Positives = 47/91 (51%)
Query: 342 LDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKI 401
L L N G I + L + +S N+I G+IPP +G+ L+VLDLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 402 PVQLEMLSSLNKLILNLNQLSGGVPLEFGSL 432
P L L+SL L LN N LSG VP G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 41/217 (18%)
Query: 603 EKFC-IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR--- 657
EK IG+G G V+K +G IVA+KKF + D+ + + +AL+EIR
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKF--------VESEDDPVIKKIALREIRMLK 55
Query: 658 ---HRNNVKFHGFCYNGPHSFLVCEYLDRGSL----ARILG-DDVTAKELGWNRRINVIK 709
H N V LV EY D L G + K++ W
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ------- 108
Query: 710 GVANALSYLH-HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT 768
A+++ H H+C IHRD+ +N+L+ + + DFG A+ + ++T++ T
Sbjct: 109 -TLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT 163
Query: 769 FGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKG 801
Y APE+ + +Y DV++ G + E++ G
Sbjct: 164 RWYRAPEL---LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 607 IGKGGQGSVYK---AELPSGDI---VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G G VY+ + G+ VA+K N + +M + EFLNE +KE +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE---NASMRERIEFLNEASVMKEFNCHH 70
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELG---WNRRINVIKGVAN 713
V+ G G + +V E + +G L L + LG + I + +A+
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG--- 770
++YL +HRD++++N ++ + + DFG+ + + T++ G
Sbjct: 131 GMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGGKGL 182
Query: 771 ----YAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ APE T K DV+SFGV+++E+
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 607 IGKGGQGSVYKAEL----PSGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G G V+ AE P D +VAVK + + A D F E L ++H +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKD-FHREAELLTNLQHEH 68
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL---GDDVT-------AKELGWNRRINVIKG 710
VKF+G C G +V EY+ G L + L G D EL ++ +++ +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAG--- 767
+A + YL +HRD++++N L+ N + DFG+++ V +S+++ G
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDV--YSTDYYRVGGHTM 183
Query: 768 -TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHP 804
+ PE + T + DV+S GV+++E+ G P
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 30/200 (15%)
Query: 645 EFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDD---VTAKELGW 701
+FL+E + + H N + G +V EY++ GSL L T +L
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-- 108
Query: 702 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV--GPHS 759
+ +++G+A+ + YL +HRD++++N+L++SN VSDFG+++ + P +
Sbjct: 109 ---VGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162
Query: 760 SNWTEFAGTFG--YAAPE-IAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSF 815
+ +T G + APE IAY + T DV+S+G++++EV+ G P +
Sbjct: 163 A-YTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERP-------YWEM 213
Query: 816 SNMIIDVNKILDP--RLPTP 833
SN DV K ++ RLP P
Sbjct: 214 SNQ--DVIKAIEEGYRLPAP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 11/199 (5%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKG G V+K + + +VA+K + + + D + E+ L + K++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G G +++ EYL GS +L A + ++K + L YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHSE---K 121
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
IHRDI + NVLL + ++DFG+A + F GT + APE+ K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 786 YDVYSFGVLVFEVIKGNHP 804
D++S G+ E+ KG P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 607 IGKGGQGSVYKA-ELPSGDI----VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G G G+V+K +P GD VA+K + SG E + +LA+ + H
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQ-EITDHMLAMGSLDHAYI 71
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
V+ G C G LV + GSL + + L R +N +A + YL
Sbjct: 72 VRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEH 128
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYT 779
+ +HR+++++N+LL S+ ++DFG+A + P ++E + A E
Sbjct: 129 RM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 780 MRATEKYDVYSFGVLVFEVI 799
R T + DV+S+GV V+E++
Sbjct: 186 GRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNS----QLLSGNMADHDEFLNEVLALKEI 656
+G+G G V+ A+ + +V VK L S EF E+ +++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS-------EFRRELDMFRKL 65
Query: 657 RHRNNVKFHGFCYNG-PHSFLVCEYLDRGSLARIL------GDDVTAKELGWNRRINVIK 709
H+N V+ G C PH +++ EY D G L + L + + L +++ +
Sbjct: 66 SHKNVVRLLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 710 GVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTF 769
+A + +L + +HRD++++N L+ S E VS ++K ++S + +
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNAL 179
Query: 770 G---YAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ APE + K DV+SFGVL++EV
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 35/211 (16%)
Query: 603 EKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEI 656
EK IG+G G VYKA + +G+IVA+KK + DE + E+ LKE+
Sbjct: 5 EK--IGEGTYGVVYKARDKLTGEIVALKKIR-------LETEDEGVPSTAIREISLLKEL 55
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG----VA 712
H N V+ ++ +LV E+LD L + + ++ G + + IK +
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMD---SSPLTGLDPPL--IKSYLYQLL 109
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
++Y H ++HRD+ +N+L+D ++DFG+A+ G +T T Y
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYR 166
Query: 773 APEIAYTMRATEKY----DVYSFGVLVFEVI 799
APEI + + +Y D++S G + E++
Sbjct: 167 APEI---LLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G V+ VA+K L G+M + FL E +K+++H V+ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIK----SLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
P +++ EY++ GSL L +L N+ I++ +A ++++ +
Sbjct: 69 VVTQEP-IYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAYTMRAT 783
IHRD+ + N+L+ ++DFG+A+ + + +T G + APE T
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 784 EKYDVYSFGVLVFEVI 799
K DV+SFG+L+ E++
Sbjct: 182 IKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 47/270 (17%)
Query: 593 EIIKATDDFDEKFCIGKGGQGSVYKAEL--PSGD----IVAVKKFNSQLLSGNMADHDEF 646
EI + F E+ +G+G G VYK EL P+ VA+K + EF
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKE---NAEPKVQQEF 55
Query: 647 LNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL-------------GDD 693
E + +++H N V G C + ++ EYL G L L GD+
Sbjct: 56 RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 694 VTAKELGWNRRINVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751
L + +++ +A + YL HH +HRD++++N L+ +SDFG+
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGL 170
Query: 752 AKFVGPHSSNWTEFAGT----FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 806
++ + +S+++ + PE + T + D++SFGV+++E+ G P
Sbjct: 171 SRDI--YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP-- 226
Query: 807 FFSINFSSFSNMIIDVNKILDPRLPTPSPS 836
+ FSN +V +++ R P P
Sbjct: 227 -----YYGFSNQ--EVIEMIRSRQLLPCPE 249
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 71/248 (28%), Positives = 112/248 (45%), Gaps = 31/248 (12%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
IGKG G VY L D AVK N ++ + ++FL E + +K+ H N +
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR---ITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 663 KFHGFCYNGPHSFLVC-EYLDRGSLARILGDDV---TAKELGWNRRINVIKGVANALSYL 718
G C S LV Y+ G L + + T K+L I VA + YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK------FVGPHSSNWTEFAGTFGYA 772
+HRD++++N +LD +F V+DFG+A+ + H N T +
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH--NHTGAKLPVKWM 169
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDPRL- 830
A E T + T K DV+SFGVL++E++ +G P + ++ + ++ ++L P
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVDSFDITVYLLQGRRLLQPEYC 227
Query: 831 PTPSPSVM 838
P P VM
Sbjct: 228 PDPLYEVM 235
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IG+G G V+ L + + K + L ++ +FL E LK+ H N V+ G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60
Query: 667 FCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
C ++V E + G L G + KEL I +++ A + YL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-----IQMVENAAAGMEYLESKH- 114
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV--GPHSSNWTEFAGTFGYAAPEIAYTMR 781
IHRD++++N L+ +SDFG+++ G ++S + APE R
Sbjct: 115 --CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 782 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM 818
+ + DV+SFG+L++E FS+ ++N+
Sbjct: 173 YSSESDVWSFGILLWEA---------FSLGAVPYANL 200
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-13
Identities = 39/89 (43%), Positives = 50/89 (56%)
Query: 204 LDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFI 263
L L G IP + L L ++L NS+ G+IPP LG++ SL L L N NG I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 264 PPSIGNLSSLRVLYLYNNGLYGFVPEEIG 292
P S+G L+SLR+L L N L G VP +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 598 TDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMAD---HDEFLNEVLAL 653
+F + IGKG VYKA L G +VA+KK Q+ M D + L E+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV--QIF--EMMDAKARQDCLKEIDLL 56
Query: 654 KEIRHRNNVKFH-GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI-NVIKGV 711
K++ H N +K+ F N +V E D G L+R++ K L R I +
Sbjct: 57 KQLDHPNVIKYLASFIENN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGY 771
+AL ++H I+HRDI NV + + + D G+ +F ++ GT Y
Sbjct: 116 CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 772 AAPEIAYTMRATEKYDVYSFGVLVFE 797
+PE + K D++S G L++E
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 9/195 (4%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G VYKA +G++VA+KK + + + E+ LKE+ H N VK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS--TAIREISLLKELNHPNIVKLL 65
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
+ +LV E+L + L + + D + + + + L++ H
Sbjct: 66 DVIHTENKLYLVFEFLHQ-DLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH---R 120
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR-ATE 784
++HRD+ +N+L+++ ++DFG+A+ G +T T Y APEI + +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 785 KYDVYSFGVLVFEVI 799
D++S G + E++
Sbjct: 181 AVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 593 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA 652
EI + + ++K +G G G V+ A VAVK G+M+ + FL E
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKP----GSMS-VEAFLAEANV 54
Query: 653 LKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA 712
+K ++H VK H P +++ E++ +GSL L D + + I+ +A
Sbjct: 55 MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIA 112
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAG-TFGY 771
++++ + IHRD+ + N+L+ ++ ++DFG+A+ + + E A +
Sbjct: 113 EGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 772 AAPEIAYTMRATEKYDVYSFGVLVFEVI 799
APE T K DV+SFG+L+ E++
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 33/204 (16%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+GKG G V+K L VAVK L +FL+E LK+ H N VK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI---KFLSEARILKQYDHPNIVKLIG 59
Query: 667 FCYNGPHSFLVCEYLDRG---SLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
C ++V E + G S R D++ K+L + A ++YL
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLE---S 111
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV--GPHSSN--------WTEFAGTFGYAA 773
+ IHRD++++N L+ N +SDFG+++ G +SS+ WT A
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT---------A 162
Query: 774 PEIAYTMRATEKYDVYSFGVLVFE 797
PE R + + DV+S+G+L++E
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 598 TDDFDEKFCIGKGGQGSVYKAELPSGDI-VAVKKFNSQLLSGNMADHDEFLNEVLALKEI 656
D+ E+ +GKG G VY A S + +A+K+ + + E+ +
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYL 62
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
+HRN V++ G + E + GSL+ +L + I K + L
Sbjct: 63 KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 717 YLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
YLH + I+HRDI NVL+++ + +SDFG +K + + F GT Y APE
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE 179
Query: 776 I------AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ Y A D++S G + E+ G P
Sbjct: 180 VIDKGPRGYGAPA----DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 11/199 (5%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKG G VYK + + ++VA+K + + + D + E+ L + +++
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYY 68
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G G +++ EYL GS +L L +++ + L YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE---R 121
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
IHRDI + NVLL + ++DFG+A + F GT + APE+ K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 786 YDVYSFGVLVFEVIKGNHP 804
D++S G+ E+ KG P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEF-LNE--VLALKEIRHRNNV 662
+GKG G V AEL + ++ AVK ++ D E + E VLAL +H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAG-KHPFLT 59
Query: 663 KFHGFCYNGP-HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
+ H C+ F V EY++ G L + E R + L +LH
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE---PRARFYAAEIVLGLQFLHER 115
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSNWTEFAGTFGYAAPEIAY 778
II+RD+ NVLLDS E H+ +DFG+ K + + T F GT Y APEI
Sbjct: 116 ---GIIYRDLKLDNVLLDS--EGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPEILS 169
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHP 804
D ++ GVL++E++ G P
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G V+ + VAVK L G M+ FL E +K ++H V+ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKT----LKPGTMS-VQAFLEEANLMKTLQHDKLVRLYA 68
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
+++ EY+ +GSL L D K L + I+ +A ++Y+ +
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERK---NY 124
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAG-TFGYAAPEIAYTMRATEK 785
IHRD+ + NVL+ + ++DFG+A+ + + E A + APE T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 786 YDVYSFGVLVFEVI 799
DV+SFG+L++E++
Sbjct: 185 SDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 1/103 (0%)
Query: 390 LDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSI 449
L L + + G IP + L L + L+ N + G +P GS+T L+ LDLS N + SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 450 PKSIGNLLKLHYLNLSNNQLSHKIPTEF-EKLIHLSELDLSHN 491
P+S+G L L LNL+ N LS ++P +L+H + + + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 599 DDFDEKFCIGKGGQGSVYK-AELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
DDF++ +G G G V+K + PSG I+A K + ++ A ++ + E+ L E
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN 61
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL--GDDVTAKELGWNRRINVIKGVANAL 715
V F+G Y+ + E++D GSL ++L + + LG I VIKG L
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG----L 116
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
+YL I+HRD+ N+L++S E + DFG++ + +N F GT Y +PE
Sbjct: 117 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 172
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ + D++S G+ + E+ G +P
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 69/257 (26%), Positives = 121/257 (47%), Gaps = 47/257 (18%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN---- 661
+GKG GSVYK P+G +A+K+ +L + N+++ +I H+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYI 61
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWN--RRIN--VIKGVANALSY 717
V F+G + ++ EY+D GSL ++ V + + + RRI V+KG L +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG----LKF 117
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE-- 775
L + +IIHRD+ NVL++ N + + DFG++ + +S G Y APE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTNIGCQSYMAPERI 173
Query: 776 --------IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILD 827
YT+++ DV+S G+ + E+ G +P +++N+ ++ I+D
Sbjct: 174 KSGGPNQNPTYTVQS----DVWSLGLSILEMALGRYPYP-----PETYANIFAQLSAIVD 224
Query: 828 ---PRLPTP-SPSVMDY 840
P LP+ S D+
Sbjct: 225 GDPPTLPSGYSDDAQDF 241
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 11/199 (5%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKG G V+K + + +VA+K + + + D + E+ L + K++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
G +++ EYL GS +L L + +++ + L YLH +
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---K 121
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
IHRDI + NVLL + E ++DFG+A + F GT + APE+ K
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 786 YDVYSFGVLVFEVIKGNHP 804
D++S G+ E+ KG P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 5/104 (4%)
Query: 368 VSMNN--ISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGV 425
+ ++N + G IP DI LQ ++LS N I G IP L ++SL L L+ N +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 426 PLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLH--YLNLSNN 467
P G LT L+ L+L+ N LS +P ++G L LH N ++N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 38/260 (14%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEV-LALKEI 656
DD + +G+G G V K +P+G I+AVK+ + + N + L ++ ++++ +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDLDISMRSV 57
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSL----ARILGDDVTAKE--LGWNRRINVIKG 710
V F+G + ++ E +D SL ++ +T E LG +I V
Sbjct: 58 DCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILG---KIAV--S 111
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
+ AL YLH S+IHRD+ NVL++ N + + DFGI+ ++ S T AG
Sbjct: 112 IVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKP 168
Query: 771 YAAPE--------IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDV 822
Y APE Y +++ DV+S G+ + E+ G P D + F ++ +
Sbjct: 169 YMAPERINPELNQKGYDVKS----DVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP 224
Query: 823 NKILDPRLP--TPSPSVMDY 840
+ P+LP SP D+
Sbjct: 225 S----PQLPAEKFSPEFQDF 240
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 46/221 (20%)
Query: 607 IGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHR 659
IG+G G V +A + + I +K+F S+ DH +F E+ L ++ H
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE------NDHRDFAGELEVLCKLGHHP 63
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSL------ARILGDDV-------TAKELGWNRRIN 706
N + G C N + ++ EY G+L +R+L D TA L + +
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA--------KFVGPH 758
VA + YL IHRD++++NVL+ N + ++DFG++ K +G
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W A + Y++ T K DV+SFGVL++E++
Sbjct: 181 PVRWM--------AIESLNYSVYTT-KSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 607 IGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADH-DEFLNEVLALKEIRHRN 660
+GKG GSV +G++VAVKK L + A+H +F E+ LK ++H N
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKK-----LQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 661 NVKFHGFCYNG--PHSFLVCEYLDRGSLARILGDDV----TAKELGWNRRINVIKGVANA 714
VK+ G CY+ + LV EYL GSL L K L + +I KG
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--CKG---- 120
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF-----AGTF 769
+ YL +HRD++++N+L++S + DFG+ K + P + + + F
Sbjct: 121 MEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYKVREPGESPIF 176
Query: 770 GYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
Y APE + + DV+SFGV+++E+
Sbjct: 177 WY-APESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKF- 664
IGKG G V A + +G+ VA+KK N + +++D L E+ L+ +RH + V+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIND--VFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 665 HGFCYNGPHSF---LVCEYLDRGSLARILG--DDVTAKELGWNRRINVIKGVANALSYLH 719
H F V L L +++ DD+T + + + + AL Y+H
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF-----FLYQLLRALKYIH 120
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV---GPHSSNWTEFAGTFGYAAPEI 776
++ HRD+ KN+L +++ + + DFG+A+ P + WT++ T Y APE+
Sbjct: 121 T---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 777 --AYTMRATEKYDVYSFGVLVFEVIKG 801
++ + T D++S G + EV+ G
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IG+G G +Y A+ S V K L + + + EV+ L +++H N V F
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIK-EIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDD--VTAKE---LGWNRRINVIKGVANALSYLHHD 721
F+V EY D G L + + V E L W +I++ L ++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHDR 120
Query: 722 CLPSIIHRDISSKNVLLDSN-FEAHVSDFGIAKFVGPHSSNWTEFA----GTFGYAAPEI 776
I+HRDI S+N+ L N A + DFGIA+ + ++ E A GT Y +PEI
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYYLSPEI 173
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
K D++S G +++E+ HP
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 607 IGKGGQGSVYKA-ELPSGDIV----AVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G G G+VYK +P G+ V A+K N +G A+ EF++E L + + H +
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANV-EFMDEALIMASMDHPHL 71
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
V+ G C + P LV + + G L + + +G +N +A + YL
Sbjct: 72 VRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEER 128
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTF--GYAAPEIAYT 779
++HRD++++NVL+ S ++DFG+A+ + + G + A E +
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 780 MRATEKYDVYSFGVLVFEVIK-GNHPRD 806
+ T + DV+S+GV ++E++ G P D
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 28/220 (12%)
Query: 591 HEEIIKATDDFDEKFCIGKGGQGSVYK---AELPSGDIVAVKKFNSQLLSGNMADHDE-F 646
H+ +K E G G+ S+Y A +G++VAVK L + +
Sbjct: 2 HKRYLKKIRVLGE----GHFGKVSLYCYDPANDGTGEMVAVK----TLKRECGQQNTSGW 53
Query: 647 LNEVLALKEIRHRNNVKFHGFCYNGPHS--FLVCEYLDRGSLARILGDDVTAKELGWNRR 704
E+ LK + H N VK+ G C L+ EY+ GSL L +L +
Sbjct: 54 KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQL 109
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE 764
+ + + ++YLH IHRD++++NVLLD++ + DFG+AK V P +
Sbjct: 110 LLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYR 165
Query: 765 F-----AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
+ F Y A E + + DV+SFGV ++E++
Sbjct: 166 VREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 40/218 (18%)
Query: 607 IGKGGQGSVYKAELPSGDI---VAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNV 662
IG+G G V KA + + A+K+ + DH +F E+ L ++ H N +
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSL------ARILGDD-------VTAKELGWNRRINVIK 709
G C + + +L EY G+L +R+L D TA L + ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 710 GVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA--------KFVGPHSSN 761
VA + YL IHRD++++N+L+ N+ A ++DFG++ K +G
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 188
Query: 762 WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W A + Y++ T DV+S+GVL++E++
Sbjct: 189 WM--------AIESLNYSVYTTNS-DVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 62/250 (24%), Positives = 106/250 (42%), Gaps = 19/250 (7%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADH--DEFLNEVLALKEIRHRNNVK 663
+G G S Y+A ++ +G ++AVK+ + + + + E+ + + H + ++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
G H L E++ GS++ +L KE IN + + LSYLH +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122
Query: 724 PSIIHRDISSKNVLLDSNFE-AHVSDFGIAKFVGPHSSNWTEFA----GTFGYAAPEIAY 778
IIHRD+ N+L+DS + ++DFG A + + EF GT + APE+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVM 838
+ DV+S G ++ E+ P N SN + + KI P +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP-----WNAEKHSNHLALIFKIASATTAPSIPEHL 236
Query: 839 DYGGCHFMLR 848
G LR
Sbjct: 237 SPGLRDVTLR 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 13/208 (6%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
DDF+ +G G G V K + PSG I+A K + ++ A ++ + E+ L E
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN 61
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGD-DVTAKELGWNRRINVIKGVANALS 716
V F+G Y+ + E++D GSL ++L + +E+ I V++G L+
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG----LA 117
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
YL I+HRD+ N+L++S E + DFG++ + +N F GT Y +PE
Sbjct: 118 YLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 173
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ + D++S G+ + E+ G +P
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRN 660
IG+G G VYKA + + + +A+KK + DE + E+ LKE++H N
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIR-------LEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI------NVIKGVANA 714
V+ ++ +LV EYLD L + + ++ + N R+ +++G+A
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLDL-DLKKHMD---SSPDFAKNPRLIKTYLYQILRGIA-- 116
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEA-HVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
Y H ++HRD+ +N+L+D A ++DFG+A+ G +T T Y A
Sbjct: 117 --YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171
Query: 774 PEIAYTMRA-TEKYDVYSFGVLVFEVI 799
PEI R + D++S G + E++
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 21/228 (9%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+DF+ IG G G VYKA + +G++ A+K +L G D E++ +K+ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI--KLEPGE--DFAVVQQEIIMMKDCK 64
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H N V + G ++ E+ GSL I VT L ++ V + L Y
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY--HVTGP-LSESQIAYVSRETLQGLYY 121
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
LH +HRDI N+LL N ++DFG++ + + F GT + APE+A
Sbjct: 122 LHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 778 YTMRA---TEKYDVYSFGVLVFEVIKGNHP-------RDFFSINFSSF 815
R + D+++ G+ E+ + P R F + S+F
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 67/225 (29%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G G G VYKA L +G++ AVK +L G+ D E+ +KE +H N V +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII--KLEPGD--DFSLIQQEIFMVKECKHCNIVAYF 72
Query: 666 GFCYNGPHSFLVC-EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
G Y +C EY GSL I EL + V + L+YLH
Sbjct: 73 G-SYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAYLHSK--- 125
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATE 784
+HRDI N+LL N + ++DFG+A + + F GT + APE+A A E
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA----AVE 181
Query: 785 KY-------DVYSFGVLVFEVIKGNHP-------RDFFSINFSSF 815
K D+++ G+ E+ + P R F ++ S+F
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 607 IGKGGQGSVYKAELPSGDIV--AVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV-K 663
IG+G G V KA + + A K + S + DH +F E+ L ++ H N+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIIN 60
Query: 664 FHGFCYNGPHSFLVCEYLDRGSL------ARILGDDV-------TAKELGWNRRINVIKG 710
G C + + +L EY G+L +R+L D TA L + ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA--------KFVGPHSSNW 762
VA + YL IHRD++++N+L+ N+ A ++DFG++ K +G W
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
A + Y++ T DV+S+GVL++E++
Sbjct: 178 M--------AIESLNYSVYTT-NSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 9/176 (5%)
Query: 649 EVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVI 708
E + L +++H N V F H ++V EY D G L + + K + +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWF 106
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT 768
+ + ++H ++HRDI SKN+ L N + + DFG A+ + + + GT
Sbjct: 107 VQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163
Query: 769 FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNK 824
Y PEI M K D++S G +++E+ HP F N S+ N+I+ V +
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP---FQAN--SWKNLILKVCQ 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 48/225 (21%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHD--EFLNEVLALKEI-R 657
+G+G G V KAE D VAVK L + + D + ++E+ +K I +
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKM-----LKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 658 HRNNVKFHGFC-YNGPHSFLVCEYLDRGSL------------------ARILGDDVTAKE 698
H+N + G C GP ++V EY G+L R + +T K+
Sbjct: 75 HKNIINLLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 699 LGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758
L ++ VA + +L IHRD++++NVL+ + ++DFG+A+ + H
Sbjct: 134 L-----VSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDI--H 183
Query: 759 SSNW----TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
++ T + APE + T + DV+SFGVL++E+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 71/194 (36%), Positives = 100/194 (51%), Gaps = 8/194 (4%)
Query: 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQ 138
+L L+LS N ++P + NL L+ LDL N LS +P + L+ L L L N+
Sbjct: 140 SNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNK 197
Query: 139 LHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKL 198
+ +PPEI LS +++L L NN + SSL NL NL+ L L N L +P IG L
Sbjct: 198 IS-DLPPEIELLSALEELDL-SNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNL 254
Query: 199 KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPI-LGNLKSLSALGLHIN 257
+L LDLS NQ S SLG+L++L + L NSLS ++P I L L L L +
Sbjct: 255 SNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT 312
Query: 258 QLNGFIPPSIGNLS 271
+ + L+
Sbjct: 313 LKALELKLNSILLN 326
|
Length = 394 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK-- 663
+G G G VYK + +G + A+K + ++G+ + +E E+ LK+ H N+
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGD--EEEEIKQEINMLKKYSHHRNIATY 68
Query: 664 FHGFCYNGP-----HSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANA 714
+ F P +LV E+ GS+ ++ G+ + + + + + + +
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----ICREILRG 123
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
LS+LH +IHRDI +NVLL N E + DFG++ + F GT + AP
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
Query: 775 EIAYTMRATE-----KYDVYSFGVLVFEVIKGNHP 804
E+ + K D++S G+ E+ +G P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G VYKA+ + A K + D F+ E+ L E +H N V +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPNIVGLYE 69
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
+ +++ E+ D G+L I+ + L + V + + AL++LH +
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY--TMRATE 784
IHRD+ + N+LL + + ++DFG++ F GT + APE+ T +
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 785 ---KYDVYSFGVLVFEVIKGNHP 804
K D++S G+ + E+ + P
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 607 IGKGGQGSVYKA---ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK 663
+G G G+V K S VAVK + + + A DE L E ++++ + V+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELLREANVMQQLDNPYIVR 60
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLARILGDD--VTAKELGWNRRINVIKGVANALSYLHHD 721
G C LV E + G L + L + VT K + ++ V+ + YL
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEET 114
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG-----YAAPEI 776
+ +HRD++++NVLL + A +SDFG++K +G + + A T G + APE
Sbjct: 115 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPEC 169
Query: 777 AYTMRATEKYDVYSFGVLVFE 797
+ + K DV+SFGVL++E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
DDF++ +G G G V K PSG I+A K + L A ++ + E+ L E
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH---LEIKPAIRNQIIRELKVLHECN 57
Query: 658 HRNNVKFHG-FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI------NVIKG 710
V F+G F +G S + E++D GSL ++L K+ G RI +
Sbjct: 58 SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL------KKAG---RIPENILGKISIA 107
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
V L+YL I+HRD+ N+L++S E + DFG++ + S F GT
Sbjct: 108 VLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRS 163
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
Y +PE T + D++S G+ + E+ G +P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 2e-11
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 26/203 (12%)
Query: 606 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN--EVLALKEI-RHRNN 661
+G G GSVY A +G++VA+KK + S +E +N EV +L+++ H N
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-----WEECMNLREVKSLRKLNEHPNI 60
Query: 662 VKFHG-FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
VK F N + V EY++ G+L +++ D K + ++I + L+++H
Sbjct: 61 VKLKEVFREND-ELYFVFEYME-GNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN-WTEFAGTFGYAAPEIAYT 779
HRD+ +N+L+ ++DFG+A+ + S +T++ T Y APEI
Sbjct: 118 H---GFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAPEI--L 170
Query: 780 MRATEKY----DVYSFGVLVFEV 798
+R+T Y D+++ G ++ E+
Sbjct: 171 LRST-SYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 28/239 (11%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
DD + +G G G V+ + S A+K +++ H NE LKE+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH--NEKRVLKEV 58
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG------ 710
H ++ ++ +++ EY+ G L L + + R + G
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFSNSTGLFYASE 109
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
+ AL YLH I++RD+ +N+LLD ++DFG AK + WT GT
Sbjct: 110 IVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL--RDRTWT-LCGTPE 163
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPR 829
Y APE+ + + D ++ G+L++E++ G P FF N I+ K+ PR
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP--FFDDNPFGIYEKILA-GKLEFPR 219
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 4/199 (2%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G VY+A L G VA+KK L A D + E+ LK++ H N +K++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHPNVIKYY 68
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
+V E D G L+R++ K L + V K S L H
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEK--TVWKYFVQLCSALEHMHSRR 126
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
++HRDI NV + + + D G+ +F ++ GT Y +PE + K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 786 YDVYSFGVLVFEVIKGNHP 804
D++S G L++E+ P
Sbjct: 187 SDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
+A AL +LH II+RD+ +N+LLD ++DFG++K H F GT
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
Y APE+ T+ D +SFGVL+FE++ G+ P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHD----EFLNEVLALKEIRHRNN 661
+GKG G V AEL G+ AVK ++ + D D VLAL N
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVV---LIDDDVECTMVEKRVLALA---WENP 56
Query: 662 VKFHGFC--YNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
H +C H F V E+L+ G L + D R + L +LH
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLH 113
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT 779
II+RD+ NV+LD + ++DFG+ K + + F GT Y APEI
Sbjct: 114 SK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 780 MRATEKYDVYSFGVLVFEVIKGNHP 804
++ T D +SFGVL++E++ G P
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 35/88 (39%), Positives = 50/88 (56%)
Query: 228 MSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFV 287
+ L N L G IP + L+ L ++ L N + G IPPS+G+++SL VL L N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 288 PEEIGYLKSLSELELCTNLLRGVIPHSI 315
PE +G L SL L L N L G +P ++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 601 FDEKFC--IGKGGQGSVYKAEL----PSGD----IVAVKKFNSQLLSGNMADHDEFLNEV 650
F+++F I G+G K EL P GD VAVK + ++AD E+
Sbjct: 1 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKEI 57
Query: 651 LALKEIRHRNNVKFHGFCYNGPHSF--LVCEYLDRGSLARILGDDVTAKELGWNRRINVI 708
L+ + H N VK+ G C + L+ E+L GSL L + L +++
Sbjct: 58 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYA 115
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT---EF 765
+ + YL +HRD++++NVL++S + + DFG+ K + +T +
Sbjct: 116 VQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
+ APE + DV+SFGV ++E++
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 35/214 (16%)
Query: 607 IGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G G G VY+ VAVK S + D +FL E L + + H+N
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE---SCSEQDESDFLMEALIMSKFNHQN 70
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDD---------VTAKELGWNRRINVIKGV 711
V+ G + F++ E + G L L ++ +T K+L + + V
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL-----LFCARDV 125
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSNFE---AHVSDFGIAKFVGPHSSNWTEFAGT 768
A YL + IHRDI+++N LL A ++DFG+A+ + + +++ G
Sbjct: 126 AKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI--YRASYYRKGGR 180
Query: 769 ----FGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ PE T K DV+SFGVL++E+
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 607 IGKGGQGSVYKAELPSGDI---VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK 663
+G+G GSV + +L D VAVK + + ++ ++FL+E + +KE H N ++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 664 FHGFCYNG------PHSFLVCEYLDRGSLARIL-----GDDVTAKELGWNRRINVIKGVA 712
G C P ++ ++ G L L GD + L + + +A
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD--CPQYLPTQMLVKFMTDIA 122
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK--FVGPHSSNWTEFAGTFG 770
+ + YL S IHRD++++N +L+ N V+DFG++K + G +
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEV-IKGNHP 804
+ A E T K DV+SFGV ++E+ +G P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 71/219 (32%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 335 DHPNLTFLDLSNNNFC---GEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLD 391
+ NLT LDL NNN I N +L +S N I S+P + N P L+ LD
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELD---LSDNKIE-SLPSPLRNLPNLKNLD 169
Query: 392 LSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPK 451
LS N + S L KL+ N L+ L LDLS NK+ S +P
Sbjct: 170 LSFNDL-----------SDLPKLLSN--------------LSNLNNLDLSGNKI-SDLPP 203
Query: 452 SIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLN 511
I L L L+LSNN + ++ + L +LS L+LS+N E++P + N+ +LE L+
Sbjct: 204 EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLD 261
Query: 512 LSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTA 550
LS+N +S + +L +D+S N L +P
Sbjct: 262 LSNNQISSI--SSLGSLTNLRELDLSGNSLSNALPLIAL 298
|
Length = 394 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 19/180 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR---HRNNV 662
IG+G G+VYKA +L +G VA+KK L + L E+ LK++ H N V
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPL--STLREIALLKQLESFEHPNIV 64
Query: 663 KFHGFCYNGPHS------FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
+ C+ GP + LV E++D+ LA L L ++++ + +
Sbjct: 65 RLLDVCH-GPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+LH I+HRD+ +N+L+ S+ + ++DFG+A+ + T T Y APE+
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEV 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
C+ KG VYK D VA+K ++ + DE + E + ++ + V+
Sbjct: 10 CVKKG----VYKMRKKQID-VAIKVLKNE---NEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILG---DDVTAKELGWNRRINVIKGVANALSYLHHDC 722
G C LV E G L + L D++T + + ++ V+ + YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYLEGK- 114
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG-----YAAPEIA 777
+ +HRD++++NVLL + A +SDFG++K +G S + A + G + APE
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECI 170
Query: 778 YTMRATEKYDVYSFGVLVFEVIK-GNHP 804
+ + + DV+S+G+ ++E G P
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 42/222 (18%)
Query: 607 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-R 657
+G+G G V AE D VAVK +++D ++E+ +K I +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEMEMMKMIGK 79
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSL------------------ARILGDDVTAKEL 699
H+N + G C +++ EY +G+L AR+ + +T K+L
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 700 GWNRRINVIKGVANALSYL-HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG-- 756
++ VA + YL C IHRD++++NVL+ N ++DFG+A+ V
Sbjct: 140 -----VSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ T + APE + T + DV+SFGVL++E+
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 38/220 (17%)
Query: 607 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADHD--EFLNEVLALKEI 656
+G+G G V +AE D VAVK +L N D D + ++E+ +K I
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-----MLKDNATDKDLADLISEMELMKLI 74
Query: 657 -RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL-------------GDDVTAKELGWN 702
+H+N + G C +++ EY +G+L L V ++L +
Sbjct: 75 GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 703 RRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762
++ VA + YL IHRD++++NVL+ + ++DFG+A+ G H ++
Sbjct: 135 DLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDY 189
Query: 763 TEFAGT----FGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ + APE + T + DV+SFG+L++E+
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 607 IGKG--GQGSVY-KAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK 663
+GKG G+ ++Y + E +V K+ N LS + + LNE++ L ++H N +
Sbjct: 8 LGKGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEK--ERRDALNEIVILSLLQHPNIIA 63
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALSYLH 719
++ + + EY + G+L + G + + W + + +A+SY+H
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIH 118
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT 779
I+HRDI + N+ L + DFGI+K +G S GT Y +PE+
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175
Query: 780 MRATEKYDVYSFGVLVFEV 798
++ K D+++ G +++E+
Sbjct: 176 VKYNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 601 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR 659
F + +GKGG G V ++ +G + A KK + + + LNE L+++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-SMALNEKQILEKVNSR 60
Query: 660 NNVKFHGFCYNGPHSF-LVCEYLDRGSLARILGDDVTAKELGWN--RRINVIKGVANALS 716
V + Y + LV ++ G L + E G+ R + + L
Sbjct: 61 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
LH + I++RD+ +N+LLD + +SD G+A V P GT GY APE+
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMAPEV 172
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
R T D ++ G L++E+I G P
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 30/237 (12%)
Query: 607 IGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+GKGG G V++ +G I A+K + N D E L+ ++H V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSL------ARILGDDVTAKELGWNRRINVIKGVANALS 716
G +L+ EYL G L I +D L ++ AL
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS---------EISLALE 114
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+LH II+RD+ +N+LLD+ ++DFG+ K + F GT Y APEI
Sbjct: 115 HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTP 833
+ D +S G L+++++ G P F++ N ++KIL +L P
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPP-------FTA-ENRKKTIDKILKGKLNLP 220
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 41/212 (19%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLN-----EVLALKEIRHRN 660
+G+G VYKA +G IVA+KK + G + + +N E+ L+E++H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKK----IKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 661 NVKFHG-FCYNGPHSFLVCEYLDRGSLARILGD--------DVTAKELGWNRRINVIKGV 711
+ F + + LV E+++ L +++ D D+ + +
Sbjct: 64 IIGLLDVFGHKSNIN-LVFEFME-TDLEKVIKDKSIVLTPADIKS----------YMLMT 111
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGY 771
L YLH + I+HRD+ N+L+ S+ ++DFG+A+ G + T T Y
Sbjct: 112 LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168
Query: 772 AAPEIAYTMRATEKY----DVYSFGVLVFEVI 799
APE+ + Y D++S G + E++
Sbjct: 169 RAPELLF---GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 39/224 (17%)
Query: 607 IGKGGQGSVYKAE------LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G G V KA VAVK + + ++ + L+E LK++ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE---NASSSELRDLLSEFNLLKQVNHPH 64
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL-----------------------GDDVTAK 697
+K +G C L+ EY GSL L D A
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 698 ELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757
+G I+ ++ + YL ++HRD++++NVL+ + +SDFG+++ V
Sbjct: 125 TMG--DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 758 HSSNWTEFAGTF--GYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
S G + A E + T + DV+SFGVL++E++
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 599 DDFDEKFCIGKGGQGSVYKA--ELPSGDI--VAVKKFNSQLLSGNMADHDEFLNEVLALK 654
+D CIG+G G VY+ P + VAVK + + + ++FL E ++
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMR 62
Query: 655 EIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA 714
+ H + VK G P ++V E G L L V L I ++ A
Sbjct: 63 QFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTA 119
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG---- 770
L+YL +HRDI+++NVL+ S + DFG+++++ S + + G
Sbjct: 120 LAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY----YKASKGKLPI 172
Query: 771 -YAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
+ APE R T DV+ FGV ++E++
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 31/87 (35%), Positives = 51/87 (58%)
Query: 462 LNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFI 521
L L N L IP + KL HL ++LS N ++ IPP + ++ SLE L+LS+N+ + I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 522 PRCFEEMRSLSCIDISYNELHGPIPNS 548
P ++ SL ++++ N L G +P +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 607 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-------RH 658
+G+G G V AE +G++ A+K L G++ DE + ++ K I RH
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKA----LKKGDIIARDE-VESLMCEKRIFETANSERH 61
Query: 659 RNNVKFHGFCYNGP-HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
V C+ H V EY G L + DV ++ R + V L Y
Sbjct: 62 PFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP----RAVFYAACVVLGLQY 116
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
LH + I++RD+ N+LLD+ ++DFG+ K + F GT + APE+
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL 173
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHP 804
T D + GVL++E++ G P
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 46/142 (32%), Positives = 64/142 (45%), Gaps = 8/142 (5%)
Query: 665 HGFC--YNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC 722
H FC H F V EYL+ G L + + R + L +LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKK- 115
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA 782
II+RD+ NVLLD + ++DFG+ K + F GT Y APEI +
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 783 TEKYDVYSFGVLVFEVIKGNHP 804
E D +SFGVL++E++ G P
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 605 FCIGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR 659
C G Q KA + + +VAVK + ++FL EV L +
Sbjct: 23 LCEADGLQDFSEKAFAENDNADAPVLVAVKVL---RPDASDNAREDFLKEVKILSRLSDP 79
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSLARIL--------GDDVTAKELGWNRRINVIKGV 711
N + G C P ++ EY++ G L + L G +K L ++ + + +
Sbjct: 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQI 139
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT--- 768
A+ + YL + +HRD++++N L+ N+ ++DFG+++ + +SS++ G
Sbjct: 140 ASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNL--YSSDYYRVQGRAPL 194
Query: 769 -FGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ A E + T K DV++FGV ++E+
Sbjct: 195 PIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 11/216 (5%)
Query: 607 IGKGGQGSVYKAELPS-GDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
IGKG G V A+ + G AVK +L H VL LK ++H V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVL-LKNVKHPFLVGL 61
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
H + V +Y++ G L L + + E R +A+AL YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS---L 115
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATE 784
+II+RD+ +N+LLDS ++DFG+ K HS + F GT Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 785 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 820
D + G +++E++ G P F+S + + + I+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP--FYSRDTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 8/195 (4%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G VYK +G IVA+KK +L S + E+ LKE++H N V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI--RLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
+L+ E+L L + L + + + + + + + H
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY-TMRATE 784
++HRD+ +N+L+D+ ++DFG+A+ G +T T Y APE+ + R +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 785 KYDVYSFGVLVFEVI 799
D++S G + E+
Sbjct: 182 PVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKF 664
+G G G VYK + +G + A+K ++ + +E E+ LK+ HRN +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-----VMDVTEDEEEEIKLEINMLKKYSHHRNIATY 78
Query: 665 HG-FCYNGP-----HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL 718
+G F P +LV E+ GS+ ++ + L + + + + L++L
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIAYICREILRGLAHL 137
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY 778
H +IHRDI +NVLL N E + DFG++ + F GT + APE+
Sbjct: 138 H---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 779 TMR---ATEKY--DVYSFGVLVFEVIKGNHP 804
AT Y D++S G+ E+ +G P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-10
Identities = 44/128 (34%), Positives = 63/128 (49%), Gaps = 14/128 (10%)
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPE 775
+HH +IHRDI S N+LL SN + DFG +K S+ F GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKIL----DPRLP 831
I ++K D++S GVL++E++ P D NM ++K L DP P
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------GENMEEVMHKTLAGRYDPLPP 267
Query: 832 TPSPSVMD 839
+ SP + +
Sbjct: 268 SISPEMQE 275
|
Length = 496 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFL---NEVLALKEIRHRNNV 662
+GKG G V+ AEL + A+K ++ M D E VL+L +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLA---WEHPF 57
Query: 663 KFHGFC--YNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
H +C + F V EYL+ G L + + + R + L +LH
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM 780
I++RD+ N+LLD++ ++DFG+ K + F GT Y APEI
Sbjct: 115 K---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 781 RATEKYDVYSFGVLVFEVIKGNHP 804
+ D +SFGVL++E++ G P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 607 IGKGGQGSVYKAELPSGDI-------VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR 659
+G+G G VY+ + G + VA+K N + +M + EFLNE +KE
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNE---AASMRERIEFLNEASVMKEFNCH 69
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSLA---RILGDDVTAKEL----GWNRRINVIKGVA 712
+ V+ G G + ++ E + RG L R L ++ + + I + +A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---- 768
+ ++YL+ + +HRD++++N ++ +F + DFG+ + + + +++ G
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLLP 184
Query: 769 FGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ +PE T DV+SFGV+++E+
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKF- 664
+GKGG G V ++ +G + A KK + + L + L KEI + N F
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLE-----KEILEKVNSPFI 55
Query: 665 --HGFCYNGP-HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
+ + H LV ++ G L + + V + L R I+ + + +LH
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS- 113
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR 781
I++RD+ +NVLLD +SD G+A + T+ AGT GY APEI
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEP 170
Query: 782 ATEKYDVYSFGVLVFEVIKGNHP-RDF 807
+ D ++ G ++E++ G P +D
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN----- 660
+G G GSV A + +G+ VA+KK + S A E+ LK ++H N
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA--YRELTLLKHMQHENVIGLL 80
Query: 661 NVKFHGFCYNGPHSF-LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
+V + F LV Y+ + L +I+G ++ ++ + ++ + L Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIH 134
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT 779
IIHRD+ N+ ++ + E + DFG+A+ + T + T Y APE+
Sbjct: 135 S---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVILN 188
Query: 780 -MRATEKYDVYSFGVLVFEVIKG 801
M + D++S G ++ E++ G
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 607 IGKGGQGSVYKAELPSGDI----VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+G+G GSV + +L D VAVK + + ++ +EFL+E +K+ H N +
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNVM 64
Query: 663 KFHGFCYNG------PHSFLVCEYLDRGSLARILGDDVTA---KELGWNRRINVIKGVAN 713
K G C+ P ++ ++ G L L ++L + + +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
+ YL + + IHRD++++N +L + V+DFG++K + +S ++
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKI--YSGDYYRQGRIAKMPV 179
Query: 774 PEIAYTMRA----TEKYDVYSFGVLVFEVI-KGNHP 804
IA A T K DV++FGV ++E+ +G P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 9/234 (3%)
Query: 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKG G V A+ G AVK +++ + LK ++H V H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
+ V ++++ G L L + + E R +A+AL YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS---IN 116
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
I++RD+ +N+LLDS ++DFG+ K S T F GT Y APE+
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 786 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVMD 839
D + G +++E++ G P F+ + + + I+ +L P + S+++
Sbjct: 177 VDWWCLGAVLYEMLYGLPP--FYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 607 IGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADHDEFLNE--VLALKEIRHRNNVK 663
+GKG G V AEL D + A+K ++ + D D + E +LAL +H
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD-DDVDCTMTEKRILALAA-KHPFLTA 60
Query: 664 FHGFCYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC 722
H C+ F V EY++ G L + +++ R V AL +LH
Sbjct: 61 LHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH- 115
Query: 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA 782
+I+RD+ N+LLD+ ++DFG+ K + T F GT Y APEI +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 783 TEKYDVYSFGVLVFEVIKGNHP 804
D ++ GVL++E++ G P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 9/234 (3%)
Query: 607 IGKGGQGSVYKAELPSGDIV-AVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKG G V A + + AVK + + + + LK ++H V H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
+ V +Y++ G L L + E R +A+AL YLH +
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLE---PRARFYAAEIASALGYLHS---LN 116
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
I++RD+ +N+LLDS ++DFG+ K H+ + F GT Y APE+ +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 786 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVMD 839
D + G +++E++ G P F+S N + + I++ L P + + +++
Sbjct: 177 VDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 70/268 (26%), Positives = 107/268 (39%), Gaps = 34/268 (12%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR---HRNNV 662
IG G G+VYKA + SG VA+K Q + + EV LK + H N V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQ--TNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 663 KFHGFCYNG-----PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
+ C LV E++D+ R D V L ++++ L +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQD--LRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
LH +C I+HRD+ +N+L+ S + ++DFG+A+ + T T Y APE+
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVL 179
Query: 778 YTMRATEKYDVYSFGVLVFEVIK------GNHPRD-----FFSINFSSFSNMIIDVN--- 823
D++S G + E+ + GN D F I + DV
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239
Query: 824 KILDPRLPTPSPSV---MDYGGCHFMLR 848
PR P P SV ++ G +L
Sbjct: 240 GAFSPRGPRPVQSVVPEIEESGAQLLLE 267
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+D + IG+G G+V K PSG I+AVK+ S + + + L ++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV---DEKEQKRLLMDLDVVMRSS 60
Query: 658 HRNN-VKFHGFCYNGPHSFLVCEYLDRGSLARI--LGDDVTAKELGWNRRINVIKGVANA 714
VKF+G + ++ E +D SL + +V + + A
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L+YL + IIHRD+ N+LLD N + DFGI+ + S T AG Y AP
Sbjct: 120 LNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAP 176
Query: 775 E-IAYTMRATEKYD----VYSFGVLVFEVIKGNHP 804
E I + R + YD V+S G+ ++EV G P
Sbjct: 177 ERIDPSAR--DGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 42/217 (19%)
Query: 607 IGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+ K G+GS KA L G +K+ N +S + +E EV L ++H N V
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK--EREESRKEVAVLSNMKHPNIV 62
Query: 663 KF-HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA----NALSY 717
++ F NG + ++V +Y + G L + +IN +GV L +
Sbjct: 63 QYQESFEENG-NLYIVMDYCEGGDLYK---------------KINAQRGVLFPEDQILDW 106
Query: 718 LHHDCLP-------SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA---- 766
CL I+HRDI S+N+ L + + DFGIA+ + ++ E A
Sbjct: 107 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCI 162
Query: 767 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 803
GT Y +PEI K D+++ G +++E+ H
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 63/240 (26%), Positives = 109/240 (45%), Gaps = 27/240 (11%)
Query: 607 IGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+GKG GSV +A+L S VAVK + + S +D +EFL E +KE H N +
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS--SDIEEFLREAACMKEFDHPNVI 64
Query: 663 KFHGFCYNG------PHSFLVCEYLDRGSLARILGDDVTAKE---LGWNRRINVIKGVAN 713
K G P ++ ++ G L L +E L + + +A+
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
+ YL + IHRD++++N +L+ N V+DFG++K + +S ++
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKI--YSGDYYRQGCASKLPV 179
Query: 774 PEIAYTMRATEKY----DVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDP 828
+A A Y DV++FGV ++E++ +G P + + S N +I N++ P
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--YAGVENSEIYNYLIKGNRLKQP 237
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK-FVGPHSSNWTEFAGTFGYA 772
AL +LH II+RDI +N+LLDS ++DFG++K F+ F GT Y
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 773 APEIAYTMRA--TEKYDVYSFGVLVFEVIKGNHP 804
APE+ + D +S GVL FE++ G P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 41/136 (30%), Positives = 58/136 (42%), Gaps = 26/136 (19%)
Query: 711 VANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT 768
+ AL YL H +IHRD+ N+LLD++ + DFGI+ + S T AG
Sbjct: 123 IVKALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRL-VDSKAKTRSAGC 177
Query: 769 FGYAAPE--------IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 820
Y APE Y +RA DV+S G+ + E+ G P F +
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRA----DVWSLGISLVELATGQFPYKNCKTEFEVLT---- 229
Query: 821 DVNKILDPRLPTPSPS 836
KIL P+ P+
Sbjct: 230 ---KILQEEPPSLPPN 242
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG-VANALSYLHHDCLPSIIHRDISSK 734
L+ +Y++ G L L KE + + + G + AL +LH II+RDI +
Sbjct: 82 LILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHLHK---LGIIYRDIKLE 134
Query: 735 NVLLDSNFEAHVSDFGIAK-FVGPHSSNWTEFAGTFGYAAPEIAYTMRA--TEKYDVYSF 791
N+LLDSN ++DFG++K F F GT Y AP+I + D +S
Sbjct: 135 NILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSM 194
Query: 792 GVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTP 833
GVL++E++ G P F+++ S I +IL P P
Sbjct: 195 GVLMYELLTGASP---FTVDGEKNSQAEIS-RRILKSEPPYP 232
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 10/110 (9%)
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF--VGPHSSNWTE 764
+ K + L YLH IIHRD+ ++N+ ++ + + D G A+F V P +
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLG 215
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 814
AGT APE+ + K D++S G+++FE++ +P F S+
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 607 IGKGGQGSVYKAELPSGDI--------VAVKKFNSQLLSGNMADHDEFLNEVLALKEI-R 657
+G+G G V AE D VAVK S +++D ++E+ +K I +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSD---LISEMEMMKMIGK 82
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILG-------------DDVTAKELGWNRR 704
H+N + G C +++ EY +G+L L V ++L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW-- 762
++ VA + YL IHRD++++NVL+ + ++DFG+A+ + H ++
Sbjct: 143 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYK 197
Query: 763 --TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
T + APE + T + DV+SFGVL++E+
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 68/249 (27%), Positives = 104/249 (41%), Gaps = 45/249 (18%)
Query: 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
DF+ +G G G V A+ +G+ A+K + E+L +K+++H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR--------------EILKMKQVQH 64
Query: 659 RNNVKFHGFCYNGPHSFLV---CEYLDRGSLARILGDDVTAKELGWNRRI------NVIK 709
K H F+V C + D + L + V EL + R +V K
Sbjct: 65 VAQEK--SILMELSHPFIVNMMCSFQDENRV-YFLLEFVVGGELFTHLRKAGRFPNDVAK 121
Query: 710 ----GVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765
+ A YLH II+RD+ +N+LLD+ V+DFG AK V +
Sbjct: 122 FYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT---L 175
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKI 825
GT Y APE+ + + D ++ GVL++E I G +P F F + KI
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG-YPPFFDDTPFRIYE-------KI 227
Query: 826 LDPRLPTPS 834
L RL P+
Sbjct: 228 LAGRLKFPN 236
|
Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G G G V A + +G VA+KK + +A E+ LK +RH N +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT--YRELKLLKHLRHENIISLS 75
Query: 666 G-FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
F + V E L L R+L K+ +++G L Y+H
Sbjct: 76 DIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRG----LKYVHS---A 127
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRAT 783
++HRD+ N+L++ N + + DFG+A+ P T + T Y APEI T +
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPEIMLTWQKYD 184
Query: 784 EKYDVYSFGVLVFEVIKG 801
+ D++S G + E+++G
Sbjct: 185 VEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 22/241 (9%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G VYKA+ +A K + + + + ++++ E+ L H VK G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKV---IETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 667 FCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINVI-KGVANALSYLHHDCLP 724
Y +++ E+ G++ A +L D E +I VI + + AL YLH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE----PQIQVICRQMLEALQYLHSM--- 129
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY--TMRA 782
IIHRD+ + NVLL + + ++DFG++ F GT + APE+ TM+
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 783 TE---KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVMD 839
T K D++S G+ + E+ + P + +++ + K P L PS M+
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEPPTLSQPSKWSME 244
Query: 840 Y 840
+
Sbjct: 245 F 245
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 601 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR 659
F + +GKGG G V ++ +G + A K+ + + + LNE L+++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGE-SMALNEKQILEKVNSQ 60
Query: 660 NNVKFHGFCYNGPHSF-LVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANAL 715
V + Y + LV ++ G L +G+ +E R + + L
Sbjct: 61 FVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE----RALFYAAEILCGL 115
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
LH + + ++RD+ +N+LLD +SD G+A + P + GT GY APE
Sbjct: 116 EDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMAPE 171
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ R T D + G L++E+I+G P
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 38/220 (17%)
Query: 607 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADHD--EFLNEVLALKEI 656
+G+G G V AE D VAVK +L + D D + ++E+ +K I
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK-----MLKDDATDKDLSDLVSEMEMMKMI 74
Query: 657 -RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL------GDD-------VTAKELGWN 702
+H+N + G C +++ EY +G+L L G D + ++L +
Sbjct: 75 GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 703 RRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762
++ VA + YL IHRD++++NVL+ + ++DFG+A+ V H+ ++
Sbjct: 135 DLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDV--HNIDY 189
Query: 763 ----TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
T + APE + T + DV+SFGVL++E+
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 607 IGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN---- 661
IG+G V L D I A+K +L+ DE ++ V K + + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-----DDEDIDWVQTEKHVFEQASSNPF 57
Query: 662 -VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
V H FLV EY++ G L + ++L + AL++LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHE 114
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK-FVGPHSSNWTEFAGTFGYAAPEIAYT 779
II+RD+ NVLLD++ ++D+G+ K +GP + T F GT Y APEI
Sbjct: 115 R---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRG 170
Query: 780 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811
D ++ GVL+FE++ G P D + N
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 38/113 (33%), Positives = 52/113 (46%), Gaps = 12/113 (10%)
Query: 249 LSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308
+ LGL L GFIP I L L+ + L N + G +P +G + SL L+L N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 309 GVIPHSI------ERVLLNQNNLSGKMYEAFGDHP----NLTFLDLSNNNFCG 351
G IP S+ + LN N+LSG++ A G + F D N CG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD--NAGLCG 530
|
Length = 623 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 23/227 (10%)
Query: 592 EEIIKATDDFDEKFCIGKGGQGSVYK-AELPSGDIVAVKKFNSQLLSGNMADHDEFLN-E 649
E + TD ++ IGKG G VYK G + AVK + ++D DE + E
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP------ISDVDEEIEAE 68
Query: 650 VLALKEI-RHRNNVKFHGFCYNGPHS-----FLVCEYLDRGSLARIL-GDDVTAKELGWN 702
L+ + H N VKF+G Y +LV E + GS+ ++ G + + L
Sbjct: 69 YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128
Query: 703 RRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762
++ G L +LH++ IIHRD+ N+LL + + DFG++ +
Sbjct: 129 MISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185
Query: 763 TEFAGTFGYAAPEI-----AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
GT + APE+ Y + DV+S G+ E+ G+ P
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 39/224 (17%)
Query: 607 IGKGGQGSVYKAELP------SGDI-VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR 659
+G G G VY+ SG I VAVK + EFL E + H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK---GATDQEKKEFLKEAHLMSNFNHP 59
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSL---------ARILGDDVTAKELGWNRRINVIKG 710
N VK G C +++ E ++ G L R +T KEL +++
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL-----LDICLD 114
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLL-----DSNFEAHVSDFGIAKFVGPHSSNWTEF 765
VA YL IHRD++++N L+ D++ + DFG+A+ + + S++
Sbjct: 115 VAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI--YKSDYYRK 169
Query: 766 AGT----FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHP 804
G + APE + T + DV+SFGVL++E++ G P
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 63/244 (25%), Positives = 112/244 (45%), Gaps = 36/244 (14%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG G QG V A + G VAVKK + N E++ LK + H+N +
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 666 GFCYNGPHS--------FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
P +LV E +D +L +++ ++ + + + ++ + + +
Sbjct: 87 NVF--TPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKH 138
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPE 775
LH IIHRD+ N+++ S+ + DFG+A+ +N+ T + T Y APE
Sbjct: 139 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPE 192
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
+ M E D++S G ++ E++KG S+ F ++ I NK+++ +L TPS
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG-------SVIFQG-TDHIDQWNKVIE-QLGTPSA 243
Query: 836 SVMD 839
M+
Sbjct: 244 EFMN 247
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 57/221 (25%), Positives = 103/221 (46%), Gaps = 37/221 (16%)
Query: 607 IGKGGQGSVYKAE----LPSGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
IG+G G V++A LP +VAVK + S +M +F E + E H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADM--QADFQREAALMAEFDHPN 69
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL------------GDDVTAKELGWNR----- 703
VK G C G L+ EY+ G L L +A++ G N
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 704 --RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN 761
++ + K VA ++YL +HRD++++N L+ N ++DFG+++ + +S++
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI--YSAD 184
Query: 762 WTEFAGT----FGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ + + + PE + R T + DV+++GV+++E+
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 43/230 (18%)
Query: 617 KAELPSGDIVAVKKFNSQLLSGNMADHDE--FLNEVLALKEIRHRNNVKFHGFCYNGPHS 674
K ELP VA+ L +D FL E L L + H N V+ G G
Sbjct: 31 KRELP----VAI-----HTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81
Query: 675 FLVCEYLDRGSLARILGD---DVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDI 731
+V EY+ G+L L + A +L + ++ G+A+ + YL +H+ +
Sbjct: 82 MIVTEYMSNGALDSFLRKHEGQLVAGQL-----MGMLPGLASGMKYLSE---MGYVHKGL 133
Query: 732 SSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG-----YAAPEIAYTMRATEKY 786
++ VL++S+ +S F + + G +AAPE +
Sbjct: 134 AAHKVLVNSDLVCKISGFR----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189
Query: 787 DVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKILDP--RLPTP 833
DV+SFG++++EV+ G P + S DV K ++ RLP P
Sbjct: 190 DVWSFGIVMWEVMSYGERP-------YWDMSGQ--DVIKAVEDGFRLPAP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-09
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 607 IGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKGG G VY A P VA+KK L S N FL E ++ H V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGD----DVTAKELGWNRRI----NVIKGVANALSY 717
C +G + Y++ +L +L + +KEL + ++ + + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV---------------GPHSSNW 762
+H ++HRD+ N+LL E + D+G A F S+
Sbjct: 129 VHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 763 T---EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
T + GT Y APE + A+E D+Y+ GV++++++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG----NMADHDEFLNEVLALKEIRHRNN 661
+GKGG G V ++ +G + A KK + + L MA LNE L+++ R
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA-----LNEKKILEKVSSRFI 55
Query: 662 VKFHGFCYNGP-HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
V + + LV ++ G L + +V R I + L +LH
Sbjct: 56 VSL-AYAFETKDDLCLVMTLMNGGDL-KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM 780
I++RD+ +NVLLD + +SD G+A + AGT GY APE+
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 781 RATEKYDVYSFGVLVFEVIKGNHP 804
D ++ G ++E+I G P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 11/216 (5%)
Query: 607 IGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKG G V A+ S G AVK + + + + LK ++H V H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
+ V +Y++ G L L + E R VA+A+ YLH +
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE---PRARFYAAEVASAIGYLHS---LN 116
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAK-FVGPHSSNWTEFAGTFGYAAPEIAYTMRATE 784
II+RD+ +N+LLDS ++DFG+ K V P + T F GT Y APE+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYDR 175
Query: 785 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 820
D + G +++E++ G P F+S + S + I+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP--FYSRDVSQMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G G V+ +V +K+ + ++ + + NE LK + H N ++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD--ERLAAQNECQVLKLLSHPNIIEYY 65
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRIN-------VIKGVANALSYL 718
+V EY G+LA + +R N ++ L L
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYI-----------QKRCNSLLDEDTILHFFVQILLAL 114
Query: 719 HHDCLPSIIHRDISSKNVLLDSN-FEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
HH I+HRD+ ++N+LLD + + DFGI+K + S +T GT Y +PE+
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELC 173
Query: 778 YTMRATEKYDVYSFGVLVFEV 798
+K D+++ G +++E+
Sbjct: 174 EGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK--FVGPHSSNWTEFAGT 768
+A L +LH II+RD+ NV+LD+ ++DFG+ K G ++ F GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--TFCGT 164
Query: 769 FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806
Y APEI + D ++FGVL++E++ G P D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDI--VAVKKF-NSQLLSGNMADHDEFLNEVLALKE 655
+DF+ +G G G V A + D VA+K+F S+++ DH +E L
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH--VFSERKILNY 87
Query: 656 IRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI-NVIKGVANA 714
I H V +G + + +LV E++ G L N+R N + A
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR---------NKRFPNDVGCFYAA 138
Query: 715 LSYLHHDCLPS--IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
L + L S I++RD+ +N+LLD + ++DFG AK V + GT Y
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT---LCGTPEYI 195
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
APEI + + D ++ G+ ++E++ G P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK-FVGPHSSNWTEFAGTFGYA 772
AL +LH I++RDI +N+LLDS ++DFG++K F+ F GT Y
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 773 APEIAYTMRATEK-YDVYSFGVLVFEVIKGNHP 804
APEI K D +S G+L+FE++ G P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 31/85 (36%), Positives = 40/85 (47%)
Query: 438 LDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEI 497
L L L IP I L L +NLS N + IP + L LDLS+N I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 498 PPQVCNMGSLEKLNLSHNNLSDFIP 522
P + + SL LNL+ N+LS +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 33/209 (15%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G +VYK +G+IVA+K+ + L + E+ +KE++H N V+ H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH---LDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 666 GFCYNGPHSFLVCEYLD------------RGSLARILGDDVTAKELGWNRRINVIKGVAN 713
+ LV EY+D RG+L D T K + ++KG+A
Sbjct: 65 DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGAL-----DPNTVKSFTYQ----LLKGIA- 114
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
+ H + ++HRD+ +N+L++ E ++DFG+A+ G + ++ T Y A
Sbjct: 115 ---FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRA 168
Query: 774 PEIAYTMRA-TEKYDVYSFGVLVFEVIKG 801
P++ R + D++S G ++ E+I G
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 43/214 (20%)
Query: 607 IGKGGQGSV-YKAELPSGDIVAVKK----FNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G G G+V + +G VA+KK F S+L + E+ LK ++H N
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRA------YRELRLLKHMKHENV 76
Query: 662 V-------------KFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVI 708
+ +FH F +LV ++ LG + ++L +R ++
Sbjct: 77 IGLLDVFTPDLSLDRFHDF-------YLVMPFMGTD-----LGKLMKHEKLSEDRIQFLV 124
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT 768
+ L Y+H IIHRD+ N+ ++ + E + DFG+A+ S T + T
Sbjct: 125 YQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVVT 178
Query: 769 FGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKG 801
Y APE+ M T+ D++S G ++ E++ G
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKK---FNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
IG+G G V A P+G VA+KK F Q L E+ L+ +H N +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT------LREIKILRRFKHENII 66
Query: 663 KFHGFCYNGPHSF-------LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
P SF +V E ++ L +++ + L + + + L
Sbjct: 67 GILDIIR--PPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGL 119
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP---HSSNWTEFAGTFGYA 772
Y+H +++HRD+ N+LL++N + + DFG+A+ P H+ TE+ T Y
Sbjct: 120 KYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 773 APEIAYTMRA-TEKYDVYSFGVLVFEVIKG 801
APEI + T+ D++S G ++ E++
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 8e-09
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 44/217 (20%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKK----FNSQLLSGNMADHDEFLNEVLALKEIR-HRN 660
+GKG G V+KA + + ++VA+KK F N D E++ L+E+ H N
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAF------RNATDAQRTFREIMFLQELGDHPN 68
Query: 661 NVKFHGF--CYNGPHSFLVCEYLD-------RGSLARILGDDVTAKELGWNRRINVIKGV 711
VK N +LV EY++ R A IL D + ++ +
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYMETDLHAVIR---ANILEDV---------HKRYIMYQL 116
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW-----TEFA 766
AL Y+H ++IHRD+ N+LL+S+ ++DFG+A+ + N T++
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 767 GTFGYAAPEI--AYTMRATEKYDVYSFGVLVFEVIKG 801
T Y APEI T R T+ D++S G ++ E++ G
Sbjct: 174 ATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 39/224 (17%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKF----------NSQLLSGNMADHDEFLNEVLALKE 655
+G+G G V KA +G IVA+KK + L G H L E+ + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 656 IRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
I+H N + G LV + + L +++ + E ++ ++ + N L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTE---SQVKCILLQILNGL 132
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA-KFVGPHSS-------------N 761
+ LH +HRD+S N+ ++S ++DFG+A ++ P S
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 762 WTEFAGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKG 801
T T Y APE+ + EKY D++S G + E++ G
Sbjct: 190 MTSKVVTLWYRAPEL---LMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 63/264 (23%), Positives = 104/264 (39%), Gaps = 42/264 (15%)
Query: 599 DDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL 653
D ++ IG G G V A + SG VA+KK L E+ L
Sbjct: 1 FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH--AFDVPTLAKRTLRELKIL 58
Query: 654 KEIRHRNNVKFHG-FCYNGPHS---FLVCEYLDRGSLARILGDDVTAKELGWNRRIN--- 706
+ +H N + G ++V + L L I+ D E I
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTE----EHIRYFL 113
Query: 707 --VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP----HSS 760
+++G L Y+H +IHRD+ N+L++ + E + DFG+A+ + H
Sbjct: 114 YQLLRG----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 761 NWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI 819
TE+ T Y APE+ ++ T D++S G + E++ F N+ +I
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL--FPGKNYVHQLKLI 224
Query: 820 IDVNKILDPRLPTPSPSVMDYGGC 843
+ V L +PS V++ G
Sbjct: 225 LSV-------LGSPSEEVLNRIGS 241
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 8/212 (3%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G VY+A L VA+KK + A D + E+ LK++ H N +K+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQD-CVKEIDLLKQLNHPNVIKYL 68
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI-NVIKGVANALSYLHHDCLP 724
+V E D G L++++ K L R + + +A+ ++H
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR--- 125
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATE 784
++HRDI NV + + + D G+ +F ++ GT Y +PE +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185
Query: 785 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS 816
K D++S G L++E+ P F+ + FS
Sbjct: 186 KSDIWSLGCLLYEMAALQSP--FYGDKMNLFS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 58/206 (28%), Positives = 87/206 (42%), Gaps = 17/206 (8%)
Query: 607 IGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-----RHRN 660
IG+G V L + I A+K +L+ + DE ++ V K + H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELV-----NDDEDIDWVQTEKHVFEQASNHPF 57
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
V H F V EY++ G L + ++L ++ AL+YLH
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE 114
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM 780
II+RD+ NVLLDS ++D+G+ K + F GT Y APEI
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 781 RATEKYDVYSFGVLVFEVIKGNHPRD 806
D ++ GVL+FE++ G P D
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 65/257 (25%), Positives = 118/257 (45%), Gaps = 31/257 (12%)
Query: 594 IIKATDDFDEKFCIGKGGQGSVYKA-ELPSGD----IVAVKKFNSQLLSGNMADHDEFLN 648
I+K T+ F + +G G G+VYK +P G+ VA+K+ + + + E L+
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILD 58
Query: 649 EVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL---ARILGDDVTAKELGWNRRI 705
E + + + + + G C L+ + + G L R D++ ++ L +
Sbjct: 59 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----L 112
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765
N +A ++YL L +HRD++++NVL+ + ++DFG+AK +G +
Sbjct: 113 NWCVQIAKGMNYLEERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 766 AGT--FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDV 822
G + A E T + DV+S+GV V+E++ G+ P D I S S+++
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEISSILEK- 226
Query: 823 NKILDPRLPTPSPSVMD 839
RLP P +D
Sbjct: 227 ----GERLPQPPICTID 239
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 607 IGKGGQGS---VYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNN 661
+GK G+G+ V KA +G A+K S + L E+ AL+ + H N
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LEQVNNLREIQALRRLSPHPNI 60
Query: 662 VKFHGFCYNGPHS--FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
++ ++ LV E +D +L ++ + L R + + + +L ++H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMH 117
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV---GPHSSNWTEFAGTFGYAAPEI 776
+ I HRDI +N+L+ + ++DFG + + P+ TE+ T Y APE
Sbjct: 118 RN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY----TEYISTRWYRAPEC 169
Query: 777 AYTM-RATEKYDVYSFGVLVFEVI 799
T K D+++ G + FE++
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 18/110 (16%)
Query: 276 LYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGD 335
L L N GL GF+P +I L+ L + L N +RG IP S G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS------------------LGS 464
Query: 336 HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSP 385
+L LDLS N+F G I + G + L ++ N++SG +P +G
Sbjct: 465 ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 13/98 (13%)
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK-FVGPHSSNWTEFAGTFGYA 772
AL++LH II+RD+ NVLLD+ ++D+G+ K + P + T F GT Y
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163
Query: 773 APEIAYTMRATEKY----DVYSFGVLVFEVIKGNHPRD 806
APEI +R E Y D ++ GVL+FE++ G P D
Sbjct: 164 APEI---LRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 35/213 (16%)
Query: 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+GKG G V A L SG + AVK ++ + D D + E R + + H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI---LQDDDV----ECTMTEKRILSLARNH 55
Query: 666 GF------CYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG------VA 712
F C+ P F V E+++ G L + +RR + + +
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDLMF---------HIQKSRRFDEARARFYAAEIT 106
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE-FAGTFGY 771
+AL +LH II+RD+ NVLLD ++DFG+ K G + T F GT Y
Sbjct: 107 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDY 162
Query: 772 AAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
APEI M D ++ GVL++E++ G+ P
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRN 660
IG+G G+V+KA + +IVA+K+ + D DE L E+ LKE++H+N
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVR-------LDDDDEGVPSSALREICLLKELKHKN 60
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILG------DDVTAKELGWNRRINVIKGVANA 714
V+ + ++ LV EY D+ L + D K ++KG
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSF----MFQLLKG---- 111
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L++ H +++HRD+ +N+L++ N E ++DFG+A+ G ++ T Y P
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 168
Query: 775 EIAYTMRA-TEKYDVYSFGVLVFEVIKGNHP 804
++ + + + D++S G + E+ P
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLAL 653
D FD IG+G G VYKA + +G++VA+KK + + F + E+ L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD------NEKEGFPITAIREIKIL 60
Query: 654 KEIRHRNNVKFHGFCYNGPHS----------FLVCEYLDRGSLARILGDDVTAKELGWNR 703
+++ HRN V + + +LV EY+D + + V E +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE---DH 117
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN-W 762
+ +K + L+Y H + +HRDI N+LL++ + ++DFG+A+ S +
Sbjct: 118 IKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 763 TEFAGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEV 798
T T Y PE+ + E+Y DV+S G ++ E+
Sbjct: 175 TNKVITLWYRPPEL---LLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 21/237 (8%)
Query: 607 IGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+GKG G V + G +KK N + S E E L +++H N V +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIVAYR 65
Query: 666 GFCYNGPHS--FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
+ G ++V + + G L L + K L N+ + +A AL YLH
Sbjct: 66 E-SWEGEDGLLYIVMGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK-- 121
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRAT 783
I+HRD+ ++NV L V D GIA+ + + GT Y +PE+
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN 180
Query: 784 EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVMDY 840
K DV++ G V+E+ H F + + +S V +I++ +LP P P DY
Sbjct: 181 YKSDVWALGCCVYEMATLKHA--FNAKDMNSL------VYRIIEGKLP-PMPK--DY 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 32/247 (12%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN-EVLALKEIRHRNNVKF 664
+G+G G VY + +G +AVK+ S + L E+ LK + H V++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 665 HGFCYNGPHSFL--VCEYLDRGSLAR------ILGDDVTAKELGWNRRINVIKGVANALS 716
+G + L E++ GS+ L ++VT K + R+I ++GV S
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK---YTRQI--LEGV----S 120
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP---HSSNWTEFAGTFGYAA 773
YLH + I+HRDI N+L DS + DFG +K + + GT + +
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTP 833
PE+ K D++S G V E++ P ++ F M P P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP-------WAEFEAMAAIFKIATQPTNPVL 230
Query: 834 SPSVMDY 840
P V D+
Sbjct: 231 PPHVSDH 237
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 29/187 (15%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLALKEIRHRNN 661
IG+G G V+KA + IVA+KK +L N + + F L E+ L+ ++H N
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKK----VLMEN--EKEGFPITALREIKILQLLKHENV 73
Query: 662 VKFHGFCYNGPHS--------FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN 713
V C +LV E+ + LA +L + L ++ V+K + N
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKMLLN 130
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK-FVGPHSSNWTEFAG---TF 769
L Y+H + I+HRD+ + N+L+ + ++DFG+A+ F +S + T
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 770 GYAAPEI 776
Y PE+
Sbjct: 188 WYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 2/88 (2%)
Query: 416 LNLNQ--LSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKI 473
L L+ L G +P + L LQ ++LS N + +IP S+G++ L L+LS N + I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 474 PTEFEKLIHLSELDLSHNILQEEIPPQV 501
P +L L L+L+ N L +P +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 10/197 (5%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G G V K + +IVA+KKF N + L E+ L+ ++ N V+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
+LV EY+++ L L +++ R + I + A+ + H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKN---D 120
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS-SNWTEFAGTFGYAAPEIAYTMRATE 784
I+HRDI +N+L+ N + DFG A+ + S +N+TE+ T Y +PE+ +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 785 KYDVYSFGVLVFEVIKG 801
D++S G ++ E+ G
Sbjct: 181 AVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L LH + I++RD+ +N+LLD +SD G+A + P GT GY AP
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAP 170
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
E+ R T D + G L++E+I+G P
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 714 ALSYLH-HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
AL +LH +D I++RD+ +N+LLD+ + DFG++K + F GT Y
Sbjct: 108 ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYL 163
Query: 773 APEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHP 804
APE+ + T+ D +S GVLVFE+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 91/336 (27%), Positives = 146/336 (43%), Gaps = 20/336 (5%)
Query: 142 TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSL--SGSIPSIIGKLK 199
P + +++LAL ++ + S +LS L L L S S + L
Sbjct: 36 NFPDSNLESVAVNRLALNLSSNTLLLLPS--SLSRLLSLDLLSPSGISSLDGSENLLNLL 93
Query: 200 SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKS-LSALGLHINQ 258
L LDL+ N+ +I L L++LT + L NN+++ IPP++G LKS L L L N+
Sbjct: 94 PLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK 151
Query: 259 LNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERV 318
+ +P + NL +L+ L L N L L +L+ L+L N + + P
Sbjct: 152 I-ESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSN-LSNLNNLDLSGNKISDLPPEIELLS 209
Query: 319 LLNQNNLSGKMYE----AFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNIS 374
L + +LS + + NL+ L+LSNN GN S L T +S N IS
Sbjct: 210 ALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESI-GNLSNLETLDLSNNQIS 268
Query: 375 GSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTK 434
+G+ L+ LDLS N + +P+ +L L L+ L L L
Sbjct: 269 --SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL----KALELKLNS 322
Query: 435 LQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLS 470
+ + + +S P+++ L L+ L +N L
Sbjct: 323 ILLNNNILSNGETSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 46/210 (21%), Positives = 85/210 (40%), Gaps = 20/210 (9%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
C + K + P+ +VAVKK N L S + D E++ ++++H N + +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKIN--LDSCSKEDLKLLQQEIITSRQLQHPNILP-Y 64
Query: 666 GFCY-NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
+ ++V + GS L + L ++K V NAL Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK--- 120
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG--------YAAPEI 776
IHR + + ++LL + + +S + + H F + +PE+
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH-GKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 777 AY-TMRA-TEKYDVYSFGVLVFEVIKGNHP 804
++ EK D+YS G+ E+ G+ P
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFL------NEVLA 652
DF+ +GKG G V AE + ++ A+K +L ++ D+ + VLA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK-----ILKKDVVIQDDDVECTMVEKRVLA 55
Query: 653 LKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA 712
L++ + + H + V EY++ G L + KE + + ++
Sbjct: 56 LQD-KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEIS 111
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
L +LH II+RD+ NV+LDS ++DFG+ K F GT Y
Sbjct: 112 VGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYI 168
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806
APEI + D +++GVL++E++ G P D
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 65/254 (25%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN-EVLALKEIRHRNNVKF 664
+G+G G VY ++ +G +A K+ S + L E+ LK ++H V++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 665 HGFCYNGPHSFLVC--EYLDRGSLAR------ILGDDVTAKELGWNRRINVIKGVANALS 716
+G + L EY+ GS+ L + VT K + R+I +S
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK---YTRQI------LEGMS 120
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT---EFAGTFGYAA 773
YLH + I+HRDI N+L DS + DFG +K + + T GT + +
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPT- 832
PE+ K DV+S G V E++ P + + + + + +P+LP+
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPW----AEYEAMAAIFKIATQPTNPQLPSH 233
Query: 833 PSPSVMDYGGCHFM 846
S D+ GC F+
Sbjct: 234 ISEHARDFLGCIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 6e-08
Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 16/201 (7%)
Query: 648 NEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKE--LGWNRRI 705
NE+LAL + H N +K + +++++ + D + + + K+ L R
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR- 270
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA-KFVGPHSSNWTE 764
++K + A+ Y+H L IHRDI +N+ L+ + + + DFG A F +
Sbjct: 271 AIMKQLLCAVEYIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG 327
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS-----NMI 819
+ GT +PEI E D++S G+++ +++ DF I I
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS----HDFCPIGDGGGKPGKQLLKI 383
Query: 820 IDVNKILDPRLPTPSPSVMDY 840
ID + D P P + DY
Sbjct: 384 IDSLSVCDEEFPDPPCKLFDY 404
|
Length = 501 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKF----NSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G+G G VY + +G +AVK+ +SQ S + + E+ LK +RH
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV---NALECEIQLLKNLRHDRI 66
Query: 662 VKFHGFCYNGPHS---FLVCEYLDRGSLAR------ILGDDVTAKELGWNRRINVIKGVA 712
V+++G C P + EY+ GS+ L ++VT + + R+I ++GV
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR---YTRQI--LQGV- 119
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT---EFAGTF 769
SYLH + I+HRDI N+L DS + DFG +K + + T GT
Sbjct: 120 ---SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 770 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ +PE+ K DV+S V E++ P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 607 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+GKGG G V ++ +G + A KK + + + LNE L+++ R V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-AMALNEKRILEKVNSRFVVSL- 65
Query: 666 GFCYNGPHSF-LVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
+ Y + LV ++ G L +G+ ++ R I + L L +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ----RAIFYAAELCCGLEDLQRE 121
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR 781
I++RD+ +N+LLD +SD G+A + P GT GY APE+ +
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEK 177
Query: 782 ATEKYDVYSFGVLVFEVIKGNHP 804
T D + G L++E+I+G P
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 59/249 (23%), Positives = 110/249 (44%), Gaps = 23/249 (9%)
Query: 595 IKATDDFDEKFCIGK-GGQGSVYKAELPSGDIV--AVKKFNSQLLSGNMADHDEFLNEVL 651
I++ D + K Q S+YK + +++ KKF+ G+ D NE+
Sbjct: 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHK----GHKVLIDITENEIK 70
Query: 652 ALKEIRHRNNVKFHGFCYNG----PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINV 707
L+ I N +K +GF + P L+ EY RG L +L + K+L + ++++
Sbjct: 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDM 127
Query: 708 IKGVANALSYLH-HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA 766
L L+ + P +++++S + L+ N++ + G+ K + F
Sbjct: 128 AIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM 184
Query: 767 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKIL 826
F Y ++ T K D+YS GV+++E+ G P F ++ ++II+ N L
Sbjct: 185 VYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIP--FENLTTKEIYDLIINKNNSL 241
Query: 827 DPRLPTPSP 835
+LP P
Sbjct: 242 --KLPLDCP 248
|
Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 35/214 (16%)
Query: 607 IGKGGQGSVYKA---ELPSGDI---VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G G VY+ ++ G+ VAVK N S ++ + EFLNE +K +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE---SASLRERIEFLNEASVMKGFTCHH 70
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLA---RILGDDV---------TAKELGWNRRINVI 708
V+ G G + +V E + G L R L + T +E+ I +
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM-----IQMA 125
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT 768
+A+ ++YL+ +HRD++++N ++ +F + DFG+ + + + +++ G
Sbjct: 126 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRKGGK 180
Query: 769 ----FGYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ APE T D++SFGV+++E+
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 38/238 (15%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G G G+VYKA L + I+AVK L + + ++E+ L + + F+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI---PLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAK----ELGWNRRINVIKGVANALSYLHHD 721
G + + E++D GSL DV K LG RI V V L+YL
Sbjct: 66 GAFFVENRISICTEFMDGGSL------DVYRKIPEHVLG---RIAV--AVVKGLTYLWS- 113
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIA-KFVGPHSSNWTEFAGTFGYAAPEIAYTM 780
I+HRD+ N+L+++ + + DFG++ + V +S + GT Y APE
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERI--- 165
Query: 781 RATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILD---PRLP 831
+ E+Y DV+S G+ E+ G P N S + + + I+D P LP
Sbjct: 166 -SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLP 221
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G VYKA+ ++A K + + + + ++++ E+ L H N VK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKV---IDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
Y + +++ E+ G++ ++ + + L + V K AL+YLH + I
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATE-- 784
IHRD+ + N+L + + ++DFG++ F GT + APE+ + +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 785 ---KYDVYSFGVLVFEVIKGNHP 804
K DV+S G+ + E+ + P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE-F----LNEVLALKEIRHRN 660
I +G G VY+A + +G+IVA+KK M E F L E+ L +++H N
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLK-------MEKEKEGFPITSLREINILLKLQHPN 65
Query: 661 --NVKFHGFCYNGPHSFLVCEYL--DRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
VK N ++V EY+ D SL + E+ ++ + + ++
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK-----CLMLQLLSGVA 120
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+LH + I+HRD+ + N+LL++ + DFG+A+ G +T+ T Y APE+
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL 177
Query: 777 AY-TMRATEKYDVYSFGVLVFEVI 799
+ D++S G + E++
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
+A L +LH II+RD+ NV+LDS ++DFG+ K F GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806
Y APEI + D ++FGVL++E++ G P +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+GKG G V E SG A+K +++ DE + L E R N + H
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAK----DEVAH---TLTESRVLKNTR-H 54
Query: 666 GFCYNGPHSF-------LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL 718
F + +SF V EY++ G L L + E +R + +AL YL
Sbjct: 55 PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSE---DRTRFYGAEIVSALDYL 111
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY 778
H I++RD+ +N++LD + ++DFG+ K ++ F GT Y APE+
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHP 804
D + GV+++E++ G P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 10/175 (5%)
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H N V G C G ++ EY G L L L ++ VA +++
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAF 156
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTF---GYAAP 774
L + IHRD++++NVLL + DFG+A+ + + SN+ + AP
Sbjct: 157 LASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI-MNDSNYVVKGNARLPVKWMAP 212
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKILDP 828
E + T + DV+S+G+L++E+ G++P ++ S F +I + ++ P
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIKEGYRMAQP 266
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 49/202 (24%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRN 660
+G+G +V+K + ++VA+K+ +H+E + EV LK+++H N
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIR--------LEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
V H + LV EYLD+ L + + DD N +I + + + L+Y H
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYM-DDCGNIMSMHNVKIFLYQ-ILRGLAYCHR 122
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY-T 779
++HRD+ +N+L++ E ++DFG+A+ + ++ T Y P++ +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 780 MRATEKYDVYSFGVLVFEVIKG 801
+ + D++ G + FE+ G
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 32/241 (13%)
Query: 607 IGKGGQGSV---YKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK 663
IG G QG V Y A L VA+KK + N E++ +K + H+N +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 664 F------HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
+LV E +D +L +++ EL R ++ + + +
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI-----QMELDHERMSYLLYQMLCGIKH 134
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
LH IIHRD+ N+++ S+ + DFG+A+ G S T + T Y APE+
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVI 190
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSV 837
M E D++S G ++ E+++ H F ++ N +I+ +L TP P
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVR--HKILFPGRDYIDQWNKVIE-------QLGTPCPEF 241
Query: 838 M 838
M
Sbjct: 242 M 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 649 EVLALKEIRHRNNVKFHG-FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINV 707
E L+ I H + ++ G F YN ++ Y + L L + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAA---KRNIAICDILAI 187
Query: 708 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF-VGPHSSNWTEFA 766
+ V A+ YLH + IIHRDI ++N+ ++ + + DFG A F V +++ + +A
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 767 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN 802
GT APE+ D++S G+++FE+ +
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLL-SGNMADHDEFLNEVLALKEIR 657
DF +G+GG G V+ A+ +G+IVA+K+ LL N H L E L +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH--VLTERDILTTTK 59
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
VK + + +L EY+ G +L + E + R + + A+
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYMAEMFE-AVDA 116
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA----GTFGYAA 773
LH IHRD+ +N L+D++ ++DFG+ S +A G+ Y A
Sbjct: 117 LHE---LGYIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYANSVVGSPDYMA 166
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
PE+ D +S G +++E + G P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 34/123 (27%), Positives = 62/123 (50%), Gaps = 6/123 (4%)
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
+ +AL YLH +++RDI +N++LD + ++DFG+ K + F GT
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRL 830
Y APE+ D + GV+++E++ G P F++ + +I+ + +I PR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFELIL-MEEIRFPRT 217
Query: 831 PTP 833
+P
Sbjct: 218 LSP 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 55/188 (29%), Positives = 77/188 (40%), Gaps = 31/188 (16%)
Query: 382 GNSPKLQVLDLSSNHIVGKIPVQLEML---SSLNKLILNLNQLS-GGVPLEFGSLT---- 433
LQ LDLS N + LE L SSL +L LN N L G+ L L
Sbjct: 78 TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPP 137
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLL----KLHYLNLSNNQLSHK-IPTEFEKLIHLSEL-- 486
L+ L L N+L + +++ L L LNL+NN + I E L L
Sbjct: 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197
Query: 487 -DLSHNILQE-------EIPPQVCNMGSLEKLNLSHNNLSDFIPRCF-EEMRSLSC---- 533
DL++N L + E + SLE LNL NNL+D + S +
Sbjct: 198 LDLNNNGLTDEGASALAETLASLK---SLEVLNLGDNNLTDAGAAALASALLSPNISLLT 254
Query: 534 IDISYNEL 541
+ +S N++
Sbjct: 255 LSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 607 IGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRN 660
+G+G +VYK D +VA+K+ +H+E + EV LK+++H N
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR--------LEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
V H + LV EYLD+ L + L D + + N ++ + + + L+Y H
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH-NVKLFLFQ-LLRGLNYCHR 122
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY-T 779
++HRD+ +N+L++ E ++DFG+A+ + ++ T Y P+I +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 780 MRATEKYDVYSFGVLVFEVIKG 801
+ + D++ G + +E+ G
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 33/123 (26%), Positives = 64/123 (52%), Gaps = 5/123 (4%)
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
+ +AL YLH + ++++RD+ +N++LD + ++DFG+ K + F GT
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 161
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRL 830
Y APE+ D + GV+++E++ G P F++ + +I+ + +I PR
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHEKLFELIL-MEEIRFPRT 218
Query: 831 PTP 833
+P
Sbjct: 219 LSP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 17/87 (19%)
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIA---KFVGPHSSNWTEFAGTFGYAAPEI-----A 777
+++RD+ N+LLD + +SD G+A PH+S GT GY APE+ A
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 172
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHP 804
Y A D +S G ++F++++G+ P
Sbjct: 173 YDSSA----DWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 3e-07
Identities = 20/49 (40%), Positives = 28/49 (57%), Gaps = 7/49 (14%)
Query: 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCN 50
LN++ ALL +K+SL S LSSW N + PCSW G++C+
Sbjct: 1 LNDDRDALLAFKSSLNG--DPSGALSSW-----NPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 25/164 (15%)
Query: 669 YNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL-HHDCLPSII 727
Y+ P S+ + + + +L DD + + L ++ VA + +L +C +
Sbjct: 208 YDRPASY---KGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKNC----V 259
Query: 728 HRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTF---GYAAPEIAYTMRATE 784
HRD++++NVLL + DFG+A+ + H SN+ TF + APE + T
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDI-MHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 785 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIID---VNKI 825
DV+S+G+L++E+ FS+ + + MI+D NKI
Sbjct: 319 LSDVWSYGILLWEI---------FSLGGTPYPGMIVDSTFYNKI 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L +LH II+RD+ +NVLLD++ +SD G+A + S +AGT G+ AP
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP 166
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
E+ D ++ GV ++E+I P
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 25/254 (9%)
Query: 594 IIKATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMAD--HDEFLNEV 650
I+K T+ + +G G G+VYK +P G+ V + ++L N + + E L+E
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIP-VAIKVLRENTSPKANKEILDEA 60
Query: 651 LALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG 710
+ + + G C LV + + G L + ++ +G +N
Sbjct: 61 YVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQ 117
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT-- 768
+A +SYL ++HRD++++NVL+ S ++DFG+A+ + + + G
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174
Query: 769 FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKILD 827
+ A E R T + DV+S+GV V+E++ G P D ++ +L+
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---------EIPDLLE 225
Query: 828 P--RLPTPSPSVMD 839
RLP P +D
Sbjct: 226 KGERLPQPPICTID 239
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 3e-07
Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 2/61 (3%)
Query: 482 HLSELDLSHNILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNE 540
+L LDLS+N L IP + +L+ L+LS NNL+ P F + SL +D+S N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 541 L 541
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 37/184 (20%), Positives = 85/184 (46%), Gaps = 15/184 (8%)
Query: 625 IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRG 684
+VAVK + + ++FL E+ + +++ N ++ G C + ++ EY++ G
Sbjct: 46 LVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG 102
Query: 685 SLARILGDDVTAKELGWNRRI------NVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 738
L + L I N++ S + + + +HRD++++N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 739 DSNFEAHVSDFGIAKFVGPHSSNWTEFAG----TFGYAAPEIAYTMRATEKYDVYSFGVL 794
+++ ++DFG+++ + +S ++ G + A E + T DV++FGV
Sbjct: 163 GNHYTIKIADFGMSRNL--YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT 220
Query: 795 VFEV 798
++E+
Sbjct: 221 LWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 65/244 (26%), Positives = 113/244 (46%), Gaps = 36/244 (14%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN----- 660
IG G QG V A + +G VA+KK + N+ E++ +K + H+N
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 661 NV-----KFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
NV F +LV E +D +L +++ D+ + + + ++ + +
Sbjct: 82 NVFTPQKSLEEF----QDVYLVMELMD-ANLCQVIQMDLDHERMSY-----LLYQMLCGI 131
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
+LH IIHRD+ N+++ S+ + DFG+A+ G S T + T Y APE
Sbjct: 132 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPE 187
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
+ M E D++S G ++ E+I+G ++ F ++ I NKI++ +L TPS
Sbjct: 188 VILGMGYKENVDIWSVGCIMGEMIRG-------TVLFPG-TDHIDQWNKIIE-QLGTPSD 238
Query: 836 SVMD 839
M
Sbjct: 239 EFMS 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 5e-07
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 17/151 (11%)
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL--GDDVTAKELGWNRRINVIKGVANAL 715
+ N +K + L+ +Y+ G L +L ++ E+ +I+ + AL
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEV-----KKIIRQLVEAL 122
Query: 716 SYLH-HDCLPSIIHRDISSKNVLLD-SNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
+ LH H +IIH DI +NVL D + ++ D+G+ K +G S + GT Y +
Sbjct: 123 NDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC----YDGTLDYFS 174
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
PE +D ++ GVL +E++ G HP
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 44/195 (22%), Positives = 80/195 (41%), Gaps = 29/195 (14%)
Query: 601 FDEKFCIGKGGQGSVYKA---ELPSGDIVAVKKFNSQLLSG---NMADHDEFLNEVLALK 654
++ + CIG+G G VYKA G A+KKF + + E+ L+
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA----CREIALLR 57
Query: 655 EIRHRNNVKFHGFCYNGPHS----FLVCEYLDRGSLARILGDDVTAKELGWNRRI--NVI 708
E++H N V H+ +L+ +Y + L +I+ AK + + +++
Sbjct: 58 ELKHENVVSLVEVFLE--HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH----VSDFGIAKFVGPHSSNWTE 764
+ N + YLH + ++HRD+ N+L+ + D G+A+ +
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 765 FAG---TFGYAAPEI 776
T Y APE+
Sbjct: 172 LDPVVVTIWYRAPEL 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 65/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 607 IGKGGQGSV---YKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK 663
IG G QG V Y A L VA+KK + N E++ +K + H+N +
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 664 FHGFCYNGPHS-------FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
+ S ++V E +D +L +++ EL R ++ + +
Sbjct: 88 LLN-VFTPQKSLEEFQDVYIVMELMD-ANLCQVI-----QMELDHERMSYLLYQMLCGIK 140
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+LH IIHRD+ N+++ S+ + DFG+A+ G S T + T Y APE+
Sbjct: 141 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEV 196
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPS 836
M E D++S G ++ E+IKG + F ++ I NK+++ +L TP P
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG-------GVLFPG-TDHIDQWNKVIE-QLGTPCPE 247
Query: 837 VM 838
M
Sbjct: 248 FM 249
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 53/246 (21%), Positives = 95/246 (38%), Gaps = 28/246 (11%)
Query: 607 IGKGGQGSVYKAELPSGDIVA---VKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK 663
IG G G V E G A VK+ + S + FL EV +E+ H N ++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRA---SATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI--NVIKGVANALSYLHHD 721
G C LV E+ G L L + + + + VA+ L +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIA--KFVGPHSSNWTEFAGTFGYAAPEIA-- 777
IH D++ +N L ++ + D+G+A ++ + A + APE+
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 778 -----YTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKILDPRLP 831
T+K +++S GV ++E+ + P + S+ + + + +
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-------YPDLSDEQVLKQVVREQDIK 229
Query: 832 TPSPSV 837
P P +
Sbjct: 230 LPKPQL 235
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G G GSV A + +G VAVKK + S + E+ LK ++H N +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDD----VTAKELGWNRRINVIKGVANALSYLHHD 721
+ S E+ D + ++G D V ++L + +I + L Y+H
Sbjct: 83 D-VFTPARSLE--EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 138
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN-WTEFAGTFGYAAPEIAYT- 779
IIHRD+ N+ ++ + E + DFG+A+ H+ + T + T Y APEI
Sbjct: 139 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNW 192
Query: 780 MRATEKYDVYSFGVLVFEVIKG 801
M + D++S G ++ E++ G
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRN 660
+G+G +V+K + ++VA+K+ +H+E + EV LK ++H N
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR--------LEHEEGAPCTAIREVSLLKNLKHAN 64
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
V H + LV EYLD L + L D+ N +I + + + LSY H
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLD-SDLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCHK 121
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY-T 779
I+HRD+ +N+L++ E ++DFG+A+ + ++ T Y P++ +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178
Query: 780 MRATEKYDVYSFGVLVFEVIKG 801
+ D++ G +++E+ G
Sbjct: 179 TEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
AL LH ++I+RD+ +N+LLD + DFG+ K F GT Y A
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLA 161
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
PE+ T+ D ++ GVL++E++ G P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 48/186 (25%), Positives = 73/186 (39%), Gaps = 41/186 (22%)
Query: 649 EVLALKEIRHRNNVKF-HGFCYNGPHSFLVC-----------EYLDRGSLARILGDDVTA 696
E+ LK I HR + H + VC Y+DR
Sbjct: 136 EIDILKTISHRAIINLIHAY-RWKS---TVCMVMPKYKCDLFTYVDRSG----------- 180
Query: 697 KELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756
L + I + + + AL+YLH IIHRD+ ++N+ LD A + DFG A +
Sbjct: 181 -PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 757 -----PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811
P W +GT +PE+ K D++S G+++FE+ N F
Sbjct: 237 AHPDTPQCYGW---SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT--LFGKQ 291
Query: 812 FSSFSN 817
S S+
Sbjct: 292 VKSSSS 297
|
Length = 392 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-07
Identities = 47/170 (27%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 646 FLNEVLALKEIRHRNNVKF--HGFCYNGPHSFLVCEYLDRGSLARILGDD--VTAKELGW 701
F E + H N V G G F V EY+ +L +L D + A E G
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPGRTLREVLAADGALPAGETG- 82
Query: 702 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DSNFEAHVSDFGIAKFV-GP 757
++ V +AL+ H+ I+HRD+ +N+++ A V DFGI + G
Sbjct: 83 ----RLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGV 135
Query: 758 HSSN------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 801
++ TE GT Y APE T D+Y++G++ E + G
Sbjct: 136 RDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-06
Identities = 23/58 (39%), Positives = 29/58 (50%)
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHN 491
L+ LDLS N+L+ + L L L+LS N L+ P F L L LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 27/83 (32%), Positives = 46/83 (55%), Gaps = 9/83 (10%)
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIA---KFVGPHSSNWTEFAGTFGYAAPEIAYTMRA 782
+++RD+ N+LLD + +SD G+A PH+S GT GY APE+ A
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGTA 172
Query: 783 TEKY-DVYSFGVLVFEVIKGNHP 804
+ D +S G ++F++++G+ P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV-GPHSSN-WTE 764
V + + +A+ Y+H + IIHRDI ++NVL++ + + DFG A F G S+
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809
AGT APE+ T D++S G+++FE H FS
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA--AVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 4/111 (3%)
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAK--FVGPHSSNWTEFAGTFGYAAPEIAYTMRATE 784
IHRD++++N+LL N + DFG+A+ + P + APE + T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 785 KYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
+ DV+SFGVL++E+ G P IN F + D ++ P TP
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGTRMRAPENATPE 305
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN-EVLALKEIR-HRNNVK 663
IGKG G V+K +G AVK + + D DE + E LK + H N VK
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP------IHDIDEEIEAEYNILKALSDHPNVVK 79
Query: 664 FHGFCY-----NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRIN--VIKGVAN-AL 715
F+G Y NG +LV E + GS+ D+ L R+ +I + + AL
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVT-----DLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
L H + IHRD+ N+LL + + DFG++ + GT + APE
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194
Query: 776 -IAYTMRATEKY----DVYSFGVLVFEVIKGNHP 804
IA + Y DV+S G+ E+ G+ P
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
DFD K +G+G G V E +GDI A+K S LL+ E ++L++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI--- 57
Query: 657 RHRNNVKFHGFCY---NGPHSFLVCEYLDRGSLARILG--DDVTAKELGWNRRINVIKGV 711
N+ Y + + +LV EY G L +L +D +++ + + + V
Sbjct: 58 --SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA---QFYLAELV 112
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA----G 767
A+ +H +HRDI +NVL+D ++DFG A + ++N + G
Sbjct: 113 L-AIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARL---TANKMVNSKLPVG 165
Query: 768 TFGYAAPEIAYTMRATEK--YDV----YSFGVLVFEVIKGNHP 804
T Y APE+ TM K Y V +S GV+ +E+I G P
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 35/210 (16%)
Query: 607 IGKGGQGSVYKAELPSGDI-VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN----- 660
+G G G V A VA+KK + S A E+ LK + H N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT--YRELRLLKHMDHENVIGLL 80
Query: 661 NVKFHGFCYNGPHS--------FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA 712
+V F P S +LV + L I+ ++L + ++ +
Sbjct: 81 DV-FT------PASSLEDFQDVYLVTHLMGA-DLNNIVK----CQKLSDDHIQFLVYQIL 128
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
L Y+H IIHRD+ N+ ++ + E + DFG+A+ T + T Y
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYR 182
Query: 773 APEIAYT-MRATEKYDVYSFGVLVFEVIKG 801
APEI M + D++S G ++ E++ G
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 24/242 (9%)
Query: 607 IGKGGQGSVY----KAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+GKG G+VY K + + +K+ L+ N E L ++ H V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSKLDHPAIV 65
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGDDV-----TAKELGWNRRINVIKGVANALSY 717
KFH ++ EY + R L + T K L N+ + + Y
Sbjct: 66 KFHASFLERDAFCIITEYCE----GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
+H I+HRD+ +KN+ L +N + DFG+++ + T F GT Y +PE
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSV 837
K D++S G +++E+ H F NF S +++ + + P LP
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHA--FEGQNFLS---VVLRIVEGPTPSLPETYSRQ 232
Query: 838 MD 839
++
Sbjct: 233 LN 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 33/124 (26%), Positives = 62/124 (50%), Gaps = 6/124 (4%)
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
+ +AL YLH +++RD+ +N++LD + ++DFG+ K + F GT
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRL 830
Y APE+ D + GV+++E++ G P F++ + +I+ + +I PR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHEKLFELIL-MEEIRFPRT 217
Query: 831 PTPS 834
+P
Sbjct: 218 LSPE 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAK--FVGPHSSNWTEFAGTFGYAAPEIAYTMRATE 784
IHRD++++N+LL N + DFG+A+ + P + + APE + T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 785 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIID 821
+ DV+SFGVL++E+ FS+ S + + ID
Sbjct: 261 QSDVWSFGVLLWEI---------FSLGASPYPGVKID 288
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 42/133 (31%), Positives = 60/133 (45%), Gaps = 24/133 (18%)
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS-NWTEFAGTFGYAA 773
L YLH I+HRDI N+L++SN + DFG+A+ P S + T+ T Y A
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 774 PEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFS-----NMIIDVNKILD 827
PEI R T D++S G + E++ I F + S ++I D+
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRR-------ILFQAQSPIQQLDLITDL----- 220
Query: 828 PRLPTPSPSVMDY 840
L TPS M
Sbjct: 221 --LGTPSLEAMRS 231
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 32/237 (13%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNE--VLALKEI 656
+DFD IG+G G V S V K S+ +D F E ++A
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA---- 98
Query: 657 RHRNN---VKFHGFCYNGPHSFLVCEYLDRGSLARILGD-DVTAKELGWNRRINVIKGVA 712
H N+ V+ H + + ++V EY+ G L ++ + D+ K W R V
Sbjct: 99 -HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---WARF--YTAEVV 152
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP----HSSNWTEFAGT 768
AL +H IHRD+ N+LLD + ++DFG + GT
Sbjct: 153 LALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT---AVGT 206
Query: 769 FGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIID 821
Y +PE+ + Y D +S GV ++E++ G+ P F++ + + I+D
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP--FYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 65/273 (23%), Positives = 118/273 (43%), Gaps = 55/273 (20%)
Query: 593 EIIKATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEF 646
EI +T F E+ +G+ G VYK L VA+K + +EF
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEF 55
Query: 647 LNEVLALKEIRHRNNVKFHG-------------FCYNGP-HSFLVCE--YLDRGSLARIL 690
+E + ++H N V G +C + H FLV + D GS
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGST---- 111
Query: 691 GDDVTAKE-LGWNRRINVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVS 747
DD T K L ++++ +A + +L HH ++H+D++++NVL+ +S
Sbjct: 112 DDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKIS 166
Query: 748 DFGIAKFVGPHSSNWTEFAGT----FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GN 802
D G+ + V +++++ + G + +PE + + D++S+GV+++EV G
Sbjct: 167 DLGLFREV--YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 803 HPRDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
P + +SN DV +++ R P P
Sbjct: 225 QP-------YCGYSNQ--DVIEMIRNRQVLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 24/86 (27%), Positives = 46/86 (53%), Gaps = 5/86 (5%)
Query: 653 LKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA 712
+ ++ H + HG C G + +V E+++ G L L + + W +I V + +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLL 738
+ALSYL +++H ++ +KN+LL
Sbjct: 128 SALSYLEDK---NLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 607 IGKGGQGSVYKAELPSG---DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK 663
IG G G V E+ SG V VK+ S ++ + +FL E + ++H N ++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRV---SASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI--NVIKGVANALSYLHHD 721
G C LV E+ G L L A+ + + + +A L +LH +
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK-------FVGPHSSNWTEFAGTFGYAAP 774
+ IH D++ +N LL ++ + D+G++ +V P W + AP
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP-DQLWVPLR----WIAP 171
Query: 775 EIAYTMRA-------TEKYDVYSFGVLVFEVIK-GNHP 804
E+ + T++ +V+S GV ++E+ + G+ P
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 711 VANALSYL-HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTF 769
VAN + +L +C +HRD++++NVL+ + DFG+A+ + SN+ TF
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYISKGSTF 302
Query: 770 ---GYAAPEIAYTMRATEKYDVYSFGVLVFEV 798
+ APE + T DV+SFG+L++E+
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 9e-06
Identities = 69/277 (24%), Positives = 107/277 (38%), Gaps = 50/277 (18%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
DDF+ IG+G G V+ + +G + A+K S ++ N H E L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADA 58
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILG--DDVTAKELGWNRRINVIKGVANA 714
VK + + H +LV EY+ G L +L D + + I + A
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF-----YIAELVLA 113
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK------------------- 753
L +H IHRDI N+L+D+ + H+ +DFG+ K
Sbjct: 114 LDSVH---KLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 754 -------FVGPHSSNWTEF---AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 803
H GT Y APE+ + D +S GV+++E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 804 PRDFFSINFSSFSNMIIDVNKILD-PRLPTPSPSVMD 839
P F+S N II+ + L P P SP +D
Sbjct: 229 P--FYSDTLQETYNKIINWKESLRFPPDPPVSPEAID 263
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 16/164 (9%)
Query: 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL-HHDCLPSIIHRDISSKNVLL 738
Y+D+ + IL +D A L ++ VA +S+L +C IHRD++++N+LL
Sbjct: 194 YIDQDVTSEILEEDELA--LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILL 247
Query: 739 DSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAYTMRATEKYDVYSFGVLV 795
+ DFG+A+ + + SN+ + APE + T + DV+S+G+L+
Sbjct: 248 THGRITKICDFGLARDIR-NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 306
Query: 796 FEVIK-GNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVM 838
+E+ G+ P ++ S F MI + ++L P +PS M
Sbjct: 307 WEIFSLGSSPYPGMPVD-SKFYKMIKEGYRMLSPEC---APSEM 346
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 39/125 (31%), Positives = 59/125 (47%), Gaps = 16/125 (12%)
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L Y+H IIHRD+ NV ++ + E + DFG+A+ T + T Y AP
Sbjct: 131 LKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATRWYRAP 184
Query: 775 EIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTP 833
EI M + D++S G ++ E++KG + F N ID K + + TP
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKG---KALFP------GNDYIDQLKRIMEVVGTP 235
Query: 834 SPSVM 838
SP V+
Sbjct: 236 SPEVL 240
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 53/225 (23%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQ---------------LLSGNMADHDEFLNEV 650
IG+G G VYKA + +G +VA+KK + LL M ++ +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLL--QMLSESIYIVRL 66
Query: 651 LALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD----------RGSLARILGDDVTAKELG 700
L ++ + +N P +LV EYLD R L T K
Sbjct: 67 LDVEHVEEKNG---------KPSLYLVFEYLDSDLKKFMDSNGRGPGRPL-PAKTIKSFM 116
Query: 701 WNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEA-HVSDFGIAK-FVGPH 758
+ ++KGVA + H ++HRD+ +N+L+D ++D G+ + F P
Sbjct: 117 YQ----LLKGVA----HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165
Query: 759 SSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGN 802
S +T T Y APE+ + D++S G + E+ +
Sbjct: 166 KS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 31/248 (12%)
Query: 591 HEEIIK-------ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADH 643
+E+I++ +D+D IG+G G V S V K S+ +D
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 644 DEFLNEVLALKEIRHRNNVKF--HGFC--YNGPHSFLVCEYLDRGSLARILGD-DVTAKE 698
F E ++I N + FC + + ++V EY+ G L ++ + DV K
Sbjct: 88 AFFWEE----RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK- 142
Query: 699 LGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758
W + V AL +H +IHRD+ N+LLD + ++DFG +
Sbjct: 143 --WAKFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195
Query: 759 SSNWTEFA-GTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFS 813
+ A GT Y +PE+ + Y D +S GV +FE++ G+ P F++ +
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP--FYADSLV 253
Query: 814 SFSNMIID 821
+ I+D
Sbjct: 254 GTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
D +++ +G+G +VYK + +G +VA+K Q G + E LK ++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA---IREASLLKGLK 61
Query: 658 HRNNVKFHGFCYNGPHSFLV--------CEYLDRGSLARILGDDVTAKELGWNRRINVIK 709
H N V H + LV C+Y+D+ + ++V +
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHP-GGLHPENVKL----------FLF 110
Query: 710 GVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTF 769
+ LSY+H I+HRD+ +N+L+ E ++DFG+A+ S ++ T
Sbjct: 111 QLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTL 167
Query: 770 GYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKG 801
Y P++ + + D++ G + E+I+G
Sbjct: 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 32/115 (27%), Positives = 60/115 (52%), Gaps = 18/115 (15%)
Query: 711 VANALSYL-HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT- 768
VA + +L +C IHRD++++NVLL A + DFG+A+ + + SN+
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNAR 275
Query: 769 --FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIID 821
+ APE + T + DV+S+G+L++E+ FS+ S + ++++
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEI---------FSLGKSPYPGILVN 321
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 8/202 (3%)
Query: 383 NSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLST 442
+ L+LSSN ++ +P L L SL+ L + S +L L LDL+
Sbjct: 45 VAVNRLALNLSSNTLL-LLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNL 102
Query: 443 NKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVC 502
N+L S+I + + L L L+L NN ++ P +L ELDLS N + E +P +
Sbjct: 103 NRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLR 160
Query: 503 NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGLMEGNKGL 562
N+ +L+ L+LS N+LSD +P+ + +L+ +D+S N++ +P L E L
Sbjct: 161 NLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE--LDL 216
Query: 563 KRVSQEEQSNSMNRLRLLSVLN 584
S E +S++ L+ LS L
Sbjct: 217 SNNSIIELLSSLSNLKNLSGLE 238
|
Length = 394 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 49/236 (20%)
Query: 597 ATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMAD--HDEFLNEVLAL 653
D++ +G+G G VYKA ++ +G +VA+KK +L N D L E+ L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKK----ILMHNEKDGFPITALREIKIL 61
Query: 654 KEIRHRNNVKFHGFCYNGPHS--------FLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
K+++H N V P ++V Y+D L+ +L N +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE----------NPSV 110
Query: 706 NV----IKGVANAL----SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA----- 752
+ IK L +YLH + I+HRDI + N+L+D+ ++DFG+A
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 753 ---KFVGPHSSNWTEFAG---TFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVIKG 801
G ++ T Y PE + R T D++ G + E+
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 51/234 (21%), Positives = 98/234 (41%), Gaps = 43/234 (18%)
Query: 601 FDEKFCIGKGGQGSVYKAE------LPSGD-----------IVAVKKFNSQLLSGNMADH 643
F EK +G+G G V+ E LP+ +VAVK N
Sbjct: 9 FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRP---DANKNAR 63
Query: 644 DEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL------------- 690
++FL EV L ++ N ++ G C + ++ EY++ G L + L
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 691 ---GDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747
+ ++ ++V +A+ + YL + +HRD++++N L+ N ++
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIA 180
Query: 748 DFGIAK--FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
DFG+++ + G + + A E + T DV++FGV ++E++
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 57/252 (22%), Positives = 90/252 (35%), Gaps = 67/252 (26%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
F + +GKG G V+ L +G + A+K +L + VL +EI
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALK-----VLDKKEMIKRNKVKRVLTEQEIL 55
Query: 658 HRNN----VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRR------INV 707
+ + + LV +Y G L R+L R+ V
Sbjct: 56 ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL-----------QRQPGKCLSEEV 104
Query: 708 IK----GVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-------- 753
+ V AL YLH L I++RD+ +N+LL + H+ SDF ++K
Sbjct: 105 ARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPP 159
Query: 754 ---------------------FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFG 792
F S F GT Y APE+ D ++ G
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219
Query: 793 VLVFEVIKGNHP 804
+L++E++ G P
Sbjct: 220 ILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 22/60 (36%), Positives = 30/60 (50%)
Query: 386 KLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKL 445
L+ LDLS+N + + L +L L L+ N L+ P F L L+ LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 38/187 (20%), Positives = 86/187 (45%), Gaps = 20/187 (10%)
Query: 625 IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRG 684
+VAVK N ++FL E+ + ++ N ++ C ++ EY++ G
Sbjct: 48 LVAVKMLRE---DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 685 SLARIL--------GDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNV 736
L + L + + ++ I + +A+ + YL + +HRD++++N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161
Query: 737 LLDSNFEAHVSDFGIAKFVGPHSSNWTEFAG----TFGYAAPEIAYTMRATEKYDVYSFG 792
L+ N+ ++DFG+++ + +S ++ G + + E + T DV++FG
Sbjct: 162 LVGKNYTIKIADFGMSRNL--YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 219
Query: 793 VLVFEVI 799
V ++E++
Sbjct: 220 VTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
+DF+ IG+G G V +L + D V K ++ A+ F E L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARILG--DDVTAKELGWNRRINVIKGVANALS 716
+ H + + +LV +Y G L +L +D +++ ++ + +++
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVH 119
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG-IAKFVGPHSSNWTEFAGTFGYAAPE 775
LH+ +HRDI N+L+D N ++DFG K + + + GT Y +PE
Sbjct: 120 QLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 776 IAYTM-----RATEKYDVYSFGVLVFEVIKGNHP 804
I M + + D +S GV ++E++ G P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGY 771
AL +H + +HRD+ S N+ L + DFG +K S + F GT Y
Sbjct: 181 ALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237
Query: 772 AAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
APE+ R ++K D++S GV+++E++ + P
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAK--FVGPHSSNWTEFAGTFGYAAPEIAYTMRATE 784
IHRD++++N+LL N + DFG+A+ + P + + APE + T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 785 KYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIID 821
+ DV+SFGVL++E+ FS+ S + + ID
Sbjct: 255 QSDVWSFGVLLWEI---------FSLGASPYPGVQID 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 28/150 (18%), Positives = 55/150 (36%), Gaps = 19/150 (12%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV--KF 664
+ G VY D V +K S+ + EV L+ + + K
Sbjct: 6 LKGGLTNRVYLLGTKDEDYV-LKINPSREKGAD------REREVAILQLLARKGLPVPKV 58
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
+ S+L+ E+++ T E+ + ++ + +A L+ LH L
Sbjct: 59 LASGESDGWSYLLMEWIE----------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754
+ H D+ N+L+D + D+ A +
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 65/288 (22%), Positives = 96/288 (33%), Gaps = 57/288 (19%)
Query: 174 LSNLAVLYLYKNSLSGS----IPSIIGKLKSLLQLDLSENQFSGSIPLS-------LGNL 222
L L VL L N+L + S + SL +L LS N +G IP L
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGLTKG 80
Query: 223 SSLTMMSLFNNSLSGSIPPILGNLKSLSALG---LHINQLNGFIPPSIG-----NLSSLR 274
L + L +N+L +L +L S+L L+ N L + +L
Sbjct: 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140
Query: 275 VLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH--SIERVLLNQNNLSG----K 328
L L N L G C L + ++ + L N +
Sbjct: 141 KLVLGRNRLEG---------------ASCEALA-KALRANRDLKELNLANNGIGDAGIRA 184
Query: 329 MYEAFGDHPNLTFLDLSNNNFCGE-ISFNWGNFS---KLSTFIVSMNNISGSIPPDI--- 381
+ E + NL LDL+NN E S + L + NN++ + +
Sbjct: 185 LAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASA 244
Query: 382 --GNSPKLQVLDLSSNHIVGK-----IPVQLEMLSSLNKLILNLNQLS 422
+ L L LS N I V E SL +L L N+
Sbjct: 245 LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK-ESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 29/222 (13%)
Query: 608 GKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADH-DEFLNEVLALKEIRHRNNVKFHG 666
GK +G +Y + +VA+K L N EF E + E+ H N V G
Sbjct: 19 GKIYKGHLYLPGMDHAQLVAIKT----LKDINNPQQWGEFQQEASLMAELHHPNIVCLLG 74
Query: 667 FCYNGPHSFLVCEYLDRGSLARIL-------------GDDVTAKE-LGWNRRINVIKGVA 712
++ EYL++G L L +D T K L +++ +A
Sbjct: 75 VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIA 134
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---- 768
+ YL +H+D++++N+L+ +SD G+++ + +S+++
Sbjct: 135 AGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREI--YSADYYRVQPKSLLP 189
Query: 769 FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFS 809
+ PE + + D++SFGV+++E+ G P FS
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF--LNEVLALKEIRHRNNVK 663
+G+G +VYK +G +VA+K ++S + F + E LK ++H N V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALK-----VISMKTEEGVPFTAIREASLLKGLKHANIVL 67
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINV---IKGVANALSYLHH 720
H + V EY+ LA+ + + G NV + + L+Y+H
Sbjct: 68 LHDIIHTKETLTFVFEYM-HTDLAQYM-----IQHPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM 780
I+HRD+ +N+L+ E ++DFG+A+ S ++ T Y P++ +
Sbjct: 122 Q---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV--LL 176
Query: 781 RATE---KYDVYSFGVLVFEVIKG 801
AT+ D++ G + E+++G
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 36/211 (17%)
Query: 606 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
IG+G G V A + + VA+KK + N D L E+ L+ + H N +
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 665 HGFCYNGPHS------FLVCEYLDRGSLARI------LGDDVTAKELGWNRRINVIKGVA 712
PH ++V E +D L +I L DD L +++G
Sbjct: 70 KD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFL-----YQLLRG-- 120
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
L Y+H +++HRD+ N+LL++N + + DFG+A+ TE+ T Y
Sbjct: 121 --LKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175
Query: 773 APEIAYTMRATEKY----DVYSFGVLVFEVI 799
APE+ + +Y DV+S G + E++
Sbjct: 176 APEL---LLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 43/228 (18%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADHDEFLNEVLALKE-- 655
DDF+ IG+G G V ++ + I A+K N E+L E
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--------------EMLKRAETA 46
Query: 656 -IRHRNNVKFHGFCY----------NGPHSFLVCEYLDRGSLARILG--DDVTAKELGWN 702
R NV +G C + + +LV +Y G L +L +D +++
Sbjct: 47 CFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF 106
Query: 703 RRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762
++ + +++ LH+ +HRDI NVLLD N ++DFG + +
Sbjct: 107 YIAEMVLAI-HSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159
Query: 763 TEFA-GTFGYAAPEIAYTMR-ATEKY----DVYSFGVLVFEVIKGNHP 804
+ A GT Y +PEI M KY D +S GV ++E++ G P
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 607 IGKGGQGSVYKA-ELPSGD-IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR---HRNN 661
IG+G G V+KA +L +G VA+K+ Q M + EV L+ + H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST--IREVAVLRHLETFEHPNV 66
Query: 662 VKFHGFCY-----NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
V+ C LV E++D+ L L D V + +++ + L
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+LH ++HRD+ +N+L+ S+ + ++DFG+A+ + T T Y APE+
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPEV 180
Query: 777 AYTMRATEKYDVYSFGVLVFEVIK 800
D++S G + E+ +
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 27/93 (29%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP----HSSNWTEFAGTF 769
L Y+H +++HRD+ N+L++++ E + DFG+A+ ++ TE+ T
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 770 GYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKG 801
Y APEI + ++ T+ DV+S G ++ E++
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 644 DEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNR 703
+ F + ++ H++ V +G C G S +V EY+ GSL L + + W
Sbjct: 44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW-- 101
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 738
++ V K +A AL +L + H ++ +KNVLL
Sbjct: 102 KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 39/136 (28%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 675 FLVCEYLDRGSLARILGD-DVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISS 733
++V EY+ G L ++ + DV K W R V AL +H IHRD+
Sbjct: 119 YMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVLALDAIHS---MGFIHRDVKP 170
Query: 734 KNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA-GTFGYAAPEIAYTMRATEKY----DV 788
N+LLD + ++DFG + + A GT Y +PE+ + Y D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 789 YSFGVLVFEVIKGNHP 804
+S GV ++E++ G+ P
Sbjct: 231 WSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 23/93 (24%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 646 FLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
F ++++ H++ V +G C + +V E+++ G L + W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 738
V K +A+ALSYL ++H ++ +KN+LL
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 72/279 (25%), Positives = 107/279 (38%), Gaps = 72/279 (25%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKF-NSQLLSGNMADHDEFLNEVLALKEI 656
DDF+ IG+G G V + +G I A+KK S++L H ++LA E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA--EA 58
Query: 657 RHRNNVKFHGFCYNGPHSF-------LVCEYLDRGSLARIL--GDDVTAKELGWNRRINV 707
+ VK + +SF L+ EYL G + +L D T +E +
Sbjct: 59 DNPWVVKLY-------YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRF-----Y 106
Query: 708 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA- 766
I A+ +H IHRDI N+LLD+ +SDFG+ G S+ TEF
Sbjct: 107 IAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYR 161
Query: 767 ---------------------------------------GTFGYAAPEIAYTMRATEKYD 787
GT Y APE+ ++ D
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221
Query: 788 VYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKIL 826
+S GV+++E++ G P F S N II+ + L
Sbjct: 222 WWSLGVIMYEMLVGYPP--FCSDNPQETYRKIINWKETL 258
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 45/173 (26%), Positives = 69/173 (39%), Gaps = 31/173 (17%)
Query: 387 LQVLDLSSNHI-VGKIPVQLEML---SSLNKLILNLNQLSG-----GVPLE-FGSLTKLQ 436
LQVL L N + L SL +L L+LN+ L+ LQ
Sbjct: 25 LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQ 84
Query: 437 YLDLSTNKLSSSIPKSIGNLLK---LHYLNLSNNQLSHKIPTEFEKLI---------HLS 484
LDLS N L + +LL+ L L L+NN L + +L+ L
Sbjct: 85 ELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRG----LRLLAKGLKDLPPALE 140
Query: 485 ELDLSHNILQ----EEIPPQVCNMGSLEKLNLSHNNLSDF-IPRCFEEMRSLS 532
+L L N L+ E + + L++LNL++N + D I E +++
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANC 193
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 6/84 (7%)
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA-GTFGYAAPEIAYTMR-ATE 784
+HRDI NVLLD N ++DFG + + + A GT Y +PEI M
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 785 KY----DVYSFGVLVFEVIKGNHP 804
+Y D +S GV ++E++ G P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 6e-04
Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 2/61 (3%)
Query: 410 SLNKLILNLNQLSGGVPLE-FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQ 468
+L L L+ N+L+ +P F L L+ LDLS N L+S P++ L L L+LS N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 469 L 469
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-04
Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 16/84 (19%)
Query: 675 FLVCEYL---DRGSLARILG--DDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHR 729
+LV EYL D SL I G D+ A + I VA AL YLH IIHR
Sbjct: 80 YLVMEYLIGGDVKSLLHIYGYFDEEMA--------VKYISEVALALDYLHRH---GIIHR 128
Query: 730 DISSKNVLLDSNFEAHVSDFGIAK 753
D+ N+L+ + ++DFG++K
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 19/166 (11%)
Query: 607 IGKGGQGSVYKAEL---PSGDIVAVKKFNS---QLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G ++YK L DIV + S ++L + D F + ++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
VK +G C + +V EY+ G L L + L W +++V K +A+AL YL
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 721 DCLPSIIHRDISSKNVLL---DSNFE----AHVSDFGIAKFVGPHS 759
++H ++ KN+L+ N +SD GI V
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 47/213 (22%), Positives = 86/213 (40%), Gaps = 39/213 (18%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQ------LLSGNMADHDEFLNEVLALK 654
IG GG G VY+ + S + ++ ++ L+ N+ D D+ + +
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDK-IALWKNIH 78
Query: 655 EIRHRNNVKFHG---FCYNGPH-SFLVCEYLDRGSLARILGDDVTAKELGWNRRI--NVI 708
I H K++G F + F++ E L + ++ + N+++ N++
Sbjct: 79 NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENT------KEIFKRIKCKNKKLIKNIM 132
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV---GPH------S 759
K + L Y+H I H DI +N+++D N ++ D+GIA G H
Sbjct: 133 KDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189
Query: 760 SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFG 792
+ GT YA + T + D+ S G
Sbjct: 190 KDLHR--GTLYYAGLDAHNGACVTRRGDLESLG 220
|
Length = 294 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 26/100 (26%), Positives = 38/100 (38%), Gaps = 16/100 (16%)
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA 766
V AL LH R S N+LL ++ + G F P S +
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILL--TWDGLLKLDGSVAFKTPEQSRPDPYF 70
Query: 767 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806
APE+ TEK D+YS G+ ++E + P +
Sbjct: 71 M-----APEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 20/60 (33%), Positives = 26/60 (43%)
Query: 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQL 139
+L +L+LS N L L+ LDL N L+ + P L LR L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 26/156 (16%)
Query: 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRN 660
+G+G +VYK +G +VA+K+ + H+E + E LK+++H N
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLE--------HEEGAPFTAIREASLLKDLKHAN 64
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI---NVIKGVANALSY 717
V H + LV EYLD L + + D + N R+ +++G L+Y
Sbjct: 65 IVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRLFLFQLLRG----LAY 118
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753
H ++HRD+ +N+L+ E ++DFG+A+
Sbjct: 119 CHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 59/248 (23%), Positives = 96/248 (38%), Gaps = 55/248 (22%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKF-NSQLLSGNMADHDEFLNEVLALKEI 656
DDF+ IG+G G V + +G I A+K + +L H ++L E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILV--EA 58
Query: 657 RHRNNVK-FHGFCYNGPHSFLVCEYLDRGSLARIL--GDDVTAKELGWNRRINVIKGVAN 713
VK F+ F + + +L+ E+L G + +L D ++ + + I
Sbjct: 59 DGAWVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF-----YIAETVL 112
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF-------- 765
A+ +H IHRDI N+LLD+ +SDFG+ G ++ TEF
Sbjct: 113 AIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLC--TGLKKAHRTEFYRNLTHNP 167
Query: 766 -----------------------------AGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 796
GT Y APE+ + D +S GV+++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 797 EVIKGNHP 804
E++ G P
Sbjct: 228 EMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 20/110 (18%)
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK----------FVGPHSSNWT 763
AL YLH+ I+HRD+ N+L+ S ++DFG++K + G +
Sbjct: 113 ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 764 EF-----AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808
EF GT Y APE+ + D ++ G++++E + G P FF
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP--FF 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 39/153 (25%), Positives = 60/153 (39%), Gaps = 20/153 (13%)
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKE---LGWNRRINVIKGVANALS 716
N V H + + FLV ++ + G L + + E W + V AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
LH + I+ RD++ N+LLD ++ F V A Y APE+
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDG---EAVENMYCAPEV 153
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGN-----HP 804
TE D +S G ++FE++ G HP
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 20/60 (33%), Positives = 26/60 (43%)
Query: 176 NLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL 235
NL L L N L+ L +L LDLS N + P + L SL + L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 21/57 (36%), Positives = 25/57 (43%)
Query: 155 KLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQF 211
L L +N L + L NL VL L N+L+ P L SL LDLS N
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 848 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.98 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.98 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.53 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.5 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.22 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.16 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.03 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.01 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.87 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.59 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.58 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.57 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.56 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.52 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.43 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-102 Score=961.83 Aligned_cols=773 Identities=36% Similarity=0.578 Sum_probs=576.3
Q ss_pred ChHHHHHHHHHHHhccCCCCCCcccCCCCCCCCCCCCCCCCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCC
Q 038003 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHL 81 (848)
Q Consensus 2 ~~~~~~all~~k~~~~~~~~~~~~l~sw~~~~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l 81 (848)
.++|+.||++||+++.++ .+.+++|+ .+.|||.|.||+|+. .++|+.|+|+++++.|.+++ ++..+++|
T Consensus 27 ~~~~~~~l~~~~~~~~~~---~~~~~~w~------~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~-~~~~l~~L 95 (968)
T PLN00113 27 HAEELELLLSFKSSINDP---LKYLSNWN------SSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISS-AIFRLPYI 95 (968)
T ss_pred CHHHHHHHHHHHHhCCCC---cccCCCCC------CCCCCCcCcceecCC-CCcEEEEEecCCCccccCCh-HHhCCCCC
Confidence 358999999999999643 35789996 356899999999986 46999999999999998854 68899999
Q ss_pred cEEeccCCccccccccccc-CCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCC
Q 038003 82 ANLNLSFNLFFGNIPLQIG-NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160 (848)
Q Consensus 82 ~~L~l~~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 160 (848)
+.|+|++|.++|.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|+|++|.+++.+|..++.+++|++|+|++
T Consensus 96 ~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~ 173 (968)
T PLN00113 96 QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG 173 (968)
T ss_pred CEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECcc
Confidence 9999999999999998765 788888888888888776664 4566777777777777766777777777777777777
Q ss_pred CcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCC
Q 038003 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIP 240 (848)
Q Consensus 161 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p 240 (848)
|.+.+.+|..++++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..++++++|++|++++|.+++.+|
T Consensus 174 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 253 (968)
T PLN00113 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253 (968)
T ss_pred CcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccC
Confidence 77766667767777777777777777766666666667777777777777766666666666777777777776666666
Q ss_pred CcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCC------c
Q 038003 241 PILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH------S 314 (848)
Q Consensus 241 ~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~------~ 314 (848)
..++++++|++|++++|++.+.+|..+.++++|++|++++|.+.+.+|..+..+++|+.|++++|.+.+.+|. .
T Consensus 254 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~ 333 (968)
T PLN00113 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333 (968)
T ss_pred hhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCC
Confidence 6666666666666666666666666666666666666666666666666666666666666666666655543 3
Q ss_pred cceeeccccCCCCccccccCCCCCccEEEccCCccccc------------------------cCccccCcccccEeeccc
Q 038003 315 IERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGE------------------------ISFNWGNFSKLSTFIVSM 370 (848)
Q Consensus 315 l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~------------------------~~~~~~~l~~L~~L~l~~ 370 (848)
++.+.+.+|.+++..+..++.+++|+.|++++|++++. .|..++.+++|+.|++++
T Consensus 334 L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~ 413 (968)
T PLN00113 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413 (968)
T ss_pred CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcC
Confidence 45555666666555555555555555555555555544 444455555666666666
Q ss_pred ccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCC
Q 038003 371 NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIP 450 (848)
Q Consensus 371 N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 450 (848)
|++++.+|..+..+++|+.|++++|.+++.++..+..+++|+.|++++|++.+.+|..++ .++|+.|++++|++++..|
T Consensus 414 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~ 492 (968)
T PLN00113 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVP 492 (968)
T ss_pred CEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCccC
Confidence 666666666666666666666666666666666666666666777777766666665543 4678888888888888889
Q ss_pred CcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccC
Q 038003 451 KSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRS 530 (848)
Q Consensus 451 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 530 (848)
..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++
T Consensus 493 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 572 (968)
T PLN00113 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572 (968)
T ss_pred hhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCccCCCCCCCCccc---ccccccccCcc---------cchhhhhhhh------------------------c
Q 038003 531 LSCIDISYNELHGPIPNSTAFK---DGLMEGNKGLK---------RVSQEEQSNS------------------------M 574 (848)
Q Consensus 531 L~~l~ls~N~l~~~~~~~~~~~---~~~~~~~~~l~---------~~s~~~~~~s------------------------~ 574 (848)
|+.+++++|++.|.+|...+|. ...+.||+.+. .|........ .
T Consensus 573 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (968)
T PLN00113 573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFI 652 (968)
T ss_pred cCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999765543 34566776432 1111000000 0
Q ss_pred cc-----cceee-----e--ecCCCCc-cHHHHHHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCc
Q 038003 575 NR-----LRLLS-----V--LNFDGKI-MHEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNM 640 (848)
Q Consensus 575 ~~-----l~~~~-----~--~~~~~~~-~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~ 640 (848)
.+ .+... + ..+.... ...........|...+.||+|+||.||+|.. .++..||||+++....
T Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---- 728 (968)
T PLN00113 653 RGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---- 728 (968)
T ss_pred HhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----
Confidence 00 00000 0 0000000 0011222335677888999999999999976 5789999999864321
Q ss_pred hhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh
Q 038003 641 ADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720 (848)
Q Consensus 641 ~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~ 720 (848)
....|++.+++++|||||+++++|.+.+..++||||+++|+|.++++ .++|.++.+|+.|||+|++|||.
T Consensus 729 ----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~ 798 (968)
T PLN00113 729 ----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHC 798 (968)
T ss_pred ----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhcc
Confidence 11246888999999999999999999999999999999999999984 37899999999999999999996
Q ss_pred CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh
Q 038003 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK 800 (848)
Q Consensus 721 ~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 800 (848)
.+.++|+||||||+||+++.++.+++. ||........ ....+++.|+|||++.+..+++++|||||||++|||+|
T Consensus 799 ~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t 873 (968)
T PLN00113 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT 873 (968)
T ss_pred CCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHh
Confidence 656699999999999999999988876 6655433221 22367899999999999999999999999999999999
Q ss_pred CCCCCcc
Q 038003 801 GNHPRDF 807 (848)
Q Consensus 801 g~~P~~~ 807 (848)
|+.||+.
T Consensus 874 g~~p~~~ 880 (968)
T PLN00113 874 GKSPADA 880 (968)
T ss_pred CCCCCCc
Confidence 9999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-58 Score=570.07 Aligned_cols=488 Identities=39% Similarity=0.570 Sum_probs=392.8
Q ss_pred ceEEEeccccCccccccCCccCCCCCCcEEec----------------------cCCcccccccccccCCCCCcEEEccc
Q 038003 55 RVISITMSTLGLNGTFHDFSFSSFPHLANLNL----------------------SFNLFFGNIPLQIGNLSKLQYLDLGS 112 (848)
Q Consensus 55 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l----------------------~~n~~~~~~p~~~~~l~~L~~L~Ls~ 112 (848)
++..|+|+++.+.|.+|...+..+++|++|+| ++|.+++.+|..++++++|++|+|++
T Consensus 94 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~ 173 (968)
T PLN00113 94 YIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG 173 (968)
T ss_pred CCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECcc
Confidence 45567777777777666544444455555554 45555555666666667777777777
Q ss_pred cCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCc
Q 038003 113 NQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192 (848)
Q Consensus 113 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 192 (848)
|.+.+.+|..++++++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..++++++|++|++++|.+++.+|
T Consensus 174 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 253 (968)
T PLN00113 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253 (968)
T ss_pred CcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccC
Confidence 76666666667777777777777777766677777777777777777777776677777777777777777777776777
Q ss_pred ccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCC
Q 038003 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSS 272 (848)
Q Consensus 193 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~ 272 (848)
..++++++|++|+|++|++++.+|..+.++++|++|++++|.+++.+|..+.++++|+.|++++|.+.+.+|..+..+++
T Consensus 254 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~ 333 (968)
T PLN00113 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333 (968)
T ss_pred hhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCC
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CceEEccCccccccCcccccCCCCCccccccccccccccCC------ccceeeccccCCCCccccccCCCCCccEEEccC
Q 038003 273 LRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH------SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSN 346 (848)
Q Consensus 273 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~------~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 346 (848)
|+.|++++|.+.+.+|..++.+++|+.|++++|.+.+.+|. .++.+.+.+|++.+..+..+..+++|+.|++++
T Consensus 334 L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~ 413 (968)
T PLN00113 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413 (968)
T ss_pred CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcC
Confidence 77777777777777777777777788888888877776664 356777888888888888888999999999999
Q ss_pred CccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCC
Q 038003 347 NNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVP 426 (848)
Q Consensus 347 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 426 (848)
|++++..|..+..++.|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|++++..|
T Consensus 414 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~ 492 (968)
T PLN00113 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVP 492 (968)
T ss_pred CEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccC
Confidence 99999999999999999999999999999999999999999999999999998888766 45899999999999999999
Q ss_pred cccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCC
Q 038003 427 LEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGS 506 (848)
Q Consensus 427 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 506 (848)
..|..+++|+.|+|++|++++.+|..+.++++|++|+|++|++++.+|..|..+++|+.|+|++|++++.+|..+..+++
T Consensus 493 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 572 (968)
T PLN00113 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572 (968)
T ss_pred hhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCcccCCCcchhccccCceeecCCCCc-cCCC
Q 038003 507 LEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNE-LHGP 544 (848)
Q Consensus 507 L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~-l~~~ 544 (848)
|+.|++++|++++.+|.. +.+..+....+.+|+ ++|.
T Consensus 573 L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~ 610 (968)
T PLN00113 573 LVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCGG 610 (968)
T ss_pred cCEEeccCCcceeeCCCc-chhcccChhhhcCCccccCC
Confidence 999999999999988854 344455556677886 5554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=363.64 Aligned_cols=238 Identities=28% Similarity=0.411 Sum_probs=205.2
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-eeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP-HSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-~~~l 676 (848)
.+.+..+.||+|..|+||+|.++ ++..+|+|++.... +....+++.+|+++++..+|||||.+||.|.... ...+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~---~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI---DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC---CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 34566788999999999999776 78899999995443 5667889999999999999999999999999988 5999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||++|||++++... +++++....+|+.++++||.|||+ . +||||||||+|||++..|+|||||||.+..+
T Consensus 156 ~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred ehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 99999999999998765 679999999999999999999996 6 9999999999999999999999999999988
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhhhhcCCCCCC--C
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPT--P 833 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 833 (848)
... ...+++||..|||||.+.+..|+.++||||||++++|+++|++||.............+..+..-.+|.+|. .
T Consensus 230 vnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f 307 (364)
T KOG0581|consen 230 VNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF 307 (364)
T ss_pred hhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 654 457789999999999999999999999999999999999999998765444445555555555555566664 5
Q ss_pred CCCcccccceeecc
Q 038003 834 SPSVMDYGGCHFML 847 (848)
Q Consensus 834 ~~~~~~~~~~~~~~ 847 (848)
+++++++..||+.+
T Consensus 308 S~ef~~FV~~CL~K 321 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRK 321 (364)
T ss_pred CHHHHHHHHHHhcC
Confidence 77788888887653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=364.24 Aligned_cols=202 Identities=30% Similarity=0.493 Sum_probs=183.6
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
...+|...+.||+|+||+||+|+++ ++..||||.+.++.. ..+..+.+..|+++++.++|||||.+++++..++..|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 3467889999999999999999765 689999999987754 3456677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC------CCEEEeec
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN------FEAHVSDF 749 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~Df 749 (848)
+|||||+||+|.++++.. +.+++.++..++.|||.|+++||++ +||||||||.|||++.. -.+||+||
T Consensus 86 lVMEyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 999999999999999876 5789999999999999999999999 99999999999999865 46899999
Q ss_pred cCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+|+...+ .....+.||+|.|||||++...+|+.|+|+||+|+|+|+++||+.||+.
T Consensus 160 GfAR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 160 GFARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred chhhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999875 3444678999999999999999999999999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=360.07 Aligned_cols=204 Identities=29% Similarity=0.407 Sum_probs=188.4
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.++||+|+||+||+++. ++++.+|+|++++...... .+.++..+|..++.+++||+||+++..|++.+..|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 457899999999999999999955 4789999999999876643 56788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+|+||+.||.|..++++. +.+++..+.-++..|+.||.|||++ ||||||+||+|||+|++|+++|+|||+++..
T Consensus 102 lVld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999999876 6788999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........+++||+.|||||++.+..|+..+|+||+|+++|||+||..||..
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 6666666779999999999999999999999999999999999999999753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=376.49 Aligned_cols=242 Identities=27% Similarity=0.444 Sum_probs=212.9
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.+|...+.||+|+|+.||.++. .+|+.||+|++.++...+ ....+.+.+||+++++++|||||+++++|++.+.+|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k-~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK-PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC-cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 6799999999999999999976 799999999999977664 45678889999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
.|+|+.++|.+++++. +.+++.++..+++||+.|+.|||+. +|+|||||..|++++++.+|||+|||+|..+..
T Consensus 97 LELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999999855 7899999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccc----------cc---cccchhhhhhhh
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI----------NF---SSFSNMIIDVNK 824 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~----------~~---~~~~~~~~~~~~ 824 (848)
+.....+.||||.|.|||++....++..+||||+|||+|.|++|++||+...- ++ ..+....+++..
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~ 250 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIR 250 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHH
Confidence 76777889999999999999999999999999999999999999999865321 00 123334445566
Q ss_pred hcCCCCCCCCCCcccccceeecc
Q 038003 825 ILDPRLPTPSPSVMDYGGCHFML 847 (848)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~ 847 (848)
.+-...|..+|.+.+....+|++
T Consensus 251 ~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 251 KLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred HHhcCCcccCCCHHHHhcCHhhh
Confidence 66666788888887777777763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=376.33 Aligned_cols=469 Identities=30% Similarity=0.429 Sum_probs=377.4
Q ss_pred EEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecc
Q 038003 57 ISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDM 136 (848)
Q Consensus 57 ~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 136 (848)
..+.++++++.--.+ .+.+|+.++.|++++|.++ +.|++++.+..++.|+.|+|+++ .+|.+++.+.+|+.|+.++
T Consensus 48 ~~lils~N~l~~l~~--dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 48 QKLILSHNDLEVLRE--DLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhccCchhhccH--hhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 345555655543333 4778999999999999997 78999999999999999999998 7899999999999999999
Q ss_pred cCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCc
Q 038003 137 NQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIP 216 (848)
Q Consensus 137 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 216 (848)
|.+. .+|++++.+..|+.|+..+|+++ ..|..++++.+|..|++.+|+++...|..+. ++.|++||..+|.++ .+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence 9998 88999999999999999999999 7899999999999999999999965555555 999999999999998 899
Q ss_pred ccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcc-cCCCCCceEEccCccccccCcccccCCC
Q 038003 217 LSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVLYLYNNGLYGFVPEEIGYLK 295 (848)
Q Consensus 217 ~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 295 (848)
..++.+.+|.-|+|..|+|. .+| .|.++..|++|+++.|+|. .+|... .++.++.+|||..|+++ ..|++++-++
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr 275 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR 275 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence 99999999999999999998 677 8999999999999999998 455544 58999999999999998 5799999999
Q ss_pred CCccccccccccccccCC----ccceeeccccCCCCccccccCCCCC--ccEEE-------ccCCccccc-----cCccc
Q 038003 296 SLSELELCTNLLRGVIPH----SIERVLLNQNNLSGKMYEAFGDHPN--LTFLD-------LSNNNFCGE-----ISFNW 357 (848)
Q Consensus 296 ~L~~L~L~~N~l~~~~p~----~l~~l~L~~n~l~~~~~~~~~~l~~--L~~L~-------Ls~N~l~~~-----~~~~~ 357 (848)
+|++||+++|.|++..+. .++.+.+.+|.+..+..+.+..-+. |++|. ++.-+=+.+ .+..|
T Consensus 276 sL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~ 355 (565)
T KOG0472|consen 276 SLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESF 355 (565)
T ss_pred hhhhhcccCCccccCCcccccceeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcc
Confidence 999999999999876442 2333445566655544443322110 11111 111100000 11112
Q ss_pred ---cCcccccEeecccccccCCCCCCCCCCCC---ccEEEccCCccCCCCcccccccccccE-EEccCCcCCCCCCcccC
Q 038003 358 ---GNFSKLSTFIVSMNNISGSIPPDIGNSPK---LQVLDLSSNHIVGKIPVQLEMLSSLNK-LILNLNQLSGGVPLEFG 430 (848)
Q Consensus 358 ---~~l~~L~~L~l~~N~i~~~~p~~l~~l~~---L~~L~Ls~N~l~~~~~~~l~~l~~L~~-L~L~~N~l~~~~~~~~~ 430 (848)
......+.|+++.-+++ .+|+.....-+ .+.++++.|++. .+|..+..++.+.+ +.+++|.++ .+|..+.
T Consensus 356 ~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~ 432 (565)
T KOG0472|consen 356 PDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELS 432 (565)
T ss_pred cchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHH
Confidence 22446678888888888 56766554444 889999999998 88888888877654 455555555 8899999
Q ss_pred CCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccc
Q 038003 431 SLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKL 510 (848)
Q Consensus 431 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 510 (848)
.+++|..|+|++|-+. .+|..++.+..|+.||+|.|+|. ..|..+-.+..|+.+-.++|++....|..+.+|.+|.+|
T Consensus 433 ~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tL 510 (565)
T KOG0472|consen 433 QLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTL 510 (565)
T ss_pred hhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhccee
Confidence 9999999999999997 78999999999999999999997 789888888888888888899977767779999999999
Q ss_pred cCCCCcccCCCcchhccccCceeecCCCCccCC
Q 038003 511 NLSHNNLSDFIPRCFEEMRSLSCIDISYNELHG 543 (848)
Q Consensus 511 ~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~ 543 (848)
||.+|.+.. +|+.+++|.+|++|++++|+++-
T Consensus 511 DL~nNdlq~-IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 511 DLQNNDLQQ-IPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred ccCCCchhh-CChhhccccceeEEEecCCccCC
Confidence 999999975 78899999999999999999983
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=363.99 Aligned_cols=241 Identities=44% Similarity=0.695 Sum_probs=202.9
Q ss_pred CCCccHHHHHHhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceE
Q 038003 586 DGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665 (848)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 665 (848)
...+.++++..++++|...+.||+|+||.||+|...+|..||||++...... . .++|.+|++++.+++|||+|+++
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEE
Confidence 3457889999999999999999999999999999999999999987665311 1 45699999999999999999999
Q ss_pred EEeecCC-eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCE
Q 038003 666 GFCYNGP-HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEA 744 (848)
Q Consensus 666 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 744 (848)
|||.+.+ +.++|||||++|+|.++++..... .++|.+|.+|+.++|+||+|||+.+.+.||||||||+|||+|+++++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999998 599999999999999999876433 88999999999999999999999988889999999999999999999
Q ss_pred EEeeccCccccCCCCCCcccc-cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc-ccccccchh----
Q 038003 745 HVSDFGIAKFVGPHSSNWTEF-AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS-INFSSFSNM---- 818 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~-~~~~~~~~~---- 818 (848)
||+|||+|+............ .||.+|+|||+......+.|+|||||||++.|++||+.|.+... .........
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999996654312222222 89999999999999899999999999999999999999877543 111111111
Q ss_pred hh--hhhhhcCCCCC
Q 038003 819 II--DVNKILDPRLP 831 (848)
Q Consensus 819 ~~--~~~~~~~~~~~ 831 (848)
+. .+..++||.+.
T Consensus 297 ~~~~~~~eiiD~~l~ 311 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLK 311 (361)
T ss_pred HHCcchhheeCCCcc
Confidence 11 46677888875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=348.28 Aligned_cols=205 Identities=31% Similarity=0.444 Sum_probs=178.2
Q ss_pred hhcCCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCch---hHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMA---DHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
..+.|.+.+.||+|+||.|-+| ..++|+.||||++++........ ....+.+|+++|++++||+||+++++|.+.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456888899999999999999 55689999999998876554332 2233579999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC---CCEEEeec
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN---FEAHVSDF 749 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Df 749 (848)
..||||||++||+|.+++-+. +.+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999998665 5666777788999999999999999 99999999999999765 78999999
Q ss_pred cCccccCCCCCCcccccccccccCccccccCCC---CccchhhhHHHHHHHHHhCCCCCccc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA---TEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
|+|+..+ ......+.||||.|.|||++.+..+ ..++|+||+||++|-+++|.+||...
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence 9999987 4566788999999999999986543 44889999999999999999998543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=366.68 Aligned_cols=464 Identities=29% Similarity=0.373 Sum_probs=384.3
Q ss_pred EEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecc
Q 038003 57 ISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDM 136 (848)
Q Consensus 57 ~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 136 (848)
+.+++.++.+. ++| ++++.+..++.|+.++|+++ .+|++++++.+|+.|++++|.+. .+|+.++.+..|+.|+..+
T Consensus 71 ~vl~~~~n~l~-~lp-~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 71 TVLNVHDNKLS-QLP-AAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred eEEEeccchhh-hCC-HHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 34555555544 233 36888999999999999997 89999999999999999999998 6788999999999999999
Q ss_pred cCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCc
Q 038003 137 NQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIP 216 (848)
Q Consensus 137 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 216 (848)
|+++ .+|+.++.+.+|..|++.+|+++ ..|...-+++.|++||...|-++ .+|..++.|.+|..|+|.+|++. .+|
T Consensus 147 N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP 222 (565)
T KOG0472|consen 147 NQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP 222 (565)
T ss_pred cccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC
Confidence 9999 89999999999999999999999 55555555999999999999998 89999999999999999999999 788
Q ss_pred ccccCCcccceeeccccCCCCCCCCccc-CcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCC
Q 038003 217 LSLGNLSSLTMMSLFNNSLSGSIPPILG-NLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLK 295 (848)
Q Consensus 217 ~~l~~l~~L~~L~l~~n~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 295 (848)
+|.+++.|++|+++.|+|. .+|.... ++.+|..|||.+|+++ ..|+.++-+.+|++||+|+|.|++ .|..++++
T Consensus 223 -ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl- 297 (565)
T KOG0472|consen 223 -EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL- 297 (565)
T ss_pred -CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-
Confidence 9999999999999999999 7787665 8999999999999999 578899999999999999999995 68889999
Q ss_pred CCccccccccccccc----cCCc----cceeec--cccCCCC-------------ccccccCCCCCccEEEccCCccccc
Q 038003 296 SLSELELCTNLLRGV----IPHS----IERVLL--NQNNLSG-------------KMYEAFGDHPNLTFLDLSNNNFCGE 352 (848)
Q Consensus 296 ~L~~L~L~~N~l~~~----~p~~----l~~l~L--~~n~l~~-------------~~~~~~~~l~~L~~L~Ls~N~l~~~ 352 (848)
.|+.|-+.+|.++.. +... +++++- ..-.++. ..+.......+.+.|++++-+++..
T Consensus 298 hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~V 377 (565)
T KOG0472|consen 298 HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLV 377 (565)
T ss_pred eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccC
Confidence 999999999999743 1111 121110 0011110 1111122245688999999999977
Q ss_pred cCccccCcc--cccEeecccccccCCCCCCCCCCCCccE-EEccCCccCCCCcccccccccccEEEccCCcCCCCCCccc
Q 038003 353 ISFNWGNFS--KLSTFIVSMNNISGSIPPDIGNSPKLQV-LDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEF 429 (848)
Q Consensus 353 ~~~~~~~l~--~L~~L~l~~N~i~~~~p~~l~~l~~L~~-L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 429 (848)
+...|..-. -.+..+++.|++. .+|..+..+..+++ +++++|.+. .+|..++.+++|..|+|++|-+. .+|..+
T Consensus 378 PdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~ 454 (565)
T KOG0472|consen 378 PDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEM 454 (565)
T ss_pred CHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhh
Confidence 666664332 3788999999998 78988888877655 555656555 99999999999999999999998 789999
Q ss_pred CCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCcc
Q 038003 430 GSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEK 509 (848)
Q Consensus 430 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 509 (848)
+.+..|+.|++|.|+|. ..|+.+-.+..|+.+-.++|++..+.|+.+.++.+|+.|||.+|.|. .+|+.+++|++|++
T Consensus 455 ~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~h 532 (565)
T KOG0472|consen 455 GSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRH 532 (565)
T ss_pred hhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeE
Confidence 99999999999999998 88999888899999999999999888888999999999999999996 78999999999999
Q ss_pred ccCCCCcccCCCcchhccccCceeecCCCC
Q 038003 510 LNLSHNNLSDFIPRCFEEMRSLSCIDISYN 539 (848)
Q Consensus 510 L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N 539 (848)
|+|++|+|. .++..+--......+..-++
T Consensus 533 LeL~gNpfr-~Pr~~iLmkgT~aiL~ylrd 561 (565)
T KOG0472|consen 533 LELDGNPFR-QPRHQILMKGTAAILSYLRD 561 (565)
T ss_pred EEecCCccC-CCHHHHhccChHHHHHHhcc
Confidence 999999998 34444433333333333333
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=325.04 Aligned_cols=200 Identities=30% Similarity=0.396 Sum_probs=184.9
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
-++|+..+.||.|+||+|..++.+ +|..+|+|++++..+. ..++.++...|.++++.+.||+++++++.|.+.+..||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-HHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 467999999999999999999765 7899999999988665 35667888999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||++||.|..+++.. +++++..+.-++.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||.|+.+.
T Consensus 122 vmeyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEeccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999999865 6799999999999999999999999 99999999999999999999999999999885
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ..+.||||.|+|||++....|..++|.|||||++|||+.|..||..
T Consensus 196 ~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 196 GR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred Cc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 42 4568999999999999999999999999999999999999999754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.90 Aligned_cols=205 Identities=33% Similarity=0.565 Sum_probs=180.0
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-eeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP-HSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-~~~lV 677 (848)
+++...+.+|+|+||+||+|.++....||||++....... ...+.|.+|+.++++++|||||+++|+|.+.. ..++|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~--~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDD--ESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcCh--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 3445556699999999999999855569999998764332 22778999999999999999999999999987 79999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEcCCCCCCeeeCCCC-CEEEeeccCcccc
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS-IIHRDISSKNVLLDSNF-EAHVSDFGIAKFV 755 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~kl~DfG~~~~~ 755 (848)
|||+++|+|.++++.. ....+++..+++|+.|||+|++|||++ + ||||||||+|||++.++ ++||+|||+++..
T Consensus 119 tEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999874 357899999999999999999999999 8 99999999999999998 9999999999887
Q ss_pred CCCCCCcccccccccccCccccc--cCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAY--TMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
.......+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 65334445578999999999999 5689999999999999999999999987543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=329.44 Aligned_cols=206 Identities=25% Similarity=0.369 Sum_probs=181.0
Q ss_pred cCCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEE-EeecCC-eeE
Q 038003 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG-FCYNGP-HSF 675 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~-~~~~~~-~~~ 675 (848)
.+|++.++||+|+||+||++ ...+|..+|.|.++-... +.+..+....|+.++++++|||||++++ -|.++. ..+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 45888899999999999999 556899999999975432 4566777899999999999999999998 344444 489
Q ss_pred EEEeccCCCCHHhHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHhhCCCC-CeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 676 LVCEYLDRGSLARILGDDVT-AKELGWNRRINVIKGVANALSYLHHDCLP-SIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
+||||+++|+|.++++.... .+.+++..+++++.|+++||.++|.+... -|+||||||.||+++.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999998875432 45789999999999999999999995432 28899999999999999999999999999
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
+.........+.+|||.||+||.+.+.+|++|+||||+||++|||+.-+.||.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence 99877777788999999999999999999999999999999999999999974
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=360.34 Aligned_cols=368 Identities=27% Similarity=0.257 Sum_probs=295.2
Q ss_pred CCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEee
Q 038003 104 KLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183 (848)
Q Consensus 104 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 183 (848)
.-+.||+|+|.++..-+..|.++++|+.++|..|.++ .||...+...+|+.|+|.+|.|+..-.+++.-++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3457999999998888888899999999999999998 788887788889999999999886666778888999999999
Q ss_pred cccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcC
Q 038003 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFI 263 (848)
Q Consensus 184 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 263 (848)
.|.++...-..|..-.++++|+|++|+|+..--..|..+.+|..|.|++|+++...+..|.+|++|+.|+|..|+|.-.-
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 99998554467777778999999999998777778888889999999999998555567888999999999999887444
Q ss_pred CCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEE
Q 038003 264 PPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLD 343 (848)
Q Consensus 264 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~ 343 (848)
-..|.++++|+.|.|..|.++......|..+.++++|+|..|++..+- ...+-+++.|+.|+
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn------------------~g~lfgLt~L~~L~ 299 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN------------------EGWLFGLTSLEQLD 299 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhh------------------cccccccchhhhhc
Confidence 557888889999999999888777778888888888888888776432 23345677888888
Q ss_pred ccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCC
Q 038003 344 LSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSG 423 (848)
Q Consensus 344 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 423 (848)
||+|.|..+.+..|...++|++|+|++|+|+...+.+|..+..|++|+|++|++...-...|..+++|+.|||++|.|+.
T Consensus 300 lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~ 379 (873)
T KOG4194|consen 300 LSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSW 379 (873)
T ss_pred cchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEE
Confidence 88888888888888888888888888888887777778888888888888888876666677778888888888888775
Q ss_pred CCCc---ccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCc
Q 038003 424 GVPL---EFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHN 491 (848)
Q Consensus 424 ~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 491 (848)
.+.+ .|.++++|+.|+|.+|+|..+.-.+|.++..|+.|||.+|.|..+-|.+|.++ +|++|.+..-
T Consensus 380 ~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs 449 (873)
T KOG4194|consen 380 CIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS 449 (873)
T ss_pred EEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence 4433 46677888888888888876666678888888888888888877777788777 7777766543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=359.10 Aligned_cols=387 Identities=25% Similarity=0.273 Sum_probs=204.3
Q ss_pred cEEEccccCCCCCCchhhhcc--ccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEee
Q 038003 106 QYLDLGSNQLSGLIPPEIGKL--NQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183 (848)
Q Consensus 106 ~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 183 (848)
+.||++++.+..+--..+.++ +.-+.||+++|+++..-+..|.++++|+++++.+|.++ .||...+...+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 457788877764211111111 12344666666666555555666666666666666665 555544444446666666
Q ss_pred cccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcC
Q 038003 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFI 263 (848)
Q Consensus 184 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 263 (848)
+|.++..-.+.+..++.|+.||||.|.|+ .+| -+.|..-.++++|+|++|+|+..-
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is-~i~-----------------------~~sfp~~~ni~~L~La~N~It~l~ 189 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLIS-EIP-----------------------KPSFPAKVNIKKLNLASNRITTLE 189 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhh-ccc-----------------------CCCCCCCCCceEEeeccccccccc
Confidence 66665444455555555555555555555 222 223333344555555555555444
Q ss_pred CCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEE
Q 038003 264 PPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLD 343 (848)
Q Consensus 264 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~ 343 (848)
...|.++.+|..|.|++|+++...+..|..+++|+.|+|..|+|+-+ ..-.|..+++|+.|.
T Consensus 190 ~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv------------------e~ltFqgL~Sl~nlk 251 (873)
T KOG4194|consen 190 TGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV------------------EGLTFQGLPSLQNLK 251 (873)
T ss_pred cccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee------------------hhhhhcCchhhhhhh
Confidence 44555555555555555555555555555555555555555554311 122344455555555
Q ss_pred ccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCC
Q 038003 344 LSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSG 423 (848)
Q Consensus 344 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 423 (848)
|..|.|.......|..+.++++|+|..|++...-..++.+++.|+.|+||+|.|..+-++.....++|++|+|++|+|+.
T Consensus 252 lqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~ 331 (873)
T KOG4194|consen 252 LQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITR 331 (873)
T ss_pred hhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccccc
Confidence 55555554444445555555555555555554444555555555555555555555555555555555555555555555
Q ss_pred CCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCCh---hHHhhhcccceecccCcccCcCCCcc
Q 038003 424 GVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIP---TEFEKLIHLSELDLSHNILQEEIPPQ 500 (848)
Q Consensus 424 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~ 500 (848)
..+.+|..+..|++|.|+.|.++...-..|..+++|+.|||++|.|+..+. ..|.+++.|+.|+|.+|+|..+.-.+
T Consensus 332 l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krA 411 (873)
T KOG4194|consen 332 LDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRA 411 (873)
T ss_pred CChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhh
Confidence 555555555555555555555554444455555555555555555554332 23555555555555555554444445
Q ss_pred ccCCCCCccccCCCCcccCCCcchhccccCceeecC
Q 038003 501 VCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDI 536 (848)
Q Consensus 501 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l 536 (848)
|.++.+|+.|||.+|.|..+.|.+|..+ .|+.|.+
T Consensus 412 fsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 412 FSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred hccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence 5555555555555555555555555555 4554443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=343.82 Aligned_cols=206 Identities=25% Similarity=0.407 Sum_probs=183.4
Q ss_pred HHhhcCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCC
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGP 672 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~ 672 (848)
.+...||.+++.||+|+|++|++|+ ..+++.||||++.+..+-.. ...+-+.+|-.+|.+| +||.|++++..|++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike-~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE-KKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh-cccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 4556789999999999999999994 45899999999988765432 2234467899999999 8999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
.+|+|+||+++|+|.++++.. +.+++..+..++.||+.|++|||++ |||||||||+|||+|++|++||+|||.|
T Consensus 148 sLYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 999999999999999999876 7799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC-------------cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSN-------------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.+.+.... ...++||..|.+||++.....++.+|+|+||||+|+|+.|++||..
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 987543221 1458999999999999999999999999999999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=320.60 Aligned_cols=201 Identities=25% Similarity=0.382 Sum_probs=177.9
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+.|+....+|+|+||+||+|+.+ +|+.||||++..+. +++.-.+-.+||++++++++|||+|.++++|......++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 46888899999999999999776 79999999996652 3455566678999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
+||++..-|.++ ++. +...+...+.+++.|+++|+.|+|++ +++||||||+|||+..+|.+||||||+|+....
T Consensus 80 FE~~dhTvL~eL-e~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 80 FEYCDHTVLHEL-ERY--PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eeecchHHHHHH-Hhc--cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 999988555444 333 34578889999999999999999999 999999999999999999999999999999986
Q ss_pred CCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....+++++.|.+|+|||.+.| .+|+..+|||++||++.||+||..-|.-
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence 6777788999999999999887 6799999999999999999999998753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.29 Aligned_cols=205 Identities=26% Similarity=0.315 Sum_probs=181.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|+.+.+||+|+||.||.|+.+ +|+.+|+|+++++... ...+.+++..|-.+|....+|+||+++-.|++.+.+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 5678999999999999999999554 7999999999987544 3456788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||++||++..++... +.+++..+..++.+++.|++.+|+. |+|||||||+|+|+|..|++||+|||++.-.
T Consensus 218 LiMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999999765 6788899999999999999999999 9999999999999999999999999998532
Q ss_pred CC----------------------CCCC-----c--------------------ccccccccccCccccccCCCCccchh
Q 038003 756 GP----------------------HSSN-----W--------------------TEFAGTFGYAAPEIAYTMRATEKYDV 788 (848)
Q Consensus 756 ~~----------------------~~~~-----~--------------------~~~~g~~~y~aPE~~~~~~~~~~~Di 788 (848)
.. .... . ...+|||.|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 0000 0 12579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCccc
Q 038003 789 YSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 789 wSlG~il~elltg~~P~~~~ 808 (848)
||+|||+|||+.|.+||...
T Consensus 372 WSLG~ImyEmLvGyPPF~s~ 391 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSE 391 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999997543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=333.79 Aligned_cols=227 Identities=26% Similarity=0.388 Sum_probs=189.5
Q ss_pred HhhcCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--C
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--P 672 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~ 672 (848)
+..+.|+.++.||+|+||.||+|+ ..+|+.||+|++..... ......-..+||.++++++||||+++.+...+. .
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 334568888999999999999994 56899999999977642 234556678999999999999999999998876 6
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..|||+|||+. +|.-++... .-.++..++..+++|++.||+|+|.+ ||+|||||.+|||+|.+|.+||+|||+|
T Consensus 192 siYlVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred eEEEEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccce
Confidence 89999999987 888877543 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC-cccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhhhhcCCCC
Q 038003 753 KFVGPHSSN-WTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRL 830 (848)
Q Consensus 753 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (848)
+++...... .+..+.|.+|+|||.+.|. .|+.++|+||.|||+.||++|+..|.-.. -.+++..+.+++....
T Consensus 266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t-----EveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT-----EVEQLHKIFKLCGSPT 340 (560)
T ss_pred eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc-----HHHHHHHHHHHhCCCC
Confidence 988765543 5778889999999999876 58999999999999999999999975322 2233455556655555
Q ss_pred CCCCC
Q 038003 831 PTPSP 835 (848)
Q Consensus 831 ~~~~~ 835 (848)
...++
T Consensus 341 e~~W~ 345 (560)
T KOG0600|consen 341 EDYWP 345 (560)
T ss_pred hhccc
Confidence 55555
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.43 Aligned_cols=199 Identities=28% Similarity=0.426 Sum_probs=184.2
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+... ..++.+.+.+|+++++.++|||||.++++|+...+.|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr--~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR--NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC--chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 56888899999999999999554 789999999987642 345677789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
.||+.| +|.+++..+ +.+++..+..++.|++.||.|||+. +|.|||+||.|||++..|.+|+||||+|+.+..
T Consensus 80 te~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred ehhhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 999988 999999876 6799999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.....+...|||.|||||+..+..|+..+|.||+|||+||+++|++||.
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 7766778899999999999999999999999999999999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=303.41 Aligned_cols=232 Identities=23% Similarity=0.316 Sum_probs=194.8
Q ss_pred cCCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|...+.+|+|.||.||+| +..+|+.||||+++.....+. ......||++.++.++||||+.++++|...+...+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG--i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG--INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC--ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 56888899999999999999 456899999999987643322 234568999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
+|||+. +|+.++++. ...+...++..++.++.+|++|+|.+ .|+||||||.|+|++++|.+||+|||+|+.++.
T Consensus 80 fEfm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEeccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 999976 999999876 35688899999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhhhhcCCCCCCCCCC
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPS 836 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (848)
.....+..+-|.+|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.- +. -.+++..+...+....+..+|+
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG-~s----DidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG-DS----DIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC-Cc----hHHHHHHHHHHcCCCCcccCcc
Confidence 76666666889999999999876 489999999999999999998765432 11 2234455666666666666776
Q ss_pred cccccce
Q 038003 837 VMDYGGC 843 (848)
Q Consensus 837 ~~~~~~~ 843 (848)
+..+..+
T Consensus 229 ~~~lpdY 235 (318)
T KOG0659|consen 229 MTSLPDY 235 (318)
T ss_pred ccccccH
Confidence 6555443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=341.30 Aligned_cols=206 Identities=25% Similarity=0.408 Sum_probs=181.7
Q ss_pred HhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCc-hhHHHHHHHHHHHhcCC-CCcccceEEEeecCC
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNM-ADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGP 672 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~ 672 (848)
.....|.+.+.||+|+||+|+.|.. .+++.||+|++..+...... ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456799999999999999999954 57899999988775332122 33456678999999998 999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC-CCEEEeeccC
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN-FEAHVSDFGI 751 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~ 751 (848)
..|+||||+.||+|.+++... +++.+..+.++++|++.|++|+|++ ||+||||||+||+++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999999764 6788899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCCcccccccccccCccccccCC-C-CccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYTMR-A-TEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~-~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+...........+.+|++.|+|||++.+.. | +.++||||+||++|.|++|+.||+.
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 998743345567899999999999999877 7 4789999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.47 Aligned_cols=232 Identities=26% Similarity=0.428 Sum_probs=191.6
Q ss_pred CcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEec
Q 038003 601 FDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
+...+.||+|-||+||.|.++....||+|.++.. ....+.|.+|+++|++++|++||+++++|..++..++||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 4556789999999999999998889999998764 23457788999999999999999999999998899999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~ 760 (848)
|+.|+|.++++.. ....+...+.+.++.|||+|++||+++ ++|||||-+.|||++++..+||+|||+|+...++..
T Consensus 283 m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999999873 456788899999999999999999999 999999999999999999999999999996554333
Q ss_pred Ccc-cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccccccccccchhhhhhhhhcCCCCCCCCCCcc
Q 038003 761 NWT-EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVM 838 (848)
Q Consensus 761 ~~~-~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (848)
... +..-+..|.|||.+....++.|+|||||||+||||+| |+.||..+. ..+..+.+....++ |..+.+++++.
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--n~ev~~~le~GyRl--p~P~~CP~~vY 434 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--NEEVLELLERGYRL--PRPEGCPDEVY 434 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--HHHHHHHHhccCcC--CCCCCCCHHHH
Confidence 222 2223568999999999999999999999999999999 999976443 33444444444444 33334566666
Q ss_pred cccceee
Q 038003 839 DYGGCHF 845 (848)
Q Consensus 839 ~~~~~~~ 845 (848)
+.|..||
T Consensus 435 ~lM~~CW 441 (468)
T KOG0197|consen 435 ELMKSCW 441 (468)
T ss_pred HHHHHHh
Confidence 6665444
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=337.54 Aligned_cols=203 Identities=27% Similarity=0.384 Sum_probs=181.7
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCe
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 673 (848)
...++|...++||+|.||+|+.|..+ +++.+|||++++..+-. ..+.+..+.|.++++.. +||+++.++..|+..++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34578999999999999999999765 78899999999986653 35677889999998887 59999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
+|+||||+.||++..+.+ .+.+++..+.-++..++.||.|||++ ||||||||.+|||+|.+|++||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 999999999999544433 25689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.---......++||||.|||||++.+..|+.++|+|||||+||||++|+.||.
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~ 569 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP 569 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC
Confidence 75434556678999999999999999999999999999999999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=333.71 Aligned_cols=198 Identities=27% Similarity=0.498 Sum_probs=181.5
Q ss_pred cCCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
..|+.-..||+|+.|.||.| +..+++.||||++.... ....+-+..|+.+|+..+|+|||.+++.|...++.|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~----Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK----QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc----CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 35777788999999999999 55688999999998763 34456678999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
||||+||+|.+.+... .+++.+++.|.+++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999999988544 588999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
......+.+|||.|||||+.....|++|+||||||++++||+-|..||-.
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 77777889999999999999999999999999999999999999999754
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=345.38 Aligned_cols=382 Identities=30% Similarity=0.451 Sum_probs=224.2
Q ss_pred CCCCCCcEEeccCCccc-ccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCcc
Q 038003 76 SSFPHLANLNLSFNLFF-GNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLID 154 (848)
Q Consensus 76 ~~l~~l~~L~l~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 154 (848)
+-||.++-.|+++|.|+ +..|.....+++++.|.|...++. .+|.+++.|.+|++|.+++|+++ .+-++++.|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 34677788888889888 468888888899999999888887 67888888888888888888887 6667777777777
Q ss_pred EEEcCCCcCCCC-CCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCccc-ccCCcccceeeccc
Q 038003 155 KLALCHNNLHGS-IPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS-LGNLSSLTMMSLFN 232 (848)
Q Consensus 155 ~L~L~~n~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~l~~ 232 (848)
.+.+.+|++... ||..+..|..|+.||||+|+++ ..|..+..-+++..|+||+|+|. .||.. |-+|+.|-.||||+
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcccc
Confidence 777777777532 6666777777777777777777 56766666677777777777776 45543 44666666667777
Q ss_pred cCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCcccc-ccCcccccCCCCCcccccccccccccc
Q 038003 233 NSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLY-GFVPEEIGYLKSLSELELCTNLLRGVI 311 (848)
Q Consensus 233 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~ 311 (848)
|++. .+|+.+..+..|++|+|++|.+...--..+-.+++|++|.+++.+-+ ..+|..+..+.
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~---------------- 222 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLH---------------- 222 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhh----------------
Confidence 7666 56666666666666666666654332223333445555555554322 22333333333
Q ss_pred CCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEE
Q 038003 312 PHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLD 391 (848)
Q Consensus 312 p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~ 391 (848)
+|..+|+|.|++. .+|+.+.++++|+.|+
T Consensus 223 --------------------------NL~dvDlS~N~Lp-------------------------~vPecly~l~~LrrLN 251 (1255)
T KOG0444|consen 223 --------------------------NLRDVDLSENNLP-------------------------IVPECLYKLRNLRRLN 251 (1255)
T ss_pred --------------------------hhhhccccccCCC-------------------------cchHHHhhhhhhheec
Confidence 4444444444443 3344444444444444
Q ss_pred ccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccC-CCCCCcccCccccceeccccCcCC
Q 038003 392 LSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLS-SSIPKSIGNLLKLHYLNLSNNQLS 470 (848)
Q Consensus 392 Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~ 470 (848)
||+|+|+ .+........+|++|+|+.|+++ .+|.+++.+++|+.|.+.+|+++ .-+|+.++.+.+|+.+..++|.+.
T Consensus 252 LS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE 329 (1255)
T KOG0444|consen 252 LSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE 329 (1255)
T ss_pred cCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc
Confidence 4444444 22223333344444444444444 44444444445555554444443 124444555555555555555553
Q ss_pred CCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCcee
Q 038003 471 HKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSC 533 (848)
Q Consensus 471 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 533 (848)
..|+.++.+..|+.|.|++|++. ..|..+.-++.|+.||+..|.--..+|+.-..-++|+.
T Consensus 330 -lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lef 390 (1255)
T KOG0444|consen 330 -LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEF 390 (1255)
T ss_pred -cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhccee
Confidence 44555555555555555555553 34555555555555555555433333333222234443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=316.59 Aligned_cols=213 Identities=24% Similarity=0.387 Sum_probs=191.0
Q ss_pred hcCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..+|++.+.||+|.||+|-+|. ...|+.||||.+++..+. +..+.-++.+|++||+.++||||+++|.+|++.+...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-deqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3568888999999999999994 478999999999988765 45666778999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||..+|.|++++.+. +.+++.++..+++||..|+.|+|++ ++||||||.+|||+|.++++||+|||++-.+.
T Consensus 131 vMEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999776 6799999999999999999999999 99999999999999999999999999999886
Q ss_pred CCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCccccccccccchhhh
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 820 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 820 (848)
. ....+++||+|.|.+||++.|.+| ++.+|-||+||++|.|+.|..||+-.+ +..++++|.
T Consensus 205 ~-~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--hk~lvrQIs 266 (668)
T KOG0611|consen 205 D-KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--HKRLVRQIS 266 (668)
T ss_pred c-ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--HHHHHHHhh
Confidence 5 455678999999999999999998 788999999999999999999987433 444444443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=298.89 Aligned_cols=225 Identities=30% Similarity=0.406 Sum_probs=193.9
Q ss_pred HhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
.+-++|++.+.||+|.||.||.|+. +++..||+|++.++.+.. .....++.+|+++-+.|+||||.++|++|.+....
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 3457899999999999999999965 478899999998876553 34467789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
|+++||...|++...+++. ..+++++.....+++|+|.|+.|+|.+ +|+||||||+|+|++.++..||+|||-+..
T Consensus 98 yLilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999999999865 346788889999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhhhhcCCC
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPR 829 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (848)
.. .....+.|||..|.|||+..+..++..+|+|++|+..||++.|..||.... .++..+.|.+++-..++.
T Consensus 174 ~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~~~p~~ 244 (281)
T KOG0580|consen 174 AP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDLKFPST 244 (281)
T ss_pred cC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHccccCCcc
Confidence 53 555678999999999999999999999999999999999999999986544 333344444444444433
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=343.98 Aligned_cols=369 Identities=31% Similarity=0.484 Sum_probs=308.0
Q ss_pred cCCCCCcEEEccccCCC-CCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccc
Q 038003 100 GNLSKLQYLDLGSNQLS-GLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLA 178 (848)
Q Consensus 100 ~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 178 (848)
+=|+..+-.|+++|.++ +..|..+..++++++|.|...++. .+|++++.|.+|++|.+++|++. .+...++.|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 34567788899999999 578999999999999999999988 88999999999999999999988 6777788889999
Q ss_pred eEEeecccccC-CCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCC-cccCccccccccccc
Q 038003 179 VLYLYKNSLSG-SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHI 256 (848)
Q Consensus 179 ~L~l~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~-~l~~l~~L~~L~l~~ 256 (848)
.+.+..|++.. -+|..+-.|..|..||||+|+++ +.|..+...+++-.|+||+|+|. .||. .+-+++.|-.|||++
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcccc
Confidence 99999988863 36777778888888999999888 78888888888888888888888 4554 455777888888888
Q ss_pred ccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCC
Q 038003 257 NQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDH 336 (848)
Q Consensus 257 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l 336 (848)
|++. .+|+....+..|+.|+|++|.+.-.-...+.. +
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPs------------------------------------------m 196 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPS------------------------------------------M 196 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCcc------------------------------------------c
Confidence 8887 35556777777788888777765332222222 3
Q ss_pred CCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEc
Q 038003 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLIL 416 (848)
Q Consensus 337 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 416 (848)
++|+.|.+++.+=+ ...+|.++..+.+|..+|+|.|.+. .+|+.+.++.+|+.|+|
T Consensus 197 tsL~vLhms~TqRT-----------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNL 252 (1255)
T KOG0444|consen 197 TSLSVLHMSNTQRT-----------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNL 252 (1255)
T ss_pred hhhhhhhcccccch-----------------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheecc
Confidence 34444455444322 1147888999999999999999999 89999999999999999
Q ss_pred cCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCC-CChhHHhhhcccceecccCcccCc
Q 038003 417 NLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH-KIPTEFEKLIHLSELDLSHNILQE 495 (848)
Q Consensus 417 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~ 495 (848)
++|+|+ .+....+...+|+.|+||.|+++ .+|.+++.+++|+.|++.+|+++- -+|..+++|.+|+++..++|.+ +
T Consensus 253 S~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L-E 329 (1255)
T KOG0444|consen 253 SGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL-E 329 (1255)
T ss_pred CcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccc-c
Confidence 999999 55666677889999999999999 899999999999999999999873 3899999999999999999999 5
Q ss_pred CCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCC
Q 038003 496 EIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHG 543 (848)
Q Consensus 496 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~ 543 (848)
.+|..++.+..|+.|.|++|++-. .|+++.-++.|+.||+..|+=-.
T Consensus 330 lVPEglcRC~kL~kL~L~~NrLiT-LPeaIHlL~~l~vLDlreNpnLV 376 (1255)
T KOG0444|consen 330 LVPEGLCRCVKLQKLKLDHNRLIT-LPEAIHLLPDLKVLDLRENPNLV 376 (1255)
T ss_pred cCchhhhhhHHHHHhcccccceee-chhhhhhcCCcceeeccCCcCcc
Confidence 899999999999999999999976 89999999999999999996443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.65 Aligned_cols=201 Identities=28% Similarity=0.438 Sum_probs=172.1
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC--eeE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP--HSF 675 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~~ 675 (848)
.++...+.||+|+||+||.+... +|+..|||.+.... ....+.+.+|++++++++|||||+++|...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 45777889999999999999654 59999999987652 222677899999999999999999999754444 689
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-CCCEEEeeccCccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKF 754 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~~~~ 754 (848)
++|||+++|+|.+++.... + .+++..+..+++||++||+|||++ |||||||||+|||++. ++.+||+|||+++.
T Consensus 93 i~mEy~~~GsL~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeeccCCCcHHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 9999999999999998762 2 699999999999999999999999 9999999999999999 79999999999987
Q ss_pred cCC---CCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 755 VGP---HSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 755 ~~~---~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
... .........||+.|||||++.. ....+++||||+||++.||+||+.||...
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 763 1122345789999999999995 33456999999999999999999999753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.09 Aligned_cols=205 Identities=28% Similarity=0.450 Sum_probs=180.8
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|+....||.|..++||+|+. ..++.||||++..+... .+.+.+.+|+..|+.++||||++++..|..+...|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 356799999999999999999954 57899999999876533 34688999999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||.||.+||+.++++..+. ..+++..+..|.+++.+||.|||++ |.||||||+.|||++.+|.|||+|||.+..+
T Consensus 101 vVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred EeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999987654 4489999999999999999999999 9999999999999999999999999998776
Q ss_pred CCCCCCc----ccccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 756 GPHSSNW----TEFAGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 756 ~~~~~~~----~~~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
....... ..++|++.|||||++.. ..|+.|+||||||++..||.+|..||..+
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~ 235 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY 235 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence 5544322 44689999999999653 45899999999999999999999998543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=321.17 Aligned_cols=241 Identities=25% Similarity=0.361 Sum_probs=206.5
Q ss_pred cCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
..|+..+.||+|+||.||+|. ..+++.||+|++.... ...+.+.+.+|+.++.+++++||.++|+.+..+..+|++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 457888999999999999995 4589999999998765 345677889999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+.||++.+.++.. ..+++..+.-|++++..|+.|+|.+ +.+|||||+.||++..+|.+|++|||.+.....
T Consensus 90 Mey~~gGsv~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSG---NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHhcCcchhhhhccC---CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999999999755 3336677778999999999999999 999999999999999999999999999998877
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccc--------------cccccchhhhhhh
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI--------------NFSSFSNMIIDVN 823 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~--------------~~~~~~~~~~~~~ 823 (848)
......+++|||.|||||++.+..|+.|+||||||++.|||++|.+||..... ....+...+++..
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHH
Confidence 66666889999999999999988999999999999999999999999854332 1114555566666
Q ss_pred hhcCCCCCCCCCCcccccceeeccC
Q 038003 824 KILDPRLPTPSPSVMDYGGCHFMLR 848 (848)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (848)
..+-..-|..+|...++....||++
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHh
Confidence 6677777777888877777776653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=301.64 Aligned_cols=232 Identities=22% Similarity=0.301 Sum_probs=188.4
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec--CC
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN--GP 672 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~ 672 (848)
+..+.|+..+.|++|+||.||+|+++ +++.||+|+++-+.- ..-..-...+||.++.+.+|||||.+-.+..- -+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 44567899999999999999999654 789999999876541 12223446799999999999999999988753 45
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..|+||||++. +|..++... .+++...++.-++.|+.+|++|||.. .|+|||||++|+|+...|.+||+|||+|
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchh
Confidence 79999999987 888887654 36788899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhhhhcCCCCC
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLP 831 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (848)
+.++......+..+-|.+|+|||.+.+.+ |++++|+||+|||+.||+++++-|.-.. -.+++..+...+.....
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-----E~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-----EIDQLDKIFKLLGTPSE 299 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-----hHHHHHHHHHHhCCCcc
Confidence 99988777778888999999999988764 8999999999999999999998864222 12233444444444444
Q ss_pred CCCCCcccc
Q 038003 832 TPSPSVMDY 840 (848)
Q Consensus 832 ~~~~~~~~~ 840 (848)
..+|.+-++
T Consensus 300 ~iwpg~~~l 308 (419)
T KOG0663|consen 300 AIWPGYSEL 308 (419)
T ss_pred ccCCCcccc
Confidence 444444333
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.23 Aligned_cols=226 Identities=24% Similarity=0.362 Sum_probs=188.8
Q ss_pred HhhcCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCC-
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGP- 672 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~- 672 (848)
...++|...+.||.|+||.||+|+ ..+++.||||+++++... -+.-.-.||+..+++++ |||||++.+++.+.+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 346789999999999999999995 458999999999887532 11222368999999998 999999999999988
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..|+|||||+. +|+++++++ .+.+++.++..|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+|
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccc
Confidence 99999999987 999999877 57899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhhhhcCCCCC
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLP 831 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (848)
+.+.. ....+.++.|.+|+|||++. ...|+.++|||++|||++|+.+=+.-|--. .-.+++.+++.++...-.
T Consensus 158 Rev~S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~-----sE~Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 158 REVRS-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA-----SEIDQIYKICEVLGTPDK 231 (538)
T ss_pred ccccc-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC-----cHHHHHHHHHHHhCCCcc
Confidence 98864 44567789999999999876 456899999999999999999988875321 123344556666555444
Q ss_pred CCCCC
Q 038003 832 TPSPS 836 (848)
Q Consensus 832 ~~~~~ 836 (848)
..+++
T Consensus 232 ~~~~e 236 (538)
T KOG0661|consen 232 DSWPE 236 (538)
T ss_pred ccchh
Confidence 44443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.64 Aligned_cols=200 Identities=28% Similarity=0.416 Sum_probs=179.7
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.-|..++.||.|+.|.|-.|++ .+|+..|||++.+.... .......+.+|+-+|+.+.||||+++|+++++..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccc-ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 3478889999999999999965 58999999999876322 223345678999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
.||++||.|.+++.+. +++++.+++++++||+.|+.|+|.. +|||||+||+|+|+|..+++||+|||+|....+
T Consensus 91 lEyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999999665 7789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~ 806 (848)
+.-..+.||+|.|.|||++.|.+| +.++||||.|||+|.|+||+.||+
T Consensus 165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 444577899999999999999998 688999999999999999999987
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=308.97 Aligned_cols=206 Identities=26% Similarity=0.372 Sum_probs=170.4
Q ss_pred HHhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCc----------hhHHHHHHHHHHHhcCCCCcccc
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNM----------ADHDEFLNEVLALKEIRHRNNVK 663 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~ 663 (848)
.+.-+.|++.+.||+|.||.|-+|+.. +++.||||++.+....... ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344567999999999999999999654 7999999999776443211 12357889999999999999999
Q ss_pred eEEEeec--CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC
Q 038003 664 FHGFCYN--GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN 741 (848)
Q Consensus 664 l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 741 (848)
++++..+ .+..|||+||+..|.+...=. ....++..++.+++++++.||+|||.+ |||||||||+|+|++++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9999876 468999999999987754321 122389999999999999999999999 99999999999999999
Q ss_pred CCEEEeeccCccccCCC-----CCCcccccccccccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCc
Q 038003 742 FEAHVSDFGIAKFVGPH-----SSNWTEFAGTFGYAAPEIAYTMR----ATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 742 ~~~kl~DfG~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
|+|||+|||.+...... .......+|||.|+|||...+.. .+.+.||||+||+||-|+.|+.||-
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 99999999999876322 11223478999999999988632 3678999999999999999999974
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=296.34 Aligned_cols=236 Identities=25% Similarity=0.398 Sum_probs=197.1
Q ss_pred HhhcCCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
...+.|++.+.||+|+|+.||++ ...+|+.+|+|++....... ...+.+.+|++|.+.++|||||++.+.+.+....
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 34567888899999999999999 44589999999998765543 3678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC---CCEEEeeccC
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN---FEAHVSDFGI 751 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~ 751 (848)
|+|+|+|+|++|..-+-.+ ..+++..+-.+++||..||.|+|.+ +|||||+||+|+++... .-+||+|||+
T Consensus 86 ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred EEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccce
Confidence 9999999999986443222 4577788889999999999999999 99999999999999643 3699999999
Q ss_pred ccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhh-hhcCCCC
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVN-KILDPRL 830 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~ 830 (848)
|..++ ....+..++|||+|||||++...+|+..+|||+.|||+|-++.|+.|| ++.+-..+.+.|+... ++..|..
T Consensus 160 Ai~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF--~~~~~~rlye~I~~g~yd~~~~~w 236 (355)
T KOG0033|consen 160 AIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF--WDEDQHRLYEQIKAGAYDYPSPEW 236 (355)
T ss_pred EEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCC--CCccHHHHHHHHhccccCCCCccc
Confidence 99987 566678899999999999999999999999999999999999999995 4434444555555444 4555577
Q ss_pred CCCCCCcccccc
Q 038003 831 PTPSPSVMDYGG 842 (848)
Q Consensus 831 ~~~~~~~~~~~~ 842 (848)
++..|+.+++..
T Consensus 237 ~~is~~Ak~Lvr 248 (355)
T KOG0033|consen 237 DTVTPEAKSLIR 248 (355)
T ss_pred CcCCHHHHHHHH
Confidence 777777666543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.44 Aligned_cols=232 Identities=24% Similarity=0.348 Sum_probs=190.0
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCc-ccceEEEeecCC---
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN-NVKFHGFCYNGP--- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~~~--- 672 (848)
...|+..+.||+|+||+||+|+. .+|+.||+|++..+.-. +-......+|+.+++.++|+| ||.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 34577778899999999999955 47899999999776432 123345689999999999999 999999998877
Q ss_pred ---eeEEEEeccCCCCHHhHhcCCCCc-ccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 673 ---HSFLVCEYLDRGSLARILGDDVTA-KELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 673 ---~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
..++|+||++. +|.+++...... ..++...+..+++||++|++|+|++ +|+||||||.||+++++|.+||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 78999999976 899888765321 3566688999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhhhhcC
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILD 827 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 827 (848)
||+|+...-.....+..++|.+|+|||++.+. .|+...||||+|||++||++++.-|.-... .+++..+.+.+.
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-----~~ql~~If~~lG 238 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-----IDQLFRIFRLLG 238 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-----HHHHHHHHHHcC
Confidence 99999887555666778899999999999987 689999999999999999998887643222 445556666666
Q ss_pred CCCCCCCCCcccc
Q 038003 828 PRLPTPSPSVMDY 840 (848)
Q Consensus 828 ~~~~~~~~~~~~~ 840 (848)
......+|.+...
T Consensus 239 tP~e~~Wp~v~~~ 251 (323)
T KOG0594|consen 239 TPNEKDWPGVSSL 251 (323)
T ss_pred CCCccCCCCcccc
Confidence 6555666665433
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.30 Aligned_cols=202 Identities=25% Similarity=0.312 Sum_probs=175.5
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|... +++.||+|++.+.... .......+.+|+.++.+++||+|+++++.+.+....|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 47899999999999999999654 6899999998765322 123446678899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... +.+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 80 MEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999998654 5688999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC-----------------------------------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCC
Q 038003 758 HSS-----------------------------------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN 802 (848)
Q Consensus 758 ~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 802 (848)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 012357999999999999989999999999999999999999
Q ss_pred CCCcc
Q 038003 803 HPRDF 807 (848)
Q Consensus 803 ~P~~~ 807 (848)
.||..
T Consensus 234 ~Pf~~ 238 (363)
T cd05628 234 PPFCS 238 (363)
T ss_pred CCCCC
Confidence 99853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.54 Aligned_cols=189 Identities=32% Similarity=0.561 Sum_probs=170.1
Q ss_pred cccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEecc
Q 038003 602 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYL 681 (848)
Q Consensus 602 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~ 681 (848)
..++.||.|+.|.||+|+.+ ++.||||+++.- -..+|+-+++|+||||+.+.|+|.....+++|||||
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 44678999999999999986 677999986432 134788899999999999999999999999999999
Q ss_pred CCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCC
Q 038003 682 DRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN 761 (848)
Q Consensus 682 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~ 761 (848)
..|-|.++++.. ..+.....+.|..+||.|+.|||.+ .|||||||+-||||..+..|||+|||-++...+. .+
T Consensus 195 a~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-ST 267 (904)
T KOG4721|consen 195 AQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-ST 267 (904)
T ss_pred ccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hh
Confidence 999999999876 5677788899999999999999999 9999999999999999999999999999988665 44
Q ss_pred cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 762 WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 762 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
.-.++||..|||||++...+.++|+||||||||||||+||..||...+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 567999999999999999999999999999999999999999976433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=318.52 Aligned_cols=196 Identities=24% Similarity=0.323 Sum_probs=172.1
Q ss_pred ceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCC
Q 038003 605 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDR 683 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~ 683 (848)
+.||+|+||.||+|.. .+++.||+|+++..... .......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999965 47899999998765322 223445678899999999999999999999999999999999999
Q ss_pred CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcc
Q 038003 684 GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT 763 (848)
Q Consensus 684 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 763 (848)
|+|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 80 GELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 9999988654 5688899999999999999999999 999999999999999999999999999976543333445
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 764 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..+|++.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 56799999999999998999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.15 Aligned_cols=205 Identities=24% Similarity=0.297 Sum_probs=179.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|+..+.||+|.-|+||.|+.+ ++..+|+|++.+..... .....+...|.+|++.++||+++.+|..|+.+...|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 356788899999999999999876 45899999999887653 3445667889999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|||||+||+|..+.+++ ..+.+++..+.-++..+..||+|||.. |||+|||||+|||+.++|++.|+||.++....
T Consensus 155 ~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999998887 567899999999999999999999999 99999999999999999999999999975431
Q ss_pred C---------------------------------C-C----------------------CCcccccccccccCccccccC
Q 038003 757 P---------------------------------H-S----------------------SNWTEFAGTFGYAAPEIAYTM 780 (848)
Q Consensus 757 ~---------------------------------~-~----------------------~~~~~~~g~~~y~aPE~~~~~ 780 (848)
- . . .....++||-+|.|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 011236789999999999999
Q ss_pred CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 781 RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 781 ~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..+.++|+|+|||.+|||+.|+.||.-
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG 337 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKG 337 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCC
Confidence 999999999999999999999999853
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.24 Aligned_cols=435 Identities=30% Similarity=0.377 Sum_probs=341.9
Q ss_pred CCcEEeccCCccccccc-ccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 80 HLANLNLSFNLFFGNIP-LQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 80 ~l~~L~l~~n~~~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
+++.|+++.|.+.. .| +.+...-+|+.||||+|+++ ..|..+..+.+|+.|+++.|-|. .+|.+.+.+.+|++|.|
T Consensus 22 ~~~~ln~~~N~~l~-~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL 98 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLS-RPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNL 98 (1081)
T ss_pred HHHhhhcccccccc-CchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhhee
Confidence 46777777776642 22 22333444888888888886 67888888888888888888888 77888888888888888
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCC
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGS 238 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ 238 (848)
.+|.+. .+|.++..+.+|++|+++.|++. .+|..+..+..+..+..++|.... .++... .+.+++..|.+.+.
T Consensus 99 ~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~ 171 (1081)
T KOG0618|consen 99 KNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGS 171 (1081)
T ss_pred ccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccc
Confidence 888888 78888888888888888888887 788888888888888888883221 223322 77888888888888
Q ss_pred CCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccc----cCCc
Q 038003 239 IPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGV----IPHS 314 (848)
Q Consensus 239 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~ 314 (848)
++..+..++. .|+|.+|.+. . ..+..+.+|+.|....|++... --..++|+.|+.++|.+... .|..
T Consensus 172 ~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~p~p~n 242 (1081)
T KOG0618|consen 172 FLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVHPVPLN 242 (1081)
T ss_pred hhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeecccccccc
Confidence 8877777766 7888888876 2 2366778888888888887643 12346788888888887644 4566
Q ss_pred cceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccC
Q 038003 315 IERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSS 394 (848)
Q Consensus 315 l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~ 394 (848)
++.+.++.|+++..+ +....+.+|+.|+..+|+++ ..|.......+|+.|.+..|.+. -+|+....++.|++|+|..
T Consensus 243 l~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~ 319 (1081)
T KOG0618|consen 243 LQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQS 319 (1081)
T ss_pred ceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehh
Confidence 788888888888888 78888899999999999884 55666677788888888888887 5677777788888888888
Q ss_pred CccCCCCcccc--------------------------cccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCC
Q 038003 395 NHIVGKIPVQL--------------------------EMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSS 448 (848)
Q Consensus 395 N~l~~~~~~~l--------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 448 (848)
|+|. ..|+.+ ..++.|+.|++.+|.+++..-..+.++.+|+.|+|++|+|..+
T Consensus 320 N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 320 NNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred cccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 8876 333211 1245688899999999987777888999999999999999877
Q ss_pred CCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccc
Q 038003 449 IPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEM 528 (848)
Q Consensus 449 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 528 (848)
....+.++..|+.|+||+|+|+ .+|..+..+..|++|...+|+|. ..| .+..++.|+.+|+|.|+|+...-..-..-
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~ 475 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS 475 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence 6677899999999999999998 68899999999999999999995 456 89999999999999999986543333333
Q ss_pred cCceeecCCCCc
Q 038003 529 RSLSCIDISYNE 540 (848)
Q Consensus 529 ~~L~~l~ls~N~ 540 (848)
++|++||++||.
T Consensus 476 p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 476 PNLKYLDLSGNT 487 (1081)
T ss_pred cccceeeccCCc
Confidence 899999999997
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=318.94 Aligned_cols=200 Identities=26% Similarity=0.358 Sum_probs=176.0
Q ss_pred hcCCcccceeccCCceeEEEEEcCC--CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPS--GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
.++|++.+.||+|+||.||+|.++. +..||+|++...... .....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4569999999999999999996542 368999998765322 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 108 lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999999765 4688899999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 432 2346799999999999988899999999999999999999999864
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=315.96 Aligned_cols=197 Identities=27% Similarity=0.400 Sum_probs=171.8
Q ss_pred ceeccCCceeEEEEEc----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEec
Q 038003 605 FCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
+.||+|+||.||+|+. .+++.||+|+++.............+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999964 367899999997654333334456678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~ 760 (848)
+++++|.++++.. +.+.+..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999998654 4577888899999999999999999 999999999999999999999999999876543333
Q ss_pred CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 761 NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 761 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
......|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 33456799999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=317.73 Aligned_cols=199 Identities=26% Similarity=0.366 Sum_probs=177.0
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|.+. +++.||+|+++..... .....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 36899999999999999999765 6899999999765422 223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999999654 4678899999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
......|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence 23456789999999999998999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.57 Aligned_cols=206 Identities=24% Similarity=0.391 Sum_probs=186.8
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe-eE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH-SF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~-~~ 675 (848)
.++|...+++|+|+||.++.++++ ++..+|+|.+...... ....+....|+.++++++|||||.+.+.|.+++. .+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 357888999999999999999665 6789999999776533 2344567899999999999999999999999988 99
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||+|++||++.+.+.+.. +..+++..+.+|+.||+.|+.|||++ .|+|||||+.||++..++.|||+|||+|+.+
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence 9999999999999998773 56799999999999999999999999 9999999999999999999999999999999
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
++......+.+|||.||.||++.+.+|..|+|||||||++|||++=+.+|...+
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 887766778899999999999999999999999999999999999999986543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=311.35 Aligned_cols=199 Identities=25% Similarity=0.353 Sum_probs=175.6
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 46889999999999999999665 7899999998654321 223456688999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. +.+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 80 MEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999998654 4688899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. .....|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 154 R---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred C---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 2345789999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=314.66 Aligned_cols=196 Identities=24% Similarity=0.320 Sum_probs=171.7
Q ss_pred ceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCC
Q 038003 605 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDR 683 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~ 683 (848)
+.||+|+||.||+|.. .+|..||+|++...... .......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 3699999999999965 47899999999765432 233456678899999999999999999999999999999999999
Q ss_pred CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcc
Q 038003 684 GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT 763 (848)
Q Consensus 684 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 763 (848)
|+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++...........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 80 GELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 9999888654 4688899999999999999999999 999999999999999999999999999876433333334
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 764 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 56799999999999988899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.67 Aligned_cols=201 Identities=25% Similarity=0.348 Sum_probs=174.3
Q ss_pred CcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|+..+.||+|+||+||+|.. .+++.||+|++...... .......+.+|++++++++|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 67788999999999999965 57999999998765432 12234557889999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 99999998877543 224588899999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......|++.|+|||++.+..+++++|||||||++|||+||+.||..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 223446789999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=317.49 Aligned_cols=200 Identities=30% Similarity=0.497 Sum_probs=173.5
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
-.+.+.+...||+|.||+||+|.|. | .||||+++..... .+..+.|+.|+..+++-+|.||+-+.|||..... .+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt--~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPT--PEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred CHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCC--HHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 3445677789999999999999986 4 4999999776433 3467889999999999999999999999998877 99
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|..+|+|.+|+.+++... ..++..+.+.|++|||+|+.|||.+ +|||||||..||++++++.|||+|||++..-.
T Consensus 465 iTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeee
Confidence 999999999999998763 5788899999999999999999999 99999999999999999999999999997543
Q ss_pred CC--CCCcccccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 757 PH--SSNWTEFAGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 757 ~~--~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.- ........|..-|||||++.. .+|++.+||||||+|+|||+||..||.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 22 222344567889999999874 458999999999999999999999986
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.21 Aligned_cols=194 Identities=25% Similarity=0.339 Sum_probs=170.8
Q ss_pred eccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCC
Q 038003 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGS 685 (848)
Q Consensus 607 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gs 685 (848)
||+|+||.||+|... +++.||+|++...... .......+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999665 6889999998764322 23345677899999999999999999999999999999999999999
Q ss_pred HHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccc
Q 038003 686 LARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765 (848)
Q Consensus 686 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 765 (848)
|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 80 LFHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 99998654 4688899999999999999999999 99999999999999999999999999998654433334456
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 766 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+|++.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 799999999999998999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=323.85 Aligned_cols=201 Identities=22% Similarity=0.253 Sum_probs=172.8
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|+..+.||+|+||+||+|.. .+++.||+|++.+.... .....+.+.+|++++++++||||+++++.+.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 588999999999999999965 47889999998764321 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++|+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 81 DYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999998654 4578888999999999999999999 9999999999999999999999999997532100
Q ss_pred C-----------------------------------------------CCcccccccccccCccccccCCCCccchhhhH
Q 038003 759 S-----------------------------------------------SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSF 791 (848)
Q Consensus 759 ~-----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSl 791 (848)
. ......+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 00123468999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCcc
Q 038003 792 GVLVFEVIKGNHPRDF 807 (848)
Q Consensus 792 G~il~elltg~~P~~~ 807 (848)
||++|||+||+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (382)
T cd05625 235 GVILYEMLVGQPPFLA 250 (382)
T ss_pred hHHHHHHHhCCCCCCC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=315.54 Aligned_cols=200 Identities=27% Similarity=0.350 Sum_probs=177.1
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 357999999999999999999765 6899999998765322 22345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 96 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999998754 4678888999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ....|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 170 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 170 DRT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred CCc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 322 345789999999999998899999999999999999999999853
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.72 Aligned_cols=196 Identities=26% Similarity=0.342 Sum_probs=172.1
Q ss_pred ceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCC
Q 038003 605 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDR 683 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~ 683 (848)
+.||+|+||.||+|.. .+++.||+|++.+.... .......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999965 47899999999765432 234456788899999999999999999999999999999999999
Q ss_pred CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcc
Q 038003 684 GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT 763 (848)
Q Consensus 684 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 763 (848)
|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 80 g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 80 GELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 9999888654 4688999999999999999999999 999999999999999999999999999876543333334
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 764 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..+|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 56799999999999988899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.17 Aligned_cols=201 Identities=23% Similarity=0.255 Sum_probs=173.4
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
.|+..+.||+|+||+||+|.. .+++.||+|++...... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 588899999999999999955 47889999999765322 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 81 DYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999998654 4578888999999999999999999 9999999999999999999999999997543110
Q ss_pred C-----------------------------------------------CCcccccccccccCccccccCCCCccchhhhH
Q 038003 759 S-----------------------------------------------SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSF 791 (848)
Q Consensus 759 ~-----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSl 791 (848)
. ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 00123579999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCcc
Q 038003 792 GVLVFEVIKGNHPRDF 807 (848)
Q Consensus 792 G~il~elltg~~P~~~ 807 (848)
||++|||+||+.||..
T Consensus 235 G~il~elltG~~Pf~~ 250 (381)
T cd05626 235 GVILFEMLVGQPPFLA 250 (381)
T ss_pred hhHHHHHHhCCCCCcC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=290.36 Aligned_cols=203 Identities=26% Similarity=0.342 Sum_probs=183.2
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|+..++||+|.||+|..++- .+++.+|||++++..+.. ..+..+...|-++++..+||++..+--.|+..+..|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 46799999999999999999955 489999999999987653 4456667889999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+.||.|.-++.+. +.+++..+.-+-..|+.||.|||++ +||+||+|.+|.|+|.+|++||+|||+++.--
T Consensus 246 VMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999998888664 5677778888899999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......++||||.|.|||++....|++++|.|.+||++|||++|+.||..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 556667889999999999999999999999999999999999999999743
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.68 Aligned_cols=202 Identities=26% Similarity=0.327 Sum_probs=175.1
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|... +++.||||++...... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 47899999999999999999664 7899999999764322 223456678899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..+..
T Consensus 80 ~E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 80 MEYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred ECCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999998654 4688999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC--------------------------------------CcccccccccccCccccccCCCCccchhhhHHHHHHHHH
Q 038003 758 HSS--------------------------------------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799 (848)
Q Consensus 758 ~~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 799 (848)
... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 110 001246899999999999888999999999999999999
Q ss_pred hCCCCCcc
Q 038003 800 KGNHPRDF 807 (848)
Q Consensus 800 tg~~P~~~ 807 (848)
+|+.||..
T Consensus 234 ~G~~Pf~~ 241 (364)
T cd05599 234 VGYPPFCS 241 (364)
T ss_pred cCCCCCCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.81 Aligned_cols=202 Identities=25% Similarity=0.284 Sum_probs=173.6
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|.. .+++.||||++.+.... .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 4689999999999999999965 47899999998664322 223456788899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... +.+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 80 MEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999998654 5678889999999999999999999 999999999999999999999999999864321
Q ss_pred CCC-----------------------------------------------CcccccccccccCccccccCCCCccchhhh
Q 038003 758 HSS-----------------------------------------------NWTEFAGTFGYAAPEIAYTMRATEKYDVYS 790 (848)
Q Consensus 758 ~~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS 790 (848)
... .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 001246899999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCcc
Q 038003 791 FGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 791 lG~il~elltg~~P~~~ 807 (848)
|||++|||+||+.||..
T Consensus 234 lGvil~elltG~~Pf~~ 250 (377)
T cd05629 234 LGAIMFECLIGWPPFCS 250 (377)
T ss_pred cchhhhhhhcCCCCCCC
Confidence 99999999999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.79 Aligned_cols=195 Identities=27% Similarity=0.368 Sum_probs=163.6
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-----
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP----- 672 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----- 672 (848)
-.|...+++|.|+||.||+|... +++.||||+.-... +---+|+++|+.+.|||||++.-+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~--------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK--------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC--------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 35777889999999999999665 57899999864432 11237999999999999999999886532
Q ss_pred eeEEEEeccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC-CCEEEeecc
Q 038003 673 HSFLVCEYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN-FEAHVSDFG 750 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG 750 (848)
...+|||||+. +|.++++.. .....++...+.-++.||++|++|||+. |||||||||.|+|+|.+ |.+||||||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence 33589999987 899888742 1235677788889999999999999998 99999999999999976 999999999
Q ss_pred CccccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.|+........ ....+|..|+|||.+.|. .|+.++||||.|||+.||+-|+.-|.
T Consensus 172 SAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 172 SAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred cceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 99998765444 567789999999999876 48999999999999999999999864
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.13 Aligned_cols=202 Identities=22% Similarity=0.247 Sum_probs=173.4
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||+|+||.||+|+. .+++.||+|++.+.... .......+.+|++++++++||||+++++.+.+++..++||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 689999999999999999965 47899999998764322 1234566889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++|+|.+++... +.++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999998654 4578888899999999999999999 9999999999999999999999999997532100
Q ss_pred -------------------------------------------CCCcccccccccccCccccccCCCCccchhhhHHHHH
Q 038003 759 -------------------------------------------SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLV 795 (848)
Q Consensus 759 -------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il 795 (848)
.......+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0001134799999999999998999999999999999
Q ss_pred HHHHhCCCCCccc
Q 038003 796 FEVIKGNHPRDFF 808 (848)
Q Consensus 796 ~elltg~~P~~~~ 808 (848)
|||+||+.||...
T Consensus 235 yell~G~~Pf~~~ 247 (376)
T cd05598 235 YEMLVGQPPFLAD 247 (376)
T ss_pred eehhhCCCCCCCC
Confidence 9999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=314.05 Aligned_cols=202 Identities=25% Similarity=0.348 Sum_probs=174.0
Q ss_pred CCcccceeccCCceeEEEEEc----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
+|++.+.||+|+||.||+|+. .+++.||+|++.+..........+.+..|+.+++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999864 368899999987654333334456778899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999988654 4588899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC-CcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSS-NWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+..... ......||+.|+|||++.+.. ++.++|||||||++|||+||+.||..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 543222 223467999999999988654 78899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.30 Aligned_cols=204 Identities=23% Similarity=0.313 Sum_probs=175.0
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
...++|++.+.||+|+||.||+|... +++.+|+|++.+.... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34567999999999999999999765 6889999998654322 223345678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
|+||||+++|+|.++++.. .++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999998543 477888999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CcccccccccccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSS-NWTEFAGTFGYAAPEIAYTMR----ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... .....+||+.|+|||++.+.. ++.++||||+||++|||+||+.||..
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 643322 223567999999999987543 68899999999999999999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=309.69 Aligned_cols=201 Identities=26% Similarity=0.354 Sum_probs=173.5
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCC-cccceEEEeecCCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR-NNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~l~~~~~~~~~~~lV 677 (848)
+|++.+.||+|+||.||+|... +++.||+|++.+.... .....+.+..|.+++..++|+ +|+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 5888999999999999999655 6789999998765432 223456678899999999765 688899999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 80 MEYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999988654 4578899999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........+|++.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 33334456799999999999998999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=280.38 Aligned_cols=204 Identities=25% Similarity=0.415 Sum_probs=177.5
Q ss_pred HhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchh----HHHHHHHHHHHhcC-CCCcccceEEEee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMAD----HDEFLNEVLALKEI-RHRNNVKFHGFCY 669 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~----~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 669 (848)
.....|...+.+|.|..++|.++.+ .+|..+|+|++.........+. .++..+|+.+++++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3455688888999999999999955 4789999999876544333332 34456899999998 7999999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
.+...++|+|.|+.|.|.+++... -.++++...+|++|+..|++|||.+ .|||||+||+|||+|++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 999999999999999999999766 3588899999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCcccccccccccCcccccc------CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYT------MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
|.++...+ .......||||+|.|||.+.- ..|+..+|+|+.|||+|.++.|..||-
T Consensus 168 GFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 168 GFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred ceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 99998865 445577999999999999862 347888999999999999999999973
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=311.56 Aligned_cols=196 Identities=29% Similarity=0.387 Sum_probs=167.8
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHH-HHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVL-ALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||+||+|... +++.||+|++....... .....++..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 36999999999999664 78999999987653322 223344555554 5678999999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 99999988654 5688889999999999999999999 99999999999999999999999999987654333334
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...+|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 556799999999999998999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=307.00 Aligned_cols=204 Identities=27% Similarity=0.426 Sum_probs=183.0
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~ 674 (848)
..+.|++.+.||+|.||.||+|..+ +|+.+|+|++.+..... ....+.+.+|+.+|+++. |||||.++++|++...+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 3456888899999999999999665 59999999998876542 235678899999999998 99999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC----CCEEEeecc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN----FEAHVSDFG 750 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfG 750 (848)
++|||++.||.|.+.+... .+++.++..++.||+.|+.|||+. ||||||+||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998655 389999999999999999999999 99999999999999643 479999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
++.+... .......+||+.|+|||++....|+..+||||+||++|.|++|..||....
T Consensus 185 la~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 185 LAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred CceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 9999877 556678999999999999999999999999999999999999999985433
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.74 Aligned_cols=202 Identities=26% Similarity=0.349 Sum_probs=174.2
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV 677 (848)
+|++.+.||+|+||.||+|... +++.||+|++.+.... .....+.+..|.+++..+ +||+|+++++++.+.+..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 5888999999999999999665 6789999998765422 223345567788888777 689999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... ..+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 80 MEYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999888654 4588899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
........+|++.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 333344567999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.72 Aligned_cols=196 Identities=24% Similarity=0.326 Sum_probs=171.1
Q ss_pred ceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCC
Q 038003 605 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDR 683 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~ 683 (848)
+.||+|+||.||+|.. .++..||+|+++..... .......+..|+++++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999965 47899999999765432 223455677899999999999999999999999999999999999
Q ss_pred CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 684 GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 684 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
|+|.+++... ..+++..+..++.||+.||+|||+ . ||+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 80 GELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 9999888654 468899999999999999999997 7 99999999999999999999999999987654333334
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence 456799999999999988999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.91 Aligned_cols=205 Identities=21% Similarity=0.294 Sum_probs=175.3
Q ss_pred HHhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
....++|++.+.||+|+||.||+|..+ +++.+|+|++.+.... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 344578999999999999999999665 6889999998654322 22334557889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++|+|.++++.. .++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999988543 477888899999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CcccccccccccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSS-NWTEFAGTFGYAAPEIAYTMR----ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 7653322 223567999999999987543 78899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=308.57 Aligned_cols=196 Identities=28% Similarity=0.379 Sum_probs=171.3
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||.||+|... +++.||+|++++.... .....+.+.+|..++.++ +||||+++++++.+.+..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 36999999999999654 7889999999775432 234456678899999888 79999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.+++... +.+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 99999888654 5689999999999999999999999 99999999999999999999999999987543333333
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...+|++.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 456899999999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=292.51 Aligned_cols=201 Identities=26% Similarity=0.432 Sum_probs=174.5
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN----- 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 670 (848)
....|...+.||+|+||.|+.|.. .+|+.||||++.... ......++..+|+++++.++|+||+.+.+++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 345566688999999999999954 589999999987543 245667888999999999999999999999876
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
-...|+|+|+|+ .+|...++.+ +.++..++..+++||.+||.|+|+. +|+|||+||+|++++.+..+||||||
T Consensus 98 f~DvYiV~elMe-tDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELME-TDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHHh-hHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 347899999994 5999999766 5588899999999999999999999 99999999999999999999999999
Q ss_pred CccccCC--CCCCcccccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 751 IAKFVGP--HSSNWTEFAGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 751 ~~~~~~~--~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
+|+.... ....++..+.|.+|.|||++. ...|+.++||||.|||+.||++|+.-|.
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 9998854 234456778899999999865 5679999999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=327.16 Aligned_cols=236 Identities=25% Similarity=0.363 Sum_probs=189.5
Q ss_pred CCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
+....+.||+|+||+||+|+.. +...||||.++... +.+...+|.+|+++++.++|||||+++|+|.+++.
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3445567999999999999643 35679999998874 44577889999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCC-------C----cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC
Q 038003 674 SFLVCEYLDRGSLARILGDDV-------T----AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 742 (848)
++||+|||..|+|.++++... . ..+++..+...|+.|||.|++||-++ .+|||||-.+|+|+.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 999999999999999996431 1 23488899999999999999999999 999999999999999999
Q ss_pred CEEEeeccCccccCCCCCCcc--cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccccccccccchhh
Q 038003 743 EAHVSDFGIAKFVGPHSSNWT--EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMI 819 (848)
Q Consensus 743 ~~kl~DfG~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~ 819 (848)
.|||+|||+++..-..+.... ...-..+|||||.+...++++++|||||||+|||++| |+.||..... +++.+.+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--~EVIe~i 718 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--QEVIECI 718 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--HHHHHHH
Confidence 999999999986533222110 1122579999999999999999999999999999999 9999764332 3344443
Q ss_pred hhhhhhcCCCCCCCCCCcccccceee
Q 038003 820 IDVNKILDPRLPTPSPSVMDYGGCHF 845 (848)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (848)
.+... -+.....+++++++|..||
T Consensus 719 ~~g~l--L~~Pe~CP~~vY~LM~~CW 742 (774)
T KOG1026|consen 719 RAGQL--LSCPENCPTEVYSLMLECW 742 (774)
T ss_pred HcCCc--ccCCCCCCHHHHHHHHHHh
Confidence 33333 3344456677777776665
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.90 Aligned_cols=204 Identities=29% Similarity=0.455 Sum_probs=179.9
Q ss_pred CcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC------e
Q 038003 601 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP------H 673 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------~ 673 (848)
+...+.||+|+||.||+++. .+|+.||||.++... .....+...+|++++++++|||||+++++-++.. .
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 44456899999999999984 589999999998865 3455677899999999999999999999865533 5
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC--CCC--CEEEeec
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD--SNF--EAHVSDF 749 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~Df 749 (848)
..+|||||.||||...+++..+...+++.+...++.+++.|+.|||++ |||||||||.||++- ++| ..||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence 689999999999999999887888899999999999999999999999 999999999999994 333 5899999
Q ss_pred cCccccCCCCCCcccccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCcccccc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~ 811 (848)
|+|+...+.. .....+||..|.+||++. .+.|+..+|.|||||++|+.+||..||......
T Consensus 169 G~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 169 GAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9999987654 567899999999999998 478899999999999999999999999876664
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.11 Aligned_cols=202 Identities=26% Similarity=0.318 Sum_probs=175.1
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|+..+.||+|+||+||+|... +++.||+|+++..... .......+.+|+.++.+++||+|+++++.+.+.+..++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 46889999999999999999654 7899999998764322 223456778899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 80 MEFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999998654 4688899999999999999999999 999999999999999999999999999875432
Q ss_pred CCC-----------------------------------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCC
Q 038003 758 HSS-----------------------------------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN 802 (848)
Q Consensus 758 ~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 802 (848)
... .....+||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 012357999999999999999999999999999999999999
Q ss_pred CCCcc
Q 038003 803 HPRDF 807 (848)
Q Consensus 803 ~P~~~ 807 (848)
.||..
T Consensus 234 ~Pf~~ 238 (360)
T cd05627 234 PPFCS 238 (360)
T ss_pred CCCCC
Confidence 99854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.64 Aligned_cols=203 Identities=26% Similarity=0.321 Sum_probs=178.8
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|... +++.||||+++..... .......+.+|++++..++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 46899999999999999999665 7899999999765432 223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 80 MEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999998755 5688899999999999999999999 999999999999999999999999999987654
Q ss_pred CC-----------------------------CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 758 HS-----------------------------SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 758 ~~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 1223457899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.66 Aligned_cols=200 Identities=28% Similarity=0.388 Sum_probs=176.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... ++..+|+|++.... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999665 78899999987542 23445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... ..+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 81 CMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EeecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999998654 45788999999999999999999862 69999999999999999999999999997664
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ......|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 156 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 32 22445789999999999998899999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=302.89 Aligned_cols=201 Identities=22% Similarity=0.359 Sum_probs=172.0
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|..+ +++.||+|+++... .......+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH---EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc---cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 357999999999999999999654 78999999986543 12234567789999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++ +|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 81 v~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 81 VFEYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred EEeCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 9999986 898887543 23578889999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+++.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 33333345578999999998875 5678999999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.31 Aligned_cols=196 Identities=29% Similarity=0.390 Sum_probs=170.5
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||.||+|... +++.||+|++++.... .....+.+.+|+.++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 36999999999999654 6889999999875432 234456677888888776 89999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99999888654 5688999999999999999999999 99999999999999999999999999987643333333
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 456799999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=308.47 Aligned_cols=199 Identities=26% Similarity=0.366 Sum_probs=170.9
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHH---hcCCCCcccceEEEeecCCeeEE
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL---KEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
|++.+.||+|+||.||+|... +++.||||+++..... .....+.+.+|++++ +.++||||+++++++.+.+..|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 667889999999999999654 7899999999765322 123345566676654 56789999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|..+++. ..+++..+..++.||+.|++|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 80 v~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 80 VMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999988754 3588999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........+|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 333334557799999999999998899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=308.52 Aligned_cols=197 Identities=28% Similarity=0.369 Sum_probs=170.5
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||+||+|..+ +++.||+|++.+.... .....+.+..|.+++..+ +||||+++++++...+..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999765 6889999998765322 223456677888888776 79999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.++++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 80 GGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 99999988654 4688899999999999999999999 99999999999999999999999999987654333334
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
....|++.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 5567999999999999888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=306.92 Aligned_cols=196 Identities=29% Similarity=0.391 Sum_probs=168.1
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhc-CCCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKE-IRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||+||+|... +++.||+|+++..... .....+.+..|.+++.. .+||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999664 6889999999765422 12334455667777665 489999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 gg~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 80 GGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 99999988654 4688899999999999999999999 99999999999999999999999999998654333344
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 556799999999999998899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=308.98 Aligned_cols=196 Identities=27% Similarity=0.374 Sum_probs=166.2
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHH-HHHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEV-LALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||+||+|... +++.||+|++........ .....+..|. .+++.++||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36999999999999665 678899999876533221 2233444444 45688899999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+++|.+++... ..+....+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 80 GGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 99999988654 4577788889999999999999999 99999999999999999999999999997654434444
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...+|++.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 556799999999999998999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=309.79 Aligned_cols=196 Identities=28% Similarity=0.386 Sum_probs=167.9
Q ss_pred ceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHH-HHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVL-ALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||+||+|.. .+|+.+|+|++.+.... .......+..|.. +++.++||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 3699999999999965 47899999998765332 2233345555655 4678999999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99999888654 5688999999999999999999999 99999999999999999999999999987643333334
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...+|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence 556799999999999998999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=315.77 Aligned_cols=203 Identities=24% Similarity=0.332 Sum_probs=173.6
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|... +++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3567999999999999999999664 7899999998754322 1233455778999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++|+|.++++.. .++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999988543 477788889999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-CcccccccccccCccccccC----CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSS-NWTEFAGTFGYAAPEIAYTM----RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..... .....+|++.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 43322 22346799999999998653 378899999999999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=330.94 Aligned_cols=206 Identities=24% Similarity=0.292 Sum_probs=182.1
Q ss_pred HHHhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 594 IIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 594 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
..-..+||++.++||+|+||.|..++.+ +++.||+|++.+-... ...+...|..|-.+|...+.++|+.++-.|++..
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl-Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML-KRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh-hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 4445678999999999999999999775 7899999999874322 2345567899999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
++|+|||||+||+|..++... .++++..+.-++..|+.||.-+|+. |+|||||||+|||+|..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999765 3688888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC-cccccccccccCccccc----c-CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 753 KFVGPHSSN-WTEFAGTFGYAAPEIAY----T-MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 753 ~~~~~~~~~-~~~~~g~~~y~aPE~~~----~-~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
-.+..++.. ....+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||.
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 888754433 35678999999999986 3 568999999999999999999999984
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=308.71 Aligned_cols=196 Identities=28% Similarity=0.363 Sum_probs=166.9
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHH-HHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVL-ALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||.||+|+.. +++.||+|++.+..... ......+.+|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999764 68899999987654322 223344555554 5788999999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+++|.+.+... ..++...+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 80 GGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99998888654 4578888999999999999999999 99999999999999999999999999987643333334
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 456789999999999988899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.67 Aligned_cols=201 Identities=24% Similarity=0.359 Sum_probs=171.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc---ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 468999999999999999999765 78999999987543 12233456789999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||++ +++.+++... ...++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 81 VFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 999996 5777776543 24578889999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+++.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 33333345678999999999875 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.71 Aligned_cols=206 Identities=27% Similarity=0.399 Sum_probs=170.5
Q ss_pred hhcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCY 669 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 669 (848)
..++|++.+.||+|+||.||+|.+ .+++.||+|++.... .....+.+.+|++++..+ +||||++++++|.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 346799999999999999999963 235689999986542 233456788999999999 8999999999887
Q ss_pred cC-CeeEEEEeccCCCCHHhHhcCCCC-----------------------------------------------------
Q 038003 670 NG-PHSFLVCEYLDRGSLARILGDDVT----------------------------------------------------- 695 (848)
Q Consensus 670 ~~-~~~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------- 695 (848)
.. ...++||||+++|+|.++++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 468899999999999988864211
Q ss_pred ------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCC--cccccc
Q 038003 696 ------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAG 767 (848)
Q Consensus 696 ------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g 767 (848)
...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........ .....+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 13477888899999999999999999 9999999999999999999999999999865432211 122345
Q ss_pred cccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 768 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 768 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
++.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999998889999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.30 Aligned_cols=238 Identities=27% Similarity=0.407 Sum_probs=193.3
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
.|...+.||.|+||.||.|++ ++.+.||||++..+..+. .+....+..|++.+++++|||+|.+-|.|......|+||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs-~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccccc-HHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 467778899999999999955 578999999997764432 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
|||-| |-.|++.-. .+++-+..+..|..+...||+|||+. +.||||||+.|||+.+.|.|||+|||.|..+.+.
T Consensus 106 EYClG-SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHhc-cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99976 666666433 35677788999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCccccc---------------cccccchhhh
Q 038003 759 SSNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI---------------NFSSFSNMII 820 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~---------------~~~~~~~~~~ 820 (848)
..++|||.|||||++. .+.|+-++||||+|+++.||.-.++|+-.+.. ....+.+.+.
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~ 255 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 255 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHH
Confidence 5689999999999976 45789999999999999999999999632211 1224555555
Q ss_pred hhhhhcCCCCCCCCCCcccccceeeccC
Q 038003 821 DVNKILDPRLPTPSPSVMDYGGCHFMLR 848 (848)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (848)
.....+-.++|..+|.--......|+.|
T Consensus 256 ~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 256 NFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 5555566666777777666666666554
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.05 Aligned_cols=202 Identities=26% Similarity=0.350 Sum_probs=173.5
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lV 677 (848)
+|+..+.||+|+||+||+|... +++.||+|++.+.... .....+.+..|.+++..+. |++|+++++++.+.+..|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 4788899999999999999654 7899999998765322 1233456778888888885 57888999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... ..+++.++..++.||+.|++|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 80 MEYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999988654 5688999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.........|++.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 333334567999999999999888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.89 Aligned_cols=192 Identities=26% Similarity=0.388 Sum_probs=170.6
Q ss_pred CCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-C-----CcccceEEEeecCC
Q 038003 600 DFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-H-----RNNVKFHGFCYNGP 672 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----p~iv~l~~~~~~~~ 672 (848)
+|++.+.||+|+||.|.+| +.++++.||||+++.. .....+...|+.++..++ | -|+|+++++|....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 7999999999999999999 5568999999999775 456677788999999996 4 47999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC--CCEEEeecc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN--FEAHVSDFG 750 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DfG 750 (848)
+.|+|+|.++. +|+++++.+ ....++...+..++.||+.||.+||+. +|||+||||+|||+.+- ..+||+|||
T Consensus 262 HlciVfELL~~-NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 HLCIVFELLST-NLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ceeeeehhhhh-hHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999966 999999877 445699999999999999999999999 99999999999999753 479999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 804 (848)
.|++..+.- ...+-+..|+|||++.|.+|+.++||||||||++||+||.+-
T Consensus 337 SSc~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 337 SSCFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL 387 (586)
T ss_pred cccccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence 999875432 356678899999999999999999999999999999999554
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.61 Aligned_cols=196 Identities=28% Similarity=0.399 Sum_probs=170.0
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||.||+|... +++.||+|++.+.... .....+.+..|.+++..+ +||+|+++++++.+.+..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 36999999999999665 6789999998765322 223445677888888865 89999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|..++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 80 GGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 99999888654 4688899999999999999999999 99999999999999999999999999997654433334
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....|++.|+|||++.+..+++++||||+||++|||+||+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 556799999999999988999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.27 Aligned_cols=196 Identities=29% Similarity=0.381 Sum_probs=168.5
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhc-CCCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKE-IRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||.||+|..+ +++.||+|+++..... .....+....|.+++.. .+||+|+++++++.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 46999999999999765 6889999999765322 12234556778888765 489999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.+++... ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 80 GGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 99999988654 4678899999999999999999999 99999999999999999999999999987543333334
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...+|++.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~ 198 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 556799999999999998999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.77 Aligned_cols=196 Identities=30% Similarity=0.453 Sum_probs=179.2
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|++...||+|+||.||+|.++ +|+.+|||.+... .+..++..|+.+|++++.|+||++||.+.....+|+|||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 677788999999999999554 7999999997654 456788999999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
||-.|++.++++.+ .+.+.+.++..+++...+||+|||.. .-+|||||+.|||++.+|.+||+|||.|-...+..
T Consensus 109 YCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999999765 46799999999999999999999998 88999999999999999999999999998876655
Q ss_pred CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....+..|||.|||||++....|+.++||||+|++..||.-|++||..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 666778999999999999999999999999999999999999999753
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.67 Aligned_cols=197 Identities=26% Similarity=0.337 Sum_probs=170.4
Q ss_pred eccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCC
Q 038003 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGS 685 (848)
Q Consensus 607 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gs 685 (848)
||+|+||+||+|... +++.||+|++...... .....+.+..|+++++.++||+|+++.+++......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999654 7899999998765322 12334567789999999999999999999999999999999999999
Q ss_pred HHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCccc
Q 038003 686 LARILGDD-VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE 764 (848)
Q Consensus 686 L~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~ 764 (848)
|.+++... .....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+............
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 98877432 1235688999999999999999999999 9999999999999999999999999999876544443445
Q ss_pred ccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 765 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 6789999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.56 Aligned_cols=195 Identities=26% Similarity=0.424 Sum_probs=166.0
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|+..+.||+|+||.||+|.+. +++.||||++.... .....+.+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 45777889999999999999654 78999999986542 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.+.. ...+..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999999986432 245667788999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.........|+..|+|||++.. ...+.++|||||||++|||++|+.||.
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 3333345679999999998743 234568999999999999999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.54 Aligned_cols=201 Identities=25% Similarity=0.377 Sum_probs=173.4
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 36899999999999999999775 688999999876532 223456678999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++++.+..+.+.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 79 FEYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9999998776554332 4688899999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ......|++.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 222 22345789999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=309.63 Aligned_cols=203 Identities=26% Similarity=0.306 Sum_probs=173.9
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+++.. +++.||+|++.+.... .......+.+|+.++..++|++|+++++++.+.+..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 47899999999999999999765 6888999998764221 223345578899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999653 24678889999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-cccccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSN-WTEFAGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... .....|++.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 3322 233579999999999875 4578899999999999999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.18 Aligned_cols=196 Identities=28% Similarity=0.381 Sum_probs=171.0
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||+||+|... +++.||+|++++.... .....+.+.+|+.++.++ +||+|+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 36999999999999654 6789999999875432 234456678899998888 69999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.+++... +.+++..+..++.||+.|++|||++ ||+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 80 GGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 99999888654 4689999999999999999999999 99999999999999999999999999987643333334
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...+|++.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 557799999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=332.39 Aligned_cols=437 Identities=31% Similarity=0.350 Sum_probs=365.9
Q ss_pred EeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcC
Q 038003 84 LNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNL 163 (848)
Q Consensus 84 L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 163 (848)
+|.+...+. .||..+-.-..|+.|+++.|-+-...-+.+.+.-+|+.|||++|++. ..|..+..+.+|+.|+++.|-|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 455666664 67877776667999999999876433345556666999999999998 8999999999999999999999
Q ss_pred CCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcc
Q 038003 164 HGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPIL 243 (848)
Q Consensus 164 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l 243 (848)
. ..|.+.+++.+|++|.|.+|++. ..|..+..+++|++|+++.|++. .+|..+..++.++.+..++|.....++
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg--- 154 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG--- 154 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhc---
Confidence 9 78999999999999999999998 89999999999999999999998 899999999999999999993332322
Q ss_pred cCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccc--cCCccceeecc
Q 038003 244 GNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGV--IPHSIERVLLN 321 (848)
Q Consensus 244 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~l~~l~L~ 321 (848)
... ++.+++..|.+.+.++..+..++. .|+|.+|.+. ...+..+.+|+.+....|++... .-.+++.++.+
T Consensus 155 -~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~ 227 (1081)
T KOG0618|consen 155 -QTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEISGPSLTALYAD 227 (1081)
T ss_pred -ccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEecCcchheeeec
Confidence 222 899999999999999888887777 7999999987 34577889999999999999855 33568888889
Q ss_pred ccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCC
Q 038003 322 QNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKI 401 (848)
Q Consensus 322 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 401 (848)
.|.+..... ...-.+|++++++.|++++.. ...+.+.+|+.+...+|++. .+|..+..+++|+.|++.+|.+. .+
T Consensus 228 ~n~l~~~~~--~p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yi 302 (1081)
T KOG0618|consen 228 HNPLTTLDV--HPVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YI 302 (1081)
T ss_pred cCcceeecc--ccccccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hC
Confidence 998883332 223468999999999999765 77788999999999999996 78888999999999999999998 78
Q ss_pred cccccccccccEEEccCCcCCCCCCcccC-------------------------CCCccCeEeccCcccCCCCCCcccCc
Q 038003 402 PVQLEMLSSLNKLILNLNQLSGGVPLEFG-------------------------SLTKLQYLDLSTNKLSSSIPKSIGNL 456 (848)
Q Consensus 402 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~-------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l 456 (848)
|..+..+++|++|+|..|+|....+..|. .+..|+.|++.+|.+++..-..+.+.
T Consensus 303 p~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~ 382 (1081)
T KOG0618|consen 303 PPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNF 382 (1081)
T ss_pred CCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccc
Confidence 88889999999999999999843332211 13447778888888888777788888
Q ss_pred cccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecC
Q 038003 457 LKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDI 536 (848)
Q Consensus 457 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l 536 (848)
..|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+.+++.|++|...+|+|.. .| .+..++.|+.+|+
T Consensus 383 ~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~-fP-e~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS-FP-ELAQLPQLKVLDL 459 (1081)
T ss_pred cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee-ch-hhhhcCcceEEec
Confidence 89999999999998666667888999999999999996 578889999999999999999876 45 8899999999999
Q ss_pred CCCccCC
Q 038003 537 SYNELHG 543 (848)
Q Consensus 537 s~N~l~~ 543 (848)
|.|+|+-
T Consensus 460 S~N~L~~ 466 (1081)
T KOG0618|consen 460 SCNNLSE 466 (1081)
T ss_pred ccchhhh
Confidence 9999974
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=303.55 Aligned_cols=200 Identities=28% Similarity=0.389 Sum_probs=175.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+.+|++++++++||||++++++|.+.+..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 467999999999999999999665 78889999886542 23345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++.. +.+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999998654 45788889999999999999999742 79999999999999999999999999997653
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 32 22345789999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=305.28 Aligned_cols=203 Identities=27% Similarity=0.328 Sum_probs=173.4
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|... +++.||+|++.+.... .....+.+.+|+.++..++||+|+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 47899999999999999999654 6899999998754221 223455688899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999998653 24588899999999999999999999 999999999999999999999999999876644
Q ss_pred CCCC-cccccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSN-WTEFAGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... .....|++.|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 3222 223568999999999863 3468899999999999999999999854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.81 Aligned_cols=196 Identities=28% Similarity=0.375 Sum_probs=170.1
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||+||+|... +++.||+|++++.... .....+.+.+|.++++.+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999665 6789999999765422 223455677888888877 79999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 80 GGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99999888654 4688999999999999999999999 99999999999999999999999999987643333333
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...+|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 456789999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=306.55 Aligned_cols=195 Identities=29% Similarity=0.392 Sum_probs=171.2
Q ss_pred ceeccCCceeEEEEEc----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEec
Q 038003 605 FCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
+.||+|+||.||+++. .+++.||+|++...... ......+..|++++++++||||+++++++.+.+..|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999854 36889999999765321 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~ 760 (848)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 80 LRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999999998654 4688999999999999999999999 999999999999999999999999999987654433
Q ss_pred CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 761 NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 761 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
......|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 34456799999999999988889999999999999999999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.46 Aligned_cols=203 Identities=26% Similarity=0.305 Sum_probs=175.2
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|... +++.||+|+++..... .....+.+.+|+.+++.++||+|+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 46899999999999999999654 7899999999765422 233456688899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 80 MEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred ECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999998654 24688899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-cccccccccccCccccc------cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSN-WTEFAGTFGYAAPEIAY------TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~-~~~~~g~~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... .....|++.|+|||++. +..++.++|||||||++|||+||+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 3322 23356899999999986 45578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=298.24 Aligned_cols=202 Identities=26% Similarity=0.356 Sum_probs=174.5
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
.|+..+.||+|+||+||++... +++.||+|++...... .......+.+|++++++++||+|+++++.+.+++..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 3788899999999999999654 7899999998764322 1223455778999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++|+|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 80 TLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred eccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999887543 234688999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 156 -ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred -CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence 222345789999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.49 Aligned_cols=203 Identities=24% Similarity=0.304 Sum_probs=172.6
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||++..+ +++.+|+|++.+.... .......+..|+.++..++|++|+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 47899999999999999999765 5788999998654221 123345578899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. ...+++..+..++.||+.|+.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred EeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999999653 24588889999999999999999999 999999999999999999999999999876543
Q ss_pred CCCC-cccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSN-WTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 2222 23357999999999986 34578899999999999999999999854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=301.18 Aligned_cols=196 Identities=27% Similarity=0.376 Sum_probs=167.8
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhc-CCCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKE-IRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||+||+|... +++.||||+++...... ....+.+..|..++.. .+||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 36999999999999765 67899999997754221 2234456677888776 499999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.++++.. ..+++.++..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 80 GGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 99999998654 4578899999999999999999999 99999999999999999999999999987543323333
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....|++.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 456789999999999998899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=304.92 Aligned_cols=199 Identities=26% Similarity=0.451 Sum_probs=167.8
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-----Ce
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG-----PH 673 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 673 (848)
+|++.+.||+|+||.||+|.. .++..||||++..... ......++.+|++++++++||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc--cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 588899999999999999965 4789999999865321 223445688999999999999999999988543 24
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 79 IYVVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 799999995 5898888654 4688999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCC---CcccccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSS---NWTEFAGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....... ......|++.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 6532221 1234578999999999875 5789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=298.82 Aligned_cols=203 Identities=23% Similarity=0.396 Sum_probs=169.2
Q ss_pred cCCcccceeccCCceeEEEEEcCC-----------------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcc
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPS-----------------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 661 (848)
++|.+.+.||+|+||.||+|.+++ +..||+|++.... ......++.+|++++++++||||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCCe
Confidence 578899999999999999996532 3369999986542 23345678999999999999999
Q ss_pred cceEEEeecCCeeEEEEeccCCCCHHhHhcCCC----------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 038003 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDV----------------TAKELGWNRRINVIKGVANALSYLHHDCLPS 725 (848)
Q Consensus 662 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ 725 (848)
+++++++.+.+..++||||+++|+|.+++.... ....+++..+.+++.||+.|+.|||+. +
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 999999999999999999999999999885421 113467888999999999999999999 9
Q ss_pred eEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh--C
Q 038003 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK--G 801 (848)
Q Consensus 726 ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g 801 (848)
|+||||||+||+++.++.+||+|||+++........ .....++..|+|||++.+..+++++||||||+++|||++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999999865432211 122345788999999988889999999999999999997 5
Q ss_pred CCCCcc
Q 038003 802 NHPRDF 807 (848)
Q Consensus 802 ~~P~~~ 807 (848)
..||..
T Consensus 239 ~~p~~~ 244 (304)
T cd05096 239 EQPYGE 244 (304)
T ss_pred CCCCCc
Confidence 567653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=321.79 Aligned_cols=205 Identities=26% Similarity=0.414 Sum_probs=174.7
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|... +++.||+|++...... .....+++.+|++++++++||||+++++++.+++..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~-~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE-NPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc-CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 57999999999999999999654 6899999998764322 234456789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCC--------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 678 CEYLDRGSLARILGDDV--------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
|||++|++|.++++... .....++..+.+++.||++||+|||++ ||+||||||+||+++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence 99999999999885321 123456778889999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCC------------------CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHS------------------SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9998662111 011124689999999999999999999999999999999999999864
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=268.84 Aligned_cols=208 Identities=24% Similarity=0.359 Sum_probs=176.7
Q ss_pred HHhhcCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP- 672 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~- 672 (848)
....+||.+.+.+|+|+|+.||.++ ..+++.||+|++.... .++.+..++|++..++++|||+++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 3456789999999999999999995 5688999999997763 466788899999999999999999999876543
Q ss_pred ----eeEEEEeccCCCCHHhHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 673 ----HSFLVCEYLDRGSLARILGDDVT-AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 673 ----~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
..|++++|...|+|.+.++.... +..+++.++.+|+.+|++||++||+.. +.+.||||||.||++.+.+.+++.
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEE
Confidence 48999999999999998875433 447999999999999999999999983 249999999999999999999999
Q ss_pred eccCccccCCCCC---------CcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 748 DFGIAKFVGPHSS---------NWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 748 DfG~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|||.++...-.-. .+....+|..|+|||.+. +...++++|||||||++|+|+.|..||+.
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 9999986632111 112346789999999875 55679999999999999999999999965
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=307.27 Aligned_cols=205 Identities=29% Similarity=0.402 Sum_probs=172.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC--CC--CE-EEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--SG--DI-VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~-vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
.++....+.||+|+||.||+|.++ ++ .. ||||..+.+... ......++++|.++|++++|||||++||++....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~-~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL-TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 445556689999999999999654 22 23 899998763212 3567888999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++|||++.||+|.++++.. ...++..++..++.++|.|++|||++ +++||||-++|+|++.++.+||+|||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999876 23689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
+.-.........-.-+..|+|||.+....|++++|||||||++||+++ |..||...
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 764311111111124579999999999999999999999999999999 88897543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=293.12 Aligned_cols=195 Identities=27% Similarity=0.355 Sum_probs=167.5
Q ss_pred eccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCC
Q 038003 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGS 685 (848)
Q Consensus 607 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gs 685 (848)
||+|+||.||+++.+ +|+.||+|++....... ....+.+..|++++++++||||+++++++.++...++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999654 68999999987643221 1223455679999999999999999999999999999999999999
Q ss_pred HHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccc
Q 038003 686 LARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765 (848)
Q Consensus 686 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 765 (848)
|.+++... ....+++..+..++.||+.|++|||+. +|+||||||+||+++.++.++|+|||++...... ......
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~ 154 (277)
T cd05607 80 LKYHIYNV-GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQR 154 (277)
T ss_pred HHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeecc
Confidence 98887543 224578899999999999999999999 9999999999999999999999999999876432 222345
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 766 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.|++.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 789999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.42 Aligned_cols=201 Identities=24% Similarity=0.344 Sum_probs=166.9
Q ss_pred cCCcccceeccCCceeEEEEEcC--CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC---CCCcccceEEEeec---
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP--SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI---RHRNNVKFHGFCYN--- 670 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~--- 670 (848)
++|++.+.||+|+||+||+|... +++.||+|+++..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 36899999999999999999753 4678999998765322 22234456677776655 69999999998852
Q ss_pred --CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 671 --GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 671 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
....++||||++ ++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence 456899999997 5898888654 234588899999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||.++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 154 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 154 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred ccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 9999876543 223456789999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=313.60 Aligned_cols=201 Identities=21% Similarity=0.241 Sum_probs=172.9
Q ss_pred CCcccceeccCCceeEEEEEcC-C-CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-S-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.|.+.+.||+|+||.||+|... + ++.||+|.+... .......+.+|+++++.++|||||++++++...+..|+|
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4889999999999999999543 4 677888876443 234445677899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 678 CEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|||+++|+|.++++... ....+++..+..++.||+.||.|+|+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 99999999998875421 234688899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 4322 12446799999999999998899999999999999999999999864
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=289.78 Aligned_cols=206 Identities=24% Similarity=0.311 Sum_probs=181.6
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..+.|..-++||+|+||.||-++.+ +|+.||.|++.++.+.. .........|..|+.+++.++||.+--.|+..+.++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3456888899999999999999654 79999999998876542 334556788999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+|+..|.||+|.-++-.. ....+++..++-++.+|+.||++||+. +||+||+||+|||+|+.|+++|+|.|+|..+
T Consensus 262 lVLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999998776433 235789999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
... ......+||.+|||||++.+..|+...|.||+||++|||+.|+.||...
T Consensus 338 ~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 338 PEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 654 3445669999999999999999999999999999999999999998653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.89 Aligned_cols=194 Identities=23% Similarity=0.353 Sum_probs=166.6
Q ss_pred ceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec----CCeeEEEEec
Q 038003 605 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN----GPHSFLVCEY 680 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~~lV~e~ 680 (848)
..||+|++|.||+|.+ +|+.||||+++..... .....+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKG-HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccc-cHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999987 5889999998765321 22335678899999999999999999999876 3468899999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~ 760 (848)
+++|+|.+++... +.+++..+.+++.|++.|+.|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999999754 56888999999999999999999732 78899999999999999999999999998654321
Q ss_pred CcccccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 761 NWTEFAGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 761 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
....|++.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 23467899999999976 67899999999999999999999998643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.24 Aligned_cols=200 Identities=22% Similarity=0.375 Sum_probs=170.8
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|.+.+.||+|+||.||+|..+ +++.||+|+++.... ......+.+|++++++++||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 57999999999999999999665 688899999875432 22334577899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++ ++.+++... ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||.+.....
T Consensus 83 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 83 FEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EeCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 999986 788777543 24578889999999999999999999 999999999999999999999999999976544
Q ss_pred CCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........+++.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3333344567899999998865 4578999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.98 Aligned_cols=192 Identities=21% Similarity=0.319 Sum_probs=167.7
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..+|++.+.||+|+||.||+|.. .+++.||+|+... +.+.+|++++++++||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 45799999999999999999955 5789999997432 346789999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|||++. ++|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 161 v~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999996 5888887554 4578899999999999999999999 99999999999999999999999999997643
Q ss_pred CCC-CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 757 PHS-SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 757 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
... .......||+.|+|||++.+..+++++|||||||++|||+||+.||.
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 222 22345679999999999998889999999999999999999998863
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=288.43 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=179.8
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.=|+..+.||+|-|++|-.|++- +|+.||||++.+.... .....++.+|++.|+.++|||||++|++.......|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD--~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD--TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc--hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 34777788999999999999654 8999999999887543 35567789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-CCCEEEeeccCccccC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVG 756 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~~~~~~ 756 (848)
.|.=++|+|++++-... ..+.+..+.+++.||..|+.|+|+. .+|||||||+|+.+-+ -|-|||+|||++-.+.
T Consensus 96 LELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999986552 4578888999999999999999999 8999999999988754 5789999999998886
Q ss_pred CCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
+ ....++.||+..|-|||++.|..| .+++||||+|||+|-|++|+.||+...
T Consensus 171 P-G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 171 P-GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred C-cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 6 445577899999999999999988 578999999999999999999987543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=302.61 Aligned_cols=194 Identities=28% Similarity=0.356 Sum_probs=164.3
Q ss_pred eccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC---CCCcccceEEEeecCCeeEEEEeccC
Q 038003 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI---RHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 607 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
||+|+||+||+|+.. +++.||+|++.+..... .........|..++... +||+|+++++++.+.+..|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 799999999999654 68999999987653221 22334455666666655 79999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+|+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 80 GGELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999888654 5688899999999999999999999 99999999999999999999999999997654433334
Q ss_pred ccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...+|++.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 557799999999998764 478999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=304.63 Aligned_cols=205 Identities=26% Similarity=0.412 Sum_probs=171.1
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 670 (848)
.++|++.+.||+|+||.||+|.+. ++..||+|+++... .....+.+.+|+++++.+ +||||++++++|..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 457999999999999999998632 34579999987653 223456688999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCC--------------------------------------------------------
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDV-------------------------------------------------------- 694 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 694 (848)
.+..++||||+++|+|.++++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999998875321
Q ss_pred -----------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCC--
Q 038003 695 -----------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN-- 761 (848)
Q Consensus 695 -----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~-- 761 (848)
....+++.++.+++.||+.||+|||++ ||+||||||+||++++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 112478888999999999999999999 9999999999999999999999999999865432221
Q ss_pred cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 762 WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 762 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
.....+++.|+|||++.+..+++++|||||||++|||++ |+.||...
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 112234568999999998889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=321.88 Aligned_cols=204 Identities=27% Similarity=0.452 Sum_probs=175.0
Q ss_pred hcCCcccceeccCCceeEEEEEcC--CCC----EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--SGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
.+..+....||+|+||.||.|... .+. .||||.+++.. +.....+|.+|..+|+.++|||||+++|+|.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~---~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS---SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 455677789999999999999654 343 48999887754 557788999999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCC----CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 672 PHSFLVCEYLDRGSLARILGDDV----TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
...++++|||+||+|..++++.. ....++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++...|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence 99999999999999999998652 245688999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCCcc-cc-cccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 748 DFGIAKFVGPHSSNWT-EF-AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~-~~-~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|||+|+..-....... .. .-...|||||.+....++.|+|||||||++||++| |..||..
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC
Confidence 9999994432222221 11 22468999999999999999999999999999999 9999764
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=290.52 Aligned_cols=202 Identities=26% Similarity=0.366 Sum_probs=173.8
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
.|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+.+|+.++++++|++|+++++.+.+.+..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 3677889999999999999654 7899999998765322 2233455778999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.+++... ....+++.++..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 80 e~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 80 TLMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999888543 224588899999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 156 Q-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred c-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 2 22345789999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=301.88 Aligned_cols=204 Identities=25% Similarity=0.397 Sum_probs=171.2
Q ss_pred hcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 670 (848)
.++|++.+.||+|+||.||+|.+ .++..||||+++... .....+.+.+|+++++.+ +||||++++++|.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 45789999999999999999953 245689999987543 223456788999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCC-------------------------------------------------------
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVT------------------------------------------------------- 695 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------- 695 (848)
.+..++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999988854210
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 696 -----------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 696 -----------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
...+++..+.+++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 12477888999999999999999999 9999999999999999999999999999876433
Q ss_pred CCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 759 SSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 759 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.... ....++..|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 2211 12334568999999999899999999999999999998 8889754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.81 Aligned_cols=202 Identities=23% Similarity=0.367 Sum_probs=171.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||.||+|.++ .+..||+|+++... .....+.+.+|+.++++++||||+++++++..++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 456889999999999999999653 45689999987642 22345678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++|+|.+++... ...+++.++..++.|++.|++|||++ +++||||||+||+++.++.+|++|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 99999999999999998654 24688999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 754 FVGPHSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
........ .....++..|+|||++.+..+++++|||||||++||+++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 54322111 112334678999999998899999999999999999875 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=289.68 Aligned_cols=196 Identities=27% Similarity=0.414 Sum_probs=173.3
Q ss_pred cceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 604 KFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
.++||.|.||+||-|.+ ++|+.||||++.+-.+.. +..+++.+|+.|++++.||.||.+..-|+..+..++|||.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~--kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT--KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC--chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 46899999999999955 489999999998876553 445788999999999999999999999999999999999997
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC---CCEEEeeccCccccCCCC
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN---FEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~~~~~~~~~ 759 (848)
| ++.+.+-.. ..+++++....-++.||..||.|||.+ +|||+||||+|||+.+. -.+||||||+|+++++.
T Consensus 647 G-DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 647 G-DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred c-hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 6 666665444 346788888888999999999999999 99999999999999754 37999999999999864
Q ss_pred CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
......+|||.|.|||++..+.|.+.-|+||.|||+|.-+.|..||..
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 455778999999999999999999999999999999999999999864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=273.69 Aligned_cols=191 Identities=24% Similarity=0.402 Sum_probs=166.1
Q ss_pred ceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+|+.|-.+ .+.+|..||||++.+. ......++.+|++++.+. .|+||++++++|++++..|+|||.|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 47999999999988 5678999999999886 234567889999999999 59999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC---CEEEeeccCccccCCC-
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF---EAHVSDFGIAKFVGPH- 758 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~~~~~~~~- 758 (848)
||+|..+++.+ +.+.+.++.+++++||.||.|||.+ ||.|||+||+|||..... -+|||||.++.-+...
T Consensus 160 GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 160 GGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred CchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 99999999876 6788999999999999999999999 999999999999997654 4999999887654211
Q ss_pred ------CCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 759 ------SSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 759 ------~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
.....+.+|+..|||||+.. ...|+.++|.||+|||+|-|+.|..||
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF 291 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF 291 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence 11224578999999999864 234788999999999999999999998
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=296.18 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=180.6
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
...|.+...||+|.|++|..|.+. ++..||||.+++... +......+.+|+++|..++|||||+++.+......+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 456888899999999999999654 799999999988754 34445558899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+.+|.+++++... ++.....+..++.|+..|++|+|++ .|||||||++||+++.+.++||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999766 4455588889999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~ 806 (848)
. .....+++|++.|.|||++.+.+| ++++|+||+|+++|.|+.|..||+
T Consensus 207 ~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 207 Y-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred c-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 4 445577999999999999999887 789999999999999999999987
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=285.94 Aligned_cols=194 Identities=24% Similarity=0.360 Sum_probs=170.1
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 4688889999999999999965 578999999986542 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++++++..+ ..+++..+..++.|++.|+.|||+. ||+|+||||+||+++.++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 78 TEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999999998654 2467788889999999999999999 999999999999999999999999999976543
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. ......|++.|+|||++.+..++.++||||||+++|+|+||+.||..
T Consensus 148 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 148 S--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred c--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2 22446789999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=311.09 Aligned_cols=208 Identities=28% Similarity=0.330 Sum_probs=176.2
Q ss_pred HHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP- 672 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~- 672 (848)
....++|++.+.||+|+||+||+|.. .+++.||||++..... .......+.+|+..+..++|++|+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34457899999999999999999965 4799999999876532 2344566789999999999999999988765432
Q ss_pred -------eeEEEEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCE
Q 038003 673 -------HSFLVCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEA 744 (848)
Q Consensus 673 -------~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 744 (848)
..++||||+++|+|.++++... ....+++..+..++.|++.||.|+|+. +|+||||||+||+++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 3689999999999999886432 235688999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCC--CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 745 HVSDFGIAKFVGPHS--SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 745 kl~DfG~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||+|||+++.+.... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999998764321 122346799999999999998999999999999999999999999864
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=289.92 Aligned_cols=200 Identities=29% Similarity=0.479 Sum_probs=175.7
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..+|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++.+......++
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC----cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 35789999999999999999965 478999999986643 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++. ..+++.++..++.|++.|++|||+. ||+||||||+||+++.++.+||+|||.+....
T Consensus 95 v~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 95 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred eecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 9999999999999854 3478889999999999999999999 99999999999999999999999999988765
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
..........+++.|+|||.+.+..+++++|||||||++|+|+||+.||...
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 4433334457889999999998888899999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=284.00 Aligned_cols=206 Identities=27% Similarity=0.351 Sum_probs=181.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~ 675 (848)
..+|..+.+||+|+||.|-.|..+ +.+.+|||++++..+-.+ .+.+--+.|-+++... +-|++++++..|+.-+.+|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 457999999999999999999655 678899999998765432 3345556788888776 6789999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+.||+|.-.++.- +.+.+..++-++..||-||-|||++ ||++||||.+|||+|.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999888755 5677788999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI 810 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 810 (848)
--...+..+++|||.|+|||++...+|+..+|.||+||++|||+.|+.||+-.+.
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 5555666789999999999999999999999999999999999999999875443
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=282.78 Aligned_cols=204 Identities=26% Similarity=0.415 Sum_probs=179.1
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 4788899999999999999664 789999999865432 2345677889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.++++.. ....+++..+..++.|++.|+.|||+. ||+||||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 79 EYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999998754 235688899999999999999999999 9999999999999999999999999999877654
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
........|++.|+|||+..+..++.++||||||+++|||+||+.||....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 444445678899999999998889999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=289.81 Aligned_cols=201 Identities=24% Similarity=0.349 Sum_probs=173.3
Q ss_pred CcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|+..+.||+|+||+||+|.+ .+++.+|+|++...... .....+.+.+|++++++++|++|+++.+++..++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 66778999999999999965 47899999998665322 12234557789999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG- 155 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence 99999999887543 224689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......|+..|+|||++.+..++.++|+||+||++|||+||+.||..
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 222345789999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=267.39 Aligned_cols=206 Identities=24% Similarity=0.364 Sum_probs=172.8
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lV 677 (848)
+.+.+..||.|+.|.||+++.+ +|...|||.+.... +.++.+++...++++...+ .|+||+.+|||..+..+++.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 4555667999999999999766 68999999998764 5566778888888877764 89999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
||.|.- ..+.++++. .+++++.-+.++...+++||.||.+++ +|+|||+||+|||+|+.|++|+||||.+-++.+
T Consensus 170 MelMs~-C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHH-HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 999854 566666554 245788888899999999999999987 999999999999999999999999999988865
Q ss_pred CCCCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCccccccccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 814 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 814 (848)
.... +..+|-+.|||||.+. ..+|+-++||||||++++||.||++||.--+.+|..
T Consensus 245 SkAh-trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ 303 (391)
T KOG0983|consen 245 SKAH-TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV 303 (391)
T ss_pred cccc-ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH
Confidence 4433 4457889999999886 346889999999999999999999998765555543
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=288.92 Aligned_cols=199 Identities=29% Similarity=0.487 Sum_probs=175.9
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..+|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 46799999999999999999965 579999999986542 2345668899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+....
T Consensus 94 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 94 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred eecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999998543 467889999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+++.|+|||.+.+..+++++|||||||++|+++||+.||..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 444333445788999999999988889999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-33 Score=300.44 Aligned_cols=197 Identities=26% Similarity=0.376 Sum_probs=172.8
Q ss_pred eeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCC
Q 038003 606 CIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRG 684 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~g 684 (848)
+||+|.||+||.|++. +...+|||-+... +......+..|+...++++|.|||+++|.+.+++..-+.||-++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 6999999999999766 4567899988665 3445566789999999999999999999999999999999999999
Q ss_pred CHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC-CCCCEEEeeccCccccCCCCCCcc
Q 038003 685 SLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-SNFEAHVSDFGIAKFVGPHSSNWT 763 (848)
Q Consensus 685 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfG~~~~~~~~~~~~~ 763 (848)
+|..+++....+-.-.+.+..-+.+||.+||.|||+. .|||||||-+|+|++ ..|.+||+|||-+++.........
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 9999998764433336678888999999999999999 999999999999996 578999999999999877777778
Q ss_pred cccccccccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 764 EFAGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 764 ~~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
++.||..|||||++..+ .|+.++|||||||++.||.||++||-..+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 89999999999999754 47889999999999999999999985544
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=286.75 Aligned_cols=200 Identities=28% Similarity=0.396 Sum_probs=173.2
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 35799999999999999999975 578899999986542 2344567889999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++.. ..+++..+..++.|++.|+.|||+. +|+|||++|+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999999988654 4678899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........|++.|+|||.+. ...++.++||||+||++|||+||+.||..
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 4333334456889999999875 34467899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=282.77 Aligned_cols=203 Identities=25% Similarity=0.331 Sum_probs=174.3
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccC-CchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG-NMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
++|+..+.||+|++|.||+|.. .+++.+|+|.+....... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999965 478999999986543221 12234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|+||+++++|.+++... ..++...+.+++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988654 4578888999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCc---ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNW---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 322111 234578899999999998899999999999999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=298.72 Aligned_cols=199 Identities=26% Similarity=0.362 Sum_probs=169.2
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-----e
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP-----H 673 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-----~ 673 (848)
+|+..+.||+|+||.||+|.. .+++.||||++.... .+....+++.+|+++++.++||||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 478899999999999999965 479999999986542 12334567889999999999999999999998776 7
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence 899999997 4787777543 5688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSS-NWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....... ......+++.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 6543222 22335678999999998874 478999999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-33 Score=271.09 Aligned_cols=238 Identities=20% Similarity=0.285 Sum_probs=188.5
Q ss_pred hhcCCcccceeccCCceeEEEEEcC---C--CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP---S--GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN- 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 670 (848)
....|+....||+|.||.||+|.-. + ...+|||+++.+.-... ......+|+..++.++|||++.+..+|.+
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG--iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG--ISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC--cCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 3456899999999999999999332 2 33699999987643221 12346899999999999999999999987
Q ss_pred CCeeEEEEeccCCCCHHhHhcC--CCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC----CCE
Q 038003 671 GPHSFLVCEYLDRGSLARILGD--DVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN----FEA 744 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ 744 (848)
+..+++++||++. +|.++++- ....+.++...+..|+.||..|+.|||++ -|+||||||.|||+..+ |.|
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence 7789999999987 88887753 23346788999999999999999999999 89999999999999877 899
Q ss_pred EEeeccCccccCCCCCCc---ccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCccccccc----cccc
Q 038003 745 HVSDFGIAKFVGPHSSNW---TEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINF----SSFS 816 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~----~~~~ 816 (848)
||+|+|+++.+...-... ...+.|.+|+|||.+.|.+ |+.++|||+.|||+.||+|-++-|.-...+. ....
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 999999999886543222 3456799999999998765 8999999999999999999988874433222 2334
Q ss_pred hhhhhhhhhcCCCCCCCCCCcccc
Q 038003 817 NMIIDVNKILDPRLPTPSPSVMDY 840 (848)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~ 840 (848)
+++..+.+++...-...+|.++++
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~ 279 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKM 279 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhC
Confidence 555666667666666667766554
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=305.19 Aligned_cols=235 Identities=23% Similarity=0.331 Sum_probs=190.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCC-CEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEE-eec---
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSG-DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGF-CYN--- 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~-~~~--- 670 (848)
...++++.++|.+|||+.||.|....+ ..||+|++-.. ++...+.+.+|+++|+.|+ |||||.+++. ...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 445678889999999999999977655 99999997554 6677888999999999995 9999999993 221
Q ss_pred ---CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 671 ---GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 671 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
.-++++.||||.||.|-+++..+.. ..+++.++++|+.|+++|+++||.. .+.|||||||-+|||+..+|..|||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence 1367899999999999999975533 3499999999999999999999987 4469999999999999999999999
Q ss_pred eccCccccCCCCCCcc---------cccccccccCcccc---ccCCCCccchhhhHHHHHHHHHhCCCCCcccc------
Q 038003 748 DFGIAKFVGPHSSNWT---------EFAGTFGYAAPEIA---YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS------ 809 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~---------~~~g~~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~P~~~~~------ 809 (848)
|||.|+-.-....... ....|+-|+|||++ .+..+++|+|||+|||+||-|+....||+..+
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln 268 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN 268 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe
Confidence 9999975433221111 13458999999986 46778999999999999999999999997652
Q ss_pred -----ccccccchhhhhhhhhcCCCCCCCCCCc
Q 038003 810 -----INFSSFSNMIIDVNKILDPRLPTPSPSV 837 (848)
Q Consensus 810 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (848)
..+..+.+.+..+.+.+-..-|.-||.+
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI 301 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNI 301 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCH
Confidence 2345677777777776666666666665
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=300.40 Aligned_cols=205 Identities=23% Similarity=0.350 Sum_probs=171.4
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeec
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYN 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~ 670 (848)
.++|.+.+.||+|+||.||+|.+. .+..||||+++... .....+.+.+|+++++++. ||||++++++|.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 467889999999999999999642 23469999986542 2344567899999999996 9999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCC--------------------------------------------------------
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDV-------------------------------------------------------- 694 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 694 (848)
.+..|+||||+++|+|.++++...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999998875321
Q ss_pred -------------------------------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCee
Q 038003 695 -------------------------------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVL 737 (848)
Q Consensus 695 -------------------------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIl 737 (848)
....+++..+..++.||+.|++|||+. +|+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012477888899999999999999999 9999999999999
Q ss_pred eCCCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 738 LDSNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 738 l~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
++.++.+||+|||+++....... ......+++.|+|||++.+..+++++|||||||++|||++ |+.||...
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999986643222 1123446788999999998889999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=283.46 Aligned_cols=205 Identities=22% Similarity=0.312 Sum_probs=176.8
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|... +++.||||.+...... +......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 57899999999999999999654 7899999987653222 334456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 678 CEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|||+++++|.+++.... ....++...+..++.|++.|++|||++ +++||||||+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999998875321 124578889999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+++.|+|||.+.+..++.++||||+|+++|||+||+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 444333445788999999999888889999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=284.07 Aligned_cols=198 Identities=27% Similarity=0.410 Sum_probs=173.0
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 4688889999999999999965 478999999986542 23445678899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.+++... +.+++.++..++.|++.|+.|||+. ||+|+||||+||+++.++.++|+|||.+.....
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 85 MEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999999988654 4688999999999999999999999 999999999999999999999999999877654
Q ss_pred CCCCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.........|++.|+|||++. ...++.++||||+||++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 433334567899999999874 4457889999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=285.49 Aligned_cols=201 Identities=24% Similarity=0.364 Sum_probs=172.1
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||+|++|.||+|... ++..||+|+++.... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 4788899999999999999764 789999999865421 2233466788999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||++ +++.++++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9997 58888886553446789999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
........+++.|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 3333344678899999988754 46889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=280.70 Aligned_cols=199 Identities=26% Similarity=0.436 Sum_probs=172.5
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
++|++.+.||+|+||.||+|.++++..+|+|.+.... ...+.+..|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 5688899999999999999998888899999876432 23467889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++|+|.++++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999999986542 3588999999999999999999999 9999999999999999999999999998865432
Q ss_pred CCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 759 SSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 759 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... .....++..|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 221 122334568999999988889999999999999999999 8999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=287.96 Aligned_cols=198 Identities=28% Similarity=0.382 Sum_probs=172.9
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|... ++..+|+|.+.... .....+++.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 36899999999999999999654 68889999876542 223456688999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. +.+++..+..++.|++.|+.|||+.+ +++||||||+||+++.++.+||+|||.+.....
T Consensus 78 ~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 78 MEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred eeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999998654 56888999999999999999999732 899999999999999999999999999876533
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
. ......+++.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 153 S--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred c--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 2 2234578999999999988889999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=295.45 Aligned_cols=199 Identities=27% Similarity=0.369 Sum_probs=168.8
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC---
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP--- 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--- 672 (848)
..++|++.+.||+|+||.||+|.. .++..||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 457899999999999999999965 4689999999876432 2344566789999999999999999999986543
Q ss_pred ---eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 673 ---HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 673 ---~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
..|+||||+++ ++.+.++. .++...+..++.||+.||.|||++ ||+||||||+||+++.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 57999999976 56555532 367788899999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+++..... .......|++.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 168 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 168 GLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred CCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 999765432 222445789999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=281.62 Aligned_cols=201 Identities=24% Similarity=0.414 Sum_probs=174.9
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 46799999999999999999988888899999876432 2356789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 80 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 80 TEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999998654 345688889999999999999999999 999999999999999999999999999987643
Q ss_pred CCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.... .....++..|+|||+..+..+++++|||||||++|+|+| |+.||..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 2211 122345678999999988889999999999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=278.80 Aligned_cols=202 Identities=25% Similarity=0.348 Sum_probs=174.2
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-CCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN-GPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lV 677 (848)
+|++.+.||+|++|.||+|..+ +++.+|+|++..... .....+.+.+|++++++++||+++++++.+.. ....++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 4888999999999999999654 678999999865432 22345668899999999999999999998764 4467999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.+++... ....+++.++..++.|++.|+++||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 79 MGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999998754 234688999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........+++.|+|||+..+..++.++||||+|+++|||++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 43344456789999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=284.52 Aligned_cols=203 Identities=27% Similarity=0.478 Sum_probs=178.4
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
...+|++.+.||+|+||.||+|...++..+|+|++.... .....++.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 456799999999999999999988889999999987652 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++.. ....+++.++..++.||+.|+.|||+. ||+||||||+||++++++.+||+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 80 ITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred EEeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999999999765 345689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
..........++..|+|||+..+..++.++||||||+++|+|++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~ 207 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207 (261)
T ss_pred CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence 43333333445778999999988889999999999999999999 8999854
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=280.69 Aligned_cols=201 Identities=24% Similarity=0.371 Sum_probs=176.1
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||+|+||.||++... ++..+|+|.++... .....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 5788899999999999999654 78999999986542 2344567888999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||++++++.+++... ....++...+..++.|++.|+.|||++ +|+|+||||+||++++++.++++|||.+......
T Consensus 78 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 78 EYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred eeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999999988643 234578889999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........|++.|+|||++.+..+++++|+||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence 3333456788999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=296.87 Aligned_cols=196 Identities=24% Similarity=0.384 Sum_probs=168.1
Q ss_pred cceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe--eEEEEec
Q 038003 604 KFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH--SFLVCEY 680 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~--~~lV~e~ 680 (848)
...||+|+|-+||+|.+ .+|-.||=-.++.......+...++|..|+++++.|+|||||++|++|.+... ..+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 45799999999999954 35666654444444444456667889999999999999999999999987654 7799999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-CCCEEEeeccCccccCCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~~~~~~~~~ 759 (848)
|..|+|.+|.++. ++...+.+..|++||.+||.|||++. |.|+|||||-+||+++. .|.|||+|.|+|+......
T Consensus 125 ~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999876 67888999999999999999999984 57999999999999975 4899999999999876533
Q ss_pred CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.....|||.|||||+.. ..|++.+||||||+++.||+|+.+||.
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 34579999999999987 679999999999999999999999974
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-33 Score=269.59 Aligned_cols=235 Identities=22% Similarity=0.272 Sum_probs=188.2
Q ss_pred hcCCccc-ceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec----
Q 038003 598 TDDFDEK-FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN---- 670 (848)
Q Consensus 598 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~---- 670 (848)
+++|++. ++||-|-.|.|-.+.. .+++++|+|++... ....+|++..-.. .|||||.++++|.+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 4556654 5799999999999955 48999999997443 3356788875555 79999999999865
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---CCCEEEe
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEAHVS 747 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~ 747 (848)
...+.+|||.|+||.|...++++ ....+++.++.+|++||+.|+.|||+. +|.||||||+|+|... +..+||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 34678999999999999999877 345699999999999999999999999 9999999999999974 4579999
Q ss_pred eccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc------------------
Q 038003 748 DFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS------------------ 809 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~------------------ 809 (848)
|||+|+.-.. .....+.+-||.|.|||++...+|+..+|+||+||++|-|++|..||....
T Consensus 207 DfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 207 DFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred ccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 9999987654 344567889999999999999999999999999999999999999984432
Q ss_pred ---ccccccchhhhhhhhhcCCCCCCCCCCcccccceeec
Q 038003 810 ---INFSSFSNMIIDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 810 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
.+-..+.+..+++.+.+-..-|+.+-.+.+.|..+||
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 2223445555555555555556666666666666665
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=283.63 Aligned_cols=199 Identities=29% Similarity=0.445 Sum_probs=176.7
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||.|+||.||+|... +++.+|+|++.... .......+.+|+++++.++||||+++++++.++...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 36888899999999999999654 68999999986543 234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
+||+++++|.++++.. .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.++....
T Consensus 78 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 78 MEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999999998643 688899999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........+++.|+|||++.+..+++++||||||+++|||+||+.||..
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 43334456788899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=283.78 Aligned_cols=202 Identities=27% Similarity=0.422 Sum_probs=172.0
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecC---
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNG--- 671 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~--- 671 (848)
+...|+..+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4567888899999999999999654 68899999986532 3345688899999998 799999999998753
Q ss_pred ---CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 672 ---PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 672 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
...++||||+.+++|.+++... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 4689999999999999998754 234688899999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||++..............|++.|+|||++. +..++.++||||+||++|||++|+.||..
T Consensus 155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999987654334445567899999999986 33578899999999999999999999854
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-33 Score=290.57 Aligned_cols=205 Identities=24% Similarity=0.388 Sum_probs=174.9
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+...+.+.||+|.||.|..+....+..||||+++... ......+|.+|+++|.+++|||||+++|+|..++.+++|+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 4466778999999999999998888999999998864 3345688999999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
|||+.|+|.+++.++.... ..-.....|+.|||.|++||.+. .+||||+.+.|+|+|+++++||+|||+++-.-..
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999998774332 34455667999999999999999 9999999999999999999999999999854322
Q ss_pred CCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCccccc
Q 038003 759 SSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK--GNHPRDFFSI 810 (848)
Q Consensus 759 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~~~~~ 810 (848)
+... ...+-..+|||||.+.-.+++.++|||+||+++||+++ ...||.....
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 2211 12344679999999999999999999999999999988 7789765543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=288.06 Aligned_cols=233 Identities=25% Similarity=0.416 Sum_probs=188.9
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~ 675 (848)
..+.|++++.||+||.+.||++.-.+.+.||+|++.... .+.....-|..|+..+.++ .|.+||++++|-..++..|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 345689999999999999999988888889999876543 3567788899999999999 5999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
|||||=+. +|..+++... .....| .+..+..||..|+.++|.+ ||||.||||.|+|+- .|.+||+|||.|..+
T Consensus 437 mvmE~Gd~-DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECGDI-DLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEeecccc-cHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99999654 8999997652 222334 6778999999999999999 999999999999986 578999999999988
Q ss_pred CCCCCCc--ccccccccccCccccccC-----------CCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhh
Q 038003 756 GPHSSNW--TEFAGTFGYAAPEIAYTM-----------RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDV 822 (848)
Q Consensus 756 ~~~~~~~--~~~~g~~~y~aPE~~~~~-----------~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 822 (848)
..+.... ..-+||+.||+||.+... +.++++||||+|||+|+|+-|+.||+ ++...+.++
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-------~~~n~~aKl 582 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-------QIINQIAKL 582 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-------HHHHHHHHH
Confidence 7765433 357899999999998632 24689999999999999999999976 445556677
Q ss_pred hhhcCCCC----C-CCCCC-cccccceee
Q 038003 823 NKILDPRL----P-TPSPS-VMDYGGCHF 845 (848)
Q Consensus 823 ~~~~~~~~----~-~~~~~-~~~~~~~~~ 845 (848)
.++.+|.- | .+.+. +.++|.||+
T Consensus 583 ~aI~~P~~~Iefp~~~~~~~li~~mK~CL 611 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPENDELIDVMKCCL 611 (677)
T ss_pred HhhcCCCccccccCCCCchHHHHHHHHHH
Confidence 77777743 2 12222 567777765
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.92 Aligned_cols=202 Identities=25% Similarity=0.387 Sum_probs=175.1
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... ++..+|+|++... .....+.+.+|++++++++||||+++++++......++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 356899999999999999999764 6899999998643 33455678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 80 LIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred EeeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999999998654 24588999999999999999999999 99999999999999999999999999987664
Q ss_pred CCCCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
..........+++.|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 4333334567899999999875 344678999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-34 Score=324.38 Aligned_cols=210 Identities=28% Similarity=0.411 Sum_probs=180.4
Q ss_pred HhhcCCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
..+-+++....||.|.||.||.| ...+|+..|+|.+...... ....+...+|+.++..++|||+|+++|+-.+.+..
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34557788889999999999999 4568999999998776433 45567788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++.||||++|+|.+.++.. +-.++.....+..|++.|++|||++ |||||||||+||+++.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence 9999999999999998655 3455566667889999999999999 999999999999999999999999999998
Q ss_pred cCCCCCC----cccccccccccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCcccccccc
Q 038003 755 VGPHSSN----WTEFAGTFGYAAPEIAYTMR---ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 813 (848)
Q Consensus 755 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 813 (848)
+...... .....||+.|||||++.+.. ...+.||||+|||+.||+||+.||..++.+++
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a 1449 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA 1449 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH
Confidence 8654322 24578999999999998643 46789999999999999999999998777655
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=285.25 Aligned_cols=200 Identities=31% Similarity=0.490 Sum_probs=175.9
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..+|+..+.||.|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 34699999999999999999954 578999999986542 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|+||+++++|.+++.. ..+++.++..++.|++.|++|||+. |++||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 94 VMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 9999999999998854 3478999999999999999999999 99999999999999999999999999988765
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
..........+++.|+|||.+.+..++.++|||||||++|+|+||+.||...
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4433334456889999999999888999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=302.85 Aligned_cols=198 Identities=24% Similarity=0.324 Sum_probs=162.4
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG---- 671 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 671 (848)
..++|++.+.||+|+||+||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 346799999999999999999965 478999999874421 2235799999999999999999887432
Q ss_pred ----CeeEEEEeccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-CEE
Q 038003 672 ----PHSFLVCEYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-EAH 745 (848)
Q Consensus 672 ----~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~k 745 (848)
...++||||+++ ++.+++... .....+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCcee
Confidence 246799999986 676665421 1235688999999999999999999999 999999999999999665 799
Q ss_pred EeeccCccccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 746 VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 746 l~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+|||+++.+.... ......|++.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 212 L~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 212 LCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred eeccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999998764322 22446789999999998764 689999999999999999999999853
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=314.17 Aligned_cols=208 Identities=22% Similarity=0.403 Sum_probs=171.4
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec--CCe
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN--GPH 673 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~ 673 (848)
...+|++.+.||+|+||+||+|... ++..+|+|++..... .......+..|+.++++++|||||+++++|.. ...
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 4568999999999999999999664 677899999876532 23446778999999999999999999998854 356
Q ss_pred eEEEEeccCCCCHHhHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEEcCCCCCCeeeCC--------
Q 038003 674 SFLVCEYLDRGSLARILGDDVT-AKELGWNRRINVIKGVANALSYLHHDCL----PSIIHRDISSKNVLLDS-------- 740 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~----~~ivH~Dlk~~NIll~~-------- 740 (848)
+|+||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+... .+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8999999999999998865322 3468999999999999999999998521 15999999999999964
Q ss_pred ---------CCCEEEeeccCccccCCCCCCcccccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 741 ---------NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 741 ---------~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..+++++||||||||+|||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3458999999998764332 2244578999999999864 4578999999999999999999999864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=289.50 Aligned_cols=200 Identities=25% Similarity=0.465 Sum_probs=169.5
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCC----EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.+|+..+.||+|+||.||+|.+. +++ .||+|+++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 56999999999999999999754 344 38999986432 234456788999999999999999999998765 5
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++|+||+++|+|.++++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 78999999999999998754 24578889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 754 FVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
......... ....++..|+|||++.+..++.++|||||||++|||+| |+.||+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 775433222 12234678999999998899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=282.70 Aligned_cols=200 Identities=25% Similarity=0.378 Sum_probs=172.9
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+.|++.+.||+|+||.||+|... ++..+|+|++... .....+.+.+|+++++.++||||+++++.+..+...++|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 56889999999999999999765 5889999998654 344567788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++++++..++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 88 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 88 IEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999999998877543 24588899999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........+++.|+|||++. ...++.++|||||||++|||+||+.||..
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 333334456889999999985 34468899999999999999999999854
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=279.11 Aligned_cols=205 Identities=25% Similarity=0.348 Sum_probs=178.4
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|... +++.||+|.++..... +....+.+.+|++++++++|++++++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57999999999999999999765 8999999998754322 233466788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 678 CEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|||+++++|.+++.... ....+++.++..++.|++.|+.|||+. ||+||||+|+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999886432 234578899999999999999999999 99999999999999999999999999988765
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+++.|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 444333446788999999999988899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=285.20 Aligned_cols=200 Identities=30% Similarity=0.383 Sum_probs=176.5
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|.+. +++.+|+|++...... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 36889999999999999999664 6899999998765322 234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. ..++...+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 80 MEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999998765 5688899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
. .....+++.|+|||.+.+..++.++||||||+++|+|+||+.||...
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 154 R---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred C---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 3 23456889999999998888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-33 Score=289.81 Aligned_cols=218 Identities=25% Similarity=0.370 Sum_probs=189.1
Q ss_pred cCCcccceeccCCceeEEEEEcCCCC-EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.+++.+..||-|+||.|=.+..+... .+|+|++++..+.+ ....+++..|-.+|...+.|+||++|..|.+...+||.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 45666778999999999999776444 38999999887763 46678889999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
||.|-||.+...+++. +.++..++.-++..+.+|++|||++ |||+|||||+|.++|.+|-+||.|||+|+.++.
T Consensus 499 mEaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999999876 6788889999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhhhh
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKI 825 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 825 (848)
...+ .++||||.|.|||++.....+.++|.||+|+.+|||+||.+||...++ ...|-..++.++.+
T Consensus 573 g~KT-wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-mktYn~ILkGid~i 638 (732)
T KOG0614|consen 573 GRKT-WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-MKTYNLILKGIDKI 638 (732)
T ss_pred CCce-eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHhhhhhh
Confidence 5555 458999999999999999999999999999999999999999865443 33333333444444
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=282.75 Aligned_cols=205 Identities=24% Similarity=0.399 Sum_probs=171.2
Q ss_pred hhcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 670 (848)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... ......++.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4567999999999999999998643 35679999985432 22345678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCC-------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVT-------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE 743 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 743 (848)
....++||||+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence 9999999999999999999864321 12457788999999999999999999 9999999999999999999
Q ss_pred EEEeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 744 AHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 744 ~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
++|+|||+++......... ....+++.|+|||++.+..+++++|||||||++|||+| |..||..
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~ 224 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 224 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999987654322211 12345678999999998889999999999999999999 7888753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=282.74 Aligned_cols=204 Identities=26% Similarity=0.449 Sum_probs=173.0
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
.++|.+.+.||+|+||.||+|... ++..||+|+++... .....+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 356888999999999999999653 34789999986542 223457889999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCC-----------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDV-----------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 740 (848)
...++||||+++++|.++++... ....+++.++..++.|++.|+.|||++ +++||||||+||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence 99999999999999999986431 124578889999999999999999999 9999999999999999
Q ss_pred CCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 741 NFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 741 ~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
++.+||+|||.++....... ......+++.|+|||++.+..+++++|||||||++|||++ |+.||..
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999976532221 1123345788999999999999999999999999999999 9999753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=285.71 Aligned_cols=201 Identities=23% Similarity=0.375 Sum_probs=171.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH---EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc---ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 357999999999999999999664 68899999986543 12234557789999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++ +|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 82 v~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 82 VFEYLDK-DLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred EEecccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 9999974 888887654 24578889999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+++.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 433333445678999999988754 478899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=285.68 Aligned_cols=202 Identities=24% Similarity=0.424 Sum_probs=171.3
Q ss_pred cCCcccceeccCCceeEEEEEcCC------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPS------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
++|++.+.||+|+||.||+|.... ...||+|.+.... .......+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 468899999999999999996542 2579999986542 2344567889999999999999999999999989
Q ss_pred eeEEEEeccCCCCHHhHhcCCCC-------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 673 HSFLVCEYLDRGSLARILGDDVT-------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
..+++|||+++++|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence 99999999999999999865321 14578889999999999999999999 999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCc
Q 038003 740 SNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 806 (848)
Q Consensus 740 ~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 806 (848)
+++.+||+|||++........ ......+++.|+|||.+.+..+++++|||||||++|||+| |..||.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999976533221 1123456788999999988889999999999999999998 999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=278.41 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=174.1
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 46689999999999999999988778889999986542 2356788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999999987652 35689999999999999999999999 999999999999999999999999999987753
Q ss_pred CCCCc-ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSSNW-TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
..... .....+..|+|||+..+..++.++||||||+++|||+| |+.||..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 22111 11223457999999998889999999999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.73 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=172.7
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|... ++..||+|.++... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 46889999999999999999765 78999999886542 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.......+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||.+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 999999999998876433457899999999999999999999632 899999999999999999999999999976643
Q ss_pred CCCCcccccccccccCccccccC------CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTM------RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. ......+++.|+|||.+.+. .++.++||||+||++|||+||+.||..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 156 S--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred C--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 2 22345678899999998643 347899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=267.01 Aligned_cols=208 Identities=27% Similarity=0.380 Sum_probs=186.4
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
...+|....+||+|+|++|.+++++ +.+.||+|++++....+ .++.+=+..|..+..+. +||++|-++..|+....+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd-dedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC-cccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3567999999999999999999765 78889999999987653 35566677788777776 899999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++|.||++||+|.-+++++ ..+++..+.-+...|+.||.|||++ ||++||+|.+|+|+|..|++|++|||+++.
T Consensus 327 ffvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999998888776 6688899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccccc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~ 811 (848)
--.......+++|||.|.|||++.+..|+..+|.|++||+++||+.|+.||+-.+.+
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~ 457 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD 457 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC
Confidence 655566667899999999999999999999999999999999999999999876643
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=279.27 Aligned_cols=202 Identities=28% Similarity=0.412 Sum_probs=173.9
Q ss_pred CCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccC--CchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG--NMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+|+..+.||+|+||+||+|...+++.+|+|.+....... .....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999987889999999886542211 123345688999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998654 4578889999999999999999999 999999999999999999999999999876532
Q ss_pred C------CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 H------SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. ........|+..|+|||++.+..++.++||||||+++|+|+||+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 1 1112335688999999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=278.29 Aligned_cols=202 Identities=25% Similarity=0.455 Sum_probs=173.5
Q ss_pred hcCCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||+||+|.++ +...||||+++... ......++.+|+.++++++||||+++++++...+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 357899999999999999999764 24579999986542 23445678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++++|.+++... ...+++..+.+++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 80 VMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhh
Confidence 99999999999999998654 24688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 754 FVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
......... ....+++.|+|||.+.+..+++++||||||+++|||++ |..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 875222221 12334678999999998889999999999999999998 9999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=282.09 Aligned_cols=201 Identities=25% Similarity=0.383 Sum_probs=173.2
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|+..+.||+|+||.||+|..+ +++.||+|++..... .....+.+.+|++++++++|||++++++++......++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 46889999999999999999765 689999999865421 122345678999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++++.+..+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 79 FEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EeccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999998888876543 4588999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........++..|+|||++.+ ..++.++||||||+++|||+||+.||..
T Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 4333344567889999999876 4578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=278.68 Aligned_cols=199 Identities=29% Similarity=0.448 Sum_probs=176.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|+..+.||+|+||.||+|... ++..+|+|.+.... ..+++.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 367999999999999999999776 47899999986542 26788999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
++||+++++|.++++.. ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+....
T Consensus 76 ~~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 76 VMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 99999999999998643 25688999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........++..|+|||++.+..++.++||||||+++|+|+||+.||..
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 543333445678999999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=244.63 Aligned_cols=225 Identities=23% Similarity=0.371 Sum_probs=183.8
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
.|+..+.||+|.||+||+|+. .+++.||+|+++...- +........+|+.+++.++|.|||+++++...+...-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 466778899999999999965 4789999999877642 3334566789999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++ +|..+...- .+.++...+..++.|+.+|+.|.|++ .+.|||+||.|.+++.+|++|++|||+++.++-.
T Consensus 81 e~cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HHhhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 99977 787776432 46788889999999999999999999 9999999999999999999999999999988765
Q ss_pred CCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhhhhcCCCCCCCCCC
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPS 836 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (848)
-......+.|.+|.+|.++.+.+ |+...|+||.|||+.|+.....|.-. +. ...++++.+...+.......+|.
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp-g~---dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-GN---DVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC-CC---cHHHHHHHHHHHhCCCccccCCc
Confidence 54555667799999999999876 78999999999999999997777422 21 23444555555554444333333
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=293.25 Aligned_cols=200 Identities=25% Similarity=0.360 Sum_probs=169.5
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC---
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--- 671 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 671 (848)
...++|+..+.||+|+||.||+|... .++.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 34578999999999999999999654 688999999876431 233456678899999999999999999988643
Q ss_pred ---CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 672 ---PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 672 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
...++||||+++ ++.+.++. .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEee
Confidence 357999999976 56666542 477888899999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||+++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 163 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 163 FGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CcccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999876432 222446789999999999998999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=277.87 Aligned_cols=200 Identities=30% Similarity=0.418 Sum_probs=175.8
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 57899999999999999999664 67889999987652 23567788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. ...++...+..++.|++.|++|||+. +|+||||+|+||+++.++.+||+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999999988654 24588899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccCccccccC---CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTM---RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........++..|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 33333445788899999998876 788999999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=280.64 Aligned_cols=198 Identities=25% Similarity=0.389 Sum_probs=170.3
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 677788999999999999765 5778899987553 23456678899999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|++++++.+++... ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 83 FCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred ecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999998887542 24688999999999999999999999 99999999999999999999999999987654433
Q ss_pred CCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......+++.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 3334457899999999974 34567899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=281.48 Aligned_cols=203 Identities=22% Similarity=0.364 Sum_probs=170.9
Q ss_pred cCCcccceeccCCceeEEEEEc-----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
++|++.+.||+|+||+||+|.. .++..+|+|.+.... .......+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 5688889999999999999964 256789999987532 23345678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCC--------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 674 SFLVCEYLDRGSLARILGDDV--------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
.++||||+++++|.+++.... ....+++.++..++.|++.|++|||++ +|+||||||+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence 999999999999999885321 123478888999999999999999999 999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 740 SNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 740 ~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999986643221 1123345678999999988889999999999999999999 9989753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=277.32 Aligned_cols=199 Identities=27% Similarity=0.444 Sum_probs=172.3
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
++|++.+.||+|+||+||.|++.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 5688899999999999999988777789999986542 23467889999999999999999999999988999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+.+++|.++++.. ...+++..+.+++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 79 EYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999999998654 23688999999999999999999999 9999999999999999999999999998866433
Q ss_pred CCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 759 SSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 759 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... .....++..|+|||+..+..++.++|||||||++|||+| |+.||..
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 211 112334578999999988889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=282.61 Aligned_cols=200 Identities=27% Similarity=0.377 Sum_probs=165.3
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC---CCCcccceEEEeec-----
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI---RHRNNVKFHGFCYN----- 670 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~----- 670 (848)
+|++.+.||+|+||+||+|... +++.||+|.++..... ......+.+|+++++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 4888899999999999999655 7899999998764322 12223455677766655 79999999998864
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
....++||||+++ ++.++++.. ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence 3457999999985 888887654 234588999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++...... ......|++.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 154 LARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred ccccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 998764322 22345688999999999988899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=276.15 Aligned_cols=202 Identities=23% Similarity=0.354 Sum_probs=177.2
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|+..+.||+|+||.||.++. .+++.+++|++..... .....+++.+|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 588899999999999999954 4789999999865432 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.+++.... ...+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999987552 35688999999999999999999999 9999999999999999999999999999877554
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........+++.|+|||+..+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 4333456789999999999888889999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=283.08 Aligned_cols=205 Identities=24% Similarity=0.331 Sum_probs=177.6
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|.. .+++.+|||.+...... +....+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 4688889999999999999975 58899999987654322 234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 678 CEYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|||+++++|.++++.. .....+++..+..++.||+.|+.|||+. |++|+||||+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999988642 1234688999999999999999999999 99999999999999999999999999988765
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 544433456788999999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=293.56 Aligned_cols=199 Identities=26% Similarity=0.367 Sum_probs=169.4
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG---- 671 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 671 (848)
..++|++.+.||+|+||.||+|.. ..++.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 457899999999999999999965 4688999999875431 234456778999999999999999999987643
Q ss_pred --CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 672 --PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 672 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
...|+||||+++ ++.+.++. .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999976 67666642 377888999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+++...... ......+++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 171 G~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 171 GLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CCccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 9998764322 22446789999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=276.68 Aligned_cols=202 Identities=22% Similarity=0.361 Sum_probs=175.3
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||+|+||.||++.. .+++.||+|++..... .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 588899999999999999955 4789999999865432 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.+++... ....+++.++.+++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||.+......
T Consensus 79 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 79 DYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred ecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999999988654 223578899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........|++.|+|||+..+..++.++|+|||||++|+|+||+.||..
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 3333345678899999999888889999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=290.17 Aligned_cols=200 Identities=26% Similarity=0.379 Sum_probs=169.5
Q ss_pred HHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG-- 671 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-- 671 (848)
....++|++.+.||+|+||.||+|.. .++..||||++..... .....+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 34567899999999999999999965 5788999999865421 123345677899999999999999999987543
Q ss_pred ----CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 672 ----PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 672 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
...++++|++ +++|.++++. ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 3568999988 6789887753 3588999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 748 DFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|||+++..... .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus 161 Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 161 DFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999876432 244578999999999876 4688999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=295.97 Aligned_cols=194 Identities=24% Similarity=0.299 Sum_probs=168.1
Q ss_pred hcCCcccceeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
..+|.+.+.||+|+||.||+|... .+..||+|.+... +...+|++++++++||||+++++++......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 457999999999999999999543 4578999987543 2245799999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++|||++. +++.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 162 ~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 99999996 5888887433 5689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 6543221 2346799999999999998999999999999999999999999743
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=276.55 Aligned_cols=200 Identities=24% Similarity=0.406 Sum_probs=172.8
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++||||+++++++. .+..++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 46789999999999999999998889999999986542 23567889999999999999999999874 4578999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999988654 235688999999999999999999999 999999999999999999999999999987653
Q ss_pred CCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... ......++..|+|||++.+..++.++||||||+++||+++ |+.||..
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 222 1123345678999999988889999999999999999999 9999853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=277.00 Aligned_cols=205 Identities=26% Similarity=0.352 Sum_probs=171.6
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
.+++.+.....||+|+||.||+|.+. ++..||+|.+... .....+.+.+|++++++++||||+++++++..++..
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 34556666678999999999999654 6788999987654 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-CCCEEEeeccCcc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAK 753 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~~~ 753 (848)
++|+||+++++|.++++........++..+..++.||+.|++|||++ +|+||||||+||+++. ++.++|+|||.+.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999987542222227788889999999999999999 9999999999999986 6799999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMR--ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.............+++.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 7644333334456889999999986543 78899999999999999999999854
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=276.37 Aligned_cols=200 Identities=28% Similarity=0.473 Sum_probs=171.7
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.+|++.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|++++++++||+|+++++++...+..++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 45888899999999999999654 6889999997643 23456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.+++... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999998654 234688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCc-ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSSNW-TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
..... ....+++.|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 22211 11233568999999998889999999999999999998 9999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=277.11 Aligned_cols=199 Identities=29% Similarity=0.456 Sum_probs=171.2
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
.+|++.+.||+|+||.||+|.++++..+|+|++.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-----MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 4588899999999999999988877889999986532 23456888999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 999999999998654 23688999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCCc-ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 759 SSNW-TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 759 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.... ....++..|+|||.+.+..++.++||||||+++||++| |+.||+.
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 2111 11223457999999998889999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=276.74 Aligned_cols=203 Identities=31% Similarity=0.438 Sum_probs=176.5
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||.|+||+||+|... ++..+|+|++..... ....+.+.+|+++++.++||+|+++++.+......++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 47899999999999999999754 688999999865432 22567789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
||++++++|.++++.......+++..+..++.|++.|++|||+. ||+||||+|+||++++++.++|+|||++..+..
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999999999997653335688999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCCc----ccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNW----TEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~----~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..... ....|+..|+|||++... .++.++|+|||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 33221 334688999999998776 688999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=284.80 Aligned_cols=199 Identities=38% Similarity=0.590 Sum_probs=165.9
Q ss_pred ccceeccCCceeEEEEEcC-----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 603 EKFCIGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 603 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
..+.||.|+||.||+|.+. .+..|+||+++... .....+.+.+|++.+++++||||++++|++...+..++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS---SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS---SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc---ccccceeeeeccccccccccccccccccccccccccccc
Confidence 4578999999999999765 35679999985532 334578899999999999999999999999988889999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. ....+++..+..|+.|||+||+|||++ +|+||||+++||++++++.+||+|||++.....
T Consensus 80 ~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999999765 335689999999999999999999999 999999999999999999999999999987632
Q ss_pred CCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 758 HSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 758 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
.... .........|+|||.+.+..++.++||||||+++||++| |+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2211 122346778999999998889999999999999999999 78997543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=288.60 Aligned_cols=204 Identities=27% Similarity=0.390 Sum_probs=169.6
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 670 (848)
.++|++.+.||+|+||.||+|... +++.||+|+++... .....+.+.+|+.+++++ +||||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 357999999999999999999532 35789999987543 223456678899999999 89999999998865
Q ss_pred C-CeeEEEEeccCCCCHHhHhcCCCC------------------------------------------------------
Q 038003 671 G-PHSFLVCEYLDRGSLARILGDDVT------------------------------------------------------ 695 (848)
Q Consensus 671 ~-~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------ 695 (848)
. ...++||||+++++|.+++.....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 568899999999999988753211
Q ss_pred ----cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCC--cccccccc
Q 038003 696 ----AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTF 769 (848)
Q Consensus 696 ----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~ 769 (848)
...+++..+.+++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.+...... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 12678999999999999999999999 9999999999999999999999999999876432221 12234567
Q ss_pred cccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 770 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 770 ~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.|+|||++.+..+++++|||||||++|||+| |+.||..
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 8999999999999999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=276.24 Aligned_cols=200 Identities=26% Similarity=0.443 Sum_probs=170.9
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
..+|++.+.||+|+||.||+|.+.++..||+|+++... ...+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-----cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 35699999999999999999987777789999987532 234578899999999999999999998754 567999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. ....+++..+..++.|++.||+|+|+. +|+||||||+||++++++.++|+|||.++....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 9999999999999754 234578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCc-ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSSNW-TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
..... ....++..|+|||+..+..++.++||||||+++|||+| |+.||..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 33211 23345678999999988889999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=279.23 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=174.0
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
..|+..+.||+|+||.||+|.+. ++..||+|++.... .......+.+|+.++++++||+|+++++++.++...++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 35778889999999999999764 68899999986542 224456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++. ..+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 81 MEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999999998854 3578888999999999999999999 999999999999999999999999999977654
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........++..|+|||++.+..++.++|+|||||++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 33333345678899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=276.05 Aligned_cols=202 Identities=32% Similarity=0.493 Sum_probs=172.8
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCC-----chhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN-----MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
+|.+...||+|+||.||+|.. .+++.+|+|.+........ ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477888999999999999965 4688999998866533221 1123567889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999654 4578889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSS------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....... ......|++.|+|||.+.+..+++++||||+||++|+|+||+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 7642211 11234578899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=278.15 Aligned_cols=201 Identities=27% Similarity=0.429 Sum_probs=167.1
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCC----EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
++|++.+.||+|+||+||+|.+. +++ .+++|.+.... ......++..|+.++++++||||+++++++. +..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc---chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 56888999999999999999764 455 36777764321 2233466778888999999999999999875 456
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++|+||+++|+|.+++... ...+++..+..++.||+.|++|||++ +++||||||+||++++++.+||+|||.++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence 78999999999999998654 24688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 754 FVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
...+... ......++..|+|||++.+..++.++|||||||++||++| |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 7643322 1223456778999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=279.60 Aligned_cols=200 Identities=32% Similarity=0.524 Sum_probs=174.0
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|++.+.||+|+||+||+|... +++.+|+|++...... ........+|+.++++++||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE--EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH--HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc--ccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 567889999999999999665 5678999999776322 1222234569999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++++|.+++.. ...+++..+..++.||++||++||+. +|+||||||+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 79 YCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp EETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred ccccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999972 35688999999999999999999999 99999999999999999999999999998653334
Q ss_pred CCcccccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 760 SNWTEFAGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.......+++.|+|||++. +..++.++||||+|+++|+|++|..||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4445677899999999998 788899999999999999999999998765
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=299.22 Aligned_cols=198 Identities=25% Similarity=0.489 Sum_probs=175.8
Q ss_pred CCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
...+.++||.|.||.|++|+++ ....||||.++.-. .++...+|..|..||.++.||||+++.|+......++
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 4566789999999999999775 24569999997754 3567788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+|.|||++|+|+.+++.+ .+++.+.+...+.++||.|+.||-+. ++|||||.+.|||++.+-..|++|||+++..
T Consensus 707 IiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999876 35699999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCCccccc-c--cccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCC
Q 038003 756 GPHSSNWTEFA-G--TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPR 805 (848)
Q Consensus 756 ~~~~~~~~~~~-g--~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~ 805 (848)
.++.....+.. | ..+|.|||.+..++++.++||||+||+|||.++ |..||
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 66553333222 2 479999999999999999999999999999999 99994
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=290.25 Aligned_cols=198 Identities=26% Similarity=0.382 Sum_probs=171.7
Q ss_pred cCCcccceeccCCceeEEEEEcCC-CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+-|.++..||.|+||.||+|..++ +-..|.|++... ..+..+.|+-|++|+..+.||+||++++.|+..+.+|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 346777889999999999997664 444566777554 356778899999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
.|||.||-+..++-.- +..+.+.++.-+.+|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+.....
T Consensus 108 iEFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EeecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 9999999887776433 45688999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 758 HSSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
.......+.|||+|||||+.. ..+|++++||||||+++.||..+.+|.
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH 235 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH 235 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc
Confidence 344456789999999999864 567999999999999999999999994
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=282.37 Aligned_cols=202 Identities=29% Similarity=0.411 Sum_probs=167.5
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCC--EEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
++|++.+.||+|+||.||+|... ++. .+++|.++... .....+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 57899999999999999999765 333 47888876422 223456788999999999 799999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC
Q 038003 675 FLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN 741 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 741 (848)
++||||+++++|.++++... ....+++..+..++.|++.|++|||++ ||+||||||+||+++++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence 99999999999999986431 123588899999999999999999999 99999999999999999
Q ss_pred CCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 742 FEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 742 ~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+.+||+|||++........ ......+..|+|||+..+..++.++|||||||++|||+| |+.||..
T Consensus 156 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred CeEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999864322111 111223557999999988889999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=279.03 Aligned_cols=203 Identities=26% Similarity=0.445 Sum_probs=171.4
Q ss_pred hcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
.++|.+.+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|++++++++||+|+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 35788999999999999999964 23456899988654 233456789999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCC----------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDV----------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN 741 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 741 (848)
+..++||||+++++|.+++.... ....+++.++..++.|++.||+|||++ |++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 99999999999999999886431 123589999999999999999999999 99999999999999999
Q ss_pred CCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 742 FEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 742 ~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+.+||+|||.++........ .....+++.|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999765332211 122335678999999998889999999999999999999 8999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=280.18 Aligned_cols=201 Identities=23% Similarity=0.371 Sum_probs=170.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|++|.||+|..+ +++.||+|.+..... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc---cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 367999999999999999999665 789999999865431 1223446789999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+.+ +|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.++...
T Consensus 81 v~e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 81 VFEYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred EEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 9999985 898888654 23678899999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........++..|+|||++.+ ..++.++||||+|+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 32222233456889999999875 4578899999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=276.08 Aligned_cols=203 Identities=25% Similarity=0.317 Sum_probs=171.0
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEccccccc-CCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--Cee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLS-GNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--PHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~ 674 (848)
.+|++.+.||+|+||.||+|.. .++..||+|.+...... ......+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688999999999999999965 46899999987643211 1123456788899999999999999999998764 467
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++++|.+++... ..+++..+.+++.|++.||+|||++ +|+||||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988654 3477888899999999999999999 999999999999999999999999999876
Q ss_pred cCCCC---CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHS---SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 53211 112335688899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=280.31 Aligned_cols=203 Identities=22% Similarity=0.306 Sum_probs=169.5
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
+..+|.+.+.||+|+||.||+|.. .++..||+|++..... ......+.+|+++++.++|+||+++++++..++..+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 457899999999999999999965 4789999999865531 222345678999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+. +++.+++... ...+.+..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.++..
T Consensus 80 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9999996 5776665433 23467788889999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
...........+++.|+|||++.+. .++.++|||||||++|||+||+.||+..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 4333333445678999999998764 4788999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=274.72 Aligned_cols=200 Identities=27% Similarity=0.445 Sum_probs=171.5
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++||+++++++++.+ ...++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-----MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-----CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEE
Confidence 35789999999999999999988888889999987642 224568899999999999999999998854 567899
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. ....+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999999998754 234588999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCCc-ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSSNW-TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
..... ....++..|+|||+..+..++.++||||||+++|||++ |..||..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 32211 22335668999999988889999999999999999999 8889754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=278.48 Aligned_cols=239 Identities=28% Similarity=0.364 Sum_probs=192.6
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|+..+.||+|+||.||+|..+ +++.+|+|++.... .....+++.+|++++++++||||+++++++......++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 36788889999999999999765 68999999987653 224456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
+||+++++|.+++.... ..++...+..++.|++.|++|+|+ . +++||||||+||+++.++.++|+|||.+....
T Consensus 78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999999987542 568889999999999999999999 8 99999999999999999999999999987654
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccccccc--------------------cc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS--------------------FS 816 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~--------------------~~ 816 (848)
.... ....++..|+|||...+..++.++||||||+++|+|++|+.||...+..... +.
T Consensus 153 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd06605 153 NSLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFS 230 (265)
T ss_pred HHHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 3222 2267889999999999888999999999999999999999998654211111 11
Q ss_pred hhhhhhhhhcCCCCCCCCCCcccccceeecc
Q 038003 817 NMIIDVNKILDPRLPTPSPSVMDYGGCHFML 847 (848)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (848)
..+.++...+-...|..+|.+.+...++|+.
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence 1222233333333466677777777776664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=281.19 Aligned_cols=199 Identities=27% Similarity=0.423 Sum_probs=172.9
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+.|+..+.||+|+||.||+|... ++..||+|.+.... .....+.+.+|++++++++||||+++++++......++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 34677788999999999999654 67889999886542 223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.+++.. ..+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 81 MEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 999999999998853 3578889999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........++..|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 33333345678899999999988889999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=280.23 Aligned_cols=210 Identities=26% Similarity=0.368 Sum_probs=174.1
Q ss_pred HHHHHHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEe
Q 038003 591 HEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFC 668 (848)
Q Consensus 591 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 668 (848)
.+.+....++|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 345556788999999999999999999965 468899999875431 2235677899999999 799999999987
Q ss_pred e-----cCCeeEEEEeccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC
Q 038003 669 Y-----NGPHSFLVCEYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742 (848)
Q Consensus 669 ~-----~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 742 (848)
. .++..++||||+++++|.+++... .....+++..+..++.|++.|+.|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 4 345789999999999999887532 1234678888999999999999999999 999999999999999999
Q ss_pred CEEEeeccCccccCCCCCCcccccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 743 EAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 743 ~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.+||+|||.++.............|++.|+|||++.. ..++.++||||+||++|||+||+.||...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999876543333344568999999998753 44788999999999999999999998643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=279.19 Aligned_cols=203 Identities=28% Similarity=0.477 Sum_probs=171.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
.++|.+.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 356888899999999999999642 3456888987654 233456788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee
Q 038003 672 PHSFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 738 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll 738 (848)
+..++||||+++++|.+++.... ....+++..+.+++.||+.|++|||++ +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 99999999999999999986431 123588999999999999999999999 99999999999999
Q ss_pred CCCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 739 DSNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 739 ~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+.++.++|+|||++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999976543221 1123446788999999998889999999999999999999 9999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=284.17 Aligned_cols=195 Identities=21% Similarity=0.344 Sum_probs=159.5
Q ss_pred cceeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec--CCeeEEEE
Q 038003 604 KFCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN--GPHSFLVC 678 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~lV~ 678 (848)
.+.||+|+||+||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 357999999999999754 56789999986542 22446789999999999999999998854 45688999
Q ss_pred eccCCCCHHhHhcCCC------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee----CCCCCEEEee
Q 038003 679 EYLDRGSLARILGDDV------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----DSNFEAHVSD 748 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~D 748 (848)
||+.+ ++.+++.... ....+++..+..++.||+.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99865 7877764321 123588899999999999999999999 99999999999999 4567899999
Q ss_pred ccCccccCCCCC---CcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 749 FGIAKFVGPHSS---NWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 749 fG~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
||+++....... ......||+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999987643221 22346789999999998764 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=279.24 Aligned_cols=201 Identities=28% Similarity=0.389 Sum_probs=174.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|... ++..||+|++.... .....+.+.+|+++++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 356888899999999999999654 68899999876542 23446778899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++.. +.+++..+..++.|++.|+.|||+.+ +++||||+|+||+++.++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999988654 46889999999999999999999732 89999999999999999999999999987553
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
... .....|+..|+|||++.+..++.++|||||||++|+++||+.||...
T Consensus 156 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 156 NSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred hhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 221 23457899999999998888899999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=276.81 Aligned_cols=201 Identities=25% Similarity=0.444 Sum_probs=169.4
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCC----EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
.++|+..+.||+|+||+||+|.+. +++ .||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 457899999999999999999653 454 48999886542 234456788999999999999999999998764
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..+++|||+++|+|.++++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence 578999999999999998654 24688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 753 KFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+......... ....+++.|+|||...+..++.++|||||||++|||+| |..||+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 8765332221 12234678999999998889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=277.86 Aligned_cols=197 Identities=23% Similarity=0.358 Sum_probs=161.9
Q ss_pred eeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 606 CIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
.||+|+||.||+|.+. ++..+|+|.++... .......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 5899999999999654 34679999886553 22344578889999999999999999999999999999999999
Q ss_pred CCCHHhHhcCCC--CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC
Q 038003 683 RGSLARILGDDV--TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760 (848)
Q Consensus 683 ~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~ 760 (848)
+|+|.++++... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999999986432 123456778889999999999999999 999999999999999999999999999875433221
Q ss_pred --CcccccccccccCccccccC-------CCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 761 --NWTEFAGTFGYAAPEIAYTM-------RATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 761 --~~~~~~g~~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 11234567889999988642 35789999999999999996 99998643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=278.18 Aligned_cols=207 Identities=26% Similarity=0.416 Sum_probs=172.9
Q ss_pred HHHHHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEee
Q 038003 592 EEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCY 669 (848)
Q Consensus 592 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 669 (848)
.+.......|++.+.||+|+||.||+|.. .+++.+|+|++... .....++..|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 34444567899999999999999999966 46889999987553 23345678899999888 7999999999985
Q ss_pred c------CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC
Q 038003 670 N------GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE 743 (848)
Q Consensus 670 ~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 743 (848)
. ....++||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 3 45789999999999999988654 234577888899999999999999999 9999999999999999999
Q ss_pred EEEeeccCccccCCCCCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 744 AHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 744 ~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
++|+|||.+..............|++.|+|||.+. +..++.++|||||||++|||+||+.||..
T Consensus 160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 99999999876643333334567899999999876 34578899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=249.11 Aligned_cols=211 Identities=25% Similarity=0.378 Sum_probs=172.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHH-hcCCCCcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL-KEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
.++...+..||+|+||.|-+.++. +|...|+|.+.... +.+..++..+|+.+. +....|++|.+||...+....|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 344555667999999999988654 89999999997764 345566677888874 4458999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 676 LVCEYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
+.||.|+- ||..+-+.- ..++.+++.-.-+|+..++.|+.|||++- .|+|||+||+|||++.+|+||+||||.+-.
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999965 776654332 23467888889999999999999999984 899999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCccccc----cCCCCccchhhhHHHHHHHHHhCCCCCcccccccccc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAY----TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 815 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~ 815 (848)
..++-. .+...|-..|||||.+. ...|+-++||||+|+++.||.++++||+.+...|+.+
T Consensus 199 L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 199 LVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred ehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 754322 23356777899999875 3468999999999999999999999998877766533
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=273.57 Aligned_cols=203 Identities=25% Similarity=0.331 Sum_probs=171.4
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccC-CchhHHHHHHHHHHHhcCCCCcccceEEEeec--CCee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG-NMADHDEFLNEVLALKEIRHRNNVKFHGFCYN--GPHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~ 674 (848)
.+|+..+.||+|+||.||+|.. .++..||+|++....... .....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999965 468999999886543211 12344568889999999999999999998875 3577
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
+++|||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998654 4578888999999999999999999 999999999999999999999999999876
Q ss_pred cCCCC---CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHS---SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..... .......++..|+|||.+.+..++.++||||+||++|||+||+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 53211 112234578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=274.67 Aligned_cols=201 Identities=25% Similarity=0.439 Sum_probs=171.1
Q ss_pred cCCcccceeccCCceeEEEEEcC-C---CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-S---GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
.+|++.+.||+|+||.||+|.+. + +..+|+|.++... .....+.+..|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 57889999999999999999653 2 3479999986542 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999999998654 24688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc---ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 755 VGPHSSNW---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+....... ....++..|+|||++.+..++.++|+||||+++||+++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 65432211 11223568999999998889999999999999999887 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=270.08 Aligned_cols=194 Identities=28% Similarity=0.414 Sum_probs=166.5
Q ss_pred eeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCC
Q 038003 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGS 685 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gs 685 (848)
.||+|+||.||+|...++..+|+|+++... .......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 699999999999988888999999986543 22334568899999999999999999999999999999999999999
Q ss_pred HHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc-cc
Q 038003 686 LARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW-TE 764 (848)
Q Consensus 686 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~-~~ 764 (848)
|.+++... ...+++..+..++.|++.|+.|+|+. |++||||||+||+++.++.+||+|||++.......... ..
T Consensus 79 L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 79 FLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 99988654 24578899999999999999999999 99999999999999999999999999987643322111 12
Q ss_pred ccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 765 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
..+++.|+|||++.+..++.++||||||+++||+++ |..||..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 234568999999988889999999999999999999 9999853
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=281.27 Aligned_cols=196 Identities=29% Similarity=0.464 Sum_probs=170.2
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|+....||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 333457999999999999654 78999999986542 2345668899999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 99 FLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred cCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 9999999987743 3578899999999999999999999 99999999999999999999999999987654433
Q ss_pred CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 333456789999999999988899999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=280.21 Aligned_cols=200 Identities=26% Similarity=0.398 Sum_probs=172.3
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|.++ +++.||+|++...... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc--chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 46888999999999999999765 6899999998664322 23355678899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++++++.++.... ..+++..+..++.||+.|++|||+. +|+||||+|+||++++++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 79 FEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999998876543 3488999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.........++..|+|||++.+ ..++.++||||||+++|||+||+.||.
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 3333344567899999999875 346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=277.20 Aligned_cols=201 Identities=26% Similarity=0.407 Sum_probs=168.3
Q ss_pred cCC-cccceeccCCceeEEEEEc-----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-
Q 038003 599 DDF-DEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG- 671 (848)
Q Consensus 599 ~~~-~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 671 (848)
++| ++.+.||+|+||+||++.. .++..||+|+++... .....+.+.+|++++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 344 8889999999999988642 367889999986542 223456788999999999999999999988653
Q ss_pred -CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 672 -PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 672 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
...++||||+++++|.+++... .+++..+..++.|++.|+.|||++ +|+||||||+||++++++.+||+|||
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence 4678999999999999998543 489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC---cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 751 IAKFVGPHSSN---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 751 ~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
+++........ .....++..|+|||...+..++.++||||||+++|||+||+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 99876532221 112335667999999988889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.39 Aligned_cols=202 Identities=27% Similarity=0.363 Sum_probs=174.4
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEccccccc-CCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLS-GNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+|+..+.||+|+||+||+|... +++.||+|.+...... ...+..+.+.+|+++++.++||+|+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778889999999999999765 7899999998654321 1123456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. ..+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998654 4578899999999999999999999 999999999999999999999999999887643
Q ss_pred CCCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.. ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||...
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 32 224456889999999987666 889999999999999999999998643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=275.39 Aligned_cols=202 Identities=31% Similarity=0.403 Sum_probs=177.5
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|++++++++||||+++++++.++...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 4788999999999999999765 6899999999765322 2244677899999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+.+++|.+++... ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 80 DLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred eCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999998654 4688899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
. ......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||....
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 154 T-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred c-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 2 2344568889999999988889999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=280.28 Aligned_cols=199 Identities=24% Similarity=0.390 Sum_probs=169.5
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|+..+.||+|+||.||+|... +|+.+|+|+++.... .......+.+|++++++++||||+++++++.+....++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 4788899999999999999664 789999999876432 2223456778999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++ ++.+++... ...+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 79 EYCDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred ecCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 99975 787776543 24589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
........+++.|+|||++.+.. ++.++|||||||++|||+||+.|+.
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 33334456789999999987654 6889999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=281.35 Aligned_cols=196 Identities=31% Similarity=0.486 Sum_probs=170.5
Q ss_pred CcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|.....||+|+||.||++.. .++..||||++... .....+.+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 44446799999999999965 47889999997653 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++++|.+++.. ..+++.++..++.||+.|++|||++ +|+||||||+||++++++.++|+|||++.......
T Consensus 100 ~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 100 FLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999998743 3578899999999999999999999 99999999999999999999999999987664433
Q ss_pred CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 333446788999999999888899999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=281.63 Aligned_cols=204 Identities=25% Similarity=0.339 Sum_probs=175.5
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+..|+++++.++||+|+++++.+.+....++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 46889999999999999999665 5899999998765322 123456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+.+++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 80 ~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 80 MDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999998754 335688999999999999999999999 999999999999999999999999999876532
Q ss_pred CCC-----------------------------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSS-----------------------------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 211 01124678899999999988899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=300.37 Aligned_cols=199 Identities=20% Similarity=0.254 Sum_probs=162.7
Q ss_pred HHHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC------CCcccceEE
Q 038003 594 IIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR------HRNNVKFHG 666 (848)
Q Consensus 594 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~l~~ 666 (848)
+....++|++.+.||+|+||+||+|.. .+++.||||+++... ...+....|+++++.++ |++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 334567899999999999999999965 468889999986431 22334455666666654 456889999
Q ss_pred EeecC-CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCC--
Q 038003 667 FCYNG-PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNF-- 742 (848)
Q Consensus 667 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~-- 742 (848)
++... .+.++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ . |||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcc
Confidence 88765 4788999988 66888887644 468899999999999999999997 6 999999999999998765
Q ss_pred --------------CEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 743 --------------EAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 743 --------------~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998864322 23456899999999999999999999999999999999999999864
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=278.59 Aligned_cols=208 Identities=28% Similarity=0.392 Sum_probs=173.5
Q ss_pred HHHHHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEee
Q 038003 592 EEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCY 669 (848)
Q Consensus 592 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 669 (848)
.++..+.++|++.+.||+|+||.||+|.. .+++.+|+|++.... ...+.+.+|+.+++++ +|||++++++++.
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 34445678899999999999999999966 478899999986531 2345677899999988 8999999999987
Q ss_pred cC-----CeeEEEEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC
Q 038003 670 NG-----PHSFLVCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE 743 (848)
Q Consensus 670 ~~-----~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 743 (848)
.. +..++||||+++++|.++++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 54 35899999999999999875421 235688999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCccccCCCCCCcccccccccccCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 744 AHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-----RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 744 ~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+||+|||.+..............|+..|+|||++... .++.++|||||||++|||++|+.||..
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~ 235 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence 9999999998765433333445688999999987643 257899999999999999999999854
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=271.45 Aligned_cols=194 Identities=29% Similarity=0.467 Sum_probs=164.3
Q ss_pred eeccCCceeEEEEEc---CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 606 CIGKGGQGSVYKAEL---PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
.||+|+||.||+|.+ .++..+|+|+++... ......+++.+|+.+++.++||||+++++++. .+..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 589999999999954 367889999986542 12345677899999999999999999999875 456789999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+++|.+++... ..+++..+.+++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||.++.........
T Consensus 79 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 79 LGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99999998654 4688899999999999999999999 99999999999999999999999999998765433211
Q ss_pred ---ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 763 ---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 763 ---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
....++..|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12234578999999988888999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=277.34 Aligned_cols=202 Identities=27% Similarity=0.396 Sum_probs=166.0
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHH-HhcCCCCcccceEEEeecCCeeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLA-LKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
++|++.+.||+|+||.||+|... +|+.||+|+++.... ......+..|+.. ++..+||||+++++++..++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 46899999999999999999665 799999999876532 2233455566665 666799999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 677 VCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
||||++ |+|.++++... ....+++..+..++.||+.|++|||+++ +++||||||+||+++.++.+||+|||.+...
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999997 57877765421 2356899999999999999999999853 8999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccCcccccc----CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYT----MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... ......++..|+|||++.+ ..++.++|+|||||++|||++|+.||..
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 155 VDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 4322 2233567889999998864 4468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=273.63 Aligned_cols=201 Identities=29% Similarity=0.425 Sum_probs=178.5
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||+|++|.||+|... +++.||+|++..... ....+.+.+|++++++++|||++++++++......++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 6888999999999999999765 599999999876531 144677899999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
||+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999654 568899999999999999999999 8 999999999999999999999999999987755
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
.........++..|+|||.+.+..++.++|+||||+++|+|+||+.||....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 4443335568899999999998888999999999999999999999986553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.74 Aligned_cols=192 Identities=23% Similarity=0.370 Sum_probs=164.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++......+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3457999999999999999999665 6788999975332 1246899999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+|||++. +++.+++... ...+++..+..|+.||+.||.|||++ +||||||||+||+++.++.+||+|||.++..
T Consensus 134 lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEEccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999996 4788877543 35689999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
... .......|++.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 208 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 208 VVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 322 2224467899999999999989999999999999999999965553
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=283.01 Aligned_cols=200 Identities=22% Similarity=0.268 Sum_probs=171.7
Q ss_pred CCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
-|..++.||-|+||+|.+++ ..+...||+|.+++..+- ......++.+|..|+.....+.||++|-.|++.+.+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-MRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH-hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 47778899999999999994 445678999999876433 2345677889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc---
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV--- 755 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~--- 755 (848)
||++||++..++-+. +-+++..+.-++..+..|+++.|+. |+|||||||+|||||.+|++||+|||+++-+
T Consensus 709 dYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999887543 5678888888999999999999999 9999999999999999999999999998532
Q ss_pred ------CCCC-------C--------------------------CcccccccccccCccccccCCCCccchhhhHHHHHH
Q 038003 756 ------GPHS-------S--------------------------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 796 (848)
Q Consensus 756 ------~~~~-------~--------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ 796 (848)
...+ . .....+||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1000 0 001247999999999999999999999999999999
Q ss_pred HHHhCCCCCc
Q 038003 797 EVIKGNHPRD 806 (848)
Q Consensus 797 elltg~~P~~ 806 (848)
||+.|+.||-
T Consensus 863 em~~g~~pf~ 872 (1034)
T KOG0608|consen 863 EMLVGQPPFL 872 (1034)
T ss_pred HHhhCCCCcc
Confidence 9999999983
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=273.41 Aligned_cols=204 Identities=28% Similarity=0.440 Sum_probs=174.8
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec--CCeeEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN--GPHSFL 676 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~l 676 (848)
+|++.+.||.|+||.||+|.. .++..+|+|++..... .....+++..|++++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 478889999999999999954 4788999999865432 23445678899999999999999999998764 456799
Q ss_pred EEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 677 VCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLH-----HDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH-----~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
+|||+++++|.++++... ....+++..+..++.||+.|++||| +. +|+||||+|+||+++.++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence 999999999999886532 2356889999999999999999999 76 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.+..............+++.|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 9988765443334567899999999999888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=278.34 Aligned_cols=203 Identities=25% Similarity=0.378 Sum_probs=172.0
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 670 (848)
.++|.+.+.||+|+||.||+|... ++..+|+|+++... .....+.+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 357999999999999999999531 34579999886542 223456788999999999 79999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
.+..++||||+++|+|.++++... ...+++.++..++.|++.|++|||++ +|+|+||||+||+++.++.++++|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999987542 23489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 751 IAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.++........ .....++..|+|||.+.+..+++++||||+||++|||+| |+.||..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 99866433221 112345678999999998889999999999999999998 9999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=275.28 Aligned_cols=198 Identities=30% Similarity=0.513 Sum_probs=172.7
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC---CCcccceEEEeecCCeeE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR---HRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~~~~~~ 675 (848)
.|+..+.||+|+||.||+|.+ .+++.+|+|.+.... .....+++.+|+.++++++ ||+++++++++.+.+..+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 377788999999999999965 578999999986542 2334567888999999886 999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++++|.++++.. .+++..+..++.|++.|+.|||+. ||+||||+|+||+++.++.++|+|||.+..+
T Consensus 79 lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999999988543 578899999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...........|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 655444455678999999998865 4468899999999999999999999854
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=278.66 Aligned_cols=204 Identities=24% Similarity=0.383 Sum_probs=172.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
.++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 457899999999999999999654 24689999986542 224456788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCC-------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCE
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVT-------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEA 744 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 744 (848)
...++||||+++++|.+++..... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 999999999999999999864321 22468889999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 745 HVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||+|||.++....... ......++..|+|||.+.+..++.++|||||||++||++| |..||..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 224 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence 9999999876543321 1123446789999999988889999999999999999998 9999753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=277.46 Aligned_cols=203 Identities=20% Similarity=0.309 Sum_probs=169.2
Q ss_pred cCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
.+|.+.+.||+|+||.||+|... ++..||+|+++... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 35777889999999999999653 35789999987542 2234567889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 673 HSFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
..++++||+++++|.+++.... ....+++..+..++.|++.||+|+|++ ||+||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence 9999999999999999874211 123478888999999999999999999 999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 740 SNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 740 ~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+++.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|||+| |..||..
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999998865432211 123345779999999988889999999999999999998 8888753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=277.73 Aligned_cols=199 Identities=30% Similarity=0.491 Sum_probs=175.1
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||++.. .++..||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc----cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 6789999999999999999964 47889999998543 223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
+||+++++|.+++... .+++..+..++.|++.|+.|||++ |++||||+|+||+++.++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999998543 467889999999999999999999 999999999999999999999999999877655
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.........+++.|+|||.+.+..++.++||||||+++|++++|+.||...
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 444444457889999999998888899999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=271.57 Aligned_cols=195 Identities=27% Similarity=0.415 Sum_probs=165.5
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDR 683 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~ 683 (848)
+.||+|+||.||+|... +++.+|+|.+.... .......+.+|++++++++||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 36999999999999664 78999999876442 234456789999999999999999999999999999999999999
Q ss_pred CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc-
Q 038003 684 GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW- 762 (848)
Q Consensus 684 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~- 762 (848)
++|.++++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..........
T Consensus 78 ~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 78 GDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred CcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 9999998653 24578999999999999999999999 99999999999999999999999999987654321111
Q ss_pred -ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 763 -TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 763 -~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.....+..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 11123457999999988889999999999999999998 8889754
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=271.22 Aligned_cols=201 Identities=28% Similarity=0.424 Sum_probs=175.1
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|+..+.||+|+||.||+|... ++..+|+|+++..... ....+.+.+|+++++.++|+||+++++++...+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 5888899999999999999654 7899999998765321 346778899999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.++++.. ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 79 EYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred ecCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999998754 4578888999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCc----ccccccccccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 759 SSNW----TEFAGTFGYAAPEIAYTMR---ATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 759 ~~~~----~~~~g~~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.... ....+++.|+|||++.+.. ++.++||||||+++||+++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 3321 1356788999999998766 789999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=280.96 Aligned_cols=193 Identities=21% Similarity=0.358 Sum_probs=158.1
Q ss_pred ceeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec--CCeeEEEEe
Q 038003 605 FCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN--GPHSFLVCE 679 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~lV~e 679 (848)
..||+|+||+||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 57999999999999754 45789999886542 22456789999999999999999998854 457899999
Q ss_pred ccCCCCHHhHhcCC------CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee----CCCCCEEEeec
Q 038003 680 YLDRGSLARILGDD------VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----DSNFEAHVSDF 749 (848)
Q Consensus 680 ~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Df 749 (848)
|+.+ ++.+++... .....+++..+..++.||+.||.|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9875 776665421 1223578899999999999999999999 99999999999999 56679999999
Q ss_pred cCccccCCCCC---CcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHSS---NWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+++....... ......|++.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99987643322 12345689999999998764 578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=288.89 Aligned_cols=205 Identities=26% Similarity=0.404 Sum_probs=170.9
Q ss_pred hhcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCY 669 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~ 669 (848)
..++|.+.+.||+|+||.||+|.+. .+..||+|+++... .....+.+.+|++++.++. ||||+++++++.
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3456888899999999999999753 34679999997643 2233456889999999997 999999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCC------------------------------------------------------
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVT------------------------------------------------------ 695 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------ 695 (848)
..+..++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999998864310
Q ss_pred -----------------------------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 038003 696 -----------------------------------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 734 (848)
Q Consensus 696 -----------------------------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~ 734 (848)
...+++..+.+++.||+.||+|||+. +|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 12367778889999999999999999 9999999999
Q ss_pred CeeeCCCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 735 NVLLDSNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 735 NIll~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||++++++.+||+|||+++....... ......+++.|+|||.+.+..+++++|||||||++|||++ |+.||..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999986533221 1122456788999999998889999999999999999998 8999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=271.23 Aligned_cols=199 Identities=26% Similarity=0.443 Sum_probs=170.0
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
++|.+...||+|++|.||+|....+..+|+|++.... ...+.+.+|++++++++||+++++++++.. +..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 5688899999999999999988777789999876532 234668899999999999999999998754 5678999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.++++.. ....+++..+..++.|++.|++|||+. |++||||||+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 80 EFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999998754 234578999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 759 SSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 759 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... .....++..|+|||+..+..++.++||||||+++|||+| |+.||..
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 221 122345678999999988889999999999999999999 8999754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=275.04 Aligned_cols=204 Identities=28% Similarity=0.410 Sum_probs=169.5
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
.++|++.+.||+|+||.||+|.+. .+..||+|.+.... .......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 467899999999999999999664 35678999875432 223345688999999999999999999999998
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCC----cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC---CE
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVT----AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF---EA 744 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ 744 (848)
...++||||+++++|.+++..... ...+++..+..++.||+.|++|||++ +++||||||+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence 899999999999999998865421 23588999999999999999999999 999999999999998755 59
Q ss_pred EEeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 745 HVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||+|||+++......... .....++.|+|||++.+..+++++|||||||++|||+| |+.||..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~ 224 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999998763222111 11223568999999998889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=282.26 Aligned_cols=199 Identities=20% Similarity=0.280 Sum_probs=165.0
Q ss_pred ccceeccC--CceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 603 EKFCIGKG--GQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 603 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
+...||+| +|++||++.. .+|+.||+|++..... .....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 45679999 7889999955 5789999999876532 12334567789999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++|++.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+.......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 80 FMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred ccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999999986542 23588999999999999999999999 99999999999999999999999998754432111
Q ss_pred C-------CcccccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 S-------NWTEFAGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~-------~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. ......++..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1 0112346778999999876 4588999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=292.14 Aligned_cols=192 Identities=26% Similarity=0.341 Sum_probs=166.0
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
...|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|++++++++|||||++++++..++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 457999999999999999999665 678899996321 235689999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|||++. ++|.+++... ...+++.++..|+.||+.||.|||++ |||||||||+|||++.++.+||+|||+++...
T Consensus 238 v~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 238 VLPKYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999995 5888877543 24689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 757 PHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 757 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 3221 123457999999999999999999999999999999999988764
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=273.35 Aligned_cols=202 Identities=24% Similarity=0.400 Sum_probs=172.6
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccC--CchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG--NMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
+|+..+.||+|+||.||+|.. .+++.+|+|++....... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999964 578999999986543111 11235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-CEEEeeccCcccc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-EAHVSDFGIAKFV 755 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~~~~~ 755 (848)
||||+++++|.+++... ..+++..+..++.|++.|+.|||++ |++||||+|+||+++.++ .+||+|||.+..+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998654 4678899999999999999999999 999999999999998776 5999999999876
Q ss_pred CCCCCC----cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSN----WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... .....++..|+|||++.+..++.++||||+|+++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 543111 1234678899999999888899999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=275.56 Aligned_cols=196 Identities=26% Similarity=0.357 Sum_probs=159.4
Q ss_pred eeccCCceeEEEEEcCC---CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 606 CIGKGGQGSVYKAELPS---GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
.||+|+||+||+|...+ ...+|+|.+.... .......+.+|++.++.++||||+++++.+...+..++||||++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 59999999999996543 3568888765432 23345668899999999999999999999999999999999999
Q ss_pred CCCHHhHhcCCCC--cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC
Q 038003 683 RGSLARILGDDVT--AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760 (848)
Q Consensus 683 ~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~ 760 (848)
+|+|.+++..... ....++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999865422 23356778889999999999999999 999999999999999999999999999875433221
Q ss_pred C--cccccccccccCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 761 N--WTEFAGTFGYAAPEIAYT-------MRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 761 ~--~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
. .....+++.|+|||+... ..++.++|||||||++|||++ |..||..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 1 122345678999998643 356889999999999999999 7888754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=276.02 Aligned_cols=201 Identities=24% Similarity=0.412 Sum_probs=171.8
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|+..+.||+|++|.||+|... +++.||||+++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 4888999999999999999765 689999999876532 223456778999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++ ++.+++........+++..+.+++.|++.|++|||+. +++||||||+||++++++.++++|||.+......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 99985 8888876543345689999999999999999999999 9999999999999999999999999999766443
Q ss_pred CCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........+++.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 203 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3333345678899999988654 468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=274.22 Aligned_cols=198 Identities=27% Similarity=0.421 Sum_probs=172.6
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
-|+..+.||+|+||.||+|.. .+++.+|+|++.... .....+.+.+|++.+++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 377888999999999999965 478899999876442 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 82 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99999999998854 3578899999999999999999999 9999999999999999999999999998766543
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........++..|+|||.+.+..++.++|+|||||++|+|+||..||..
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 3333345678899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=276.52 Aligned_cols=205 Identities=23% Similarity=0.376 Sum_probs=169.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 670 (848)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4578999999999999999999543 24579999876442 22344567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCC-------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVT-------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE 743 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 743 (848)
.+..++||||+++|+|.++++.... ....++..+.+++.|++.|+.|||++ +|+||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 9999999999999999999864211 13456778889999999999999999 9999999999999999999
Q ss_pred EEEeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 744 AHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 744 ~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
++|+|||+++......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987654322111 12234678999999988889999999999999999999 7889753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=277.99 Aligned_cols=204 Identities=27% Similarity=0.437 Sum_probs=171.5
Q ss_pred hhcCCcccceeccCCceeEEEEEcC--------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGF 667 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~ 667 (848)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3567889999999999999999631 34579999986542 234456788999999999 89999999999
Q ss_pred eecCCeeEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 038003 668 CYNGPHSFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 734 (848)
Q Consensus 668 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~ 734 (848)
+......++||||+++|+|.+++.... ....+++.++..++.||+.|+.|||++ ||+||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence 999999999999999999999986532 123578889999999999999999999 9999999999
Q ss_pred CeeeCCCCCEEEeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCc
Q 038003 735 NVLLDSNFEAHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 806 (848)
Q Consensus 735 NIll~~~~~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 806 (848)
||+++.++.+||+|||.++......... ....+++.|+|||++.+..++.++||||||+++|||+| |..||.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999998765432221 22345678999999998889999999999999999999 788864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=276.41 Aligned_cols=203 Identities=21% Similarity=0.389 Sum_probs=169.2
Q ss_pred cCCcccceeccCCceeEEEEEcC-----------------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcc
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-----------------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 661 (848)
++|++.+.||+|+||.||+|... +...+|+|++.... .....+.+.+|+++++.++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCc
Confidence 56999999999999999998533 23468999986542 23345678899999999999999
Q ss_pred cceEEEeecCCeeEEEEeccCCCCHHhHhcCCC--------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCC
Q 038003 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDV--------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISS 733 (848)
Q Consensus 662 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~ 733 (848)
+++++++...+..++||||+++++|.+++.... ....+++.++..++.|++.|++|||+. +|+||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp 158 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT 158 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence 999999999999999999999999999886532 123477888999999999999999999 999999999
Q ss_pred CCeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCcc
Q 038003 734 KNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK--GNHPRDF 807 (848)
Q Consensus 734 ~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~~ 807 (848)
+||+++.++.++|+|||.++.+...... .....+++.|+|||+..+..++.++|||||||++|||+| |..||..
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999865432211 112234678999999888889999999999999999998 7788753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=275.84 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=171.2
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|+..+.||+|++|.||+|... +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 4788899999999999999664 789999999865432 2233457889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+. +++.+++... ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 79 e~~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 79 EFLH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eccc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9996 5888887654 235688999999999999999999999 9999999999999999999999999998866543
Q ss_pred CCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........+++.|+|||++.+.. ++.++||||||+++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 33334445788999999887654 58889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=273.55 Aligned_cols=197 Identities=30% Similarity=0.469 Sum_probs=171.5
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|...+.||+|++|.||+|.. .+++.+|+|++... .....+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 355567899999999999965 47889999987543 2234566889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.+......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 99999999998865 3578889999999999999999999 9999999999999999999999999988765443
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........|++.|+|||...+..++.++||||||+++|||++|+.||..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 3333445689999999999888899999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=272.93 Aligned_cols=201 Identities=27% Similarity=0.477 Sum_probs=174.6
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|..+++..+|||.+.... ...+++.+|+.++++++||||+++++++......++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 46799999999999999999988888889999986542 3356788999999999999999999999998899999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.+++... ....+++.++..++.|++.|+.|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 80 ~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 80 TEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999999764 235689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.... .....++..|+|||.+.+..+++++||||+|+++||++| |+.||..
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 2111 112334568999999998889999999999999999999 9999743
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.65 Aligned_cols=203 Identities=25% Similarity=0.454 Sum_probs=170.8
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
.++|...+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 356888899999999999999532 4567899987654 234456789999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCC------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVT------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
+..++||||+++++|.+++..... ...+++.++..++.|++.|++|||+. +|+||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 999999999999999999865321 13578899999999999999999999 999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 740 SNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 740 ~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+++.+||+|||++..+...... .....+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999998765332211 122334678999999998889999999999999999999 9999753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=274.85 Aligned_cols=203 Identities=29% Similarity=0.427 Sum_probs=173.4
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCC--
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGP-- 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~-- 672 (848)
.+++|++.+.||+|++|.||+|..+ +++.+|+|++.... ...+.+.+|+++++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 4688999999999999999999764 67899999986542 2346788999999998 7999999999997644
Q ss_pred ----eeEEEEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 673 ----HSFLVCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 673 ----~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
..++||||+++++|.++++... ....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence 5899999999999999886532 235688999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCCcccccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 748 DFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|||.+..............|++.|+|||++.. ..+++++|||||||++|+|+||+.||..
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 99999876544444445678999999998753 3467899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=277.49 Aligned_cols=202 Identities=26% Similarity=0.364 Sum_probs=172.1
Q ss_pred CCcccceeccCCceeEEEEEc----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
+|++.+.||+|+||.||+|.. .+|..||+|++............+++.+|+++++++ +||+|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999965 368999999987654333334456788899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998654 4578889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CcccccccccccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSS-NWTEFAGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... ......|+..|+|||.+.+. .++.++||||||+++|+|+||+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 643321 22345688999999998753 467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=271.78 Aligned_cols=203 Identities=25% Similarity=0.329 Sum_probs=171.5
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccc-cCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--Cee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLL-SGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--PHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~ 674 (848)
.+|++.+.||+|+||.||+|.. .++..||+|++..... .......+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999965 4689999998754321 11234456788999999999999999999998764 467
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999988654 4578888999999999999999999 999999999999999999999999999986
Q ss_pred cCCC---CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPH---SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 5321 1112335688999999999988889999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=270.64 Aligned_cols=193 Identities=25% Similarity=0.436 Sum_probs=162.2
Q ss_pred eeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 606 CIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
.||+|+||.||+|.+. .+..||+|++.... .....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence 3899999999999653 35569999986542 2344567899999999999999999999875 457899999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+++|.+++... ...+++..+.+++.|++.|++|||++ |++||||||+||+++.++.+||+|||.+..........
T Consensus 78 ~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 78 GGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99999998643 24688999999999999999999999 99999999999999999999999999998664432221
Q ss_pred ---ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 763 ---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 763 ---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
....+++.|+|||.+.+..++.++|||||||++||+++ |+.||..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 11223578999999988889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=277.08 Aligned_cols=201 Identities=25% Similarity=0.318 Sum_probs=171.0
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCC-chhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN-MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+|+..+.||+|+||.||+|... +++.||||++........ ......+..|++++++++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999754 789999999876543211 12344567899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+ +++|.++++... ..+++..+..++.||++||.|||++ ||+||||+|+||+++.++.++|+|||.++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889999997652 3689999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.........+++.|+|||.+.+ ..++.++|||||||++|||++|..||.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 4333344456789999998865 457889999999999999999977764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=279.15 Aligned_cols=207 Identities=27% Similarity=0.410 Sum_probs=173.8
Q ss_pred HHhhcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEE
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGF 667 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~ 667 (848)
....++|+..+.||+|+||.||++... ....+|+|++.... .......+.+|+++++++ +||||++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 344567999999999999999999654 23679999987542 233456688999999999 89999999999
Q ss_pred eecCCeeEEEEeccCCCCHHhHhcCC-------------CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 038003 668 CYNGPHSFLVCEYLDRGSLARILGDD-------------VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 734 (848)
Q Consensus 668 ~~~~~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~ 734 (848)
+...+..++||||+++|+|.++++.. .....+++..+.+++.|++.|++|||+. +|+||||||+
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~ 161 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR 161 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence 99999999999999999999998642 1245688999999999999999999999 9999999999
Q ss_pred CeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 735 NVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 735 NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||+++.++.+||+|||.++.+...... .....++..|+|||+..+..++.++|||||||++||+++ |..||..
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 999999999999999999876543211 122234578999999988889999999999999999998 9999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=275.29 Aligned_cols=202 Identities=27% Similarity=0.402 Sum_probs=168.8
Q ss_pred CCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
+|++.+.||+|+||.||+|... ....+|+|.+.... .....+++.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 4778899999999999999643 23568888876542 22345678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCC---------------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 038003 674 SFLVCEYLDRGSLARILGDDV---------------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 732 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 732 (848)
.++||||+.+++|.+++.... ....+++.++..++.|++.|++|||+. +|+|||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dik 154 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLA 154 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhh
Confidence 999999999999999875321 123578899999999999999999999 99999999
Q ss_pred CCCeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 733 SKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 733 ~~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|+||++++++.+||+|||.++........ .....++..|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999765332211 122345678999999988889999999999999999999 9999753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=279.89 Aligned_cols=204 Identities=27% Similarity=0.417 Sum_probs=170.5
Q ss_pred hcCCcccceeccCCceeEEEEEcC--------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFC 668 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 668 (848)
.++|.+.+.||+|+||.||+|.+. +...+|+|.++... .......+.+|+++++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 357999999999999999999642 23569999987642 233456788899999999 799999999999
Q ss_pred ecCCeeEEEEeccCCCCHHhHhcCCCC-------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCC
Q 038003 669 YNGPHSFLVCEYLDRGSLARILGDDVT-------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 735 (848)
Q Consensus 669 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 735 (848)
...+..++||||+++|+|.+++..... ...+++.++.+++.|++.||+|||+. |++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999865321 23588899999999999999999999 99999999999
Q ss_pred eeeCCCCCEEEeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 736 VLLDSNFEAHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 736 Ill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|+++.++.+||+|||.++......... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 999999999999999987654322111 11234568999999998889999999999999999998 8888753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=270.33 Aligned_cols=200 Identities=25% Similarity=0.430 Sum_probs=172.2
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|++|+++++++.+ ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 4678999999999999999998878888999987643 2335678899999999999999999999887 778999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 79 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999999764 235678889999999999999999999 999999999999999999999999999976543
Q ss_pred CCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.... .....++..|+|||++.+..++.++|+|||||++|+++| |+.||..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 2211 122345678999999988889999999999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.83 Aligned_cols=201 Identities=25% Similarity=0.311 Sum_probs=171.3
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||++... +++.||+|.+...... .....+.+.+|+++++.++||||+++++.+..++..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 36888999999999999999665 6789999998765321 223456778999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 80 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 80 MEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999999654 4578889999999999999999999 999999999999999999999999998864211
Q ss_pred CCC---------------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSS---------------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
... ......++..|+|||.+.+..++.++|||||||++|||+||+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 000 0012457889999999988889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=279.67 Aligned_cols=203 Identities=28% Similarity=0.420 Sum_probs=168.0
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCC--EEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.++... .....+.+.+|++++.++ +||||+++++++.+.+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC---CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 457899999999999999999764 454 35777765432 233456788999999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC
Q 038003 674 SFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 740 (848)
.++||||+++++|.++++... ....+++.++..++.|++.|++|||++ ||+||||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC
Confidence 999999999999999986432 123578899999999999999999999 9999999999999999
Q ss_pred CCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 741 NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 741 ~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
++.+||+|||++....... ......++..|+|||++.+..+++++|||||||++|||+| |..||..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 226 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226 (303)
T ss_pred CCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence 9999999999986432111 1111234568999999988888999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=274.60 Aligned_cols=196 Identities=27% Similarity=0.333 Sum_probs=168.1
Q ss_pred eccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCC
Q 038003 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGS 685 (848)
Q Consensus 607 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gs 685 (848)
||+|+||+||+|... +++.||+|.+...... .......+..|++++++++||+|+++++++...+..|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999654 7899999998764322 12234556789999999999999999999999999999999999999
Q ss_pred HHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccc
Q 038003 686 LARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765 (848)
Q Consensus 686 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 765 (848)
|.+++.... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+..... .......
T Consensus 80 L~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~ 154 (277)
T cd05577 80 LKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGR 154 (277)
T ss_pred HHHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccc
Confidence 999886552 24688999999999999999999999 999999999999999999999999999876643 2222345
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 766 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.++..|+|||++.+..++.++||||+|+++|+|++|+.||...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 6788999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=273.99 Aligned_cols=200 Identities=28% Similarity=0.458 Sum_probs=168.0
Q ss_pred hcCCcccceeccCCceeEEEEEc-----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec--
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN-- 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-- 670 (848)
..+|++.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|++++++++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 35788899999999999999964 35789999998654 23445678899999999999999999998754
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
....++||||+++++|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+||++++++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCc
Confidence 34689999999999999998654 24588999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCc---ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 751 IAKFVGPHSSNW---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 751 ~~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
++.......... ....++..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 998764432211 11223456999999988889999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=275.09 Aligned_cols=201 Identities=26% Similarity=0.493 Sum_probs=169.9
Q ss_pred cCCcccceeccCCceeEEEEEcC-CC---CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SG---DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
.+|++.+.||+|+||.||+|.+. ++ ..||||++.... ......++..|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 45788899999999999999764 33 369999986542 234567789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++++|.++++.. .+.+++.++..++.|++.|++|||++ |++||||||+||+++.++.+||+|||.+..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 81 MIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999999998654 34688999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCc--cc-cc--ccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 755 VGPHSSNW--TE-FA--GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~--~~-~~--g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
........ .. .. .+..|+|||++.+..++.++|||||||++||+++ |..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 64322211 11 11 2457999999998889999999999999999997 9999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=279.02 Aligned_cols=204 Identities=24% Similarity=0.424 Sum_probs=171.9
Q ss_pred hcCCcccceeccCCceeEEEEEcCC-----------------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCc
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPS-----------------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 660 (848)
..+|++.+.||+|+||.||+|.... +..||+|++.... .....+.+.+|++++++++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCC
Confidence 4578999999999999999986542 2458999987653 2345677889999999999999
Q ss_pred ccceEEEeecCCeeEEEEeccCCCCHHhHhcCCC--------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 038003 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDV--------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 732 (848)
Q Consensus 661 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 732 (848)
|+++++++..++..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +|+|||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 9999999999999999999999999999986542 123688999999999999999999999 99999999
Q ss_pred CCCeeeCCCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCcc
Q 038003 733 SKNVLLDSNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK--GNHPRDF 807 (848)
Q Consensus 733 ~~NIll~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~~ 807 (848)
|+||+++.++.++|+|||.++....... ......+++.|+|||++.+..+++++|||||||++|||++ |..||..
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999876543221 1123445778999999988889999999999999999998 7778754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=273.64 Aligned_cols=199 Identities=24% Similarity=0.417 Sum_probs=169.3
Q ss_pred cCCcccceeccCCceeEEEEEc-----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG-- 671 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-- 671 (848)
+-|++.+.||+|+||.||+|.+ .++..||+|.++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3478889999999999999963 357889999986542 234456789999999999999999999998775
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
...++||||+++++|.+++... ...+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence 5689999999999999998654 23578999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC---cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 752 AKFVGPHSSN---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 752 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
++........ .....++..|+|||++.+..+++++|||||||++|||+|++.|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 9876433221 12345677899999998888999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=268.42 Aligned_cols=201 Identities=22% Similarity=0.362 Sum_probs=174.0
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|+..+.||+|+||.||+|.. .+++.+|+|++..... .....+.+.+|++++++++||+++++++.+...+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 488889999999999999965 4788999999876532 2344677889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-CEEEeeccCccccCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-EAHVSDFGIAKFVGP 757 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~~~~~~~ 757 (848)
||+++++|.++++.. ....+++..+.+++.|++.|++|||++ +|+||||+|+||+++.++ .+||+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 79 EYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred ecCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999999654 234578899999999999999999999 999999999999998654 689999999987754
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||+.
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 155 KSK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred Ccc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 322 2345688999999999988889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=271.11 Aligned_cols=202 Identities=25% Similarity=0.414 Sum_probs=167.7
Q ss_pred CcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe---
Q 038003 601 FDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH--- 673 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~--- 673 (848)
|++.+.||+|+||.||+|... .+..||+|+++.... .....+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 567889999999999999654 236799999875421 23445678999999999999999999998876554
Q ss_pred ---eEEEEeccCCCCHHhHhcCCC---CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 674 ---SFLVCEYLDRGSLARILGDDV---TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 674 ---~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
.++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 789999999999998875431 234688999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 748 DFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 748 DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|||.++.+....... ....++..|+|||++.+..+++++|||||||++|||++ |..||..
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 999998764433211 12234678999999988889999999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=273.39 Aligned_cols=207 Identities=29% Similarity=0.381 Sum_probs=173.5
Q ss_pred hcCCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCC---chhHHHHHHHHHHHhcCCCCcccceEEEeec-CC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGN---MADHDEFLNEVLALKEIRHRNNVKFHGFCYN-GP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 672 (848)
.++|-.++.||+|+|+.||+| ++...+.||||+-.....+.+ ....++..+|.+|.+.+.||.||++|+||.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 467888899999999999999 555678899998544432222 2345778899999999999999999999964 45
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---CCCEEEeec
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEAHVSDF 749 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Df 749 (848)
.+|-|.||++|.+|.-+++.. +-++++++..|+-||+.||.||.+.. +.|||.||||.|||+-. -|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 778999999999999999766 66889999999999999999999884 47999999999999953 478999999
Q ss_pred cCccccCCCCCC-------cccccccccccCccccccC----CCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 750 GIAKFVGPHSSN-------WTEFAGTFGYAAPEIAYTM----RATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 750 G~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
|+++++..+... ....+||.+|.+||.+.-. +.+.|+||||+|||+|.-+.|+.||+..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 999998765443 2347899999999987532 3578999999999999999999999753
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=273.50 Aligned_cols=202 Identities=26% Similarity=0.497 Sum_probs=170.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CC---CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SG---DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
..+|+..+.||+|+||.||+|... ++ ..+|+|+++... .....+.+..|++++++++||||+++.+++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 356888999999999999999764 33 379999886542 23345678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++++|.++++.. ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 81 AMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence 99999999999999998653 24688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcc---cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 754 FVGPHSSNWT---EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.......... ....++.|+|||++.+..++.++|||||||++||++| |+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 6643222111 1223457999999988889999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=268.63 Aligned_cols=194 Identities=29% Similarity=0.456 Sum_probs=164.0
Q ss_pred ceeccCCceeEEEEEcC-C---CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEec
Q 038003 605 FCIGKGGQGSVYKAELP-S---GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
+.||+|+||.||+|.+. . +..+|+|.+...... ...+++.+|+++++++.||||+++++++. .+..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence 46999999999999653 2 268999998765422 34567889999999999999999999876 4568999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~ 760 (848)
+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 77 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 77 APLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999999765 3688999999999999999999999 999999999999999999999999999987654332
Q ss_pred Ccc---cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 761 NWT---EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 761 ~~~---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
... ...++..|+|||.+.+..++.++||||||+++|||+| |+.||+..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 221 1223467999999998889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=270.90 Aligned_cols=202 Identities=26% Similarity=0.419 Sum_probs=165.1
Q ss_pred CcccceeccCCceeEEEEEcCC-CC--EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC------
Q 038003 601 FDEKFCIGKGGQGSVYKAELPS-GD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG------ 671 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------ 671 (848)
|.+.+.||+|+||.||+|.+.+ +. .+|+|.++.... .....+.+.+|+++++.++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC--TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 3567889999999999997654 32 589998866421 234467788999999999999999999987432
Q ss_pred CeeEEEEeccCCCCHHhHhcCC---CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 672 PHSFLVCEYLDRGSLARILGDD---VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
...++||||+++|+|.+++... .....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence 2468999999999998877422 1234588999999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 749 FGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||.++.+...... .....+++.|+|||+..+..+++++|||||||++|||++ |+.||..
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999876443221 122345678999999998889999999999999999999 8889753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=269.18 Aligned_cols=195 Identities=28% Similarity=0.442 Sum_probs=167.8
Q ss_pred ceeccCCceeEEEEEcCC--C--CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEec
Q 038003 605 FCIGKGGQGSVYKAELPS--G--DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+.+|++++++++||||+++++++.. ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 368999999999997643 3 36899998776422 456778999999999999999999999988 889999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~ 760 (848)
+++++|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+........
T Consensus 77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999876532 5689999999999999999999999 999999999999999999999999999987754322
Q ss_pred Cc---ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 761 NW---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 761 ~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.. ....++..|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 11 12456789999999998889999999999999999999 9999853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=275.58 Aligned_cols=203 Identities=22% Similarity=0.313 Sum_probs=168.3
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCe---
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPH--- 673 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~--- 673 (848)
++|++.+.||+|+||.||+|... +++.||+|+++.... .......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 46889999999999999999654 789999999866532 122345678899999999 46999999999887665
Q ss_pred --eEEEEeccCCCCHHhHhcCCCC--cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-CCCEEEee
Q 038003 674 --SFLVCEYLDRGSLARILGDDVT--AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSD 748 (848)
Q Consensus 674 --~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~D 748 (848)
.|+||||+++ ++.+++..... ...+++..+..++.||+.||.|||++ +|+||||||+||+++. ++.+||+|
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 7999999986 78887754322 24689999999999999999999999 9999999999999998 88999999
Q ss_pred ccCccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||.+..+...........+++.|+|||++.+ ..++.++||||||+++|+|+||..||..
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999876443333333456889999998865 4578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=268.78 Aligned_cols=198 Identities=29% Similarity=0.482 Sum_probs=173.1
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|... ++.||+|.++... ...+++.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 457899999999999999999765 7889999986652 2467789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence 99999999999987552 23689999999999999999999999 999999999999999999999999999987633
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
... ....+..|+|||++.+..++.++||||||+++||+++ |+.||...
T Consensus 155 ~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 155 GQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 221 2334668999999988889999999999999999998 99997543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=268.83 Aligned_cols=198 Identities=29% Similarity=0.470 Sum_probs=171.8
Q ss_pred ceeccCCceeEEEEEcCC----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEec
Q 038003 605 FCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
+.||+|+||.||+|.... +..+|+|+++..... ...+.+.+|++.++.++|++|+++++++.+....++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE---EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch---hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 369999999999996653 788999998765321 2467789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhcCCCC------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 681 LDRGSLARILGDDVT------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
+++++|.++++.... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence 999999999876421 36789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC--CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 755 VGPHS--SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 755 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
..... .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 75433 22234567889999999988889999999999999999999 69998654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=278.84 Aligned_cols=205 Identities=26% Similarity=0.417 Sum_probs=171.0
Q ss_pred hhcCCcccceeccCCceeEEEEEcC--------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGF 667 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~ 667 (848)
..++|.+.+.||+|+||.||+|... ....+|+|+++... .....+.+..|+++++++ +||||++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3467899999999999999999642 24568999986542 234456788999999999 69999999999
Q ss_pred eecCCeeEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 038003 668 CYNGPHSFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 734 (848)
Q Consensus 668 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~ 734 (848)
+...+..++||||+++|+|.++++... ....+++.++.+++.|++.||.|||++ ||+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 999999999999999999999986532 124588899999999999999999999 9999999999
Q ss_pred CeeeCCCCCEEEeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 735 NVLLDSNFEAHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 735 NIll~~~~~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||++++++.+||+|||.++......... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999998764322211 11234467999999988889999999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=273.60 Aligned_cols=202 Identities=30% Similarity=0.476 Sum_probs=176.9
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..+.|+..+.||+|+||.||+|.+. ++..+|+|++.... ...+.+.+|++++++++|+|++++++++...+..+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 4556888899999999999999766 78899999986542 14567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+|+||+++++|.+++.... ..+++..+..++.|++.|++|||+. ||+|+||+|+||+++.++.++|+|||.+...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 9999999999999997652 3789999999999999999999999 9999999999999999999999999998766
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
...........+++.|+|||++.+..++.++||||||+++|+|+||+.||...
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 54333333445788999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=281.98 Aligned_cols=204 Identities=27% Similarity=0.399 Sum_probs=168.2
Q ss_pred hcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 670 (848)
.++|++.+.||+|+||+||+|.+ .+++.||||+++... .....+.+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 46799999999999999999963 356789999986542 223456788999999999 78999999998865
Q ss_pred C-CeeEEEEeccCCCCHHhHhcCCCC------------------------------------------------------
Q 038003 671 G-PHSFLVCEYLDRGSLARILGDDVT------------------------------------------------------ 695 (848)
Q Consensus 671 ~-~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------ 695 (848)
. ...++||||+++|+|.++++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 467899999999999998753210
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCC--cc
Q 038003 696 ----------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WT 763 (848)
Q Consensus 696 ----------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~ 763 (848)
...+++..+..++.||+.|++|||++ +|+||||||+||++++++.+||+|||++......... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 12467888899999999999999999 9999999999999999999999999999865332211 11
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 764 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
...+++.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2345678999999988889999999999999999997 9999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=273.57 Aligned_cols=203 Identities=27% Similarity=0.463 Sum_probs=171.1
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
.++|+..+.||+|+||.||+|... ++..+|+|++.... .....+.+.+|+.++++++||||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 467999999999999999999653 56789999986542 233456788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCC-------------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDV-------------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 732 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 732 (848)
+..++||||+++++|.+++.... ....+++.++..++.|++.||+|||+. +++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 99999999999999999986321 113477888999999999999999999 99999999
Q ss_pred CCCeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCc
Q 038003 733 SKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 806 (848)
Q Consensus 733 ~~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 806 (848)
|+||+++.++.++|+|||.+..+...... ......++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999998765332211 122334678999999988889999999999999999998 888874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=278.95 Aligned_cols=234 Identities=25% Similarity=0.394 Sum_probs=187.3
Q ss_pred cCCcccceeccCCceeEEEEEcC---CCC--EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP---SGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
+..+..+.||+|.||.||+|.+. .|+ .||||.-+... .....+.|..|..+|+.++|||||+++|+|.+. .
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 44556678999999999999543 233 47888876654 345578899999999999999999999999876 5
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.|+|||.++-|.|..+++.+ ...++......++.||+.|++|||++ .+|||||-..|||+...-.|||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence 79999999999999999876 35688889999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCccc-ccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccccccccccchhhhhhhhhcCCCCC
Q 038003 754 FVGPHSSNWTE-FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKILDPRLP 831 (848)
Q Consensus 754 ~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (848)
.+.+....... ..-..-|||||-+.-++++.++|||-|||++||++. |..||.-.. -......++...+. |..|
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk--NsDVI~~iEnGeRl--P~P~ 615 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK--NSDVIGHIENGERL--PCPP 615 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc--ccceEEEecCCCCC--CCCC
Confidence 88765443222 223568999999999999999999999999999998 999975322 22333333333332 4445
Q ss_pred CCCCCcccccceee
Q 038003 832 TPSPSVMDYGGCHF 845 (848)
Q Consensus 832 ~~~~~~~~~~~~~~ 845 (848)
.++|.+..+|..||
T Consensus 616 nCPp~LYslmskcW 629 (974)
T KOG4257|consen 616 NCPPALYSLMSKCW 629 (974)
T ss_pred CCChHHHHHHHHHh
Confidence 56677766666554
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=274.35 Aligned_cols=201 Identities=27% Similarity=0.393 Sum_probs=173.8
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|++++++++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 36889999999999999999765 688999999876432 233457788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++++.+..+.+.. ..+++..+..++.||+.|+.|||+. +++||||+|+||++++++.+||+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 79 FEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9999987776665433 4578899999999999999999999 999999999999999999999999999987754
Q ss_pred CCC-CcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 432 23446678899999999887 789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=276.33 Aligned_cols=204 Identities=21% Similarity=0.393 Sum_probs=168.7
Q ss_pred hcCCcccceeccCCceeEEEEEcCC---------------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCccc
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPS---------------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 662 (848)
.++|++.+.||+|+||.||+|.... ...||+|+++... .....+.+.+|++++++++|||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3579999999999999999986532 2348999987542 233456788999999999999999
Q ss_pred ceEEEeecCCeeEEEEeccCCCCHHhHhcCCC---------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCC
Q 038003 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGDDV---------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISS 733 (848)
Q Consensus 663 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~ 733 (848)
++++++...+..++||||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++||||||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp 157 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT 157 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence 99999999999999999999999999885431 112467889999999999999999999 999999999
Q ss_pred CCeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCcc
Q 038003 734 KNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK--GNHPRDF 807 (848)
Q Consensus 734 ~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~~ 807 (848)
+||+++.++.+||+|||++......... .....+++.|+|||+..+..++.++|||||||++|||++ |..||..
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999999999765332211 122334678999999988889999999999999999998 6667654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=274.58 Aligned_cols=202 Identities=23% Similarity=0.354 Sum_probs=171.5
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--Cee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--PHS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~ 674 (848)
.++|++.+.||+|+||.||+|..+ +++.+|+|.++..... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 357889999999999999999765 6889999998755322 22334567899999999999999999998877 889
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++ +|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+..
T Consensus 82 ~lv~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred EEEehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 999999975 898888654 23688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
............+++.|+|||.+.+.. ++.++||||+|+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 765433334456788999999987644 68899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=273.74 Aligned_cols=205 Identities=22% Similarity=0.360 Sum_probs=173.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcCC-----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPS-----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN- 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 670 (848)
..++|++.+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA---SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 35679999999999999999997654 6889999876432 33456778899999999999999999998766
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCc-----ccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEE
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTA-----KELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH 745 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 745 (848)
....++++||+++++|.+++...... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence 46789999999999999998654222 4688999999999999999999999 999999999999999999999
Q ss_pred EeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 746 VSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 746 l~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|+|||+++.+.+..... ....++..|+|||++.+..++.++|||||||++||+++ |+.||..
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 99999998664322211 12335668999999998889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=269.17 Aligned_cols=202 Identities=25% Similarity=0.400 Sum_probs=174.2
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|+..+.||+|+||.||+|..+ +|..+|+|.+..... .....+.+.+|++++++++||||+++++.+.+.+..++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 5788899999999999999665 688999999866432 1234567789999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-CEEEeeccCccccCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-EAHVSDFGIAKFVGP 757 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~~~~~~~ 757 (848)
||+++++|.+++.+. ....+++..+..++.|++.|+.|||+. +++|+||||+||++++++ .+|++|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 79 EYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred ecCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999998654 223578999999999999999999999 999999999999999886 469999999987754
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........|++.|+|||+..+..++.++|+||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 43333345688999999999888899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=268.30 Aligned_cols=196 Identities=30% Similarity=0.473 Sum_probs=167.9
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEee-cCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCY-NGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... +..+|+|.++.. ...+.+.+|+.++++++|++++++++++. .....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 357899999999999999999765 788999987543 23467889999999999999999999764 4567899
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++.. ....+++..+..++.|++.|++|||++ ||+||||||+||++++++.+||+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 78 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred EEECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecc
Confidence 99999999999998754 223578899999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... ....++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 154 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 154 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 322 22344678999999988889999999999999999998 9999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=275.40 Aligned_cols=204 Identities=23% Similarity=0.244 Sum_probs=155.0
Q ss_pred hcCCcccceeccCCceeEEEEEcCC----CCEEEEEEcccccccCCch-------hHHHHHHHHHHHhcCCCCcccceEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMA-------DHDEFLNEVLALKEIRHRNNVKFHG 666 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~l~~ 666 (848)
.++|.+.+.||+|+||+||+|.+.+ +..+|+|+..........+ .......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999997654 4556666543221100000 0111223444566789999999999
Q ss_pred EeecCC----eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC
Q 038003 667 FCYNGP----HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742 (848)
Q Consensus 667 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 742 (848)
.+.... ..++++|++.. ++.+.++.. ...++..+..++.|++.|++|||+. +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 765543 34678887754 566655432 2356778889999999999999999 999999999999999999
Q ss_pred CEEEeeccCccccCCCCC-------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 743 EAHVSDFGIAKFVGPHSS-------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 743 ~~kl~DfG~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.++|+|||+|+.+..... ......||+.|+|||++.+..+++++|||||||++|||+||+.||...
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999987643221 112356999999999999999999999999999999999999999754
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=270.31 Aligned_cols=199 Identities=26% Similarity=0.445 Sum_probs=171.7
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
.+|++.+.||+|+||.||+|.+.++..+|+|++.... ...+.+.+|++++++++||+++++++++......++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-----MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-----CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 4688889999999999999988778899999986542 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.++++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 79 EFMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 999999999998654 24578899999999999999999999 9999999999999999999999999998766432
Q ss_pred CCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 759 SSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 759 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... .....++.+|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 211 122334678999999998889999999999999999998 9999754
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=269.05 Aligned_cols=195 Identities=29% Similarity=0.363 Sum_probs=170.7
Q ss_pred eccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCC
Q 038003 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGS 685 (848)
Q Consensus 607 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gs 685 (848)
||.|+||.||+|... ++..+|+|++...... .....+.+.+|+.+++.++||||+++++++.++...++||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999765 5899999998765322 22345778999999999999999999999999999999999999999
Q ss_pred HHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccc
Q 038003 686 LARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765 (848)
Q Consensus 686 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 765 (848)
|.+++... ..++...+..++.|++.|++|+|+. +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 80 L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~ 152 (262)
T cd05572 80 LWTILRDR---GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTF 152 (262)
T ss_pred HHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccc
Confidence 99999765 4578899999999999999999999 99999999999999999999999999998775432 22345
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 766 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
.+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 68899999999988889999999999999999999999986544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=270.26 Aligned_cols=195 Identities=22% Similarity=0.363 Sum_probs=157.2
Q ss_pred eeccCCceeEEEEEcCCCC---EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 606 CIGKGGQGSVYKAELPSGD---IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
.||+|+||+||+|...++. .+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 5999999999999654433 45566654432 23446788999999999999999999999999999999999999
Q ss_pred CCCHHhHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC--
Q 038003 683 RGSLARILGDDVT-AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS-- 759 (848)
Q Consensus 683 ~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~-- 759 (848)
+|+|.++++.... ....+...+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999875422 23466677889999999999999999 99999999999999999999999999986432211
Q ss_pred CCcccccccccccCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCc
Q 038003 760 SNWTEFAGTFGYAAPEIAYT-------MRATEKYDVYSFGVLVFEVIK-GNHPRD 806 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~P~~ 806 (848)
.......++..|+|||+... ..+++++|||||||++|||++ |..||.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 11234567889999998753 245789999999999999997 566764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=263.88 Aligned_cols=204 Identities=29% Similarity=0.381 Sum_probs=166.3
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHH-HhcCCCCcccceEEEeecCCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLA-LKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+.+....||.|+||+|++..++ .|...|||+++... ...+.+++..|.+. ++.-+.||||++||.+..++..|+.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 3444567999999999999665 79999999998765 34566778888886 4555899999999999999999999
Q ss_pred EeccCCCCHHhHhcCC--CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 678 CEYLDRGSLARILGDD--VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
||.|+- |+..+-..- ....++++.-..+|....+.||.||.+.. .|+|||+||+|||++..|.+||||||.+-..
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999965 665543321 12346777778888999999999999875 8999999999999999999999999998776
Q ss_pred CCCCCCcccccccccccCccccc--cCCCCccchhhhHHHHHHHHHhCCCCCccccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAY--TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI 810 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 810 (848)
..+ -..+..+|-..|||||.+. +..|+-++||||+|+++||+.||++||+-++.
T Consensus 219 v~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 219 VDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred HHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 442 2234456777899999886 33588999999999999999999999876655
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=272.68 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=168.8
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|++|+||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 57899999999999999999765 789999999866432 123346678899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-CCCEEEeeccCccccC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVG 756 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~~~~~~ 756 (848)
|||+++ ++.+++... ....+++..+..++.||+.||+|||++ +|+||||+|+||+++. ++.+||+|||.+....
T Consensus 80 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 80 FEYLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred Eecccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 999964 787777543 223467788889999999999999999 9999999999999985 5579999999998665
Q ss_pred CCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+++.|+|||++.+. .++.++||||+||++|+|+||+.||..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 433333445678899999988764 578899999999999999999999853
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=279.30 Aligned_cols=232 Identities=27% Similarity=0.468 Sum_probs=195.5
Q ss_pred cCCcccceeccCCceeEEEEEcCC-CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
-+....+.||.|.||.||.|.|+. .-.||||.++.. ....++|..|..+|+.++|||+|+++|+|.....+|+|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 356677899999999999998874 567999998664 45678999999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
.|||..|+|.+++++- ....++......++.||+.|++||..+ .+|||||-+.|.|+.++..||++|||+++.+..
T Consensus 342 TEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 9999999999999875 334566667788999999999999999 999999999999999999999999999999865
Q ss_pred CCCCcccccc---cccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccccccccccchhhhhhhhhcCCCCCCC
Q 038003 758 HSSNWTEFAG---TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFSNMIIDVNKILDPRLPTP 833 (848)
Q Consensus 758 ~~~~~~~~~g---~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (848)
+.. +.++| .+-|.|||-+....++.|+|||+|||++||+.| |..| +.+++.+.+...+...-++ .....+
T Consensus 418 DTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsP--YPGidlSqVY~LLEkgyRM--~~PeGC 491 (1157)
T KOG4278|consen 418 DTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYGLLEKGYRM--DGPEGC 491 (1157)
T ss_pred Cce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCC--CCCccHHHHHHHHhccccc--cCCCCC
Confidence 443 44455 468999999999999999999999999999999 8889 4566666555554444333 334567
Q ss_pred CCCcccccceee
Q 038003 834 SPSVMDYGGCHF 845 (848)
Q Consensus 834 ~~~~~~~~~~~~ 845 (848)
+|.+.++|..||
T Consensus 492 PpkVYeLMraCW 503 (1157)
T KOG4278|consen 492 PPKVYELMRACW 503 (1157)
T ss_pred CHHHHHHHHHHh
Confidence 888888887766
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=267.16 Aligned_cols=190 Identities=24% Similarity=0.361 Sum_probs=158.0
Q ss_pred ceeccCCceeEEEEEcCC-------------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 605 FCIGKGGQGSVYKAELPS-------------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
+.||+|+||.||+|.+.+ ...+|+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 368999999999996532 2258888875542 23445678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC-------E
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE-------A 744 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~ 744 (848)
...++||||+++++|..++... ...+++..+.+++.||+.|++|||++ +|+||||||+||+++.++. +
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence 9999999999999998887643 24588899999999999999999999 9999999999999987664 8
Q ss_pred EEeeccCccccCCCCCCcccccccccccCccccc-cCCCCccchhhhHHHHHHHHH-hCCCCCcc
Q 038003 745 HVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVI-KGNHPRDF 807 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-tg~~P~~~ 807 (848)
+++|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||..
T Consensus 152 ~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 152 KLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred EeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998765322 2345788999999886 466889999999999999998 58888753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=271.04 Aligned_cols=202 Identities=25% Similarity=0.461 Sum_probs=170.5
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCC----EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
..+|++.+.||+|+||.||+|.++ +++ .+|+|++.... ......++.+|+.++++++||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 356889999999999999999654 333 58999876553 23445678899999999999999999999987 7
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++|+|.+++... ...+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence 889999999999999998654 23588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCcc--cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 753 KFVGPHSSNWT--EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 753 ~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
+.......... ...++..|+|||.+....++.++|+||||+++||++| |+.||+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 87654332221 1223568999999988888999999999999999999 99998643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=269.86 Aligned_cols=196 Identities=32% Similarity=0.516 Sum_probs=165.3
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhc--CCCCcccceEEEeecCC---
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKE--IRHRNNVKFHGFCYNGP--- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~l~~~~~~~~--- 672 (848)
.+..+..+.+|+|.||.||+|.+. ++.||||++.. .+++.|..|.+|.+. ++|+||++++++-..++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 344566778999999999999886 58899999854 456778888888665 48999999999877666
Q ss_pred -eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEEcCCCCCCeeeCCCCCEE
Q 038003 673 -HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC------LPSIIHRDISSKNVLLDSNFEAH 745 (848)
Q Consensus 673 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~k 745 (848)
.+++|+||.+.|+|.+++..+ .++|....+|+..+++||+|||+.. .|+|+|||||+.|||+..|++..
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 899999999999999999654 6899999999999999999999754 36799999999999999999999
Q ss_pred EeeccCccccCCCCC--CcccccccccccCccccccCC------CCccchhhhHHHHHHHHHhCCCCC
Q 038003 746 VSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMR------ATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 746 l~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltg~~P~ 805 (848)
|+|||+|.++.+... .....+||.+|||||++.+.- .-.+.||||+|.|+|||++...-+
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999999998865332 223478999999999998642 123689999999999999976544
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=270.97 Aligned_cols=199 Identities=26% Similarity=0.424 Sum_probs=171.8
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.++++++||||+++++++..+...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 5888899999999999999764 7899999998765322 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+ +++|.+++.... ..+++.++..++.||++||+|||+. +++|+||||+||+++.++.++|+|||.+......
T Consensus 79 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 79 EYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred ccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 999 999999886542 5688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-CcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCc
Q 038003 759 SS-NWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 759 ~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.. ......++..|+|||++.+.. +++++||||+|+++|||+||..||.
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 21 123456889999999987544 6889999999999999999987764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=277.62 Aligned_cols=204 Identities=27% Similarity=0.406 Sum_probs=170.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC--------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFC 668 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 668 (848)
..+|++.+.||+|+||.||+|... .+..+|+|.++... .....+++.+|+++++++ +||||+++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 356899999999999999999642 12368999886542 234467789999999999 899999999999
Q ss_pred ecCCeeEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCC
Q 038003 669 YNGPHSFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 735 (848)
Q Consensus 669 ~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 735 (848)
...+..++||||+++|+|.+++.... ....+++.++..++.|++.|++|||++ ||+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999986431 123578899999999999999999999 99999999999
Q ss_pred eeeCCCCCEEEeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 736 VLLDSNFEAHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 736 Ill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|+++.++.+||+|||.++......... ....++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999998664322211 22234568999999998889999999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=271.13 Aligned_cols=200 Identities=26% Similarity=0.381 Sum_probs=169.8
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|++.+.||.|++|.||+|... +|..||+|++..... .....+.+.+|+++++.++||+++++++++.+++..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 677889999999999999654 799999999876532 12334567889999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|++ ++|.+++.... ...+++..+.+++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 79 FLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred ccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 995 58998886552 24688999999999999999999999 99999999999999999999999999997664333
Q ss_pred CCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......+++.|+|||++.+. .++.++||||||+++|+|+||+.||..
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 333334568899999988764 468899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=268.07 Aligned_cols=202 Identities=27% Similarity=0.394 Sum_probs=170.0
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCC------chhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN------MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
+|...+.||+|+||.||+|.. .+++.+|+|.++....... ....+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999965 4789999998864321111 112356788999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++++|.++++.. ..+++..+..++.||+.|+.|||+. +++||||+|+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998765 5688889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--CcccccccccccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSS--NWTEFAGTFGYAAPEIAYTMR--ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........ ......|+..|+|||++.... ++.++|+||||+++||+++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 76532211 122346788999999987654 78899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=283.14 Aligned_cols=198 Identities=26% Similarity=0.429 Sum_probs=171.1
Q ss_pred CcccceeccCCceeEEEEEcC--CCC--EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 601 FDEKFCIGKGGQGSVYKAELP--SGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
....+.||+|+||+|++|.|. .|+ .||||.++..... ..-+.|.+|+.+|.+++|||++++||+..+ ....|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 344567999999999999775 444 4899998776432 256789999999999999999999999887 56789
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|||.++.|+|.+++++. ....+-......++.|||.|+.||..+ ++||||+-..|+++-....|||+|||+++..+
T Consensus 188 V~ELaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 99999999999999883 456788889999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCCcc---cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCc
Q 038003 757 PHSSNWT---EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 806 (848)
Q Consensus 757 ~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 806 (848)
.....+. ...-...|+|||.+...+++.++|||+|||++|||+| |..||-
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence 6544332 1223568999999999999999999999999999999 888984
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=272.69 Aligned_cols=202 Identities=29% Similarity=0.362 Sum_probs=172.0
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--CeeE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--PHSF 675 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~ 675 (848)
++|+..+.||.|++|.||+|... +++.+|+|.+.... ......++.+|++++++++||||++++++|.+. +..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 36888899999999999999764 68899999986542 224457789999999999999999999998653 4789
Q ss_pred EEEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 676 LVCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
+||||+++++|.++++... ....++...+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 9999999999988765321 234678889999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
...... ....++..|+|||.+.+..++.++||||+||++|+|+||+.||+..
T Consensus 155 ~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 155 LVNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 543221 2345788999999999888999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=270.59 Aligned_cols=193 Identities=22% Similarity=0.305 Sum_probs=160.0
Q ss_pred eeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHH---HhcCCCCcccceEEEeecCCeeEEEEecc
Q 038003 606 CIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLA---LKEIRHRNNVKFHGFCYNGPHSFLVCEYL 681 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~---l~~l~hp~iv~l~~~~~~~~~~~lV~e~~ 681 (848)
.||+|+||.||+|... +++.+|+|.+....... ......+.+|..+ +...+||+|+.+++++...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc-chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 4899999999999664 68999999987654321 1222333444443 34457999999999999999999999999
Q ss_pred CCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCC
Q 038003 682 DRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN 761 (848)
Q Consensus 682 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~ 761 (848)
++++|.+++... +.+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 80 ~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 80 NGGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999988654 5689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cccccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 762 WTEFAGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 762 ~~~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.....|++.|+|||... +..++.++||||+||++|||+||+.||..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 23356899999999886 45578999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=274.13 Aligned_cols=203 Identities=28% Similarity=0.378 Sum_probs=169.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--Ce
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--PH 673 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~ 673 (848)
..++|++.+.||+|+||.||+|... +++.||+|+++..... ......+.+|++++++++|+||+++++++... +.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 3567999999999999999999664 6899999998654321 12233456899999999999999999998754 56
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+.+ +|.+++... ...+++.++..++.||+.|++|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred EEEEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceee
Confidence 8999999975 788877543 25688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.............+++.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 77544333334456788999999875 4578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=268.63 Aligned_cols=194 Identities=22% Similarity=0.288 Sum_probs=160.7
Q ss_pred eeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHH---HHHhcCCCCcccceEEEeecCCeeEEEEecc
Q 038003 606 CIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEV---LALKEIRHRNNVKFHGFCYNGPHSFLVCEYL 681 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~ 681 (848)
.||+|+||.||+|.. .+++.||+|.+........ .....+..|. +.++...||+|+++++++.+.+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 489999999999965 4689999999876543211 1122233333 3455568999999999999999999999999
Q ss_pred CCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCC
Q 038003 682 DRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN 761 (848)
Q Consensus 682 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~ 761 (848)
+|++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 80 NGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999999988654 5689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 762 WTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 762 ~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.....|+..|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 2345789999999998744 5889999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=266.73 Aligned_cols=192 Identities=27% Similarity=0.330 Sum_probs=161.7
Q ss_pred ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHH-HhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 605 FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLA-LKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.||+|+||.||+|... +++.||+|++.+..... ......+..|..+ ....+|||++++++++.+.+..++||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 46999999999999654 68999999986543211 1222334455444 445689999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+++|.++++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.+..... .
T Consensus 81 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~ 150 (260)
T cd05611 81 GGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N 150 (260)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence 99999998654 4578899999999999999999999 999999999999999999999999999876433 2
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....+++.|+|||.+.+..++.++||||+|+++|||+||..||..
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 335678899999999888889999999999999999999999853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=267.90 Aligned_cols=195 Identities=29% Similarity=0.440 Sum_probs=161.3
Q ss_pred eeccCCceeEEEEEcC-CCC--EEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEEEecc
Q 038003 606 CIGKGGQGSVYKAELP-SGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVCEYL 681 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV~e~~ 681 (848)
.||+|+||.||+|.+. ++. .+|+|.++... .....+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 6899999999999765 343 46888876432 234456788999999999 8999999999999999999999999
Q ss_pred CCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 682 DRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 682 ~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
++|+|.++++... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 9999999986432 123478899999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||++....... .......+..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 156 fgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 156 FGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred CCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99986432111 1111233567999999988889999999999999999997 9999853
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=270.95 Aligned_cols=193 Identities=30% Similarity=0.479 Sum_probs=168.4
Q ss_pred cceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 604 KFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
...||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 35799999999999966 47899999987543 22345668899999999999999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
+++|.+++.. ..+++..+..++.|++.|++|||+. |++||||+|+||++++++.++|+|||.+..........
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 101 GGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 9999998743 3478889999999999999999999 99999999999999999999999999987664433333
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||..
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 445688999999999888889999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=267.35 Aligned_cols=195 Identities=23% Similarity=0.372 Sum_probs=163.1
Q ss_pred HHHhhcCCccccee--ccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEee
Q 038003 594 IIKATDDFDEKFCI--GKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCY 669 (848)
Q Consensus 594 ~~~~~~~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 669 (848)
.....++|++.+.+ |+|+||.||++.. .++..+|+|.+...... .. |+.....+ +||||+++++.+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~-----e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----AI-----EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----hh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence 34445667776666 9999999999965 47888999998654221 11 22222212 7999999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-CEEEee
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-EAHVSD 748 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~D 748 (848)
..+..++||||+++++|.++++.. ..+++.++..++.||++|+.|||+. +++||||||+||+++.++ .++|+|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 999999999999999999999755 3789999999999999999999999 999999999999999998 999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||.+...... ....++..|+|||++.+..++.++||||+|+++|||+||+.||..
T Consensus 154 fg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 208 (267)
T PHA03390 154 YGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208 (267)
T ss_pred CccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 9998866432 234678999999999988899999999999999999999999863
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=269.33 Aligned_cols=189 Identities=23% Similarity=0.364 Sum_probs=156.8
Q ss_pred eeccCCceeEEEEEcCC-------------------------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCc
Q 038003 606 CIGKGGQGSVYKAELPS-------------------------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 660 (848)
.||+|+||.||+|.+.. ...||+|++.... ......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 59999999999985421 1358889886542 233456788999999999999
Q ss_pred ccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC
Q 038003 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 661 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 740 (848)
|+++++++.+....++||||+++|+|..++... ...+++..+..++.||++|++|||++ +|+||||||+||+++.
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~ 152 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR 152 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence 999999999999999999999999999988653 24678899999999999999999999 9999999999999976
Q ss_pred CC-------CEEEeeccCccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHH-hCCCCCcc
Q 038003 741 NF-------EAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVI-KGNHPRDF 807 (848)
Q Consensus 741 ~~-------~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell-tg~~P~~~ 807 (848)
.+ .+|++|||.+...... ....++..|+|||.+.+ ..+++++|||||||++||++ +|+.||..
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred cCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 43 3899999988654322 22356788999998865 56789999999999999995 69999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=271.39 Aligned_cols=199 Identities=30% Similarity=0.436 Sum_probs=168.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|+..+.||+|+||.||+|... +++.||+|++...... .....+++.+|+++++.++||||+++++++.+.+..++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 355888999999999999999664 6899999998654221 22344678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++ ++.+.+... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9999975 676666432 24588999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ....+++.|+|||++. ...++.++||||||+++|||+||+.||..
T Consensus 167 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 167 PA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred CC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 32 2346788999999874 34578899999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=265.30 Aligned_cols=194 Identities=29% Similarity=0.473 Sum_probs=158.5
Q ss_pred ceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-CCeeEEEEe
Q 038003 605 FCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN-GPHSFLVCE 679 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lV~e 679 (848)
+.||+|+||.||+|.+. +...+|+|++.... .....+.+.+|+.+++.++||||+++++++.. ++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 36899999999999653 23579999875431 23445678899999999999999999998764 556889999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+.+++|.++++.. ....++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.++......
T Consensus 78 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 78 YMKHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999999998654 23467788889999999999999999 99999999999999999999999999997653321
Q ss_pred C----CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCC-CCCc
Q 038003 760 S----NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN-HPRD 806 (848)
Q Consensus 760 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~P~~ 806 (848)
. ......+++.|+|||++.+..++.++|||||||++|||+||+ .||.
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 1 112234567899999998888999999999999999999965 4543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=265.01 Aligned_cols=194 Identities=27% Similarity=0.459 Sum_probs=166.6
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
++|++.+.||+|+||.||++.. +++.+|+|+++.. ...+.+.+|+.++++++|||++++++++... ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 4688999999999999999975 6788999998543 2346788999999999999999999998765 479999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.+++... ....+++..+..++.|++.|+.|||+. |++||||||+||+++.++.+||+|||.+......
T Consensus 78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999999998654 234578899999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
......+..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 200 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 122334678999999988889999999999999999998 9999754
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=262.77 Aligned_cols=200 Identities=29% Similarity=0.427 Sum_probs=177.5
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++||+++++++++.++...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 4788899999999999999654 6889999998776321 245677899999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.+++... ..+++..+..++.|++.|+.|||+. ||+||||+|+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 79 EYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred ecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999998655 5688999999999999999999999 9999999999999999999999999999887654
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........++..|+|||...+..++.++||||+|+++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 4433456788999999999887789999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=263.78 Aligned_cols=202 Identities=28% Similarity=0.394 Sum_probs=177.9
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--CeeEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--PHSFL 676 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~l 676 (848)
+|+..+.||+|++|.||+|... ++..+++|++...... ....+.+.+|++++++++||+|+++++.+... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 4778899999999999999765 7899999998765321 34567789999999999999999999999988 88999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+....
T Consensus 79 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 79 FLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999999999998755 3789999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 757 PHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 757 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
.... ......++..|+|||...+..++.++||||||+++|+|++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432 1344568899999999988889999999999999999999999987644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=266.32 Aligned_cols=201 Identities=28% Similarity=0.391 Sum_probs=168.2
Q ss_pred hcCCcccceeccCCceeEEEEEcCC----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||.||+|.+.+ ...+|||...... .....+.+.+|+.++++++||||+++++++.+ +.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 3568888999999999999996543 2468999876542 23456678999999999999999999999876 45
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence 78999999999999998654 23578999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 754 FVGPHSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
........ .....+++.|+|||.+.+..++.++||||||+++||+++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 66433211 122334568999999988889999999999999999996 9999854
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=273.12 Aligned_cols=201 Identities=25% Similarity=0.443 Sum_probs=167.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCC----EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
..+|+..+.||+|+||.||+|.+. +++ .+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 356888899999999999999654 444 47888876542 223345688999999999999999999998754
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++|+||+++|++.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred CceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence 467999999999999998654 23578889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 753 KFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+........ .....++..|+|||++.+..++.++|||||||++||++| |+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876432221 122345678999999998889999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=261.44 Aligned_cols=199 Identities=32% Similarity=0.470 Sum_probs=176.5
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|+..+.||+|++|.||+|... ++..+++|++..... ...+.+.+|++++++++||+++++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4788899999999999999765 788999999876531 35677889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 77 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 77 EFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred ecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 9999999999986542 5689999999999999999999998 9999999999999999999999999999877654
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 152 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 152 KA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 32 34456889999999998888899999999999999999999998654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=293.87 Aligned_cols=202 Identities=20% Similarity=0.306 Sum_probs=159.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC--CCCEEEEEE--------------cccccccCCchhHHHHHHHHHHHhcCCCCcc
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--SGDIVAVKK--------------FNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 661 (848)
.++|++.+.||+|+||+||+|.++ ++...++|. +.+. ..........+.+|++++++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~-~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKR-VKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHH-hhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 468999999999999999998653 222222221 1111 11122334567899999999999999
Q ss_pred cceEEEeecCCeeEEEEeccCCCCHHhHhcCCCC--cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVT--AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 662 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
+++++++...+..|+|+|++.+ ++.+++..... ........+..|+.||+.||+|||++ +||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999965 67666543211 12234566788999999999999999 999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 038003 740 SNFEAHVSDFGIAKFVGPHSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804 (848)
Q Consensus 740 ~~~~~kl~DfG~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 804 (848)
.++.+||+|||+++.+..... ......|++.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999987654322 22346799999999999998999999999999999999998864
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=267.02 Aligned_cols=194 Identities=30% Similarity=0.412 Sum_probs=168.5
Q ss_pred eccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCC
Q 038003 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGS 685 (848)
Q Consensus 607 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gs 685 (848)
||+|+||.||+|... +++.+|+|++...... .....+.+.+|++++++++||||+++++.+...+..++||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-RKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh-hhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999776 5999999998765322 23445678899999999999999999999999999999999999999
Q ss_pred HHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC-----
Q 038003 686 LARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS----- 760 (848)
Q Consensus 686 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~----- 760 (848)
|.++++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 80 L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 80 LASLLENV---GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99998754 3688999999999999999999999 999999999999999999999999999876543211
Q ss_pred ---CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 761 ---NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 761 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
......++..|+|||...+..++.++||||||+++||++||+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 22335678899999999888889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=271.51 Aligned_cols=202 Identities=26% Similarity=0.362 Sum_probs=171.4
Q ss_pred CCcccceeccCCceeEEEEEc----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
+|++.+.||+|+||.||+|.. .+++.||||++++..........+.+.+|+++++++ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999864 357889999987653332334456788999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999988644 4578889999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCC-cccccccccccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSN-WTEFAGTFGYAAPEIAYTMR--ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....... .....|+..|+|||.+.+.. .+.++||||||+++|||+||..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 5433222 12356889999999987655 68899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=271.87 Aligned_cols=202 Identities=28% Similarity=0.385 Sum_probs=166.3
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~l 676 (848)
++|+..+.||+|+||.||++... +++.+|+|++.... .......+.+|+.++.++. ||||+++++++..+...++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV---DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc---ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 45677788999999999999654 68999999987643 2244567889999999996 9999999999999999999
Q ss_pred EEeccCCCCHHhHhc---CCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 677 VCEYLDRGSLARILG---DDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 677 V~e~~~~gsL~~~l~---~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
+|||+.. ++.++.. .. ....+++..+.+++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 9999865 5544332 11 2356889999999999999999999742 89999999999999999999999999997
Q ss_pred ccCCCCCCcccccccccccCccccccC---CCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTM---RATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
....... .....|++.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 157 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 157 QLVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred HhccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 6543222 2334678899999998766 6889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=272.52 Aligned_cols=205 Identities=22% Similarity=0.349 Sum_probs=168.9
Q ss_pred CCcccceeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--Cee
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--PHS 674 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~ 674 (848)
+|++.+.||+|+||.||+|... ++..||+|.+...... .....+.+.+|+.++++++||||+++++++.+. +..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-YTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 4788899999999999999664 4789999998774311 223345678899999999999999999999988 789
Q ss_pred EEEEeccCCCCHHhHhcCCCC--cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC----CCCEEEee
Q 038003 675 FLVCEYLDRGSLARILGDDVT--AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS----NFEAHVSD 748 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~D 748 (848)
++||||+++ ++.+.+..... ...++...+..++.||+.|++|||+. +|+||||||+||+++. ++.+||+|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999976 66666543221 23688899999999999999999999 9999999999999999 99999999
Q ss_pred ccCccccCCCCC---CcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 749 FGIAKFVGPHSS---NWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 749 fG~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
||++........ ......+++.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 999987643322 12335678899999988764 57889999999999999999999986443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=264.15 Aligned_cols=189 Identities=26% Similarity=0.396 Sum_probs=159.7
Q ss_pred ceeccCCceeEEEEEcCCCC-----------EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 605 FCIGKGGQGSVYKAELPSGD-----------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
+.||+|+||.||+|.+.+.. .+++|++.... .....+.+|+.++++++||||+++++++.. +.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 36999999999999775433 47777765432 125778899999999999999999999988 77
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-------CEEE
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-------EAHV 746 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl 746 (848)
.++||||+++|+|.++++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence 899999999999999987652 2688899999999999999999999 999999999999999888 7999
Q ss_pred eeccCccccCCCCCCcccccccccccCccccccC--CCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 747 SDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 747 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
+|||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...
T Consensus 150 ~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 150 SDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 99999987643 2234567789999998876 78899999999999999999 57776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=268.42 Aligned_cols=201 Identities=28% Similarity=0.441 Sum_probs=171.3
Q ss_pred cCCcccceeccCCceeEEEEEcC-----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec--C
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN--G 671 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~ 671 (848)
++|+..+.||+|+||.||+|.+. ++..+|+|++..... ....+.+.+|+++++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 46888899999999999999653 468899999876531 1346778999999999999999999999887 5
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
...++||||+++++|.+++... ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence 5789999999999999999754 23588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCc---ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSSNW---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.......... ....++..|+|||...+..++.++||||||+++|||+||+.|+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 98775332211 122345679999999888899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=267.60 Aligned_cols=202 Identities=26% Similarity=0.422 Sum_probs=171.1
Q ss_pred cCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
++|+..+.||+|+||.||+|..+ +...+|+|.+.... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 57889999999999999999754 34679999875532 2224567899999999999999999999999989
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCc------ccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEE
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTA------KELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV 746 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 746 (848)
..++||||+++++|.++++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence 999999999999999998755321 2589999999999999999999999 9999999999999999999999
Q ss_pred eeccCccccCCCC-CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCc
Q 038003 747 SDFGIAKFVGPHS-SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 806 (848)
Q Consensus 747 ~DfG~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 806 (848)
+|||++....... .......+++.|+|||.+.+..+++++||||||+++|+|++ |..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9999987543221 12233456778999999988888999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=262.44 Aligned_cols=195 Identities=31% Similarity=0.420 Sum_probs=166.5
Q ss_pred ceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCC
Q 038003 605 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRG 684 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~g 684 (848)
+.||+|+||.||+|...+++.||+|++..... ....+.+.+|++++++++||+|+++++++.+....++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 36999999999999876699999999876532 235567899999999999999999999999999999999999999
Q ss_pred CHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc--
Q 038003 685 SLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW-- 762 (848)
Q Consensus 685 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~-- 762 (848)
+|.++++.. ...+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+..........
T Consensus 78 ~l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 78 SLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 999998654 23578889999999999999999999 99999999999999999999999999997654211111
Q ss_pred ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 763 ~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.....+..|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 11223567999999988889999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=262.06 Aligned_cols=204 Identities=27% Similarity=0.411 Sum_probs=178.6
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||.|+||.||+|... ++..+|+|++..... .....+.+.+|+++++.++|||++++++.+...+..++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 5788899999999999999664 689999999876532 2345667889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 679 EYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
||+++++|.++++... ....+++..+..++.|++.|+.|||+. |++|+||+|+||++++++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 9999999999887542 236789999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.........|++.|+|||...+..++.++|+||+|+++|+|++|+.||+..
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 433334457889999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=266.70 Aligned_cols=197 Identities=27% Similarity=0.419 Sum_probs=164.3
Q ss_pred ceeccCCceeEEEEEcCC-------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 605 FCIGKGGQGSVYKAELPS-------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+.||+|+||.||+|...+ +..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 369999999999996542 2579999876542 123456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCC----CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-----CEEEee
Q 038003 678 CEYLDRGSLARILGDDV----TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-----EAHVSD 748 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~D 748 (848)
|||+++++|.++++... ....+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++++|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999999999986432 123478899999999999999999999 999999999999999877 899999
Q ss_pred ccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 749 FGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||++......... .....++..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 9998765332211 122345678999999998889999999999999999998 9999854
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=264.71 Aligned_cols=204 Identities=26% Similarity=0.437 Sum_probs=171.6
Q ss_pred CCcccceeccCCceeEEEEEcCC--CCEEEEEEccccccc------CCchhHHHHHHHHHHHhc-CCCCcccceEEEeec
Q 038003 600 DFDEKFCIGKGGQGSVYKAELPS--GDIVAVKKFNSQLLS------GNMADHDEFLNEVLALKE-IRHRNNVKFHGFCYN 670 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~------~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~ 670 (848)
.|++.+.||+|+||.||+|.... ++.+|+|.+...... .......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999997654 788999987644221 112334567788888765 799999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 671 GPHSFLVCEYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
++..++||||+++++|.+++... .....+++..+.+++.|++.|+.|||+ . +++||||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887432 123468889999999999999999996 5 899999999999999999999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||.+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 99998765433 33456788999999999988899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=262.44 Aligned_cols=190 Identities=28% Similarity=0.464 Sum_probs=159.4
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC--CCCcccceEEEeecC----C
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI--RHRNNVKFHGFCYNG----P 672 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~~~~~~~----~ 672 (848)
++....+.||+|.||+||+|+|+ |+.||||+|... +.+...+|.++.+.+ +|+||..+++.-..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 45777889999999999999997 889999998543 345678899988775 999999998865433 3
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD-----CLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
++|+|.+|.+.|||+|++.+. .++.....+++..+|.||+|||.. ..|.|.|||||+.|||+..++...|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 789999999999999999764 578889999999999999999954 34689999999999999999999999
Q ss_pred eccCccccCCCCCC----cccccccccccCccccccC------CCCccchhhhHHHHHHHHHh
Q 038003 748 DFGIAKFVGPHSSN----WTEFAGTFGYAAPEIAYTM------RATEKYDVYSFGVLVFEVIK 800 (848)
Q Consensus 748 DfG~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~DiwSlG~il~ellt 800 (848)
|+|+|......... ....+||.+|||||++... +.-..+||||||.|+||++-
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99999887654322 2457899999999998632 11235899999999999987
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=268.17 Aligned_cols=203 Identities=27% Similarity=0.407 Sum_probs=176.0
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~l 676 (848)
++|.+.+.||+|+||.||+|... ++..||+|++...... .....+.+.+|++++++++ ||||+++++++...+..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 36889999999999999999664 7999999998765332 2233466788999999998 9999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 80 v~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 80 VLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999998755 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--------------------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 757 PHSS--------------------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 757 ~~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.... ......++..|+|||+..+..++.++||||||++++++++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 4321 112345788999999998888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=262.04 Aligned_cols=200 Identities=30% Similarity=0.463 Sum_probs=170.3
Q ss_pred CcccceeccCCceeEEEEEcCC-----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 601 FDEKFCIGKGGQGSVYKAELPS-----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
|++.+.||+|+||.||+|.+.. +..+|+|++.... .....+.+..|+++++.++||||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 4567889999999999996653 3889999986542 2225678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
++|||+++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999875421 2289999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcc-cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 756 GPHSSNWT-EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
........ ...+++.|+|||.+.+..++.++||||+|+++|+|++ |..||..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 54322211 2236789999999988889999999999999999999 7888753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=292.18 Aligned_cols=197 Identities=28% Similarity=0.465 Sum_probs=160.8
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC---
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--- 671 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 671 (848)
+-..+|+..+.||+||||.||+|+.+ ||+.||||++.... .......+.+|+..+++++|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 34567889999999999999999876 89999999998764 234566788999999999999999988432210
Q ss_pred --------------------------------------------------------------------------------
Q 038003 672 -------------------------------------------------------------------------------- 671 (848)
Q Consensus 672 -------------------------------------------------------------------------------- 671 (848)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ------------------------------------CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHH
Q 038003 672 ------------------------------------PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715 (848)
Q Consensus 672 ------------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L 715 (848)
...|+-||||+...+.+++++..... .....++++++|+.||
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGL 710 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHH
Confidence 12478888998877777776652211 3456789999999999
Q ss_pred HHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC------------------CCCCCcccccccccccCcccc
Q 038003 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG------------------PHSSNWTEFAGTFGYAAPEIA 777 (848)
Q Consensus 716 ~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~------------------~~~~~~~~~~g~~~y~aPE~~ 777 (848)
+|+|++ |||||||||.||++++++.|||+|||+|+... ......+..+||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999998721 112234568899999999998
Q ss_pred ccC---CCCccchhhhHHHHHHHHHh
Q 038003 778 YTM---RATEKYDVYSFGVLVFEVIK 800 (848)
Q Consensus 778 ~~~---~~~~~~DiwSlG~il~ellt 800 (848)
.+. .|+.|+|+||+|||++||+-
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc
Confidence 765 49999999999999999984
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=268.63 Aligned_cols=196 Identities=30% Similarity=0.452 Sum_probs=166.8
Q ss_pred CcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|+..+.||+|+||.||+|.. .++..+|+|++...... .......+..|++++++++|||++++++++.++...++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 77788999999999999965 47899999998654322 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+.+ ++.+.+... ...+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 777766433 24588999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....|++.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 3346788999999874 45678899999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=274.83 Aligned_cols=199 Identities=27% Similarity=0.396 Sum_probs=169.5
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG---- 671 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 671 (848)
..++|+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 457899999999999999999965 4789999999865421 233455677899999999999999999988643
Q ss_pred --CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 672 --PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 672 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
...|+||||+.+ ++.+.+... ++...+..++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 357999999965 788777432 77888999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|.++...... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 163 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 163 GLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred ccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 9998765432 22345678999999999998999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=266.18 Aligned_cols=189 Identities=24% Similarity=0.380 Sum_probs=158.2
Q ss_pred ceeccCCceeEEEEEcC-C-------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 605 FCIGKGGQGSVYKAELP-S-------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
+.||+|+||.||+|... . ...+|+|.+... .....+.+..|+.+++.++||||+++++++..++..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 36999999999999653 2 234788877543 23445678889999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC--------EEEee
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE--------AHVSD 748 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~D 748 (848)
||||+++|+|.++++... ..+++..+.+++.||+.|++|||++ +|+||||||+||+++.++. ++++|
T Consensus 77 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence 999999999999997642 3578899999999999999999999 9999999999999987765 69999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCC-CCCc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGN-HPRD 806 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~-~P~~ 806 (848)
||.+...... ....+++.|+|||++.+. .++.++|||||||++|||++|. .||.
T Consensus 152 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 152 PGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred cccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 9998765432 334678899999998864 4788999999999999999995 5543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=275.14 Aligned_cols=201 Identities=24% Similarity=0.352 Sum_probs=168.7
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec----CC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN----GP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~ 672 (848)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 36799999999999999999965 4799999999876432 22345667789999999999999999998753 34
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+. ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred eEEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence 6899999996 5898888654 4589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC----cccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSN----WTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
......... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 766432211 123568889999998765 4578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=273.71 Aligned_cols=199 Identities=25% Similarity=0.415 Sum_probs=166.5
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 46899999999999999999965 478999999986431 2234566788999999999999999999876543
Q ss_pred -eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 673 -HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 673 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
..++|+||+.+ ++.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred ceEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 57999999975 78777743 4588899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC---CcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSS---NWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+........ ......|++.|+|||++.+ ..++.++||||+||++|+|+||+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 976543221 1123567899999998754 4578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=268.15 Aligned_cols=201 Identities=25% Similarity=0.378 Sum_probs=165.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
..++|++.+.||+|+||.||+|.++ +++.||||+++... .......+.+|+.++.+. .||||+++++++.+....
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 3467899999999999999999776 48999999987542 122345566677766666 599999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
++||||+.+ ++.++.... ...+++..+..++.||+.|++|||+ . +|+||||+|+||++++++.+||+|||.+.
T Consensus 90 ~~v~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 90 FICMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred EEEeeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccch
Confidence 999999854 676665442 2368889999999999999999997 5 89999999999999999999999999987
Q ss_pred ccCCCCCCcccccccccccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMR----ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....... .....+++.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 164 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 164 RLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred hccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 6643222 23345788999999987554 78899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=267.96 Aligned_cols=204 Identities=27% Similarity=0.410 Sum_probs=169.0
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC--
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP-- 672 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-- 672 (848)
...++|++.+.||+|+||.||+|..+ +++.||+|+++..... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 34578999999999999999999765 6899999998764321 223456778999999999999999999987654
Q ss_pred --------eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCE
Q 038003 673 --------HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEA 744 (848)
Q Consensus 673 --------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 744 (848)
..++|+||+++ ++...+... ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999987 666666543 24688999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCC-CcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 745 HVSDFGIAKFVGPHSS-NWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||+|||.+........ ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999987654332 1222346788999998765 3468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=271.74 Aligned_cols=202 Identities=24% Similarity=0.336 Sum_probs=173.8
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhH----HHHHHHHHHHhcCC---CCcccceEEEe
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADH----DEFLNEVLALKEIR---HRNNVKFHGFC 668 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~----~~~~~E~~~l~~l~---hp~iv~l~~~~ 668 (848)
...+|+..+.+|+|+||.|+.|.++ +...|+||.+.++.+-.+.--+ -.+-.|+.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999765 5677999998877543221111 12446999999997 99999999999
Q ss_pred ecCCeeEEEEecc-CCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 669 YNGPHSFLVCEYL-DRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 669 ~~~~~~~lV~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
++++.+|++||-. +|-+|.+++... .++++.++..|++|++.|+++||+. ||||||||-+|+.++.+|-+||+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 9999999999986 455899998765 6788999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCc
Q 038003 748 DFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~ 806 (848)
|||.|.... ......++||.+|.|||++.|.+| +..-|||++|+++|.++....||.
T Consensus 713 dfgsaa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhc--CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999998763 344577899999999999999988 667999999999999999999974
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=271.46 Aligned_cols=202 Identities=25% Similarity=0.348 Sum_probs=166.6
Q ss_pred cCCcc-cceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCc----------hhHHHHHHHHHHHhcCCCCcccceEE
Q 038003 599 DDFDE-KFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNM----------ADHDEFLNEVLALKEIRHRNNVKFHG 666 (848)
Q Consensus 599 ~~~~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~l~~ 666 (848)
++|.. .+.||+|+||+||+|... +++.||+|++......... .....+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 567999999999999654 7899999998664322111 01224678999999999999999999
Q ss_pred EeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEE
Q 038003 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV 746 (848)
Q Consensus 667 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 746 (848)
++...+..++||||++ +++.+++... ..+++..+..++.|++.|++|||+. ||+||||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 5898888654 4588899999999999999999999 9999999999999999999999
Q ss_pred eeccCccccCC--------------CCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 747 SDFGIAKFVGP--------------HSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 747 ~DfG~~~~~~~--------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+|||.+..... .........+++.|+|||.+.+. .++.++||||+||++|||+||+.||..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999987651 11122234567899999998764 468899999999999999999999853
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=263.83 Aligned_cols=196 Identities=24% Similarity=0.338 Sum_probs=162.6
Q ss_pred CcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecC--CeeEE
Q 038003 601 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNG--PHSFL 676 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~--~~~~l 676 (848)
|++.+.||+|+||.||+|.. .+++.||+|+++..... .......+|+.+++++. |||++++++++.+. +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC---chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 56778999999999999965 47899999998765321 12223457888888885 99999999999987 88999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++ ++.+.+... ...+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.+....
T Consensus 78 v~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 78 VFELMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEecCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9999975 777777543 24688999999999999999999999 9999999999999999 999999999998764
Q ss_pred CCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 151 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 151 SKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred cCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 3322 233567899999997654 4568899999999999999999999853
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=264.22 Aligned_cols=199 Identities=27% Similarity=0.424 Sum_probs=169.4
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--CeeEEE
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--PHSFLV 677 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lV 677 (848)
|++.+.||+|+||.||+|... +++.+|+|++.... ........+.+|++++++++|||++++++++... +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 667889999999999999765 58899999998764 1233456688999999999999999999999988 789999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++ ++.+++... ...+++..+..++.||+.|++|||+. +++|+||+|+||++++++.+||+|||.+.....
T Consensus 79 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 79 FEYMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred eccccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 999975 888887544 24688999999999999999999999 999999999999999999999999999987754
Q ss_pred CCC-CcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ......++..|+|||.+.+ ..+++++||||||+++|||+||+.||..
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 331 1233456788999998765 4578999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=260.88 Aligned_cols=202 Identities=27% Similarity=0.407 Sum_probs=165.2
Q ss_pred CcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 601 FDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
|.+.+.||+|+||.||+|.+. ++..+|||++..... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF--SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC--ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 567789999999999999643 468899999876532 2344667889999999999999999999886532
Q ss_pred --eeEEEEeccCCCCHHhHhcCCC---CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 673 --HSFLVCEYLDRGSLARILGDDV---TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 673 --~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
..++++||+.+|++.+++.... ....+++..+.+++.||+.|++|||++ +|+||||||+||+++.++.+|++
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 2478999999999988764321 123578889999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 748 DFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 748 DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|||.++........ .....+++.|++||...+..++.++|||||||++|||++ |+.||..
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~ 218 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence 99999876432211 122345678999999988888999999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=268.11 Aligned_cols=200 Identities=26% Similarity=0.393 Sum_probs=168.6
Q ss_pred HHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-CC
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN-GP 672 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 672 (848)
...+++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34678899999999999999999964 4899999998865422 12334667889999999999999999999865 55
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+ +++|.++++. ..++...+..++.|++.|+.|||+. +|+||||+|+||++++++.++|+|||.+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 789999998 5588888753 3467788889999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... .....+++.|+|||++.+ ..++.++||||||+++|+|+||+.||..
T Consensus 156 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 156 RIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred cccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 765332 233467889999998765 5688999999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=270.33 Aligned_cols=204 Identities=25% Similarity=0.400 Sum_probs=170.5
Q ss_pred cHHHHHHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEe
Q 038003 590 MHEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFC 668 (848)
Q Consensus 590 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 668 (848)
...++....++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3455666789999999999999999999954 5789999999875421 123345678899999999999999999988
Q ss_pred ecC------CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC
Q 038003 669 YNG------PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742 (848)
Q Consensus 669 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 742 (848)
... ...+++++++ +++|.++++. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 643 3467888876 7799887753 3588899999999999999999999 999999999999999999
Q ss_pred CEEEeeccCccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 743 EAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 743 ~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.+||+|||+++.... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 ~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 158 ELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred CEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999876533 2234567889999998876 457889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=270.94 Aligned_cols=201 Identities=28% Similarity=0.430 Sum_probs=167.4
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecC--C
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNG--P 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~--~ 672 (848)
..++|++.+.||+|+||.||+|... +++.+|+|++..... .......+.+|+.+++++ +||||+++++++... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC--cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3567999999999999999999765 688999998865321 223345677899999999 999999999998654 3
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++ +|.++++.. .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||.+
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 67999999975 898887543 577888899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-----CcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSS-----NWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........ ......|++.|+|||++.+ ..++.++||||||+++|+|+||+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 86643321 2233568899999998765 4578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=266.14 Aligned_cols=203 Identities=25% Similarity=0.372 Sum_probs=166.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC---
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP--- 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--- 672 (848)
..++|++.+.||+|+||.||+|... +++.||||++..... .......+.+|++++++++||+|+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 3457999999999999999999664 789999999865421 1223345678999999999999999999987654
Q ss_pred -----eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 673 -----HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 673 -----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
..++||||+.+ ++.+.+... ...+++.++..++.||+.|++|||++ +++|+||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEEC
Confidence 45999999975 787777543 24688999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCC----cccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 748 DFGIAKFVGPHSSN----WTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 748 DfG~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|||.+......... .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999866432211 12345788999999887643 68899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=260.09 Aligned_cols=203 Identities=27% Similarity=0.390 Sum_probs=175.6
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|++.+.||+|+||.||++.. .+++.+|+|++...... ......+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 478889999999999999954 47889999998765322 234566788999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 679 EYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
||+++++|.+++.... ....+++..+..++.|++.|++|||+. |++||||+|+||++++++.+|++|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999999999886532 134688899999999999999999999 999999999999999999999999999987754
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
. ......+++.|+|||...+..++.++|+||+|+++|||++|+.||...+
T Consensus 156 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 156 N--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred C--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3 2233567899999999998889999999999999999999999986433
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=271.04 Aligned_cols=201 Identities=25% Similarity=0.380 Sum_probs=169.5
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG----- 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 671 (848)
.++|.+.+.||+|+||+||+|.. .+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45799999999999999999965 4789999999875421 223345677899999999999999999988654
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
...++||||+. ++|.+++... ..+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 34799999996 5888888654 5688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+..............++..|+|||.+.. ..++.++|||||||++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 9876543333344567889999998764 4588999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=263.24 Aligned_cols=196 Identities=30% Similarity=0.433 Sum_probs=165.6
Q ss_pred CcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|...+.||+|+||+||+|.. .+++.||+|++...... .....+.+.+|+++++.++|||++++++++.+....|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 66677899999999999965 47889999998654322 22344568889999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+.+ ++.+++... ...+++.++..++.||+.|+.|||+. ||+||||+|+||+++.++.+||+|||.+.....
T Consensus 102 ~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 102 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred cCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 9964 777766543 24588999999999999999999999 999999999999999999999999999865432
Q ss_pred CCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.....|+..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 23456889999999974 35578899999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=261.77 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=166.4
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC---CCCcccceEEEeecCCe---
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI---RHRNNVKFHGFCYNGPH--- 673 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~~~--- 673 (848)
|++.+.||+|+||.||+|.++ +++.+|+|+++..... ......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc--chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 567889999999999999776 5899999998765321 22234566777776655 69999999999988776
Q ss_pred --eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 674 --SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 674 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
.+++|||+.+ ++.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999975 788887654 223589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+..+..... .....+++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 154 ARIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred ceeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 987654322 2334578899999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=263.15 Aligned_cols=199 Identities=29% Similarity=0.404 Sum_probs=171.1
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|+..+.||+|++|.||+|... +++.+|+|++..... .....+.+..|++++++++||+++++++++.+.+..++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc--cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 566788999999999999665 589999999877541 23345667889999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++ +|.+++.... ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 79 YCDM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred CcCc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 9985 8999986542 4688999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......++..|+|||++.+. .++.++|||||||++||+++|+.||..
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 333344567889999998766 788999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=256.48 Aligned_cols=195 Identities=30% Similarity=0.409 Sum_probs=171.1
Q ss_pred eccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCC
Q 038003 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGS 685 (848)
Q Consensus 607 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gs 685 (848)
||+|+||.||++... +++.+|+|++...... .....+.+..|++++++++||+|+++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999665 6899999998776432 23356678899999999999999999999999999999999999999
Q ss_pred HHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccc
Q 038003 686 LARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765 (848)
Q Consensus 686 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 765 (848)
|.+++... ..+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||.+.............
T Consensus 80 L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 80 LFSHLSKE---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 99998655 3588999999999999999999998 99999999999999999999999999998765433333456
Q ss_pred cccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 766 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.++..|+|||...+...+.++|+||||+++|++++|+.||...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 7888999999998888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=274.83 Aligned_cols=202 Identities=28% Similarity=0.444 Sum_probs=176.6
Q ss_pred hhcCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN---- 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~---- 670 (848)
-++.|++.+.||+|.+|.||+++ .++++..|+|+..... ...+++..|.++++.. .|||++.++|+|..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 35668999999999999999995 4578999999986643 3345677888998887 79999999999864
Q ss_pred -CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 671 -GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 671 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
++++|+|||||.+||..|+++... +.++.|..++.|++.+++|+.+||.. .++|||||-.|||++.++.||++||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeee
Confidence 578999999999999999998764 77899999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCcccccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|.+.....--....+.+|||.|||||++.- ..|+.++|+||+|++..||.-|.+|+..
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 999888665555667899999999999863 3467889999999999999999999654
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=270.25 Aligned_cols=199 Identities=27% Similarity=0.426 Sum_probs=172.1
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-----e
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP-----H 673 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-----~ 673 (848)
+|++.+.||+|++|.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++...+ .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 5888999999999999999765 589999999876431 2344567889999999999999999999988775 7
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.|+||||+.+ +|.+++... ..+++..+..++.|++.|++|||+. ||+||||||+||+++.++.++|+|||.+.
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred eEEEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 8999999985 888888654 3788999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC---CCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHS---SNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... .......+++.|+|||++.+. .++.++||||+|+++|+|+||+.||..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~ 209 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence 775543 123345678899999999887 789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=268.84 Aligned_cols=201 Identities=24% Similarity=0.389 Sum_probs=169.5
Q ss_pred HHHhhcCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 594 IIKATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 594 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
+....++|++.+.||+|+||.||+|. ..++..||||++..... .....+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 33456789999999999999999995 45799999999865321 2234456789999999999999999999987653
Q ss_pred ------eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEE
Q 038003 673 ------HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV 746 (848)
Q Consensus 673 ------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 746 (848)
..++||||+ ++++.+++.. ..+++..+..++.||+.|++|||+. ||+||||||+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 458999998 6799888753 3588899999999999999999999 9999999999999999999999
Q ss_pred eeccCccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 747 SDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 747 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+|||.+...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||..
T Consensus 160 ~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 160 LDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred eecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999865432 234567889999999876 4578899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=268.39 Aligned_cols=196 Identities=25% Similarity=0.416 Sum_probs=165.0
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
.++|.....||+|+||.||+|.. .+++.||+|++..... .......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 46899999999999999999965 4789999999876432 1233456789999999999999999999987542
Q ss_pred --eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 673 --HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 673 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
..++|+||+.. ++.++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred CceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 46899999965 7766552 3578889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++.... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 163 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 163 LARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9876532 2234567889999999876 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=263.48 Aligned_cols=198 Identities=30% Similarity=0.449 Sum_probs=166.4
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+.|+..+.||+|+||.||+|... +++.+|+|.+...... .....+++.+|+++++.++|||++++++++......++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34777788999999999999754 6888999988653222 223456678899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+. |++.+.+... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99997 5777766433 24578899999999999999999999 999999999999999999999999999876643
Q ss_pred CCCCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. ....+++.|+|||.+. ...++.++|||||||++|+|++|+.||..
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 168 A----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred c----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2 2346788999999875 34578899999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=277.68 Aligned_cols=197 Identities=27% Similarity=0.498 Sum_probs=170.6
Q ss_pred CcccceeccCCceeEEEEEc-CCCC----EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 601 FDEKFCIGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
....++||+|+||+||+|.| ..|+ +||||++.... ..+..+++.+|+-.|..++|||+++++++|.... ..
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34567899999999999955 3454 57888876543 3455678999999999999999999999998876 78
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+|.+||+.|+|.++++.. ...+.......|..|||+|+.|||++ .+|||||-.+|||+.+-..+||.|||+++..
T Consensus 774 lvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 999999999999999875 35678889999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCCccccc--ccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCc
Q 038003 756 GPHSSNWTEFA--GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 806 (848)
Q Consensus 756 ~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 806 (848)
.++........ -.+-|||-|.+....|+.++|||||||++||++| |..||+
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~ 902 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD 902 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC
Confidence 77665544333 3578999999999999999999999999999999 999965
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=261.66 Aligned_cols=199 Identities=27% Similarity=0.399 Sum_probs=170.7
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|++.+.||+|++|.||+|... +++.+|+|++...... ......+.+|++++++++||+|+++++++..++..++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES--EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 567789999999999999664 7899999998765322 2345677889999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++ ++.+++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 79 FMDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred ccCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 9976 888877653 25688999999999999999999999 99999999999999999999999999998775543
Q ss_pred CCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||..
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 223345678899999998876 688999999999999999999999843
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=270.42 Aligned_cols=196 Identities=28% Similarity=0.379 Sum_probs=166.1
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
.++.|.....+|.|+|+.|-.+.. .+++..++|++.+.. .+..+|+.++... +||||+++.+.+.++.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceecCCcee
Confidence 466788888999999999999955 478889999997762 1233466555554 899999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee-CCCCCEEEeeccCcc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL-DSNFEAHVSDFGIAK 753 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DfG~~~ 753 (848)
|+|||.+.|+-+.+.+... .... ..+..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|+|||.++
T Consensus 392 ~~v~e~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeehhccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhh
Confidence 9999999999887777544 2333 67778999999999999999 99999999999999 689999999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI 810 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 810 (848)
...+. ....+-|..|.|||+.....|++++|+||||++||+|++|+.||.....
T Consensus 465 ~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 465 ELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred hCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 77654 3345668899999999999999999999999999999999999865443
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=260.20 Aligned_cols=197 Identities=25% Similarity=0.427 Sum_probs=166.9
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeEEEE
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lV~ 678 (848)
|++.+.||+|++|+||+|... +++.||||++...... .......+|+..+++++ ||+++++++++.+++..++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 667889999999999999775 5788999998665321 22233457899999998 999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+ +|++.+++.... ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 78 EYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred ecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 999 779988886552 34689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCcccccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 759 SSNWTEFAGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
. ......++..|+|||++. +..++.++|+||||+++|||+||+.||.
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~ 200 (283)
T cd07830 153 P-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200 (283)
T ss_pred C-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccC
Confidence 2 223456788999999875 4457889999999999999999999984
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=267.02 Aligned_cols=196 Identities=22% Similarity=0.305 Sum_probs=161.3
Q ss_pred eeccC--CceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 606 CIGKG--GQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 606 ~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
.||+| +||+||+|.+ .+++.||+|++..... .....+.+.+|+.+++.++||||++++++|..++..++||||+.
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 46666 9999999966 4799999999865422 22345778899999999999999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW 762 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 762 (848)
++++.++++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999887642 24588899999999999999999999 99999999999999999999999998654332111111
Q ss_pred -------ccccccccccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 763 -------TEFAGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 763 -------~~~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....++..|+|||++.+. .+++++||||+||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 112345679999998764 468899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=265.20 Aligned_cols=201 Identities=26% Similarity=0.397 Sum_probs=165.0
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
.++|++.+.||+|+||.||+|... +++.+|+|++...... ......+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 578999999999999999999654 7899999998654321 122345678999999999999999999875433
Q ss_pred ----eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 673 ----HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 673 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
..++||||+.+ ++.+.+... ...+++.++..++.|+++||+|||++ ||+||||||+||++++++.++|+|
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 46999999976 676666543 34689999999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCC-----------cccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 749 FGIAKFVGPHSSN-----------WTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 749 fG~~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
||++......... .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 9999865432211 1223567889999987654 57889999999999999999999985
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=258.98 Aligned_cols=204 Identities=24% Similarity=0.312 Sum_probs=168.8
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccC-CchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG-NMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+|.+.+.||+|+||.||+|... .+..+++|+++...... ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999664 34556666655432211 122344567899999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 678 CEYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
|||+++++|.++++.. .....+++..+..++.|++.|+.|||+. |++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887542 1235689999999999999999999999 9999999999999975 569999999998765
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........|++.|+|||...+..++.++|+||||+++|+|++|..||..
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 444333455688899999999888888999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=265.06 Aligned_cols=198 Identities=21% Similarity=0.272 Sum_probs=162.5
Q ss_pred ccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccC
Q 038003 603 EKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 603 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
+.+.+|.|+++.||++.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..+++|||++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 334455555555555544 699999999876521 23456778999999999999999999999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC--
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS-- 760 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~-- 760 (848)
++++.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 83 YGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 999999987542 24578889999999999999999999 999999999999999999999999998876532211
Q ss_pred -----CcccccccccccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 761 -----NWTEFAGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 761 -----~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
......++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 11234567789999998753 578899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=264.33 Aligned_cols=199 Identities=24% Similarity=0.336 Sum_probs=163.9
Q ss_pred CCcccceeccCCceeEEEEEcC-C--CCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecC----
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-S--GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNG---- 671 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~---- 671 (848)
+|++.+.||+|+||.||+|... + +..||+|++..... .....+.+.+|+++++++ +||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4788899999999999999765 4 78899999865321 223356678899999999 599999999875432
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
...++++||+. ++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 45788999986 5898888543 5688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC----CcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSS----NWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+........ ......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||..
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 986543221 1233568899999998765 4678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=285.44 Aligned_cols=149 Identities=27% Similarity=0.317 Sum_probs=132.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|.+.+.||+|+||.||+|.+. +++.||||+++..... .......+.+|+.+++.++||||+++++++...+..|+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 367999999999999999999765 7899999998765322 23445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
||||+.+++|.++++.. ..+++..+..|+.||+.||.|||.+ +||||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999998654 4578889999999999999999999 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=266.83 Aligned_cols=197 Identities=24% Similarity=0.401 Sum_probs=168.0
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe--
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH-- 673 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~-- 673 (848)
..++|++.+.||+|++|.||+|... +++.||+|++..... .....+.+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc--hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4678999999999999999999765 688999999865421 22344567789999999999999999998876554
Q ss_pred ----eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 674 ----SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 674 ----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
.++|+||+ +++|.+++.. ..+++..+..++.|++.|++|||+. ||+||||||+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 5699988854 4588999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
|.+...... .....++..|+|||++.+ ..++.++||||+||++||++||+.||.
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 999876432 234567889999998865 357889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=265.65 Aligned_cols=197 Identities=24% Similarity=0.366 Sum_probs=162.8
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG----- 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 671 (848)
..+|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 36799999999999999999965 478999999986542 24456788999999999999999999876543
Q ss_pred ---------CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-C
Q 038003 672 ---------PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-N 741 (848)
Q Consensus 672 ---------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~ 741 (848)
...++||||+++ +|.+++.. ..+++..+..++.||+.|+.|||+. ||+||||||+||+++. +
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~ 151 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMET-DLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccccceEEEEeecccc-cHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence 357899999974 88887743 3578899999999999999999999 9999999999999974 5
Q ss_pred CCEEEeeccCccccCCCCC---CcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 742 FEAHVSDFGIAKFVGPHSS---NWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 742 ~~~kl~DfG~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
+.+|++|||.++....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 6789999999976533211 1122457889999998654 557889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=252.12 Aligned_cols=213 Identities=22% Similarity=0.270 Sum_probs=178.2
Q ss_pred cCCCCccHHHHHHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-C-C-
Q 038003 584 NFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-H-R- 659 (848)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-p- 659 (848)
+.+|...+...-....+|.+...+|+|.||.|-++.+ ..+..||+|+++.. ....+..+-|++++.++. + |
T Consensus 74 D~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~ 148 (415)
T KOG0671|consen 74 DKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPN 148 (415)
T ss_pred CCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCC
Confidence 4455444443334478999999999999999999954 46799999998765 345667788999999993 2 2
Q ss_pred ---cccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCe
Q 038003 660 ---NNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNV 736 (848)
Q Consensus 660 ---~iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NI 736 (848)
.+|++.++|.-.++.++|+|.+ |-|+.+++..+ .-.+++..++..|+.|++++++|||+. +++|-||||+||
T Consensus 149 g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENI 223 (415)
T KOG0671|consen 149 GKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENI 223 (415)
T ss_pred CceEEEeeehhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheE
Confidence 3788999999999999999999 55999999876 345788999999999999999999999 999999999999
Q ss_pred eeCC--------------------CCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHH
Q 038003 737 LLDS--------------------NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 796 (848)
Q Consensus 737 ll~~--------------------~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ 796 (848)
++.+ +..++++|||.|++..+.. ...+.|..|.|||++.+-.++.++||||+||||+
T Consensus 224 Lfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 224 LFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred EEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 9941 3469999999999865433 5567899999999999999999999999999999
Q ss_pred HHHhCCCCCcccc
Q 038003 797 EVIKGNHPRDFFS 809 (848)
Q Consensus 797 elltg~~P~~~~~ 809 (848)
|+.||..-|...+
T Consensus 301 ElytG~~LFqtHe 313 (415)
T KOG0671|consen 301 ELYTGETLFQTHE 313 (415)
T ss_pred EeeccceecccCC
Confidence 9999999987544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=249.20 Aligned_cols=180 Identities=22% Similarity=0.237 Sum_probs=154.0
Q ss_pred CCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCCHHh
Q 038003 610 GGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLAR 688 (848)
Q Consensus 610 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gsL~~ 688 (848)
|.+|.||+|.. .+++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 89999999965 478999999986642 12344555556679999999999999999999999999999999
Q ss_pred HhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCccccccc
Q 038003 689 ILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT 768 (848)
Q Consensus 689 ~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~ 768 (848)
++... ..+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.++++|||.+...... .....++
T Consensus 75 ~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~ 145 (237)
T cd05576 75 HISKF---LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVE 145 (237)
T ss_pred HHHHh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcC
Confidence 88654 3588999999999999999999999 9999999999999999999999999988765432 2234567
Q ss_pred ccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 769 FGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 769 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..|+|||...+..+++++||||+|+++|||++|+.|+..
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 789999999888889999999999999999999988653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-30 Score=244.85 Aligned_cols=199 Identities=27% Similarity=0.380 Sum_probs=165.9
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-----e
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP-----H 673 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-----~ 673 (848)
+.+-.+.||-|+||+||.+.+ ++|+.||.|++.... ..-...+.+.+|+.+++..+|.|+...+++-+... +
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf--q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF--QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH--HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 455567899999999999955 589999999986643 13345678899999999999999999888765432 4
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.|+|.|.|.. +|.+++-. +..++...+.-+++||.+||.|||+. +|.||||||.|.|++.+..+||||||+++
T Consensus 132 iYV~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence 5788888854 88887743 46788888888999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSS-NWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....+.. ..+..+.|-.|+|||+++|.+ |+.++||||.|||+.|++..+.-|..
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 7654332 334556788999999999764 89999999999999999999988754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=239.81 Aligned_cols=229 Identities=23% Similarity=0.342 Sum_probs=178.3
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-------
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN------- 670 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------- 670 (848)
..|+....||+|.||.||+|+.+ +|+.||+|++--+.- ..-......+|++++..++|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34666778999999999999665 678889887533211 12234556789999999999999999888754
Q ss_pred -CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 671 -GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 671 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
....|+||++++. +|..++... ..+++..++.+++.++..||.|+|+. .|+|||+||+|+|++.+|.+||+||
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence 2357999999977 888887544 35688899999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCC----CCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhhh
Q 038003 750 GIAKFVGPHS----SNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNK 824 (848)
Q Consensus 750 G~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 824 (848)
|+++.+.... ...+..+.|.+|.+||.+.|. .|+++.|||..|||+.||+||..-+.... -.+.+..+..
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt-----eqqql~~Is~ 243 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT-----EQQQLHLISQ 243 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh-----HHHHHHHHHH
Confidence 9997653322 223445679999999988764 58999999999999999999988754322 2233455666
Q ss_pred hcCCCCCCCCCCcccc
Q 038003 825 ILDPRLPTPSPSVMDY 840 (848)
Q Consensus 825 ~~~~~~~~~~~~~~~~ 840 (848)
.+....+.-+|.+.++
T Consensus 244 LcGs~tkevWP~~d~l 259 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNL 259 (376)
T ss_pred HhccCCcccCCCcccc
Confidence 6666666666665443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=273.50 Aligned_cols=203 Identities=28% Similarity=0.448 Sum_probs=170.5
Q ss_pred cCCcccceeccCCceeEEEEEcC----C----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP----S----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCY 669 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 669 (848)
++..+.+.+|+|+||.|++|... . ...||||.++... ...+.+.+..|+++|+.+ +||||+.++|+|.
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 33455668999999999999532 1 4569999988765 336678899999999999 6999999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCC-----C------c--ccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCe
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDV-----T------A--KELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNV 736 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NI 736 (848)
..+..++|+||+..|+|.++++... . . ..++..+...++.|||.|++||+++ ++||||+-++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 9899999999999999999997653 0 1 1388899999999999999999999 999999999999
Q ss_pred eeCCCCCEEEeeccCccccCCCCCCc-ccccc--cccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 737 LLDSNFEAHVSDFGIAKFVGPHSSNW-TEFAG--TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 737 ll~~~~~~kl~DfG~~~~~~~~~~~~-~~~~g--~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|+.++..+||+|||+|+......... ..-.| ...|||||.+....|+.++|||||||++||++| |..||..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999654433322 21222 456999999999999999999999999999999 9999753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-28 Score=225.32 Aligned_cols=199 Identities=20% Similarity=0.340 Sum_probs=167.8
Q ss_pred hcCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecC--Ce
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNG--PH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~--~~ 673 (848)
.++|++.+.+|+|.|++||.|. ..+.++++||+++.. ..+.+.+|+.+++.+. ||||++++++..+. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4678999999999999999994 557889999998654 3567899999999996 99999999998765 46
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC-CCEEEeeccCc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN-FEAHVSDFGIA 752 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG~~ 752 (848)
..+|+||+.+.+...+. ..++...+..++.++..||.|+|+. ||+|||+||.|+++|.. -.++|+|+|+|
T Consensus 110 paLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred chhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence 67999999998776654 3466678889999999999999999 99999999999999865 47999999999
Q ss_pred cccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcccccccc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 813 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 813 (848)
.++-+... ....+.+..|.-||.+-.. .|+..-|+|||||++..|+..+.||-....+..
T Consensus 181 EFYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D 241 (338)
T KOG0668|consen 181 EFYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 241 (338)
T ss_pred hhcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH
Confidence 99976433 3445667788999988754 478999999999999999999999866555444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=257.30 Aligned_cols=207 Identities=20% Similarity=0.267 Sum_probs=152.7
Q ss_pred hhcCCcccceeccCCceeEEEEEc-----------------CCCCEEEEEEcccccccCC----------chhHHHHHHH
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-----------------PSGDIVAVKKFNSQLLSGN----------MADHDEFLNE 649 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~----------~~~~~~~~~E 649 (848)
..++|++.++||+|+||+||+|.. ..++.||||++........ ....+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999853 2356799999864321000 0011234457
Q ss_pred HHHHhcCCCCcc-----cceEEEeec--------CCeeEEEEeccCCCCHHhHhcCCC---------------------C
Q 038003 650 VLALKEIRHRNN-----VKFHGFCYN--------GPHSFLVCEYLDRGSLARILGDDV---------------------T 695 (848)
Q Consensus 650 ~~~l~~l~hp~i-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~---------------------~ 695 (848)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 677777753 356899999999999999886421 0
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCc-ccccccccccCc
Q 038003 696 AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW-TEFAGTFGYAAP 774 (848)
Q Consensus 696 ~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~-~~~~g~~~y~aP 774 (848)
...+++..+..++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||++.......... ....+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12346778889999999999999999 99999999999999999999999999997654322111 122347899999
Q ss_pred cccccCC--------------------C--CccchhhhHHHHHHHHHhCCC-CCc
Q 038003 775 EIAYTMR--------------------A--TEKYDVYSFGVLVFEVIKGNH-PRD 806 (848)
Q Consensus 775 E~~~~~~--------------------~--~~~~DiwSlG~il~elltg~~-P~~ 806 (848)
|.+.... + ..+.||||+||++|+|++|.. ||.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9875322 1 234799999999999999986 654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=234.08 Aligned_cols=199 Identities=31% Similarity=0.473 Sum_probs=171.6
Q ss_pred CcccceeccCCceeEEEEEcCC-CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|+..+.||+|++|.||+|.... ++.+|+|.+...... ...+.+.+|++.++.++|++++++++++...+..++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 5667889999999999997764 899999998765321 256788899999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++++|.+++..... .+++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 78 YCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred ccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999999999876521 178899999999999999999999 99999999999999999999999999998775432
Q ss_pred -CCcccccccccccCcccc-ccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 -SNWTEFAGTFGYAAPEIA-YTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 -~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122345678899999998 666778899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=232.63 Aligned_cols=196 Identities=26% Similarity=0.363 Sum_probs=168.7
Q ss_pred hcCCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
..+|...+.+|.|+- .|..| +.-.+++||+|++.... . +....++..+|...+..++|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-Q-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-c-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 457888889999998 55555 44478999999987772 3 3556677889999999999999999999997543
Q ss_pred --eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 673 --HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 673 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
..|+|||+|+. +|...++ -+++..++..++.|++.|+.|||+. ||+||||||+||++..++.+||.|||
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence 57999999976 8887775 3477788899999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
+|+..+.. -..+..+.+..|.|||++.+..+.+.+||||+||++.||++|+.-|.
T Consensus 164 ~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 164 LARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred hhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 99876554 34567888999999999999889999999999999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=248.11 Aligned_cols=214 Identities=22% Similarity=0.229 Sum_probs=180.7
Q ss_pred eecCCCCccHHHHHHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC---
Q 038003 582 VLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR--- 657 (848)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--- 657 (848)
|.+..|.+...-...-..+|.+....|+|-|++|.+|.+ ..|..||||++.... ...+.=..|++++++|+
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----~M~KtGl~EleiLkKL~~AD 489 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----VMHKTGLKELEILKKLNDAD 489 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-----HHhhhhhHHHHHHHHhhccC
Confidence 455566665555555677899999999999999999954 468899999997653 33445568999999994
Q ss_pred ---CCcccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 038003 658 ---HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 734 (848)
Q Consensus 658 ---hp~iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~ 734 (848)
.-|+++++..|....++|||+|-+.- +|.++++.....-.+...++..++.|++-||..|... ||+|.||||+
T Consensus 490 ~Edk~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPD 565 (752)
T KOG0670|consen 490 PEDKFHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPD 565 (752)
T ss_pred chhhhHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCcc
Confidence 35899999999999999999999865 8999998765555688899999999999999999998 9999999999
Q ss_pred CeeeCCC-CCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 735 NVLLDSN-FEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 735 NIll~~~-~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
|||+++. ..+||||||.|.++.+.. .+.+..+-.|.|||++.|.+|+...|+||+||+|||+.||+.-|.
T Consensus 566 NiLVNE~k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 566 NILVNESKNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred ceEeccCcceeeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 9999875 469999999999886543 344556778999999999999999999999999999999999863
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=263.13 Aligned_cols=199 Identities=24% Similarity=0.280 Sum_probs=141.6
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-C----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEE----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-S----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGF---- 667 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~---- 667 (848)
..++|++.+.||+|+||.||+|.+. + +..||+|++.... ..+....| + ++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e-~-l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE-R-VRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH-H-HHhhchhhHHHHHHhhhcc
Confidence 4568999999999999999999765 4 6899999875431 11111111 1 111222222222211
Q ss_pred --eecCCeeEEEEeccCCCCHHhHhcCCCCc-----------------ccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEE
Q 038003 668 --CYNGPHSFLVCEYLDRGSLARILGDDVTA-----------------KELGWNRRINVIKGVANALSYLHHDCLPSIIH 728 (848)
Q Consensus 668 --~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH 728 (848)
.......++||||+.+++|.++++..... .......+..++.||+.||+|||++ +|+|
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiH 278 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVH 278 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 24556889999999999999988643110 0112334567999999999999999 9999
Q ss_pred cCCCCCCeeeCC-CCCEEEeeccCccccCCCC-CCcccccccccccCccccccC----------------------CCCc
Q 038003 729 RDISSKNVLLDS-NFEAHVSDFGIAKFVGPHS-SNWTEFAGTFGYAAPEIAYTM----------------------RATE 784 (848)
Q Consensus 729 ~Dlk~~NIll~~-~~~~kl~DfG~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----------------------~~~~ 784 (848)
|||||+|||++. ++.+||+|||+++...... .......+++.|+|||.+... .++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 999999999986 5799999999998653321 222456789999999965322 2344
Q ss_pred cchhhhHHHHHHHHHhCCCCCc
Q 038003 785 KYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 785 ~~DiwSlG~il~elltg~~P~~ 806 (848)
++||||+||++|||+++..|++
T Consensus 359 k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCc
Confidence 6799999999999999887754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=226.40 Aligned_cols=212 Identities=20% Similarity=0.329 Sum_probs=168.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEE-eecCCe
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGF-CYNGPH 673 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~-~~~~~~ 673 (848)
..+.|++.+.+|+|.||.+-.|+++ +.+.+|+|.++... ...++|.+|...--.| .|.||+.-|++ |+..+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 3466999999999999999999877 56789999887653 4467899998875555 68999987764 677888
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC-C-CCCEEEeeccC
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-S-NFEAHVSDFGI 751 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~-~~~~kl~DfG~ 751 (848)
+++++||++-|+|.+-+.. ..+.+....+++.|++.|+.|||++ .+||||||.+|||+- . ...+|+||||.
T Consensus 97 YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence 9999999999999887644 4577788889999999999999999 999999999999993 2 34799999999
Q ss_pred ccccCCCCCCcccccccccccCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCccccccccccchhhhhhh
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYTM-----RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVN 823 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 823 (848)
.+..+. .......+..|.|||+.... ...+.+|||.||+++|..+||+.||+......+.+.+.++-..
T Consensus 170 t~k~g~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~ 243 (378)
T KOG1345|consen 170 TRKVGT---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK 243 (378)
T ss_pred ccccCc---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc
Confidence 886543 22223346679999986532 3478899999999999999999999866655555555544433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=230.72 Aligned_cols=187 Identities=32% Similarity=0.524 Sum_probs=164.5
Q ss_pred CceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCCHHhH
Q 038003 611 GQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARI 689 (848)
Q Consensus 611 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 689 (848)
+||.||+|... +++.+|+|++...... ...+.+.+|++.+++++|++++++++++......++|+||+++++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999776 5899999998765321 1167889999999999999999999999999999999999999999999
Q ss_pred hcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccccccc
Q 038003 690 LGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTF 769 (848)
Q Consensus 690 l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~ 769 (848)
+... ..+++..+..++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++.
T Consensus 78 ~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 150 (244)
T smart00220 78 LKKR---GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTP 150 (244)
T ss_pred HHhc---cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCc
Confidence 8654 2378899999999999999999999 99999999999999999999999999998875432 234456788
Q ss_pred cccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 770 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 770 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.|+|||.+.+..+++++||||+|+++|++++|..||..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999888889999999999999999999999865
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=254.00 Aligned_cols=196 Identities=28% Similarity=0.427 Sum_probs=160.9
Q ss_pred CcccceeccCCce-eEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEEE
Q 038003 601 FDEKFCIGKGGQG-SVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 601 ~~~~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
|.-.+.+|.|+.| .||+|... |+.||||++-.. ..+-..+|+..++.- +|||||++++.-.+....|++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 4445679999998 56899774 889999997443 345568999999888 7999999999999999999999
Q ss_pred eccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---C--CCEEEeeccCc
Q 038003 679 EYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---N--FEAHVSDFGIA 752 (848)
Q Consensus 679 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~DfG~~ 752 (848)
|.|.. +|.+++... ...........+.+..|++.||++||+. +||||||||.||||.. + ..++|+|||++
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99977 999999763 1111122245577899999999999998 9999999999999975 3 47999999999
Q ss_pred cccCCCCCCc---ccccccccccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCccc
Q 038003 753 KFVGPHSSNW---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG-NHPRDFF 808 (848)
Q Consensus 753 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P~~~~ 808 (848)
+..+...... ....||-+|+|||.+.....+.++||||+||++|+.+|| ..||+..
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 9986544322 346789999999999988888899999999999999995 8998753
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-27 Score=240.74 Aligned_cols=388 Identities=25% Similarity=0.289 Sum_probs=233.2
Q ss_pred CCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEee
Q 038003 104 KLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183 (848)
Q Consensus 104 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 183 (848)
.-+.++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|++|.++..|..|-+.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg----------------------- 124 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYG----------------------- 124 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhc-----------------------
Confidence 345566666666655555666666666666666666655555555555544444333
Q ss_pred cccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCC-cccCcccccccccccccccC-
Q 038003 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNG- 261 (848)
Q Consensus 184 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~-~l~~l~~L~~L~l~~N~l~~- 261 (848)
+|+|+....+.|++|.+|+.|.+.-|++.-...+.|..+++|..|.+.+|.+. .++. .|..+.+++.+.+..|.+..
T Consensus 125 ~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icd 203 (498)
T KOG4237|consen 125 NNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICD 203 (498)
T ss_pred CCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccc
Confidence 14444333334445555555555555554444444555555555555555554 2332 45555555555555554211
Q ss_pred -----------cCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccc
Q 038003 262 -----------FIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMY 330 (848)
Q Consensus 262 -----------~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~ 330 (848)
..|..++......-..+.++++....+..|... ++.+ | .++....+.....+.
T Consensus 204 CnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~--~esl-----------~---s~~~~~d~~d~~cP~ 267 (498)
T KOG4237|consen 204 CNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS--LESL-----------P---SRLSSEDFPDSICPA 267 (498)
T ss_pred cccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh--HHhH-----------H---HhhccccCcCCcChH
Confidence 112222222333333333444333222222111 1111 0 112223334444555
Q ss_pred cccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCccccccccc
Q 038003 331 EAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSS 410 (848)
Q Consensus 331 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 410 (848)
..|..+++|++|+|++|+|+++-..+|....++++|+|..|+|..+-...|.++..|+.|+|.+|+|+...|.+|..+.+
T Consensus 268 ~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 268 KCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS 347 (498)
T ss_pred HHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence 67889999999999999999999999999999999999999998777778889999999999999999888999999999
Q ss_pred ccEEEccCCcCC-----------------CCCCcccCCCCccCeEeccCcccCC---CCCCcccC---------ccccce
Q 038003 411 LNKLILNLNQLS-----------------GGVPLEFGSLTKLQYLDLSTNKLSS---SIPKSIGN---------LLKLHY 461 (848)
Q Consensus 411 L~~L~L~~N~l~-----------------~~~~~~~~~l~~L~~L~Ls~N~l~~---~~p~~~~~---------l~~L~~ 461 (848)
|.+|+|-.|.+. ...|.. +.-..++.+.++.+-+.. ..|+..+. ++-+..
T Consensus 348 l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~t 426 (498)
T KOG4237|consen 348 LSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRC-QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDT 426 (498)
T ss_pred eeeeehccCcccCccchHHHHHHHhhCCCCCCCCC-CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhh
Confidence 999999888653 011111 122346667776665542 12332221 222332
Q ss_pred -eccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCC
Q 038003 462 -LNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYN 539 (848)
Q Consensus 462 -L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N 539 (848)
...|++.++ .+|..+.. .-.+|++.+|.++ .+|.. .+.+| .+|+++|+|+-..-..|.++..|.+|-+|+|
T Consensus 427 VvRcSnk~lk-~lp~~iP~--d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 427 VVRCSNKLLK-LLPRGIPV--DVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hHhhcccchh-hcCCCCCc--hhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 334444444 44444432 4567899999996 56666 67788 9999999998877788999999999999887
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-24 Score=269.87 Aligned_cols=343 Identities=23% Similarity=0.240 Sum_probs=175.1
Q ss_pred cccCCCCCcEEEccccC------CCCCCchhhhccc-cccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCc
Q 038003 98 QIGNLSKLQYLDLGSNQ------LSGLIPPEIGKLN-QLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSS 170 (848)
Q Consensus 98 ~~~~l~~L~~L~Ls~n~------l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 170 (848)
+|..|++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..+ ...+|++|+|++|++. .+|..
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence 45556666666665432 2233455555543 4666666666655 555555 3566666666666665 45666
Q ss_pred ccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCccccc
Q 038003 171 LGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLS 250 (848)
Q Consensus 171 l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~ 250 (848)
+..+++|+.|+|++|...+.+|. ++.+++|++|+|++|.....+|..++++++|+.|++++|.....+|..+ ++++|+
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~ 707 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence 66666666666666543335553 5566666666666665555666666666666666666654444555544 566666
Q ss_pred ccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccc
Q 038003 251 ALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMY 330 (848)
Q Consensus 251 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~ 330 (848)
.|++++|.....+|.. .++|++|++++|.+. .+|..+ .+++|+.|++..+..... +.. +.....
T Consensus 708 ~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l-~~~----------~~~l~~ 771 (1153)
T PLN03210 708 RLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKL-WER----------VQPLTP 771 (1153)
T ss_pred EEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhc-ccc----------ccccch
Confidence 6666666544344432 345666777776665 344433 455666665554322110 000 000000
Q ss_pred cccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCccccccccc
Q 038003 331 EAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSS 410 (848)
Q Consensus 331 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 410 (848)
..+...++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ .+++
T Consensus 772 ~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-------------------------~L~s 826 (1153)
T PLN03210 772 LMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-------------------------NLES 826 (1153)
T ss_pred hhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-------------------------Cccc
Confidence 111123455555555555444444444444444444444443323344333 3444
Q ss_pred ccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceecccc-CcCCCCChhHHhhhcccceeccc
Q 038003 411 LNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSN-NQLSHKIPTEFEKLIHLSELDLS 489 (848)
Q Consensus 411 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls 489 (848)
|+.|++++|..-..+|.. .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |+++ .+|..+..+++|+.|+++
T Consensus 827 L~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~ 901 (1153)
T PLN03210 827 LESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFS 901 (1153)
T ss_pred cCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecC
Confidence 444444444332222221 234555555555554 3445555555555555555 2333 344444555555555555
Q ss_pred Cc
Q 038003 490 HN 491 (848)
Q Consensus 490 ~N 491 (848)
+|
T Consensus 902 ~C 903 (1153)
T PLN03210 902 DC 903 (1153)
T ss_pred CC
Confidence 44
|
syringae 6; Provisional |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=229.97 Aligned_cols=133 Identities=26% Similarity=0.372 Sum_probs=112.9
Q ss_pred hcCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-----C---CcccceEEEe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-----H---RNNVKFHGFC 668 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---p~iv~l~~~~ 668 (848)
..+|.+.+.||=|-|++||+|. ..+.+.||+|+.+.. ....+....||+++++++ | .+||+++++|
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 3689999999999999999994 457788999998765 245667789999999883 3 3699999999
Q ss_pred ec----CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 669 YN----GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 669 ~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
.. +.+++||+|++ |.+|..++.... -+.++...+.+|++||..||.|||++| ||||.||||+|||+.
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 64 56899999999 668888887653 355888999999999999999999998 999999999999994
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=269.99 Aligned_cols=347 Identities=22% Similarity=0.240 Sum_probs=236.2
Q ss_pred CchhhhccccccEEEecccCc------CCCCCccccCcC-CccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCC
Q 038003 119 IPPEIGKLNQLRRLYLDMNQL------HGTIPPEIGQLS-LIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSI 191 (848)
Q Consensus 119 ~p~~~~~l~~L~~L~L~~n~l------~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 191 (848)
.+.+|.++++|+.|.+..+.. ...+|..+..++ +|+.|++.++.++ .+|..+ ...+|+.|++.+|++. .+
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence 345677888888888866542 334566666553 4777777777776 667666 3577777777777776 56
Q ss_pred cccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCC
Q 038003 192 PSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLS 271 (848)
Q Consensus 192 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~ 271 (848)
|..+..+++|++|+|+++...+.+| .++.+++|+.|+|++|.....+|..++.+++|+.|++++|..-..+|..+ +++
T Consensus 627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~ 704 (1153)
T PLN03210 627 WDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK 704 (1153)
T ss_pred ccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC
Confidence 6666777777777777665444555 36667777777777766555677777777777777777654434455543 566
Q ss_pred CCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCcccc
Q 038003 272 SLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCG 351 (848)
Q Consensus 272 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 351 (848)
+|+.|++++|.....+|.. ..+|+.|++++|.+.. +|..+ .+++|+.|++.++....
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-------------------~l~~L~~L~l~~~~~~~ 761 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-------------------RLENLDELILCEMKSEK 761 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-------------------cccccccccccccchhh
Confidence 7777777766544344432 2345555555555432 22211 23455555555433211
Q ss_pred ccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCC
Q 038003 352 EISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGS 431 (848)
Q Consensus 352 ~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 431 (848)
. . +.+....+......++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ .
T Consensus 762 l-~----------------~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~ 823 (1153)
T PLN03210 762 L-W----------------ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-N 823 (1153)
T ss_pred c-c----------------ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-C
Confidence 0 0 01111112223345789999999998887899999999999999999986555777766 7
Q ss_pred CCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccC-cccCcCCCccccCCCCCccc
Q 038003 432 LTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSH-NILQEEIPPQVCNMGSLEKL 510 (848)
Q Consensus 432 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 510 (848)
+++|+.|++++|..-..+|.. .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |++ ..+|..+..+++|+.|
T Consensus 824 L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L-~~l~~~~~~L~~L~~L 898 (1153)
T PLN03210 824 LESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNL-QRVSLNISKLKHLETV 898 (1153)
T ss_pred ccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCc-CccCcccccccCCCee
Confidence 899999999998654455543 368999999999998 6899999999999999999 455 4588888999999999
Q ss_pred cCCCCc
Q 038003 511 NLSHNN 516 (848)
Q Consensus 511 ~Ls~N~ 516 (848)
+++++.
T Consensus 899 ~l~~C~ 904 (1153)
T PLN03210 899 DFSDCG 904 (1153)
T ss_pred ecCCCc
Confidence 999884
|
syringae 6; Provisional |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-26 Score=245.31 Aligned_cols=197 Identities=28% Similarity=0.417 Sum_probs=176.4
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|+..+++|.|+||.||+|++ +.++..|+|+++... .....-...|+-+++..+|||||.+++.+...+..|+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 46799999999999999999965 478999999998763 2345567789999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
.|||+.+|+|++.-+.. +.+++.++..+.+...+|++|||++ |-+|||||-.||++.+.|.+|++|||.+..+.
T Consensus 90 cMEycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 99999999999987665 6788899999999999999999999 99999999999999999999999999998887
Q ss_pred CCCCCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCC
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHP 804 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P 804 (848)
.--.....+.|||.|||||+.. ...|...+|||+.|++..|+---+.|
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 6666678899999999999864 45688999999999999999888877
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-26 Score=228.47 Aligned_cols=244 Identities=19% Similarity=0.285 Sum_probs=192.6
Q ss_pred HHHHHhhcCCcccceeccCCceeEEEEEcCC------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceE
Q 038003 592 EEIIKATDDFDEKFCIGKGGQGSVYKAELPS------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665 (848)
Q Consensus 592 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 665 (848)
.++.....|++....+-+|.||.||+|.|++ .+.|.+|.++... .+-+...+..|--.+..+.|||+.++.
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 4555566778888899999999999996653 3456777765543 334567788898889999999999999
Q ss_pred EEeec-CCeeEEEEeccCCCCHHhHhc-----CCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 666 GFCYN-GPHSFLVCEYLDRGSLARILG-----DDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 666 ~~~~~-~~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
+++.+ .+..++++.++.-|+|..+++ +....+.+.-.+...++.|++.|++|||++ +|||.||-++|.++|
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 99865 457788999999999999987 444556677788899999999999999999 999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCCCcc--cccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccccccccccc
Q 038003 740 SNFEAHVSDFGIAKFVGPHSSNWT--EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFSINFSSFS 816 (848)
Q Consensus 740 ~~~~~kl~DfG~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~ 816 (848)
+.-.+||+|=.+++..-+.+...- ....+..||+||.+....|+.++|||||||++|||+| |+.||. ++|-.++.
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya--eIDPfEm~ 508 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA--EIDPFEME 508 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc--ccCHHHHH
Confidence 999999999999987765443321 2234678999999999999999999999999999999 999954 44445566
Q ss_pred hhhhhhhhhcCCCCCCCCCCcccccceee
Q 038003 817 NMIIDVNKILDPRLPTPSPSVMDYGGCHF 845 (848)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (848)
.++++.-++.-|.. ++.++...|.|||
T Consensus 509 ~ylkdGyRlaQP~N--CPDeLf~vMacCW 535 (563)
T KOG1024|consen 509 HYLKDGYRLAQPFN--CPDELFTVMACCW 535 (563)
T ss_pred HHHhccceecCCCC--CcHHHHHHHHHHH
Confidence 66666555433332 3445566677776
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-26 Score=234.10 Aligned_cols=396 Identities=23% Similarity=0.239 Sum_probs=266.3
Q ss_pred CCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecc-cCcCCCCCccccCcCCccEEEc
Q 038003 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDM-NQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 80 ~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L 158 (848)
..+.++|..|.++..-|.+|+.+.+|+.||||+|+|+.+-|++|.+|.+|..|-+.+ |+|+..-.+.|+.|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 568899999999876677899999999999999999999999999999988887776 9999555568999999999999
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccCCCccccccccccccccccccccc------------ccCcccccCCcccc
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFS------------GSIPLSLGNLSSLT 226 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------~~~p~~l~~l~~L~ 226 (848)
.-|++.-...+.|..|++|..|.+..|.+...--..|..+.+++.+.+..|.+- ...|..++...-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 999999777788999999999999999998433348999999999999999843 22333444444444
Q ss_pred eeeccccCCCCCCCCccc-CcccccccccccccccCcCC-CcccCCCCCceEEccCccccccCcccccCCCCCccccccc
Q 038003 227 MMSLFNNSLSGSIPPILG-NLKSLSALGLHINQLNGFIP-PSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCT 304 (848)
Q Consensus 227 ~L~l~~n~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 304 (848)
-..+.++++...-+.-|. .++.+..=-.+.+...++-| ..|..+++|++|+|++|+++.+-+.+|..+..+++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 444555555433222222 11222111122222333333 3577788888888888888877777888777777777777
Q ss_pred cccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCC-CCCC--
Q 038003 305 NLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSI-PPDI-- 381 (848)
Q Consensus 305 N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~-p~~l-- 381 (848)
|+|.. +....|.++..|+.|+|.+|+|+...|.+|..+..|.+|.+-.|.+.-.- -.|+
T Consensus 308 N~l~~------------------v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~ 369 (498)
T KOG4237|consen 308 NKLEF------------------VSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE 369 (498)
T ss_pred chHHH------------------HHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH
Confidence 76652 33345677777888888888888777777777777777777666553100 0000
Q ss_pred -------------CCCCCccEEEccCCccCCC---CcccccccccccEEEccCCcCCCCCCcccCCCCccCe-EeccCcc
Q 038003 382 -------------GNSPKLQVLDLSSNHIVGK---IPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQY-LDLSTNK 444 (848)
Q Consensus 382 -------------~~l~~L~~L~Ls~N~l~~~---~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~Ls~N~ 444 (848)
+.-..++.+.++++.+... .|++.+- .-++.-| ...+-+.+ ...|++.
T Consensus 370 Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~------------~~s~~cP---~~c~c~~tVvRcSnk~ 434 (498)
T KOG4237|consen 370 WLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGC------------LTSSPCP---PPCTCLDTVVRCSNKL 434 (498)
T ss_pred HHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCC------------CCCCCCC---CCcchhhhhHhhcccc
Confidence 0111233444444433311 1111000 0000001 11223332 3345555
Q ss_pred cCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCC
Q 038003 445 LSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHN 515 (848)
Q Consensus 445 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (848)
++ .+|..+- ..-.+|++.+|.++ .+|.. .+.+| .+|+|+|++...-...|.+|+.|.+|-||+|
T Consensus 435 lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 435 LK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 55 5555442 35678999999998 56666 66678 8999999998777788999999999998876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=227.85 Aligned_cols=209 Identities=24% Similarity=0.354 Sum_probs=171.9
Q ss_pred HHHhhcCCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEe
Q 038003 594 IIKATDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFC 668 (848)
Q Consensus 594 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 668 (848)
+....+.|...+.||+|.|++||++.+. ..+.||+|.+.... ...++..|++++..+ .+.||+++.+.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhh
Confidence 3344567888999999999999999443 46789999986653 346688999999998 699999999999
Q ss_pred ecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-CCCEEEe
Q 038003 669 YNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVS 747 (848)
Q Consensus 669 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~ 747 (848)
...+++.+|+||++.....++. ..++...+..+++.+..||+++|.+ |||||||||+|++.+. .+.-.|+
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred ccCCeeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEE
Confidence 9999999999999998888877 3466788999999999999999999 9999999999999974 5778999
Q ss_pred eccCccccCCCC-------------C-------------------------------CcccccccccccCccccccCC-C
Q 038003 748 DFGIAKFVGPHS-------------S-------------------------------NWTEFAGTFGYAAPEIAYTMR-A 782 (848)
Q Consensus 748 DfG~~~~~~~~~-------------~-------------------------------~~~~~~g~~~y~aPE~~~~~~-~ 782 (848)
|||+|..+.... . .....+||++|.|||++...+ .
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999997321000 0 001246999999999987654 6
Q ss_pred CccchhhhHHHHHHHHHhCCCCCccccccccccch
Q 038003 783 TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 817 (848)
Q Consensus 783 ~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 817 (848)
++++||||.|||+.-++++++||-...++.....+
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~e 290 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAE 290 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHH
Confidence 88999999999999999999999776666664443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=208.26 Aligned_cols=184 Identities=35% Similarity=0.588 Sum_probs=159.9
Q ss_pred eccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCC
Q 038003 607 IGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGS 685 (848)
Q Consensus 607 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gs 685 (848)
||+|++|.||++... +++.+++|++...... ...+.+.+|++.++.++|++++++++++......+++|||+++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999775 4899999998765321 135678999999999999999999999999999999999999999
Q ss_pred HHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-CCCEEEeeccCccccCCCCCCccc
Q 038003 686 LARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHSSNWTE 764 (848)
Q Consensus 686 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~~~~~~~~~~~~~~ 764 (848)
|.+++.... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+............
T Consensus 78 l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 78 LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 999986531 3578899999999999999999999 9999999999999999 899999999999877554322344
Q ss_pred ccccccccCccccccC-CCCccchhhhHHHHHHHH
Q 038003 765 FAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEV 798 (848)
Q Consensus 765 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~el 798 (848)
..+...|++||..... .++.+.|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 5678899999998877 778899999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=241.40 Aligned_cols=94 Identities=29% Similarity=0.406 Sum_probs=49.9
Q ss_pred cccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccc
Q 038003 128 QLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLS 207 (848)
Q Consensus 128 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 207 (848)
+-..|+|+.|.++ .+|+.+. .+|+.|++++|+|+ .+|.. +++|++|++++|+|+ .+|.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 3456666666666 4555554 25666666666666 35532 355666666666666 34432 2355555666
Q ss_pred cccccccCcccccCCcccceeeccccCCC
Q 038003 208 ENQFSGSIPLSLGNLSSLTMMSLFNNSLS 236 (848)
Q Consensus 208 ~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 236 (848)
+|.++ .+|..+ ++|+.|++++|+++
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt 295 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLT 295 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCccc
Confidence 66555 333321 33445555555554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=241.62 Aligned_cols=263 Identities=26% Similarity=0.325 Sum_probs=142.9
Q ss_pred CcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeec
Q 038003 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYK 184 (848)
Q Consensus 105 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~ 184 (848)
-..|||++|+|+ .+|+.+. ++|+.|++++|+++ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 344555555554 3444443 24555555555555 23431 344555555555555 34432 23455555555
Q ss_pred ccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCC
Q 038003 185 NSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIP 264 (848)
Q Consensus 185 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 264 (848)
|.++ .+|..+ ++|+.|+|++|+++ .+|.. +++|+.|+|++|++++ +|... .+|+.|++++|++++ +|
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP 338 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LP 338 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cc
Confidence 5555 333322 34555555555555 33432 2455666666666653 33321 235555666666653 33
Q ss_pred CcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEc
Q 038003 265 PSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDL 344 (848)
Q Consensus 265 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L 344 (848)
.. ..+|++|+|++|+|++ +|.. ..+|+.|++++|+|.+ +|. ...+|+.|++
T Consensus 339 ~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~---------------------l~~~L~~LdL 389 (788)
T PRK15387 339 TL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPA---------------------LPSGLKELIV 389 (788)
T ss_pred cc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Ccc---------------------cccccceEEe
Confidence 21 1356666666666663 3332 2345555666665553 221 0134666666
Q ss_pred cCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCC
Q 038003 345 SNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGG 424 (848)
Q Consensus 345 s~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 424 (848)
++|+|++.. .. .++|+.|++++|++++ +|... .+|+.|++++|+|+ .+|..+..+++|+.|+|++|.|++.
T Consensus 390 s~N~Lt~LP-~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 390 SGNRLTSLP-VL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred cCCcccCCC-Cc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCch
Confidence 666666432 21 2456677777777763 45432 45777888888887 6777788888888888888888876
Q ss_pred CCccc
Q 038003 425 VPLEF 429 (848)
Q Consensus 425 ~~~~~ 429 (848)
.+..+
T Consensus 461 ~~~~L 465 (788)
T PRK15387 461 TLQAL 465 (788)
T ss_pred HHHHH
Confidence 66655
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=236.24 Aligned_cols=358 Identities=22% Similarity=0.276 Sum_probs=197.1
Q ss_pred ChHHHHHHHHHHHhccCCCCCCcccCCCCCCCCCCCCCCCCccCc----------------eEEcCCCCceEEEeccccC
Q 038003 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFG----------------ISCNHAGSRVISITMSTLG 65 (848)
Q Consensus 2 ~~~~~~all~~k~~~~~~~~~~~~l~sw~~~~~~~~~~~~c~w~g----------------v~C~~~~~~v~~l~l~~~~ 65 (848)
-++|.+.++++.+.+..++...++-+.|.+ ++|+|-=.. |.|. ++.|+.+...+..
T Consensus 61 ~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~------~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~ 132 (754)
T PRK15370 61 SPEEIKSKFECLRMLAFPAYADNIQYSRGG------ADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESE 132 (754)
T ss_pred CHHHHHHHHHHHHHhcCCchhhccccccCC------CCcccccCCcchhhheeeecCCceEEecC--CCccccccccccc
Confidence 468899999999999776433334444973 578885433 6675 3456655543321
Q ss_pred ccccc----cC-----------------------Ccc-----CCCCCCcEEeccCCcccccccccccCCCCCcEEEcccc
Q 038003 66 LNGTF----HD-----------------------FSF-----SSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSN 113 (848)
Q Consensus 66 l~g~~----~~-----------------------~~~-----~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n 113 (848)
....- .. ... +-..+.+.|+++++.++ .+|..+. +.|+.|+|++|
T Consensus 133 ~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N 209 (754)
T PRK15370 133 QASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNN 209 (754)
T ss_pred ccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCC
Confidence 11100 00 000 11134556666666665 3555443 45666666666
Q ss_pred CCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcc
Q 038003 114 QLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193 (848)
Q Consensus 114 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 193 (848)
+++ .+|..+. ++|++|+|++|+++ .+|..+. .+|+.|+|++|+++ .+|..+. .+|+.|++++|+++ .+|.
T Consensus 210 ~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~ 279 (754)
T PRK15370 210 ELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPE 279 (754)
T ss_pred CCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-cccc
Confidence 666 3454443 36666666666666 4555443 35666666666666 5565543 35666666666666 4555
Q ss_pred cccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCC
Q 038003 194 IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSL 273 (848)
Q Consensus 194 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L 273 (848)
.+. ++|++|+|++|+|+ .+|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|.+++ +|..+. ++|
T Consensus 280 ~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL 348 (754)
T PRK15370 280 NLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PEL 348 (754)
T ss_pred ccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--Ccc
Confidence 443 35666666666666 3444332 35666666666666 3444332 456666666666664 444332 466
Q ss_pred ceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCcccccc
Q 038003 274 RVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI 353 (848)
Q Consensus 274 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 353 (848)
+.|++++|+++. +|..+. ++|+.|++++|.++. ++.... ..|+.|++++|++....
T Consensus 349 ~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~------------------LP~~l~---~sL~~LdLs~N~L~~LP 404 (754)
T PRK15370 349 QVLDVSKNQITV-LPETLP--PTITTLDVSRNALTN------------------LPENLP---AALQIMQASRNNLVRLP 404 (754)
T ss_pred cEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCC------------------CCHhHH---HHHHHHhhccCCcccCc
Confidence 666666666652 444332 456666666665553 322211 35788888888887432
Q ss_pred ---CccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCC-CCcccccccccccEEEccCCcCC
Q 038003 354 ---SFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVG-KIPVQLEMLSSLNKLILNLNQLS 422 (848)
Q Consensus 354 ---~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~ 422 (848)
+...+..+.+..+++.+|.++. ..+++|+.| ++.+.+.| .++...+.+++++....-.+...
T Consensus 405 ~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~ 470 (754)
T PRK15370 405 ESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQ 470 (754)
T ss_pred hhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHh
Confidence 2223445777888888888762 345556666 44455543 23334444455544333333333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=215.72 Aligned_cols=168 Identities=20% Similarity=0.162 Sum_probs=130.0
Q ss_pred HHhhcCCcccceeccCCceeEEEEEcC--CCCEEEEEEccccccc-CCchhHHHHHHHHHHHhcCCCCcccc-eEEEeec
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAELP--SGDIVAVKKFNSQLLS-GNMADHDEFLNEVLALKEIRHRNNVK-FHGFCYN 670 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~-l~~~~~~ 670 (848)
....++|+..+.||+|+||+||+|.+. +++.+|||++...... ......+.+.+|++++++++|+++++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 344577999999999999999999664 5777899987533110 12234566899999999999999985 4432
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCC-CCCCeeeCCCCCEEEeec
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDI-SSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~Df 749 (848)
+..|+||||++|++|... ... . ...++.|+++||.|+|+. ||+|||| ||+||+++.++.+||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~---~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPH---G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Ccc---c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999999632 111 1 146789999999999999 9999999 999999999999999999
Q ss_pred cCccccCCCCCC--------cccccccccccCcccccc
Q 038003 750 GIAKFVGPHSSN--------WTEFAGTFGYAAPEIAYT 779 (848)
Q Consensus 750 G~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~ 779 (848)
|+|+.+...... .+...+++.|+|||++..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999977543211 123567888999999863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=199.42 Aligned_cols=199 Identities=20% Similarity=0.295 Sum_probs=170.2
Q ss_pred cCCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~l 676 (848)
-.|.+++.||+|+||++|.| ..-+++.||||.-..+ .+..++..|.+..+.| .-+.|..+|-|-.++.+-.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 45899999999999999999 4558999999975443 3345677899998888 46899999999899999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-----CEEEeeccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-----EAHVSDFGI 751 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~DfG~ 751 (848)
|+|.+ |-||+|++. ..+.+++.++++-+|.|++.-++|+|++ .+|+|||||+|+||...+ .+.++|||+
T Consensus 102 VidLL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 99999 568888774 2356799999999999999999999999 999999999999997543 588999999
Q ss_pred ccccCCCCCCc-------ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 752 AKFVGPHSSNW-------TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 752 ~~~~~~~~~~~-------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
|+.+.+..... ....||.+||+-..+.|.+.+++.|.-|+|-++++.+-|..||.-..
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 99986544322 34679999999999999999999999999999999999999996543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-23 Score=193.84 Aligned_cols=201 Identities=21% Similarity=0.308 Sum_probs=168.2
Q ss_pred hcCCcccceeccCCceeEEEE-EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC-CcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH-RNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~~ 675 (848)
...|...+.||.|+||.+|.| ...+|+.||||+-.... ...++..|.++.+.+++ ..|..+..|..+...-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA------KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC------CCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 356999999999999999999 56689999999865542 23456778999999965 56777788888888889
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC---CCEEEeeccCc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN---FEAHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~~ 752 (848)
+|||.+ |-+|++++.- ..+.++.+++.-.+-|++.-++|+|.+ +++||||||+|+|+.-+ ..+.++|||+|
T Consensus 88 lVMdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 999999 6699988753 346788899999999999999999999 99999999999999643 46899999999
Q ss_pred cccCCCCCCc-------ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccc
Q 038003 753 KFVGPHSSNW-------TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI 810 (848)
Q Consensus 753 ~~~~~~~~~~-------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 810 (848)
+.+-+..... ....||.+|.+-..+.+.+.+++.|+-|+|.++.++--|..||+-...
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 9885433221 346799999999999998999999999999999999999999975443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=212.39 Aligned_cols=201 Identities=24% Similarity=0.293 Sum_probs=164.9
Q ss_pred CCcccceeccCCceeEEEEEcCCC--CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC----CcccceEEEe-ecCC
Q 038003 600 DFDEKFCIGKGGQGSVYKAELPSG--DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH----RNNVKFHGFC-YNGP 672 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----p~iv~l~~~~-~~~~ 672 (848)
+|.+.+.||+|+||.||.|..... ..+|+|........ . ...+..|..++..+.. +++..+++.. ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~---~-~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS---K-PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC---C-CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 799999999999999999976543 47888886554211 1 1156678888888863 6899999998 5777
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC-----CCEEEe
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN-----FEAHVS 747 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~ 747 (848)
..|+||+.+ |.+|.++..... .+.++..++..|+.|++.+|+++|+. |++||||||+|+++... ..+.+.
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence 899999998 669999876553 57899999999999999999999999 99999999999999865 469999
Q ss_pred eccCcc--ccCCCCC-------C-cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 748 DFGIAK--FVGPHSS-------N-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 748 DfG~~~--~~~~~~~-------~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
|||+++ .+..... . ...++||..|++++++.+.+.+++.|+||++.++.|+..|..||....
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 999998 3321111 1 234669999999999999999999999999999999999999996433
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=226.00 Aligned_cols=116 Identities=28% Similarity=0.460 Sum_probs=51.9
Q ss_pred cEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeecccc
Q 038003 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNN 233 (848)
Q Consensus 154 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n 233 (848)
..|+++++.++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|+|++|+++ .+|..+. ++|+.|+|++|
T Consensus 181 ~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N 251 (754)
T PRK15370 181 TELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSIN 251 (754)
T ss_pred eEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCC
Confidence 34444444444 3343332 24444555555444 2333222 24445555555544 3343322 24555555555
Q ss_pred CCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCcccc
Q 038003 234 SLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLY 284 (848)
Q Consensus 234 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 284 (848)
++. .+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|+++
T Consensus 252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 252 RIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR 296 (754)
T ss_pred ccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccc
Confidence 554 3443332 245555555555552 343332 35556666666555
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-22 Score=237.92 Aligned_cols=147 Identities=16% Similarity=0.184 Sum_probs=115.1
Q ss_pred cCCC-CcccceEEEe-------ecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 038003 655 EIRH-RNNVKFHGFC-------YNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726 (848)
Q Consensus 655 ~l~h-p~iv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~i 726 (848)
.++| +||++++++| .+.+..+.++||+ +++|.++++.. ...+++.++..+++||++||+|||++ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4456 6888888887 2334567888887 55999999653 34589999999999999999999999 99
Q ss_pred EEcCCCCCCeeeCC-------------------CCCEEEeeccCccccCCCC----------------CCcccccccccc
Q 038003 727 IHRDISSKNVLLDS-------------------NFEAHVSDFGIAKFVGPHS----------------SNWTEFAGTFGY 771 (848)
Q Consensus 727 vH~Dlk~~NIll~~-------------------~~~~kl~DfG~~~~~~~~~----------------~~~~~~~g~~~y 771 (848)
+||||||+|||++. ++.+|++|||+++...... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456667777665432100 001124578899
Q ss_pred cCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 772 AAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 772 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||||++.+..++.++|||||||++|||++|..|+..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999999999998653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-21 Score=189.61 Aligned_cols=173 Identities=11% Similarity=0.140 Sum_probs=134.9
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHH------HHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDE------FLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
..+|...+.+|.|+||.||.++. ++..+|||++...... .+..... +.+|++.+.+++||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~-~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKR-TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCc-hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999876 5778999999766432 2222222 57899999999999999999886643
Q ss_pred --------CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC
Q 038003 672 --------PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE 743 (848)
Q Consensus 672 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 743 (848)
...++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+||+++.+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 35789999999999987631 221 2466999999999999 999999999999999988
Q ss_pred EEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHH
Q 038003 744 AHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799 (848)
Q Consensus 744 ~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 799 (848)
++++|||..+....... . ..+.....+..++|+||||+++....
T Consensus 173 i~liDfg~~~~~~e~~a--~----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA--K----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh--H----------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999998876532111 1 11344455677899999999987554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=181.98 Aligned_cols=144 Identities=18% Similarity=0.174 Sum_probs=110.2
Q ss_pred cceeccCCceeEEEEEcCCCCEEEEEEcccccccCCch----------------------hHHHHHHHHHHHhcCCCCcc
Q 038003 604 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMA----------------------DHDEFLNEVLALKEIRHRNN 661 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~----------------------~~~~~~~E~~~l~~l~hp~i 661 (848)
...||+|+||.||+|...+|+.||||+++......... .......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999988789999999997653211110 01123459999999988877
Q ss_pred cceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEcCCCCCCeeeCC
Q 038003 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL-HHDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 662 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~L-H~~~~~~ivH~Dlk~~NIll~~ 740 (848)
.....+.. ...++||||++|+++...... ...++..++..++.|++.++.++ |+. ||+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 54443322 234899999999876544322 24578889999999999999999 688 999999999999998
Q ss_pred CCCEEEeeccCccccC
Q 038003 741 NFEAHVSDFGIAKFVG 756 (848)
Q Consensus 741 ~~~~kl~DfG~~~~~~ 756 (848)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 5789999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-19 Score=196.51 Aligned_cols=203 Identities=32% Similarity=0.475 Sum_probs=171.5
Q ss_pred CcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCC-cccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR-NNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~l~~~~~~~~~~~lV~e 679 (848)
|...+.||.|+||.||++... ..+++|.+....... ......+.+|+.+++.+.|+ +++++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 667788999999999999776 889999987765331 12467789999999999988 79999999977777899999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-CEEEeeccCccccCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-EAHVSDFGIAKFVGPH 758 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~~~~~~~~ 758 (848)
++.++++.+++........+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999997775442112578889999999999999999999 999999999999999988 7999999999866543
Q ss_pred CC------CcccccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 759 SS------NWTEFAGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 759 ~~------~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
.. ......|+..|+|||...+ ..+....|+||+|++++++++|..||....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 2356789999999999987 577889999999999999999999965443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-20 Score=177.24 Aligned_cols=186 Identities=13% Similarity=0.082 Sum_probs=140.5
Q ss_pred cccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeEEEEec
Q 038003 602 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 602 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
.....|++|+||+||.+.. .+.+++.+.+..............+.+|+++++++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4456899999999998866 688888888766543211122335789999999995 5889999886 346999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCC-CCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDI-SSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
++|.+|.+.... ....++.|++.++.++|+. ||+|||| ||+||+++.++.++|+|||++....+..
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998754311 1135788999999999999 9999999 7999999999999999999998665433
Q ss_pred CC-----cc--------cccccccccCccccccC-CCC-ccchhhhHHHHHHHHHhCCCCC
Q 038003 760 SN-----WT--------EFAGTFGYAAPEIAYTM-RAT-EKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 760 ~~-----~~--------~~~g~~~y~aPE~~~~~-~~~-~~~DiwSlG~il~elltg~~P~ 805 (848)
.. .. ....++.|++|+...-- ..+ ...+.++-|+-+|.++|++.|+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 21 00 12356777888754321 222 4678999999999999999984
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=177.29 Aligned_cols=144 Identities=21% Similarity=0.224 Sum_probs=111.8
Q ss_pred cceeccCCceeEEEEEcCCCCEEEEEEcccccccCCc--------------------h--hHHHHHHHHHHHhcCCCCcc
Q 038003 604 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNM--------------------A--DHDEFLNEVLALKEIRHRNN 661 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~--------------------~--~~~~~~~E~~~l~~l~hp~i 661 (848)
...||+|+||.||+|...+|+.||||+++........ . ......+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999998778999999998765311000 0 01223578999999999988
Q ss_pred cceEEEeecCCeeEEEEeccCCCCHHhH-hcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeC
Q 038003 662 VKFHGFCYNGPHSFLVCEYLDRGSLARI-LGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 662 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~ 739 (848)
.....+... ..++||||++|+++... +.. ..++..++..++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 655544433 24899999998855332 321 346778889999999999999999 8 999999999999998
Q ss_pred CCCCEEEeeccCccccCC
Q 038003 740 SNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 740 ~~~~~kl~DfG~~~~~~~ 757 (848)
++.++|+|||+++....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-21 Score=174.40 Aligned_cols=165 Identities=34% Similarity=0.574 Sum_probs=119.8
Q ss_pred cCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccce
Q 038003 100 GNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAV 179 (848)
Q Consensus 100 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 179 (848)
.+++..+.|.||+|+++ .+|+.++.|.+|+.|++++|+++ .+|.+++++++|+.|+++-|++. .+|..||.++.|++
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 34556666667777776 45666777777777777777776 66777777777777777777766 67777777777777
Q ss_pred EEeecccccC-CCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCccccccccccccc
Q 038003 180 LYLYKNSLSG-SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQ 258 (848)
Q Consensus 180 L~l~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~ 258 (848)
|||.+|.+.. .+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|++.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 7777777653 46777777788888888888887 77778888888888888888777 677788888888888888888
Q ss_pred ccCcCCCcccCC
Q 038003 259 LNGFIPPSIGNL 270 (848)
Q Consensus 259 l~~~~p~~l~~l 270 (848)
++ .+|+.++++
T Consensus 185 l~-vlppel~~l 195 (264)
T KOG0617|consen 185 LT-VLPPELANL 195 (264)
T ss_pred ee-ecChhhhhh
Confidence 77 445555543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-21 Score=176.75 Aligned_cols=166 Identities=33% Similarity=0.575 Sum_probs=155.0
Q ss_pred cCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCcc
Q 038003 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLID 154 (848)
Q Consensus 75 ~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 154 (848)
+..+.+++.|.||+|.++ .+|+.|++|.+|+.|++++|+++ .+|.+++.+++|+.|+++-|++. .+|..||.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 556778899999999997 78999999999999999999998 68999999999999999999999 8999999999999
Q ss_pred EEEcCCCcCCC-CCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeecccc
Q 038003 155 KLALCHNNLHG-SIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNN 233 (848)
Q Consensus 155 ~L~L~~n~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n 233 (848)
.|||.+|++.. .+|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 99999999874 58999999999999999999998 88999999999999999999998 89999999999999999999
Q ss_pred CCCCCCCCcccCc
Q 038003 234 SLSGSIPPILGNL 246 (848)
Q Consensus 234 ~l~~~~p~~l~~l 246 (848)
+++ .+|+.++++
T Consensus 184 rl~-vlppel~~l 195 (264)
T KOG0617|consen 184 RLT-VLPPELANL 195 (264)
T ss_pred eee-ecChhhhhh
Confidence 999 778777654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.1e-21 Score=205.39 Aligned_cols=188 Identities=27% Similarity=0.336 Sum_probs=160.2
Q ss_pred eeccCCceeEEEEE----cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeEEEEec
Q 038003 606 CIGKGGQGSVYKAE----LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 606 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
.+|+|+||.|+.++ ...+..+|+|+.++........ .+...|..++..++ ||++|++...++.+.+.++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~--~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR--THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc--cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 37999999999873 3357889999988765443222 26677888888886 99999999999999999999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~ 760 (848)
..+|.+...+... ..++......+...+|-|++++|+. +|+|||+|++||+++.+|++++.|||+++..-+...
T Consensus 79 ~rgg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 79 LRGGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cccchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 9999998887655 4466677778888999999999999 999999999999999999999999999987654332
Q ss_pred CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 761 NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 761 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. +||..|||||++. ......|.||||++++||+||..||..
T Consensus 153 ~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 A----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred c----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 2 8999999999998 456689999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-19 Score=175.61 Aligned_cols=106 Identities=28% Similarity=0.289 Sum_probs=94.1
Q ss_pred CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcc
Q 038003 684 GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT 763 (848)
Q Consensus 684 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 763 (848)
|+|.++++.. ...+++.++..|+.||+.||+|||+. + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888653 34689999999999999999999998 6 999999999999999 99998765422
Q ss_pred cccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 764 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..|++.|+|||++.+..+++++|||||||++|||+||+.||..
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 2688999999999999999999999999999999999999854
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.3e-20 Score=209.66 Aligned_cols=202 Identities=20% Similarity=0.217 Sum_probs=160.3
Q ss_pred ccceeccCCceeEEEEEc-CCCCEEEEEEcccc--cccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 603 EKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQ--LLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 603 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
....+|.|++|.|+.+.. ...+.++.|.+... ...........+..|+.+-+.+.||+++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 346799999998887743 34455555554321 111111222236778888999999999998888888777777799
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++ +|..++.+. ..+...++..+++|+..|+.|+|.. ||.|||+|++|+++..+|.+||+|||.+.......
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 999988654 4577788889999999999999999 99999999999999999999999999997654322
Q ss_pred C----CcccccccccccCccccccCCCCc-cchhhhHHHHHHHHHhCCCCCcccccc
Q 038003 760 S----NWTEFAGTFGYAAPEIAYTMRATE-KYDVYSFGVLVFEVIKGNHPRDFFSIN 811 (848)
Q Consensus 760 ~----~~~~~~g~~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~P~~~~~~~ 811 (848)
. .....+|+..|+|||++.+.+|++ ..||||.|++++.|.+|+.||......
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 2 235688999999999999999865 589999999999999999999765544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-20 Score=204.56 Aligned_cols=106 Identities=24% Similarity=0.224 Sum_probs=55.9
Q ss_pred EEeccCCccc-ccccccccCCCCCcEEEccccCCCCC----CchhhhccccccEEEecccCcCC------CCCccccCcC
Q 038003 83 NLNLSFNLFF-GNIPLQIGNLSKLQYLDLGSNQLSGL----IPPEIGKLNQLRRLYLDMNQLHG------TIPPEIGQLS 151 (848)
Q Consensus 83 ~L~l~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~------~~p~~~~~l~ 151 (848)
.|+|..+.++ +..+..+..+..|++|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566666666 34555566666677777777776432 44455566667777777766652 1223334444
Q ss_pred CccEEEcCCCcCCCCCCCcccCccc---cceEEeeccccc
Q 038003 152 LIDKLALCHNNLHGSIPSSLGNLSN---LAVLYLYKNSLS 188 (848)
Q Consensus 152 ~L~~L~L~~n~l~~~~p~~l~~l~~---L~~L~l~~N~l~ 188 (848)
+|++|++++|.+.+..+..+..+.+ |++|++++|+++
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~ 121 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG 121 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccc
Confidence 5555555555444333333333332 444444444443
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-20 Score=203.23 Aligned_cols=209 Identities=22% Similarity=0.272 Sum_probs=132.3
Q ss_pred cCCCCCccEEEccCCccccccCccccCccc---ccEeecccccccC----CCCCCCCCC-CCccEEEccCCccCCC----
Q 038003 333 FGDHPNLTFLDLSNNNFCGEISFNWGNFSK---LSTFIVSMNNISG----SIPPDIGNS-PKLQVLDLSSNHIVGK---- 400 (848)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~l~~N~i~~----~~p~~l~~l-~~L~~L~Ls~N~l~~~---- 400 (848)
+..+++|+.|++++|.+.+..+..+..+.+ |+.|++++|++++ .+...+..+ ++|+.|++++|.+++.
T Consensus 77 l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 156 (319)
T cd00116 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA 156 (319)
T ss_pred HHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence 334455566666665555433333333333 5566665555542 122234445 6788888888887743
Q ss_pred CcccccccccccEEEccCCcCCCC----CCcccCCCCccCeEeccCcccCCCC----CCcccCccccceeccccCcCCCC
Q 038003 401 IPVQLEMLSSLNKLILNLNQLSGG----VPLEFGSLTKLQYLDLSTNKLSSSI----PKSIGNLLKLHYLNLSNNQLSHK 472 (848)
Q Consensus 401 ~~~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~ 472 (848)
++..+..+++|+.|++++|.+++. ++..+..+++|+.|++++|.+++.. +..+..+++|+.|++++|.+++.
T Consensus 157 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~ 236 (319)
T cd00116 157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA 236 (319)
T ss_pred HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence 333455667788888888888742 2233445568888888888876432 33456677888888888888764
Q ss_pred ChhHHhh-----hcccceecccCcccCc----CCCccccCCCCCccccCCCCcccCCC----cchhccc-cCceeecCCC
Q 038003 473 IPTEFEK-----LIHLSELDLSHNILQE----EIPPQVCNMGSLEKLNLSHNNLSDFI----PRCFEEM-RSLSCIDISY 538 (848)
Q Consensus 473 ~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l-~~L~~l~ls~ 538 (848)
....+.. .+.|+.|++++|.+++ .+...+..+++|+++++++|.++... ...+... +.|+.+++.+
T Consensus 237 ~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (319)
T cd00116 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKD 316 (319)
T ss_pred HHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCC
Confidence 4444433 2688888888888862 23345566678888899988888653 3333344 6788888888
Q ss_pred Ccc
Q 038003 539 NEL 541 (848)
Q Consensus 539 N~l 541 (848)
|++
T Consensus 317 ~~~ 319 (319)
T cd00116 317 DSF 319 (319)
T ss_pred CCC
Confidence 864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5e-19 Score=170.70 Aligned_cols=197 Identities=20% Similarity=0.308 Sum_probs=156.4
Q ss_pred CcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEec
Q 038003 601 FDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
....-.|.+...|+.|+|+|. |..+++|++...... ....+.|..|.-.++-+.||||.++++.|.......++..|
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t--~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT--ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcc--hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 344456889999999999997 666777887655332 23345688888889999999999999999999999999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe--eccCccccCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS--DFGIAKFVGPH 758 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~--DfG~~~~~~~~ 758 (848)
|+.|+|+..+++. ..-..+..++.+++.+||+|++|||+..+ -|----+.+..+++|++.+.+|+ |--++..
T Consensus 269 mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred ccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee----
Confidence 9999999999887 34457778999999999999999999742 34455789999999999988875 3222211
Q ss_pred CCCcccccccccccCccccccCCC---CccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRA---TEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
.......|.||+||.+...+. -+++|+|||++++||+-|...||....
T Consensus 343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 122345789999999987664 357999999999999999999976433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=166.40 Aligned_cols=139 Identities=14% Similarity=0.223 Sum_probs=106.5
Q ss_pred CcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-----CCCcccceEEEeecCC---
Q 038003 601 FDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-----RHRNNVKFHGFCYNGP--- 672 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~l~~~~~~~~--- 672 (848)
.+..+.||+|+||.||. +......+||++.... ....+.+.+|+++++.+ .||||++++|++.++.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 34457899999999996 4333434799886542 23456789999999999 5799999999998863
Q ss_pred e-eEEEEec--cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEEcCCCCCCeeeCC----CCCE
Q 038003 673 H-SFLVCEY--LDRGSLARILGDDVTAKELGWNRRINVIKGVANAL-SYLHHDCLPSIIHRDISSKNVLLDS----NFEA 744 (848)
Q Consensus 673 ~-~~lV~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~ 744 (848)
. +.+|+|| +++++|.++++.. .+++. ..++.|++.++ +|||++ +||||||||+||+++. ++.+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence 3 3378999 5579999999653 24444 35678888777 999999 9999999999999974 3479
Q ss_pred EEee-ccCccc
Q 038003 745 HVSD-FGIAKF 754 (848)
Q Consensus 745 kl~D-fG~~~~ 754 (848)
+|+| ||....
T Consensus 149 ~LiDg~G~~~~ 159 (210)
T PRK10345 149 VVCDNIGESTF 159 (210)
T ss_pred EEEECCCCcce
Confidence 9999 554443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-18 Score=199.62 Aligned_cols=199 Identities=22% Similarity=0.210 Sum_probs=160.8
Q ss_pred HHHHhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC---CCcccceEEEee
Q 038003 593 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR---HRNNVKFHGFCY 669 (848)
Q Consensus 593 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~ 669 (848)
+.....+.|.+.+.+|+|+||+||+|...+|+.||+|+=+....+. |.-=.+++.+|+ -+.|..+...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-------fYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-------FYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-------eeehHHHHHhhchhhhcchHHHHHHHc
Confidence 3445567799999999999999999988889999999976654331 111123344444 244555555555
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-------CC
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-------NF 742 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~ 742 (848)
-.+..++|+||.+.|+|.++++. .+..++.-++.++.|+++.++.||.. +||||||||+|.++.. ..
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred cCCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence 56777899999999999999983 47788999999999999999999999 9999999999999952 34
Q ss_pred CEEEeeccCccccC--CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 038003 743 EAHVSDFGIAKFVG--PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804 (848)
Q Consensus 743 ~~kl~DfG~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 804 (848)
.++|+|||.+..+. ++.......++|-.+-.+|+..|+.+++.+|-|.++.+++-|+.|++=
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 69999999997653 333345667889999999999999999999999999999999999874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=5e-18 Score=173.74 Aligned_cols=202 Identities=21% Similarity=0.288 Sum_probs=134.7
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC----------CcccceEEEe
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH----------RNNVKFHGFC 668 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------p~iv~l~~~~ 668 (848)
.+.....||.|+++.||.+.+. +++.+|+|++.... .......+++.+|.-....+.+ -.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3455678999999999999654 79999999987665 2234456777777765555432 1222222221
Q ss_pred e---------cC---C-----eeEEEEeccCCCCHHhHhcC----CCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 038003 669 Y---------NG---P-----HSFLVCEYLDRGSLARILGD----DVTAKELGWNRRINVIKGVANALSYLHHDCLPSII 727 (848)
Q Consensus 669 ~---------~~---~-----~~~lV~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iv 727 (848)
. .. . ..+++|+-+. ++|.+++.. ......+....+..+..|+++.+++||+. |+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 1 11 1 2367888884 488776532 11123455566678889999999999999 999
Q ss_pred EcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccccccccccCcccccc--------CCCCccchhhhHHHHHHHHH
Q 038003 728 HRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT--------MRATEKYDVYSFGVLVFEVI 799 (848)
Q Consensus 728 H~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell 799 (848)
|+||+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... ..++++.|.|++|+++|.|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999998887654221 1234578999997643 24688999999999999999
Q ss_pred hCCCCCcccc
Q 038003 800 KGNHPRDFFS 809 (848)
Q Consensus 800 tg~~P~~~~~ 809 (848)
+|..||+-..
T Consensus 245 C~~lPf~~~~ 254 (288)
T PF14531_consen 245 CGRLPFGLSS 254 (288)
T ss_dssp HSS-STCCCG
T ss_pred HccCCCCCCC
Confidence 9999997543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=167.70 Aligned_cols=148 Identities=19% Similarity=0.161 Sum_probs=113.1
Q ss_pred cCCcccceeccCCceeEEEEE--cCCCCEEEEEEcccccccCCc------------------h--hHHHHHHHHHHHhcC
Q 038003 599 DDFDEKFCIGKGGQGSVYKAE--LPSGDIVAVKKFNSQLLSGNM------------------A--DHDEFLNEVLALKEI 656 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~~~------------------~--~~~~~~~E~~~l~~l 656 (848)
.-|.+.+.||+|+||.||+|. ..+|+.||+|+++........ . ....+.+|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347888999999999999997 568999999998764321000 0 112356899999999
Q ss_pred CCCc--ccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEcCCCC
Q 038003 657 RHRN--NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS-IIHRDISS 733 (848)
Q Consensus 657 ~hp~--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~-ivH~Dlk~ 733 (848)
.+.. +.+++++ ...++||||++|+++....... ......++..++.||+.++.+||+. | |+||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 7533 3444443 2358999999998886654222 2345566788999999999999999 9 99999999
Q ss_pred CCeeeCCCCCEEEeeccCccccCC
Q 038003 734 KNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 734 ~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
+||+++ ++.++|+|||.+...+.
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999999886544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.2e-18 Score=191.66 Aligned_cols=199 Identities=23% Similarity=0.208 Sum_probs=151.1
Q ss_pred CCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 600 DFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
++...+.||.+.|=+|.+|+++.|. |+||++-++.-.-.-...++-..|++ ....+|||++++.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4677788999999999999998888 99999877642222233344444555 555699999999888777778899999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc-CCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV-GPH 758 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~-~~~ 758 (848)
|... +|+|++.-+ .-+...+...|+.|+..|+.-+|+. ||||||||.+|||++.=..+.|+||..-+.. -+.
T Consensus 102 yvkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9966 899988544 3456677778999999999999999 9999999999999999999999999765432 111
Q ss_pred CCC--ccc----ccccccccCccccccC----------C-CCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 759 SSN--WTE----FAGTFGYAAPEIAYTM----------R-ATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 759 ~~~--~~~----~~g~~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+.. ... ....--|.|||.+... . .+++.||||+||+++|+++ |++||..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 111 111 1223469999987531 1 4678999999999999999 6888753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=161.06 Aligned_cols=139 Identities=18% Similarity=0.310 Sum_probs=115.3
Q ss_pred ceeccCCceeEEEEEcCCCCEEEEEEcccccccCC----chhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEec
Q 038003 605 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN----MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
+.||+|++|.||+|.+ +|..+++|+......... ......+.+|++++..+.|++++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899998655432111 11234577899999999999998888787777888999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
++|++|.+++... .. .+..++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.+...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999988543 11 7788999999999999999 999999999999999 789999999998763
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.4e-17 Score=166.38 Aligned_cols=143 Identities=25% Similarity=0.382 Sum_probs=110.8
Q ss_pred CCCcccceEEEeec---------------------------CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHH
Q 038003 657 RHRNNVKFHGFCYN---------------------------GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIK 709 (848)
Q Consensus 657 ~hp~iv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 709 (848)
+|||||++.++|.+ +...|+||.-.+. +|.+++-.+ ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 69999999988753 2356899998876 888888433 345566777999
Q ss_pred HHHHHHHHHhhCCCCCeEEcCCCCCCeeeC--CCC--CEEEeeccCccccCCCC------CCcccccccccccCcccccc
Q 038003 710 GVANALSYLHHDCLPSIIHRDISSKNVLLD--SNF--EAHVSDFGIAKFVGPHS------SNWTEFAGTFGYAAPEIAYT 779 (848)
Q Consensus 710 qia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~DfG~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~ 779 (848)
|+.+|+.|||++ ||.|||+|++|||+. +|+ .+.++|||++-.-.... ....+..|...-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 999999999999993 444 57789999985432211 12234557788999999875
Q ss_pred CCC------CccchhhhHHHHHHHHHhCCCCCcc
Q 038003 780 MRA------TEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 780 ~~~------~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.+- -.|+|.|+.|.+.||+++...||..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 431 3489999999999999999999854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-17 Score=187.36 Aligned_cols=163 Identities=28% Similarity=0.368 Sum_probs=122.8
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
...+|+.++.|..|+||.||.++++ +.+++|+|+ .++.. +.+- ++.....|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l---------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL---------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch---------hhhc--cccccCCccee-------------
Confidence 3467999999999999999999877 567899944 33321 1111 34444555544
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
|+-.+.++.. +.++. +++.|++|+|+. ||||||+||+|.++..-|++|++|||++++.
T Consensus 136 --------gDc~tllk~~---g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 --------GDCATLLKNI---GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred --------chhhhhcccC---CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhh
Confidence 3333333322 33332 238899999999 9999999999999999999999999998764
Q ss_pred CCCCC---------------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 756 GPHSS---------------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 756 ~~~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
..... .....+|||.|+|||++....|+..+|+|++|+|+||.+.|+.||+
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 32111 1134689999999999999999999999999999999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=159.20 Aligned_cols=135 Identities=18% Similarity=0.337 Sum_probs=108.9
Q ss_pred eeccCCceeEEEEEcCCCCEEEEEEcccccccCC----chhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEecc
Q 038003 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN----MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYL 681 (848)
Q Consensus 606 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~ 681 (848)
.||+|+||.||+|.+ ++..+++|+......... ....+++.+|+++++.+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 578899998654322111 112356778999999999988766666666667779999999
Q ss_pred CCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 682 DRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 682 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+|++|.+++... .. .++.|++.++.++|+. |++|||++|+||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999887433 11 7899999999999999 999999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=158.12 Aligned_cols=146 Identities=23% Similarity=0.176 Sum_probs=111.7
Q ss_pred HhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCC-c-----------------hhHHHHHHHHHHHhcCC
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN-M-----------------ADHDEFLNEVLALKEIR 657 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~-----------------~~~~~~~~E~~~l~~l~ 657 (848)
+...-|.+.+.||+|+||.||+|...+|+.||||++........ . .....+.+|+.++..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 33334777889999999999999888899999998765320000 0 01123567888898887
Q ss_pred CC--cccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCC
Q 038003 658 HR--NNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 735 (848)
Q Consensus 658 hp--~iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 735 (848)
|+ .+.+.++. ...++||||++|+++.+.... .....++.+++.++.++|+. ||+||||||+|
T Consensus 92 ~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N 155 (198)
T cd05144 92 EEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN 155 (198)
T ss_pred HcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence 77 44455542 345899999999998765421 23457889999999999999 99999999999
Q ss_pred eeeCCCCCEEEeeccCccccCC
Q 038003 736 VLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 736 Ill~~~~~~kl~DfG~~~~~~~ 757 (848)
|++++++.++|+|||.+.....
T Consensus 156 ill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=185.14 Aligned_cols=153 Identities=33% Similarity=0.522 Sum_probs=109.4
Q ss_pred ChHHHHHHHHHHHhccCCCCCCcccCCCCCCCCCCCCCCCC-----ccCceEEcCCCCceEEEeccccCccccccCCccC
Q 038003 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPC-----SWFGISCNHAGSRVISITMSTLGLNGTFHDFSFS 76 (848)
Q Consensus 2 ~~~~~~all~~k~~~~~~~~~~~~l~sw~~~~~~~~~~~~c-----~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~ 76 (848)
.++|..||++||+++..+. ..+|.. |+| .|.||.|+.....
T Consensus 370 ~~~~~~aL~~~k~~~~~~~-----~~~W~g--------~~C~p~~~~w~Gv~C~~~~~~--------------------- 415 (623)
T PLN03150 370 LLEEVSALQTLKSSLGLPL-----RFGWNG--------DPCVPQQHPWSGADCQFDSTK--------------------- 415 (623)
T ss_pred CchHHHHHHHHHHhcCCcc-----cCCCCC--------CCCCCcccccccceeeccCCC---------------------
Confidence 4579999999999995431 248962 444 7999999632110
Q ss_pred CCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEE
Q 038003 77 SFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKL 156 (848)
Q Consensus 77 ~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 156 (848)
....++.|+|++|.+.|.+|..|+.|++|++|+|++|+++|.+|+.++.+++|+.|+|++|+++|.+|..++.+++|++|
T Consensus 416 ~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L 495 (623)
T PLN03150 416 GKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRIL 495 (623)
T ss_pred CceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEE
Confidence 00123456667777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred EcCCCcCCCCCCCcccCc-cccceEEeeccccc
Q 038003 157 ALCHNNLHGSIPSSLGNL-SNLAVLYLYKNSLS 188 (848)
Q Consensus 157 ~L~~n~l~~~~p~~l~~l-~~L~~L~l~~N~l~ 188 (848)
+|++|+++|.+|..++.+ .++..+++.+|...
T Consensus 496 ~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 496 NLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred ECcCCcccccCChHHhhccccCceEEecCCccc
Confidence 777777777777777653 45667778777644
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.8e-16 Score=177.47 Aligned_cols=142 Identities=20% Similarity=0.278 Sum_probs=113.3
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccC----CchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG----NMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
..|...+.||+|+||+||+|.+.... +++|+........ .....+++.+|+++++.++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34566789999999999999775444 4444432221111 112245688999999999999999888888777788
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++++|.+++. ....++.|+++++.+||+. +|+|||+||+||++ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998874 3567899999999999999 99999999999999 678999999999986
Q ss_pred cC
Q 038003 755 VG 756 (848)
Q Consensus 755 ~~ 756 (848)
..
T Consensus 477 ~~ 478 (535)
T PRK09605 477 SD 478 (535)
T ss_pred CC
Confidence 53
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.4e-15 Score=145.63 Aligned_cols=139 Identities=22% Similarity=0.218 Sum_probs=99.2
Q ss_pred cceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHH----------------------HHHHHHHHhcCCCCc-
Q 038003 604 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDE----------------------FLNEVLALKEIRHRN- 660 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~hp~- 660 (848)
.+.||+|+||+||+|...+++.||||++....... ..... ...|.+.+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSF--KKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccch--hhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 46799999999999988889999999987642211 11111 134555566654432
Q ss_pred -ccceEEEeecCCeeEEEEeccCCCCHHhH-hcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCee
Q 038003 661 -NVKFHGFCYNGPHSFLVCEYLDRGSLARI-LGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVL 737 (848)
Q Consensus 661 -iv~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIl 737 (848)
+.+.+++ ...++||||++++.+... +... . .. .++..++.+++.++.++|. . +|+||||||+||+
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil 147 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL 147 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-h---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence 4445443 245899999999543211 1111 0 01 5577899999999999999 7 9999999999999
Q ss_pred eCCCCCEEEeeccCccccCC
Q 038003 738 LDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 738 l~~~~~~kl~DfG~~~~~~~ 757 (848)
++ ++.++++|||.+.....
T Consensus 148 i~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EE-CCcEEEEECcccccccC
Confidence 99 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=8e-15 Score=139.84 Aligned_cols=136 Identities=18% Similarity=0.173 Sum_probs=113.3
Q ss_pred ccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC--CcccceEEEeecCCeeEEEEec
Q 038003 603 EKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH--RNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 603 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~~~~~~lV~e~ 680 (848)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| +.+++++.+....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 34679999999999998754 7899999765421 4568889999999976 5899999998888889999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
++++.+..+ +......++.+++++++++|.....+++|||++|+||++++.+.++++|||.++..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 998766543 44566778999999999999864347999999999999999899999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.8e-16 Score=175.42 Aligned_cols=208 Identities=25% Similarity=0.308 Sum_probs=166.7
Q ss_pred cCCcccceeccCCceeEEEEEcCC--CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPS--GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~ 675 (848)
..|...+.||+|+|+.|-.+.... ...+|+|.+.... ......++...|..+-..+. |+|++.+++...+.+..+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 457777789999999998885533 4446666554442 23344556667888878886 999999999999999999
Q ss_pred EEEeccCCCCHHhHh-cCCCCcccCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEEcCCCCCCeeeCCCC-CEEEeeccCc
Q 038003 676 LVCEYLDRGSLARIL-GDDVTAKELGWNRRINVIKGVANALSYLH-HDCLPSIIHRDISSKNVLLDSNF-EAHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qia~~L~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~~ 752 (848)
++.+|.+|+++.+.+ ... ....+...+..++.|+..++.|+| .. +++|+|+||+|.+++..+ ..+++|||+|
T Consensus 98 ~~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999998887 333 113455667789999999999999 77 999999999999999999 9999999999
Q ss_pred cccCC-CCC--Ccccccc-cccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcccccccc
Q 038003 753 KFVGP-HSS--NWTEFAG-TFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 813 (848)
Q Consensus 753 ~~~~~-~~~--~~~~~~g-~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 813 (848)
..+.. ... .....+| ++.|+|||...+. ...+..|+||.|+++..+++|..||++......
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~ 238 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG 238 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc
Confidence 98765 222 2245678 9999999999885 457789999999999999999999987665433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.4e-14 Score=145.31 Aligned_cols=141 Identities=15% Similarity=0.223 Sum_probs=107.6
Q ss_pred cceec-cCCceeEEEEEcCCCCEEEEEEcccccc-----c----CCchhHHHHHHHHHHHhcCCCCcc--cceEEEeecC
Q 038003 604 KFCIG-KGGQGSVYKAELPSGDIVAVKKFNSQLL-----S----GNMADHDEFLNEVLALKEIRHRNN--VKFHGFCYNG 671 (848)
Q Consensus 604 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~----~~~~~~~~~~~E~~~l~~l~hp~i--v~l~~~~~~~ 671 (848)
...|| .|+.|+||.+... +..+|+|.+..... . ........+.+|++++..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999775 77899998854221 1 011234567889999999998875 6677664432
Q ss_pred -C---eeEEEEeccCC-CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEE
Q 038003 672 -P---HSFLVCEYLDR-GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV 746 (848)
Q Consensus 672 -~---~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 746 (848)
. ..++|||+++| .+|.+++... .++.. .+.||+.++.+||+. ||+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6898887543 23332 467899999999999 9999999999999999999999
Q ss_pred eeccCccccC
Q 038003 747 SDFGIAKFVG 756 (848)
Q Consensus 747 ~DfG~~~~~~ 756 (848)
+|||.++...
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999987653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.3e-14 Score=156.16 Aligned_cols=156 Identities=29% Similarity=0.536 Sum_probs=128.9
Q ss_pred HhcCCCCcccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCe-EEcCC
Q 038003 653 LKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI-IHRDI 731 (848)
Q Consensus 653 l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~i-vH~Dl 731 (848)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...+++.-...++++|+.|++|+|.. .| +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 46789999999999999999999999999999999999763 35678888888999999999999988 45 99999
Q ss_pred CCCCeeeCCCCCEEEeeccCccccCCC--CCCcccccccccccCccccccCC-------CCccchhhhHHHHHHHHHhCC
Q 038003 732 SSKNVLLDSNFEAHVSDFGIAKFVGPH--SSNWTEFAGTFGYAAPEIAYTMR-------ATEKYDVYSFGVLVFEVIKGN 802 (848)
Q Consensus 732 k~~NIll~~~~~~kl~DfG~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwSlG~il~elltg~ 802 (848)
++.|.++|..+.+|++|||+....... ...........-|.|||.+.+.. .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999999877421 11112223456799999987642 366799999999999999999
Q ss_pred CCCcccccccc
Q 038003 803 HPRDFFSINFS 813 (848)
Q Consensus 803 ~P~~~~~~~~~ 813 (848)
.||+.......
T Consensus 156 ~~~~~~~~~~~ 166 (484)
T KOG1023|consen 156 GPFDLRNLVED 166 (484)
T ss_pred CccccccccCC
Confidence 99976444333
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.5e-16 Score=164.69 Aligned_cols=173 Identities=35% Similarity=0.524 Sum_probs=97.5
Q ss_pred CCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEe
Q 038003 103 SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182 (848)
Q Consensus 103 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l 182 (848)
+--...||+.|++. ++|.++..+-.|+.|.|+.|.+. .+|..++++..|++|+|+.|+++ .+|..++.|+ |+.|-+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence 33344555555554 45555555555555555555555 55555555555555555555555 4555555443 555556
Q ss_pred ecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCc
Q 038003 183 YKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGF 262 (848)
Q Consensus 183 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 262 (848)
++|+++ .+|+.++.+..|..||.+.|++. .+|..++.+.+|+.|.+..|++. .+|+.+..| .|..||++.|++. .
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~ 225 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-Y 225 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-e
Confidence 666655 55555555555666666666655 55555555666666666666655 455555533 3555666666665 4
Q ss_pred CCCcccCCCCCceEEccCcccc
Q 038003 263 IPPSIGNLSSLRVLYLYNNGLY 284 (848)
Q Consensus 263 ~p~~l~~l~~L~~L~Ls~N~l~ 284 (848)
+|-.|.+|+.|++|-|.+|.+.
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC
Confidence 5555666666666666666665
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.3e-15 Score=159.14 Aligned_cols=122 Identities=23% Similarity=0.443 Sum_probs=110.4
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..|+.|+++...+|.+++.+.......++.....++.|++.|++| + +.+|+|+||.||++..+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999877677788899999999999999999 6 8999999999999999999999999999
Q ss_pred cccCCCC------CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh
Q 038003 753 KFVGPHS------SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK 800 (848)
Q Consensus 753 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 800 (848)
..+.... ...+...||..||+||-+.+..|+.|+||||||++++|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8775443 12355789999999999999999999999999999999998
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-15 Score=161.91 Aligned_cols=197 Identities=29% Similarity=0.390 Sum_probs=172.6
Q ss_pred CCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccE
Q 038003 76 SSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDK 155 (848)
Q Consensus 76 ~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 155 (848)
-.|..-...||+.|.|. .+|.++..+-.|+.|.|..|.+. .+|..+++|..|++|||+.|+++ .+|..++.|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 35667788899999997 89999999999999999999998 78999999999999999999999 8999999887 899
Q ss_pred EEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCC
Q 038003 156 LALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL 235 (848)
Q Consensus 156 L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l 235 (848)
|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|..++.| .|..||++.|++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki 223 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI 223 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence 999999999 89999999999999999999998 78889999999999999999998 788888855 689999999999
Q ss_pred CCCCCCcccCcccccccccccccccCcCCCcccCCC---CCceEEccCcc
Q 038003 236 SGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLS---SLRVLYLYNNG 282 (848)
Q Consensus 236 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~---~L~~L~Ls~N~ 282 (848)
+ .+|-.|.+|+.|++|-|.+|.+.. +|..++-.- =-++|+..-++
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQS-PPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCCC-ChHHHHhccceeeeeeecchhcc
Confidence 9 899999999999999999999984 455554322 23566666663
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-13 Score=153.06 Aligned_cols=199 Identities=41% Similarity=0.569 Sum_probs=155.9
Q ss_pred cEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcC-CccEEEcCCCcCCCCCCCcccCccccceEEeec
Q 038003 106 QYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLS-LIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYK 184 (848)
Q Consensus 106 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~ 184 (848)
..|+++.|.+.. .+..+..++.++.|++.+|.++ .+|...+.++ +|+.|++++|.+. .+|..++.+++|+.|++++
T Consensus 96 ~~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 367888887743 3445667788888888888888 7777777774 8888888888888 6767788888888888888
Q ss_pred ccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCC
Q 038003 185 NSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIP 264 (848)
Q Consensus 185 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 264 (848)
|+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+..+.++..+.+.+|++.. ++
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~ 248 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LP 248 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-cc
Confidence 8888 66766667888888888888888 77777666777888888888644 466778888888888888888874 36
Q ss_pred CcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCC
Q 038003 265 PSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH 313 (848)
Q Consensus 265 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 313 (848)
..++.++++++|++++|.++.... ++.+.+++.|++++|.+....|.
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred chhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 677888889999999998875433 88888889999988888876654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.4e-13 Score=153.58 Aligned_cols=201 Identities=37% Similarity=0.532 Sum_probs=173.1
Q ss_pred EEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccc-cccEEEecccCcCCCCCccccCcCCccEEEcCCC
Q 038003 83 NLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLN-QLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHN 161 (848)
Q Consensus 83 ~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 161 (848)
.++++.|.+...+ ..+..++.++.|++.+|.++ .+|+..+.++ +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5788888775333 34566789999999999998 5787888885 9999999999999 78888999999999999999
Q ss_pred cCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCC
Q 038003 162 NLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP 241 (848)
Q Consensus 162 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 241 (848)
+++ .+|...+.+++|+.|++++|+++ .+|..+..+..|++|.+++|.+. ..+..+.+++++..|.+.+|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 999 78887778999999999999999 78887777788999999999755 67788999999999999999998 4578
Q ss_pred cccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCccccc
Q 038003 242 ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIG 292 (848)
Q Consensus 242 ~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 292 (848)
.++.+.++++|++++|+++...+ ++.+.+++.|++++|.+....|....
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 88999999999999999995433 88999999999999999877665544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1e-12 Score=146.29 Aligned_cols=145 Identities=20% Similarity=0.205 Sum_probs=100.2
Q ss_pred ceeccCCceeEEEEEcCCCCEEEEEEcccccccCCch--------------------------h----------HHHHHH
Q 038003 605 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMA--------------------------D----------HDEFLN 648 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~--------------------------~----------~~~~~~ 648 (848)
+.||.|++|.||+|+.++|+.||||+.+......-.. . .-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6899999999999999999999999986542110000 0 012445
Q ss_pred HHHHHhcC----C-CCcccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHH-HHHHHhhCC
Q 038003 649 EVLALKEI----R-HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN-ALSYLHHDC 722 (848)
Q Consensus 649 E~~~l~~l----~-hp~iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-~L~~LH~~~ 722 (848)
|.+.+.++ + ++++.-..-+....+..++||||++|+++.++..... ... .+.+++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHhC-
Confidence 55555554 2 3443222222223446799999999999987764221 111 23456666666 46788988
Q ss_pred CCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 723 ~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|++|+|++|.||+++.++.++++|||++..+.+
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.3e-12 Score=148.92 Aligned_cols=113 Identities=36% Similarity=0.628 Sum_probs=103.9
Q ss_pred CCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEee
Q 038003 104 KLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183 (848)
Q Consensus 104 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 183 (848)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|+.+++|++|++|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccc-ccccccccccccccccCc
Q 038003 184 KNSLSGSIPSIIGKL-KSLLQLDLSENQFSGSIP 216 (848)
Q Consensus 184 ~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p 216 (848)
+|+++|.+|..++.+ .++..+++++|......|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999988764 467889999997654333
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.2e-12 Score=141.84 Aligned_cols=148 Identities=18% Similarity=0.210 Sum_probs=96.5
Q ss_pred cCCcccceeccCCceeEEEEEcCC-CCEEEEEEcccccccC-------------------------C-c----hhHH---
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSG-------------------------N-M----ADHD--- 644 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-------------------------~-~----~~~~--- 644 (848)
.+|+. +.||+|++|.||+|..++ |+.||||+.++..... + . +..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44666 789999999999999887 9999999997642100 0 0 0011
Q ss_pred ---HHHHHHHHHhcC----CCCcccceEEEeec-CCeeEEEEeccCCCCHHhHh--cCC-CCcccCCHHHHHHHHHHHHH
Q 038003 645 ---EFLNEVLALKEI----RHRNNVKFHGFCYN-GPHSFLVCEYLDRGSLARIL--GDD-VTAKELGWNRRINVIKGVAN 713 (848)
Q Consensus 645 ---~~~~E~~~l~~l----~hp~iv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l--~~~-~~~~~l~~~~~~~i~~qia~ 713 (848)
.+.+|...+.++ .+...+.+-.++.+ ....++||||++|+.+.++. ... .....+....+..++.|+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 134455444444 23333333333322 45678999999999997642 211 1111233333444445544
Q ss_pred HHHHHhhCCCCCeEEcCCCCCCeeeCCCC----CEEEeeccCccccCC
Q 038003 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNF----EAHVSDFGIAKFVGP 757 (848)
Q Consensus 714 ~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG~~~~~~~ 757 (848)
.. |++|+|+||.||+++.++ .++++|||++..+.+
T Consensus 278 ------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45 999999999999999888 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-11 Score=118.97 Aligned_cols=131 Identities=19% Similarity=0.113 Sum_probs=95.9
Q ss_pred cceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCccc-ceEEEeecCCeeEEEEeccC
Q 038003 604 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV-KFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~l~~~~~~~~~~~lV~e~~~ 682 (848)
.+.++.|.++.||+++.. +..|++|+..... .....+.+|+++++.+.+..++ +++.+.. +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT-----ELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCc-----ccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 357899999999999865 7789999875442 1123456788888888655544 4555432 34589999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC--LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
|.++.+. . .....++.+++++++.||... ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~---~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE---D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc---c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9876542 0 011245789999999999982 12359999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.1e-10 Score=113.87 Aligned_cols=140 Identities=19% Similarity=0.199 Sum_probs=99.8
Q ss_pred ceeccCCceeEEEEEcCC-------CCEEEEEEcccccccC---------C---------chhHHHHH----HHHHHHhc
Q 038003 605 FCIGKGGQGSVYKAELPS-------GDIVAVKKFNSQLLSG---------N---------MADHDEFL----NEVLALKE 655 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~---------~---------~~~~~~~~----~E~~~l~~ 655 (848)
.+||.|.-+.||.|...+ +..+|||+.+.....- + ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999996542 4789999875432210 0 01122333 79999998
Q ss_pred CCC--CcccceEEEeecCCeeEEEEeccCCCCHHh-HhcCCCCcccCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEcCC
Q 038003 656 IRH--RNNVKFHGFCYNGPHSFLVCEYLDRGSLAR-ILGDDVTAKELGWNRRINVIKGVANALSYL-HHDCLPSIIHRDI 731 (848)
Q Consensus 656 l~h--p~iv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~~L~~L-H~~~~~~ivH~Dl 731 (848)
+.. -.+.+++++ ...++||||+.++.+.. .+++ ..++..+...+..+++.++..+ |+. ||||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 456666664 45689999997754321 2221 1234456677889999999999 788 9999999
Q ss_pred CCCCeeeCCCCCEEEeeccCccccC
Q 038003 732 SSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 732 k~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
++.||+++ ++.+.++|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.3e-11 Score=130.33 Aligned_cols=170 Identities=19% Similarity=0.254 Sum_probs=127.5
Q ss_pred EcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCccc
Q 038003 619 ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKE 698 (848)
Q Consensus 619 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~ 698 (848)
+..++.+|.|.+.+... ....+...+-++-++.++||+|+++++.+...+..|+|+|-+. .|..++..
T Consensus 33 ~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------ 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------ 100 (690)
T ss_pred eeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------
Confidence 44467888888776542 2334556778888999999999999999999999999999884 45555533
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccccccccccCccccc
Q 038003 699 LGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY 778 (848)
Q Consensus 699 l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 778 (848)
+....+...+.||+.||.|||+.| +++|++|.-+.|++++.|+.||++|.++..............--..|..|+.+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID 178 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence 334566778999999999999776 899999999999999999999999988865543222112222233566676543
Q ss_pred cCCCCccchhhhHHHHHHHHHhCCCC
Q 038003 779 TMRATEKYDVYSFGVLVFEVIKGNHP 804 (848)
Q Consensus 779 ~~~~~~~~DiwSlG~il~elltg~~P 804 (848)
...+ ..|.|-|||+++|++.|..+
T Consensus 179 ~s~~--s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 179 PSEW--SIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred cccc--chhhhhHHHHHHHHhCcccC
Confidence 3222 37999999999999999433
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2e-12 Score=127.25 Aligned_cols=138 Identities=24% Similarity=0.306 Sum_probs=115.4
Q ss_pred cccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhc
Q 038003 402 PVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLI 481 (848)
Q Consensus 402 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 481 (848)
-......+.|+++||++|.|+ .+..+..-+++++.|++|+|.|..+ ..+..+++|+.||||+|.++ .+..+-.++.
T Consensus 277 ~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLG 352 (490)
T KOG1259|consen 277 LVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLG 352 (490)
T ss_pred EEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhc
Confidence 334445578999999999998 5666777789999999999999844 34888999999999999998 5677888899
Q ss_pred ccceecccCcccCcCCCccccCCCCCccccCCCCcccCCC-cchhccccCceeecCCCCccCCCC
Q 038003 482 HLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFI-PRCFEEMRSLSCIDISYNELHGPI 545 (848)
Q Consensus 482 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~l~ls~N~l~~~~ 545 (848)
+++.|.|+.|.|... +.+.++-+|..||+++|+|.... ...++++|-|+++.+.+|++.+.+
T Consensus 353 NIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 353 NIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred CEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 999999999999643 67888999999999999997542 356889999999999999998754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.7e-13 Score=134.07 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=125.1
Q ss_pred cCCCCCceEEccCcccccc----CcccccCCCCCcccccccc---ccccccCCccceeeccccCCCCccccccCCCCCcc
Q 038003 268 GNLSSLRVLYLYNNGLYGF----VPEEIGYLKSLSELELCTN---LLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLT 340 (848)
Q Consensus 268 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N---~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~ 340 (848)
..+..+++++||+|.+... +...+...++|+..++++- ++...+|+.+..+ ..++...++|+
T Consensus 27 ~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l-----------~~aL~~~~~L~ 95 (382)
T KOG1909|consen 27 EPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKML-----------SKALLGCPKLQ 95 (382)
T ss_pred cccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHH-----------HHHHhcCCcee
Confidence 3445566666666665422 2233445556666555432 1222244443321 13455667888
Q ss_pred EEEccCCccccccCccc----cCcccccEeecccccccCCCC-------------CCCCCCCCccEEEccCCccCCCCcc
Q 038003 341 FLDLSNNNFCGEISFNW----GNFSKLSTFIVSMNNISGSIP-------------PDIGNSPKLQVLDLSSNHIVGKIPV 403 (848)
Q Consensus 341 ~L~Ls~N~l~~~~~~~~----~~l~~L~~L~l~~N~i~~~~p-------------~~l~~l~~L~~L~Ls~N~l~~~~~~ 403 (848)
+||||+|-+.-..+..| ..+..|++|+|.+|.+....- .-.+.-++|+++..+.|++......
T Consensus 96 ~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~ 175 (382)
T KOG1909|consen 96 KLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGAT 175 (382)
T ss_pred EeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHH
Confidence 88888888764443333 234555555555555431111 1122233455555555554422111
Q ss_pred cccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCC----CCCcccCccccceeccccCcCCCC----Chh
Q 038003 404 QLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSS----IPKSIGNLLKLHYLNLSNNQLSHK----IPT 475 (848)
Q Consensus 404 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 475 (848)
. +...|...+.|+.+.+++|.|... +...|..++.|+.|||.+|-++.. +..
T Consensus 176 ~--------------------~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 176 A--------------------LAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred H--------------------HHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 0 111233344555555555554311 122345556666666666665532 223
Q ss_pred HHhhhcccceecccCcccCcCCCccc-----cCCCCCccccCCCCcccCC----CcchhccccCceeecCCCCcc
Q 038003 476 EFEKLIHLSELDLSHNILQEEIPPQV-----CNMGSLEKLNLSHNNLSDF----IPRCFEEMRSLSCIDISYNEL 541 (848)
Q Consensus 476 ~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~l~ls~N~l 541 (848)
.++.+++|++|+++++.+.......| ...++|++|.|.+|.|+.. +..++...|.|..|+|++|++
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 44555566666666666654332222 1246788888888887642 344566788888888888888
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.7e-11 Score=115.60 Aligned_cols=125 Identities=30% Similarity=0.370 Sum_probs=44.8
Q ss_pred cccccccEEEccCCcCCCCCCcccC-CCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccc
Q 038003 406 EMLSSLNKLILNLNQLSGGVPLEFG-SLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS 484 (848)
Q Consensus 406 ~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 484 (848)
.+...+++|+|++|.|+. +. .++ .+.+|+.|+|++|+|+.. +.+..++.|+.|++++|+|+...+.....+++|+
T Consensus 16 ~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQ 91 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--
T ss_pred cccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCC
Confidence 344456666666666662 22 333 466777778888877743 2466777888888888888754332224577888
Q ss_pred eecccCcccCcCC-CccccCCCCCccccCCCCcccCCCcc----hhccccCceeec
Q 038003 485 ELDLSHNILQEEI-PPQVCNMGSLEKLNLSHNNLSDFIPR----CFEEMRSLSCID 535 (848)
Q Consensus 485 ~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~l~ 535 (848)
+|+|++|+|.+.. -..+..+++|+.|+|.+|+++.. +. .+..+|+|+.||
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence 8888888886531 24566778888888888888653 22 346688888877
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.6e-12 Score=139.71 Aligned_cols=159 Identities=29% Similarity=0.309 Sum_probs=96.6
Q ss_pred CCCCCCCccEEEccCCccCCCCc-ccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCcc-
Q 038003 380 DIGNSPKLQVLDLSSNHIVGKIP-VQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL- 457 (848)
Q Consensus 380 ~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~- 457 (848)
.+..++.|+.+++++|+++...+ . ...+.+++.+++.+|.+.. ...+..+..+..+++..|.++...+ +..+.
T Consensus 157 ~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~ 231 (414)
T KOG0531|consen 157 GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVM 231 (414)
T ss_pred CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchh
Confidence 34446667777777777764333 2 4566677777777777752 2233444555555777777763322 22222
Q ss_pred -ccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCC---Ccch-hccccCce
Q 038003 458 -KLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDF---IPRC-FEEMRSLS 532 (848)
Q Consensus 458 -~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~ 532 (848)
.|+.+++++|++. ..+..+..+..+..|++++|++... ..+.....+..+.++.|.+... .... ....+.++
T Consensus 232 ~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (414)
T KOG0531|consen 232 LHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLV 308 (414)
T ss_pred HHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccc
Confidence 3777888888776 3335666677777888888877543 3455566777777777776532 1111 34567777
Q ss_pred eecCCCCccCCCCC
Q 038003 533 CIDISYNELHGPIP 546 (848)
Q Consensus 533 ~l~ls~N~l~~~~~ 546 (848)
.+.+.+|+.....+
T Consensus 309 ~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 309 TLTLELNPIRKISS 322 (414)
T ss_pred ccccccCccccccc
Confidence 77777777765443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.3e-10 Score=105.12 Aligned_cols=136 Identities=20% Similarity=0.299 Sum_probs=102.9
Q ss_pred ceeccCCceeEEEEEcCCCCEEEEEEcccccccCCc----hhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEec
Q 038003 605 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNM----ADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
..+++|+-+.+|.+.+. |..+++|.-.++...... -..++..+|.+++.+++--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999775 444666654333322111 1134567899999999777777666677777888899999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
++|..|.+.+... ...++..+-.-+.-||.. ||||||+.++||.+..+. +.++|||++.+-
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9998888887544 134667777778889999 999999999999997665 999999999753
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-11 Score=137.71 Aligned_cols=197 Identities=32% Similarity=0.350 Sum_probs=116.8
Q ss_pred CCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceE
Q 038003 101 NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVL 180 (848)
Q Consensus 101 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 180 (848)
.+..++.+++..|.+.. +-..+..+++|+.|++..|+|. .+...+..+.+|++|+|++|+|+...+ +..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence 45556666666666653 2334666667777777777766 333335666777777777777663322 4555667777
Q ss_pred EeecccccCCCcccccccccccccccccccccccCccc-ccCCcccceeeccccCCCCCCCCcccCcccccccccccccc
Q 038003 181 YLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS-LGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQL 259 (848)
Q Consensus 181 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l 259 (848)
++++|.++. + ..+..+++|+.+++++|+++.. ... ...+.+++.+++.+|.+.. ...+..+..+..+++..|++
T Consensus 146 ~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~i-e~~~~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDI-ENDELSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcchh-c-cCCccchhhhcccCCcchhhhh-hhhhhhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccc
Confidence 777777762 2 2344567777777777777633 222 4566677777777777652 33344455555667777766
Q ss_pred cCcCCCcccCCCC--CceEEccCccccccCcccccCCCCCcccccccccccc
Q 038003 260 NGFIPPSIGNLSS--LRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRG 309 (848)
Q Consensus 260 ~~~~p~~l~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 309 (848)
+-.-+ +..+.. |+.+++++|++.. .+..+..+..+..|++.+|++..
T Consensus 221 ~~~~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 221 SKLEG--LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred eeccC--cccchhHHHHHHhcccCcccc-ccccccccccccccchhhccccc
Confidence 53322 222222 6777777777652 22455566666666766666653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.5e-10 Score=102.38 Aligned_cols=148 Identities=16% Similarity=0.212 Sum_probs=108.4
Q ss_pred ccceeccCCceeEEEEEcCCCCEEEEEEcccccccCC----chhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 603 EKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN----MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 603 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
....+-||+-+.|+++.+. |+...||.-..+..... .-...+..+|++.+.++.--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999885 78777775433322211 122455778999999887666665555666666678999
Q ss_pred eccCC-CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC---CEEEeeccCccc
Q 038003 679 EYLDR-GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF---EAHVSDFGIAKF 754 (848)
Q Consensus 679 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~~~~ 754 (848)
||++| .++.+++........ ........+++|-+.+.-||.. +||||||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99988 467777765533222 2233367888999999999999 999999999999997665 468999999865
Q ss_pred c
Q 038003 755 V 755 (848)
Q Consensus 755 ~ 755 (848)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.8e-12 Score=126.12 Aligned_cols=233 Identities=20% Similarity=0.198 Sum_probs=160.7
Q ss_pred cCCCCCCcEEeccCCcccc----cccccccCCCCCcEEEcccc---CCCCCCchh-------hhccccccEEEecccCcC
Q 038003 75 FSSFPHLANLNLSFNLFFG----NIPLQIGNLSKLQYLDLGSN---QLSGLIPPE-------IGKLNQLRRLYLDMNQLH 140 (848)
Q Consensus 75 ~~~l~~l~~L~l~~n~~~~----~~p~~~~~l~~L~~L~Ls~n---~l~~~~p~~-------~~~l~~L~~L~L~~n~l~ 140 (848)
+.....+++++||+|.|.. .|...+.+.++|+.-++|+- .+...+|+. +..+++|++||||.|-+.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 3456677888888888853 25556777788888888763 233345543 345668888888888876
Q ss_pred CCCCcc----ccCcCCccEEEcCCCcCCCC-------------CCCcccCccccceEEeecccccCCC----cccccccc
Q 038003 141 GTIPPE----IGQLSLIDKLALCHNNLHGS-------------IPSSLGNLSNLAVLYLYKNSLSGSI----PSIIGKLK 199 (848)
Q Consensus 141 ~~~p~~----~~~l~~L~~L~L~~n~l~~~-------------~p~~l~~l~~L~~L~l~~N~l~~~~----p~~~~~l~ 199 (848)
-.-+.. +.+++.|++|.|.+|.+.-. .-.-.+.-+.|+++...+|++.... ...|...+
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~ 185 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHP 185 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcc
Confidence 443333 45677888888888876511 1112344577999999999986322 23456677
Q ss_pred ccccccccccccccc----CcccccCCcccceeeccccCCCCC----CCCcccCcccccccccccccccCcCCCcc----
Q 038003 200 SLLQLDLSENQFSGS----IPLSLGNLSSLTMMSLFNNSLSGS----IPPILGNLKSLSALGLHINQLNGFIPPSI---- 267 (848)
Q Consensus 200 ~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p~~l---- 267 (848)
.|+.+.++.|.|... +-..+..++.|+.|||.+|-++-. +...+..+++|+.|++++|.+......+|
T Consensus 186 ~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al 265 (382)
T KOG1909|consen 186 TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDAL 265 (382)
T ss_pred ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHH
Confidence 889999999988632 224577889999999999988743 33456677889999999998875544443
Q ss_pred -cCCCCCceEEccCccccc----cCcccccCCCCCcccccccccc
Q 038003 268 -GNLSSLRVLYLYNNGLYG----FVPEEIGYLKSLSELELCTNLL 307 (848)
Q Consensus 268 -~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l 307 (848)
...++|++|.|.+|.++. .+...+...+.|+.|+|++|++
T Consensus 266 ~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 266 KESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred hccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 236789999999998862 2233455678888999999888
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-11 Score=121.30 Aligned_cols=135 Identities=27% Similarity=0.296 Sum_probs=80.7
Q ss_pred cccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccc
Q 038003 170 SLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSL 249 (848)
Q Consensus 170 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L 249 (848)
++.....|++|||++|.++ .+.+++.-++.++.|++|+|.+. .+ ..+..+++|++|||++|.++ .+..+-..+-+.
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3344455666666666666 55555555566666666666665 22 22556666666666666666 444444555666
Q ss_pred cccccccccccCcCCCcccCCCCCceEEccCccccccC-cccccCCCCCccccccccccccc
Q 038003 250 SALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFV-PEEIGYLKSLSELELCTNLLRGV 310 (848)
Q Consensus 250 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~ 310 (848)
+.|.|+.|.|... ..+.++-+|.+||+++|+|.... ...+++++-|+.+.|.+|.+.+.
T Consensus 355 KtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 355 KTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 6666666666532 23555666677777777765321 24566777777777777777654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.8e-11 Score=113.89 Aligned_cols=58 Identities=31% Similarity=0.473 Sum_probs=8.0
Q ss_pred CCCcEEEccccCCCCCCchhhh-ccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCC
Q 038003 103 SKLQYLDLGSNQLSGLIPPEIG-KLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLH 164 (848)
Q Consensus 103 ~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 164 (848)
.++++|+|++|+|+.+ ..++ .+.+|+.|+|++|+|+. ++ .+..++.|++|++++|+|+
T Consensus 19 ~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred cccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC
Confidence 3444444444444421 1233 24444444444444441 21 2333344444444444443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-10 Score=138.89 Aligned_cols=317 Identities=26% Similarity=0.262 Sum_probs=180.2
Q ss_pred CCCCcEEeccCCcccccccccccCCCCCcEEEccccC--CCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccE
Q 038003 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQ--LSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDK 155 (848)
Q Consensus 78 l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 155 (848)
....+...+-+|.+. .++.... .++|++|-+..|. +....+..|..++.|++|||++|.=-+.+|..+++|-+|++
T Consensus 522 ~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 522 WNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 345566666666654 3333332 3368888888775 44344445777888888888887766688888888888888
Q ss_pred EEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccccccccccccccccccc--ccCcccccCCcccceeecccc
Q 038003 156 LALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFS--GSIPLSLGNLSSLTMMSLFNN 233 (848)
Q Consensus 156 L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~l~~n 233 (848)
|+|++..++ .+|..+++|..|.+|++..+.-...+|..+..|++|++|.+..-... ...-..+.++..|+.+.....
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~ 678 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS 678 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc
Confidence 888888888 78888888888888888877755566666777888888887765422 222234445555555555433
Q ss_pred CCCCCCCCcccCccccc----ccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCc------ccccc
Q 038003 234 SLSGSIPPILGNLKSLS----ALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLS------ELELC 303 (848)
Q Consensus 234 ~l~~~~p~~l~~l~~L~----~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~------~L~L~ 303 (848)
.. .+-..+..+..|. .+.+..+... ..+..+..+.+|+.|.+.++.+.............+. .+...
T Consensus 679 s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~ 755 (889)
T KOG4658|consen 679 SV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSIL 755 (889)
T ss_pred hh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhh
Confidence 32 1112223333333 3333333332 3445677788888888888887643333322222111 11111
Q ss_pred ccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCC-CCCCCC
Q 038003 304 TNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGS-IPPDIG 382 (848)
Q Consensus 304 ~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~-~p~~l~ 382 (848)
.. . ......+ ..-.++|+.|.+..+.....+......+..+..+.+..+.+.+. .-...+
T Consensus 756 ~~--~---------------~~r~l~~--~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~ 816 (889)
T KOG4658|consen 756 NC--H---------------MLRDLTW--LLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLG 816 (889)
T ss_pred cc--c---------------cccccch--hhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCC
Confidence 10 0 0000110 01236777777777776655555555555555556666666655 344555
Q ss_pred CCCCccEEEccCCccCCCCc---ccccccccccEEEccCC
Q 038003 383 NSPKLQVLDLSSNHIVGKIP---VQLEMLSSLNKLILNLN 419 (848)
Q Consensus 383 ~l~~L~~L~Ls~N~l~~~~~---~~l~~l~~L~~L~L~~N 419 (848)
.++++..+.++.=.+....- ..+..++.+..+.+.++
T Consensus 817 ~l~~i~~~~l~~~~l~~~~ve~~p~l~~~P~~~~~~i~~~ 856 (889)
T KOG4658|consen 817 GLPQLYWLPLSFLKLEELIVEECPKLGKLPLLSTLTIVGC 856 (889)
T ss_pred CCceeEecccCccchhheehhcCcccccCccccccceecc
Confidence 56666555555544432111 12345566666666664
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-09 Score=112.00 Aligned_cols=143 Identities=21% Similarity=0.255 Sum_probs=108.5
Q ss_pred ceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCC--cccceEEEeecCC---eeEEEEe
Q 038003 605 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR--NNVKFHGFCYNGP---HSFLVCE 679 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~l~~~~~~~~---~~~lV~e 679 (848)
+.++.|.++.||++...+|..+++|........ .....+.+|+++++.+++. .+.+++.+....+ ..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998776788999997554211 1345678899999999753 4577888776543 6689999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC------------------------------------- 722 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~------------------------------------- 722 (848)
|++|.++.+.+.. ..++..+...++.++++++..||+..
T Consensus 81 ~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9999887665421 23566677778888888888888521
Q ss_pred ----------------CCCeEEcCCCCCCeeeCC--CCCEEEeeccCccc
Q 038003 723 ----------------LPSIIHRDISSKNVLLDS--NFEAHVSDFGIAKF 754 (848)
Q Consensus 723 ----------------~~~ivH~Dlk~~NIll~~--~~~~kl~DfG~~~~ 754 (848)
...+||+|+.|.||+++. ++.+.++||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.1e-10 Score=125.45 Aligned_cols=198 Identities=27% Similarity=0.305 Sum_probs=155.0
Q ss_pred cCCcccceecc--CCceeEEEEEc---CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCC
Q 038003 599 DDFDEKFCIGK--GGQGSVYKAEL---PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGP 672 (848)
Q Consensus 599 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~ 672 (848)
..|...+.+|. |.+|.||.+.. .++..+|+|+-+.... ......+-.+|+.....+ .|++.++.+..+...+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s--~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS--PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC--CccccccccchhhcccccCccccccccCcccccCC
Confidence 45777888999 99999999965 4688899998443321 122233345788877777 5999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEEcCCCCCCeeeCCC-CCEEEe
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN----ALSYLHHDCLPSIIHRDISSKNVLLDSN-FEAHVS 747 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~ 747 (848)
..++-.|++. .++.++.+.. ...++......+..+..+ |+.++|.. .++|-|+||.||+...+ ...+++
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 9999999986 5777776544 123555667777777777 99999999 99999999999999999 889999
Q ss_pred eccCccccCCCCCCccc-----ccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 748 DFGIAKFVGPHSSNWTE-----FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~~-----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
|||+...+.+..-.... ..|..-|++||...+ -++...|+|++|.++.+..+|..+.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 99999888665422222 257889999998876 4677899999999999999977653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4e-11 Score=124.56 Aligned_cols=188 Identities=27% Similarity=0.232 Sum_probs=91.2
Q ss_pred cCCCCCccEEEccCCccccccC--ccccCcccccEeecccccccCCCCCCC-CCCCCccEEEccCCccCCC-Cccccccc
Q 038003 333 FGDHPNLTFLDLSNNNFCGEIS--FNWGNFSKLSTFIVSMNNISGSIPPDI-GNSPKLQVLDLSSNHIVGK-IPVQLEML 408 (848)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~l~~N~i~~~~p~~l-~~l~~L~~L~Ls~N~l~~~-~~~~l~~l 408 (848)
...+++++.||||.|-+....+ .....+++|+.|+++.|++........ ..+++|+.|.|+.|.|+-. +-..+..+
T Consensus 142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~f 221 (505)
T KOG3207|consen 142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTF 221 (505)
T ss_pred hhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhC
Confidence 4467788888888887764322 122445666666666665542222111 1234555555555555411 11222334
Q ss_pred ccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecc
Q 038003 409 SSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDL 488 (848)
Q Consensus 409 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 488 (848)
++|+.|+|..|..-........-+..|+.|||++|++-.. + .-...+.++.|..|++
T Consensus 222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~-~----------------------~~~~~~~l~~L~~Lnl 278 (505)
T KOG3207|consen 222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDF-D----------------------QGYKVGTLPGLNQLNL 278 (505)
T ss_pred CcHHHhhhhcccccceecchhhhhhHHhhccccCCccccc-c----------------------cccccccccchhhhhc
Confidence 4555555555532222222233344444444444444321 1 0022334444444445
Q ss_pred cCcccCcC-CCcc-----ccCCCCCccccCCCCcccCC-CcchhccccCceeecCCCCccCC
Q 038003 489 SHNILQEE-IPPQ-----VCNMGSLEKLNLSHNNLSDF-IPRCFEEMRSLSCIDISYNELHG 543 (848)
Q Consensus 489 s~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~l~ls~N~l~~ 543 (848)
+.+.+... .|+. ....++|++|+++.|++... .-..+..+++|+.+....|.+..
T Consensus 279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred cccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 54444332 1221 23456777777777777432 12334456677777777777764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.5e-11 Score=123.58 Aligned_cols=208 Identities=23% Similarity=0.248 Sum_probs=142.6
Q ss_pred CCCCCCcEEeccCCccccccc--ccccCCCCCcEEEccccCCCCCC--chhhhccccccEEEecccCcCCCCCccc-cCc
Q 038003 76 SSFPHLANLNLSFNLFFGNIP--LQIGNLSKLQYLDLGSNQLSGLI--PPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQL 150 (848)
Q Consensus 76 ~~l~~l~~L~l~~n~~~~~~p--~~~~~l~~L~~L~Ls~n~l~~~~--p~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l 150 (848)
+++..|+...|.+..+. .++ .-...|++++.||||.|-|..-. -.-...|++|+.|+|+.|++.-...... ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45777888888777664 222 24567888888888888776432 2344678888889998888864333322 357
Q ss_pred CCccEEEcCCCcCCCC-CCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCc--ccccCCcccce
Q 038003 151 SLIDKLALCHNNLHGS-IPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIP--LSLGNLSSLTM 227 (848)
Q Consensus 151 ~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~ 227 (848)
+.|+.|.|+.|.++-. +-..+..+++|+.|+|..|..-+.......-++.|+.|||++|++- ..+ ...+.++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence 7888888998888732 2223456788899999888533233344455778889999988876 344 45678888888
Q ss_pred eeccccCCCCC-CCCc-----ccCcccccccccccccccCc-CCCcccCCCCCceEEccCccccc
Q 038003 228 MSLFNNSLSGS-IPPI-----LGNLKSLSALGLHINQLNGF-IPPSIGNLSSLRVLYLYNNGLYG 285 (848)
Q Consensus 228 L~l~~n~l~~~-~p~~-----l~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~ 285 (848)
|+++.+.+... .|+. ...+++|++|++..|++..- .-..+..+.+|+.|.+..|.+..
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 88988888743 2332 35678899999999998521 11234556778888888888863
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.4e-10 Score=81.19 Aligned_cols=43 Identities=44% Similarity=0.874 Sum_probs=30.2
Q ss_pred ChHHHHHHHHHHHhccCCCCCCcccCCCCCCCCCCCCCCCCccCceEEc
Q 038003 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCN 50 (848)
Q Consensus 2 ~~~~~~all~~k~~~~~~~~~~~~l~sw~~~~~~~~~~~~c~w~gv~C~ 50 (848)
.++|++||++||+++..++ .+.+++|+.. ...+||.|.||+|+
T Consensus 1 ~~~d~~aLl~~k~~l~~~~--~~~l~~W~~~----~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDP--SGVLSSWNPS----SDSDPCSWSGVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC---CCCTT--TT------S-CCCSTTEEE-
T ss_pred CcHHHHHHHHHHHhccccc--CcccccCCCc----CCCCCeeeccEEeC
Confidence 3689999999999998754 5799999841 13799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.3e-10 Score=134.85 Aligned_cols=132 Identities=30% Similarity=0.357 Sum_probs=96.5
Q ss_pred cCCCCCcEEEccccCCCCCCchhhhccccccEEEecccC--cCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCcccc
Q 038003 100 GNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQ--LHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNL 177 (848)
Q Consensus 100 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 177 (848)
.+....+...+-+|.+. .++... .+++|+.|-+..|. +....++.|..++.|++|||++|.=-+.+|++++.|-+|
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred cchhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 34467777888777775 344443 33478888888886 442333456778888888888877666788888888888
Q ss_pred ceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccC
Q 038003 178 AVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234 (848)
Q Consensus 178 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 234 (848)
++|+++...++ .+|..+++|+.|.+|++..+.-...+|.....+++|++|.+..-.
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 88888888887 778888888888888888877665666667778888888777654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.8e-10 Score=124.48 Aligned_cols=198 Identities=23% Similarity=0.231 Sum_probs=148.8
Q ss_pred HHhhcCCcccceeccCCceeEEEEEcC--CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecC
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAELP--SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNG 671 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 671 (848)
.....+|..+..||.|.|+.|+++..+ ++..|++|......... .+...-..|+.+...+ .|.+++.....|...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--ASDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--HhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 344567899999999999999998543 67889999876654321 1111124566666666 588889888888888
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC-CCEEEeecc
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN-FEAHVSDFG 750 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG 750 (848)
++.|+--||+++++...... ....++...+.++..|++.++.++|+. .++|+|+||+||++..+ +.-++.|||
T Consensus 339 r~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 88889999999998876552 234466677888999999999999999 99999999999999886 788999999
Q ss_pred CccccCCCCCCccccccccccc--CccccccCCCCccchhhhHHHHHHHHHhCCC
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYA--APEIAYTMRATEKYDVYSFGVLVFEVIKGNH 803 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 803 (848)
.++.+.-.. ......-+++ +|+......+..+.|++|||..+.+.+||..
T Consensus 413 ~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 413 CWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccccceec---ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 987532111 1122233444 5555566678889999999999999999875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.5e-09 Score=108.96 Aligned_cols=152 Identities=26% Similarity=0.366 Sum_probs=116.8
Q ss_pred HHHhcCCCCcccceEEEeecC-----CeeEEEEeccCCCCHHhHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 038003 651 LALKEIRHRNNVKFHGFCYNG-----PHSFLVCEYLDRGSLARILGDDVT-AKELGWNRRINVIKGVANALSYLHHDCLP 724 (848)
Q Consensus 651 ~~l~~l~hp~iv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~ 724 (848)
.-+-++.|.|+|+++.|+.+. ....++.|||..|++..++++... ...+......+|.-||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345566899999999998754 357899999999999999976533 44677788889999999999999986 56
Q ss_pred CeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC-----CCcccccccccccCccccccCCCCccchhhhHHHHHHHHH
Q 038003 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS-----SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799 (848)
Q Consensus 725 ~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 799 (848)
.|+|+++..+-|++..+|-+|+.----. ...+.- .....-.+-++|.|||.-.....+.++|||+||.+..||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 7999999999999999998888421111 010000 0011234578999999877767777899999999999999
Q ss_pred hCCCC
Q 038003 800 KGNHP 804 (848)
Q Consensus 800 tg~~P 804 (848)
.+..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 98764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.1e-08 Score=99.56 Aligned_cols=130 Identities=26% Similarity=0.320 Sum_probs=83.4
Q ss_pred eEEEEEcCCCCEEEEEEcccccccCC----------------------chhHHHHHHHHHHHhcCCCC--cccceEEEee
Q 038003 614 SVYKAELPSGDIVAVKKFNSQLLSGN----------------------MADHDEFLNEVLALKEIRHR--NNVKFHGFCY 669 (848)
Q Consensus 614 ~V~~~~~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~E~~~l~~l~hp--~iv~l~~~~~ 669 (848)
.||.|...+|..+|+|+.+....... ........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999888899999998755322100 01123466899999999766 456666552
Q ss_pred cCCeeEEEEeccC--CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHH-HhhCCCCCeEEcCCCCCCeeeCCCCCEEE
Q 038003 670 NGPHSFLVCEYLD--RGSLARILGDDVTAKELGWNRRINVIKGVANALSY-LHHDCLPSIIHRDISSKNVLLDSNFEAHV 746 (848)
Q Consensus 670 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~-LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 746 (848)
..++||||++ |..+.++.... ++......++.+++..+.. +|.. ||||||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 4579999998 65554443222 1123345677788885555 4677 99999999999999887 8999
Q ss_pred eeccCccccC
Q 038003 747 SDFGIAKFVG 756 (848)
Q Consensus 747 ~DfG~~~~~~ 756 (848)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.7e-10 Score=128.02 Aligned_cols=206 Identities=25% Similarity=0.233 Sum_probs=144.8
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..+.|.+.+.+-+|+++.++.+.-. .|...++|+....-.- ...+.+...++-.+.-..++|.++...--+.-....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i-~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI-RTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhh-ccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 4566778888899999999988543 4555565554332100 0111222222322333334566665544444556789
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+|++|+.++++...++.. ...+...+...+..+..+.+|||.. .+.|+|++|.|++...+++.++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999888755 2333344455667788999999998 7999999999999999999999999844332
Q ss_pred CCC----------C---------------------CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 038003 756 GPH----------S---------------------SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804 (848)
Q Consensus 756 ~~~----------~---------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 804 (848)
+.. . .......||+.|.|||...+......+|+|+.|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 0 011235689999999999999999999999999999999999999
Q ss_pred Ccccc
Q 038003 805 RDFFS 809 (848)
Q Consensus 805 ~~~~~ 809 (848)
|....
T Consensus 1035 ~na~t 1039 (1205)
T KOG0606|consen 1035 FNAET 1039 (1205)
T ss_pred CCCcc
Confidence 86533
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.7e-08 Score=98.83 Aligned_cols=140 Identities=24% Similarity=0.224 Sum_probs=99.1
Q ss_pred CcccceeccCCceeEEEEEcCCCCEEEEEEccccccc----------------CC--chhHHHHHHHHHHHhcCCCC--c
Q 038003 601 FDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLS----------------GN--MADHDEFLNEVLALKEIRHR--N 660 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------~~--~~~~~~~~~E~~~l~~l~hp--~ 660 (848)
..+...||-|.-+.||.|....|.++|||.=+.-..+ .. ........+|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3456789999999999999999999999952211100 00 11234467899999999654 6
Q ss_pred ccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC
Q 038003 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 661 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 740 (848)
|.+.+++ +...+|||+++|-.|.+.- ++....-.++..|..-+.-.-.. ||||||+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 7777775 4567999999997665432 12223334555555555555566 9999999999999999
Q ss_pred CCCEEEeeccCcccc
Q 038003 741 NFEAHVSDFGIAKFV 755 (848)
Q Consensus 741 ~~~~kl~DfG~~~~~ 755 (848)
+|.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.3e-08 Score=100.76 Aligned_cols=145 Identities=20% Similarity=0.110 Sum_probs=101.1
Q ss_pred ceeccCCceeEEEEEcCCCCEEEEEEcccccccC---C----chhHHHHHHHHHHHhcCCCCcc--cceEEEeec-----
Q 038003 605 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG---N----MADHDEFLNEVLALKEIRHRNN--VKFHGFCYN----- 670 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~----~~~~~~~~~E~~~l~~l~hp~i--v~l~~~~~~----- 670 (848)
+.+-......|+++.+ +|+.|.||......... . ......+.+|.+.+.++..-+| ++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444445555777765 57789999764432110 0 0111247789998888854444 344555543
Q ss_pred CCeeEEEEeccCCC-CHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-------CC
Q 038003 671 GPHSFLVCEYLDRG-SLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-------NF 742 (848)
Q Consensus 671 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~ 742 (848)
....++|+|++++. +|.+++.... ....+...+..++.+++..+.-||.. ||+|||++++|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999986 7888875321 13345567778999999999999999 9999999999999975 46
Q ss_pred CEEEeeccCccc
Q 038003 743 EAHVSDFGIAKF 754 (848)
Q Consensus 743 ~~kl~DfG~~~~ 754 (848)
.+.++||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=6e-09 Score=81.74 Aligned_cols=59 Identities=36% Similarity=0.459 Sum_probs=32.1
Q ss_pred CCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccC
Q 038003 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQ 138 (848)
Q Consensus 80 ~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 138 (848)
+|++|++++|.++..-+..|..+++|++|++++|.++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555553333455555555555555555555444555555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.8e-09 Score=82.27 Aligned_cols=56 Identities=45% Similarity=0.597 Sum_probs=21.9
Q ss_pred cEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccC
Q 038003 412 NKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNN 467 (848)
Q Consensus 412 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 467 (848)
++|++++|+++...+..|..+++|++|++++|+++.+.|..|.++++|++|++++|
T Consensus 4 ~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 4 ESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp SEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred cEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 33333333333333333334444444444444444333333444444444444444
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.3e-07 Score=94.77 Aligned_cols=191 Identities=16% Similarity=0.217 Sum_probs=130.2
Q ss_pred cccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEe------ec-CCe
Q 038003 602 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFC------YN-GPH 673 (848)
Q Consensus 602 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~------~~-~~~ 673 (848)
.....||+|+.+.+|-..-- ...+.|+++..- ..... ..+..|... .||-+-.-+.+- .+ +..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pp----pa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPP----PAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCC----chHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 34567999999999976321 224567766542 11111 222333333 566443211111 12 223
Q ss_pred eEEEEeccCCC-CHHhHhc---CCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 674 SFLVCEYLDRG-SLARILG---DDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 674 ~~lV~e~~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
..+.|+.+.|. ....+.. +........|.-..++++.+|.+.+.||.. |.+-||+.++|+|+.+++.|.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 67888888765 2222222 122234578899999999999999999999 9999999999999999999999987
Q ss_pred cCccccCCCCCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhC-CCCC
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKG-NHPR 805 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg-~~P~ 805 (848)
..-... .........+|.++|.+||... +...++..|-|.+|+++++++.| +.||
T Consensus 162 Dsfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPy 222 (637)
T COG4248 162 DSFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY 222 (637)
T ss_pred cceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCC
Confidence 655443 2333344567899999999754 45567789999999999999996 8897
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.1e-09 Score=116.81 Aligned_cols=127 Identities=35% Similarity=0.408 Sum_probs=102.2
Q ss_pred CccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCC-cccCccccceecc
Q 038003 386 KLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPK-SIGNLLKLHYLNL 464 (848)
Q Consensus 386 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L 464 (848)
.|.+.+.++|.++ .+...+.-++.|+.|+|++|+++... .+..+++|++|||++|.++ .+|. ....+. |+.|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 5888999999998 77788899999999999999998543 7888999999999999998 4443 333344 999999
Q ss_pred ccCcCCCCChhHHhhhcccceecccCcccCcCCC-ccccCCCCCccccCCCCcccC
Q 038003 465 SNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIP-PQVCNMGSLEKLNLSHNNLSD 519 (848)
Q Consensus 465 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 519 (848)
++|.++.. ..+.+|.+|+.|||++|-|.+.-- .-+..+..|+.|+|.+|++-.
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 99999742 457889999999999999876321 234556788999999999854
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.2e-09 Score=117.97 Aligned_cols=181 Identities=24% Similarity=0.212 Sum_probs=129.1
Q ss_pred CccccCcccccEeecccccccCCCCCCCCCC-CCccEEEccCCccCCCCcc-------ccc---ccccccEEEccCCcCC
Q 038003 354 SFNWGNFSKLSTFIVSMNNISGSIPPDIGNS-PKLQVLDLSSNHIVGKIPV-------QLE---MLSSLNKLILNLNQLS 422 (848)
Q Consensus 354 ~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~~~-------~l~---~l~~L~~L~L~~N~l~ 422 (848)
|..+..+.+|+.|.+.++.++. ...+..+ ..|+.|.. +|.+. .+.. .++ ....|...+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~-Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLD-ALRHVFASCGGDISNSPVWNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHH-HHHHHHHHhccccccchhhhhHhhhhcchhhHH
Confidence 5566677888888888888763 2222222 23444432 23322 1100 011 1135778889999998
Q ss_pred CCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCcccc
Q 038003 423 GGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVC 502 (848)
Q Consensus 423 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 502 (848)
.+..++.-++.|+.|+|++|+++... .+..|+.|+.|||+.|+++.+.--....+. |+.|.+++|.++.. ..+.
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHH
Confidence 66677778899999999999998653 788999999999999999854333344444 99999999999754 5788
Q ss_pred CCCCCccccCCCCcccCCCc-chhccccCceeecCCCCccCCC
Q 038003 503 NMGSLEKLNLSHNNLSDFIP-RCFEEMRSLSCIDISYNELHGP 544 (848)
Q Consensus 503 ~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~l~ls~N~l~~~ 544 (848)
++++|+.||+++|-|.+.-. ..+..+..|+.|+|.||++...
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 99999999999999876432 2345678899999999999764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.9e-09 Score=91.59 Aligned_cols=131 Identities=28% Similarity=0.372 Sum_probs=72.1
Q ss_pred CcEEEccccCCCCCCchhhhccc---cccEEEecccCcCCCCCccccC-cCCccEEEcCCCcCCCCCCCcccCccccceE
Q 038003 105 LQYLDLGSNQLSGLIPPEIGKLN---QLRRLYLDMNQLHGTIPPEIGQ-LSLIDKLALCHNNLHGSIPSSLGNLSNLAVL 180 (848)
Q Consensus 105 L~~L~Ls~n~l~~~~p~~~~~l~---~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 180 (848)
+..|||+++++- .+++....+. .|...+|++|.+. ..|+.|.. .+.++.|+|++|.|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 445566666553 3444444333 3444466666665 34444432 335566666666666 566666666667777
Q ss_pred EeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCC
Q 038003 181 YLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIP 240 (848)
Q Consensus 181 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p 240 (848)
+++.|.+. ..|..|..|.+|-.|+..+|.+. .+|..+-.-+..-...+.++.+.+.-+
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 77777666 55666666666777776666665 455443332333333445555554433
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1e-08 Score=90.17 Aligned_cols=132 Identities=27% Similarity=0.331 Sum_probs=78.1
Q ss_pred CccEEEccCCccCCCCccccc---ccccccEEEccCCcCCCCCCccc-CCCCccCeEeccCcccCCCCCCcccCccccce
Q 038003 386 KLQVLDLSSNHIVGKIPVQLE---MLSSLNKLILNLNQLSGGVPLEF-GSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHY 461 (848)
Q Consensus 386 ~L~~L~Ls~N~l~~~~~~~l~---~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 461 (848)
.+..++|+.|+|. .+++... ....|+..+|++|.+.. +|..| ..++.++.|+|++|.|+ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3556777777765 4444433 33455556777777763 33333 34456777777777776 56666777777777
Q ss_pred eccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCc
Q 038003 462 LNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIP 522 (848)
Q Consensus 462 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 522 (848)
|+++.|.|. ..|..+..|.+|-.|+..+|.+. .+|-.+..-...-..++.++.+.+..+
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 777777776 56666666777777777777764 344333222223333444555544433
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.52 E-value=9.1e-07 Score=94.93 Aligned_cols=170 Identities=18% Similarity=0.233 Sum_probs=125.8
Q ss_pred CceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec----CCeeEEEEeccCCC-
Q 038003 611 GQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN----GPHSFLVCEYLDRG- 684 (848)
Q Consensus 611 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~~lV~e~~~~g- 684 (848)
...+.|++. ..||..|+.|+++........ ....-+++++++.|+|+|++.++|.. +...++||+|.++.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n----k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN----KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc----cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 445778994 458999999999655433221 12345788999999999999998873 34678999999864
Q ss_pred CHHhHhcCC------------CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 685 SLARILGDD------------VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 685 sL~~~l~~~------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
+|.++.-.. ..+...++...+.++.|++.||.++|+. |+.-+-+.+.+|+++.+.+++|+..|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccce
Confidence 676654221 1223466788899999999999999999 9999999999999999999999877776
Q ss_pred cccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 804 (848)
.....+.. |-+.+ -.+-|.-.||.++..|.||..-
T Consensus 441 Dvl~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 441 DVLQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eeecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 55544321 11111 1257999999999999999554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=8.7e-07 Score=88.77 Aligned_cols=129 Identities=19% Similarity=0.234 Sum_probs=92.4
Q ss_pred CCCEEEEEEcccccccC---CchhHHHHHHHHHHHhcCCCCc--ccceEEEeecC----CeeEEEEeccCCC-CHHhHhc
Q 038003 622 SGDIVAVKKFNSQLLSG---NMADHDEFLNEVLALKEIRHRN--NVKFHGFCYNG----PHSFLVCEYLDRG-SLARILG 691 (848)
Q Consensus 622 ~~~~vavK~~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~~~~----~~~~lV~e~~~~g-sL~~~l~ 691 (848)
.++.+.+|......... ..-......+|.+.+..+..-. +.+++++.... ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 35566666543322111 0123345778888877775443 45666666542 2458999999884 7998886
Q ss_pred CCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC---CEEEeeccCccccC
Q 038003 692 DDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF---EAHVSDFGIAKFVG 756 (848)
Q Consensus 692 ~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~~~~~~ 756 (848)
... ..+......++.+++..+.-||+. ||+|+|+++.|||++.++ .+.++||+.++...
T Consensus 111 ~~~---~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 111 QWE---QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred hhc---ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 531 145566788999999999999999 999999999999999887 89999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.9e-06 Score=84.20 Aligned_cols=142 Identities=19% Similarity=0.181 Sum_probs=102.0
Q ss_pred eccCCceeEEEEEcCCCCEEEEEEccccccc--CCchhHHHHHHHHHHHhcCCCCc--ccceEEEeec---C--CeeEEE
Q 038003 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLS--GNMADHDEFLNEVLALKEIRHRN--NVKFHGFCYN---G--PHSFLV 677 (848)
Q Consensus 607 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~~~---~--~~~~lV 677 (848)
-|+|+-+.|++.... |..+-+|.-...... .-+-....|.+|+..+.++..-+ +.++. ++.. + -..++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 466888888888765 447889986522111 11224567899999988884322 44444 3321 1 145799
Q ss_pred EeccCC-CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC--EEEeeccCccc
Q 038003 678 CEYLDR-GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE--AHVSDFGIAKF 754 (848)
Q Consensus 678 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfG~~~~ 754 (848)
+|-+++ .+|.+++... ...+.+...+..++.+++.++.-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998864 4888887553 223556777889999999999999999 9999999999999986666 99999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.1e-07 Score=100.57 Aligned_cols=145 Identities=22% Similarity=0.230 Sum_probs=93.0
Q ss_pred ceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchh--------------------------HH----------HHHH
Q 038003 605 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMAD--------------------------HD----------EFLN 648 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~--------------------------~~----------~~~~ 648 (848)
..|+.++-|.||+|++++|+.||||+.+......-..+ .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999999999999999765432100000 01 1334
Q ss_pred HHHHHhcC-----CCCcccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHH-HHHHhhCC
Q 038003 649 EVLALKEI-----RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA-LSYLHHDC 722 (848)
Q Consensus 649 E~~~l~~l-----~hp~iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~-L~~LH~~~ 722 (848)
|...+.++ +.|.+.-..=|++-.....++|||++|-.+.+...-.. ...+.+. ++..++++ +.-+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhc-
Confidence 44444444 23443333333333456789999999998877642221 2233233 33333332 1222224
Q ss_pred CCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 723 LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 723 ~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|+.|.|..|.||+++.+|.+.+.|||+.....+
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999987754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 848 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-46 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-46 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-22 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-10 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-10 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 6e-09 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-10 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 5e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-09 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 5e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-09 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 3e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 3ulu_A | 694 | Structure Of Quaternary Complex Of Human Tlr3ecd Wi | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 2a0z_A | 705 | The Molecular Structure Of Toll-like Receptor 3 Lig | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-07 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 7e-07 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 9e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-07 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 7e-07 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 8e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-07 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 7e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-07 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-06 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 5e-05 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 3e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 1e-05 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 2e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 2e-05 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 7e-05 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 2e-05 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 5e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 4e-05 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 6e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-05 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 848 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-145 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-141 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-17 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-89 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-72 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-63 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-40 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-32 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-14 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-04 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-91 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-21 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-89 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-80 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-77 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-59 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-51 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-46 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-28 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 9e-88 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-78 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-67 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-48 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-85 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-79 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-78 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-65 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-58 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-46 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-05 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-78 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-78 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-75 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-72 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-63 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-52 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-37 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-29 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-19 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-77 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-75 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-69 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-67 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-66 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-32 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 7e-70 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-66 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-63 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-58 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-13 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 3e-65 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-62 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-61 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-37 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-26 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-22 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-57 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-57 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-56 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-51 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-20 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-56 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-55 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-27 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-08 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-55 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-55 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-53 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-50 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-49 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-42 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-52 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-52 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-51 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-50 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-49 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-49 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-43 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-30 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-50 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-49 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-34 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-30 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-49 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-39 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-34 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-20 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-17 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-48 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-46 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-43 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-11 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-46 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-45 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-45 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-45 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-35 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-17 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-44 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-44 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-44 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 7e-44 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-44 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-23 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-11 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-43 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-41 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-09 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-43 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-42 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-33 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-17 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-08 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 8e-43 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-42 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-40 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-36 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-35 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-32 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-21 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-42 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 8e-42 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-41 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-41 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-33 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-21 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-41 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-31 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-31 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-19 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-40 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-38 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-35 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-31 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-26 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-40 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-31 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-28 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-11 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-34 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-30 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-09 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-06 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-34 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-34 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-31 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-28 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-23 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-20 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-08 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-04 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-33 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-31 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-32 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-32 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-32 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-27 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-17 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-31 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-31 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-30 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-30 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-30 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-30 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 6e-30 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 7e-30 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-29 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-29 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-29 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-29 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-26 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-24 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-14 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-06 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-29 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-29 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-29 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-04 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-29 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-29 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-29 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 8e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-26 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 9e-26 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-21 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-28 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-28 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-28 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-28 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-28 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-25 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-06 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-28 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-28 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-28 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-27 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-27 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-27 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-27 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-27 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-27 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-27 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-27 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-27 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-27 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-27 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 7e-27 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-26 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-26 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-26 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-26 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-26 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-26 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-26 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-26 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-26 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-24 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-20 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-26 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-26 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-26 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-26 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-26 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-26 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-26 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 7e-26 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 9e-26 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-25 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-20 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-20 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-18 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-25 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-25 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-25 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-25 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-25 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-20 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-25 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-25 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-24 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 9e-23 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 9e-23 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-19 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-16 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-14 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-10 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-25 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-25 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-25 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-25 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-25 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-25 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-25 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 9e-25 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-24 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-24 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-24 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-24 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-24 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-24 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-24 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-24 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-24 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-21 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-13 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-09 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 8e-24 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-23 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-23 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-23 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-23 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-23 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-23 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-23 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-23 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-23 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-23 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-23 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-23 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 7e-23 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 5e-17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-23 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-15 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-22 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-22 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-22 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-22 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-22 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-22 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-21 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-19 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-22 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-20 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-20 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-20 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-16 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-13 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 4e-22 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-22 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-22 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-22 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 9e-22 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-21 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-21 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-21 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-21 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-21 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-21 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-21 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-21 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 5e-21 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-21 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-21 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-21 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-21 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-20 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-20 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-20 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-20 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-20 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-19 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-19 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 8e-18 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-16 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 7e-20 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-20 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 9e-20 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-19 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-19 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 6e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 9e-09 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-19 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-18 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-18 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 7e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-09 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 6e-18 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 6e-18 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-17 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-17 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-17 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-17 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-17 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-17 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 9e-10 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-06 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 9e-17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 9e-14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-12 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-17 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-17 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-16 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 6e-12 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 9e-10 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-07 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 8e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 9e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-13 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-16 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-16 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-16 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 9e-15 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-14 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-13 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-12 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-16 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-16 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-15 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 8e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 6e-07 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-16 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-15 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-15 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-15 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-15 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-14 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-07 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-15 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-15 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-15 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-15 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-15 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-15 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 5e-15 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-15 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-15 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 7e-15 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 9e-15 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 9e-14 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-09 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-07 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-14 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-14 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-14 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 5e-14 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-14 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 5e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-14 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 8e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 8e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-10 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 9e-14 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-13 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-13 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 9e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-07 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-13 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-13 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-13 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-04 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-13 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-13 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-13 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-13 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 4e-13 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 5e-13 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 9e-13 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 8e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 8e-05 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 9e-05 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-12 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-12 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-12 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-11 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-10 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-10 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-05 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-12 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-11 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-11 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-11 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-04 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-11 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-11 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 3e-11 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-07 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-11 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-11 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-11 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-11 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-10 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-10 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-10 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-10 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 6e-10 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 8e-07 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-10 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 7e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-04 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-10 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-09 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-08 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-09 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-09 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-09 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-09 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 7e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-09 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 9e-08 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 2e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-04 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 7e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-04 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 4e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 5e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 6e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 9e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 7e-08 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 8e-08 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 8e-08 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 6e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-06 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 5e-06 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 4e-05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-05 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 5e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 6e-05 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 8e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 446 bits (1150), Expect = e-145
Identities = 173/514 (33%), Positives = 251/514 (48%), Gaps = 23/514 (4%)
Query: 65 GLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEI- 123
L+G F + S+ L LN+S N F G IP L LQYL L N+ +G IP +
Sbjct: 234 KLSGDFSR-AISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLS 290
Query: 124 GKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIP-SSLGNLSNLAVLYL 182
G + L L L N +G +PP G SL++ LAL NN G +P +L + L VL L
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350
Query: 183 YKNSLSGSIPSIIGKLKSLLQ-LDLSENQFSGSIPLSLGN--LSSLTMMSLFNNSLSGSI 239
N SG +P + L + L LDLS N FSG I +L ++L + L NN +G I
Sbjct: 351 SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410
Query: 240 PPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSE 299
PP L N L +L L N L+G IP S+G+LS LR L L+ N L G +P+E+ Y+K+L
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470
Query: 300 LELCTNLLRGVIPHSI------ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI 353
L L N L G IP + + L+ N L+G++ + G NL L LSNN+F G I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 354 SFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNK 413
G+ L ++ N +G+IP + Q +++N I GK V ++ +
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFK----QSGKIAANFIAGKRYVYIKNDGMKKE 586
Query: 414 LIL--NLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH 471
NL + G + L+ ++++ + N + +L++S N LS
Sbjct: 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 646
Query: 472 KIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSL 531
IP E + +L L+L HN + IP +V ++ L L+LS N L IP+ + L
Sbjct: 647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 706
Query: 532 SCIDISYNELHGPIPNSTAFK---DGLMEGNKGL 562
+ ID+S N L GPIP F+ N GL
Sbjct: 707 TEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 436 bits (1123), Expect = e-141
Identities = 161/564 (28%), Positives = 254/564 (45%), Gaps = 57/564 (10%)
Query: 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITM 61
L E + L+ +K L ++NL L W+ + +PC++ G++C +V SI +
Sbjct: 10 LYREIHQLISFKDVLPDKNL----LPDWS------SNKNPCTFDGVTCRD--DKVTSIDL 57
Query: 62 STLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPP 121
S+ LN F + + +L+ L+ L L ++ ++G +
Sbjct: 58 SSKPLNVGF----------------------SAVSSSLLSLTGLESLFLSNSHINGSV-S 94
Query: 122 EIGKLNQLRRLYLDMNQLHGTIPP--EIGQLSLIDKLALCHNNLHGSIPSSLG-NLSNLA 178
L L L N L G + +G S + L + N L S G L++L
Sbjct: 95 GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE 154
Query: 179 VLYLYKNSLSGSIPS---IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL 235
VL L NS+SG+ + L L +S N+ SG + + +L + + +N+
Sbjct: 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNF 212
Query: 236 SGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLK 295
S IP + G+ +L L + N+L+G +I + L++L + +N G +P LK
Sbjct: 213 STGIPFL-GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LK 269
Query: 296 SLSELELCTNLLRGVIPHSI-------ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNN 348
SL L L N G IP + + L+ N+ G + FG L L LS+NN
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 349 FCGEISFNW-GNFSKLSTFIVSMNNISGSIPPDIGN-SPKLQVLDLSSNHIVGKIPVQL- 405
F GE+ + L +S N SG +P + N S L LDLSSN+ G I L
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 389
Query: 406 -EMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNL 464
++L +L L N +G +P + ++L L LS N LS +IP S+G+L KL L L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 465 SNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRC 524
N L +IP E + L L L N L EIP + N +L ++LS+N L+ IP+
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 525 FEEMRSLSCIDISYNELHGPIPNS 548
+ +L+ + +S N G IP
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAE 533
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-17
Identities = 32/129 (24%), Positives = 54/129 (41%), Gaps = 4/129 (3%)
Query: 430 GSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLS 489
+T + N S++ S+ +L L L LSN+ ++ + F+ L+ LDLS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 490 HNILQEEIPP--QVCNMGSLEKLNLSHNNLSDFIPR-CFEEMRSLSCIDISYNELHGPIP 546
N L + + + L+ LN+S N L ++ SL +D+S N + G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 547 NSTAFKDGL 555
DG
Sbjct: 169 VGWVLSDGC 177
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = 6e-96
Identities = 111/517 (21%), Positives = 185/517 (35%), Gaps = 37/517 (7%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQ 128
+F+ + L +L++ FN P L L+ L+L N+LS L
Sbjct: 39 RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98
Query: 129 LRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLS 188
L L+L N + + + L L HN L + + L NL L L N +
Sbjct: 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158
Query: 189 GSIPSIIG--KLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILG-- 244
+ SL +L+LS NQ P + L + L N L S+ L
Sbjct: 159 ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE 218
Query: 245 -NLKSLSALGLHINQLNGFIPPSIGNL--SSLRVLYLYNNGLYGFVPEEIGYLKSLSELE 301
S+ L L +QL+ + L ++L +L L N L + +L L
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFF 278
Query: 302 LCTNLLRGVIPHSI---------------ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSN 346
L N ++ + HS+ + ++ +L +F L L++ +
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 347 NNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIG----NSPKLQVLDLSSNHIVGKIP 402
N+ G S + L +S + S + L +L+L+ N I
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
Query: 403 VQLEMLSSLNKLILNLNQLSGGVP-LEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHY 461
L L L L LN++ + E+ L + + LS NK S + L
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR 458
Query: 462 LNLSNNQLSH--KIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSD 519
L L L + P+ F+ L +L+ LDLS+N + + + LE L+L HNNL+
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518
Query: 520 F--------IPRCFEEMRSLSCIDISYNELHGPIPNS 548
+ + L +++ N
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 6e-89
Identities = 112/487 (22%), Positives = 184/487 (37%), Gaps = 36/487 (7%)
Query: 84 LNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTI 143
+ S +P + + + L+L NQL L + +QL L + N +
Sbjct: 9 ADCSHL-KLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 144 PPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQ 203
P +L ++ L L HN L + +NL L+L NS+ + K K+L+
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 204 LDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLK--SLSALGLHINQLNG 261
LDLS N S + + L +L + L NN + L SL L L NQ+
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 262 FIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLN 321
F P + L L+L N L + E++ + + + + L+
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI---------------RNLSLS 230
Query: 322 QNNLSGKMYEAFG--DHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPP 379
+ LS F NLT LDLS NN + ++ +L F + NNI
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
Query: 380 DIGNSPKLQVLDLSSN---------HIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFG 430
+ ++ L+L + + + L L L + N + G F
Sbjct: 291 SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT 350
Query: 431 SLTKLQYLDLSTNKLSSSIPKSIG----NLLKLHYLNLSNNQLSHKIPTEFEKLIHLSEL 486
L L+YL LS + S + LH LNL+ N++S F L HL L
Sbjct: 351 GLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVL 410
Query: 487 DLSHNILQEEIPPQV-CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPI 545
DL N + +E+ Q + ++ ++ LS+N F + SL + + L
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470
Query: 546 PNSTAFK 552
+ + F+
Sbjct: 471 SSPSPFQ 477
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 6e-72
Identities = 103/540 (19%), Positives = 168/540 (31%), Gaps = 97/540 (17%)
Query: 64 LGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNL--SKLQYLDLGSNQLSGLIPP 121
LG + T + + NL+LS + L + L LDL N L+ +
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 122 EIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLY 181
L QL +L+ +NN+ SL L N+ L
Sbjct: 267 SFAWLPQLEYFFLE------------------------YNNIQHLFSHSLHGLFNVRYLN 302
Query: 182 LYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP 241
L ++ + +S S L L +++ +N + G
Sbjct: 303 LKRS---------------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
Query: 242 ILGNLKSLSALGLHINQLNGFIPPSIG----NLSSLRVLYLYNNGLYGFVPEEIGYLKSL 297
+ L +L L L + + + S L +L L N + + +L L
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407
Query: 298 SELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNW 357
L+L N + + + N+ + LS N
Sbjct: 408 EVLDLGLNEIGQELTGQ-----------------EWRGLENIFEIYLSYNK--------- 441
Query: 358 GNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI--VGKIPVQLEMLSSLNKLI 415
P LQ L L + V P + L +L L
Sbjct: 442 ---------------YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486
Query: 416 LNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSS--------SIPKSIGNLLKLHYLNLSNN 467
L+ N ++ L KL+ LDL N L+ + L LH LNL +N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 468 QLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEE 527
F+ L L +DL N L N SL+ LNL N ++ + F
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 528 -MRSLSCIDISYNELHGPIPNSTAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNFD 586
R+L+ +D+ +N + F + + E + + +S N+ V FD
Sbjct: 607 AFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFD 666
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 3e-63
Identities = 82/376 (21%), Positives = 142/376 (37%), Gaps = 25/376 (6%)
Query: 200 SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQL 259
S D S + + +P L +++T+++L +N L L++L + N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 260 NGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI---- 315
+ P L L+VL L +N L + + +L+EL L +N ++ + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 316 --ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCG--EISFNWGNFSKLSTFIVSMN 371
+ L+ N LS NL L LSNN + S L +S N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 372 NISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEM---LSSLNKLILNLNQLSGGVPLE 428
I P +L L L++ + + +L + +S+ L L+ +QLS
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 429 FGSL--TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSEL 486
F L T L LDLS N L+ S L +L Y L N + H L ++ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 487 DLSHNILQ--------EEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDIS 537
+L + + +I + LE LN+ N++ F + +L + +S
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 538 YNELHGPIPNSTAFKD 553
+ + F
Sbjct: 362 NSFTSLRTLTNETFVS 377
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-40
Identities = 50/220 (22%), Positives = 82/220 (37%), Gaps = 5/220 (2%)
Query: 338 NLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397
+ D S+ + ++ ++ N + + +L LD+ N I
Sbjct: 5 SHEVADCSHLKL---TQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 398 VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL 457
P + L L L L N+LS F T L L L +N +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 458 KLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPP--QVCNMGSLEKLNLSHN 515
L L+LS+N LS +L +L EL LS+N +Q + SL+KL LS N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 516 NLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGL 555
+ +F P CF + L + ++ +L + +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELAN 221
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-32
Identities = 48/253 (18%), Positives = 83/253 (32%), Gaps = 18/253 (7%)
Query: 66 LNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL--IPPEI 123
+ + ++ + LS+N + + LQ L L L + P
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
Query: 124 GKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLH--------GSIPSSLGNLS 175
L L L L N + + L ++ L L HNNL G L LS
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536
Query: 176 NLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL 235
+L +L L N + L L +DL N + N SL ++L N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 236 SGSIPPILG-NLKSLSALGLHINQLNGFIP-----PSIGNLSSLRVLYLYNNGLYGFVPE 289
+ + G ++L+ L + N + + N + + L ++ L P
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPH 656
Query: 290 EIGYLKSLSELEL 302
G + +
Sbjct: 657 YHG--FPVRLFDT 667
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-14
Identities = 32/161 (19%), Positives = 53/161 (32%), Gaps = 8/161 (4%)
Query: 58 SITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSG 117
++ N + HL LNL N F +L +L+ +DLG N L+
Sbjct: 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT 574
Query: 118 LIPPEIGKLNQLRRLYLDMNQLHGTIPPEIG-QLSLIDKLALCHNNLHGSIPSSLG---- 172
L L+ L L N + G + +L + N + S
Sbjct: 575 LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNW 634
Query: 173 -NLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFS 212
N ++ + L + L + P G + D S + S
Sbjct: 635 INETHTNIPELSSHYLCNTPPHYHG--FPVRLFDTSSCKDS 673
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 16/68 (23%), Positives = 28/68 (41%), Gaps = 3/68 (4%)
Query: 481 IHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNE 540
+ D SH L ++P + ++ LNL+HN L F L+ +D+ +N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 541 LHGPIPNS 548
+ P
Sbjct: 61 ISKLEPEL 68
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = 8e-96
Identities = 88/509 (17%), Positives = 163/509 (32%), Gaps = 43/509 (8%)
Query: 65 GLNGTFHDFSFSSFPHLANLNLS--FNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPE 122
LNG AN N + +++ + + + ++ L L SG +P
Sbjct: 41 ALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA 100
Query: 123 IGKLNQLRRLYLDMNQLHG----TIPPEIGQLSLIDKLALCHNNLHGSIPSSLG--NLSN 176
IG+L +L L L + P I ++ + + + S+
Sbjct: 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160
Query: 177 LAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLS 236
L + + SI Q+ N + + ++ L+ L + N+
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFV 219
Query: 237 GSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKS 296
++ Q NL L + +YN +P + L
Sbjct: 220 AENICEAWENENSE-----YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE 274
Query: 297 LSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFC-GEISF 355
+ + + N S E++ + L+ + + + NN +
Sbjct: 275 MQLINVACNRG-----ISGEQLKDDWQALAD-----APVGEKIQIIYIGYNNLKTFPVET 324
Query: 356 NWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLI 415
+ KL N + G P G+ KL L+L+ N I + L
Sbjct: 325 SLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLS 383
Query: 416 LNLNQLSGGVP-LEFGSLTKLQYLDLSTNKLSS-------SIPKSIGNLLKLHYLNLSNN 467
N+L + S++ + +D S N++ S + + + + +NLSNN
Sbjct: 384 FAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443
Query: 468 QLSHKIPTEFEKLIHLSELDLSHNILQE-------EIPPQVCNMGSLEKLNLSHNNLSDF 520
Q+S F LS ++L N+L E + N L ++L N L+
Sbjct: 444 QISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKL 503
Query: 521 IP-RCFEEMRSLSCIDISYNELHGPIPNS 548
+ L ID+SYN P
Sbjct: 504 SDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = 4e-95
Identities = 82/513 (15%), Positives = 160/513 (31%), Gaps = 71/513 (13%)
Query: 61 MSTLGLNGTF-HDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLI 119
+ TF F L ++ + +I K + SN ++ +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-V 198
Query: 120 PPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAV 179
+ +L +LR+ Y+ + E + + + + NL +L
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAWENEN-----SEYAQQYKTEDLKWDNLKDLTD 253
Query: 180 LYLYKNSLSGSIPSIIGKLKSLLQLDLSENQF--------SGSIPLSLGNLSSLTMMSLF 231
+ +Y +P+ + L + ++++ N+ + ++ +
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313
Query: 232 NNSL-SGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEE 290
N+L + + L +K L L NQL G P+ G+ L L L N +
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANF 372
Query: 291 IGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFC 350
G+ + + L N L+ IP+ + ++ +D S N
Sbjct: 373 CGFTEQVENLSFAHNKLKY-IPNIFD----------------AKSVSVMSAIDFSYNEIG 415
Query: 351 GEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSS 410
+ P + ++LS+N I S
Sbjct: 416 SVD-----------------GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 411 LNKLILNLNQLSG-------GVPLEFGSLTKLQYLDLSTNKLSSSIPKSI--GNLLKLHY 461
L+ + L N L+ F + L +DL NKL + + L L
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVG 517
Query: 462 LNLSNNQLSHKIPTEFEKLIHLSELDLSHNI------LQEEIPPQVCNMGSLEKLNLSHN 515
++LS N S K PT+ L + + E P + SL +L + N
Sbjct: 518 IDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSN 576
Query: 516 NLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548
++ + ++S +DI N +
Sbjct: 577 DIRK-VNEKI--TPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = 1e-91
Identities = 73/476 (15%), Positives = 150/476 (31%), Gaps = 49/476 (10%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
S + N + + L+KL+ +G++ E +
Sbjct: 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----EN 231
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSL------ 187
+ Q + T + L + + + + +P+ L L + ++ + N
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291
Query: 188 --SGSIPSIIGKLKSLLQLDLSENQF-SGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILG 244
+ + + + + N + + SL + L M+ N L G P G
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFG 350
Query: 245 NLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPE-EIGYLKSLSELELC 303
+ L++L L NQ+ G + L +N L + + +S ++
Sbjct: 351 SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFS 410
Query: 304 TNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKL 363
N + V + N++ ++LSNN + S L
Sbjct: 411 YNEIGSVDG-----------KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 364 STFIVSMNNISG-------SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEM--LSSLNKL 414
S+ + N ++ + N+ L +DL N + + L L +
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGI 518
Query: 415 ILNLNQLSGGVPLEFGSLTKLQYLDLST------NKLSSSIPKSIGNLLKLHYLNLSNNQ 468
L+ N S P + + + L+ + N+ P+ I L L + +N
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 469 LSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRC 524
+ + + ++S LD+ N VC L ++ D I C
Sbjct: 578 IRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD-IRGC 629
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-21
Identities = 28/192 (14%), Positives = 54/192 (28%), Gaps = 7/192 (3%)
Query: 363 LSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS 422
L ++N + S + + + V L + L L S
Sbjct: 35 LKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGAS 94
Query: 423 GGVPLEFGSLTKLQYLDLSTNKLS----SSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-- 476
G VP G LT+L+ L L ++ PK I +
Sbjct: 95 GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154
Query: 477 FEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDI 536
E L + ++ + Q+ I ++ NN++ F+ + + L +
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYM 213
Query: 537 SYNELHGPIPNS 548
+
Sbjct: 214 GNSPFVAENICE 225
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 4e-89
Identities = 113/499 (22%), Positives = 185/499 (37%), Gaps = 22/499 (4%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQ 128
+SF SFP L L+LS +LS L L L N + L L+
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 129 LRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG-SIPSSLGNLSNLAVLYLYKNSL 187
L++L L IG L + +L + HN + +P NL+NL L L N +
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 188 SGSIPSIIGKLKSL----LQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-I 242
+ + L + L LDLS N + P + + L ++L NN S ++
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTC 220
Query: 243 LGNLKSLSALGLHINQLNG------FIPPSIGNLSSLRVLYL---YNNGLYGFVPEEIGY 293
+ L L L + + F ++ L +L + Y + + +
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280
Query: 294 LKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI 353
L ++S L + + V S L + F + L+ + G
Sbjct: 281 LTNVSSFSLVSVTIERVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
Query: 354 SFNWGNFSKLSTFIVSMNNIS--GSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSL 411
+F+ + L +S N +S G + L+ LDLS N ++ + L L
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL 398
Query: 412 NKLILNLNQLSGGVPLE-FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLS 470
L + L F SL L YLD+S + L L L ++ N
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 471 HKIPTE-FEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMR 529
+ F +L +L+ LDLS L++ P ++ SL+ LN+SHNN ++ +
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 530 SLSCIDISYNELHGPIPNS 548
SL +D S N +
Sbjct: 519 SLQVLDYSLNHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 7e-80
Identities = 98/470 (20%), Positives = 167/470 (35%), Gaps = 32/470 (6%)
Query: 103 SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNN 162
+ LDL N L L +L+ L L ++ LS + L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 163 LHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQF-SGSIPLSLGN 221
+ + LS+L L + +L+ IG LK+L +L+++ N S +P N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 222 LSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFI---PPSIGNLSSLRVLYL 278
L++L + L +N + L L + L L ++ + P L L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207
Query: 279 YNNGLYGFVPEEIGY-LKSLSELELCTN--------------LLRGVIPHSIERVLLNQN 323
NN V + L L L L G+ +IE L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 324 NLS-GKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIG 382
+ + + F N++ L + F + +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 383 NSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS--GGVPLEFGSLTKLQYLDL 440
+ +L + ++ L SL L L+ N LS G T L+YLDL
Sbjct: 326 SLKRLTFTSNKGGNAFSEVD-----LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 441 STNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSHNILQEEIPP 499
S N + ++ + L +L +L+ ++ L F L +L LD+SH +
Sbjct: 381 SFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 500 QVCNMGSLEKLNLSHNNLSDFIPRC-FEEMRSLSCIDISYNELHGPIPNS 548
+ SLE L ++ N+ + F E+R+L+ +D+S +L P +
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 2e-77
Identities = 98/471 (20%), Positives = 161/471 (34%), Gaps = 25/471 (5%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL-IPPEIGKLN 127
+ +FS L L IG+L L+ L++ N + +P L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 128 QLRRLYLDMNQLHGTIPPEIGQLS----LIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183
L L L N++ ++ L L L L N ++ P + + L L L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLR 208
Query: 184 KNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPL---SLGNLSSLTMMSLFNNSLS--- 236
N S ++ I L L L +F L L L +++ L+
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 237 ---GSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGY 293
I + L ++S+ L + + L L N F ++
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 294 LKSLSELELCTNLLRGVIPHSIERVL---LNQNNLSGKMYEAFGDHPNLTFLDLSNNNFC 350
LK L+ + L N + G ++ +L +LDLS N
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV- 385
Query: 351 GEISFNWGNFSKLSTFIVSMNNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQLEMLS 409
+S N+ +L +N+ + + L LD+S H LS
Sbjct: 386 ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 410 SLNKLILNLNQLSGGVPLE-FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQ 468
SL L + N + F L L +LDLS +L P + +L L LN+S+N
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 469 LSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNM-GSLEKLNLSHNNLS 518
++ L L LD S N + ++ + SL LNL+ N+ +
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-59
Identities = 78/422 (18%), Positives = 135/422 (31%), Gaps = 34/422 (8%)
Query: 151 SLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQ 210
+ + C IP +L + L L N L L LDLS +
Sbjct: 6 VVPNITYQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 211 FSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNL 270
+ +LS L+ + L N + L SL L L IG+L
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 271 SSLRVLYLYNNGLYGF-VPEEIGYLKSLSELELCTNLLRGVIPHSIE----------RVL 319
+L+ L + +N + F +PE L +L L+L +N ++ + + +
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 320 LNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNW-GNFSKLSTFIVSMNNISGSI- 377
L+ N ++ AF L L L NN + + L + +
Sbjct: 184 LSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 378 --PPDIGNSPKLQVLDLSSNHI------VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEF 429
D L L + + + I L++++ L + +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 430 GSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLS 489
Q+L+L K + +L +L + + L L LDLS
Sbjct: 303 --NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLS 355
Query: 490 HNIL--QEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPN 547
N L + SL+ L+LS N + + F + L +D ++ L
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 548 ST 549
S
Sbjct: 415 SV 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 9e-51
Identities = 74/393 (18%), Positives = 130/393 (33%), Gaps = 43/393 (10%)
Query: 173 NLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFN 232
+ N+ + N IP + S LDLS N S + L ++ L
Sbjct: 6 VVPNITYQCMELNFYK--IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 233 NSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIG 292
+ +L LS L L N + + LSSL+ L L IG
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 293 YLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGE 352
+LK+L EL + NL++ F + NL LDLS+N
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPE-----------------YFSNLTNLEHLDLSSNKIQSI 164
Query: 353 ISFNWGNFSKLSTFIV----SMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIP-VQLEM 407
+ ++ + S+N ++ I P +L L L +N + ++
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
Query: 408 LSSLNKLILNLNQLSGGVPLE---FGSLTKLQYLDLSTNKLSS------SIPKSIGNLLK 458
L+ L L L + LE +L L L + +L+ I L
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 459 LHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS 518
+ +L + + +F L+L + + ++ ++ L+ +
Sbjct: 284 VSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSL-----KRLTFTSNK 336
Query: 519 DFIPRCFEEMRSLSCIDISYNELHGPIPNSTAF 551
++ SL +D+S N L S +
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-46
Identities = 60/354 (16%), Positives = 111/354 (31%), Gaps = 22/354 (6%)
Query: 56 VISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQL 115
+ ++ L F+ ++++ +L Q+L+L + +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKF 316
Query: 116 SGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLH--GSIPSSLGN 173
++ L L G L ++ L L N L G S
Sbjct: 317 GQFPTLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 174 LSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS-LGNLSSLTMMSLFN 232
++L L L N + + S L+ L LD + S +L +L + + +
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 233 NSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVLYLYNNGLYGFVPEEI 291
+ I L SL L + N P I L +L L L L P
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 292 GYLKSLSELELCTNLLRGVIPHSI------ERVLLNQNNLSGKMYEAFGDHP-NLTFLDL 344
L SL L + N + + + + N++ + P +L FL+L
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550
Query: 345 SNNNFCGEISFNW--GNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396
+ N+F +V + + + P D P + L+++
Sbjct: 551 TQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNITCQM 603
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-28
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 5/171 (2%)
Query: 379 PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYL 438
P + P + + N KIP L S L L+ N L F S +LQ L
Sbjct: 2 PCVEVVPNITYQCMELNFY--KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 439 DLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIP 498
DLS ++ + + +L L L L+ N + F L L +L L
Sbjct: 58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117
Query: 499 PQVCNMGSLEKLNLSHNNLSDF-IPRCFEEMRSLSCIDISYNELHGPIPNS 548
+ ++ +L++LN++HN + F +P F + +L +D+S N++
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 9e-88
Identities = 89/308 (28%), Positives = 140/308 (45%), Gaps = 16/308 (5%)
Query: 3 NEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAG--SRVISIT 60
++ ALL+ K L N + LSSW T +W G+ C+ RV ++
Sbjct: 5 PQDKQALLQIKKDLGNP----TTLSSWL----PTTDCCNRTWLGVLCDTDTQTYRVNNLD 56
Query: 61 MSTLGLNGTFH-DFSFSSFPHLANLNLS-FNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL 118
+S L L + S ++ P+L L + N G IP I L++L YL + +SG
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 119 IPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLA 178
IP + ++ L L N L GT+PP I L + + N + G+IP S G+ S L
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 179 -VLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG 237
+ + +N L+G IP L +L +DLS N G + G+ + + L NSL+
Sbjct: 177 TSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 238 SIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSL 297
+ +G K+L+ L L N++ G +P + L L L + N L G +P+ G L+
Sbjct: 236 DLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRF 293
Query: 298 SELELCTN 305
N
Sbjct: 294 DVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 4e-78
Identities = 78/344 (22%), Positives = 125/344 (36%), Gaps = 71/344 (20%)
Query: 151 SLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGS--IPSIIGKLKSLLQLDLS- 207
S + C+ G + + + L L +L IPS + L L L +
Sbjct: 26 SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGG 85
Query: 208 ENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSI 267
N G IP ++ L+ L + + + ++SG+IP L +K+L L N L+G +PPSI
Sbjct: 86 INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
Query: 268 GNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSG 327
+L +L + N + G +P+ G L
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKL------------------------------ 175
Query: 328 KMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKL 387
T + +S N +G IPP N L
Sbjct: 176 -----------FTSMTISRNRL------------------------TGKIPPTFANL-NL 199
Query: 388 QVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSS 447
+DLS N + G V + K+ L N L+ + + G L LDL N++
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYG 258
Query: 448 SIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHN 491
++P+ + L LH LN+S N L +IP L ++N
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-67
Identities = 80/360 (22%), Positives = 135/360 (37%), Gaps = 79/360 (21%)
Query: 214 SIPLSLGNLSSL----TMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNG--FIPPSI 267
I LGN ++L N + G + ++ L L L IP S+
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 268 GNLSSLRVLYLYN-NGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLS 326
NL L LY+ N L G +P I L
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLT------------------------------- 101
Query: 327 GKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPK 386
L +L +++ N SG+IP +
Sbjct: 102 -----------QLHYLYITHTNV------------------------SGAIPDFLSQIKT 126
Query: 387 LQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKL-QYLDLSTNKL 445
L LD S N + G +P + L +L + + N++SG +P +GS +KL + +S N+L
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 446 SSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMG 505
+ IP + NL L +++LS N L F + ++ L+ N L ++ +V
Sbjct: 187 TGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSK 244
Query: 506 SLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKD---GLMEGNKGL 562
+L L+L +N + +P+ +++ L +++S+N L G IP + NK L
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 1e-48
Identities = 57/170 (33%), Positives = 78/170 (45%), Gaps = 5/170 (2%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKL-QYLDLGSNQLSGLIPPEIGKLNQLRRL 132
S SS P+L + N G IP G+ SKL + + N+L+G IPP LN L +
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV 202
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
L N L G G K+ L N+L + +G NL L L N + G++P
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLP 261
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS-LSGSIPP 241
+ +LK L L++S N G IP GNL + + NN L GS P
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 3e-85
Identities = 91/578 (15%), Positives = 184/578 (31%), Gaps = 77/578 (13%)
Query: 35 NATKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGN 94
A ++ + N+ + L + G + + L+L+ G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 95 IPLQIGNLSKLQYLDLGSNQLSGLIPPEIGK-------LNQLRRLYLDMNQLHGTIPPEI 147
+P IG L++L+ L G++ + + + R+ + ++ +
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 148 GQ----------------------LSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKN 185
+SL D N I ++ L+ L ++Y +
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANS 458
Query: 186 SLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGN 245
+ ++ + + + LS NL LT + L+N +P L +
Sbjct: 459 PFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
Query: 246 LKSLSALGLHINQLNGF---------IPPSIGNLSSLRVLYLYNNGLYGFVPE-EIGYLK 295
L L +L + N+ + +++ Y+ N L F + +
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573
Query: 296 SLSELELCTNLLRGVIP----HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCG 351
L L+ N +R + + + L+ N + + + L S+N
Sbjct: 574 KLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY 633
Query: 352 -EISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSP------KLQVLDLSSNHIVGKIPVQ 404
FN + + + S N I S +I S + LS N I
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
Query: 405 LEMLSSLNKLILNLNQLS-------GGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI--GN 455
S ++ +IL+ N ++ + + L +DL NKL+S +
Sbjct: 693 FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATT 751
Query: 456 LLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNI------LQEEIPPQVCNMGSLEK 509
L L +++S N S PT+ L + H + + P + SL +
Sbjct: 752 LPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQ 810
Query: 510 LNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL-HGPIP 546
L + N++ + L +DI+ N +
Sbjct: 811 LQIGSNDIRKVDE---KLTPQLYILDIADNPNISIDVT 845
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 6e-79
Identities = 86/512 (16%), Positives = 163/512 (31%), Gaps = 45/512 (8%)
Query: 62 STLGLNGTFHDFSFSSFPHLANLNLS--FNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLI 119
+ G N ++ + ++ H N N + +++ + + N ++ L L G +
Sbjct: 280 ALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339
Query: 120 PPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPS-SLGNLSNLA 178
P IG+L +L+ L + + + D + + L L
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399
Query: 179 VLYLYKNSLS-----GSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNN 233
+ L +++++ I Q+ N+ + I ++ L+ L ++ N+
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANS 458
Query: 234 SLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGY 293
+ + + + S NL L + LYN +P+ +
Sbjct: 459 PFTYDNIAVDWEDANSDY-----AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
Query: 294 LKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCG-E 352
L L L + N + L + P + + NN
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLA---------DDEDTGPKIQIFYMGYNNLEEFP 564
Query: 353 ISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQL-EMLSSL 411
S + KL N + G + KL L L N I IP +
Sbjct: 565 ASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQV 621
Query: 412 NKLILNLNQLSGGVP--LEFGSLTKLQYLDLSTNKLSS-----SIPKSIGNLLKLHYLNL 464
L + N+L +P S+ + +D S NK+ S S + + L
Sbjct: 622 EGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 465 SNNQLSHKIPTEFEKLIHLSELDLSHNILQE-------EIPPQVCNMGSLEKLNLSHNNL 517
S N++ F +S + LS+N++ N L ++L N L
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 518 SDFIPR-CFEEMRSLSCIDISYNELHGPIPNS 548
+ + LS +D+SYN P
Sbjct: 741 TSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 8e-78
Identities = 76/498 (15%), Positives = 157/498 (31%), Gaps = 59/498 (11%)
Query: 66 LNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL------I 119
+ + L +L + N ++ + K + L Q+ L I
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFI 440
Query: 120 PPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAV 179
I +L +L+ +Y + + + + + + S NL +L
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN-----SDYAKQYENEELSWSNLKDLTD 495
Query: 180 LYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSG---------SIPLSLGNLSSLTMMSL 230
+ LY +P + L L L+++ N+ + + + +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555
Query: 231 FNNSLSGSIPPI-LGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPE 289
N+L L + L L N++ + G L L L N + +PE
Sbjct: 556 GYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE-IPE 612
Query: 290 EIGY-LKSLSELELCTNLLRGVIP-------HSIERVLLNQNNLSGKMYEAFGDHP---- 337
+ + L N L+ + + + V + N + +
Sbjct: 613 DFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 338 -NLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNIS-------GSIPPDIGNSPKLQV 389
N + + LS N + + S +ST I+S N ++ + N+ L
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 390 LDLSSNHIVGKIPVQLEM--LSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDL------S 441
+DL N + + L L+ + ++ N S P + + ++L+ +
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAE 790
Query: 442 TNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV 501
N++ P I L L + +N + + + L LD++ N V
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSV 847
Query: 502 CNMGSLEKLNLSHNNLSD 519
C L ++ D
Sbjct: 848 CPYIEAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 5e-65
Identities = 78/433 (18%), Positives = 141/433 (32%), Gaps = 46/433 (10%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+ + N + + N L NL L ++L + +P + L +L+ L
Sbjct: 462 YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521
Query: 134 LDMNQLHG---------TIPPEIGQLSLIDKLALCHNNLHGSIPS-SLGNLSNLAVLYLY 183
+ N+ + + I + +NNL S SL + L +L
Sbjct: 522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581
Query: 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLG-NLSSLTMMSLFNNSLSGSIPPI 242
N + + + G L L L NQ IP + + +N L IP I
Sbjct: 582 HNKVR-HLEAF-GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637
Query: 243 --LGNLKSLSALGLHINQL-----NGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLK 295
++ + ++ N++ N + + L N + F E
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 296 SLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI-- 353
+S + L NL+ + N + + LT +DL N +
Sbjct: 698 PISTIILSNNLMTSIPE-----------NSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSD 745
Query: 354 SFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDL------SSNHIVGKIPVQLEM 407
F LS VS N S S P NS +L+ + N I+ + P +
Sbjct: 746 DFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT 804
Query: 408 LSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNN 467
SL +L + N + V + +L LD++ N S S+ ++ L +
Sbjct: 805 CPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
Query: 468 QLSHKIPTEFEKL 480
+ + +
Sbjct: 862 KTQDIRGCDALGI 874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-58
Identities = 75/411 (18%), Positives = 133/411 (32%), Gaps = 55/411 (13%)
Query: 160 HNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSL 219
+ L N + L L G +P IG+L L L + + S L
Sbjct: 308 LDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367
Query: 220 GNLSSLTMMSLFNNSLSGSIPP----ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRV 275
+ M + + L L IN+ P + SL+
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427
Query: 276 LYL--YNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVL-LNQNNLSGKMYEA 332
+ N + F+ + I L L + + + +
Sbjct: 428 TQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS 486
Query: 333 FGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDL 392
+ + +LT ++L N +P + + P+LQ L++
Sbjct: 487 WSNLKDLTDVELYNCP------------------------NMTQLPDFLYDLPELQSLNI 522
Query: 393 SSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSS-SIPK 451
+ N S +L + +L + + K+Q + N L
Sbjct: 523 ACNR-----------GISAAQLKADWTRL----ADDEDTGPKIQIFYMGYNNLEEFPASA 567
Query: 452 SIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVC-NMGSLEKL 510
S+ ++KL L+ +N++ H F + L++L L +N + EEIP C +E L
Sbjct: 568 SLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGL 624
Query: 511 NLSHNNLSDFIPRCFE--EMRSLSCIDISYNELHGPIPNSTAFKDGLMEGN 559
SHN L IP F + + +D SYN++ N + D N
Sbjct: 625 GFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-46
Identities = 57/377 (15%), Positives = 115/377 (30%), Gaps = 36/377 (9%)
Query: 185 NSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPI-L 243
+ I LD ++ + + + + + G P + L
Sbjct: 262 KETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELD--MWGDQPGVDL 319
Query: 244 GNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELC 303
N ++ L L G +P +IG L+ L+VL + + E
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 304 TNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKL 363
+ +R N +L ++ N I + K
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLS------------DLLQDAINRNPEMKPIKKDSRISLKD 427
Query: 364 STFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSG 423
+ N I+ I I KLQ++ +++ + +
Sbjct: 428 TQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYE 481
Query: 424 GVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH---------KIP 474
L + +L L ++L + +P + +L +L LN++ N+ ++
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541
Query: 475 TEFEKLIHLSELDLSHNILQEEIPPQV--CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLS 532
+ + + + +N L EE P M L L+ HN + F L+
Sbjct: 542 DDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLT 598
Query: 533 CIDISYNELHGPIPNST 549
+ + YN++ IP
Sbjct: 599 DLKLDYNQIEE-IPEDF 614
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 8/101 (7%), Positives = 32/101 (31%)
Query: 485 ELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGP 544
+ ++ ++ + N G + L+L+ +P ++ L + +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 545 IPNSTAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNF 585
+ + R+ + ++ + L++ +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 2e-78
Identities = 99/488 (20%), Positives = 169/488 (34%), Gaps = 33/488 (6%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+FS +L L+L+ + + +L L L +N L + + L+ L+
Sbjct: 52 TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
+ + ++ L L N++ L VL N++
Sbjct: 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171
Query: 194 IIGKLKSL--LQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGN--LKSL 249
+ L+ L L+L+ N + I + + ++ I L N ++SL
Sbjct: 172 DMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
Query: 250 SALGLHINQLNGFIPPSIGNLS--SLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLL 307
P L S+ + L + + L EL+
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD------ 284
Query: 308 RGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFI 367
L +LS ++ L L LS N F + NF L+
Sbjct: 285 ------------LTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331
Query: 368 VSMNNISGSIPPD-IGNSPKLQVLDLSSNHI--VGKIPVQLEMLSSLNKLILNLNQLSGG 424
+ N + + N L+ LDLS + I +QL LS L L L+ N+
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 425 VPLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTEFEKLIHL 483
F +L+ LDL+ +L +S NL L LNLS++ L F+ L L
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451
Query: 484 SELDLSHNILQEEI---PPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNE 540
L+L N + + +G LE L LS +LS F ++ ++ +D+S+N
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511
Query: 541 LHGPIPNS 548
L +
Sbjct: 512 LTSSSIEA 519
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 6e-78
Identities = 96/483 (19%), Positives = 178/483 (36%), Gaps = 22/483 (4%)
Query: 84 LNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTI 143
N NL IP + + + L+ N L + +L L L L Q++
Sbjct: 17 YNCE-NLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 144 PPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQ 203
+D L L N L ++L L L+ + +S + K+L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 204 LDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN-GF 262
L L N S L ++ NN++ + +L+ + L L++N +
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 263 IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGY--LKSLSELELCTNLLRGVIPH------- 313
I P + + + L + + + ++SL + P
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 314 -SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNN 372
S+E + L ++ F L LDL+ + E+ S L ++S N
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANK 312
Query: 373 ISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQ-LEMLSSLNKLILNLNQL--SGGVPLEF 429
N P L L + N ++ LE L +L +L L+ + + S L+
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 430 GSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIP-TEFEKLIHLSELDL 488
+L+ LQ L+LS N+ S ++ +L L+L+ +L K + F+ L L L+L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 489 SHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRC---FEEMRSLSCIDISYNELHGPI 545
SH++L + +L+ LNL N+ + + + L + +S+ +L
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 546 PNS 548
++
Sbjct: 493 QHA 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 8e-75
Identities = 90/465 (19%), Positives = 157/465 (33%), Gaps = 19/465 (4%)
Query: 106 QYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG 165
+ + + L+ IP + N L N L +L + L L ++
Sbjct: 15 KTYNCENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 166 SIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSL 225
+ + L L L N L + + K+L L + S + L N +L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 226 TMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLY- 284
+ L +N +S P + L L N ++ + +L L L NG
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 285 GFVPEEIGYLKSLSELELCTNLLRGVIP--------HSIERVLLNQNNLSGKMYEAFGD- 335
+ L VI S+ + F
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 336 -HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSS 394
++ ++L + F S + FS L ++ ++S +P + L+ L LS+
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 395 NHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLE-FGSLTKLQYLDLSTNKLSSS--IPK 451
N + SL L + N + +L L+ LDLS + + +S
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 452 SIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV-CNMGSLEKL 510
+ NL L LNLS N+ F++ L LDL+ L+ + N+ L+ L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 511 NLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGL 555
NLSH+ L + F+ + +L +++ N T L
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-72
Identities = 90/458 (19%), Positives = 163/458 (35%), Gaps = 28/458 (6%)
Query: 71 HDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLR 130
+ L +L L N + KL+ LD +N + L ++ L Q
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180
Query: 131 RLYLDMNQLH-GTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGN--LSNLAVLYLYKNSL 187
L L++N I P ++ L I L N + +L +
Sbjct: 181 NLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 188 SGSIPSIIGKLK--SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGN 245
P++ L S+ ++L ++ F + S L + L LS +P L
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG 299
Query: 246 LKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEE-IGYLKSLSELELCT 304
L +L L L N+ S N SL L + N + + L++L EL+L
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359
Query: 305 NLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS 364
+ + + + +L L+LS N + + +L
Sbjct: 360 DDIETSDCCN----------------LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403
Query: 365 TFIVSMNNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSG 423
++ + N L+VL+LS + + + L +L L L N
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 424 GVPLE---FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKL 480
G + +L +L+ L LS LSS + +L +++++LS+N+L+ L
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523
Query: 481 IHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS 518
+ L+L+ N + +P + + +NL N L
Sbjct: 524 KGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-63
Identities = 87/414 (21%), Positives = 149/414 (35%), Gaps = 19/414 (4%)
Query: 151 SLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQ 210
++K C N IP +L ++ L N L + +L +L LDL+ Q
Sbjct: 11 KEVNKTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQ 68
Query: 211 FSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNL 270
+ + L + L N L L K+L L ++ + N
Sbjct: 69 IYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQ 128
Query: 271 SSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIE--------RVLLNQ 322
+L LYL +N + + + L L+ N + + + + LN
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 323 NNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI--SFNWGNFSKLSTFIVSMNNISGSIPPD 380
N+++G AF D L+ I L + P
Sbjct: 189 NDIAGIEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 381 IGNSPK--LQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYL 438
+ ++ ++L ++ S L +L L LS +P L+ L+ L
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306
Query: 439 DLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSHNILQ--E 495
LS NK + S N L +L++ N ++ T E L +L ELDLSH+ ++ +
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366
Query: 496 EIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNST 549
Q+ N+ L+ LNLS+N F+E L +D+++ L S
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-52
Identities = 85/431 (19%), Positives = 138/431 (32%), Gaps = 55/431 (12%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSK--LQYLDLGSNQLSGLIPPEIGKL 126
F S+ L P L + ++ ++L + +
Sbjct: 218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF 277
Query: 127 NQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNS 186
+ L+ L L L +P + LS + KL L N S N +L L + N+
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336
Query: 187 LSGSIPS-IIGKLKSLLQLDLSENQ--FSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPIL 243
+ + + L++L +LDLS + S L L NLS L ++L N
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 244 GNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELEL 302
L L L +L S NL L+VL L ++ L + L +L L L
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456
Query: 303 CTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSK 362
N + L L LS
Sbjct: 457 QGNHFPKGNIQKT---------------NSLQTLGRLEILVLSF---------------- 485
Query: 363 LSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNL--NQ 420
++S + + +DLS N + +E LS L + LNL N
Sbjct: 486 --------CDLSSIDQHAFTSLKMMNHVDLSHNRLTS---SSIEALSHLKGIYLNLASNH 534
Query: 421 LSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKL 480
+S +P L++ + ++L N L + N+ L + + +L T E
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDC----TCSNIYFLEWYKENMQKLEDTEDTLCENP 590
Query: 481 IHLSELDLSHN 491
L + LS
Sbjct: 591 PLLRGVRLSDV 601
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-37
Identities = 65/290 (22%), Positives = 107/290 (36%), Gaps = 10/290 (3%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQ-IGNLSKLQYLDLGSNQL--SGLIPPEIGK 125
S S+FP L +L++ N + + NL L+ LDL + + S ++
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
Query: 126 LNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIP-SSLGNLSNLAVLYLYK 184
L+ L+ L L N+ + ++ L L L S NL L VL L
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434
Query: 185 NSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPL---SLGNLSSLTMMSLFNNSLSGSIPP 241
+ L S + L +L L+L N F SL L L ++ L LS
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
Query: 242 ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELE 301
+LK ++ + L N+L ++ +L + L L +N + +P + L +
Sbjct: 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTIN 553
Query: 302 LCTNLLRGVIPHS--IERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF 349
L N L + +E N L + P L + LS+
Sbjct: 554 LRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-29
Identities = 39/219 (17%), Positives = 80/219 (36%), Gaps = 8/219 (3%)
Query: 371 NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFG 430
++ IP + NS + L+ S N + L +L L L Q+ F
Sbjct: 22 LGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQ 78
Query: 431 SLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSH 490
S +L L L+ N L ++ L +L +S L L L
Sbjct: 79 SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGS 138
Query: 491 NILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCI--DISYNELHGPIP-- 546
N + P+ L+ L+ +N + ++ + + +++ N++ G P
Sbjct: 139 NHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGA 198
Query: 547 -NSTAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLN 584
+S F+ G + L + + +++++ L L + +
Sbjct: 199 FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-19
Identities = 36/155 (23%), Positives = 58/155 (37%), Gaps = 4/155 (2%)
Query: 66 LNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLI---PPE 122
L F + L LNLS +L + L LQ+L+L N
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 123 IGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182
+ L +L L L L L +++ + L HN L S +L +L + L L
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530
Query: 183 YKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPL 217
N +S +PS++ L ++L +N +
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-77
Identities = 85/252 (33%), Positives = 124/252 (49%), Gaps = 18/252 (7%)
Query: 592 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVL 651
E+ A+D+F K +G+GG G VYK L G +VAVK+ + G +F EV
Sbjct: 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL---QFQTEVE 79
Query: 652 ALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL-GDDVTAKELGWNRRINVIKG 710
+ HRN ++ GFC LV Y+ GS+A L + L W +R + G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP---HSSNWTEFAG 767
A L+YLH C P IIHRD+ + N+LLD FEA V DFG+AK + H + T G
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRG 197
Query: 768 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII------- 820
T G+ APE T +++EK DV+ +GV++ E+I G D + ++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 821 --DVNKILDPRL 830
+ ++D L
Sbjct: 258 EKKLEALVDVDL 269
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 3e-75
Identities = 108/518 (20%), Positives = 187/518 (36%), Gaps = 28/518 (5%)
Query: 71 HDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLR 130
D ++ HL+NL L+ N P L+ L+ L +L+ L IG+L L+
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 131 RLYLDMNQLHG-TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLA----VLYLYKN 185
+L + N +H +P L+ + + L +N + + L L L + N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 186 SLSGSIPSIIGKLKSLLQLDLSENQFSGSIP-LSLGNLSSLTMMSLFNNSLSGSI----- 239
+ I + L +L L N S +I L NL+ L + L
Sbjct: 192 PID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250
Query: 240 -PPILGNLKSLSALGLHINQLNGF--IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKS 296
P I+ L ++ + N F L+++ + L + E++
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFK 308
Query: 297 LSELELCTNLLRGVIP---HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNN--NFCG 351
L + L+ ++ + L N S P+L++LDLS N +F G
Sbjct: 309 WQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSI--SFKKVALPSLSYLDLSRNALSFSG 366
Query: 352 EISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQ-LEMLSS 410
S++ + L +S N + + +LQ LD + + L
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 411 LNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQL 469
L L ++ F LT L L ++ N + ++ N L +L+LS QL
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485
Query: 470 SHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMR 529
F+ L L L++SHN L + SL L+ S N + +
Sbjct: 486 EQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
Query: 530 SLSCIDISYNELHGPIPNSTAFKDGLMEGNKGLKRVSQ 567
SL+ +++ N + I F + E + L V Q
Sbjct: 546 SLAFFNLTNNSVAC-ICEHQKFLQWVKEQKQFLVNVEQ 582
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 4e-69
Identities = 111/493 (22%), Positives = 168/493 (34%), Gaps = 45/493 (9%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
SFS+F L L+LS L L L L N + P L L L
Sbjct: 51 SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG-SIPSSLGNLSNLAVLYLYKNSLSGSIP 192
+L IGQL + KL + HN +H +P+ NL+NL + L N +
Sbjct: 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170
Query: 193 SIIGKLK----SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLK 247
+ + L+ L LD+S N I L ++L N S +I L NL
Sbjct: 171 NDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLA 229
Query: 248 SLSALGL------HINQLNGFIPPSIGNLSSLRVLYLYNNGLYGF--VPEEIGYLKSLSE 299
L L L F P + L + + F + L ++S
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289
Query: 300 LELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGN 359
+ L ++ H L + F +
Sbjct: 290 MS------------------LAGVSIKYLEDVPK--HFKWQSLSIIRCQLK---QFPTLD 326
Query: 360 FSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI--VGKIPVQLEMLSSLNKLILN 417
L + ++MN SI P L LDLS N + G +SL L L+
Sbjct: 327 LPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 418 LNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKS-IGNLLKLHYLNLSNNQLSHKIPTE 476
N + F L +LQ+LD + L S +L KL YL++S
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 477 FEKLIHLSELDLSHNILQEEIPPQV-CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCID 535
F L L+ L ++ N ++ V N +L L+LS L F+ + L ++
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503
Query: 536 ISYNELHGPIPNS 548
+S+N L +
Sbjct: 504 MSHNNLLFLDSSH 516
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 1e-67
Identities = 94/458 (20%), Positives = 165/458 (36%), Gaps = 32/458 (6%)
Query: 103 SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNN 162
S + +DL N L L ++L+ L L ++ L + L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 163 LHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSG-SIPLSLGN 221
+ P S L++L L + L+ IG+L +L +L+++ N +P N
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 222 LSSLTMMSLFNNSLSGSIPPILGNLKSLSA----LGLHINQLNGFIPPSIGNLSSLRVLY 277
L++L + L N + L L+ L + +N ++ FI L L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210
Query: 278 LYNNGLYGFVPEEIGY-LKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDH 336
L N + + L L L + ++ NL
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK------------DERNLEIFEPSIMEGL 258
Query: 337 PNLTF--LDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSS 394
++T L+ N + + + +S ++ +I D+ K Q L +
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIR 316
Query: 395 NHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIG 454
+ + L L L L +N+ S + + +L L YLDLS N LS S S
Sbjct: 317 CQLKQFPTLD---LPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYS 371
Query: 455 NL--LKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV-CNMGSLEKLN 511
+L L +L+LS N + F L L LD H+ L+ ++ L L+
Sbjct: 372 DLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLD 430
Query: 512 LSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNST 549
+S+ N F + SL+ + ++ N ++
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 7e-66
Identities = 100/472 (21%), Positives = 161/472 (34%), Gaps = 29/472 (6%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL-IPPEIGKLN 127
+F SFS L NL IG L L+ L++ N + +P L
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 128 QLRRLYLDMNQLHGTIPPEIGQLS----LIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183
L + L N + ++ L + L + N + I L L L
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLR 212
Query: 184 KNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPLSLGNLS--------SLTMMSLFNNS 234
N S +I + L L L +F L + S ++ L +
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 235 LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYL 294
L ++SA+ L + + + L + L F + L
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQFPTLD---L 327
Query: 295 KSLSELELCTNLLRGVIP----HSIERVLLNQNNLSGKMYEAFGD--HPNLTFLDLSNNN 348
L L L N S+ + L++N LS ++ D +L LDLS N
Sbjct: 328 PFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387
Query: 349 FCGEISFNWGNFSKLSTFIVSMNNISGSIPPD-IGNSPKLQVLDLSSNHIVGKIPVQLEM 407
+S N+ +L + + + KL LD+S +
Sbjct: 388 AI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG 446
Query: 408 LSSLNKLILNLNQLSGGVPLE-FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSN 466
L+SLN L + N F + T L +LDLS +L L +L LN+S+
Sbjct: 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506
Query: 467 NQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS 518
N L + + +L LS LD S N ++ SL NL++N+++
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 62/304 (20%), Positives = 103/304 (33%), Gaps = 35/304 (11%)
Query: 261 GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLL 320
G + P I + ++ + L VP++ IP S + + L
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLSK-VPDD--------------------IPSSTKNIDL 39
Query: 321 NQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPD 380
+ N L +F + L +LDLS W LS I++ N I P
Sbjct: 40 SFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGS 99
Query: 381 IGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSG-GVPLEFGSLTKLQYLD 439
L+ L + + L +L KL + N + +P F +LT L ++D
Sbjct: 100 FSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVD 159
Query: 440 LSTNKLSSSIPKSIGNLLKLH----YLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495
LS N + + + L + L++S N + I + + I L EL L N
Sbjct: 160 LSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSS 218
Query: 496 EIPPQVC-NMGSLEKLNLSHN------NLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548
I N+ L L NL F P E + ++ + + +
Sbjct: 219 NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278
Query: 549 TAFK 552
F
Sbjct: 279 VKFH 282
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 7e-70
Identities = 93/257 (36%), Positives = 126/257 (49%), Gaps = 33/257 (12%)
Query: 592 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVL 651
++ +AT++FD KF IG G G VYK L G VA+K+ + G +EF E+
Sbjct: 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG----IEEFETEIE 87
Query: 652 ALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL-GDDVTAKELGWNRRINVIKG 710
L RH + V GFC L+ +Y++ G+L R L G D+ + W +R+ + G
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP-----HSSNWTEF 765
A L YLH IIHRD+ S N+LLD NF ++DFGI+K G H S T
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLS--TVV 201
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII----- 820
GT GY PE R TEK DVYSFGV++FEV+ I S M+
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA-----IVQSLPREMVNLAEWA 256
Query: 821 -------DVNKILDPRL 830
+ +I+DP L
Sbjct: 257 VESHNNGQLEQIVDPNL 273
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 9e-66
Identities = 101/479 (21%), Positives = 183/479 (38%), Gaps = 40/479 (8%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
F+ ++ L + +L ++ L + + + LN L ++
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQI 73
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
NQL P + L+ + + + +N + P L NL+NL L L+ N ++ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSAL 252
+ L +L +L+LS N S LS L+SL +S N ++ P L NL +L L
Sbjct: 130 --LKNLTNLNRLELSSNTISDISALS--GLTSLQQLSF-GNQVTDLKP--LANLTTLERL 182
Query: 253 GLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP 312
+ N+++ + L++L L NN + +G L +L EL L N L+ +
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDI--TPLGILTNLDELSLNGNQLKDIGT 238
Query: 313 ----HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIV 368
++ + L N +S LT L L N + L+ +
Sbjct: 239 LASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPL--AGLTALTNLEL 294
Query: 369 SMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLE 428
+ N + P I N L L L N+I P + L+ L +L N++S
Sbjct: 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSS 348
Query: 429 FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDL 488
+LT + +L N++S P + NL ++ L L++ ++ +S +
Sbjct: 349 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN---VSIPNT 403
Query: 489 SHNILQEEIPP-QVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIP 546
N+ I P + + GS + +++ N S + I G +
Sbjct: 404 VKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-63
Identities = 101/468 (21%), Positives = 177/468 (37%), Gaps = 52/468 (11%)
Query: 81 LANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLH 140
L + ++ + I L++ LG ++ + L+Q+ L D +
Sbjct: 3 LGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58
Query: 141 GTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKS 200
+ L+ + ++ +N L P L NL+ L + + N ++ P + L +
Sbjct: 59 -KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113
Query: 201 LLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN 260
L L L NQ + PL NL++L + L +N++S L L SL L +
Sbjct: 114 LTGLTLFNNQITDIDPL--KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD 169
Query: 261 GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLL 320
+ NL++L L + +N + + L +L L N + + P
Sbjct: 170 ---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP-------- 216
Query: 321 NQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPD 380
G NL L L+ N + + + L+ ++ N IS P
Sbjct: 217 ------------LGILTNLDELSLNGNQLKDIGTL--ASLTNLTDLDLANNQISNLAP-- 260
Query: 381 IGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDL 440
+ KL L L +N I P L L++L L LN NQL +L L YL L
Sbjct: 261 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTL 316
Query: 441 STNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQ 500
N +S P + +L KL L NN++S + L +++ L HN + + P
Sbjct: 317 YFNNISDISP--VSSLTKLQRLFFYNNKVS--DVSSLANLTNINWLSAGHNQISDLTP-- 370
Query: 501 VCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548
+ N+ + +L L+ ++ + + + L P S
Sbjct: 371 LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-58
Identities = 103/459 (22%), Positives = 179/459 (38%), Gaps = 36/459 (7%)
Query: 64 LGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEI 123
LG S + + L + L+ L ++ +NQL+ + P +
Sbjct: 31 LGKTNVTDTVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--L 86
Query: 124 GKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183
L +L + ++ NQ+ + L+ + L L +N + P L NL+NL L L
Sbjct: 87 KNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELS 142
Query: 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPIL 243
N++S S + L SL QL NQ + PL NL++L + + +N +S +L
Sbjct: 143 SNTISD--ISALSGLTSLQQLSFG-NQVTDLKPL--ANLTTLERLDISSNKVSD--ISVL 195
Query: 244 GNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELC 303
L +L +L NQ++ P +G L++L L L N L + L +L++L+L
Sbjct: 196 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 251
Query: 304 TNLLRGVIP----HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGN 359
N + + P + + L N +S LT L+L+ N N
Sbjct: 252 NNQISNLAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISPI--SN 307
Query: 360 FSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLN 419
L+ + NNIS P + + KLQ L +N + L L+++N L N
Sbjct: 308 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHN 363
Query: 420 QLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEK 479
Q+S PL +LT++ L L+ +++ N+ + + L P
Sbjct: 364 QISDLTPL--ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISD 419
Query: 480 LIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS 518
+E D++ N+ + S
Sbjct: 420 GGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFS 457
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 26/146 (17%), Positives = 52/146 (35%), Gaps = 7/146 (4%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
SS L L N + + NL+ + +L G NQ+S L P + L ++ +L
Sbjct: 326 PVSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
L+ +S+ + + L P+++ + + + N S
Sbjct: 382 LNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNE 438
Query: 194 IIGKLKSLLQLDLSENQFSGSIPLSL 219
+ + + FSG++ L
Sbjct: 439 VSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-65
Identities = 76/224 (33%), Positives = 110/224 (49%), Gaps = 13/224 (5%)
Query: 592 EEIIKATDDFDEKFC------IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDE 645
E+ T++FDE+ +G+GG G VYK + VAVKK + + +
Sbjct: 18 YELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQ 76
Query: 646 FLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
F E+ + + +H N V+ GF +G LV Y+ GSL L L W+ R
Sbjct: 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF--VGPHSSNWT 763
+ +G AN +++LH + IHRDI S N+LLD F A +SDFG+A+ + +
Sbjct: 137 KIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193
Query: 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807
GT Y APE A T K D+YSFGV++ E+I G D
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-62
Identities = 107/490 (21%), Positives = 173/490 (35%), Gaps = 34/490 (6%)
Query: 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMN 137
NL+LSFN + +LQ LDL ++ + L+ L L L N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 138 QLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSL-SGSIPSIIG 196
+ LS + KL NL +G+L L L + N + S +P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 197 KLKSLLQLDLSENQFSGSIPLSLGNLSSLTMM----SLFNNSLSGSIPPILGNLKSLSAL 252
L +L LDLS N+ L L + ++ L N ++ I P L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKL 205
Query: 253 GLHINQLNGFIPP-SIGNLSSLRVLYLYNNGLYG---FVPEEIGYLKSLSELELCTNLLR 308
L N + + I L+ L V L + L+ L L + L
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 309 GV------------IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFN 356
+ ++ L + ++ + L+L N F F
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFG---QFP 320
Query: 357 WGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI--VGKIPVQLEMLSSLNKL 414
L + N + ++ P L+ LDLS N + G +SL L
Sbjct: 321 TLKLKSLKRLTFTSNKGG-NAFSEVDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 415 ILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKI 473
L+ N + + F L +L++LD + L S+ +L L YL++S+
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 474 PTEFEKLIHLSELDLSHNILQEEIPPQV-CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLS 532
F L L L ++ N QE P + + +L L+LS L P F + SL
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 533 CIDISYNELH 542
++++ N+L
Sbjct: 498 VLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-61
Identities = 101/471 (21%), Positives = 176/471 (37%), Gaps = 26/471 (5%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQ 128
T D ++ S HL+ L L+ N LS LQ L L+ L IG L
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 129 LRRLYLDMNQL-HGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNL----AVLYLY 183
L+ L + N + +P L+ ++ L L N + + L L + L L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIP-LSLGNLSSLTMMSLF------NNSLS 236
N ++ I K L +L L N S ++ + L+ L + L +L
Sbjct: 186 LNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 237 GSIPPILGNLKSLSALGLHINQLNGF---IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGY 293
L L +L+ + L+ + I L+++ L + + +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 294 -LKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNN--NFC 350
+ L + + S++R+ N + D P+L FLDLS N +F
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFK 362
Query: 351 GEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPV-QLEMLS 409
G S + + L +S N + ++ + +L+ LD +++ L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 410 SLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQ 468
+L L ++ F L+ L+ L ++ N + I L L +L+LS Q
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 469 LSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV-CNMGSLEKLNLSHNNLS 518
L PT F L L L+++ N L+ +P + + SL+K+ L N
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 6e-37
Identities = 73/395 (18%), Positives = 123/395 (31%), Gaps = 45/395 (11%)
Query: 173 NLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFN 232
+ N+ + + IP + S LDLS N S + L ++ L
Sbjct: 6 VVPNITY-QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 233 NSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIG 292
+ +L LS L L N + + LSSL+ L L IG
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 293 YLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGE 352
+LK+L EL + NL++ E F + NL LDLS+N
Sbjct: 122 HLKTLKELNVAHNLIQSFKLP-----------------EYFSNLTNLEHLDLSSNKIQSI 164
Query: 353 ISFNWGNFSKLSTFIV----SMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIP------ 402
+ ++ + S+N ++ I P +L L L +N +
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 223
Query: 403 -VQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKL---SSSIPKSIGNLLK 458
LE+ + N L L L + L I L
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 459 LHYLNLSNNQLSHKIPTEFE-KLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNL 517
+ +L + + + HL ++ + SL++L + N
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKG 337
Query: 518 SDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFK 552
+ ++ SL +D+S N L S +
Sbjct: 338 GNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 65/289 (22%), Positives = 111/289 (38%), Gaps = 19/289 (6%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
+P S + + L+ N L +F P L LDLS + + S LST I++
Sbjct: 26 LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85
Query: 371 NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQL-SGGVPLEF 429
N I LQ L ++ + L +L +L + N + S +P F
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 430 GSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHY----LNLSNNQLSHKIPTEFEKLIHLSE 485
+LT L++LDLS+NK+ S + L ++ L+LS N ++ I K I L +
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHK 204
Query: 486 LDLSHNILQEEIPPQVC-NMGSLEKLNL------SHNNLSDFIPRCFEEMRSLSCIDISY 538
L L +N + + LE L + NL F E + +L+ +
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 539 NELHGPIPNSTAFKDGLME------GNKGLKRVSQEEQSNSMNRLRLLS 581
L + + + L + ++RV + L L++
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVN 313
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 55/202 (27%), Positives = 83/202 (41%), Gaps = 5/202 (2%)
Query: 63 TLGLNGTFHDFSFSSFPHLANLNLSFNL--FFGNIPLQIGNLSKLQYLDLGSNQLSGLIP 120
T N + FS P L L+LS N F G + L+YLDL N + +
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MS 389
Query: 121 PEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSLGNLSNLAV 179
L QL L + L + L + L + H + + LS+L V
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449
Query: 180 LYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGS 238
L + NS + I +L++L LDLS+ Q P + +LSSL ++++ +N L
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV 509
Query: 239 IPPILGNLKSLSALGLHINQLN 260
I L SL + LH N +
Sbjct: 510 PDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-22
Identities = 41/178 (23%), Positives = 62/178 (34%), Gaps = 5/178 (2%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEI-GKLN 127
S L L+LSFN + L +L++LD + L + + L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 128 QLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKN 185
L L + I LS ++ L + N+ + L NL L L +
Sbjct: 422 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 186 SLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPIL 243
L P+ L SL L+++ NQ L+SL + L N S P I
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-57
Identities = 86/415 (20%), Positives = 156/415 (37%), Gaps = 69/415 (16%)
Query: 81 LANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLH 140
A L P +L++ L ++ ++ +L + +L + ++
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 141 GTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKS 200
I L+ ++ L L N + P L NL L LY+ N ++ S + L +
Sbjct: 57 -ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 201 LLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN 260
L +L L+E+ S PL NL+ + ++L N + P L N+ L+ L + +++
Sbjct: 112 LRELYLNEDNISDISPL--ANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVK 168
Query: 261 GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLL 320
P I NL+ L L L N + + L SL N + + P
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITP-------- 216
Query: 321 NQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPD 380
+ L L + NN I+ P
Sbjct: 217 ------------VANMTRLNSLKIGNNK------------------------ITDLSP-- 238
Query: 381 IGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDL 440
+ N +L L++ +N I I ++ L+ L L + NQ+S +L++L L L
Sbjct: 239 LANLSQLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 441 STNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495
+ N+L + + IG L L L LS N ++ P L + D ++ ++++
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 4e-57
Identities = 80/369 (21%), Positives = 159/369 (43%), Gaps = 31/369 (8%)
Query: 155 KLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGS 214
LA ++ P +L+ L K S++ + +L+S+ +L ++ + + S
Sbjct: 4 TLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-S 58
Query: 215 IPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLR 274
I + L++L ++L N ++ P L NL L+ L + N++ ++ NL++LR
Sbjct: 59 IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLR 113
Query: 275 VLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH-----SIERVLLNQNNLSGKM 329
LYL + + + L + L L N + + + + ++ +
Sbjct: 114 ELYLNEDNISDI--SPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD-- 169
Query: 330 YEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQV 389
+ +L L L+ N + + L F +N I+ P + N +L
Sbjct: 170 VTPIANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITP--VANMTRLNS 225
Query: 390 LDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSI 449
L + +N I P L LS L L + NQ+S LTKL+ L++ +N++S
Sbjct: 226 LKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-- 279
Query: 450 PKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEK 509
+ NL +L+ L L+NNQL ++ L +L+ L LS N + + P + ++ ++
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337
Query: 510 LNLSHNNLS 518
+ ++ +
Sbjct: 338 ADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 4e-56
Identities = 87/398 (21%), Positives = 152/398 (38%), Gaps = 67/398 (16%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
F + L + L + L + +++ + I L L L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAGEKVASI--QGIEYLTNLEYL 71
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
L+ NQ+ P + L + L + N + + S+L NL+NL LYL ++++S P
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP 127
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSAL 252
+ L + L+L N + L N++ L +++ + + P + NL L +L
Sbjct: 128 --LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 253 GLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP 312
L+ NQ+ P + +L+SL Y N + + + L+ L++ N + + P
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPVANMTRLNSLKIGNNKITDLSP 238
Query: 313 HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNN 372
+ LT+L++ N
Sbjct: 239 --------------------LANLSQLTWLEIGTNQI----------------------- 255
Query: 373 ISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSL 432
S + + KL++L++ SN I I V L LS LN L LN NQL G L
Sbjct: 256 ---SDINAVKDLTKLKMLNVGSNQI-SDISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGL 310
Query: 433 TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLS 470
T L L LS N ++ P + +L K+ + +N +
Sbjct: 311 TNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-51
Identities = 80/370 (21%), Positives = 148/370 (40%), Gaps = 43/370 (11%)
Query: 177 LAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLS 236
A L ++ P L ++ L + + + L S+T + + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57
Query: 237 GSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKS 296
SI I L +L L L+ NQ+ P + NL L LY+ N + + L +
Sbjct: 58 -SIQGI-EYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 297 LSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFN 356
L EL L + + + P + + L+L N+ ++S
Sbjct: 112 LRELYLNEDNISDISP--------------------LANLTKMYSLNLGANHNLSDLS-P 150
Query: 357 WGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLIL 416
N + L+ V+ + + P I N L L L+ N I P L L+SL+
Sbjct: 151 LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTA 206
Query: 417 NLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE 476
+NQ++ P+ ++T+L L + NK++ P + NL +L +L + NQ+S
Sbjct: 207 YVNQITDITPV--ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INA 260
Query: 477 FEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDI 536
+ L L L++ N + + + N+ L L L++N L + + +L+ + +
Sbjct: 261 VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318
Query: 537 SYNELHGPIP 546
S N + P
Sbjct: 319 SQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 3e-20
Identities = 32/161 (19%), Positives = 64/161 (39%), Gaps = 12/161 (7%)
Query: 387 LQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLS 446
L I P L+ + +L ++ + L + L ++ K++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 447 SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGS 506
S + I L L YLNL+ NQ++ P L+ L+ L + N + + N+ +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 507 LEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPN 547
L +L L+ +N+SD P + + +++ N +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-56
Identities = 93/472 (19%), Positives = 176/472 (37%), Gaps = 20/472 (4%)
Query: 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQ 138
+ F +IP + + ++ LDL N+++ + ++ L+ L L ++
Sbjct: 5 DASGVCDGRSR-SFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 139 LHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG-SIPSIIG 196
++ TI + L ++ L L N+L S G LS+L L L N + S+
Sbjct: 62 IN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
Query: 197 KLKSLLQLDLSENQFSGSIP-LSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLH 255
L +L L + + I + L+SL + + SL L +++ + L LH
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 256 INQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI 315
+++ + LSS+R L L + L F + + S ++ + S
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 316 ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISG 375
+L + F D D + + + + +
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGV---PLEFGSL 432
+ K++ + + ++ + + L SL L L+ N + G+
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360
Query: 433 TKLQYLDLSTNKLSS--SIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSH 490
LQ L LS N L S + + L L L++S N H +P + + L+LS
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSS 419
Query: 491 NILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELH 542
++ + C +LE L++S+NNL F + L + IS N+L
Sbjct: 420 TGIR-VVKT--CIPQTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKLK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-55
Identities = 98/489 (20%), Positives = 172/489 (35%), Gaps = 43/489 (8%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+ +L L L + +L L++LDL N LS L G L+ L+ L
Sbjct: 45 DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104
Query: 134 LDMNQLHG-TIPPEIGQLSLIDKLALCHNNLHGSIP-SSLGNLSNLAVLYLYKNSLSGSI 191
L N + L+ + L + + I L++L L + SL
Sbjct: 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164
Query: 192 PSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSA 251
+ ++ + L L ++ + + + LSS+ + L + +L+ L + S
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224
Query: 252 LGLHINQLNGF----------IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELE 301
+ + + + I LS + NGL F P E + L ++E
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284
Query: 302 LCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFS 361
+I R+ + Q L + + + + + N+
Sbjct: 285 TV----------TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV---FLVPCSFSQ 331
Query: 362 KLSTFIV---SMNNISGSIPPD---IGNSPKLQVLDLSSNHI--VGKIPVQLEMLSSLNK 413
L + S N + + G P LQ L LS NH+ + K L L +L
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391
Query: 414 LILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKI 473
L ++ N +P K+++L+LS+ + + I L L++SNN L
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNNNLDS-F 446
Query: 474 PTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSC 533
L L EL +S N L+ +P L + +S N L F+ + SL
Sbjct: 447 SLF---LPRLQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQK 501
Query: 534 IDISYNELH 542
I + N
Sbjct: 502 IWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-34
Identities = 56/384 (14%), Positives = 128/384 (33%), Gaps = 27/384 (7%)
Query: 173 NLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFN 232
+ V S + SIPS + ++ LDLS N+ + L ++L ++ L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 233 NSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGF-VPEEI 291
+ ++ +L SL L L N L+ G LSSL+ L L N V
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 292 GYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCG 351
L +L L + I F +L L++ +
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRI-----------------DFAGLTSLNELEIKALSLRN 162
Query: 352 EISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSL 411
S + + + + ++ + + ++ L+L ++ L +
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222
Query: 412 NKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH 471
+ + + S F L KL L +++ + + + ++
Sbjct: 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDV 276
Query: 472 KIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSL 531
+ + + L + L ++ + ++++ + ++ + + ++SL
Sbjct: 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL 336
Query: 532 SCIDISYNELHGPIPNSTAFKDGL 555
+D+S N + ++A K
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAW 360
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 49/298 (16%), Positives = 96/298 (32%), Gaps = 22/298 (7%)
Query: 13 KTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHD 72
K + + L + ++S + + N + + +
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN-------GLGDFNPSESDVVSE 279
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
+ L++ F ++ L K++ + + ++++ + L L L
Sbjct: 280 LGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFL 339
Query: 133 YLDMNQLHGTIPPE---IGQLSLIDKLALCHNNLH--GSIPSSLGNLSNLAVLYLYKNSL 187
L N + G + L L N+L L L NL L + +N+
Sbjct: 340 DLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399
Query: 188 SGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLK 247
+P + + L+LS + +L ++ + NN+L S L L+
Sbjct: 400 H-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNLD-SFSLFLPRLQ 454
Query: 248 SLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTN 305
L + N+L P L V+ + N L L SL ++ L TN
Sbjct: 455 ELY---ISRNKLKTL--PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 30/139 (21%), Positives = 57/139 (41%), Gaps = 20/139 (14%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL---IPPEIGKLN-- 127
+ +L +L++S N F +P K+++L+L S + + IP + L+
Sbjct: 381 EILLTLKNLTSLDISRN-TFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVS 439
Query: 128 ------------QLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLS 175
+L+ LY+ N+L T+P L+ + + N L L+
Sbjct: 440 NNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLL-VMKISRNQLKSVPDGIFDRLT 497
Query: 176 NLAVLYLYKNSLSGSIPSI 194
+L ++L+ N S P I
Sbjct: 498 SLQKIWLHTNPWDCSCPRI 516
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-55
Identities = 75/272 (27%), Positives = 119/272 (43%), Gaps = 44/272 (16%)
Query: 592 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNE-- 649
E + + +G G V+KA+L + VAVK F Q D + NE
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-------DKQSWQNEYE 68
Query: 650 VLALKEIRHRNNVKFHGFCYNGPHS----FLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
V +L ++H N ++F G G +L+ + ++GSL+ L +V + WN
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELC 124
Query: 706 NVIKGVANALSYLHHDCL-------PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758
++ + +A L+YLH D P+I HRDI SKNVLL +N A ++DFG+A
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 759 SSNW--TEFAGTFGYAAPEIA-----YTMRATEKYDVYSFGVLVFEVIKGNHPRDF---- 807
S GT Y APE+ + A + D+Y+ G++++E+ D
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 808 FSINFS-------SFSNMIIDV-NKILDPRLP 831
+ + F S +M V +K P L
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-55
Identities = 76/232 (32%), Positives = 117/232 (50%), Gaps = 8/232 (3%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IG G G+V++AE G VAVK Q + EFL EV +K +RH N V F G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVN--EFLREVAIMKRLRHPNIVLFMG 101
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
P+ +V EYL RGSL R+L ++L RR+++ VA ++YLH+ P I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKY 786
+HR++ S N+L+D + V DFG+++ + AGT + APE+ + EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 787 DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVM 838
DVYSFGV+++E+ P + ++N + + K +P +
Sbjct: 221 DVYSFGVILWELATLQQP--WGNLNPAQVVAAV--GFKCKRLEIPRNLNPQV 268
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 1e-53
Identities = 120/520 (23%), Positives = 194/520 (37%), Gaps = 52/520 (10%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLN 127
T SF L L L I + NL L+ LDLGS+++ L P L
Sbjct: 38 TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLF 97
Query: 128 QLRRLYLDMNQLHGTIPPE--IGQLSLIDKLALCHNNLHG-SIPSSLGNLSNLAVLYLYK 184
L L L L + + L + +L L N + + S G L++L +
Sbjct: 98 HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157
Query: 185 NSLSGSIPSIIGKL--KSLLQLDLSENQFSGSIPLSL------------------GNLSS 224
N + + L K+L L+ N + + GN +
Sbjct: 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT 217
Query: 225 LTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNL--SSLRVLYLYNNG 282
+ + F+N++S S L + G + + + L SS+R L L +
Sbjct: 218 VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF 277
Query: 283 LYGFVPEEIGYLKSLSELELCTNLLRGVIPH------SIERVLLNQNNLSGKMYEAFGDH 336
++ LK L L L N + + +++ + L+ N L F
Sbjct: 278 VFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL 337
Query: 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396
P + ++DL N+ + KL T + N ++ I P + + LS N
Sbjct: 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNK 392
Query: 397 IVGKIPVQLEMLS-SLNKLILNLNQLSGGVPLEF-GSLTKLQYLDLSTNKLSS-SIPKSI 453
+V L ++ + N + L+ N+L L F + LQ L L+ N+ SS S ++
Sbjct: 393 LV-----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP 447
Query: 454 GNLLKLHYLNLSNNQLSHKIPTE-----FEKLIHLSELDLSHNILQEEIPPQVCNMGSLE 508
L L L N L TE FE L HL L L+HN L P ++ +L
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 509 KLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548
L+L+ N L+ +L +DIS N+L P P+
Sbjct: 508 GLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDV 545
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-50
Identities = 109/483 (22%), Positives = 172/483 (35%), Gaps = 54/483 (11%)
Query: 101 NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALC 159
L+ + L L N + + L QL+ L L TI E L + L L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 160 HNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSI--PSIIGKLKSLLQLDLSENQFSG-SIP 216
+ ++ P + L +L L LY LS ++ LK+L +LDLS+NQ +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 217 LSLGNLSSLTMMSLFNNSLSGSIPPILGNL--KSLSALGLHINQLNGFIPPSIGNLS--- 271
S G L+SL + +N + L L K+LS L N L + G
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 272 ---SLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGK 328
L +L + NG + + S + ++ H I +N+
Sbjct: 202 RNMVLEILDVSGNGWTVDIT------GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255
Query: 329 MYEAFG--DHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDI-GNSP 385
F ++ LDLS+ S + L ++ N I+ I +
Sbjct: 256 DQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLD 314
Query: 386 KLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKL 445
LQVL+LS N + L + + L N ++ F L KLQ LDL N L
Sbjct: 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374
Query: 446 SSSIPKSIGNLLKLHYLNLSNNQLSH---------------------KIPTEFEKLIHLS 484
+ +I + + + LS N+L I ++ HL
Sbjct: 375 T-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQ 429
Query: 485 ELDLSHNILQEEIPPQVC-NMGSLEKLNLSHNNL-----SDFIPRCFEEMRSLSCIDISY 538
L L+ N Q SLE+L L N L ++ FE + L + +++
Sbjct: 430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489
Query: 539 NEL 541
N L
Sbjct: 490 NYL 492
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-49
Identities = 119/560 (21%), Positives = 193/560 (34%), Gaps = 55/560 (9%)
Query: 66 LNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPE-- 122
T +F + P+L L+L + + L L L L LS + +
Sbjct: 60 TPLTIDKEAFRNLPNLRILDLGSSKI-YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY 118
Query: 123 IGKLNQLRRLYLDMNQLHG-TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLS--NLAV 179
L L RL L NQ+ + P G+L+ + + N + L L L+
Sbjct: 119 FRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178
Query: 180 LYLYKNSLSGSIPSIIGKLKSLLQ------LDLSENQFS------------GSIPLSLGN 221
L NSL + GK + + LD+S N ++ S SL
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238
Query: 222 LSSLTMMSLFNNSLSGSIPPILGNLK--SLSALGLHINQLNGFIPPSIGNLSSLRVLYLY 279
+ +++ L S+ L L + L L+VL L
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298
Query: 280 NNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP------HSIERVLLNQNNLSGKMYEAF 333
N + E L +L L L NLL + + + L +N+++ + F
Sbjct: 299 YNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTF 358
Query: 334 GDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLS 393
L LDL +N + +S N + ++P + ++ LS
Sbjct: 359 KFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPK---INLTANLIHLS 409
Query: 394 SNHIVG-KIPVQLEMLSSLNKLILNLNQLSGGVPLE-FGSLTKLQYLDLSTNKLSSSIPK 451
N + I L + L LILN N+ S + L+ L L N L +
Sbjct: 410 ENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWET 469
Query: 452 SI-----GNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGS 506
+ L L L L++N L+ P F L L L L+ N L + +
Sbjct: 470 ELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHND-LPAN 527
Query: 507 LEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGLMEGNKGLKRVS 566
LE L++S N L P F SLS +DI++N+ ST F + L N +
Sbjct: 528 LEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECELST-FINWLNHTNVTIAGPP 583
Query: 567 QEEQSNSMNRLRLLSVLNFD 586
+ + +S+ +
Sbjct: 584 ADIYCVYPDSFSGVSLFSLS 603
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-42
Identities = 92/450 (20%), Positives = 163/450 (36%), Gaps = 41/450 (9%)
Query: 151 SLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQ 210
S ++A +P L L L N + S L+ L L+L
Sbjct: 3 SFDGRIAFYRFCNLTQVPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQLLELGSQY 59
Query: 211 FSGSI-PLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPS--I 267
+I + NL +L ++ L ++ + P L L L L+ L+ +
Sbjct: 60 TPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
Query: 268 GNLSSLRVLYLYNNGLYGF-VPEEIGYLKSLSELELCTNLLRGVIPH--------SIERV 318
NL +L L L N + + G L SL ++ +N + V H ++
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFF 179
Query: 319 LLNQNNLSGKMYEAFGDHPN------LTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNN 372
L N+L ++ +G N L LD+S N + +I+ N N
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGN------------FSNA 227
Query: 373 ISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEML--SSLNKLILNLNQLSGGVPLEFG 430
IS S + + + ++I L SS+ L L+ + F
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE 287
Query: 431 SLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSH 490
+L L+ L+L+ NK++ ++ L L LNLS N L + F L ++ +DL
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 491 NILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTA 550
N + + L+ L+L N L+ + S+ I +S N+L +P
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKINL 401
Query: 551 FKDGLMEGNKGLKRVSQEEQSNSMNRLRLL 580
+ + L+ + + L++L
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQIL 431
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-52
Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 21/236 (8%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IG GG G VY+A GD VAVK + E ++H N + G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
C P+ LV E+ G L R+L K + + +N +A ++YLH + + I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 727 IHRDISSKNVLLDSNFEAH--------VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY 778
IHRD+ S N+L+ E ++DFG+A+ H + AG + + APE+
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGAYAWMAPEVIR 187
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
++ DV+S+GVL++E++ G P F I+ + + + LP PS
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP--FRGIDGLAVAYGVAMNKL----ALPIPS 237
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-52
Identities = 65/241 (26%), Positives = 109/241 (45%), Gaps = 16/241 (6%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
+ + + +G+G G V KA+ VA+K+ S+ ++ F+ E+ L + H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE------SERKAFIVELRQLSRVNH 60
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL 718
N VK +G C N LV EY + GSL +L ++ + ++YL
Sbjct: 61 PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFE-AHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
H ++IHRD+ N+LL + + DFG A + ++ T G+ + APE+
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNKGSAAWMAPEVF 175
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSV 837
+EK DV+S+G++++EVI P F I +F M V+ P L P
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA-VHNGTRPPLIKNLPKP 232
Query: 838 M 838
+
Sbjct: 233 I 233
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-51
Identities = 71/261 (27%), Positives = 121/261 (46%), Gaps = 28/261 (10%)
Query: 589 IMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADHD--- 644
+ EI +++++ IGKGG G V+K L +VA+K G +
Sbjct: 16 LADNEI-----EYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68
Query: 645 EFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRR 704
EF EV + + H N VK +G +N P +V E++ G L L D A + W+ +
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVK 124
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE-----AHVSDFGIAKFVGPHS 759
+ ++ +A + Y+ + P I+HRD+ S N+ L S E A V+DFG+++
Sbjct: 125 LRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS---V 180
Query: 760 SNWTEFAGTFGYAAPEI--AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 817
+ + G F + APE A TEK D YSF ++++ ++ G P F ++
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKF 238
Query: 818 MIIDVNKILDPRLPTPSPSVM 838
+ + + L P +P P +
Sbjct: 239 INMIREEGLRPTIPEDCPPRL 259
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-50
Identities = 99/481 (20%), Positives = 173/481 (35%), Gaps = 86/481 (17%)
Query: 95 IPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKL-------------NQLRRLYLDMNQLHG 141
+P++ N+ ++ PP G+ Q L L+ L
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS- 84
Query: 142 TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSL 201
++P L L N+L +P +L +L V +LS P L
Sbjct: 85 SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LL 133
Query: 202 LQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNG 261
L +S NQ +P L N S L ++ + NNSL +P + +L+ ++A + +L
Sbjct: 134 EYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLEEL-- 188
Query: 262 FIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGV----IPHSIER 317
P + NL L +Y NN L P+ SL + N+L + +
Sbjct: 189 ---PELQNLPFLTAIYADNNSLKKL-PDLPL---SLESIVAGNNILEELPELQNLPFLTT 241
Query: 318 VLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSI 377
+ + N L P+L L++ +N ++ + + L + +S
Sbjct: 242 IYADNNLLK----TLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELP 296
Query: 378 PPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQY 437
P L L+ SSN I + ++ SL +L ++ N+L +P +L+
Sbjct: 297 -------PNLYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELP---ALPPRLER 341
Query: 438 LDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS------------- 484
L S N L + +P+ N L L++ N L + P E + L
Sbjct: 342 LIASFNHL-AEVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQ 396
Query: 485 ---ELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
+L + N L+ E P S+E L ++ + D E L ++
Sbjct: 397 NLKQLHVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
Query: 542 H 542
H
Sbjct: 453 H 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-49
Identities = 98/473 (20%), Positives = 166/473 (35%), Gaps = 76/473 (16%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLS-------------KLQYLDLGSNQLSGLIP 120
+ +++ + N P G + L+L + LS L P
Sbjct: 29 EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-P 87
Query: 121 PEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPS----------- 169
L L N L +P L + L P
Sbjct: 88 ELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQL 143
Query: 170 ----SLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSL 225
L N S L ++ + NSL +P + L+ + NQ +P L NL L
Sbjct: 144 EKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLE-ELP-ELQNLPFL 197
Query: 226 TMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYG 285
T + NNSL +P + +L+S+ A N L P + NL L +Y NN L
Sbjct: 198 TAIYADNNSLK-KLPDLPLSLESIVAGN---NILE--ELPELQNLPFLTTIYADNNLL-K 250
Query: 286 FVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLS 345
+P+ L++L+ + L + S+ + +++N SG PNL +L+ S
Sbjct: 251 TLPDLPPSLEALNVRDNYLTDLPELPQ-SLTFLDVSENIFSGLSELP----PNLYYLNAS 305
Query: 346 NNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQL 405
+N + + L VS N + +P L+ L S NH+ ++P
Sbjct: 306 SNEIR-SLCDLPPS---LEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP--- 353
Query: 406 EMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLS 465
E+ +L +L + N L P S+ L+ N + +P+ NL L++
Sbjct: 354 ELPQNLKQLHVEYNPLRE-FPDIPESVEDLRM-----NSHLAEVPELPQNL---KQLHVE 404
Query: 466 NNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS 518
N L P E + +L ++ + + LE H++
Sbjct: 405 TNPLRE-FPDIPESV---EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-49
Identities = 95/426 (22%), Positives = 159/426 (37%), Gaps = 60/426 (14%)
Query: 118 LIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNL 177
I P L+ + L +P E + + + + P G +
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 178 AVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG 237
AV L + +L+L+ S S+P +L SL NSL+
Sbjct: 61 AVSRLRDC-----------LDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT- 104
Query: 238 SIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSL 297
+P + +LKSL ++ L+ P L L + NN L +P E+ L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQL-EKLP-ELQNSSFL 155
Query: 298 SELELCTNLLRGVI--PHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISF 355
+++ N L+ + P S+E + N L + P LT + NN+
Sbjct: 156 KIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLPD- 212
Query: 356 NWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLI 415
L + + N + P++ N P L + +N + +P L +LN
Sbjct: 213 ---LPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRD 266
Query: 416 LNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPT 475
L L P SLT L + + LS P L+YLN S+N++ +
Sbjct: 267 NYLTDL----PELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRS-LC- 313
Query: 476 EFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCID 535
+ L EL++S+N L E+P LE+L S N+L++ E ++L +
Sbjct: 314 --DLPPSLEELNVSNNKL-IELPA---LPPRLERLIASFNHLAEVP----ELPQNLKQLH 363
Query: 536 ISYNEL 541
+ YN L
Sbjct: 364 VEYNPL 369
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-43
Identities = 85/412 (20%), Positives = 142/412 (34%), Gaps = 61/412 (14%)
Query: 76 SSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLD 135
PHL +L S N +P +L L + LS L P L L +
Sbjct: 88 ELPPHLESLVASCN-SLTELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVS 139
Query: 136 MNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSII 195
NQL PE+ S + + + +N+L +P +L + N L +P +
Sbjct: 140 NNQL--EKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELPEL- 191
Query: 196 GKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLH 255
L L + N +P +L S+ NN L P L NL L+ +
Sbjct: 192 QNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE--ELPELQNLPFLTTIYAD 245
Query: 256 INQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI 315
N L +P +L +L V Y L PE L L E + L + P ++
Sbjct: 246 NNLLKT-LPDLPPSLEALNVRDNYLTDL----PELPQSLTFLDVSENIFSGLSELPP-NL 299
Query: 316 ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISG 375
+ + N + P+L L++SNN E+ L I S N+++
Sbjct: 300 YYLNASSNEIR----SLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA- 350
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLN----------------KLILNLN 419
+P N L+ L + N + + P E + L +L + N
Sbjct: 351 EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETN 406
Query: 420 QLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH 471
L P ++ L +++ ++ + KL ++ H
Sbjct: 407 PLRE-FPDI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHHH 454
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 54/281 (19%), Positives = 108/281 (38%), Gaps = 32/281 (11%)
Query: 262 FIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLN 321
FI P + + L+ +++ L +P E +KS +E + P
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGN---GEQ 57
Query: 322 QNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDI 381
+ ++ + L+L+N + + L + + S N+++ +P
Sbjct: 58 REMAVSRLRDCL--DRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELP 110
Query: 382 GNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLS 441
+ L V + + + P L L ++ NQL +P E + + L+ +D+
Sbjct: 111 QSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVD 161
Query: 442 TNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV 501
N L +P +L ++ NNQL +P E + L L+ + +N L +++P
Sbjct: 162 NNSL-KKLPDLPPSLE---FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSL-KKLPDL- 213
Query: 502 CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELH 542
SLE + +N L + + + L+ I N L
Sbjct: 214 --PLSLESIVAGNNILEE--LPELQNLPFLTTIYADNNLLK 250
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 7e-50
Identities = 63/357 (17%), Positives = 117/357 (32%), Gaps = 47/357 (13%)
Query: 165 GSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSS 224
GS + S LY ++ ++ + + D + N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57
Query: 225 LTMMSLFNNSLSGSIPPILGNLKS--LSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNG 282
+ + +L + +L + AL L L P LS L+ + + G
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 283 LYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFL 342
L +P+ + L L L N LR +P SI +L+ L L
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPLR-ALPASIA-------SLN-----------RLREL 155
Query: 343 DLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIP 402
+ +L+ + + + LQ L L I +P
Sbjct: 156 SIRACP-------------ELTELPEPLASTD--ASGEHQGLVNLQSLRLEWTGIR-SLP 199
Query: 403 VQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYL 462
+ L +L L + + LS + L KL+ LDL + P G L L
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 463 NLSN-NQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS 518
L + + L +P + +L L +LDL + +P + + + + + + +
Sbjct: 259 ILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-49
Identities = 57/251 (22%), Positives = 97/251 (38%), Gaps = 16/251 (6%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
++ P L L P Q LS LQ++ + + L L P + + L L
Sbjct: 75 LEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLMEL-PDTMQQFAGLETL 132
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGN---------LSNLAVLYLY 183
L N L +P I L+ + +L++ +P L + L NL L L
Sbjct: 133 TLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191
Query: 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPIL 243
+ S+P+ I L++L L + + S ++ ++ +L L + L + + PPI
Sbjct: 192 WTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
Query: 244 GNLKSLSALGL-HINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELEL 302
G L L L + L +P I L+ L L L +P I L + + +
Sbjct: 250 GGRAPLKRLILKDCSNL-LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308
Query: 303 CTNLLRGVIPH 313
+L + H
Sbjct: 309 PPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-47
Identities = 61/392 (15%), Positives = 108/392 (27%), Gaps = 93/392 (23%)
Query: 81 LANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLH 140
NL + + + D N + L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK 69
Query: 141 GTIPPEIGQLSLID--KLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKL 198
+ + L L L P LS+L + + L +P + +
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 199 KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQ 258
L L L+ N ++P S+ +L+ L +S+ +P L + +
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA---------- 175
Query: 259 LNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERV 318
L +L+ L L G+ +P I L++L L++ + L + +I
Sbjct: 176 -----SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIH-- 226
Query: 319 LLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIP 378
+L L LDL + P
Sbjct: 227 -----HLP-----------KLEELDLRGCTA------------------------LRNYP 246
Query: 379 PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYL 438
P G L+ L L + L +PL+ LT+L+ L
Sbjct: 247 PIFGGRAPLKRLILKDC-----------------------SNLL-TLPLDIHRLTQLEKL 282
Query: 439 DLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLS 470
DL S +P I L + + + +
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 41/298 (13%), Positives = 90/298 (30%), Gaps = 43/298 (14%)
Query: 264 PPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH-SIERVLLNQ 322
+ S LY + + + + + + + ++
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRT 64
Query: 323 NNLSGKMYEAFGD--HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPD 380
+ D P L+L + P
Sbjct: 65 GRALKATADLLEDATQPGRVALELRSVPL-------------------------PQFPDQ 99
Query: 381 IGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDL 440
LQ + + + ++ ++P ++ + L L L N L +P SL +L+ L +
Sbjct: 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSI 157
Query: 441 STNKLSSSIPKSIGN---------LLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHN 491
+ +P+ + + L+ L L L + +P L +L L + ++
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
Query: 492 ILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDIS-YNELHGPIPNS 548
L + P + ++ LE+L+L P F L + + + L +P
Sbjct: 217 PL-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLD 272
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 37/182 (20%), Positives = 65/182 (35%), Gaps = 11/182 (6%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGN---------LSKLQYLDLGSNQLSGLIPPEIG 124
S +S L L++ +P + + L LQ L L + L P I
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSL-PASIA 203
Query: 125 KLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYK 184
L L+ L + + L + P I L +++L L + P G + L L L
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262
Query: 185 NSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILG 244
S ++P I +L L +LDL +P + L + ++ + + +
Sbjct: 263 CSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPV 322
Query: 245 NL 246
Sbjct: 323 AR 324
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-49
Identities = 98/467 (20%), Positives = 174/467 (37%), Gaps = 39/467 (8%)
Query: 103 SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHN 161
K L++ N +S L +I L++LR L + N++ + + ++ L L HN
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79
Query: 162 NLHGSIPSSLGNLSNLAVLYLYKNSL-SGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLG 220
L I NL L L N+ + I G + L L LS S L +
Sbjct: 80 KLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 221 NLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYN 280
+L+ ++ + + P L+ + LHI I ++S V L
Sbjct: 137 HLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 281 NGLYGFVPEEIGYLKSLSELELCTN--------------------LLRGVIPHSIERVLL 320
+ + + + +L TN +L+ V ++ +
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254
Query: 321 NQNNLSGKMYEAFGDHPN-----LTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISG 375
+ L G++ D+ L+ + ++ F S+ + FS ++ +++
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS--GGVPLEFGSLT 433
LD S+N + + L+ L LIL +NQL + +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 434 KLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNI 492
LQ LD+S N +S K L LN+S+N L+ I + LDL N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNK 432
Query: 493 LQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYN 539
++ IP QV + +L++LN++ N L F+ + SL I + N
Sbjct: 433 IKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-39
Identities = 86/471 (18%), Positives = 155/471 (32%), Gaps = 80/471 (16%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
S L L +S N +L+YLDL N+L + L+ L
Sbjct: 40 DILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKIS---CHPTVNLKHLD 96
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
L N ++P I
Sbjct: 97 LSFNAFD-------------------------ALP----------------------ICK 109
Query: 194 IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALG 253
G + L L LS S L + +L+ ++ + + P L+ +
Sbjct: 110 EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTES 167
Query: 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH 313
LHI I ++S V L + + + + +L TN +
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL-- 225
Query: 314 SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNI 373
++ + N+ + H + + +SN G++ F ++S S
Sbjct: 226 TLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL-------- 275
Query: 374 SGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLT 433
L + + S+ E+ S++N ++ L ++
Sbjct: 276 -----------KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH--KIPTEFEKLIHLSELDLSHN 491
+LD S N L+ ++ ++ G+L +L L L NQL KI ++ L +LD+S N
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384
Query: 492 ILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
+ + C SL LN+S N L+D I RC + +D+ N++
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 85/441 (19%), Positives = 155/441 (35%), Gaps = 68/441 (15%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQ--IGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLR 130
S +L +L+LSFN F +P+ GN+S+L++L L + L I LN +
Sbjct: 84 ISCHPTVNLKHLDLSFNA-FDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142
Query: 131 RLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG- 189
L + P L + +L + ++S V L +++
Sbjct: 143 VLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 190 ----------SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNL---SSLTMMSLFNNSLS 236
SI + + L L L+ + + + + + L +++ S+ N L
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 237 G-----SIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEI 291
G +LK+LS + + S++ + +G
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 292 GYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCG 351
+ L+ + N L+ ++E G L L L N
Sbjct: 321 SKISPFLHLD------------------FSNNLLTDTVFENCGHLTELETLILQMNQL-K 361
Query: 352 EISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI-VGKIPVQLEMLSS 410
E+S +++ LQ LD+S N + + S
Sbjct: 362 ELSKIAEMTTQM---------------------KSLQQLDISQNSVSYDEKKGDCSWTKS 400
Query: 411 LNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLS 470
L L ++ N L+ + +++ LDL +NK+ SIPK + L L LN+++NQL
Sbjct: 401 LLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLK 457
Query: 471 HKIPTEFEKLIHLSELDLSHN 491
F++L L ++ L N
Sbjct: 458 SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 1e-21
Identities = 56/373 (15%), Positives = 117/373 (31%), Gaps = 44/373 (11%)
Query: 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITM 61
+E L+ + + + + + ++ I C ++
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211
Query: 62 STLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPP 121
L + + L N+ ++N F LQ+ + + Y + + +L G +
Sbjct: 212 ILAKLQTNPKLSNLT----LNNIETTWNSFIR--ILQLVWHTTVWYFSISNVKLQGQLDF 265
Query: 122 EIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLY 181
+ L ++Q+ + SN+ +
Sbjct: 266 RDFDYSGTSLKALSIHQVV-------------------SDVFGFPQSYIYEIFSNMNIKN 306
Query: 182 LYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP 241
+ K+ L LD S N + ++ + G+L+ L + L N L +
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSK 365
Query: 242 ILG---NLKSLSALGLHINQLNGFIPPSI-GNLSSLRVLYLYNNGLYGFVPEEIGYLKSL 297
I +KSL L + N ++ SL L + +N L + + +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRI 423
Query: 298 SELELCTNLLRGVIPHSI------ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF-- 349
L+L +N ++ IP + + + + N L F +L + L N +
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 482
Query: 350 -CGEISF--NWGN 359
C I + W N
Sbjct: 483 SCPRIDYLSRWLN 495
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 54/384 (14%), Positives = 105/384 (27%), Gaps = 55/384 (14%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218
N +P L +L + +N +S S I L L L +S N+
Sbjct: 7 RSKNGLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 219 LGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVLY 277
L + L +N L I +L L L N + GN+S L+ L
Sbjct: 65 FKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121
Query: 278 LYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHP 337
L L I +L L + E
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGE--------------------KEDPEGLQ 161
Query: 338 NLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397
+ L + + S + + ++NI + + + + L +N
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPK 221
Query: 398 VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL 457
+ + L + + + + QL + + S++ ++ L S +L
Sbjct: 222 LSNL--TLNNIETTWNSFIRILQLVWHTTVWYFSISNVK---LQGQLDFRDFDYSGTSLK 276
Query: 458 KLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNL 517
L + ++ +E ++ N + +
Sbjct: 277 ALSIHQVVSDVFGFPQSYIYEIFS------------------------NMNIKNFTVSGT 312
Query: 518 SDFIPRCFEEMRSLSCIDISYNEL 541
C ++ +D S N L
Sbjct: 313 RMVHMLCPSKISPFLHLDFSNNLL 336
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 5e-17
Identities = 46/251 (18%), Positives = 84/251 (33%), Gaps = 11/251 (4%)
Query: 338 NLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397
+ +D S N I K + +S N IS DI + KL++L +S N I
Sbjct: 1 SEFLVDRSKNGL---IHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57
Query: 398 VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSS-SIPKSIGNL 456
+ L L L+ N+L + L++LDLS N + I K GN+
Sbjct: 58 QYLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNM 114
Query: 457 LKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNN 516
+L +L LS L L L + E+ P+ + +L
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVF 172
Query: 517 LSDFIPRCFEEMRSLSCIDISYNELHG--PIPNSTAFKDGLMEGNKGLKRVSQEEQSNSM 574
++ ++ + ++ + + + F L + K + +
Sbjct: 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
Query: 575 NRLRLLSVLNF 585
+ +L
Sbjct: 233 TWNSFIRILQL 243
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-48
Identities = 67/474 (14%), Positives = 149/474 (31%), Gaps = 42/474 (8%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYL 134
+ ++ + + + ++ LDL N LS + ++ +L L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 135 DMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSI 194
N L ++ LS + L L +N + L ++ L+ N++S +
Sbjct: 66 SSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSC- 116
Query: 195 IGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG-SIPPILGNLKSLSALG 253
+ + + L+ N+ + L G S + + L N + + + + +L L
Sbjct: 117 -SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH 313
L N + + + + L+ L L +N L F+ E ++ + L N L +I
Sbjct: 176 LQYNFIYD-VKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIE- 230
Query: 314 SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF-CGEISFNWGNFSKLSTFIVSMNN 372
+A NL DL N F CG + + ++ T V+
Sbjct: 231 -----------------KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQT 271
Query: 373 ISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSG----GVPLE 428
+ + + + + L +L + L G + E
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331
Query: 429 FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDL 488
+ + + +D + + I + L L ++ L
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQ 391
Query: 489 SHNILQEEIPPQVCNMGSLEKLNLSHNNLSD-FIPRCFEEMRSLSCIDISYNEL 541
E+ L+ L + ++ + + ++ D+ ++
Sbjct: 392 QAVGQI-ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 7e-46
Identities = 62/437 (14%), Positives = 135/437 (30%), Gaps = 28/437 (6%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQ 128
S ++ L+LS N + +KL+ L+L SN L ++ L+
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET--LDLESLST 81
Query: 129 LRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLS 188
LR L L+ N + E+ I+ L +NN+ + S +YL N ++
Sbjct: 82 LRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKIT 133
Query: 189 GSIPSIIGKLKSLLQLDLSENQFSG-SIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLK 247
G + LDL N+ + + +L ++L N + + +
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191
Query: 248 SLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLL 307
L L L N+L F+ P + + + + L NN L + + + + ++L +L N
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGF 249
Query: 308 RGVIPHSIERVL-----LNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGN--- 359
+ + + + + T C ++ + +
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC-CEDLPAPFADRLI 308
Query: 360 --FSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILN 417
K + + + + + N + + +D I + L
Sbjct: 309 ALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368
Query: 418 LNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHK-IPTE 476
L V + +L + + L L + + +
Sbjct: 369 KKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQ 427
Query: 477 FEKLIHLSELDLSHNIL 493
+ + + D+ +
Sbjct: 428 SVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-43
Identities = 65/431 (15%), Positives = 146/431 (33%), Gaps = 29/431 (6%)
Query: 166 SIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSL 225
+I N + + + +SL ++ S+ ++ +LDLS N S L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 226 TMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYG 285
+++L +N L + +L +L L L+ N + + S+ L+ NN +
Sbjct: 61 ELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 286 FVPEEIGYLKSLSELELCTNLLRGVIPHSI------ERVLLNQNNLSGKMYEAF-GDHPN 338
V + + L N + + + + L N + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 339 LTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIV 398
L L+L N ++ F+KL T +S N ++ + P+ ++ + + L +N +V
Sbjct: 171 LEHLNLQYNFI-YDVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 399 GKIPVQLEMLSSLNKLILNLNQLSGGVPLE-FGSLTKLQYLDLSTNKLSSSIPKSIGNLL 457
I L +L L N G + F ++Q + + ++
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECT 284
Query: 458 KLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQ----EEIPPQVCNMGSLEKLNLS 513
+ ++LI L + + Q E + + N +++
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 514 HNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGLMEGN-KGLKRVSQEEQSN 572
I + ++ ++ L + N L + + ++ + +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404
Query: 573 SMNRLRLLSVL 583
+ L+LL +
Sbjct: 405 EQSPLQLLRAI 415
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 30/258 (11%), Positives = 68/258 (26%), Gaps = 32/258 (12%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPE-IGKLNQLRRL 132
F S + ++L N I + L++ DL N + K +++ +
Sbjct: 209 EFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267
Query: 133 YLDMNQ-LHGTIPPEIGQLSLIDKLALC-------------------------HNNLHGS 166
+ L G E +L A C +
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER 327
Query: 167 IPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLT 226
+ N + + K I + + ++ + L+ + + + L
Sbjct: 328 LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387
Query: 227 MMSLFNNSLSG--SIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLY 284
L+ L A+ ++ ++ +++R +Y +
Sbjct: 388 GTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEM--YVEQQSVQNNAIRDWDMYQHKET 445
Query: 285 GFVPEEIGYLKSLSELEL 302
E K E +L
Sbjct: 446 QLAEENARLKKLNGEADL 463
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 46/237 (19%), Positives = 93/237 (39%), Gaps = 19/237 (8%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+ + G ++K G+ + VK + S + +F E L+ H N + G
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR--DFNEECPRLRIFSHPNVLPVLG 74
Query: 667 FCYNGP--HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
C + P H L+ ++ GSL +L + T + ++ + +A +++LH P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT-LEP 132
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI---AYTMR 781
I ++S++V++D + A +S + S + APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 782 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVM 838
D++SF VL++E++ P F ++ + + L P +P +
Sbjct: 188 NRRSADMWSFAVLLWELVTREVP--FADLSNMEIGMKV--ALEGLRPTIPPGISPHV 240
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 57/256 (22%), Positives = 102/256 (39%), Gaps = 31/256 (12%)
Query: 563 KRVSQEEQSNSMNRLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPS 622
+S + + S+ + I E++ + E IGKG G VY
Sbjct: 4 MNLSLLSARSFPRKASQTSIFLQEWDIPFEQL-----EIGEL--IGKGRFGQVYHGRW-H 55
Query: 623 GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682
G+ VA++ + + + + F EV+A ++ RH N V F G C + PH ++
Sbjct: 56 GE-VAIRLIDIERDNEDQLK--AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112
Query: 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742
+L ++ L N+ + + + + YLH I+H+D+ SKNV D N
Sbjct: 113 GRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NG 166
Query: 743 EAHVSDFGIAK-----FVGPHSSNWTEFAGTFGYAAPEI---------AYTMRATEKYDV 788
+ ++DFG+ G G + APEI + ++ DV
Sbjct: 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226
Query: 789 YSFGVLVFEVIKGNHP 804
++ G + +E+ P
Sbjct: 227 FALGTIWYELHAREWP 242
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-45
Identities = 72/387 (18%), Positives = 127/387 (32%), Gaps = 38/387 (9%)
Query: 157 ALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIP 216
+ I S+L +++ + L + + +
Sbjct: 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 62
Query: 217 LSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRV 275
L + + +++L + + I ++ L + N + P N+ L V
Sbjct: 63 ALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121
Query: 276 LYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGD 335
L L N L L+ L + N L + + F
Sbjct: 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED------------------DTFQA 163
Query: 336 HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSN 395
+L L LS+N + L VS N +S + ++ LD S N
Sbjct: 164 TTSLQNLQLSSNRL---THVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 215
Query: 396 HIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGN 455
I V+ + L L L N L+ + L +DLS N+L +
Sbjct: 216 SINV---VRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK 270
Query: 456 LLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHN 515
+ +L L +SNN+L + + + L LDLSHN L + LE L L HN
Sbjct: 271 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHN 328
Query: 516 NLSDFIPRCFEEMRSLSCIDISYNELH 542
++ +++L +S+N+
Sbjct: 329 SIVTLKLSTHHTLKNL---TLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-45
Identities = 75/416 (18%), Positives = 140/416 (33%), Gaps = 43/416 (10%)
Query: 119 IPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLA 178
I + +++DM E L+ + ++ + + L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 179 VLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGS 238
+L L + ++ +L + N P N+ LT++ L N LS S
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 131
Query: 239 IPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSL 297
+P I N L+ L + N L + +SL+ L L +N L ++ + SL
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSL 188
Query: 298 SELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNW 357
+ NLL + LD S+N+
Sbjct: 189 FHANVSYNLL-----------------------STLAIPIAVEELDASHNSIN---VVRG 222
Query: 358 GNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILN 417
+L+ + NN++ + N P L +DLS N + + + L +L ++
Sbjct: 223 PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280
Query: 418 LNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEF 477
N+L + L + L+ LDLS N L + ++ +L L L +N + +
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIVT-LK--L 335
Query: 478 EKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSC 533
L L LSHN + + +D + ++ C
Sbjct: 336 STHHTLKNLTLSHNDWDC-----NSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-35
Identities = 75/412 (18%), Positives = 130/412 (31%), Gaps = 90/412 (21%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLN 127
SF + LNL+ I +Q L +G N + L P +
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 117
Query: 128 QLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNS 186
L L L+ N L ++P I + L++ +NNL + ++L L L N
Sbjct: 118 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 176
Query: 187 LSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNL 246
L+ + + + SL ++S N S +L ++ + +NS++ +
Sbjct: 177 LT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVN 225
Query: 247 KSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNL 306
L+ L L N L + N L + L N L ++
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYN--------------ELEKIM----- 264
Query: 307 LRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTF 366
Y F L L +SNN
Sbjct: 265 -----------------------YHPFVKMQRLERLYISNNRL----------------- 284
Query: 367 IVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVP 426
++ P L+VLDLS NH++ + L L L+ N +
Sbjct: 285 --------VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---T 332
Query: 427 LEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFE 478
L+ + L+ L LS N + +++ + + + KI + E
Sbjct: 333 LKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 36/173 (20%), Positives = 66/173 (38%), Gaps = 9/173 (5%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
L L L N + + N L +DL N+L ++ K+ +L RL
Sbjct: 220 VRGPVNVELTILKLQHNNL-TDTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 277
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
Y+ N+L + + + L L HN+L + + L LYL NS+ ++
Sbjct: 278 YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK 334
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGN 245
+ +L L LS N + + +L ++ ++ + I L +
Sbjct: 335 --LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNE--VLALKEIRHRNNVK 663
C+GKG G V++ G+ VAVK F+S+ D + E + +RH N +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 664 FHGFCYNGPHS----FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
F HS +L+ Y + GSL L L + ++ +A+ L++LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 720 HDCL-----PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS----NWTEFAGTFG 770
+ P+I HRD+ SKN+L+ N + ++D G+A ++ GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 771 YAAPEI------AYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806
Y APE+ + ++ D+++FG++++EV +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 65/282 (23%), Positives = 106/282 (37%), Gaps = 54/282 (19%)
Query: 592 EEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNE-- 649
E D+ IG+G G+VYK L VAVK F+ + F+NE
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-------NRQNFINEKN 57
Query: 650 VLALKEIRHRNNVKFHGFCYNGPHS-----FLVCEYLDRGSLARILGDDVTAKELGWNRR 704
+ + + H N +F LV EY GSL + L + W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSS 113
Query: 705 INVIKGVANALSYLHHD------CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758
+ V L+YLH + P+I HRD++S+NVL+ ++ +SDFG++ + +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 759 SSNWTEF--------AGTFGYAAPEIA-------YTMRATEKYDVYSFGVLVFEVIKGNH 803
GT Y APE+ A ++ D+Y+ G++ +E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 804 PRDFFSI-------------NFSSFSNMIIDV-NKILDPRLP 831
N +F +M + V + P+ P
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP 275
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-44
Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 29/263 (11%)
Query: 591 HEEIIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNE 649
H + E +GKG G K +G+++ +K+ L+ + FL E
Sbjct: 4 HRIFRPSDLIHGEV--LGKGCFGQAIKVTHRETGEVMVMKE----LIRFDEETQRTFLKE 57
Query: 650 VLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIK 709
V ++ + H N +KF G Y + EY+ G+L I+ + W++R++ K
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAK 115
Query: 710 GVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV-------------- 755
+A+ ++YLH +IIHRD++S N L+ N V+DFG+A+ +
Sbjct: 116 DIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 815
P G + APE+ EK DV+SFG+++ E+I + +
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL---PRT 229
Query: 816 SNMIIDVNKILDPRLPTPSPSVM 838
+ ++V LD P P
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSF 252
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-44
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IG G G+VYK + GD VAVK N + F NEV L++ RH N + F G
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQ--AFKNEVGVLRKTRHVNILLFMG 87
Query: 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSI 726
+ P +V ++ + SL L + + + I++ + A + YLH SI
Sbjct: 88 YS-TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 727 IHRDISSKNVLLDSNFEAHVSDFGIAKFV--GPHSSNWTEFAGTFGYAAPEI---AYTMR 781
IHRD+ S N+ L + + DFG+A S + + +G+ + APE+ +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 782 ATEKYDVYSFGVLVFEVIKGNHP 804
+ + DVY+FG++++E++ G P
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP 224
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 8e-44
Identities = 100/452 (22%), Positives = 164/452 (36%), Gaps = 85/452 (18%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNL 163
+ Y+DL N ++ L +L L+ L ++ I LS + L L +N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 164 HGSIPSS-LGNLSNLAVLYLYKNSLSGSI--PSIIGKLKSLLQLDLSENQFSGSIPLSL- 219
+ + L+NL VL L + +L G++ + L SL L L +N P S
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 220 GNLSSLTMMSLFNNSLSGSIPPILGNL--KSLSALGLHINQL-----NGFIPPSIGN--- 269
N+ ++ L N + L N K + L L L GN
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 270 LSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKM 329
+S+ L L NG + + + +++ ++ + +L + N S
Sbjct: 211 NTSITTLDLSGNGFKESMAK--RFFDAIAGTKIQSLILS-----------NSYNMGSSFG 257
Query: 330 YEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDI-GNSPKLQ 388
+ F D N TF L + + T +S + I ++ + + L+
Sbjct: 258 HTNFKDPDNFTFKGLEASG--------------VKTCDLSKSKIF-ALLKSVFSHFTDLE 302
Query: 389 VLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSS 448
L L+ N +N++ F LT L L+LS N L S
Sbjct: 303 QLTLAQN---------------------EINKIDDNA---FWGLTHLLKLNLSQNFLGSI 338
Query: 449 IPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSHNILQEEIPPQV-CNMGS 506
+ NL KL L+LS N + + + F L +L EL L N L+ +P + + S
Sbjct: 339 DSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTS 396
Query: 507 LEKLNLSHNNLSDFIPRCFEEMRSLSCIDISY 538
L+K+ L N C SC I Y
Sbjct: 397 LQKIWLHTNPW-----DC-------SCPRIDY 416
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 57/327 (17%), Positives = 104/327 (31%), Gaps = 49/327 (14%)
Query: 75 FSSFPHLANLNLSFN-LFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRR 131
F+ +L L L+ L + L+ L+ L L N + + P + +
Sbjct: 99 FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHV 158
Query: 132 LYLDMNQLHGTIPPEI---GQLSLIDKLALCHNNLH--------GSIPSSLGNLSNLAVL 180
L L N++ +I E Q L L L + +++ L
Sbjct: 159 LDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL 217
Query: 181 YLYKNSLSGSIPSIIGKLKSLLQL-------------DLSENQFSGSIPLSLGNL--SSL 225
L N S+ + ++ F + L S +
Sbjct: 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGV 277
Query: 226 TMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVLYLYNNGL 283
L + + ++ + + L L L N++N I + L+ L L L N L
Sbjct: 278 KTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL 335
Query: 284 YGFVPEEI-GYLKSLSELELCTNLLRGVIPH-------SIERVLLNQNNLSGKMYEAFGD 335
G + + L L L+L N +R + +++ + L+ N L F
Sbjct: 336 -GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDR 393
Query: 336 HPNLTFLDLSNNNF---CGEISF--NW 357
+L + L N + C I + W
Sbjct: 394 LTSLQKIWLHTNPWDCSCPRIDYLSRW 420
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 38/191 (19%), Positives = 68/191 (35%), Gaps = 15/191 (7%)
Query: 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITM 61
+ + T +Q+ L++S + N ++ G+ + +
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS-------GVKT 279
Query: 62 STLGLNG--TFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGL 118
L + FS F L L L+ N I L+ L L+L N L +
Sbjct: 280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNE-INKIDDNAFWGLTHLLKLNLSQNFLGSI 338
Query: 119 IPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSS-LGNLSN 176
L++L L L N + + + L + +LAL N L S+P L++
Sbjct: 339 DSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTS 396
Query: 177 LAVLYLYKNSL 187
L ++L+ N
Sbjct: 397 LQKIWLHTNPW 407
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-43
Identities = 71/420 (16%), Positives = 128/420 (30%), Gaps = 88/420 (20%)
Query: 97 LQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKL 156
++ + L++G + L+ L P + + L + N L ++P +L L
Sbjct: 34 MRACLNNGNAVLNVGESGLTTL-PDCLPA--HITTLVIPDNNLT-SLPALPPELR---TL 86
Query: 157 ALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIP 216
+ N L S+P L L++ L L +L + NQ + S+P
Sbjct: 87 EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLP 137
Query: 217 LSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVL 276
+ L L+ + +N L+ S+P + L L A + L P L+ L
Sbjct: 138 VLPPGLQELS---VSDNQLA-SLPALPSELCKLWAYNNQLTSL----PMLPSG---LQEL 186
Query: 277 YLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDH 336
+ +N L +P L L N L +P
Sbjct: 187 SVSDNQL-ASLPTLPSELYKLWAYN---NRLT-SLPALP--------------------- 220
Query: 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396
L L +S N S+P L+ L +S N
Sbjct: 221 SGLKELIVSGNRL-------------------------TSLPVLPSE---LKELMVSGNR 252
Query: 397 IVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNL 456
+ +P + S L L + NQL+ +P L+ ++L N LS +++ +
Sbjct: 253 LT-SLP---MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307
Query: 457 LKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNN 516
S + + + + + L + N
Sbjct: 308 TSAP--GYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 2e-41
Identities = 73/383 (19%), Positives = 130/383 (33%), Gaps = 62/383 (16%)
Query: 198 LKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHIN 257
L++ E+ + ++P L +T + + +N+L+ S+P + L++L + N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE---VSGN 91
Query: 258 QLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIER 317
QL +P L L + L P L +L + N L +P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHL----PALPS---GLCKLWIFGNQLT-SLPVLP-- 140
Query: 318 VLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSI 377
P L L +S+N + KL N ++ S+
Sbjct: 141 -------------------PGLQELSVSDNQL-ASLPALPSELCKLW---AYNNQLT-SL 176
Query: 378 PPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQY 437
P LQ L +S N + +P L L L L + L+
Sbjct: 177 PMLPSG---LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPA-------LPSGLKE 225
Query: 438 LDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEI 497
L +S N+L+S +P L L +S N+L+ +P L L + N L +
Sbjct: 226 LIVSGNRLTS-LPVLPSEL---KELMVSGNRLTS-LPML---PSGLLSLSVYRNQLTR-L 276
Query: 498 PPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGLME 557
P + ++ S +NL N LS+ + E+ S ++ L
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL 336
Query: 558 GNKGLKRVSQEEQSNSMNRLRLL 580
++E + +R +
Sbjct: 337 AAADWLVPAREGEPAPADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 68/344 (19%), Positives = 118/344 (34%), Gaps = 57/344 (16%)
Query: 76 SSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLD 135
+ P L L +S N ++P+ L +L L L L +L++
Sbjct: 78 ALPPELRTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIF 129
Query: 136 MNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSII 195
NQL ++P L +L++ N L S+P+ L L+ Y N L+ S+P +
Sbjct: 130 GNQLT-SLPVLPPGLQ---ELSVSDNQL-ASLPALPSELCK---LWAYNNQLT-SLPMLP 180
Query: 196 GKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLH 255
L+ L +S+NQ + S+P L L +NN L+ S+P + LK L G
Sbjct: 181 SGLQE---LSVSDNQLA-SLPTLPSELYKLW---AYNNRLT-SLPALPSGLKELIVSG-- 230
Query: 256 INQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI 315
N+L +P L+ L + N L +P L L + N L +P
Sbjct: 231 -NRLTS-LPVLPSE---LKELMVSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLP--- 277
Query: 316 ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISG 375
E+ + T ++L N + + S I
Sbjct: 278 ---------------ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGY--SGPIIRF 320
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLN 419
+ + +++ +V + + N
Sbjct: 321 DMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 24/136 (17%), Positives = 46/136 (33%), Gaps = 10/136 (7%)
Query: 76 SSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLD 135
L L +S N ++P+ L L + NQL+ L P + L+ + L+
Sbjct: 238 VLPSELKELMVSGN-RLTSLPMLPSGL---LSLSVYRNQLTRL-PESLIHLSSETTVNLE 292
Query: 136 MNQLHGTIPPEIGQLSLIDKLA---LCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
N L + +++ + + + S P L A +L P
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE--P 350
Query: 193 SIIGKLKSLLQLDLSE 208
+ + Q D ++
Sbjct: 351 APADRWHMFGQEDNAD 366
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 8e-43
Identities = 76/438 (17%), Positives = 153/438 (34%), Gaps = 25/438 (5%)
Query: 140 HGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLK 199
+ I + + + + L+N ++ +++ +++ +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 200 SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQ 258
+ L+L++ Q + ++ + + N++ +PP + N+ L+ L L N
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 259 LNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGV---IPHSI 315
L+ N L L + NN L + SL L+L +N L V + S+
Sbjct: 135 LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL 194
Query: 316 ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISG 375
++ N LS + LD S+N+ +L+ + NN++
Sbjct: 195 FHANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD 246
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKL 435
+ N P L +DLS N + + + L +L ++ N+L + L + L
Sbjct: 247 --TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 303
Query: 436 QYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495
+ LDLS N L + ++ +L L L +N + + L L LSHN
Sbjct: 304 KVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDC 359
Query: 496 EIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGL 555
+ + +D + ++ C S + A +
Sbjct: 360 -----NSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVV 414
Query: 556 MEGNKGLKRVSQEEQSNS 573
+ + R S + NS
Sbjct: 415 EKVQRAQGRCSATDTINS 432
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-42
Identities = 73/387 (18%), Positives = 128/387 (33%), Gaps = 38/387 (9%)
Query: 157 ALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIP 216
+ I S+L +++ + L + + +
Sbjct: 9 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 68
Query: 217 LSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRV 275
L + + +++L + + I ++ L + N + P N+ L V
Sbjct: 69 ALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 127
Query: 276 LYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGD 335
L L N L L+ L ++ NNL + F
Sbjct: 128 LVLERNDLSSLPRGIFHNTPKLTTLS------------------MSNNNLERIEDDTFQA 169
Query: 336 HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSN 395
+L L LS+N + L VS N +S + ++ LD S N
Sbjct: 170 TTSLQNLQLSSNRL---THVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 221
Query: 396 HIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGN 455
I V+ + L L L N L+ + L +DLS N+L +
Sbjct: 222 SINV---VRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276
Query: 456 LLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHN 515
+ +L L +SNN+L + + + L LDLSHN L + LE L L HN
Sbjct: 277 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 334
Query: 516 NLSDFIPRCFEEMRSLSCIDISYNELH 542
++ + +L + +S+N+
Sbjct: 335 SIVT-LK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-33
Identities = 87/528 (16%), Positives = 165/528 (31%), Gaps = 103/528 (19%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLN 127
SF + LNL+ I +Q L +G N + L P +
Sbjct: 65 KLPAALLDSFRQVELLNLNDL-QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 123
Query: 128 QLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNS 186
L L L+ N L ++P I + L++ +NNL + ++L L L N
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182
Query: 187 LSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNL 246
L+ + + + SL ++S N S +L ++ + +NS++ +
Sbjct: 183 LT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVN 231
Query: 247 KSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNL 306
L+ L L N L + N L + L N L ++
Sbjct: 232 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYN--------------ELEKIM----- 270
Query: 307 LRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTF 366
Y F L L +SNN
Sbjct: 271 -----------------------YHPFVKMQRLERLYISNNRL----------------- 290
Query: 367 IVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVP 426
++ P L+VLDLS NH++ + L L L+ N +
Sbjct: 291 --------VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---T 338
Query: 427 LEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSEL 486
L+ + L+ L LS N + +++ + + + KI + E + E
Sbjct: 339 LKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKES 396
Query: 487 D----------LSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDI 536
D ++ + E++ + + +N + + ++ ++
Sbjct: 397 DKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEA 456
Query: 537 SYNELHGPIPNSTAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLN 584
NEL + T + ++ + L+ + E +N L
Sbjct: 457 EVNELRAEVQQLT---NEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLA 501
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 8e-17
Identities = 51/314 (16%), Positives = 106/314 (33%), Gaps = 19/314 (6%)
Query: 71 HDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLR 130
+ L L L N + + N L +DL N+L ++ K+ +L
Sbjct: 224 NVVRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281
Query: 131 RLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGS 190
RLY+ N+L + + + L L HN+L + + L LYL NS+ +
Sbjct: 282 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 338
Query: 191 IPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGN-LKSL 249
+ + +L L LS N + + +L ++ ++ + I L + L
Sbjct: 339 LK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCK 394
Query: 250 SALGLHINQLNGFIPPS---------IGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSEL 300
+ ++++L +I + G S+ + + + + L+ +L
Sbjct: 395 ESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQL 454
Query: 301 ELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNF 360
E N LR + + + L G E + ++ + +
Sbjct: 455 EAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHL 514
Query: 361 SKLSTFIVSMNNIS 374
+ F +
Sbjct: 515 KERQAFKLRETQAR 528
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 11/109 (10%), Positives = 38/109 (34%), Gaps = 2/109 (1%)
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNIL 493
+ +Y I ++ + +++ E L + + ++ +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 494 QEEIPPQV-CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
++P + + +E LNL+ + + F ++ + + +N +
Sbjct: 64 -RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 111
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-42
Identities = 54/235 (22%), Positives = 94/235 (40%), Gaps = 33/235 (14%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNE--VLALKEIRHRNNVK 663
IGKG G V+ + G+ VAVK F + + + E + +RH N +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILG 95
Query: 664 FHGFCYNGPHS----FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
F G S +L+ +Y + GSL L + L + + + L +LH
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 720 -----HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW----TEFAGTFG 770
P+I HRD+ SKN+L+ N ++D G+A ++ GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 771 YAAPEI------AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI 819
Y PE+ ++ D+YSFG++++EV + + +++
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNE--VLALKEIRHRNNVK 663
IGKG G V++ + G+ VAVK F+S+ + + E + +RH N +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILG 100
Query: 664 FHGFC----YNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
F +LV +Y + GSL L + I + A+ L++LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 720 HD-----CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS----NWTEFAGTFG 770
+ P+I HRD+ SKN+L+ N ++D G+A + GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 771 YAAPEI------AYTMRATEKYDVYSFGVLVFEVI 799
Y APE+ + ++ D+Y+ G++ +E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-41
Identities = 70/444 (15%), Positives = 146/444 (32%), Gaps = 83/444 (18%)
Query: 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQ 138
+ A+ + + L+ L LD ++ ++ + I KL L +L N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75
Query: 139 LHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKL 198
+ ++ L +NL L N L+ ++ + L
Sbjct: 76 I-------------------------TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPL 105
Query: 199 KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQ 258
L L+ N+ + L + LT ++ N+L+ I + + L+ L H+N+
Sbjct: 106 TKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNK 159
Query: 259 LNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERV 318
+ + L L N + ++ K L+ L TN + ++
Sbjct: 160 KIT--KLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-----KLD-- 207
Query: 319 LLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIP 378
+ LTFLD S+N + ++L+ F S+N ++ +
Sbjct: 208 --------------LNQNIQLTFLDCSSNKL---TEIDVTPLTQLTYFDCSVNPLT-ELD 249
Query: 379 PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYL 438
+ KL L ++ ++++ + + L+ T+L L
Sbjct: 250 --VSTLSKLTTLHCIQTDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLL 302
Query: 439 DLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIP 498
D ++ + KL YL L+N +L+ ++ L L + +Q+
Sbjct: 303 DCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF-- 354
Query: 499 PQVCNMGSLEKLNLSHNNLSDFIP 522
V + +L +
Sbjct: 355 SSVGKIPALNNNFEAEGQTITMPK 378
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 66/423 (15%), Positives = 140/423 (33%), Gaps = 43/423 (10%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
S L +L+ + ++ I L+ L L SN ++ L ++ + L L
Sbjct: 37 SEEQLATLTSLDCHNS-SITDMT-GIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLA 91
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
D N+L + + L+ + L N L + L L +N+L+ I
Sbjct: 92 CDSNKLT-NLD--VTPLTKLTYLNCDTNKL---TKLDVSQNPLLTYLNCARNTLT-EID- 143
Query: 194 IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALG 253
+ L +LD N+ + ++ + LT + N ++ + + K L+ L
Sbjct: 144 -VSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLN 197
Query: 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH 313
N + + L L +N L ++ L L+ + N L +
Sbjct: 198 CDTNNITKL---DLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTELDVS 251
Query: 314 ---SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
+ + Q +L + L + E+ + ++L
Sbjct: 252 TLSKLTTLHCIQTDLL---EIDLTHNTQLIYFQAEGCRKIKELDV--THNTQLYLLDCQA 306
Query: 371 NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFG 430
I+ + D+ +PKL L L++ + ++ + + L L + + G
Sbjct: 307 AGIT-EL--DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDFSSV--G 358
Query: 431 SLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSH 490
+ L + + ++PK L + +S + L + D +
Sbjct: 359 KIPALNNNFEAEGQT-ITMPKETLTNNSLT-IAVSPDLLDQFGNPMNIEPGDGGVYDQAT 416
Query: 491 NIL 493
N +
Sbjct: 417 NTI 419
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-21
Identities = 55/328 (16%), Positives = 108/328 (32%), Gaps = 30/328 (9%)
Query: 54 SRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSN 113
S +T LN + L L+ SFN L + L L+ +N
Sbjct: 145 SHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKI---TELDVSQNKLLNRLNCDTN 201
Query: 114 QLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGN 173
++ L ++ + QL L N+L I + L+ + N L + S
Sbjct: 202 NITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--T 252
Query: 174 LSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNN 233
LS L L+ + L I + L+ + + ++ + + L ++
Sbjct: 253 LSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVT--HNTQLYLLDCQAA 307
Query: 234 SLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGY 293
++ + L L L L+ +L + + + L+ L N + F +G
Sbjct: 308 GIT-ELD--LSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQDF--SSVGK 359
Query: 294 LKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSN----NNF 349
+ +L+ +P +S + + FG+ N+ D N
Sbjct: 360 IPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNT 418
Query: 350 CGEISFNWGNFSKLSTFIVSMNNISGSI 377
+ + N + TF I G++
Sbjct: 419 ITWENLSTDNPAVTYTFTSENGAIVGTV 446
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-41
Identities = 77/391 (19%), Positives = 133/391 (34%), Gaps = 72/391 (18%)
Query: 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSG 213
D+ LCH ++P + + +L L KN + L +L+L+EN S
Sbjct: 13 DRAVLCHRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70
Query: 214 SIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSS 272
P + NL +L + L +N L IP + L +L+ L + N++ + +L +
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129
Query: 273 LRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEA 332
L+ L + +N L + + A
Sbjct: 130 LKSLEVGDN--------------DLVYIS----------------------------HRA 147
Query: 333 FGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDL 392
F +L L L N I S L L VL L
Sbjct: 148 FSGLNSLEQLTLEKCNL-TSIPTEA--LSHL---------------------HGLIVLRL 183
Query: 393 SSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKS 452
+I + L L L ++ + L L ++ L++ +
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLA 243
Query: 453 IGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV-CNMGSLEKLN 511
+ +L+ L +LNLS N +S + +L+ L E+ L L + P + L LN
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLN 302
Query: 512 LSHNNLSDFIPRCFEEMRSLSCIDISYNELH 542
+S N L+ F + +L + + N L
Sbjct: 303 VSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 78/329 (23%), Positives = 131/329 (39%), Gaps = 26/329 (7%)
Query: 42 CSWFG--ISCNHAG-SRV---ISITMSTLGLNG----TFHDFSFSSFPHLANLNLSFNLF 91
CS + C+ V I L L T + F+SFPHL L L+ N+
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI- 67
Query: 92 FGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRRLYLDMNQLHGTIPPEI-G 148
+ NL L+ L L SN+L LIP + L+ L +L + N++ + +
Sbjct: 68 VSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQ 125
Query: 149 QLSLIDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDL 206
L + L + N+L I + L++L L L K +L+ SIP+ + L L+ L L
Sbjct: 126 DLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRL 183
Query: 207 SENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPS 266
+ S L L ++ + + ++ P +L++L + L +
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLA 243
Query: 267 IGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP------HSIERVLL 320
+ +L LR L L N + + L L E++L L V P + + + +
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303
Query: 321 NQNNLSGKMYEAFGDHPNLTFLDLSNNNF 349
+ N L+ F NL L L +N
Sbjct: 304 SGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-31
Identities = 63/322 (19%), Positives = 110/322 (34%), Gaps = 26/322 (8%)
Query: 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMN 137
L+L N + + L+ L+L N +S + P L LR L L N
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90
Query: 138 QLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS-II 195
+L IP + LS + KL + N + + +L NL L + N L I
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 196 GKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLH 255
L SL QL L + + +L +L L ++ L + +++ L L L +
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208
Query: 256 INQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI 315
+ P+ +L L + + L + +L L L L N + +
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS-- 266
Query: 316 ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFN-WGNFSKLSTFIVSMNNIS 374
+ L + L + + + L VS N ++
Sbjct: 267 ----------------MLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309
Query: 375 GSIPPDI-GNSPKLQVLDLSSN 395
++ + + L+ L L SN
Sbjct: 310 -TLEESVFHSVGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 42/195 (21%), Positives = 82/195 (42%), Gaps = 6/195 (3%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLN 127
+FS L L L +IP + +L L L L ++ + +L
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLY 200
Query: 128 QLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKNS 186
+L+ L + T+ P + L++ H NL ++P ++ +L L L L N
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNP 259
Query: 187 LSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGN 245
+S S++ +L L ++ L Q + P + L+ L ++++ N L+ ++ + +
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 246 LKSLSALGLHINQLN 260
+ +L L L N L
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 60/353 (16%), Positives = 124/353 (35%), Gaps = 40/353 (11%)
Query: 166 SIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSL 225
+I N + + + +SL ++ S+ ++ +LDLS N S L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 226 TMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYG 285
+++L +N L + +L +L L L+ N + + S+ L+ NN +
Sbjct: 61 ELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 286 FVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLS 345
V + + L N + + G + +LDL
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDL------------------DEGCRSRVQYLDLK 152
Query: 346 NNNFCGEISFNW--GNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPV 403
N ++F + L + N I + + KL+ LDLSSN + +
Sbjct: 153 LNEI-DTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGP 208
Query: 404 QLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSS-SIPKSIGNLLKLHYL 462
+ + + + + L N+L + L++ DL N ++ ++ +
Sbjct: 209 EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267
Query: 463 NLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIP-PQVCNMGSLEKLNLSH 514
+ K+ + E+ + L E++P P + +L + H
Sbjct: 268 AKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 54/374 (14%), Positives = 107/374 (28%), Gaps = 63/374 (16%)
Query: 99 IGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158
N ++ + + + L + ++ L L N L I
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAA------------ 52
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218
L + L +L L N L + L +L LDL+ N
Sbjct: 53 -----------DLAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----E 94
Query: 219 LGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYL 278
L S+ + NN++S + + + L N++ G S ++ L L
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 279 YNNGLYGF-VPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHP 337
N + E +L L L N + + +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-------------------VFA 191
Query: 338 NLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397
L LDLS+N + + + + ++ + N + I + S L+ DL N
Sbjct: 192 KLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 398 VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL 457
++ + + + + + + L +P + L
Sbjct: 250 HC-GTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307
Query: 458 KLHYLNLSNNQLSH 471
+ L ++ H
Sbjct: 308 ----IALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 51/290 (17%), Positives = 102/290 (35%), Gaps = 19/290 (6%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
S ++ L+LS N + +KL+ L+L SN L ++ L+ LR L
Sbjct: 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLD 86
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
L+ N + E+ I+ L +NN+ + S +YL N ++
Sbjct: 87 LNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDL 138
Query: 194 IIGKLKSLLQLDLSENQFSG-SIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSAL 252
G + LDL N+ + + +L ++L N + + + L L
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTL 196
Query: 253 GLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP 312
L N+L F+ P + + + + L NN L + + + + ++L +L N
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTL 254
Query: 313 HSIERVLLNQNNLSGKMYEAFGDHP----NLTFLDLSNNNFCGEISFNWG 358
++ + + + L C ++ +
Sbjct: 255 RDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 54/316 (17%), Positives = 107/316 (33%), Gaps = 34/316 (10%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYL 134
+ ++ + + + ++ LDL N LS + ++ +L L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 135 DMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSI 194
N L ++ LS + L L +N + L ++ L+ N++S +
Sbjct: 66 SSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSC- 116
Query: 195 IGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG-SIPPILGNLKSLSALG 253
+ + + L+ N+ + L G S + + L N + + + + +L L
Sbjct: 117 -SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH 313
L N + + + + L+ L L +N L F+ E ++ + L N L +I
Sbjct: 176 LQYNFIYD-VKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIE- 230
Query: 314 SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF-CGEISFNWGNFSKLSTFIVSMNN 372
+A NL DL N F CG + + ++ T
Sbjct: 231 -----------------KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
Query: 373 ISGSIPPDIGNSPKLQ 388
+ P L
Sbjct: 274 KLTGQNEEECTVPTLG 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 46/260 (17%), Positives = 91/260 (35%), Gaps = 16/260 (6%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQ 128
+ F L LNLS N+ + +LS L+ LDL +N + E+
Sbjct: 48 QISAADLAPFTKLELLNLSSNV-LYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPS 100
Query: 129 LRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLS 188
+ L+ N + + GQ + L +N + G S + L L N +
Sbjct: 101 IETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 189 G-SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLK 247
+ + +L L+L N + + + L + L +N L+ + P +
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAA 214
Query: 248 SLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLL 307
++ + L N+L I ++ +L L NG + + K+ + +
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTV 272
Query: 308 RGVIPHSIERVLLNQNNLSG 327
+ + + E + G
Sbjct: 273 KKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 29/166 (17%), Positives = 67/166 (40%), Gaps = 10/166 (6%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKL 435
+I N + ++ ++ + + + + ++ +L L+ N LS + TKL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 436 QYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495
+ L+LS+N L + +L L L+L+NN + E + L ++N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112
Query: 496 EIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
+ + + L++N ++ + +D+ NE+
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 31/188 (16%), Positives = 60/188 (31%), Gaps = 6/188 (3%)
Query: 69 TFHDFSFSSFPHLANLNLSFN-LFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLN 127
D + L+L N + N + L++L+L N + + ++
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FA 191
Query: 128 QLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSL 187
+L+ L L N+L + PE + + ++L +N L I +L NL L N
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 188 SGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLK 247
K+ +++ + + T+ P L
Sbjct: 250 H-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308
Query: 248 SLSALGLH 255
+L H
Sbjct: 309 ALGHHHHH 316
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-40
Identities = 94/468 (20%), Positives = 180/468 (38%), Gaps = 43/468 (9%)
Query: 103 SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHN 161
+ + L L N +S L P+I L++LR L L N++ ++ + ++ L + HN
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110
Query: 162 NLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP--SIIGKLKSLLQLDLSENQFSGSIPLSL 219
L +I +++L L L N +P G L L L LS +F L L
Sbjct: 111 RLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ---LDL 163
Query: 220 GNLSSLTMMSLFNNSLSGSIPPI-LGNLKSLSALGLHINQLNGFIPPSIGNLS------- 271
++ L + + + +S I +L+ + LH+ + N+S
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL 223
Query: 272 SLRVLYLYNNGLYGFVPEEIGYLKSLSELEL-----------CTNLLRGVIPHSIERVLL 320
L + L + + + + L + L + P +E + +
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283
Query: 321 NQNNLSGKMYEAFGDH-----PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISG 375
++ ++ + +L + N F + F++++ ++S+++
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS--GGVPLEFGSLT 433
+ L+ + N + L L LIL N L V L +++
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS 403
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLL-KLHYLNLSNNQLSHKIPTEFEKL-IHLSELDLSHN 491
L+ LD+S N L+S + LNLS+N L+ + F L + LDL +N
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNN 460
Query: 492 ILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYN 539
+ IP V ++ +L++LN++ N L F+ + SL I + N
Sbjct: 461 RIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-31
Identities = 80/473 (16%), Positives = 150/473 (31%), Gaps = 88/473 (18%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYL 134
S L L LS N +++ LD L L +
Sbjct: 72 ISFLSELRVLRLSHN--------------RIRSLDFHV----------FLFNQDLEYLDV 107
Query: 135 DMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP-- 192
N+L +I +++L L L N +P
Sbjct: 108 SHNRLQ-------------------------NISC--CPMASLRHLDLSFNDFD-VLPVC 139
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPI-LGNLKSLSA 251
G L L L LS +F L L ++ L + + + +S I +L+ +
Sbjct: 140 KEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT 196
Query: 252 LGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVI 311
LH+ + N+S + +L + + + LSEL LL +
Sbjct: 197 TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL 256
Query: 312 PHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMN 371
H + F + +L++ N I +S+ +
Sbjct: 257 QH------IETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL------ 304
Query: 372 NISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGS 431
L + + + + + + +N +L+++ + S
Sbjct: 305 -------------KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPS 351
Query: 432 LTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH--KIPTEFEKLIHLSELDLS 489
+ +L+ + N + S+ + L +L L L N L + K+ + + L LD+S
Sbjct: 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVS 411
Query: 490 HNILQEEIPPQVCN-MGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
N L + C S+ LNLS N L+ + RC + +D+ N +
Sbjct: 412 LNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRI 462
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-29
Identities = 82/419 (19%), Positives = 149/419 (35%), Gaps = 33/419 (7%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL-IPPEIGKLNQLRRLY 133
F L L++S N NI ++ L++LDL N L + E G L +L L
Sbjct: 96 FLFNQDLEYLDVSHNRL-QNIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
L + + L L L + + + N VL+L + S
Sbjct: 153 LSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 194 IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGN-------- 245
+ + +L L LS + + L S +++
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 246 -----LKSLSALGLHINQLNGFIPPSIGN--LSSLRVLYLYNNGLYGFVPEEIGYLKSLS 298
++ L+ L I + + L SL + ++ N ++
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 299 ELELCTNLLRGV------IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF--C 350
L + + P S + QN + +++ L L L N
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF 392
Query: 351 GEISFNWGNFSKLSTFIVSMNNI-SGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLS 409
+++ N S L T VS+N++ S + + + VL+LSSN + G + L
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PP 450
Query: 410 SLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNN 467
+ L L+ N++ +P + L LQ L++++N+L S+P + L L Y+ L +N
Sbjct: 451 KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL-KSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 84/429 (19%), Positives = 152/429 (35%), Gaps = 48/429 (11%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPL--QIGNLSKLQYLDLGSNQLSGLIPPEIGKLN-QLR 130
S L +L+LSFN F +P+ + GNL+KL +L L + + L + L+
Sbjct: 116 SCCPMASLRHLDLSFND-FDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCI 174
Query: 131 RLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGS 190
L L + G + + + H N S+ ++ ++ L L L L+
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS-VNALGHLQLSNIKLNDE 233
Query: 191 IPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLS 250
+ S L + + L + + LF ++ L+
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVT----LQHIETTWKCSVKLFQFFW-------PRPVEYLN 282
Query: 251 ALGLHINQLNGFIPPSIGN--LSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308
L I + + L SL + ++ N +E+ N+
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE---ALYSVFAEM----NIKM 335
Query: 309 GVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIV 368
L+ ++ + TFL+ + N F + +L T I+
Sbjct: 336 -----------LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 369 SMNNISGSIPPDIGNSPKLQVLDLSSNHIV----GKIPVQLEMLSSLNKLILNLNQLSGG 424
N + + + + L+ + S+ L L+ N L+G
Sbjct: 385 QRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443
Query: 425 VPLEFGSLT-KLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIH 482
V F L K++ LDL N++ SIPK + +L L LN+++NQL +P F++L
Sbjct: 444 V---FRCLPPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTS 498
Query: 483 LSELDLSHN 491
L + L N
Sbjct: 499 LQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 44/236 (18%), Positives = 87/236 (36%), Gaps = 12/236 (5%)
Query: 54 SRVISITMSTLGLNG----TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLD 109
V + + L + +S ++ L ++ +F + +++
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 110 LGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPS 169
L + + + L N ++ L + L L N L +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 170 SLGNLSNLAVLYLYKNSL----SGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSL 225
N++ L SL S + +S+L L+LS N +GS+ L +
Sbjct: 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKV 452
Query: 226 TMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNN 281
++ L NN + SIP + +L++L L + NQL L+SL+ ++L++N
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-18
Identities = 56/365 (15%), Positives = 122/365 (33%), Gaps = 45/365 (12%)
Query: 14 TSLQNQNLNSSLLSSWTLYPANATKISPCSW--FGISCNHAGSRVISITMSTLGLNGTFH 71
L + ++ S + + F + N + + + + +S + LN
Sbjct: 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235
Query: 72 DFSFSSFPHLANLNLSFNLFFGNIP---------LQIGNLSKLQYLDLGSNQLSGLIPPE 122
+ L N+ +I Q ++YL++ + ++ I E
Sbjct: 236 QRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295
Query: 123 IG-----KLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNL 177
L L ++ + + ++ L ++ + S+
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355
Query: 178 AVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL-- 235
L +N + S+ LK L L L N + +++ + + SL
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS 414
Query: 236 --SGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGY 293
S + +S+ L L N L G + + ++VL L+NN + P+++ +
Sbjct: 415 LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMSI-PKDVTH 471
Query: 294 LKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF---C 350
L++L EL + +N L+ +P F +L ++ L +N + C
Sbjct: 472 LQALQELNVASNQLK-SVPDG-----------------VFDRLTSLQYIWLHDNPWDCTC 513
Query: 351 GEISF 355
I +
Sbjct: 514 PGIRY 518
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 53/289 (18%), Positives = 99/289 (34%), Gaps = 34/289 (11%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
+P + + L+QN++S L L LS+N S ++ F
Sbjct: 50 LPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR---SLDFHVFLFN------- 99
Query: 371 NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQL-SGGVPLEF 429
L+ LD+S N + I ++SL L L+ N V EF
Sbjct: 100 --------------QDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEF 142
Query: 430 GSLTKLQYLDLSTNKLSSSIPKSIGNL-LKLHYLNLSNNQLSHKIPTEFEKLIHLSELDL 488
G+LTKL +L LS K + +L L L+L + + + + + L L
Sbjct: 143 GNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHL 201
Query: 489 SHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548
+ ++ +L L LS+ L+D + S + + +
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261
Query: 549 TAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNFDGKIMHEEIIKA 597
T + + V + ++ L + ++ + E +K+
Sbjct: 262 TWKCSVKLFQFFWPRPV----EYLNIYNLTITERIDREEFTYSETALKS 306
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 52/367 (14%), Positives = 110/367 (29%), Gaps = 64/367 (17%)
Query: 180 LYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSI 239
+ +L+ +P + L LS+N S + LS L ++ L +N + S+
Sbjct: 36 VDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SL 91
Query: 240 PP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLS 298
+ + L L + N+L I ++SLR L L N L
Sbjct: 92 DFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDF-----------DVLP 137
Query: 299 ELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWG 358
+ NL LTFL LS F +
Sbjct: 138 VCKEFGNL------------------------------TKLTFLGLSAAKF---RQLDLL 164
Query: 359 NFSKLSTFIVSMNNISGSIP---PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLI 415
+ L + ++ +S I + P VL L + +++L L
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQ 224
Query: 416 LNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPT 475
L+ +L+ + + ++ ++ + + +
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY---- 280
Query: 476 EFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCID 535
+++ L ++ I +EE + SL ++ + + ++
Sbjct: 281 -----LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 536 ISYNELH 542
+S ++
Sbjct: 336 LSISDTP 342
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 80/350 (22%), Positives = 127/350 (36%), Gaps = 62/350 (17%)
Query: 176 NLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL 235
+L V+ L +P + LDL N+ + NL +L + L NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 236 SGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYL 294
S I P L L L L NQL +P + +L+ L ++ N + L
Sbjct: 89 S-KISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGL 144
Query: 295 KSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEIS 354
+ +EL TN L+ IE AF L+++ +++ N
Sbjct: 145 NQMIVVELGTNPLKSS---GIEN-------------GAFQGMKKLSYIRIADTN------ 182
Query: 355 FNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQ-LEMLSSLNK 413
I+ +IP G P L L L N I K+ L+ L++L K
Sbjct: 183 ------------------IT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAK 220
Query: 414 LILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH-- 471
L L+ N +S + L+ L L+ NKL +P + + + + L NN +S
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIG 279
Query: 472 ----KIPTEFEKLIHLSELDLSHNILQ-EEIPPQV-CNMGSLEKLNLSHN 515
P K S + L N +Q EI P + + L +
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 69/350 (19%), Positives = 116/350 (33%), Gaps = 83/350 (23%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLH 164
LDL +N+++ + + L L L L N++ I P
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPG------------------ 94
Query: 165 GSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSS 224
+ L L LYL KN L +P K+L +L + EN+ + L+
Sbjct: 95 -----AFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 225 LTMMSLFNNSL-SGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNG 282
+ ++ L N L S I +K LS + + + IP G SL L+L N
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNK 203
Query: 283 LYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFL 342
+ + L +L++L L N + V + + P+L L
Sbjct: 204 ITKVDAASLKGLNNLAKLGLSFNSISAVDNG------------------SLANTPHLREL 245
Query: 343 DLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI----- 397
L+NN L +P + + +QV+ L +N+I
Sbjct: 246 HLNNNK--------------LV-----------KVPGGLADHKYIQVVYLHNNNISAIGS 280
Query: 398 -VGKIPVQLEMLSSLNKLILNLNQLSGGV--PLEFGSLTKLQYLDLSTNK 444
P +S + + L N + P F + + L K
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 61/297 (20%), Positives = 106/297 (35%), Gaps = 38/297 (12%)
Query: 263 IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQ 322
+P + +L L NN + + LK+L L L N + + P
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP---------- 93
Query: 323 NNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDI- 381
AF L L LS N L V N I+ + +
Sbjct: 94 --------GAFAPLVKLERLYLSKNQL---KELPEKMPKTLQELRVHENEIT-KVRKSVF 141
Query: 382 GNSPKLQVLDLSSNHI-VGKIPVQ-LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLD 439
++ V++L +N + I + + L+ + + ++ + G L L
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELH 198
Query: 440 LSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPP 499
L NK++ S+ L L L LS N +S HL EL L++N L ++P
Sbjct: 199 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257
Query: 500 QVCNMGSLEKLNLSHNNLSDF------IPRCFEEMRSLSCIDISYNEL-HGPIPNST 549
+ + ++ + L +NN+S P + S S + + N + + I ST
Sbjct: 258 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 314
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 70/287 (24%), Positives = 109/287 (37%), Gaps = 25/287 (8%)
Query: 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMN 137
P A L+L N NL L L L +N++S + P L +L RLYL N
Sbjct: 51 PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110
Query: 138 QLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSI--PSII 195
QL +P + +L + N + S L+ + V+ L N L S
Sbjct: 111 QLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 196 GKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGL 254
+K L + +++ + +IP L SLT + L N ++ + L L +L+ LGL
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGL 223
Query: 255 HINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP-- 312
N ++ S+ N LR L+L NN L VP + K + + L N + +
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 313 ----------HSIERVLLNQNNLSGKMYE--AFGDHPNLTFLDLSNN 347
S V L N + + F + L N
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 27/144 (18%), Positives = 46/144 (31%), Gaps = 23/144 (15%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLN 127
S +LA L LSFN + N L+ L L +N+L +P +
Sbjct: 206 KVDAASLKGLNNLAKLGLSFNS-ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263
Query: 128 QLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSL 187
++ +YL N +S I C P ++ + + L+ N +
Sbjct: 264 YIQVVYLHNN-----------NISAIGSNDFCP-------PGYNTKKASYSGVSLFSNPV 305
Query: 188 SGSI--PSIIGKLKSLLQLDLSEN 209
PS + + L
Sbjct: 306 QYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 22/111 (19%), Positives = 43/111 (38%), Gaps = 13/111 (11%)
Query: 63 TLGLNG----TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL 118
LGL+ + S ++ PHL L+L+ N +P + + +Q + L +N +S +
Sbjct: 220 KLGLSFNSISAVDNGSLANTPHLRELHLNNNK-LVKVPGGLADHKYIQVVYLHNNNISAI 278
Query: 119 ------IPPEIGKLNQLRRLYLDMNQL-HGTIPPEI-GQLSLIDKLALCHN 161
P K + L N + + I P + + + L +
Sbjct: 279 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 22/240 (9%)
Query: 606 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
IG+G +VYK + + VA + Q ++ F E LK ++H N V+F
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 665 HGFCYNGPHS----FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
+ + LV E + G+L L K + + + + L +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH- 146
Query: 721 DCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT 779
P IIHRD+ N+ + + D G+A +S GT + APE+ Y
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEM-YE 203
Query: 780 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVMD 839
+ E DVY+FG+ + E+ +P +S N ++ P V
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASFDKVAI 256
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 64/306 (20%), Positives = 115/306 (37%), Gaps = 23/306 (7%)
Query: 224 SLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGL 283
L ++ + L ++P + + L L N ++ L L L L NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 284 YGFVPEEIGYLKSLSELELCTNLLRGV---IPHSIERVLLNQNNLSGKMYEAFGDHPNLT 340
+ L+ L +L + N L + +P S+ + ++ N + F N+
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMN 150
Query: 341 FLDLSNNNFCGEISFNWGNFS--KLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIV 398
+++ N F G F KL+ +S ++ IP D+ L L L N I
Sbjct: 151 CIEMGGNPL-ENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ 206
Query: 399 GKIPVQ-LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL 457
I ++ L S L +L L NQ+ L L+ L L NKLS +P + +L
Sbjct: 207 -AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLK 264
Query: 458 KLHYLNLSNNQLSHKIPTEF------EKLIHLSELDLSHNILQ-EEIPPQV-CNMGSLEK 509
L + L N ++ +F K + + + L +N + E+ P +
Sbjct: 265 LLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324
Query: 510 LNLSHN 515
+ +
Sbjct: 325 IQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 72/326 (22%), Positives = 113/326 (34%), Gaps = 39/326 (11%)
Query: 176 NLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL 235
+L V+ L ++P I LDL N S L L + L NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 236 SGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYL 294
S I L+ L L + N L IPP++ SSL L +++N + L
Sbjct: 91 S-KIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGL 146
Query: 295 KSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEIS 354
++++ +E+ N L E AF D L +L +S
Sbjct: 147 RNMNCIEMGGNPLENS---GFEP-------------GAF-DGLKLNYLRISEAKL---TG 186
Query: 355 FNWGNFSKLSTFIVSMNNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNK 413
L+ + N I +I + KL L L N I L L +L +
Sbjct: 187 IPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245
Query: 414 LILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSS------SIPKSIGNLLKLHYLNLSNN 467
L L+ N+LS VP L LQ + L TN ++ + ++L NN
Sbjct: 246 LHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNN 304
Query: 468 QLSHKI--PTEFEKLIHLSELDLSHN 491
+ + P F + + +
Sbjct: 305 PVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 66/368 (17%), Positives = 115/368 (31%), Gaps = 75/368 (20%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPE-IGQLSLIDKLALCHNNL 163
L+ + L +P EI L L N + + + L + L L +N +
Sbjct: 35 LRVVQCSDLGLKA-VPKEISP--DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 164 HGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLS 223
+ L L LY+ KN L IP SL++L + +N+ L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 224 SLTMMSLFNNSL-SGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNG 282
++ + + N L + P + L+ L + +L G IP +L L+L +N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPETLNELHLDHNK 204
Query: 283 LYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFL 342
+ E++ L L L N +R + + P L L
Sbjct: 205 IQAIELEDLLRYSKLYRLGLGHNQIRMIENG------------------SLSFLPTLREL 246
Query: 343 DLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIP 402
L NN KLS +P + + LQV+ L +N+I K+
Sbjct: 247 HLDNN--------------KLS-----------RVPAGLPDLKLLQVVYLHTNNIT-KVG 280
Query: 403 VQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLS-SSIPKSI-GNLLKLH 460
V + + L N + + + +
Sbjct: 281 V--NDFCPVG---------------FGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323
Query: 461 YLNLSNNQ 468
+ N +
Sbjct: 324 AIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 67/286 (23%), Positives = 104/286 (36%), Gaps = 24/286 (8%)
Query: 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMN 137
P L+L N L L L L +N++S + L +L++LY+ N
Sbjct: 53 SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 138 QLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSL-SGSIPSIIG 196
L IPP S + +L + N + L N+ + + N L +
Sbjct: 113 HLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 197 KLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLH 255
L L +SE + + IP L +L + L +N + +I L L LGL
Sbjct: 170 DGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225
Query: 256 INQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR------- 308
NQ+ S+ L +LR L+L NN L VP + LK L + L TN +
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284
Query: 309 -----GVIPHSIERVLLNQNNLSGKMYE--AFGDHPNLTFLDLSNN 347
GV + L N + + F + + N
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 56/244 (22%), Positives = 90/244 (36%), Gaps = 18/244 (7%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQ 128
H+ +FS L L +S N + S L L + N++ + L
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLVE---IPPNLPSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 129 LRRLYLDMNQL-HGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSL 187
+ + + N L + P ++ L + L IP L L L+L N +
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKI 205
Query: 188 SGSIPS-IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNL 246
+I + + L +L L NQ SL L +L + L NN LS +P L +L
Sbjct: 206 Q-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263
Query: 247 KSLSALGLHINQL-----NGFIPPSIG-NLSSLRVLYLYNNGL-YGFVPEEI-GYLKSLS 298
K L + LH N + N F P G + + L+NN + Y V +
Sbjct: 264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323
Query: 299 ELEL 302
++
Sbjct: 324 AIQF 327
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 42/230 (18%), Positives = 76/230 (33%), Gaps = 27/230 (11%)
Query: 331 EAFGDHPNLTFLDLSNNNFCGEISFNWGNF------------SKLSTFIV----SMNNIS 374
E P+L L + + C ++S N+IS
Sbjct: 8 ETTSGIPDLDSLPPTYSAMCPFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS 67
Query: 375 GSIPPD-IGNSPKLQVLDLSSNHIVGKIPVQ-LEMLSSLNKLILNLNQLSGGVPLEFGSL 432
+ D L L L +N I KI + L L KL ++ N L +
Sbjct: 68 -ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLVE---IPPNLP 122
Query: 433 TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH-KIPTEFEKLIHLSELDLSHN 491
+ L L + N++ L ++ + + N L + + L+ L +S
Sbjct: 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182
Query: 492 ILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
L IP + +L +L+L HN + L + + +N++
Sbjct: 183 KLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI 229
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 23/143 (16%), Positives = 42/143 (29%), Gaps = 23/143 (16%)
Query: 71 HDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLNQL 129
+ L L L N I L L+ L L +N+LS +P + L L
Sbjct: 209 ELEDLLRYSKLYRLGLGHNQ-IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLL 266
Query: 130 RRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG 189
+ +YL N ++ + C + + L+ N +
Sbjct: 267 QVVYLHTN-----------NITKVGVNDFCP-------VGFGVKRAYYNGISLFNNPVPY 308
Query: 190 SI--PSIIGKLKSLLQLDLSENQ 210
P+ + L + +
Sbjct: 309 WEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 12/94 (12%)
Query: 63 TLGLNG----TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL 118
LGL + S S P L L+L N +P + +L LQ + L +N ++ +
Sbjct: 221 RLGLGHNQIRMIENGSLSFLPTLRELHLDNNK-LSRVPAGLPDLKLLQVVYLHTNNITKV 279
Query: 119 IP------PEIGKLNQLRRLYLDMNQL-HGTIPP 145
K + L N + + + P
Sbjct: 280 GVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-33
Identities = 59/324 (18%), Positives = 108/324 (33%), Gaps = 51/324 (15%)
Query: 214 SIPLSLGNLSSLTMMSLFNN--SLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLS 271
SI L + N SL+ S +N + + G + N+ + + ++
Sbjct: 2 SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59
Query: 272 SLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYE 331
L L L +P+ + ++ LE+ N L +P
Sbjct: 60 QFSELQLNRLNL-SSLPDNLP--PQITVLEITQNALI-SLPELP---------------- 99
Query: 332 AFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLD 391
+L +LD +N + + L V N ++ +P L+ ++
Sbjct: 100 -----ASLEYLDACDNRL-STLPELPASLKHLD---VDNNQLT-MLPELPAL---LEYIN 146
Query: 392 LSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPK 451
+N + +P E+ +SL L + NQL+ +P L+ LD+STN L S +P
Sbjct: 147 ADNNQLT-MLP---ELPTSLEVLSVRNNQLTF-LP---ELPESLEALDVSTNLLES-LPA 197
Query: 452 SIGNLLKL----HYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSL 507
+ N+++H IP L + L N L I + +
Sbjct: 198 VPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256
Query: 508 EKLNLSHNNLSDFIPRCFEEMRSL 531
+ S + R L
Sbjct: 257 PDYHGPRIYFSMSDGQQNTLHRPL 280
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 71/421 (16%), Positives = 133/421 (31%), Gaps = 62/421 (14%)
Query: 75 FSSFPHLANLNLSFNLFFGNIP--LQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
FS++ L L+ +++ L L LS L P + Q+ L
Sbjct: 30 FSAWDKWEKQALPGENR-NEAVSLLKECLINQFSELQLNRLNLSSL-PDNLPP--QITVL 85
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
+ N L ++P L L C N L ++P +L + L + N L+ +P
Sbjct: 86 EITQNALI-SLPELPASLE---YLDACDNRLS-TLPELPASLKH---LDVDNNQLT-MLP 136
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSAL 252
+ L+ ++ NQ + +P +L L S+ NN L+ +P + +L++L
Sbjct: 137 ELPALLEY---INADNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPELPESLEALD-- 186
Query: 253 GLHINQLNGFIPPSIGNLSSLR----VLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308
+ N L +P N + +PE I L + L N L
Sbjct: 187 -VSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNPLS 243
Query: 309 GVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIV 368
I S+ T + I F+ + + +
Sbjct: 244 SRIRESL---------------------SQQTAQPDYHGP---RIYFSMSDGQQNTLHRP 279
Query: 369 SMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLE 428
+ ++ P + + L+ LS N + V
Sbjct: 280 LADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSA-RNTSGFREQVAAW 338
Query: 429 FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKI-----PTEFEKLIHL 483
L+ L + +++ +S + + L + NL L H+ + L+ L
Sbjct: 339 LEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
Query: 484 S 484
Sbjct: 399 G 399
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 51/263 (19%), Positives = 107/263 (40%), Gaps = 42/263 (15%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
DF+ C+G+GG G V++A+ A+K+ L ++ + EV AL ++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKVMREVKALAKLE 61
Query: 658 HRNNVKFHG-FCYNGPHS-----------FLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
H V++ + ++ + + +L + T +E + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV---------- 755
++ +A A+ +LH ++HRD+ N+ + V DFG+ +
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 756 --GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFS 813
P + T GT Y +PE + + K D++S G+++FE++ +P FS
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP-------FS 228
Query: 814 SFSNMIIDVNKILDPRLPTPSPS 836
+ + + + + + P P +
Sbjct: 229 TQMERVRTLTDVRNLKFP-PLFT 250
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 61/279 (21%), Positives = 111/279 (39%), Gaps = 26/279 (9%)
Query: 568 EEQSNSMNRLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAE-LPSGDIV 626
+EQS M + + + +F + IG+G VY+A L G V
Sbjct: 2 DEQSQGMQGPPVPQFQP-QKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 627 AVKKFNSQLLSGNMADHD--EFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRG 684
A+KK + M + + E+ LK++ H N +K++ +V E D G
Sbjct: 61 ALKKVQ---IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117
Query: 685 SLARILGDDVTAKELGWNRR-------INVIKGVANALSYLHHDCLPSIIHRDISSKNVL 737
L+R++ K +R + +AL ++H ++HRDI NV
Sbjct: 118 DLSRMI------KHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVF 168
Query: 738 LDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFE 797
+ + + D G+ +F ++ GT Y +PE + K D++S G L++E
Sbjct: 169 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228
Query: 798 VIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPS 836
+ P F + + ++ + + P LP+ S
Sbjct: 229 MAALQSP---FYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 8/238 (3%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNN--FCGEISFNWGNFSKLSTFIV 368
IP S R+ L N L + F LT L LS+N F G S + + L +
Sbjct: 26 IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 369 SMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLSGGVPL 427
S N + ++ + +L+ LD +++ + L +L L ++
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 144
Query: 428 EFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSEL 486
F L+ L+ L ++ N + I L L +L+LS QL PT F L L L
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204
Query: 487 DLSHNILQEEIPPQV-CNMGSLEKLNLSHNNLSDFIPRCFEEM-RSLSCIDISYNELH 542
++SHN + + SL+ L+ S N++ + + SL+ ++++ N+
Sbjct: 205 NMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 61/250 (24%), Positives = 101/250 (40%), Gaps = 24/250 (9%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQL-HGTIPPEIGQ-LSLIDKLALCHNN 162
L+L SN+L L KL QL +L L N L + + + L L N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 163 LHGSIPSSLGNLSNLAVLYLYKNSLSGSIP--SIIGKLKSLLQLDLSENQFSGSIPLSLG 220
+ ++ S+ L L L ++L + S+ L++L+ LD+S +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147
Query: 221 NLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLY 279
LSSL ++ + NS + P I L++L+ L L QL P + +LSSL+VL +
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207
Query: 280 NNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNL 339
+N + L SL L+ N + ++ +L
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP-----------------SSL 250
Query: 340 TFLDLSNNNF 349
FL+L+ N+F
Sbjct: 251 AFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 69/325 (21%), Positives = 110/325 (33%), Gaps = 77/325 (23%)
Query: 200 SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQ 258
S ++ + + S+P + SS T + L +N L S+P + L L+ L L N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNG 63
Query: 259 LN--GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIE 316
L+ G S +SL+ L L NG+ + L+ L L+ + L+ + S
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS-- 120
Query: 317 RVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGS 376
F NL +LD+S+ +
Sbjct: 121 ---------------VFLSLRNLIYLDISHTH------------------------TR-V 140
Query: 377 IPPDI-GNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKL 435
I L+VL ++ N + F L L
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDI-----------------------FTELRNL 177
Query: 436 QYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495
+LDLS +L P + +L L LN+S+N ++ L L LD S N +
Sbjct: 178 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM- 236
Query: 496 EIPPQVCN--MGSLEKLNLSHNNLS 518
Q SL LNL+ N+ +
Sbjct: 237 TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 55/216 (25%), Positives = 84/216 (38%), Gaps = 12/216 (5%)
Query: 74 SFSSFPHLANLNLSFNL--FFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRR 131
F L L+LS N F G + L+YLDL N + + L QL
Sbjct: 47 VFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEH 105
Query: 132 LYLDMNQLHGTIPPE--IGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG 189
L + L + L + L + H + + LS+L VL + NS
Sbjct: 106 LDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164
Query: 190 SIPS-IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLK 247
+ I +L++L LDLS+ Q P + +LSSL ++++ +N+ S+ L
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLN 223
Query: 248 SLSALGLHINQLNGFIPPSI--GNLSSLRVLYLYNN 281
SL L +N + SSL L L N
Sbjct: 224 SLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 7/165 (4%)
Query: 388 QVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLS- 446
+ +S + +P + SS +L L N+L F LT+L L LS+N LS
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 447 -SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV-CNM 504
+S L YL+LS N + + + F L L LD H+ L++ V ++
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 505 GSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNST 549
+L L++SH + F + SL + ++ N
Sbjct: 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 37/166 (22%), Positives = 58/166 (34%), Gaps = 5/166 (3%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
F L +L+ + + +L L YLD+ L+ L L
Sbjct: 97 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156
Query: 134 LDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
+ N P+I +L + L L L P++ +LS+L VL + N+
Sbjct: 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 216
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSL--GNLSSLTMMSLFNNSLS 236
L SL LD S N + SSL ++L N +
Sbjct: 217 FPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 10/228 (4%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+D++ + IG G G K G I+ K+ + ++ + ++EV L+E++
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELK 63
Query: 658 HRNNVKFHGFCY--NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI-NVIKGVANA 714
H N V+++ ++V EY + G LA ++ ++ + V+ + A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 715 LSYLH--HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
L H D +++HRD+ NV LD + DFG+A+ + +S F GT Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 820
+PE M EK D++S G L++E+ P F + + + I
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELAGKIR 229
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 607 IGKGGQGSVYKAELPSGD-IVAVKKFNSQLLSGNMADHDEFL----NEVLALKEIRHRNN 661
+G+GG G VY+AE + IVA+K L+S ++ F E ++ +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALK-----LMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
V H F ++ ++ LA +L L R + +++ + +AL H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE---FAGTFGYAAPEIAY 778
HRD+ +N+L+ ++ A++ DFGIA T+ GT Y APE
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFS 208
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHP 804
AT + D+Y+ +++E + G+ P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPP 234
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 52/258 (20%), Positives = 97/258 (37%), Gaps = 32/258 (12%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN--VK 663
IG GG V++ I A+K N + D + NE+ L +++ ++ ++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS--YRNEIAYLNKLQQHSDKIIR 92
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
+ + + ++V E + L L K + R + K + A+ +H
Sbjct: 93 LYDYEITDQYIYMVMECGN-IDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEI----- 776
I+H D+ N L+ + DFGIA + P +++ GT Y PE
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 777 ------AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRL 830
+ + K DV+S G +++ + G P F N I ++ I+DP
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNH 257
Query: 831 PTPSPSVMDYGGCHFMLR 848
P + + +
Sbjct: 258 EIEFPDIPEKDLQDVLKC 275
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-30
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 30/211 (14%)
Query: 606 CIGKGGQGSVYKAE---LPSGDIVAVKKFNSQLL--SGNMADHDEFLNEVLALKEIRHRN 660
CI GG G +Y A + +G V +K L SG+ + E L E+ H +
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLK-----GLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 661 NVKFHGF-----CYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
V+ F + P ++V EY+ SL R G +L I + + AL
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPAL 195
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
SYLH +++ D+ +N++L + + D G + GT G+ APE
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----LYGTPGFQAPE 247
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806
I T T D+Y+ G + + R+
Sbjct: 248 IVRT-GPTVATDIYTVGRTLAALTLDLPTRN 277
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 13/225 (5%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+ + IG+G G + G +K+ N +S + +E EV L ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS--KEREESRREVAVLANMK 81
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDD--VTAKELGWNRRINVIKGVANAL 715
H N V++ ++V +Y + G L + + V +E ++ ++ + AL
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE---DQILDWFVQICLAL 138
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
++H I+HRDI S+N+ L + + DFGIA+ + GT Y +PE
Sbjct: 139 KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMII 820
I K D+++ G +++E+ H F + + + II
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA--FEAGSMKNLVLKII 238
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 14/215 (6%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
+DF+ +GKG G+VY A E S I+A+K +QL + EV +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSHL 66
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
RH N ++ +G+ ++ +L+ EY G++ R L + R I +ANALS
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
Y H +IHRDI +N+LL S E ++DFG + P S GT Y PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTD-LCGTLDYLPPEM 178
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811
EK D++S GVL +E + G P F +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANT 211
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 52/258 (20%), Positives = 97/258 (37%), Gaps = 32/258 (12%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN--VK 663
IG GG V++ I A+K N + D + NE+ L +++ ++ ++
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS--YRNEIAYLNKLQQHSDKIIR 73
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
+ + + ++V E + L L K + R + K + A+ +H
Sbjct: 74 LYDYEITDQYIYMVMECGN-IDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEI----- 776
I+H D+ N L+ + DFGIA + P +++ GT Y PE
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 777 --AYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRL 830
++ K DV+S G +++ + G P F N I ++ I+DP
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNH 238
Query: 831 PTPSPSVMDYGGCHFMLR 848
P + + +
Sbjct: 239 EIEFPDIPEKDLQDVLKC 256
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-30
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 589 IMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDI-VAVKKFNSQLLSGNMADH-DEF 646
+ HE+++ E+ IG+G G V+ L + + VAVK D +F
Sbjct: 111 LNHEDLV-----LGEQ--IGRGNFGEVFSGRLRADNTLVAVKSCRE----TLPPDLKAKF 159
Query: 647 LNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNR 703
L E LK+ H N V+ G C ++V E + G L G + K L
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTL---- 215
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT 763
+ ++ A + YL IHRD++++N L+ +SDFG+++ +
Sbjct: 216 -LQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271
Query: 764 EFAGTFGY--AAPEIAYTMRATEKYDVYSFGVLVFEVI 799
APE R + + DV+SFG+L++E
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 52/258 (20%), Positives = 98/258 (37%), Gaps = 32/258 (12%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN--VK 663
IG GG V++ I A+K N L + D + NE+ L +++ ++ ++
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVN--LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
+ + + ++V E + L L K + R + K + A+ +H
Sbjct: 121 LYDYEITDQYIYMVMECGN-IDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE--FAGTFGYAAPEI----- 776
I+H D+ N L+ + DFGIA + P +++ + G Y PE
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 777 ------AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRL 830
+ + K DV+S G +++ + G P F N I ++ I+DP
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNH 285
Query: 831 PTPSPSVMDYGGCHFMLR 848
P + + +
Sbjct: 286 EIEFPDIPEKDLQDVLKC 303
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 50/252 (19%), Positives = 93/252 (36%), Gaps = 29/252 (11%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+GG V E L G A+K+ D +E E + H N ++
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLV 92
Query: 666 GFCYNGPHS----FLVCEYLDRGSLARILGDDVTAKELGWNRRI-NVIKGVANALSYLHH 720
+C + +L+ + RG+L + +I ++ G+ L +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN---------WTEFAGTFGY 771
HRD+ N+LL + + D G H W T Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 772 AAPEI----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILD 827
APE+ ++ + E+ DV+S G +++ ++ G P + + S + N++
Sbjct: 210 RAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVALAVQNQLSI 266
Query: 828 PRLPTPSPSVMD 839
P+ P S ++
Sbjct: 267 PQSPRHSSALWQ 278
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 48/255 (18%), Positives = 97/255 (38%), Gaps = 48/255 (18%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
DF E IG GG G V+KA+ G +K+ ++++ EV AL ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY--------NNEKAEREVKALAKLD 62
Query: 658 HRNNVKFHGFCYNGPHS----------------FLVCEYLDRGSLARIL----GDDVTAK 697
H N V ++G + F+ E+ D+G+L + + G+ +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 698 ELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757
+ + + + + Y+H +I+RD+ N+ L + + DFG+ +
Sbjct: 123 LA-----LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK- 173
Query: 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSN 817
+ T GT Y +PE + ++ D+Y+ G+++ E++
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----------AFE 223
Query: 818 MIIDVNKILDPRLPT 832
+ D +
Sbjct: 224 TSKFFTDLRDGIISD 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFL----NEVLALKEIRHRNN 661
+G GG +VY AE VA+K + + +E L EV ++ H+N
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIK-----AIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
V +LV EY++ +L+ + L + IN + + + + H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM 130
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA-GTFGYAAPEIAYTM 780
I+HRDI +N+L+DSN + DFGIAK + S T GT Y +PE A
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 781 RATEKYDVYSFGVLVFEVIKGNHP 804
E D+YS G++++E++ G P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 598 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI 656
+ F + IGKG G V+K + + +VA+K + L + ++ E+ L +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLSQC 77
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVI-KGVANAL 715
K++G +++ EYL GS D + L +I I + + L
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-ETQIATILREILKGL 132
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
YLH + IHRDI + NVLL + E ++DFG+A + F GT + APE
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ K D++S G+ E+ +G P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 7/211 (3%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNW-GNFSKLSTFIVS 369
IP + +R+ L+ N +S +F NLT L L +N I + L +S
Sbjct: 30 IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLS 88
Query: 370 MNNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQ-LEMLSSLNKLILNLNQLSGGVPL 427
N S+ P +L L L + ++ L++L L L N L
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 428 EFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELD 487
F L L +L L N++SS ++ L L L L N+++H P F L L L
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 488 LSHNILQEEIPPQV-CNMGSLEKLNLSHNNL 517
L N L +P + + +L+ L L+ N
Sbjct: 208 LFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 51/235 (21%), Positives = 86/235 (36%), Gaps = 25/235 (10%)
Query: 263 IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQ 322
+P I ++ + ++L+ N + ++L+ L L +N+L +
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA--------- 74
Query: 323 NNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFN-WGNFSKLSTFIVSMNNISGSIPPDI 381
AF L LDLS+N + + +L T + + + P +
Sbjct: 75 ---------AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL 124
Query: 382 -GNSPKLQVLDLSSNHIVGKIPVQ-LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLD 439
LQ L L N + +P L +L L L+ N++S F L L L
Sbjct: 125 FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 440 LSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQ 494
L N+++ P + +L +L L L N LS L L L L+ N
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 9/206 (4%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNL 163
Q + L N++S + L L+L N L I L+L+++L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 164 HGSIPSS-LGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIP-LSLG 220
S+ + L L L+L + L + + L +L L L +N ++P +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 221 NLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLY 279
+L +LT + L N +S S+P L SL L LH N++ P + +L L LYL+
Sbjct: 151 DLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 280 NNGLYGFVPEEIGYLKSLSELELCTN 305
N L E + L++L L L N
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 9/192 (4%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRR 131
SF + +L L L N+ I L+ L+ LDL N + P L +L
Sbjct: 51 SFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109
Query: 132 LYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKNSLSG 189
L+LD L + P + L+ + L L N L ++P + +L NL L+L+ N +S
Sbjct: 110 LHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS 167
Query: 190 SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKS 248
L SL +L L +N+ + P + +L L + LF N+LS ++P L L++
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRA 226
Query: 249 LSALGLHINQLN 260
L L L+ N
Sbjct: 227 LQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 6/144 (4%)
Query: 71 HDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLNQL 129
+F L L+L + + L+ LQYL L N L L L L
Sbjct: 97 DPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL 155
Query: 130 RRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLS 188
L+L N++ ++P L +D+L L N + P + +L L LYL+ N+LS
Sbjct: 156 THLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
Query: 189 GSIPS-IIGKLKSLLQLDLSENQF 211
++P+ + L++L L L++N +
Sbjct: 215 -ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 26/98 (26%), Positives = 39/98 (39%), Gaps = 4/98 (4%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLN 127
D +F +L +L L N ++P + L L L L N+++ + P L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNR-ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 128 QLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLH 164
+L LYL N L +P E L + L L N
Sbjct: 202 RLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 22/225 (9%)
Query: 591 HEEIIKA----------TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGN 639
EEI++ + IG+G G+VY A ++ +G VA+++ N Q
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----Q 57
Query: 640 MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKEL 699
+ +NE+L ++E ++ N V + G ++V EYL GSL D VT +
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCM 113
Query: 700 GWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759
+ V + AL +LH + +IHRDI S N+LL + ++DFG + P
Sbjct: 114 DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 760 SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
S + GT + APE+ K D++S G++ E+I+G P
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 22/229 (9%)
Query: 587 GKIMHEEIIKA----------TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQL 635
G + HE+ A D IG+G G V A E SG VAVK + L
Sbjct: 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--L 80
Query: 636 LSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVT 695
+ NEV+ +++ +H N V+ + G +++ E+L G+L D V+
Sbjct: 81 RKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVS 134
Query: 696 AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755
L + V + V AL+YLH +IHRDI S ++LL + +SDFG +
Sbjct: 135 QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191
Query: 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
GT + APE+ + D++S G++V E++ G P
Sbjct: 192 SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-29
Identities = 67/257 (26%), Positives = 102/257 (39%), Gaps = 18/257 (7%)
Query: 271 SSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP------HSIERVLLNQNN 324
+ + GL VP+ I + L L N ++ + H +E + L +N+
Sbjct: 54 NQFSKVVCTRRGL-SEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 325 LSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNW-GNFSKLSTFIVSMNNISGSIPPDI-G 382
+ AF +L L+L +N I SKL + N I SIP
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
Query: 383 NSPKLQVLDLSSNHIVGKIPVQ-LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLS 441
P L LDL + I E L +L L L + + +P L L+ L++S
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMS 226
Query: 442 TNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV 501
N P S L L L + N+Q+S F+ L L EL+L+HN L +P +
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
Query: 502 C-NMGSLEKLNLSHNNL 517
+ L +L+L HN
Sbjct: 286 FTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 81/357 (22%), Positives = 121/357 (33%), Gaps = 58/357 (16%)
Query: 200 SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQ 258
++ + S +P + S+ ++L N++ I +L L L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110
Query: 259 LNGFIPPSI-GNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIER 317
+ I L+SL L L++N L YL L EL L N + IP
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSY--- 165
Query: 318 VLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSI 377
AF P+L LDL IS G F L
Sbjct: 166 --------------AFNRVPSLMRLDLGELKKLEYIS--EGAFEGL-------------- 195
Query: 378 PPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQY 437
L+ L+L +I +P L L L +L ++ N P F L+ L+
Sbjct: 196 -------FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246
Query: 438 LDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEI 497
L + +++S + L L LNL++N LS F L +L EL L HN +
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD- 305
Query: 498 PPQVCNMGSL-EKLNLSHNNLSDFIPRCF--EEMRSLSCIDISYNELHGPIPNSTAF 551
C++ L L S RC MR +++ P
Sbjct: 306 ----CDILWLAWWLREYIPTNSTCCGRCHAPMHMRGRYLVEVDQASFQCSAPFIMDA 358
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 62/248 (25%), Positives = 96/248 (38%), Gaps = 25/248 (10%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNL 163
+YL+L N + + L+ L L L N + I L+ ++ L L N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL 135
Query: 164 HGSIPS-SLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSE-NQFSGSIPLSLGN 221
IPS + LS L L+L N + ++ SL++LDL E + +
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 222 LSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNN 281
L +L ++L ++ +P L L L L + N P S LSSL+ L++ N+
Sbjct: 195 LFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 282 GLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTF 341
+ L SL EL L N L +PH + F L
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLS-SLPH-----------------DLFTPLRYLVE 294
Query: 342 LDLSNNNF 349
L L +N +
Sbjct: 295 LHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 11/213 (5%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
+F HL L L N I + L+ L L+L N L+ + L++LR L
Sbjct: 94 TFRHLHHLEVLQLGRNS-IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLREL 152
Query: 133 YLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKNSLSGS 190
+L N + +IP ++ + +L L I + L NL L L ++
Sbjct: 153 WLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-D 210
Query: 191 IPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSL 249
+P++ L L +L++S N F P S LSSL + + N+ +S I L SL
Sbjct: 211 MPNLTP-LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASL 268
Query: 250 SALGLHINQLNGFIPPSI-GNLSSLRVLYLYNN 281
L L N L+ +P + L L L+L++N
Sbjct: 269 VELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-21
Identities = 55/195 (28%), Positives = 82/195 (42%), Gaps = 11/195 (5%)
Query: 71 HDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI-GKLNQ 128
+F+ L L L N IP LSKL+ L L +N + IP ++
Sbjct: 115 EVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPS 172
Query: 129 LRRLYL-DMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNS 186
L RL L ++ +L I L + L L N+ +P+ L L L L + N
Sbjct: 173 LMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNH 229
Query: 187 LSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGN 245
P L SL +L + +Q S + L+SL ++L +N+LS S+P +
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTP 288
Query: 246 LKSLSALGLHINQLN 260
L+ L L LH N N
Sbjct: 289 LRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 18/73 (24%), Positives = 24/73 (32%), Gaps = 2/73 (2%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQ-IGNLSKLQYLDLGSNQLSGLIPPEIGKLN 127
SF L L + + I L+ L L+L N LS L L
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQ-VSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290
Query: 128 QLRRLYLDMNQLH 140
L L+L N +
Sbjct: 291 YLVELHLHHNPWN 303
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 43/225 (19%), Positives = 85/225 (37%), Gaps = 30/225 (13%)
Query: 598 TDDFDEKFCIGKGGQ--GSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALK 654
++ IGKG + +V A P+G+ V V++ N L + + E+ K
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN--LEACSNEMVTFLQGELHVSK 81
Query: 655 EIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRIN------VI 708
H N V + ++V ++ GS ++ + +N ++
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-------CTHFMDGMNELAIAYIL 134
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN------- 761
+GV AL Y+HH +HR + + ++L+ + + ++S + H
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 762 WTEFAGTFGYAAPEIAYTMRA--TEKYDVYSFGVLVFEVIKGNHP 804
+ +PE+ K D+YS G+ E+ G+ P
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-29
Identities = 53/250 (21%), Positives = 96/250 (38%), Gaps = 36/250 (14%)
Query: 600 DFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RH 658
F K +G G +G++ + VAVK+ + EV L+E H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE-------CFSFADREVQLLRESDEH 77
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLA-RILGDDVTAKELGWNRRINVIKGVANALSY 717
N +++ + ++ E +L + D L I +++ + L++
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAH 133
Query: 718 LHHDCLPSIIHRDISSKNVLL-----DSNFEAHVSDFGIAKFVGPHSS---NWTEFAGTF 769
LH +I+HRD+ N+L+ +A +SDFG+ K + + GT
Sbjct: 134 LHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 770 GYAAPEI---AYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKI 825
G+ APE+ T D++S G + + VI +G+HP F ++ +
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-------FGKSLQRQANI-LL 242
Query: 826 LDPRLPTPSP 835
L P
Sbjct: 243 GACSLDCLHP 252
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-29
Identities = 70/257 (27%), Positives = 106/257 (41%), Gaps = 18/257 (7%)
Query: 271 SSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP------HSIERVLLNQNN 324
+ + L VP+ I + L L N ++ + +E + L++N+
Sbjct: 43 NQFSKVICVRKNL-REVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 325 LSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNW-GNFSKLSTFIVSMNNISGSIPPDI-G 382
+ AF NL L+L +N I SKL + N I SIP
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
Query: 383 NSPKLQVLDLSSNHIVGKIPVQ-LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLS 441
P L+ LDL + I E LS+L L L + L +P L KL LDLS
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLS 215
Query: 442 TNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV 501
N LS+ P S L+ L L + +Q+ F+ L L E++L+HN L +P +
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274
Query: 502 C-NMGSLEKLNLSHNNL 517
+ LE+++L HN
Sbjct: 275 FTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-28
Identities = 75/354 (21%), Positives = 123/354 (34%), Gaps = 56/354 (15%)
Query: 200 SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQ 258
++ +P + ++ +++L N + I +L+ L L L N
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99
Query: 259 LNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERV 318
+ + L++L L L++N L YL L EL L N + SI
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-----SIPS- 153
Query: 319 LLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIP 378
AF P+L LDL IS G F L
Sbjct: 154 ------------YAFNRIPSLRRLDLGELKRLSYIS--EGAFEGL--------------- 184
Query: 379 PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYL 438
L+ L+L+ ++ +IP L L L++L L+ N LS P F L LQ L
Sbjct: 185 ------SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL 236
Query: 439 DLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIP 498
+ +++ + NL L +NL++N L+ F L HL + L HN
Sbjct: 237 WMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN-- 294
Query: 499 PQVCNMGSL-EKLNLSHNNLSDFIPRCF--EEMRSLSCIDISYNELHGPIPNST 549
C++ L + + + RC ++ ++ N P
Sbjct: 295 ---CDILWLSWWIKDMAPSNTACCARCNTPPNLKGRYIGELDQNYFTCYAPVIV 345
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 65/248 (26%), Positives = 100/248 (40%), Gaps = 19/248 (7%)
Query: 47 ISCNHAG-SRV---ISITMSTLGLNG----TFHDFSFSSFPHLANLNLSFNLFFGNIPLQ 98
+ C V IS L L+ SF HL L LS N I +
Sbjct: 48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH-IRTIEIG 106
Query: 99 I-GNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKL 156
L+ L L+L N+L+ + L++L+ L+L N + +IP ++ + +L
Sbjct: 107 AFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165
Query: 157 ALCHNNLHGSIPS-SLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSI 215
L I + LSNL L L +L IP++ L L +LDLS N S
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP-LIKLDELDLSGNHLSAIR 223
Query: 216 PLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSL 273
P S L L + + + + I NL+SL + L N L +P + L L
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHL 281
Query: 274 RVLYLYNN 281
++L++N
Sbjct: 282 ERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 63/248 (25%), Positives = 100/248 (40%), Gaps = 25/248 (10%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNL 163
+ L+L NQ+ + L L L L N + TI L+ ++ L L N L
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL 124
Query: 164 HGSIPS-SLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSE-NQFSGSIPLSLGN 221
+IP+ + LS L L+L N + ++ SL +LDL E + S +
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 222 LSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNN 281
LS+L ++L +L IP L L L L L N L+ P S L L+ L++ +
Sbjct: 184 LSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 282 GLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTF 341
+ L+SL E+ L N L ++PH + F +L
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT-LLPH-----------------DLFTPLHHLER 283
Query: 342 LDLSNNNF 349
+ L +N +
Sbjct: 284 IHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-26
Identities = 62/235 (26%), Positives = 89/235 (37%), Gaps = 9/235 (3%)
Query: 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMN 137
+ LNL N +L L+ L L N + + L L L L N
Sbjct: 63 STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122
Query: 138 QLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSL-GNLSNLAVLYLYK-NSLSGSIPSI 194
+L TIP LS + +L L +N + SIPS + +L L L + LS
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180
Query: 195 IGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALG 253
L +L L+L+ IP +L L L + L N LS +I P L L L
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237
Query: 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308
+ +Q+ + NL SL + L +N L + L L + L N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 58/195 (29%), Positives = 84/195 (43%), Gaps = 11/195 (5%)
Query: 71 HDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI-GKLNQ 128
+F+ +L L L N IP LSKL+ L L +N + IP ++
Sbjct: 104 EIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPS 161
Query: 129 LRRLYL-DMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNS 186
LRRL L ++ +L I LS + L L NL IP+ L L L L L N
Sbjct: 162 LRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNH 218
Query: 187 LSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGN 245
LS P L L +L + ++Q + NL SL ++L +N+L+ +P +
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTP 277
Query: 246 LKSLSALGLHINQLN 260
L L + LH N N
Sbjct: 278 LHHLERIHLHHNPWN 292
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 26/222 (11%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
DD++ + IG G V A P + VA+K+ N L DE L E+ A+ +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN---LEKCQTSMDELLKEIQAMSQCH 71
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWN----RRINVI-KGVA 712
H N V ++ +LV + L GS+ I+ V E I I + V
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE-----FAG 767
L YLH + IHRD+ + N+LL + ++DFG++ F+ F G
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 768 TFGYAAPEI-----AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
T + APE+ Y +A D++SFG+ E+ G P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAP 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 31/252 (12%)
Query: 560 KGLKRVSQEEQSNSMNRLRLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAE 619
K L+ + +EQ R RL + L K+ + DDF++ +G G G V+K
Sbjct: 2 KKLEELELDEQQ----RKRLEAFLTQKQKVGELKD----DDFEKISELGAGNGGVVFKVS 53
Query: 620 L-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678
PSG ++A K + L A ++ + E+ L E V F+G Y+ +
Sbjct: 54 HKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110
Query: 679 EYLDRGSLARIL--GDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNV 736
E++D GSL ++L + + LG V V L+YL I+HRD+ N+
Sbjct: 111 EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNI 163
Query: 737 LLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE----IAYTMRATEKYDVYSFG 792
L++S E + DFG++ + S F GT Y +PE Y++++ D++S G
Sbjct: 164 LVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYSVQS----DIWSMG 217
Query: 793 VLVFEVIKGNHP 804
+ + E+ G +P
Sbjct: 218 LSLVEMAVGRYP 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
DDFD +GKG G+VY A E + I+A+K SQL + E+ +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHL 71
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
RH N ++ + + ++ +L+ E+ RG L + L R ++ +A+AL
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALH 128
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
Y H +IHRDI +N+L+ E ++DFG + P T GT Y PE+
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRT-MCGTLDYLPPEM 183
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811
EK D++ GVL +E + G P F S +
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPP--FDSPS 216
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 61/341 (17%), Positives = 112/341 (32%), Gaps = 69/341 (20%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218
+ SIPS L + L L N ++ S + + +L L L+ N + S
Sbjct: 38 GSSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS 95
Query: 219 LGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVL 276
+L SL + L N LS ++ L SL+ L L N S+ +L+ L++L
Sbjct: 96 FSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154
Query: 277 YLYNNGLYGFVPEEI-GYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGD 335
+ N + + + L L ELE+ + L+ P ++
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP------------------KSLKS 196
Query: 336 HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDI-GNSPKLQVLDLSS 394
N++ L L + + ++ L+L
Sbjct: 197 IQNVSHLILHMKQHI-------------------------LLLEIFVDVTSSVECLELRD 231
Query: 395 NHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIG 454
+ + ++LS G + + ++ L + K +
Sbjct: 232 TDLDT----------------FHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLN 274
Query: 455 NLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSHNILQ 494
+ L L S NQL +P F++L L ++ L N
Sbjct: 275 QISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 57/279 (20%), Positives = 109/279 (39%), Gaps = 28/279 (10%)
Query: 103 SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHN 161
++ LDL +N+++ + ++ + L+ L L N ++ TI + L ++ L L +N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 162 NLHGSIPSSL-GNLSNLAVLYLYKNSLSGSIP--SIIGKLKSLLQLDLSENQFSGSIPL- 217
L ++ SS LS+L L L N ++ S+ L L L + I
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 218 SLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVL 276
L+ L + + + L S P L +++++S L LH+ Q + + SS+ L
Sbjct: 169 DFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECL 227
Query: 277 YLYNNGLYGFVPEEI--------GYLKSLSELELCTNLLRGVIP-----HSIERVLLNQN 323
L + L F E+ + +++ L V+ + + ++N
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287
Query: 324 NLSGKMYEAFGDHPNLTFLDLSNNNF---CGEISF--NW 357
L F +L + L N + C I + W
Sbjct: 288 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 326
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 62/324 (19%), Positives = 114/324 (35%), Gaps = 58/324 (17%)
Query: 205 DLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFI 263
S + SIP L ++ + L NN ++ I L +L AL L N +N I
Sbjct: 37 KGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TI 91
Query: 264 PPSI-GNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQ 322
+L SL L L N L L SL+ L L N + + S
Sbjct: 92 EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETS-------- 143
Query: 323 NNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIG 382
F L L + N + +I +F+ L
Sbjct: 144 ---------LFSHLTKLQILRVGNMDTFTKIQR--KDFAGL------------------- 173
Query: 383 NSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLST 442
L+ L++ ++ + P L+ + +++ LIL++ Q + + + ++ L+L
Sbjct: 174 --TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 443 NKLSSSIPKSI--------GNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQ 494
L + + + +++ L + ++ L EL+ S N L+
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLK 290
Query: 495 EEIPPQVC-NMGSLEKLNLSHNNL 517
+P + + SL+K+ L N
Sbjct: 291 S-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 49/266 (18%), Positives = 91/266 (34%), Gaps = 21/266 (7%)
Query: 57 ISITMSTLGLNG----TFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLG 111
++ + +L L+ + +L L L+ N I +L L++LDL
Sbjct: 50 LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG-INTIEEDSFSSLGSLEHLDLS 108
Query: 112 SNQLSGLIPPEI-GKLNQLRRLYLDMNQLHGTIPPEI--GQLSLIDKLALCHNNLHGSIP 168
N LS + L+ L L L N T+ L+ + L + + + I
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 169 S-SLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTM 227
L+ L L + + L P + ++++ L L Q + + + SS+
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226
Query: 228 MSLFNNSLSG----SIPPI----LGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLY 279
+ L + L + L + + + L + + +S L L
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFS 285
Query: 280 NNGLYGFVPEEIGYLKSLSELELCTN 305
N L L SL ++ L TN
Sbjct: 286 RNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 44/245 (17%), Positives = 91/245 (37%), Gaps = 19/245 (7%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS---TFI 367
+ +++ + L+ N ++ NL L L++N + +FS L
Sbjct: 50 LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN---TIEEDSFSSLGSLEHLD 106
Query: 368 VSMNNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLSGGV 425
+S N +S ++ L L+L N L L+ L L + +
Sbjct: 107 LSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 426 PLE-FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS 484
+ F LT L+ L++ + L S PKS+ ++ + +L L Q + + +
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 485 ELDLSHNILQE----EIPPQVCN----MGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDI 536
L+L L E+ N + + ++ +L + + ++ L ++
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEF 284
Query: 537 SYNEL 541
S N+L
Sbjct: 285 SRNQL 289
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 23/124 (18%), Positives = 45/124 (36%), Gaps = 13/124 (10%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI--------G 124
S S ++++L L + S ++ L+L L E+
Sbjct: 193 SLKSIQNVSHLILHMKQH-ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251
Query: 125 KLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSS-LGNLSNLAVLYLY 183
K R + + L + + Q+S + +L N L S+P L++L ++L+
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLH 309
Query: 184 KNSL 187
N
Sbjct: 310 TNPW 313
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 607 IGKGGQGSVYKAE---LPSGDIVAVKKFNSQLLSGNMADHDEFL----NEVLALKEIRHR 659
+G GG V+ A VAVK +L ++A F E + H
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVK-----VLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 660 NNVKFH--GF--CYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
V + G GP ++V EY+D +L I+ + + R I VI AL
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQAL 129
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA---GTFGYA 772
++ H + IIHRD+ N+++ + V DFGIA+ + ++ T+ A GT Y
Sbjct: 130 NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+PE A + DVYS G +++EV+ G P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G +V++ +GD+ A+K FN+ + D + E LK++ H+N VK
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV---DVQMREFEVLKKLNHKNIVKLF 73
Query: 666 GF--CYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
H L+ E+ GSL +L + A L + + V++ V +++L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 724 PSIIHRDISSKNVLLDSNFEAH----VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI--- 776
I+HR+I N++ + ++DFG A+ + + GT Y P++
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDMYER 189
Query: 777 -AYTMRATEKY----DVYSFGVLVFEVIKGNHP 804
+KY D++S GV + G+ P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 59/254 (23%), Positives = 107/254 (42%), Gaps = 35/254 (13%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEV-LALKEI 656
+D + IG+G GSV K PSG I+AVK+ + + + + L ++ + ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMRSS 78
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI--NVIKGVANA 714
V+F+G + ++ E + S + + + I + A
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI-AKFVGPHSSNWTEFAGTFGYAA 773
L++L + IIHRDI N+LLD + + DFGI + V S T AG Y A
Sbjct: 138 LNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMA 193
Query: 774 PE--------IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKI 825
PE Y +R+ DV+S G+ ++E+ G P + ++++ + ++
Sbjct: 194 PERIDPSASRQGYDVRS----DVWSLGITLYELATGRFP-------YPKWNSVFDQLTQV 242
Query: 826 LD---PRLPTPSPS 836
+ P+L
Sbjct: 243 VKGDPPQLSNSEER 256
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 57/252 (22%), Positives = 110/252 (43%), Gaps = 42/252 (16%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEV-LALKEI 656
DD + +G+G G V K +PSG I+AVK+ + N + L ++ ++++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLLMDLDISMRTV 63
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRIN------VIKG 710
V F+G + ++ E +D SL D + + + I +
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELMD-TSL-----DKFYKQVIDKGQTIPEDILGKIAVS 117
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG 770
+ AL +LH S+IHRD+ NVL+++ + + DFGI+ ++ AG
Sbjct: 118 IVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKP 174
Query: 771 YAAPE--------IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDV 822
Y APE Y++++ D++S G+ + E+ P + S+ +
Sbjct: 175 YMAPERINPELNQKGYSVKS----DIWSLGITMIELAILRFP-------YDSWGTPFQQL 223
Query: 823 NKILD---PRLP 831
++++ P+LP
Sbjct: 224 KQVVEEPSPQLP 235
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 32/261 (12%), Positives = 69/261 (26%), Gaps = 46/261 (17%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+ G + V+ ++ + A+K F + + ++ + A + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLGESPEEAR 128
Query: 666 GFC--------------------------YNGPHSFLVCEYL--DRGSLARILGDDVTAK 697
Y + L+ D L L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 698 E-LGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756
G + + + L ++H + N+ + + + D VG
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 757 PHSSNWTEFAGTFGYAAPEI--AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 814
+ + YA E A T T + + G+ ++ V P F
Sbjct: 246 ---TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP-------FGL 295
Query: 815 FSNMIIDVNKILDPRLPTPSP 835
+ I K R+P
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDS 316
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 22/206 (10%)
Query: 606 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+G+G G V++ + +G AVKK + + E++A + V
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLE---------VFRVEELVACAGLSSPRIVPL 115
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
+G GP + E L+ GSL +++ E +R + + L YLH
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTRR-- 170
Query: 725 SIIHRDISSKNVLLDSN-FEAHVSDFGIAKFVGPHSSNWTE-----FAGTFGYAAPEIAY 778
I+H D+ + NVLL S+ A + DFG A + P + GT + APE+
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHP 804
K D++S ++ ++ G HP
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 598 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI 656
+ FD +G+G GSVYKA +G IVA+K+ + +D E + E+ +++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE------SDLQEIIKEISIMQQC 81
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
+ VK++G + ++V EY GS++ I+ + K L + +++ L
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLE 139
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
YLH IHRDI + N+LL++ A ++DFG+A + + GT + APE+
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ D++S G+ E+ +G P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 37/238 (15%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IG G G V+ + D VA+K + G M ++F+ E + ++ H V+ +G
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIK----TIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 667 FCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALSYL--HHD 721
C LV E+++ G L+ L A+ L + + V ++YL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 124
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAY 778
+IHRD++++N L+ N VSDFG+ +FV +T GT +A+PE+
Sbjct: 125 ----VIHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFS 178
Query: 779 TMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDP--RLPTP 833
R + K DV+SFGVL++EV +G P + + SN +V + + RL P
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIP-------YENRSNS--EVVEDISTGFRLYKP 227
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 19/207 (9%)
Query: 606 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+GKG G VY +L + +A+K ++ + E+ K ++H+N V++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIK----EIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
G + E + GSL+ +L + K + L YLH +
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142
Query: 725 SIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI------A 777
I+HRDI NVL+++ + +SDFG +K + + F GT Y APEI
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHP 804
Y A D++S G + E+ G P
Sbjct: 202 YGKAA----DIWSLGCTIIEMATGKPP 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 56/250 (22%), Positives = 102/250 (40%), Gaps = 54/250 (21%)
Query: 607 IGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNM-ADHDEFLNEVLALKEIRHRN 660
+G G G+VYK VA+K+ L + E L+E + + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE----LREATSPKANKEILDEAYVMASVDNPH 78
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALSY 717
+ G C L+ + + G L + D++ ++ L +N +A ++Y
Sbjct: 79 VCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS-----------NWTEFA 766
L L +HRD++++NVL+ + ++DFG+AK +G W
Sbjct: 133 LEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM--- 186
Query: 767 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKI 825
A E T + DV+S+GV V+E++ G+ P + +++ I
Sbjct: 187 ------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-------YDGIPAS--EISSI 231
Query: 826 LDP--RLPTP 833
L+ RLP P
Sbjct: 232 LEKGERLPQP 241
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 10/200 (5%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+GKGG ++ + + ++ A K S LL + + E+ + + H++ V F
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGF 80
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
HGF + F+V E R SL + K L ++ + YLH +
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNR-- 135
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATE 784
+IHRD+ N+ L+ + E + DFG+A V GT Y APE+ +
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 785 KYDVYSFGVLVFEVIKGNHP 804
+ DV+S G +++ ++ G P
Sbjct: 195 EVDVWSIGCIMYTLLVGKPP 214
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 64/267 (23%), Positives = 104/267 (38%), Gaps = 49/267 (18%)
Query: 598 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI 656
DF+E +G+G G V KA A+KK + L+EV+ L +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK-----IRHTEEKLSTILSEVMLLASL 59
Query: 657 RHRNNVKFHGF-------------CYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNR 703
H+ V+++ F+ EY + G+L ++ + ++
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV-------- 755
R+ + + ALSY+H IIHRD+ N+ +D + + DFG+AK V
Sbjct: 120 RL--FRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 756 ------GPHSSNWTEFAGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808
S N T GT Y A E + T EK D+YS G++ FE+I
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------- 227
Query: 809 SINFSSFSNMIIDVNKILDPRLPTPSP 835
FS+ + + K+ + P
Sbjct: 228 ---FSTGMERVNILKKLRSVSIEFPPD 251
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 10/200 (5%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+GKGG ++ + + ++ A K S LL + + E+ + + H++ V F
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGF 106
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
HGF + F+V E R SL + K L ++ + YLH +
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNR-- 161
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATE 784
+IHRD+ N+ L+ + E + DFG+A V GT Y APE+ +
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 785 KYDVYSFGVLVFEVIKGNHP 804
+ DV+S G +++ ++ G P
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP 240
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 33/236 (13%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G V + VAVK + G+M DEF E + ++ H VKF+G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVK----MIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 667 FCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
C ++V EY+ G L L G + +L + + V +++L
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLESH-- 123
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAYTM 780
IHRD++++N L+D + VSDFG+ ++V + GT ++APE+ +
Sbjct: 124 -QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 781 RATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDP--RLPTP 833
+ + K DV++FG+L++EV G P + ++N +V + RL P
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP-------YDLYTNS--EVVLKVSQGHRLYRP 227
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 598 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI 656
F + IG G G+VY A ++ + ++VA+KK + N + + EV L+++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDIIKEVRFLQKL 111
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
RH N +++ G ++LV EY GS + +L +V K L V G L+
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLA 168
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
YLH ++IHRD+ + N+LL + DFG A + P +S F GT + APE+
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEV 221
Query: 777 AYTMRATE---KYDVYSFGVLVFEVIKGNHP 804
M + K DV+S G+ E+ + P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 39/242 (16%)
Query: 607 IGKGGQGSVYKAELPSGDI---VAVKKFNSQLLSGNM--ADHDEFLNEVLALKEIRHRNN 661
+G G G+V K + VAVK L + A DE L E ++++ +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVK----ILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARIL--GDDVTAKELGWNRRINVIKGVANALSYL- 718
V+ G C LV E + G L + L V K + I ++ V+ + YL
Sbjct: 81 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 134
Query: 719 -HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAP 774
+ +HRD++++NVLL + A +SDFG++K + + + + AP
Sbjct: 135 ESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDP--RLP 831
E + + K DV+SFGVL++E G P + +V +L+ R+
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP-------YRGMKGS--EVTAMLEKGERMG 240
Query: 832 TP 833
P
Sbjct: 241 CP 242
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 15/213 (7%)
Query: 598 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI 656
+ ++ +G G G VYKA +G + A K S + ++++ E+ L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEE--ELEDYIVEIEILATC 73
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
H VK G Y+ +++ E+ G++ I+ + L + V + + AL+
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALN 131
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+LH IIHRD+ + NVL+ + ++DFG++ F GT + APE+
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 777 AYTMRATE-----KYDVYSFGVLVFEVIKGNHP 804
+ K D++S G+ + E+ + P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 9/200 (4%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+GKG VY+A + +G VA+K + + M NEV +++H + ++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQLKHPSILEL 76
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
+ + + + +LV E G + R L K N + + + + YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATE 784
I+HRD++ N+LL N ++DFG+A + GT Y +PEIA
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191
Query: 785 KYDVYSFGVLVFEVIKGNHP 804
+ DV+S G + + ++ G P
Sbjct: 192 ESDVWSLGCMFYTLLIGRPP 211
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 57/248 (22%), Positives = 93/248 (37%), Gaps = 30/248 (12%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL-KEI 656
+D + +G G G V+K +G ++AVK+ SGN ++ L ++ + K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKSH 81
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL--GDDVTAKELGWNRRINVIKGVANA 714
V+ G F+ E + + + + LG + + A
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKA 136
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L YL +IHRD+ N+LLD + + DFGI+ + AG Y AP
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAP 193
Query: 775 E-IAYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILD-- 827
E I Y DV+S G+ + E+ G P + + + K+L
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP-------YKNCKTDFEVLTKVLQEE 246
Query: 828 -PRLPTPS 834
P LP
Sbjct: 247 PPLLPGHM 254
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 33/241 (13%)
Query: 607 IGKGGQGSVYKAEL--PSGDI--VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+G G G V + E PSG VAVK +LS A D+F+ EV A+ + HRN +
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA-MDDFIREVNAMHSLDHRNLI 84
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALSYLH 719
+ +G P +V E GSL L L VA + YL
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTL-----SRYAVQVAEGMGYLE 138
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEI 776
IHRD++++N+LL + + DFG+ + + + ++ F + APE
Sbjct: 139 SKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 777 AYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDP---RLPT 832
T + D + FGV ++E+ G P + + + +D RLP
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP-------WIGLNGS--QILHKIDKEGERLPR 246
Query: 833 P 833
P
Sbjct: 247 P 247
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 606 CIGKGGQGSVYKAELPSGDI-VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+G G G VY+ + VAVK L M + +EFL E +KEI+H N V+
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTM-EVEEFLKEAAVMKEIKHPNLVQL 281
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALSYLHH 720
G C P +++ E++ G+L L +V+A L + + +++A+ YL
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLEK 336
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIA 777
+ IHR+++++N L+ N V+DFG+++ + +T AG + APE
Sbjct: 337 K---NFIHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESL 391
Query: 778 YTMRATEKYDVYSFGVLVFEVI-KGNHP 804
+ + K DV++FGVL++E+ G P
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+G G G V + VA+K + G+M DEF+ E + + H V+ +G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIK----MIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 667 FCYNGPHSFLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANALSYL--HHD 721
C F++ EY+ G L R + ++L + + K V A+ YL
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLESKQ- 140
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAY 778
+HRD++++N L++ VSDFG++++V +T G+ ++ PE+
Sbjct: 141 ----FLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLM 194
Query: 779 TMRATEKYDVYSFGVLVFEVI-KGNHP 804
+ + K D+++FGVL++E+ G P
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 51/259 (19%), Positives = 92/259 (35%), Gaps = 62/259 (23%)
Query: 607 IGKGGQGSVYKAELPSGDI--------VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
+G+G ++K V +K L + + F + ++ H
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLK----VLDKAHRNYSESFFEAASMMSKLSH 71
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANAL 715
++ V +G C G + LV E++ GSL L + + + V K +A A+
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----LEVAKQLAAAM 126
Query: 716 SYL--HHDCLPSIIHRDISSKNVLLDSNFEAH--------VSDFGIAKFVGPHSS----- 760
+L + +IH ++ +KN+LL + +SD GI+ V P
Sbjct: 127 HFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 761 NWTEFAGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNM 818
W PE I D +SFG ++E+ G+ P S+ +
Sbjct: 182 PWV---------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-------LSALDSQ 225
Query: 819 IIDVNKILDP--RLPTPSP 835
+ + +LP P
Sbjct: 226 --RKLQFYEDRHQLPAPKA 242
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 58/237 (24%), Positives = 91/237 (38%), Gaps = 36/237 (15%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
+P S + + L+ N L +F P L LDLS ++
Sbjct: 26 LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC--------------EIQ------ 65
Query: 371 NNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLSGGVPLE 428
+I + L L L+ N I + + LSSL KL+ L+
Sbjct: 66 -----TIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 429 FGSLTKLQYLDLSTNKLSS-SIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIHL--- 483
G L L+ L+++ N + S +P+ NL L +L+LS+N++ I L +
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLL 178
Query: 484 -SELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYN 539
LDLS N + I P L++L L N L F+ + SL I + N
Sbjct: 179 NLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 22/222 (9%)
Query: 94 NIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSL 152
N+P + LDL N L L +L+ L L ++ TI LS
Sbjct: 25 NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 153 IDKLALCHNNLHGSIPSSL-GNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQ 210
+ L L N + S+ LS+L L + +L+ S+ + IG LK+L +L+++ N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 211 FSGSIPLS--LGNLSSLTMMSLFNNSLSGSIPP----ILGNLKSLSA-LGLHINQLNGFI 263
S L NL++L + L +N + SI +L + L+ L L +N +N FI
Sbjct: 136 IQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 264 PPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTN 305
P L+ L L N L L SL ++ L TN
Sbjct: 193 QPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 40/175 (22%), Positives = 69/175 (39%), Gaps = 13/175 (7%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS---GGVPLEFGSL 432
IP ++ + LDLS N + L L L+ ++ G + SL
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA---YQSL 75
Query: 433 TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNI 492
+ L L L+ N + S + L L L L+ L L EL+++HN+
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 493 LQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCI----DISYNELH 542
+Q P+ N+ +LE L+LS N + + + + D+S N ++
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 52/239 (21%), Positives = 88/239 (36%), Gaps = 36/239 (15%)
Query: 263 IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQ 322
IP ++ S + L L N L L L+L ++ I
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG-------- 70
Query: 323 NNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS---TFIVSMNNISGSIPP 379
A+ +L+ L L+ N S G FS LS + N++ S+
Sbjct: 71 ---------AYQSLSHLSTLILTGNPI---QSLALGAFSGLSSLQKLVAVETNLA-SLEN 117
Query: 380 DI-GNSPKLQVLDLSSNHIVGKIPVQ--LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQ 436
G+ L+ L+++ N I + L++L L L+ N++ + L ++
Sbjct: 118 FPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 437 Y----LDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHN 491
LDLS N ++ I ++L L L NQL F++L L ++ L N
Sbjct: 177 LLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 56/195 (28%), Positives = 78/195 (40%), Gaps = 18/195 (9%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRR 131
SF SFP L L+LS I +LS L L L N + + L+ L++
Sbjct: 47 SFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQK 104
Query: 132 LYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSS--LGNLSNLAVLYLYKNSLS 188
L L ++ G L + +L + HN + S NL+NL L L N +
Sbjct: 105 LVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 189 GSIPS-IIGKLKSL----LQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-I 242
SI + L + L LDLS N + I L ++L N L S+P I
Sbjct: 163 -SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGI 219
Query: 243 LGNLKSLSALGLHIN 257
L SL + LH N
Sbjct: 220 FDRLTSLQKIWLHTN 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G G G V+ A VAVK + G+M + FL E +K ++H VK H
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVK----TMKPGSM-SVEAFLAEANVMKTLQHDKLVKLH 249
Query: 666 GFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALSYLHHD 721
P +++ E++ +GSL L G +L I+ +A ++++
Sbjct: 250 AVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQR 303
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAY 778
+ IHRD+ + N+L+ ++ ++DFG+A+ + + +T G + APE
Sbjct: 304 ---NYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAIN 358
Query: 779 TMRATEKYDVYSFGVLVFEVI-KGNHP 804
T K DV+SFG+L+ E++ G P
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G G V+ VA+K L G M + FL E +K++RH V+ +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIK----TLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 666 GFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALSYLHHD 721
P ++V EY+ +GSL L G + +L +++ +A+ ++Y+
Sbjct: 246 AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVERM 299
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAY 778
+ +HRD+ + N+L+ N V+DFG+A+ + + +T G + APE A
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAAL 354
Query: 779 TMRATEKYDVYSFGVLVFEVI-KGNHP 804
R T K DV+SFG+L+ E+ KG P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G G G V+ VAVK L G+M D FL E +K+++H+ V+ +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVK----SLKQGSM-SPDAFLAEANLMKQLQHQRLVRLY 74
Query: 666 GFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALSYLHHD 721
P +++ EY++ GSL L G +T +L +++ +A ++++
Sbjct: 75 AVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEER 128
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAY 778
+ IHRD+ + N+L+ ++DFG+A+ + + +T G + APE
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAIN 183
Query: 779 TMRATEKYDVYSFGVLVFEVI-KGNHP 804
T K DV+SFG+L+ E++ G P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G +V++ +GD+ A+K FN+ + D + E LK++ H+N VK
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV---DVQMREFEVLKKLNHKNIVKLF 73
Query: 666 GF--CYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
H L+ E+ GSL +L + A L + + V++ V +++L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 724 PSIIHRDISSKNVLLDSNFEAH----VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI--- 776
I+HR+I N++ + ++DFG A+ + + GT Y P++
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDMYER 189
Query: 777 -AYTMRATEKY----DVYSFGVLVFEVIKGNHP 804
+KY D++S GV + G+ P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 47/217 (21%)
Query: 607 IGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+GKG GSV +G++VAVK +L +F E+ LK ++H N
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVK----KLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 662 VKFHGFCYNGPHS--FLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALS 716
VK+ G CY+ L+ EYL GSL L + + +L + + +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGME 128
Query: 717 YLH-HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN-------------W 762
YL IHRD++++N+L+++ + DFG+ K + P W
Sbjct: 129 YLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFW 183
Query: 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
APE + + DV+SFGV+++E+
Sbjct: 184 Y---------APESLTESKFSVASDVWSFGVVLYELF 211
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 58/254 (22%), Positives = 106/254 (41%), Gaps = 33/254 (12%)
Query: 592 EEIIKATDDFDEKFCIGKGGQGSVYKAEL--PSGDI-VAVKKFNSQLLSGNMA-DHDEFL 647
+ +K + +G G GSV + I VA+K L G D +E +
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK----VLKQGTEKADTEEMM 58
Query: 648 NEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINV 707
E + ++ + V+ G C LV E G L + L +E+ + +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAEL 115
Query: 708 IKGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765
+ V+ + YL + +HRD++++NVLL + A +SDFG++K +G S +T
Sbjct: 116 LHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170
Query: 766 AGT---FGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIID 821
+ + APE + + + DV+S+GV ++E + G P + +
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-------YKKMKGP--E 221
Query: 822 VNKILDP--RLPTP 833
V ++ R+ P
Sbjct: 222 VMAFIEQGKRMECP 235
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 607 IGKGGQGSVYKAELPSGDI-VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G G G VY+ + VAVK L M + +EFL E +KEI+H N V+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 666 GFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALSYL-HH 720
G C P +++ E++ G+L L +V+A L + + +++A+ YL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLEKK 130
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH----SSN------WTEFAGTFG 770
+ IHRD++++N L+ N V+DFG+++ + + WT
Sbjct: 131 NF----IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------- 179
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHP 804
APE + + K DV++FGVL++E+ G P
Sbjct: 180 --APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 47/217 (21%)
Query: 607 IGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+GKG GSV +G++VAVK +L +F E+ LK ++H N
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVK----KLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 662 VKFHGFCYNGPHS--FLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALS 716
VK+ G CY+ L+ EYL GSL L + + +L + + +
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGME 159
Query: 717 YLH-HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN-------------W 762
YL IHRD++++N+L+++ + DFG+ K + P W
Sbjct: 160 YLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYYKVKEPGESPIFW 214
Query: 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
APE + + DV+SFGV+++E+
Sbjct: 215 Y---------APESLTESKFSVASDVWSFGVVLYELF 242
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 38/211 (18%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IGKG G V + G+ VAVK + + A FL E + ++RH N V+ G
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVK----CIKNDATAQ--AFLAEASVMTQLRHSNLVQLLG 81
Query: 667 FCY-NGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALSYL-HH 720
++V EY+ +GSL L + L + V A+ YL +
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGN 136
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN------WTEFAGTFGYAAP 774
+ +HRD++++NVL+ + A VSDFG+ K WT AP
Sbjct: 137 NF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------AP 183
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVI-KGNHP 804
E + + K DV+SFG+L++E+ G P
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 53/180 (29%), Positives = 77/180 (42%), Gaps = 10/180 (5%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLH 164
L L N L + +L +L LD +L T G L ++ L L HN L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 165 GSIPSSLGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPLSL-GNL 222
S+P L L VL + N L+ S+P + L L +L L N+ ++P L
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 223 SSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNN 281
L +SL NN+L+ +P +L L++L L L N L IP L +L+ N
Sbjct: 148 PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 55/228 (24%), Positives = 82/228 (35%), Gaps = 41/228 (17%)
Query: 296 SLSELELCTNLLRGV---IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGE 352
S E+ L + +P + L++N L + LT L+L
Sbjct: 11 SHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA----- 65
Query: 353 ISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLN 412
+KL G P L LDLS N + +P+ + L +L
Sbjct: 66 ------ELTKLQVD---------------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALT 103
Query: 413 KLILNLNQ---LSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQ 468
L ++ N+ L G L +LQ L L N+L ++P + KL L+L+NN
Sbjct: 104 VLDVSFNRLTSLPLGA---LRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNN 159
Query: 469 LSHKIPTE-FEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHN 515
L+ +P L +L L L N L IP L L N
Sbjct: 160 LTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 8/173 (4%)
Query: 369 SMNNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPL 427
S N + + +L L+L + K+ V L L L L+ NQL +PL
Sbjct: 39 SENLLY-TFSLATLMPYTRLTQLNLDRAEL-TKLQV-DGTLPVLGTLDLSHNQLQS-LPL 94
Query: 428 EFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELD 487
+L L LD+S N+L+S ++ L +L L L N+L P L +L
Sbjct: 95 LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154
Query: 488 LSHNILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYN 539
L++N L E +P + + +L+ L L N+L IP+ F L + N
Sbjct: 155 LANNNLTE-LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 7/167 (4%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKL 435
++PPD+ +L LS N + L + L +L L+ +L+ G+L L
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVL 79
Query: 436 QYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495
LDLS N+L S +P L L L++S N+L+ L L EL L N L+
Sbjct: 80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137
Query: 496 EIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
+PP + LEKL+L++NNL++ + +L + + N L
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 59/277 (21%), Positives = 90/277 (32%), Gaps = 85/277 (30%)
Query: 221 NLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLY 279
++S ++ +L+ ++PP + + L L N L F ++ + L L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 280 NNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNL 339
L++L + G P L
Sbjct: 64 RA--------------ELTKL------------------------------QVDGTLPVL 79
Query: 340 TFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVG 399
LDLS+N +L S+P P L VLD+S N +
Sbjct: 80 GTLDLSHN--------------QLQ-----------SLPLLGQTLPALTVLDVSFNRLT- 113
Query: 400 KIPVQL-EMLSSLNKLILNLNQLS---GGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-G 454
+P+ L L +L L N+L G+ KL+ L L+ N L + +P +
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGL---LTPTPKLEKLSLANNNL-TELPAGLLN 169
Query: 455 NLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHN 491
L L L L N L IP F L L N
Sbjct: 170 GLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 45/163 (27%), Positives = 66/163 (40%), Gaps = 10/163 (6%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+ + L LNL + + G L L LDL NQL L P L L L
Sbjct: 50 TLMPYTRLTQLNLDRAE-LTKLQV-DGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLD 106
Query: 134 LDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSL-GNLSNLAVLYLYKNSLSGSI 191
+ N+L ++P L + +L L N L ++P L L L L N+L+ +
Sbjct: 107 VSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-EL 163
Query: 192 PS-IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNN 233
P+ ++ L++L L L EN +IP L L N
Sbjct: 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 39/161 (24%), Positives = 63/161 (39%), Gaps = 8/161 (4%)
Query: 383 NSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLST 442
++ ++ +P L L L+ N L T+L L+L
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 443 NKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV- 501
+L+ + G L L L+LS+NQL +P + L L+ LD+S N L +P
Sbjct: 65 AELTK-LQVD-GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTS-LPLGAL 120
Query: 502 CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELH 542
+G L++L L N L P L + ++ N L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 67/252 (26%), Positives = 106/252 (42%), Gaps = 57/252 (22%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMA-DHDEFLNEVLALKEIRHRNN 661
IG G G V L VA+K L +G +FL+E + + H N
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIK----ALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALSYL 718
++ G G + +V EY++ GSL L T +L + +++GV + YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-----VGMLRGVGAGMRYL 167
Query: 719 --HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN------------WTE 764
+HRD++++NVL+DSN VSDFG+++ + WT
Sbjct: 168 SDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT- 221
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVN 823
APE + DV+SFGV+++EV+ G P + + +N DV
Sbjct: 222 --------APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP-------YWNMTNR--DVI 264
Query: 824 KILDP--RLPTP 833
++ RLP P
Sbjct: 265 SSVEEGYRLPAP 276
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 50/238 (21%), Positives = 82/238 (34%), Gaps = 25/238 (10%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI- 656
F +G G G V+K G + AVK+ S D L EV + +++
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG--PKDRARKLAEVGSHEKVG 114
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALS 716
+H V+ G +L E SL + L + ++ AL+
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAW--GASLPEAQVWGYLRDTLLALA 171
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+LH ++H D+ N+ L + DFG+ +G + G Y APE+
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAPEL 227
Query: 777 ---AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLP 831
+Y A DV+S G+ + EV + + L P
Sbjct: 228 LQGSYGTAA----DVFSLGLTILEVACNMEL--PH--GGEGWQQLR---QGYLPPEFT 274
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G G V+ VA+K L G M + FL E +K++RH V+ +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIK----TLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 666 GFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALSYLHHD 721
P ++V EY+ +GSL L G + +L +++ +A+ ++Y+
Sbjct: 329 AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVERM 382
Query: 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPEIAY 778
+ +HRD+ + N+L+ N V+DFG+A+ + + +T G + APE A
Sbjct: 383 ---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAAL 437
Query: 779 TMRATEKYDVYSFGVLVFEVI-KGNHP 804
R T K DV+SFG+L+ E+ KG P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-25
Identities = 67/303 (22%), Positives = 118/303 (38%), Gaps = 38/303 (12%)
Query: 230 LFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPE 289
+ + I P L + + L+S+ + N+ +
Sbjct: 6 TVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI------ 55
Query: 290 EIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF 349
KS+ ++ N+ ++ LN N L+ + + NL +L L N
Sbjct: 56 -----KSVQGIQYLPNV---------TKLFLNGNKLTD--IKPLTNLKNLGWLFLDENKI 99
Query: 350 CGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLS 409
++S + + KL + + N IS I + + P+L+ L L +N I I V L L+
Sbjct: 100 K-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLT 153
Query: 410 SLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQL 469
L+ L L NQ+S VPL LTKLQ L LS N +S +++ L L L L + +
Sbjct: 154 KLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQEC 209
Query: 470 SHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMR 529
+K L+ + + + L P + + G EK N+ + F +
Sbjct: 210 LNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQ 267
Query: 530 SLS 532
++
Sbjct: 268 PVT 270
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 47/255 (18%), Positives = 93/255 (36%), Gaps = 25/255 (9%)
Query: 294 LKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI 353
+K + + + L + +++ + ++ + +N++ +
Sbjct: 11 IKQIFPDDAFAET---------IKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-KSV 58
Query: 354 SFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNK 413
++ ++ N ++ I P + N L L L N I + L+ L L
Sbjct: 59 Q-GIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKS 113
Query: 414 LILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKI 473
L L N +S L L +L+ L L NK++ + L KL L+L +NQ+S I
Sbjct: 114 LSLEHNGISDINGLV--HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DI 168
Query: 474 PTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSC 533
L L L LS N + ++ + + +L+ L L + + +
Sbjct: 169 V-PLAGLTKLQNLYLSKNHI-SDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 225
Query: 534 IDISYNELHGPIPNS 548
+ + L P S
Sbjct: 226 VKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 59/312 (18%), Positives = 108/312 (34%), Gaps = 38/312 (12%)
Query: 169 SSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMM 228
+ L K S++ ++ +L S+ Q+ + + S+ + L ++T +
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 70
Query: 229 SLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVP 288
L N L+ I P L NLK+L L L N++ + +L L+ L L +NG
Sbjct: 71 FLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNG------ 120
Query: 289 EEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNN 348
+ ++ L L E + L N ++ L L L +N
Sbjct: 121 -----ISDINGLVHLPQL---------ESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQ 164
Query: 349 FCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEML 408
+I +KL +S N+IS + + L VL+L S + K L
Sbjct: 165 IS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNL 220
Query: 409 SSLNKLILNLNQLSGGVPLE----FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNL 464
N + L + + +L TN++S + + +
Sbjct: 221 VVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHG 280
Query: 465 SNNQLSHKIPTE 476
Q ++ T
Sbjct: 281 RVTQPLKEVYTV 292
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 9e-22
Identities = 56/312 (17%), Positives = 108/312 (34%), Gaps = 60/312 (19%)
Query: 101 NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160
++ +L ++ + +LN + ++ + + I +
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD--------------IKSV---- 58
Query: 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLG 220
+ L N+ L+L N L+ I + LK+L L L EN+ + SL
Sbjct: 59 --------QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLS-SLK 106
Query: 221 NLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYN 280
+L L +SL +N +S I L +L L +L L N++ + L+ L L L +
Sbjct: 107 DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 162
Query: 281 NGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLT 340
N + + L T L + + L++N++S A NL
Sbjct: 163 N-----------QISDIVPLAGLTKL---------QNLYLSKNHIS--DLRALAGLKNLD 200
Query: 341 FLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGK 400
L+L + + + N +T V + S P I + + ++ +
Sbjct: 201 VLELFSQECLNKPINHQSNLVVPNT--VKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 258
Query: 401 IPVQLEMLSSLN 412
V +
Sbjct: 259 NEVSFIFYQPVT 270
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.6 bits (237), Expect = 2e-20
Identities = 56/274 (20%), Positives = 101/274 (36%), Gaps = 16/274 (5%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+ + + + + + ++ I L + L L N+L+ + P + L L L+
Sbjct: 38 TQNELNSIDQIIANNSDI-KSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
LD N++ + + L + L+L HN + S + L +L L LYL N + + +
Sbjct: 94 LDENKIK-DLSS-LKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKI--TDIT 147
Query: 194 IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALG 253
++ +L L L L +NQ S I L L+ L + L N +S + L LK+L L
Sbjct: 148 VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLE 203
Query: 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH 313
L + NL + + L PE I + + +L
Sbjct: 204 LFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEV 261
Query: 314 SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNN 347
S + + P +S +
Sbjct: 262 SFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYD 295
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 64/258 (24%), Positives = 101/258 (39%), Gaps = 53/258 (20%)
Query: 607 IGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+GKG GSV P GD +VAVK QL +F E+ LK +
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVK----QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 662 VKFHGFCYNGPHS--FLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALS 716
VK+ G Y LV EYL G L L + A L + + +
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGME 141
Query: 717 YLH-HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS------------NWT 763
YL C +HRD++++N+L++S ++DFG+AK + W
Sbjct: 142 YLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHP----RDFFSINFSSFSNM 818
APE + + DV+SFGV+++E+ + +F +
Sbjct: 198 ---------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
Query: 819 II-DVNKILDP--RLPTP 833
+ + ++L+ RLP P
Sbjct: 249 ALSRLLELLEEGQRLPAP 266
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 64/298 (21%), Positives = 113/298 (37%), Gaps = 40/298 (13%)
Query: 101 NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160
L+ + G + ++ + L+ + L + TI + L+ + L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLG 220
N + + + L NL+ + L L N L ++ + I L+S+ LDL+ Q + PL+
Sbjct: 73 NQI--TDLAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTPLA-- 126
Query: 221 NLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYN 280
LS+L ++ L N ++ +I P L L +L L + Q++ P + NLS L L +
Sbjct: 127 GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 281 NGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLT 340
N + +S L NL V L N +S + NL
Sbjct: 183 NK-----------ISDISPLASLPNL---------IEVHLKNNQIS--DVSPLANTSNLF 220
Query: 341 FLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPD-IGNSPKLQVLDLSSNHI 397
+ L+N + + L V I P I ++ +L+ N
Sbjct: 221 IVTLTNQTI---TNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 60/304 (19%), Positives = 107/304 (35%), Gaps = 38/304 (12%)
Query: 169 SSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMM 228
L+N + K++++ ++ L + L + +I + L++L +
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGL 68
Query: 229 SLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVP 288
L +N ++ + P L NL ++ L L N L I L S++ L L + + P
Sbjct: 69 ELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP 124
Query: 289 EEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNN 348
+ L +L L L N + + NL +L + N
Sbjct: 125 --LAGLSNLQVLYLDLNQITNI--------------------SPLAGLTNLQYLSIGNAQ 162
Query: 349 FCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEML 408
N SKL+T N IS I P + + P L + L +N I P L
Sbjct: 163 VSDLTPL--ANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANT 216
Query: 409 SSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQ 468
S+L + L ++ +L + + + P +I + NL+ N
Sbjct: 217 SNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA--PATISDNGTYASPNLTWNL 274
Query: 469 LSHK 472
S
Sbjct: 275 TSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 57/259 (22%), Positives = 107/259 (41%), Gaps = 20/259 (7%)
Query: 294 LKSLSELELCTNLLRGVIP----HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF 349
L + ++ + + + I + + E NL L+L +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQ- 74
Query: 350 CGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLS 409
+++ N +K++ +S N + ++ I ++ LDL+S I P L LS
Sbjct: 75 ITDLA-PLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLS 129
Query: 410 SLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQL 469
+L L L+LNQ++ PL LT LQYL + ++S P + NL KL L +N++
Sbjct: 130 NLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185
Query: 470 SHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMR 529
S I L +L E+ L +N + + P + N +L + L++ +++ +
Sbjct: 186 S-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLV 241
Query: 530 SLSCIDISYNELHGPIPNS 548
+ + P S
Sbjct: 242 VPNVVKGPSGAPIAPATIS 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 59/297 (19%), Positives = 109/297 (36%), Gaps = 38/297 (12%)
Query: 197 KLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHI 256
L + +++ ++ + ++ + +L +T +S F ++ +I + L +L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 257 NQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIE 316
NQ+ P + NL+ + L L N L I L+S+ L+L + + V P
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTP---- 124
Query: 317 RVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGS 376
NL L L N IS + L + +S
Sbjct: 125 ----------------LAGLSNLQVLYLDLNQI-TNIS-PLAGLTNLQYLSIGNAQVS-D 165
Query: 377 IPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQ 436
+ P + N KL L N I I L L +L ++ L NQ+S PL + + L
Sbjct: 166 LTP-LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLA--NTSNLF 220
Query: 437 YLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNIL 493
+ L+ +++ NL+ + + P + +L+ N+
Sbjct: 221 IVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 16/227 (7%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+ + + L+ I + L+ L L+L NQ++ L P + L ++ L
Sbjct: 36 TQADLDGITTLSAFGTGV-TTIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
L N L I L I L L + + + L LSNL VLYL N ++ +I
Sbjct: 92 LSGNPL--KNVSAIAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQIT-NISP 146
Query: 194 IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALG 253
+ L +L L + Q S PL+ NLS LT + +N +S I P L +L +L +
Sbjct: 147 -LAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADDNKIS-DISP-LASLPNLIEVH 201
Query: 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSEL 300
L NQ++ P + N S+L ++ L N + L + +
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 46/261 (17%), Positives = 101/261 (38%), Gaps = 22/261 (8%)
Query: 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396
N + +N ++ + ++T ++ +I + L L+L N
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 397 IVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNL 456
I + L+ L+ + +L L+ N L + L ++ LDL++ +++ P + L
Sbjct: 75 IT-DLAP-LKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITDVTP--LAGL 128
Query: 457 LKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNN 516
L L L NQ+++ P L +L L + + + ++ P + N+ L L N
Sbjct: 129 SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV-SDLTP-LANLSKLTTLKADDNK 184
Query: 517 LSDFIPRCFEEMRSLSCIDISYNELHG--PIPNSTAFKDGLMEGNKGLKRVSQEEQSNSM 574
+SD P + +L + + N++ P+ N++ + ++ + +
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT----ITNQPVFYNN 238
Query: 575 NRLRLLSVLNFDGKIMHEEII 595
N + V G + I
Sbjct: 239 NLVVPNVVKGPSGAPIAPATI 259
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 40/187 (21%), Positives = 82/187 (43%), Gaps = 14/187 (7%)
Query: 355 FNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKL 414
F + +N++ ++ + + L + I ++ L++L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68
Query: 415 ILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIP 474
L NQ++ PL+ +LTK+ L+LS N L + +I L + L+L++ Q++ P
Sbjct: 69 ELKDNQITDLAPLK--NLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 475 TEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCI 534
L +L L L N + I P + + +L+ L++ + +SD P + L+ +
Sbjct: 125 --LAGLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 535 DISYNEL 541
N++
Sbjct: 179 KADDNKI 185
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 12/185 (6%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYL 134
+ + L LS N N+ I L ++ LDL S Q++ + P + L+ L+ LYL
Sbjct: 81 LKNLTKITELELSGNPL-KNVS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYL 136
Query: 135 DMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSI 194
D+NQ+ T + L+ + L++ + + S + L NLS L L N +S I
Sbjct: 137 DLNQI--TNISPLAGLTNLQYLSIGNAQV--SDLTPLANLSKLTTLKADDNKIS-DISP- 190
Query: 195 IGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGL 254
+ L +L+++ L NQ S PL+ N S+L +++L N +++ NL + +
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKG 248
Query: 255 HINQL 259
Sbjct: 249 PSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 40/188 (21%), Positives = 73/188 (38%), Gaps = 12/188 (6%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
+ + + L+L+ PL LS LQ L L NQ++ + P + L L+ L
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQITNISP--LAGLTNLQYL 156
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
+ Q+ + P + LS + L N + S S L +L NL ++L N +S P
Sbjct: 157 SIGNAQVS-DLTP-LANLSKLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQISDVSP 212
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSAL 252
+ +L + L+ + NL + S + P + + + ++
Sbjct: 213 --LANTSNLFIVTLTNQTITNQPVFYNNNLVVPN--VVKGPSGAPIAPATISDNGTYASP 268
Query: 253 GLHINQLN 260
L N +
Sbjct: 269 NLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 38/163 (23%), Positives = 69/163 (42%), Gaps = 9/163 (5%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYL 134
+ +L L L N NI + L+ LQYL +G+ Q+S L P + L++L L
Sbjct: 125 LAGLSNLQVLYLDLNQI-TNIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 135 DMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSI 194
D N++ I P + L + ++ L +N + S S L N SNL ++ L +++
Sbjct: 181 DDNKIS-DISP-LASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQPVFY 236
Query: 195 IGKLKSLLQL-DLSENQFSGSIPLSLGNLSSLTMMSLFNNSLS 236
L + S + + G +S + + ++
Sbjct: 237 NNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFIN 279
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-25
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 38/212 (17%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKG G V + G+ VAVK + + A FL E + ++RH N V+
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVK----CIKNDATAQ--AFLAEASVMTQLRHSNLVQLL 252
Query: 666 GFC-YNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALSYL-H 719
G ++V EY+ +GSL L + L + V A+ YL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEG 307
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN------WTEFAGTFGYAA 773
++ +HRD++++NVL+ + A VSDFG+ K WT A
Sbjct: 308 NNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------A 354
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVI-KGNHP 804
PE + + K DV+SFG+L++E+ G P
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 17/208 (8%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G GG G V + +G+ VA+K+ +L + + + + E+ +K++ H N V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 666 ------GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
L EY + G L + L L ++ +++AL YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+ IIHRD+ +N++L + + D G AK + TEF GT Y APE+
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEFVGTLQYLAPEL 194
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ T D +SFG L FE I G P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
IGKG G VY E A+K + M + FL E L ++ + H N +
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR---ITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 663 KFHGFCYNG-PHSFLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANALSYL 718
G ++ Y+ G L R + T K+L I+ VA + YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGMEYL 140
Query: 719 --HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFG------ 770
+HRD++++N +LD +F V+DFG+A+ + +
Sbjct: 141 AEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVK 193
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
+ A E T R T K DV+SFGVL++E++
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 47/230 (20%), Positives = 81/230 (35%), Gaps = 32/230 (13%)
Query: 598 TDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI 656
T +F E IG G GSV+K + G I A+K+ S+ D L EV A +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHAVL 67
Query: 657 -RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI-NVIKGVANA 714
+H + V++ H + EY + GSLA + ++ + +++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS-------------------DFGIAKFV 755
L Y+H S++H DI N+ + + + D G
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-- 182
Query: 756 GPHSSNWTEFAGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
S+ G + A E + K D+++ + V
Sbjct: 183 --RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 56/241 (23%), Positives = 104/241 (43%), Gaps = 36/241 (14%)
Query: 607 IGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNM-ADHDEFLNEVLALKEIRHRN 660
+G G G+VYK VA+K+ L + E L+E + + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE----LREATSPKANKEILDEAYVMASVDNPH 78
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALSY 717
+ G C L+ + + G L + D++ ++ L +N +A ++Y
Sbjct: 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTF--GYAAPE 775
L L +HRD++++NVL+ + ++DFG+AK +G + G + A E
Sbjct: 133 LEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 776 IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDP--RLPT 832
T + DV+S+GV V+E++ G+ P + +++ IL+ RLP
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP-------YDGIPAS--EISSILEKGERLPQ 240
Query: 833 P 833
P
Sbjct: 241 P 241
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-25
Identities = 56/257 (21%), Positives = 109/257 (42%), Gaps = 49/257 (19%)
Query: 578 RLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLS 637
R+ ++ NF+ + + + + +G G G+V G VAVK+
Sbjct: 2 RIANIPNFEQSLKNLVVSEKI--------LGYGSSGTVVFQGSFQGRPVAVKRMLID--- 50
Query: 638 GNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLA-RILGDDVT 695
D L E+ L E H N ++++ ++ E + +L + +V+
Sbjct: 51 ----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVS 105
Query: 696 AKELGWNRR---INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS------------ 740
+ L + I++++ +A+ +++LH IIHRD+ +N+L+ +
Sbjct: 106 DENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA 162
Query: 741 -NFEAHVSDFGIAKFVGPHSSNWT----EFAGTFGYAAPEI-------AYTMRATEKYDV 788
N +SDFG+ K + S++ +GT G+ APE+ R T D+
Sbjct: 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222
Query: 789 YSFGVLVFEVI-KGNHP 804
+S G + + ++ KG HP
Sbjct: 223 FSMGCVFYYILSKGKHP 239
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 50/249 (20%)
Query: 607 IGKGGQGSVYKAEL--PSGDI---VAVKKFNSQLLSGNMA-DHDEFLNEVLALKEIRHRN 660
IG G G VYK L SG VA+K L +G +FL E + + H N
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIK----TLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
++ G ++ EY++ G+L + L + E + + +++G+A + YL +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN------------WTEFAGT 768
+HRD++++N+L++SN VSDFG+++ + WT
Sbjct: 166 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----- 217
Query: 769 FGYAAPE-IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKIL 826
APE I+Y + T DV+SFG++++EV+ G P + SN +V K +
Sbjct: 218 ----APEAISYR-KFTSASDVWSFGIVMWEVMTYGERP-------YWELSNH--EVMKAI 263
Query: 827 DP--RLPTP 833
+ RLPTP
Sbjct: 264 NDGFRLPTP 272
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 62/249 (24%), Positives = 103/249 (41%), Gaps = 51/249 (20%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMA-DHDEFLNEVLALKEIRHRNN 661
+G G G V L VA+K L G +FL E + + H N
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIK----TLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL--H 719
++ G +V EY++ GSL L + + + +++G+A+ + YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN------------WTEFAG 767
+HRD++++N+L++SN VSDFG+ + + WT
Sbjct: 167 G-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT---- 217
Query: 768 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKIL 826
+PE + T DV+S+G++++EV+ G P + SN DV K +
Sbjct: 218 -----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQ--DVIKAV 263
Query: 827 DP--RLPTP 833
D RLP P
Sbjct: 264 DEGYRLPPP 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 61/242 (25%), Positives = 104/242 (42%), Gaps = 40/242 (16%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMA-DHDEFLNEVLALKEIRHRNN 661
IG+G G V++ S + VA+K + ++FL E L +++ H +
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIK----TCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANALSYL 718
VK G P +++ E G L ++ + L I ++ AL+YL
Sbjct: 79 VKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYL 132
Query: 719 -HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAP 774
+HRDI+++NVL+ SN + DFG+++++ S + + + + AP
Sbjct: 133 ESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 186
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDP--RLP 831
E R T DV+ FGV ++E++ G P F N DV ++ RLP
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNN--DVIGRIENGERLP 237
Query: 832 TP 833
P
Sbjct: 238 MP 239
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 56/241 (23%), Positives = 102/241 (42%), Gaps = 38/241 (15%)
Query: 607 IGKGGQGSVYKAELPSGDI----VAVKKFNSQLLSGNMADH-DEFLNEVLALKEIRHRNN 661
+G+G G VY+ + VAVK D+ ++F++E + +K + H +
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVK----TCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANALSYL 718
VK G P +++ E G L + + L + + A++YL
Sbjct: 76 VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMAYL 129
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAPE 775
+HRDI+ +N+L+ S + DFG+++++ ++ + + T + +PE
Sbjct: 130 ESINC---VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTRLPIKWMSPE 184
Query: 776 IAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDP--RLPT 832
R T DV+ F V ++E++ G P F N DV +L+ RLP
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQP-------FFWLENK--DVIGVLEKGDRLPK 235
Query: 833 P 833
P
Sbjct: 236 P 236
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 42/215 (19%)
Query: 607 IGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G+G G V P GD VAVK + SG + E+ L+ + H N
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGN-HIADLKKEIEILRNLYHENI 85
Query: 662 VKFHGFCYNGPHS--FLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALS 716
VK+ G C + L+ E+L GSL L + + K+ + + +
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMD 140
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN------------WTE 764
YL +HRD++++NVL++S + + DFG+ K + W
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY- 196
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
APE + DV+SFGV + E++
Sbjct: 197 --------APECLMQSKFYIASDVWSFGVTLHELL 223
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 58/250 (23%), Positives = 105/250 (42%), Gaps = 29/250 (11%)
Query: 594 IIKATDDFDEKFCIGKGGQGSVYKAEL--PSGDI-VAVKKFNSQLLSGNM-ADHDEFLNE 649
+K + +G G GSV + I VA+K L G AD +E + E
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK----VLKQGTEKADTEEMMRE 386
Query: 650 VLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIK 709
+ ++ + V+ G C LV E G L + L +E+ + ++
Sbjct: 387 AQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLH 443
Query: 710 GVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT- 768
V+ + YL +HR+++++NVLL + A +SDFG++K +G S +T +
Sbjct: 444 QVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 769 --FGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKI 825
+ APE + + + DV+S+GV ++E + G P + +V
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-------YKKMKGP--EVMAF 551
Query: 826 LDP--RLPTP 833
++ R+ P
Sbjct: 552 IEQGKRMECP 561
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 31/207 (14%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG----NMADHDEFLNEVLALKEIRHRNN 661
+G G G V A E + VA++ + + + E+ LK++ H
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSL-ARI-----LGDDVTAKELGWNRRINVIKGVANAL 715
+K F ++ ++V E ++ G L ++ L + + A+
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLLAV 252
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNWTEFAGTFGYA 772
YLH + IIHRD+ +NVLL S E ++DFG +K +G S GT Y
Sbjct: 253 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 308
Query: 773 APEIAYTMRA---TEKYDVYSFGVLVF 796
APE+ ++ D +S GV++F
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILF 335
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 41/339 (12%), Positives = 94/339 (27%), Gaps = 50/339 (14%)
Query: 535 DISYNELHGPIPNSTAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNFDGKIMHEEI 594
++ + G P ++ + R + E ++ + L S+ N E
Sbjct: 13 NLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESE 72
Query: 595 IKA-TDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA 652
+ +G+ + +A +G+ V + + EVL
Sbjct: 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN-AIKQMKEEVLR 131
Query: 653 LKEIRHRNN---------------------------VKFHGFCYNGPHSFLVCEYL--DR 683
L+ +R N V+ F + + +
Sbjct: 132 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 191
Query: 684 GSLARILGDDVTAKE-LGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742
+ +L + + L + R+ + V L+ LHH ++H + +++LD
Sbjct: 192 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRG 248
Query: 743 EAHVSDFGIAKFVG-PHSSNWTEFAGTFGYAAPEIAYTMRATEKY-----DVYSFGVLVF 796
++ F G S A + + D ++ G+ ++
Sbjct: 249 GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308
Query: 797 EVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
+ + P + + I P P
Sbjct: 309 WIWCADLP-------NTD-DAALGGSEWIFRSCKNIPQP 339
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 55/219 (25%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 592 EEIIKATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF 646
E ++ A+ F + + +GKG V + +G A K N++ LS D +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKL 75
Query: 647 LNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRR-- 704
E ++++H N V+ H +LV + + G L +D+ A+E ++
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREF-YSEADA 130
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSN 761
+ I+ + +++Y H + I+HR++ +N+LL S + ++DFG+A V S
Sbjct: 131 SHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEA 186
Query: 762 WTEFAGTFGYAAPEI----AYTMRATEKYDVYSFGVLVF 796
W FAGT GY +PE+ Y ++ D+++ GV+++
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILY 221
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 59/249 (23%), Positives = 100/249 (40%), Gaps = 52/249 (20%)
Query: 607 IGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G G G+V+K V +K + SG + +LA+ + H +
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQ-SFQAVTDHMLAIGSLDHAHI 77
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANALSYL 718
V+ G C LV +YL GSL R + + L +N +A + YL
Sbjct: 78 VRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYYL 131
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS-----------NWTEFAG 767
+ +HR+++++NVLL S + V+DFG+A + P W
Sbjct: 132 EEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM---- 184
Query: 768 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKIL 826
A E + + T + DV+S+GV V+E++ G P ++ +V +L
Sbjct: 185 -----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP-------YAGLRLA--EVPDLL 230
Query: 827 DP--RLPTP 833
+ RL P
Sbjct: 231 EKGERLAQP 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 598 TDDFDEKFC----IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA 652
F E++ +GKG V + ++ +G A N++ LS DH + E
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR--DHQKLEREARI 63
Query: 653 LKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRR--INVIKG 710
+ ++H N V+ H H +L+ + + G L +D+ A+E ++ + I+
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF----EDIVAREY-YSEADASHCIQQ 118
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNWTEFAG 767
+ A+ + H ++HR++ +N+LL S + ++DFG+A V W FAG
Sbjct: 119 ILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 768 TFGYAAPEI----AYTMRATEKYDVYSFGVLVF 796
T GY +PE+ Y + D+++ GV+++
Sbjct: 176 TPGYLSPEVLRKDPY----GKPVDLWACGVILY 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 58/241 (24%), Positives = 102/241 (42%), Gaps = 40/241 (16%)
Query: 588 KIMHEEIIKATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMAD 642
+ + E + A D F +G G G VYK + +G + A+K + ++G+ +
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGD--E 63
Query: 643 HDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSF-------LVCEYLDRGSLARILGDDV 694
+E E+ LK+ HRN ++G + + LV E+ GS+ ++
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYG-AFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---- 118
Query: 695 TAKELGWNRRIN------VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748
+ + + + + LS+LH +IHRDI +NVLL N E + D
Sbjct: 119 ---KNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172
Query: 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATE-----KYDVYSFGVLVFEVIKGNH 803
FG++ + F GT + APE+ + K D++S G+ E+ +G
Sbjct: 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 804 P 804
P
Sbjct: 233 P 233
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
IG+G G VY L D AVK N ++ + +FL E + +K+ H N +
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 663 KFHGFCY-NGPHSFLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANALSYL 718
G C + +V Y+ G L R + T K+L I VA + YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 144
Query: 719 --HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA---- 772
+HRD++++N +LD F V+DFG+A+ + + + G
Sbjct: 145 ASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVK 197
Query: 773 --APEIAYTMRATEKYDVYSFGVLVFEVI 799
A E T + T K DV+SFGVL++E++
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 46/248 (18%), Positives = 87/248 (35%), Gaps = 22/248 (8%)
Query: 314 SIERVLLNQNNLSGKMYE---AFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
S++R+ + + ++ L L L N G + I+++
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 371 NNISGSIPPDIGNS------PKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGG 424
N+S + P L+VL ++ H + Q+ + +L+ L L+ N G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 425 VPLE----FGSLTKLQYLDLSTNKLSS---SIPKSIGNLLKLHYLNLSNNQLSHKIPTE- 476
L LQ L L + + ++L L+LS+N L
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 477 FEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDI 536
+ L+ L+LS L +++P L L+LS+N L +E+ + + +
Sbjct: 249 CDWPSQLNSLNLSFTGL-KQVPK--GLPAKLSVLDLSYNRLDRNPS--PDELPQVGNLSL 303
Query: 537 SYNELHGP 544
N
Sbjct: 304 KGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 54/305 (17%), Positives = 98/305 (32%), Gaps = 35/305 (11%)
Query: 58 SITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSG 117
S + + S L ++ +L + L+ L + + ++
Sbjct: 26 SAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDII---KSLSLKRLTVRAARIPS 82
Query: 118 LIPPEIGKL---NQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL-CHNNLHGSIPSSLGN 173
I ++ + L+ L L+ ++ GT PP + + + D L N + + L
Sbjct: 83 RILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAE 142
Query: 174 LSN-----LAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMM 228
L L VL + + + +L LDLS+N G L
Sbjct: 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI---------- 192
Query: 229 SLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVP 288
S P L+ L+ + +G L+ L L +N L
Sbjct: 193 -------SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 289 EEI-GYLKSLSELELCTNLLRGV---IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDL 344
+ L+ L L L+ V +P + + L+ N L + + P + L L
Sbjct: 246 APSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDRN--PSPDELPQVGNLSL 303
Query: 345 SNNNF 349
N F
Sbjct: 304 KGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 42/229 (18%), Positives = 71/229 (31%), Gaps = 16/229 (6%)
Query: 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396
P + N ++ G S DI S L+ L + +
Sbjct: 20 PKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAAR 79
Query: 397 IVGKIPVQLEML---SSLNKLILNLNQLSGGVPLEFGSLT--KLQYLDLSTNKLSS--SI 449
I +I + S L +L L +++G P T L L+L ++ +
Sbjct: 80 IPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW 139
Query: 450 PKSIGNLLK--LHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIP----PQVCN 503
+ LK L L+++ + + LS LDLS N E
Sbjct: 140 LAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199
Query: 504 MGSLEKLNLSHNN---LSDFIPRCFEEMRSLSCIDISYNELHGPIPNST 549
+L+ L L + S L +D+S+N L +
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 39/186 (20%), Positives = 57/186 (30%), Gaps = 13/186 (6%)
Query: 61 MSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIP 120
+S + + P L L+++ Q+ L LDL N G
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 121 PEI----GKLNQLRRLYLDMNQLH---GTIPPEIGQLSLIDKLALCHNNLHGSIPSSL-G 172
K L+ L L + G + L L HN+L + +
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 173 NLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFN 232
S L L L L +P + L LDLS N+ P L + +SL
Sbjct: 251 WPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKG 305
Query: 233 NSLSGS 238
N S
Sbjct: 306 NPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 46/202 (22%), Positives = 67/202 (33%), Gaps = 14/202 (6%)
Query: 21 LNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPH 80
L ++ L N + + +W + ++++ F FP
Sbjct: 116 LEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPA 174
Query: 81 LANLNLSFNLFFGNIPLQI----GNLSKLQYLDLGSNQ---LSGLIPPEIGKLNQLRRLY 133
L+ L+LS N G L LQ L L + SG+ QL+ L
Sbjct: 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLD 234
Query: 134 LDMNQLHGTIPPEIGQ-LSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
L N L S ++ L L L +P L + L+VL L N L P
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNP 290
Query: 193 SIIGKLKSLLQLDLSENQFSGS 214
S L + L L N F S
Sbjct: 291 SPDE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 26/150 (17%), Positives = 50/150 (33%), Gaps = 9/150 (6%)
Query: 414 LILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL---KLHYLNLSNNQLS 470
L + G + L+ L + ++ S I +L L L L N +++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 471 HKIPTEFEKLIH--LSELDLSHNILQEEIPP----QVCNMGSLEKLNLSHNNLSDFIPRC 524
P + L+ L+L + Q L+ L+++ + +F
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 525 FEEMRSLSCIDISYNELHGPIPNSTAFKDG 554
+LS +D+S N G +A
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPL 198
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 31/207 (14%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG----NMADHDEFLNEVLALKEIRHRNN 661
+G G G V A E + VA+K + + + E+ LK++ H
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSL-ARI-----LGDDVTAKELGWNRRINVIKGVANAL 715
+K F ++ ++V E ++ G L ++ L + + A+
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLLAV 127
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNWTEFAGTFGYA 772
YLH + IIHRD+ +NVLL S E ++DFG +K +G S GT Y
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 183
Query: 773 APEI---AYTMRATEKYDVYSFGVLVF 796
APE+ T D +S GV++F
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILF 210
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 45/220 (20%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+G+G GSV + L D VAVK S + +EFL+E +K+ H N +
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS--QREIEEFLSEAACMKDFSHPNVI 99
Query: 663 KFHGFC-----YNGPHSFLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANA 714
+ G C P ++ ++ G L + K + + + +A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 715 LSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN----------- 761
+ YL + +HRD++++N +L + V+DFG++K + +S +
Sbjct: 160 MEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGDYYRQGRIAKMP 212
Query: 762 --WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W A E T K DV++FGV ++E+
Sbjct: 213 VKWI---------AIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 598 TDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA 652
+ F + + + GKG V + +G A K N++ LS D + E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARI 58
Query: 653 LKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI--NVIKG 710
++++H N V+ H +LV + + G L +D+ A+E ++ + I+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREF-YSEADASHCIQQ 113
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFE-AHV--SDFGIAKFVGPHSSNWTEFAG 767
+ +++Y H + I+HR++ +N+LL S + A V +DFG+A V S W FAG
Sbjct: 114 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAWHGFAG 169
Query: 768 TFGYAAPEI----AYTMRATEKYDVYSFGVLVF 796
T GY +PE+ Y ++ D+++ GV+++
Sbjct: 170 TPGYLSPEVLKKDPY----SKPVDIWACGVILY 198
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 44/200 (22%), Positives = 80/200 (40%), Gaps = 17/200 (8%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
IGKG V + +G AVK + ++ S ++ E ++H + V+
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNR-----RINVIKGVANALSYLH 719
+ ++V E++D L ++ + + ++ + AL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLC----FEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+ +IIHRD+ VLL S + + FG+A +G GT + APE+
Sbjct: 148 DN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 777 AYTMRATEKYDVYSFGVLVF 796
+ DV+ GV++F
Sbjct: 205 VKREPYGKPVDVWGCGVILF 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 48/255 (18%)
Query: 607 IGKGGQGSVYKAEL-PSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN 661
+G+G G V P+ D +VAVK + + E+ L+ + H +
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA---DAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 662 VKFHGFCYNGPHS--FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
+K+ G C + + LV EY+ GSL L +G + + + + ++YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLH 151
Query: 720 -HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN------------WTEFA 766
IHRD++++NVLLD++ + DFG+AK V W
Sbjct: 152 AQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 204
Query: 767 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-----KGNHPRDFFSINFSSFSNMI-I 820
APE + DV+SFGV ++E++ + P F + + M +
Sbjct: 205 ------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 821 DVNKILDP--RLPTP 833
+ ++L+ RLP P
Sbjct: 259 RLTELLERGERLPRP 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 39/234 (16%), Positives = 72/234 (30%), Gaps = 28/234 (11%)
Query: 592 EEIIKATDDFDEKFCIGKGGQGSVYKAE------LPSGDIVAVKKFNSQLLSGNMADHDE 645
E + +G+G VY+A + +K N +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYI 113
Query: 646 FLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL--GDDVTAKELGWNR 703
+ LK +KF+ S LV E G+L + + K +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH-----------VSDFGIA 752
I+ + + +H IIH DI N +L + F + D G +
Sbjct: 174 VISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 753 KFVG--PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ P + +T T G+ E+ + D + V+ ++ G +
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 21/246 (8%)
Query: 559 NKGLKRVSQEEQSNSMNRLRLLSVLNFDGKIMHEEIIKATDDFDEKFCI----GKGGQGS 614
+ G K + + + + + K + + + + + I G G G
Sbjct: 9 HHGSKVRGKYDGPKINDYDKF--YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66
Query: 615 VYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673
V++ E +G + K N+ D NE+ + ++ H + H +
Sbjct: 67 VHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122
Query: 674 SFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 732
L+ E+L G L RI +D E IN ++ L ++H SI+H DI
Sbjct: 123 MVLILEFLSGGELFDRIAAEDYKMSE---AEVINYMRQACEGLKHMHEH---SIVHLDIK 176
Query: 733 SKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYS 790
+N++ ++ + V DFG+A + P T +AAPEI D+++
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWA 235
Query: 791 FGVLVF 796
GVL +
Sbjct: 236 IGVLGY 241
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 29/222 (13%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKF 664
+ +GG VY+A+ + SG A+K+ LLS + + EV +K++ H N V+F
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKR----LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 665 HGFCYNGPHS-------FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
G FL+ L +G L L + L + + + A+ +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN------------WTEF 765
+H P IIHRD+ +N+LL + + DFG A + +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 766 AGTFGYAAPEIAYTMR---ATEKYDVYSFGVLVFEVIKGNHP 804
T Y PEI EK D+++ G +++ + HP
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 46/221 (20%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
+GKG GSV +A+L D VAVK + +++ +D +EFL E +KE H +
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA--SSDIEEFLREAACMKEFDHPHVA 88
Query: 663 KFHGFC------YNGPHSFLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVAN 713
K G P ++ ++ G L L + + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 714 ALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN---------- 761
+ YL + IHRD++++N +L + V+DFG+++ + +S +
Sbjct: 149 GMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDYYRQGCASKL 201
Query: 762 ---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W A E T DV++FGV ++E++
Sbjct: 202 PVKWL---------ALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 598 TDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA 652
F E++ I GKG G V K + + AVK N D L EV
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVEL 74
Query: 653 LKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI-NVIKGV 711
LK++ H N +K + ++V E G L D++ ++ +IK V
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF----DEIIKRKRFSEHDAARIIKQV 130
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNWTEFAGT 768
+ ++Y+H +I+HRD+ +N+LL+S + + DFG++ ++ + GT
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRIGT 186
Query: 769 FGYAAPEI---AYTMRATEKYDVYSFGVLVF 796
Y APE+ Y EK DV+S GV+++
Sbjct: 187 AYYIAPEVLRGTY----DEKCDVWSAGVILY 213
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 590 MHEEIIKATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN 648
M I+ T F E +G G V+ + +G + A+K N
Sbjct: 2 MQTTNIRKTFIFMEV--LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF----RDSSLEN 55
Query: 649 EVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAK----ELGWNRR 704
E+ LK+I+H N V + H +LV + + G L D + + E
Sbjct: 56 EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF----DRILERGVYTE---KDA 108
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSN 761
VI+ V +A+ YLH + I+HRD+ +N+L + E ++DFG++K
Sbjct: 109 SLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163
Query: 762 WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 796
+ GT GY APE+ ++ D +S GV+ +
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITY 198
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 45/216 (20%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662
IG+G G VY L D AVK N ++ + +FL E + +K+ H N +
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 663 KFHGFCY-NGPHSFLVCEYLDRGSLA---RILGDDVTAKELGWNRRINVIKGVANALSYL 718
G C + +V Y+ G L R + T K+L I VA + +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFL 208
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN---------------WT 763
+HRD++++N +LD F V+DFG+A+ + + W
Sbjct: 209 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFDSVHNKTGAKLPVKWM 263
Query: 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
A E T + T K DV+SFGVL++E++
Sbjct: 264 ---------ALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-23
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 20/220 (9%)
Query: 594 IIKATDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN 648
I E + G G G V + + A+K +S + + + L
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLE 85
Query: 649 EVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINV 707
EV LK + H N +K + F + + +LV E G L I + + +
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI----IHRMKFNEVDAAVI 141
Query: 708 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNWTE 764
IK V + ++YLH +I+HRD+ +N+LL+S + + DFG++ E
Sbjct: 142 IKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-QKKMKE 197
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
GT Y APE+ + EK DV+S GV++F ++ G P
Sbjct: 198 RLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-23
Identities = 78/422 (18%), Positives = 149/422 (35%), Gaps = 69/422 (16%)
Query: 175 SNLAVLYLYKNSLS-GSIPSIIGKLKSLLQLDLSENQFS----GSIPLSLGNLSSLTMMS 229
++ L + LS ++ L+ + L + + I +L +L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 230 LFNNSLSGS-IPPILGNLKS----LSALGLHINQLN----GFIPPSIGNLSSLRVLYLYN 280
L +N L + +L L++ + L L L G + ++ L +L+ L+L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 281 NGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGD----H 336
N L + G L+ L E L +E++ L +LS E
Sbjct: 123 NLL-----GDAG-LQLLCEGLLDPQC-------RLEKLQLEYCSLSAASCEPLASVLRAK 169
Query: 337 PNLTFLDLSNNNFCGEISFNW------GNFSKLSTFIVSMNNIS----GSIPPDIGNSPK 386
P+ L +SNN+ E + +L + ++ + + +
Sbjct: 170 PDFKELTVSNNDI-NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKAS 228
Query: 387 LQVLDLSSNHIVGK-----IPVQLEMLSSLNKLILNLNQLS--GGVPLEFG--SLTKLQY 437
L+ L L SN + P L S L L + ++ G L + L+
Sbjct: 229 LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKE 288
Query: 438 LDLSTNKLSSSIPKSIGNLLK-----LHYLNLSNNQLSHK----IPTEFEKLIHLSELDL 488
L L+ N+L + + L L L + + + + + L EL +
Sbjct: 289 LSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348
Query: 489 SHNILQEEIPPQVC-----NMGSLEKLNLSHNNLSD----FIPRCFEEMRSLSCIDISYN 539
S+N L++ ++C L L L+ ++SD + SL +D+S N
Sbjct: 349 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408
Query: 540 EL 541
L
Sbjct: 409 CL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 85/468 (18%), Positives = 153/468 (32%), Gaps = 109/468 (23%)
Query: 103 SKLQYLDLGSNQLSGLIPPEIGK-LNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHN 161
+Q LD+ +LS E+ L Q + + LD + + D
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCG--------LTEARCKD------- 47
Query: 162 NLHGSIPSSLGNLSNLAVLYLYKNSLSGS-IPSIIGKLKS----LLQLDLSENQFS---- 212
I S+L LA L L N L + ++ L++ + +L L +
Sbjct: 48 -----ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 102
Query: 213 GSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSS 272
G + +L L +L + L +N L + L+ L L
Sbjct: 103 GVLSSTLRTLPTLQELHLSDNLLGDA------GLQLLCEGLLDPQ-------------CR 143
Query: 273 LRVLYLYNNGLYGFVPEEIGYL----KSLSELELCTN--------LLRGVIPHS---IER 317
L L L L E + + EL + N +L + S +E
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 318 VLLNQNNLSGKMYEAFGD----HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNI 373
+ L ++ +L L L +N ++L ++ +
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV------GMAELCPGLLHPS-- 255
Query: 374 SGSIPPDIGNSPKLQVLDLSSNHI----VGKIPVQLEMLSSLNKLILNLNQLSG-GVPLE 428
+L+ L + I G + L SL +L L N+L G L
Sbjct: 256 -----------SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304
Query: 429 FGSL----TKLQYLDLSTNKLSSSIPKSIGNLLK----LHYLNLSNNQLSHKIPTEFEKL 480
+L +L+ L + + +++ ++L L L +SNN+L E +
Sbjct: 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364
Query: 481 I-----HLSELDLSHNILQEE----IPPQVCNMGSLEKLNLSHNNLSD 519
+ L L L+ + + + + SL +L+LS+N L D
Sbjct: 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 75/462 (16%), Positives = 143/462 (30%), Gaps = 113/462 (24%)
Query: 99 IGNLSKLQYLDLGSNQLSG----LIPPEIGKLN-QLRRLYLDMNQLHGTIPPEIGQLSLI 153
+ L L+L SN+L + + + ++++L L +
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC--------LTGAGC- 102
Query: 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGS-IPSIIGKLKS----LLQLDLSE 208
G + S+L L L L+L N L + + + L L +L L
Sbjct: 103 -----------GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEY 151
Query: 209 NQFS----GSIPLSLGNLSSLTMMSLFNNSLSGS----IPPILGNLK-SLSALGLHINQL 259
S + L +++ NN ++ + + L + L AL L +
Sbjct: 152 CSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211
Query: 260 N----GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI 315
+ + + +SLR L L +N L ++G + L L + +
Sbjct: 212 TSDNCRDLCGIVASKASLRELALGSNKL-----GDVG-MAELCPGLLHPS-------SRL 258
Query: 316 ERVLLNQNNLSGK----MYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMN 371
+ + + ++ K + +L L L+ N E
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE----------------GAR 302
Query: 372 NISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGS 431
+ ++ + +L+ L + S SS+
Sbjct: 303 LLCETL---LEPGCQLESLWVKSCSF---TAACCSHFSSV-----------------LAQ 339
Query: 432 LTKLQYLDLSTNKLSSSIPKSIGNLLK-----LHYLNLSNNQLSHK----IPTEFEKLIH 482
L L +S N+L + + + L L L L++ +S +
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399
Query: 483 LSELDLSHNILQEEIPPQVC-----NMGSLEKLNLSHNNLSD 519
L ELDLS+N L + Q+ LE+L L S+
Sbjct: 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-14
Identities = 84/444 (18%), Positives = 147/444 (33%), Gaps = 89/444 (20%)
Query: 75 FSSFPHLANLNLSFNLFFGNI-------PLQIGNLSKLQYLDLGSNQLS----GLIPPEI 123
P LA LNL N G++ LQ + K+Q L L + L+ G++ +
Sbjct: 52 LRVNPALAELNLRSN-ELGDVGVHCVLQGLQTPS-CKIQKLSLQNCCLTGAGCGVLSSTL 109
Query: 124 GKLNQLRRLYLDMNQLHGTIPPEIGQLSL-----IDKLALCHNNLH----GSIPSSLGNL 174
L L+ L+L N L + + L ++KL L + +L + S L
Sbjct: 110 RTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAK 169
Query: 175 SNLAVLYLYKNSLSGS-IPSIIGKLK----SLLQLDLSENQFS----GSIPLSLGNLSSL 225
+ L + N ++ + + + LK L L L + + + + +SL
Sbjct: 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229
Query: 226 TMMSLFNNSLSGS-----IPPILGNLKSLSALGLHINQLN----GFIPPSIGNLSSLRVL 276
++L +N L P +L L L + + G + + SL+ L
Sbjct: 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289
Query: 277 YLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGD- 335
L N L + G + L E L +E + + + + F
Sbjct: 290 SLAGNEL-----GDEG-ARLLCETLLEPGC-------QLESLWVKSCSFTAACCSHFSSV 336
Query: 336 ---HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDL 392
+ L L +SNN +L + L+VL L
Sbjct: 337 LAQNRFLLELQISNNRLEDA------GVRELCQGLGQPG-------------SVLRVLWL 377
Query: 393 SSNHI----VGKIPVQLEMLSSLNKLILNLNQLS-GGVPLEFGSL----TKLQYLDLSTN 443
+ + + L SL +L L+ N L G+ S+ L+ L L
Sbjct: 378 ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI 437
Query: 444 KLSSSIPKSIGNLLK----LHYLN 463
S + + L K L ++
Sbjct: 438 YWSEEMEDRLQALEKDKPSLRVIS 461
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-23
Identities = 30/183 (16%), Positives = 74/183 (40%), Gaps = 10/183 (5%)
Query: 359 NFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNL 418
F ++ ++ + L + L++ ++ +E ++ L +N
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 419 NQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFE 478
+ P+ L+ L+ L + ++S ++ L L L++S++ I T+
Sbjct: 76 IHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 479 KLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISY 538
L ++ +DLS+N +I P + + L+ LN+ + + D+ E+ L+ +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 539 NEL 541
+
Sbjct: 191 QTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-21
Identities = 31/174 (17%), Positives = 68/174 (39%), Gaps = 9/174 (5%)
Query: 346 NNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQL 405
+ I+ + L+ ++ N++ + I + ++ L +++ H P +
Sbjct: 31 GQSSTANITE--AQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--I 84
Query: 406 EMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLS 465
LS+L +L + ++ LT L LD+S + SI I L K++ ++LS
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144
Query: 466 NNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSD 519
N I + L L L++ + + + + + L +L +
Sbjct: 145 YNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 36/206 (17%), Positives = 71/206 (34%), Gaps = 34/206 (16%)
Query: 76 SSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLD 135
S+F N L + + ++ L Y+ L + ++ L I + ++ L ++
Sbjct: 20 STFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTIN 74
Query: 136 MNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSII 195
+ + + LSNL L + ++ +
Sbjct: 75 NIHA--------------------------TNYNPISGLSNLERLRIMGKDVTSDKIPNL 108
Query: 196 GKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLH 255
L SL LD+S + SI + L + + L N I P L L L +L +
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQ 167
Query: 256 INQLNGFIPPSIGNLSSLRVLYLYNN 281
+ ++ + I + L LY ++
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 25/166 (15%), Positives = 59/166 (35%), Gaps = 7/166 (4%)
Query: 72 DFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRR 131
+ + + L + L+ ++ ++ L + + + P I L+ L R
Sbjct: 37 NITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNYNP--ISGLSNLER 92
Query: 132 LYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSI 191
L + + P + L+ + L + H+ SI + + L + + L N I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 192 PSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG 237
+ L L L++ + + + L + F+ ++ G
Sbjct: 153 -MPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 31/226 (13%), Positives = 72/226 (31%), Gaps = 52/226 (23%)
Query: 245 NLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCT 304
K+ L + + ++SL + L N + L+ +E
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-----------TDLTGIEYAH 66
Query: 305 NLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS 364
N+ + + +N + + Y NL L +
Sbjct: 67 NI---------KDLTINNIHATN--YNPISGLSNLERLRIMG------------------ 97
Query: 365 TFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGG 424
+++ P++ L +LD+S + I ++ L +N + L+ N
Sbjct: 98 ------KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 425 VPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLS 470
+ +L +L+ L++ + + I + KL+ L + +
Sbjct: 152 IM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 33/200 (16%), Positives = 72/200 (36%), Gaps = 28/200 (14%)
Query: 198 LKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHIN 257
K+ L L ++ + ++ ++SLT ++L N +++ + + ++ L ++
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNI 76
Query: 258 QLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIER 317
+ P I LS+L L + + + L SL+ L+
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD---------------- 118
Query: 318 VLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSI 377
++ + + P + +DLS N +I +L + + + +
Sbjct: 119 --ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL-KTLPELKSLNIQFDGVH-DY 174
Query: 378 PPDIGNSPKLQVLDLSSNHI 397
I + PKL L S I
Sbjct: 175 RG-IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 26/131 (19%), Positives = 52/131 (39%), Gaps = 4/131 (3%)
Query: 409 SSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQ 468
S+ + L S + + L Y+ L+ ++ I + L ++N
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH 77
Query: 469 LSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEM 528
++ P L +L L + + + P + + SL L++SH+ D I +
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 529 RSLSCIDISYN 539
++ ID+SYN
Sbjct: 136 PKVNSIDLSYN 146
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 56/228 (24%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G G V+ AE + +VAVK L +A +F E L ++H +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL-------------GDDVTAKELGWNRRINV 707
VKF+G C +G +V EY+ G L + L ELG ++ +++
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 708 IKGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN---- 761
+A+ + YL H +HRD++++N L+ +N + DFG+++ V +S++
Sbjct: 139 ASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYRV 191
Query: 762 ---------WTEFAGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVI 799
W PE I Y + T + DV+SFGV+++E+
Sbjct: 192 GGHTMLPIRWM---------PPESIMYR-KFTTESDVWSFGVILWEIF 229
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 32/219 (14%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G G G VY+ ++ VAVK + D +FL E L + + H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALIISKFNHQN 94
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALS 716
V+ G F++ E + G L L L ++V + +A
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 717 YL--HHDCLPSIIHRDISSKNVLLDSNFEAHV---SDFGIAKFVGPHSSNWTEFAGTFGY 771
YL +H IHRDI+++N LL V DFG+A+ + + +++ G
Sbjct: 155 YLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYR-KGGCAM 206
Query: 772 -----AAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHP 804
PE T K D +SFGVL++E+ G P
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 42/221 (19%), Positives = 90/221 (40%), Gaps = 19/221 (8%)
Query: 584 NFDGKIMHEEIIKATDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG 638
+ + + + D + + I G G G V++ E +G+ A K +
Sbjct: 138 DIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---- 193
Query: 639 NMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAK 697
+ +D + E+ + +RH V H + ++ E++ G L ++ +
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 253
Query: 698 ELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFV 755
E + + ++ V L ++H + + +H D+ +N++ + + DFG+ +
Sbjct: 254 E---DEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
Query: 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 796
P + GT +AAPE+A D++S GVL +
Sbjct: 308 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSY 347
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 55/227 (24%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G G V+ AE + +VAVK L + + +F E L ++H++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVK----ALKEASESARQDFQREAELLTMLQHQH 104
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL------------GDDVTAKELGWNRRINVI 708
V+F G C G +V EY+ G L R L G+DV LG + + V
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 709 KGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN----- 761
VA + YL H +HRD++++N L+ + DFG+++ + +S++
Sbjct: 165 SQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYRVG 217
Query: 762 --------WTEFAGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVI 799
W PE I Y + T + DV+SFGV+++E+
Sbjct: 218 GRTMLPIRWM---------PPESILYR-KFTTESDVWSFGVVLWEIF 254
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 49/227 (21%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G G VY+ VA+K N + +M + EFLNE +KE +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE---AASMRERIEFLNEASVMKEFNCHH 89
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL-------GDDVTAKELGWNRRINVIKGVAN 713
V+ G G + ++ E + RG L L ++ ++ I + +A+
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 714 ALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN---------- 761
++YL + +HRD++++N ++ +F + DFG+ + + + ++
Sbjct: 150 GMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRKGGKGLL 202
Query: 762 ---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHP 804
W +PE T DV+SFGV+++E+ P
Sbjct: 203 PVRWM---------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 23/211 (10%)
Query: 598 TDDFDEKFCIGK----GGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA 652
D+ F + G G V+ E SG +K N ++ E+
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV---PMEQIEAEIEV 73
Query: 653 LKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINVIKGV 711
LK + H N +K + + ++V E + G L RI+ K L ++K +
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNWTEFAGT 768
NAL+Y H ++H+D+ +N+L + DFG+A+ + T AGT
Sbjct: 134 MNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAAGT 189
Query: 769 FGYAAPEI---AYTMRATEKYDVYSFGVLVF 796
Y APE+ T K D++S GV+++
Sbjct: 190 ALYMAPEVFKRDV----TFKCDIWSAGVVMY 216
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 64/276 (23%), Positives = 110/276 (39%), Gaps = 36/276 (13%)
Query: 243 LGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELEL 302
L + + L+S+ + N+ + KS+ ++
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-----------KSVQGIQY 66
Query: 303 CTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSK 362
N+ ++ LN N L+ + + NL +L L N ++S + + K
Sbjct: 67 LPNV---------TKLFLNGNKLT--DIKPLANLKNLGWLFLDENKV-KDLS-SLKDLKK 113
Query: 363 LSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS 422
L + + N IS I + + P+L+ L L +N I I V L L+ L+ L L NQ+S
Sbjct: 114 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS 169
Query: 423 GGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIH 482
VPL LTKLQ L LS N +S +++ L L L L + + +K L+
Sbjct: 170 DIVPLA--GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVV 225
Query: 483 LSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS 518
+ + + L P + + G EK N+ +
Sbjct: 226 PNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 45/234 (19%), Positives = 90/234 (38%), Gaps = 16/234 (6%)
Query: 315 IERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNIS 374
+ L + +++ + ++ + +N++ + ++ ++ N ++
Sbjct: 26 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-KSVQ-GIQYLPNVTKLFLNGNKLT 81
Query: 375 GSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTK 434
I P + N L L L N + + L+ L L L L N +S L L +
Sbjct: 82 -DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDINGLV--HLPQ 135
Query: 435 LQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQ 494
L+ L L NK++ + L KL L+L +NQ+S +P L L L LS N +
Sbjct: 136 LESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI- 190
Query: 495 EEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548
++ + + +L+ L L + + + + + L P S
Sbjct: 191 SDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 53/253 (20%), Positives = 92/253 (36%), Gaps = 34/253 (13%)
Query: 169 SSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMM 228
S + L K S++ ++ +L S+ Q+ + + S+ + L ++T +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 73
Query: 229 SLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVP 288
L N L+ I P L NLK+L L L N++ + +L L+ L L +N
Sbjct: 74 FLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHN------- 122
Query: 289 EEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNN 348
+ ++ L L E + L N ++ L L L +N
Sbjct: 123 ----GISDINGLVHLPQL---------ESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQ 167
Query: 349 FCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEML 408
+I +KL +S N+IS + + L VL+L S + K L
Sbjct: 168 IS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNL 223
Query: 409 SSLNKLILNLNQL 421
N + L
Sbjct: 224 VVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 55/295 (18%), Positives = 106/295 (35%), Gaps = 60/295 (20%)
Query: 101 NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160
++ +L ++ + +LN + ++ + + I +
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD--------------IKSV---- 61
Query: 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLG 220
+ L N+ L+L N L+ I + LK+L L L EN+ + SL
Sbjct: 62 --------QGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLS-SLK 109
Query: 221 NLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYN 280
+L L +SL +N +S I L +L L +L L N++ + L+ L L L +
Sbjct: 110 DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 165
Query: 281 NGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLT 340
N + + L T L + + L++N++S A NL
Sbjct: 166 N-----------QISDIVPLAGLTKL---------QNLYLSKNHIS--DLRALAGLKNLD 203
Query: 341 FLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSN 395
L+L + + + N +T V + S P I + + ++ +
Sbjct: 204 VLELFSQECLNKPINHQSNLVVPNT--VKNTDGSLVTPEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 16/234 (6%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+ + + + + + ++ I L + L L N+L+ + P + L L L+
Sbjct: 41 TQNELNSIDQIIANNS-DIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF 96
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
LD N++ + + L + L+L HN + S + L +L L LYL N + + +
Sbjct: 97 LDENKVK-DLSS-LKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKI--TDIT 150
Query: 194 IIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALG 253
++ +L L L L +NQ S I L L+ L + L N +S + L LK+L L
Sbjct: 151 VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLE 206
Query: 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLL 307
L + NL + + L PE I + + +L
Sbjct: 207 LFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLP 258
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 10/163 (6%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
++ +L L L N L+ +L KL+ L L N +S + + L QL L
Sbjct: 84 KPLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGISDING--LVHLPQLESL 139
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
YL N++ T + +L+ +D L+L N + I L L+ L LYL KN +S +
Sbjct: 140 YLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLR 194
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL 235
++ LK+L L+L + NL + + SL
Sbjct: 195 AL-AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 61/182 (33%), Positives = 89/182 (48%), Gaps = 10/182 (5%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNL 163
+ LDL SN+LS L +L +LR LYL+ N+L T+P I +L ++ L + N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 164 HGSIPSSL-GNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPLSL-G 220
++P + L NLA L L +N L S+P + L L L L N+ S+P +
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 221 NLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLY 279
L+SL + L+NN L +P L L L L NQL + +L L++L L
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 280 NN 281
N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 36/211 (17%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
IP +++ L N LS +AF L L L++N KL
Sbjct: 35 IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDN--------------KLQ------ 74
Query: 371 NNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQ---LSGGV 425
++P I L+ L ++ N + +P+ + + L +L +L L+ NQ L V
Sbjct: 75 -----TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRV 128
Query: 426 PLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS 484
F SLTKL YL L N+L S +PK + L L L L NNQL F+KL L
Sbjct: 129 ---FDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELK 184
Query: 485 ELDLSHNILQEEIPPQVCNMGSLEKLNLSHN 515
L L +N L+ ++ L+ L L N
Sbjct: 185 TLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS---GGVPLEFGSL 432
+IP +I + LDL SN + L+ L L LN N+L G+ F L
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI---FKEL 84
Query: 433 TKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSH 490
L+ L ++ NKL + +P + L+ L L L NQL +P F+ L L+ L L +
Sbjct: 85 KNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGY 142
Query: 491 NILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
N LQ +P V + SL++L L +N L F+++ L + + N+L
Sbjct: 143 NELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL 193
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 12/177 (6%)
Query: 369 SMNNISGSIPPDIGNS-PKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLSGGVP 426
N +S S+P + KL++L L+ N + +P + + L +L L + N+L +P
Sbjct: 45 QSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LP 101
Query: 427 LE-FGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTE-FEKLIHL 483
+ F L L L L N+L S +P + +L KL YL+L N+L +P F+KL L
Sbjct: 102 IGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSL 159
Query: 484 SELDLSHNILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYN 539
EL L +N L+ +P + L+ L L +N L F+ + L + + N
Sbjct: 160 KELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 52/165 (31%), Positives = 75/165 (45%), Gaps = 12/165 (7%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRRL 132
F L L L+ N +P I L L+ L + N+L L P + +L L L
Sbjct: 57 FHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQAL-PIGVFDQLVNLAEL 114
Query: 133 YLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSL-GNLSNLAVLYLYKNSLSGS 190
LD NQL ++PP + L+ + L+L +N L S+P + L++L L LY N L
Sbjct: 115 RLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-R 171
Query: 191 IPS-IIGKLKSLLQLDLSENQFSGSIPL-SLGNLSSLTMMSLFNN 233
+P KL L L L NQ +P + +L L M+ L N
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 45/137 (32%), Positives = 74/137 (54%), Gaps = 6/137 (4%)
Query: 409 SSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNN 467
+ KL L N+LS F LTKL+ L L+ NKL + +P I L L L +++N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDN 95
Query: 468 QLSHKIPTE-FEKLIHLSELDLSHNILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCF 525
+L +P F++L++L+EL L N L+ +PP+V ++ L L+L +N L F
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQSLPKGVF 153
Query: 526 EEMRSLSCIDISYNELH 542
+++ SL + + N+L
Sbjct: 154 DKLTSLKELRLYNNQLK 170
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 61/258 (23%), Positives = 91/258 (35%), Gaps = 76/258 (29%)
Query: 190 SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKS 248
+IPS I +LDL N+ S + L+ L ++ L +N L ++P I LK+
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 249 LSALGLHINQLNGFIPPSI-GNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLL 307
L L + N+L +P + L +L L L N LKSL
Sbjct: 87 LETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQ-----------LKSLPP-------- 126
Query: 308 RGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFI 367
F LT+L L N +L
Sbjct: 127 -----------------------RVFDSLTKLTYLSLGYN--------------ELQ--- 146
Query: 368 VSMNNISGSIPPDIGNS-PKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLSGGV 425
S+P + + L+ L L +N + ++P + L+ L L L+ NQL
Sbjct: 147 --------SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVP 197
Query: 426 PLEFGSLTKLQYLDLSTN 443
F SL KL+ L L N
Sbjct: 198 EGAFDSLEKLKMLQLQEN 215
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-22
Identities = 47/221 (21%), Positives = 90/221 (40%), Gaps = 31/221 (14%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFN-SQLLSGNMADH------------DEFLNEVLAL 653
+ +G + E A+KK+ S L D+F NE+ +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 654 KEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-----ARILGDDVTAKELGWNRRINVI 708
+I++ + G N +++ EY++ S+ + D + +I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT 768
K V N+ SY+H++ +I HRD+ N+L+D N +SDFG ++++ GT
Sbjct: 158 KSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKGSRGT 213
Query: 769 FGYAAPEI-----AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ + PE +Y K D++S G+ ++ + P
Sbjct: 214 YEFMPPEFFSNESSY---NGAKVDIWSLGICLYVMFYNVVP 251
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 6e-22
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 592 EEIIKATDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF 646
E + F E++ I GKG G V K + + AVK N D
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTI 68
Query: 647 LNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDV-TAKELGWNRR 704
L EV LK++ H N +K + ++V E G L I+ + +
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---- 124
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSN 761
+IK V + ++Y+H +I+HRD+ +N+LL+S + + DFG++ ++
Sbjct: 125 -RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTK 179
Query: 762 WTEFAGTFGYAAPEI---AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ GT Y APE+ Y EK DV+S GV+++ ++ G P
Sbjct: 180 MKDRIGTAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP 221
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-22
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 27/224 (12%)
Query: 594 IIKATDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN 648
+ +T F +++ GKG G V + +G AVK + + + D + L
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLR 75
Query: 649 EVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDV----TAKELGWNR 703
EV LK++ H N +K + F + + +LV E G L I+ A
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----- 130
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEAHVSDFGIAKFVGPHSS 760
+I+ V + ++Y+H + I+HRD+ +N+LL+S + + DFG++ S
Sbjct: 131 ---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SK 183
Query: 761 NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ GT Y APE+ EK DV+S GV+++ ++ G P
Sbjct: 184 KMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-22
Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G G G VY+ ++ VAVK + D +FL E L + + H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALIISKFNHQN 135
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL----GDDVTAKELGWNRRINVIKGVANALS 716
V+ G F++ E + G L L L ++V + +A
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 717 YL--HHDCLPSIIHRDISSKNVLLDSNFEAHV---SDFGIAKFVGPHSSNWTEFAGTFGY 771
YL +H IHRDI+++N LL V DFG+A+ + + + + G
Sbjct: 196 YLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYYR-KGGCAM 247
Query: 772 -----AAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHP 804
PE T K D +SFGVL++E+ G P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 49/208 (23%), Positives = 81/208 (38%), Gaps = 25/208 (12%)
Query: 596 KATDDFDEKFCIGK----GGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEV 650
D + F + G VY+ + + A+K D E+
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEI 99
Query: 651 LALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRR--INVI 708
L + H N +K LV E + G L D + K ++ R + +
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF----DRIVEKG-YYSERDAADAV 154
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE-AHV--SDFGIAKFVGPHSSNWTEF 765
K + A++YLH + I+HRD+ +N+L + A + +DFG++K V
Sbjct: 155 KQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVLMKTV 210
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGV 793
GT GY APEI + D++S G+
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 596 KATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVK-----KFNSQLLSGNMADHDE 645
+T F E + +G+G V + P+ AVK S +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 646 FLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKE-LGWNR 703
L EV L+++ H N ++ FLV + + +G L D +T K L
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF----DYLTEKVTLSEKE 125
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT 763
+++ + + LH +I+HRD+ +N+LLD + ++DFG + + P
Sbjct: 126 TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLR 181
Query: 764 EFAGTFGYAAPEI--AYTMRATEKY----DVYSFGVLVF 796
E GT Y APEI Y D++S GV+++
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 29/236 (12%), Positives = 58/236 (24%), Gaps = 52/236 (22%)
Query: 606 CIGKGGQGSVYKAE---LPSGDIVAVKKFNSQLLSGNMADHD---EFLNEVLALKEIRHR 659
G ++A L VA+ + + D E L+ L L I
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALT----FVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
+ + +V E++ GSL + + I ++ +A A H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV-----GAIRAMQSLAAAADAAH 146
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT 779
+ V VS G
Sbjct: 147 RA---GVALSIDHPSRVR--------VSIDGDVV------------LAYPATMPD----- 178
Query: 780 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
A + D+ G ++ ++ P + + + + + P+
Sbjct: 179 --ANPQDDIRGIGASLYALLVNRWPLP-----EAGVRSGLAPAERDTAGQPIEPAD 227
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 27/229 (11%)
Query: 594 IIKATDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVK---------KFNSQLLSGN 639
+ K E + G G G V E A+K S
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 640 MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKE 698
H+E NE+ LK + H N +K + + +LV E+ + G L +I + +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI----INRHK 142
Query: 699 LGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEAHVSDFGIAKFV 755
N++K + + + YLH +I+HRDI +N+LL++ + DFG++ F
Sbjct: 143 FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ GT Y APE+ + EK DV+S GV+++ ++ G P
Sbjct: 200 SK-DYKLRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 46/220 (20%), Positives = 88/220 (40%), Gaps = 31/220 (14%)
Query: 594 IIKATDDFDEKFCI-----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFL 647
++ ++F+ + + G+G V + +G A K + + E L
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEIL 76
Query: 648 NEVLALKEIRHRNN-VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGW---NR 703
+E+ L+ + + H N L+ EY G + + N
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF----SLCLPELAEMVSEND 132
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSS 760
I +IK + + YLH + +I+H D+ +N+LL S + + DFG+++ +G +
Sbjct: 133 VIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-AC 188
Query: 761 NWTEFAGTFGYAAPEI----AYTMRATEKYDVYSFGVLVF 796
E GT Y APEI T D+++ G++ +
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTAT----DMWNIGIIAY 224
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 35/271 (12%), Positives = 80/271 (29%), Gaps = 58/271 (21%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN---- 661
+G+ + +A + +G+ V + + EVL L+ +R N
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN-AIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 662 -----------------------VKFHGFCYNGPHSFLVCE--YLDRGSLARILGDDVTA 696
V+ F + + + +L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 697 KE-LGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755
+ L + R+ + V L+ LHH ++H + +++LD ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 756 GPHSSNWTEFAGTFGYAAPEI-----------AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
G + + G+ PE+ T +D ++ G++++ + + P
Sbjct: 257 G----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 805 RDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
+ + I P P
Sbjct: 313 -------ITK-DAALGGSEWIFRSCKNIPQP 335
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 22/212 (10%)
Query: 598 TDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG--NMADHDEFLNEV 650
++ + I G G V K E +G A K + +E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 651 LALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDV-TAKELGWNRRINVI 708
L+++ H N + H N L+ E + G L + + + +E + I
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----TSFI 121
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH----VSDFGIAKFVGPHSSNWTE 764
K + + ++YLH I H D+ +N++L + DFG+A + +
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKN 177
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 796
GT + APEI + D++S GV+ +
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 38/218 (17%)
Query: 596 KATDDFDEKFCIGK----GGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEV 650
D ++ + + G G V A + + A KK + D D F E+
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVDRFKQEI 57
Query: 651 LALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRIN---- 706
+K + H N ++ + + +LV E G L + V K
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF----ERVVHKR-----VFRESDA 108
Query: 707 --VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSN 761
++K V +A++Y H ++ HRD+ +N L ++ + DFG+A P
Sbjct: 109 ARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GKM 164
Query: 762 WTEFAGTFGYAAPEI---AYTMRATEKYDVYSFGVLVF 796
GT Y +P++ Y + D +S GV+++
Sbjct: 165 MRTKVGTPYYVSPQVLEGLY----GPECDEWSAGVMMY 198
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 54/247 (21%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
IG+G G V A E + I A+K N +++ N D + EV +K++ H N +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 665 HGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRI------------------ 705
+ + + LV E G L ++ + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 706 ------------------NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV- 746
N+++ + +AL YLH+ I HRDI +N L +N +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 747 -SDFGIAKFVGPHSSN----WTEFAGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFE 797
DFG++K ++ T AGT + APE+ T E Y D +S GVL+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN--ESYGPKCDAWSAGVLLHL 268
Query: 798 VIKGNHP 804
++ G P
Sbjct: 269 LLMGAVP 275
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 51/235 (21%), Positives = 92/235 (39%), Gaps = 61/235 (25%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+G G V KA VAVK + + ++ + L+E LK++ H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE---NASPSELRDLLSEFNVLKQVNHPH 87
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSL------ARILGDDVTAKELGWNRRINVIKG---- 710
+K +G C L+ EY GSL +R +G N
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 711 -----------VANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757
++ + YL ++HRD++++N+L+ + +SDFG+++ V
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDV-- 200
Query: 758 HSSN-------------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
+ + W A E + T + DV+SFGVL++E++
Sbjct: 201 YEEDSYVKRSQGRIPVKWM---------AIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 600 DFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
+ +G G G V+K E +G +A K ++ M D +E NE+ + ++ H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEVKNEISVMNQLDH 145
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINVIKGVANALSY 717
N ++ + + LV EY+D G L RI+ + EL I +K + + +
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL---DTILFMKQICEGIRH 202
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
+H I+H D+ +N+L + + DFG+A+ P GT + APE
Sbjct: 203 MHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVNFGTPEFLAPE 258
Query: 776 IAYTMRATEKYDVYSFGVLVF 796
+ + D++S GV+ +
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAY 279
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 22/212 (10%)
Query: 598 TDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG--NMADHDEFLNEV 650
++ + I G G V K E +G A K + +E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 651 LALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDV-TAKELGWNRRINVI 708
L+++ H N + H N L+ E + G L + + + +E + I
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----TSFI 121
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH----VSDFGIAKFVGPHSSNWTE 764
K + + ++YLH I H D+ +N++L + DFG+A + +
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKN 177
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 796
GT + APEI + D++S GV+ +
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 6e-21
Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 40/242 (16%)
Query: 607 IGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNM-ADHDEFLNEVLALKEIRHRNN 661
IG+G G V++ S + VA+K + + ++FL E L +++ H +
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIK----TCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARIL---GDDVTAKELGWNRRINVIKGVANALSYL 718
VK G P +++ E G L L + L I ++ AL+YL
Sbjct: 454 VKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLSTALAYL 507
Query: 719 H-HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGT---FGYAAP 774
+HRDI+++NVL+ SN + DFG+++++ S + + + + AP
Sbjct: 508 ESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 561
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDP--RLP 831
E R T DV+ FGV ++E++ G P F N DV ++ RLP
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNN--DVIGRIENGERLP 612
Query: 832 TP 833
P
Sbjct: 613 MP 614
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 46/221 (20%)
Query: 607 IGKGGQGSVYKAELPSGD---IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNV 662
IG+G G V KA + A+K+ + DH +F E+ L ++ H N +
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 663 KFHGFCYNGPHSFLVCEYLDRGSL-------------ARILGDDVTAKELGWNRRINVIK 709
G C + + +L EY G+L + TA L + ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 710 GVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN------ 761
VA + YL IHRD++++N+L+ N+ A ++DFG+++ +
Sbjct: 150 DVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 762 --WTEFAGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVI 799
W A E + Y+ T DV+S+GVL++E++
Sbjct: 205 VRWM---------AIESLNYS-VYTTNSDVWSYGVLLWEIV 235
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 22/210 (10%)
Query: 598 TDDFDEKFCI----GKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG--NMADHDEFLNEV 650
++ D+ + G G V K E +G A K + ++ EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 651 LALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDV-TAKELGWNRRINVI 708
LKEI+H N + H N L+ E + G L + + T +E +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA-----TEFL 120
Query: 709 KGVANALSYLHHDCLPSIIHRDISSKNVLL-DSNFEAH---VSDFGIAKFVGPHSSNWTE 764
K + N + YLH I H D+ +N++L D N + DFG+A + + +
Sbjct: 121 KQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKN 176
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVL 794
GT + APEI + D++S GV+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 8e-21
Identities = 50/197 (25%), Positives = 79/197 (40%), Gaps = 18/197 (9%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSG--NMADHDEFLNEVLALKEIRHRNNVK 663
+G G V K + +G A K + LS +E EV L+EIRH N +
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 664 FHGFCYNGPHSFLVCEYLDRGSL-ARILGDDV-TAKELGWNRRINVIKGVANALSYLHHD 721
H N L+ E + G L + + T E +K + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA-----TQFLKQILDGVHYLHSK 127
Query: 722 CLPSIIHRDISSKNVLLDSNFEAH----VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
I H D+ +N++L + + DFGIA + + + GT + APEI
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIV 183
Query: 778 YTMRATEKYDVYSFGVL 794
+ D++S GV+
Sbjct: 184 NYEPLGLEADMWSIGVI 200
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 42/199 (21%), Positives = 77/199 (38%), Gaps = 26/199 (13%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G G V++ E S K + D E+ L RHRN + H
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAK-----FVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRR--INVIKGVANALSYLHHDCL 723
+ ++ E++ + + + N R ++ + V AL +LH
Sbjct: 68 ESFESMEELVMIFEFISGLDIF----ERINTSAFELNEREIVSYVHQVCEALQFLHSH-- 121
Query: 724 PSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWTEFAGTFGYAAPEI----A 777
+I H DI +N++ + + + +FG A+ + P N+ Y APE+
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDV 179
Query: 778 YTMRATEKYDVYSFGVLVF 796
+ D++S G LV+
Sbjct: 180 VSTAT----DMWSLGTLVY 194
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 596 KATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE----F 646
A +F +K+ IG+G V + +G AVK + +E
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 647 LNEVLALKEIR-HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
E L+++ H + + + FLV + + +G L D +T K +
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF----DYLTEKV-----AL 197
Query: 706 ------NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759
++++ + A+S+LH + +I+HRD+ +N+LLD N + +SDFG + + P
Sbjct: 198 SEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-G 253
Query: 760 SNWTEFAGTFGYAAPEI--AYTMRATEKY----DVYSFGVLVF 796
E GT GY APEI Y D+++ GV++F
Sbjct: 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 48/228 (21%), Positives = 87/228 (38%), Gaps = 55/228 (24%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
+G+ G VYK L VA+K +EF +E + ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD---KAEGPLREEFRHEAMLRARLQHPN 73
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARIL-------------GDDVTAKELGWNRRINV 707
V G ++ Y G L L D L +++
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 708 IKGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN---- 761
+ +A + YL HH ++H+D++++NVL+ +SD G+ + V ++++
Sbjct: 134 VAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYKL 186
Query: 762 ---------WTEFAGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVI 799
W APE I Y + + D++S+GV+++EV
Sbjct: 187 LGNSLLPIRWM---------APEAIMYG-KFSIDSDIWSYGVVLWEVF 224
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 53/230 (23%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 607 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-R 657
+G+G G V AE D VAVK D + ++E+ +K I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 99
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL-------------GDDVTAKELGWNRR 704
H+N + G C +++ EY +G+L L + V +++ +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 705 INVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN- 761
++ +A + YL IHRD++++NVL+ N ++DFG+A+ + ++ +
Sbjct: 160 VSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDY 212
Query: 762 ------------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W APE + T + DV+SFGVL++E+
Sbjct: 213 YKKTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 45/178 (25%), Positives = 71/178 (39%), Gaps = 8/178 (4%)
Query: 371 NNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQ-LEMLSSLNKL-ILNLNQLSGGVPL 427
+ I L+ +++S N ++ I L L+++ I N L P
Sbjct: 40 TKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPE 98
Query: 428 EFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKL-IHLSE 485
F +L LQYL +S + + L+ L++ +N H I F L
Sbjct: 99 AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI 158
Query: 486 LDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPR-CFEEMRSLSCIDISYNELH 542
L L+ N +QE I N L++LNLS NN + +P F +DIS +H
Sbjct: 159 LWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 44/296 (14%), Positives = 88/296 (29%), Gaps = 53/296 (17%)
Query: 224 SLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGL 283
S + + ++ IP L ++ L + +L + L + + N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 284 YGFVPEEI-GYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFL 342
+ ++ L L E+ + NNL EAF + PNL +L
Sbjct: 67 LEVIEADVFSNLPKLHEIRI-----------------EKANNLLYINPEAFQNLPNLQYL 109
Query: 343 DLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDI-GNSPKLQVLDLSSNHIVGKI 401
+SN +P +S + +LD+ N + I
Sbjct: 110 LISNTGIK-------------------------HLPDVHKIHSLQKVLLDIQDNINIHTI 144
Query: 402 PVQL--EMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKL 459
+ L LN N + F + N L
Sbjct: 145 ERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGP 204
Query: 460 HYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHN 515
L++S ++ E L L + +++P + + +L + +L++
Sbjct: 205 VILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 49/216 (22%), Positives = 80/216 (37%), Gaps = 16/216 (7%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDL-GSNQLSGLIPPEI-GKLNQLR 130
+FS F L + +S N I + NL KL + + +N L I PE L L+
Sbjct: 49 AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQ 107
Query: 131 RLYLDMNQLHGTIPPEIGQLSL-IDKLALCHNNLHGSIPSSL--GNLSNLAVLYLYKNSL 187
L + + +P SL L + N +I + G +L+L KN +
Sbjct: 108 YLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 188 SGSIPSIIGKLKSLLQLDLSE-NQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGN 245
I + L +L+LS+ N S ++ + + S+P L N
Sbjct: 167 Q-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLEN 224
Query: 246 LKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNN 281
LK L A + + P++ L +L L
Sbjct: 225 LKKLRARSTYNLK----KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 8e-18
Identities = 41/235 (17%), Positives = 80/235 (34%), Gaps = 30/235 (12%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
+P + + L AF +L +++S N+
Sbjct: 28 LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND---------------------- 65
Query: 371 NNISGSIPPDI-GNSPKLQVLDLS-SNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLE 428
+ I D+ N PKL + + +N+++ P + L +L L+++ + +
Sbjct: 66 --VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 123
Query: 429 FGSLTKLQYLDLSTNKLSSSIPKSI--GNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSEL 486
+ LD+ N +I ++ G + L L+ N + I L EL
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDEL 182
Query: 487 DLSHNILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNE 540
+LS N EE+P V L++S + E ++ L +
Sbjct: 183 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 35/231 (15%), Positives = 72/231 (31%), Gaps = 17/231 (7%)
Query: 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRRLYL-D 135
+ L L+ +++ N + +I ++ L +L + +
Sbjct: 29 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 136 MNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKNSLSGSIPS 193
N L I PE L + L + + + +P + +L + N +I
Sbjct: 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 194 -IIGKLKSLLQ-LDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLS 250
L L L++N + + NN+L +P +
Sbjct: 147 NSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPV 205
Query: 251 ALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELE 301
L + +++ + NL LR YN +++ L+ L L
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRARSTYNL-------KKLPTLEKLVALM 249
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 38/252 (15%), Positives = 72/252 (28%), Gaps = 30/252 (11%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNL 163
L +L + L ++ + N + I ++ L + ++ + N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 164 HGSIPSS-LGNLSNLAVLYLYKNSLSGSIPSII-GKLKSLLQLDLSENQFSGSIP-LSLG 220
I NL NL L + + +P + + LD+ +N +I S
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 221 NLSS-LTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYL 278
LS ++ L N + I + N L S +L +
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 279 YNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPN 338
+ +P L++L +L + NL K
Sbjct: 210 SRTRI-HSLPSYG--LENLKKLRA-----------------RSTYNL--KKLPTLEKLVA 247
Query: 339 LTFLDLSNNNFC 350
L L+ + C
Sbjct: 248 LMEASLTYPSHC 259
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 7e-20
Identities = 43/291 (14%), Positives = 105/291 (36%), Gaps = 45/291 (15%)
Query: 562 LKRVSQEEQSNSMNRL----RLLSVLNFDGKIMHEEIIKATDDFDEKFCIGKGGQGSVYK 617
+KR+ + + ++ + L+ L H I++ + + E K
Sbjct: 36 IKRIRLPNRELAREKVMREVKALAKLE------HPGIVRYFNAWLETPP---------EK 80
Query: 618 AELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677
+ +I + LS + + D ++ + +N V + ++
Sbjct: 81 WQEEMDEIWLKDESTDWPLS-SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQ 139
Query: 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVL 737
+ + +L + + ++ +++ +A A+ +LH ++HRD+ N+
Sbjct: 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIF 196
Query: 738 LDSNFEAHVSDFGIAKFV------------GPHSSNWTEFAGTFGYAAPEIAYTMRATEK 785
+ V DFG+ + P + T GT Y +PE + + K
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 786 YDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPS 836
D++S G+++FE++ + FS+ + + + + + P
Sbjct: 257 VDIFSLGLILFELL---YS-------FSTQMERVRIITDVRNLKFPLLFTQ 297
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-20
Identities = 60/252 (23%), Positives = 101/252 (40%), Gaps = 41/252 (16%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
D F+ IGKG G V + + + A+K N + + N + E+ ++ +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN--VFKELQIMQGL 72
Query: 657 RHRNNVKFHGFCYNGPHS-FLVCEYLDRGSL------ARILGDDVT---AKELGWNRRIN 706
H V + + F+V + L G L ++ EL
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL------- 124
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFA 766
AL YL + IIHRD+ N+LLD + H++DF IA + + T A
Sbjct: 125 -----VMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MA 175
Query: 767 GTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDV 822
GT Y APE+ ++ R Y D +S GV +E+++G P + + +S ++
Sbjct: 176 GTKPYMAPEM-FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP--YHIRSSTSSKEIV--- 229
Query: 823 NKILDPRLPTPS 834
+ + PS
Sbjct: 230 HTFETTVVTYPS 241
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-20
Identities = 52/230 (22%), Positives = 95/230 (41%), Gaps = 56/230 (24%)
Query: 607 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-R 657
+G+G G V AE D VAVK D + ++E+ +K I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 145
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSL-------------ARILGDDVTAKELGWNRR 704
H+N + G C +++ EY +G+L + V +++ +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 705 INVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN- 761
++ +A + YL IHRD++++NVL+ N ++DFG+A+ + ++ +
Sbjct: 206 VSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDI--NNIDY 258
Query: 762 ------------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W APE + T + DV+SFGVL++E+
Sbjct: 259 YKKTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 53/229 (23%), Positives = 88/229 (38%), Gaps = 55/229 (24%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHR 659
+G+G G V +A+ D VAVK ++H ++E+ L I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 91
Query: 660 NNVKFHGFC-YNGPHSFLVCEYLDRGSL-------------ARILGDDVTAKELGWNRRI 705
N V G C G ++ E+ G+L ++ +D+ L I
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 706 NVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN-- 761
VA + +L IHRD++++N+LL + DFG+A+ + +
Sbjct: 152 CYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDY 204
Query: 762 -----------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W APE + T + DV+SFGVL++E+
Sbjct: 205 VRKGDARLPLKWM---------APETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 56/230 (24%)
Query: 607 IGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-R 657
+G+G G V AE D VAVK S D + ++E+ +K I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 133
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSL-------------ARILGDDVTAKELGWNRR 704
H+N + G C +++ EY +G+L ++L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 705 INVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN- 761
++ VA + YL IHRD++++NVL+ + ++DFG+A+ + H +
Sbjct: 194 VSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 246
Query: 762 ------------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W APE + T + DV+SFGVL++E+
Sbjct: 247 YKKTTNGRLPVKWM---------APEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 49/226 (21%), Positives = 90/226 (39%), Gaps = 52/226 (23%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHR 659
+G G G V +A VAVK S + + + + ++E+ + + +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS---TAHADEKEALMSELKIMSHLGQHE 110
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSLARIL-----------GDDVTAKELGWNRRINVI 708
N V G C +G ++ EY G L L + ++
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 709 KGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN----- 761
VA +++L + IHRD++++NVLL + A + DFG+A+ + + +
Sbjct: 171 SQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDI--MNDSNYIVK 223
Query: 762 --------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W APE + T + DV+S+G+L++E+
Sbjct: 224 GNARLPVKWM---------APESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 40/191 (20%), Positives = 81/191 (42%), Gaps = 12/191 (6%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRR 131
+FS+ P+++ + +S ++ + NLSK+ ++++ + + I P+ +L L+
Sbjct: 50 AFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109
Query: 132 LYLDMNQLHGTIPPE--IGQLSLIDKLALCHNNLHGSIPS-SLGNLSN-LAVLYLYKNSL 187
L + L P + + L + N SIP + L N L LY N
Sbjct: 110 LGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
Query: 188 SGSIPSIIGKLKSLLQLDLSENQFSGSIPLSL--GNLSSLTMMSLFNNSLSGSIPP-ILG 244
+ S+ L + L++N++ I G S +++ + S++ ++P L
Sbjct: 169 T-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLE 226
Query: 245 NLKSLSALGLH 255
+LK L A
Sbjct: 227 HLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 43/229 (18%), Positives = 80/229 (34%), Gaps = 34/229 (14%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI---SFNWGNFSKLSTFI 367
+P S + + L + +L AF + PN++ + +S + ++ SF N SK++
Sbjct: 29 LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFY--NLSKVTHIE 86
Query: 368 VSMNNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVP 426
+ I PD P L+ L + + L+M L K
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNT--------GLKMFPDLTK------------- 125
Query: 427 LEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLK--LHYLNLSNNQLSHKIPTEFEKLIHLS 484
S L+++ N +SIP + L L L NN + + L
Sbjct: 126 --VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLD 182
Query: 485 ELDLSHNILQEEIPPQVCN--MGSLEKLNLSHNNLSDFIPRCFEEMRSL 531
+ L+ N I L++S +++ + E ++ L
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 36/187 (19%), Positives = 70/187 (37%), Gaps = 10/187 (5%)
Query: 105 LQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNL 163
Q L L L + L + R+Y+ ++ + LS + + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 164 HGSIPSS-LGNLSNLAVLYLYKNSLSGSIP--SIIGKLKSLLQLDLSENQFSGSIPL-SL 219
I L L L L ++ L P + + L++++N + SIP+ +
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 220 GNLSSLTM-MSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSI--GNLSSLRVL 276
L + T+ + L+NN + S+ N L A+ L+ N+ I G S +L
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 277 YLYNNGL 283
+ +
Sbjct: 211 DVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 50/296 (16%), Positives = 87/296 (29%), Gaps = 72/296 (24%)
Query: 175 SNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234
+ + IPS+ S L L E + NL +++ + + +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSL---PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 235 LSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVLYLYNNGLYGFVPEE-I 291
+ NL ++ + + + +I P L L+ L ++N GL F +
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV 126
Query: 292 GYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTF-LDLSNNNFC 350
LE+ N IP + AF N T L L NN F
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVN-----------------AFQGLCNETLTLKLYNNGF- 168
Query: 351 GEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSS 410
S+ N KL + L+ N L+
Sbjct: 169 ------------------------TSVQGYAFNGTKLDAVYLNKNK----------YLTV 194
Query: 411 LNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSN 466
++K G + LD+S +++ K + +L +L N
Sbjct: 195 IDKDAFG------------GVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 33/172 (19%), Positives = 61/172 (35%), Gaps = 11/172 (6%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPE--IGK 125
SF + + ++ + I L L++L + + L + P +
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128
Query: 126 LNQLRRLYLDMNQLHGTIPPEI--GQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183
+ L + N +IP G + L L +N S+ N + L +YL
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187
Query: 184 KNSLSGSIPS-IIGKLKSLLQ-LDLSENQFSGSIP-LSLGNLSSLTMMSLFN 232
KN I G + S LD+S+ + ++P L +L L + +
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 19/121 (15%), Positives = 42/121 (34%), Gaps = 3/121 (2%)
Query: 432 LTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSH 490
Q L L L + + NL + + +S + ++ + F L ++ +++ +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 491 NILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCF-EEMRSLSCIDISYNELHGPIPNS 548
I P + L+ L + + L F ++I+ N IP +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 549 T 549
Sbjct: 150 A 150
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 18/119 (15%), Positives = 41/119 (34%), Gaps = 11/119 (9%)
Query: 438 LDLSTNKLSS--SIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495
++ + S+P S L L L F L ++S + +S ++ +
Sbjct: 16 FRVTCKDIQRIPSLPPS------TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 496 EIPPQV-CNMGSLEKLNLSHNNLSDFIPR-CFEEMRSLSCIDISYNELHGPIPNSTAFK 552
++ N+ + + + + +I +E+ L + I L P+ T
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVY 127
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 53/236 (22%), Positives = 92/236 (38%), Gaps = 63/236 (26%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN 660
IG+G G V++A P +VAVK + +F E + E + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASADMQADFQREAALMAEFDNPN 111
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSL---------------------ARILGDDVTAKEL 699
VK G C G L+ EY+ G L R L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 700 GWNRRINVIKGVANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757
++ + + VA ++YL +HRD++++N L+ N ++DFG+++ +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNI-- 224
Query: 758 HSSN-------------WTEFAGTFGYAAPE-IAYTMRATEKYDVYSFGVLVFEVI 799
+S++ W PE I Y R T + DV+++GV+++E+
Sbjct: 225 YSADYYKADGNDAIPIRWM---------PPESIFYN-RYTTESDVWAYGVVLWEIF 270
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 52/228 (22%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHR 659
+G G G V +A VAVK S ++ + + ++E+ L + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP---SAHLTEREALMSELKVLSYLGNHM 87
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSL------ARILGDDVTAKELGWNRRINVIKG--- 710
N V G C G + ++ EY G L R +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 711 ------VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--- 761
VA +++L + IHRD++++N+LL + DFG+A+ + + +
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI--KNDSNYV 202
Query: 762 ----------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
W APE + T + DV+S+G+ ++E+
Sbjct: 203 VKGNARLPVKWM---------APESIFNCVYTFESDVWSYGIFLWELF 241
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-18
Identities = 32/128 (25%), Positives = 58/128 (45%), Gaps = 2/128 (1%)
Query: 413 KLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHK 472
++ L N + P F KL+ +DLS N++S P + L L+ L L N+++
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 473 IPTEFEKLIHLSELDLSHNILQEEIPPQV-CNMGSLEKLNLSHNNLSDFIPRCFEEMRSL 531
+ FE L L L L+ N + + ++ +L L+L N L F +R++
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154
Query: 532 SCIDISYN 539
+ ++ N
Sbjct: 155 QTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 30/131 (22%), Positives = 57/131 (43%), Gaps = 6/131 (4%)
Query: 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFS 212
++ L N + P + L + L N +S + L+SL L L N+ +
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 213 GSIPLSL-GNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNL 270
+P SL L SL ++ L N ++ + +L +L+ L L+ N+L + L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 271 SSLRVLYLYNN 281
+++ ++L N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 41/182 (22%), Positives = 67/182 (36%), Gaps = 50/182 (27%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
+P +I + L QN + AF + L +DLSNN ++S
Sbjct: 30 LPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN--------------QISE----- 70
Query: 371 NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFG 430
+ PD + L SLN L+L N+++ F
Sbjct: 71 ------LAPDA-----------------------FQGLRSLNSLVLYGNKITELPKSLFE 101
Query: 431 SLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLS 489
L LQ L L+ NK+ + + +L L+ L+L +N+L F L + + L+
Sbjct: 102 GLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA 160
Query: 490 HN 491
N
Sbjct: 161 QN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 33/158 (20%), Positives = 63/158 (39%), Gaps = 30/158 (18%)
Query: 106 QYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG 165
+ L N + + P +LRR+ L NQ+ + P+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA------------------ 75
Query: 166 SIPSSLGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPL-SLGNLS 223
L +L L LY N ++ +P + L SL L L+ N+ + + + + +L
Sbjct: 76 -----FQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLH 128
Query: 224 SLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLN 260
+L ++SL++N L +I L+++ + L N
Sbjct: 129 NLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 38/150 (25%), Positives = 67/150 (44%), Gaps = 8/150 (5%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPL- 217
C IP++L + + L +N++ P K L ++DLS NQ S +
Sbjct: 18 CRGKGLTEIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74
Query: 218 SLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRV 275
+ L SL + L+ N ++ +P + L SL L L+ N++N + +L +L +
Sbjct: 75 AFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNL 132
Query: 276 LYLYNNGLYGFVPEEIGYLKSLSELELCTN 305
L LY+N L L+++ + L N
Sbjct: 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 33/149 (22%), Positives = 57/149 (38%), Gaps = 24/149 (16%)
Query: 204 LDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGF 262
+ L +N P + L + L NN +S + P L+SL++L L+ N++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 263 IPPSI-GNLSSLRVLYLYNNGLYGFVPEEI-GYLKSLSELELCTNLLRGVIPHSIERVLL 320
+P S+ L SL++L L N + + + L +L+ L L
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSL------------------ 135
Query: 321 NQNNLSGKMYEAFGDHPNLTFLDLSNNNF 349
N L F + + L+ N F
Sbjct: 136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 21/81 (25%), Positives = 37/81 (45%), Gaps = 2/81 (2%)
Query: 462 LNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCN-MGSLEKLNLSHNNLSDF 520
+ L N + P F L +DLS+N + E + P + SL L L N +++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 521 IPRCFEEMRSLSCIDISYNEL 541
FE + SL + ++ N++
Sbjct: 96 PKSLFEGLFSLQLLLLNANKI 116
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 52/250 (20%), Positives = 91/250 (36%), Gaps = 45/250 (18%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADHDEFLN---EVLALKEIRHRNN 661
+G G G V+ A V VK ++L + + E+ L + H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGD--D--VTAKELGWNRRINVIKGVANALSY 717
+K N LV E G D L + + + +A+ Y
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG------LDLFAFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
L IIHRDI +N+++ +F + DFG A ++ +T F GT Y APE
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPE-- 199
Query: 778 YTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPT 832
+ Y +++S GV ++ ++ +P ++ + ++ +
Sbjct: 200 --VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC--------------ELEETVEAAIHP 243
Query: 833 P---SPSVMD 839
P S +M
Sbjct: 244 PYLVSKELMS 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 48/235 (20%), Positives = 83/235 (35%), Gaps = 61/235 (25%)
Query: 607 IGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHR 659
+G G G V A VAVK + ++ + ++E+ + ++ H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE---KADSSEREALMSELKMMTQLGSHE 109
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRGSL------ARILGDDVTAKELGWNRRINVIKG--- 710
N V G C +L+ EY G L R + + R
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 711 -----------VANALSYL--HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757
VA + +L +HRD++++NVL+ + DFG+A+ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDI-- 222
Query: 758 HSSN-------------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
S + W APE + T K DV+S+G+L++E+
Sbjct: 223 MSDSNYVVRGNARLPVKWM---------APESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 48/227 (21%), Positives = 85/227 (37%), Gaps = 42/227 (18%)
Query: 587 GKIMHEEIIKATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE 645
+ +H I+ TD ++ K IG G + + AVK + +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EE 65
Query: 646 FLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRR 704
E+L L+ +H N + +G + ++V E + G L +IL ++
Sbjct: 66 --IEIL-LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-----------RQK 111
Query: 705 I-------NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH----VSDFGIAK 753
V+ + + YLH ++HRD+ N+L + DFG AK
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 754 FVGPHSSNWTEFAGTFGYAAPEI----AYTMRATEKYDVYSFGVLVF 796
+ + T + APE+ Y D++S GVL++
Sbjct: 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAAC----DIWSLGVLLY 211
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 50/228 (21%), Positives = 86/228 (37%), Gaps = 40/228 (17%)
Query: 597 ATDDFDEKF---------CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF 646
+TD F +F +G+G V L + AVK Q
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH----IRSRV 57
Query: 647 LNEVLALKEIR-HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
EV L + + HRN ++ F +LV E + GS+ + + +N
Sbjct: 58 FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSIL----SHIHKRRH-FNELE 112
Query: 706 --NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSS 760
V++ VA+AL +LH+ I HRD+ +N+L + + + DF + + +
Sbjct: 113 ASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 761 -------NWTEFAGTFGYAAPEI-AYTMRATEKY----DVYSFGVLVF 796
G+ Y APE+ Y D++S GV+++
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 34/227 (14%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
+DF +G+G +V A EL + A+K ++ N + E + +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY--VTRERDVMSRL 87
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRRINV 707
H VK + + + Y G L + T E
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------- 138
Query: 708 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN---WTE 764
+ +AL YLH IIHRD+ +N+LL+ + ++DFG AK + P S +
Sbjct: 139 ---IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS- 191
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811
F GT Y +PE+ A + D+++ G ++++++ G P F + N
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGN 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 36/204 (17%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKF 664
+G+G K S AVK + ++ E+ ALK H N VK
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRME-------ANTQKEITALKLCEGHPNIVKL 71
Query: 665 HGFCYNGPHSFLVCEYLDRGSL-ARILG----DDVTAKELGWNRRINVIKGVANALSYLH 719
H ++ H+FLV E L+ G L RI + A +++ + +A+S++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY--------IMRKLVSAVSHMH 123
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
++HRD+ +N+L + + DFG A+ P + T YAAPE+
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 777 ----AYTMRATEKYDVYSFGVLVF 796
Y D++S GV+++
Sbjct: 181 LNQNGYDESC----DLWSLGVILY 200
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 86.0 bits (212), Expect = 2e-17
Identities = 42/244 (17%), Positives = 83/244 (34%), Gaps = 29/244 (11%)
Query: 320 LNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPP 379
LN + + L + + +L +S+ + +
Sbjct: 309 LNDQLPQHTFRVIWTGSDSQKECVLLKDR-PECWCRDSATDEQLFRCELSVEKST-VLQS 366
Query: 380 DIGNSPKLQVLDLSSNHIVGKI---PVQLEMLSSLNKLILNLNQLSGGVPLEFGSL---- 432
++ + +LQ L+ + + I L+ L + + + L P+ L
Sbjct: 367 ELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLR 426
Query: 433 --------------TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFE 478
++ L L+ L+ + LL + +L+LS+N+L +P
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALA 483
Query: 479 KLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDF-IPRCFEEMRSLSCIDIS 537
L L L S N L E + V N+ L++L L +N L + L +++
Sbjct: 484 ALRCLEVLQASDNAL-ENVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQ 541
Query: 538 YNEL 541
N L
Sbjct: 542 GNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 85.2 bits (210), Expect = 2e-17
Identities = 42/286 (14%), Positives = 85/286 (29%), Gaps = 35/286 (12%)
Query: 202 LQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNG 261
L +Q + S + + L L + +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST- 362
Query: 262 FIPPSIGNLSSLRVLYLYNNGL---YGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERV 318
+ + + L+ L N + + L E + L+ V P +
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422
Query: 319 LLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIP 378
++ + ++ ++ L L++ + ++
Sbjct: 423 DDLRSKFLLENSVLKMEYADVRVLHLAHKDL--------------------------TVL 456
Query: 379 PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYL 438
+ + LDLS N + +P L L L L + N L +L +LQ L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--NVDGVANLPRLQEL 513
Query: 439 DLSTNKLSS-SIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHL 483
L N+L + + + + +L LNL N L + E+L +
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 3e-16
Identities = 42/211 (19%), Positives = 71/211 (33%), Gaps = 26/211 (12%)
Query: 330 YEAFGDHPNLTFLDLSNN----------NFCGEISFNWGNFSKLSTFIVSMNNISGSIPP 379
L +LS + N L T I+ M + +
Sbjct: 342 CRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYE 401
Query: 380 D--IGNSPKLQVLD--------LSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEF 429
+ L+ +D + + + V + + L L L+ V
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHL 459
Query: 430 GSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLS 489
L + +LDLS N+L + +P ++ L L L S+N L + + L L EL L
Sbjct: 460 EQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516
Query: 490 HN-ILQEEIPPQVCNMGSLEKLNLSHNNLSD 519
+N + Q + + L LNL N+L
Sbjct: 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 2e-14
Identities = 43/234 (18%), Positives = 70/234 (29%), Gaps = 28/234 (11%)
Query: 264 PPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQN 323
L L + E+ K L ELE +L+
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENK-----WCLLTIILLMRAL 395
Query: 324 NLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGN 383
+ E L +D + + +
Sbjct: 396 DPLLYEKETLQYFSTLKAVD----------------PMRAAYLDDLRSKFLLENSVLKME 439
Query: 384 SPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTN 443
++VL L+ + + LE L + L L+ N+L +P +L L+ L S N
Sbjct: 440 YADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDN 496
Query: 444 KLSSSIPKSIGNLLKLHYLNLSNNQLS-HKIPTEFEKLIHLSELDLSHNILQEE 496
L + + + NL +L L L NN+L L L+L N L +E
Sbjct: 497 ALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 8e-14
Identities = 55/351 (15%), Positives = 106/351 (30%), Gaps = 55/351 (15%)
Query: 1 MLNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISIT 60
+ EEA + + L + +LL P + +P S +
Sbjct: 250 VSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASL 309
Query: 61 MSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIP 120
L + ++ S L +L +L + + ++
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVL---LKDRPECWCRDSATDEQLFRCELSVEKST-VLQ 365
Query: 121 PEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVL 180
E+ +L+ L + TI I + +D L +L S L +
Sbjct: 366 SELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKE--------TLQYFSTLKAV 414
Query: 181 YLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIP 240
LD ++F + + + ++ L + L+ +
Sbjct: 415 DP----------------MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC 457
Query: 241 PILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSEL 300
L L ++ L L N+L +PP++ L L VL +N L+++ +
Sbjct: 458 H-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDN-----------ALENVDGV 504
Query: 301 ELCTNLLRGVIPHSIERVLLNQNNLSG-KMYEAFGDHPNLTFLDLSNNNFC 350
L + +LL N L + P L L+L N+ C
Sbjct: 505 ANLPRL---------QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 9e-10
Identities = 27/129 (20%), Positives = 44/129 (34%), Gaps = 27/129 (20%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+ +L+LS N +P + L L+ L N L + + L +L+ L
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELL 514
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS 193
L N+ + Q + I L + L +L L NSL
Sbjct: 515 LCNNR--------LQQSAAIQP---------------LVSCPRLVLLNLQGNSLC-QEEG 550
Query: 194 IIGKLKSLL 202
I +L +L
Sbjct: 551 IQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 7e-06
Identities = 32/236 (13%), Positives = 74/236 (31%), Gaps = 12/236 (5%)
Query: 314 SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNI 373
V + LS + L L + + + + + + +
Sbjct: 246 CCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLP 305
Query: 374 SGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLT 433
+ S+ + + S + + + + + QL L T
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQK--ECVLLKDRPECWCRDSATDEQLFR-CELSVEKST 362
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKI--PTEFEKLIHLSELDLS-- 489
LQ S +L P++ LL + L + + L ++ F L + + +
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422
Query: 490 ---HNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELH 542
+ E + L+L+H +L+ E++ ++ +D+S+N L
Sbjct: 423 DDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR 476
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 50/300 (16%), Positives = 103/300 (34%), Gaps = 63/300 (21%)
Query: 243 LGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELEL 302
L + L + + LS ++ N+ + +SL+ ++
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-----------QSLAGMQF 61
Query: 303 CTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSK 362
TNL + + L+ N +S D L L ++ N
Sbjct: 62 FTNL---------KELHLSHNQIS--DLSPLKDLTKLEELSVNRNR-------------- 96
Query: 363 LSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS 422
+ ++N I L L L +N + L L +L L + N+L
Sbjct: 97 ----LKNLNGIPS---------ACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK 141
Query: 423 GGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIH 482
V L L+KL+ LDL N++++ + L K+++++L+ + ++ +L
Sbjct: 142 SIVMLG--FLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYI 197
Query: 483 LSELDLSHNILQEEIPP-QVCNMGSLEKLNLSHNNLS--DFIPRCFEEMRSLSCIDISYN 539
+ + + I P + N GS + D + F E ++ + ++
Sbjct: 198 TNTV---KDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVGETEAIFD 254
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 42/183 (22%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 99 IGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158
L+ +LG ++ L+ +L+ ++ D + + ++ + + + +L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218
HN + S S L +L+ L L + +N L ++ I L +L L N+ + L
Sbjct: 71 SHNQI--SDLSPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELRDTDSLI 125
Query: 219 LGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYL 278
+L +L ++S+ NN L SI LG L L L LH N++ + L + + L
Sbjct: 126 --HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDL 179
Query: 279 YNN 281
Sbjct: 180 TGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 49/218 (22%), Positives = 78/218 (35%), Gaps = 15/218 (6%)
Query: 64 LGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEI 123
LG S + N N + ++ + + L+ L L NQ+S L P +
Sbjct: 26 LGKQSVTDLVSQKELSGVQNFNGDNSN-IQSLA-GMQFFTNLKELHLSHNQISDLSP--L 81
Query: 124 GKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183
L +L L ++ N+L I L +L L +N L SL +L NL +L +
Sbjct: 82 KDLTKLEELSVNRNRL--KNLNGIPSACL-SRLFLDNNEL--RDTDSLIHLKNLEILSIR 136
Query: 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPIL 243
N L SI +G L L LDL N+ + + L+ L + + L
Sbjct: 137 NNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCVNEPVKYQ 192
Query: 244 GNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNN 281
L + + + P I N S +
Sbjct: 193 PELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWE 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 44/253 (17%), Positives = 78/253 (30%), Gaps = 57/253 (22%)
Query: 169 SSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMM 228
L+N L K S++ + +L + + + S+ + ++L +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKEL 68
Query: 229 SLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVP 288
L +N +S + P L +L L L ++ N+L + + L L+L NN
Sbjct: 69 HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNN------- 116
Query: 289 EEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNN 348
L+ L NL E + + N L G L LDL N
Sbjct: 117 ----ELRDTDSLIHLKNL---------EILSIRNNKLK--SIVMLGFLSKLEVLDLHGNE 161
Query: 349 FCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEML 408
+ N G + K+ +DL+ V + L
Sbjct: 162 ---------------------ITNTGG-----LTRLKKVNWIDLTGQKCVNEPVKYQPEL 195
Query: 409 SSLNKLILNLNQL 421
N + +
Sbjct: 196 YITNTVKDPDGRW 208
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 56/181 (30%), Positives = 82/181 (45%), Gaps = 26/181 (14%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS---GGVPLEFGSL 432
S+P I + LDL S + L+ L L L+ NQL GV F L
Sbjct: 28 SVPSGIPAD--TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV---FDDL 82
Query: 433 TKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSH 490
T+L L L+ N+L+S +P + +L +L L L NQL +P+ F++L L EL L+
Sbjct: 83 TELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNT 140
Query: 491 NILQEEIPPQVCN-MGSLEKLNLSHNNLSDFIPRCFEEMRSL------------SCIDIS 537
N LQ IP + + +L+ L+LS N L F+ + L S +I
Sbjct: 141 NQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEIL 199
Query: 538 Y 538
Y
Sbjct: 200 Y 200
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 50/179 (27%), Positives = 70/179 (39%), Gaps = 30/179 (16%)
Query: 106 QYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG 165
+ LDL S L+ L L +L L LD NQL T+ +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFD---------------- 80
Query: 166 SIPSSLGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPLSL-GNLS 223
+L+ L L L N L+ S+P + L L +L L NQ S+P + L+
Sbjct: 81 -------DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT 131
Query: 224 SLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNN 281
L + L N L SIP L +L L L NQL + L L+ + L+ N
Sbjct: 132 KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 53/155 (34%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 83 NLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGT 142
L+L L+KL +L+L NQL L L +L L L NQL +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 143 IPPEI-GQLSLIDKLALCHNNLHGSIPSSL-GNLSNLAVLYLYKNSLSGSIPS-IIGKLK 199
+P + L+ +DKL L N L S+PS + L+ L L L N L SIP+ KL
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 200 SLLQLDLSENQFSGSIPL-SLGNLSSLTMMSLFNN 233
+L L LS NQ S+P + L L ++LF N
Sbjct: 156 NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 36/187 (19%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
IP E++ L L+ F LT+L+L N +L
Sbjct: 33 IPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYN--------------QLQ------ 72
Query: 371 NNISGSIPPDIGNSP-KLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLSG---GV 425
++ + + +L L L++N + +P+ + + L+ L+KL L NQL GV
Sbjct: 73 -----TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGV 126
Query: 426 PLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS 484
F LTKL+ L L+TN+L S IP L L L+LS NQL F++L L
Sbjct: 127 ---FDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQ 182
Query: 485 ELDLSHN 491
+ L N
Sbjct: 183 TITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 41/131 (31%), Positives = 66/131 (50%), Gaps = 4/131 (3%)
Query: 413 KLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHK 472
KL L L+ F LTKL +L+L N+L + +L +L L L+NNQL+
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 473 IPTE-FEKLIHLSELDLSHNILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRS 530
+P F+ L L +L L N L+ +P V + L++L L+ N L F+++ +
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156
Query: 531 LSCIDISYNEL 541
L + +S N+L
Sbjct: 157 LQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 45/156 (28%), Positives = 67/156 (42%), Gaps = 8/156 (5%)
Query: 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFS 212
+KL L L ++ L+ L L L N L ++ + + L L L L+ NQ +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 213 GSIPLSL-GNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GN 269
S+PL + +L+ L + L N L S+P + L L L L+ NQL IP
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDK 153
Query: 270 LSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTN 305
L++L+ L L N L L L + L N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 17/169 (10%)
Query: 203 QLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNG 261
+LDL + + L+ LT ++L N L ++ + +L L LGL NQL
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA- 96
Query: 262 FIPPSI-GNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH------- 313
+P + +L+ L LYL N L L L EL L TN L+ IP
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 314 SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF---CGEISF--NW 357
+++ + L+ N L + AF L + L N F EI + W
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQW 204
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 57/188 (30%), Positives = 81/188 (43%), Gaps = 27/188 (14%)
Query: 46 GISCNHAGSRV-------------ISITMSTLGLNG----TFHDFSFSSFPHLANLNLSF 88
G +CN V I L L T D +F L LNL +
Sbjct: 9 GCTCNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDY 68
Query: 89 NLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRRLYLDMNQLHGTIPPE 146
N + + +L++L L L +NQL+ L P + L QL +LYL NQL ++P
Sbjct: 69 NQL-QTLSAGVFDDLTELGTLGLANNQLASL-PLGVFDHLTQLDKLYLGGNQLK-SLPSG 125
Query: 147 I-GQLSLIDKLALCHNNLHGSIPSSL-GNLSNLAVLYLYKNSLSGSIP-SIIGKLKSLLQ 203
+ +L+ + +L L N L SIP+ L+NL L L N L S+P +L L
Sbjct: 126 VFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQT 183
Query: 204 LDLSENQF 211
+ L NQF
Sbjct: 184 ITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 54/211 (25%), Positives = 77/211 (36%), Gaps = 54/211 (25%)
Query: 263 IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQ 322
+P I + L L + GL L L+ L L N L+ + +
Sbjct: 29 VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGV------- 78
Query: 323 NNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIG 382
F D L L L+NN +L+ S+P +
Sbjct: 79 ----------FDDLTELGTLGLANN--------------QLA-----------SLPLGVF 103
Query: 383 NSP-KLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLS---GGVPLEFGSLTKLQY 437
+ +L L L N + +P + + L+ L +L LN NQL G F LT LQ
Sbjct: 104 DHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGA---FDKLTNLQT 159
Query: 438 LDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQ 468
L LSTN+L S + L KL + L NQ
Sbjct: 160 LSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 2/107 (1%)
Query: 436 QYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495
+ LDL + L++ + L KL +LNL NQL F+ L L L L++N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 496 EIPPQV-CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
+P V ++ L+KL L N L F+ + L + ++ N+L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 7e-17
Identities = 69/314 (21%), Positives = 116/314 (36%), Gaps = 40/314 (12%)
Query: 508 EKLNLSHNNLSDFIPRCFEEMR---SLSCIDISYNELHGPIPNSTAFKDGLMEGNKGLKR 564
E+L S +I + S S I+ L F+ + E + L+
Sbjct: 100 ERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRG 159
Query: 565 VSQEEQSNSMNRLRLLSVLNFDGKIMHEEIIKAT-DDFDEKFCIGKGGQGSVYKAEL-PS 622
++ S R N + I T +DF IG+GG G VY +
Sbjct: 160 DVFQKFIESDKFTRFCQWKNVELNI------HLTMNDFSVHRIIGRGGFGEVYGCRKADT 213
Query: 623 GDIVAVKKFN-SQLLSGNMADHDEFLNE--VLAL-KEIRHRNNVKFHGFCYNGPHS-FLV 677
G + A+K + ++ LNE +L+L V + ++ P +
Sbjct: 214 GKMYAMKCLDKKRIKMKQGETLA--LNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFI 270
Query: 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVL 737
+ ++ G L L E + L ++H+ +++RD+ N+L
Sbjct: 271 LDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILGLEHMHNR---FVVYRDLKPANIL 324
Query: 738 LDSNFEAHV--SDFGIAKFVGPHSSNWTEFAGTFGYAAPEI-----AYTMRATEKYDVYS 790
LD HV SD G+A GT GY APE+ AY A D +S
Sbjct: 325 LDE--HGHVRISDLGLACDF-SKKKPHA-SVGTHGYMAPEVLQKGVAYDSSA----DWFS 376
Query: 791 FGVLVFEVIKGNHP 804
G ++F++++G+ P
Sbjct: 377 LGCMLFKLLRGHSP 390
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 8e-17
Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 337 PNLTFLDLSNNNFCGEISFNW--GNFSKLSTFIVSMNNISGSIPPDI-GNSPKLQVLDLS 393
LDLS+NN + W + L + ++S N+++ I + P L+ LDLS
Sbjct: 39 SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 394 SNHIVGKIPVQ-LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIP-- 450
SNH+ + L +L L+L N + F + +LQ L LS N++ S P
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI-SRFPVE 154
Query: 451 --KSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSE--LDLSHN 491
K L KL L+LS+N+L T+ +KL + L L +N
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 9e-14
Identities = 44/213 (20%), Positives = 72/213 (33%), Gaps = 22/213 (10%)
Query: 204 LDLSENQFSGSIP--LSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLN 260
LDLS N S + + L++L + L +N L+ I + +L L L N L+
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 261 GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEI-GYLKSLSELELCTNLLRGVIP------- 312
+L +L VL LYNN + V + L +L L N +
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGN 160
Query: 313 --HSIERVLLNQNNLSGKMYEAFGDHPNLT--FLDLSNNNF---CGEISF-NWGNFSKLS 364
+ + L+ N L P L L NN C + + +LS
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLS 220
Query: 365 TFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397
+ + ++ + N L + S
Sbjct: 221 SVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKE 253
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 37/176 (21%), Positives = 62/176 (35%), Gaps = 32/176 (18%)
Query: 57 ISITMSTLGLNGTF-----HDFSFSSFPHLANLNLSFNLFFGNIPLQIG--------NLS 103
+ + L L+ +++ + +L +L LS N + +
Sbjct: 37 LPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN--------HLNFISSEAFVPVP 88
Query: 104 KLQYLDLGSNQLSGLIPPEI-GKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHN 161
L+YLDL SN L L + L L L L N + + ++ + KL L N
Sbjct: 89 NLRYLDLSSNHLHTL-DEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 162 NLHGSIP----SSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQ--LDLSENQF 211
+ P L L +L L N L + + KL + ++ L L N
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 63/266 (23%), Positives = 106/266 (39%), Gaps = 25/266 (9%)
Query: 546 PNSTAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNFDGKIMHEEIIKAT-DDFDEK 604
P F++ ++ L + +S+ R L + + T + F +
Sbjct: 137 PCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQ-------PVTKNTFRQY 189
Query: 605 FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEF--LNEVLALKEIRHRNN 661
+GKGG G V ++ +G + A KK + + E LNE L+++ R
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGEAMALNEKQILEKVNSRFV 246
Query: 662 VKFHGFCYNGP-HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
V + Y LV ++ G L + + R + + L LH
Sbjct: 247 VSLA-YAYETKDALCLVLTLMNGGDLKFHI-YHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY 778
+ I++RD+ +N+LLD H+ SD G+A V + GT GY APE+
Sbjct: 305 E---RIVYRDLKPENILLDD--HGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVVK 358
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHP 804
R T D ++ G L++E+I G P
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 50/254 (19%), Positives = 99/254 (38%), Gaps = 36/254 (14%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
+D++ IG+G G V + + A+K + +++ + + F E +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFA 126
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG------ 710
V+ + + ++V EY+ G L ++ N +
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS----------NYDVPEKWARFYTAE 176
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE-FAGTF 769
V AL +H IHRD+ N+LLD + ++DFG + + GT
Sbjct: 177 VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 770 GYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKI 825
Y +PE+ + Y D +S GV ++E++ G+ P F++ +++ +KI
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP--FYA------DSLVGTYSKI 285
Query: 826 LDPRLPTPSPSVMD 839
++ + P D
Sbjct: 286 MNHKNSLTFPDDND 299
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 57/211 (27%), Positives = 85/211 (40%), Gaps = 23/211 (10%)
Query: 33 PANATKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFF 92
A K + ++ + + SI + P++ L L N
Sbjct: 18 FAETIKAN-LKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGN--- 73
Query: 93 GNIPLQIG------NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPE 146
++ L+ L YL L NQL L KL L+ L L NQL ++P
Sbjct: 74 -----KLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDG 127
Query: 147 I-GQLSLIDKLALCHNNLHGSIPSSL-GNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQ 203
+ +L+ + L L HN L S+P + L+NL L L N L S+P + KL L
Sbjct: 128 VFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKD 185
Query: 204 LDLSENQFSGSIPL-SLGNLSSLTMMSLFNN 233
L L +NQ S+P L+SL + L +N
Sbjct: 186 LRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 9/168 (5%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSG-GVPLEFGSLTK 434
+ + + +++ I + ++ L ++ L L N+L LT
Sbjct: 33 DAVTQNELN-SIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLHDISA---LKELTN 86
Query: 435 LQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQ 494
L YL L+ N+L S L L L L NQL F+KL +L+ L+L+HN LQ
Sbjct: 87 LTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 495 EEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
+P V + +L +L+LS+N L F+++ L + + N+L
Sbjct: 147 -SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-14
Identities = 57/251 (22%), Positives = 92/251 (36%), Gaps = 60/251 (23%)
Query: 224 SLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGL 283
+L S++ L S+ + + + + I L ++R L L N L
Sbjct: 20 ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKL 75
Query: 284 YGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLD 343
+I LK L+ L ++L N L F NL L
Sbjct: 76 -----HDISALKELTNLT---------------YLILTGNQLQSLPNGVFDKLTNLKELV 115
Query: 344 LSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSP-KLQVLDLSSNHIVGKIP 402
L N +L S+P + + L L+L+ N + +P
Sbjct: 116 LVEN--------------QLQ-----------SLPDGVFDKLTNLTYLNLAHNQLQ-SLP 149
Query: 403 VQL-EMLSSLNKLILNLNQLS---GGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLL 457
+ + L++L +L L+ NQL GV F LT+L+ L L N+L S+P + L
Sbjct: 150 KGVFDKLTNLTELDLSYNQLQSLPEGV---FDKLTQLKDLRLYQNQL-KSVPDGVFDRLT 205
Query: 458 KLHYLNLSNNQ 468
L Y+ L +N
Sbjct: 206 SLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 32/235 (13%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
+ L + +++ + ++ + +N++ + +
Sbjct: 17 AFAETIKANLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGG 72
Query: 371 NNISGSIPP-DIGNSPKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLS---GGV 425
N + I L L L+ N + +P + + L++L +L+L NQL GV
Sbjct: 73 NKLH-DISALK--ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGV 128
Query: 426 PLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLS 484
F LT L YL+L+ N+L S L L L+LS NQL +P F+KL L
Sbjct: 129 ---FDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLK 184
Query: 485 ELDLSHNILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISY 538
+L L N L+ +P V + SL+ + L H+N D C +C I Y
Sbjct: 185 DLRLYQNQLK-SVPDGVFDRLTSLQYIWL-HDNPWD----C-------TCPGIRY 226
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 119 IPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLA 178
P + + + L + + S+ + +N+ S+ + L N+
Sbjct: 13 FPDDA--FAETIKANLKKKSV-TDAVTQNELNSI--DQIIANNSDIKSVQG-IQYLPNVR 66
Query: 179 VLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSL-GNLSSLTMMSLFNNSLSG 237
L L N L I + +L +L L L+ NQ S+P + L++L + L N L
Sbjct: 67 YLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ- 122
Query: 238 SIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVLYLYNNGLYGFVPEEI-GYL 294
S+P + L +L+ L L NQL +P + L++L L L N L +PE + L
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKL 180
Query: 295 KSLSELELCTNLLRGVIPH-------SIERVLLNQN 323
L +L L N L+ V P S++ + L+ N
Sbjct: 181 TQLKDLRLYQNQLKSV-PDGVFDRLTSLQYIWLHDN 215
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 64/266 (24%), Positives = 108/266 (40%), Gaps = 22/266 (8%)
Query: 546 PNSTAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNFDGKIMHEEIIKATDDFDEKF 605
F+ L L + +E +S+ LR L + + M E D F +
Sbjct: 138 AGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGE------DWFLDFR 191
Query: 606 CIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEF--LNEVLALKEIRHRNNV 662
+G+GG G V+ ++ +G + A KK N + L + E L ++ R V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRL---KKRKGYQGAMVEKKILAKVHSRFIV 248
Query: 663 KFHGFCYNGP-HSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
+ + LV ++ G + I D R I + + L +LH
Sbjct: 249 SLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY 778
+II+RD+ +NVLLD + +V SD G+A + + +AGT G+ APE+
Sbjct: 308 R---NIIYRDLKPENVLLDD--DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 779 TMRATEKYDVYSFGVLVFEVIKGNHP 804
D ++ GV ++E+I P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 43/139 (30%), Positives = 65/139 (46%), Gaps = 15/139 (10%)
Query: 413 KLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSH 471
L L+ NQ++ P F SL L+ L L +N+L ++P + +L +L L+L NQL+
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 472 KIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSL 531
F++L+HL EL + N L E+P + + L L L N L F+ + SL
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 532 ------------SCIDISY 538
C DI Y
Sbjct: 162 THAYLFGNPWDCECRDIMY 180
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 44/130 (33%), Positives = 62/130 (47%), Gaps = 5/130 (3%)
Query: 106 QYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLH 164
Q L L NQ++ L P L L+ LYL NQL +P + L+ + L L N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 165 GSIPSSL-GNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLS 223
+PS++ L +L L++ N L+ +P I +L L L L +NQ + LS
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 224 SLTMMSLFNN 233
SLT LF N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 3/110 (2%)
Query: 433 TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNI 492
T Q L L N+++ P +L+ L L L +NQL F+ L L+ LDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99
Query: 493 LQEEIPPQVCN-MGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
L +P V + + L++L + N L++ +PR E + L+ + + N+L
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 30/85 (35%), Positives = 47/85 (55%), Gaps = 3/85 (3%)
Query: 102 LSKLQYLDLGSNQLSGLIPPEI-GKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160
L++L LDLG+NQL+ L P + +L L+ L++ N+L +P I +L+ + LAL
Sbjct: 87 LTQLTVLDLGTNQLTVL-PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQ 144
Query: 161 NNLHGSIPSSLGNLSNLAVLYLYKN 185
N L + LS+L YL+ N
Sbjct: 145 NQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 25/160 (15%)
Query: 190 SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKS 248
S+P+ I + L L +NQ + P +L +L + L +N L ++P + +L
Sbjct: 33 SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 249 LSALGLHINQLNGFIPPSI-GNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLL 307
L+ L L NQL +P ++ L L+ L++ N L +P I L L+ L L N L
Sbjct: 90 LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147
Query: 308 RGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNN 347
+ + PH AF +LT L N
Sbjct: 148 KSI-PH-----------------GAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 32/137 (23%), Positives = 57/137 (41%), Gaps = 9/137 (6%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS---TFI 367
IP + + + L+ N ++ F NL L L +N + G F L+
Sbjct: 38 IPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL---GALPVGVFDSLTQLTVLD 94
Query: 368 VSMNNISGSIPPDIGNS-PKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVP 426
+ N ++ +P + + L+ L + N + ++P +E L+ L L L+ NQL
Sbjct: 95 LGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPH 152
Query: 427 LEFGSLTKLQYLDLSTN 443
F L+ L + L N
Sbjct: 153 GAFDRLSSLTHAYLFGN 169
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 52/256 (20%), Positives = 91/256 (35%), Gaps = 68/256 (26%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADHDEFLN-EVLALKEIR----HR 659
+GKGG G+V+ L VA+K +++L + EV L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 660 NNVKFHGFCYNGPHSFLVCEYLDRG---------------SLARILGDDVTAKELGWNRR 704
++ + LV E +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR---------------- 142
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHSSNWT 763
V A+ + H ++HRDI +N+L+D A + DFG H +T
Sbjct: 143 -CFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYT 196
Query: 764 EFAGTFGYAAPEIAYTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM 818
+F GT Y+ PE + +Y V+S G+L+++++ G+ P +
Sbjct: 197 DFDGTRVYSPPE----WISRHQYHALPATVWSLGILLYDMVCGDIPFE------------ 240
Query: 819 IIDVNKILDPRLPTPS 834
+IL+ L P+
Sbjct: 241 --RDQEILEAELHFPA 254
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 51/250 (20%), Positives = 95/250 (38%), Gaps = 58/250 (23%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADHDEFLN-EVLALKEIRHR--NN 661
+G GG GSVY + VA+K ++ + + EV+ LK++
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 662 VKFHGFCYNGPHSFLVCEYLD-----------RGSLARILGDDVTAKELGWNRRINVIKG 710
++ + L+ E + RG+L + A R
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL-----QEELA------RSF--FWQ 157
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSN-FEAHVSDFGIAKFVGPHSSNWTEFAGTF 769
V A+ + H+ ++HRDI +N+L+D N E + DFG + +T+F GT
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDFDGTR 212
Query: 770 GYAAPEIAYTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNK 824
Y+ PE +Y V+S G+L+++++ G+ P + +
Sbjct: 213 VYSPPE----WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEE 254
Query: 825 ILDPRLPTPS 834
I+ ++
Sbjct: 255 IIRGQVFFRQ 264
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 58/248 (23%), Positives = 96/248 (38%), Gaps = 40/248 (16%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G G V A + + VAVK + + + ++ + E+ K + H N VKF+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIK--KEICINKMLNHENVVKFY 71
Query: 666 GFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
G G +L EY G L RI + + + YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI--- 124
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW---TEFAGTFGYAAPEI----A 777
I HRDI +N+LLD +SDFG+A ++ GT Y APE+
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLKRRE 183
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHP----------------RDFFSINFSSFSNMIID 821
+ E DV+S G+++ ++ G P + + + + +
Sbjct: 184 F---HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 822 -VNKILDP 828
++KIL
Sbjct: 241 LLHKILVE 248
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 58/252 (23%), Positives = 103/252 (40%), Gaps = 37/252 (14%)
Query: 598 TDDFD-EKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL-K 654
TDD+ K +G G G V + +G A+K D + EV +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---------DSPKARQEVDHHWQ 77
Query: 655 EIRHRNNVKFHGFCYNGPHS----FLVCEYLDRGSL-ARIL--GDDV-TAKELGWNRRIN 706
+ V N H ++ E ++ G L +RI GD T +E
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-----E 132
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNWT 763
+++ + A+ +LH +I HRD+ +N+L S + ++DFG AK ++
Sbjct: 133 IMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQ 187
Query: 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVN 823
T Y APE+ + + D++S GV+++ ++ G P F+S + S +
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP--FYSNTGQAISPGMK--R 243
Query: 824 KILDPRLPTPSP 835
+I + P+P
Sbjct: 244 RIRLGQYGFPNP 255
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 29/130 (22%), Positives = 61/130 (46%), Gaps = 5/130 (3%)
Query: 413 KLILNLNQLSGGVPL-EFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH 471
+L LN N+ + F L +L+ ++ S NK++ + ++ + L++N+L +
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 472 KIPTE-FEKLIHLSELDLSHNILQEEIPPQV-CNMGSLEKLNLSHNNLSDFIPRCFEEMR 529
+ + F+ L L L L N + + + S+ L+L N ++ P F+ +
Sbjct: 96 -VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153
Query: 530 SLSCIDISYN 539
SLS +++ N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 31/159 (19%)
Query: 106 QYLDLGSNQLSGLIPPEI-GKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLH 164
L L +N+ + L I KL QLR++ N++ I
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEE------------------- 74
Query: 165 GSIPSSLGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPL-SLGNL 222
+ S + + L N L ++ + L+SL L L N+ + + S L
Sbjct: 75 ----GAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGL 128
Query: 223 SSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLN 260
SS+ ++SL++N ++ ++ P L SLS L L N N
Sbjct: 129 SSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 24/109 (22%), Positives = 50/109 (45%), Gaps = 3/109 (2%)
Query: 436 QYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQ 494
L L+ N+ + I L +L +N SNN+++ FE ++E+ L+ N L+
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 495 EEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELH 542
+ ++ + SL+ L L N ++ F + S+ + + N++
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 29/133 (21%), Positives = 58/133 (43%), Gaps = 7/133 (5%)
Query: 83 NLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHG 141
L L+ N F I L +L+ ++ +N+++ + + + + L N+L
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE- 94
Query: 142 TIPPEI-GQLSLIDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKNSLSGSIP-SIIGKL 198
+ ++ L + L L N + + + S LS++ +L LY N ++ ++ L
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTL 152
Query: 199 KSLLQLDLSENQF 211
SL L+L N F
Sbjct: 153 HSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 31/165 (18%), Positives = 53/165 (32%), Gaps = 35/165 (21%)
Query: 311 IPHSIERVLLNQNNLSGKMYEA-FGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS---TF 366
IP + LN N + F P L ++ SNN G F S
Sbjct: 30 IPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI---TDIEEGAFEGASGVNEI 86
Query: 367 IVSMNNISGSIPPDI-GNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGV 425
+++ N + ++ + L+ L L SN + +
Sbjct: 87 LLTSNRLE-NVQHKMFKGLESLKTLMLRSNR---------------------ITCVGNDS 124
Query: 426 PLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQL 469
F L+ ++ L L N++ +++ L L LNL N
Sbjct: 125 ---FIGLSSVRLLSLYDNQI-TTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 39/195 (20%), Positives = 68/195 (34%), Gaps = 51/195 (26%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS--IIGKLKSLLQLDLSENQFSGSIP 216
C N IP + A L L N + + + I KL L +++ S N+ +
Sbjct: 18 CSNQKLNKIPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEE 74
Query: 217 LSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLR 274
+ S + + L +N L ++ + L+SL L L N++ + LSS+R
Sbjct: 75 GAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVR 132
Query: 275 VLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFG 334
+L LY+N + + + AF
Sbjct: 133 LLSLYDNQI-----------TT--------------VAP-----------------GAFD 150
Query: 335 DHPNLTFLDLSNNNF 349
+L+ L+L N F
Sbjct: 151 TLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 28/113 (24%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRRL 132
F + + L+ N N+ ++ L L+ L L SN+++ + + L+ +R L
Sbjct: 77 FEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRITCV-GNDSFIGLSSVRLL 134
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKN 185
L NQ+ T+ P L +L+ L L N
Sbjct: 135 SLYDNQIT-TVAPGA-----------------------FDTLHSLSTLNLLAN 163
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 65/281 (23%), Positives = 108/281 (38%), Gaps = 40/281 (14%)
Query: 566 SQEEQSNSMNRLRLLSVLNFDGKIMHEEIIKAT-DDFDEKFCIGKGGQGSVYKAEL-PSG 623
+ + S+ + +F K A D FD +G G G V + SG
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 624 DIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLD 682
+ A+K + +++ +H LNE L+ + VK + + ++V EY+
Sbjct: 67 NHYAMKILDKQKVVKLKQIEH--TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 683 RGSL------ARILGDDVT---AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISS 733
G + + A + + YLH +I+RD+
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQ------------IVLTFEYLHSL---DLIYRDLKP 169
Query: 734 KNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGV 793
+N+L+D V+DFG AK V WT GT APEI + + D ++ GV
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 794 LVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
L++E+ G P FF+ I KI+ ++ PS
Sbjct: 227 LIYEMAAGYPP--FFA------DQPIQIYEKIVSGKVRFPS 259
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 25/233 (10%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKG V A + +G VA+K + L+ EV +K + H N VK
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF--REVRIMKILNHPNIVKLF 80
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
+L+ EY G + L V + + + + +A+ Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIVSAVQYCHQKR--- 134
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI----AYTMR 781
I+HRD+ ++N+LLD++ ++DFG + F G YAAPE+ Y
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQGKKYDGP 193
Query: 782 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
DV+S GV+++ ++ G+ P F N+ ++L + P
Sbjct: 194 EV---DVWSLGVILYTLVSGSLP-------FDG-QNLKELRERVLRGKYRIPF 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 35/219 (15%)
Query: 595 IKATDDFDEKFC----IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNE 649
IK D+ +G G G V + + + A+K + D + E
Sbjct: 54 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM---------LQDCPKARRE 104
Query: 650 VLALKEI-RHRNNVKFHGFCYNGPHS----FLVCEYLDRGSL-ARIL--GDDV-TAKELG 700
V + + V+ N +V E LD G L +RI GD T +E
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 701 WNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGP 757
++K + A+ YLH +I HRD+ +N+L S ++DFG AK
Sbjct: 165 -----EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVF 796
H+S T T Y APE+ + + D++S GV+++
Sbjct: 217 HNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 254
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+G G G V E +G VAVK N ++ S ++ + E+ LK RH + +K
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76
Query: 665 HGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
+ F+V EY+ G L I + + + + +A+ Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRH-- 130
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRAT 783
++HRD+ +NVLLD++ A ++DFG++ + T G+ YAAPE+ +
Sbjct: 131 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVI----SG 184
Query: 784 EKY-----DVYSFGVLVFEVIKGNHPRD 806
Y D++S GV+++ ++ G P D
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 18/210 (8%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G G V + + AVK + L E+ L+ +RH+N ++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 666 GFCYN--GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
YN ++V EY G + D V K + + + L YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-- 128
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT--EFAGTFGYAAPEIAYTMR 781
I+H+DI N+LL + +S G+A+ + P +++ T G+ + PEIA
Sbjct: 129 -GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA---N 184
Query: 782 ATEKY-----DVYSFGVLVFEVIKGNHPRD 806
+ + D++S GV ++ + G +P +
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 43/180 (23%), Positives = 82/180 (45%), Gaps = 23/180 (12%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRN 660
+G G +VYK +G VA+K+ D +E + E+ +KE++H N
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAIREISLMKELKHEN 64
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA----NALS 716
V+ + + LV E++D L + + D T +N++K L+
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+ H + I+HRD+ +N+L++ + + DFG+A+ G + ++ T Y AP++
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 55/261 (21%), Positives = 90/261 (34%), Gaps = 51/261 (19%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
DDF+ IG+G V ++ +G + A+K N +L F E L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC--FREERDVLVNG 118
Query: 657 RHRNNVKFHGFCYNGP-HSFLVCEYLDRGSL-------ARILGDDVT---AKELGWNRRI 705
R + H F + + +LV EY G L + ++ E+
Sbjct: 119 DRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI------ 171
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWT 763
A+ +H +HRDI N+LLD H+ +DFG + + +
Sbjct: 172 ------VMAIDSVHRL---GYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRS 220
Query: 764 E-FAGTFGYAAPEIAYTMRATEKYDVY-------SFGVLVFEVIKGNHPRDFFSINFSSF 815
GT Y +PEI + Y + GV +E+ G P F++
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP--FYA------ 272
Query: 816 SNMIIDVNKILDPRLPTPSPS 836
+ KI+ + P
Sbjct: 273 DSTAETYGKIVHYKEHLSLPL 293
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 42/206 (20%), Positives = 81/206 (39%), Gaps = 29/206 (14%)
Query: 590 MHEEIIKATDDFD-EKFCIGKGGQGSVYKA---ELPSGDIVAVKKFNSQLLSGNMADHDE 645
+ E + D F+ E +G+G G VYKA + A+K+ +S
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS------MS 64
Query: 646 FLNEVLALKEIRHRNNVKFHGFCYNGPHS--FLVCEYLDRGSLARILGDDVTAKELGWNR 703
E+ L+E++H N + + +L+ +Y + L I+ +K
Sbjct: 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPV 123
Query: 704 RIN--VIKGVA----NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH----VSDFGIAK 753
++ ++K + + + YLH + ++HRD+ N+L+ ++D G A+
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 754 FVGPHSSNWTEFAG---TFGYAAPEI 776
+ TF Y APE+
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPEL 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 19/176 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN-----EVLALKEIRHRN 660
+G+G G V K +G IVA+KKF +D D+ + E+ LK++RH N
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFL-------ESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
V C +LV E++D ++ L ++ L + + + N + + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+IIHRDI +N+L+ + + DFG A+ + + + T Y APE+
Sbjct: 143 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 58/248 (23%), Positives = 96/248 (38%), Gaps = 40/248 (16%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
+G+G G V A + + VAVK + + + ++ + E+ K + H N VKF+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIK--KEICINKMLNHENVVKFY 71
Query: 666 GFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
G G +L EY G L RI + + + YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI--- 124
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW---TEFAGTFGYAAPEI----A 777
I HRDI +N+LLD +SDFG+A ++ GT Y APE+
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLKRRE 183
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHP----------------RDFFSINFSSFSNMIID 821
+ E DV+S G+++ ++ G P + + + + +
Sbjct: 184 F---HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 822 -VNKILDP 828
++KIL
Sbjct: 241 LLHKILVE 248
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-15
Identities = 56/168 (33%), Positives = 77/168 (45%), Gaps = 24/168 (14%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS---GGVPLEFGSL 432
S+P I LDL +N + + L+SL +L L N+L GV F L
Sbjct: 21 SVPTGIPAQ--TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV---FNKL 75
Query: 433 TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSHN 491
T L YL+LSTN+L S L +L L L+ NQL +P F+KL L +L L N
Sbjct: 76 TSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
Query: 492 ILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISY 538
L+ +P V + SL+ + L H+N D C +C I Y
Sbjct: 135 QLK-SVPDGVFDRLTSLQYIWL-HDNPWD----C-------TCPGIRY 169
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-14
Identities = 44/132 (33%), Positives = 65/132 (49%), Gaps = 8/132 (6%)
Query: 106 QYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLH 164
YLDL +N L L +L L +LYL N+L ++P + +L+ + L L N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 165 GSIPSSL-GNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPL-SLGN 221
S+P+ + L+ L L L N L S+P + KL L L L +NQ S+P
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDR 146
Query: 222 LSSLTMMSLFNN 233
L+SL + L +N
Sbjct: 147 LTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 42/131 (32%), Positives = 63/131 (48%), Gaps = 6/131 (4%)
Query: 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSG 213
L L N+L L++L LYL N L + KL SL L+LS NQ
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 214 SIPLSL-GNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNL 270
S+P + L+ L ++L N L S+P + L L L L+ NQL +P + L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRL 147
Query: 271 SSLRVLYLYNN 281
+SL+ ++L++N
Sbjct: 148 TSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 35/110 (31%), Positives = 51/110 (46%), Gaps = 2/110 (1%)
Query: 433 TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNI 492
+ YLDL TN L S L L L L N+L F KL L+ L+LS N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 493 LQEEIPPQVCN-MGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541
LQ +P V + + L++L L+ N L F+++ L + + N+L
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 6/87 (6%)
Query: 102 LSKLQYLDLGSNQLSGLIPPEI-GKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALC 159
L+ L YL+L +NQL L P + KL QL+ L L+ NQL ++P + +L+ + L L
Sbjct: 75 LTSLTYLNLSTNQLQSL-PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLY 132
Query: 160 HNNLHGSIPS-SLGNLSNLAVLYLYKN 185
N L S+P L++L ++L+ N
Sbjct: 133 QNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 43/144 (29%), Positives = 63/144 (43%), Gaps = 16/144 (11%)
Query: 190 SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKS 248
S+P+ I LDL N L+SLT + L N L S+P + L S
Sbjct: 21 SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 249 LSALGLHINQLNGFIPPSI-GNLSSLRVLYLYNNGLYGFVPEEI-GYLKSLSELELCTNL 306
L+ L L NQL +P + L+ L+ L L N L +P+ + L L +L L N
Sbjct: 78 LTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQ 135
Query: 307 LRGVIPH-------SIERVLLNQN 323
L+ V P S++ + L+ N
Sbjct: 136 LKSV-PDGVFDRLTSLQYIWLHDN 158
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 19/176 (10%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN-----EVLALKEIRHRN 660
IG+G G V+K +G IVA+KKF ++ D + E+ LK+++H N
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFL-------ESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
V LV EY D ++ L D + + + ++ A+++ H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+ IHRD+ +N+L+ + + DFG A+ + S + + T Y +PE+
Sbjct: 121 H---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 43/230 (18%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLN----------------- 648
IGKG G V A A+K + + L
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 649 -----EVLALKEIRHRNNVKFHG--FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGW 701
E+ LK++ H N VK N H ++V E +++G + + T K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLKPLSE 136
Query: 702 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI-AKFVGPHSS 760
++ + + + YLH+ IIHRDI N+L+ + ++DFG+ +F G +
Sbjct: 137 DQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 761 NWTEFAGTFGYAAPEI------AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
GT + APE ++ +A DV++ GV ++ + G P
Sbjct: 194 LSN-TVGTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQCP 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLALKEIRHRNN 661
IG G QG V A + VA+KK + + E++ +K + H+N
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 662 VK-FHGFC-YNGPHSF----LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
+ + F F LV E +D +L +++ EL R ++ + +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGI 177
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
+LH IIHRD+ N+++ S+ + DFG+A+ G S T + T Y APE
Sbjct: 178 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPE 233
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
+ M E D++S G ++ E+++ + F + I NK+++ +L TP P
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRH---KILFPGR-----DYIDQWNKVIE-QLGTPCP 284
Query: 836 SVMD 839
M
Sbjct: 285 EFMK 288
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
DF +G G G V+ +G A+K ++ +H +E L L +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH--TNDERLMLSIV 63
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRRINV 707
H ++ G + F++ +Y++ G L ++ + V A E
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE--------- 114
Query: 708 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWTEF 765
V AL YLH II+RD+ +N+LLD H+ +DFG AK+V +T
Sbjct: 115 ---VCLALEYLHSK---DIIYRDLKPENILLDK--NGHIKITDFGFAKYVP--DVTYT-L 163
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811
GT Y APE+ T + D +SFG+L++E++ G P F+ N
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDSN 207
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 56/261 (21%), Positives = 98/261 (37%), Gaps = 47/261 (18%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
+DF+ IG+G G V +L + + A+K N ++L F E L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC--FREERDVLVNG 131
Query: 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRGSL-------ARILGDDVT---AKELGWNRRIN 706
+ H + + +LV +Y G L L +++ E+
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM------- 184
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWTE 764
A+ +H +HRDI N+L+D N H+ +DFG + + +
Sbjct: 185 -----VIAIDSVHQL---HYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSS 234
Query: 765 -FAGTFGYAAPEIAYTMRATEKY-----DVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM 818
GT Y +PEI M + D +S GV ++E++ G P F++ S
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP--FYA---ESLVET 289
Query: 819 IIDVNKILDPRLPTPSPSVMD 839
KI++ + P+ +
Sbjct: 290 Y---GKIMNHKERFQFPTQVT 307
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 63/244 (25%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLALKEIRHRNN 661
IG G QG V A + VA+KK + + E++ +K + H+N
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLS------RPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 662 VK-FHGFC-YNGPHSF----LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
+ + F F +V E +D +L +++ EL R ++ + +
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGI 140
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
+LH IIHRD+ N+++ S+ + DFG+A+ G S T + T Y APE
Sbjct: 141 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPE 196
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
+ M E D++S G ++ E+IKG F + I NK+++ +L TP P
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKG---GVLFPGT-----DHIDQWNKVIE-QLGTPCP 247
Query: 836 SVMD 839
M
Sbjct: 248 EFMK 251
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 26/180 (14%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN-----EVLALKEIRHRN 660
IG+G G VYKA +G++VA+KK + E + E+ LKE+ H N
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIR-------LDTETEGVPSTAIREISLLKELNHPN 63
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA----NALS 716
VK + +LV E+L + L + + D + + +IK L+
Sbjct: 64 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIP----LPLIKSYLFQLLQGLA 117
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+ H ++HRD+ +N+L+++ ++DFG+A+ G +T T Y APEI
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 26/179 (14%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRNN 661
IG+G G VYKA+ G+ A+KK + DE + E+ LKE++H N
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA----NALSY 717
VK + + LV E+LD+ L ++L DV L K N ++Y
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLE----SVTAKSFLLQLLNGIAY 115
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
H ++HRD+ +N+L++ E ++DFG+A+ G +T T Y AP++
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
++F+ +GKG G V + +G A+K +++ + H L E L+
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH--TLTENRVLQNS 205
Query: 657 RHRNNVKFHGFCYNGP-HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
RH + + V EY + G L L + E +R + +AL
Sbjct: 206 RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE---DRARFYGAEIVSAL 261
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSNWTEFAGTFGYA 772
YLH + ++++RD+ +N++LD + H+ +DFG+ K + ++ T F GT Y
Sbjct: 262 DYLHSEK--NVVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 316
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
APE+ D + GV+++E++ G P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 58/338 (17%), Positives = 119/338 (35%), Gaps = 58/338 (17%)
Query: 219 LGNLSSLTMMSLFNNSLSG----SIPPILGNLKSLSALGLHINQLNG----FIPPSIGNL 270
+ S + SL ++++ S+ +L S+ + L N + ++ +I +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 271 SSLRVLYLYNNGLYGFVPEEIGYLKSLSE-LELCTNLLRGVIPHSIERVLLNQNNLSGK- 328
L + + E L+ L + L C L V L+ N
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL---------HTVRLSDNAFGPTA 110
Query: 329 ---MYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSP 385
+ + H L L L NN G + +K++ + + + N+P
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGL-GPQAG-----AKIARALQELAVNKKAK-----NAP 159
Query: 386 KLQVLDLSSNHI----VGKIPVQLEMLSSLNKLILNLNQLSG-GVPLEFGSL----TKLQ 436
L+ + N + + + + L+ + + N + G+ +L+
Sbjct: 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219
Query: 437 YLDLSTNKLS----SSIPKSIGNLLKLHYLNLSNNQLSHK----IPTEFEKLIH--LSEL 486
LDL N + S++ ++ + L L L++ LS + + F KL + L L
Sbjct: 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 279
Query: 487 DLSHNILQEEIPPQVC-----NMGSLEKLNLSHNNLSD 519
L +N ++ + + M L L L+ N S+
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 46/282 (16%), Positives = 89/282 (31%), Gaps = 54/282 (19%)
Query: 314 SIERVLLNQNNLSGK----MYEAFGDHPNLTFLDLSNNNF----CGEISFNWGNFSKLST 365
SIE L + ++ + ++ + ++ + LS N +S N + L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 366 FIVSMNNIS----------GSIPPDIGNSPKLQVLDLSSNHI----VGKIPVQLEMLSSL 411
S + + PKL + LS N + L + L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 412 NKLILNLNQLS--GGVPL-----------EFGSLTKLQYLDLSTNKLSSSIPKSIGNLLK 458
L L+ N L G + + + L+ + N+L + K +
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184
Query: 459 ----LHYLNLSNNQLSHK-----IPTEFEKLIHLSELDLSHNILQEE----IPPQVCNMG 505
LH + + N + + + L LDL N + + +
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244
Query: 506 SLEKLNLSHNNLSD----FIPRCFEEM--RSLSCIDISYNEL 541
+L +L L+ LS + F ++ L + + YNE+
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 57/389 (14%), Positives = 113/389 (29%), Gaps = 104/389 (26%)
Query: 171 LGNLSNLAVLYLYKNSLSG----SIPSIIGKLKSLLQLDLSENQFS--GSIPLSLG---- 220
+ S + L ++++ S+ +++ + S+ ++ LS N + LS
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 221 -NLSSLTMMSLFNNSLSGSIPPI-------LGNLKSLSALGLHINQLNG----FIPPSIG 268
+L +F + IP L L + L N + +
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 269 NLSSLRVLYLYNNGL-------------YGFVPEEIGYLKSLSELELCTNLLR--GVI-- 311
+ L LYL+NNGL V ++ L + N L +
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 312 ------PHSIERVLLNQNNLSGK-----MYEAFGDHPNLTFLDLSNNNFCGEISFNWGNF 360
+ V + QN + + + E L LDL +N F
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL-------- 231
Query: 361 SKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI--VGKIPVQLEMLSSLNKLILNL 418
+ ++ ++ + P L+ L L+ + G +
Sbjct: 232 --------GSSALAIALK----SWPNLRELGLNDCLLSARG-----AAAVVDA------- 267
Query: 419 NQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLK-----LHYLNLSNNQLS--- 470
LQ L L N++ +++ ++ L +L L+ N+ S
Sbjct: 268 --------FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319
Query: 471 ---HKIPTEFEKLIHLSELDLSHNILQEE 496
+I F +L +
Sbjct: 320 DVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 9e-14
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+G G G V + +G VAVK N ++ S ++ E+ LK RH + +K
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81
Query: 665 HGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
+ F+V EY+ G L I L + + + + + Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRHM- 136
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRAT 783
++HRD+ +NVLLD++ A ++DFG++ + T G+ YAAPE+ +
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVI----SG 189
Query: 784 EKY-----DVYSFGVLVFEVIKGNHPRD 806
Y D++S GV+++ ++ G P D
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 41/128 (32%), Positives = 58/128 (45%), Gaps = 7/128 (5%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218
C N +P G ++ LYL N + +P + K L +DLS N+ S S
Sbjct: 17 CSNKGLKVLPK--GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQS 73
Query: 219 LGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVL 276
N++ L + L N L IPP LKSL L LH N ++ +P +LS+L L
Sbjct: 74 FSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHL 131
Query: 277 YLYNNGLY 284
+ N LY
Sbjct: 132 AIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 16/133 (12%)
Query: 413 KLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHK 472
+L L+ NQ + VP E + L +DLS N++S+ +S N+ +L L LS N+L
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 473 IPTE-FEKLIHLSELDLSHNILQEEIPPQV-CNMGSLEKLNLSHNN----------LSDF 520
IP F+ L L L L N + +P ++ +L L + N LSD+
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAI-GANPLYCDCNMQWLSDW 150
Query: 521 IPRCFEEMRSLSC 533
+ ++E C
Sbjct: 151 VKSEYKEPGIARC 163
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 130 RRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG 189
LYLD NQ +P E+ + + L +N + S N++ L L L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 190 SIPS-IIGKLKSLLQLDLSENQFSGSIPL-SLGNLSSLTMMSLFNN 233
IP LKSL L L N S +P + +LS+L+ +++ N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 5/101 (4%)
Query: 371 NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLSGGVPLEF 429
N + +P ++ N L ++DLS+N I + Q ++ L LIL+ N+L P F
Sbjct: 41 NQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTF 98
Query: 430 GSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQL 469
L L+ L L N + S +P+ +L L +L + N L
Sbjct: 99 DGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 5/105 (4%)
Query: 83 NLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGT 142
L L N F +P ++ N L +DL +N++S L + QL L L N+L
Sbjct: 35 ELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 143 IPPEI-GQLSLIDKLALCHNNLHGSIP-SSLGNLSNLAVLYLYKN 185
IPP L + L+L N++ +P + +LS L+ L + N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 462 LNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVC-NMGSLEKLNLSHNNLSDF 520
L L NQ + +P E HL+ +DLS+N + + Q NM L L LS+N L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 521 IPRCFEEMRSLSCIDISYNEL 541
PR F+ ++SL + + N++
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDI 114
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 36/212 (16%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
IG G G + ++VAVK + N+ E++ + +RH N V+F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ------REIINHRSLRHPNIVRF 81
Query: 665 HGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWN--RRI--NVIKGVANALSYLH 719
H ++ EY G L RI A + R ++ GV SY H
Sbjct: 82 KEVILTPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLSGV----SYCH 133
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAH--VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
I HRD+ +N LLD + + DFG +K HS + GT Y APE+
Sbjct: 134 SM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL 189
Query: 778 YTMRATEKY-----DVYSFGVLVFEVIKGNHP 804
++Y DV+S GV ++ ++ G +P
Sbjct: 190 ----LRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 23/103 (22%), Positives = 36/103 (34%), Gaps = 4/103 (3%)
Query: 442 TNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSHNILQEEIPPQ 500
T + + L L + N Q + L L L + + L + P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPD 74
Query: 501 V-CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELH 542
L +LNLS N L + + + SL + +S N LH
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 2/107 (1%)
Query: 364 STFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIP-VQLEMLSSLNKLILNLNQLS 422
S+ + + + + + L L + + + + L L L L + + L
Sbjct: 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 423 GGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQL 469
P F +L L+LS N L S+ L L L LS N L
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 30/160 (18%), Positives = 49/160 (30%), Gaps = 9/160 (5%)
Query: 401 IPVQLEMLSSLNKLILNLNQLSGGVPLE-FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKL 459
L +L +L + Q + L L +L+ L + + L P + +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 460 HYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSD 519
LNLS N L + L L EL LS N L C + L++
Sbjct: 83 SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH-----CSCALRWLQRWEEEGLGGVP 136
Query: 520 FIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGLMEGN 559
L+ + + P + G+
Sbjct: 137 EQKLQCHGQGPLAHMPNAS--CGVPTLKVQVPNASVDVGD 174
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 21/103 (20%), Positives = 35/103 (33%), Gaps = 2/103 (1%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPL 217
C + L NL LY+ + + L L L + ++ P
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 218 SLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN 260
+ L+ ++L N+L S+ SL L L N L+
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 19/101 (18%), Positives = 31/101 (30%), Gaps = 2/101 (1%)
Query: 136 MNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKNSLSGSIPSI 194
+ + +L + + + L L L L + K+ L P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 195 IGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL 235
L +L+LS N S+ SL + L N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 23/111 (20%), Positives = 36/111 (32%), Gaps = 22/111 (19%)
Query: 263 IPPSIGNLSSLRVLYL-YNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLN 321
+ +L LY+ L ++ L L L + + LR V P
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD-------- 74
Query: 322 QNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNN 372
AF P L+ L+LS N S +W LS + ++
Sbjct: 75 ----------AFHFTPRLSRLNLSFNAL---ESLSWKTVQGLSLQELVLSG 112
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 21/100 (21%), Positives = 38/100 (38%), Gaps = 6/100 (6%)
Query: 232 NNSLSGSIPPILGNLKSLSALGLHINQLNGFIPP-SIGNLSSLRVLYLYNNGLYGFVPEE 290
+ L ++L+ L + Q + + L LR L + +GL P+
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 291 IGYLKSLSELELCTNLLRGVIPH-----SIERVLLNQNNL 325
+ LS L L N L + S++ ++L+ N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 20/112 (17%), Positives = 34/112 (30%), Gaps = 15/112 (13%)
Query: 42 CSWF-GISCNHAGSRVI------SITMSTLGLNG-----TFHDFSFSSFPHLANLNLSFN 89
G+ C G+ + ++ L + L NL + +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 90 LFFGNIPLQI-GNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLH 140
+ +L L+L N L L + L+ L+ L L N LH
Sbjct: 67 GL-RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 30/183 (16%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF--------LNEVLALKEIR 657
+G+G +VYKA + + IVA+KK + E L E+ L+E+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIK-------LGHRSEAKDGINRTALREIKLLQELS 70
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG----VAN 713
H N + + + LV ++++ L I+ + L + IK
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLT----PSHIKAYMLMTLQ 123
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
L YLH I+HRD+ N+LLD N ++DFG+AK G + +T T Y A
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180
Query: 774 PEI 776
PE+
Sbjct: 181 PEL 183
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 33/185 (17%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRN 660
+G+G G VYKA + + + VA+K+ + +E + EV LKE++HRN
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIR-------LEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG----VANALS 716
++ ++ L+ EY + L + + + VIK + N ++
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM-------RVIKSFLYQLINGVN 146
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAH-----VSDFGIAKFVGPHSSNWTEFAGTFGY 771
+ H +HRD+ +N+LL + + + DFG+A+ G +T T Y
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203
Query: 772 AAPEI 776
PEI
Sbjct: 204 RPPEI 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 3e-13
Identities = 46/180 (25%), Positives = 85/180 (47%), Gaps = 27/180 (15%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN-----EVLALKEIRHRN 660
IG+G G+V+KA + +IVA+K+ + D DE + E+ LKE++H+N
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVR-------LDDDDEGVPSSALREICLLKELKHKN 62
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA----NALS 716
V+ H ++ LV E+ D+ L + D +L ++K L
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLD----PEIVKSFLFQLLKGLG 115
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
+ H ++HRD+ +N+L++ N E +++FG+A+ G ++ T Y P++
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEIRHRNNVKF 664
+G+G G V A + VA+K + L +M E E+ LK +RH + +K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74
Query: 665 HGFCYNGPHSFLVCEYLDRGSL-ARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
+ +V EY G L I V K + + + + A+ Y H
Sbjct: 75 YDVITTPTDIVMVIEYAG-GELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRH-- 127
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRAT 783
I+HRD+ +N+LLD N ++DFG++ + + T G+ YAAPE+
Sbjct: 128 -KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVI----NG 181
Query: 784 EKY-----DVYSFGVLVFEVIKGNHPRD 806
+ Y DV+S G++++ ++ G P D
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 26/179 (14%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLN-----EVLALKEIRHRNN 661
+G+G G VYKA+ G IVA+K+ + DE + E+ LKE+ H N
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIR-------LDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA----NALSY 717
V ++ LV E++++ L ++L D L + IK +++
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQ----DSQIKIYLYQLLRGVAH 134
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
H I+HRD+ +N+L++S+ ++DFG+A+ G ++T T Y AP++
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 52/282 (18%), Positives = 97/282 (34%), Gaps = 53/282 (18%)
Query: 586 DGKIMHEEIIKATDDFDEKF----CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMA 641
G+ ++I + I G G+V G VA+K+ + + G
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV 64
Query: 642 DHDEFLNEVLA---------LKEIRHRNNVK-FHGFCYNGPHSF----LVCEYLDRGSLA 687
+ + L L H N + F + + LV E + LA
Sbjct: 65 N--ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA 121
Query: 688 RILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDSNFEAH 745
+++ D + + + L LH ++HRD+ N+LL N +
Sbjct: 122 QVIHDQ--RIVISPQHIQYFMYHILLGLHVLH-----EAGVVHRDLHPGNILLADNNDIT 174
Query: 746 VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVI----- 799
+ DF +A+ +N T + Y APE+ T+ D++S G ++ E+
Sbjct: 175 ICDFNLAREDTA-DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233
Query: 800 -KGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVMDY 840
+G+ + N I++V + TP +
Sbjct: 234 FRGSTFYNQL--------NKIVEV-------VGTPKIEDVVM 260
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-13
Identities = 43/128 (33%), Positives = 57/128 (44%), Gaps = 16/128 (12%)
Query: 413 KLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHK 472
+L L N+L F LT+L L LS N++ S L KL L L N+L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 473 IPTE-FEKLIHLSELDLSHNILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRS 530
+P F+KL L EL L N L+ +P + + SL+K+ L H N D C
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWL-HTNPWD----C------ 138
Query: 531 LSCIDISY 538
SC I Y
Sbjct: 139 -SCPRIDY 145
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 39/125 (31%), Positives = 59/125 (47%), Gaps = 6/125 (4%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218
C++ S+P+ G S+ L L N L + KL L +L LS+NQ S+P
Sbjct: 14 CNSKGLTSVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDG 70
Query: 219 L-GNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVL 276
+ L+ LT++ L N L S+P + L L L L NQL L+SL+ +
Sbjct: 71 VFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKI 129
Query: 277 YLYNN 281
+L+ N
Sbjct: 130 WLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 40/130 (30%), Positives = 58/130 (44%), Gaps = 28/130 (21%)
Query: 106 QYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG 165
L+L SN+L L KL QL +L L NQ+ ++P + DK
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGV-----FDK---------- 74
Query: 166 SIPSSLGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPL-SLGNLS 223
L+ L +LYL++N L S+P+ + KL L +L L NQ S+P L+
Sbjct: 75 --------LTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLT 124
Query: 224 SLTMMSLFNN 233
SL + L N
Sbjct: 125 SLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 102 LSKLQYLDLGSNQLSGLIPPEI-GKLNQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALC 159
L++L L L NQ+ L P + KL +L LYL N+L ++P + +L+ + +LAL
Sbjct: 51 LTQLTKLSLSQNQIQSL-PDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALD 108
Query: 160 HNNLHGSIPS-SLGNLSNLAVLYLYKN 185
N L S+P L++L ++L+ N
Sbjct: 109 TNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 42/162 (25%), Positives = 55/162 (33%), Gaps = 56/162 (34%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
IP S R+ L N L + F LT L LS N ++
Sbjct: 26 IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQN--------------QIQ------ 65
Query: 371 NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS---GGVPL 427
S+P V D L+ L L L+ N+L GV
Sbjct: 66 -----SLPDG--------VFD---------------KLTKLTILYLHENKLQSLPNGV-- 95
Query: 428 EFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQ 468
F LT+L+ L L TN+L S+P I L L + L N
Sbjct: 96 -FDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 2/82 (2%)
Query: 461 YLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCN-MGSLEKLNLSHNNLSD 519
L L +N+L F+KL L++L LS N +Q +P V + + L L L N L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQS 90
Query: 520 FIPRCFEEMRSLSCIDISYNEL 541
F+++ L + + N+L
Sbjct: 91 LPNGVFDKLTQLKELALDTNQL 112
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 28/180 (15%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIRHRN 660
+G+G +VYK + ++VA+K+ +H+E + EV LK+++H N
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIR--------LEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG----VANALS 716
V H + LV EYLD+ L + L D + ++ +K + L+
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIIN----MHNVKLFLFQLLRGLA 114
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEI 776
Y H ++HRD+ +N+L++ E ++DFG+A+ + + T Y P+I
Sbjct: 115 YCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 54/252 (21%), Positives = 100/252 (39%), Gaps = 51/252 (20%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLALKEIRHRNN 661
+G G GSV A + SG+ VA+KK + + F E+L LK ++H N
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLS------RPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 662 VK-FHGFCYNGPHS-----FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
+ F +LV ++ L +I+G + +++ + ++ + L
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-----LVYQMLKGL 139
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
Y+H ++HRD+ N+ ++ + E + DFG+A+ T + T Y APE
Sbjct: 140 KYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPE 193
Query: 776 IAYT-MRATEKYDVYSFGVLVFEVI------KGNHPRDFFSINFSSFSNMIIDVNKILDP 828
+ + M + D++S G ++ E++ KG D I+ V
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--------TQILKV------ 239
Query: 829 RLPTPSPSVMDY 840
P +
Sbjct: 240 -TGVPGTEFVQK 250
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 39/121 (32%), Positives = 52/121 (42%), Gaps = 11/121 (9%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLSG---GVPLEFGS 431
IP DI L L+ N + L L L KL L NQL+G F
Sbjct: 22 EIPRDIPLH--TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA---FEG 76
Query: 432 LTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSH 490
+ +Q L L NK+ K L +L LNL +NQ+S + FE L L+ L+L+
Sbjct: 77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLAS 135
Query: 491 N 491
N
Sbjct: 136 N 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 34/128 (26%), Positives = 53/128 (41%), Gaps = 11/128 (8%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPS--IIGKLKSLLQLDLSENQFSGSIP 216
C IP + L L N L I S + G+L L++L+L NQ + I
Sbjct: 15 CTGRGLKEIPR--DIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIE 70
Query: 217 LSL-GNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSL 273
+ S + + L N + I + L L L L+ NQ++ + P +L+SL
Sbjct: 71 PNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSL 128
Query: 274 RVLYLYNN 281
L L +N
Sbjct: 129 TSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 7/108 (6%)
Query: 436 QYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDLSHNIL 493
L L+ N+L + G L L L L NQL+ I FE H+ EL L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 494 QEEIPPQVCN-MGSLEKLNLSHNNLSDFIPR-CFEEMRSLSCIDISYN 539
+ EI ++ + L+ LNL N +S + FE + SL+ ++++ N
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 33/131 (25%), Positives = 53/131 (40%), Gaps = 29/131 (22%)
Query: 106 QYLDLGSNQLSGLIPPEI-GKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLH 164
L L N+L + + G+L L +L L NQL I P +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNA-----FEG--------- 76
Query: 165 GSIPSSLGNLSNLAVLYLYKNSLSGSIPS-IIGKLKSLLQLDLSENQFSGSIPL-SLGNL 222
S++ L L +N + I + + L L L+L +NQ S + S +L
Sbjct: 77 ---------ASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHL 125
Query: 223 SSLTMMSLFNN 233
+SLT ++L +N
Sbjct: 126 NSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 13/122 (10%)
Query: 143 IPPEIGQLSLIDKLALCHNNLHGSIPSS--LGNLSNLAVLYLYKNSLSGSIPSIIGKLKS 200
IP +L L ++N G I S G L +L L L +N L+G P+
Sbjct: 27 IPLHTTELLL-------NDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 201 LLQLDLSENQFSGSIPLSL-GNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQ 258
+ +L L EN+ I + L L ++L++N +S + P +L SL++L L N
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNP 137
Query: 259 LN 260
N
Sbjct: 138 FN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 33/162 (20%), Positives = 54/162 (33%), Gaps = 57/162 (35%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDH-PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVS 369
IP +LLN N L + P+L L+L N +L+
Sbjct: 27 IPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN--------------QLT----- 67
Query: 370 MNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS---GGVP 426
I P+ E S + +L L N++ +
Sbjct: 68 ------GIEPNA-----------------------FEGASHIQELQLGENKIKEISNKM- 97
Query: 427 LEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNN 467
F L +L+ L+L N++ S + +L L LNL++N
Sbjct: 98 --FLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 22/80 (27%), Positives = 33/80 (41%), Gaps = 19/80 (23%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQIG--------NLSKLQYLDLGSNQLSGLIPPEI-GK 125
F PHL L L N Q+ S +Q L LG N++ + ++
Sbjct: 50 FGRLPHLVKLELKRN--------QLTGIEPNAFEGASHIQELQLGENKIKEI-SNKMFLG 100
Query: 126 LNQLRRLYLDMNQLHGTIPP 145
L+QL+ L L NQ+ + P
Sbjct: 101 LHQLKTLNLYDNQIS-CVMP 119
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 21/84 (25%), Positives = 42/84 (50%), Gaps = 5/84 (5%)
Query: 461 YLNLSNNQLSHKIPTE--FEKLIHLSELDLSHNILQEEIPPQVC-NMGSLEKLNLSHNNL 517
L L++N+L +I ++ F +L HL +L+L N L I P +++L L N +
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI 90
Query: 518 SDFIPRCFEEMRSLSCIDISYNEL 541
+ + F + L +++ N++
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQI 114
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 60/252 (23%), Positives = 102/252 (40%), Gaps = 50/252 (19%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLALKEIRHRNN 661
+G G G+V A + +G VA+KK + F E+ LK +RH N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 662 VK-FHGFCYNGPHS-----FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
+ F + +LV ++ L +++ ++LG +R ++ + L
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEKLGEDRIQFLVYQMLKGL 141
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
Y+H IIHRD+ N+ ++ + E + DFG+A+ S T + T Y APE
Sbjct: 142 RYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPE 195
Query: 776 IAYT-MRATEKYDVYSFGVLVFEVI------KGNHPRDFFSINFSSFSNMIIDVNKILDP 828
+ MR T+ D++S G ++ E+I KG+ D I+ V
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL--------KEIMKV------ 241
Query: 829 RLPTPSPSVMDY 840
TP +
Sbjct: 242 -TGTPPAEFVQR 252
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 55/261 (21%), Positives = 98/261 (37%), Gaps = 64/261 (24%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA---------LKEI 656
IG+G G V A + + VA+KK + F ++ L
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISP------------FEHQTYCQRTLREIKILLRF 82
Query: 657 RHRNNVK-FHGFCYNGPHSF----LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGV 711
RH N + +V + ++ L ++L + L + + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQI 137
Query: 712 ANALSYLHHDCLPS--IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN---WTEFA 766
L Y+H S ++HRD+ N+LL++ + + DFG+A+ P + TE+
Sbjct: 138 LRGLKYIH-----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 767 GTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVI------KGNHPRDFFSINFSSFSNMI 819
T Y APEI T+ D++S G ++ E++ G H D N I
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--------NHI 244
Query: 820 IDVNKILDPRLPTPSPSVMDY 840
+ + L +PS ++
Sbjct: 245 LGI-------LGSPSQEDLNC 258
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 50/191 (26%), Positives = 75/191 (39%), Gaps = 38/191 (19%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN--------EVLALKEIR 657
IG G G+VYKA + SG VA+K + + EV L+ +
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVR-------VPNGGGGGGGLPISTVREVALLRRLE 69
Query: 658 ---HRNNVK----FHGFCYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIK 709
H N V+ + LV E++D+ L L D L IK
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLP----AETIK 123
Query: 710 GVA----NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765
+ L +LH +C I+HRD+ +N+L+ S ++DFG+A+ T
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPV 179
Query: 766 AGTFGYAAPEI 776
T Y APE+
Sbjct: 180 VVTLWYRAPEV 190
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 39/200 (19%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDE-F----LNEVLA 652
+++ IG+G G V+KA +G VA+KK M + E F L E+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-------MENEKEGFPITALREIKI 69
Query: 653 LKEIRHRNNVKFHGFCYNGPHS--------FLVCEYLDRGSLARILGDDVTAKELGWNRR 704
L+ ++H N V C +LV ++ + LA +L +
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFT---- 122
Query: 705 INVIKGVA----NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG-PHS 759
++ IK V N L Y+H + I+HRD+ + NVL+ + ++DFG+A+ +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 760 SNWTEFAG---TFGYAAPEI 776
S + T Y PE+
Sbjct: 180 SQPNRYTNRVVTLWYRPPEL 199
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 46/234 (19%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALK 654
+ F+ +GKGG G V++ +G I A+K ++ N D E L+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 655 EIRHRNNVKFHGFCY-NGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRR 704
E++H V + + G +L+ EYL G L I +D E
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE------ 129
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSN 761
++ AL +LH II+RD+ +N++L+ + HV +DFG+ K + +
Sbjct: 130 ------ISMALGHLHQK---GIIYRDLKPENIMLNH--QGHVKLTDFGLCKESIHDGTVT 178
Query: 762 WTEFAGTFGYAAPEI----AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811
T F GT Y APEI + D +S G L+++++ G P F N
Sbjct: 179 HT-FCGTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP--FTGEN 225
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 2e-11
Identities = 82/664 (12%), Positives = 164/664 (24%), Gaps = 217/664 (32%)
Query: 277 YLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVI-----------PHSIERV------L 319
Y Y + L F ++ + + + ++ + ++ ++ L
Sbjct: 16 YQYKDILSVFEDA---FVDNF-DCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL 71
Query: 320 LNQNNLSGKMYEAF---GDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGS 376
L++ +M + F N FL + S +I + +
Sbjct: 72 LSKQE---EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM------TRMYIEQRDRLYND 122
Query: 377 IPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLE----FG-- 430
K V +L+ L + +L L + V ++ G
Sbjct: 123 NQV----FAKYNV-------------SRLQPYLKLRQALLELRP-AKNVLIDGVLGSGKT 164
Query: 431 SLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSH 490
+ L K+ + I +LNL N + +KL++ + + +
Sbjct: 165 WVALDVCLS---YKVQCKMDFKI------FWLNLKNCNSPETVLEMLQKLLYQIDPNWTS 215
Query: 491 NILQEEIPPQVCNMGSLEKLNL----SHNN----LSD---------FIPRCFEEMRSL-- 531
+ E L + N L + F C + L
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC----KILLT 271
Query: 532 ----SCIDISYNELHGPIPNSTAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNFDG 587
D + +T L + L ++ S+ LL L+
Sbjct: 272 TRFKQVTDF--------LSAATTTHISLDHHSMTL----TPDEVKSL----LLKYLD--- 312
Query: 588 KIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFL 647
+ D LP V N + LS + L
Sbjct: 313 -------CRPQD--------------------LPR----EVLTTNPRRLSIIAESIRDGL 341
Query: 648 NEVLALKEIRHRNNVKFHGF---CYNGPHSFLVCEYLDRGSLARILGDDV--TAKELG-- 700
+H N K N + D L+ + L
Sbjct: 342 AT---WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD--RLS-VFPPSAHIPTILLSLI 395
Query: 701 WN---------------RRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH 745
W + V K + + I+ ++ K L++ + H
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS------IYLELKVK---LENEYALH 446
Query: 746 VSDFGIAKFVGPHSSNWTEFA--GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 803
S + + P + + + Y I + ++ E + + F ++
Sbjct: 447 RSI--VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTL----FRMV---- 496
Query: 804 PRDFFSINF---------------SSFSNMIIDVNK----ILDPRLPTPSPSVMDYGGCH 844
F F S N + + I D P V
Sbjct: 497 ---FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD-NDPKYERLVNAIL--D 550
Query: 845 FMLR 848
F+ +
Sbjct: 551 FLPK 554
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 93/612 (15%), Positives = 183/612 (29%), Gaps = 196/612 (32%)
Query: 132 LYLDMNQLHGTIPPEIGQLSLIDKLAL-CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGS 190
L ++ L I E Q S++ ++ + + L+ + V S
Sbjct: 87 LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV----FAKYNV----------S 132
Query: 191 IPSIIGKLKS-LLQLDLSENQF----SGSIPLSLGNLSSLTMMSLFNNSLSGSIP-PI-- 242
KL+ LL+L ++N GS G + + + + + + I
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVLGS-----GK-TWVALDVCLSYKVQCKMDFKIFW 186
Query: 243 --LGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSL-SE 299
L N S + + +L I P+ + S + L+ L
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR------IHSIQAELRRLLKS 240
Query: 300 LELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPN------LTFLDLSNNNFCGEI 353
LL VLLN N K + AF N LT +F
Sbjct: 241 KPYENCLL----------VLLNVQN--AKAWNAF----NLSCKILLTTRFKQVTDF---- 280
Query: 354 SFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSS---NHIVGKIPVQLEMLSS 410
S +T +S+++ S ++ PD +V L + +P ++ +
Sbjct: 281 ------LSAATTTHISLDHHSMTLTPD-------EVKSLLLKYLDCRPQDLPREV---LT 324
Query: 411 LNKLILNLNQLSGGVPLEFGSLTKL------QYLDLSTNKLSSSIPKSIGNL----LKLH 460
N L++ + + ++ +KL++ I S+ L +
Sbjct: 325 TNPRRLSI----------IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
Query: 461 YLNLSNNQLSHKIPT--------------------EFEK--LIHLSELDLSHNI--LQEE 496
+ LS S IPT + K L+ + + +I + E
Sbjct: 375 FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE 434
Query: 497 IPPQVCNMGSLEKLNLSHNNLSDF--IPRCFE-EMRSLSCID------ISYNELHGPIPN 547
+ ++ N +L H ++ D IP+ F+ + +D I + H
Sbjct: 435 LKVKLENEYAL------HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH---H----- 480
Query: 548 STAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNF-DGKIMHEEIIKATDDFDEKFC 606
LK + E+ + L F + KI H+
Sbjct: 481 --------------LKNIEHPERMTLFRMV-FLD-FRFLEQKIRHD-------------- 510
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
+ + A + + KF + N ++ +N +L + +
Sbjct: 511 ------STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAIL--------DFLPKIE 556
Query: 667 -FCYNGPHSFLV 677
++ L+
Sbjct: 557 ENLICSKYTDLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 7e-04
Identities = 68/442 (15%), Positives = 127/442 (28%), Gaps = 123/442 (27%)
Query: 123 IGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182
+ N + + +L I P S N+ I S L L
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS------NIKLRIHSIQAELRRLLKSKP 242
Query: 183 YKNSL-------SGSI----------------PSIIGKLKSLLQLDLSENQFSGSIPLSL 219
Y+N L + + L + +S + S + L
Sbjct: 243 YENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT----L 298
Query: 220 GNLSSLTMMSLFNNSLSGSIPP--ILGNLKSLSALG-------------LHIN--QLNGF 262
+++ + + +P + N + LS + H+N +L
Sbjct: 299 TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358
Query: 263 IPPSIGNLSS--LRVLYLYNNGLYGF-----VPEEIGYLKSL------SELELCTNLLRG 309
I S+ L R ++ L F +P + L + S++ + N L
Sbjct: 359 IESSLNVLEPAEYRKMFDR---LSVFPPSAHIPTIL--LSLIWFDVIKSDVMVVVNKLH- 412
Query: 310 VIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVS 369
+ L+ + + P++ +L+L N L IV
Sbjct: 413 ------KYSLVEKQPKESTIS-----IPSI-YLELKVKL---------ENEYALHRSIVD 451
Query: 370 MNNISGSIPPDIGNSPKLQVLDLSSNHIVG---KIPVQLEMLSSLNKLILNLNQLSGGVP 426
NI + D + + +HI G K E ++ + L+ L
Sbjct: 452 HYNIPKTFDSD--DLIPPYLDQYFYSHI-GHHLKNIEHPERMTLFRMVFLDFRFLEQ--- 505
Query: 427 LEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLK-----LHYLNLSNNQLSHKIPT--EF-- 477
K+++ + N SI N L+ Y+ ++ + + +F
Sbjct: 506 -------KIRHDSTAWNA-----SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLP 553
Query: 478 ---EKLIHLSELDLSHNILQEE 496
E LI DL L E
Sbjct: 554 KIEENLICSKYTDLLRIALMAE 575
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 62/256 (24%), Positives = 100/256 (39%), Gaps = 42/256 (16%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALK 654
++F+ +G G G V+ +G + A+K + + E L+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 655 EIRHRN-NVKFHGFCY-NGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNR 703
IR V H + + L+ +Y++ G L + E+
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI---- 168
Query: 704 RINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSS 760
AL +LH II+RDI +N+LLDS HV +DFG++K FV +
Sbjct: 169 --------VLALEHLHKL---GIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETE 215
Query: 761 NWTEFAGTFGYAAPEIAYTMRA--TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM 818
+F GT Y AP+I + + D +S GVL++E++ G P F +
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAE 273
Query: 819 IIDVNKILDPRLPTPS 834
I +IL P P
Sbjct: 274 ISR--RILKSEPPYPQ 287
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 44/225 (19%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
+DFD +GKG G V +G A+K +++ + H + E L+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH--TVTESRVLQNT 62
Query: 657 RHRNNVKFHGFCY-NGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRRIN 706
RH + + V EY + G L R+ ++ E
Sbjct: 63 RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-------- 113
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSNWT 763
+ +AL YLH +++RDI +N++LD + H+ +DFG+ K + ++ T
Sbjct: 114 ----IVSALEYLHSR---DVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATMKT 164
Query: 764 EFAGTFGYAAPEI----AYTMRATEKYDVYSFGVLVFEVIKGNHP 804
F GT Y APE+ Y D + GV+++E++ G P
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 75/498 (15%), Positives = 140/498 (28%), Gaps = 92/498 (18%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQIGN---------------LSKLQYLDLGSNQLS--G 117
FP+L +L L L N L +L+ + +S
Sbjct: 69 SRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLD 128
Query: 118 LIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHN----NLHGSIPSSLG- 172
L + + L L LD L+ + C + S S
Sbjct: 129 LDRLAKARADDLETLKLDKC-------SGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDG 181
Query: 173 --------NLSNLAVLYLYKNSLSG----SIPSIIGKLKSLLQLDLSENQFS--GSIPLS 218
+ ++L VL Y + + +I +SL+ + + + + +
Sbjct: 182 KWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKA 241
Query: 219 LGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYL 278
NL SL + L + L LGL N +P + +R L L
Sbjct: 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDL 300
Query: 279 -YNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDH- 336
Y I +L LE N + + E +
Sbjct: 301 LYALLETEDHCTLIQKCPNLEVLETR-------------------NVIGDRGLEVLAQYC 341
Query: 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396
L L + + G S+ ++ +L+ + + +
Sbjct: 342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC------------QELEYMAVYVSD 389
Query: 397 I----VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFG------SLTKLQYLDLSTN--K 444
I + I L+ L ++L+ + +PL+ G KL+
Sbjct: 390 ITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGG 449
Query: 445 LSSSIPKSIGNLLK-LHYLNLSNNQLSHK-IPTEFEKLIHLSELDLSH-NILQEEIPPQV 501
L+ IG + ++ L S + + +L +L++ + I V
Sbjct: 450 LTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAV 509
Query: 502 CNMGSLEKLNLSHNNLSD 519
+ SL L + S
Sbjct: 510 TKLPSLRYLWVQGYRASM 527
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 57/448 (12%), Positives = 128/448 (28%), Gaps = 64/448 (14%)
Query: 76 SSFPHLANLNLSFNLF--FGNIPLQIGNLSKLQYLDLGS-NQLSGLIPPEIGK-LNQLRR 131
++ L +++ + L L+ L L + + I +++
Sbjct: 109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKT 168
Query: 132 LYLDMNQLH-------GTIPPEIGQLSLIDKLALCHNNLH----GSIPSSLGNLSNLAVL 180
L ++ + + L +++ + +I + +L ++ V
Sbjct: 169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG 228
Query: 181 YLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG--S 238
L G L+ L+E+ ++L L + L +
Sbjct: 229 DFEILELVG-FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPI 287
Query: 239 IPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYN----NGLYGFVPEEIGYL 294
+ P ++ L L + + I +L VL N GL Y
Sbjct: 288 LFPFAAQIRKLDLLYALLETEDHC--TLIQKCPNLEVLETRNVIGDRGLEVLAQ----YC 341
Query: 295 KSLSELEL--CTNLLRGVIP----------------HSIERVLLNQNNLSGKMYEAFGDH 336
K L L + + +E + + ++++ + E+ G +
Sbjct: 342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTY 401
Query: 337 -PNLTFLDLSNNNFCGEISFNWG---------NFSKLSTFIVSMN--NISGSIPPDIG-N 383
NL L + I+ KL F + ++ IG
Sbjct: 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQY 461
Query: 384 SPKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLS-GGVPLEFGSLTKLQYLDLS 441
SP ++ + L + ++ +L KL + S + L L+YL +
Sbjct: 462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQ 521
Query: 442 TNKLSSSIPKSIG---NLLKLHYLNLSN 466
+ S + + + +
Sbjct: 522 GYRASMTGQDLMQMARPYWNIELIPSRR 549
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 47/261 (18%), Positives = 94/261 (36%), Gaps = 57/261 (21%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKK--FNSQLLSGNMADHDEFLNEVLALKEIRHRN--- 660
+G GG G V+ A + VA+KK + L E+ ++ + H N
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA------LREIKIIRRLDHDNIVK 72
Query: 661 -------NVKFHGFCYNGPHSF----LVCEYLDRGSLARILGDDVTAKELGWNRRINVIK 709
+ +V EY++ LA +L L +
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL----EQGPLLEEHARLFMY 127
Query: 710 GVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHSSN---WTEF 765
+ L Y+H +++HRD+ N+ +++ + + DFG+A+ + PH S+ +E
Sbjct: 128 QLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 766 AGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVI------KGNHPRDFFSINFSSFSNM 818
T Y +P + + T+ D+++ G + E++ G H + +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM--------QL 236
Query: 819 IIDVNKILDPRLPTPSPSVMD 839
I++ +P
Sbjct: 237 ILES-------IPVVHEEDRQ 250
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 607 IGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLN-EVLALKEIRHRNNVKF 664
IG G G VY+A+L SG++VA+KK + F N E+ ++++ H N V+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKK---------VLQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 665 HGFCYNGPHSF------LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG----VANA 714
F Y+ LV +Y+ ++ R+ AK+ + +K + +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 168
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSN-FEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
L+Y+H I HRDI +N+LLD + + DFG AK + N + + Y A
Sbjct: 169 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRA 224
Query: 774 PEIAYT-MRATEKYDVYSFGVLVFEVIKG 801
PE+ + T DV+S G ++ E++ G
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLG 253
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 56/253 (22%), Positives = 94/253 (37%), Gaps = 50/253 (19%)
Query: 606 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLALKEIRHRN 660
+G G GSV A + +G VAVKK E+ LK ++H N
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 661 NVK-FHGFC-YNGPHSF----LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA 714
+ F F LV + L I+ ++L + +I +
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQKLTDDHVQFLIYQILRG 144
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L Y+H IIHRD+ N+ ++ + E + DFG+A+ + T + T Y AP
Sbjct: 145 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAP 198
Query: 775 EIAYT-MRATEKYDVYSFGVLVFEVI------KGNHPRDFFSINFSSFSNMIIDVNKILD 827
EI M + D++S G ++ E++ G D +I+ +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL--------KLILRL----- 245
Query: 828 PRLPTPSPSVMDY 840
+ TP ++
Sbjct: 246 --VGTPGAELLKK 256
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 5e-11
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
DF+ +GKG G V +E + ++ AVK ++ + + VLAL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-G 399
Query: 657 RHRNNVKFHGFCYNGP-HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
+ + H C+ + V EY++ G L + KE + +A L
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---PHAVFYAAEIAIGL 455
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSNWTEFAGTFGYA 772
+L II+RD+ NV+LDS E H+ +DFG+ K + + T F GT Y
Sbjct: 456 FFLQSK---GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKT-FCGTPDYI 509
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
APEI + D ++FGVL++E++ G P
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 38/229 (16%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALK 654
F+ +G+G G V+ + + + A+K L D E L
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILV 81
Query: 655 EIRHRNNVKFHGFCY-NGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRR 704
E+ H VK H + + +L+ ++L G L + ++ EL
Sbjct: 82 EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL----- 135
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNW 762
A AL +LH II+RD+ +N+LLD E H+ +DFG++K H
Sbjct: 136 -------ALALDHLHSL---GIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKKA 183
Query: 763 TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811
F GT Y APE+ T+ D +SFGVL+FE++ G P F +
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP--FQGKD 230
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 44/215 (20%), Positives = 85/215 (39%), Gaps = 39/215 (18%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKF 664
+G+G V++A + + + V VK + E+ L+ +R N +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITL 96
Query: 665 HGFCYNGPHSF---LVCEYLDRGSLARI---LGDDVTAKELGWNRRINVIKGVANALSYL 718
+ P S LV E+++ ++ L D + + AL Y
Sbjct: 97 ADIVKD-PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF---------YMYEILKALDYC 146
Query: 719 HHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
H I+HRD+ NV++D + + + D+G+A+F P + + + PE+
Sbjct: 147 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPEL- 201
Query: 778 YTMRATEKY----DVYSFGVLVFEVIKGNHPRDFF 808
+ + Y D++S G ++ +I P FF
Sbjct: 202 --LVDYQMYDYSLDMWSLGCMLASMIFRKEP--FF 232
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 41/217 (18%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKK-FNSQLLSGNMADHDEF----LNEVLALKEIRHRN 660
G+G G+V E +G VA+KK F L + L + H N
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVI----------QDPRFRNRELQIMQDLAVLHHPN 80
Query: 661 NVK-FHGFCYNGPHSF------LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG--- 710
V+ F G +V EY+ +L R + + +IK
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV---APPPILIKVFLF 136
Query: 711 -VANALSYLHHDCLPSIIHRDISSKNVLLD-SNFEAHVSDFGIAKFVGPHSSNWTEFAGT 768
+ ++ LH + ++ HRDI NVL++ ++ + DFG AK + P N + +
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYICS 194
Query: 769 FGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKG 801
Y APE+ + + Y D++S G + E++ G
Sbjct: 195 RYYRAPEL---IFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 37/228 (16%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
DF IGKG G V A AVK +L H VL K +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL-KNV 96
Query: 657 RHRNNVKFHGFCY-NGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRRIN 706
+H V H F + + V +Y++ G L R + A E
Sbjct: 97 KHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-------- 147
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSNWT 763
+A+AL YLH +I++RD+ +N+LLDS + H+ +DFG+ K + +S+ T
Sbjct: 148 ----IASALGYLHSL---NIVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNSTTST 198
Query: 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN 811
F GT Y APE+ + D + G +++E++ G P F+S N
Sbjct: 199 -FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRN 243
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 52/293 (17%), Positives = 95/293 (32%), Gaps = 56/293 (19%)
Query: 269 NLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGK 328
+ L L N L S+S +EL P S+ + L+ N+L K
Sbjct: 20 IPHGVTSLDLSLNNL-----------YSISTVELIQAFAN--TPASVTSLNLSGNSLGFK 66
Query: 329 MYEAFGD-----HPNLTFLDLSNNNFCGEISFNW------GNFSKLSTFIVSMNNISGSI 377
+ N+T L+LS N S + ++ + N+ S
Sbjct: 67 NSDELVQILAAIPANVTSLNLSGNFL-SYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS 125
Query: 378 PPDIG-----NSPKLQVLDLSSNHIVGKIPVQL-EMLSSLN----KLILNLNQLSGGVPL 427
+ + L+L N + K +L ++L+++ L L N L+
Sbjct: 126 SSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCA 185
Query: 428 EFGSL-----TKLQYLDLSTNKLSSSIPKSIGNLLK-----LHYLNLSNNQLSHK----I 473
E + LDLS N L + + + LNL N L +
Sbjct: 186 ELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENL 245
Query: 474 PTEFEKLIHLSELDLSHNILQEEIPPQ-------VCNMGSLEKLNLSHNNLSD 519
+ L HL + L ++I++ Q N+ + ++ + +
Sbjct: 246 KLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 58/392 (14%), Positives = 118/392 (30%), Gaps = 91/392 (23%)
Query: 160 HNNLHGS-----IPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKL-----KSLLQLDLSEN 209
+ L + + L L N+L + + S+ L+LS N
Sbjct: 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN 61
Query: 210 QFS--GSIPLS---LGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIP 264
S L +++T ++L N LS KS L + +
Sbjct: 62 SLGFKNSDELVQILAAIPANVTSLNLSGNFLSY---------KSSDELVKTLAAIP---- 108
Query: 265 PSIGNLSSLRVLYLYNNGLYGFVPEEIGYL--------KSLSELELCTNLLRGVIPHSIE 316
++ VL L N + S++ L L N L +
Sbjct: 109 ------FTITVLDLGWNDFS---SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI 159
Query: 317 RVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF----CGEIS--FNWGNFSKLSTFIVSM 370
++L N+ L+L NN C E++ + +++ +S
Sbjct: 160 QILAAIPA-------------NVNSLNLRGNNLASKNCAELAKFLASIP-ASVTSLDLSA 205
Query: 371 NNISGSIPPDIG-----NSPKLQVLDLSSNHI----VGKIPVQLEMLSSLNKLILNLNQL 421
N + ++ + L+L N + + + + + L L + L+ + +
Sbjct: 206 NLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV 265
Query: 422 S--GGVPLE-----FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIP 474
+ F ++ K+ +D + ++ S I NL++ L ++
Sbjct: 266 KNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCL 325
Query: 475 TEFEKLI----------HLSELDLSHNILQEE 496
+K L E + L E
Sbjct: 326 IFAQKHQTNIEDLNIPDELRESIQTCKPLLEH 357
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 52/361 (14%), Positives = 109/361 (30%), Gaps = 95/361 (26%)
Query: 199 KSLLQLDLSENQFSGSIPLSLG-----NLSSLTMMSLFNNSLSGSIPPILGNLKSLSALG 253
+ LDLS N + L +S+T ++L NSL N L +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK------NSDELVQIL 75
Query: 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH 313
I +++ L L N L L +
Sbjct: 76 AAIP-------------ANVTSLNLSGNFL-----SYKS-SDELVKTLAAIPF------- 109
Query: 314 SIERVLLNQNNLSGKMYEAFGD-----HPNLTFLDLSNNNFCGE---------ISFNWGN 359
+I + L N+ S K F ++T L+L N+ + +
Sbjct: 110 TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP--- 166
Query: 360 FSKLSTFIVSMNNISGSIPPDIG-----NSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKL 414
+ +++ + NN++ ++ + LDLS+N + L+ + L +
Sbjct: 167 -ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLL------GLKSYAELAYI 219
Query: 415 ILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLK----LHYLNLSNNQLS 470
++ + L+L N L +++ L L + L + +
Sbjct: 220 FSSIP-------------NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266
Query: 471 HKIPTEFEKLI-------HLSELDLSHNILQEEIPPQVCNM-----GSLEKLNLSHNNLS 518
+ + + L + +D + + + N+ G + +L + L
Sbjct: 267 NMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI 326
Query: 519 D 519
Sbjct: 327 F 327
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 28/129 (21%), Positives = 53/129 (41%), Gaps = 20/129 (15%)
Query: 433 TKLQYLDLSTNKLSSSIPKSIGNLLK-----LHYLNLSNNQLSHKIPTEFEKLI-----H 482
+ LDLS N L S + + LNLS N L K E +++ +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 483 LSELDLSHNILQEEIPPQVCNM-----GSLEKLNLSHNNLSDFIPRCFEEM-----RSLS 532
++ L+LS N L + ++ ++ L+L N+ S F++ S++
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 533 CIDISYNEL 541
+++ N+L
Sbjct: 142 SLNLRGNDL 150
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 50/223 (22%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA---------LKEI 656
+G+G G V A P+G+IVA+KK F + A LK
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEP------------FDKPLFALRTLREIKILKHF 66
Query: 657 RHRNNVK-FHGFCYNGPHSF----LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGV 711
+H N + F+ + +F ++ E + L R++ + + L + I
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQYFIYQT 121
Query: 712 ANALSYLHHDCLPS--IIHRDISSKNVLLDSNFEAHVSDFGIA----------KFVGPHS 759
A+ LH +IHRD+ N+L++SN + V DFG+A
Sbjct: 122 LRAVKVLH-----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 760 SNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKG 801
S EF T Y APE+ T + + DV+S G ++ E+
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 59/223 (26%), Positives = 89/223 (39%), Gaps = 39/223 (17%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVK---KFNSQLLSGNMADHDEFLNEVLALK 654
+DF +GKG G V+ AE + A+K K +L + + VL+L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSL- 73
Query: 655 EIRHRNNVKFHGFCY-NGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRR 704
H + + F V EYL+ G L A E
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE------ 126
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSN 761
+ L +LH I++RD+ N+LLD + H+ +DFG+ K + +
Sbjct: 127 ------IILGLQFLHSK---GIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKT 175
Query: 762 WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
T F GT Y APEI + D +SFGVL++E++ G P
Sbjct: 176 NT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 25/116 (21%), Positives = 45/116 (38%), Gaps = 6/116 (5%)
Query: 383 NSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLE-FGSLTKLQYLDLS 441
N+ + + LDL I I L + + + N++ L+ F L +L+ L ++
Sbjct: 17 NAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVN 72
Query: 442 TNKLSSSIPKSIGNLLKLHYLNLSNNQLSH-KIPTEFEKLIHLSELDLSHNILQEE 496
N++ L L L L+NN L L L+ L + N + +
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 128
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 23/115 (20%), Positives = 51/115 (44%), Gaps = 4/115 (3%)
Query: 428 EFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELD 487
++ + + + LDL K+ I L + ++ S+N++ K+ F L L L
Sbjct: 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLL 70
Query: 488 LSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDF-IPRCFEEMRSLSCIDISYNEL 541
+++N + + L +L L++N+L + ++SL+ + I N +
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 24/135 (17%), Positives = 46/135 (34%), Gaps = 32/135 (23%)
Query: 76 SSFPHLANLNLSFNLF--FGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
++ ++ S N P L +L+ L + +N++ + L L L
Sbjct: 39 ATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKN---SLSGS 190
L N + +L +D LA +L +L L + +N +
Sbjct: 95 LTNNS--------LVELGDLDPLA---------------SLKSLTYLCILRNPVTNKKHY 131
Query: 191 IPSIIGKLKSLLQLD 205
+I K+ + LD
Sbjct: 132 RLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 24/133 (18%), Positives = 38/133 (28%), Gaps = 29/133 (21%)
Query: 169 SSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMM 228
+ N L L + I ++ L +D S+N+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGFP----- 61
Query: 229 SLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVP 288
L+ L L ++ N++ L L L L NN L
Sbjct: 62 ----------------LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL-- 103
Query: 289 EEIGYLKSLSELE 301
++ L SL L
Sbjct: 104 GDLDPLASLKSLT 116
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 5/83 (6%)
Query: 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396
+D S+N ++ + +L T +V+ N I P L L L++N
Sbjct: 42 DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
Query: 397 IVGKIPVQLEMLSSLNKL-ILNL 418
+ L+ L+SL L L +
Sbjct: 100 L--VELGDLDPLASLKSLTYLCI 120
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 27/128 (21%), Positives = 48/128 (37%), Gaps = 8/128 (6%)
Query: 84 LNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTI 143
+ L+ L Q N + + LDL ++ +I L+Q + N++ +
Sbjct: 2 VKLTAELI-EQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 144 PPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSI--IGKLKSL 201
L + L + +N + L +L L L NSL + + + LKSL
Sbjct: 58 DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSL 115
Query: 202 LQLDLSEN 209
L + N
Sbjct: 116 TYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 12/80 (15%), Positives = 30/80 (37%), Gaps = 5/80 (6%)
Query: 462 LNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFI 521
+ L+ + + ++ + ELDL + I + + ++ S N +
Sbjct: 2 VKLTAELIE-QAA-QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKL- 57
Query: 522 PRCFEEMRSLSCIDISYNEL 541
F +R L + ++ N +
Sbjct: 58 -DGFPLLRRLKTLLVNNNRI 76
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHG 666
IG G G V++A+L D VA+KK + D E+ ++ ++H N V
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKV--------LQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 667 FCYNGPHS------FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG----VANALS 716
F Y+ LV EY+ ++ R K+ + +IK + +L+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQ---TMPMLLIKLYMYQLLRSLA 155
Query: 717 YLHHDCLPSIIHRDISSKNVLLDSN-FEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
Y+H I HRDI +N+LLD + DFG AK + N + + Y APE
Sbjct: 156 YIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYICSRYYRAPE 211
Query: 776 IAYT-MRATEKYDVYSFGVLVFEVIKG 801
+ + T D++S G ++ E+++G
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQG 238
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 607 IGKGGQGSVYKA--ELPSGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLALKEIR-- 657
IG+G G V+KA G VA+K+ + +E + EV L+ +
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIREVAVLRHLETF 71
Query: 658 -HRNNVK----FHGFCYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGV 711
H N V+ + LV E++D+ L L D V + IK +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVP----TETIKDM 125
Query: 712 A----NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAG 767
L +LH ++HRD+ +N+L+ S+ + ++DFG+A+ T
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVV 181
Query: 768 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 801
T Y APE+ D++S G + E+ +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 24/133 (18%), Positives = 58/133 (43%), Gaps = 8/133 (6%)
Query: 411 LNKLILNLNQLSGGVPLEFGSLTKLQYLDL--STNKLSSSIPKSIGNLLKLHYLNLSNNQ 468
+ K + + + T+ + ++L + + ++ L +L LS N
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNN 59
Query: 469 LSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEM 528
+ KI + + +L L L N++ ++I +LE+L +S+N ++ E++
Sbjct: 60 IE-KI-SSLSGMENLRILSLGRNLI-KKIENLDAVADTLEELWISYNQIASL--SGIEKL 114
Query: 529 RSLSCIDISYNEL 541
+L + +S N++
Sbjct: 115 VNLRVLYMSNNKI 127
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 26/121 (21%), Positives = 50/121 (41%), Gaps = 8/121 (6%)
Query: 94 NIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLI 153
+ + L ++L L +N + + + + LR L L N + I +
Sbjct: 39 KMDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSI--IGKLKSLLQLDLSENQF 211
++L + +N + + S + L NL VLY+ N ++ + I + L L L L+ N
Sbjct: 96 EELWISYNQI--ASLSGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPL 152
Query: 212 S 212
Sbjct: 153 Y 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 32/185 (17%), Positives = 67/185 (36%), Gaps = 34/185 (18%)
Query: 242 ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELE 301
+ + + L I + + ++ L + + L L N + + +++L L
Sbjct: 21 VATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILS 76
Query: 302 LCTNLLRGV-----IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFN 356
L NL++ + + ++E + ++ N ++ + NL L +SNN I+ N
Sbjct: 77 LGRNLIKKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNK----IT-N 129
Query: 357 WGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLIL 416
WG KL+ KL+ L L+ N + +++
Sbjct: 130 WGEIDKLAAL------------------DKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171
Query: 417 NLNQL 421
L L
Sbjct: 172 RLPNL 176
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 34/148 (22%), Positives = 57/148 (38%), Gaps = 22/148 (14%)
Query: 72 DFSFSSFPHLANLNLSFNLFFGNIPLQIGNLS---KLQYLDLGSNQLSGLIPPEIGKLNQ 128
D + S+ +L LS N +I +LS L+ L LG N + I +
Sbjct: 41 DATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIKK-IENLDAVADT 94
Query: 129 LRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG-SIPSSLGNLSNLAVLYLYKNSL 187
L L++ NQ+ ++ I +L + L + +N + L L L L L N L
Sbjct: 95 LEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152
Query: 188 SGSIPS----------IIGKLKSLLQLD 205
++ +L +L +LD
Sbjct: 153 YNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 50/227 (22%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK-- 663
+G G +V+ A+ + + VA+K ++ G+ + +E+ L+ + +N K
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 664 ----------FHGFCYNGP---HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINV--I 708
F + GP H +V E L +L ++ K+ +R I + +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI------KKYE-HRGIPLIYV 133
Query: 709 KGVA----NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH------VSDFGIAKFVGPH 758
K ++ L Y+H C IIH DI +NVL++ ++D G A + H
Sbjct: 134 KQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 759 SSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 803
+N T Y +PE+ D++S L+FE+I G+
Sbjct: 192 YTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFN-SQLLSGNMADHDEFLNEVLALKEI 656
DF+ +GKG G V +E + ++ AVK ++ + + VLAL
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 78
Query: 657 RHRNNVKFHGFCY-NGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRRIN 706
+ + H C+ + V EY++ G L + A E
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-------- 129
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSNWT 763
+A L +L II+RD+ NV+LDS E H+ +DFG+ K + + T
Sbjct: 130 ----IAIGLFFLQSK---GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKT 180
Query: 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
F GT Y APEI + D ++FGVL++E++ G P
Sbjct: 181 -FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 69/246 (28%), Positives = 100/246 (40%), Gaps = 42/246 (17%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVK---KFNSQLLSGNMADHDEFLNEVLALK 654
DFD IG+G V L + I A+K K + D + V +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK--ELVNDDEDIDWVQTEKHVFE-Q 65
Query: 655 EIRHRNNVKFHGFCY-NGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRR 704
H V H C+ F V EY++ G L R L ++ + E
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE------ 118
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSN 761
++ AL+YLH II+RD+ NVLLDS E H+ +D+G+ K + P +
Sbjct: 119 ------ISLALNYLHER---GIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTT 167
Query: 762 WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIID 821
T F GT Y APEI D ++ GVL+FE++ G P F I SS +
Sbjct: 168 ST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP---FDIVGSSDNPDQNT 223
Query: 822 VNKILD 827
+ +
Sbjct: 224 EDYLFQ 229
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 59.6 bits (143), Expect = 2e-09
Identities = 29/163 (17%), Positives = 54/163 (33%), Gaps = 21/163 (12%)
Query: 375 GSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGS--L 432
+ P + P L L + + + L SL + L V + L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE---IISGGLPDSVVEDILGSDL 218
Query: 433 TKLQYLDL---STNKLSSSIPKSIGNLL------KLHYLNLSNNQLSHKIPT---EFEKL 480
L+ L L + L L +L + + + + + E + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 481 IHLSELDLSHNILQ----EEIPPQVCNMGSLEKLNLSHNNLSD 519
L +D+S +L + V + L+ +N+ +N LSD
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.9 bits (136), Expect = 1e-08
Identities = 29/202 (14%), Positives = 68/202 (33%), Gaps = 28/202 (13%)
Query: 327 GKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNS-- 384
+ P L L + +S L + + + S+ DI S
Sbjct: 162 VDLSPVLDAMPLLNNLKIKG---TNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 385 PKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNK 444
P L+ L L + + L L++L + +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPL---------------FSKDRFPNLKWLGIVDAE 263
Query: 445 LSSSIPKSIGN---LLKLHYLNLSNNQLSHK----IPTEFEKLIHLSELDLSHNILQEEI 497
+ + + L +L +++S L+ + + +K+ HL +++ +N L +E+
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323
Query: 498 PPQVCNMGSLEKLNLSHNNLSD 519
++ + K+++S + D
Sbjct: 324 KKELQKSLPM-KIDVSDSQEYD 344
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 5e-08
Identities = 26/174 (14%), Positives = 62/174 (35%), Gaps = 23/174 (13%)
Query: 336 HPNLTFLDLSNNNFCGEI-----SFNWGNFSKLSTFIVSMNNISGSIPPDI------GNS 384
PNL L++ + + + N KL ++ +
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251
Query: 385 PKLQVLDLSSNHIVGKIPVQL---EMLSSLNKLILNLNQLS--GGVPL--EFGSLTKLQY 437
P L+ L + + ++L L + ++ L+ G L + L++
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 438 LDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHN 491
+++ N LS + K + L + +++S++Q + ++EL+ H+
Sbjct: 312 INMKYNYLSDEMKKELQKSLPMK-IDVSDSQ----EYDDDYSYPMITELEHHHH 360
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVK---KFNSQLLSGNMADHDEFLNEVLALK 654
D+F+ +GKG G V A + +GD+ AVK K +L + + +L+L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK--DVILQDDDVECTMTEKRILSLA 80
Query: 655 EIRHRNNVKFHGFCY-NGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRR 704
H + C+ F V E+++ G L +R + A E
Sbjct: 81 -RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE------ 132
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSN 761
+ +AL +LH II+RD+ NVLLD E H +DFG+ K + +
Sbjct: 133 ------IISALMFLHDK---GIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGVTT 181
Query: 762 WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
T F GT Y APEI M D ++ GVL++E++ G+ P
Sbjct: 182 AT-FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 70/253 (27%), Positives = 103/253 (40%), Gaps = 42/253 (16%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVK---KFNSQLLSGNMADHDEFLNEVLALK 654
DFD IG+G V L + I A++ K + D + V +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK--ELVNDDEDIDWVQTEKHVFE-Q 108
Query: 655 EIRHRNNVKFHGFCY-NGPHSFLVCEYLDRGSL------ARILGDDVT---AKELGWNRR 704
H V H C+ F V EY++ G L R L ++ + E
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE------ 161
Query: 705 INVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK-FVGPHSSN 761
++ AL+YLH II+RD+ NVLLDS E H+ +D+G+ K + P +
Sbjct: 162 ------ISLALNYLHER---GIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTT 210
Query: 762 WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIID 821
T F GT Y APEI D ++ GVL+FE++ G P D + + N
Sbjct: 211 ST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269
Query: 822 V-NKIL--DPRLP 831
+ IL R+P
Sbjct: 270 LFQVILEKQIRIP 282
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 2e-09
Identities = 35/240 (14%), Positives = 65/240 (27%), Gaps = 59/240 (24%)
Query: 595 IKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKF----NSQLLSGNMADHDEFLNEV 650
T+ IG+G G V++ VA+K + + +E L E+
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 651 LALKEI---------RHRNNVKFHGFC------------------------------YNG 671
+ KE+ R + + +
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDI 731
F+V E+ G + + K +++ + +L+ HRD+
Sbjct: 135 DQLFIVLEFEFGGIDL----EQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDL 188
Query: 732 SSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSF 791
NVLL + K + G I YT+ E+ + F
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTI---------PSCGLQVSIIDYTLSRLERDGIVVF 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 55/272 (20%), Positives = 90/272 (33%), Gaps = 91/272 (33%)
Query: 607 IGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHR 659
+G+G G V +A+ + VAVK ++H ++E+ L I H
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHL 86
Query: 660 NNVKFHG--------------FCYNG-PHSFL------VCEYLDRGSLARILGDDVTAKE 698
N V G FC G ++L Y +G+ R D V A
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 699 LGWNRRINVIKGVANALSYLHHDCLPS--------------------------------- 725
+ RR++ I ++ S +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 726 -------IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN-----------WTEFAG 767
IHRD++++N+LL + DFG+A+ + W
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM---- 262
Query: 768 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI 799
APE + T + DV+SFGVL++E+
Sbjct: 263 -----APETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 20/156 (12%)
Query: 383 NSPKLQVLDLSSNHIVGKIPVQ--LEMLSSLNKLILNLNQLSGGVPLEFGSL-----TKL 435
L ++L+S + ++ L + KL L LN L + L ++
Sbjct: 99 GRHALDEVNLASCQL-DPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQI 157
Query: 436 QYLDLSTNKLSSSIPKSIGNLLK----LHYLNLSNNQLSHK----IPTEFEKLIHLSELD 487
L LS N L+++ + L + +L+L + L + + + ++ L EL+
Sbjct: 158 TTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELN 217
Query: 488 LSHNILQEEIPPQVCNM----GSLEKLNLSHNNLSD 519
+++N + + SLE L+L N LS
Sbjct: 218 VAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 32/159 (20%), Positives = 61/159 (38%), Gaps = 25/159 (15%)
Query: 405 LEMLSSLNKLILNLNQLS--GGVPLEFG---SLTKLQYLDLSTNKLSSSIPKSIGN-LLK 458
E+LSSL +L L +++ + L ++L++ +L + +++ L+
Sbjct: 68 AEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR 127
Query: 459 LHYLNLSNNQLSHKIPTEFEKL--------IHLSELDLSHNILQEEIPPQVCNM----GS 506
L L N L P + L ++ L LS+N L + S
Sbjct: 128 ARKLGLQLNSLG---PEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 507 LEKLNLSHNNLSD----FIPRCFEEMRSLSCIDISYNEL 541
+ L+L H L D + + R L ++++YN
Sbjct: 185 VTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA 223
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 45/343 (13%), Positives = 93/343 (27%), Gaps = 57/343 (16%)
Query: 232 NNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEI 291
N ++ + + NL +L +L + L L+ + E+
Sbjct: 11 NRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV 70
Query: 292 GYLKSLSELELCTNLL--RGVI---------PHSIERVLLNQNNLSGKMYEAFGDH-PNL 339
L SL +L L + H+++ V L L
Sbjct: 71 --LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRA 128
Query: 340 TFLDLSNNNFCGE-----ISFNWGNFSKLSTFIVSMNNISGSIPPDIG----NSPKLQVL 390
L L N+ E + +++T +S N ++ + + + + L
Sbjct: 129 RKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL 188
Query: 391 DLSSNHI----VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSL----TKLQYLDLST 442
L + + + QL+ L +L + N L L+ L L
Sbjct: 189 SLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYF 248
Query: 443 NKLS-------SSIPKSIGNLLKLHYLNLSNNQLS---------------HKIPTEFEKL 480
N+LS + + ++ +S ++
Sbjct: 249 NELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRH 308
Query: 481 IHLSELDLSHNILQEEIPPQVCNM----GSLEKLNLSHNNLSD 519
+ L DL + P + + G + L +
Sbjct: 309 LELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGS 351
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 49/314 (15%), Positives = 90/314 (28%), Gaps = 78/314 (24%)
Query: 173 NLSNLAVLYLYKNSLSG-SIPSIIGKLKSLLQLDLSENQFS--GSIPLS---LGNLSSLT 226
L + L L + +++ +L L N L L + +T
Sbjct: 99 GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQIT 158
Query: 227 MMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGF 286
+ L NN L+ + + L GL N S+ L L + GL
Sbjct: 159 TLRLSNNPLTAA------GVAVLME-GLAGNT-------------SVTHLSLLHTGL--- 195
Query: 287 VPEEIGYLKSLSE-LELCTNLLRGVIPHSIERVL-LNQNNLSGK----MYEAFGDHPNLT 340
+ G L+ L+ L+ L + L + N + A +HP+L
Sbjct: 196 --GDEG-LELLAAQLDRNRQL----------QELNVAYNGAGDTAALALARAAREHPSLE 242
Query: 341 FLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGK 400
L L N L + + ++ V +
Sbjct: 243 LLHLYFNEL-SSEGRQV-----LRDLGGAAEGGA-----------RVVVSLTEGTAVS-- 283
Query: 401 IPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLK-- 458
+LS + + + + ++ LE L DL ++ ++ P LL+
Sbjct: 284 -EYWSVILSEVQRNLNSWDRARVQRHLE------LLLRDLEDSRGATLNPWRKAQLLRVE 336
Query: 459 --LHYLNLSNNQLS 470
+ L
Sbjct: 337 GEVRALLEQLGSSG 350
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 10/96 (10%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS---GGVPLEFGSL 432
S+P I Q L L++N I P + L +L +L N N+L+ GV F L
Sbjct: 26 SVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGV---FDKL 80
Query: 433 TKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNN 467
T+L LDL+ N L SIP+ NL L ++ L NN
Sbjct: 81 TQLTQLDLNDNHL-KSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 33/125 (26%), Positives = 50/125 (40%), Gaps = 30/125 (24%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218
C N S+P+ G ++ L+L N ++ P + L +L QL + N+ +
Sbjct: 19 CQNIRLASVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT------ 70
Query: 219 LGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVL 276
+IP + L L+ L L+ N L IP NL SL +
Sbjct: 71 -------------------AIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHI 110
Query: 277 YLYNN 281
YLYNN
Sbjct: 111 YLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 94 NIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSL 152
IP + Q L L +NQ++ L P L L++LY + N+L IP + +L+
Sbjct: 30 GIP------TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 153 IDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKN 185
+ +L L N+L SIP + NL +L +YLY N
Sbjct: 83 LTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 34/117 (29%), Positives = 55/117 (47%), Gaps = 19/117 (16%)
Query: 436 QYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495
++ +L+S +P I L L+NNQ++ P F+ L++L +L + N L
Sbjct: 15 TLVNCQNIRLAS-VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT- 70
Query: 496 EIPPQVC-NMGSLEKLNLSHNNLSDFIPR-CFEEMRSL------------SCIDISY 538
IP V + L +L+L+ N+L IPR F+ ++SL C DI Y
Sbjct: 71 AIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNNPWDCECRDIMY 126
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 30/117 (25%), Positives = 45/117 (38%), Gaps = 6/117 (5%)
Query: 383 NSPKLQVLDLSSNHI-VGKIPVQLEMLSSLNKLILNLNQLSGGVPLE-FGSLTKLQYLDL 440
++ L L + GKI +L L L L + L KL+ L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS---VSNLPKLPKLKKLEL 78
Query: 441 STNKLSSSIPKSIGNLLKLHYLNLSNNQLSH-KIPTEFEKLIHLSELDLSHNILQEE 496
S N++ + L L +LNLS N+L +KL L LDL + +
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNL 135
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 28/117 (23%), Positives = 48/117 (41%), Gaps = 4/117 (3%)
Query: 427 LEFGSLTKLQYLDLSTNKLS-SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSE 485
L + ++ L L K + I + L +L+L N L + KL L +
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKK 75
Query: 486 LDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDF-IPRCFEEMRSLSCIDISYNEL 541
L+LS N + + + +L LNLS N L D +++ L +D+ E+
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 41/130 (31%), Positives = 52/130 (40%), Gaps = 10/130 (7%)
Query: 316 ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISG 375
E VL N + GK+ + NL FL L N +S N KL +S N I G
Sbjct: 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIFG 85
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKL-ILNLN-----QLSGGVPLEF 429
+ P L L+LS N + K LE L L L L+L L+ F
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKL--KDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVF 143
Query: 430 GSLTKLQYLD 439
L +L YLD
Sbjct: 144 KLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 4/113 (3%)
Query: 126 LNQLRRLYLDMNQLH-GTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYK 184
+R L LD + + G I + ++ L+L + L S+ S+L L L L L +
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 185 NSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS-LGNLSSLTMMSLFNNSLS 236
N + G + + KL +L L+LS N+ L L L L + LFN ++
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 26/112 (23%), Positives = 45/112 (40%), Gaps = 6/112 (5%)
Query: 173 NLSNLAVLYLYKNSLS-GSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLF 231
+ + L L + G I + + +L L L S+ +L L L + L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 232 NNSLSGSIPPILGNLKSLSALGLHINQLNGF--IPPSIGNLSSLRVLYLYNN 281
N + G + + L +L+ L L N+L + P + L L+ L L+N
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 28/100 (28%), Positives = 39/100 (39%), Gaps = 5/100 (5%)
Query: 202 LQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNG 261
L LD ++ G I +L +SL N L S+ L L L L L N++ G
Sbjct: 29 LVLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIFG 85
Query: 262 FIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELE 301
+ L +L L L N L + LK L L+
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKKLECLK 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 31/140 (22%), Positives = 51/140 (36%), Gaps = 32/140 (22%)
Query: 76 SSFPHLANLNLSFNLF--FGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+ F +L L+L N+P L KL+ L+L N++ G + KL L L
Sbjct: 46 AEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKN---SLSGS 190
L N+ + +S ++ L L L L L+ +L+
Sbjct: 102 LSGNK--------LKDISTLEPLK---------------KLECLKSLDLFNCEVTNLNDY 138
Query: 191 IPSIIGKLKSLLQLDLSENQ 210
S+ L L LD + +
Sbjct: 139 RESVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 33/171 (19%), Positives = 53/171 (30%), Gaps = 44/171 (25%)
Query: 245 NLKSLSALGLHINQLN-GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELC 303
++ L L + N G I +L L L N GL S+S L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----------ISVSNLPKL 70
Query: 304 TNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKL 363
L +++ L++N + G + PNLT L+LS N + L
Sbjct: 71 PKL---------KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-----DISTLEPL 116
Query: 364 STFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKL 414
L+ LDL + + + + L +L
Sbjct: 117 KKL------------------ECLKSLDLFNCEVTNLNDYRESVFKLLPQL 149
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 46/237 (19%), Positives = 82/237 (34%), Gaps = 55/237 (23%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLN-EVLALKEIRHRNNVK- 663
+G G G V + ++ SG A+KK + N E+ +K + H N +K
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV---------LQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 664 ---FHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRIN-------------- 706
F+ P + ++ ++ + +
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125
Query: 707 -VIKGVAN-------------------ALSYLHHDCLPSIIHRDISSKNVLLDSN-FEAH 745
V+K A+ ++H I HRDI +N+L++S
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLK 182
Query: 746 VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKG 801
+ DFG AK + P + + + Y APE+ T D++S G + E+I G
Sbjct: 183 LCDFGSAKKLIPSEPS-VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-09
Identities = 24/113 (21%), Positives = 49/113 (43%), Gaps = 4/113 (3%)
Query: 431 SLTKLQYLDLSTNKLSS-SIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLS 489
+ + ++ L L ++ + + +L +L+ N L+ I KL L +L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 490 HNILQEEIPPQVCNMGSLEKLNLSHNNLSDF-IPRCFEEMRSLSCIDISYNEL 541
N + + +L LNLS N + D +++ +L +D+ E+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-09
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 6/112 (5%)
Query: 383 NSPKLQVLDLSSNHI-VGKIPVQLEMLSSLNKLILNLNQLSGGVPLE-FGSLTKLQYLDL 440
++ L L ++ GK+ + L L L+ + L KL+ L+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLEL 71
Query: 441 STNKLSSSIPKSIGNLLKLHYLNLSNNQLSH-KIPTEFEKLIHLSELDLSHN 491
S N++S + L +LNLS N++ +KL +L LDL +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 32/134 (23%), Positives = 60/134 (44%), Gaps = 7/134 (5%)
Query: 359 NFSKLSTFIVSMNNIS-GSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILN 417
S + ++ + + G + +L+ L + + I L L+ L KL L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 418 LNQLSGGVPLEFGSLTKLQYLDLSTNKLSS-SIPKSIGNLLKLHYLNLSNNQLSHKI--- 473
N++SGG+ + L +L+LS NK+ S + + L L L+L N ++++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132
Query: 474 PTEFEKLIHLSELD 487
F+ L L+ LD
Sbjct: 133 ENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 29/111 (26%), Positives = 51/111 (45%), Gaps = 4/111 (3%)
Query: 125 KLNQLRRLYLDMNQL-HGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183
+ ++ L LD ++ G + + ++ L+ + L SI ++L L+ L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFSG-SIPLSLGNLSSLTMMSLFNN 233
N +SG + + K +L L+LS N+ S L L +L + LFN
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 31/129 (24%), Positives = 47/129 (36%), Gaps = 27/129 (20%)
Query: 316 ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISG 375
E VL N + GK+ + L FL N + S+ N+
Sbjct: 21 ELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG------------------LTSIANLP- 61
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLE-FGSLTK 434
KL+ L+LS N + G + V E +L L L+ N++ +E L
Sbjct: 62 -------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN 114
Query: 435 LQYLDLSTN 443
L+ LDL
Sbjct: 115 LKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 32/125 (25%), Positives = 51/125 (40%), Gaps = 7/125 (5%)
Query: 156 LALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSI 215
L +N G + L L L+ SI + + KL L +L+LS+N+ SG +
Sbjct: 24 LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGL 80
Query: 216 PLSLGNLSSLTMMSLFNNSLSG-SIPPILGNLKSLSALGLHIN---QLNGFIPPSIGNLS 271
+ +LT ++L N + S L L++L +L L LN + L
Sbjct: 81 EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLP 140
Query: 272 SLRVL 276
L L
Sbjct: 141 QLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 27/100 (27%), Positives = 38/100 (38%), Gaps = 5/100 (5%)
Query: 202 LQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNG 261
L LD S + G + L +S N L+ SI L L L L L N+++G
Sbjct: 22 LVLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSG 78
Query: 262 FIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELE 301
+ +L L L N + I LK L L+
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDL--STIEPLKKLENLK 116
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 32/135 (23%), Positives = 47/135 (34%), Gaps = 32/135 (23%)
Query: 76 SSFPHLANLNLSFNLF--FGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
F L L+ N+P L+KL+ L+L N++SG + K L L
Sbjct: 39 DEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSI-- 191
L N+ I LS I+ L L NL L L+ ++
Sbjct: 95 LSGNK--------IKDLSTIEPLK---------------KLENLKSLDLFNCEVTNLNDY 131
Query: 192 -PSIIGKLKSLLQLD 205
++ L L LD
Sbjct: 132 RENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 29/153 (18%), Positives = 45/153 (29%), Gaps = 45/153 (29%)
Query: 245 NLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCT 304
++K L N G + L L N GL S++ L
Sbjct: 18 DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGL-----------TSIANLPKLN 64
Query: 305 NLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS 364
L +++ L+ N +SG + PNLT L+LS N + L
Sbjct: 65 KL---------KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK-----DLSTIEPLK 110
Query: 365 TFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397
L+ LDL + +
Sbjct: 111 KL------------------ENLKSLDLFNCEV 125
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 43/178 (24%), Positives = 66/178 (37%), Gaps = 34/178 (19%)
Query: 595 IKATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNE 649
IK D+ +G G G V + + + A+K D + E
Sbjct: 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARRE 60
Query: 650 VLALKEI-RHRNNVKFHGFCYNGPHS----FLVCEYLDRGSL-ARIL--GDDV-TAKELG 700
V + + V+ N +V E LD G L +RI GD T +E
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 701 WNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFV 755
++K + A+ YLH +I HRD+ +N+L S ++DFG AK
Sbjct: 121 -----EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 29/85 (34%), Positives = 46/85 (54%), Gaps = 4/85 (4%)
Query: 409 SSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-GNLLKLHYLNLSNN 467
++ L L NQ++ P F LT+L LDL N+L + +P + L +L L+L++N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQLTQLSLNDN 88
Query: 468 QLSHKIPTE-FEKLIHLSELDLSHN 491
QL IP F+ L L+ + L +N
Sbjct: 89 QL-KSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 5e-08
Identities = 35/125 (28%), Positives = 50/125 (40%), Gaps = 30/125 (24%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218
C S+P+ G + VLYLY N ++ P + +L L +LDL NQ +
Sbjct: 16 CSGKSLASVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT------ 67
Query: 219 LGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSI-GNLSSLRVL 276
+P + L L+ L L+ NQL IP NL SL +
Sbjct: 68 -------------------VLPAGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHI 107
Query: 277 YLYNN 281
+L NN
Sbjct: 108 WLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 6e-08
Identities = 38/111 (34%), Positives = 53/111 (47%), Gaps = 16/111 (14%)
Query: 430 GSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-FEKLIHLSELDL 488
G T Q L L N+++ P L +L L+L NNQL+ +P F+KL L++L L
Sbjct: 27 GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSL 85
Query: 489 SHNILQEEIPPQVC-NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISY 538
+ N L+ IP N+ SL + L NN D C +C DI Y
Sbjct: 86 NDNQLK-SIPRGAFDNLKSLTHIWL-LNNPWD----C-------ACSDILY 123
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 9e-07
Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 94 NIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEI-GQLSL 152
IP + Q L L NQ++ L P +L QL RL LD NQL +P + +L+
Sbjct: 27 GIP------TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 153 IDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKN 185
+ +L+L N L SIP + NL +L ++L N
Sbjct: 80 LTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 65/487 (13%), Positives = 135/487 (27%), Gaps = 70/487 (14%)
Query: 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYL 134
FP + ++ L F + L Y + + L + L
Sbjct: 62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEA---------MSSSYTWLEEIRL 112
Query: 135 DMNQLHGTIPPEIGQ-LSLIDKLAL--CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG-- 189
+ I + L L C + + NL L L ++ +
Sbjct: 113 KRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVS 172
Query: 190 --SIPSIIGKLKSLLQLDLS--ENQFSGSIPLSLG-NLSSLTMMSLFNNSLSGSIPPILG 244
+ SL+ L++S ++ S S L +L + L + +L
Sbjct: 173 GHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQ 232
Query: 245 NLKSLSALGLH------INQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLS 298
L LG + + ++ LR L + + + ++P L+
Sbjct: 233 RAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLT 292
Query: 299 ELEL--CTNLLRGVIPHSIE----RVLLNQNNLSGKMYEAFGDH-PNLTFLDLSNNNFCG 351
L L T ++ + + L + + E +L L + +
Sbjct: 293 TLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFV 352
Query: 352 EISFNW----------GNFSKLSTFIVSMNNISGSIPPDIG------NSPKLQVLDLSSN 395
KL + + ++ + N P + L
Sbjct: 353 MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMT-----NAALITIARNRPNMTRFRLCI- 406
Query: 396 HIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGN 455
+ L L L G L+ L LS L+ + + IG
Sbjct: 407 ------------IEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS-GLLTDKVFEYIGT 453
Query: 456 LLK-LHYLNLSNNQLSHK-IPTEFEKLIHLSELDLSH-NILQEEIPPQVCNMGSLEKLNL 512
K + L+++ S + L +L++ + + + ++ L +
Sbjct: 454 YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWM 513
Query: 513 SHNNLSD 519
S ++S
Sbjct: 514 SSCSVSF 520
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 51/239 (21%), Positives = 77/239 (32%), Gaps = 81/239 (33%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA---------LKEI 656
IG G G V +A + +VA+KK F + + L +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKI-----------LRVFEDLIDCKRILREIAILNRL 109
Query: 657 RHRNNVK-FHGFCYNGPHSF----LVCEYLDRGSLARILGDDVTAKELGWNRRI-----N 706
H + VK F +V E D ++ T L I N
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF---RTPVYLT-ELHIKTLLYN 164
Query: 707 VIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--- 761
++ G + Y+H S I+HRD+ N L++ + V DFG+A+ V +
Sbjct: 165 LLVG----VKYVH-----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 762 ------------------------WTEFAGTFGYAAPEIAYTMRATEKY----DVYSFG 792
T T Y APE+ + E Y DV+S G
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL---ILLQENYTEAIDVWSIG 271
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 52/238 (21%), Positives = 83/238 (34%), Gaps = 66/238 (27%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF----LNEVLALKEIRHRNN 661
IG+G G VY A + + VA+KK N M + L E+ L ++
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVN------RMFEDLIDCKRILREITILNRLKSDYI 87
Query: 662 VK-FHGFCYNGPHSF----LVCEYLDRGSLARILGDDVTAKELGWNRRI-----NVIKGV 711
++ + + F +V E D L ++ T L I N++ G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF---KTPIFLT-EEHIKTILYNLLLG- 141
Query: 712 ANALSYLHHDCLPS--IIHRDISSKNVLLDSNFEAHVSDFGIA----------------- 752
+++H IIHRD+ N LL+ + V DFG+A
Sbjct: 142 ---ENFIH-----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 753 -----KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVIKG 801
T T Y APE+ + E Y D++S G + E++
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPEL---ILLQENYTKSIDIWSTGCIFAELLNM 248
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 61/282 (21%), Positives = 104/282 (36%), Gaps = 89/282 (31%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA---LKEIR----- 657
+GKG G V+K+ + +G++VAVKK D F N A +EI
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI-----------FDAFQNSTDAQRTFREIMILTEL 65
Query: 658 --HRNNVKFHGFCYNGPHSF----LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGV 711
H N V + LV +Y++ L ++ A L + V+ +
Sbjct: 66 SGHENIVNLLNVLR--ADNDRDVYLVFDYME-TDLHAVI----RANILEPVHKQYVVYQL 118
Query: 712 ANALSYLHHDCLPS--IIHRDISSKNVLLDSNFEAHVSDFGIA----------------- 752
+ YLH S ++HRD+ N+LL++ V+DFG++
Sbjct: 119 IKVIKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 753 ----KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKY----DVYSFGVLVFEVI----- 799
+ T++ T Y APEI + + KY D++S G ++ E++
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEI---LLGSTKYTKGIDMWSLGCILGEILCGKPI 230
Query: 800 -KGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVMDY 840
G+ + II V + PS ++
Sbjct: 231 FPGSSTMNQL--------ERIIGV-------IDFPSNEDVES 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 52/278 (18%), Positives = 88/278 (31%), Gaps = 90/278 (32%)
Query: 599 DDFDEKFCI----GKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL 653
D F+ ++ + G G +V+ + + VA+K S A E+ L
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-----EIRLL 87
Query: 654 KEIRHRNN--------VKFHG-FCYNGP---HSFLVCEYLDRGSLARILGDDVTAKELGW 701
K +R+ + V+ F +G H +V E L L + +
Sbjct: 88 KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWI-------IKSN 139
Query: 702 NRRI------NVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----------------- 738
+ + +I+ V L YLH C IIH DI +N+LL
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEW 197
Query: 739 --------------------------------DSNFEAHVSDFGIAKFVGPHSSNWTEFA 766
+ ++D G A +V H TE
Sbjct: 198 QRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDI 254
Query: 767 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
T Y + E+ D++S + FE+ G++
Sbjct: 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 36/211 (17%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR------ 659
IGKG G V KA VA+K ++ H + E+ L+ +R +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 660 NNVKFHG-FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA----NA 714
N + F + H + E L +L ++ + K G++ + +++ A
Sbjct: 160 NVIHMLENFTFRN-HICMTFELLSM-NLYELIKKN---KFQGFS--LPLVRKFAHSILQC 212
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAH--VSDFGIAKFVGPHSSNW--TEFAGTFG 770
L LH IIH D+ +N+LL + V DFG + + + + F
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF----- 264
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKG 801
Y APE+ R D++S G ++ E++ G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTG 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 34/212 (16%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR------ 659
IGKG G V KA + VA+K ++ A ++ EV L+ +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIK-----IIKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 660 NNVKFHG-FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA----NA 714
V F + H LV E L +L +L + G + +N+ + A A
Sbjct: 117 YIVHLKRHFMFRN-HLCLVFEMLSY-NLYDLLRNT---NFRGVS--LNLTRKFAQQMCTA 169
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAH--VSDFGIAKFVGPHSSNW--TEFAGTFG 770
L +L L SIIH D+ +N+LL + + + DFG + +G + + F
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF----- 223
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN 802
Y +PE+ M D++S G ++ E+ G
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 31/173 (17%), Positives = 62/173 (35%), Gaps = 39/173 (22%)
Query: 607 IGKGGQGSVYKAE---------LPSGDIVAVK--KFNSQLLS-----GNMADHDEFLNEV 650
+ QG +Y+A P ++K + +L + A + +N+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ-VNKW 108
Query: 651 LALKEIRHRNNVKFHGF-CYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIK 709
L GF + + FLV L R SL L + + +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVS--------PKHVLSER 159
Query: 710 GVA-------NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK 753
V +AL +LH + +H +++++N+ +D ++ V + +G A
Sbjct: 160 SVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 34/173 (19%), Positives = 65/173 (37%), Gaps = 39/173 (22%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVK---------KFNSQLLSG----NMADHDEFLNEVLAL 653
IG+GG G +Y A++ S + V N L + A E + + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 654 KEIRHRNNVKFHGF----CYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIK 709
+++++ K+ G + F++ + L +I + +R + K
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEAN--------AKRFS-RK 152
Query: 710 GVA-------NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAK 753
V + L Y+H +H DI + N+LL+ V D+G+A
Sbjct: 153 TVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 33/161 (20%), Positives = 63/161 (39%), Gaps = 33/161 (20%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV-KF 664
IG G G + + L + + VA+K L + + E K++ + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA-------NALSY 717
+ F G ++ +V E L SL + R +K V + + Y
Sbjct: 71 YYFGPCGKYNAMVLELLGP-SLEDL---------FDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 718 LHHDCLPSIIHRDISSKNVLL-----DSNFEAHVSDFGIAK 753
+H ++I+RD+ +N L+ + H+ DF +AK
Sbjct: 121 VHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 38/185 (20%), Positives = 65/185 (35%), Gaps = 38/185 (20%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV-KF 664
IG G G +Y + +G+ VA+K + H + E K ++ +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA-------NALSY 717
G ++ +V E L SL + + R +K V + + Y
Sbjct: 71 RWCGAEGDYNVMVMELLGP-SLEDL---------FNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 718 LHHDCLPSIIHRDISSKNVLL---DSNFEAHVSDFGIAKFVGPHSSNW-------TEFAG 767
+H + IHRD+ N L+ ++ DFG+AK ++ G
Sbjct: 121 IHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 768 TFGYA 772
T YA
Sbjct: 178 TARYA 182
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 35/215 (16%), Positives = 72/215 (33%), Gaps = 33/215 (15%)
Query: 313 HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNN 372
++ + L LS + + NL L+LS C S ++
Sbjct: 118 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG---CSGFS------------EFALQT 162
Query: 373 ISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKL-ILNLNQLSG-----GVP 426
+ + +L L+LS + VQ+ + + LNL+ +
Sbjct: 163 LL-------SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS 215
Query: 427 LEFGSLTKLQYLDLS-TNKLSSSIPKSIGNLLKLHYLNLSN-NQLSHKIPTEFEKLIHLS 484
L +LDLS + L + + L L +L+LS + + E ++ L
Sbjct: 216 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 275
Query: 485 ELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSD 519
L + + + +L L ++ ++ +
Sbjct: 276 TLQVFGIVPDGTL---QLLKEALPHLQINCSHFTT 307
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 37/162 (22%), Positives = 63/162 (38%), Gaps = 35/162 (21%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV-KF 664
IG+G G +++ L + VA+K +D + +E K + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF------EPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA-------NALSY 717
+ F G H+ LV + L SL +L R +K VA +
Sbjct: 72 YYFGQEGLHNVLVIDLLGP-SLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQS 121
Query: 718 LHHDCLPSIIHRDISSKNVLL------DSNFEAHVSDFGIAK 753
+H S+++RDI N L+ ++N +V DFG+ K
Sbjct: 122 IHEK---SLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 34/171 (19%), Positives = 60/171 (35%), Gaps = 38/171 (22%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVK------KFNSQLLSG----NMADHDEFLNEVLALKE 655
IG GG G +Y A + A + N L S + + + + K+
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 656 IRHRNNVKFHGF----CYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGV 711
+ + F+G + F+V E L L +I G N V
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKI---------SGQNGTFK-KSTV 153
Query: 712 A-------NALSYLHHDCLPSIIHRDISSKNVLLDSNFE--AHVSDFGIAK 753
+ L Y+H + +H DI + N+LL +++D+G++
Sbjct: 154 LQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 42/185 (22%), Positives = 69/185 (37%), Gaps = 38/185 (20%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV-KF 664
IG G G +Y + + + VA+K N + H + L E + ++ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK------TKHPQLLYESKIYRILQGGTGIPNV 68
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA-------NALSY 717
F G ++ LV + L SL + + R +K V N + +
Sbjct: 69 RWFGVEGDYNVLVMDLLGP-SLEDL---------FNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAH---VSDFGIAKFVGPHSSNW-------TEFAG 767
+H S +HRDI N L+ A+ + DFG+AK S++ G
Sbjct: 119 VHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 768 TFGYA 772
T YA
Sbjct: 176 TARYA 180
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 15/101 (14%), Positives = 33/101 (32%), Gaps = 14/101 (13%)
Query: 433 TKLQYLDLSTNKLSSSIPKSIGNLLK----LHYLNLSNNQLSHK----IPTEFEKLIHLS 484
T ++ + + + + ++ +LK L LN+ +N +S + + L
Sbjct: 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLI 124
Query: 485 ELDLSHNILQ------EEIPPQVCNMGSLEKLNLSHNNLSD 519
EL + + EI + +L K
Sbjct: 125 ELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 848 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.98 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.63 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.6 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.55 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.36 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.31 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.31 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.2 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.99 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.96 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.95 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.68 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.64 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.47 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.44 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.11 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.83 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.83 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.67 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.57 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.47 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.28 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.15 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.05 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.84 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.84 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.73 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.68 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.6 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.49 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.44 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 91.74 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.21 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.96 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-77 Score=721.55 Aligned_cols=548 Identities=33% Similarity=0.493 Sum_probs=408.8
Q ss_pred hHHHHHHHHHHHhccCCCCCCcccCCCCCCCCCCCCCCCCccCceEEcCCCCceEEEeccccCcccc---ccC-------
Q 038003 3 NEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNGT---FHD------- 72 (848)
Q Consensus 3 ~~~~~all~~k~~~~~~~~~~~~l~sw~~~~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~---~~~------- 72 (848)
++|++|||+||+++.++ . .++||+ .+.|||.|.||+|+ ++||++|+|++.++.|. +++
T Consensus 11 ~~~~~all~~k~~~~~~---~-~l~~W~------~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~ 78 (768)
T 3rgz_A 11 YREIHQLISFKDVLPDK---N-LLPDWS------SNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTG 78 (768)
T ss_dssp HHHHHHHHHHHTTCSCT---T-SSTTCC------TTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTT
T ss_pred HHHHHHHHHHHhhCCCc---c-cccCCC------CCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCc
Confidence 68999999999999743 3 799996 36799999999998 68999999999999987 443
Q ss_pred ---------------CccCCCCCCcEEeccCCcccccccc--cccCCCCCcEEEccccCCCCCCchhh-hccccccEEEe
Q 038003 73 ---------------FSFSSFPHLANLNLSFNLFFGNIPL--QIGNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRRLYL 134 (848)
Q Consensus 73 ---------------~~~~~l~~l~~L~l~~n~~~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~L 134 (848)
..+..+++|++|||++|.++|.+|. .++++++|++|||++|.+++.+|..+ +++++|++|+|
T Consensus 79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence 4688899999999999999999998 89999999999988888887777654 44444444444
Q ss_pred cccCcCCCCCcc-------------------------ccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccC
Q 038003 135 DMNQLHGTIPPE-------------------------IGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG 189 (848)
Q Consensus 135 ~~n~l~~~~p~~-------------------------~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 189 (848)
++|++++..|.. ++.+++|++|+|++|++++.+|. ++++++|++|++++|++++
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~ 237 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSG 237 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCS
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCC
Confidence 444444332221 13344455555555555544444 5555555555555555554
Q ss_pred CCcccccccccc----------------------cccccccccccccCcccccCC-cccceeeccccCCCCCCCCcccCc
Q 038003 190 SIPSIIGKLKSL----------------------LQLDLSENQFSGSIPLSLGNL-SSLTMMSLFNNSLSGSIPPILGNL 246 (848)
Q Consensus 190 ~~p~~~~~l~~L----------------------~~L~L~~N~l~~~~p~~l~~l-~~L~~L~l~~n~l~~~~p~~l~~l 246 (848)
.+|..++.+++| ++|+|++|++++.+|..+..+ ++|++|++++|++++.+|..++.+
T Consensus 238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l 317 (768)
T 3rgz_A 238 DFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317 (768)
T ss_dssp CHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGC
T ss_pred cccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcC
Confidence 444444444444 444444444444566666554 777777777777777777777777
Q ss_pred ccccccccccccccCcCCCc-ccCCCCCceEEccCccccccCcccccCCC-CCcccccccccc-----------------
Q 038003 247 KSLSALGLHINQLNGFIPPS-IGNLSSLRVLYLYNNGLYGFVPEEIGYLK-SLSELELCTNLL----------------- 307 (848)
Q Consensus 247 ~~L~~L~l~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l----------------- 307 (848)
++|++|++++|++.+.+|.. +.++++|++|++++|.+++.+|..+..++ +|+.|++++|.+
T Consensus 318 ~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~ 397 (768)
T 3rgz_A 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 397 (768)
T ss_dssp TTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCC
T ss_pred CCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCcc
Confidence 77777777777777666654 67777777777777777766666665554 555555555554
Q ss_pred ---------ccccCC------ccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeeccccc
Q 038003 308 ---------RGVIPH------SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNN 372 (848)
Q Consensus 308 ---------~~~~p~------~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 372 (848)
++.+|. .++.|.+.+|++++..+..++.+++|++|++++|++++..|..+..+++|+.|++++|+
T Consensus 398 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 477 (768)
T 3rgz_A 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477 (768)
T ss_dssp EEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred EEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCc
Confidence 444442 24455666666666666666666777777777777777777777777777777777777
Q ss_pred ccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCc
Q 038003 373 ISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKS 452 (848)
Q Consensus 373 i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 452 (848)
+++.+|..++.+++|++|+|++|++++.+|.++..+++|++|+|++|++++.+|..++.+++|++|++++|+++|.+|..
T Consensus 478 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~ 557 (768)
T 3rgz_A 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557 (768)
T ss_dssp CCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGG
T ss_pred ccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChH
Confidence 77777777777888888888888888888888888888888888888888888888888888888888888887666643
Q ss_pred c----------------------------------------------------------------------cCcccccee
Q 038003 453 I----------------------------------------------------------------------GNLLKLHYL 462 (848)
Q Consensus 453 ~----------------------------------------------------------------------~~l~~L~~L 462 (848)
+ +.+++|++|
T Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~L 637 (768)
T 3rgz_A 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637 (768)
T ss_dssp GGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEE
T ss_pred HhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEE
Confidence 3 335678899
Q ss_pred ccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccC
Q 038003 463 NLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELH 542 (848)
Q Consensus 463 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~ 542 (848)
+|++|+++|.+|..|+.+++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|..+..+++|+.||+++|+++
T Consensus 638 dLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp ECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred ECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcc---cccccccccCcc
Q 038003 543 GPIPNSTAF---KDGLMEGNKGLK 563 (848)
Q Consensus 543 ~~~~~~~~~---~~~~~~~~~~l~ 563 (848)
|++|...+| ....|.||++++
T Consensus 718 g~iP~~~~~~~~~~~~~~gN~~Lc 741 (768)
T 3rgz_A 718 GPIPEMGQFETFPPAKFLNNPGLC 741 (768)
T ss_dssp EECCSSSSGGGSCGGGGCSCTEEE
T ss_pred ccCCCchhhccCCHHHhcCCchhc
Confidence 999988765 445788998764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-62 Score=592.52 Aligned_cols=483 Identities=35% Similarity=0.499 Sum_probs=439.6
Q ss_pred ceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEe
Q 038003 55 RVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYL 134 (848)
Q Consensus 55 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 134 (848)
+.+.|+++++.+.|..+ +..+++|++|+|++|.+++.+|. ++++++|++|+|++|++++.+|..++++++|++|+|
T Consensus 179 ~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L 254 (768)
T 3rgz_A 179 ELKHLAISGNKISGDVD---VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI 254 (768)
T ss_dssp TCCEEECCSSEEESCCB---CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEEC
T ss_pred CCCEEECCCCcccccCC---cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEEC
Confidence 45566666666666543 47888999999999999888887 999999999999999999989999999999999999
Q ss_pred cccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCc-cccceEEeecccccCCCcccccccccccccccccccccc
Q 038003 135 DMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNL-SNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSG 213 (848)
Q Consensus 135 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 213 (848)
++|++++.+|.. .+++|++|+|++|++++.+|..+..+ ++|++|++++|++++.+|..|+.+++|++|+|++|+++|
T Consensus 255 s~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 332 (768)
T 3rgz_A 255 SSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332 (768)
T ss_dssp CSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred CCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccC
Confidence 999999888775 88999999999999999999988775 999999999999999999999999999999999999998
Q ss_pred cCccc-ccCCcccceeeccccCCCCCCCCcccCcc-cccccccccccccCcCCCcccC--CCCCceEEccCccccccCcc
Q 038003 214 SIPLS-LGNLSSLTMMSLFNNSLSGSIPPILGNLK-SLSALGLHINQLNGFIPPSIGN--LSSLRVLYLYNNGLYGFVPE 289 (848)
Q Consensus 214 ~~p~~-l~~l~~L~~L~l~~n~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~p~~l~~--l~~L~~L~Ls~N~l~~~~p~ 289 (848)
.+|.. +..+++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+.. +++|++|++++|.+++.+|.
T Consensus 333 ~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~ 412 (768)
T 3rgz_A 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412 (768)
T ss_dssp ECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCG
T ss_pred cCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCH
Confidence 88876 89999999999999999999999999887 9999999999999988888877 88999999999999999999
Q ss_pred cccCCCCCccccccccccccccCC------ccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccc
Q 038003 290 EIGYLKSLSELELCTNLLRGVIPH------SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKL 363 (848)
Q Consensus 290 ~~~~l~~L~~L~L~~N~l~~~~p~------~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 363 (848)
.+..+++|+.|++++|.+++.+|. .++.+.+.+|.+++..+..+..+++|++|++++|++++..|..+..+++|
T Consensus 413 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 492 (768)
T 3rgz_A 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492 (768)
T ss_dssp GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC
T ss_pred HHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCC
Confidence 999999999999999999988875 47789999999999999999999999999999999999999999999999
Q ss_pred cEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcc---------------
Q 038003 364 STFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLE--------------- 428 (848)
Q Consensus 364 ~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~--------------- 428 (848)
+.|++++|++++.+|.+++.+++|++|+|++|++++.+|..+..+++|+.|++++|.++|.+|..
T Consensus 493 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~ 572 (768)
T 3rgz_A 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572 (768)
T ss_dssp CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCS
T ss_pred CEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccc
Confidence 99999999999999999999999999999999999999999999999999999999998777654
Q ss_pred -------------------------------------------------------cCCCCccCeEeccCcccCCCCCCcc
Q 038003 429 -------------------------------------------------------FGSLTKLQYLDLSTNKLSSSIPKSI 453 (848)
Q Consensus 429 -------------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~ 453 (848)
++.+++|++|||++|+++|.+|..|
T Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l 652 (768)
T 3rgz_A 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652 (768)
T ss_dssp CEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGG
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHH
Confidence 3446789999999999999999999
Q ss_pred cCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCcee
Q 038003 454 GNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSC 533 (848)
Q Consensus 454 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 533 (848)
+++++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|++|++++|+++|.+|.. ..+..+..
T Consensus 653 ~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~ 731 (768)
T 3rgz_A 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPP 731 (768)
T ss_dssp GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCG
T ss_pred hccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999864 45566667
Q ss_pred ecCCCCc-cCCC
Q 038003 534 IDISYNE-LHGP 544 (848)
Q Consensus 534 l~ls~N~-l~~~ 544 (848)
..+.+|+ ++|.
T Consensus 732 ~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 732 AKFLNNPGLCGY 743 (768)
T ss_dssp GGGCSCTEEEST
T ss_pred HHhcCCchhcCC
Confidence 7788885 7774
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-61 Score=566.46 Aligned_cols=486 Identities=20% Similarity=0.254 Sum_probs=327.1
Q ss_pred HHHHHHHHHHHhccCCCCC-----CcccCCCCCCCCCCCCCCCCcc---CceEEcCCCCceEEEeccccCccccccCCcc
Q 038003 4 EEAYALLKWKTSLQNQNLN-----SSLLSSWTLYPANATKISPCSW---FGISCNHAGSRVISITMSTLGLNGTFHDFSF 75 (848)
Q Consensus 4 ~~~~all~~k~~~~~~~~~-----~~~l~sw~~~~~~~~~~~~c~w---~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~ 75 (848)
.|++||.+||+++..+... ....++|+ .+.|||.| .||+|+.. +||++|+|+++++.|++|+ ++
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~------~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~-~l 101 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWN------FNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPD-AI 101 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCC------CSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECG-GG
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCC------CCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCCh-HH
Confidence 6999999999999665321 11234776 36899999 99999865 8999999999999999985 79
Q ss_pred CCCCCCcEEeccCCcc------cc------cccccccCCCCCcEEEccccCCCCCCchhhhc-cccccEEEec-------
Q 038003 76 SSFPHLANLNLSFNLF------FG------NIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGK-LNQLRRLYLD------- 135 (848)
Q Consensus 76 ~~l~~l~~L~l~~n~~------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~L~------- 135 (848)
+.|++|++|+|++|.+ .| .+|... +..|+ +++++|.+.+.+|..+.. +.++..+++.
T Consensus 102 ~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~ 178 (636)
T 4eco_A 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178 (636)
T ss_dssp GGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCC
T ss_pred hcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccc
Confidence 9999999999999987 44 566555 67777 888888888888877763 2233333333
Q ss_pred -------------ccCcCCCCCccccCcCCccEEEcCCCcCCCC-----------------CCCccc--CccccceEEee
Q 038003 136 -------------MNQLHGTIPPEIGQLSLIDKLALCHNNLHGS-----------------IPSSLG--NLSNLAVLYLY 183 (848)
Q Consensus 136 -------------~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-----------------~p~~l~--~l~~L~~L~l~ 183 (848)
.|+++| +|.+++++++|++|+|++|+++|. +|+.++ ++++|++|+|+
T Consensus 179 ~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~ 257 (636)
T 4eco_A 179 SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257 (636)
T ss_dssp CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred cccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEec
Confidence 567776 777777777788888887777765 777777 77778888887
Q ss_pred cccccCCCccccccccccccccccccc-ccc-cCcccccCC------cccceeeccccCCCCCCCC--cccCcccccccc
Q 038003 184 KNSLSGSIPSIIGKLKSLLQLDLSENQ-FSG-SIPLSLGNL------SSLTMMSLFNNSLSGSIPP--ILGNLKSLSALG 253 (848)
Q Consensus 184 ~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l------~~L~~L~l~~n~l~~~~p~--~l~~l~~L~~L~ 253 (848)
+|++.+.+|..|+++++|++|+|++|+ ++| .+|..++.+ ++|++|++++|+++ .+|. .++.+++|++|+
T Consensus 258 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~ 336 (636)
T 4eco_A 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLE 336 (636)
T ss_dssp CCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEE
T ss_pred CCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEe
Confidence 777777777777777777778887777 777 777777665 77777777777777 6777 777777777777
Q ss_pred cccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCC-CccccccccccccccCCccceeeccccCCCCccccc
Q 038003 254 LHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKS-LSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEA 332 (848)
Q Consensus 254 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~ 332 (848)
+++|+++|.+| .+..+++|++|++++|.++ .+|..+..+++ |++|++++|.++ .+|..+.
T Consensus 337 L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~---------------- 397 (636)
T 4eco_A 337 CLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFD---------------- 397 (636)
T ss_dssp CCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCC----------------
T ss_pred CcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhh----------------
Confidence 77777777777 6777777777777777777 56666776666 777777666666 3443211
Q ss_pred cCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCccccccccccc
Q 038003 333 FGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLN 412 (848)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 412 (848)
...+++|++|++++|++++..|..+... ......+++|++|+|++|++++..+..+..+++|+
T Consensus 398 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~~-----------------~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~ 460 (636)
T 4eco_A 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPL-----------------DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460 (636)
T ss_dssp TTCSSCEEEEECCSSCTTTTTTCSSCTT-----------------CSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCS
T ss_pred hcccCccCEEECcCCcCCCcchhhhccc-----------------ccccccCCCCCEEECcCCccCcCCHHHHccCCCCC
Confidence 0112356666666666655544444300 00000445566666666666533333344455666
Q ss_pred EEEccCCcCCCCCCcccCCC-------CccCeEeccCcccCCCCCCccc--CccccceeccccCcCCCCChhHHhhhccc
Q 038003 413 KLILNLNQLSGGVPLEFGSL-------TKLQYLDLSTNKLSSSIPKSIG--NLLKLHYLNLSNNQLSHKIPTEFEKLIHL 483 (848)
Q Consensus 413 ~L~L~~N~l~~~~~~~~~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 483 (848)
+|+|++|+++...+..+... ++|++|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|
T Consensus 461 ~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L 538 (636)
T 4eco_A 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538 (636)
T ss_dssp EEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSC
T ss_pred EEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCC
Confidence 66666666652222222222 25666666666666 4555554 56666666666666665 55566666666
Q ss_pred ceecc------cCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCC
Q 038003 484 SELDL------SHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHG 543 (848)
Q Consensus 484 ~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~ 543 (848)
+.|+| ++|++.+.+|..+..+++|++|+|++|++ +.+|..+. ++|+.|++++|++..
T Consensus 539 ~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp CEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred CEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 66666 45667777777777777777777777777 44565554 677777777777653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-59 Score=558.87 Aligned_cols=486 Identities=17% Similarity=0.241 Sum_probs=326.9
Q ss_pred hHHHHHHHHHHHhccCCCCCCcccCCCCCCCCCCCCCCC--Ccc------------CceEEcCCCCceEEEeccccCccc
Q 038003 3 NEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISP--CSW------------FGISCNHAGSRVISITMSTLGLNG 68 (848)
Q Consensus 3 ~~~~~all~~k~~~~~~~~~~~~l~sw~~~~~~~~~~~~--c~w------------~gv~C~~~~~~v~~l~l~~~~l~g 68 (848)
.+|++||++||+++.++ +|+... +|...+| |.| .||+|+. ++||++|+|+++++.|
T Consensus 268 ~~d~~ALl~~k~~l~~~--------~W~~~~-~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 268 IKDYKALKAIWEALDGK--------NWRYYS-GTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKG 337 (876)
T ss_dssp HHHHHHHHHHHHHTTGG--------GCCCCC-SSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEE
T ss_pred hHHHHHHHHHHHHcCCC--------CCCcCC-CcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCC
Confidence 47999999999999442 897422 1223466 999 9999986 6899999999999999
Q ss_pred cccCCccCCCCCCcEEec-cCCccccccccccc-----------------------------------------------
Q 038003 69 TFHDFSFSSFPHLANLNL-SFNLFFGNIPLQIG----------------------------------------------- 100 (848)
Q Consensus 69 ~~~~~~~~~l~~l~~L~l-~~n~~~~~~p~~~~----------------------------------------------- 100 (848)
.+|+ ++++|++|+.|+| ++|.++|..|-...
T Consensus 338 ~ip~-~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~ 416 (876)
T 4ecn_A 338 RVPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416 (876)
T ss_dssp EECG-GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred cCch-HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence 9985 7999999999999 89999887543211
Q ss_pred ----CCCCCcEEEccc--cCCCCCCchhhhccccccEEEecccCcCC-----------------CCCcccc--CcCCccE
Q 038003 101 ----NLSKLQYLDLGS--NQLSGLIPPEIGKLNQLRRLYLDMNQLHG-----------------TIPPEIG--QLSLIDK 155 (848)
Q Consensus 101 ----~l~~L~~L~Ls~--n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~ 155 (848)
....++.+.++. |++++ +|+.|+++++|++|+|++|+++| .+|..++ .+++|++
T Consensus 417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~ 495 (876)
T 4ecn_A 417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495 (876)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence 112233334433 77777 78888888888888888888887 2777766 7777777
Q ss_pred EEcCCCcCCCCCCCcccCccccceEEeeccc-ccC-CCcccccccc-------cccccccccccccccCcc--cccCCcc
Q 038003 156 LALCHNNLHGSIPSSLGNLSNLAVLYLYKNS-LSG-SIPSIIGKLK-------SLLQLDLSENQFSGSIPL--SLGNLSS 224 (848)
Q Consensus 156 L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~l~~l~~ 224 (848)
|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..++.++ +|++|+|++|+++ .+|. .++++++
T Consensus 496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~ 574 (876)
T 4ecn_A 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK 574 (876)
T ss_dssp EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence 7777777777777777777777777777776 776 6776666655 7777777777777 6776 7777777
Q ss_pred cceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCC-CceEEccCccccccCcccccCCCC--Ccccc
Q 038003 225 LTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSS-LRVLYLYNNGLYGFVPEEIGYLKS--LSELE 301 (848)
Q Consensus 225 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~ 301 (848)
|+.|+|++|+++ .+| .++.+++|+.|+|++|+++ .+|..+.++++ |++|+|++|.++ .+|..+..++. |+.|+
T Consensus 575 L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~ 650 (876)
T 4ecn_A 575 LGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVD 650 (876)
T ss_dssp CCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEE
T ss_pred CCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEE
Confidence 777777777777 666 6777777777777777777 56666777777 777777777776 56666665543 77777
Q ss_pred ccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCC
Q 038003 302 LCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDI 381 (848)
Q Consensus 302 L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l 381 (848)
+++|++.+.+|.....+ ..-.+++|+.|+|++|+++......+..+++|+.|++++|+|+ .+|..+
T Consensus 651 Ls~N~l~g~ip~l~~~l-------------~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~ 716 (876)
T 4ecn_A 651 FSYNKIGSEGRNISCSM-------------DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENS 716 (876)
T ss_dssp CCSSCTTTTSSSCSSCT-------------TTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTS
T ss_pred CcCCcCCCccccchhhh-------------ccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHH
Confidence 77777766554211000 0012346666667666666433333345555666666666555 344333
Q ss_pred CCC--------CCccEEEccCCccCCCCccccc--ccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCC
Q 038003 382 GNS--------PKLQVLDLSSNHIVGKIPVQLE--MLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPK 451 (848)
Q Consensus 382 ~~l--------~~L~~L~Ls~N~l~~~~~~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 451 (848)
... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+
T Consensus 717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------- 787 (876)
T 4ecn_A 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------- 787 (876)
T ss_dssp SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB-------
T ss_pred hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC-------
Confidence 221 14555555555554 3444443 44555555555555543 34444444555555554433
Q ss_pred cccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCc
Q 038003 452 SIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSL 531 (848)
Q Consensus 452 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 531 (848)
++++|++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|+|++|++....+..+.....+
T Consensus 788 -----------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~ 853 (876)
T 4ecn_A 788 -----------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEA 853 (876)
T ss_dssp -----------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHT
T ss_pred -----------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccc
Confidence 3345777777888888888888888888888 56777665 588888888888877666666666666
Q ss_pred eeecCCCCccC
Q 038003 532 SCIDISYNELH 542 (848)
Q Consensus 532 ~~l~ls~N~l~ 542 (848)
..+.+.+|++.
T Consensus 854 ~~~~L~~n~~~ 864 (876)
T 4ecn_A 854 GMYVLLYDKTQ 864 (876)
T ss_dssp TCCEEECCTTS
T ss_pred hheeecCCCcc
Confidence 66677777553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=541.10 Aligned_cols=492 Identities=23% Similarity=0.279 Sum_probs=325.9
Q ss_pred CceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEE
Q 038003 54 SRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133 (848)
Q Consensus 54 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 133 (848)
.+++.|+++++.+.+. ++..|.++++|++|+|++|.+++..|.+|+++++|++|+|++|++++..+..|+++++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRL-PAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCCC-CGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCCc-CHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 4789999999988874 445689999999999999999999999999999999999999999976666899999999999
Q ss_pred ecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccc--ccccccccccccccc
Q 038003 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIG--KLKSLLQLDLSENQF 211 (848)
Q Consensus 134 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l 211 (848)
|++|++++..|..|+.+++|++|+|++|.+++..|..++++++|++|++++|.+++..+..++ .+++|++|++++|++
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 999999987788999999999999999999998899999999999999999999987776654 457899999999988
Q ss_pred cccCcccccCC---------------------------cccceeeccccCCCCCCCCcccCccc--ccccccccccccCc
Q 038003 212 SGSIPLSLGNL---------------------------SSLTMMSLFNNSLSGSIPPILGNLKS--LSALGLHINQLNGF 262 (848)
Q Consensus 212 ~~~~p~~l~~l---------------------------~~L~~L~l~~n~l~~~~p~~l~~l~~--L~~L~l~~N~l~~~ 262 (848)
++..|..+..+ ++|+.|++++|.+++..|..+..++. |+.|++++|++++.
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence 87777665543 34555666666666666666666544 66666666666666
Q ss_pred CCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccc-----cC----------CccceeeccccCCCC
Q 038003 263 IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGV-----IP----------HSIERVLLNQNNLSG 327 (848)
Q Consensus 263 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----~p----------~~l~~l~L~~n~l~~ 327 (848)
.|.+|..+++|++|++++|.+.+..|..+..+++|+.|++++|...+. +| ..++.+.+.+|.+++
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~ 343 (680)
T 1ziw_A 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence 666666666666666666666666555555555555555544433221 11 234444444444444
Q ss_pred ccccccCCCCCccE----------------------------EEccCCccccccCccccCcccccEeecccccccCCCC-
Q 038003 328 KMYEAFGDHPNLTF----------------------------LDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIP- 378 (848)
Q Consensus 328 ~~~~~~~~l~~L~~----------------------------L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p- 378 (848)
+....|..+++|++ |++++|++++..+..+..+++|+.|++++|.+.+.+|
T Consensus 344 ~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 423 (680)
T 1ziw_A 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423 (680)
T ss_dssp CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCS
T ss_pred CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCc
Confidence 44444433333333 3333344444455555666666666666666654443
Q ss_pred CCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCC--CCCCcccCCCCccCeEeccCcccCCCCCCcccCc
Q 038003 379 PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS--GGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNL 456 (848)
Q Consensus 379 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 456 (848)
..+..+++|++|++++|++++..+..+..+++|+.|++++|.++ +..|..|..+++|++|++++|++++..+..|.++
T Consensus 424 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l 503 (680)
T 1ziw_A 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL 503 (680)
T ss_dssp GGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccc
Confidence 34555666666666666665555555555555555555555554 3455555555555555555555555555555555
Q ss_pred cccceeccccCcCCCCCh--------hHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccc
Q 038003 457 LKLHYLNLSNNQLSHKIP--------TEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEM 528 (848)
Q Consensus 457 ~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 528 (848)
++|++|+|++|++++..+ ..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..+..|..+
T Consensus 504 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l 583 (680)
T 1ziw_A 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQ 583 (680)
T ss_dssp TTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred cccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCC
Confidence 555555555555553211 124555555555555555553333345555555555555555555555555555
Q ss_pred cCceeecCCCCccCCCCC
Q 038003 529 RSLSCIDISYNELHGPIP 546 (848)
Q Consensus 529 ~~L~~l~ls~N~l~~~~~ 546 (848)
++|+.|++++|++++..|
T Consensus 584 ~~L~~L~L~~N~l~~~~~ 601 (680)
T 1ziw_A 584 VSLKSLNLQKNLITSVEK 601 (680)
T ss_dssp TTCCEEECTTSCCCBCCH
T ss_pred CCCCEEECCCCcCCccCh
Confidence 555555555555555443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-57 Score=530.62 Aligned_cols=499 Identities=20% Similarity=0.204 Sum_probs=393.9
Q ss_pred cCceEEcCC---------CCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccC
Q 038003 44 WFGISCNHA---------GSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQ 114 (848)
Q Consensus 44 w~gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~ 114 (848)
+.-|.|... ...++.|+++++.+++.. +.+|.++++|++|+|++|.+++..|.+|+++++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQ-NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEEC-TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCC-hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 445778642 135666777777666543 3356777777777777777776667777777777777777777
Q ss_pred CCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccc
Q 038003 115 LSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSI 194 (848)
Q Consensus 115 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~ 194 (848)
+++..|..|+++++|++|+|++|++++..|..++.+++|++|+|++|++++..+..+..+++|++|++++|.+++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 77666777777777777777777777555666777777777777777777533233344777777777777777666666
Q ss_pred cccccccc--ccccccccccccCcccccCCcccceeeccccCC--------------------------CCCCCCcccCc
Q 038003 195 IGKLKSLL--QLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL--------------------------SGSIPPILGNL 246 (848)
Q Consensus 195 ~~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l--------------------------~~~~p~~l~~l 246 (848)
|+.+++|+ +|++++|++++..|..+.. .+|+.|++++|.. ....+..+..+
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l 251 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchh
Confidence 77777777 6777777777655554433 4566666555430 00011122222
Q ss_pred c--cccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccC------Ccccee
Q 038003 247 K--SLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP------HSIERV 318 (848)
Q Consensus 247 ~--~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------~~l~~l 318 (848)
. +|+.|++++|++++..+..|..+++|++|++++|.++ .+|..+..+++|++|++++|.+.+..| ..++.+
T Consensus 252 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 330 (606)
T 3t6q_A 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330 (606)
T ss_dssp GGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEE
T ss_pred hcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEE
Confidence 2 6888888888888887778888888889999888887 577788888888888888888887655 357788
Q ss_pred eccccCCC-CccccccCCCCCccEEEccCCcccccc--CccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCC
Q 038003 319 LLNQNNLS-GKMYEAFGDHPNLTFLDLSNNNFCGEI--SFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSN 395 (848)
Q Consensus 319 ~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N 395 (848)
.+.+|.+. .++...+..+++|++|++++|.+++.. +..+..+++|+.|++++|.+.+..|..+..+++|++|++++|
T Consensus 331 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 410 (606)
T 3t6q_A 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410 (606)
T ss_dssp ECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTC
T ss_pred ECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCC
Confidence 88888877 455566889999999999999999876 778999999999999999999999999999999999999999
Q ss_pred ccCCCCcc-cccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCC---CCCcccCccccceeccccCcCCC
Q 038003 396 HIVGKIPV-QLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSS---IPKSIGNLLKLHYLNLSNNQLSH 471 (848)
Q Consensus 396 ~l~~~~~~-~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~ 471 (848)
++++..+. .+..+++|+.|++++|.+++..|..|..+++|++|++++|++++. .+..+..+++|++|+|++|++++
T Consensus 411 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 490 (606)
T 3t6q_A 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490 (606)
T ss_dssp CEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCE
T ss_pred cCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCc
Confidence 99977665 489999999999999999999999999999999999999999862 34678999999999999999999
Q ss_pred CChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCCCC
Q 038003 472 KIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIP 546 (848)
Q Consensus 472 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~ 546 (848)
..|..|..+++|++|+|++|++++..|..+..+++| +|+|++|++++.+|..+..+++|+.+++++|++.+..+
T Consensus 491 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 999999999999999999999999999999999999 99999999999999999999999999999999987544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=524.61 Aligned_cols=498 Identities=22% Similarity=0.215 Sum_probs=423.0
Q ss_pred CCCCccC----ceEEcCC---------CCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCC
Q 038003 39 ISPCSWF----GISCNHA---------GSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKL 105 (848)
Q Consensus 39 ~~~c~w~----gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L 105 (848)
.+||.|. .|.|... ..+++.|+++++.+.+.. +..|.++++|++|+|++|.+++..|.+|+++++|
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L 82 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILK-SYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEEC-TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeC-hhhccCCccCcEEeCCCCcccccCHHHhhchhhc
Confidence 3567663 5777542 246888888888887644 3468889999999999999988888889999999
Q ss_pred cEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCC-CCCCcccCccccceEEeec
Q 038003 106 QYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG-SIPSSLGNLSNLAVLYLYK 184 (848)
Q Consensus 106 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~l~~ 184 (848)
++|+|++|.+++..|..|+++++|++|+|++|++++..|..++.+++|++|+|++|.+++ .+|..++++++|++|++++
T Consensus 83 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~ 162 (606)
T 3vq2_A 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162 (606)
T ss_dssp CEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCS
T ss_pred CEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccC
Confidence 999999999988888889999999999999999987777889999999999999999886 5788899999999999999
Q ss_pred ccccCCCccccccccccc----ccccccccccccCcccccCCcccceeeccccCCCC-CCCCcccCccccccccc-----
Q 038003 185 NSLSGSIPSIIGKLKSLL----QLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG-SIPPILGNLKSLSALGL----- 254 (848)
Q Consensus 185 N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~l----- 254 (848)
|++++..|..|+.+++|+ +|++++|.+++..+..+... +|+.|++++|.+++ .+|..+.+++.|+.+++
T Consensus 163 n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~ 241 (606)
T 3vq2_A 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241 (606)
T ss_dssp SCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECC
T ss_pred CcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccc
Confidence 999887788888887776 69999999986555555444 89999999988763 34455555555555444
Q ss_pred ----------------------------ccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccc
Q 038003 255 ----------------------------HINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNL 306 (848)
Q Consensus 255 ----------------------------~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 306 (848)
..|.+.+.+|. +..+++|+.|++++|.+.. +| .+..+++|+.|++++|.
T Consensus 242 ~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~ 318 (606)
T 3vq2_A 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQ 318 (606)
T ss_dssp TTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCC
T ss_pred ccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEccccc
Confidence 56677777776 8889999999999999974 45 88899999999999999
Q ss_pred cccccC----CccceeeccccCCCCccccccCCCCCccEEEccCCcccccc--CccccCcccccEeecccccccCCCCCC
Q 038003 307 LRGVIP----HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI--SFNWGNFSKLSTFIVSMNNISGSIPPD 380 (848)
Q Consensus 307 l~~~~p----~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~l~~N~i~~~~p~~ 380 (848)
+ +.+| ..++.+.+.+|...... .+..+++|++|++++|++++.. +..+..+++|+.|++++|.+.+ +|..
T Consensus 319 l-~~lp~~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~ 394 (606)
T 3vq2_A 319 L-KQFPTLDLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSAN 394 (606)
T ss_dssp C-SSCCCCCCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCC
T ss_pred C-cccccCCCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhh
Confidence 9 5566 35778889888544322 6778999999999999999774 7788899999999999999985 6789
Q ss_pred CCCCCCccEEEccCCccCCCCc-ccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCC-CCCCcccCccc
Q 038003 381 IGNSPKLQVLDLSSNHIVGKIP-VQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSS-SIPKSIGNLLK 458 (848)
Q Consensus 381 l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~ 458 (848)
+..+++|+.|++++|++.+..+ ..+..+++|++|++++|.+++..|..|..+++|++|++++|++++ .+|..|+.+++
T Consensus 395 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 474 (606)
T 3vq2_A 395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474 (606)
T ss_dssp CTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred ccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCC
Confidence 9999999999999999998877 689999999999999999999999999999999999999999997 47999999999
Q ss_pred cceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhcccc-CceeecCC
Q 038003 459 LHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMR-SLSCIDIS 537 (848)
Q Consensus 459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~l~ls 537 (848)
|++|+|++|++++..|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|+|+. +|..+..++ +|+.++++
T Consensus 475 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~ 553 (606)
T 3vq2_A 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLT 553 (606)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECC
T ss_pred CCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEcc
Confidence 9999999999999999999999999999999999999999999999999999999999985 677799997 59999999
Q ss_pred CCccCCCCC
Q 038003 538 YNELHGPIP 546 (848)
Q Consensus 538 ~N~l~~~~~ 546 (848)
+|++.+..+
T Consensus 554 ~N~~~c~c~ 562 (606)
T 3vq2_A 554 NNSVACICE 562 (606)
T ss_dssp SCCCCCSST
T ss_pred CCCcccCCc
Confidence 999987554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=519.29 Aligned_cols=469 Identities=25% Similarity=0.242 Sum_probs=417.2
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
+++++|+|++|.+++..|..|+++++|++|||++|.+++..|..|+++++|++|+|++|++++..+..|+.+++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 78999999999999888888999999999999999999999999999999999999999999665668999999999999
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCccccc--CCcccceeeccccCCC
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLG--NLSSLTMMSLFNNSLS 236 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~l~~n~l~ 236 (848)
++|++++..|..|+++++|++|++++|.+++..|..++++++|++|+|++|.+++..+..+. .+++|+.|++++|+++
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 99999977778999999999999999999999899999999999999999999988777665 5689999999999999
Q ss_pred CCCCCcccCc---------------------------ccccccccccccccCcCCCcccCCCC--CceEEccCccccccC
Q 038003 237 GSIPPILGNL---------------------------KSLSALGLHINQLNGFIPPSIGNLSS--LRVLYLYNNGLYGFV 287 (848)
Q Consensus 237 ~~~p~~l~~l---------------------------~~L~~L~l~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~l~~~~ 287 (848)
+..|..+..+ ++|+.|++++|++.+..|.++..++. |++|++++|.+++..
T Consensus 185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~ 264 (680)
T 1ziw_A 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264 (680)
T ss_dssp CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEEC
T ss_pred ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccC
Confidence 8888777654 45778888999999989999988765 999999999999999
Q ss_pred cccccCCCCCccccccccccccccCC------ccceeeccccCCC---------CccccccCCCCCccEEEccCCccccc
Q 038003 288 PEEIGYLKSLSELELCTNLLRGVIPH------SIERVLLNQNNLS---------GKMYEAFGDHPNLTFLDLSNNNFCGE 352 (848)
Q Consensus 288 p~~~~~l~~L~~L~L~~N~l~~~~p~------~l~~l~L~~n~l~---------~~~~~~~~~l~~L~~L~Ls~N~l~~~ 352 (848)
|..|..+++|++|++++|.+.+..|. .++.+.+.+|... .+....|..+++|++|++++|++++.
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~ 344 (680)
T 1ziw_A 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCC
T ss_pred cccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCC
Confidence 99999999999999999999988775 4677888766433 33334788899999999999999998
Q ss_pred cCccccCcccccEeecc----------------------------cccccCCCCCCCCCCCCccEEEccCCccCCCCc-c
Q 038003 353 ISFNWGNFSKLSTFIVS----------------------------MNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIP-V 403 (848)
Q Consensus 353 ~~~~~~~l~~L~~L~l~----------------------------~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~ 403 (848)
.+..|..+++|+.|+++ +|++++..|..+..+++|++|+|++|++++.+| .
T Consensus 345 ~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 424 (680)
T 1ziw_A 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSG
T ss_pred ChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcc
Confidence 88777777666666654 455666678889999999999999999987665 7
Q ss_pred cccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccC--CCCCCcccCccccceeccccCcCCCCChhHHhhhc
Q 038003 404 QLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLS--SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLI 481 (848)
Q Consensus 404 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 481 (848)
.+..+++|++|++++|++++..+..|..+++|+.|++++|.++ +..|..|+.+++|+.|+|++|++++..+..|.+++
T Consensus 425 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~ 504 (680)
T 1ziw_A 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504 (680)
T ss_dssp GGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred cccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccc
Confidence 8999999999999999999999999999999999999999987 57899999999999999999999998888999999
Q ss_pred ccceecccCcccCcCCC--------ccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCCCCC
Q 038003 482 HLSELDLSHNILQEEIP--------PQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPN 547 (848)
Q Consensus 482 ~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~~ 547 (848)
+|++|+|++|++++..+ ..+..+++|++|+|++|+++...+..|..+++|+.|++++|++++..+.
T Consensus 505 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~ 578 (680)
T 1ziw_A 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578 (680)
T ss_dssp TCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred ccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHh
Confidence 99999999999986422 2478999999999999999987677899999999999999999965543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=509.97 Aligned_cols=483 Identities=21% Similarity=0.232 Sum_probs=426.8
Q ss_pred EeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccC
Q 038003 59 ITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQ 138 (848)
Q Consensus 59 l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 138 (848)
++..+.++. .+|. .+ -+++++|+|++|.+++..|.+|+++++|++|+|++|++++..|.+|+++++|++|+|++|+
T Consensus 17 ~~c~~~~l~-~iP~-~l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 17 YNCENLGLN-EIPG-TL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EECTTSCCS-SCCT-TS--CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EECCCCCcc-cCcC-CC--CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 455555554 3332 12 2479999999999999889999999999999999999999999999999999999999999
Q ss_pred cCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCccc
Q 038003 139 LHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218 (848)
Q Consensus 139 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 218 (848)
+++..|..|+.+++|++|+|++|++++..|..++++++|++|++++|++++..+..+..+++|++|+|++|++++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 99999999999999999999999999777888999999999999999999754444555999999999999999888999
Q ss_pred ccCCcccc--eeeccccCCCCCCCCcccCccccccccccccccc--------------------------CcCCCcccCC
Q 038003 219 LGNLSSLT--MMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN--------------------------GFIPPSIGNL 270 (848)
Q Consensus 219 l~~l~~L~--~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~--------------------------~~~p~~l~~l 270 (848)
++.+++|+ .|++++|.+++..|..+.. .+|+.|++++|... ...+..+..+
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l 251 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchh
Confidence 99999999 8999999999776666544 68999999887510 1112223333
Q ss_pred C--CCceEEccCccccccCcccccCCCCCccccccccccccccC-----CccceeeccccCCCCccccccCCCCCccEEE
Q 038003 271 S--SLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP-----HSIERVLLNQNNLSGKMYEAFGDHPNLTFLD 343 (848)
Q Consensus 271 ~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-----~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~ 343 (848)
. +|+.|++++|.+++..+..|..+++|++|++++|.++...+ ..++.|.+.+|.++...+..+..+++|++|+
T Consensus 252 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 331 (606)
T 3t6q_A 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS 331 (606)
T ss_dssp GGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEE
T ss_pred hcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEE
Confidence 2 78999999999999888889999999999999999985432 3578899999999999999999999999999
Q ss_pred ccCCccccccCc-cccCcccccEeecccccccCCC--CCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCc
Q 038003 344 LSNNNFCGEISF-NWGNFSKLSTFIVSMNNISGSI--PPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQ 420 (848)
Q Consensus 344 Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~i~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 420 (848)
+++|.+.+..+. .+..+++|+.|++++|.+.+.. +..+..+++|++|++++|++.+..|..+..+++|+.|++++|+
T Consensus 332 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 411 (606)
T 3t6q_A 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411 (606)
T ss_dssp CCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCC
T ss_pred CCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCc
Confidence 999999866654 4899999999999999998766 7889999999999999999998899999999999999999999
Q ss_pred CCCCCCcc-cCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCC---ChhHHhhhcccceecccCcccCcC
Q 038003 421 LSGGVPLE-FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHK---IPTEFEKLIHLSELDLSHNILQEE 496 (848)
Q Consensus 421 l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~ 496 (848)
+++..+.. |..+++|++|++++|.+++..|..|+.+++|++|+|++|++++. .+..+..+++|++|+|++|++++.
T Consensus 412 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 491 (606)
T 3t6q_A 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491 (606)
T ss_dssp EECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEE
T ss_pred CCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCcc
Confidence 99776654 89999999999999999999999999999999999999999873 346799999999999999999999
Q ss_pred CCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCCCCC
Q 038003 497 IPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPN 547 (848)
Q Consensus 497 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~~ 547 (848)
.|..|..+++|++|+|++|++++..|..|..+++| .|++++|++++.+|.
T Consensus 492 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~ 541 (606)
T 3t6q_A 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS 541 (606)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGG
T ss_pred ChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHh
Confidence 99999999999999999999999999999999999 999999999987764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=521.45 Aligned_cols=488 Identities=23% Similarity=0.238 Sum_probs=377.1
Q ss_pred CccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccc-cccccCCCCCcEEEccccCCCCCCc
Q 038003 42 CSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNI-PLQIGNLSKLQYLDLGSNQLSGLIP 120 (848)
Q Consensus 42 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p 120 (848)
|.|..|.+ ...+++.|+|+++.+++..+ .+|.++++|++|+|++|.+.+.+ |.+|+++++|++|+|++|.+++..|
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~-~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p 90 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTA-SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECS-SSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccCh-hHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence 57888887 45689999999998876544 47999999999999999887777 7789999999999999999999999
Q ss_pred hhhhccccccEEEecccCcCCCCCcc--ccCcCCccEEEcCCCcCCCCCC-CcccCccccceEEeecccccCCCcccccc
Q 038003 121 PEIGKLNQLRRLYLDMNQLHGTIPPE--IGQLSLIDKLALCHNNLHGSIP-SSLGNLSNLAVLYLYKNSLSGSIPSIIGK 197 (848)
Q Consensus 121 ~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~ 197 (848)
..|+++++|++|+|++|.+++.+|.. ++.+++|++|+|++|.+++..| ..|+++++|++|+|++|.+++..|..++.
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 99999999999999999999877765 9999999999999999997655 57999999999999999999989999988
Q ss_pred c--ccccccccccccccccCcccccCCcc------cceeeccccCCCCCCCCcccCc-----------------------
Q 038003 198 L--KSLLQLDLSENQFSGSIPLSLGNLSS------LTMMSLFNNSLSGSIPPILGNL----------------------- 246 (848)
Q Consensus 198 l--~~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~l~~n~l~~~~p~~l~~l----------------------- 246 (848)
+ ++|+.|+|++|.+++..|..++.+++ |+.|++++|.+++.+|..+...
T Consensus 171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~ 250 (844)
T 3j0a_A 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250 (844)
T ss_dssp HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence 8 89999999999999999888877766 9999999999988777655432
Q ss_pred ---------------ccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccccccccccc
Q 038003 247 ---------------KSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVI 311 (848)
Q Consensus 247 ---------------~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 311 (848)
++|+.|++++|.+.+..|..|..+++|+.|+|++|.+.+..|..|..+++|++|++++|.+++..
T Consensus 251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 330 (844)
T 3j0a_A 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330 (844)
T ss_dssp SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence 46777777777777777777777777777777777777777777777777777777777776665
Q ss_pred CC------ccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCC
Q 038003 312 PH------SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSP 385 (848)
Q Consensus 312 p~------~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~ 385 (848)
|. .++.+.+++|+++.+....|..+++|++|+|++|.+++. ..+++|+.|++++|+++ .+|.. ..
T Consensus 331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~ 401 (844)
T 3j0a_A 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NL 401 (844)
T ss_dssp SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CT
T ss_pred HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---cc
Confidence 53 456667777777777766777777777777777776643 22666777777777776 33433 34
Q ss_pred CccEEEccCCccCCCC-cccccccccccEEEccCCcCCCCCCc-ccCCCCccCeEeccCcccC-----CCCCCcccCccc
Q 038003 386 KLQVLDLSSNHIVGKI-PVQLEMLSSLNKLILNLNQLSGGVPL-EFGSLTKLQYLDLSTNKLS-----SSIPKSIGNLLK 458 (848)
Q Consensus 386 ~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~ 458 (848)
+++.|++++|++++.. +..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++
T Consensus 402 ~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~ 481 (844)
T 3j0a_A 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481 (844)
T ss_dssp TCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCC
T ss_pred ccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCccc
Confidence 5677777777777432 22345677777777777777754433 3455677777777777776 344556777777
Q ss_pred cceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCC
Q 038003 459 LHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISY 538 (848)
Q Consensus 459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~ 538 (848)
|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..| .+|+.+++++
T Consensus 482 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~ 556 (844)
T 3j0a_A 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITH 556 (844)
T ss_dssp EECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEE
T ss_pred ccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecC
Confidence 77788888877777777777777777888888877766555554 677777888887777777654 3677777777
Q ss_pred CccCCCCC
Q 038003 539 NELHGPIP 546 (848)
Q Consensus 539 N~l~~~~~ 546 (848)
|++.+..+
T Consensus 557 Np~~C~c~ 564 (844)
T 3j0a_A 557 NKFICECE 564 (844)
T ss_dssp ECCCCSSS
T ss_pred CCcccccc
Confidence 77766444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=501.85 Aligned_cols=477 Identities=23% Similarity=0.236 Sum_probs=419.6
Q ss_pred EEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEeccc
Q 038003 58 SITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMN 137 (848)
Q Consensus 58 ~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 137 (848)
.++.++.+++ .+|.. -.+++++|+|++|.+++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|
T Consensus 15 ~~~c~~~~l~-~ip~~---~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDD---IPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp EEECTTSCCS-SCCTT---SCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEccCCCcc-cCCCC---CCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 3566666654 33431 2378999999999999988889999999999999999999988999999999999999999
Q ss_pred CcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccC-CCcccccccccccccccccccccccCc
Q 038003 138 QLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG-SIPSIIGKLKSLLQLDLSENQFSGSIP 216 (848)
Q Consensus 138 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p 216 (848)
++++..|..|+.+++|++|+|++|.+++..|..++++++|++|++++|.+++ .+|..|+++++|++|+|++|++++..|
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~ 170 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred cccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence 9998889999999999999999999997777899999999999999999986 579999999999999999999999888
Q ss_pred ccccCCcccc----eeeccccCCCCCCCCcccCccccccccccccccc-CcCCCcccCCCCCceEEc-------------
Q 038003 217 LSLGNLSSLT----MMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN-GFIPPSIGNLSSLRVLYL------------- 278 (848)
Q Consensus 217 ~~l~~l~~L~----~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~-~~~p~~l~~l~~L~~L~L------------- 278 (848)
..++.+++|+ +|++++|.+++..+..+.. .+|+.|++++|.+. +..|..+.++++|+.+++
T Consensus 171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~ 249 (606)
T 3vq2_A 171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249 (606)
T ss_dssp TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred hhhhhhhccccccceeeccCCCcceeCcccccC-ceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence 8888888776 7999999999655555544 49999999999986 445666777777776665
Q ss_pred --------------------cCccccccCcccccCCCCCcccccccccccccc--C--CccceeeccccCCCCccccccC
Q 038003 279 --------------------YNNGLYGFVPEEIGYLKSLSELELCTNLLRGVI--P--HSIERVLLNQNNLSGKMYEAFG 334 (848)
Q Consensus 279 --------------------s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p--~~l~~l~L~~n~l~~~~~~~~~ 334 (848)
..|.+.+.+|. +..+++|+.|++++|.+.... + ..++.+.+.+|.+..++ .+
T Consensus 250 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp--~~- 325 (606)
T 3vq2_A 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFP--TL- 325 (606)
T ss_dssp CCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCC--CC-
T ss_pred cChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccc--cC-
Confidence 56677777776 889999999999999997542 1 36889999999996665 45
Q ss_pred CCCCccEEEccCCccccccCccccCcccccEeecccccccCC--CCCCCCCCCCccEEEccCCccCCCCccccccccccc
Q 038003 335 DHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGS--IPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLN 412 (848)
Q Consensus 335 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 412 (848)
.+++|+.|++++|...+.. .+..+++|+.|++++|++++. +|..+..+++|++|++++|.+++ +|..+..+++|+
T Consensus 326 ~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~ 402 (606)
T 3vq2_A 326 DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQ 402 (606)
T ss_dssp CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCC
T ss_pred CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCC
Confidence 8999999999999765543 677899999999999999866 37788899999999999999984 668899999999
Q ss_pred EEEccCCcCCCCCC-cccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCC-CChhHHhhhcccceecccC
Q 038003 413 KLILNLNQLSGGVP-LEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH-KIPTEFEKLIHLSELDLSH 490 (848)
Q Consensus 413 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~ 490 (848)
.|++++|++++..| ..|..+++|++|++++|++++..|..|+.+++|++|++++|++++ .+|..|..+++|++|+|++
T Consensus 403 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 482 (606)
T 3vq2_A 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482 (606)
T ss_dssp EEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred eeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCC
Confidence 99999999998877 689999999999999999999999999999999999999999997 4788999999999999999
Q ss_pred cccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCCCCC
Q 038003 491 NILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPN 547 (848)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~~ 547 (848)
|++++..|..+..+++|++|+|++|++++.+|..|..+++|+.|++++|+++. +|.
T Consensus 483 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~ 538 (606)
T 3vq2_A 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKG 538 (606)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EES
T ss_pred CcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCH
Confidence 99999999999999999999999999999999999999999999999999984 444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=510.08 Aligned_cols=478 Identities=26% Similarity=0.249 Sum_probs=400.8
Q ss_pred CCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCC-chhhhccccccEEEecccCcCCCCCccccCcCCccE
Q 038003 77 SFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLI-PPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDK 155 (848)
Q Consensus 77 ~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 155 (848)
..+++++|||++|.+++..|..|+++++|++|||++|.+.+.+ |.+|+++++|++|+|++|++++..|..|+.+++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 4578999999999999999999999999999999999766666 788999999999999999999999999999999999
Q ss_pred EEcCCCcCCCCCCCc--ccCccccceEEeecccccCCCc-ccccccccccccccccccccccCcccccCC--cccceeec
Q 038003 156 LALCHNNLHGSIPSS--LGNLSNLAVLYLYKNSLSGSIP-SIIGKLKSLLQLDLSENQFSGSIPLSLGNL--SSLTMMSL 230 (848)
Q Consensus 156 L~L~~n~l~~~~p~~--l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~l 230 (848)
|+|++|.+++.+|.. ++++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..|..+..+ ++|+.|++
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L 181 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence 999999999877765 9999999999999999997765 579999999999999999999999999888 89999999
Q ss_pred cccCCCCCCCCcccCccc------ccccccccccccCcCCCcccCC----------------------------------
Q 038003 231 FNNSLSGSIPPILGNLKS------LSALGLHINQLNGFIPPSIGNL---------------------------------- 270 (848)
Q Consensus 231 ~~n~l~~~~p~~l~~l~~------L~~L~l~~N~l~~~~p~~l~~l---------------------------------- 270 (848)
++|.+.+..|..++.+.+ |+.|++++|++++.++..+...
T Consensus 182 ~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~ 261 (844)
T 3j0a_A 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261 (844)
T ss_dssp CCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTT
T ss_pred CCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhh
Confidence 999999998888877766 9999999999887776655432
Q ss_pred ----CCCceEEccCccccccCcccccCCCCCccccccccccccccCC------ccceeeccccCCCCccccccCCCCCcc
Q 038003 271 ----SSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH------SIERVLLNQNNLSGKMYEAFGDHPNLT 340 (848)
Q Consensus 271 ----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~------~l~~l~L~~n~l~~~~~~~~~~l~~L~ 340 (848)
++|+.|++++|.+.+..|..+..+++|+.|++++|.+++..|. .++.|.+++|.++.+.+..|..+++|+
T Consensus 262 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 341 (844)
T 3j0a_A 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341 (844)
T ss_dssp TTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCC
T ss_pred ccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCC
Confidence 5688888888888877788888888888888888888776553 466777888888877777788888888
Q ss_pred EEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCc
Q 038003 341 FLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQ 420 (848)
Q Consensus 341 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 420 (848)
.|++++|++.+..+..|..+++|+.|++++|.+++ +..+++|+.|++++|+++ .+|.. ..+++.|++++|+
T Consensus 342 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-----i~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~ 412 (844)
T 3j0a_A 342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENR 412 (844)
T ss_dssp EEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-----CSSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCC
T ss_pred EEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-----ccCCCCcchhccCCCCcc-ccccc---ccccceeecccCc
Confidence 88888888877777777788888888888888763 223677888888888887 44433 4578888888888
Q ss_pred CCCCCC-cccCCCCccCeEeccCcccCCCCCC-cccCccccceeccccCcCC-----CCChhHHhhhcccceecccCccc
Q 038003 421 LSGGVP-LEFGSLTKLQYLDLSTNKLSSSIPK-SIGNLLKLHYLNLSNNQLS-----HKIPTEFEKLIHLSELDLSHNIL 493 (848)
Q Consensus 421 l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l 493 (848)
+++... ..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|
T Consensus 413 l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 492 (844)
T 3j0a_A 413 LENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492 (844)
T ss_dssp CCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHH
T ss_pred cccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcc
Confidence 885422 2356899999999999999976544 4667899999999999997 44556789999999999999999
Q ss_pred CcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCCCCCCCcc-cccccccccCcccc
Q 038003 494 QEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAF-KDGLMEGNKGLKRV 565 (848)
Q Consensus 494 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~~~~~~-~~~~~~~~~~l~~~ 565 (848)
++..|..|..+++|++|+|++|+|++..+..+. ++|+.|++++|++++.+|..... ..-.+.+|+..+.|
T Consensus 493 ~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICEC 563 (844)
T ss_dssp TTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSS
T ss_pred cccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccc
Confidence 999999999999999999999999998777776 89999999999999998865331 11134566655444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=491.43 Aligned_cols=480 Identities=23% Similarity=0.224 Sum_probs=395.9
Q ss_pred CCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCc
Q 038003 41 PCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIP 120 (848)
Q Consensus 41 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 120 (848)
.|.|.|| |+-....++ .+|+. + .++|++|+|++|.+++..|.+|+++++|++|+|++|++++..|
T Consensus 3 ~C~~~~~-c~~~~~~l~-----------~ip~~-~--~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~ 67 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFT-----------SIPSG-L--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67 (549)
T ss_dssp EECTTSE-EECTTSCCS-----------SCCSC-C--CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT
T ss_pred cCCCCce-EECCCCccc-----------ccccc-C--CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh
Confidence 4999999 975443332 23331 2 3789999999999998888999999999999999999998888
Q ss_pred hhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCC-CCCCcccCccccceEEeecccccCCCc-cccccc
Q 038003 121 PEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG-SIPSSLGNLSNLAVLYLYKNSLSGSIP-SIIGKL 198 (848)
Q Consensus 121 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l 198 (848)
.+|+++++|++|+|++|++++..|..|+.+++|++|+|++|++++ .+|..++++++|++|++++|.+.+.+| ..|+++
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 899999999999999999998777789999999999999999986 467789999999999999998555555 689999
Q ss_pred ccccccccccccccccCcccccCCcccceeeccccCCCCCCCCc-ccCcccccccccccccccCcC--C-CcccCCCCCc
Q 038003 199 KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPI-LGNLKSLSALGLHINQLNGFI--P-PSIGNLSSLR 274 (848)
Q Consensus 199 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~-l~~l~~L~~L~l~~N~l~~~~--p-~~l~~l~~L~ 274 (848)
++|++|++++|++++.+|..++.+++|++|++++|.+. .+|.. +..+++|++|++++|++++.. | .....+++|+
T Consensus 148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~ 226 (549)
T 2z81_A 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226 (549)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred cccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence 99999999999999999999999999999999999987 45544 356899999999999998752 2 2234578899
Q ss_pred eEEccCccccccCc----ccccCCCCCcccccccccccccc------------CCccceeeccccCCCCccc-----ccc
Q 038003 275 VLYLYNNGLYGFVP----EEIGYLKSLSELELCTNLLRGVI------------PHSIERVLLNQNNLSGKMY-----EAF 333 (848)
Q Consensus 275 ~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~------------p~~l~~l~L~~n~l~~~~~-----~~~ 333 (848)
.|++++|.+++..+ ..+..+++|+.+++++|.+.+.. -..++.+.+.++.+..... ..+
T Consensus 227 ~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~ 306 (549)
T 2z81_A 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306 (549)
T ss_dssp EEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHH
T ss_pred ceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhh
Confidence 99999999876544 34467789999999999887641 1246667777776654321 112
Q ss_pred CCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCC---CCCCCCCCccEEEccCCccCCCCc--cccccc
Q 038003 334 GDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIP---PDIGNSPKLQVLDLSSNHIVGKIP--VQLEML 408 (848)
Q Consensus 334 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p---~~l~~l~~L~~L~Ls~N~l~~~~~--~~l~~l 408 (848)
...++|+.|++++|.++......+..+++|+.|++++|++.+.+| ..++.+++|++|+|++|++++..+ ..+..+
T Consensus 307 ~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l 386 (549)
T 2z81_A 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386 (549)
T ss_dssp HHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred hhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence 234689999999999985443334679999999999999987663 458889999999999999986543 568999
Q ss_pred ccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecc
Q 038003 409 SSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDL 488 (848)
Q Consensus 409 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 488 (848)
++|++|++++|+++ .+|..+..+++|++|++++|++++ +|..+ .++|++|+|++|+|++.+ ..+++|++|+|
T Consensus 387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~L 458 (549)
T 2z81_A 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYI 458 (549)
T ss_dssp TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEEC
Confidence 99999999999999 678889999999999999999984 44443 268999999999999754 57889999999
Q ss_pred cCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCCCC
Q 038003 489 SHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIP 546 (848)
Q Consensus 489 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~ 546 (848)
++|+|+ .+|. ...+++|++|+|++|++++.+|..|..+++|+.+++++|++.+..|
T Consensus 459 s~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 459 SRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 999997 5665 5789999999999999999999999999999999999999987665
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=497.95 Aligned_cols=434 Identities=22% Similarity=0.297 Sum_probs=348.3
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCC------CC------CCchhhhccccccEEEecccCcCCCCCcc
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQL------SG------LIPPEIGKLNQLRRLYLDMNQLHGTIPPE 146 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l------~~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 146 (848)
.+++.|+|++|.+.|.+|++|++|++|++|||++|.+ .| .+|... +.+|+ ++++.|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4789999999999999999999999999999999976 34 566655 67788 999999999988888
Q ss_pred ccC-cCCccEEEcCCCcCCCCCCCcccCccccceEEe--ecccccCCCccccccccccccccccccccccc---------
Q 038003 147 IGQ-LSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL--YKNSLSGSIPSIIGKLKSLLQLDLSENQFSGS--------- 214 (848)
Q Consensus 147 ~~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l--~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--------- 214 (848)
++. +..+..+++....+.. .....++.+.+ ..|+++| +|..|+++++|++|+|++|+++|.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 774 3344444444333321 11122333333 3466776 677777777777777777777764
Q ss_pred --------Cccccc--CCcccceeeccccCCCCCCCCcccCccccccccccccc-ccC-cCCCcccCC------CCCceE
Q 038003 215 --------IPLSLG--NLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQ-LNG-FIPPSIGNL------SSLRVL 276 (848)
Q Consensus 215 --------~p~~l~--~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~p~~l~~l------~~L~~L 276 (848)
+|..++ ++++|++|++++|++.+.+|..++++++|++|++++|+ ++| .+|..++.+ ++|++|
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L 310 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEE
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEE
Confidence 777777 77788888888887777777777778888888888887 777 677777665 788888
Q ss_pred EccCccccccCcc--cccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccC
Q 038003 277 YLYNNGLYGFVPE--EIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEIS 354 (848)
Q Consensus 277 ~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 354 (848)
++++|.++ .+|. .++.+++|+.|++++|.++|.+| .+ +.+++|++|++++|+++ .+|
T Consensus 311 ~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~------------------~~l~~L~~L~L~~N~l~-~lp 369 (636)
T 4eco_A 311 YIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF------------------GSEIKLASLNLAYNQIT-EIP 369 (636)
T ss_dssp ECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC------------------EEEEEESEEECCSSEEE-ECC
T ss_pred ECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh------------------CCCCCCCEEECCCCccc-ccc
Confidence 88888887 6777 78888888888888888877666 33 34568888888888888 667
Q ss_pred ccccCccc-ccEeecccccccCCCCCCCCCCC--CccEEEccCCccCCCCccccc-------ccccccEEEccCCcCCCC
Q 038003 355 FNWGNFSK-LSTFIVSMNNISGSIPPDIGNSP--KLQVLDLSSNHIVGKIPVQLE-------MLSSLNKLILNLNQLSGG 424 (848)
Q Consensus 355 ~~~~~l~~-L~~L~l~~N~i~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~~~~l~-------~l~~L~~L~L~~N~l~~~ 424 (848)
..+..+++ |+.|++++|+++ .+|..+..++ +|++|++++|++++..|..+. .+++|+.|+|++|++++.
T Consensus 370 ~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~l 448 (636)
T 4eco_A 370 ANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448 (636)
T ss_dssp TTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSC
T ss_pred HhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcC
Confidence 77888888 999999999988 7888888765 899999999999999999888 888999999999999955
Q ss_pred CCcccCCCCccCeEeccCcccCCCCCCc-ccCc-------cccceeccccCcCCCCChhHHh--hhcccceecccCcccC
Q 038003 425 VPLEFGSLTKLQYLDLSTNKLSSSIPKS-IGNL-------LKLHYLNLSNNQLSHKIPTEFE--KLIHLSELDLSHNILQ 494 (848)
Q Consensus 425 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~ 494 (848)
.+..+..+++|++|+|++|+++ .+|.. +..+ ++|++|+|++|+|+ .+|..+. .+++|+.|+|++|+|+
T Consensus 449 p~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~ 526 (636)
T 4eco_A 449 PKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFS 526 (636)
T ss_dssp CTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCS
T ss_pred CHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCC
Confidence 5555667999999999999999 55544 4333 39999999999999 6788886 9999999999999998
Q ss_pred cCCCccccCCCCCccccC------CCCcccCCCcchhccccCceeecCCCCccCCCCCCC
Q 038003 495 EEIPPQVCNMGSLEKLNL------SHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548 (848)
Q Consensus 495 ~~~p~~~~~l~~L~~L~L------s~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~~~ 548 (848)
+ +|..+..+++|++|+| ++|++.+.+|..+..+++|+.|++++|++ +.+|..
T Consensus 527 ~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~ 584 (636)
T 4eco_A 527 K-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK 584 (636)
T ss_dssp S-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC
T ss_pred C-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh
Confidence 7 8999999999999999 56888999999999999999999999999 777764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=483.22 Aligned_cols=485 Identities=23% Similarity=0.238 Sum_probs=311.2
Q ss_pred ceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEe
Q 038003 55 RVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYL 134 (848)
Q Consensus 55 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 134 (848)
++..|+++++.+.+. ++.+|..+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 29 ~l~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 29 STKNLDLSFNPLRHL-GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SCCEEECCSCCCCEE-CTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred cccEEEccCCccCcc-ChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 344455555444432 2223455555555555555555444444555555555555555555444445555555555555
Q ss_pred cccCcCCCCCccccCcCCccEEEcCCCcCCC-CCCCcccCccccceEEeecccccCCCcccccccccc----cccccccc
Q 038003 135 DMNQLHGTIPPEIGQLSLIDKLALCHNNLHG-SIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSL----LQLDLSEN 209 (848)
Q Consensus 135 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L----~~L~L~~N 209 (848)
++|++++..+..++.+++|++|+|++|.+++ .+|..++++++|++|++++|++++..|..++.+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 5555553333345555555555555555543 245555555555555555555554444445555444 44555555
Q ss_pred cccccCcccccCCcccceeeccccCCCCC-CCCcccCccccccccccccc------ccCcCCCcccCCC--CCceEEccC
Q 038003 210 QFSGSIPLSLGNLSSLTMMSLFNNSLSGS-IPPILGNLKSLSALGLHINQ------LNGFIPPSIGNLS--SLRVLYLYN 280 (848)
Q Consensus 210 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~-~p~~l~~l~~L~~L~l~~N~------l~~~~p~~l~~l~--~L~~L~Ls~ 280 (848)
.+++..|..+..+ +|+.|++++|..... ++..+..++.++.+.+..+. +.......+..+. .++.+++++
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 5554444444333 455555554422110 11111111111111111000 0000111111111 123344444
Q ss_pred c-cccccCcccccCCCCCccccccccccccccCC-----ccceeeccccCCCCccccccCCCCCccEEEccCCccccccC
Q 038003 281 N-GLYGFVPEEIGYLKSLSELELCTNLLRGVIPH-----SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEIS 354 (848)
Q Consensus 281 N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-----~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 354 (848)
| .+.+..|..+..+++|+.|++++|.+.+. |. .++.+.+.+|.+..++. ..+++|+.|++++|.+.+..+
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l-~~~~~~~~L~~L~l~~n~~~~l~~---~~l~~L~~L~l~~n~~~~~~~ 342 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERV-KDFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNAFS 342 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEECSC-CBCCSCCCCSEEEEESCBCSSCCB---CBCSSCCEEEEESCBSCCBCC
T ss_pred chhhhhhchhhhcCcCcccEEEecCccchhh-hhhhccCCccEEeeccCcccccCc---ccccccCEEeCcCCccccccc
Confidence 4 34444445555555555555555555432 21 34445555555554333 356889999999999887665
Q ss_pred ccccCcccccEeecccccccCCC--CCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCC-cccCC
Q 038003 355 FNWGNFSKLSTFIVSMNNISGSI--PPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVP-LEFGS 431 (848)
Q Consensus 355 ~~~~~l~~L~~L~l~~N~i~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~ 431 (848)
. ..+++|+.|++++|++++.. |..+..+++|++|++++|.+++..+. +..+++|+.|++++|.+++..+ ..+..
T Consensus 343 ~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 419 (570)
T 2z63_A 343 E--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLS 419 (570)
T ss_dssp C--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTT
T ss_pred c--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhc
Confidence 4 78899999999999998654 66788899999999999999965544 9999999999999999997766 57899
Q ss_pred CCccCeEeccCcccCCCCCCcccCccccceeccccCcCC-CCChhHHhhhcccceecccCcccCcCCCccccCCCCCccc
Q 038003 432 LTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLS-HKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKL 510 (848)
Q Consensus 432 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 510 (848)
+++|++|++++|++++..|..|..+++|++|+|++|+++ +.+|..|..+++|++|+|++|++++..|..+..+++|++|
T Consensus 420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 499 (570)
T 2z63_A 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499 (570)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence 999999999999999999999999999999999999998 5788999999999999999999999889999999999999
Q ss_pred cCCCCcccCCCcchhccccCceeecCCCCccCCCCCCC
Q 038003 511 NLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548 (848)
Q Consensus 511 ~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~~~ 548 (848)
+|++|++++.++..|..+++|+.+++++|++++..|..
T Consensus 500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 99999999988889999999999999999999988754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=470.08 Aligned_cols=462 Identities=22% Similarity=0.218 Sum_probs=372.2
Q ss_pred ceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEe
Q 038003 55 RVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYL 134 (848)
Q Consensus 55 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 134 (848)
.+..|+++++.+.+ +++..|.++++|++|+|++|.+++..|.+|+.+++|++|+|++|++++..+..|+++++|++|+|
T Consensus 53 ~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 131 (570)
T 2z63_A 53 ELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (570)
T ss_dssp SCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred CceEEECCCCcCCc-cCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence 57789999988876 44457999999999999999999888899999999999999999999776667999999999999
Q ss_pred cccCcCC-CCCccccCcCCccEEEcCCCcCCCCCCCcccCcccc----ceEEeecccccCCCcccccccccccccccccc
Q 038003 135 DMNQLHG-TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNL----AVLYLYKNSLSGSIPSIIGKLKSLLQLDLSEN 209 (848)
Q Consensus 135 ~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L----~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 209 (848)
++|.+++ .+|..|+.+++|++|++++|++++..|..++.+++| +.|++++|.+++..|..+..+ +|++|++++|
T Consensus 132 ~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n 210 (570)
T 2z63_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNN 210 (570)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESC
T ss_pred CCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccc
Confidence 9999997 579999999999999999999998888889999999 899999999998888888766 8999999998
Q ss_pred cccc-cCcccccCCcccceeeccccCCCC------CCCCcccCcc--cccccccccc-cccCcCCCcccCCCCCceEEcc
Q 038003 210 QFSG-SIPLSLGNLSSLTMMSLFNNSLSG------SIPPILGNLK--SLSALGLHIN-QLNGFIPPSIGNLSSLRVLYLY 279 (848)
Q Consensus 210 ~l~~-~~p~~l~~l~~L~~L~l~~n~l~~------~~p~~l~~l~--~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~Ls 279 (848)
.... .++..+..+++++.+.+..+.+.+ .....+..+. .++.++++.| .+.+.+|..+..+++|++|+++
T Consensus 211 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~ 290 (570)
T 2z63_A 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290 (570)
T ss_dssp CSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEE
T ss_pred cccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEec
Confidence 6442 344555566665555443322211 1111222222 2344555555 5555566666666666666666
Q ss_pred CccccccCcccccCCCCCccccccccccccccC---CccceeeccccCCCCccccccCCCCCccEEEccCCcccccc--C
Q 038003 280 NNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP---HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI--S 354 (848)
Q Consensus 280 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~ 354 (848)
+|.+. .+|..+..+ +|+.|++++|.+....+ ..++.+.+.+|.+...... ..+++|++|++++|++++.. +
T Consensus 291 ~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~ 366 (570)
T 2z63_A 291 SVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCS 366 (570)
T ss_dssp SCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEE
T ss_pred Cccch-hhhhhhccC-CccEEeeccCcccccCcccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCcccccc
Confidence 66665 355555555 66666666666653211 2355566666665544333 57899999999999998765 6
Q ss_pred ccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCc-ccccccccccEEEccCCcCCCCCCcccCCCC
Q 038003 355 FNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIP-VQLEMLSSLNKLILNLNQLSGGVPLEFGSLT 433 (848)
Q Consensus 355 ~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 433 (848)
..+..+++|+.|++++|.+.+..+. +..+++|++|++++|.+.+..+ ..+..+++|++|++++|.+++..|..|..++
T Consensus 367 ~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 445 (570)
T 2z63_A 367 QSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445 (570)
T ss_dssp HHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred ccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCC
Confidence 6788899999999999999865544 8999999999999999997766 5789999999999999999999999999999
Q ss_pred ccCeEeccCcccC-CCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccC
Q 038003 434 KLQYLDLSTNKLS-SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNL 512 (848)
Q Consensus 434 ~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 512 (848)
+|++|++++|+++ +.+|..++.+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|++|++
T Consensus 446 ~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 525 (570)
T 2z63_A 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWL 525 (570)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred cCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEe
Confidence 9999999999998 578999999999999999999999988999999999999999999999988888999999999999
Q ss_pred CCCcccCCCcc
Q 038003 513 SHNNLSDFIPR 523 (848)
Q Consensus 513 s~N~l~~~~~~ 523 (848)
++|++++..|.
T Consensus 526 ~~N~~~~~~~~ 536 (570)
T 2z63_A 526 HTNPWDCSCPR 536 (570)
T ss_dssp CSSCBCCCTTT
T ss_pred cCCcccCCCcc
Confidence 99999987664
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=464.12 Aligned_cols=458 Identities=22% Similarity=0.185 Sum_probs=373.3
Q ss_pred EEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEeccc
Q 038003 58 SITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMN 137 (848)
Q Consensus 58 ~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 137 (848)
.+++++++++ .+|.. +. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 4 ~l~ls~n~l~-~ip~~-~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKD-LS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp EEECTTSCCS-SCCCS-CC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred eEecCCCCcc-ccccc-cc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 4677777777 46542 33 78999999999998877788899999999999999998887888999999999999999
Q ss_pred CcCCCCCccccCcCCccEEEcCCCcCCC-CCCCcccCccccceEEeecccccCCCcccccccccc--cccccccccc--c
Q 038003 138 QLHGTIPPEIGQLSLIDKLALCHNNLHG-SIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSL--LQLDLSENQF--S 212 (848)
Q Consensus 138 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~ 212 (848)
+++ .+|.. .+++|++|+|++|++++ .+|..++++++|++|++++|++++ ..++.+++| ++|+|++|++ +
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 988 56666 78889999999999887 478888999999999999998875 456677777 8999999988 7
Q ss_pred ccCcccccCCc-ccceeeccccCCCCCCCC-cccCccccccccccccc-------ccCcCCCcccCCCCCceEEccCccc
Q 038003 213 GSIPLSLGNLS-SLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQ-------LNGFIPPSIGNLSSLRVLYLYNNGL 283 (848)
Q Consensus 213 ~~~p~~l~~l~-~L~~L~l~~n~l~~~~p~-~l~~l~~L~~L~l~~N~-------l~~~~p~~l~~l~~L~~L~Ls~N~l 283 (848)
+..|..+..+. +...+++++|.+.+.++. .+..+++|+.|++++|+ +.+.+| .+..+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 78888887766 455678888888876654 67788899999999887 776666 688888899999988887
Q ss_pred cccCccccc---CCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccC-ccccC
Q 038003 284 YGFVPEEIG---YLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEIS-FNWGN 359 (848)
Q Consensus 284 ~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~ 359 (848)
.+..+..+. ..++|++|++++|.+.|.+|..+... ..+.+++|+.+++++|.+ ..| ..+..
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~-------------~~~~l~~L~~l~l~~n~~--~~p~~~~~~ 297 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY-------------SGTSLKALSIHQVVSDVF--GFPQSYIYE 297 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCC-------------CSCCCCEEEEEEEEECCC--CSCTHHHHH
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhc-------------ccccCceeEeccccccce--ecchhhhhc
Confidence 754332221 24578888888888887777643110 126789999999999998 333 33444
Q ss_pred c---ccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCC--CCCcccCCCCc
Q 038003 360 F---SKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSG--GVPLEFGSLTK 434 (848)
Q Consensus 360 l---~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~ 434 (848)
+ .+|+.|++++|.+.... .+..+++|++|++++|++++..|..+..+++|++|++++|++++ .+|..+..+++
T Consensus 298 ~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~ 375 (520)
T 2z7x_B 298 IFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375 (520)
T ss_dssp HHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTT
T ss_pred ccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCC
Confidence 3 67999999999987432 23688999999999999999899999999999999999999996 45677999999
Q ss_pred cCeEeccCcccCCCCCC-cccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCC
Q 038003 435 LQYLDLSTNKLSSSIPK-SIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLS 513 (848)
Q Consensus 435 L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 513 (848)
|++|++++|++++.+|. .+..+++|++|+|++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|+
T Consensus 376 L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~ 452 (520)
T 2z7x_B 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVA 452 (520)
T ss_dssp CCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECC
T ss_pred CCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECC
Confidence 99999999999985554 588899999999999999987776664 68999999999997 788888899999999999
Q ss_pred CCcccCCCcchhccccCceeecCCCCccCCCCC
Q 038003 514 HNNLSDFIPRCFEEMRSLSCIDISYNELHGPIP 546 (848)
Q Consensus 514 ~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~ 546 (848)
+|+|++..+..|..+++|+.+++++|++++..+
T Consensus 453 ~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 453 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 999997554559999999999999999986443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=474.95 Aligned_cols=415 Identities=21% Similarity=0.247 Sum_probs=278.5
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEc-cccCCCCCCchhhhc--------------------------------
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDL-GSNQLSGLIPPEIGK-------------------------------- 125 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~~~~-------------------------------- 125 (848)
.+++.|+|++|++.|.+|++|++|++|++||| ++|.++|..|-....
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 889888874422111
Q ss_pred -------------------cccccEEEec--ccCcCCCCCccccCcCCccEEEcCCCcCCC-----------------CC
Q 038003 126 -------------------LNQLRRLYLD--MNQLHGTIPPEIGQLSLIDKLALCHNNLHG-----------------SI 167 (848)
Q Consensus 126 -------------------l~~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~ 167 (848)
...++.+.++ .|+++| +|..|+.+++|++|+|++|+|+| .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 1112222222 255665 66666666666666666666665 25
Q ss_pred CCccc--CccccceEEeecccccCCCccccccccccccccccccc-ccc-cCcccccCCc-------ccceeeccccCCC
Q 038003 168 PSSLG--NLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQ-FSG-SIPLSLGNLS-------SLTMMSLFNNSLS 236 (848)
Q Consensus 168 p~~l~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~-------~L~~L~l~~n~l~ 236 (848)
|+.++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ ++| .+|..++.++ +|+.|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 66655 66666666666666666666666666666666666665 665 5565555444 5666666666665
Q ss_pred CCCCC--cccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCC-CccccccccccccccCC
Q 038003 237 GSIPP--ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKS-LSELELCTNLLRGVIPH 313 (848)
Q Consensus 237 ~~~p~--~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~ 313 (848)
.+|. .++++++|+.|+|++|+++ .+| .|+.+++|+.|+|++|.+. .+|..+..+++ |+.|++++|.++ .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 5555 5566666666666666655 445 5555666666666666655 45555555555 555555555554 2332
Q ss_pred ccceeeccccCCCCccccccCCC--CCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCC--CCCCccE
Q 038003 314 SIERVLLNQNNLSGKMYEAFGDH--PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIG--NSPKLQV 389 (848)
Q Consensus 314 ~l~~l~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~--~l~~L~~ 389 (848)
. +..+ ++|+.|+|++|++++.++. ++..+. .+++|+.
T Consensus 637 ~------------------~~~~~~~~L~~L~Ls~N~l~g~ip~---------------------l~~~l~~~~~~~L~~ 677 (876)
T 4ecn_A 637 I------------------FNAKSVYVMGSVDFSYNKIGSEGRN---------------------ISCSMDDYKGINAST 677 (876)
T ss_dssp C------------------CCTTCSSCEEEEECCSSCTTTTSSS---------------------CSSCTTTCCCCCEEE
T ss_pred h------------------hhccccCCCCEEECcCCcCCCcccc---------------------chhhhccccCCCcCE
Confidence 1 1111 2355555555555443221 111222 3357888
Q ss_pred EEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCC--------CCccCeEeccCcccCCCCCCccc--Ccccc
Q 038003 390 LDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGS--------LTKLQYLDLSTNKLSSSIPKSIG--NLLKL 459 (848)
Q Consensus 390 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L 459 (848)
|+|++|+++...+..+..+++|+.|+|++|+++ .+|..+.. +++|+.|+|++|+|+ .+|..+. .+++|
T Consensus 678 L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L 755 (876)
T 4ecn_A 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYL 755 (876)
T ss_dssp EECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTC
T ss_pred EEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCc
Confidence 888888888433334457888888888888888 44443332 238888888888888 6777776 88888
Q ss_pred ceeccccCcCCCCChhHHhhhcccceecccC------cccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCcee
Q 038003 460 HYLNLSNNQLSHKIPTEFEKLIHLSELDLSH------NILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSC 533 (848)
Q Consensus 460 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 533 (848)
+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..+..+++|+.|+|++|+| +.+|..+. ++|+.
T Consensus 756 ~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~ 831 (876)
T 4ecn_A 756 SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYI 831 (876)
T ss_dssp CEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCE
T ss_pred CEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCE
Confidence 888888888886 687888888888888866 889999999999999999999999999 66787765 69999
Q ss_pred ecCCCCccCCC
Q 038003 534 IDISYNELHGP 544 (848)
Q Consensus 534 l~ls~N~l~~~ 544 (848)
|++++|++...
T Consensus 832 LdLs~N~l~~i 842 (876)
T 4ecn_A 832 LDIADNPNISI 842 (876)
T ss_dssp EECCSCTTCEE
T ss_pred EECCCCCCCcc
Confidence 99999998643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=458.00 Aligned_cols=469 Identities=19% Similarity=0.164 Sum_probs=401.1
Q ss_pred CccCceEEcC--CCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCC
Q 038003 42 CSWFGISCNH--AGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLI 119 (848)
Q Consensus 42 c~w~gv~C~~--~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 119 (848)
|++.+++.-+ ...+++.|+++++.+.+..+ ..|..+++|++|+|++|.+++..|.+|+++++|++|||++|++++..
T Consensus 12 ~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 90 (549)
T 2z81_A 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGH-GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS 90 (549)
T ss_dssp CTTSCCSSCCSCCCTTCCEEECCSSCCCEECS-STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCC
T ss_pred CCCCccccccccCCCCccEEECcCCccCccCh-hhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccC
Confidence 4566665432 22479999999999887654 46899999999999999999988899999999999999999999888
Q ss_pred chhhhccccccEEEecccCcCC-CCCccccCcCCccEEEcCCCcCCCCCC-CcccCccccceEEeecccccCCCcccccc
Q 038003 120 PPEIGKLNQLRRLYLDMNQLHG-TIPPEIGQLSLIDKLALCHNNLHGSIP-SSLGNLSNLAVLYLYKNSLSGSIPSIIGK 197 (848)
Q Consensus 120 p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~ 197 (848)
|..|+++++|++|+|++|++++ .+|..++.+++|++|++++|.+.+.+| ..++++++|++|++++|++++.+|..++.
T Consensus 91 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 170 (549)
T 2z81_A 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170 (549)
T ss_dssp HHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred HHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhc
Confidence 8889999999999999999997 467899999999999999999655666 58999999999999999999999999999
Q ss_pred cccccccccccccccccCccc-ccCCcccceeeccccCCCCCC--C-CcccCcccccccccccccccCcCCC----cccC
Q 038003 198 LKSLLQLDLSENQFSGSIPLS-LGNLSSLTMMSLFNNSLSGSI--P-PILGNLKSLSALGLHINQLNGFIPP----SIGN 269 (848)
Q Consensus 198 l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~l~~n~l~~~~--p-~~l~~l~~L~~L~l~~N~l~~~~p~----~l~~ 269 (848)
+++|++|+++.|.+. .+|.. +..+++|++|++++|++++.. | .....+++|+.|++++|++++..+. .+..
T Consensus 171 l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~ 249 (549)
T 2z81_A 171 IRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249 (549)
T ss_dssp CSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGG
T ss_pred cccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhh
Confidence 999999999999987 45554 467999999999999999742 2 2334678999999999999875443 3467
Q ss_pred CCCCceEEccCccccccC------cccccCCCCCccccccccccccc-----------cCCccceeeccccCCCCccccc
Q 038003 270 LSSLRVLYLYNNGLYGFV------PEEIGYLKSLSELELCTNLLRGV-----------IPHSIERVLLNQNNLSGKMYEA 332 (848)
Q Consensus 270 l~~L~~L~Ls~N~l~~~~------p~~~~~l~~L~~L~L~~N~l~~~-----------~p~~l~~l~L~~n~l~~~~~~~ 332 (848)
+++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+... ....++.+.+.+|.++.++...
T Consensus 250 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~ 329 (549)
T 2z81_A 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329 (549)
T ss_dssp CTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHH
T ss_pred hccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHH
Confidence 789999999999987632 23456788999999998877643 2346899999999999888777
Q ss_pred cCCCCCccEEEccCCccccccC---ccccCcccccEeecccccccCCCC--CCCCCCCCccEEEccCCccCCCCcccccc
Q 038003 333 FGDHPNLTFLDLSNNNFCGEIS---FNWGNFSKLSTFIVSMNNISGSIP--PDIGNSPKLQVLDLSSNHIVGKIPVQLEM 407 (848)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~~N~i~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~ 407 (848)
+..+++|++|++++|++++..+ ..++.+++|+.|++++|++++..+ ..+..+++|++|++++|+++ .+|..+..
T Consensus 330 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 408 (549)
T 2z81_A 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408 (549)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCC
T ss_pred HhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcc
Confidence 7789999999999999998763 447889999999999999986432 45888999999999999999 68888999
Q ss_pred cccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceec
Q 038003 408 LSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELD 487 (848)
Q Consensus 408 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 487 (848)
+++|++|++++|++++ +|..+ .++|++|++++|+|++.. ..+++|++|+|++|+|+ .+|. ...+++|++|+
T Consensus 409 ~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~ 479 (549)
T 2z81_A 409 PEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMK 479 (549)
T ss_dssp CTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEE
T ss_pred cccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEe
Confidence 9999999999999984 44443 268999999999999653 57899999999999998 5665 56789999999
Q ss_pred ccCcccCcCCCccccCCCCCccccCCCCcccCCCc
Q 038003 488 LSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIP 522 (848)
Q Consensus 488 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 522 (848)
|++|+|++.+|..+..+++|+.|++++|++++..|
T Consensus 480 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99999999888899999999999999999998765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=451.17 Aligned_cols=438 Identities=21% Similarity=0.203 Sum_probs=376.0
Q ss_pred CceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEE
Q 038003 54 SRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133 (848)
Q Consensus 54 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 133 (848)
.+++.|+++++.+.+..+ ..|..+++|++|+|++|.+++..|..|+++++|++|||++|+++ .+|.. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYISELWT-SDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCCCCCH-HHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred ccccEEECCCCcccccCh-hhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 578999999999887543 36899999999999999999988999999999999999999999 46766 899999999
Q ss_pred ecccCcCC-CCCccccCcCCccEEEcCCCcCCCCCCCcccCcccc--ceEEeecccc--cCCCcccccccc-cccccccc
Q 038003 134 LDMNQLHG-TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNL--AVLYLYKNSL--SGSIPSIIGKLK-SLLQLDLS 207 (848)
Q Consensus 134 L~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~l~~N~l--~~~~p~~~~~l~-~L~~L~L~ 207 (848)
|++|++++ .+|..++.+++|++|+|++|++++ ..++.+++| ++|++++|.+ ++..|..++.+. +...++++
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 173 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence 99999997 589999999999999999999986 457778888 9999999999 888898888876 45578899
Q ss_pred cccccccCcc-cccCCcccceeeccccC-------CCCCCCCcccCcccccccccccccccCcCCCccc---CCCCCceE
Q 038003 208 ENQFSGSIPL-SLGNLSSLTMMSLFNNS-------LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIG---NLSSLRVL 276 (848)
Q Consensus 208 ~N~l~~~~p~-~l~~l~~L~~L~l~~n~-------l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~L~~L 276 (848)
+|++.+.++. .+..+++|+.|++++|. +.+.+| .++.+++|+.|++++|.+.+..+..+. ..++|++|
T Consensus 174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L 252 (520)
T 2z7x_B 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252 (520)
T ss_dssp SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred cCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence 9999877665 57889999999999998 666666 789999999999999998764333221 24689999
Q ss_pred EccCccccccCcccc-----cCCCCCccccccccccccccCC-ccceeeccccCCCCccccccCCCCCccEEEccCCccc
Q 038003 277 YLYNNGLYGFVPEEI-----GYLKSLSELELCTNLLRGVIPH-SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFC 350 (848)
Q Consensus 277 ~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p~-~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 350 (848)
++++|.+.+.+|..+ ..+++|+.++++.|.+ .+|. .+.. +....+|+.|++++|.+.
T Consensus 253 ~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~---------------~~~~~~L~~L~l~~n~l~ 315 (520)
T 2z7x_B 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYE---------------IFSNMNIKNFTVSGTRMV 315 (520)
T ss_dssp EEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHH---------------HHHTCCCSEEEEESSCCC
T ss_pred EeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhc---------------ccccCceeEEEcCCCccc
Confidence 999999999999998 8999999999999988 4442 1110 001257899999999887
Q ss_pred cccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCC--CCcccccccccccEEEccCCcCCCCCCc-
Q 038003 351 GEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVG--KIPVQLEMLSSLNKLILNLNQLSGGVPL- 427 (848)
Q Consensus 351 ~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~L~~N~l~~~~~~- 427 (848)
... .+..+++|+.|++++|++++.+|..++.+++|++|+|++|++++ .+|..+..+++|++|++++|.+++.+|.
T Consensus 316 ~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~ 393 (520)
T 2z7x_B 316 HML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393 (520)
T ss_dssp CCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGC
T ss_pred ccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccc
Confidence 543 12688999999999999999899999999999999999999996 5667899999999999999999985665
Q ss_pred ccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCcc-ccCCCC
Q 038003 428 EFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQ-VCNMGS 506 (848)
Q Consensus 428 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~ 506 (848)
.+..+++|++|++++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++ +|.. +..+++
T Consensus 394 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~ 469 (520)
T 2z7x_B 394 DCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTS 469 (520)
T ss_dssp SCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTT
T ss_pred hhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCc
Confidence 488899999999999999988877765 79999999999999 678878899999999999999985 5554 999999
Q ss_pred CccccCCCCcccCCCc
Q 038003 507 LEKLNLSHNNLSDFIP 522 (848)
Q Consensus 507 L~~L~Ls~N~l~~~~~ 522 (848)
|++|++++|++++..+
T Consensus 470 L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 470 LQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CCEEECCSSCBCCCHH
T ss_pred ccEEECcCCCCcccCC
Confidence 9999999999988644
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=444.35 Aligned_cols=458 Identities=22% Similarity=0.241 Sum_probs=332.6
Q ss_pred CCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcC
Q 038003 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALC 159 (848)
Q Consensus 80 ~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 159 (848)
++++|||++|.+++..|.+|+++++|++|||++|+|+++.|.+|++|++|++|+|++|+|++..|..|+++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 56666666666665555566666666666666666666555566666666666666666665555556666666666666
Q ss_pred CCcCCCCCCCcccCccccceEEeecccccC-CCcccccccccccccccccccccccCcccccCCcccc----eeeccccC
Q 038003 160 HNNLHGSIPSSLGNLSNLAVLYLYKNSLSG-SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLT----MMSLFNNS 234 (848)
Q Consensus 160 ~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~l~~n~ 234 (848)
+|++++..+..|+++++|++|+|++|++++ .+|..++.+++|++|+|++|++++..|..+..+.+++ .++++.|.
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~ 212 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 212 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence 666665444556666666666666666654 2455666666666666666666665565555444333 35555565
Q ss_pred CCCCCCCcccCccccccccccccccc------------------------------------------------------
Q 038003 235 LSGSIPPILGNLKSLSALGLHINQLN------------------------------------------------------ 260 (848)
Q Consensus 235 l~~~~p~~l~~l~~L~~L~l~~N~l~------------------------------------------------------ 260 (848)
++...+..+ ....+..+++.+|...
T Consensus 213 l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~ 291 (635)
T 4g8a_A 213 MNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 291 (635)
T ss_dssp CCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred ccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence 553222222 2222333333332111
Q ss_pred ----CcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCC---ccceeeccccCCCCcccccc
Q 038003 261 ----GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH---SIERVLLNQNNLSGKMYEAF 333 (848)
Q Consensus 261 ----~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~l~~l~L~~n~l~~~~~~~~ 333 (848)
...+..+..+.+++.+++.+|.+... ..+.....|+.|++.+|.+.+..+. .++.+.+..|.+.... .+
T Consensus 292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~--~~ 367 (635)
T 4g8a_A 292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SE 367 (635)
T ss_dssp CSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBC--CC
T ss_pred cccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCc--cc
Confidence 01122234455666777777766543 2355667888888888888765443 4566677777765443 34
Q ss_pred CCCCCccEEEccCCccccc--cCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCc-cccccccc
Q 038003 334 GDHPNLTFLDLSNNNFCGE--ISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIP-VQLEMLSS 410 (848)
Q Consensus 334 ~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~ 410 (848)
..+++|+.|++++|.+... .+..+..+.+|+.+++..|.+.. .+..+..+++|+.++++.|......+ ..+..+++
T Consensus 368 ~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~ 446 (635)
T 4g8a_A 368 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 446 (635)
T ss_dssp CBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTT
T ss_pred ccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccc
Confidence 5688999999999998643 44556678899999999998874 56678889999999999988875544 56789999
Q ss_pred ccEEEccCCcCCCCCCcccCCCCccCeEeccCccc-CCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceeccc
Q 038003 411 LNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKL-SSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLS 489 (848)
Q Consensus 411 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 489 (848)
++.++++.|.+.+..+..+..+++|+.|++++|++ .+..|..|..+++|++|+|++|+|++.+|..|.++++|++|+|+
T Consensus 447 l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls 526 (635)
T 4g8a_A 447 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 526 (635)
T ss_dssp CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred cccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECC
Confidence 99999999999999999999999999999999974 45688899999999999999999999999999999999999999
Q ss_pred CcccCcCCCccccCCCCCccccCCCCcccCCCcchhccc-cCceeecCCCCccCC
Q 038003 490 HNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEM-RSLSCIDISYNELHG 543 (848)
Q Consensus 490 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~l~ls~N~l~~ 543 (848)
+|+|++..|..|..+++|++|+|++|+|++..|..|..+ ++|+.|++++|+++.
T Consensus 527 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 527 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp TSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred CCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 999999989999999999999999999999999999998 689999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=408.66 Aligned_cols=204 Identities=22% Similarity=0.360 Sum_probs=176.5
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|++ .+|+.||||++++... .....+.+.+|++++++++|||||++++++.+.+..|+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 36899999999999999999965 4799999999977643 23456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||++||+|.++++.. ....+++.++..|+.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+...
T Consensus 101 VmEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999999999654 234678899999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~ 227 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 433333557899999999999999999999999999999999999999864
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=439.71 Aligned_cols=458 Identities=20% Similarity=0.176 Sum_probs=364.0
Q ss_pred EEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecc
Q 038003 57 ISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDM 136 (848)
Q Consensus 57 ~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 136 (848)
..++++++++++ +|.. + .++|++|+|++|.+++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 34 ~~l~ls~~~L~~-ip~~-~--~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKD-L--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCCS-CCTT-S--CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCcc-CCCC-C--CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 557788888875 5542 2 28899999999999988888999999999999999999988899999999999999999
Q ss_pred cCcCCCCCccccCcCCccEEEcCCCcCCC-CCCCcccCccccceEEeecccccCCCcccccccccc--cccccccccc--
Q 038003 137 NQLHGTIPPEIGQLSLIDKLALCHNNLHG-SIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSL--LQLDLSENQF-- 211 (848)
Q Consensus 137 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l-- 211 (848)
|+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++. .+..+++| ++|+|++|++
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 9998 67766 89999999999999986 4568899999999999999999863 45555555 9999999999
Q ss_pred cccCcccccCCc-ccceeeccccCCCCCCCC-cccCccccccccccccc-----ccCcCCCcccCCCCCceEEccCcccc
Q 038003 212 SGSIPLSLGNLS-SLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQ-----LNGFIPPSIGNLSSLRVLYLYNNGLY 284 (848)
Q Consensus 212 ~~~~p~~l~~l~-~L~~L~l~~n~l~~~~p~-~l~~l~~L~~L~l~~N~-----l~~~~p~~l~~l~~L~~L~Ls~N~l~ 284 (848)
++..|..+..+. ....+++++|.+.+.++. .+..+++|+.|++++|+ +.+.+ ..+..+++|+.|+++++.+.
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~-~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL-SELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH-HHHHSCSSCEEEEEEEEEEC
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHH-HHHhccCcceEEEecCCcCc
Confidence 888888888765 223668899998887665 56688999999999985 33322 35677888888888888776
Q ss_pred ccC----cccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccC-ccccC
Q 038003 285 GFV----PEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEIS-FNWGN 359 (848)
Q Consensus 285 ~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~ 359 (848)
+.. +..+ ...+|++|++++|.++|.+|..+-.. ....++.|+.++++.|.+ ..| ..+..
T Consensus 263 ~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~-------------~~~~L~~L~~~~~~~~~~--~~p~~~~~~ 326 (562)
T 3a79_B 263 WKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTY-------------SETALKSLMIEHVKNQVF--LFSKEALYS 326 (562)
T ss_dssp HHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCC-------------CSCSCCEEEEEEEEECCC--SSCHHHHHH
T ss_pred HHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhc-------------ccccchheehhhccccee--ecChhhhhh
Confidence 432 2222 23589999999999988877643110 124566777777777776 222 12221
Q ss_pred ---cccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCC--CcccCCCCc
Q 038003 360 ---FSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGV--PLEFGSLTK 434 (848)
Q Consensus 360 ---l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~ 434 (848)
..+|+.|++++|.+.... ....+++|++|++++|++++..|..+..+++|++|++++|++++.. |..|..+++
T Consensus 327 ~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~ 404 (562)
T 3a79_B 327 VFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSS 404 (562)
T ss_dssp HHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTT
T ss_pred hhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCC
Confidence 256899999999876322 1267889999999999999889999999999999999999998633 467899999
Q ss_pred cCeEeccCcccCCCCC-CcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCC
Q 038003 435 LQYLDLSTNKLSSSIP-KSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLS 513 (848)
Q Consensus 435 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 513 (848)
|++|++++|++++.+| ..+..+++|++|+|++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++|++|+|+
T Consensus 405 L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~ 481 (562)
T 3a79_B 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVA 481 (562)
T ss_dssp CCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECC
T ss_pred CCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECC
Confidence 9999999999998444 4588899999999999999877666554 68999999999997 677777799999999999
Q ss_pred CCcccCCCcchhccccCceeecCCCCccCCCCC
Q 038003 514 HNNLSDFIPRCFEEMRSLSCIDISYNELHGPIP 546 (848)
Q Consensus 514 ~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~ 546 (848)
+|+|++..+..|..+++|+.+++++|++++..+
T Consensus 482 ~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 482 SNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp SSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 999997544459999999999999999987554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=403.48 Aligned_cols=198 Identities=30% Similarity=0.468 Sum_probs=180.8
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|+..+.||+|+||+||+|.++ +|+.||||+++... ....+.+.+|++++++++|||||+++++|.+.+..|+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG----CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 56999999999999999999664 79999999997653 23345678999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++||+|.++++. ..+++..+..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 150 mEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 150 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp ECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 999999999999864 3589999999999999999999999 999999999999999999999999999998866
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 55556778999999999999999999999999999999999999999853
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=400.38 Aligned_cols=202 Identities=23% Similarity=0.365 Sum_probs=182.4
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|+. .+++.||||++.+.... .....+.+.+|++++++++|||||+++++|++.+..|+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 5799999999999999999965 57999999999876433 234467789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++||+|.++++.. +.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999999754 5799999999999999999999999 999999999999999999999999999998754
Q ss_pred CC--CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HS--SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 32 234567999999999999999999999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=405.13 Aligned_cols=198 Identities=30% Similarity=0.468 Sum_probs=181.0
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|+..+.||+|+||+||+|.++ +|+.||||++.... ....+.+.+|+++|++++|||||+++++|.+.+.+|+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT----CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 56999999999999999999664 79999999997653 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
||||+||+|.++++. ..+++..+..|+.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 227 mEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 227 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 999999999999854 3589999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........+||+.|||||++.+..|+.++|||||||++|||+||+.||..
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 55566778999999999999999999999999999999999999999853
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=427.46 Aligned_cols=437 Identities=21% Similarity=0.202 Sum_probs=358.5
Q ss_pred CceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEE
Q 038003 54 SRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133 (848)
Q Consensus 54 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 133 (848)
.+++.|+++++.+.+.. +.+|..+++|++|+|++|.+++..|.+|+++++|++|||++|+++ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELR-MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCC-GGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCccccC-hhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 46889999999988654 447999999999999999999988999999999999999999999 56766 899999999
Q ss_pred ecccCcCC-CCCccccCcCCccEEEcCCCcCCCCCCCcccCcccc--ceEEeecccc--cCCCcccccccc-cccccccc
Q 038003 134 LDMNQLHG-TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNL--AVLYLYKNSL--SGSIPSIIGKLK-SLLQLDLS 207 (848)
Q Consensus 134 L~~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~l~~N~l--~~~~p~~~~~l~-~L~~L~L~ 207 (848)
|++|++++ .+|..|+.+++|++|+|++|++++. .+..+++| ++|++++|++ ++..|..+..+. ....++++
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 204 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEEC
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEec
Confidence 99999997 4578999999999999999999863 45566666 9999999999 888898888765 22366899
Q ss_pred cccccccCcc-cccCCcccceeeccccCC-----CCCCCCcccCcccccccccccccccCcC----CCcccCCCCCceEE
Q 038003 208 ENQFSGSIPL-SLGNLSSLTMMSLFNNSL-----SGSIPPILGNLKSLSALGLHINQLNGFI----PPSIGNLSSLRVLY 277 (848)
Q Consensus 208 ~N~l~~~~p~-~l~~l~~L~~L~l~~n~l-----~~~~p~~l~~l~~L~~L~l~~N~l~~~~----p~~l~~l~~L~~L~ 277 (848)
+|.+.+.++. .+..+++|+.|++++|+. .+ .+..+..+++|+.|+++++.+.+.. +..+ ..++|++|+
T Consensus 205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~ 282 (562)
T 3a79_B 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLN 282 (562)
T ss_dssp SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEE
T ss_pred CccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEE
Confidence 9999887665 567899999999999962 21 2235677888888888887765431 2222 235999999
Q ss_pred ccCccccccCcccc-----cCCCCCccccccccccccccCC-ccceeeccccCCCCccccccCCCCCccEEEccCCcccc
Q 038003 278 LYNNGLYGFVPEEI-----GYLKSLSELELCTNLLRGVIPH-SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCG 351 (848)
Q Consensus 278 Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p~-~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 351 (848)
+++|.+++.+|..+ ..++.|+.+++..|.+ .+|. .+. .+-...+|+.|++++|.+..
T Consensus 283 l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~---------------~~~~~~~L~~L~l~~n~~~~ 345 (562)
T 3a79_B 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALY---------------SVFAEMNIKMLSISDTPFIH 345 (562)
T ss_dssp EEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHH---------------HHHHTCCCSEEEEESSCCCC
T ss_pred EeccEeeccccchhhhcccccchheehhhccccee--ecChhhhh---------------hhhccCcceEEEccCCCccc
Confidence 99999999999887 6667777667666665 2331 110 01112578999999999864
Q ss_pred ccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCC--CcccccccccccEEEccCCcCCCCCC-cc
Q 038003 352 EISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGK--IPVQLEMLSSLNKLILNLNQLSGGVP-LE 428 (848)
Q Consensus 352 ~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~~~~l~~l~~L~~L~L~~N~l~~~~~-~~ 428 (848)
.. ....+++|+.|++++|++++.+|..++.+++|++|+|++|++++. +|..+..+++|+.|++++|++++.+| ..
T Consensus 346 ~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 423 (562)
T 3a79_B 346 MV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRT 423 (562)
T ss_dssp CC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCC
T ss_pred cc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhh
Confidence 32 126789999999999999998999999999999999999999964 35678999999999999999998444 45
Q ss_pred cCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCcc-ccCCCCC
Q 038003 429 FGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQ-VCNMGSL 507 (848)
Q Consensus 429 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L 507 (848)
+..+++|++|++++|++++..|..+. ++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +|.. +..+++|
T Consensus 424 ~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L 499 (562)
T 3a79_B 424 CAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSL 499 (562)
T ss_dssp CCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTC
T ss_pred hcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCC
Confidence 88999999999999999987777665 79999999999998 577766799999999999999985 5555 9999999
Q ss_pred ccccCCCCcccCCCc
Q 038003 508 EKLNLSHNNLSDFIP 522 (848)
Q Consensus 508 ~~L~Ls~N~l~~~~~ 522 (848)
+.|++++|++++..+
T Consensus 500 ~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 500 QYIWLHDNPWDCTCP 514 (562)
T ss_dssp CCEECCSCCBCCCHH
T ss_pred CEEEecCCCcCCCcc
Confidence 999999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=395.69 Aligned_cols=201 Identities=28% Similarity=0.365 Sum_probs=173.0
Q ss_pred cCCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
++|++.+.||+|+||+||+|+.. +++.||||++++..... ....++.+|++++++++|||||++++++.+.+..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 57999999999999999999652 57899999998764332 2234678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
|+||||++||+|.++++.. +.+++.++..++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+.
T Consensus 102 ~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999999999999754 5789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...........+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence 65555555678999999999999999999999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=383.20 Aligned_cols=200 Identities=24% Similarity=0.381 Sum_probs=163.4
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|... +++.||||++++.... .....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999764 7999999999876433 234467789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+ +|+|.+++... +.+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+|+...+
T Consensus 92 mEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 67999988654 5699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. ......+||+.|||||++.+..| ++++||||+||++|||+||+.||..
T Consensus 165 ~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 165 G-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred C-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 3 33456789999999999998876 5899999999999999999999864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=393.89 Aligned_cols=295 Identities=31% Similarity=0.500 Sum_probs=275.6
Q ss_pred ChHHHHHHHHHHHhccCCCCCCcccCCCCCCCCCCCCCCCCc--cCceEEcCCC--CceEEEeccccCccc--cccCCcc
Q 038003 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCS--WFGISCNHAG--SRVISITMSTLGLNG--TFHDFSF 75 (848)
Q Consensus 2 ~~~~~~all~~k~~~~~~~~~~~~l~sw~~~~~~~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~l~g--~~~~~~~ 75 (848)
.++|++||++||+++.++ ..+++|. .+.|||. |.||+|+..+ ++|+.|+|+++++.| .+++ .+
T Consensus 4 ~~~~~~aL~~~k~~~~~~----~~l~~W~------~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l 72 (313)
T 1ogq_A 4 NPQDKQALLQIKKDLGNP----TTLSSWL------PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SL 72 (313)
T ss_dssp CHHHHHHHHHHHHHTTCC----GGGTTCC------TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GG
T ss_pred CHHHHHHHHHHHHhcCCc----ccccCCC------CCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hH
Confidence 368999999999999643 3789996 2578998 9999998765 899999999999999 7775 79
Q ss_pred CCCCCCcEEeccC-CcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCcc
Q 038003 76 SSFPHLANLNLSF-NLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLID 154 (848)
Q Consensus 76 ~~l~~l~~L~l~~-n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 154 (848)
..+++|++|+|++ |.+.+.+|.+|+++++|++|+|++|++++.+|..|+++++|++|+|++|++++.+|..++.+++|+
T Consensus 73 ~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 152 (313)
T 1ogq_A 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152 (313)
T ss_dssp GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCC
T ss_pred hCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCC
Confidence 9999999999995 999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEcCCCcCCCCCCCcccCcc-ccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeecccc
Q 038003 155 KLALCHNNLHGSIPSSLGNLS-NLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNN 233 (848)
Q Consensus 155 ~L~L~~n~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n 233 (848)
+|+|++|++++.+|..+++++ +|++|++++|++++.+|..++.++ |++|+|++|++++.+|..+..+++|+.|++++|
T Consensus 153 ~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 231 (313)
T 1ogq_A 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231 (313)
T ss_dssp EEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSS
T ss_pred eEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCC
Confidence 999999999999999999998 999999999999999999999997 999999999999999999999999999999999
Q ss_pred CCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccc-cccc
Q 038003 234 SLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNL-LRGV 310 (848)
Q Consensus 234 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~ 310 (848)
++++.+|. +..+++|++|++++|++++.+|.++..+++|++|+|++|++++.+|.. ..+++|+.|++++|+ +.|.
T Consensus 232 ~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 232 SLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp EECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred ceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCC
Confidence 99976665 888999999999999999999999999999999999999999999987 889999999999998 6654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=422.80 Aligned_cols=487 Identities=25% Similarity=0.230 Sum_probs=389.4
Q ss_pred cccCCCCCCCCCCCCCCCCccC----ceEEcCC---------CCceEEEeccccCccccccCCccCCCCCCcEEeccCCc
Q 038003 24 SLLSSWTLYPANATKISPCSWF----GISCNHA---------GSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNL 90 (848)
Q Consensus 24 ~~l~sw~~~~~~~~~~~~c~w~----gv~C~~~---------~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~ 90 (848)
..+++|.... ....++|.|. .|.|... ...++.|+|+++.+++ +++.+|.++++|++|||++|.
T Consensus 11 ~~~~~~~~~~--p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 11 DKLAAANSSI--PESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp ----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCC
T ss_pred chhhcccCCC--CCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCc
Confidence 4567775321 1223567553 4678642 2368899999999875 566689999999999999999
Q ss_pred ccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCC-CCCC
Q 038003 91 FFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG-SIPS 169 (848)
Q Consensus 91 ~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~ 169 (848)
+++..|.+|++|++|++|+|++|+|++..|..|+++++|++|+|++|++++..+..|+.+++|++|+|++|.+++ .+|.
T Consensus 88 i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~ 167 (635)
T 4g8a_A 88 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 167 (635)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred CCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCch
Confidence 998888899999999999999999998877889999999999999999998777789999999999999999986 4688
Q ss_pred cccCccccceEEeecccccCCCccccccccccc----ccccccccccccCcccccCCcccceeeccccCCCC--------
Q 038003 170 SLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLL----QLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG-------- 237 (848)
Q Consensus 170 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~-------- 237 (848)
.++++++|++|++++|++++..|..|..+.+++ .++++.|.++...+..+ ....+..+++.+|..+.
T Consensus 168 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~ 246 (635)
T 4g8a_A 168 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQ 246 (635)
T ss_dssp GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHH
T ss_pred hhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhc
Confidence 899999999999999999988888888777655 57788888875443333 22334444444442210
Q ss_pred --------------------------------------------------CCCCcccCcccccccccccccccCcCCCcc
Q 038003 238 --------------------------------------------------SIPPILGNLKSLSALGLHINQLNGFIPPSI 267 (848)
Q Consensus 238 --------------------------------------------------~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l 267 (848)
.++..+..+.+++.+++..|.+.... .+
T Consensus 247 ~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~ 324 (635)
T 4g8a_A 247 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DF 324 (635)
T ss_dssp TTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GG
T ss_pred CCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--cc
Confidence 01122334456677777777776543 35
Q ss_pred cCCCCCceEEccCccccccCcccccCCCCCccccccccccccccC----CccceeeccccCCCCcc--ccccCCCCCccE
Q 038003 268 GNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP----HSIERVLLNQNNLSGKM--YEAFGDHPNLTF 341 (848)
Q Consensus 268 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~l~~l~L~~n~l~~~~--~~~~~~l~~L~~ 341 (848)
.....|+.|++++|.+.+..+. .+..|+.+++..|.+...++ +.++.+.+.+|.+.... ...+..+.+|+.
T Consensus 325 ~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~ 401 (635)
T 4g8a_A 325 SYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKY 401 (635)
T ss_dssp GSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCE
T ss_pred ccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhh
Confidence 6677899999999998765443 45678888888888765533 36788888888886533 344557789999
Q ss_pred EEccCCccccccCccccCcccccEeecccccccCCCC-CCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCc
Q 038003 342 LDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIP-PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQ 420 (848)
Q Consensus 342 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 420 (848)
|+++.|.+... +..+..+++|+.+++..|+.....+ ..+..+++++.++++.|.+.+..+..+..+++|+.|++++|.
T Consensus 402 L~~~~~~~~~~-~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~ 480 (635)
T 4g8a_A 402 LDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 480 (635)
T ss_dssp EECCSCSEEEE-CSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCE
T ss_pred hhccccccccc-cccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcc
Confidence 99999998754 4567889999999999888776554 457889999999999999999999999999999999999998
Q ss_pred C-CCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCc
Q 038003 421 L-SGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPP 499 (848)
Q Consensus 421 l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 499 (848)
+ .+..|..|..+++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|.
T Consensus 481 ~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 560 (635)
T 4g8a_A 481 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 560 (635)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSS
T ss_pred cccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHH
Confidence 5 456788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCC-CCCccccCCCCcccCC
Q 038003 500 QVCNM-GSLEKLNLSHNNLSDF 520 (848)
Q Consensus 500 ~~~~l-~~L~~L~Ls~N~l~~~ 520 (848)
.+..+ ++|++|+|++|+++..
T Consensus 561 ~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 561 ELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CTTCCCTTCCEEECTTCCBCCS
T ss_pred HHHhhhCcCCEEEeeCCCCccc
Confidence 99988 6899999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.36 Aligned_cols=195 Identities=26% Similarity=0.372 Sum_probs=171.9
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|+..+.||+|+||+||+|++ .+|+.||||+++.+.. ..+|++++++++|||||++++++.+++..|+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45688889999999999999976 4799999999976532 1469999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-CEEEeeccCcccc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-EAHVSDFGIAKFV 755 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~~~~~ 755 (848)
||||++||+|.++++.. +.+++..+..|+.||+.||+|||++ +||||||||+|||++.+| .+||+|||+|+..
T Consensus 128 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 99999999999999754 5699999999999999999999999 999999999999999988 6999999999987
Q ss_pred CCCCC-----CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSS-----NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 258 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 54322 12346899999999999999999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=381.45 Aligned_cols=195 Identities=26% Similarity=0.356 Sum_probs=170.5
Q ss_pred cccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec----CCeeEE
Q 038003 602 DEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN----GPHSFL 676 (848)
Q Consensus 602 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~~l 676 (848)
.+.+.||+|+||+||+|.+. ++..||+|++..... .....+.+.+|++++++++|||||+++++|.+ .+..|+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 56678999999999999654 789999999976542 23456779999999999999999999999865 346799
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCCeeeCC-CCCEEEeeccCcc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDS-NFEAHVSDFGIAK 753 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~-~~~~kl~DfG~~~ 753 (848)
||||++||+|.++++.. ..+++..+..|+.||+.||+|||++ + ||||||||+|||++. ++.+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999999754 5789999999999999999999998 7 999999999999984 7999999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... ......+||+.|||||++.+ +|++++|||||||++|||+||+.||..
T Consensus 181 ~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 181 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 6533 33456799999999999875 699999999999999999999999853
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=387.88 Aligned_cols=200 Identities=28% Similarity=0.448 Sum_probs=170.0
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.+++++.+.||+|+||+||+|++++ .||||+++... ......+.|.+|++++++++|||||++++++.+ +..++|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 4678889999999999999998753 59999987542 234556789999999999999999999998865 568999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. ...+++.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999754 25699999999999999999999999 999999999999999999999999999987653
Q ss_pred CC--CCcccccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HS--SNWTEFAGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||..
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 22 22345789999999999864 3589999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=391.19 Aligned_cols=203 Identities=26% Similarity=0.449 Sum_probs=176.3
Q ss_pred cCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
++|.+.+.||+|+||+||+|++. ++..||||+++.. .....++|.+|++++++++|||||+++|+|.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 56888999999999999999764 4778999998754 3455678999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCC----------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC
Q 038003 673 HSFLVCEYLDRGSLARILGDDV----------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 742 (848)
..++||||+++|+|.++++... ....+++.++..|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 9999999999999999996531 235799999999999999999999999 999999999999999999
Q ss_pred CEEEeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 743 EAHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 743 ~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
.+||+|||+|+......... ....||+.|||||++.+..|++++|||||||++|||+| |+.||...
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999998764433221 23568999999999999999999999999999999999 99998643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=391.99 Aligned_cols=202 Identities=27% Similarity=0.465 Sum_probs=171.0
Q ss_pred cCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
++|.+.+.||+|+||+||+|+++ ++..||||+++.. .....++|.+|++++++++|||||+++|+|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 56788899999999999999764 4788999999754 3455678999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCC------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC
Q 038003 673 HSFLVCEYLDRGSLARILGDDV------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 740 (848)
..++||||+++|+|.++++... ....+++.++..|+.|||+||+|||++ +||||||||+|||+++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence 9999999999999999987542 234689999999999999999999999 9999999999999999
Q ss_pred CCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 741 NFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 741 ~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
++.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~ 263 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence 99999999999987644322 2234679999999999999999999999999999999999 9999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=388.62 Aligned_cols=203 Identities=22% Similarity=0.326 Sum_probs=175.9
Q ss_pred cCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
.++++.+.||+|+||+||+|.+. +++.||||+++... .....++|.+|+.++++++|||||+++|+|.+.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 34677889999999999999763 46789999997653 3345678999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 673 HSFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
..++||||+++|+|.++++... ....+++.++..|+.|||+||+|||++ +||||||||+|||++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence 9999999999999999996431 124689999999999999999999999 999999999999999
Q ss_pred CCCCEEEeeccCccccCCCC--CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 740 SNFEAHVSDFGIAKFVGPHS--SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 740 ~~~~~kl~DfG~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+++.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence 99999999999998764322 22345679999999999999999999999999999999999 8999864
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=405.71 Aligned_cols=386 Identities=25% Similarity=0.299 Sum_probs=217.5
Q ss_pred CCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccc-------------cEEEecccCcCCCC
Q 038003 77 SFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQL-------------RRLYLDMNQLHGTI 143 (848)
Q Consensus 77 ~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L-------------~~L~L~~n~l~~~~ 143 (848)
+.++|++|++++|.+ |.+|.+|++|++|++|++++|.++|.+|.+++++++| ++|++++|.+++ +
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-l 86 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-L 86 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-C
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-C
Confidence 457889999999999 8999999999999999999999999999999988876 666666666663 3
Q ss_pred CccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCc
Q 038003 144 PPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLS 223 (848)
Q Consensus 144 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 223 (848)
|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .+++++
T Consensus 87 p~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~ 153 (454)
T 1jl5_A 87 PEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSS 153 (454)
T ss_dssp CSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCT
T ss_pred CCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCC
Confidence 331 2456666666666664 5543 2556666666666663 2221 1456666666666664 55 466666
Q ss_pred ccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccc
Q 038003 224 SLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELC 303 (848)
Q Consensus 224 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 303 (848)
+|++|++++|++++ +|..+ .+|++|++++|++++ +| .++++++|++|++++|.+++ +|... ++|++|+++
T Consensus 154 ~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~ 223 (454)
T 1jl5_A 154 FLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAG 223 (454)
T ss_dssp TCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECC
T ss_pred CCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECc
Confidence 66666666666663 44332 356666666666655 33 35666666666666666654 23221 345555555
Q ss_pred ccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCC
Q 038003 304 TNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGN 383 (848)
Q Consensus 304 ~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~ 383 (848)
+|.++ .++ .++.+++|++|++++|++++... .+++|+.|++++|++++ +|..
T Consensus 224 ~n~l~------------------~lp--~~~~l~~L~~L~l~~N~l~~l~~----~~~~L~~L~l~~N~l~~-l~~~--- 275 (454)
T 1jl5_A 224 NNILE------------------ELP--ELQNLPFLTTIYADNNLLKTLPD----LPPSLEALNVRDNYLTD-LPEL--- 275 (454)
T ss_dssp SSCCS------------------SCC--CCTTCTTCCEEECCSSCCSSCCS----CCTTCCEEECCSSCCSC-CCCC---
T ss_pred CCcCC------------------ccc--ccCCCCCCCEEECCCCcCCcccc----cccccCEEECCCCcccc-cCcc---
Confidence 55444 332 26677888888888888876332 24778888888888875 4543
Q ss_pred CCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCC-CccCeEeccCcccCCCCCCcccCcccccee
Q 038003 384 SPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSL-TKLQYLDLSTNKLSSSIPKSIGNLLKLHYL 462 (848)
Q Consensus 384 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 462 (848)
.++|++|++++|++++. |.. .++|+.|++++|++++ ++ .+ ++|++|++++|++++ +|.. +++|++|
T Consensus 276 ~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L 342 (454)
T 1jl5_A 276 PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERL 342 (454)
T ss_dssp CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEE
Confidence 36788888888888752 211 2578888888888874 22 22 478888888888885 4543 4778888
Q ss_pred ccccCcCCCCChhHHhhhcccceecccCcccCc--CCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCc
Q 038003 463 NLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE--EIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNE 540 (848)
Q Consensus 463 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~ 540 (848)
++++|++++ +|. .+++|++|++++|++++ .+|..+..+ +.|.+.+.+|.. +++|+.|++++|+
T Consensus 343 ~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~ 407 (454)
T 1jl5_A 343 IASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNP 407 (454)
T ss_dssp ECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC------------------------
T ss_pred ECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCCEEECCCCc
Confidence 888888874 454 46778888888888877 566666554 123333333321 2455555555555
Q ss_pred cCC
Q 038003 541 LHG 543 (848)
Q Consensus 541 l~~ 543 (848)
+++
T Consensus 408 l~~ 410 (454)
T 1jl5_A 408 LRE 410 (454)
T ss_dssp ---
T ss_pred CCc
Confidence 554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=402.83 Aligned_cols=364 Identities=22% Similarity=0.221 Sum_probs=243.8
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCC-chhhhccccccEEEecccCcCCCCCccccCcCCccEEE
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLI-PPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLA 157 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 157 (848)
++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|+.+++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 68999999999999888889999999999999999987655 56789999999999999999988888999999999999
Q ss_pred cCCCcCCCCCCCc--ccCccccceEEeecccccCCCccc-ccccccccccccccccccccCcccccCC--cccceeeccc
Q 038003 158 LCHNNLHGSIPSS--LGNLSNLAVLYLYKNSLSGSIPSI-IGKLKSLLQLDLSENQFSGSIPLSLGNL--SSLTMMSLFN 232 (848)
Q Consensus 158 L~~n~l~~~~p~~--l~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~l~~ 232 (848)
|++|++++.+|.. ++++++|++|+|++|++++..|.. ++++++|++|+|++|++++..|..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999998755554 888999999999999998777765 7888999999999999988888887766 6788888888
Q ss_pred cCCCCCCCCcc--------cCcccccccccccccccCcCCCcccCC---CCCceEEccCccccccCcccccCCCCCcccc
Q 038003 233 NSLSGSIPPIL--------GNLKSLSALGLHINQLNGFIPPSIGNL---SSLRVLYLYNNGLYGFVPEEIGYLKSLSELE 301 (848)
Q Consensus 233 n~l~~~~p~~l--------~~l~~L~~L~l~~N~l~~~~p~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 301 (848)
|.+.+..+..+ ..+++|++|++++|++++..|..+... ++|+.|++++|.+.+...
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~------------- 256 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF------------- 256 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT-------------
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc-------------
Confidence 88886544332 244556666666666655555544332 555556655555433210
Q ss_pred ccccccccccCCccceeeccccCCCCccccccC--CCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCC
Q 038003 302 LCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFG--DHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPP 379 (848)
Q Consensus 302 L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~ 379 (848)
..+.+. ......+. ..++|+.|++++|++++..+..+..+++|+.|++++|++.+..|.
T Consensus 257 -~~~~~~------------------~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 317 (455)
T 3v47_A 257 -GHTNFK------------------DPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDN 317 (455)
T ss_dssp -TCCSSC------------------CCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT
T ss_pred -chhhhc------------------cCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChh
Confidence 001111 11111111 124667777777777666555555555555555555555555555
Q ss_pred CCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCcccc
Q 038003 380 DIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKL 459 (848)
Q Consensus 380 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 459 (848)
.|+.+++|++|+|++|++++..+..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|
T Consensus 318 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 397 (455)
T 3v47_A 318 AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSL 397 (455)
T ss_dssp TTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred HhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcc
Confidence 55555555555555555555555555555555555555555555555555555555555555555554444445555555
Q ss_pred ceeccccCcCCCCCh
Q 038003 460 HYLNLSNNQLSHKIP 474 (848)
Q Consensus 460 ~~L~Ls~N~l~~~~p 474 (848)
++|+|++|++++..|
T Consensus 398 ~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 398 QKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEEECCSSCBCCCTT
T ss_pred cEEEccCCCcccCCC
Confidence 555555555554443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=401.97 Aligned_cols=393 Identities=22% Similarity=0.196 Sum_probs=253.1
Q ss_pred cEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCC-CccccCcCCccEEEcCC
Q 038003 82 ANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTI-PPEIGQLSLIDKLALCH 160 (848)
Q Consensus 82 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~ 160 (848)
+.++.+++.++ .+|. + .++|++|||++|.+++..|..|+++++|++|+|++|.+.+.+ |..|..+++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 45677777775 5665 3 277888888888888777888888888888888888887555 45677777788888888
Q ss_pred CcCCCCCCCcccCccccceEEeecccccCCCccc--ccccccccccccccccccccCccc-ccCCcccceeeccccCCCC
Q 038003 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSI--IGKLKSLLQLDLSENQFSGSIPLS-LGNLSSLTMMSLFNNSLSG 237 (848)
Q Consensus 161 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~l~~n~l~~ 237 (848)
|++++..|..|+++++|++|++++|++++.+|.. |+.+++|++|+|++|++++..|.. +..+++|++|++++|++++
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 8777666777777777777777777777644443 667777777777777777665654 5666666666666666666
Q ss_pred CCCCcccCc--ccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCcc
Q 038003 238 SIPPILGNL--KSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI 315 (848)
Q Consensus 238 ~~p~~l~~l--~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 315 (848)
..|..+..+ .+|+.|++++|.+.+..+..+.. .....+..+++|+.|++++|.+.+.+|..+
T Consensus 169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 232 (455)
T 3v47_A 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRF 232 (455)
T ss_dssp CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHH
T ss_pred cChhhhhccccccccccccccCcccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhh
Confidence 555555544 44555555555554433222110 000001122233333333333332222111
Q ss_pred ceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCC
Q 038003 316 ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSN 395 (848)
Q Consensus 316 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N 395 (848)
. .....++|+.|++++|.+.+.. +..+
T Consensus 233 ~---------------~~~~~~~L~~L~l~~~~~~~~~--------------------------------------~~~~ 259 (455)
T 3v47_A 233 F---------------DAIAGTKIQSLILSNSYNMGSS--------------------------------------FGHT 259 (455)
T ss_dssp H---------------HHTTTCCEEEEECTTCTTTSCC--------------------------------------TTCC
T ss_pred h---------------ccccccceeeEeeccccccccc--------------------------------------cchh
Confidence 0 0011245555555555543211 0111
Q ss_pred ccCCCCcccccc--cccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCC
Q 038003 396 HIVGKIPVQLEM--LSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKI 473 (848)
Q Consensus 396 ~l~~~~~~~l~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 473 (848)
.+.+..+..+.. .++|+.|++++|.+++..|..|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++..
T Consensus 260 ~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 339 (455)
T 3v47_A 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSID 339 (455)
T ss_dssp SSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred hhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcC
Confidence 122122222222 256777777777777667777777777777777777777777777777888888888888887777
Q ss_pred hhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCCCCC
Q 038003 474 PTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPN 547 (848)
Q Consensus 474 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~~ 547 (848)
|..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|++++|++++..|.
T Consensus 340 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 340 SRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp GGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred hhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 77788888888888888888777777888888888888888888877777778888888888888888887774
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=375.19 Aligned_cols=200 Identities=23% Similarity=0.404 Sum_probs=165.3
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-----
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP----- 672 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----- 672 (848)
.+|++.+.||+|+||+||+|+++ +++.||||+++... .....+.+.+|++++++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 46999999999999999999654 79999999987542 3345677899999999999999999999987544
Q ss_pred -------eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEE
Q 038003 673 -------HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH 745 (848)
Q Consensus 673 -------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 745 (848)
..|+||||+++|+|.++++........++..+..|+.||+.||+|||++ |||||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 3689999999999999998765555677788899999999999999999 999999999999999999999
Q ss_pred EeeccCccccCCCCC------------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 746 VSDFGIAKFVGPHSS------------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 746 l~DfG~~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+|||+|+....... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999999987754322 1234679999999999999999999999999999999996 7643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=387.55 Aligned_cols=406 Identities=25% Similarity=0.277 Sum_probs=275.3
Q ss_pred CceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCC-------------cEEEccccCCCCCCc
Q 038003 54 SRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKL-------------QYLDLGSNQLSGLIP 120 (848)
Q Consensus 54 ~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L-------------~~L~Ls~n~l~~~~p 120 (848)
.++..+.++++.+ |.+|+ +++++++|++|++++|.+.|.+|.+++++++| ++|++++|++++ +|
T Consensus 11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp 87 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence 3677888999999 89986 59999999999999999999999999999875 999999999996 45
Q ss_pred hhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccccccc
Q 038003 121 PEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKS 200 (848)
Q Consensus 121 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 200 (848)
.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|... ++|++|++++|++++ +| .|+++++
T Consensus 88 ~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~~---~~L~~L~L~~n~l~~-lp-~~~~l~~ 154 (454)
T 1jl5_A 88 EL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDLP---PLLEYLGVSNNQLEK-LP-ELQNSSF 154 (454)
T ss_dssp SC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSCC---TTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred CC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCCC---CCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence 42 4789999999999997 7754 4889999999999995 44422 689999999999996 77 5999999
Q ss_pred ccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccC
Q 038003 201 LLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYN 280 (848)
Q Consensus 201 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~ 280 (848)
|++|++++|++++ +|..+ ++|++|++++|++++ +| .++.+++|++|++++|++++ +|.. .++|++|++++
T Consensus 155 L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~ 224 (454)
T 1jl5_A 155 LKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGN 224 (454)
T ss_dssp CCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCS
T ss_pred CCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcC
Confidence 9999999999995 67554 589999999999996 66 69999999999999999997 4543 25899999999
Q ss_pred ccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCc
Q 038003 281 NGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNF 360 (848)
Q Consensus 281 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 360 (848)
|.+. .+| .++.+++|++|++++|++++. |. ..++|+.|++++|++++.. . ..
T Consensus 225 n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l-~~---------------------~~~~L~~L~l~~N~l~~l~-~---~~ 276 (454)
T 1jl5_A 225 NILE-ELP-ELQNLPFLTTIYADNNLLKTL-PD---------------------LPPSLEALNVRDNYLTDLP-E---LP 276 (454)
T ss_dssp SCCS-SCC-CCTTCTTCCEEECCSSCCSSC-CS---------------------CCTTCCEEECCSSCCSCCC-C---CC
T ss_pred CcCC-ccc-ccCCCCCCCEEECCCCcCCcc-cc---------------------cccccCEEECCCCcccccC-c---cc
Confidence 9998 566 489999999999999999863 32 1257888888888887632 2 23
Q ss_pred ccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCccccccc-ccccEEEccCCcCCCCCCcccCCCCccCeEe
Q 038003 361 SKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEML-SSLNKLILNLNQLSGGVPLEFGSLTKLQYLD 439 (848)
Q Consensus 361 ~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 439 (848)
++|+.|++++|++++. |.. .++|+.|++++|++++ ++ .+ ++|+.|++++|++++ +|.. +++|++|+
T Consensus 277 ~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~ 343 (454)
T 1jl5_A 277 QSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLI 343 (454)
T ss_dssp TTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred CcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEE
Confidence 7788888888888752 221 2688999999999985 22 23 589999999999986 5544 57899999
Q ss_pred ccCcccCCCCCCcccCccccceeccccCcCCC--CChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcc
Q 038003 440 LSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH--KIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNL 517 (848)
Q Consensus 440 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 517 (848)
+++|++++ +|. .+++|++|++++|++++ .+|.++.. |+.|.+.+.+|.. +++|++|++++|++
T Consensus 344 L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l 408 (454)
T 1jl5_A 344 ASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPL 408 (454)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-------------------------
T ss_pred CCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcC
Confidence 99999984 565 47889999999999998 56765543 3456777777763 57899999999999
Q ss_pred cC--CCcchhccccCceeecCCCCccCCCCCC
Q 038003 518 SD--FIPRCFEEMRSLSCIDISYNELHGPIPN 547 (848)
Q Consensus 518 ~~--~~~~~~~~l~~L~~l~ls~N~l~~~~~~ 547 (848)
++ .+|. +++.+.+.+|.+.+++|.
T Consensus 409 ~~~~~iP~------sl~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 409 REFPDIPE------SVEDLRMNSERVVDPYEF 434 (454)
T ss_dssp --------------------------------
T ss_pred Cccccchh------hHhheeCcCcccCCcccc
Confidence 87 4553 356677888888887764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=378.54 Aligned_cols=207 Identities=26% Similarity=0.365 Sum_probs=177.0
Q ss_pred HhhcCCcccceeccCCceeEEEEEcCC------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC-CcccceEEEe
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELPS------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH-RNNVKFHGFC 668 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~ 668 (848)
...++|++.+.||+|+||+||+|.+.. ++.||||+++... .....+++.+|++++++++| ||||+++|+|
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 345789999999999999999997542 3579999987653 33456779999999999965 9999999998
Q ss_pred ecC-CeeEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 038003 669 YNG-PHSFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 734 (848)
Q Consensus 669 ~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~ 734 (848)
.+. +..++|||||++|+|.++++... ....+++.++..|+.|||+||+|||++ +||||||||+
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~ 214 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 214 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcc
Confidence 764 56899999999999999996431 124589999999999999999999999 9999999999
Q ss_pred CeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 735 NVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 735 NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
|||+++++.+||+|||+|+........ ....+||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999876543322 234678999999999999999999999999999999998 99998643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=365.07 Aligned_cols=199 Identities=27% Similarity=0.367 Sum_probs=164.1
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----ee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP----HS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----~~ 674 (848)
++|.+.+.||+|+||+||+|++ +|+.||||+++... .......+|+..+.+++|||||+++++|.+.+ ..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 5688889999999999999987 58999999986542 11222345666677889999999999998654 57
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC-----LPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
|+||||+++|+|.++++. ..+++..+.+++.|+|+||+|||+++ .++||||||||+|||++.++.+||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 999999999999999964 35899999999999999999999762 348999999999999999999999999
Q ss_pred cCccccCCCCCC----cccccccccccCccccccC------CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHSSN----WTEFAGTFGYAAPEIAYTM------RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+|+........ ....+||+.|||||++.+. .+++++|||||||++|||+||+.||+.
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 999877543322 2346799999999998754 467899999999999999999988754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=372.01 Aligned_cols=200 Identities=25% Similarity=0.387 Sum_probs=173.3
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec------C
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN------G 671 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------~ 671 (848)
++|++.+.||+|+||+||+|.+ .+|+.||||+++.... .....+.+.+|+++|+.++|||||++++++.. .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD--VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc--chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 5799999999999999999965 4899999999976532 23456778899999999999999999998764 3
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
+..|+||||++ |+|.+++... +.+++..+..+++||+.||+|||++ |||||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 57899999996 5799998754 6799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC----CCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPH----SSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+.+... .......+||+.|||||++.+.. ++.++||||+|||+|||+||+.||..
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 9876432 22335679999999999988754 69999999999999999999999853
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=389.06 Aligned_cols=201 Identities=21% Similarity=0.287 Sum_probs=175.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHH---HHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFL---NEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~---~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||+||+|+.+ +|+.||||++++...... .....+. .++.+++.++|||||+++++|++.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~-~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchh-hhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 467999999999999999999654 799999999977643321 2223333 34667788899999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
+|+||||++||+|.++++.. +.+++..+..++.||+.||+|||++ |||||||||+|||++.+|++||+|||+|+
T Consensus 267 lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999754 5689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..... ...+.+||+.|||||++. +..|+.++||||+||++|||+||+.||..
T Consensus 341 ~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 341 DFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp ECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred ecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 87543 235679999999999996 45799999999999999999999999864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=377.95 Aligned_cols=317 Identities=20% Similarity=0.207 Sum_probs=186.5
Q ss_pred ccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCc
Q 038003 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLI 153 (848)
Q Consensus 74 ~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 153 (848)
+++.+++|++|++++|.+++. | .++.+++|++|+|++|++++. | ++.+++|++|+|++|++++. | ++.+++|
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L 108 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKL 108 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTC
T ss_pred ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcC
Confidence 355667777777777777653 4 577777777777777777753 3 67777777777777777753 3 6677777
Q ss_pred cEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeecccc
Q 038003 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNN 233 (848)
Q Consensus 154 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n 233 (848)
++|++++|++++ +| ++++++|++|++++|++++. + ++.+++|++|++++|+..+.+ .++.+++|++|++++|
T Consensus 109 ~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n 180 (457)
T 3bz5_A 109 TYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFN 180 (457)
T ss_dssp CEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCC
Confidence 777777777774 33 66777777777777777653 2 666677777777777554444 3666667777777777
Q ss_pred CCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCC
Q 038003 234 SLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH 313 (848)
Q Consensus 234 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 313 (848)
++++ +| ++.+++|+.|++++|++++. .++.+++|++|++++|++++ +| +..+++|+.|++++|++++..+
T Consensus 181 ~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~- 250 (457)
T 3bz5_A 181 KITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV- 250 (457)
T ss_dssp CCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC-
T ss_pred ccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH-
Confidence 7764 33 56666677777777766654 25666666666666666665 33 5566666666666666654321
Q ss_pred ccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEcc
Q 038003 314 SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLS 393 (848)
Q Consensus 314 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls 393 (848)
+.+++|+.|++++|+ |+.|++++|.+.+.+| ++.+++|+.|+++
T Consensus 251 --------------------~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls 294 (457)
T 3bz5_A 251 --------------------STLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVT 294 (457)
T ss_dssp --------------------TTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCT
T ss_pred --------------------HHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECC
Confidence 234455555555543 2344455555444443 3344555555555
Q ss_pred CCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCC
Q 038003 394 SNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH 471 (848)
Q Consensus 394 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 471 (848)
+|.+.+.+|. ...+|+.|++++| ++|++|++++|+|++. .++.+++|+.|++++|+|++
T Consensus 295 ~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 295 HNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp TCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB
T ss_pred CCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC
Confidence 5554444442 1222333322222 3455555555555542 14445555555555555543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=376.73 Aligned_cols=367 Identities=20% Similarity=0.206 Sum_probs=301.4
Q ss_pred CCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCC
Q 038003 88 FNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSI 167 (848)
Q Consensus 88 ~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 167 (848)
.....+..+..++++++|++|+|++|.+++. | .++.+++|++|+|++|++++. | ++.+++|++|+|++|++++ +
T Consensus 27 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~ 100 (457)
T 3bz5_A 27 AFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-L 100 (457)
T ss_dssp HTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-C
T ss_pred hcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-e
Confidence 3445566677899999999999999999975 5 799999999999999999964 4 8999999999999999996 4
Q ss_pred CCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcc
Q 038003 168 PSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLK 247 (848)
Q Consensus 168 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~ 247 (848)
| ++++++|++|++++|++++ +| ++.+++|++|++++|++++ ++ ++.+++|++|++++|+..+.+ .++.++
T Consensus 101 ~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~ 170 (457)
T 3bz5_A 101 D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQT 170 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCT
T ss_pred e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCC
Confidence 4 8899999999999999996 44 8899999999999999996 33 888999999999999766666 478889
Q ss_pred cccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCC
Q 038003 248 SLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSG 327 (848)
Q Consensus 248 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~ 327 (848)
+|++|++++|++++. | +..+++|++|++++|.+++. .++.+++|+.|++++|++++. |
T Consensus 171 ~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--------------- 228 (457)
T 3bz5_A 171 QLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--------------- 228 (457)
T ss_dssp TCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C---------------
T ss_pred cCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C---------------
Confidence 999999999999874 4 78888999999999998875 377888888888888887752 2
Q ss_pred ccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccc
Q 038003 328 KMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEM 407 (848)
Q Consensus 328 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~ 407 (848)
+..+++|+.|++++|++++.. ++.+++|+.|+++.| +|+.|++++|.+.+.+| +..
T Consensus 229 -----~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~ 284 (457)
T 3bz5_A 229 -----VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEG 284 (457)
T ss_dssp -----CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTT
T ss_pred -----ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccc
Confidence 346678888888888888753 455677777777655 35667888888777666 467
Q ss_pred cccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceec
Q 038003 408 LSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELD 487 (848)
Q Consensus 408 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 487 (848)
+++|+.|++++|.+.+.+|. ...+|+.|++++| ++|++|+|++|+|++. + +..+++|+.|+
T Consensus 285 l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~ 345 (457)
T 3bz5_A 285 CRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLS 345 (457)
T ss_dssp CTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEE
T ss_pred cccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEE
Confidence 78888888888887766664 3455666666555 6899999999999985 3 88999999999
Q ss_pred ccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCCCCCC
Q 038003 488 LSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548 (848)
Q Consensus 488 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~~~ 548 (848)
+++|+|++ ++.|+.|++++|.++|. ..+..|..++++.|+++|.+|..
T Consensus 346 l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 346 CVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp CCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred CCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 99999976 36788899999999985 35677888999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=364.65 Aligned_cols=197 Identities=24% Similarity=0.328 Sum_probs=170.2
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN 670 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 670 (848)
...++|++.+.||+|+||+||+|..+ +++.||||++... ....++.+|+++++.+ +|||||+++++|.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~------~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT------SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT------SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc------cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 34578999999999999999999643 5678999998654 2345678999999988 69999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC-CCEEEeec
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN-FEAHVSDF 749 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Df 749 (848)
.+..|+||||+++|+|.++++ .+++.++..+++||+.||+|||++ |||||||||+|||++.+ +.+||+||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 999999999999999999983 488899999999999999999999 99999999999999876 79999999
Q ss_pred cCccccCCCCC----------------------------CcccccccccccCccccccC-CCCccchhhhHHHHHHHHHh
Q 038003 750 GIAKFVGPHSS----------------------------NWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIK 800 (848)
Q Consensus 750 G~~~~~~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt 800 (848)
|+|+...+... .....+||+.|+|||++.+. .|+.++||||+|||+|||+|
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 99986543211 12345799999999999876 48999999999999999999
Q ss_pred CCCCCcc
Q 038003 801 GNHPRDF 807 (848)
Q Consensus 801 g~~P~~~ 807 (848)
|+.||..
T Consensus 243 G~~Pf~~ 249 (361)
T 4f9c_A 243 GRYPFYK 249 (361)
T ss_dssp TCSSSSC
T ss_pred CCCCCCC
Confidence 9999843
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=370.06 Aligned_cols=345 Identities=29% Similarity=0.440 Sum_probs=174.5
Q ss_pred CCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEE
Q 038003 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLA 157 (848)
Q Consensus 78 l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 157 (848)
+++++.|+++++.+.. +| .+..+++|++|||++|.+++..| ++++++|++|+|++|++++..| ++.+++|++|+
T Consensus 45 l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 4566666666666542 44 25566666666666666664432 6666666666666666664333 56666666666
Q ss_pred cCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCC
Q 038003 158 LCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG 237 (848)
Q Consensus 158 L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~ 237 (848)
|++|.+++. |. ++++++|++|++++|.+++ ++ .++.+++|++|+++ |.+.+.. .+.++++|++|++++|.+++
T Consensus 119 L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC
Confidence 666666532 22 5556666666666666553 22 25555555555554 3333221 14455555555555555442
Q ss_pred CCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccce
Q 038003 238 SIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIER 317 (848)
Q Consensus 238 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 317 (848)
. .. +..+++|++|++++|.+.+..| ++.+++|+.|++++|.+++.
T Consensus 192 ~--~~------------------------l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~------- 236 (466)
T 1o6v_A 192 I--SV------------------------LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI------- 236 (466)
T ss_dssp C--GG------------------------GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-------
T ss_pred C--hh------------------------hccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-------
Confidence 1 12 3444444444444444443322 33344444444444443321
Q ss_pred eeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCcc
Q 038003 318 VLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397 (848)
Q Consensus 318 l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l 397 (848)
..+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++
T Consensus 237 -------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l 299 (466)
T 1o6v_A 237 -------------GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL 299 (466)
T ss_dssp -------------GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCC
T ss_pred -------------hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcc
Confidence 113334555555555555554332 3344444444444444443222 44555555555555555
Q ss_pred CCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHH
Q 038003 398 VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEF 477 (848)
Q Consensus 398 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 477 (848)
++..+ +..+++|+.|++++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +
T Consensus 300 ~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~ 371 (466)
T 1o6v_A 300 EDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--L 371 (466)
T ss_dssp SCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--G
T ss_pred cCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--h
Confidence 54332 4455555555555555554433 44555555555555555543 244555555555555555554443 4
Q ss_pred hhhcccceecccCcccCc
Q 038003 478 EKLIHLSELDLSHNILQE 495 (848)
Q Consensus 478 ~~l~~L~~L~Ls~N~l~~ 495 (848)
..+++|+.|++++|++++
T Consensus 372 ~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 372 ANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp TTCTTCCEEECCCEEEEC
T ss_pred hcCCCCCEEeccCCcccC
Confidence 555555555555555543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=366.74 Aligned_cols=343 Identities=29% Similarity=0.447 Sum_probs=267.4
Q ss_pred ceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEe
Q 038003 55 RVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYL 134 (848)
Q Consensus 55 ~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 134 (848)
+++.|++.++++.. ++ .+..+++|++|+|++|.+++..| ++++++|++|+|++|++++..| ++++++|++|+|
T Consensus 47 ~l~~L~l~~~~i~~-l~--~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp TCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred cccEEecCCCCCcc-Cc--chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 57888888887764 44 37889999999999999986544 9999999999999999997654 999999999999
Q ss_pred cccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccccccccccccccccccccc
Q 038003 135 DMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGS 214 (848)
Q Consensus 135 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 214 (848)
++|++++. |. ++.+++|++|++++|.+++ +| .++++++|++|+++ |.+.+..+ ++.+++|++|++++|.+++.
T Consensus 120 ~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~ 192 (466)
T 1o6v_A 120 FNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI 192 (466)
T ss_dssp CSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCCC
Confidence 99999965 43 9999999999999999995 44 48999999999997 56664433 89999999999999999853
Q ss_pred CcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCC
Q 038003 215 IPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYL 294 (848)
Q Consensus 215 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 294 (848)
..+..+++|++|++++|.+++..| ++.+++|+.|++++|++++. ..+..+++|++|++++|.+.+..+ +..+
T Consensus 193 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l 264 (466)
T 1o6v_A 193 --SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL 264 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred --hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcC
Confidence 358899999999999999997655 77788899999999988764 357778888888888888876543 6666
Q ss_pred CCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeeccccccc
Q 038003 295 KSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNIS 374 (848)
Q Consensus 295 ~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 374 (848)
++|+.|++++|.+++..| +..+++|+.|++++|++++.
T Consensus 265 ~~L~~L~l~~n~l~~~~~--------------------~~~l~~L~~L~L~~n~l~~~---------------------- 302 (466)
T 1o6v_A 265 TKLTELKLGANQISNISP--------------------LAGLTALTNLELNENQLEDI---------------------- 302 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--------------------GTTCTTCSEEECCSSCCSCC----------------------
T ss_pred CCCCEEECCCCccCcccc--------------------ccCCCccCeEEcCCCcccCc----------------------
Confidence 666666666666554321 33455666666666655532
Q ss_pred CCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCccc
Q 038003 375 GSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIG 454 (848)
Q Consensus 375 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 454 (848)
.+ +..+++|+.|++++|++++..| +..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..| +.
T Consensus 303 --~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~ 372 (466)
T 1o6v_A 303 --SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LA 372 (466)
T ss_dssp --GG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GT
T ss_pred --hh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hh
Confidence 22 5566777777777777776555 66777777777777777754 357777888888888888877666 77
Q ss_pred CccccceeccccCcCCC
Q 038003 455 NLLKLHYLNLSNNQLSH 471 (848)
Q Consensus 455 ~l~~L~~L~Ls~N~l~~ 471 (848)
.+++|+.|++++|++++
T Consensus 373 ~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 373 NLTRITQLGLNDQAWTN 389 (466)
T ss_dssp TCTTCCEEECCCEEEEC
T ss_pred cCCCCCEEeccCCcccC
Confidence 78888888888888875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=377.77 Aligned_cols=199 Identities=22% Similarity=0.400 Sum_probs=179.4
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|.. .+|+.||+|++... .....+.+.+|+++|+.++|||||+++++|.+.+..|+|
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 6799999999999999999965 47999999998764 234567788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC--CCEEEeeccCcccc
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN--FEAHVSDFGIAKFV 755 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DfG~~~~~ 755 (848)
|||++||+|.+++... ...+++.++..+++||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 233 ~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 233 YEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 9999999999998644 24688999999999999999999999 99999999999999854 89999999999988
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..
T Consensus 308 ~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 308 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp CTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 653 334567899999999999999999999999999999999999999853
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=357.19 Aligned_cols=302 Identities=23% Similarity=0.165 Sum_probs=171.5
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
++++.|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+.+++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 46677777777777666667777777777777777777666777777777777777777777544455666667777777
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCC
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGS 238 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ 238 (848)
++|++++..|..|.++++|++|++++|.+++..|..|+.+++|++|+|++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~ 191 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEE
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEe
Confidence 77766666666666666666666666666655555666666666666666666644444555555555555555555544
Q ss_pred CCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCcccee
Q 038003 239 IPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERV 318 (848)
Q Consensus 239 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 318 (848)
.+..+..+++|+.|++++|.+.+.+|.......+|++|++++|.+++..+
T Consensus 192 ~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~------------------------------ 241 (477)
T 2id5_A 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY------------------------------ 241 (477)
T ss_dssp CTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCH------------------------------
T ss_pred ChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCH------------------------------
Confidence 44444444444444444444433333333333334444444443332221
Q ss_pred eccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccC
Q 038003 319 LLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIV 398 (848)
Q Consensus 319 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~ 398 (848)
..|..+++|+.|+|++|++++..+ ..|..+++|+.|+|++|+++
T Consensus 242 ------------~~~~~l~~L~~L~Ls~n~l~~~~~------------------------~~~~~l~~L~~L~L~~n~l~ 285 (477)
T 2id5_A 242 ------------LAVRHLVYLRFLNLSYNPISTIEG------------------------SMLHELLRLQEIQLVGGQLA 285 (477)
T ss_dssp ------------HHHTTCTTCCEEECCSSCCCEECT------------------------TSCTTCTTCCEEECCSSCCS
T ss_pred ------------HHhcCccccCeeECCCCcCCccCh------------------------hhccccccCCEEECCCCccc
Confidence 223344455555555555544333 33444444555555555555
Q ss_pred CCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccC
Q 038003 399 GKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLS 446 (848)
Q Consensus 399 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 446 (848)
+..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 286 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 286 VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp EECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred eECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 444445555555555555555555444444555555555555555554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=355.63 Aligned_cols=321 Identities=21% Similarity=0.206 Sum_probs=212.2
Q ss_pred cEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccc
Q 038003 130 RRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSEN 209 (848)
Q Consensus 130 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 209 (848)
+.++.++++++ .+|..+. +++++|+|++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 56777777776 5665543 46677777777777666666777777777777777777666666777777777777777
Q ss_pred cccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcc
Q 038003 210 QFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPE 289 (848)
Q Consensus 210 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 289 (848)
++++..+..|.++++|++|+|++|++++..|..+..+++|++|++++|++.+..+..|.++++|++|+|++|.+++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 77644444566666666666666666655566666666666666666666666566666666666666666666654444
Q ss_pred cccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecc
Q 038003 290 EIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVS 369 (848)
Q Consensus 290 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 369 (848)
.+..+++|+.|++++|.+ .+..+..|..+++|+.|+++
T Consensus 171 ~l~~l~~L~~L~l~~n~i------------------------------------------~~~~~~~~~~l~~L~~L~l~ 208 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNI------------------------------------------NAIRDYSFKRLYRLKVLEIS 208 (477)
T ss_dssp HHTTCTTCCEEEEESCCC------------------------------------------CEECTTCSCSCTTCCEEEEE
T ss_pred HhcccCCCcEEeCCCCcC------------------------------------------cEeChhhcccCcccceeeCC
Confidence 455555555555554444 44444444444444444554
Q ss_pred cccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCC
Q 038003 370 MNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSI 449 (848)
Q Consensus 370 ~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 449 (848)
+|.+.+.+|..+....+|++|+|++|++++..+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..
T Consensus 209 ~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 288 (477)
T 2id5_A 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288 (477)
T ss_dssp CCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEEC
T ss_pred CCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceEC
Confidence 44444445555555557777777777777555566777777777777777777666667777777777777777777777
Q ss_pred CCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCc
Q 038003 450 PKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495 (848)
Q Consensus 450 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 495 (848)
|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 289 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 289 PYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp TTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred HHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 7777777777777777777777666677777777777777777754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.48 Aligned_cols=238 Identities=26% Similarity=0.388 Sum_probs=199.0
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 46799999999999999999975 579999999987653 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.+++... .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999998643 588899999999999999999999 99999999999999999999999999998877
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccccc----------------ccccchhhh
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN----------------FSSFSNMII 820 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~----------------~~~~~~~~~ 820 (848)
..........||+.|+|||++.+..+++++|||||||++|||+||+.||...... ...+...+.
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 6555556678999999999999999999999999999999999999998543211 112233334
Q ss_pred hhhhhcCCCCCCCCCCcccccceeec
Q 038003 821 DVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
++...+-..-|..||.+.+.....|+
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HHHHHHccCChhHCcCHHHHhhChhh
Confidence 44444444556667776666665554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.61 Aligned_cols=203 Identities=25% Similarity=0.329 Sum_probs=181.6
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|+.+ +++.||+|++++.... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 467999999999999999999665 7999999999775322 12345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 83 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999988654 5688999999999999999999999 99999999999999999999999999998755
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 444455667899999999999999999999999999999999999999854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=341.51 Aligned_cols=205 Identities=27% Similarity=0.373 Sum_probs=175.6
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
..++|++.+.||+|+||+||+|+.+ +++.||||++++.... .....+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4578999999999999999999764 7899999999775322 223456788999999988 799999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
|+||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999998654 5689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
...........+||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 554444556678999999999999989999999999999999999999998643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.26 Aligned_cols=202 Identities=26% Similarity=0.421 Sum_probs=180.2
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
...+|++.+.||+|+||.||+|.+ .+|+.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 346799999999999999999976 5899999999976532 3345677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 999999999999998654 5688999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccCccccccCCCC-ccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRAT-EKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ......+||+.|+|||++.+..+. +++||||+||++|||+||+.||..
T Consensus 165 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 165 TVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp SSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 543 334567899999999999888764 789999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.06 Aligned_cols=204 Identities=29% Similarity=0.394 Sum_probs=179.9
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
..++|++.+.||+|+||+||+|+.+ +++.||+|++++.... .....+.+.+|..++.++ +||||+++++++.+.+..
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 3567999999999999999999765 6889999999876433 223345678899998877 899999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999998754 5689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...........+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred cccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 54444555678999999999999999999999999999999999999999953
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.17 Aligned_cols=205 Identities=26% Similarity=0.375 Sum_probs=180.4
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCe
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 673 (848)
...++|++.+.||+|+||.||+|+.+ +++.||||++++.... .....+.+.+|.++++.+ +||||+++++++.+.+.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999765 6899999999775322 123456678899998876 99999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.|+||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999998654 5688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
............+||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 754444445667899999999999999999999999999999999999999864
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.40 Aligned_cols=310 Identities=20% Similarity=0.201 Sum_probs=153.4
Q ss_pred CCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEE
Q 038003 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLA 157 (848)
Q Consensus 78 l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 157 (848)
+++++.|++++|.++..-+..+..+++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..++.+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 45566666666665432222345566666666666666655555666666666666666666655555555666666666
Q ss_pred cCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCC
Q 038003 158 LCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG 237 (848)
Q Consensus 158 L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~ 237 (848)
|++|+++...+..|+++++|++|++++|++++..|..|+.+++|++|++++|++++. .+..+++|+.|++++|.++
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~- 199 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS- 199 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS-
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc-
Confidence 666665522222345555555555555555554455555555555555555555532 1333444444444444443
Q ss_pred CCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccce
Q 038003 238 SIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIER 317 (848)
Q Consensus 238 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 317 (848)
+. ...++|++|++++|.+... |.. ..++|+.|++++|.+++.
T Consensus 200 -----------------------~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~------- 241 (390)
T 3o6n_A 200 -----------------------TL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT------- 241 (390)
T ss_dssp -----------------------EE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC-------
T ss_pred -----------------------cc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc-------
Confidence 21 1123444444444444322 111 112333333333333211
Q ss_pred eeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCcc
Q 038003 318 VLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397 (848)
Q Consensus 318 l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l 397 (848)
..+..+++|++|++++|.+++. .|..+..+++|++|+|++|++
T Consensus 242 -------------~~l~~l~~L~~L~Ls~n~l~~~------------------------~~~~~~~l~~L~~L~L~~n~l 284 (390)
T 3o6n_A 242 -------------AWLLNYPGLVEVDLSYNELEKI------------------------MYHPFVKMQRLERLYISNNRL 284 (390)
T ss_dssp -------------GGGGGCTTCSEEECCSSCCCEE------------------------ESGGGTTCSSCCEEECCSSCC
T ss_pred -------------HHHcCCCCccEEECCCCcCCCc------------------------ChhHccccccCCEEECCCCcC
Confidence 1122334444444444444433 334444444455555555544
Q ss_pred CCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCC
Q 038003 398 VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH 471 (848)
Q Consensus 398 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 471 (848)
++ +|..+..+++|++|++++|+++ .+|..+..+++|+.|++++|+++.. + +..+++|+.|++++|+++.
T Consensus 285 ~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 285 VA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred cc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 42 3333344455555555555554 3344445555566666666665533 1 4555666666666666654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=333.50 Aligned_cols=243 Identities=22% Similarity=0.286 Sum_probs=197.3
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCC--chhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN--MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
..++|++.+.||+|+||+||+|... +|+.||+|++++...... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999665 799999999987643221 1245778999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC----CEEEeec
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF----EAHVSDF 749 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Df 749 (848)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999654 5689999999999999999999999 999999999999998877 7999999
Q ss_pred cCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccccc-----------------c
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN-----------------F 812 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~-----------------~ 812 (848)
|+++..... ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .
T Consensus 164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp SSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 999887543 2335578999999999999989999999999999999999999998542210 0
Q ss_pred cccchhhhhhhhhcCCCCCCCCCCcccccceeec
Q 038003 813 SSFSNMIIDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
..+...+.++...+-..-|..+|...+...+.|+
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 1223333444444444445556666555555554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=349.24 Aligned_cols=209 Identities=24% Similarity=0.292 Sum_probs=180.4
Q ss_pred HHHHhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 593 EIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 593 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
++....++|++.+.||+|+||+||+|+.+ +++.||+|++++..... ....+.+.+|+.++..++||||++++++|.+.
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 44455789999999999999999999765 57899999997643221 12234478899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
+..|+||||+++|+|.++++.. ...+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 9999999999999999999763 25689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-cccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSSN-WTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
++........ ....+||+.|+|||++. +..++.++|||||||++|||+||+.||..
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 9876543332 23468999999999987 45689999999999999999999999854
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=333.77 Aligned_cols=203 Identities=30% Similarity=0.396 Sum_probs=181.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~ 675 (848)
.++|++.+.||+|+||.||+|+.+ +++.||+|++++.... .....+.+.+|+.+++++ +||||+++++++.+.+..|
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC-SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc-chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 367999999999999999999765 6889999999876433 334566788999999887 8999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999998654 4689999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 4444445667899999999999999999999999999999999999999964
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=326.56 Aligned_cols=196 Identities=29% Similarity=0.454 Sum_probs=177.3
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 677789999999999999765 79999999986542 3446778899999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHS 759 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~ 759 (848)
|+++++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++.......
T Consensus 123 ~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 123 FLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp CCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred cCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 9999999999854 3589999999999999999999999 99999999999999999999999999998876554
Q ss_pred CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 760 SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 760 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.......||+.|+|||++.+..+++++||||||+++|||+||+.||..
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 445567899999999999998999999999999999999999999854
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=347.09 Aligned_cols=207 Identities=21% Similarity=0.298 Sum_probs=179.0
Q ss_pred HHHHhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 593 EIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 593 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
+.....++|++.+.||+|+||+||+|+.+ +++.||+|++++..... ....+.+.+|+.+++.++||||++++++|.+.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34455678999999999999999999765 68999999987643221 12234578899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
+..|+||||++||+|.++++. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999864 3588899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-CcccccccccccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSS-NWTEFAGTFGYAAPEIAYTMR----ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
++....... .....+||+.|+|||++.+.. ++.++|||||||++|||+||+.||..
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 987754332 224578999999999998655 78899999999999999999999854
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.67 Aligned_cols=204 Identities=26% Similarity=0.395 Sum_probs=168.4
Q ss_pred hcCCcccceeccCCceeEEEEEc----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||.||+|+. .+++.||+|++++............+.+|+++++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999976 47899999999876543334455667899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.|+||||+++++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999998654 4688899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
............+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 654444444567899999999999998899999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=327.59 Aligned_cols=200 Identities=28% Similarity=0.429 Sum_probs=179.0
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|+.. +++.||+|++++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 467999999999999999999664 7999999999775432 12345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999999754 5688999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ....+||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 158 DV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp SC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 32 3456899999999999999999999999999999999999999854
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=353.60 Aligned_cols=310 Identities=21% Similarity=0.246 Sum_probs=186.8
Q ss_pred CCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEE
Q 038003 77 SFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKL 156 (848)
Q Consensus 77 ~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 156 (848)
.+++++.|++++|.+.+..+..++.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+.+++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 35667777777777765444456677777777777777777666677777777777777777776666667777777777
Q ss_pred EcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCC
Q 038003 157 ALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLS 236 (848)
Q Consensus 157 ~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 236 (848)
+|++|.+++..+..|+++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++. .++.+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccc
Confidence 7777777744444456777777777777777766666677777777777777776643 2444556666666666655
Q ss_pred CCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccc
Q 038003 237 GSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIE 316 (848)
Q Consensus 237 ~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 316 (848)
+ +....+|+.|++++|.+....+.. .++|+.|+|++|.+++ +..
T Consensus 206 ~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~-------------------------- 249 (597)
T 3oja_B 206 T-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAW-------------------------- 249 (597)
T ss_dssp E-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGG--------------------------
T ss_pred c-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--Chh--------------------------
Confidence 3 122234555555555554322211 1344444444444443 122
Q ss_pred eeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCc
Q 038003 317 RVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396 (848)
Q Consensus 317 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~ 396 (848)
+..+++|+.|+|++|.+++..+..|+.+++|+.|++++|.+++ +|..+..+++|+.|+|++|.
T Consensus 250 ----------------l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~ 312 (597)
T 3oja_B 250 ----------------LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNH 312 (597)
T ss_dssp ----------------GGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSC
T ss_pred ----------------hccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCC
Confidence 3445566666666666665555555555555555555555543 34455556677777777777
Q ss_pred cCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccC
Q 038003 397 IVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLS 446 (848)
Q Consensus 397 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 446 (848)
++ .+|..+..+++|+.|+|++|.+++.. +..+++|+.|++++|.++
T Consensus 313 l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~ 358 (597)
T 3oja_B 313 LL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWD 358 (597)
T ss_dssp CC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEE
T ss_pred CC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCC
Confidence 76 45555666666666666666665331 344455555555555544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.15 Aligned_cols=281 Identities=22% Similarity=0.256 Sum_probs=234.7
Q ss_pred ChHHHHHHHHHHHhccCCCCCCcccCCCCCCCCCCCCCCCCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCC
Q 038003 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHL 81 (848)
Q Consensus 2 ~~~~~~all~~k~~~~~~~~~~~~l~sw~~~~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l 81 (848)
+.+|++||++||+++..++ .+++++|... .....++|.|.||+|+.....+ .-...+++
T Consensus 25 ~~~~~~aLl~~k~~~~~~~--~~~~~~w~~~--~~~~~~~~~~~g~~~~~~~~~l-----------------~~~~~~~l 83 (328)
T 4fcg_A 25 LRPYHDVLSQWQRHYNADR--NRWHSAWRQA--NSNNPQIETRTGRALKATADLL-----------------EDATQPGR 83 (328)
T ss_dssp CCCHHHHHHHHHHHHHHCC--TTHHHHHHHH--TTTCTTSCCSHHHHHHHHHHHH-----------------HHHTSTTC
T ss_pred CchHHHHHHHHHHhccCCc--hhhhhhhccc--ccccccccccCCcchhhhHHHH-----------------hcccccce
Confidence 4679999999999997654 4678899421 1135789999999996321100 01234567
Q ss_pred cEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCC
Q 038003 82 ANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHN 161 (848)
Q Consensus 82 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 161 (848)
+.|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++.+++|++|+|++|
T Consensus 84 ~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n 160 (328)
T 4fcg_A 84 VALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRAC 160 (328)
T ss_dssp CEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEE
T ss_pred eEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCC
Confidence 78888888887 78888888888888888888888 77888888888888888888888 77888888888888888888
Q ss_pred cCCCCCCCcccC---------ccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccc
Q 038003 162 NLHGSIPSSLGN---------LSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFN 232 (848)
Q Consensus 162 ~l~~~~p~~l~~---------l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~ 232 (848)
++.+.+|..++. +++|++|++++|+++ .+|..++.+++|++|+|++|+++ .+|..++.+++|++|++++
T Consensus 161 ~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~ 238 (328)
T 4fcg_A 161 PELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRG 238 (328)
T ss_dssp TTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTT
T ss_pred CCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcC
Confidence 888888877664 899999999999998 78888999999999999999999 4677899999999999999
Q ss_pred cCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccc
Q 038003 233 NSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308 (848)
Q Consensus 233 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 308 (848)
|.+.+.+|..++.+++|++|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|+.++.+++|+.+++..|.+.
T Consensus 239 n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 239 CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998877665
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=336.18 Aligned_cols=202 Identities=27% Similarity=0.387 Sum_probs=179.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... +++.||+|++.+.... .....+.+.+|+++++.++||||++++++|.+.+..|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 367999999999999999999654 6899999999765432 22345778899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+.+|+|.++++.. ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999999764 5689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCcccccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ......+||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 167 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 167 RE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp TT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 43 33456789999999999874 4588999999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=342.61 Aligned_cols=204 Identities=23% Similarity=0.358 Sum_probs=179.8
Q ss_pred HhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
...++|++.+.||+|+||+||+|.. .+++.+|+|++..... .....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 3457799999999999999999955 5789999999876532 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC---CCCCEEEeeccC
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD---SNFEAHVSDFGI 751 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfG~ 751 (848)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++ .++.+||+|||+
T Consensus 86 ~lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 9999999999999988654 5689999999999999999999999 999999999999998 467899999999
Q ss_pred ccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+..............||+.|+|||++.+..+++++||||+||++|+|++|+.||..
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 98876655555667899999999999998999999999999999999999999843
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=333.70 Aligned_cols=204 Identities=25% Similarity=0.336 Sum_probs=180.9
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
..++|++.+.||+|+||+||+|+.+ +++.||||++++.... .....+.+.+|.+++..+ +||+|+++++++.+.+..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 3568999999999999999999765 5789999999775432 123456788999999988 899999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
|+||||++||+|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999998654 4689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 54444445667899999999999999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.90 Aligned_cols=203 Identities=28% Similarity=0.486 Sum_probs=178.6
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|.+.+.||+|+||+||+|.+. +++.||+|++... +....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 467999999999999999999664 7899999988543 34567789999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++.. ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 99999999999999753 35689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCc--------------ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 757 PHSSNW--------------TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 757 ~~~~~~--------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
...... ....||+.|+|||++.+..+++++||||||+++|||++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 432211 14679999999999999999999999999999999999999986543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=324.97 Aligned_cols=203 Identities=24% Similarity=0.373 Sum_probs=175.0
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..++|++.+.||+|+||+||+|.+.+++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 3477999999999999999999888899999999876532 23345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++ ++.+++... ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 97 v~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999986 787777654 24588999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence 55455556788999999999876 4589999999999999999999999854
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.98 Aligned_cols=210 Identities=24% Similarity=0.288 Sum_probs=180.7
Q ss_pred HHHHHhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec
Q 038003 592 EEIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN 670 (848)
Q Consensus 592 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 670 (848)
.+.....++|++.+.||+|+||+||+|+.+ +++.||||++++.... .....+.+.+|..++..++||||+++++++.+
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 344456788999999999999999999764 7999999999764321 11233457889999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
.+..|+||||+++|+|.++++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999653 24688999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC-cccccccccccCccccc-------cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSN-WTEFAGTFGYAAPEIAY-------TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++........ ....+||+.|+|||++. +..++.++|||||||++|||+||+.||..
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 99887554332 23468999999999987 35689999999999999999999999854
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=336.73 Aligned_cols=203 Identities=28% Similarity=0.360 Sum_probs=171.5
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHH-HhcCCCCcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLA-LKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
.++|++.+.||+|+||+||+|+.+ +++.||||++++..... ....+.+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 467999999999999999999765 68899999998765432 2334556777776 57789999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||++||+|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999998654 4688899999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 4444445667899999999999999999999999999999999999999854
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=328.96 Aligned_cols=207 Identities=36% Similarity=0.529 Sum_probs=172.5
Q ss_pred HhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
....+|++.+.||+|+||+||+|++ +++.||||++..... .....+++.+|++++++++||||+++++++.+.+..+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 4456899999999999999999977 588899999876532 2344567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
+||||+++|+|.+++........+++..+..++.||+.||+|||++ | |+||||||+||+++.++.+||+|||+++
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999997764344589999999999999999999999 8 9999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.............||+.|+|||++.+..+++++|||||||++|||+||+.||...
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 7655444445678999999999999999999999999999999999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=328.26 Aligned_cols=204 Identities=27% Similarity=0.373 Sum_probs=174.9
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.. .++..||+|++...... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE-KEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc-cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 46799999999999999999965 47899999998654322 34456778999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++.. ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 89 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998654 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 757 PHSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 757 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.... ......||+.|+|||++.+..+++++||||+|+++|||+||+.||...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4332 223467899999999999999999999999999999999999998643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.20 Aligned_cols=240 Identities=25% Similarity=0.340 Sum_probs=191.6
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 468999999999999999999665 899999999865532 2234567899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999999998655 5689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCC--CCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCccccccc----------------cccch
Q 038003 757 PHS--SNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINF----------------SSFSN 817 (848)
Q Consensus 757 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~----------------~~~~~ 817 (848)
... ......+||+.|+|||++.+..+ +.++|||||||++|||+||+.||....... ..+..
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCH
Confidence 222 22345689999999999987775 778999999999999999999996543321 12222
Q ss_pred hhhhhhhhcCCCCCCCCCCcccccceeec
Q 038003 818 MIIDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
.+.++...+-..-|..||.+.+.....|+
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 33333333444445666666666555554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.38 Aligned_cols=207 Identities=22% Similarity=0.284 Sum_probs=179.6
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccC-CchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG-NMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
.++|++.+.||+|+||+||+|.. .+++.||||++....... .....+.+.+|+++++.++||||+++++++.+.+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999965 478999999987643221 1234677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC---EEEeeccC
Q 038003 676 LVCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE---AHVSDFGI 751 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfG~ 751 (848)
+||||+++++|.+.+.... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775431 223588999999999999999999999 9999999999999986654 99999999
Q ss_pred ccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.............+||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 98876654444567899999999999998999999999999999999999999854
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.55 Aligned_cols=200 Identities=26% Similarity=0.328 Sum_probs=179.4
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... +++.||+|++.+.... .....+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 467999999999999999999765 7999999999765432 12345778899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 119 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999998754 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ....+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 193 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 193 GR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp SC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 42 2456899999999999999999999999999999999999999854
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.37 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=191.2
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCC----------------------chhHHHHHHHHHHHh
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN----------------------MADHDEFLNEVLALK 654 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~E~~~l~ 654 (848)
.++|++.+.||+|+||.||+|.. .+++.||||++........ ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46799999999999999999965 4788999999876532211 112356889999999
Q ss_pred cCCCCcccceEEEeec--CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 038003 655 EIRHRNNVKFHGFCYN--GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 732 (848)
Q Consensus 655 ~l~hp~iv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 732 (848)
+++||||+++++++.+ .+..++||||+++++|.++.. ...+++..+..++.||+.||+|||++ +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999986 568899999999999987653 24689999999999999999999999 99999999
Q ss_pred CCCeeeCCCCCEEEeeccCccccCCCCCCcccccccccccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 733 SKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR---ATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 733 ~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
|+||+++.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|||+||+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999988765444445678999999999998655 3778999999999999999999986432
Q ss_pred cc---------------ccccchhhhhhhhhcCCCCCCCCCCcccccceeeccC
Q 038003 810 IN---------------FSSFSNMIIDVNKILDPRLPTPSPSVMDYGGCHFMLR 848 (848)
Q Consensus 810 ~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (848)
.. ...+...+.++...+-..-|..+|.+.+...+.|+.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 10 1123334444444444555667777777766666654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.14 Aligned_cols=203 Identities=25% Similarity=0.350 Sum_probs=179.4
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCC--chhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN--MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
.++|++.+.||+|+||.||+|... +++.||+|++........ ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999665 789999999977543211 12467789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC----CEEEeecc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF----EAHVSDFG 750 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG 750 (848)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999654 5689999999999999999999999 999999999999999887 89999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||..
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 998875432 23456799999999999988999999999999999999999999853
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=330.04 Aligned_cols=202 Identities=25% Similarity=0.413 Sum_probs=178.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3567999999999999999999654 789999999976532 2345577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC---CEEEeeccCc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF---EAHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~~ 752 (848)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 999999999999988654 5688999999999999999999999 999999999999998654 5999999999
Q ss_pred cccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... ......+||+.|+|||++.+..++.++|||||||++|+|+||+.||..
T Consensus 179 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 232 (362)
T 2bdw_A 179 IEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232 (362)
T ss_dssp BCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 877543 333557899999999999998999999999999999999999999853
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.98 Aligned_cols=199 Identities=22% Similarity=0.301 Sum_probs=177.8
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... +++.+|+|++... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 468999999999999999999665 6889999998643 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC--CCCEEEeeccCccc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS--NFEAHVSDFGIAKF 754 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfG~~~~ 754 (848)
||||+++++|.+++... ...+++..+..++.||+.||.|||++ ||+||||||+||+++. ++.+||+|||+++.
T Consensus 79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 79 IFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999999999999654 24689999999999999999999999 9999999999999987 78999999999988
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... .......||+.|+|||++.+..+++++||||+||++|+|+||+.||..
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 7543 333556799999999999988889999999999999999999999854
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=344.69 Aligned_cols=207 Identities=25% Similarity=0.331 Sum_probs=183.6
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|...+.||+|+||.||+|+.+ +|+.||+|++.+.... .....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 467999999999999999999765 7999999999775432 12345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 677 VCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
||||++||+|.+++.... ....+++..+..++.||+.||+|||++ ||+||||||+||+++.+|.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999886542 234689999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
..........+||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 65544445568999999999999999999999999999999999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.04 Aligned_cols=200 Identities=24% Similarity=0.394 Sum_probs=174.6
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 57999999999999999999664 789999999976542 234457788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++ ++.+.+... ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||.++....
T Consensus 80 ~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred EecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 999987 555444332 25689999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.........||+.|+|||++.+.. ++.++||||+||++|||+||+.||.
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 555556678899999999998766 7999999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.24 Aligned_cols=201 Identities=26% Similarity=0.380 Sum_probs=172.0
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
++|++.+.||+|+||+||+|...+++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 57999999999999999999888899999999876532 2233467889999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++ +|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||.++.....
T Consensus 80 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp ECCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 99986 898888654 24688999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........||+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4444556789999999998764 589999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.55 Aligned_cols=201 Identities=26% Similarity=0.392 Sum_probs=176.2
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++...... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35799999999999999999975 58899999998765322 12234578899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+ +|+|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 67888887544 5689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... .....+||+.|+|||++.+..+ ++++||||+||++|+|+||+.||+.
T Consensus 160 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 160 DGN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp TSB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred CCc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 432 3355689999999999998776 7899999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.89 Aligned_cols=217 Identities=37% Similarity=0.663 Sum_probs=189.2
Q ss_pred CccHHHHHHhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEE
Q 038003 588 KIMHEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGF 667 (848)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 667 (848)
.+...++....++|++.+.||+|+||.||+|...+++.||||++...... .....+.+|+++++.++||||++++++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEE
Confidence 35567888899999999999999999999998888999999999765422 222358899999999999999999999
Q ss_pred eecCCeeEEEEeccCCCCHHhHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEE
Q 038003 668 CYNGPHSFLVCEYLDRGSLARILGDDVT-AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV 746 (848)
Q Consensus 668 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 746 (848)
+.+.+..++||||+++|+|.++++.... ...+++..+..++.|++.||+|||+++.+||+||||||+||+++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999976532 345899999999999999999999987779999999999999999999999
Q ss_pred eeccCccccCCCCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 747 SDFGIAKFVGPHSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 747 ~DfG~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+|||+++........ .....||+.|+|||++.+..+++++|||||||++|||+||+.||+.
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence 999999877543332 2345699999999999988899999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.35 Aligned_cols=204 Identities=21% Similarity=0.390 Sum_probs=176.5
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC---
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP--- 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--- 672 (848)
..++|++.+.||+|+||.||+|.+. +++.||||+++... .....+.+.+|++++++++||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 3467999999999999999999765 89999999997543 3345678999999999999999999999986543
Q ss_pred ------------------------------------------------------eeEEEEeccCCCCHHhHhcCCCCccc
Q 038003 673 ------------------------------------------------------HSFLVCEYLDRGSLARILGDDVTAKE 698 (848)
Q Consensus 673 ------------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~ 698 (848)
..++||||+++++|.++++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 37999999999999999988766667
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC------------Cccccc
Q 038003 699 LGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS------------NWTEFA 766 (848)
Q Consensus 699 l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~------------~~~~~~ 766 (848)
.++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++....... ......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 78888999999999999999999 999999999999999999999999999988765421 223457
Q ss_pred ccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 767 GTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 767 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
||+.|+|||++.+..+++++|||||||++|||+||..|+.
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999999999988853
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=323.38 Aligned_cols=204 Identities=23% Similarity=0.365 Sum_probs=163.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|... +++.||+|+++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS---EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS---TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc---ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 3467999999999999999999765 68999999987653 2233466889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCC---CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 676 LVCEYLDRGSLARILGDD---VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
+||||+++ +|.+++... .....+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 80 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 80 LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccc
Confidence 99999984 898887532 1224588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.............||+.|+|||++.+. .+++++|||||||++|||+||+.||..
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 8876544444566889999999998764 589999999999999999999999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=341.96 Aligned_cols=203 Identities=24% Similarity=0.330 Sum_probs=169.9
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.. .+++.||||+++..... .......+.+|+++++.++||||+++++++.+.+..++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 46799999999999999999965 47899999999765332 23345667889999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ . ||+||||||+|||++.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999988654 568999999999999999999998 8 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 5544555668899999999999999999999999999999999999999854
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=343.50 Aligned_cols=206 Identities=26% Similarity=0.353 Sum_probs=182.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|... +|+.||+|++.+.... .......+.+|+++++.++||||+++++++.+.+..|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 3567999999999999999999764 7999999999775432 1234567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||++||+|.+++... ....+++..+..++.||+.||+|||++ |||||||||+||+++.++.+||+|||+++..
T Consensus 261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999998764 234589999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 337 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 337 PEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred ccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 5432 335568999999999999988999999999999999999999998653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=323.54 Aligned_cols=208 Identities=38% Similarity=0.608 Sum_probs=183.4
Q ss_pred HHHHhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 593 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 593 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
++....++|+..+.||+|+||.||+|.+++++.||||++... .....+.+.+|+++++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 444567899999999999999999999888999999998664 2345677899999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 673 HSFLVCEYLDRGSLARILGDDVT-AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999865422 23689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~ 243 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence 987543222 22345689999999999988999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.15 Aligned_cols=200 Identities=23% Similarity=0.340 Sum_probs=177.5
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+....++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 467999999999999999999654 78999999986542 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC--CCCEEEeeccCccc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS--NFEAHVSDFGIAKF 754 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfG~~~~ 754 (848)
||||+++|+|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+||+++. ++.+||+|||+++.
T Consensus 126 v~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999999998654 34689999999999999999999999 9999999999999974 47899999999988
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 201 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 201 LNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp CCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 75433 33456799999999999998999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=322.28 Aligned_cols=192 Identities=27% Similarity=0.407 Sum_probs=152.1
Q ss_pred cceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeEEEEecc
Q 038003 604 KFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSFLVCEYL 681 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lV~e~~ 681 (848)
.+.||+|+||.||+|... +++.||||++... ....+.+|+++++.+. ||||+++++++.+....++||||+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 378999999999999664 7899999998543 3456778999999996 999999999999999999999999
Q ss_pred CCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC---CEEEeeccCccccCCC
Q 038003 682 DRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF---EAHVSDFGIAKFVGPH 758 (848)
Q Consensus 682 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfG~~~~~~~~ 758 (848)
++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 89 NGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999999999754 5689999999999999999999999 999999999999997665 8999999999877665
Q ss_pred CCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.......+||+.|+|||++.+..+++++||||+||++|||+||+.||...
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 55556678899999999999999999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=329.61 Aligned_cols=204 Identities=26% Similarity=0.428 Sum_probs=177.1
Q ss_pred hcCCcccceeccCCceeEEEEEcC--------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFC 668 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 668 (848)
.++|++.+.||+|+||.||+|.+. ++..||||+++... .....+.+.+|+++++++ +||||+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 467999999999999999999652 35679999997653 334567789999999999 899999999999
Q ss_pred ecCCeeEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCC
Q 038003 669 YNGPHSFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 735 (848)
Q Consensus 669 ~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 735 (848)
.+.+..|+||||+++|+|.++++... ....+++.++..++.||+.||+|||++ ||+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence 99999999999999999999987542 123588999999999999999999999 99999999999
Q ss_pred eeeCCCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 736 VLLDSNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 736 Ill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999987654332 2233557889999999999999999999999999999999 9999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.67 Aligned_cols=205 Identities=24% Similarity=0.400 Sum_probs=178.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC--ee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP--HS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~ 674 (848)
.++|.+.+.||+|+||+||+|.+. +++.||||++..... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 467999999999999999999665 689999999976542 234567789999999999999999999988755 77
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee----CCCCCEEEeecc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----DSNFEAHVSDFG 750 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfG 750 (848)
++||||+++++|.++++.......+++..+..++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 99999999999999998764444589999999999999999999999 99999999999999 788889999999
Q ss_pred CccccCCCCCCcccccccccccCccccc--------cCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAY--------TMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
+++...... ......||+.|+|||++. +..++.++|||||||++|||+||+.||....
T Consensus 162 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 162 AARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998875533 334567999999999986 4678999999999999999999999986433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.49 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=174.9
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 46799999999999999999965 57999999998765322 12335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998754 35689999999999999999999999 99999999999999999999999999998875
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccccc-------------cccchhhhhhh
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF-------------SSFSNMIIDVN 823 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~-------------~~~~~~~~~~~ 823 (848)
..........|++.|+|||++.+..+++++||||||+++|||+||+.||....... ..+...+.++.
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHH
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHH
Confidence 44444445678999999999998889999999999999999999999986533210 01222233333
Q ss_pred hhcCCCCCCCCCCcccccceeec
Q 038003 824 KILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
..+-..-|..||.+.+...+.|+
T Consensus 244 ~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTTSTTT
T ss_pred HHHcccCHhhCCCHHHHhcCccc
Confidence 33334445566666666555554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=334.42 Aligned_cols=202 Identities=25% Similarity=0.406 Sum_probs=179.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 357999999999999999999765 8999999999765322 12345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.+++... +.+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 94 v~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999999754 5689999999999999999999999 99999999999999999999999999998875
Q ss_pred CCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ......+||+.|+|||++.+..+ ++++||||+||++|||+||+.||+.
T Consensus 168 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 168 DG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp TT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 43 33355789999999999988765 7899999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=325.45 Aligned_cols=198 Identities=24% Similarity=0.386 Sum_probs=160.9
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|.+. +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 4567999999999999999999765 68899999987542 3456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---CCCEEEeeccCc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEAHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfG~~ 752 (848)
+||||+++++|.+++... ..+++.++..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 125 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp EEECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 999999999999998754 5689999999999999999999999 9999999999999975 889999999999
Q ss_pred cccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+..... .......||+.|+|||++.+..+++++|||||||++|||+||+.||..
T Consensus 199 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 199 KIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 876542 223456799999999999998999999999999999999999999854
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=328.31 Aligned_cols=203 Identities=18% Similarity=0.182 Sum_probs=174.4
Q ss_pred HhhcCCcccceeccCCceeEEEEE------cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC---CCcccceEE
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAE------LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR---HRNNVKFHG 666 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~ 666 (848)
...++|.+.+.||+|+||+||+|. ..+++.||||+++.. ...++.+|+++++.++ |++|+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 345779999999999999999993 447889999998653 2456777888877776 999999999
Q ss_pred EeecCCeeEEEEeccCCCCHHhHhcCC--CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC----
Q 038003 667 FCYNGPHSFLVCEYLDRGSLARILGDD--VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---- 740 (848)
Q Consensus 667 ~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---- 740 (848)
++...+..++||||+++|+|.++++.. .....+++..+..|+.||+.||+|||++ +||||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccC
Confidence 999999999999999999999998642 1235699999999999999999999999 9999999999999998
Q ss_pred -------CCCEEEeeccCccccC--CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 741 -------NFEAHVSDFGIAKFVG--PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 741 -------~~~~kl~DfG~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
++.+||+|||+++.+. .........+||+.|+|||++.+..+++++|||||||++|||+||+.||...
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999997653 2222335578999999999999999999999999999999999999998543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.29 Aligned_cols=311 Identities=22% Similarity=0.235 Sum_probs=241.0
Q ss_pred CcCCccEEEcCCCcCCCCCCC-cccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccce
Q 038003 149 QLSLIDKLALCHNNLHGSIPS-SLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTM 227 (848)
Q Consensus 149 ~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 227 (848)
.++++++|++++|.++ .+|. .+.++++|++|++++|.+++..+..|+.+++|++|+|++|++++..|..++.+++|++
T Consensus 43 ~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 4677888899888888 4554 4678888899999888888776778888888888888888888777777888888888
Q ss_pred eeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccccccc
Q 038003 228 MSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLL 307 (848)
Q Consensus 228 L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 307 (848)
|++++|+++...+..+..+++|++|++++|++++..|..+..+++|++|++++|.+++. .+..+++|+.|++++|.+
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence 88888888844444467888888888888888877777788888888888888887754 244556666666666665
Q ss_pred ccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCc
Q 038003 308 RGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKL 387 (848)
Q Consensus 308 ~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L 387 (848)
++. ...++|+.|++++|.+... |.. ..++|
T Consensus 199 ~~~-----------------------~~~~~L~~L~l~~n~l~~~-------------------------~~~--~~~~L 228 (390)
T 3o6n_A 199 STL-----------------------AIPIAVEELDASHNSINVV-------------------------RGP--VNVEL 228 (390)
T ss_dssp SEE-----------------------ECCSSCSEEECCSSCCCEE-------------------------ECC--CCSSC
T ss_pred ccc-----------------------CCCCcceEEECCCCeeeec-------------------------ccc--ccccc
Confidence 532 1123556666666655432 221 13678
Q ss_pred cEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccC
Q 038003 388 QVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNN 467 (848)
Q Consensus 388 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 467 (848)
+.|++++|++++. ..+..+++|++|++++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|++|+|++|
T Consensus 229 ~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n 305 (390)
T 3o6n_A 229 TILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHN 305 (390)
T ss_dssp CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSS
T ss_pred cEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCC
Confidence 8888888888854 568888899999999999988888889999999999999999984 5667778899999999999
Q ss_pred cCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCC
Q 038003 468 QLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDF 520 (848)
Q Consensus 468 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 520 (848)
+++ .+|..+..+++|+.|+|++|+|+.. + +..+++|++|++++|+++..
T Consensus 306 ~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 306 HLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred cce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccch
Confidence 998 5677788899999999999999754 2 67788899999999988764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.69 Aligned_cols=204 Identities=25% Similarity=0.402 Sum_probs=181.8
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|.+.+.||+|+||.||+|... +++.+|+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 467999999999999999999765 6889999998765432 33456778899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... ..+++..+..++.|++.|++|||++ ||+||||||+||+++.++.+||+|||.+....
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999988654 4688999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
..........|++.|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 5444445677999999999999888999999999999999999999998653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.58 Aligned_cols=202 Identities=24% Similarity=0.334 Sum_probs=171.3
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 67999999999999999999765 68999999986653 2234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++++++.++++.. ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999999888654 5688999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.........|++.|+|||++.+ ..++.++||||+|+++|+|+||+.||...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 4444456789999999999876 56799999999999999999999998543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=322.81 Aligned_cols=243 Identities=20% Similarity=0.292 Sum_probs=194.6
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCC----chhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN----MADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
..++|++.+.||+|+||.||+|.. .+++.||||+++....... ....+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356799999999999999999964 5789999999977643221 11234567899999999999999999999999
Q ss_pred CeeEEEEeccCCC-CHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 672 PHSFLVCEYLDRG-SLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 672 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
+..++||||+.+| +|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 999998765 4689999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCcccccccc-------ccchhhhhh
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFS-------SFSNMIIDV 822 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~-------~~~~~~~~~ 822 (848)
+++...... ......||+.|+|||++.+..+ ++++|||||||++|||+||+.||........ .+...+.++
T Consensus 176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~l 254 (335)
T 3dls_A 176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL 254 (335)
T ss_dssp TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHH
T ss_pred cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHH
Confidence 998875533 3345679999999999988776 8899999999999999999999865433211 123333444
Q ss_pred hhhcCCCCCCCCCCcccccceeec
Q 038003 823 NKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
...+-..-|..||.+.+.....|+
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred HHHHccCChhhCcCHHHHhcCccc
Confidence 444444445556666555554443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=323.46 Aligned_cols=198 Identities=22% Similarity=0.323 Sum_probs=173.2
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCe
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 673 (848)
...++|++.+.||+|+||+||+|..+ +++.||||++++... ...+|++++.++ +||||+++++++.+.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 34567999999999999999999665 788999999876531 134688888777 79999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC----CCEEEeec
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN----FEAHVSDF 749 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~Df 749 (848)
.|+||||+++|+|.+++... +.+++..+..++.||+.||+|||++ ||+||||||+||++..+ +.+||+||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 99999999999999998765 5689999999999999999999999 99999999999998543 35999999
Q ss_pred cCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+++............+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 165 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp TTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 9999876555555667899999999999988899999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=312.49 Aligned_cols=216 Identities=35% Similarity=0.542 Sum_probs=186.6
Q ss_pred ccHHHHHHhhcCCccc------ceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCccc
Q 038003 589 IMHEEIIKATDDFDEK------FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV 662 (848)
Q Consensus 589 ~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 662 (848)
+...++..++++|... +.||+|+||.||+|.. +++.||||++............+.+.+|++++++++||||+
T Consensus 15 ~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp CCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 4567778888888777 8999999999999987 58899999987654333345567889999999999999999
Q ss_pred ceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC
Q 038003 663 KFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742 (848)
Q Consensus 663 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 742 (848)
++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||+|||++ ||+||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF 170 (307)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTC
T ss_pred EEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCC
Confidence 99999999999999999999999999987654445689999999999999999999999 999999999999999999
Q ss_pred CEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 743 EAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 743 ~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
.+||+|||.++........ .....|++.|+|||++.+ .++.++||||||+++|+|+||+.||....
T Consensus 171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 9999999999876543222 234578999999998875 47889999999999999999999986543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.49 Aligned_cols=202 Identities=27% Similarity=0.461 Sum_probs=173.8
Q ss_pred hcCCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||.||+|.+. .+..||||+++... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 467999999999999999999764 34469999987643 33456778999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++++|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999654 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc---ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 754 FVGPHSSNW---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
......... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 257 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence 875433221 22345778999999998899999999999999999999 9999854
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.74 Aligned_cols=204 Identities=25% Similarity=0.408 Sum_probs=182.3
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|.+.+.||+|+||.||+|.+. +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 3467999999999999999999665 6889999998765432 3445677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++++|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 118 lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 999999999999988654 5688999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...........|++.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 192 EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp CSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 6544445567899999999999998899999999999999999999999865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=316.50 Aligned_cols=203 Identities=24% Similarity=0.342 Sum_probs=179.5
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCC--chhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN--MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
.++|++.+.||+|+||.||+|... +++.||+|++........ ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999765 789999999977543221 12467789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC----CEEEeecc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF----EAHVSDFG 750 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG 750 (848)
++||||+++++|.+++... ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999754 5688999999999999999999999 999999999999999888 79999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
++....... ......|++.|+|||++.+..++.++||||||+++|+|+||+.||..
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 998775432 23456799999999999998999999999999999999999999854
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=347.45 Aligned_cols=205 Identities=25% Similarity=0.328 Sum_probs=181.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
..++|++.+.||+|+||+||+|... +++.||||++++.... .....+.+..|.+++..+ +||+|+++++++.+.+..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4568999999999999999999765 6889999999875332 123456678899999988 799999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
|+||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.
T Consensus 418 ~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999999754 5689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
...........+||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 554455556788999999999999999999999999999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=324.72 Aligned_cols=197 Identities=25% Similarity=0.341 Sum_probs=168.5
Q ss_pred CcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEe
Q 038003 601 FDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e 679 (848)
|...+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34467899999999999965 579999999987642 3456778999999999999999999999999999999999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee--CCCCCEEEeeccCccccCC
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL--DSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll--~~~~~~kl~DfG~~~~~~~ 757 (848)
|+++++|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.+..
T Consensus 167 ~~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 167 YVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp CCTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred CCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 99999999888643 24688999999999999999999999 99999999999999 6778999999999998754
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 242 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 290 (373)
T 2x4f_A 242 RE-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290 (373)
T ss_dssp TC-BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cc-ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 33 23446799999999999988899999999999999999999999854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.72 Aligned_cols=200 Identities=27% Similarity=0.357 Sum_probs=165.8
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||+||+|... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-----AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-----TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-----cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3568999999999999999999765 89999999986542 22356789999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC--EEEeeccCcc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE--AHVSDFGIAK 753 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfG~~~ 753 (848)
+||||+++|+|.+++... +.+++..+..++.|++.||+|||++ ||+||||||+||+++.++. +||+|||+++
T Consensus 93 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred EEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 999999999999998644 4689999999999999999999999 9999999999999987765 9999999997
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCcc-chhhhHHHHHHHHHhCCCCCccc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEK-YDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~P~~~~ 808 (848)
..... ......+||+.|+|||++.+..++.+ +||||+||++|+|+||+.||...
T Consensus 167 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 167 SSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred ccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 54332 22345679999999999988877655 89999999999999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=309.56 Aligned_cols=202 Identities=25% Similarity=0.414 Sum_probs=178.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 3578999999999999999999654 689999999876542 2345577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC---EEEeeccCc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE---AHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfG~~ 752 (848)
+||||+++++|.+.+... ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++. +||+|||.+
T Consensus 82 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 999999999998888654 5688999999999999999999999 9999999999999986655 999999999
Q ss_pred cccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..
T Consensus 156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 156 IEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp EECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 877543 333456799999999999999999999999999999999999999843
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=324.13 Aligned_cols=205 Identities=20% Similarity=0.265 Sum_probs=178.1
Q ss_pred hhcCCcccceeccC--CceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 597 ATDDFDEKFCIGKG--GQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 597 ~~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
..++|++.+.||+| +||.||+|... +++.||||+++.... .....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 35679999999999 99999999765 799999999977542 23456778899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999998654 234589999999999999999999999 99999999999999999999999999886
Q ss_pred ccCCCC-------CCcccccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHS-------SNWTEFAGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 542211 11233478999999999987 5789999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=322.26 Aligned_cols=203 Identities=27% Similarity=0.385 Sum_probs=169.7
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe---
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH--- 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~--- 673 (848)
.++|++.+.||+|+||.||+|.+ .+++.||||+++..... .....+.+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT-SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC-CHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 46799999999999999999975 57899999999775322 34456678999999999999999999999876543
Q ss_pred -eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 674 -SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 674 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
.|+||||+++++|.++++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999998654 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSS---NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 87654322 12345689999999999999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.08 Aligned_cols=211 Identities=28% Similarity=0.324 Sum_probs=174.2
Q ss_pred HHHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccC-CchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 594 IIKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG-NMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 594 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
+....++|++.+.||+|+||+||+|.. .++..||+|++....... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445667899999999999999999965 478899999987653321 234567889999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCC-------------------------------------CcccCCHHHHHHHHHHHHHH
Q 038003 672 PHSFLVCEYLDRGSLARILGDDV-------------------------------------TAKELGWNRRINVIKGVANA 714 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~~ 714 (848)
+..++||||+++|+|.++++... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999885210 01224567788999999999
Q ss_pred HHHHhhCCCCCeEEcCCCCCCeeeCCCC--CEEEeeccCccccCCCCC----CcccccccccccCcccccc--CCCCccc
Q 038003 715 LSYLHHDCLPSIIHRDISSKNVLLDSNF--EAHVSDFGIAKFVGPHSS----NWTEFAGTFGYAAPEIAYT--MRATEKY 786 (848)
Q Consensus 715 L~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DfG~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~ 786 (848)
|+|||++ +|+||||||+||+++.++ .+||+|||+++.+..... ......||+.|+|||++.+ ..+++++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999986533221 2245679999999999875 6788999
Q ss_pred hhhhHHHHHHHHHhCCCCCcc
Q 038003 787 DVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 787 DiwSlG~il~elltg~~P~~~ 807 (848)
|||||||++|||+||+.||..
T Consensus 258 DiwslG~il~el~~g~~pf~~ 278 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPG 278 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999854
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=308.07 Aligned_cols=238 Identities=21% Similarity=0.279 Sum_probs=194.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF----VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 3567999999999999999999665 67899999987653 234677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee---CCCCCEEEeeccCc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DSNFEAHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~~ 752 (848)
+||||+++++|.+++... ..+++..+..++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||.+
T Consensus 83 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 999999999999988654 5688999999999999999999999 99999999999999 78899999999999
Q ss_pred cccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccccc-----------------cccc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN-----------------FSSF 815 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~-----------------~~~~ 815 (848)
....... ......||+.|+|||++.+. +++++||||||+++|||+||+.||...... ...+
T Consensus 157 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (277)
T 3f3z_A 157 ARFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV 234 (277)
T ss_dssp EECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS
T ss_pred eeccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcC
Confidence 8775433 33456799999999998764 899999999999999999999998643221 0022
Q ss_pred chhhhhhhhhcCCCCCCCCCCcccccceeec
Q 038003 816 SNMIIDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
...+.++...+-..-|..||...+.....|+
T Consensus 235 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 235 SPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 3334444444444556666666665555443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=313.67 Aligned_cols=205 Identities=26% Similarity=0.365 Sum_probs=171.9
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccC-CchhHHHHHHHHHHHhcC---CCCcccceEEEeecC
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSG-NMADHDEFLNEVLALKEI---RHRNNVKFHGFCYNG 671 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~ 671 (848)
..++|++.+.||+|+||+||+|.+ .+++.||||++....... .......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999976 578999999987543211 112234566777777766 499999999999876
Q ss_pred C-----eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEE
Q 038003 672 P-----HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV 746 (848)
Q Consensus 672 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl 746 (848)
. ..++||||+.+ +|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5 57999999975 999998765 234489999999999999999999999 9999999999999999999999
Q ss_pred eeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 747 SDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 747 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+|||.++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999998775433 33557899999999999999999999999999999999999999854
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.76 Aligned_cols=241 Identities=25% Similarity=0.337 Sum_probs=195.4
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG---CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc---chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 3467999999999999999999765 78999999987653 2244577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++++|.+++... ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||.+...
T Consensus 82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 999999999999998654 5688999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCC--CCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCccccccc----------------cccc
Q 038003 756 GPHS--SNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINF----------------SSFS 816 (848)
Q Consensus 756 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~----------------~~~~ 816 (848)
.... .......|++.|+|||++.+..+ +.++||||||+++|||+||+.||....... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcC
Confidence 4322 22344678999999999987765 778999999999999999999996543211 1222
Q ss_pred hhhhhhhhhcCCCCCCCCCCcccccceeec
Q 038003 817 NMIIDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
..+.++...+-..-|..||.+.+...+.|+
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 236 SAPLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred HHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 333333444444456667776666655554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=314.91 Aligned_cols=306 Identities=25% Similarity=0.383 Sum_probs=149.1
Q ss_pred ccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccc
Q 038003 147 IGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLT 226 (848)
Q Consensus 147 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 226 (848)
+..+++|++|++++|.++ .+|. +..+++|++|++++|++++. +. +..+++|++|+|++|.+++ +| .+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence 445666777777777766 3443 66667777777777776643 33 6666666666666666663 32 455666666
Q ss_pred eeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccc
Q 038003 227 MMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNL 306 (848)
Q Consensus 227 ~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 306 (848)
+|++++|.+++. +. +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..
T Consensus 114 ~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~------------- 175 (347)
T 4fmz_A 114 ELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IAN------------- 175 (347)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGG-------------
T ss_pred EEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hcc-------------
Confidence 666666666532 22 4555555555555553332222 24444555555555554443211 333
Q ss_pred cccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCC
Q 038003 307 LRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPK 386 (848)
Q Consensus 307 l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~ 386 (848)
+++|+.|++++|.+.+..+ +..+++
T Consensus 176 -----------------------------l~~L~~L~l~~n~l~~~~~--------------------------~~~l~~ 200 (347)
T 4fmz_A 176 -----------------------------LTDLYSLSLNYNQIEDISP--------------------------LASLTS 200 (347)
T ss_dssp -----------------------------CTTCSEEECTTSCCCCCGG--------------------------GGGCTT
T ss_pred -----------------------------CCCCCEEEccCCccccccc--------------------------ccCCCc
Confidence 3444444444444432211 223333
Q ss_pred ccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceecccc
Q 038003 387 LQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSN 466 (848)
Q Consensus 387 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 466 (848)
|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|++|++++|++++. ..+..+++|++|++++
T Consensus 201 L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~ 274 (347)
T 4fmz_A 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGS 274 (347)
T ss_dssp CCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCS
T ss_pred cceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccC
Confidence 4444444444432222 3344444444444444442222 44444444444444444432 2344444444444444
Q ss_pred CcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCcc
Q 038003 467 NQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNEL 541 (848)
Q Consensus 467 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l 541 (848)
|++++. ..+..+++|+.|++++|++++..|..+..+++|++|++++|++++..| +..+++|+.+++++|++
T Consensus 275 n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 275 NQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp SCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred CccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhcc
Confidence 444432 234444455555555555544444445555555555555555554333 44555555555555554
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=340.88 Aligned_cols=311 Identities=22% Similarity=0.216 Sum_probs=250.9
Q ss_pred cCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceee
Q 038003 150 LSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMS 229 (848)
Q Consensus 150 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 229 (848)
+.+++.|++++|.+....+..++++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 56788899999998854444578889999999999999987778889999999999999999988788888899999999
Q ss_pred ccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccccccccc
Q 038003 230 LFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRG 309 (848)
Q Consensus 230 l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 309 (848)
|++|.+++..+..|+.+++|++|+|++|.+++..|..|..+++|++|+|++|.+++.. +..+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence 9999988655556788888888888888888888888888888888888888887642 4556667777777776654
Q ss_pred ccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccE
Q 038003 310 VIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQV 389 (848)
Q Consensus 310 ~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~ 389 (848)
. ...++|+.|++++|.++... ..+ .++|+.
T Consensus 207 l-----------------------~~~~~L~~L~ls~n~l~~~~-------------------------~~~--~~~L~~ 236 (597)
T 3oja_B 207 L-----------------------AIPIAVEELDASHNSINVVR-------------------------GPV--NVELTI 236 (597)
T ss_dssp E-----------------------ECCTTCSEEECCSSCCCEEE-------------------------CSC--CSCCCE
T ss_pred c-----------------------cCCchhheeeccCCcccccc-------------------------ccc--CCCCCE
Confidence 2 12245666666666665321 111 257888
Q ss_pred EEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcC
Q 038003 390 LDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQL 469 (848)
Q Consensus 390 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 469 (848)
|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.+
T Consensus 237 L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l 313 (597)
T 3oja_B 237 LKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 313 (597)
T ss_dssp EECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCC
T ss_pred EECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCC
Confidence 8999998885 3678889999999999999998888899999999999999999985 577778899999999999999
Q ss_pred CCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCC
Q 038003 470 SHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDF 520 (848)
Q Consensus 470 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 520 (848)
+ .+|..+..+++|+.|+|++|.|++. | +..+++|+.|+|++|++++.
T Consensus 314 ~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 314 L-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp C-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred C-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 8 5788889999999999999999764 2 67788999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.46 Aligned_cols=200 Identities=28% Similarity=0.434 Sum_probs=177.2
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-----cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 46799999999999999999998889999999987642 2346789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999654 24688999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... ......+++.|+|||++.+..+++++||||+|+++|||+| |+.||..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence 221 1233456788999999998899999999999999999999 9999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=319.51 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=201.3
Q ss_pred HHHHHHhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCc----hhHHHHHHHHHHHhcC-CCCcccce
Q 038003 591 HEEIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNM----ADHDEFLNEVLALKEI-RHRNNVKF 664 (848)
Q Consensus 591 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~l 664 (848)
........++|++.+.||+|+||.||+|.+. +|+.||||++......... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999775 7999999998765321111 2245678899999999 89999999
Q ss_pred EEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCE
Q 038003 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEA 744 (848)
Q Consensus 665 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 744 (848)
++++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999998643 5689999999999999999999999 99999999999999999999
Q ss_pred EEeeccCccccCCCCCCcccccccccccCcccccc------CCCCccchhhhHHHHHHHHHhCCCCCcccccc-------
Q 038003 745 HVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT------MRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN------- 811 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~P~~~~~~~------- 811 (848)
||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 240 kl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp EECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 999999998876433 3355789999999999863 35788999999999999999999998542210
Q ss_pred ----------ccccchhhhhhhhhcCCCCCCCCCCcccccceeeccC
Q 038003 812 ----------FSSFSNMIIDVNKILDPRLPTPSPSVMDYGGCHFMLR 848 (848)
Q Consensus 812 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (848)
.......+.++...+-..-|..+|...+...+.|+.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 319 EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 0122222344444444555777788777777777654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=323.05 Aligned_cols=202 Identities=24% Similarity=0.443 Sum_probs=165.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||.||+|.+. ++..||||+++... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 357999999999999999999764 57789999987642 33456779999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++|+|.++++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999999754 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc---ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 754 FVGPHSSNW---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
......... ....+++.|+|||++.+..+++++|||||||++|||++ |+.||..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~ 253 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 775432211 22345678999999999999999999999999999998 9999854
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.61 Aligned_cols=202 Identities=32% Similarity=0.477 Sum_probs=174.4
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
+.++|++.+.||+|+||.||+|... ++..||+|++...... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 3567999999999999999999654 6789999998665322 1233567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999988654 5688999999999999999999999 9999999999999999999999999998665
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 160 PSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Ccc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 432 23456789999999999998899999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.24 Aligned_cols=195 Identities=26% Similarity=0.339 Sum_probs=161.0
Q ss_pred cCCccc-ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHH-hcCCCCcccceEEEeec----C
Q 038003 599 DDFDEK-FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL-KEIRHRNNVKFHGFCYN----G 671 (848)
Q Consensus 599 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~l~~~~~~----~ 671 (848)
++|.+. +.||+|+||+||+|... +++.||||+++.. ..+.+|++++ +..+||||+++++++.. .
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 457766 68999999999999654 7899999998532 3456788876 44589999999999875 5
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---CCCEEEee
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEAHVSD 748 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~D 748 (848)
...|+||||+++|+|.+++... ....+++..+..|+.||+.||.|||+. +|+||||||+||+++. ++.+||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 5789999999999999999764 234689999999999999999999999 9999999999999997 78999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||+++..... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 208 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 208 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 9999876542 233557889999999999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=313.17 Aligned_cols=239 Identities=21% Similarity=0.218 Sum_probs=186.9
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~l 676 (848)
++|++.+.||+|+||+||+|.+. +++.||||++..... ..........|+..+.++ +||||++++++|.+.+..++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 57999999999999999999765 799999999765431 223344555666665555 99999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+ +++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 66888887654 24689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccc-c-----------ccccchhhhhhhh
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSI-N-----------FSSFSNMIIDVNK 824 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~-~-----------~~~~~~~~~~~~~ 824 (848)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... . ...+...+.++..
T Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHH
Confidence 432 2345679999999999876 789999999999999999999665432111 0 1123344444555
Q ss_pred hcCCCCCCCCCCcccccceeecc
Q 038003 825 ILDPRLPTPSPSVMDYGGCHFML 847 (848)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~ 847 (848)
.+-..-|..||...+.....|+.
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPVLR 309 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGS
T ss_pred HHcCCChhhCcCHHHHHhCcccc
Confidence 55555677778877777776664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.26 Aligned_cols=176 Identities=26% Similarity=0.401 Sum_probs=148.3
Q ss_pred CcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeE
Q 038003 359 NFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYL 438 (848)
Q Consensus 359 ~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 438 (848)
.+++|+.|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.+++..+ +..+++|++|
T Consensus 153 ~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L 226 (347)
T 4fmz_A 153 NMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSL 226 (347)
T ss_dssp TCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred hCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEE
Confidence 33344444444444433222 6678899999999999985544 8899999999999999996655 8899999999
Q ss_pred eccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCccc
Q 038003 439 DLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS 518 (848)
Q Consensus 439 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 518 (848)
++++|++++..+ +..+++|++|++++|.+++. ..+..+++|+.|++++|++++. +.+..+++|++|++++|+++
T Consensus 227 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 227 KIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred EccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCC
Confidence 999999996654 89999999999999999864 5789999999999999999875 56899999999999999999
Q ss_pred CCCcchhccccCceeecCCCCccCCCCC
Q 038003 519 DFIPRCFEEMRSLSCIDISYNELHGPIP 546 (848)
Q Consensus 519 ~~~~~~~~~l~~L~~l~ls~N~l~~~~~ 546 (848)
+..+..|..+++|+.|++++|++++..|
T Consensus 301 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 301 NEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp GGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred CcChhHhhccccCCEEEccCCccccccC
Confidence 9999999999999999999999998666
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=307.28 Aligned_cols=201 Identities=27% Similarity=0.465 Sum_probs=177.7
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|+++++..||+|+++... ...+++.+|++++++++||||+++++++.+....++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-----MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-----BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-----CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 46799999999999999999998888899999987642 2356789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.+.....
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999999998654 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 758 HSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 758 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
.... .....+++.|+|||++.+..+++++||||+|+++|||+| |+.||+..
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 3321 123456778999999998889999999999999999999 99998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=309.08 Aligned_cols=242 Identities=25% Similarity=0.336 Sum_probs=189.8
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|.+.+.||+|+||.||+|.. .++..+|+|++.... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR---SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG---CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc---cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 35699999999999999999965 478999999987754 23446778999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee---CCCCCEEEeeccCc
Q 038003 677 VCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DSNFEAHVSDFGIA 752 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~~ 752 (848)
||||+++++|.+++.... ....+++..+..++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 999999999998875431 235689999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccccc----------------ccccc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN----------------FSSFS 816 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~----------------~~~~~ 816 (848)
....... ......|++.|+|||++. ..++.++||||||+++|||+||+.||...... ...+.
T Consensus 175 ~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 175 ELFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp CC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC
T ss_pred eecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC
Confidence 8765432 234567899999999876 46889999999999999999999998543211 01123
Q ss_pred hhhhhhhhhcCCCCCCCCCCcccccceeecc
Q 038003 817 NMIIDVNKILDPRLPTPSPSVMDYGGCHFML 847 (848)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (848)
..+.++...+-..-|..||...+.....|+.
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~ 283 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence 3334444444445566677777766666654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.40 Aligned_cols=200 Identities=23% Similarity=0.376 Sum_probs=164.7
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|.+.+.||+|+||+||+|... +++.||+|++...... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 57999999999999999999765 7899999998654311 1112345799999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++ +|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred eccccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 999985 888887654 34688999999999999999999999 999999999999999999999999999987665
Q ss_pred CCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4444456678999999999876 5679999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=316.18 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=171.8
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 467999999999999999999665 68999999986543 223445667899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||++++++.++.... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||.++...
T Consensus 102 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999999998886544 4689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
..........|++.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 544444567899999999998875 6899999999999999999999998643
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.81 Aligned_cols=249 Identities=33% Similarity=0.502 Sum_probs=227.9
Q ss_pred CCCcEEeccCCcccc--cccccccCCCCCcEEEccc-cCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccE
Q 038003 79 PHLANLNLSFNLFFG--NIPLQIGNLSKLQYLDLGS-NQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDK 155 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~--~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 155 (848)
.+++.|+|++|.++| .+|..|+++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|+.+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 578999999999999 8999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccc-cccccccccccccccCcccccCCcccceeeccccC
Q 038003 156 LALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLK-SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234 (848)
Q Consensus 156 L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 234 (848)
|+|++|.+++.+|..++++++|++|++++|++++.+|..++.++ +|++|+|++|++++.+|..+..++ |+.|++++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999999999999999999999999999999999999999998 999999999999999999999987 9999999999
Q ss_pred CCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCc
Q 038003 235 LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHS 314 (848)
Q Consensus 235 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 314 (848)
+++.+|..+..+++|+.|++++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9988899999999999999999999877665 788899999999999999889999998888988888888888877742
Q ss_pred cceeeccccCCCCccccccCCCCCccEEEccCCc
Q 038003 315 IERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNN 348 (848)
Q Consensus 315 l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 348 (848)
..+++|+.|++++|+
T Consensus 288 -------------------~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 288 -------------------GNLQRFDVSAYANNK 302 (313)
T ss_dssp -------------------TTGGGSCGGGTCSSS
T ss_pred -------------------ccccccChHHhcCCC
Confidence 345677777777777
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=325.93 Aligned_cols=204 Identities=25% Similarity=0.378 Sum_probs=174.7
Q ss_pred hcCCcccceeccCCceeEEEEEc----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~ 672 (848)
.++|++.+.||+|+||.||+|+. .+++.||||+++...........+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46799999999999999999976 478999999997654322233445567899999999 6999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998654 4688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC-CCcccccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHS-SNWTEFAGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.+.... ......+||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 8764322 22234679999999999985 3478899999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.33 Aligned_cols=203 Identities=26% Similarity=0.428 Sum_probs=172.0
Q ss_pred hcCCcccceeccCCceeEEEEEc-----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG- 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 671 (848)
.++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 46799999999999999999973 36889999998754 345567789999999999999999999998653
Q ss_pred -CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 672 -PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 672 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
...++||||+++++|.++++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence 4689999999999999999754 24589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC---CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 751 IAKFVGPHSS---NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 751 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
+++....... ......+++.|+|||++.+..+++++||||||+++|||+||..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 221 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 221 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh
Confidence 9987754322 1223456778999999999999999999999999999999999986543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.87 Aligned_cols=204 Identities=26% Similarity=0.410 Sum_probs=176.0
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|.+.+.||+|+||.||+|.+. +++.||||+++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3467999999999999999999775 78999999987542 2334556889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++|+|.++++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 189 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999999998643 34688999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 756 GPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 756 ~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
....... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321111 11235678999999998889999999999999999999 99998643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=318.04 Aligned_cols=199 Identities=18% Similarity=0.223 Sum_probs=174.6
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~ 675 (848)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS------RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC------SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc------chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 46799999999999999999965 578999999986542 123477899999999 9999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC-----EEEeecc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE-----AHVSDFG 750 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DfG 750 (848)
+||||+ +++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 999999 89999998754 35789999999999999999999999 9999999999999998887 9999999
Q ss_pred CccccCCCCCC-------cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 751 IAKFVGPHSSN-------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 751 ~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
+++.+...... .....||+.|+|||++.+..+++++|||||||++|||+||+.||...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 99876443221 24568999999999999999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=322.31 Aligned_cols=201 Identities=26% Similarity=0.424 Sum_probs=162.9
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCC--
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGP-- 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~-- 672 (848)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|+.+++.+. ||||+++++++...+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 357899999999999999999965 579999999986542 23455677889999999997 999999999997544
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..|+||||+++ +|.++++. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 85 ~~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp CEEEEEECCSE-EHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecccCc-CHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 78999999985 89888854 3588899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC---------------------CCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPH---------------------SSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.+... .......+||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 875321 112244689999999999886 5689999999999999999999999853
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=316.31 Aligned_cols=202 Identities=32% Similarity=0.454 Sum_probs=171.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
..++|++.+.||+|+||+||+|++. ++.||||++.... .......+|+.++++++||||+++++++.+..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 4568999999999999999999875 7899999986542 33445667899999999999999999998754
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC-------CCCeEEcCCCCCCeeeCCCCCEE
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC-------LPSIIHRDISSKNVLLDSNFEAH 745 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-------~~~ivH~Dlk~~NIll~~~~~~k 745 (848)
..++||||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 469999999999999999643 4899999999999999999999761 23899999999999999999999
Q ss_pred EeeccCccccCCCCC--CcccccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 746 VSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 746 l~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
|+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 999999987654332 2234679999999999886 35677899999999999999999998643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=306.16 Aligned_cols=204 Identities=29% Similarity=0.464 Sum_probs=163.6
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|.+. ++.||||+++...........+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467999999999999999999875 8899999987764333344567789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC--------CCCEEEeec
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS--------NFEAHVSDF 749 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------~~~~kl~Df 749 (848)
|||+++++|.++++. ..+++..+..++.|++.||+|||++..++|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999853 46889999999999999999999991112999999999999986 678999999
Q ss_pred cCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
|.++....... ....|++.|+|||++.+..+++++||||||+++|+|+||+.||...
T Consensus 161 g~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 161 GLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred Ccccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99987654322 3457899999999999988999999999999999999999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.55 Aligned_cols=200 Identities=27% Similarity=0.420 Sum_probs=179.6
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT---CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 35699999999999999999965 578999999987653 23456778999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++. ..+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||.+....
T Consensus 98 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence 9999999999999854 4688999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........|++.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp TTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 544444567799999999999998999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.89 Aligned_cols=203 Identities=23% Similarity=0.345 Sum_probs=165.1
Q ss_pred HhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
...++|++.+.||+|+||+||+|.. .+++.||||+++.... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3456899999999999999999964 4789999999976532 223345678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee-----CCCCCEEEeec
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL-----DSNFEAHVSDF 749 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll-----~~~~~~kl~Df 749 (848)
++||||+++ +|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||++ +.++.+||+||
T Consensus 109 ~lv~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999999985 999988655 4588999999999999999999999 99999999999999 45556999999
Q ss_pred cCccccCCCCCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+++.............||+.|+|||++.+.. ++.++|||||||++|||+||+.||..
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 99988765444455667899999999998754 79999999999999999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.56 Aligned_cols=210 Identities=22% Similarity=0.324 Sum_probs=177.5
Q ss_pred HHHHHHhhcCCccc-ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEE
Q 038003 591 HEEIIKATDDFDEK-FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGF 667 (848)
Q Consensus 591 ~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~ 667 (848)
........++|.+. +.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.+ +||||++++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 33444556678877 88999999999999655 799999999977542 234467789999999999 56999999999
Q ss_pred eecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---CCCE
Q 038003 668 CYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEA 744 (848)
Q Consensus 668 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ 744 (848)
+.+.+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ ||+||||||+||+++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999998654 335689999999999999999999999 9999999999999998 7899
Q ss_pred EEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 745 HVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||+|||+++...... ......|++.|+|||++.+..+++++|||||||++|||+||+.||..
T Consensus 174 kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp EECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999998875432 23456799999999999999999999999999999999999999854
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=317.94 Aligned_cols=198 Identities=30% Similarity=0.450 Sum_probs=171.9
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|+..+.||+|+||+||+|.. .+++.||||++...... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 4589999999999999999965 57899999998764321 223456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+. |++.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99998 4787777532 25688999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. ....||+.|+|||++. +..++.++|||||||++|||+||+.||..
T Consensus 207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 3457999999999985 46689999999999999999999999854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=308.41 Aligned_cols=202 Identities=25% Similarity=0.437 Sum_probs=175.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..++|++.+.||+|+||+||+|.+.++..||+|+++... ...+++.+|++++++++||||+++++++.+.+..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-----CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 346799999999999999999999888899999987642 234678999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++...
T Consensus 97 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 97 ITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999763 34689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 757 PHSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 757 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
.... ......+++.|+|||++.+..+++++||||+|+++|||+| |+.||...
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 3221 1123456788999999998899999999999999999999 99998643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.67 Aligned_cols=242 Identities=24% Similarity=0.306 Sum_probs=182.6
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCC----chhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN----MADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
..++|.+.+.||+|+||.||+|.. .+++.||||++........ ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 457899999999999999999965 4789999999976543211 1122347899999999999999999999754
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC---CEEEee
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF---EAHVSD 748 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~D 748 (848)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 5689999999999999988654 5689999999999999999999999 999999999999997544 599999
Q ss_pred ccCccccCCCCCCcccccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCccccccc-------------
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF------------- 812 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~------------- 812 (848)
||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......
T Consensus 286 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~ 364 (419)
T 3i6u_A 286 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364 (419)
T ss_dssp SSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred cccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence 9999887543 23355789999999999863 567889999999999999999999986432211
Q ss_pred -----cccchhhhhhhhhcCCCCCCCCCCcccccceeec
Q 038003 813 -----SSFSNMIIDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 813 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
..+...+.++...+-..-|..+|...+...+.|+
T Consensus 365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 1122333334444444456666666666655554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.67 Aligned_cols=201 Identities=25% Similarity=0.364 Sum_probs=171.5
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
+|.....||+|+||.||+|.+ .++..||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 455566899999999999965 57889999998664 2344577899999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-CCCEEEeeccCccccCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG~~~~~~~ 757 (848)
||+++++|.++++.......+++..+..++.||+.||+|||++ ||+||||||+||+++. ++.+||+|||.+.....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999997654445677888999999999999999999 9999999999999987 89999999999988765
Q ss_pred CCCCcccccccccccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMR--ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........|++.|+|||++.+.. ++.++||||||+++|||+||+.||..
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 444345567899999999987643 78899999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.54 Aligned_cols=200 Identities=23% Similarity=0.340 Sum_probs=168.0
Q ss_pred hcCCccc-ceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 598 TDDFDEK-FCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 598 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
.++|++. +.||+|+||.||+|... +++.||||++... .....+.+.+|++++.++ +||||+++++++.+.+..
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC----SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC----cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 4568874 78999999999999754 7899999998764 234467788999999885 799999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC---EEEeeccC
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE---AHVSDFGI 751 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfG~ 751 (848)
++||||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 9999999999999998654 4688999999999999999999999 9999999999999998776 99999999
Q ss_pred ccccCCCCC-------CcccccccccccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSS-------NWTEFAGTFGYAAPEIAYT-----MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+........ .....+||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 976542211 1223568999999999875 5578999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=308.06 Aligned_cols=201 Identities=28% Similarity=0.434 Sum_probs=177.4
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... ++..||+|++...... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 367999999999999999999665 6788999998765322 12335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... ..+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||.+....
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999998654 4688999999999999999999999 99999999999999999999999999997664
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ......|++.|+|||++.+..++.++||||||+++|+|+||+.||..
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 32 23456789999999999998899999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=328.97 Aligned_cols=198 Identities=25% Similarity=0.360 Sum_probs=166.6
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG----- 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 671 (848)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ......+++.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 57899999999999999999965 478999999997652 1334567788999999999999999999999654
Q ss_pred -CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 672 -PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 672 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
...|+||||++++ +.+.+.. .+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 139 ~~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 139 FQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 4579999999874 6666643 388899999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 210 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp CC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99877543 234557899999999999999999999999999999999999999854
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=312.67 Aligned_cols=205 Identities=24% Similarity=0.349 Sum_probs=168.6
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.++++++||||+++++++...+..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 3578999999999999999999764 7889999999765422 3344577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++++|.++++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999998654 4688999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 756 GPHSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 756 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
..... ......|++.|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 54321 223467899999999999988999999999999999999999998653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=318.01 Aligned_cols=201 Identities=22% Similarity=0.331 Sum_probs=169.9
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC--CcccceEEEeecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH--RNNVKFHGFCYNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~~~~~ 674 (848)
..++|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|++++++++| |||+++++++.+....
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3467999999999999999999888899999999876532 33455778999999999976 9999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||| +.+++|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+||+++ ++.+||+|||+++.
T Consensus 85 ~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99999 5677999999754 5688999999999999999999999 999999999999997 67899999999987
Q ss_pred cCCCCC--CcccccccccccCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSS--NWTEFAGTFGYAAPEIAYT-----------MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... .....+||+.|+|||++.+ ..+++++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 754332 1235679999999999865 5688899999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.94 Aligned_cols=204 Identities=27% Similarity=0.412 Sum_probs=177.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC--------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFC 668 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 668 (848)
.++|.+.+.||+|+||.||+|.+. .+..||||+++... .....+.+.+|+++++++ +||||+++++++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 467999999999999999999652 33579999987653 344567789999999999 999999999999
Q ss_pred ecCCeeEEEEeccCCCCHHhHhcCCCC-------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCC
Q 038003 669 YNGPHSFLVCEYLDRGSLARILGDDVT-------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 735 (848)
Q Consensus 669 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 735 (848)
.+.+..++||||+++|+|.++++.... ...+++..+..++.||+.||+|||++ +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999865421 24589999999999999999999999 99999999999
Q ss_pred eeeCCCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 736 VLLDSNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 736 Ill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999987654322 2234567889999999999999999999999999999999 9999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.83 Aligned_cols=203 Identities=26% Similarity=0.388 Sum_probs=175.6
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCC--chhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN--MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
.++|++.+.||+|+||.||+|... +++.||+|+++....... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356999999999999999999765 789999999877543221 12467889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC----CEEEeecc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF----EAHVSDFG 750 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG 750 (848)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999998643 4689999999999999999999999 999999999999998877 89999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.+....... ......|++.|+|||++.+..++.++||||||+++|+|+||+.||..
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 998775432 23456789999999999988899999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=332.22 Aligned_cols=201 Identities=27% Similarity=0.439 Sum_probs=178.5
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|... +++.||||++...... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 467999999999999999999765 8999999999765432 23456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee---CCCCCEEEeeccCcc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DSNFEAHVSDFGIAK 753 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~~~ 753 (848)
||||+.+|+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999988655 5689999999999999999999999 99999999999999 567899999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.+.... .....+||+.|+|||++.+ .+++++||||+||++|+|+||+.||..
T Consensus 178 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 178 HFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp HBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Eccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 875433 3455689999999999876 689999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.09 Aligned_cols=206 Identities=25% Similarity=0.322 Sum_probs=169.6
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCC-chhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN-MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
...++|++.+.||+|+||.||+|... +++.||||++........ ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999775 689999999976432211 1112467899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++ ++.+++... ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999987 888888654 24578888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.............||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~ 215 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 215 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 876555455567899999999998764 478999999999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=316.19 Aligned_cols=199 Identities=26% Similarity=0.283 Sum_probs=175.2
Q ss_pred HhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-----CCcccceEEEee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-----HRNNVKFHGFCY 669 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~l~~~~~ 669 (848)
...++|++.+.||+|+||+||+|.+ .+++.||||+++.. ....+.+..|+++++.++ ||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 3457899999999999999999966 47899999998643 244566778999999886 999999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---------
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS--------- 740 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------- 740 (848)
..+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ ||+||||||+||+++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccc
Confidence 999999999999 88999998755 224588999999999999999999999 9999999999999975
Q ss_pred ----------------CCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 038003 741 ----------------NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804 (848)
Q Consensus 741 ----------------~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 804 (848)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 789999999999875432 2446789999999999999999999999999999999999999
Q ss_pred Ccc
Q 038003 805 RDF 807 (848)
Q Consensus 805 ~~~ 807 (848)
|..
T Consensus 259 f~~ 261 (360)
T 3llt_A 259 FRT 261 (360)
T ss_dssp CCC
T ss_pred CCC
Confidence 854
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=323.84 Aligned_cols=205 Identities=24% Similarity=0.400 Sum_probs=177.4
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC--ee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP--HS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~ 674 (848)
.++|.+.+.||+|+||+||+|.+. +++.||||++..... ....+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 467999999999999999999665 689999999976542 234567789999999999999999999998755 77
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee----CCCCCEEEeecc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----DSNFEAHVSDFG 750 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfG 750 (848)
++||||+++|+|.++++.......+++..+..++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999999998764444589999999999999999999999 99999999999999 778889999999
Q ss_pred CccccCCCCCCcccccccccccCcccccc--------CCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYT--------MRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 162 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 162 AARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp GCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 998775432 2345679999999999865 567889999999999999999999986433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.21 Aligned_cols=202 Identities=32% Similarity=0.523 Sum_probs=171.8
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchh---HHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMAD---HDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||+||+|.+ .+++.||+|++........... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46799999999999999999966 4789999999876543222111 167889999999999999999999997665
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCCeeeCCCCC-----EEE
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDSNFE-----AHV 746 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~-----~kl 746 (848)
++||||+++++|.+++... ...+++..+..++.|++.||+|||++ + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 6999999999998888654 34689999999999999999999999 8 999999999999988776 999
Q ss_pred eeccCccccCCCCCCcccccccccccCccccc--cCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 747 SDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY--TMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 747 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
+|||+++.... ......|++.|+|||++. ...+++++||||+||++|||+||+.||....
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99999985433 334567999999999984 4557889999999999999999999986433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=317.51 Aligned_cols=206 Identities=25% Similarity=0.432 Sum_probs=177.2
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCY 669 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 669 (848)
...++|++.+.||+|+||.||+|.+. +++.||||+++... .....+.+.+|++++++++||||+++++++.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34578999999999999999999764 34789999997653 3345677899999999999999999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCC---------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEE
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVT---------------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIH 728 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH 728 (848)
+.+..++||||+++|+|.++++.... ...+++.++..++.||+.||.|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 99999999999999999999865311 25689999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCCEEEeeccCccccCCCC--CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCC
Q 038003 729 RDISSKNVLLDSNFEAHVSDFGIAKFVGPHS--SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPR 805 (848)
Q Consensus 729 ~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~ 805 (848)
|||||+||+++.++.+||+|||+++...... .......+++.|+|||++.+..++.++||||||+++|||+| |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999998764322 12234567899999999998899999999999999999999 99998
Q ss_pred cc
Q 038003 806 DF 807 (848)
Q Consensus 806 ~~ 807 (848)
..
T Consensus 278 ~~ 279 (343)
T 1luf_A 278 YG 279 (343)
T ss_dssp TT
T ss_pred CC
Confidence 64
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=321.97 Aligned_cols=200 Identities=24% Similarity=0.373 Sum_probs=169.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG----- 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 671 (848)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ......+++.+|++++++++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 467999999999999999999654 68899999997642 2345567889999999999999999999999776
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
...|+||||+++ +|.++++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEecCCc-CHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 578999999875 999998754 5689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC----------------------CcccccccccccCcccc-ccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 752 AKFVGPHSS----------------------NWTEFAGTFGYAAPEIA-YTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 752 ~~~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
++....... .....+||+.|+|||++ .+..++.++||||+||++|||+||..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 987754321 23567899999999986 56668999999999999999998766553
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=326.67 Aligned_cols=195 Identities=25% Similarity=0.373 Sum_probs=156.1
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-----C
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN-----G 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~ 671 (848)
.++|++.+.||+|+||+||+|.+. +++.||||++.... ......+++.+|+++++.++||||+++++++.. .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 468999999999999999999654 78999999986542 234556788999999999999999999999944 3
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
...|+||||+. ++|.++++.. ..+++..+..++.||+.||+|||++ |||||||||+|||++.++.+||+|||+
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CCEEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence 57899999985 5899988654 5689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC---------------------------CCcccccccccccCcccc-ccCCCCccchhhhHHHHHHHHHhC
Q 038003 752 AKFVGPHS---------------------------SNWTEFAGTFGYAAPEIA-YTMRATEKYDVYSFGVLVFEVIKG 801 (848)
Q Consensus 752 ~~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg 801 (848)
++...... ......+||+.|+|||++ .+..++.++|||||||++|||+||
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 98764321 123456789999999986 466799999999999999999994
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=330.29 Aligned_cols=200 Identities=27% Similarity=0.425 Sum_probs=174.6
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|... +++.||||++...... ......+.+|++++++++||||+++++++.+....++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 467999999999999999999665 7999999998765432 2346778999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC---CCCCEEEeeccCcc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD---SNFEAHVSDFGIAK 753 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfG~~~ 753 (848)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++ .++.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999888654 5689999999999999999999999 999999999999995 45679999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... .....+||+.|+|||++.+ .+++++||||+||++|+|+||+.||..
T Consensus 173 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 224 (486)
T 3mwu_A 173 CFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (486)
T ss_dssp TBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ECCCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 775432 3355689999999999876 589999999999999999999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.97 Aligned_cols=239 Identities=26% Similarity=0.377 Sum_probs=190.5
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 4567999999999999999999665 68999999986542 3456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||.+...
T Consensus 101 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 999999999999998632 35688999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccccc----------------ccccchhh
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN----------------FSSFSNMI 819 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~----------------~~~~~~~~ 819 (848)
...........|++.|+|||++.+..++.++||||||+++|+|+||+.||...... ...+...+
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 255 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF 255 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHH
Confidence 65444445567899999999999988999999999999999999999998643211 01122333
Q ss_pred hhhhhhcCCCCCCCCCCcccccceeec
Q 038003 820 IDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
.++...+-..-|..+|.+.+...+.|+
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 444444444456666666665555443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=329.84 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=190.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCC---------chhHHHHHHHHHHHhcCCCCcccceEE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGN---------MADHDEFLNEVLALKEIRHRNNVKFHG 666 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~hp~iv~l~~ 666 (848)
..++|.+.+.||+|+||+||+|... +++.||+|++........ ....+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3577999999999999999999664 688999999976543211 134567889999999999999999999
Q ss_pred EeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC---C
Q 038003 667 FCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF---E 743 (848)
Q Consensus 667 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~ 743 (848)
++.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999988654 5689999999999999999999999 999999999999998776 6
Q ss_pred EEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccccc------------
Q 038003 744 AHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN------------ 811 (848)
Q Consensus 744 ~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~------------ 811 (848)
+||+|||+++..... ......+||+.|+|||++.+ .+++++||||+||++|+|++|+.||......
T Consensus 188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999999887543 33455689999999999874 6899999999999999999999998643211
Q ss_pred -----ccccchhhhhhhhhcCCCCCCCCCCcccccceeec
Q 038003 812 -----FSSFSNMIIDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 812 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
...+...+.++...+-..-|..||...+.....|+
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 11233334444444444445566666555555444
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=321.15 Aligned_cols=200 Identities=27% Similarity=0.388 Sum_probs=175.8
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 467999999999999999999665 78999999987653 34456778999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.++++.. ..+++..+..++.|++.||+|||+.+ ||+||||||+||+++.++.+||+|||++....
T Consensus 109 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999998654 46889999999999999999999832 89999999999999999999999999997653
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ......|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22 22346789999999999999999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=311.98 Aligned_cols=199 Identities=30% Similarity=0.452 Sum_probs=166.3
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||+||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 357899999999999999999875 788999998543 345778999999999999999999999874 47999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC-EEEeeccCccccC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE-AHVSDFGIAKFVG 756 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~kl~DfG~~~~~~ 756 (848)
|||+++++|.++++.......+++..+..++.|+++||+|||+.+..||+||||||+||+++.++. +||+|||.+....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999987644456888999999999999999999932129999999999999998886 7999999997654
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.. .....|++.|+|||++.+..+++++||||||+++|||+||+.||+..
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 158 TH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred cc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 32 23456899999999999989999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=325.43 Aligned_cols=239 Identities=14% Similarity=0.140 Sum_probs=180.1
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHH---HHHhcCCCCcccceE-------E
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEV---LALKEIRHRNNVKFH-------G 666 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hp~iv~l~-------~ 666 (848)
.++|++.+.||+|+||+||+|.+ .+++.||||++...... .....+.+.+|+ +++++++|||||+++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 46799999999999999999976 47999999999765322 234567789999 556666899999998 6
Q ss_pred EeecCC-----------------eeEEEEeccCCCCHHhHhcCCC----CcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 038003 667 FCYNGP-----------------HSFLVCEYLDRGSLARILGDDV----TAKELGWNRRINVIKGVANALSYLHHDCLPS 725 (848)
Q Consensus 667 ~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ 725 (848)
++.+.+ ..|+||||+ +|+|.++++... ....+++..+..|+.||+.||+|||++ |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 665543 278999999 579999986431 112344578889999999999999999 9
Q ss_pred eEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccccccccccCccccccC-----------CCCccchhhhHHHH
Q 038003 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-----------RATEKYDVYSFGVL 794 (848)
Q Consensus 726 ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DiwSlG~i 794 (848)
|+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .+++++|||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 99999999999999999999999999986433 3345677 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCcccccc---------ccccchhhhhhhhhcCCCCCCCCCCcccccceee
Q 038003 795 VFEVIKGNHPRDFFSIN---------FSSFSNMIIDVNKILDPRLPTPSPSVMDYGGCHF 845 (848)
Q Consensus 795 l~elltg~~P~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (848)
+|||+||+.||...... ...+...+.++...+-..-|..+|...+.....|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp HHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred HHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 99999999998643321 1122233333333344444555565555544443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=319.67 Aligned_cols=204 Identities=27% Similarity=0.384 Sum_probs=174.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
.++|++.+.||+|+||+||+|.+. ++..||||+++... .......+.+|+.++++++||||+++++++.+.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 467999999999999999999743 46689999986542 334556788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCC----CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC---CE
Q 038003 672 PHSFLVCEYLDRGSLARILGDDV----TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF---EA 744 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ 744 (848)
...++||||+++|+|.++++... ....+++.++..++.||+.||+|||++ ||+||||||+||+++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999986432 224689999999999999999999999 999999999999999555 59
Q ss_pred EEeeccCccccCCCC--CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 745 HVSDFGIAKFVGPHS--SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 745 kl~DfG~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||+|||+++...... .......||+.|+|||++.+..+++++|||||||++|||+| |+.||..
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999997552211 22234567899999999999899999999999999999998 9999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.28 Aligned_cols=200 Identities=22% Similarity=0.327 Sum_probs=170.4
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC--CCcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR--HRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~~ 675 (848)
.++|++.+.||+|+||+||+|...+++.||||++..... .....+.+.+|++++++++ ||||+++++++...+..+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 356999999999999999999888899999999876532 3445678899999999996 599999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||| +.+++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++.+
T Consensus 133 lv~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 9999 5678999998755 4688889999999999999999999 999999999999995 589999999999877
Q ss_pred CCCCC--CcccccccccccCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSS--NWTEFAGTFGYAAPEIAYT-----------MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..... .....+||+.|+|||++.+ ..+++++|||||||++|||+||+.||..
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 54332 1245679999999999865 3688899999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=321.08 Aligned_cols=210 Identities=25% Similarity=0.372 Sum_probs=177.6
Q ss_pred HHHHhhcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceE
Q 038003 593 EIIKATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFH 665 (848)
Q Consensus 593 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~ 665 (848)
......++|++.+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+++++++ +||||++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444568899999999999999999963 356889999997643 334557789999999999 899999999
Q ss_pred EEeecCC-eeEEEEeccCCCCHHhHhcCCCC-------------------------------------------------
Q 038003 666 GFCYNGP-HSFLVCEYLDRGSLARILGDDVT------------------------------------------------- 695 (848)
Q Consensus 666 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------- 695 (848)
+++.+.+ ..++||||+++|+|.++++....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998755 48999999999999999875421
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC-
Q 038003 696 --------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS- 760 (848)
Q Consensus 696 --------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~- 760 (848)
...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 11288999999999999999999999 999999999999999999999999999987644332
Q ss_pred -CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 761 -NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 761 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 2234567899999999999999999999999999999999 99998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=327.81 Aligned_cols=200 Identities=28% Similarity=0.402 Sum_probs=170.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|... ++..||+|++...... ....+.+.+|+++++.++||||+++++++.+....++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 456999999999999999999765 7899999999775432 2335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC---CCEEEeeccCcc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN---FEAHVSDFGIAK 753 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~~~ 753 (848)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||+++.. +.+||+|||+++
T Consensus 114 v~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999888654 5688999999999999999999999 99999999999999764 559999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... .....+||+.|+|||++.+ .+++++||||+||++|+|++|+.||..
T Consensus 188 ~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 188 VFENQK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp ECBTTB-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ECCCCc-cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 775432 3355689999999999864 689999999999999999999999854
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=329.50 Aligned_cols=201 Identities=24% Similarity=0.423 Sum_probs=175.5
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..++|++.+.||+|+||.||+|.++++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 356789999999999999999998888999999987642 34678999999999999999999999986 567899
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.++++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 260 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999999754 224688899999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 757 PHSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 757 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 3211 1123446789999999998899999999999999999999 9999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.69 Aligned_cols=205 Identities=26% Similarity=0.404 Sum_probs=177.4
Q ss_pred hhcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 670 (848)
..++|.+.+.||+|+||.||+|.. .++..||||+++... .....+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 356799999999999999999965 245789999987543 34556778999999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCC---------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEc
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVT---------------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHR 729 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~ 729 (848)
.+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||++ +|+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 9999999999999999999875422 23488999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCc
Q 038003 730 DISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 806 (848)
Q Consensus 730 Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 806 (848)
||||+||+++.++.+||+|||+++........ .....+++.|+|||++.+..+++++|||||||++|||+| |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999877543322 233456789999999998889999999999999999999 999986
Q ss_pred c
Q 038003 807 F 807 (848)
Q Consensus 807 ~ 807 (848)
.
T Consensus 255 ~ 255 (314)
T 2ivs_A 255 G 255 (314)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.39 Aligned_cols=205 Identities=20% Similarity=0.304 Sum_probs=168.8
Q ss_pred hhcCCcccceeccCCceeEEEEEcCC------CCEEEEEEcccccccCC-------chhHHHHHHHHHHHhcCCCCcccc
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPS------GDIVAVKKFNSQLLSGN-------MADHDEFLNEVLALKEIRHRNNVK 663 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~ 663 (848)
..++|++.+.||+|+||.||+|.+.. ++.||||++........ ......+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999997754 47899999865421100 001123445667788889999999
Q ss_pred eEEEeecC----CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 664 FHGFCYNG----PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 664 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
+++++... ...++||||+ +++|.+++... ...+++..+..|+.||+.||+|||++ +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99998764 4589999999 99999998653 35689999999999999999999999 999999999999999
Q ss_pred --CCCCEEEeeccCccccCCCCC-------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 740 --SNFEAHVSDFGIAKFVGPHSS-------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 740 --~~~~~kl~DfG~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.++.+||+|||+++.+..... ......||+.|+|||++.+..+++++|||||||++|||+||+.||..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 889999999999987643221 11335699999999999999999999999999999999999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.89 Aligned_cols=206 Identities=24% Similarity=0.391 Sum_probs=174.4
Q ss_pred hhcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCY 669 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 669 (848)
..++|++.+.||+|+||.||+|.+ .++..||||++.... .....+.+.+|+++++++ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 457899999999999999999975 245689999997543 233456789999999999 8999999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCC--------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEc
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVT--------------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHR 729 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~ 729 (848)
..+..++||||+++|+|.+++..... ...+++..+..++.||+.||+|||++ ||+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 99999999999999999999976422 13478999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCc
Q 038003 730 DISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRD 806 (848)
Q Consensus 730 Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 806 (848)
||||+||+++.++.+||+|||++......... .....||+.|+|||++.+..+++++|||||||++|||+| |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876543322 233557889999999998899999999999999999998 999986
Q ss_pred cc
Q 038003 807 FF 808 (848)
Q Consensus 807 ~~ 808 (848)
..
T Consensus 277 ~~ 278 (344)
T 1rjb_A 277 GI 278 (344)
T ss_dssp TC
T ss_pred cC
Confidence 53
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=313.99 Aligned_cols=197 Identities=26% Similarity=0.403 Sum_probs=166.9
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+++.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 46799999999999999999965 579999999986642 13345677889999999999999999999997653
Q ss_pred --eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 673 --HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 673 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
..|+||||+ +++|.++++. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 7899998864 3588899999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++..... ....++|+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 174 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 174 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 99876432 345678999999999887 6789999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.94 Aligned_cols=206 Identities=25% Similarity=0.396 Sum_probs=160.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCC----EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
..++|++.+.||+|+||.||+|.+.... .||||+++.... .....+.+.+|++++++++||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 4567999999999999999999765432 799999976532 2345678999999999999999999999998776
Q ss_pred ee------EEEEeccCCCCHHhHhcCCC---CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC
Q 038003 673 HS------FLVCEYLDRGSLARILGDDV---TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE 743 (848)
Q Consensus 673 ~~------~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 743 (848)
.. ++||||+++|+|.+++.... ....+++..+..++.||+.||+|||++ ||+||||||+||+++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 55 99999999999999885431 122589999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 744 AHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 744 ~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 242 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 999999999876443221 223456789999999999999999999999999999999 9999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.98 Aligned_cols=202 Identities=26% Similarity=0.402 Sum_probs=169.4
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.+. +++.||||++...... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 467999999999999999999765 7999999998765322 22345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||.+....
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999998654 4688999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ......|++.|+|||++.+..+ ++++||||||+++|+|+||+.||+.
T Consensus 163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 163 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp C--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 432 2344678999999999988765 6899999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.94 Aligned_cols=199 Identities=26% Similarity=0.390 Sum_probs=173.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 3467999999999999999999764 79999999987642 223456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee---CCCCCEEEeeccCc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DSNFEAHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~~ 752 (848)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++ ||+||||||+||++ +.++.+||+|||.+
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp EEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEEEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 999999999999988654 4688999999999999999999999 99999999999999 78899999999999
Q ss_pred cccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... ......|++.|+|||++.+..+++++||||+|+++|||+||+.||..
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 157 KMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp CCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 765432 23445789999999999998999999999999999999999999854
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.16 Aligned_cols=204 Identities=26% Similarity=0.429 Sum_probs=175.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC--------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFC 668 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 668 (848)
.++|++.+.||+|+||.||+|.+. ++..||||+++... .....+.+.+|+++++++ +||||+++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 467999999999999999999753 56789999987653 334567789999999999 899999999999
Q ss_pred ecCCeeEEEEeccCCCCHHhHhcCCCC-------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCC
Q 038003 669 YNGPHSFLVCEYLDRGSLARILGDDVT-------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 735 (848)
Q Consensus 669 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 735 (848)
.+.+..++||||+++|+|.+++..... ...+++..+..++.||+.||+|||++ ||+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 999999999999999999999976421 23488999999999999999999999 99999999999
Q ss_pred eeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 736 VLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 736 Ill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
|+++.++.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 99999999999999999876543321 233456789999999998889999999999999999999 9999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.34 Aligned_cols=206 Identities=24% Similarity=0.392 Sum_probs=178.1
Q ss_pred hhcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCY 669 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 669 (848)
..++|++.+.||+|+||.||+|.+ .+++.||+|+++... .....+.+.+|+++++++ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 346799999999999999999964 356789999987653 234567789999999999 9999999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCC---------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCC
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVT---------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSK 734 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~ 734 (848)
+.+..++||||+++|+|.+++..... ...+++..+..++.||+.||+|||++ ||+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 99999999999999999999865421 12589999999999999999999999 9999999999
Q ss_pred CeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 735 NVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 735 NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
||+++.++.+||+|||.++........ .....+++.|+|||++.+..+++++||||||+++|||+| |+.||...
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999999877554332 123456789999999999899999999999999999999 99998653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=300.99 Aligned_cols=198 Identities=25% Similarity=0.341 Sum_probs=171.7
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec----CCe
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN----GPH 673 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~ 673 (848)
+.|.+.+.||+|+||.||+|.+ .++..||+|++..... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 4578888999999999999965 4788999999876532 23456778999999999999999999998865 356
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCCeeeC-CCCCEEEeecc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLD-SNFEAHVSDFG 750 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~kl~DfG 750 (848)
.++||||+++++|.++++.. ..+++..+..++.||+.||.|||+. + |+||||||+||+++ .++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 89999999999999999654 5688999999999999999999999 8 99999999999997 78999999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
++...... ......|++.|+|||++.+ .++.++||||+|+++|+|+||+.||..
T Consensus 178 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 178 LATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred Cccccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 99765432 3345679999999998874 589999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=305.16 Aligned_cols=189 Identities=29% Similarity=0.484 Sum_probs=160.9
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhc--CCCCcccceEEEeec----C
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKE--IRHRNNVKFHGFCYN----G 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~l~~~~~~----~ 671 (848)
.++|++.+.||+|+||+||+|.+ +++.||||++... ..+.+.+|.+++.. ++||||+++++++.. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 46899999999999999999987 6899999998543 23445566666555 799999999998654 3
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEcCCCCCCeeeCCCCC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH--------HDCLPSIIHRDISSKNVLLDSNFE 743 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH--------~~~~~~ivH~Dlk~~NIll~~~~~ 743 (848)
...++||||+++|+|.++++. ..+++..+..++.||+.||+||| +. +|+||||||+||+++.++.
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred ceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 468999999999999999954 36899999999999999999999 77 9999999999999999999
Q ss_pred EEEeeccCccccCCCCCC----cccccccccccCccccccC------CCCccchhhhHHHHHHHHHhC
Q 038003 744 AHVSDFGIAKFVGPHSSN----WTEFAGTFGYAAPEIAYTM------RATEKYDVYSFGVLVFEVIKG 801 (848)
Q Consensus 744 ~kl~DfG~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg 801 (848)
+||+|||+++........ .....||+.|+|||++.+. .+++++|||||||++|||+||
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 999999999876543322 1234799999999999876 456799999999999999999
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=325.34 Aligned_cols=197 Identities=29% Similarity=0.462 Sum_probs=171.2
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-eeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP-HSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-~~~l 676 (848)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 467899999999999999999875 7899999987542 3467899999999999999999999987665 7899
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.++++.. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999999754 223478899999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
.. .....+++.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 390 (450)
T 1k9a_A 341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 123367889999999999999999999999999999999 99998643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.91 Aligned_cols=201 Identities=27% Similarity=0.434 Sum_probs=168.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCE----EEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDI----VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
.++|++.+.||+|+||+||+|.+. +++. ||+|++.... .....+.+.+|+.++++++||||+++++++. .+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 357999999999999999999754 4554 7777765432 1223345678999999999999999999986 45
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++|+|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred ccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence 689999999999999998754 34688899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 753 KFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+....... ......|++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence 98754332 2244567889999999998899999999999999999999 9999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=308.45 Aligned_cols=241 Identities=25% Similarity=0.318 Sum_probs=185.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccC----CchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG----NMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
.++|.+.+.||+|+||.||+|... +++.||||++....... .......+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999654 68899999987653211 1122345789999999999999999999987665
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC---EEEeec
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE---AHVSDF 749 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Df 749 (848)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 89999999999999988654 5688999999999999999999999 9999999999999987664 999999
Q ss_pred cCccccCCCCCCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCccccccc--------------
Q 038003 750 GIAKFVGPHSSNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF-------------- 812 (848)
Q Consensus 750 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~-------------- 812 (848)
|+++..... .......|++.|+|||++. +..++.++|||||||++|+|+||+.||.......
T Consensus 162 g~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 162 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp TTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred ccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 999877542 2223467899999999974 4568899999999999999999999986433211
Q ss_pred ----cccchhhhhhhhhcCCCCCCCCCCcccccceeec
Q 038003 813 ----SSFSNMIIDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 813 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
..+...+.++...+-..-|..+|...+...+.|+
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~ 278 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence 1122233333333444445666666665555554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=308.43 Aligned_cols=203 Identities=24% Similarity=0.383 Sum_probs=170.4
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 3567999999999999999999765 6899999998664 2345678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++++|.+++... ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++...
T Consensus 93 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999987643 24588999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCCCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
...........|++.|+|||++. +..++.++||||||+++|+|+||+.||...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 22111223457899999999983 566889999999999999999999998653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.56 Aligned_cols=201 Identities=24% Similarity=0.421 Sum_probs=175.0
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 456799999999999999999998888899999986542 345678999999999999999999999864 46899
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... ....+++..+..++.|++.||+|||++ ||+||||||+||++++++.+||+|||.+....
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999654 223689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 757 PHSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 757 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
..... .....+++.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 43221 233456789999999998889999999999999999999 9999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.04 Aligned_cols=202 Identities=26% Similarity=0.380 Sum_probs=162.8
Q ss_pred hhcCCcccceeccCCceeEEEEEcCC----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
..++|++.+.||+|+||.||+|.+.. +..||+|+++... .....+.+.+|+.++++++||||+++++++. .+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 34679999999999999999997642 4569999986542 3345677899999999999999999999985 45
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++++|.++++.. ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred ccEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence 789999999999999998654 24688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 753 KFVGPHSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+........ .....+++.|+|||++.+..++.++||||||+++|||+| |..||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 877543221 223456789999999998899999999999999999997 9999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=307.44 Aligned_cols=206 Identities=24% Similarity=0.327 Sum_probs=166.6
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... +....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 45799999999999999999965 57999999998764322 34456778999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 677 VCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
||||+++++|.+++.... ....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999886421 234688999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...........|++.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 5544444556789999999999998899999999999999999999999854
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.54 Aligned_cols=195 Identities=23% Similarity=0.372 Sum_probs=169.8
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CC-------CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SG-------DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCY 669 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 669 (848)
.++|++.+.||+|+||+||+|... ++ ..||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG----GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc----cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 467999999999999999999654 33 46999998654 2345678899999999999999999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC------
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE------ 743 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~------ 743 (848)
+.+..++||||+++++|.++++.. ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred eCCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence 999999999999999999999754 24488999999999999999999999 9999999999999998887
Q ss_pred --EEEeeccCccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 744 --AHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 744 --~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
+||+|||.+..... .....|++.|+|||++.+ ..+++++|||||||++|||+||..|+
T Consensus 158 ~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp CEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 99999999876532 234568899999999987 67899999999999999999965553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=330.40 Aligned_cols=202 Identities=27% Similarity=0.469 Sum_probs=176.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..+|++.+.||+|+||.||+|.++ ++..||||+++... ...+++.+|++++++++||||++++++|.+.+..++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 456889999999999999999776 48899999987542 346789999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.++++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999754 235688999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 757 PHSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 757 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
..... .....+++.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 33211 123445789999999998889999999999999999999 99998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=303.41 Aligned_cols=205 Identities=23% Similarity=0.348 Sum_probs=172.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEee--cCCee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCY--NGPHS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~~~ 674 (848)
.++|++.+.||+|+||.||+|... +++.||+|+++...........+.+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999764 789999999977644333445678899999999999999999999984 45688
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||++++ +.+++... ....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||.+..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999986 66666543 235689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC--CCcccccccccccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHS--SNWTEFAGTFGYAAPEIAYTMR--ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..... .......|++.|+|||++.+.. ++.++||||||+++|||+||+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 65322 2223467899999999987644 37899999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=302.39 Aligned_cols=201 Identities=23% Similarity=0.325 Sum_probs=172.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 674 (848)
..++|++.+.||+|+||+||+|... +++.||+|++..... .......+.+|+..+..+ +||||+++++++.+.+..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 3467999999999999999999765 899999999876532 234456788999999999 999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCC-cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC------------
Q 038003 675 FLVCEYLDRGSLARILGDDVT-AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN------------ 741 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------------ 741 (848)
++||||+++++|.++++.... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999999865321 24589999999999999999999999 99999999999999844
Q ss_pred -------CCEEEeeccCccccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 742 -------FEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 742 -------~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
..+||+|||.+...... ....|++.|+|||++.+. .+++++|||||||++|+|++|..|+.
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 47999999999877543 234589999999998865 56789999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.46 Aligned_cols=202 Identities=23% Similarity=0.389 Sum_probs=173.3
Q ss_pred hcCCcccceeccCCceeEEEEEc-----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG- 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 671 (848)
.++|++.+.||+|+||.||+|.+ .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 35588999999999999999973 468999999987653 234567789999999999999999999999876
Q ss_pred -CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 672 -PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 672 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
...++||||+++++|.++++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence 6689999999999999998543 24588999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC---CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSS---NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.+........ ......||+.|+|||++.+..++.++||||+|+++|||+||+.|+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 9988765432 12345678889999999998899999999999999999999999643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=300.97 Aligned_cols=200 Identities=28% Similarity=0.434 Sum_probs=176.5
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 46799999999999999999988888999999987653 2346789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+.....
T Consensus 82 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp ECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence 9999999999998654 24588999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... ......+++.|+|||++.+..+++++||||||+++|||+| |+.||..
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 211 1123456789999999998889999999999999999999 8999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.41 Aligned_cols=202 Identities=24% Similarity=0.354 Sum_probs=171.4
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec------
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN------ 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 670 (848)
.++|++.+.||+|+||+||+|.. .+++.||||++...... ......+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 46799999999999999999976 57999999998765322 2334567899999999999999999999987
Q ss_pred --CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 671 --GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 671 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
.+..++||||+++ ++.+.+... ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred cCCceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEcc
Confidence 3468999999986 676666543 24589999999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCC----CCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHS----SNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||+++.+.... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 99998765221 22345678999999999876 4579999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.64 Aligned_cols=206 Identities=28% Similarity=0.458 Sum_probs=175.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEee--cCCee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCY--NGPHS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~~~ 674 (848)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 467999999999999999999665 789999999876532 2345677899999999999999999999874 46689
Q ss_pred EEEEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eEEcCCCCCCeeeCCCCCEEEee
Q 038003 675 FLVCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPS-----IIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~-----ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 99999999999999986431 123589999999999999999999999 8 99999999999999999999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
||.++.............|++.|+|||++.+..++.++||||||+++|+|+||+.||...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 999987755433334567899999999999888999999999999999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.40 Aligned_cols=193 Identities=21% Similarity=0.330 Sum_probs=170.4
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeec--CCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYN--GPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~--~~~ 673 (848)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ...
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 36799999999999999999964 57899999998643 3467889999999997 9999999999987 667
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-CEEEeeccCc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-EAHVSDFGIA 752 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~~ 752 (848)
.++||||+++++|.++++ .+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus 108 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp EEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 899999999999999873 478889999999999999999999 999999999999999777 8999999999
Q ss_pred cccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+...... ......|++.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 179 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 179 EFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp EECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred eEcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8775433 3345678999999999887 5689999999999999999999999843
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.13 Aligned_cols=201 Identities=24% Similarity=0.451 Sum_probs=166.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCE----EEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDI----VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+.... .....+++.+|++++++++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 357999999999999999999754 4554 5777775432 2345678899999999999999999999998764
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
.++|+||+++|+|.+++... ...+++..+..|+.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred -eEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence 78999999999999998754 25689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 753 KFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+........ .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||+.
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 877543332 233456889999999999999999999999999999999 9999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=303.90 Aligned_cols=198 Identities=20% Similarity=0.263 Sum_probs=174.0
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~ 675 (848)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++.+ +|++++++++++.+....+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 46799999999999999999975 578999999986542 223477899999999 8999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC-----EEEeecc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE-----AHVSDFG 750 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DfG 750 (848)
+||||+ +++|.++++.. ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++. +||+|||
T Consensus 83 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 999999 99999999754 24589999999999999999999999 9999999999999987776 9999999
Q ss_pred CccccCCCCC-------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSS-------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++....... ......||+.|+|||++.+..+++++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 9987754322 12456799999999999999999999999999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.47 Aligned_cols=202 Identities=28% Similarity=0.472 Sum_probs=178.3
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|.+. ++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 4577999999999999999999765 5888999998653 345677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++++|.++++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+...
T Consensus 86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999999754 235689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 756 GPHSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 756 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
...... .....+++.|+|||++.+..+++++||||||+++|+|+| |..||..
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 543322 233456789999999998899999999999999999999 9999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.92 Aligned_cols=206 Identities=27% Similarity=0.412 Sum_probs=158.2
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
...++|++.+.||+|+||.||+|... +++.||||++..... ....+++.+|++++++++||||+++++++...+..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 34578999999999999999999764 789999999866432 23456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCC-----CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeec
Q 038003 675 FLVCEYLDRGSLARILGDD-----VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDF 749 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df 749 (848)
++||||+++++|.+++... .....+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999988531 1235689999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCC-----CcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 750 GIAKFVGPHSS-----NWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 750 G~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|.+........ ......|++.|+|||++.+ ..++.++||||||+++|||+||+.||..
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99987643221 1234578999999999876 5689999999999999999999999865
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.43 Aligned_cols=203 Identities=19% Similarity=0.240 Sum_probs=166.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCC-------chhHHHHHHHHHHHhcCCCCcccceEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGN-------MADHDEFLNEVLALKEIRHRNNVKFHG 666 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~l~~ 666 (848)
.++|++.+.||+|+||.||+|.+. ++..+|||++........ ......+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999765 578899999876421100 001234667889999999999999999
Q ss_pred Eeec----CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC
Q 038003 667 FCYN----GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742 (848)
Q Consensus 667 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 742 (848)
++.. ....++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9987 67899999999 99999999765 3789999999999999999999999 999999999999998877
Q ss_pred --CEEEeeccCccccCCCC-------CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 743 --EAHVSDFGIAKFVGPHS-------SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 743 --~~kl~DfG~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.+||+|||+++.+.... .......||+.|+|||++.+..+++++|||||||++|||+||+.||..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999998764321 112446799999999999998999999999999999999999999954
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=305.34 Aligned_cols=198 Identities=26% Similarity=0.413 Sum_probs=172.7
Q ss_pred CcccceeccCCceeEEEEEcC-----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--Ce
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--PH 673 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~ 673 (848)
|++.+.||+|+||+||++.+. +++.||||+++... .....+.+.+|++++++++||||+++++++.+. ..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 489999999999999988542 68889999997652 345567789999999999999999999999874 57
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++++|.+++... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.+.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence 89999999999999999654 488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 754 FVGPHSSN---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
........ .....+++.|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 87654321 23456788899999999988999999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.09 Aligned_cols=198 Identities=20% Similarity=0.310 Sum_probs=172.6
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC--CeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--PHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~ 675 (848)
.++|++.+.||+|+||.||+|.+. ++.||||+++.... .....+.+.+|++++++++||||+++++++.+. +..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 467999999999999999999875 88999999876532 234557789999999999999999999999887 7889
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
+||||+++|+|.++++.. ....+++..+..++.||+.||+|||++ + |+||||||+||+++.++.++|+|||++.
T Consensus 86 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence 999999999999999765 223589999999999999999999998 8 9999999999999999999999999876
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCc---cchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATE---KYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... ....||+.|+|||++.+..++. ++||||||+++|||+||+.||..
T Consensus 162 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 162 SFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp TTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred eecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 5332 3356899999999998765544 79999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=325.83 Aligned_cols=200 Identities=27% Similarity=0.450 Sum_probs=169.7
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|.+..+..||||+++... ...+++.+|++++++++||||+++++++.+ +..++|
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 46788999999999999999998888889999987642 235678999999999999999999999876 678999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 257 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp ECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999999643 234588999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 322 1233456789999999998899999999999999999999 9999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=311.54 Aligned_cols=210 Identities=21% Similarity=0.281 Sum_probs=170.6
Q ss_pred HHHHHHhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccC-------CchhHHHHHHHHHHHhcCCCCcccc
Q 038003 591 HEEIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSG-------NMADHDEFLNEVLALKEIRHRNNVK 663 (848)
Q Consensus 591 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~ 663 (848)
..++....++|++.+.||+|+||.||+|...++..||||++....... +....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 346667789999999999999999999988889999999986653221 1223477899999999999999999
Q ss_pred eEEEeec-----CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee
Q 038003 664 FHGFCYN-----GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL 738 (848)
Q Consensus 664 l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll 738 (848)
+++++.. ....++||||+++ ++.+++... ...+++..+..++.||+.||.|||++ ||+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 9999854 3468999999984 787777643 34689999999999999999999999 99999999999999
Q ss_pred CCCCCEEEeeccCccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 739 DSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 739 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.++.+||+|||.+....... ......|++.|+|||++.+ ..++.++||||+||++|+|+||+.||..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 999999999999998654332 2345678999999999876 6689999999999999999999999864
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=301.73 Aligned_cols=176 Identities=24% Similarity=0.317 Sum_probs=78.7
Q ss_pred CCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEe
Q 038003 103 SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182 (848)
Q Consensus 103 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l 182 (848)
++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 34444555544444444444444445555555554444444444444444444444444444 3443333 44555555
Q ss_pred ecccccCCCccccccccccccccccccccc--ccCcccccCCcccceeeccccCCCCCCCCcccCccccccccccccccc
Q 038003 183 YKNSLSGSIPSIIGKLKSLLQLDLSENQFS--GSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN 260 (848)
Q Consensus 183 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~ 260 (848)
++|++++..+..|+.+++|++|++++|.++ +..|..+..+ +|+.|++++|++++ +|..+. ++|++|++++|+++
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~ 206 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ 206 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCC
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCC
Confidence 555554333334444555555555555443 2333334433 44444444444442 332222 33444444444444
Q ss_pred CcCCCcccCCCCCceEEccCccccc
Q 038003 261 GFIPPSIGNLSSLRVLYLYNNGLYG 285 (848)
Q Consensus 261 ~~~p~~l~~l~~L~~L~Ls~N~l~~ 285 (848)
+..+..+..+++|++|++++|.+++
T Consensus 207 ~~~~~~l~~l~~L~~L~L~~N~l~~ 231 (332)
T 2ft3_A 207 AIELEDLLRYSKLYRLGLGHNQIRM 231 (332)
T ss_dssp CCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred ccCHHHhcCCCCCCEEECCCCcCCc
Confidence 4333344444444444444444433
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=310.56 Aligned_cols=204 Identities=23% Similarity=0.413 Sum_probs=177.6
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCc-------------hhHHHHHHHHHHHhcCCCCcccce
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNM-------------ADHDEFLNEVLALKEIRHRNNVKF 664 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~l 664 (848)
.++|++.+.||+|+||.||+|.. +++.||+|++......... ...+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999988 8999999999766433211 112778999999999999999999
Q ss_pred EEEeecCCeeEEEEeccCCCCHHhH------hcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCee
Q 038003 665 HGFCYNGPHSFLVCEYLDRGSLARI------LGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVL 737 (848)
Q Consensus 665 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIl 737 (848)
++++.+.+..++||||+++++|.++ +... ....+++..+..++.||+.||.|||+ . ||+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 5432 24678999999999999999999999 8 9999999999999
Q ss_pred eCCCCCEEEeeccCccccCCCCCCcccccccccccCccccccC-CCCc-cchhhhHHHHHHHHHhCCCCCccc
Q 038003 738 LDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATE-KYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 738 l~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DiwSlG~il~elltg~~P~~~~ 808 (848)
++.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||||+++|||+||+.||...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999876443 33456789999999999877 5665 999999999999999999998643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=307.95 Aligned_cols=203 Identities=26% Similarity=0.383 Sum_probs=176.3
Q ss_pred hcCCcccceeccCCceeEEEEEc-----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEee--c
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCY--N 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~ 670 (848)
.++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++++++||||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 46799999999999999999973 46889999998764 3445677899999999999999999999886 4
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
....++||||+++++|.++++.. ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred CceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence 56789999999999999998653 24589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC---cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 751 IAKFVGPHSSN---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 751 ~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
.+......... .....|++.|+|||++.+..+++++||||||+++|+|+||+.||....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 99877543321 233457888999999999889999999999999999999999985443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=307.96 Aligned_cols=203 Identities=27% Similarity=0.424 Sum_probs=168.1
Q ss_pred HhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec---
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN--- 670 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--- 670 (848)
...++|++.+.||+|+||.||+|.+ .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 3567899999999999999999976 478999999986542 2346788999999998 89999999999976
Q ss_pred ---CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 671 ---GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 671 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence 46889999999999999998754 235688999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 748 DFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|||++..............|++.|+|||++. +..+++++|||||||++|+|+||+.||..
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999987754433345567899999999987 55688999999999999999999999854
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=301.65 Aligned_cols=201 Identities=29% Similarity=0.489 Sum_probs=162.3
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
..++|++.+.||+|+||+||+|.+. ..+|+|+++.... .....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 3567999999999999999999865 3599999876532 344567789999999999999999999965 4557899
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999998654 35689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCC--CCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHS--SNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... .......|++.|+|||++. +..++.++||||||+++|||+||+.||..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 322 2224467899999999986 56678899999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=316.50 Aligned_cols=198 Identities=25% Similarity=0.301 Sum_probs=164.6
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC-----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP----- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----- 672 (848)
..+|++.+.||+|+||+||+|....+..+|+|++..... ...+|+++++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~--------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR--------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc--------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 357999999999999999999887777799998755321 1236999999999999999999986543
Q ss_pred -eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC-CCCCEEEeecc
Q 038003 673 -HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-SNFEAHVSDFG 750 (848)
Q Consensus 673 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfG 750 (848)
..++||||++++.+............+++..+..++.||++||+|||++ ||+||||||+||+++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 3789999998854443332221235688999999999999999999999 999999999999999 79999999999
Q ss_pred CccccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 188 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 188 SAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp TCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 998775433 23456789999999998765 589999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.54 Aligned_cols=202 Identities=26% Similarity=0.408 Sum_probs=173.5
Q ss_pred hcCCcccc-eeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKF-CIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|.+.. .||+|+||.||+|.+. ++..||||+++... .....+.+.+|++++++++||||+++++++ ..+.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 35566666 8999999999999653 57789999987652 345567789999999999999999999999 4567
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccccee
Confidence 89999999999999998644 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 754 FVGPHSSN---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
........ .....+++.|+|||++.+..+++++||||||+++|||+| |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 77543321 123456889999999998889999999999999999999 99998643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.41 Aligned_cols=205 Identities=23% Similarity=0.374 Sum_probs=176.2
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccC-----CchhHHHHHHHHHHHhcCC-CCcccceEEEe
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSG-----NMADHDEFLNEVLALKEIR-HRNNVKFHGFC 668 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~ 668 (848)
...++|++.+.||+|+||.||+|... +++.||||+++...... .....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999765 78999999987643111 0123456789999999995 99999999999
Q ss_pred ecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 669 YNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 669 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
.+.+..++||||+++++|.++++.. ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999998654 5688999999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccc------cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAY------TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||.+....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 168 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 168 FGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp CTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 99998775433 334567899999999985 34578899999999999999999999854
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=300.58 Aligned_cols=267 Identities=25% Similarity=0.282 Sum_probs=140.8
Q ss_pred ccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccc
Q 038003 176 NLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLH 255 (848)
Q Consensus 176 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~ 255 (848)
+|++|++++|.+++..|..|+++++|++|+|++|++++..|..++.+++|++|++++|+++ .+|..+. ++|++|+++
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~ 131 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIH 131 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECC
Confidence 4444444444444333344444444444444444444444444444445555555555444 3333333 455555555
Q ss_pred cccccCcCCCcccCCCCCceEEccCcccc--ccCcccccCCCCCccccccccccccccCCccceeeccccCCCCcccccc
Q 038003 256 INQLNGFIPPSIGNLSSLRVLYLYNNGLY--GFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAF 333 (848)
Q Consensus 256 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~ 333 (848)
+|++++..+..+.++++|++|++++|.++ +..+..+..+ +|+.|++++|.+++. |..+
T Consensus 132 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l-~~~~------------------ 191 (332)
T 2ft3_A 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGI-PKDL------------------ 191 (332)
T ss_dssp SSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSC-CSSS------------------
T ss_pred CCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCcc-Cccc------------------
Confidence 55555544445566666666666666664 2445555555 555566655555432 2110
Q ss_pred CCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccE
Q 038003 334 GDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNK 413 (848)
Q Consensus 334 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 413 (848)
.++|++|++++|.+++ ..+..+..+++|++|+|++|++++..+..+..+++|++
T Consensus 192 --~~~L~~L~l~~n~i~~------------------------~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 245 (332)
T 2ft3_A 192 --PETLNELHLDHNKIQA------------------------IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245 (332)
T ss_dssp --CSSCSCCBCCSSCCCC------------------------CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCE
T ss_pred --cCCCCEEECCCCcCCc------------------------cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCE
Confidence 1344555555555443 33444555555555555555555555555555555666
Q ss_pred EEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccC------ccccceeccccCcCC--CCChhHHhhhcccce
Q 038003 414 LILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGN------LLKLHYLNLSNNQLS--HKIPTEFEKLIHLSE 485 (848)
Q Consensus 414 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~ 485 (848)
|++++|+++ .+|..+..+++|++|++++|++++..+..|.. ...|+.|++++|.+. +..|..|..+++|+.
T Consensus 246 L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~ 324 (332)
T 2ft3_A 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324 (332)
T ss_dssp EECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTT
T ss_pred EECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhh
Confidence 666666555 44555556666666666666666555555443 245667777777766 556666777777777
Q ss_pred ecccCcc
Q 038003 486 LDLSHNI 492 (848)
Q Consensus 486 L~Ls~N~ 492 (848)
|++++|+
T Consensus 325 l~l~~n~ 331 (332)
T 2ft3_A 325 IQFGNYK 331 (332)
T ss_dssp EEC----
T ss_pred hhccccc
Confidence 7777663
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=299.91 Aligned_cols=178 Identities=21% Similarity=0.327 Sum_probs=100.9
Q ss_pred CCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEe
Q 038003 103 SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182 (848)
Q Consensus 103 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l 182 (848)
+.|++|+|++|++++..+..|+++++|++|+|++|++++..|..|+.+++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 45666666666666555555666666666666666666555666666666666666666665 4555443 56666666
Q ss_pred ecccccCCCcccccccccccccccccccccc--cCcccccCCcccceeeccccCCCCCCCCcccCccccccccccccccc
Q 038003 183 YKNSLSGSIPSIIGKLKSLLQLDLSENQFSG--SIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN 260 (848)
Q Consensus 183 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~ 260 (848)
++|++++..+..|+++++|++|++++|+++. ..+..+..+++|++|++++|.++ .+|..+. ++|++|++++|+++
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT 205 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCC
Confidence 6666665555556666666666666666642 44555566666666666666655 2333322 34444444444444
Q ss_pred CcCCCcccCCCCCceEEccCcccccc
Q 038003 261 GFIPPSIGNLSSLRVLYLYNNGLYGF 286 (848)
Q Consensus 261 ~~~p~~l~~l~~L~~L~Ls~N~l~~~ 286 (848)
+..|..+..+++|++|++++|.+++.
T Consensus 206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~ 231 (330)
T 1xku_A 206 KVDAASLKGLNNLAKLGLSFNSISAV 231 (330)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred ccCHHHhcCCCCCCEEECCCCcCcee
Confidence 44444444444444444444444433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.92 Aligned_cols=207 Identities=24% Similarity=0.384 Sum_probs=177.0
Q ss_pred HHhhcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEe
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFC 668 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 668 (848)
....++|++.+.||+|+||.||+|.+. ++..||+|++.... .......+.+|++++++++||||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 345678999999999999999999654 46789999987542 334556788999999999999999999999
Q ss_pred ecCCeeEEEEeccCCCCHHhHhcCCC-------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC
Q 038003 669 YNGPHSFLVCEYLDRGSLARILGDDV-------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN 741 (848)
Q Consensus 669 ~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 741 (848)
.+.+..++||||+++|+|.++++... ....+++..+..++.||+.||.|||++ ||+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 99999999999999999999986421 124568899999999999999999999 99999999999999999
Q ss_pred CCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 742 FEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 742 ~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 99999999999866432221 123456889999999998889999999999999999999 8999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.72 Aligned_cols=198 Identities=22% Similarity=0.255 Sum_probs=171.4
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC------CCCcccceEEEeec
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI------RHRNNVKFHGFCYN 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~l~~~~~~ 670 (848)
..+|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+++++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 45799999999999999999955 46899999998653 23455677788877766 67899999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC--EEEee
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE--AHVSD 748 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~D 748 (848)
....++||||+. ++|.+++... ....+++..+..++.||+.||+|||++ +||||||||+|||++.++. +||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred CCeEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 999999999996 5898888654 234589999999999999999999999 9999999999999999887 99999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
||+++..... ....+||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 246 FG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 246 FGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999875432 24467899999999999999999999999999999999999998543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.44 Aligned_cols=200 Identities=24% Similarity=0.373 Sum_probs=171.5
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG---- 671 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 671 (848)
...+|++.+.||+|+||.||+|... ++..||||++.... .....+.+.+|++++++++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc---CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 3468999999999999999999654 78899999987532 334457788999999999999999999998754
Q ss_pred -CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 672 -PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 672 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
...++||||+++ +|.++++. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence 368999999985 89888854 3588999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC---CcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSS---NWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.++....... .....+||+.|+|||++.+ ..+++++||||+||++|||+||+.||..
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 9987654322 1244689999999998764 4589999999999999999999999854
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.92 Aligned_cols=202 Identities=26% Similarity=0.463 Sum_probs=167.9
Q ss_pred hcCCcccceeccCCceeEEEEEcCC-----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPS-----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
..+|+..+.||+|+||.||+|.+.. +..||||+++... .......+.+|++++++++||||+++++++.+.+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3568888999999999999996542 2359999987543 3345567899999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++++|.++++.. ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||.+
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CcEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence 999999999999999998653 35689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC---cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 753 KFVGPHSSN---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+........ .....+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 876543221 122345788999999998899999999999999999999 9999854
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=311.28 Aligned_cols=199 Identities=24% Similarity=0.290 Sum_probs=165.4
Q ss_pred HhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC---
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG--- 671 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 671 (848)
...++|++.+.||+|+||+||+|.. .+++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 3467899999999999999999965 5899999999865421 123699999999999999999998443
Q ss_pred -----------------------------------CeeEEEEeccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHH
Q 038003 672 -----------------------------------PHSFLVCEYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANAL 715 (848)
Q Consensus 672 -----------------------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L 715 (848)
...++||||+++ +|.+.+... .....+++..+..++.||++||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 347899999985 777666431 1235689999999999999999
Q ss_pred HHHhhCCCCCeEEcCCCCCCeeeC-CCCCEEEeeccCccccCCCCCCcccccccccccCccccccCC-CCccchhhhHHH
Q 038003 716 SYLHHDCLPSIIHRDISSKNVLLD-SNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGV 793 (848)
Q Consensus 716 ~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~ 793 (848)
+|||++ ||+||||||+||+++ .++.+||+|||.++...... ......||+.|+|||++.+.. ++.++||||+||
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999 999999999999997 68899999999998775433 334567899999999988754 899999999999
Q ss_pred HHHHHHhCCCCCcc
Q 038003 794 LVFEVIKGNHPRDF 807 (848)
Q Consensus 794 il~elltg~~P~~~ 807 (848)
++|||++|+.||..
T Consensus 231 il~ell~g~~pf~~ 244 (383)
T 3eb0_A 231 VFGELILGKPLFSG 244 (383)
T ss_dssp HHHHHHHSSCSSCC
T ss_pred HHHHHHhCCCCCCC
Confidence 99999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=314.20 Aligned_cols=201 Identities=28% Similarity=0.443 Sum_probs=160.9
Q ss_pred cCCcccceeccCCceeEEEEEcC--CC--CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-CCe
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP--SG--DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN-GPH 673 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 673 (848)
..|++.+.||+|+||.||+|.+. ++ ..||+|+++... .....+++.+|+.++++++||||+++++++.+ .+.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS---CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 35777889999999999999653 22 358999986532 34566789999999999999999999998754 457
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccc
Confidence 89999999999999999754 34578899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC----CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 754 FVGPHSS----NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
....... ......+++.|+|||++.+..+++++|||||||++|||+| |..||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 6643221 1133457789999999999999999999999999999999 6677653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=307.06 Aligned_cols=204 Identities=22% Similarity=0.369 Sum_probs=171.3
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec----C
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN----G 671 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~ 671 (848)
..++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+++++.++||||+++++++.. .
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 346799999999999999999976 57999999998653 34556778999999999999999999999872 3
Q ss_pred CeeEEEEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 672 PHSFLVCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
...++||||+++|+|.+++.... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence 47899999999999999886421 235689999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC---------cccccccccccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSN---------WTEFAGTFGYAAPEIAYTMR---ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.+......... .....|++.|+|||++.+.. +++++||||||+++|||+||+.||+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 98765421111 12345799999999987554 68899999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=311.66 Aligned_cols=197 Identities=25% Similarity=0.392 Sum_probs=154.8
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG----- 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 671 (848)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 47899999999999999999964 578999999987642 1334567788999999999999999999998654
Q ss_pred -CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 672 -PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 672 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
...++|||++ +++|.++++. ..+++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 6788888754 4689999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 178 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 178 LARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99876432 345678999999999887 6789999999999999999999999854
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=315.39 Aligned_cols=200 Identities=11% Similarity=0.080 Sum_probs=153.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHH---HHhcCCCCcccceE-------E
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVL---ALKEIRHRNNVKFH-------G 666 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~---~l~~l~hp~iv~l~-------~ 666 (848)
..+|+..+.||+|+||+||+|.+. +++.||||++...... .....+.+.+|++ .++. +||||++++ +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-HHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence 456999999999999999999754 7899999999875321 2344566777854 5555 799988755 4
Q ss_pred EeecC-----------------CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHH------HHHHHHHHHHHHHHhhCCC
Q 038003 667 FCYNG-----------------PHSFLVCEYLDRGSLARILGDDVTAKELGWNRR------INVIKGVANALSYLHHDCL 723 (848)
Q Consensus 667 ~~~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~~L~~LH~~~~ 723 (848)
++... ...++||||++ |+|.++++.. ...+++..+ ..++.||+.||+|||++
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-- 213 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSK-- 213 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence 44332 33799999999 7999998753 123344445 67789999999999999
Q ss_pred CCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccccccccccCcccccc--CCCCccchhhhHHHHHHHHHhC
Q 038003 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKG 801 (848)
Q Consensus 724 ~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg 801 (848)
||+||||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp -TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred -CCccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876432 224567799999999987 6789999999999999999999
Q ss_pred CCCCccc
Q 038003 802 NHPRDFF 808 (848)
Q Consensus 802 ~~P~~~~ 808 (848)
+.||...
T Consensus 290 ~~Pf~~~ 296 (371)
T 3q60_A 290 FLPFGLV 296 (371)
T ss_dssp SCSTTBC
T ss_pred CCCCCCc
Confidence 9998765
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.22 Aligned_cols=198 Identities=26% Similarity=0.369 Sum_probs=163.3
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 46799999999999999999965 478999999987642 13345677889999999999999999999997654
Q ss_pred --eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 673 --HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 673 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
..++||||+++ ++.+.++. .+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence 78999999986 78877753 478899999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 173 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 173 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp C-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99876542 223456799999999999998999999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.97 Aligned_cols=198 Identities=19% Similarity=0.268 Sum_probs=170.1
Q ss_pred hcCCcccceeccCCceeEEEEEcCC---------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccc-----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPS---------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK----- 663 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~----- 663 (848)
.++|++.+.||+|+||.||+|.... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhh
Confidence 3679999999999999999997653 788999998643 34778999999999999987
Q ss_pred ----------eEEEeec-CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 038003 664 ----------FHGFCYN-GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 732 (848)
Q Consensus 664 ----------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 732 (848)
+++++.. ....++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ +|+|||||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dik 186 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVT 186 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCC
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCC
Confidence 6677765 67889999999 99999999754 235789999999999999999999999 99999999
Q ss_pred CCCeeeCCCC--CEEEeeccCccccCCCCC-------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCC
Q 038003 733 SKNVLLDSNF--EAHVSDFGIAKFVGPHSS-------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH 803 (848)
Q Consensus 733 ~~NIll~~~~--~~kl~DfG~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 803 (848)
|+||+++.++ .+||+|||+++.+..... ......||+.|+|||++.+..+++++|||||||++|||+||+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 999999999987643221 1234578999999999999899999999999999999999999
Q ss_pred CCcccc
Q 038003 804 PRDFFS 809 (848)
Q Consensus 804 P~~~~~ 809 (848)
||....
T Consensus 267 pf~~~~ 272 (352)
T 2jii_A 267 PWTNCL 272 (352)
T ss_dssp TTGGGT
T ss_pred CcccCC
Confidence 997654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.96 Aligned_cols=202 Identities=24% Similarity=0.451 Sum_probs=165.4
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCE----EEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDI----VAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... .....+.+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 467999999999999999999754 5554 4666654432 3345678899999999999999999999998765
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
.++|+||+++|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred -ceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 78999999999999998654 24688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 753 KFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 753 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
+........ .....+++.|+|||++.+..+++++|||||||++|||+| |+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 877543322 233456789999999999999999999999999999999 99998643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.16 Aligned_cols=201 Identities=28% Similarity=0.437 Sum_probs=168.3
Q ss_pred hcCCcccceeccCCceeEEEEEcCC----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEee-cCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCY-NGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~ 672 (848)
..+|++.+.||+|+||.||+|.+.+ ...+|+|++.... .....+.+.+|++++++++||||+++++++. ..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC---CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 4568889999999999999997542 2358999886532 3455677899999999999999999999864 456
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++|+|.++++.. ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||.+
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred ceEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence 789999999999999999754 35678999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC----CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCc
Q 038003 753 KFVGPHS----SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKG-NHPRD 806 (848)
Q Consensus 753 ~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P~~ 806 (848)
+...... .......+++.|+|||.+.+..+++++||||+|+++|||+|| ..||.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 234 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCc
Confidence 8764322 112345678899999999998999999999999999999995 55543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.63 Aligned_cols=203 Identities=27% Similarity=0.416 Sum_probs=171.5
Q ss_pred hhcCCcccc-eeccCCceeEEEEEc---CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 597 ATDDFDEKF-CIGKGGQGSVYKAEL---PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 597 ~~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
..++|.+.+ .||+|+||.||+|.+ .+++.||||+++.... .....+.+.+|++++++++||||+++++++ ..+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 346788887 999999999999944 2468899999876531 234467889999999999999999999999 566
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++++|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 789999999999999999754 4588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc---ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 753 KFVGPHSSNW---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 753 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
.......... ....+++.|+|||++.+..+++++||||||+++|||+| |+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 8775433221 22345788999999998889999999999999999999 99998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.80 Aligned_cols=204 Identities=24% Similarity=0.355 Sum_probs=171.6
Q ss_pred HhhcCCcccceeccCCceeEEEEEc--CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC---CCCcccceEEEee-
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL--PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI---RHRNNVKFHGFCY- 669 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~- 669 (848)
...++|++.+.||+|+||.||+|.. .+++.||+|+++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 4567899999999999999999976 467899999987654221 1223455677776655 8999999999987
Q ss_pred ----cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEE
Q 038003 670 ----NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH 745 (848)
Q Consensus 670 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 745 (848)
.....++||||++ |+|.+++... ....+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 4567899999998 5999988654 224588999999999999999999999 999999999999999999999
Q ss_pred EeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 746 VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 746 l~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+|||.++..... .......|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 161 l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 161 LADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp ECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999876432 223456789999999999998999999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.97 Aligned_cols=202 Identities=23% Similarity=0.378 Sum_probs=170.5
Q ss_pred hhcCCcccceeccCCceeEEEEEcCC----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
..++|.+.+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|++++++++||||+++++++.++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 35679999999999999999996542 3469999987653 334567789999999999999999999998754
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++++|.++++.. ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||.+
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred CCEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCC
Confidence 568999999999999998653 24588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 753 KFVGPHSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
........ ......+++.|+|||++.+..+++++||||||+++|||+| |+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 87654322 1233456889999999998889999999999999999998 9999854
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.76 Aligned_cols=208 Identities=23% Similarity=0.356 Sum_probs=165.5
Q ss_pred HHhhcCCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN 670 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 670 (848)
....++|.+.+.||+|+||.||+|... ++..||+|+++.... .....+.+.+|++++++++||||+++++++.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 345678999999999999999999653 345899999876532 23455778999999999999999999999987
Q ss_pred CC-----eeEEEEeccCCCCHHhHhcCC---CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC
Q 038003 671 GP-----HSFLVCEYLDRGSLARILGDD---VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742 (848)
Q Consensus 671 ~~-----~~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 742 (848)
.+ ..++||||+++++|.+++... .....+++..+..++.||+.||.|||++ +|+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 55 359999999999999988432 1235689999999999999999999999 999999999999999999
Q ss_pred CEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 743 EAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 743 ~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.+||+|||+++....... ......+++.|+|||++.+..+++++||||||+++|||+| |..||..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 252 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 999999999987644321 1233456889999999999899999999999999999999 8899864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=307.27 Aligned_cols=196 Identities=24% Similarity=0.419 Sum_probs=167.4
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee--
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS-- 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~-- 674 (848)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc--chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 46799999999999999999965 4789999999876431 234467788999999999999999999999877654
Q ss_pred ----EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 675 ----FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 675 ----~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred ceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999998 48888774 3488999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 190 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 190 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp CC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 99876432 345678999999999887 6789999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=298.81 Aligned_cols=200 Identities=21% Similarity=0.308 Sum_probs=167.5
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEe-ecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFC-YNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~~ 674 (848)
..++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++.++|++++..+.++ .+.+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 457899999999999999999965 5789999998655421 23477899999999988877766665 567788
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee---CCCCCEEEeeccC
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DSNFEAHVSDFGI 751 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~ 751 (848)
++||||+ +++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+||++ +.++.+||+|||+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 9999999 88999998643 24689999999999999999999999 99999999999999 7889999999999
Q ss_pred ccccCCCCC-------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 752 AKFVGPHSS-------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 752 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
++....... ......||+.|+|||++.+..+++++|||||||++|||+||+.||...
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence 987654322 123467899999999999999999999999999999999999998653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=353.33 Aligned_cols=135 Identities=22% Similarity=0.179 Sum_probs=75.7
Q ss_pred CCCcEEeccCCccccccccc-ccCCCCCcEEEccccCCCC----CCchhhhccccccEEEecccCcCCCCCcccc-CcC-
Q 038003 79 PHLANLNLSFNLFFGNIPLQ-IGNLSKLQYLDLGSNQLSG----LIPPEIGKLNQLRRLYLDMNQLHGTIPPEIG-QLS- 151 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~-~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~- 151 (848)
++|++|||++|.++...... +..+++|++|+|++|++++ .+|..+..+++|++|+|++|++++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 46677777777776443332 6667777777777777764 2455666667777777777776643333332 233
Q ss_pred ---CccEEEcCCCcCCC----CCCCcccCccccceEEeecccccCCCcccccc-----cccccccccccccccc
Q 038003 152 ---LIDKLALCHNNLHG----SIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGK-----LKSLLQLDLSENQFSG 213 (848)
Q Consensus 152 ---~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~ 213 (848)
+|++|+|++|+++. .+|..+..+++|++|++++|.+++..+..+.. .++|++|+|++|++++
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~ 156 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA 156 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCH
Confidence 46666666666552 33555555556666666665554332222221 2345555555554443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=308.65 Aligned_cols=206 Identities=25% Similarity=0.398 Sum_probs=175.9
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC-CC-----CEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEe
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP-SG-----DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFC 668 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 668 (848)
...++|++.+.||+|+||.||+|.+. ++ ..||+|++.... .....+.+.+|+++++++ +||||+++++++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34578999999999999999999754 22 479999987653 334567789999999999 899999999999
Q ss_pred ecCCeeEEEEeccCCCCHHhHhcCCC-----------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCee
Q 038003 669 YNGPHSFLVCEYLDRGSLARILGDDV-----------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVL 737 (848)
Q Consensus 669 ~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIl 737 (848)
.+.+..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||++ ||+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 99999999999999999999886431 124578999999999999999999999 9999999999999
Q ss_pred eCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 738 LDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 738 l~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
++.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999876433221 123456789999999998899999999999999999999 9999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.35 Aligned_cols=209 Identities=25% Similarity=0.369 Sum_probs=177.4
Q ss_pred HHHhhcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEE
Q 038003 594 IIKATDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHG 666 (848)
Q Consensus 594 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~ 666 (848)
.....++|++.+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+++++++ +||||+++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334567899999999999999999963 356889999987653 334556789999999999 7999999999
Q ss_pred EeecCC-eeEEEEeccCCCCHHhHhcCCCC-------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCC
Q 038003 667 FCYNGP-HSFLVCEYLDRGSLARILGDDVT-------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDIS 732 (848)
Q Consensus 667 ~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 732 (848)
++...+ ..++||||+++++|.+++..... ...+++..+..++.||+.||.|||++ +|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence 987754 58999999999999999976522 12278899999999999999999999 99999999
Q ss_pred CCCeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 733 SKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 733 ~~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
|+||+++.++.+||+|||+++........ .....|++.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999876543322 233567889999999999899999999999999999998 99998643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.87 Aligned_cols=199 Identities=21% Similarity=0.310 Sum_probs=170.8
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEe-ecCCee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFC-YNGPHS 674 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~~ 674 (848)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++.++|++++..+.++ .+.+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS------SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc------chhHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 356899999999999999999975 589999999986542 123578999999999988877666655 566788
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee---CCCCCEEEeeccC
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DSNFEAHVSDFGI 751 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~ 751 (848)
++||||+ +++|.++++.. ...+++..+..++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 9999999 88999998643 24689999999999999999999999 99999999999999 4888999999999
Q ss_pred ccccCCCCC-------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSS-------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
++....... ......|++.|+|||++.+..+++++|||||||++|||+||+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 987754332 12456789999999999999999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.56 Aligned_cols=198 Identities=27% Similarity=0.408 Sum_probs=168.9
Q ss_pred CCcccceeccCCceeEEEEEcC-CC---CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee-
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SG---DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS- 674 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~- 674 (848)
.|...+.||+|+||+||+|.+. ++ ..+|+|++.... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT---EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc---cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 4667789999999999999653 22 379999986532 344567889999999999999999999999876655
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+.+++|.++++.. ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 99 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EEEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999999999764 35678899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC----CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 755 VGPHS----SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 755 ~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
..... .......+++.|+|||.+.+..+++++||||||+++|+|+||+.|+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 54321 2223456789999999999999999999999999999999966664
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=326.95 Aligned_cols=200 Identities=25% Similarity=0.405 Sum_probs=167.4
Q ss_pred CCcccc-eeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 600 DFDEKF-CIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 600 ~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
++.+.. .||+|+||.||+|.++ ++..||||+++... .....+++.+|++++++++|||||++++++.. +..+
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 344444 7999999999999653 45679999997652 33456789999999999999999999999976 5689
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 412 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999999999999999654 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCc---ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 756 GPHSSNW---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 756 ~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
....... ....+++.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 5432211 22345689999999998899999999999999999998 99998643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=313.69 Aligned_cols=197 Identities=27% Similarity=0.354 Sum_probs=163.1
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC----C
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG----P 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----~ 672 (848)
..+|+..+.||+|+||+||+|.+. +++.||||++.... +...+|+++++.++||||++++++|... +
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 356999999999999999999765 69999999986532 1123699999999999999999998542 2
Q ss_pred --eeEEEEeccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC-CCEEEee
Q 038003 673 --HSFLVCEYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN-FEAHVSD 748 (848)
Q Consensus 673 --~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~D 748 (848)
..++||||+++ ++.+.+... .....+++..+..++.||++||+|||++ ||+||||||+|||++.+ +.+||+|
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEecc
Confidence 36799999987 565554321 1235689999999999999999999999 99999999999999965 5789999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||+++...... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 201 FG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 201 FGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp CTTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred chhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99998765433 23456789999999998765 689999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.56 Aligned_cols=197 Identities=24% Similarity=0.422 Sum_probs=172.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN----- 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 670 (848)
...+|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 3467999999999999999999765 79999999986542 245689999999999999999998854
Q ss_pred -----------CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 671 -----------GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 671 -----------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
....++||||+++++|.++++.. ....+++..+..++.||+.||.|||++ +|+||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 34579999999999999999654 235688999999999999999999999 999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 740 SNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 740 ~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.++.+||+|||.+....... ......|++.|+|||++.+..++.++||||||+++|||+||..|+.
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp ETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999999999998775433 2345678999999999999889999999999999999999999964
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-32 Score=295.29 Aligned_cols=289 Identities=23% Similarity=0.248 Sum_probs=146.9
Q ss_pred cccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccc
Q 038003 128 QLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLS 207 (848)
Q Consensus 128 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 207 (848)
+|+.++++++.++ .+|..+. +.|++|+|++|++++..+..|+++++|++|++++|++++..|..|+.+++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 5666666666665 4444432 345555555555554444455555555555555555554445555555555555555
Q ss_pred cccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccc--
Q 038003 208 ENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYG-- 285 (848)
Q Consensus 208 ~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-- 285 (848)
+|+++ .+|..+. + +|++|++++|++++..+..+.++++|++|++++|.+..
T Consensus 109 ~n~l~-~l~~~~~--~------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 161 (330)
T 1xku_A 109 KNQLK-ELPEKMP--K------------------------TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161 (330)
T ss_dssp SSCCS-BCCSSCC--T------------------------TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred CCcCC-ccChhhc--c------------------------cccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC
Confidence 55554 3333322 3 44444444444444434444444455555555554431
Q ss_pred cCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccE
Q 038003 286 FVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLST 365 (848)
Q Consensus 286 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 365 (848)
..+..+..+++|+.|++++|.++.. |.. -.++|++|++++|++++.
T Consensus 162 ~~~~~~~~l~~L~~L~l~~n~l~~l-~~~--------------------~~~~L~~L~l~~n~l~~~------------- 207 (330)
T 1xku_A 162 IENGAFQGMKKLSYIRIADTNITTI-PQG--------------------LPPSLTELHLDGNKITKV------------- 207 (330)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCCSC-CSS--------------------CCTTCSEEECTTSCCCEE-------------
T ss_pred cChhhccCCCCcCEEECCCCccccC-Ccc--------------------ccccCCEEECCCCcCCcc-------------
Confidence 3334444444444444444444321 110 013445555555554433
Q ss_pred eecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCccc
Q 038003 366 FIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKL 445 (848)
Q Consensus 366 L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 445 (848)
.|..+..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|+|
T Consensus 208 -----------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 208 -----------DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp -----------CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred -----------CHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcC
Confidence 3344444555555555555555444445555555555555555555 4455555566666666666666
Q ss_pred CCCCCCcccC------ccccceeccccCcCCC--CChhHHhhhcccceecccCcc
Q 038003 446 SSSIPKSIGN------LLKLHYLNLSNNQLSH--KIPTEFEKLIHLSELDLSHNI 492 (848)
Q Consensus 446 ~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~ 492 (848)
++..+..|.. ...|+.|++++|.+.. ..|..|..+.+|+.++|++|+
T Consensus 276 ~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 276 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 6555554433 2556667777776652 456667777777777777764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=315.97 Aligned_cols=199 Identities=21% Similarity=0.357 Sum_probs=153.6
Q ss_pred cCCcc-cceeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEee--cCC
Q 038003 599 DDFDE-KFCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCY--NGP 672 (848)
Q Consensus 599 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~ 672 (848)
+.|++ .+.||+|+||+||+|.++ +++.||||++.... ..+.+.+|++++++++||||+++++++. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS------CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC------CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 44666 457999999999999765 57889999986542 2246789999999999999999999995 467
Q ss_pred eeEEEEeccCCCCHHhHhcCC------CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee----CCCC
Q 038003 673 HSFLVCEYLDRGSLARILGDD------VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----DSNF 742 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~ 742 (848)
..++||||+.+ +|.+++... .....+++..+..|+.||+.||+|||++ +|+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 89999999975 777766421 1223589999999999999999999999 99999999999999 6788
Q ss_pred CEEEeeccCccccCCCC---CCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 743 EAHVSDFGIAKFVGPHS---SNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 743 ~~kl~DfG~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.+||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999998765322 222456789999999999874 489999999999999999999999853
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=328.35 Aligned_cols=200 Identities=27% Similarity=0.450 Sum_probs=174.2
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||.||+|.+..+..||||+++... ...+++.+|++++++++||||+++++++.+ +..++|
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 46788999999999999999998888889999987642 235679999999999999999999999876 678999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. ....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999643 224588999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 211 1123456789999999998899999999999999999999 9999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=308.62 Aligned_cols=206 Identities=24% Similarity=0.273 Sum_probs=159.4
Q ss_pred HHHHHhhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec
Q 038003 592 EEIIKATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN 670 (848)
Q Consensus 592 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 670 (848)
.+.....++|++.+.||+|+||.||+|... +++.||||++.... .......+|++.++.++||||+++++++..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-----cccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 455567789999999999999999999764 78999999985542 223345678888888999999999999865
Q ss_pred CCe-------eEEEEeccCCCCHHhHhcC-CCCcccCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEEcCCCCCCeeeCC
Q 038003 671 GPH-------SFLVCEYLDRGSLARILGD-DVTAKELGWNRRINVIKGVANALSYLH--HDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 671 ~~~-------~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~LH--~~~~~~ivH~Dlk~~NIll~~ 740 (848)
.+. .++||||++++ +.+.+.. ......+++..+..++.|++.|+.||| +. ||+||||||+||+++.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE 166 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET
T ss_pred cccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC
Confidence 433 78999999874 4433321 112356888999999999999999999 88 9999999999999997
Q ss_pred -CCCEEEeeccCccccCCCCCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 741 -NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 741 -~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||+||+.||..
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 8999999999998775433 234567899999999987654 89999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=304.91 Aligned_cols=200 Identities=27% Similarity=0.401 Sum_probs=170.0
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG----- 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 671 (848)
.++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|++++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc---cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 568999999999999999999765 78999999986432 334556788999999999999999999988754
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
...++||||+.+ +|.+++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 87 NEVYIIQELMQT-DLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CCEEEEECCCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccCc-cHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 678999999974 89888854 3588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC----------cccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 752 AKFVGPHSSN----------WTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 752 ~~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
++........ ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9876532211 123578999999998764 67899999999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.64 Aligned_cols=205 Identities=24% Similarity=0.376 Sum_probs=158.6
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+.++...++.++||||+++++++.+.+..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 46799999999999999999965 5789999999876531 12223334555556888999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCC-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 677 VCEYLDRGSLARILGDD-VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
||||+++ ++.+++... .....+++..+..++.|++.||+|||+++ ||+||||||+||+++.++.+||+|||.++..
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9999985 887766431 12356899999999999999999999842 8999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccCcccc----ccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIA----YTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.... ......|++.|+|||++ .+..+++++||||+||++|||+||+.||+..
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 5432 22445789999999996 5567899999999999999999999998743
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=301.81 Aligned_cols=202 Identities=26% Similarity=0.429 Sum_probs=174.4
Q ss_pred hcCCcccceeccCCceeEEEEEc-----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
.++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 45689999999999999999973 36889999998764 3455678899999999999999999999987654
Q ss_pred --eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 673 --HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 673 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
..++||||+++++|.++++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence 789999999999999999754 24588999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC---cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 751 IAKFVGPHSSN---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 751 ~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
+++........ .....++..|+|||++.+..++.++||||||+++|||+||..||...
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99887544321 12345677899999999888999999999999999999999997643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=302.62 Aligned_cols=203 Identities=28% Similarity=0.424 Sum_probs=170.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEE--EEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIV--AVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||.||+|... ++..+ |+|+++... .....+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 367999999999999999999664 55544 999886532 233456688999999999 99999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC
Q 038003 674 SFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 740 (848)
.++||||+++++|.+++.... ....+++..+..++.||+.||+|||++ ||+||||||+||+++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcC
Confidence 999999999999999997642 234689999999999999999999999 9999999999999999
Q ss_pred CCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 741 NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 741 ~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
++.+||+|||+++..... .......+++.|+|||++.+..+++++|||||||++|||+| |+.||..
T Consensus 178 ~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 999999999999754322 12233456889999999998889999999999999999998 9999854
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=295.92 Aligned_cols=201 Identities=27% Similarity=0.419 Sum_probs=175.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 4568999999999999999999765 7899999998765422 345677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC---CCEEEeeccCc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN---FEAHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfG~~ 752 (848)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||+++.+ +.+||+|||.+
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999888644 4688999999999999999999999 99999999999999754 47999999999
Q ss_pred cccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....... ......|++.|+|||++.+. ++.++||||||+++|+|+||+.||..
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 172 TCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp GTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 8765432 22445689999999998764 88999999999999999999999854
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.52 Aligned_cols=196 Identities=30% Similarity=0.472 Sum_probs=164.1
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-CeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG-PHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~~l 676 (848)
.++|++.+.||+|+||.||+|... ++.||||+++.. ...+.+.+|++++++++||||+++++++.+. +..++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 467999999999999999999875 889999998653 2456788999999999999999999997654 47899
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999998654 123478899999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
... ....+++.|+|||++.+..+++++||||||+++|||+| |+.||..
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 169 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 322 23467889999999998889999999999999999998 9999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=311.94 Aligned_cols=198 Identities=26% Similarity=0.328 Sum_probs=168.5
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC--------CCcccceEEEe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR--------HRNNVKFHGFC 668 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hp~iv~l~~~~ 668 (848)
.++|++.+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+++++.++ ||||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 46799999999999999999965 57889999998643 344567889999999885 78899999998
Q ss_pred e----cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC--
Q 038003 669 Y----NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-- 742 (848)
Q Consensus 669 ~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-- 742 (848)
. +....++||||+. +++.+.+... ....+++..+..++.||+.||+|||+++ ||+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 111 KISGVNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEETTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred eecCCCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 7 5568899999995 4565555433 2246899999999999999999999964 899999999999999775
Q ss_pred -----------------------------------------------CEEEeeccCccccCCCCCCcccccccccccCcc
Q 038003 743 -----------------------------------------------EAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775 (848)
Q Consensus 743 -----------------------------------------------~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE 775 (848)
.+||+|||.++..... .....||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE 263 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence 7999999999876542 34457899999999
Q ss_pred ccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 776 ~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
++.+..++.++|||||||++|||+||+.||..
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 295 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEP 295 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence 99999999999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=300.21 Aligned_cols=199 Identities=23% Similarity=0.355 Sum_probs=163.6
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEee-------
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCY------- 669 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~------- 669 (848)
.++|++.+.||+|+||.||+|... +++.||+|++... +....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 467999999999999999999765 5899999998654 3455678899999999999999999999874
Q ss_pred -------cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC-CC
Q 038003 670 -------NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-SN 741 (848)
Q Consensus 670 -------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~ 741 (848)
+....++||||++ |+|.++++. ..+++..+..++.||+.||+|||++ ||+||||||+||+++ ++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 3467899999998 599998854 4588899999999999999999999 999999999999997 56
Q ss_pred CCEEEeeccCccccCCCC---CCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 742 FEAHVSDFGIAKFVGPHS---SNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 742 ~~~kl~DfG~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
+.+||+|||.++...... .......+++.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 799999999998764321 12234567899999998865 67899999999999999999999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=302.58 Aligned_cols=196 Identities=24% Similarity=0.414 Sum_probs=166.7
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe---
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH--- 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~--- 673 (848)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 46799999999999999999965 478999999987643 123446778899999999999999999999987654
Q ss_pred ---eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 674 ---SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 674 ---~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred ceeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999998 48887764 2488999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.++..... .....|++.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 172 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 172 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp CTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred cccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99875432 244678999999999876 6789999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=301.48 Aligned_cols=198 Identities=21% Similarity=0.303 Sum_probs=172.1
Q ss_pred hcCCcccceeccCCceeEEEEEc--CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCC------cccceEEEee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL--PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR------NNVKFHGFCY 669 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------~iv~l~~~~~ 669 (848)
.++|++.+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+++++.++|+ +++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 46799999999999999999965 36889999998643 24456788899998888665 4999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---------
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS--------- 740 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------- 740 (848)
+.+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ ||+||||||+||+++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence 999999999999 78999988655 224688999999999999999999999 9999999999999987
Q ss_pred ----------CCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 741 ----------NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 741 ----------~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
++.+||+|||.++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 678999999999875432 24467899999999999989999999999999999999999998643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=303.08 Aligned_cols=203 Identities=24% Similarity=0.338 Sum_probs=157.9
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEee-----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCY----- 669 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~----- 669 (848)
...+|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 345799999999999999999975 47899999998554 3455677889999999995 999999999984
Q ss_pred ---cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCCeeeCCCCCE
Q 038003 670 ---NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLDSNFEA 744 (848)
Q Consensus 670 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~ 744 (848)
.....++||||+. |+|.+++........+++..+..++.||+.||+|||++ + |+||||||+||+++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence 3345799999996 58988876533345699999999999999999999999 8 9999999999999999999
Q ss_pred EEeeccCccccCCCCCC------------cccccccccccCcccc---ccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 745 HVSDFGIAKFVGPHSSN------------WTEFAGTFGYAAPEIA---YTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~~------------~~~~~g~~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||+|||+++........ .....|++.|+|||++ .+..+++++|||||||++|||+||+.||..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999877543221 1135689999999998 566788999999999999999999999864
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=350.29 Aligned_cols=111 Identities=23% Similarity=0.120 Sum_probs=64.2
Q ss_pred CCccEEEccCCccCCC----CcccccccccccEEEccCCcCCCCCCcccCC-----CCccCeEeccCcccCC----CCCC
Q 038003 385 PKLQVLDLSSNHIVGK----IPVQLEMLSSLNKLILNLNQLSGGVPLEFGS-----LTKLQYLDLSTNKLSS----SIPK 451 (848)
Q Consensus 385 ~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~p~ 451 (848)
++|++|++++|.+++. ++..+..+++|++|++++|.+++..+..+.. .++|++|++++|++++ .+|.
T Consensus 313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 392 (461)
T 1z7x_W 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence 4566666666666544 3444555666666666666665443333322 4567777777777764 5566
Q ss_pred cccCccccceeccccCcCCCCChhHHhh-----hcccceecccCcccCc
Q 038003 452 SIGNLLKLHYLNLSNNQLSHKIPTEFEK-----LIHLSELDLSHNILQE 495 (848)
Q Consensus 452 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~ 495 (848)
.+..+++|++|+|++|++++.....+.+ ..+|+.|++.++.+..
T Consensus 393 ~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 393 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred HHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 6666777777777777776543333321 1245566655555543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.66 Aligned_cols=202 Identities=22% Similarity=0.329 Sum_probs=169.0
Q ss_pred HhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC--CCcccceEEEeecCCe
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR--HRNNVKFHGFCYNGPH 673 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~ 673 (848)
...++|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|++++++++ ||||+++++++.+.+.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 34577999999999999999999888899999999876432 3345677899999999997 5999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||| +.+++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++ ++.+||+|||+++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccc
Confidence 999999 5678999998754 4688899999999999999999999 999999999999996 4899999999998
Q ss_pred ccCCCCCC--cccccccccccCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSN--WTEFAGTFGYAAPEIAYT-----------MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~--~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........ .....|++.|+|||++.+ ..++.++||||||+++|||+||+.||..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 76543221 234578999999999875 4678899999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=312.19 Aligned_cols=199 Identities=23% Similarity=0.340 Sum_probs=170.7
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC-CcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH-RNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~~ 675 (848)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... .+++.+|+++++.++| +++..+..++.+.+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS------SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 46799999999999999999975 5799999998765431 2347789999999977 55666667777888999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee---CCCCCEEEeeccCc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL---DSNFEAHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfG~~ 752 (848)
+||||+ +++|.++++.. ...+++..+..|+.||+.||+|||++ +||||||||+|||+ +.++.+||+|||++
T Consensus 80 lvme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 999999 88999998643 35689999999999999999999999 99999999999999 58899999999999
Q ss_pred cccCCCCCC-------cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 753 KFVGPHSSN-------WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 753 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
+.+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~ 216 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 877543321 12567999999999999999999999999999999999999998653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=301.91 Aligned_cols=198 Identities=21% Similarity=0.287 Sum_probs=146.5
Q ss_pred hhcCCcccc-eeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec----
Q 038003 597 ATDDFDEKF-CIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN---- 670 (848)
Q Consensus 597 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---- 670 (848)
..++|.+.+ .||+|+||+||+|... +++.||||++... .... ......++.++||||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKAR---QEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 356788854 6999999999999665 7999999998543 1111 222233566799999999999876
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---CCCEEEe
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEAHVS 747 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~ 747 (848)
....++||||+++|+|.+++... ....+++..+..++.||+.||.|||++ ||+||||||+||+++. ++.+||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CceEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence 44589999999999999999765 234689999999999999999999999 9999999999999976 4559999
Q ss_pred eccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 748 DFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
|||+++..... ......||+.|+|||++.+..+++++|||||||++|+|+||+.||...
T Consensus 174 Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 174 DFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp CCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 99999876532 234567899999999998888999999999999999999999998543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=296.48 Aligned_cols=204 Identities=27% Similarity=0.405 Sum_probs=164.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC--CCC--EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--SGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||.||+|.+. +++ .||||+++..... .....+.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 467999999999999999999753 333 6899998765332 2345678899999999999999999999998765
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 88999999999999998653 24688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 754 FVGPHSSN---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
........ .....+++.|+|||++.+..+++++||||||+++|||+| |+.||...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 87543322 123457789999999998889999999999999999999 99998643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=301.71 Aligned_cols=204 Identities=28% Similarity=0.402 Sum_probs=170.6
Q ss_pred hcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 671 (848)
.++|++.+.||+|+||.||+|.+ .++..||||++.... ......++.+|+.++++++||||+++++++.+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 46799999999999999999974 357789999986542 334566788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCC----cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---CCCE
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVT----AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEA 744 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ 744 (848)
+..++||||+++++|.++++.... ...+++..+..++.||+.||.|||++ ||+||||||+||+++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999875421 24588999999999999999999999 9999999999999984 4469
Q ss_pred EEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 745 HVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||+|||.+........ ......|++.|+|||++.+..+++++||||||+++|||+| |+.||..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 248 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999976533221 1233567899999999998889999999999999999999 9999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=297.62 Aligned_cols=194 Identities=29% Similarity=0.474 Sum_probs=162.5
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN----- 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 670 (848)
..++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 356799999999999999999975 47999999998543 2445778899999999999999999998865
Q ss_pred --------CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC
Q 038003 671 --------GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742 (848)
Q Consensus 671 --------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 742 (848)
.+..++||||+++++|.++++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCC
Confidence 35679999999999999999754 24577889999999999999999999 999999999999999999
Q ss_pred CEEEeeccCccccCCCC--------------CCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHh
Q 038003 743 EAHVSDFGIAKFVGPHS--------------SNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIK 800 (848)
Q Consensus 743 ~~kl~DfG~~~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt 800 (848)
.+||+|||.+....... .......|++.|+|||++.+. .++.++|||||||++|||+|
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999999998764321 122345789999999998864 68999999999999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=325.07 Aligned_cols=195 Identities=28% Similarity=0.423 Sum_probs=165.4
Q ss_pred ceeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEecc
Q 038003 605 FCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYL 681 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~ 681 (848)
+.||+|+||+||+|.+. .++.||||+++.... .....+++.+|++++++++|||||++++++.. +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG--CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 47999999999999542 567899999976532 33456789999999999999999999999965 4688999999
Q ss_pred CCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCC
Q 038003 682 DRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN 761 (848)
Q Consensus 682 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~ 761 (848)
++|+|.++++.. ..+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.+......
T Consensus 452 ~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 452 ELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999999654 5689999999999999999999999 9999999999999999999999999999877543321
Q ss_pred ---cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 762 ---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 762 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
.....+++.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 223456789999999999999999999999999999999 99998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=302.79 Aligned_cols=243 Identities=21% Similarity=0.288 Sum_probs=192.1
Q ss_pred HhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCc--hhHHHHHHHHHHHhcCC--CCcccceEEEeec
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNM--ADHDEFLNEVLALKEIR--HRNNVKFHGFCYN 670 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~ 670 (848)
...++|++.+.||+|+||.||+|.. .+++.||||++......... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 4467899999999999999999965 57899999999776432110 12244667999999996 5999999999999
Q ss_pred CCeeEEEEeccCC-CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC-CCCCEEEee
Q 038003 671 GPHSFLVCEYLDR-GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-SNFEAHVSD 748 (848)
Q Consensus 671 ~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~D 748 (848)
.+..++|||++.+ ++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 8999998654 5688999999999999999999999 999999999999999 789999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCccccccc-------cccchhhh
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINF-------SSFSNMII 820 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~-------~~~~~~~~ 820 (848)
||+++..... ......||+.|+|||++.+..+ ++++||||||+++|||+||+.||....... ..+...+.
T Consensus 194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 271 (320)
T 3a99_A 194 FGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271 (320)
T ss_dssp CTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHH
T ss_pred Cccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHHH
Confidence 9999877542 2345679999999999887665 688999999999999999999986533211 12333444
Q ss_pred hhhhhcCCCCCCCCCCcccccceeec
Q 038003 821 DVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
++...+-..-|..||.+.+.....|+
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHccCChhhCcCHHHHhcCHhh
Confidence 44444444555666666665555544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-33 Score=319.06 Aligned_cols=203 Identities=29% Similarity=0.428 Sum_probs=175.8
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec------
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN------ 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 670 (848)
.++|++.+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|++++++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 36899999999999999999966 478999999987642 34556778999999999999999999999765
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCC---EEEe
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFE---AHVS 747 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~ 747 (848)
.+..++||||+++|+|.+++........+++..+..++.|++.||+|||+. ||+||||||+||+++.++. +||+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 667899999999999999998764445688899999999999999999999 9999999999999997765 9999
Q ss_pred eccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 748 DFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|||.+....... ......|++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 167 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 167 DLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp SCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999998875433 33556899999999999999999999999999999999999999853
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-33 Score=300.01 Aligned_cols=244 Identities=22% Similarity=0.274 Sum_probs=182.3
Q ss_pred HHhhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCc--hhHHHHHHHHHHHhcC----CCCcccceEEE
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNM--ADHDEFLNEVLALKEI----RHRNNVKFHGF 667 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l----~hp~iv~l~~~ 667 (848)
....++|++.+.||+|+||.||+|.. .+++.||||+++........ .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999966 47899999999765322111 1223355788888888 89999999999
Q ss_pred eecCCeeEEEEec-cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC-CCCCEE
Q 038003 668 CYNGPHSFLVCEY-LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-SNFEAH 745 (848)
Q Consensus 668 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~k 745 (848)
+...+..++|||| +.+++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 7899999998654 4689999999999999999999999 999999999999999 889999
Q ss_pred EeeccCccccCCCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCccccccc-------cccch
Q 038003 746 VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINF-------SSFSN 817 (848)
Q Consensus 746 l~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~-------~~~~~ 817 (848)
|+|||.++..... ......|++.|+|||++.+..+ +.++||||||+++|||+||+.||....... ..+..
T Consensus 181 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 258 (312)
T 2iwi_A 181 LIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSP 258 (312)
T ss_dssp ECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSCH
T ss_pred EEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCCH
Confidence 9999999877543 2345678999999999887666 458999999999999999999986432210 12233
Q ss_pred hhhhhhhhcCCCCCCCCCCcccccceeec
Q 038003 818 MIIDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
.+.++...+-..-|..||...+...+.|+
T Consensus 259 ~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 259 DCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 33444444444455666666655554444
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.4e-33 Score=301.54 Aligned_cols=198 Identities=29% Similarity=0.420 Sum_probs=160.8
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHH--HhcCCCCcccceEEEeec----
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA--LKEIRHRNNVKFHGFCYN---- 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~--l~~l~hp~iv~l~~~~~~---- 670 (848)
..++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 346899999999999999999976 58999999986532 2334444444 556899999999985432
Q ss_pred -CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEEcCCCCCCeeeCCCCC
Q 038003 671 -GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC------LPSIIHRDISSKNVLLDSNFE 743 (848)
Q Consensus 671 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~------~~~ivH~Dlk~~NIll~~~~~ 743 (848)
....++||||+++|+|.++++.. ..++..+..++.||+.||+|||+.+ .++|+||||||+||+++.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 23678999999999999999644 3478899999999999999999863 238999999999999999999
Q ss_pred EEEeeccCccccCCCC--------CCcccccccccccCcccccc-------CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 744 AHVSDFGIAKFVGPHS--------SNWTEFAGTFGYAAPEIAYT-------MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 744 ~kl~DfG~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
+||+|||+++.+.... .......||+.|+|||++.+ ..+++++|||||||++|||+||+.||.
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 9999999998764321 11234579999999999886 456788999999999999999988864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=296.01 Aligned_cols=195 Identities=27% Similarity=0.432 Sum_probs=161.5
Q ss_pred HhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC--CCCcccceEEEeecC--
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI--RHRNNVKFHGFCYNG-- 671 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~~~~~~~-- 671 (848)
...++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|.+++... +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34568999999999999999999875 899999998543 233445566665554 999999999999887
Q ss_pred --CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEcCCCCCCeeeCCCCCE
Q 038003 672 --PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC-----LPSIIHRDISSKNVLLDSNFEA 744 (848)
Q Consensus 672 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~ 744 (848)
...++||||+++|+|.++++.. .+++..+..++.|++.||+|||+++ .++|+||||||+||+++.++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 6889999999999999999543 5889999999999999999999752 2389999999999999999999
Q ss_pred EEeeccCccccCCCCCCc----ccccccccccCccccccCCCCcc------chhhhHHHHHHHHHhCC
Q 038003 745 HVSDFGIAKFVGPHSSNW----TEFAGTFGYAAPEIAYTMRATEK------YDVYSFGVLVFEVIKGN 802 (848)
Q Consensus 745 kl~DfG~~~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~------~DiwSlG~il~elltg~ 802 (848)
||+|||+++.+....... ....||+.|+|||++.+..++.+ +|||||||++|||+||.
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 999999998765433221 24579999999999987766554 99999999999999993
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=297.19 Aligned_cols=204 Identities=26% Similarity=0.361 Sum_probs=151.9
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHH-HHhcCCCCcccceEEEeecCCeeE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVL-ALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
.++|+..+.||+|+||.||+|... +++.||||+++... ......++..|+. +++.++||||+++++++.+.+..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 367999999999999999999764 78999999987653 2334455666666 678889999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCC--CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 676 LVCEYLDRGSLARILGDD--VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
+||||+++ +|.+++... .....+++..+..++.|++.||.|||+.. ||+||||||+||+++.++.+||+|||+++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 99999986 777766421 11356889999999999999999999852 89999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccCcccc----ccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIA----YTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
...... ......|++.|+|||++ .+..++.++|||||||++|||+||+.||...
T Consensus 175 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 175 QLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp C-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred eccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 765432 22345789999999998 4566899999999999999999999998653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=301.97 Aligned_cols=198 Identities=25% Similarity=0.294 Sum_probs=169.9
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CC-----cccceEEEee
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HR-----NNVKFHGFCY 669 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~iv~l~~~~~ 669 (848)
..++|++.+.||+|+||+||+|... +++.||||+++.. ....+++.+|+++++.++ |+ +|+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 4578999999999999999999654 7889999998643 234566778888888774 44 4999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh--CCCCCeEEcCCCCCCeeeC--CCCCEE
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH--DCLPSIIHRDISSKNVLLD--SNFEAH 745 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~--~~~~~ivH~Dlk~~NIll~--~~~~~k 745 (848)
..+..++||||+++ +|.+++... ....+++..+..++.|++.||.|||. . |||||||||+||+++ .++.+|
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~---~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPEL---SIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTT---CEECCCCSGGGEEESSTTSCCEE
T ss_pred cCCceEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCC---CEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999965 999988654 22458999999999999999999994 5 899999999999994 578899
Q ss_pred EeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 746 VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 746 l~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 202 L~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 202 IVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp ECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999887542 2456789999999999999999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=297.03 Aligned_cols=198 Identities=27% Similarity=0.404 Sum_probs=169.7
Q ss_pred HHhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhc--CCCCcccceEEEeecCC
Q 038003 595 IKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKE--IRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 595 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~l~~~~~~~~ 672 (848)
....++|++.+.||+|+||.||+|.+ +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 34457899999999999999999987 4899999998543 34567788888877 79999999999998876
Q ss_pred ----eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEcCCCCCCeeeCC
Q 038003 673 ----HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH--------HDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 673 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH--------~~~~~~ivH~Dlk~~NIll~~ 740 (848)
..++||||+++|+|.++++. ..+++..+..++.|++.||+||| +. +|+||||||+||+++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 78999999999999999964 35889999999999999999999 77 9999999999999999
Q ss_pred CCCEEEeeccCccccCCCCCC----cccccccccccCccccccC------CCCccchhhhHHHHHHHHHhC---------
Q 038003 741 NFEAHVSDFGIAKFVGPHSSN----WTEFAGTFGYAAPEIAYTM------RATEKYDVYSFGVLVFEVIKG--------- 801 (848)
Q Consensus 741 ~~~~kl~DfG~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg--------- 801 (848)
++.+||+|||++......... .....||+.|+|||++.+. .+++++|||||||++|||+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999877543321 2345789999999998765 334789999999999999999
Q ss_pred -CCCCcc
Q 038003 802 -NHPRDF 807 (848)
Q Consensus 802 -~~P~~~ 807 (848)
+.||..
T Consensus 263 ~~~p~~~ 269 (342)
T 1b6c_B 263 YQLPYYD 269 (342)
T ss_dssp CCCTTTT
T ss_pred cccCccc
Confidence 778754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-32 Score=297.59 Aligned_cols=197 Identities=23% Similarity=0.327 Sum_probs=168.9
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CC-CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCc------ccceEEEee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SG-DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN------NVKFHGFCY 669 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~------iv~l~~~~~ 669 (848)
.++|++.+.||+|+||+||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 468999999999999999999764 44 68999998643 244567788999999887665 899999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeee-----------
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLL----------- 738 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll----------- 738 (848)
..+..++||||+ ++++.+++... ....+++..+..++.||+.||+|||++ ||+||||||+||++
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred eCCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence 999999999999 55666666543 224689999999999999999999999 99999999999999
Q ss_pred --------CCCCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 739 --------DSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 739 --------~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 56789999999999875432 2446799999999999999999999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=302.89 Aligned_cols=199 Identities=22% Similarity=0.296 Sum_probs=168.9
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-----------CCcccceE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-----------HRNNVKFH 665 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~l~ 665 (848)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|++++++++ ||||++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 46799999999999999999965 57899999998643 234567788999988886 89999999
Q ss_pred EEeecCC----eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC--
Q 038003 666 GFCYNGP----HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD-- 739 (848)
Q Consensus 666 ~~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~-- 739 (848)
+++...+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ ||+||||||+||+++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 9987654 789999999 88999988654 2345889999999999999999999953 899999999999994
Q ss_pred ----CCCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 740 ----SNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 740 ----~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4458999999999876542 23457899999999999999999999999999999999999998643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=308.76 Aligned_cols=198 Identities=25% Similarity=0.369 Sum_probs=157.2
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV 677 (848)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 345556889999999998877678999999998543 235678899999876 899999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCccc----CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC------------
Q 038003 678 CEYLDRGSLARILGDDVTAKE----LGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN------------ 741 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~----l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------------ 741 (848)
|||+. |+|.+++........ ..+..+..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCC
Confidence 99996 599999976422111 12334578999999999999999 99999999999999654
Q ss_pred -CCEEEeeccCccccCCCCCC----cccccccccccCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 742 -FEAHVSDFGIAKFVGPHSSN----WTEFAGTFGYAAPEIAYT-------MRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 742 -~~~kl~DfG~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+.+||+|||+++........ ....+||+.|+|||++.+ ..++.++|||||||++|||+| |+.||+.
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 48999999999987543321 234679999999999875 568999999999999999999 9999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-33 Score=298.96 Aligned_cols=203 Identities=26% Similarity=0.414 Sum_probs=168.3
Q ss_pred HhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
...++|++.+.||+|+||.||+|.+.. .+|+|+++.... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 345789999999999999999998753 499999876532 2233455778999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++++|.++++.. ...+++..+..++.||+.||+|||++ ||+||||||+||+++ ++.+||+|||+++..
T Consensus 106 iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999764 34688899999999999999999999 999999999999998 689999999998765
Q ss_pred CCC-----CCCcccccccccccCcccccc---------CCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 756 GPH-----SSNWTEFAGTFGYAAPEIAYT---------MRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 756 ~~~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
... ........|++.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 122234568999999999874 34788999999999999999999998643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=293.54 Aligned_cols=201 Identities=22% Similarity=0.318 Sum_probs=151.8
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+..+..+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 467999999999999999999765 789999999876531 11223334455567888899999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
||||+ ++.+..+.... ...+++..+..++.||+.||.|||+ . ||+||||||+||+++.++.+||+|||++...
T Consensus 102 v~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 99999 55665555322 2468899999999999999999998 6 8999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... ......|++.|+|||++. +..+++++|||||||++|||+||+.||..
T Consensus 176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 176 VDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 5432 234457899999999984 45678899999999999999999999865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=306.17 Aligned_cols=198 Identities=25% Similarity=0.352 Sum_probs=159.2
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~ 675 (848)
...+|+..+.||+|+||+||.....+++.||||++..... +.+.+|+++++.+ +|||||++++++.+....|
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 3457899999999999997766666899999999865432 1245799999999 8999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-----CCCEEEeecc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-----NFEAHVSDFG 750 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DfG 750 (848)
+||||+.+ +|.+++.... .......+..++.||+.||+|||++ +|+||||||+||+++. ...+||+|||
T Consensus 95 lv~E~~~g-~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 95 IAIELCAA-TLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EEEECCSE-EHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EEEECCCC-CHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 99999975 9999987552 2233445678999999999999999 9999999999999953 3368899999
Q ss_pred CccccCCCC---CCcccccccccccCccccc---cCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 751 IAKFVGPHS---SNWTEFAGTFGYAAPEIAY---TMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~---~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+++...... ......+||+.|+|||++. +..++.++|||||||++|||+| |..||+.
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 998775432 2234567999999999987 4567889999999999999999 9999854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=320.98 Aligned_cols=202 Identities=26% Similarity=0.380 Sum_probs=170.3
Q ss_pred hhcCCcccceeccCCceeEEEEEcC----CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP----SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
..++|++.+.||+|+||.||+|.+. .+..||||+++... .....+.+.+|+.++++++||||+++++++.+ +
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence 4567999999999999999999764 24579999986542 33455778999999999999999999999854 5
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 689999999999999999754 24588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 753 KFVGPHSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
+........ .....+++.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 877543221 223456789999999998899999999999999999997 9999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-33 Score=304.33 Aligned_cols=196 Identities=16% Similarity=0.175 Sum_probs=162.1
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEccccccc----CCchhHHHHHHHHHHHhcCC---------CCcccc
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLS----GNMADHDEFLNEVLALKEIR---------HRNNVK 663 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~---------hp~iv~ 663 (848)
..++|++.+.||+|+||+||+|.+ +++.||||++...... ......+.+.+|+++++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346799999999999999999987 6899999999876422 12334577889999988885 555555
Q ss_pred eEEE-----------------eec-------------CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHH
Q 038003 664 FHGF-----------------CYN-------------GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN 713 (848)
Q Consensus 664 l~~~-----------------~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~ 713 (848)
+.++ +.+ .+..|+||||+++|++.+.+.. ..+++..+..++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence 5554 443 6789999999999976666533 45789999999999999
Q ss_pred HHHHHh-hCCCCCeEEcCCCCCCeeeCCCC--------------------CEEEeeccCccccCCCCCCccccccccccc
Q 038003 714 ALSYLH-HDCLPSIIHRDISSKNVLLDSNF--------------------EAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772 (848)
Q Consensus 714 ~L~~LH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~ 772 (848)
||+||| ++ +|+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~ 244 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeeccc
Confidence 999999 89 999999999999999887 899999999987753 2347999999
Q ss_pred CccccccCCCCccchhhhHHHH-HHHHHhCCCCCc
Q 038003 773 APEIAYTMRATEKYDVYSFGVL-VFEVIKGNHPRD 806 (848)
Q Consensus 773 aPE~~~~~~~~~~~DiwSlG~i-l~elltg~~P~~ 806 (848)
|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 999998766 889999998777 888999999975
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-35 Score=344.56 Aligned_cols=430 Identities=17% Similarity=0.112 Sum_probs=257.7
Q ss_pred CCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcc---ccccccccc------------CCCCC
Q 038003 41 PCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLF---FGNIPLQIG------------NLSKL 105 (848)
Q Consensus 41 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~---~~~~p~~~~------------~l~~L 105 (848)
|++|.++.+.. .+.+.+ ... . +..++..+..+++|++|+|+++.. .+.+|..++ .+++|
T Consensus 41 ck~W~~~~~~~--~~~l~~--~~~-~-~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L 114 (592)
T 3ogk_B 41 CRRWFKIDSET--REHVTM--ALC-Y-TATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114 (592)
T ss_dssp CHHHHHHHHHH--CCEEEE--SCG-G-GSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred hHHHHHhhhcc--ccEEEE--eec-c-ccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence 44799996542 222222 211 1 122333466789999999988543 245555444 78999
Q ss_pred cEEEccccCCCCCCchhhhcc--ccccEEEecccC-cCC-CCCccccCcCCccEEEcCCCcCCCC----CCCcccCcccc
Q 038003 106 QYLDLGSNQLSGLIPPEIGKL--NQLRRLYLDMNQ-LHG-TIPPEIGQLSLIDKLALCHNNLHGS----IPSSLGNLSNL 177 (848)
Q Consensus 106 ~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~L~~n~-l~~-~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L 177 (848)
++|+|++|.+++..+..++.+ .+|++|+|++|. ++. .++..+..+++|++|+|++|.+++. ++..+.++++|
T Consensus 115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L 194 (592)
T 3ogk_B 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194 (592)
T ss_dssp CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence 999999999988777778774 459999999887 221 1233344788999999999998765 33445678899
Q ss_pred ceEEeecccccC----CCcccccccccccccccccccccccCcccccCCcccceeeccccCCC---CCCCCcccCccccc
Q 038003 178 AVLYLYKNSLSG----SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLS---GSIPPILGNLKSLS 250 (848)
Q Consensus 178 ~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~---~~~p~~l~~l~~L~ 250 (848)
++|++++|.+++ .++..+.++++|++|+|++|.+.+ +|..+..+++|++|+++.+... +..+..+..+++|+
T Consensus 195 ~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~ 273 (592)
T 3ogk_B 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC 273 (592)
T ss_dssp CEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCC
T ss_pred cEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhcccccc
Confidence 999999999873 345556778999999999999885 7788889999999999864333 23445677788888
Q ss_pred ccccccccccCcCCCcccCCCCCceEEccCccccccCc-ccccCCCCCccccccccccccccCCccceeeccccCCCCcc
Q 038003 251 ALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVP-EEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKM 329 (848)
Q Consensus 251 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~ 329 (848)
.|+++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++ +.+.....
T Consensus 274 ~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l----------------- 334 (592)
T 3ogk_B 274 RLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGL----------------- 334 (592)
T ss_dssp EEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHH-----------------
T ss_pred ccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHH-----------------
Confidence 888887643 3566777778888888888888764433 345777888888887 33332100
Q ss_pred ccccCCCCCccEEEccC-----------CccccccCcc-ccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCcc
Q 038003 330 YEAFGDHPNLTFLDLSN-----------NNFCGEISFN-WGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397 (848)
Q Consensus 330 ~~~~~~l~~L~~L~Ls~-----------N~l~~~~~~~-~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l 397 (848)
...+..+++|++|++++ |.+++..... ...+++ |++|+++.|.+
T Consensus 335 ~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~------------------------L~~L~l~~~~l 390 (592)
T 3ogk_B 335 EVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQE------------------------LEYMAVYVSDI 390 (592)
T ss_dssp HHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTT------------------------CSEEEEEESCC
T ss_pred HHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCcc------------------------CeEEEeecCCc
Confidence 01123456777777773 4444332111 122444 44444444444
Q ss_pred CCCCcccccc-cccccEEEcc----CCcCCCC-----CCcccCCCCccCeEeccCc--ccCCCCCCcccC-ccccceecc
Q 038003 398 VGKIPVQLEM-LSSLNKLILN----LNQLSGG-----VPLEFGSLTKLQYLDLSTN--KLSSSIPKSIGN-LLKLHYLNL 464 (848)
Q Consensus 398 ~~~~~~~l~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~L 464 (848)
++..+..+.. +++|+.|+++ .|.+++. ++..+..+++|+.|++++| .+++..+..+.. +++|++|+|
T Consensus 391 ~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L 470 (592)
T 3ogk_B 391 TNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLL 470 (592)
T ss_dssp CHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEE
T ss_pred cHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeec
Confidence 4433333332 4445555553 3444432 1122333455555555432 233333323322 455555555
Q ss_pred ccCcCCCC-ChhHHhhhcccceecccCcccCcC-CCccccCCCCCccccCCCCcccCC
Q 038003 465 SNNQLSHK-IPTEFEKLIHLSELDLSHNILQEE-IPPQVCNMGSLEKLNLSHNNLSDF 520 (848)
Q Consensus 465 s~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~ 520 (848)
++|++++. ++..+..+++|++|+|++|.+++. ++..+..+++|++|+|++|+++..
T Consensus 471 ~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 471 GYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp CSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred cCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 55555432 223334455555555555555433 222233455555555555555543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=319.15 Aligned_cols=193 Identities=26% Similarity=0.375 Sum_probs=166.4
Q ss_pred hcCCcccceeccCCceeEEEEEcC--CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe--
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH-- 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~-- 673 (848)
.++|++.+.||+|+||.||+|.+. +++.||||++.... .....+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG---DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC---CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 368999999999999999999764 68999999986542 33456678899999999999999999999987655
Q ss_pred ---eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 674 ---SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 674 ---~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
.|+||||++|++|.+++.. .+++.++..|+.||+.||.|||++ |||||||||+||+++.+ .+||+|||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 6999999999999887643 589999999999999999999999 99999999999999875 89999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||..
T Consensus 227 ~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 227 AVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred cchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 99876543 445799999999998765 48899999999999999999988653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=292.42 Aligned_cols=281 Identities=19% Similarity=0.207 Sum_probs=222.6
Q ss_pred CCCCCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCC
Q 038003 38 KISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSG 117 (848)
Q Consensus 38 ~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~ 117 (848)
...+|.|.|+ |+-...+++ .+|. .-.++|++|++++|.+++..+..|+++++|++|+|++|++++
T Consensus 26 ~~~~C~~~~~-c~~~~~~l~-----------~iP~---~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 90 (353)
T 2z80_A 26 ASLSCDRNGI-CKGSSGSLN-----------SIPS---GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT 90 (353)
T ss_dssp -CCEECTTSE-EECCSTTCS-----------SCCT---TCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCE
T ss_pred cCCCCCCCeE-eeCCCCCcc-----------cccc---cccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCc
Confidence 4567999998 875433332 2232 223589999999999997666689999999999999999998
Q ss_pred CCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCC--cccCccccceEEeecc-cccCCCccc
Q 038003 118 LIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPS--SLGNLSNLAVLYLYKN-SLSGSIPSI 194 (848)
Q Consensus 118 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~l~~N-~l~~~~p~~ 194 (848)
..|..|+++++|++|+|++|++++..+..++.+++|++|+|++|+++ .+|. .++++++|++|++++| .+++..|..
T Consensus 91 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 169 (353)
T 2z80_A 91 IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169 (353)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTT
T ss_pred cCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHH
Confidence 88889999999999999999999655556999999999999999999 4555 7899999999999999 577666788
Q ss_pred ccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCC-cccCcccccccccccccccCcCCCccc---CC
Q 038003 195 IGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP-ILGNLKSLSALGLHINQLNGFIPPSIG---NL 270 (848)
Q Consensus 195 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~-~l~~l~~L~~L~l~~N~l~~~~p~~l~---~l 270 (848)
|+++++|++|++++|++++..|..+..+++|++|++++|+++. +|. .+..+++|+.|++++|++++..+..+. ..
T Consensus 170 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~ 248 (353)
T 2z80_A 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248 (353)
T ss_dssp TTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT-HHHHHHHHTTTEEEEEEESCBCTTCCCC------CC
T ss_pred ccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc-chhhhhhhcccccEEECCCCcccccccccccccccc
Confidence 9999999999999999998889999999999999999999974 444 445688999999999999876655443 35
Q ss_pred CCCceEEccCccccc----cCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccC
Q 038003 271 SSLRVLYLYNNGLYG----FVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSN 346 (848)
Q Consensus 271 ~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 346 (848)
+.++.++++++.+.+ .+|+.+..+++|+.|++++|+++. +|. ..|..+++|++|++++
T Consensus 249 ~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~-i~~-----------------~~~~~l~~L~~L~L~~ 310 (353)
T 2z80_A 249 SLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPD-----------------GIFDRLTSLQKIWLHT 310 (353)
T ss_dssp CCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC-CCT-----------------TTTTTCTTCCEEECCS
T ss_pred chhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc-cCH-----------------HHHhcCCCCCEEEeeC
Confidence 667788888887764 356667777778877777777763 232 2355677788888888
Q ss_pred Ccccccc
Q 038003 347 NNFCGEI 353 (848)
Q Consensus 347 N~l~~~~ 353 (848)
|++.+..
T Consensus 311 N~~~~~~ 317 (353)
T 2z80_A 311 NPWDCSC 317 (353)
T ss_dssp SCBCCCH
T ss_pred CCccCcC
Confidence 8777543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=276.53 Aligned_cols=175 Identities=14% Similarity=0.098 Sum_probs=152.5
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||.||+|.+. +++.||||++...... .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc-CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 57999999999999999999765 5899999999775432 234557789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++|++|.++++.. ....++.+|+.|++.||+|||++ ||+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999543 34567889999999999999999 99999999999999999999998543
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
|++ .++.++|||||||++|||+||+.||....
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 333 26789999999999999999999986533
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=276.16 Aligned_cols=213 Identities=23% Similarity=0.287 Sum_probs=167.6
Q ss_pred cCCccc-ceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHH-hcCCCCcccceEEEeec----C
Q 038003 599 DDFDEK-FCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL-KEIRHRNNVKFHGFCYN----G 671 (848)
Q Consensus 599 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~l~~~~~~----~ 671 (848)
++|.+. +.||+|+||.||+|.. .+++.||+|+++.. ..+.+|++++ +..+||||+++++++.. .
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 557776 7899999999999965 57899999998532 3466788887 66699999999999876 6
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---CCCEEEee
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEAHVSD 748 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~D 748 (848)
...++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred ceEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 6789999999999999999764 234689999999999999999999999 9999999999999998 78999999
Q ss_pred ccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccccccc----------------
Q 038003 749 FGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINF---------------- 812 (848)
Q Consensus 749 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~---------------- 812 (848)
||++..... ..++.++|||||||++|||+||+.||.......
T Consensus 164 fg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 164 FGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221 (299)
T ss_dssp CTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred ccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence 999875431 346778999999999999999999985432110
Q ss_pred -----cccchhhhhhhhhcCCCCCCCCCCcccccceeec
Q 038003 813 -----SSFSNMIIDVNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 813 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
..+...+.++...+-..-|..+|.+.+...+.|+
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 1233344444444445556667776666555554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=293.27 Aligned_cols=202 Identities=17% Similarity=0.209 Sum_probs=155.4
Q ss_pred hcCCcccceeccCCceeEEEEE-cCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC-Ccccc------------
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH-RNNVK------------ 663 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~------------ 663 (848)
.+.|...+.||+|+||+||+|. ..+|+.||||++...... .....+.+.+|+.+++.++| ++...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4557888999999999999997 458999999998744322 22345778999999999977 32211
Q ss_pred ---------eEEEeec-----CCeeEEEEeccCCCCHHhHhcC----CCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 038003 664 ---------FHGFCYN-----GPHSFLVCEYLDRGSLARILGD----DVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725 (848)
Q Consensus 664 ---------l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ 725 (848)
+..++.. ....+++|+++ +++|.++++. ......+++..+..++.||++||+|||++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 1111111 12456777766 5699888741 11235678889999999999999999999 9
Q ss_pred eEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccccccccccCcccc----------ccCCCCccchhhhHHHHH
Q 038003 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA----------YTMRATEKYDVYSFGVLV 795 (848)
Q Consensus 726 ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DiwSlG~il 795 (848)
|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999999876443 345677 999999998 555688899999999999
Q ss_pred HHHHhCCCCCccc
Q 038003 796 FEVIKGNHPRDFF 808 (848)
Q Consensus 796 ~elltg~~P~~~~ 808 (848)
|||+||+.||...
T Consensus 308 ~elltg~~Pf~~~ 320 (413)
T 3dzo_A 308 YWIWCADLPNTDD 320 (413)
T ss_dssp HHHHHSSCCCCTT
T ss_pred HHHHHCCCCCCCc
Confidence 9999999998653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=276.83 Aligned_cols=252 Identities=25% Similarity=0.243 Sum_probs=221.9
Q ss_pred CccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCC--CC
Q 038003 42 CSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSG--LI 119 (848)
Q Consensus 42 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~--~~ 119 (848)
|.|.+|.|+..+ ++ .+|. .-.++|++|+|++|.++...+..|+++++|++|+|++|+++. ..
T Consensus 7 C~~~~l~c~~~~--l~-----------~ip~---~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 70 (306)
T 2z66_A 7 CSGTEIRCNSKG--LT-----------SVPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70 (306)
T ss_dssp EETTEEECCSSC--CS-----------SCCS---CCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEE
T ss_pred eCCCEEEcCCCC--cc-----------cCCC---CCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCc
Confidence 799999997532 21 1221 223689999999999985444458999999999999999984 34
Q ss_pred chhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCC-CcccCccccceEEeecccccCCCccccccc
Q 038003 120 PPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIP-SSLGNLSNLAVLYLYKNSLSGSIPSIIGKL 198 (848)
Q Consensus 120 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l 198 (848)
|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+.++++|++|++++|.+++..|..++.+
T Consensus 71 ~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 149 (306)
T 2z66_A 71 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 149 (306)
T ss_dssp EHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTC
T ss_pred ccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccC
Confidence 788889999999999999998 578889999999999999999996554 579999999999999999998889999999
Q ss_pred ccccccccccccccc-cCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEE
Q 038003 199 KSLLQLDLSENQFSG-SIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLY 277 (848)
Q Consensus 199 ~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 277 (848)
++|++|+|++|.+++ .+|..+..+++|++|++++|++++..|..+..+++|++|++++|++++..+..+..+++|++|+
T Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 229 (306)
T 2z66_A 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229 (306)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEE
T ss_pred cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeE
Confidence 999999999999987 6888999999999999999999988889999999999999999999988887899999999999
Q ss_pred ccCccccccCcccccCC-CCCccccccccccccc
Q 038003 278 LYNNGLYGFVPEEIGYL-KSLSELELCTNLLRGV 310 (848)
Q Consensus 278 Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~ 310 (848)
+++|++.+..|..+..+ ++|++|++++|.+.+.
T Consensus 230 L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred CCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 99999999999999998 4999999999999865
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-33 Score=330.07 Aligned_cols=406 Identities=13% Similarity=0.045 Sum_probs=236.1
Q ss_pred ccccccCCCCCcEEEccccCC---CCCCchhhh------------ccccccEEEecccCcCCCCCccccCc--CCccEEE
Q 038003 95 IPLQIGNLSKLQYLDLGSNQL---SGLIPPEIG------------KLNQLRRLYLDMNQLHGTIPPEIGQL--SLIDKLA 157 (848)
Q Consensus 95 ~p~~~~~l~~L~~L~Ls~n~l---~~~~p~~~~------------~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~ 157 (848)
.+..+.++++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..++.. .+|++|+
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~ 144 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence 344456667777777766421 123332222 55666666666666554444444442 2356666
Q ss_pred cCCCc-CCC-CCCCcccCccccceEEeecccccCC----Cccccccccccccccccccccc----ccCcccccCCcccce
Q 038003 158 LCHNN-LHG-SIPSSLGNLSNLAVLYLYKNSLSGS----IPSIIGKLKSLLQLDLSENQFS----GSIPLSLGNLSSLTM 227 (848)
Q Consensus 158 L~~n~-l~~-~~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~ 227 (848)
|++|. ++. .++....++++|++|+|++|.+++. ++..+..+++|++|+|++|.++ +.++..+.++++|+.
T Consensus 145 L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~ 224 (592)
T 3ogk_B 145 LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224 (592)
T ss_dssp EESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCE
T ss_pred CcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcE
Confidence 65554 110 0111222445555555555555433 2223334455555555555554 222333334455555
Q ss_pred eeccccCCCCCCCCcccCccccccccccccccc---CcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccc
Q 038003 228 MSLFNNSLSGSIPPILGNLKSLSALGLHINQLN---GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCT 304 (848)
Q Consensus 228 L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 304 (848)
|++++|.+.+ +|..+..+++|+.|+++.+... +..+..+..+++|+.|+++++.. +.+|..+.
T Consensus 225 L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~------------ 290 (592)
T 3ogk_B 225 VKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFP------------ 290 (592)
T ss_dssp EECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGG------------
T ss_pred EeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHh------------
Confidence 5555555442 3344444444554444432111 11222333344444444443321 12233333
Q ss_pred cccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccC-ccccCcccccEeecccccccCCCCCCCCC
Q 038003 305 NLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEIS-FNWGNFSKLSTFIVSMNNISGSIPPDIGN 383 (848)
Q Consensus 305 N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~i~~~~p~~l~~ 383 (848)
.+++|++|+|++|.+++... ..+..+++|+.|+++++...+.++..+..
T Consensus 291 ------------------------------~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~ 340 (592)
T 3ogk_B 291 ------------------------------FAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQY 340 (592)
T ss_dssp ------------------------------GGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHH
T ss_pred ------------------------------hcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHh
Confidence 34455555555555543322 22345556666666522211122222345
Q ss_pred CCCccEEEcc-----------CCccCCCC-cccccccccccEEEccCCcCCCCCCcccCC-CCccCeEecc----CcccC
Q 038003 384 SPKLQVLDLS-----------SNHIVGKI-PVQLEMLSSLNKLILNLNQLSGGVPLEFGS-LTKLQYLDLS----TNKLS 446 (848)
Q Consensus 384 l~~L~~L~Ls-----------~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls----~N~l~ 446 (848)
+++|++|+++ .|.+++.. +.....+++|++|+++.|++++..+..++. +++|+.|+++ .|+++
T Consensus 341 ~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~ 420 (592)
T 3ogk_B 341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERIT 420 (592)
T ss_dssp CTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCS
T ss_pred CCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcccc
Confidence 6788899998 35666432 233456899999999999999776666665 8899999996 77888
Q ss_pred CC-----CCCcccCccccceeccccC--cCCCCChhHHhh-hcccceecccCcccCcC-CCccccCCCCCccccCCCCcc
Q 038003 447 SS-----IPKSIGNLLKLHYLNLSNN--QLSHKIPTEFEK-LIHLSELDLSHNILQEE-IPPQVCNMGSLEKLNLSHNNL 517 (848)
Q Consensus 447 ~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l 517 (848)
+. ++..+.++++|++|+|+.| .+++..+..+.. +++|+.|+|++|++++. ++..+..+++|++|+|++|.+
T Consensus 421 ~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l 500 (592)
T 3ogk_B 421 DLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500 (592)
T ss_dssp SCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred CchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence 64 3344677999999999854 477766666655 88999999999999873 445567899999999999998
Q ss_pred cCCC-cchhccccCceeecCCCCccCCC
Q 038003 518 SDFI-PRCFEEMRSLSCIDISYNELHGP 544 (848)
Q Consensus 518 ~~~~-~~~~~~l~~L~~l~ls~N~l~~~ 544 (848)
++.. +..+..+++|+.|++++|+++..
T Consensus 501 ~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 501 SERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp BHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred cHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 7653 44456799999999999998754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=274.53 Aligned_cols=228 Identities=22% Similarity=0.301 Sum_probs=214.3
Q ss_pred CCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccE
Q 038003 52 AGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRR 131 (848)
Q Consensus 52 ~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 131 (848)
...+|+.|+|+++++. .+|+ .+..+++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~-~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~ 154 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPD-QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE 154 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCS-CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCE
T ss_pred cccceeEEEccCCCch-hcCh-hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCE
Confidence 3468999999999988 6765 4788999999999999999 89999999999999999999999 78999999999999
Q ss_pred EEecccCcCCCCCccccC---------cCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccccccccc
Q 038003 132 LYLDMNQLHGTIPPEIGQ---------LSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLL 202 (848)
Q Consensus 132 L~L~~n~l~~~~p~~~~~---------l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 202 (848)
|+|++|++.+.+|..++. +++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..++.+++|+
T Consensus 155 L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~ 232 (328)
T 4fcg_A 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLE 232 (328)
T ss_dssp EEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCC
T ss_pred EECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCC
Confidence 999999999999998765 999999999999999 899999999999999999999995 677899999999
Q ss_pred ccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCcc
Q 038003 203 QLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNG 282 (848)
Q Consensus 203 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 282 (848)
+|+|++|.+.+.+|..++.+++|+.|++++|.+.+.+|..+..+++|++|+|++|++.+.+|..++++++|+.+++..+.
T Consensus 233 ~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp EEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred EEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999887
Q ss_pred ccc
Q 038003 283 LYG 285 (848)
Q Consensus 283 l~~ 285 (848)
+..
T Consensus 313 ~~~ 315 (328)
T 4fcg_A 313 QAQ 315 (328)
T ss_dssp SCC
T ss_pred HHH
Confidence 653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=271.06 Aligned_cols=263 Identities=22% Similarity=0.229 Sum_probs=142.6
Q ss_pred ccceEEeecccccCCCcccccccccccccccccccccc--cCcccccCCcccceeeccccCCCCCCCCcccCcccccccc
Q 038003 176 NLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSG--SIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALG 253 (848)
Q Consensus 176 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ 253 (848)
+|++|++++|+++...+..|+++++|++|+|++|+++. ..|..+..+++|++|++++|.++ .+|..+..+++|++|+
T Consensus 29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~ 107 (306)
T 2z66_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 107 (306)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEE
T ss_pred CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEE
Confidence 44555555555543222334455555555555555441 12344444555555555555554 2444445555555555
Q ss_pred cccccccCcCC-CcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccc
Q 038003 254 LHINQLNGFIP-PSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEA 332 (848)
Q Consensus 254 l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~ 332 (848)
+++|++++..+ ..+..+++|++|++++|.+.+..+..+..+
T Consensus 108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-------------------------------------- 149 (306)
T 2z66_A 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL-------------------------------------- 149 (306)
T ss_dssp CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTC--------------------------------------
T ss_pred CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccC--------------------------------------
Confidence 55555554433 345555566666666665554444433333
Q ss_pred cCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCccccccccccc
Q 038003 333 FGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLN 412 (848)
Q Consensus 333 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 412 (848)
++|++|++++|.+++. ..|..+..+++|++|+|++|++++..|..+..+++|+
T Consensus 150 ----~~L~~L~l~~n~l~~~-----------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 202 (306)
T 2z66_A 150 ----SSLEVLKMAGNSFQEN-----------------------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202 (306)
T ss_dssp ----TTCCEEECTTCEEGGG-----------------------EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ----cCCCEEECCCCccccc-----------------------cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCC
Confidence 3444444444443320 1234444555555555555555555555555666666
Q ss_pred EEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCcc-ccceeccccCcCCCCCh--hHHhhhcccceeccc
Q 038003 413 KLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL-KLHYLNLSNNQLSHKIP--TEFEKLIHLSELDLS 489 (848)
Q Consensus 413 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls 489 (848)
.|+|++|++++..+..|..+++|++|++++|++++..|..+..++ +|++|+|++|.+++..+ .....+...+.+.+.
T Consensus 203 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~ 282 (306)
T 2z66_A 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVE 282 (306)
T ss_dssp EEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSC
T ss_pred EEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhcc
Confidence 666666666655555666677777777777777777777777763 77777777777765422 122334445556666
Q ss_pred CcccCcCCCccccCC
Q 038003 490 HNILQEEIPPQVCNM 504 (848)
Q Consensus 490 ~N~l~~~~p~~~~~l 504 (848)
.+.+....|..+.+.
T Consensus 283 ~~~~~C~~p~~~~g~ 297 (306)
T 2z66_A 283 VERMECATPSDKQGM 297 (306)
T ss_dssp GGGCBEEESGGGTTC
T ss_pred ccccccCCchhhCCc
Confidence 666666666665543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-30 Score=280.35 Aligned_cols=204 Identities=21% Similarity=0.211 Sum_probs=115.9
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
+.....+++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 33444666666665 4565544 46666777766666555556666666666666666666555566666666666666
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccCCCc-ccccccccccccccccc-cccccCcccccCCcccceeeccccCCC
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP-SIIGKLKSLLQLDLSEN-QFSGSIPLSLGNLSSLTMMSLFNNSLS 236 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~l~~n~l~ 236 (848)
++|++++..+..++++++|++|++++|++++..+ ..++.+++|++|++++| .+++..|..+..+++|++|++++|+++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence 6666663333335666666666666666663222 25556666666666665 344444455555555555555555555
Q ss_pred CCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccc
Q 038003 237 GSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYG 285 (848)
Q Consensus 237 ~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 285 (848)
+..|..+..+++|++|++++|+++...+..+..+++|++|++++|.+++
T Consensus 188 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~ 236 (353)
T 2z80_A 188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236 (353)
T ss_dssp EECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTT
T ss_pred ccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccc
Confidence 5555555555555555555555543322223334555555555555544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-32 Score=307.60 Aligned_cols=235 Identities=23% Similarity=0.255 Sum_probs=171.3
Q ss_pred ccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCC
Q 038003 247 KSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLS 326 (848)
Q Consensus 247 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~ 326 (848)
++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.+++..+
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-------------- 97 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-------------- 97 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE--------------
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC--------------
Confidence 356666666666666555666666666666666666655443 5555555555555555543211
Q ss_pred CccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCccccc
Q 038003 327 GKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLE 406 (848)
Q Consensus 327 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~ 406 (848)
.++|++|++++|.+ ++..+. .+++|+.|+|++|.+++..|..+.
T Consensus 98 ---------~~~L~~L~L~~N~l------------------------~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~ 141 (487)
T 3oja_A 98 ---------GPSIETLHAANNNI------------------------SRVSCS---RGQGKKNIYLANNKITMLRDLDEG 141 (487)
T ss_dssp ---------CTTCCEEECCSSCC------------------------CCEEEC---CCSSCEEEECCSSCCCSGGGBCGG
T ss_pred ---------CCCcCEEECcCCcC------------------------CCCCcc---ccCCCCEEECCCCCCCCCCchhhc
Confidence 13445555555544 443333 246788888888888888888888
Q ss_pred ccccccEEEccCCcCCCCCCcccC-CCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccce
Q 038003 407 MLSSLNKLILNLNQLSGGVPLEFG-SLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSE 485 (848)
Q Consensus 407 ~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 485 (848)
.+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|++..+ +..+++|+.|+|++|+|++.+| .|..+++|+.
T Consensus 142 ~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~ 218 (487)
T 3oja_A 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTW 218 (487)
T ss_dssp GGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSE
T ss_pred CCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccE
Confidence 888888888888888887777776 68889999999999886532 3458899999999999987555 4888999999
Q ss_pred ecccCcccCcCCCccccCCCCCccccCCCCccc-CCCcchhccccCceeecCC
Q 038003 486 LDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS-DFIPRCFEEMRSLSCIDIS 537 (848)
Q Consensus 486 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~l~ls 537 (848)
|+|++|.|++ +|..+..+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus 219 L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 219 ISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp EECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred EEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 9999999975 6778889999999999999998 5677788888888888876
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-31 Score=284.07 Aligned_cols=249 Identities=24% Similarity=0.256 Sum_probs=183.3
Q ss_pred cCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCC-CCCCchhhh-------ccccccEEEecccCcCCCCCcc
Q 038003 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQL-SGLIPPEIG-------KLNQLRRLYLDMNQLHGTIPPE 146 (848)
Q Consensus 75 ~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l-~~~~p~~~~-------~l~~L~~L~L~~n~l~~~~p~~ 146 (848)
++..++|+.|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34456778888888888 678777655 88888888888 456777666 7888888888888888888887
Q ss_pred c--cCcCCccEEEcCCCcCCCCCCCcccCc-----cccceEEeecccccCCCccccccccccccccccccccccc--Ccc
Q 038003 147 I--GQLSLIDKLALCHNNLHGSIPSSLGNL-----SNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGS--IPL 217 (848)
Q Consensus 147 ~--~~l~~L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~ 217 (848)
+ +.+++|++|+|++|++++. |..++.+ ++|++|++++|++++..|..|+.+++|++|+|++|++.+. +|.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 6 7888888888888888866 7777777 8888888888888877778888888888888888887765 334
Q ss_pred cc--cCCcccceeeccccCCCC--CCC-CcccCcccccccccccccccCcCC-CcccCCCCCceEEccCccccccCcccc
Q 038003 218 SL--GNLSSLTMMSLFNNSLSG--SIP-PILGNLKSLSALGLHINQLNGFIP-PSIGNLSSLRVLYLYNNGLYGFVPEEI 291 (848)
Q Consensus 218 ~l--~~l~~L~~L~l~~n~l~~--~~p-~~l~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 291 (848)
.+ ..+++|++|++++|++++ .++ ..+..+++|++|++++|++++.+| ..+..+++|++|+|++|.++ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 44 778888888888888873 122 233466778888888888777664 44556777777777777777 455555
Q ss_pred cCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCcccc
Q 038003 292 GYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCG 351 (848)
Q Consensus 292 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 351 (848)
. ++|++|++++|++++. | .+..+++|++|++++|++++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p-------------------~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-P-------------------SPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-C-------------------CTTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCC-h-------------------hHhhCCCCCEEeccCCCCCC
Confidence 4 5666666666666543 2 14456677777777776654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=291.69 Aligned_cols=267 Identities=28% Similarity=0.352 Sum_probs=166.2
Q ss_pred CcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCC
Q 038003 81 LANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160 (848)
Q Consensus 81 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 160 (848)
++.|++++|.++ .+|..+. ++|++|+|++|+++. +|. .+++|++|+|++|+++ .+|. .+++|++|+|++
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECS
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcC
Confidence 567777777776 6676665 678888888888773 554 5677888888888777 4555 567777777777
Q ss_pred CcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCC
Q 038003 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIP 240 (848)
Q Consensus 161 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p 240 (848)
|++++ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|++++ +|. .+++|+.|++++|.+++ +|
T Consensus 111 N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~ 177 (622)
T 3g06_A 111 NPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP 177 (622)
T ss_dssp CCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred CcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc
Confidence 77773 454 45667777777777773 4543 3667777777777763 343 23456666777776663 44
Q ss_pred CcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeec
Q 038003 241 PILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLL 320 (848)
Q Consensus 241 ~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L 320 (848)
..+++|+.|++++|++++ +|.. +++|+.|++++|.++. +|.. +++
T Consensus 178 ---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~------------------------ 222 (622)
T 3g06_A 178 ---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSG------------------------ 222 (622)
T ss_dssp ---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTT------------------------
T ss_pred ---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCC------------------------
Confidence 334566666666666654 2322 3456666666666553 2221 233
Q ss_pred cccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCC
Q 038003 321 NQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGK 400 (848)
Q Consensus 321 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 400 (848)
|+.|+|++|++++.. ..+++|+.|++++|+|+ .+|. .+++|+.|+|++|+|+ .
T Consensus 223 ------------------L~~L~Ls~N~L~~lp----~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~ 275 (622)
T 3g06_A 223 ------------------LKELIVSGNRLTSLP----VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-R 275 (622)
T ss_dssp ------------------CCEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-S
T ss_pred ------------------CCEEEccCCccCcCC----CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-c
Confidence 444444444444321 23344555555555554 3444 4567788888888887 6
Q ss_pred CcccccccccccEEEccCCcCCCCCCcccCCCC
Q 038003 401 IPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLT 433 (848)
Q Consensus 401 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 433 (848)
+|..+..+++|+.|+|++|.+++..|..+..++
T Consensus 276 lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 276 LPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 677788888888888888888776666655443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=280.28 Aligned_cols=260 Identities=20% Similarity=0.172 Sum_probs=216.8
Q ss_pred CCCCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcc-ccccccccc-------CCCCCcEEEc
Q 038003 39 ISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLF-FGNIPLQIG-------NLSKLQYLDL 110 (848)
Q Consensus 39 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~-~~~~p~~~~-------~l~~L~~L~L 110 (848)
..|+.|..+.+.....+++.+++.++.+ .+|. .+.. .|+.|+|++|.+ .+.+|..+. ++++|++|+|
T Consensus 28 ~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~-~~~~--~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L 102 (312)
T 1wwl_A 28 FNCLGAADVELYGGGRSLEYLLKRVDTE--ADLG-QFTD--IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTL 102 (312)
T ss_dssp GGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCH-HHHH--HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEE
T ss_pred hhhhccccEEEEccCCCceeEeeccccc--ccHH-HHHH--HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEc
Confidence 4566666654332223466667777776 4443 2222 289999999999 567888777 8999999999
Q ss_pred cccCCCCCCchhh--hccccccEEEecccCcCCCCCccccCc-----CCccEEEcCCCcCCCCCCCcccCccccceEEee
Q 038003 111 GSNQLSGLIPPEI--GKLNQLRRLYLDMNQLHGTIPPEIGQL-----SLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183 (848)
Q Consensus 111 s~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 183 (848)
++|++++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..++++++|++|+++
T Consensus 103 ~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 181 (312)
T 1wwl_A 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181 (312)
T ss_dssp EEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECC
T ss_pred cCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECC
Confidence 9999999999887 9999999999999999977 8888888 999999999999998888999999999999999
Q ss_pred cccccCC--Ccccc--cccccccccccccccccc--cCc-ccccCCcccceeeccccCCCCCCC-CcccCcccccccccc
Q 038003 184 KNSLSGS--IPSII--GKLKSLLQLDLSENQFSG--SIP-LSLGNLSSLTMMSLFNNSLSGSIP-PILGNLKSLSALGLH 255 (848)
Q Consensus 184 ~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~--~~p-~~l~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~l~ 255 (848)
+|++.+. .|..+ +.+++|++|+|++|++++ .++ ..+..+++|++|++++|++++.+| ..+..+++|++|+|+
T Consensus 182 ~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls 261 (312)
T 1wwl_A 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261 (312)
T ss_dssp SCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECT
T ss_pred CCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECC
Confidence 9998865 34444 899999999999999983 223 345688999999999999998775 567778999999999
Q ss_pred cccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccccccccc
Q 038003 256 INQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRG 309 (848)
Q Consensus 256 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 309 (848)
+|+++ .+|..+. ++|++|+|++|++++. |. +..+++|++|++++|++++
T Consensus 262 ~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 262 FTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp TSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 99999 6777776 8999999999999976 65 8999999999999999875
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=263.10 Aligned_cols=237 Identities=22% Similarity=0.185 Sum_probs=179.1
Q ss_pred CCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccC-cCCCCCccccCcCCccE
Q 038003 77 SFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQ-LHGTIPPEIGQLSLIDK 155 (848)
Q Consensus 77 ~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~ 155 (848)
-.++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|+ +++..|..+..+++|++
T Consensus 30 ~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~ 109 (285)
T 1ozn_A 30 IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109 (285)
T ss_dssp CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCE
T ss_pred CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCE
Confidence 34688888888888887777778888888888888888888778888888888888888887 77666778888888888
Q ss_pred EEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCC
Q 038003 156 LALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSL 235 (848)
Q Consensus 156 L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l 235 (848)
|+|++|++++..|..+.++++|++|++++|++++..+..|+.+++|++|+|++|++++..+..+..+++|++|++++|++
T Consensus 110 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 189 (285)
T 1ozn_A 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189 (285)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcc
Confidence 88888888877777888888888888888888866666788888888888888888865556677788888888888888
Q ss_pred CCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCc
Q 038003 236 SGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHS 314 (848)
Q Consensus 236 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 314 (848)
++..|..+..+++|+.|++++|++++..+..+..+++|++|++++|.+....+. ......++.+....+.+....|..
T Consensus 190 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGG
T ss_pred cccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchH
Confidence 777677777777788888888877776666677777777777777777643221 111223444445555555555544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=277.30 Aligned_cols=229 Identities=23% Similarity=0.170 Sum_probs=211.5
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
+++++|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|+.+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 68999999999999999999999999999999999999988899999999999999999999777778999999999999
Q ss_pred CCCcCCCCCCCcccCccccceEEeecc-cccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCC
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKN-SLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG 237 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~ 237 (848)
++|++++..+..|.++++|++|++++| .+....+..|.++++|++|+|++|++++ +| .+..+++|+.|+|++|++++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~ 232 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPE 232 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcc
Confidence 999999666678999999999999995 5553344579999999999999999995 45 58899999999999999998
Q ss_pred CCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccccccccc
Q 038003 238 SIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRG 309 (848)
Q Consensus 238 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 309 (848)
..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+..
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 889999999999999999999999999999999999999999999998888889999999999999998763
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-28 Score=275.79 Aligned_cols=249 Identities=24% Similarity=0.268 Sum_probs=199.7
Q ss_pred CcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCC
Q 038003 81 LANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160 (848)
Q Consensus 81 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 160 (848)
.+.++.+++.++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 456777777775 5776654 6899999999999988888899999999999999999988888899999999999999
Q ss_pred CcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccc-cccccCcccccCCcccceeeccccCCCCCC
Q 038003 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSEN-QFSGSIPLSLGNLSSLTMMSLFNNSLSGSI 239 (848)
Q Consensus 161 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 239 (848)
|++++..+..|+++++|++|+|++|++++..+..|..+++|++|+|++| .+....+..|..+++|++|+|++|++++ +
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~ 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-M 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-C
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-c
Confidence 9998666667888999999999999998666678888999999999984 4543334468888888999999888884 3
Q ss_pred CCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceee
Q 038003 240 PPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVL 319 (848)
Q Consensus 240 p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 319 (848)
| .+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++..+
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------- 283 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH------- 283 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT-------
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccCh-------
Confidence 4 47788888888888888888888888888888888888888888778788888888888887777765433
Q ss_pred ccccCCCCccccccCCCCCccEEEccCCccccc
Q 038003 320 LNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGE 352 (848)
Q Consensus 320 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 352 (848)
..|..+++|+.|+|++|.+...
T Consensus 284 -----------~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 284 -----------DLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp -----------TSSTTCTTCCEEECCSSCEECS
T ss_pred -----------HHhccccCCCEEEccCCCcCCC
Confidence 3355667788888888877644
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-28 Score=274.50 Aligned_cols=228 Identities=24% Similarity=0.180 Sum_probs=211.3
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
++++.|+|++|.+++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 68999999999999988899999999999999999999888899999999999999999999777778999999999999
Q ss_pred CCCcCCCCCCCcccCccccceEEeeccc-ccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCC
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNS-LSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG 237 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~ 237 (848)
++|++++..+..|.++++|++|++++|. +....+..|.++++|++|+|++|+++ .+| .+..+++|+.|+|++|++++
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~ 221 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA 221 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCE
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCc
Confidence 9999997667789999999999999954 55344457999999999999999999 566 58899999999999999998
Q ss_pred CCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccc
Q 038003 238 SIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308 (848)
Q Consensus 238 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 308 (848)
..|..|..+++|+.|+|++|++++..+.+|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 88999999999999999999999999999999999999999999999888888999999999999999886
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-28 Score=273.89 Aligned_cols=246 Identities=24% Similarity=0.263 Sum_probs=207.7
Q ss_pred EeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcC
Q 038003 84 LNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNL 163 (848)
Q Consensus 84 L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 163 (848)
++.+++.++ .+|..+. +++++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++
T Consensus 48 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 48 VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp EECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred EEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 334444443 5676665 7899999999999998889999999999999999999988888999999999999999999
Q ss_pred CCCCCCcccCccccceEEeecccccCCCcccccccccccccccccc-cccccCcccccCCcccceeeccccCCCCCCCCc
Q 038003 164 HGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSEN-QFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPI 242 (848)
Q Consensus 164 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~ 242 (848)
++..+..|..+++|++|+|++|+++...+..|..+++|++|+|++| .++...+..|.++++|++|++++|+++ .+| .
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~ 202 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-N 202 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-C
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-c
Confidence 9666668999999999999999999777778999999999999995 455444457889999999999999998 455 4
Q ss_pred ccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccc
Q 038003 243 LGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQ 322 (848)
Q Consensus 243 l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~ 322 (848)
+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++..+
T Consensus 203 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---------- 272 (440)
T 3zyj_A 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH---------- 272 (440)
T ss_dssp CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCT----------
T ss_pred cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccCh----------
Confidence 7888999999999999998888889999999999999999998888888888888888888888775433
Q ss_pred cCCCCccccccCCCCCccEEEccCCccccc
Q 038003 323 NNLSGKMYEAFGDHPNLTFLDLSNNNFCGE 352 (848)
Q Consensus 323 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 352 (848)
..|..+++|+.|+|++|.+...
T Consensus 273 --------~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 273 --------DLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp --------TTTSSCTTCCEEECCSSCEECS
T ss_pred --------hHhccccCCCEEEcCCCCccCC
Confidence 3456678888888888887654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=259.60 Aligned_cols=247 Identities=23% Similarity=0.268 Sum_probs=210.7
Q ss_pred EeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCc-
Q 038003 84 LNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNN- 162 (848)
Q Consensus 84 L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~- 162 (848)
++.+++.++ .+|..+ .++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|++|.
T Consensus 16 ~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~ 92 (285)
T 1ozn_A 16 TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (285)
T ss_dssp EECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCC
Confidence 444555554 466544 4789999999999998877889999999999999999998889999999999999999997
Q ss_pred CCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCc
Q 038003 163 LHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPI 242 (848)
Q Consensus 163 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~ 242 (848)
++...|..+..+++|++|++++|++++..|..+..+++|++|+|++|++++..+..+..+++|++|++++|++++..+..
T Consensus 93 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 172 (285)
T 1ozn_A 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (285)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred ccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHH
Confidence 77666888999999999999999999888889999999999999999999777777999999999999999999766667
Q ss_pred ccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCC-----ccce
Q 038003 243 LGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPH-----SIER 317 (848)
Q Consensus 243 l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-----~l~~ 317 (848)
+..+++|++|++++|++++..|..+..+++|++|++++|.+++..+..+..+++|+.|++++|.+....+. .++.
T Consensus 173 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~ 252 (285)
T 1ozn_A 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQK 252 (285)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHH
T ss_pred hcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHh
Confidence 99999999999999999999899999999999999999999988778899999999999999999865442 2444
Q ss_pred eeccccCCCCcccccc
Q 038003 318 VLLNQNNLSGKMYEAF 333 (848)
Q Consensus 318 l~L~~n~l~~~~~~~~ 333 (848)
+....+.+....+..+
T Consensus 253 ~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 253 FRGSSSEVPCSLPQRL 268 (285)
T ss_dssp CCSEECCCBEEESGGG
T ss_pred cccccCccccCCchHh
Confidence 4455555554444433
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-30 Score=294.97 Aligned_cols=190 Identities=18% Similarity=0.124 Sum_probs=136.3
Q ss_pred eeccCCceeEEEE-EcCCCCEEEEEEcccccccCC------chhHHHHHHHHHHHhcC-CCCcccceEEEeecCCeeEEE
Q 038003 606 CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGN------MADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 606 ~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~------~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lV 677 (848)
..+.|+.|.+..+ +.-.|+.+|+|++.+...... ....+++.+|+++|+++ .|+||++++++++++...|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4667777766665 334689999999976532211 12346689999999999 799999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++|++|.+++++. ++++.. +|+.||+.||+|+|++ |||||||||+|||++.+|.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999765 455543 5899999999999999 999999999999999999999999999998766
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
........+||++|||||++.+. +..++|+||+|++++++.++..|+
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 55556778999999999999864 567899999999998887766553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=274.92 Aligned_cols=269 Identities=26% Similarity=0.386 Sum_probs=161.8
Q ss_pred CCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEe
Q 038003 103 SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182 (848)
Q Consensus 103 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l 182 (848)
.++++|++++|+++ .+|..+. ++|++|+|++|+++ .+|. .+++|++|+|++|+|+ .+|. .+++|++|++
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 45899999999998 6787765 78999999999988 5665 4677888888888877 4665 5577777777
Q ss_pred ecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCc
Q 038003 183 YKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGF 262 (848)
Q Consensus 183 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 262 (848)
++|++++ +|. .+++|++|+|++|++++ +|.. +++|++|++++|++++ +|.
T Consensus 109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~--------------------- 158 (622)
T 3g06_A 109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA--------------------- 158 (622)
T ss_dssp CSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---------------------
T ss_pred cCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---------------------
Confidence 7777774 343 34566666666666652 3432 2445555555554442 221
Q ss_pred CCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEE
Q 038003 263 IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFL 342 (848)
Q Consensus 263 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L 342 (848)
.+++|+.|++++|.+++ +| ..+++|+.|++++|.+++. |. ..++|+.|
T Consensus 159 ------~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l-~~---------------------~~~~L~~L 206 (622)
T 3g06_A 159 ------LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASL-PT---------------------LPSELYKL 206 (622)
T ss_dssp ------CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-CC---------------------CCTTCCEE
T ss_pred ------ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCC-CC---------------------ccchhhEE
Confidence 12345555555555543 22 2223333333333333321 10 11344555
Q ss_pred EccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCC
Q 038003 343 DLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLS 422 (848)
Q Consensus 343 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 422 (848)
++++|.++. +|.. +++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+
T Consensus 207 ~L~~N~l~~-------------------------l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~ 254 (622)
T 3g06_A 207 WAYNNRLTS-------------------------LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT 254 (622)
T ss_dssp ECCSSCCSS-------------------------CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS
T ss_pred ECcCCcccc-------------------------cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC
Confidence 555554442 2221 2567777777777764 33 34466777777777776
Q ss_pred CCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhc
Q 038003 423 GGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLI 481 (848)
Q Consensus 423 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 481 (848)
. +|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|.+++.+|..+..++
T Consensus 255 ~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 255 S-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp C-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred c-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 3 343 4566777777777777 5566677777777777777777766666666554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-29 Score=269.87 Aligned_cols=245 Identities=22% Similarity=0.216 Sum_probs=133.9
Q ss_pred CCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccc
Q 038003 221 NLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSEL 300 (848)
Q Consensus 221 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 300 (848)
.+++|++|++++|++++..|..+..+++|++|+|++|++++..+ +..+++|++|++++|.+++.. ..++|+.|
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L 104 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL 104 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEE
Confidence 33444444444444444333444444444444444444443332 444555555555555554321 12444555
Q ss_pred cccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCC
Q 038003 301 ELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPD 380 (848)
Q Consensus 301 ~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~ 380 (848)
++++|.+++..+ ..+++|++|++++|++++..+..+..+++|+.|++++|.+.+..+..
T Consensus 105 ~l~~n~l~~~~~---------------------~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 163 (317)
T 3o53_A 105 HAANNNISRVSC---------------------SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163 (317)
T ss_dssp ECCSSCCSEEEE---------------------CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGG
T ss_pred ECCCCccCCcCc---------------------cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHH
Confidence 555444443321 12345666666666666555555555555555555555555444444
Q ss_pred CC-CCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCcccc
Q 038003 381 IG-NSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKL 459 (848)
Q Consensus 381 l~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 459 (848)
+. .+++|++|+|++|++++. + ....+++|++|+|++|++++ +|..|..+++|+.|+|++|+++ .+|..+..+++|
T Consensus 164 ~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L 239 (317)
T 3o53_A 164 LAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239 (317)
T ss_dssp GGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTC
T ss_pred HhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCC
Confidence 42 456666666666666643 2 22236666666777666663 3334666677777777777776 456666667777
Q ss_pred ceeccccCcCC-CCChhHHhhhcccceeccc-CcccCcCC
Q 038003 460 HYLNLSNNQLS-HKIPTEFEKLIHLSELDLS-HNILQEEI 497 (848)
Q Consensus 460 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~ 497 (848)
+.|+|++|.++ +.+|..+..+++|+.|+++ .+.+++..
T Consensus 240 ~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~ 279 (317)
T 3o53_A 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279 (317)
T ss_dssp CEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSS
T ss_pred CEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCc
Confidence 77777777776 5566666666677777766 33444433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-32 Score=316.41 Aligned_cols=457 Identities=14% Similarity=0.118 Sum_probs=271.1
Q ss_pred CCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCccccc---cc------------ccccCCCCC
Q 038003 41 PCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGN---IP------------LQIGNLSKL 105 (848)
Q Consensus 41 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~---~p------------~~~~~l~~L 105 (848)
|++|+++... ....+++.... +..+...+..+++|++|+|+++..... .| .....+++|
T Consensus 34 ck~W~~~~~~----~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 34 CKSWYEIERW----CRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp CHHHHHHHHH----HCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHhhhh----hceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 4479988221 23344444322 222333466789999999999764322 22 123467899
Q ss_pred cEEEccccCCCCCCchhhh-ccccccEEEeccc-CcCCC-CCccccCcCCccEEEcCCCcCCCCCCCccc----Cccccc
Q 038003 106 QYLDLGSNQLSGLIPPEIG-KLNQLRRLYLDMN-QLHGT-IPPEIGQLSLIDKLALCHNNLHGSIPSSLG----NLSNLA 178 (848)
Q Consensus 106 ~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~----~l~~L~ 178 (848)
++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+. .+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 9999999999887777776 7899999999998 55432 445556789999999999998765544443 567899
Q ss_pred eEEeeccc--ccC-CCcccccccccccccccccc-cccccCcccccCCcccceeeccccC-------CCCCCCCcccCcc
Q 038003 179 VLYLYKNS--LSG-SIPSIIGKLKSLLQLDLSEN-QFSGSIPLSLGNLSSLTMMSLFNNS-------LSGSIPPILGNLK 247 (848)
Q Consensus 179 ~L~l~~N~--l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~l~~n~-------l~~~~p~~l~~l~ 247 (848)
+|++++|. ++. .++..+..+++|++|+|++| .++ .+|..+..+++|++|+++.+. +.+ ++..+.+++
T Consensus 188 ~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~ 265 (594)
T 2p1m_B 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCK 265 (594)
T ss_dssp EEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCT
T ss_pred EEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCC
Confidence 99999887 221 11222345688999999988 444 477788888888888866543 221 233455556
Q ss_pred ccccc-ccccccccCcCCCcccCCCCCceEEccCccccccCc-ccccCCCCCccccccccccccccCCccceeeccccCC
Q 038003 248 SLSAL-GLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVP-EEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNL 325 (848)
Q Consensus 248 ~L~~L-~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l 325 (848)
+|+.| .+..... +.++..+..+++|++|++++|.+++... ..+..+++|+.|++++| +.... +
T Consensus 266 ~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~---l---------- 330 (594)
T 2p1m_B 266 ELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAG---L---------- 330 (594)
T ss_dssp TCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHH---H----------
T ss_pred CcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHH---H----------
Confidence 66655 3332222 1233333445666666666666543221 12334555555555544 22100 0
Q ss_pred CCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCC-CCCCccEEEccCCccCCCCccc
Q 038003 326 SGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIG-NSPKLQVLDLSSNHIVGKIPVQ 404 (848)
Q Consensus 326 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~ 404 (848)
......+++|++|+++++.-.| ....+.+++.....+. .+++|+.|+++.|.+++.....
T Consensus 331 ----~~l~~~~~~L~~L~L~~~~~~g---------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~ 391 (594)
T 2p1m_B 331 ----EVLASTCKDLRELRVFPSEPFV---------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALIT 391 (594)
T ss_dssp ----HHHHHHCTTCCEEEEECSCTTC---------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHH
T ss_pred ----HHHHHhCCCCCEEEEecCcccc---------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHH
Confidence 0011123455555553211000 0011222211111111 2567777777777776555545
Q ss_pred cc-ccccccEEEcc--C----CcCCCCC-----CcccCCCCccCeEeccCcccCCCCCCcccC-ccccceeccccCcCCC
Q 038003 405 LE-MLSSLNKLILN--L----NQLSGGV-----PLEFGSLTKLQYLDLSTNKLSSSIPKSIGN-LLKLHYLNLSNNQLSH 471 (848)
Q Consensus 405 l~-~l~~L~~L~L~--~----N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~ 471 (848)
+. .+++|+.|+++ + |.+++.. +..+..+++|+.|++++ .+++..+..++. +++|+.|+|++|.+++
T Consensus 392 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~ 470 (594)
T 2p1m_B 392 IARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSD 470 (594)
T ss_dssp HHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSH
T ss_pred HHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcH
Confidence 54 46778888877 3 4555221 11245567888888866 666555555554 7778888888888876
Q ss_pred CChhHH-hhhcccceecccCcccCcCCCc-cccCCCCCccccCCCCcccCCCcchh-ccccCceeecCCCCc
Q 038003 472 KIPTEF-EKLIHLSELDLSHNILQEEIPP-QVCNMGSLEKLNLSHNNLSDFIPRCF-EEMRSLSCIDISYNE 540 (848)
Q Consensus 472 ~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~l~ls~N~ 540 (848)
..+..+ ..+++|++|+|++|.+++..+. ....+++|++|++++|+++......+ ..+|.|+...+..+.
T Consensus 471 ~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 471 LGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred HHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 555555 6678888888888888654433 33457888888888888754444444 456777665555543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=248.44 Aligned_cols=217 Identities=28% Similarity=0.324 Sum_probs=139.2
Q ss_pred CCCCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCC
Q 038003 39 ISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL 118 (848)
Q Consensus 39 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 118 (848)
.|+|.|.|+.|.-.. .+ +.++++++.++ .+|..+. ++|++|+|++|++++.
T Consensus 2 ~~~C~~~~~~C~c~~-~~-------------------------~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~ 52 (270)
T 2o6q_A 2 EALCKKDGGVCSCNN-NK-------------------------NSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSL 52 (270)
T ss_dssp CCCBGGGTCSBEEET-TT-------------------------TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCC
T ss_pred CccCCCCCCCCEeCC-CC-------------------------CEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCee
Confidence 479999999986321 22 34455555554 3554443 4566677777766655
Q ss_pred CchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccccc
Q 038003 119 IPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKL 198 (848)
Q Consensus 119 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l 198 (848)
.+..|+++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+.++++|++|++++|++++..+..|+.+
T Consensus 53 ~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 132 (270)
T 2o6q_A 53 PSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL 132 (270)
T ss_dssp CTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTC
T ss_pred CHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcC
Confidence 55566666777777777776664444445666666666666666665444556666677777777777766555666666
Q ss_pred ccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEc
Q 038003 199 KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYL 278 (848)
Q Consensus 199 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L 278 (848)
++|++|+|++|++++..+..+..+++|+.|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|
T Consensus 133 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 212 (270)
T 2o6q_A 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence 67777777777666544445666666777777777666555555666666666777666666655555666677777777
Q ss_pred cCcccc
Q 038003 279 YNNGLY 284 (848)
Q Consensus 279 s~N~l~ 284 (848)
++|.+.
T Consensus 213 ~~N~~~ 218 (270)
T 2o6q_A 213 QENPWD 218 (270)
T ss_dssp CSSCBC
T ss_pred cCCCee
Confidence 777664
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-29 Score=268.77 Aligned_cols=269 Identities=20% Similarity=0.179 Sum_probs=189.1
Q ss_pred CcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCC
Q 038003 81 LANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160 (848)
Q Consensus 81 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 160 (848)
++.++++.+.+...++..+..+++|++|+|++|++++..|..|+++++|++|+|++|++++..| ++.+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3455666666655555555666777888888887777766777778888888888887775443 77777788888888
Q ss_pred CcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCC
Q 038003 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIP 240 (848)
Q Consensus 161 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p 240 (848)
|++++ +| ..++|++|++++|++++..+.. +++|++|++++|++++..|..++.+++|++|++++|.+++..+
T Consensus 90 n~l~~-l~----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (317)
T 3o53_A 90 NYVQE-LL----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (317)
T ss_dssp SEEEE-EE----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred Ccccc-cc----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence 87773 22 2367788888888877554433 4667788888888877666677777788888888888776656
Q ss_pred Cccc-CcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceee
Q 038003 241 PILG-NLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVL 319 (848)
Q Consensus 241 ~~l~-~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 319 (848)
..+. .+++|++|++++|++++. +. ...+++|++|+|++|++++..+ .+..+++|+.|++++|++++. |.
T Consensus 162 ~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~l-~~------ 231 (317)
T 3o53_A 162 AELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLI-EK------ 231 (317)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEE-CT------
T ss_pred HHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccch-hh------
Confidence 5553 677788888888887755 22 3347788888888888876443 477788888888888877742 32
Q ss_pred ccccCCCCccccccCCCCCccEEEccCCccc-cccCccccCcccccEeecc-cccccCCCCCCC
Q 038003 320 LNQNNLSGKMYEAFGDHPNLTFLDLSNNNFC-GEISFNWGNFSKLSTFIVS-MNNISGSIPPDI 381 (848)
Q Consensus 320 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~-~N~i~~~~p~~l 381 (848)
.+..+++|+.|++++|.+. +..+..+..+++|+.+++. .+.+.+..|...
T Consensus 232 ------------~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~~ 283 (317)
T 3o53_A 232 ------------ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283 (317)
T ss_dssp ------------TCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCCC
T ss_pred ------------HhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhcc
Confidence 2456678888888888887 5566666777888888877 345565554443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-27 Score=268.95 Aligned_cols=234 Identities=23% Similarity=0.220 Sum_probs=145.2
Q ss_pred ccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccc
Q 038003 224 SLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELC 303 (848)
Q Consensus 224 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 303 (848)
+|+.|+|++|.+++..|..|+.+++|++|+|++|.+++.+| +..+++|++|+|++|.+++..+ .++|+.|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 55555555555555444555555555555555555554443 5556666666666666654321 2566666666
Q ss_pred ccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCC-
Q 038003 304 TNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIG- 382 (848)
Q Consensus 304 ~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~- 382 (848)
+|.+++..+. .+++|+.|+|++|.+++..+..++.+++|+.|++++|.+++..|..+.
T Consensus 108 ~N~l~~~~~~---------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 166 (487)
T 3oja_A 108 NNNISRVSCS---------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166 (487)
T ss_dssp SSCCCCEEEC---------------------CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGG
T ss_pred CCcCCCCCcc---------------------ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhh
Confidence 6666544321 235677777777777776666666666666666666666665566554
Q ss_pred CCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCcccccee
Q 038003 383 NSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYL 462 (848)
Q Consensus 383 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 462 (848)
.+++|++|+|++|.|++..+ +..+++|+.|+|++|.+++. |..|..+++|+.|+|++|+|++ +|..+..+++|+.|
T Consensus 167 ~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L 242 (487)
T 3oja_A 167 SSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHF 242 (487)
T ss_dssp GTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEE
T ss_pred hCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEE
Confidence 56777777777777764422 33466777777777777743 3346677777777777777773 56667777777777
Q ss_pred ccccCcCC-CCChhHHhhhcccceeccc
Q 038003 463 NLSNNQLS-HKIPTEFEKLIHLSELDLS 489 (848)
Q Consensus 463 ~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls 489 (848)
++++|.++ +.+|..+..++.|+.|+++
T Consensus 243 ~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp ECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred EcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 77777776 4556666666666666665
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=240.50 Aligned_cols=206 Identities=25% Similarity=0.260 Sum_probs=163.1
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
++|++|+|++|.+++..+..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++..|..+..+++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46889999999998777778888999999999999988777778888999999999999988777788888889999999
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccCC-CcccccccccccccccccccccccCcccccCCcccc----eeecccc
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGS-IPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLT----MMSLFNN 233 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~l~~n 233 (848)
++|++++..+..++++++|++|++++|++++. +|..++.+++|++|+|++|++++..+..+..+++|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99988876666788888888899888888763 578888888888888888888877777777777666 6777777
Q ss_pred CCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccc
Q 038003 234 SLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYG 285 (848)
Q Consensus 234 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 285 (848)
++++..+..+ ...+|++|++++|++++..+..+..+++|++|++++|.+.+
T Consensus 188 ~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 188 PMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred cccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 7774433333 33467777777777776665566777777777777777664
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=234.53 Aligned_cols=210 Identities=26% Similarity=0.256 Sum_probs=189.0
Q ss_pred CCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEc
Q 038003 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLIL 416 (848)
Q Consensus 337 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 416 (848)
++|++|++++|++++..+..+..+++|+.|++++|++.+..+..|..+++|++|+|++|++++..+..+..+++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46889999999999888878889999999999999998877788999999999999999999888889999999999999
Q ss_pred cCCcCCCCCCcccCCCCccCeEeccCcccCCC-CCCcccCccccceeccccCcCCCCChhHHhhhcccc----eecccCc
Q 038003 417 NLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSS-IPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS----ELDLSHN 491 (848)
Q Consensus 417 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N 491 (848)
++|.+++..+..++.+++|++|++++|++++. +|..|+.+++|++|+|++|++++..+..|..+.+|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999988787899999999999999999874 589999999999999999999998888999888888 8999999
Q ss_pred ccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCCCCC
Q 038003 492 ILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPN 547 (848)
Q Consensus 492 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~~ 547 (848)
.+++..+..+. ..+|++|+|++|++++..+..|..+++|+.+++++|++++..|.
T Consensus 188 ~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 188 PMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred cccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 99876555554 45899999999999998888889999999999999999986654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-29 Score=293.08 Aligned_cols=407 Identities=15% Similarity=0.148 Sum_probs=249.5
Q ss_pred CCCCCCcEEeccCCccccccccccc-CCCCCcEEEcccc-CCCCC-CchhhhccccccEEEecccCcCCCCCcccc----
Q 038003 76 SSFPHLANLNLSFNLFFGNIPLQIG-NLSKLQYLDLGSN-QLSGL-IPPEIGKLNQLRRLYLDMNQLHGTIPPEIG---- 148 (848)
Q Consensus 76 ~~l~~l~~L~l~~n~~~~~~p~~~~-~l~~L~~L~Ls~n-~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~---- 148 (848)
..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 4688999999999999988887776 7999999999999 56543 455556899999999999999876655554
Q ss_pred CcCCccEEEcCCCc--CCCC-CCCcccCccccceEEeecc-cccCCCcccccccccccccccc-------cccccccCcc
Q 038003 149 QLSLIDKLALCHNN--LHGS-IPSSLGNLSNLAVLYLYKN-SLSGSIPSIIGKLKSLLQLDLS-------ENQFSGSIPL 217 (848)
Q Consensus 149 ~l~~L~~L~L~~n~--l~~~-~p~~l~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~L~-------~N~l~~~~p~ 217 (848)
.+++|++|++++|. ++.. ++..+.++++|++|++++| .+.+ +|..+..+++|++|+++ .|.+.+ ++.
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~ 259 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSV 259 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHH
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHH
Confidence 66799999999997 2211 1122345699999999999 5554 78888999999999954 445553 555
Q ss_pred cccCCccccee-eccccCCCCCCCCcccCcccccccccccccccCcCCC-cccCCCCCceEEccCcccccc-CcccccCC
Q 038003 218 SLGNLSSLTMM-SLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPP-SIGNLSSLRVLYLYNNGLYGF-VPEEIGYL 294 (848)
Q Consensus 218 ~l~~l~~L~~L-~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l 294 (848)
.+.++++|+.| .+.+... +.++..+..+++|++|+|++|.+++.... .+..+++|++|++++| +... ++.....+
T Consensus 260 ~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~ 337 (594)
T 2p1m_B 260 ALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTC 337 (594)
T ss_dssp HHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHC
T ss_pred HHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhC
Confidence 78899999999 4544333 24555566789999999999997654322 3568899999999998 4422 23334458
Q ss_pred CCCccccccccccccccCCccceeeccccCCCCccccccC-CCCCccEEEccCCccccccCcccc-CcccccEeecc--c
Q 038003 295 KSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFG-DHPNLTFLDLSNNNFCGEISFNWG-NFSKLSTFIVS--M 370 (848)
Q Consensus 295 ~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~l~--~ 370 (848)
++|++|+++++.-.| ....+.++......+. .+++|+.|+++.|.+++.....+. .+++|+.|+++ +
T Consensus 338 ~~L~~L~L~~~~~~g---------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~ 408 (594)
T 2p1m_B 338 KDLRELRVFPSEPFV---------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIE 408 (594)
T ss_dssp TTCCEEEEECSCTTC---------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESS
T ss_pred CCCCEEEEecCcccc---------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeeccc
Confidence 899999885432110 0011222222222222 367888888888887765444443 35566666665 2
Q ss_pred ----ccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCC-CCccCeEeccCccc
Q 038003 371 ----NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGS-LTKLQYLDLSTNKL 445 (848)
Q Consensus 371 ----N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l 445 (848)
|.+++. |.. ..++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+
T Consensus 409 ~~~~~~l~~~-~~~------------------~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i 468 (594)
T 2p1m_B 409 PKAPDYLTLE-PLD------------------IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGD 468 (594)
T ss_dssp TTCCCTTTCC-CTH------------------HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCS
T ss_pred CCCcccccCC-chh------------------hHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCC
Confidence 222211 000 00111133444555555544 333322223332 45555555555555
Q ss_pred CCCCCCcc-cCccccceeccccCcCCCCChh-HHhhhcccceecccCcccCcCCCccc-cCCCCCccccCCCC
Q 038003 446 SSSIPKSI-GNLLKLHYLNLSNNQLSHKIPT-EFEKLIHLSELDLSHNILQEEIPPQV-CNMGSLEKLNLSHN 515 (848)
Q Consensus 446 ~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N 515 (848)
++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|++++|+++......+ ..+++|+...+..+
T Consensus 469 ~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~ 541 (594)
T 2p1m_B 469 SDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDER 541 (594)
T ss_dssp SHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSS
T ss_pred cHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCC
Confidence 44333333 3455555555555555433222 22335556666666665533222223 33455554444444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-26 Score=238.11 Aligned_cols=226 Identities=24% Similarity=0.270 Sum_probs=165.1
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
..+..+++..+.+...+ .+..+++|++|++++|.++. + +.++.+++|++|+|++|++++ + ..++.+++|++|+|
T Consensus 19 ~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 19 AETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEEC
T ss_pred HHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEEC
Confidence 34445556666555432 35567777777777777763 2 357777777777777777775 2 36777777777888
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCC
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGS 238 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ 238 (848)
++|++++..+..++++++|++|++++|++++..+..|+.+++|++|+|++|++++..+..++.+++|+.|++++|++++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 77777766666677777888888888887766666677777888888888888766666677778888888888888766
Q ss_pred CCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccce
Q 038003 239 IPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIER 317 (848)
Q Consensus 239 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 317 (848)
.+..++.+++|++|++++|++++..|..+..+++|++|++++|.+.+. +++|+.|++..|.++|.+|.++..
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~ 244 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGS 244 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSC
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccc
Confidence 666677788888888888888877777778888888888888877643 456788888888888888876543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=232.65 Aligned_cols=211 Identities=25% Similarity=0.313 Sum_probs=186.9
Q ss_pred cCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCcc
Q 038003 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLID 154 (848)
Q Consensus 75 ~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 154 (848)
+..+++|+.|++++|.++. + +.++.+++|++|+|++|.+++. +.++.+++|++|+|++|++++..|..++.+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 5678899999999998863 3 4588999999999999999873 4889999999999999999987778889999999
Q ss_pred EEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccC
Q 038003 155 KLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234 (848)
Q Consensus 155 ~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 234 (848)
+|+|++|++++..|..++++++|++|++++|++++..+..++.+++|++|+|++|++++..+..++.+++|++|++++|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 99999999997777778999999999999999998777788999999999999999998777778999999999999999
Q ss_pred CCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCC
Q 038003 235 LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKS 296 (848)
Q Consensus 235 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 296 (848)
+++..|..+..+++|++|++++|.+.+. +++|++|+++.|.++|.+|..++.+..
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 9988787889999999999999988754 457899999999999999998887654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-24 Score=226.14 Aligned_cols=206 Identities=24% Similarity=0.268 Sum_probs=180.5
Q ss_pred CCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEc
Q 038003 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLIL 416 (848)
Q Consensus 337 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 416 (848)
.+.+.+++++++++.. |..+. ++++.|++++|++++..+..|..+++|++|+|++|+++...+..|..+++|++|++
T Consensus 16 ~~~~~l~~~~~~l~~i-p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLTAI-PSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCSSC-CSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCCcc-CCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 3567889999988854 33332 57889999999998777778999999999999999999777777889999999999
Q ss_pred cCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcC
Q 038003 417 NLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEE 496 (848)
Q Consensus 417 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 496 (848)
++|++++..+..|..+++|++|++++|++++..+..|+.+++|++|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 99999987778889999999999999999988888899999999999999999987777899999999999999999887
Q ss_pred CCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCCC
Q 038003 497 IPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPI 545 (848)
Q Consensus 497 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~ 545 (848)
.+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++....
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 7778999999999999999999887788999999999999999987544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-25 Score=235.96 Aligned_cols=225 Identities=19% Similarity=0.158 Sum_probs=186.8
Q ss_pred CCCcEEeccCCcccccc-cc--cccCCCCCcEEEccccCCCCCCchhh--hccccccEEEecccCcCCCCC----ccccC
Q 038003 79 PHLANLNLSFNLFFGNI-PL--QIGNLSKLQYLDLGSNQLSGLIPPEI--GKLNQLRRLYLDMNQLHGTIP----PEIGQ 149 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~-p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~p----~~~~~ 149 (848)
..++.+.+.++.++... .. .+..+++|++|+|++|.+++.+|..+ +.+++|++|+|++|++++..| ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 45788888888775321 11 12345779999999999999999988 999999999999999998766 45567
Q ss_pred cCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCC--C--cccccccccccccccccccccccCcc----cccC
Q 038003 150 LSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGS--I--PSIIGKLKSLLQLDLSENQFSGSIPL----SLGN 221 (848)
Q Consensus 150 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~ 221 (848)
+++|++|+|++|++++..|..++++++|++|+|++|++.+. + +..++.+++|++|+|++|+++ .++. .++.
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 99999999999999988888999999999999999998752 2 233578999999999999997 3443 2578
Q ss_pred CcccceeeccccCCCCCCCCcccCc---ccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCc
Q 038003 222 LSSLTMMSLFNNSLSGSIPPILGNL---KSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLS 298 (848)
Q Consensus 222 l~~L~~L~l~~n~l~~~~p~~l~~l---~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 298 (848)
+++|++|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 8999999999999998888888777 69999999999999 5677664 7999999999999974 33 67889999
Q ss_pred ccccccccccc
Q 038003 299 ELELCTNLLRG 309 (848)
Q Consensus 299 ~L~L~~N~l~~ 309 (848)
.|++++|+++.
T Consensus 298 ~L~L~~N~l~~ 308 (310)
T 4glp_A 298 NLTLDGNPFLV 308 (310)
T ss_dssp CEECSSTTTSC
T ss_pred EEECcCCCCCC
Confidence 99999998864
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=226.80 Aligned_cols=191 Identities=25% Similarity=0.299 Sum_probs=90.8
Q ss_pred CCCCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCC
Q 038003 39 ISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL 118 (848)
Q Consensus 39 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 118 (848)
.+||.|.|.+|.... ..+++++. .++ .+|..+. +.|++|+|++|++++.
T Consensus 2 ~~Cp~~~gC~C~~~~---~~l~~~~~-------------------------~l~-~~p~~~~--~~l~~L~L~~n~l~~~ 50 (251)
T 3m19_A 2 KTCETVTGCTCNEGK---KEVDCQGK-------------------------SLD-SVPSGIP--ADTEKLDLQSTGLATL 50 (251)
T ss_dssp --CHHHHSSEEEGGG---TEEECTTC-------------------------CCS-SCCSCCC--TTCCEEECTTSCCCCC
T ss_pred ccCCCCCceEcCCCC---eEEecCCC-------------------------Ccc-ccCCCCC--CCCCEEEccCCCcCcc
Confidence 368899999996422 12334443 333 3343333 3455555555555554
Q ss_pred CchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccccc
Q 038003 119 IPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKL 198 (848)
Q Consensus 119 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l 198 (848)
.|..|+++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+
T Consensus 51 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 130 (251)
T 3m19_A 51 SDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRL 130 (251)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccC
Confidence 44455555555555555555554444444555555555555555554333444455555555555555544333344444
Q ss_pred ccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCccccccccccccccc
Q 038003 199 KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN 260 (848)
Q Consensus 199 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~ 260 (848)
++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|++.
T Consensus 131 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 131 TKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence 44444444444444333333444444444444444444333333333444444444444433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=229.89 Aligned_cols=203 Identities=26% Similarity=0.270 Sum_probs=154.2
Q ss_pred cCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCcc
Q 038003 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLID 154 (848)
Q Consensus 75 ~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 154 (848)
+.++++++.+++++|.++ .+|..+. +.+++|+|++|++++..|..|.++++|++|+|++|++++. |.. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCC
Confidence 556778888888888886 5676664 6788888888888877778888888888888888888753 332 6778888
Q ss_pred EEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccC
Q 038003 155 KLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234 (848)
Q Consensus 155 ~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 234 (848)
+|+|++|+++ .+|..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 8888888887 677777888888888888888886666778888888888888888876666667777778888888887
Q ss_pred CCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCcccc
Q 038003 235 LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLY 284 (848)
Q Consensus 235 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 284 (848)
+++..+..+..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|.+.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 77554455667777777777777777 45556666667777777777664
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-26 Score=259.81 Aligned_cols=188 Identities=14% Similarity=0.170 Sum_probs=148.1
Q ss_pred cccceeccCCceeEEEEEcCCCCEEEEEEcccccccCC----chhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 602 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN----MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 602 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
...+.||+|+||+||+|.. .+..+|+|+......... ....+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 478899998655432211 11245588999999999999999666666677788999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++++|.++++. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999865 457999999999999999 9999999999999998 999999999998754
Q ss_pred CCCC-------cccccccccccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSSN-------WTEFAGTFGYAAPEIAYT--MRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.... ....+||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3221 135689999999999986 567888999999999999998888763
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=254.64 Aligned_cols=264 Identities=19% Similarity=0.148 Sum_probs=194.1
Q ss_pred EEeccCCcccccccccccCCCCCcEEEccccCCCCCCc----hhhhccc-cccEEEecccCcCCCCCccccCc-----CC
Q 038003 83 NLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIP----PEIGKLN-QLRRLYLDMNQLHGTIPPEIGQL-----SL 152 (848)
Q Consensus 83 ~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~ 152 (848)
.++++.|.++|.+|..+...++|++|||++|.+++..+ ..+.+++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35678888888888877777778888888888887666 6777787 88888888888887777777775 88
Q ss_pred ccEEEcCCCcCCCCCCCcccCc-----cccceEEeecccccCCCcccccc-----cccccccccccccccccCc----cc
Q 038003 153 IDKLALCHNNLHGSIPSSLGNL-----SNLAVLYLYKNSLSGSIPSIIGK-----LKSLLQLDLSENQFSGSIP----LS 218 (848)
Q Consensus 153 L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p----~~ 218 (848)
|++|+|++|.+++..+..++.. ++|++|+|++|++++..+..++. .++|++|+|++|++++..+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 8888888888886666544443 78888888888888666655433 2588888999888885443 33
Q ss_pred ccCCc-ccceeeccccCCCCCCCCccc----Cc-ccccccccccccccCc----CCCcccC-CCCCceEEccCccccccC
Q 038003 219 LGNLS-SLTMMSLFNNSLSGSIPPILG----NL-KSLSALGLHINQLNGF----IPPSIGN-LSSLRVLYLYNNGLYGFV 287 (848)
Q Consensus 219 l~~l~-~L~~L~l~~n~l~~~~p~~l~----~l-~~L~~L~l~~N~l~~~----~p~~l~~-l~~L~~L~Ls~N~l~~~~ 287 (848)
+..++ +|++|+|++|++++..+..+. .+ ++|++|+|++|++++. ++..+.. .++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 889999999988876665444 34 5899999999988863 3444554 358999999999998765
Q ss_pred c----ccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccc
Q 038003 288 P----EEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNW 357 (848)
Q Consensus 288 p----~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 357 (848)
+ ..+..+++|+.|++++|.+.+..+..+.. ....+..+++|+.||+++|++.+..+..+
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~-----------l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKA-----------LGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHH-----------HHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHH-----------HHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 4 34567788999999999866543332221 12356678899999999999987644433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=227.56 Aligned_cols=205 Identities=24% Similarity=0.253 Sum_probs=186.2
Q ss_pred cccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCcccc
Q 038003 98 QIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNL 177 (848)
Q Consensus 98 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 177 (848)
.++++++|+++++++|+++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|.+++ +|.. +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcC
Confidence 3788999999999999998 5676664 689999999999998888999999999999999999995 4443 789999
Q ss_pred ceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccc
Q 038003 178 AVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHIN 257 (848)
Q Consensus 178 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N 257 (848)
++|++++|+++ .+|..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 99999999999 78889999999999999999999877788999999999999999999877778899999999999999
Q ss_pred cccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccccccccc
Q 038003 258 QLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRG 309 (848)
Q Consensus 258 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 309 (848)
++++..+..|..+++|++|+|++|+++ .+|..+..+.+|+.+++++|.+..
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 999877778899999999999999998 578888888999999999998864
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-26 Score=252.44 Aligned_cols=264 Identities=14% Similarity=0.171 Sum_probs=217.8
Q ss_pred CCccCceEEcCCCCceEEEeccccCccccccCCccCCC--CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCC
Q 038003 41 PCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSF--PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL 118 (848)
Q Consensus 41 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l--~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 118 (848)
|.+|.++.|+.. .+..++++++.+.. ..+..+ ++++.|++++|.+.+..|. +..+++|++|+|++|.+++.
T Consensus 36 c~~W~~~~~~~~--~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~ 108 (336)
T 2ast_B 36 CKRWYRLASDES--LWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS 108 (336)
T ss_dssp CHHHHHHHTCST--TSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred HHHHHHHhcCch--hheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence 457999988743 46678888776653 235556 8999999999999887665 66899999999999999876
Q ss_pred -CchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCC-cCCCC-CCCcccCccccceEEeecc-cccCC-Ccc
Q 038003 119 -IPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHN-NLHGS-IPSSLGNLSNLAVLYLYKN-SLSGS-IPS 193 (848)
Q Consensus 119 -~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~l~~N-~l~~~-~p~ 193 (848)
+|..+..+++|++|+|++|++++..|..++.+++|++|+|++| .+++. +|..+.++++|++|++++| .+++. ++.
T Consensus 109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~ 188 (336)
T 2ast_B 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 188 (336)
T ss_dssp HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHH
T ss_pred HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHH
Confidence 8888999999999999999999888999999999999999999 68763 6777889999999999999 88864 677
Q ss_pred cccccc-cccccccccc--ccc-ccCcccccCCcccceeeccccC-CCCCCCCcccCccccccccccccc-ccCcCCCcc
Q 038003 194 IIGKLK-SLLQLDLSEN--QFS-GSIPLSLGNLSSLTMMSLFNNS-LSGSIPPILGNLKSLSALGLHINQ-LNGFIPPSI 267 (848)
Q Consensus 194 ~~~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~l~~n~-l~~~~p~~l~~l~~L~~L~l~~N~-l~~~~p~~l 267 (848)
.+..++ +|++|+|++| .++ +.+|..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......+
T Consensus 189 ~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l 268 (336)
T 2ast_B 189 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL 268 (336)
T ss_dssp HHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGG
T ss_pred HHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHH
Confidence 788999 9999999999 565 5677888899999999999999 777788899999999999999995 332222367
Q ss_pred cCCCCCceEEccCccccccCcccccCC-CCCccccccccccccccCCcc
Q 038003 268 GNLSSLRVLYLYNNGLYGFVPEEIGYL-KSLSELELCTNLLRGVIPHSI 315 (848)
Q Consensus 268 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l 315 (848)
.++++|++|++++| ++. +.+..+ .++..|+++.|.+++..|...
T Consensus 269 ~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 269 GEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp GGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred hcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcc
Confidence 88999999999999 443 233444 347778899999998887654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=231.06 Aligned_cols=203 Identities=19% Similarity=0.162 Sum_probs=178.4
Q ss_pred CCCCCcEEeccCCcccccccccc--cCCCCCcEEEccccCCCCCCc----hhhhccccccEEEecccCcCCCCCccccCc
Q 038003 77 SFPHLANLNLSFNLFFGNIPLQI--GNLSKLQYLDLGSNQLSGLIP----PEIGKLNQLRRLYLDMNQLHGTIPPEIGQL 150 (848)
Q Consensus 77 ~l~~l~~L~l~~n~~~~~~p~~~--~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 150 (848)
.+++|++|+|++|.+++.+|..+ +.+++|++|+|++|.+++..| ..+..+++|++|+|++|++++..|..++.+
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 34679999999999999999998 999999999999999998766 455689999999999999998888999999
Q ss_pred CCccEEEcCCCcCCCC--C--CCcccCccccceEEeecccccCCCcc----cccccccccccccccccccccCcccccCC
Q 038003 151 SLIDKLALCHNNLHGS--I--PSSLGNLSNLAVLYLYKNSLSGSIPS----IIGKLKSLLQLDLSENQFSGSIPLSLGNL 222 (848)
Q Consensus 151 ~~L~~L~L~~n~l~~~--~--p~~l~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 222 (848)
++|++|+|++|++.+. + +..++.+++|++|+|++|+++ .++. .++.+++|++|+|++|++++.+|..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 9999999999998753 2 234578999999999999997 3443 35788999999999999998889888877
Q ss_pred ---cccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccc
Q 038003 223 ---SSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYG 285 (848)
Q Consensus 223 ---~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 285 (848)
++|++|+|++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|+.|+|++|+++.
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999999 7788775 7999999999999975 43 6788999999999999874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=216.33 Aligned_cols=196 Identities=18% Similarity=0.172 Sum_probs=121.7
Q ss_pred CCcEEeccCCcccccccccccCCCCCcEEEccccC-CCCCCchhhhccccccEEEecc-cCcCCCCCccccCcCCccEEE
Q 038003 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQ-LSGLIPPEIGKLNQLRRLYLDM-NQLHGTIPPEIGQLSLIDKLA 157 (848)
Q Consensus 80 ~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~ 157 (848)
+|++|++++|.+++..+..|+++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67777777777776666677777777777777775 6655555677777777777777 777755556667777777777
Q ss_pred cCCCcCCCCCCCcccCccccc---eEEeecc-cccCCCccccccccccc-ccccccccccccCcccccCCcccceeeccc
Q 038003 158 LCHNNLHGSIPSSLGNLSNLA---VLYLYKN-SLSGSIPSIIGKLKSLL-QLDLSENQFSGSIPLSLGNLSSLTMMSLFN 232 (848)
Q Consensus 158 L~~n~l~~~~p~~l~~l~~L~---~L~l~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~ 232 (848)
+++|++++ +|. ++.+++|+ +|++++| ++++..+..|..+++|+ +|++++|+++ .+|......++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 77777764 555 66666666 7777776 66655455566666666 6666666666 4443332235566666666
Q ss_pred cC-CCCCCCCcccCc-ccccccccccccccCcCCCcccCCCCCceEEccCc
Q 038003 233 NS-LSGSIPPILGNL-KSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNN 281 (848)
Q Consensus 233 n~-l~~~~p~~l~~l-~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N 281 (848)
|+ +++..+..|..+ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 63 554334445555 5555555555555533222 3445555555443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-25 Score=246.03 Aligned_cols=263 Identities=20% Similarity=0.142 Sum_probs=174.0
Q ss_pred EEEccccCCCCCCchhhhccccccEEEecccCcCCCCC----ccccCcC-CccEEEcCCCcCCCCCCCcccCc-----cc
Q 038003 107 YLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIP----PEIGQLS-LIDKLALCHNNLHGSIPSSLGNL-----SN 176 (848)
Q Consensus 107 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l-----~~ 176 (848)
+++|++|+++|.+|..+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999988888877889999999999997766 6777888 89999999999987777777775 88
Q ss_pred cceEEeecccccCCCccccccc-----ccccccccccccccccCccccc----C-CcccceeeccccCCCCCCCCc----
Q 038003 177 LAVLYLYKNSLSGSIPSIIGKL-----KSLLQLDLSENQFSGSIPLSLG----N-LSSLTMMSLFNNSLSGSIPPI---- 242 (848)
Q Consensus 177 L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~l~----~-l~~L~~L~l~~n~l~~~~p~~---- 242 (848)
|++|+|++|++++..+..++.. ++|++|+|++|++++..+..+. . .++|++|+|++|.+++..+..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999987776655443 7889999999998876665543 3 358888888888887543332
Q ss_pred ccCcc-cccccccccccccCcCCCccc----CC-CCCceEEccCcccccc----CcccccC-CCCCcccccccccccccc
Q 038003 243 LGNLK-SLSALGLHINQLNGFIPPSIG----NL-SSLRVLYLYNNGLYGF----VPEEIGY-LKSLSELELCTNLLRGVI 311 (848)
Q Consensus 243 l~~l~-~L~~L~l~~N~l~~~~p~~l~----~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~~ 311 (848)
+..++ +|++|+|++|++++..+..+. .. ++|++|+|++|.+++. ++..+.. .++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 33443 777777777777766554433 23 4777777777777653 2333333 235666666655555432
Q ss_pred CCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEE
Q 038003 312 PHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLD 391 (848)
Q Consensus 312 p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~ 391 (848)
+..+. ..+..+++|+.|+|++|.+.+..+..+ ..++..+..+++|+.||
T Consensus 242 ~~~l~--------------~~~~~l~~L~~L~L~~n~l~~i~~~~~-----------------~~l~~~~~~l~~L~~Ld 290 (362)
T 3goz_A 242 LENLK--------------LLKDSLKHLQTVYLDYDIVKNMSKEQC-----------------KALGAAFPNIQKIILVD 290 (362)
T ss_dssp HHHHH--------------HTTTTTTTCSEEEEEHHHHTTCCHHHH-----------------HHHHTTSTTCCEEEEEC
T ss_pred HHHHH--------------HHHhcCCCccEEEeccCCccccCHHHH-----------------HHHHHHhccCCceEEEe
Confidence 21111 223445556666666665432221100 01223455666677777
Q ss_pred ccCCccCCC
Q 038003 392 LSSNHIVGK 400 (848)
Q Consensus 392 Ls~N~l~~~ 400 (848)
+++|++...
T Consensus 291 L~~N~l~~~ 299 (362)
T 3goz_A 291 KNGKEIHPS 299 (362)
T ss_dssp TTSCBCCGG
T ss_pred cCCCcCCCc
Confidence 777776644
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=216.70 Aligned_cols=203 Identities=22% Similarity=0.273 Sum_probs=175.9
Q ss_pred cccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccC-cCCCCCccccCcCCccEEEcCC-CcCCCCCCCcc
Q 038003 94 NIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQ-LHGTIPPEIGQLSLIDKLALCH-NNLHGSIPSSL 171 (848)
Q Consensus 94 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l 171 (848)
.+|. +. ++|++|+|++|++++..+..|+++++|++|+|++|+ +++..+..|+.+++|++|+|++ |++++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 3565 43 489999999999998877799999999999999997 8866667899999999999999 99997666789
Q ss_pred cCccccceEEeecccccCCCccccccccccc---ccccccc-cccccCcccccCCcccc-eeeccccCCCCCCCCcccCc
Q 038003 172 GNLSNLAVLYLYKNSLSGSIPSIIGKLKSLL---QLDLSEN-QFSGSIPLSLGNLSSLT-MMSLFNNSLSGSIPPILGNL 246 (848)
Q Consensus 172 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~-~L~l~~n~l~~~~p~~l~~l 246 (848)
.++++|++|++++|++++ +|. ++.+++|+ +|++++| ++++..+..|..+++|+ +|++++|+++ .+|......
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~ 178 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG 178 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC
Confidence 999999999999999996 676 88888888 9999999 99977777899999999 9999999999 666654444
Q ss_pred cccccccccccc-ccCcCCCcccCC-CCCceEEccCccccccCcccccCCCCCcccccccc
Q 038003 247 KSLSALGLHINQ-LNGFIPPSIGNL-SSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTN 305 (848)
Q Consensus 247 ~~L~~L~l~~N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 305 (848)
++|+.|++++|+ +++..+..|..+ ++|++|++++|++++..+. .+++|+.|+++++
T Consensus 179 ~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 179 TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 899999999995 998778889999 9999999999999865443 6778888888765
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-23 Score=207.16 Aligned_cols=184 Identities=25% Similarity=0.296 Sum_probs=115.8
Q ss_pred CCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCc
Q 038003 41 PCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIP 120 (848)
Q Consensus 41 ~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 120 (848)
.|.|.+|.|+..+ ++ .+| ....++|++|++++|.+++..+..|+.+++|++|+|++|++++..+
T Consensus 6 ~C~~~~v~c~~~~--l~-----------~~p---~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (208)
T 2o6s_A 6 SCSGTTVECYSQG--RT-----------SVP---TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPN 69 (208)
T ss_dssp EEETTEEECCSSC--CS-----------SCC---SCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred EECCCEEEecCCC--cc-----------CCC---CCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccCh
Confidence 3789999997532 11 111 1223567777777777776555566777777777777777776555
Q ss_pred hhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccccccc
Q 038003 121 PEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKS 200 (848)
Q Consensus 121 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 200 (848)
..|.++++|++|+|++|++++..+..++.+++|++|+|++|++++..+..+.++++|++|++++|++++..+..+..+++
T Consensus 70 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 149 (208)
T 2o6s_A 70 GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149 (208)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred hhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCC
Confidence 55677777777777777777555555666777777777777776554555666666666666666666555555666666
Q ss_pred ccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcc
Q 038003 201 LLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLK 247 (848)
Q Consensus 201 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~ 247 (848)
|++|+|++|.+.+ .+++|++|+++.|+++|.+|..++.++
T Consensus 150 L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 150 LQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp CCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred ccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 6666666665543 233455555555555555555554443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-25 Score=248.92 Aligned_cols=239 Identities=18% Similarity=0.182 Sum_probs=196.6
Q ss_pred ccCCCCCCcEEeccCCccccc----ccccccCCCCCcEEEcccc---CCCCCCchhh-------hccccccEEEecccCc
Q 038003 74 SFSSFPHLANLNLSFNLFFGN----IPLQIGNLSKLQYLDLGSN---QLSGLIPPEI-------GKLNQLRRLYLDMNQL 139 (848)
Q Consensus 74 ~~~~l~~l~~L~l~~n~~~~~----~p~~~~~l~~L~~L~Ls~n---~l~~~~p~~~-------~~l~~L~~L~L~~n~l 139 (848)
.+..+++|++|+|++|.+++. ++..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|++
T Consensus 27 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l 106 (386)
T 2ca6_A 27 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 106 (386)
T ss_dssp HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred HHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcC
Confidence 356788999999999999876 4455778999999999985 5666777666 6889999999999999
Q ss_pred CC----CCCccccCcCCccEEEcCCCcCCCCCCCcc----cCc---------cccceEEeeccccc-CCCc---cccccc
Q 038003 140 HG----TIPPEIGQLSLIDKLALCHNNLHGSIPSSL----GNL---------SNLAVLYLYKNSLS-GSIP---SIIGKL 198 (848)
Q Consensus 140 ~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l----~~l---------~~L~~L~l~~N~l~-~~~p---~~~~~l 198 (848)
++ .+|..+..+++|++|+|++|.+++..+..+ ..+ ++|++|++++|+++ +.+| ..+..+
T Consensus 107 ~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~ 186 (386)
T 2ca6_A 107 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 186 (386)
T ss_dssp CTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhC
Confidence 97 478888999999999999999975444333 334 89999999999997 4455 467788
Q ss_pred cccccccccccccc--c---cCcccccCCcccceeeccccCCC----CCCCCcccCcccccccccccccccCc----CCC
Q 038003 199 KSLLQLDLSENQFS--G---SIPLSLGNLSSLTMMSLFNNSLS----GSIPPILGNLKSLSALGLHINQLNGF----IPP 265 (848)
Q Consensus 199 ~~L~~L~L~~N~l~--~---~~p~~l~~l~~L~~L~l~~n~l~----~~~p~~l~~l~~L~~L~l~~N~l~~~----~p~ 265 (848)
++|++|+|++|+++ | .+|..+..+++|+.|+|++|.++ +.+|..+..+++|++|+|++|++++. ++.
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 266 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHH
Confidence 99999999999998 3 34558889999999999999996 56788889999999999999999866 456
Q ss_pred cc--cCCCCCceEEccCccccc----cCcccc-cCCCCCccccccccccccccC
Q 038003 266 SI--GNLSSLRVLYLYNNGLYG----FVPEEI-GYLKSLSELELCTNLLRGVIP 312 (848)
Q Consensus 266 ~l--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~~p 312 (848)
.+ +.+++|++|+|++|.+++ .+|..+ ..+++|+.|++++|.+++..|
T Consensus 267 ~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 66 348999999999999987 477777 668999999999999987653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=210.56 Aligned_cols=159 Identities=29% Similarity=0.314 Sum_probs=92.7
Q ss_pred CccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccc
Q 038003 386 KLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLS 465 (848)
Q Consensus 386 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 465 (848)
+|+.|+|++|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 45555555555555555555555555555555555555555555555556666666666555555555555666666666
Q ss_pred cCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCCC
Q 038003 466 NNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGP 544 (848)
Q Consensus 466 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~ 544 (848)
+|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|++++|++++.
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 6666555555555556666666666666554444555666666666666666655555566666666666666666543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.4e-26 Score=251.74 Aligned_cols=113 Identities=18% Similarity=0.268 Sum_probs=52.3
Q ss_pred CCCccCeEeccCcccCC-----CCCCcccCccccceeccccCcCC----CCChhHHhhhcccceecccCcccCcC----C
Q 038003 431 SLTKLQYLDLSTNKLSS-----SIPKSIGNLLKLHYLNLSNNQLS----HKIPTEFEKLIHLSELDLSHNILQEE----I 497 (848)
Q Consensus 431 ~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~ 497 (848)
.+++|++|+|++|+++. ..|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.|++. +
T Consensus 185 ~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l 264 (386)
T 2ca6_A 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264 (386)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred hCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHH
Confidence 34444444444444431 22224444444555555555443 23444444445555555555555433 2
Q ss_pred Cccc--cCCCCCccccCCCCcccC----CCcchh-ccccCceeecCCCCccCC
Q 038003 498 PPQV--CNMGSLEKLNLSHNNLSD----FIPRCF-EEMRSLSCIDISYNELHG 543 (848)
Q Consensus 498 p~~~--~~l~~L~~L~Ls~N~l~~----~~~~~~-~~l~~L~~l~ls~N~l~~ 543 (848)
|..+ +.+++|++|+|++|.+++ .+|..+ .++++|+.|++++|++++
T Consensus 265 ~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 265 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 3333 224555555555555554 234443 334555555555555544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=219.85 Aligned_cols=195 Identities=29% Similarity=0.390 Sum_probs=119.8
Q ss_pred cCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCcc
Q 038003 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLID 154 (848)
Q Consensus 75 ~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 154 (848)
+..+++|++|++++|.+.. +| .+..+++|++|+|++|++++. |+ +..+++|++|+|++|++++ +| .++.+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCC
Confidence 3456667777777776653 44 466677777777777777654 33 6677777777777777664 23 566666777
Q ss_pred EEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccC
Q 038003 155 KLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234 (848)
Q Consensus 155 ~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 234 (848)
+|+|++|++++ +|. +..+++|++|++++|++++..+ ++.+++|++|+|++|++++. +. +..+++|+.|++++|+
T Consensus 111 ~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCc
Confidence 77777776664 332 6666667777777766664332 66666666666666666643 22 6666666666666666
Q ss_pred CCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccc
Q 038003 235 LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYG 285 (848)
Q Consensus 235 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 285 (848)
+++..+ +..+++|++|++++|++++..+ +..+++|++|++++|++++
T Consensus 185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred cCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 664322 5556666666666666654432 5556666666666666553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-24 Score=236.14 Aligned_cols=256 Identities=19% Similarity=0.204 Sum_probs=122.0
Q ss_pred CcEEeccCCcccccccccccCC--CCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCC-CCccccCcCCccEEE
Q 038003 81 LANLNLSFNLFFGNIPLQIGNL--SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGT-IPPEIGQLSLIDKLA 157 (848)
Q Consensus 81 l~~L~l~~n~~~~~~p~~~~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~ 157 (848)
++.+++++|.+. |..++.+ +++++|++++|.+++..|. +..+++|++|+|++|.+++. +|..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 455555555543 3334444 5555555555555544332 33455555555555555433 444455555555555
Q ss_pred cCCCcCCCCCCCcccCccccceEEeecc-cccCC-Ccccccccccccccccccc-ccccc-CcccccCCc-ccceeeccc
Q 038003 158 LCHNNLHGSIPSSLGNLSNLAVLYLYKN-SLSGS-IPSIIGKLKSLLQLDLSEN-QFSGS-IPLSLGNLS-SLTMMSLFN 232 (848)
Q Consensus 158 L~~n~l~~~~p~~l~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~-~L~~L~l~~ 232 (848)
|++|.+++..|..++.+++|++|++++| .+++. ++..+..+++|++|+|++| .+++. ++..+..++ +|++|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 5555554444444445555555555555 34331 3333444444555555544 44432 333344444 444444444
Q ss_pred cCCCCCCCCcccCccccccccccccccc-CcCCCcccCCCCCceEEccCcc-ccccCcccccCCCCCccccccccccccc
Q 038003 233 NSLSGSIPPILGNLKSLSALGLHINQLN-GFIPPSIGNLSSLRVLYLYNNG-LYGFVPEEIGYLKSLSELELCTNLLRGV 310 (848)
Q Consensus 233 n~l~~~~p~~l~~l~~L~~L~l~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 310 (848)
|.+ .++ +.+|..+..+++|++|++++|. +++..+..+..+++|+.|++++|. +.
T Consensus 205 ~~~----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~ 260 (336)
T 2ast_B 205 YRK----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DI 260 (336)
T ss_dssp CGG----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TC
T ss_pred Ccc----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CC
Confidence 421 222 2233344455555555555555 444444455555555555555553 11
Q ss_pred cCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCc-ccccEeecccccccCCCCCCCCC
Q 038003 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNF-SKLSTFIVSMNNISGSIPPDIGN 383 (848)
Q Consensus 311 ~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~l~~N~i~~~~p~~l~~ 383 (848)
.+.. ...+..+++|+.|++++| ++. ..+..+ ..+..|+++.|++++..|..++.
T Consensus 261 ~~~~---------------~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 261 IPET---------------LLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp CGGG---------------GGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CHHH---------------HHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 1111 112344566777777666 332 122222 22445555666666555555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=9.7e-23 Score=217.72 Aligned_cols=211 Identities=23% Similarity=0.316 Sum_probs=181.5
Q ss_pred cEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCC
Q 038003 82 ANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHN 161 (848)
Q Consensus 82 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 161 (848)
..+.+..+.+...+ .+.++++|++|++++|.++. +| .+..+++|++|+|++|++++. |. +..+++|++|+|++|
T Consensus 22 ~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n 95 (308)
T 1h6u_A 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGN 95 (308)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCC
Confidence 33445556665443 35678999999999999985 55 699999999999999999954 44 999999999999999
Q ss_pred cCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCC
Q 038003 162 NLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP 241 (848)
Q Consensus 162 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 241 (848)
++++ +| .+.++++|++|++++|++++ ++. +..+++|++|+|++|++++..+ +..+++|++|++++|++++. +.
T Consensus 96 ~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~ 168 (308)
T 1h6u_A 96 PLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP 168 (308)
T ss_dssp CCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG
T ss_pred cCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh
Confidence 9995 44 69999999999999999996 443 8999999999999999996544 88999999999999999964 43
Q ss_pred cccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccc
Q 038003 242 ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGV 310 (848)
Q Consensus 242 ~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 310 (848)
+..+++|+.|++++|++++..+ +..+++|++|++++|++++.. .+..+++|+.|++++|.+++.
T Consensus 169 -l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 169 -LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp -GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECC
T ss_pred -hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecC
Confidence 8999999999999999997654 889999999999999999765 389999999999999999864
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-23 Score=239.65 Aligned_cols=210 Identities=21% Similarity=0.262 Sum_probs=127.1
Q ss_pred ccCCCCCCCCCCCCCCCC-----ccCce-EEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCccccccccc
Q 038003 25 LLSSWTLYPANATKISPC-----SWFGI-SCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQ 98 (848)
Q Consensus 25 ~l~sw~~~~~~~~~~~~c-----~w~gv-~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~ 98 (848)
.+.+|. .+.++| .|.|+ .|.. .+++ .|+|++|.+++ +|..
T Consensus 32 ~l~~W~------~~~~~~~~~~~~~~~l~~C~~--~~L~-------------------------~L~Ls~n~L~~-lp~~ 77 (571)
T 3cvr_A 32 AWDKWE------KQALPGENRNEAVSLLKECLI--NQFS-------------------------ELQLNRLNLSS-LPDN 77 (571)
T ss_dssp HHHHHH------TTCCTTCCHHHHHHHHHHHHH--TTCS-------------------------EEECCSSCCSC-CCSC
T ss_pred HHHHHh------ccCCccccccchhhhcccccc--CCcc-------------------------EEEeCCCCCCc-cCHh
Confidence 456675 245778 79999 7863 2344 44555555544 4544
Q ss_pred ccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccc
Q 038003 99 IGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLA 178 (848)
Q Consensus 99 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 178 (848)
+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.. +|++|+|++|+|++ +|. .+++|+
T Consensus 78 l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~ 143 (571)
T 3cvr_A 78 LP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLE 143 (571)
T ss_dssp CC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCC
T ss_pred Hc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCcccc
Confidence 42 55666666666655 344 335556666666666654 454 443 56666666666664 454 455666
Q ss_pred eEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccc-------cc
Q 038003 179 VLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSL-------SA 251 (848)
Q Consensus 179 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L-------~~ 251 (848)
+|+|++|++++ +|. .+++|++|+|++|++++ +|. +. ++|+.|+|++|+|+ .+|. +.. +| +.
T Consensus 144 ~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~ 211 (571)
T 3cvr_A 144 YINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIF 211 (571)
T ss_dssp EEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEE
T ss_pred EEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceE
Confidence 66666666664 444 34566666666666664 554 44 56666666666666 4555 443 55 77
Q ss_pred cccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCC
Q 038003 252 LGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLK 295 (848)
Q Consensus 252 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 295 (848)
|+|++|+|+. +|..+..+++|+.|+|++|.+++.+|..+..+.
T Consensus 212 L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 212 FRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp EECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred EecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 8888888774 666677788888888888888877777766544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=4e-22 Score=217.19 Aligned_cols=203 Identities=14% Similarity=0.142 Sum_probs=114.0
Q ss_pred CccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCc-
Q 038003 42 CSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIP- 120 (848)
Q Consensus 42 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p- 120 (848)
|.|..|.|+.. +++ .+|. .+ .+++++|+|++|.++..-+.+|+++++|++|+|++|++.+.+|
T Consensus 9 C~~~~v~C~~~--~Lt-----------~iP~-~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~ 72 (350)
T 4ay9_X 9 CSNRVFLCQES--KVT-----------EIPS-DL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72 (350)
T ss_dssp EETTEEEEEST--TCC-----------SCCT-TC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred eeCCEEEecCC--CCC-----------ccCc-Cc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence 78989999743 122 1222 11 2456777777777764333456777777777777777655444
Q ss_pred hhhhccccccE-EEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeec-ccccCCCccccccc
Q 038003 121 PEIGKLNQLRR-LYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYK-NSLSGSIPSIIGKL 198 (848)
Q Consensus 121 ~~~~~l~~L~~-L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~-N~l~~~~p~~~~~l 198 (848)
..|.++++|++ +.++.|++++..|..|..+++|++|++++|++++..+..+....++..|++.+ |++....+..|..+
T Consensus 73 ~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~ 152 (350)
T 4ay9_X 73 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152 (350)
T ss_dssp TSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred hHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhc
Confidence 34566666553 45556666655566666666666666666666644444555555666666644 34543333444444
Q ss_pred c-cccccccccccccccCcccccCCcccceeeccc-cCCCCCCC-CcccCcccccccccccccccCc
Q 038003 199 K-SLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFN-NSLSGSIP-PILGNLKSLSALGLHINQLNGF 262 (848)
Q Consensus 199 ~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~-n~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~ 262 (848)
. .+++|+|++|+|+ .+|.......+|+.|++++ |.++ .+| ..|..+++|++|+|++|+|+..
T Consensus 153 ~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 153 SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp BSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred chhhhhhcccccccc-CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCcc
Confidence 3 4556666666665 3444444445566666553 3444 333 3445555555555555555543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-21 Score=197.16 Aligned_cols=180 Identities=25% Similarity=0.304 Sum_probs=151.1
Q ss_pred EEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCc
Q 038003 83 NLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNN 162 (848)
Q Consensus 83 ~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 162 (848)
.++++++.++ .+|..+ .++|++|+|++|++++..+..|+++++|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus 11 ~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 4566677765 566554 4689999999999998777778999999999999999997666678899999999999999
Q ss_pred CCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCc
Q 038003 163 LHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPI 242 (848)
Q Consensus 163 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~ 242 (848)
+++..+..++++++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~---- 163 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT---- 163 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC----
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC----
Confidence 9966666788999999999999999977777788999999999999999976666788899999999999987753
Q ss_pred ccCcccccccccccccccCcCCCcccCCCC
Q 038003 243 LGNLKSLSALGLHINQLNGFIPPSIGNLSS 272 (848)
Q Consensus 243 l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~ 272 (848)
+++|++|+++.|+++|.+|.+++.++.
T Consensus 164 ---~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 164 ---CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ---TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ---CCCHHHHHHHHHhCCceeeccCccccC
Confidence 457888899999999988888876654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=211.87 Aligned_cols=166 Identities=18% Similarity=0.132 Sum_probs=127.1
Q ss_pred HHHhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCC-c-------------hhHHHHHHHHHHHhcCCCC
Q 038003 594 IIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN-M-------------ADHDEFLNEVLALKEIRHR 659 (848)
Q Consensus 594 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~-------------~~~~~~~~E~~~l~~l~hp 659 (848)
.......|.+.+.||+|+||.||+|.+.+|+.||+|+++....... . .....+.+|++++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3444556778899999999999999887899999999865421110 0 13566889999999998
Q ss_pred cccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC
Q 038003 660 NNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD 739 (848)
Q Consensus 660 ~iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 739 (848)
| +++.+++.. +..++||||++|++|.+ +.. .....++.|++.|+.|||+. ||+||||||+||+++
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 4 556555443 45699999999999988 422 12346999999999999999 999999999999999
Q ss_pred CCCCEEEeeccCccccCCCCCCcccccccccccCcccccc----------CCCCccchhhh
Q 038003 740 SNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT----------MRATEKYDVYS 790 (848)
Q Consensus 740 ~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~DiwS 790 (848)
++.+||+|||+|+.. ..++|||++.. .+++..+|+|.
T Consensus 228 -~~~vkl~DFG~a~~~-------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEV-------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp -TTEEEECCCTTCEET-------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred -CCcEEEEECCCCeEC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999998643 34688998753 34555566664
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=213.45 Aligned_cols=216 Identities=17% Similarity=0.102 Sum_probs=167.8
Q ss_pred EEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCc-cccCcCCccE-EEcCC
Q 038003 83 NLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPP-EIGQLSLIDK-LALCH 160 (848)
Q Consensus 83 ~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~-L~L~~ 160 (848)
.++.++++++ .||..+ .+++++|+|++|+|+.+.+.+|+++++|++|+|++|++.+.+|. .|.++++|.+ +.++.
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 3456677776 678766 36889999999999866556789999999999999998776664 6788888765 66677
Q ss_pred CcCCCCCCCcccCccccceEEeecccccCCCccccccccccccccccc-ccccccCcccccCCc-ccceeeccccCCCCC
Q 038003 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSE-NQFSGSIPLSLGNLS-SLTMMSLFNNSLSGS 238 (848)
Q Consensus 161 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~-~L~~L~l~~n~l~~~ 238 (848)
|++++..|..|.++++|++|++++|++++..+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+ .
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~ 168 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-E 168 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-E
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-C
Confidence 889877788889999999999999999876666677777888888865 567655555666664 6888999999998 5
Q ss_pred CCCcccCccccccccccc-ccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccc
Q 038003 239 IPPILGNLKSLSALGLHI-NQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELEL 302 (848)
Q Consensus 239 ~p~~l~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 302 (848)
+|.......+|+.|++++ |+++...+.+|..+++|++|+|++|+|+...+..+.++++|+.+++
T Consensus 169 i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 233 (350)
T ss_dssp ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC
T ss_pred CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC
Confidence 666666677899999874 6777665667889999999999999998766666766666666655
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.5e-22 Score=225.65 Aligned_cols=188 Identities=27% Similarity=0.346 Sum_probs=164.2
Q ss_pred CCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEee
Q 038003 104 KLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183 (848)
Q Consensus 104 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 183 (848)
+|++|+|++|++++ +|..+. ++|++|+|++|+|+ .+| +.+++|++|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 89999999999997 777663 89999999999999 788 568999999999999996 888 765 99999999
Q ss_pred cccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcC
Q 038003 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFI 263 (848)
Q Consensus 184 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 263 (848)
+|++++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 999997 666 68999999999999996 676 57899999999999996 777 66 89999999999999 56
Q ss_pred CCcccCCCCC-------ceEEccCccccccCcccccCCCCCccccccccccccccCCccceee
Q 038003 264 PPSIGNLSSL-------RVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVL 319 (848)
Q Consensus 264 p~~l~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 319 (848)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|..+..+.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 66 654 77 99999999999 4788888899999999999999999998776543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-22 Score=241.49 Aligned_cols=229 Identities=22% Similarity=0.221 Sum_probs=126.3
Q ss_pred hHHHHHHHHHHHhccCCCCCCcccCCCCCCCCCCCCCCCCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCc
Q 038003 3 NEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLA 82 (848)
Q Consensus 3 ~~~~~all~~k~~~~~~~~~~~~l~sw~~~~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~ 82 (848)
+.+++||+++..+..... ...-++|.. +.+.++.|.++++.. .+|+.++|.++++.+. + ...++
T Consensus 131 ~~~~~~l~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~------~~~l~ 194 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSK--TAKKQQPTG-----DSTPSGTATNSAVST--PLTPKIELFANGKDEA-N------QALLQ 194 (727)
T ss_dssp -CCCHHHHHHHHHHHHHH--TTC---------------------------------------------------------
T ss_pred ccchhhhhhhhhhccccc--CcccCCCcC-----CCCccccCCCceecC--CccceEEeeCCCCCcc-h------hhHhh
Confidence 457889999998874431 123345532 234567899999875 5789999887776652 1 12234
Q ss_pred EEeccCCcccc---------cccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCc
Q 038003 83 NLNLSFNLFFG---------NIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLI 153 (848)
Q Consensus 83 ~L~l~~n~~~~---------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 153 (848)
.++|+.|.+.+ ..|..+..++.|++|+|++|.+. .+|..+.++++|++|+|++|+|+ .+|..|+.|++|
T Consensus 195 ~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L 272 (727)
T 4b8c_D 195 HKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNL 272 (727)
T ss_dssp ---------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTC
T ss_pred cCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCC
Confidence 44444444432 34677888888888888888887 67777778888888888888888 788888888888
Q ss_pred cEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcc-cceeeccc
Q 038003 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSS-LTMMSLFN 232 (848)
Q Consensus 154 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~l~~ 232 (848)
++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|+.|++|++|+|++|.|++.+|..+..+.. +..|+|++
T Consensus 273 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~ 350 (727)
T 4b8c_D 273 RVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRD 350 (727)
T ss_dssp CEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhcc
Confidence 88888888888 77888888888888888888887 67777888888888888888888888877765532 23477888
Q ss_pred cCCCCCCCCcccCcccccccccccc
Q 038003 233 NSLSGSIPPILGNLKSLSALGLHIN 257 (848)
Q Consensus 233 n~l~~~~p~~l~~l~~L~~L~l~~N 257 (848)
|.++|.+|.. |..|+++.|
T Consensus 351 N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 351 NRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp CCCCCCCCCC---------------
T ss_pred CcccCcCccc------cceeEeecc
Confidence 8888777753 445556555
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=192.34 Aligned_cols=160 Identities=26% Similarity=0.270 Sum_probs=103.3
Q ss_pred CCCCCCccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCC
Q 038003 37 TKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLS 116 (848)
Q Consensus 37 ~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~ 116 (848)
.+.+.|+|.+|.|.... ++ .+|. .-.++|++|+|++|.+++..|..|+.+++|++|+|++|+++
T Consensus 14 ~~~~~Cs~~~v~c~~~~--l~-----------~ip~---~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 77 (229)
T 3e6j_A 14 PSQCSCSGTTVDCRSKR--HA-----------SVPA---GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG 77 (229)
T ss_dssp CTTCEEETTEEECTTSC--CS-----------SCCS---CCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCEEeCCEeEccCCC--cC-----------ccCC---CCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC
Confidence 46788999999997432 11 2221 11256777777777777666666777777777777777776
Q ss_pred CCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccc
Q 038003 117 GLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIG 196 (848)
Q Consensus 117 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~ 196 (848)
+..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|.
T Consensus 78 ~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 156 (229)
T 3e6j_A 78 ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156 (229)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTT
T ss_pred CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHh
Confidence 554555667777777777777776555555666666666666666666 5666666666666666666666654445566
Q ss_pred ccccccccccccccccc
Q 038003 197 KLKSLLQLDLSENQFSG 213 (848)
Q Consensus 197 ~l~~L~~L~L~~N~l~~ 213 (848)
.+++|++|+|++|.+.+
T Consensus 157 ~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 157 RLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp TCTTCCEEECTTSCBCT
T ss_pred CCCCCCEEEeeCCCccC
Confidence 66666666666666553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-22 Score=233.25 Aligned_cols=203 Identities=20% Similarity=0.191 Sum_probs=131.5
Q ss_pred CCCCCCcEEeccCCcccccccccccCCCCCcEEEccccC-------------CCCCCchhhhccccccEEE-ecccCcCC
Q 038003 76 SSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQ-------------LSGLIPPEIGKLNQLRRLY-LDMNQLHG 141 (848)
Q Consensus 76 ~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~-------------l~~~~p~~~~~l~~L~~L~-L~~n~l~~ 141 (848)
...++|+.|+|++|.++ .+|.+|++|++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 56778888888888886 778888888888888887765 5667777778888888887 5665432
Q ss_pred CCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccC
Q 038003 142 TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGN 221 (848)
Q Consensus 142 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 221 (848)
.|..+.+++|.++. +|. ..|+.|+|++|++++ +|. |+.+++|++|+|++|+|+ .+|..++.
T Consensus 424 ----------~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 23334444444442 111 136666666666664 454 666666666666666666 56666666
Q ss_pred CcccceeeccccCCCCCCCCcccCcccccccccccccccCcC-CCcccCCCCCceEEccCccccccCccc---ccCCCCC
Q 038003 222 LSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFI-PPSIGNLSSLRVLYLYNNGLYGFVPEE---IGYLKSL 297 (848)
Q Consensus 222 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L 297 (848)
+++|+.|+|++|+|++ +| .++.+++|++|+|++|+|++.. |..++.+++|+.|+|++|.+++.+|.. +..+++|
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L 562 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence 6666666666666664 44 5666666666666666666655 666666677777777777666554321 2335666
Q ss_pred cccc
Q 038003 298 SELE 301 (848)
Q Consensus 298 ~~L~ 301 (848)
+.|+
T Consensus 563 ~~L~ 566 (567)
T 1dce_A 563 SSIL 566 (567)
T ss_dssp SEEE
T ss_pred CccC
Confidence 6664
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-20 Score=219.20 Aligned_cols=190 Identities=25% Similarity=0.343 Sum_probs=115.5
Q ss_pred CcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCC
Q 038003 81 LANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160 (848)
Q Consensus 81 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 160 (848)
+..++++.+.+...++ +..|++|++|+|++|.+.. +| .|+.|++|+.|+|++|++++..| +..+++|++|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 4444555555554333 4556666666666666664 23 46666667777776666664333 66666666666666
Q ss_pred CcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCC
Q 038003 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIP 240 (848)
Q Consensus 161 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p 240 (848)
|.+++ +| .++.+++|+.|+|++|++++ + ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++..|
T Consensus 97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 97 NKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 66663 33 46666666666666666664 2 3466666666666666666643 456666666666666666665444
Q ss_pred CcccCcccccccccccccccCcCCCcccCCCCCceEEccCcccccc
Q 038003 241 PILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGF 286 (848)
Q Consensus 241 ~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 286 (848)
+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+.+.
T Consensus 171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 66666666666666666643 2456666666666666666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-20 Score=200.09 Aligned_cols=187 Identities=25% Similarity=0.346 Sum_probs=108.4
Q ss_pred EEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCc
Q 038003 83 NLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNN 162 (848)
Q Consensus 83 ~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 162 (848)
.+.+..+.+.+..+ +..+++|++|++++|.++.. | .+..+++|++|+|++|++++..| ++.+++|++|+|++|+
T Consensus 28 ~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~ 101 (291)
T 1h6t_A 28 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK 101 (291)
T ss_dssp HHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCc
Confidence 33444444443222 34566666666666666543 3 36666666666666666664332 6666666666666666
Q ss_pred CCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCc
Q 038003 163 LHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPI 242 (848)
Q Consensus 163 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~ 242 (848)
+++ +| .++.+++|++|++++|++++. ..+..+++|++|+|++|++++. ..+..+++|++|++++|++++..|
T Consensus 102 l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-- 173 (291)
T 1h6t_A 102 VKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 173 (291)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred CCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--
Confidence 653 22 256666666666666666642 3455666666666666666643 455666666666666666664333
Q ss_pred ccCcccccccccccccccCcCCCcccCCCCCceEEccCccccc
Q 038003 243 LGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYG 285 (848)
Q Consensus 243 l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 285 (848)
+..+++|+.|++++|++++. | .+..+++|+.|++++|++..
T Consensus 174 l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 174 LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 56666666666666666543 2 35666666666666666654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-20 Score=198.30 Aligned_cols=174 Identities=26% Similarity=0.410 Sum_probs=154.2
Q ss_pred cCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCcc
Q 038003 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLID 154 (848)
Q Consensus 75 ~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 154 (848)
+..+++|+.|++++|.+.. +| .++.+++|++|+|++|++++..| ++++++|++|+|++|++++ +| .++.+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred hhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 5578899999999999974 44 58999999999999999997544 9999999999999999985 44 499999999
Q ss_pred EEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccC
Q 038003 155 KLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234 (848)
Q Consensus 155 ~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 234 (848)
+|+|++|++++ + ..+..+++|++|++++|++++. ..++.+++|++|+|++|++++..| +..+++|+.|++++|.
T Consensus 116 ~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 116 SLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp EEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence 99999999996 3 5688999999999999999965 678999999999999999996555 9999999999999999
Q ss_pred CCCCCCCcccCcccccccccccccccCc
Q 038003 235 LSGSIPPILGNLKSLSALGLHINQLNGF 262 (848)
Q Consensus 235 l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 262 (848)
+++ ++ .+..+++|+.|++++|++...
T Consensus 190 i~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 190 ISD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred CCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 995 44 489999999999999999864
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6.3e-20 Score=212.62 Aligned_cols=181 Identities=26% Similarity=0.376 Sum_probs=158.5
Q ss_pred cCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCcc
Q 038003 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLID 154 (848)
Q Consensus 75 ~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 154 (848)
+..|++|+.|++++|.+.. +| .|+.|++|++|+|++|++++..| +..+++|++|+|++|++++ +| .++.+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence 5678899999999999974 44 69999999999999999997654 9999999999999999985 44 799999999
Q ss_pred EEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccC
Q 038003 155 KLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234 (848)
Q Consensus 155 ~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 234 (848)
+|+|++|++++ + ..+..+++|+.|+|++|++++. ..++.+++|+.|+|++|++++..| +..+++|+.|+|++|+
T Consensus 113 ~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 113 SLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp EEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence 99999999995 3 4689999999999999999965 678999999999999999997766 9999999999999999
Q ss_pred CCCCCCCcccCcccccccccccccccCcCCCcccC
Q 038003 235 LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGN 269 (848)
Q Consensus 235 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~ 269 (848)
|++. +.+..+++|+.|+|++|++.+.....+..
T Consensus 187 i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~ 219 (605)
T 1m9s_A 187 ISDL--RALAGLKNLDVLELFSQECLNKPINHQSN 219 (605)
T ss_dssp CCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSS
T ss_pred CCCC--hHHccCCCCCEEEccCCcCcCCccccccc
Confidence 9964 46899999999999999998754444433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7e-20 Score=185.19 Aligned_cols=151 Identities=23% Similarity=0.272 Sum_probs=73.6
Q ss_pred EeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcc
Q 038003 365 TFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNK 444 (848)
Q Consensus 365 ~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 444 (848)
.++++++.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4455555554 3343332 345555555555554444445555555555555555554444455555555555555555
Q ss_pred cCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCccc
Q 038003 445 LSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS 518 (848)
Q Consensus 445 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 518 (848)
|+...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 55444444444555555555555554444444444444444444444444444444444444444444444443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=6.8e-20 Score=185.26 Aligned_cols=152 Identities=22% Similarity=0.283 Sum_probs=83.3
Q ss_pred EEEccCCccCCCCcccccccccccEEEccCCcCCCCCC-cccCCCCccCeEeccCcccCCCCCCcccCccccceeccccC
Q 038003 389 VLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVP-LEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNN 467 (848)
Q Consensus 389 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 467 (848)
.+++++|.++ .+|..+. ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4444444444 2333221 233455555555554322 23455555555555555555555555555555555555555
Q ss_pred cCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCC
Q 038003 468 QLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHG 543 (848)
Q Consensus 468 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~ 543 (848)
+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|++++|++++
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 5555555555555566666666666655555556666666666666666666555666666666666666666654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.4e-20 Score=201.17 Aligned_cols=157 Identities=26% Similarity=0.278 Sum_probs=103.4
Q ss_pred CccEEEccCCccCCCCccccc-ccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceecc
Q 038003 386 KLQVLDLSSNHIVGKIPVQLE-MLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNL 464 (848)
Q Consensus 386 ~L~~L~Ls~N~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 464 (848)
.++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 119 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL 119 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence 456666666666655555555 6666666666666666555566666667777777777766655566666777777777
Q ss_pred ccCcCCCCChhHHhhhcccceecccCcccCcCCCccc---cCCCCCccccCCCCcccCCCcchhccccCc--eeecCCCC
Q 038003 465 SNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQV---CNMGSLEKLNLSHNNLSDFIPRCFEEMRSL--SCIDISYN 539 (848)
Q Consensus 465 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L--~~l~ls~N 539 (848)
++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++..+..|..++.+ +.|++++|
T Consensus 120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N 199 (361)
T 2xot_A 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSS
T ss_pred CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCC
Confidence 7777766666667777777777777777765433334 456777777777777777666667666663 66777777
Q ss_pred ccC
Q 038003 540 ELH 542 (848)
Q Consensus 540 ~l~ 542 (848)
++.
T Consensus 200 ~~~ 202 (361)
T 2xot_A 200 PLE 202 (361)
T ss_dssp CEE
T ss_pred Ccc
Confidence 775
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=182.91 Aligned_cols=134 Identities=22% Similarity=0.264 Sum_probs=79.4
Q ss_pred CCcEEeccCCccccccc-ccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 80 HLANLNLSFNLFFGNIP-LQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 80 ~l~~L~l~~n~~~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
.+++|+|++|.+++..| ..|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 34566666666665543 23566666666666666666555556666666666666666666555555666666666666
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccc
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSG 213 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 213 (848)
++|+|++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+++
T Consensus 113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 6666665555555556666666666666655555555555555555555555553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=181.71 Aligned_cols=134 Identities=25% Similarity=0.302 Sum_probs=81.8
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
+.|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 45666666666666555556666666666666666666666666666666666666666666444444555666666666
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccCCCccccccccccccccccccccc
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFS 212 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 212 (848)
++|+|++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+.
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 666666555555666666666666666665544445555555555555555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.9e-20 Score=199.09 Aligned_cols=133 Identities=28% Similarity=0.275 Sum_probs=70.8
Q ss_pred CCcEEeccCCccccccccccc-CCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 80 HLANLNLSFNLFFGNIPLQIG-NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 80 ~l~~L~l~~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
.++.|+|++|.+++..+..+. .+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 119 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL 119 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence 355666666666555555554 5666666666666665555555566666666666666655444445555555555555
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccCCCcccc---ccccccccccccccccc
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSII---GKLKSLLQLDLSENQFS 212 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~ 212 (848)
++|+|++..|..|.++++|++|+|++|++++..+..| ..+++|++|+|++|+|+
T Consensus 120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 5555554445555555555555555555553222222 23444444444444444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-19 Score=180.86 Aligned_cols=134 Identities=29% Similarity=0.362 Sum_probs=66.2
Q ss_pred ccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecc
Q 038003 409 SSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDL 488 (848)
Q Consensus 409 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 488 (848)
++|+.|+|++|++++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 44444444444444444444444444555555555444433344444455555555555554444444444555555555
Q ss_pred cCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCC
Q 038003 489 SHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHG 543 (848)
Q Consensus 489 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~ 543 (848)
++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|++++
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 555554 344445555555555555555554444445555555555555555543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.5e-20 Score=219.46 Aligned_cols=218 Identities=23% Similarity=0.200 Sum_probs=128.4
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcE-----EEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCc
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQY-----LDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLI 153 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~-----L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 153 (848)
++++.|+|++|.+.. +|..+.....|.. ++++.|.+. ..|..+..+++|+.|+|++|.+. .+|..+..+++|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 568899999998875 4544333333333 233334444 45888999999999999999998 889888999999
Q ss_pred cEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeecccc
Q 038003 154 DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNN 233 (848)
Q Consensus 154 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n 233 (848)
++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|+.|++|++|+|++|.|+ .+|..|+.+++|+.|+|++|
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 99999999999 89999999999999999999999 78999999999999999999998 88999999999999999999
Q ss_pred CCCCCCCCcccCccc-ccccccccccccCcCCCcccCCCCCceEEccCc--------cccccCcccccCCCCCccccccc
Q 038003 234 SLSGSIPPILGNLKS-LSALGLHINQLNGFIPPSIGNLSSLRVLYLYNN--------GLYGFVPEEIGYLKSLSELELCT 304 (848)
Q Consensus 234 ~l~~~~p~~l~~l~~-L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~L~~ 304 (848)
.|++.+|..+..+.. +..++|++|.+++.+|.. |+.|++++| .+.+..+..+..+..+....++.
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~ 400 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSY 400 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------------------------------------------
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeec
Confidence 999988888766533 345889999999988864 556677776 33333344445555556666666
Q ss_pred cccc
Q 038003 305 NLLR 308 (848)
Q Consensus 305 N~l~ 308 (848)
|-+.
T Consensus 401 Nil~ 404 (727)
T 4b8c_D 401 NTLC 404 (727)
T ss_dssp -CCC
T ss_pred cccc
Confidence 6554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-19 Score=188.92 Aligned_cols=171 Identities=21% Similarity=0.289 Sum_probs=124.9
Q ss_pred CCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEE
Q 038003 77 SFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKL 156 (848)
Q Consensus 77 ~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 156 (848)
.+..++.+++++|.+++ ++ .+..+++|++|++++|+++. +| .++.+++|++|+|++|++++. |. ++.+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEE
Confidence 45566777788777764 33 57778888888888888874 45 678888888888888888854 33 7788888888
Q ss_pred EcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCC
Q 038003 157 ALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLS 236 (848)
Q Consensus 157 ~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~ 236 (848)
+|++|++++ +|.... ++|++|++++|++++ ++ .++.+++|++|+|++|++++. + .+..+++|+.|++++|+++
T Consensus 91 ~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 888888874 444322 778888888888875 33 477778888888888888753 3 5777778888888888877
Q ss_pred CCCCCcccCcccccccccccccccCc
Q 038003 237 GSIPPILGNLKSLSALGLHINQLNGF 262 (848)
Q Consensus 237 ~~~p~~l~~l~~L~~L~l~~N~l~~~ 262 (848)
+. ..+..+++|+.|++++|++.+.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 54 5677777777777777777654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-21 Score=222.55 Aligned_cols=120 Identities=28% Similarity=0.310 Sum_probs=67.3
Q ss_pred ccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceecccc
Q 038003 387 LQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSN 466 (848)
Q Consensus 387 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 466 (848)
|+.|+|++|+|++ +|. +..+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .|+.+++|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 4555555555553 333 555555555555555555 445555556666666666666654 34 555666666666666
Q ss_pred CcCCCCC-hhHHhhhcccceecccCcccCcCCCcc---ccCCCCCcccc
Q 038003 467 NQLSHKI-PTEFEKLIHLSELDLSHNILQEEIPPQ---VCNMGSLEKLN 511 (848)
Q Consensus 467 N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~ 511 (848)
|+|++.+ |..|..+++|+.|+|++|+|++.+|.. +..+++|+.|+
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 6666554 566666666666666666665543321 22355666654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=3e-19 Score=177.32 Aligned_cols=154 Identities=18% Similarity=0.270 Sum_probs=104.3
Q ss_pred cCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccce
Q 038003 100 GNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAV 179 (848)
Q Consensus 100 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 179 (848)
+.+++|++|++++|+++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 55666777777777776 344 5667777777777777554 2346666777777777777777666667777777777
Q ss_pred EEeecccccCCCccccccccccccccccccc-ccccCcccccCCcccceeeccccCCCCCCCCcccCccccccccccccc
Q 038003 180 LYLYKNSLSGSIPSIIGKLKSLLQLDLSENQ-FSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQ 258 (848)
Q Consensus 180 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~ 258 (848)
|++++|++++..|..++.+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 7777777776666677777777777777776 44 455 57777777777777777774 33 56777777777777777
Q ss_pred ccC
Q 038003 259 LNG 261 (848)
Q Consensus 259 l~~ 261 (848)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.4e-19 Score=174.51 Aligned_cols=155 Identities=21% Similarity=0.305 Sum_probs=117.5
Q ss_pred hhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccccccccc
Q 038003 123 IGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLL 202 (848)
Q Consensus 123 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 202 (848)
.+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 467778888888888887 566 5778888888888888665 234677788888888888888876777788888888
Q ss_pred ccccccccccccCcccccCCcccceeeccccC-CCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCc
Q 038003 203 QLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS-LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNN 281 (848)
Q Consensus 203 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~-l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N 281 (848)
+|+|++|++++..|..++.+++|++|++++|. ++ .+| .+..+++|++|++++|++++. + .+..+++|++|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCc
Confidence 88888888887777788888888888888887 55 455 577788888888888888753 3 5777888888888888
Q ss_pred cccc
Q 038003 282 GLYG 285 (848)
Q Consensus 282 ~l~~ 285 (848)
++.+
T Consensus 192 ~i~~ 195 (197)
T 4ezg_A 192 TIGG 195 (197)
T ss_dssp ----
T ss_pred ccCC
Confidence 7753
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.7e-19 Score=185.11 Aligned_cols=171 Identities=23% Similarity=0.332 Sum_probs=143.1
Q ss_pred CCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceE
Q 038003 101 NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVL 180 (848)
Q Consensus 101 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 180 (848)
.+.+++.+++++|.+++. + .+..+++|++|++++|+++ .+| .++.+++|++|+|++|++++..| ++++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 577888999999999864 4 6899999999999999998 566 78899999999999999996444 8999999999
Q ss_pred EeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCccccccccccccccc
Q 038003 181 YLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN 260 (848)
Q Consensus 181 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~ 260 (848)
++++|++++ +|.... ++|++|+|++|++++ ++ .+..+++|+.|++++|++++. + .+..+++|+.|++++|+++
T Consensus 91 ~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 999999985 444333 889999999999985 33 588899999999999999854 3 6888888899999999888
Q ss_pred CcCCCcccCCCCCceEEccCcccccc
Q 038003 261 GFIPPSIGNLSSLRVLYLYNNGLYGF 286 (848)
Q Consensus 261 ~~~p~~l~~l~~L~~L~Ls~N~l~~~ 286 (848)
+. ..+..+++|++|++++|.+...
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 76 5678888888888888888755
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=179.58 Aligned_cols=141 Identities=16% Similarity=0.142 Sum_probs=107.2
Q ss_pred CCcccceeccCCceeEEEEEc-CCCCE--EEEEEcccccccCC--------------------chhHHHHHHHHHHHhcC
Q 038003 600 DFDEKFCIGKGGQGSVYKAEL-PSGDI--VAVKKFNSQLLSGN--------------------MADHDEFLNEVLALKEI 656 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~~--------------------~~~~~~~~~E~~~l~~l 656 (848)
-|++.+.||+|+||.||+|.. .+|+. ||||+++....... ......+.+|+++++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367788999999999999987 67888 99999755421100 01123578899999999
Q ss_pred CCCcc--cceEEEeecCCeeEEEEeccCC-C----CHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEE
Q 038003 657 RHRNN--VKFHGFCYNGPHSFLVCEYLDR-G----SLARILGDDVTAKELGWNRRINVIKGVANALSYLH-HDCLPSIIH 728 (848)
Q Consensus 657 ~hp~i--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH-~~~~~~ivH 728 (848)
.|+++ +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.|+.||| +. ||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 88864 344442 356899999942 3 66665422 123456789999999999999 88 9999
Q ss_pred cCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 729 RDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 729 ~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999765
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=9.6e-18 Score=165.58 Aligned_cols=110 Identities=25% Similarity=0.307 Sum_probs=53.1
Q ss_pred CCcEEeccCCcccccccc-cccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEc
Q 038003 80 HLANLNLSFNLFFGNIPL-QIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLAL 158 (848)
Q Consensus 80 ~l~~L~l~~n~~~~~~p~-~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 158 (848)
++++|+|++|.+++..|. .|+.+++|++|+|++|++++..|..|+++++|++|+|++|+|++..|..|..+++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 445555555555433332 2445555555555555555444445555555555555555555444444444444444444
Q ss_pred CCCcCCCCCCCcccCccccceEEeecccccC
Q 038003 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG 189 (848)
Q Consensus 159 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 189 (848)
++|+|++..|..+..+++|++|+|++|.+++
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 4444444444444444444444444444443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=163.78 Aligned_cols=131 Identities=28% Similarity=0.348 Sum_probs=89.9
Q ss_pred cEEeccCCcccccccccccCCCCCcEEEccccCCCCCCch-hhhccccccEEEecccCcCCCCCccccCcCCccEEEcCC
Q 038003 82 ANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPP-EIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160 (848)
Q Consensus 82 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 160 (848)
+.+++++|.++ .+|..+.. +|++|+|++|++++..|. .|+++++|++|+|++|++++..|..|+.+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56777777773 66765543 777777777777765543 367777777777777777766677777777777777777
Q ss_pred CcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccC
Q 038003 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSI 215 (848)
Q Consensus 161 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 215 (848)
|+|++..|..|+++++|++|+|++|++++.+|..|+.+++|++|+|++|.+++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 7777666666666777777777777776666666666666666666666666443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=159.95 Aligned_cols=133 Identities=23% Similarity=0.234 Sum_probs=87.0
Q ss_pred CCCCcEEeccCCccc-ccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEE
Q 038003 78 FPHLANLNLSFNLFF-GNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKL 156 (848)
Q Consensus 78 l~~l~~L~l~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 156 (848)
.++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 356777777777776 66777677777777777777777654 566777777777777777776666666666677777
Q ss_pred EcCCCcCCCC-CCCcccCccccceEEeecccccCCCc---cccccccccccccccccccc
Q 038003 157 ALCHNNLHGS-IPSSLGNLSNLAVLYLYKNSLSGSIP---SIIGKLKSLLQLDLSENQFS 212 (848)
Q Consensus 157 ~L~~n~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~ 212 (848)
+|++|++++. .+..++.+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 7777766642 11456666666666666666664333 35556666666666666555
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=7e-18 Score=181.99 Aligned_cols=103 Identities=17% Similarity=0.122 Sum_probs=72.2
Q ss_pred CCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCcc-EEEccCCccCCCCcccccccccccEE
Q 038003 336 HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQ-VLDLSSNHIVGKIPVQLEMLSSLNKL 414 (848)
Q Consensus 336 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~~~~l~~l~~L~~L 414 (848)
+++|+.|+|++|+++.+...+|.++.+|+.+++.+| +..+.+..|.++++|+ .+++.+ .++.+.+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 456666666666666666666666666777776666 5555566677777777 777776 6665666777777777777
Q ss_pred EccCCcCCCCCCcccCCCCccCeEec
Q 038003 415 ILNLNQLSGGVPLEFGSLTKLQYLDL 440 (848)
Q Consensus 415 ~L~~N~l~~~~~~~~~~l~~L~~L~L 440 (848)
+++.|+++...+.+|.++++|+.++.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EeCCCccCccchhhhcCCcchhhhcc
Confidence 77777777666777777777777653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.8e-18 Score=185.06 Aligned_cols=262 Identities=14% Similarity=0.037 Sum_probs=169.0
Q ss_pred cccccccccccccccCcCCCcccC-CCCCceEEccCcccc--ccCcccccCCCCCccccccccccccccCCccceeeccc
Q 038003 246 LKSLSALGLHINQLNGFIPPSIGN-LSSLRVLYLYNNGLY--GFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQ 322 (848)
Q Consensus 246 l~~L~~L~l~~N~l~~~~p~~l~~-l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~ 322 (848)
+.+++.|.++++- ...--..+.. +++|+.|||++|++. ......+ +.+..+.+..|
T Consensus 24 ~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~----------------- 82 (329)
T 3sb4_A 24 ANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMAN----------------- 82 (329)
T ss_dssp HHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTT-----------------
T ss_pred hCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccc-----------------
Confidence 5667777777642 1111112333 667888888888776 2111111 11222333332
Q ss_pred cCCCCccccccCC--------CCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccC
Q 038003 323 NNLSGKMYEAFGD--------HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSS 394 (848)
Q Consensus 323 n~l~~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~ 394 (848)
.++..+|.+ +++|+.|+|.+ .++.+...+|.++++|+.+++..|.+....+..|..+.++..+.+..
T Consensus 83 ----~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 83 ----FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp ----EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTC
T ss_pred ----ccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcc
Confidence 223345555 77888888877 77777777777788888888888877766677777777777776665
Q ss_pred Ccc----CCCCccccccccccc--------------------------EEEccCCcCCCCCCccc-CCCCccCeEeccCc
Q 038003 395 NHI----VGKIPVQLEMLSSLN--------------------------KLILNLNQLSGGVPLEF-GSLTKLQYLDLSTN 443 (848)
Q Consensus 395 N~l----~~~~~~~l~~l~~L~--------------------------~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N 443 (848)
+.. .......|.++..|+ .+.+.++-.. .....+ ..+++|+.|+|++|
T Consensus 158 ~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n 236 (329)
T 3sb4_A 158 SDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKT 236 (329)
T ss_dssp THHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTB
T ss_pred hhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCC
Confidence 322 222333444444444 3333222110 000011 12578888888888
Q ss_pred ccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccc-eecccCcccCcCCCccccCCCCCccccCCCCcccCCCc
Q 038003 444 KLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS-ELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIP 522 (848)
Q Consensus 444 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 522 (848)
+++.+.+.+|.++++|+.|+|.+| ++.+.+..|.++.+|+ .|++.+ .++...+..|.++++|+.|++++|+++.+.+
T Consensus 237 ~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~ 314 (329)
T 3sb4_A 237 NATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGD 314 (329)
T ss_dssp CCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECT
T ss_pred CcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccch
Confidence 888777778888888888888887 7777778888888888 888888 6776777888888888888888888888888
Q ss_pred chhccccCceeecC
Q 038003 523 RCFEEMRSLSCIDI 536 (848)
Q Consensus 523 ~~~~~l~~L~~l~l 536 (848)
.+|.++++|+.++.
T Consensus 315 ~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 315 ELFGNGVPSKLIYK 328 (329)
T ss_dssp TTTCTTCCCCEEEC
T ss_pred hhhcCCcchhhhcc
Confidence 88888888888763
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.2e-17 Score=157.36 Aligned_cols=133 Identities=23% Similarity=0.212 Sum_probs=96.6
Q ss_pred CCCCcEEEccccCCC-CCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceE
Q 038003 102 LSKLQYLDLGSNQLS-GLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVL 180 (848)
Q Consensus 102 l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 180 (848)
.++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 478888999988887 67788888888888888888888854 667777777777777777776666666667777777
Q ss_pred EeecccccCCC-cccccccccccccccccccccccCc---ccccCCcccceeeccccCCC
Q 038003 181 YLYKNSLSGSI-PSIIGKLKSLLQLDLSENQFSGSIP---LSLGNLSSLTMMSLFNNSLS 236 (848)
Q Consensus 181 ~l~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~l~~n~l~ 236 (848)
++++|++++.. +..++.+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 77777777432 2566667777777777777764433 35666666666666666665
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.5e-17 Score=155.40 Aligned_cols=128 Identities=21% Similarity=0.251 Sum_probs=91.8
Q ss_pred CCCCcEEeccCCccc-ccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEE
Q 038003 78 FPHLANLNLSFNLFF-GNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKL 156 (848)
Q Consensus 78 l~~l~~L~l~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 156 (848)
.++|+.|++++|.++ +.+|..++.+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..++.+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 466778888888887 67777777888888888888887765 667777788888888888776677777777777777
Q ss_pred EcCCCcCCCC-CCCcccCccccceEEeecccccCCCc---ccccccccccccccc
Q 038003 157 ALCHNNLHGS-IPSSLGNLSNLAVLYLYKNSLSGSIP---SIIGKLKSLLQLDLS 207 (848)
Q Consensus 157 ~L~~n~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~L~ 207 (848)
++++|++++. .|..++++++|++|++++|.+++..+ ..++.+++|++|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 7777777752 33566677777777777777765444 356666666666665
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=150.82 Aligned_cols=129 Identities=22% Similarity=0.291 Sum_probs=105.1
Q ss_pred cccccEEEccCCcCC-CCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhccccee
Q 038003 408 LSSLNKLILNLNQLS-GGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSEL 486 (848)
Q Consensus 408 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 486 (848)
.++|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..++.+++|++|+|++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 366777777777777 66777778888888888888888765 678888888888888888887788888888889999
Q ss_pred cccCcccCcC-CCccccCCCCCccccCCCCcccCCCc---chhccccCceeecCCC
Q 038003 487 DLSHNILQEE-IPPQVCNMGSLEKLNLSHNNLSDFIP---RCFEEMRSLSCIDISY 538 (848)
Q Consensus 487 ~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~l~ls~ 538 (848)
++++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999988763 34778889999999999999988665 5788899999998864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.7e-16 Score=151.32 Aligned_cols=134 Identities=26% Similarity=0.303 Sum_probs=87.6
Q ss_pred CccCceEEcCCCCceEEEeccccCccccccCCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCch
Q 038003 42 CSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPP 121 (848)
Q Consensus 42 c~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 121 (848)
|.|.+|.|+... ++ .+| ....++|+.|++++|.+++..+..|+.+++|++|+|++|++++..+.
T Consensus 7 C~~~~l~~~~~~--l~-----------~~p---~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (177)
T 2o6r_A 7 CSGTEIRCNSKG--LT-----------SVP---TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG 70 (177)
T ss_dssp EETTEEECCSSC--CS-----------SCC---TTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred eCCCEEEecCCC--Cc-----------cCC---CCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh
Confidence 789999997532 11 111 12235677777777777765555667777777777777777765555
Q ss_pred hhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCC
Q 038003 122 EIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSI 191 (848)
Q Consensus 122 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 191 (848)
.|+++++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|++++|.+++..
T Consensus 71 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 71 VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred HccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 6677777777777777777655555666777777777777776444444566666777777766666443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=6e-16 Score=152.64 Aligned_cols=109 Identities=23% Similarity=0.317 Sum_probs=58.9
Q ss_pred CCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEe
Q 038003 103 SKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182 (848)
Q Consensus 103 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l 182 (848)
++|++|+|++|+++ .+|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 35555555555555 34555555555555555555555444455555555555555555555444445555555555555
Q ss_pred ecccccCCCccccccccccccccccccccc
Q 038003 183 YKNSLSGSIPSIIGKLKSLLQLDLSENQFS 212 (848)
Q Consensus 183 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 212 (848)
++|++++..+..|..+++|++|+|++|.+.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 555555433344555555555555555544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=8.5e-17 Score=172.64 Aligned_cols=143 Identities=13% Similarity=0.114 Sum_probs=102.5
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCc----------hhHHH--------HHHHHHHHhcCCCCc
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNM----------ADHDE--------FLNEVLALKEIRHRN 660 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~--------~~~E~~~l~~l~hp~ 660 (848)
.-|.+...||+|+||.||+|...+|+.||||+++........ ..... ..+|...+.++.+++
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348999999999999999999889999999997653221000 00111 234566666665444
Q ss_pred ccceEEEeecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC
Q 038003 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 661 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 740 (848)
+....-+.. ...++||||++|+++.++... .....++.|++.++.+||+. |||||||||.|||+++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 322211111 134799999999888765421 12356889999999999999 9999999999999987
Q ss_pred CC----------CEEEeeccCcccc
Q 038003 741 NF----------EAHVSDFGIAKFV 755 (848)
Q Consensus 741 ~~----------~~kl~DfG~~~~~ 755 (848)
++ .+.|+||+.+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999988654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.8e-16 Score=154.01 Aligned_cols=128 Identities=27% Similarity=0.343 Sum_probs=74.7
Q ss_pred cEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccC
Q 038003 388 QVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNN 467 (848)
Q Consensus 388 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 467 (848)
+++++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46677777766 4444332 45666666666665 44555666666666666666666555555666666666666666
Q ss_pred cCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccC
Q 038003 468 QLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSD 519 (848)
Q Consensus 468 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 519 (848)
+|++..|..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 6665555555555555555555555554444445555555555555555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=9.9e-16 Score=149.04 Aligned_cols=130 Identities=27% Similarity=0.296 Sum_probs=81.5
Q ss_pred cEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCC
Q 038003 82 ANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHN 161 (848)
Q Consensus 82 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 161 (848)
+.+++++|.++ .+|..+. ++|++|++++|++++..+..|+++++|++|+|++|++++..+..++.+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 45566666665 4554332 56777777777777655556677777777777777776555555666666666666666
Q ss_pred cCCCCCCCcccCccccceEEeecccccCCCccccccccccccccccccccccc
Q 038003 162 NLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGS 214 (848)
Q Consensus 162 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 214 (848)
++++..+..+.++++|++|++++|++++..+..+..+++|++|+|++|.+++.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 66655455556666666666666666644444455566666666666666543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4e-18 Score=169.36 Aligned_cols=137 Identities=20% Similarity=0.262 Sum_probs=87.7
Q ss_pred CCCCCCcEEeccCCcccccccc------cccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccC
Q 038003 76 SSFPHLANLNLSFNLFFGNIPL------QIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQ 149 (848)
Q Consensus 76 ~~l~~l~~L~l~~n~~~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 149 (848)
...+.++.++++.+.++|.+|. .++.+++|++|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3445566666666666666665 67777777777777777775 55 6777777777777777776 56666666
Q ss_pred cCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCc-ccccccccccccccccccccccCcc
Q 038003 150 LSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP-SIIGKLKSLLQLDLSENQFSGSIPL 217 (848)
Q Consensus 150 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~ 217 (848)
+++|++|+|++|++++ +| .++.+++|++|++++|++++..+ ..+..+++|++|++++|.+++.+|.
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 6666666666666664 44 45666666666666666663222 3555666666666666666554443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-17 Score=166.04 Aligned_cols=135 Identities=22% Similarity=0.285 Sum_probs=90.0
Q ss_pred ccCCCCCcEEEccccCCCCCCch------hhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCccc
Q 038003 99 IGNLSKLQYLDLGSNQLSGLIPP------EIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLG 172 (848)
Q Consensus 99 ~~~l~~L~~L~Ls~n~l~~~~p~------~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~ 172 (848)
+.....++.++++.+.++|.+|. .++.+++|++|+|++|++++ +| .++.+++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 45567778888888888887776 77788888888888888775 55 6677777777777777776 5666666
Q ss_pred CccccceEEeecccccCCCcccccccccccccccccccccccCc-ccccCCcccceeeccccCCCCC
Q 038003 173 NLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIP-LSLGNLSSLTMMSLFNNSLSGS 238 (848)
Q Consensus 173 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~l~~n~l~~~ 238 (848)
.+++|++|++++|++++ +| .++.+++|++|+|++|++++..+ ..+..+++|++|++++|.+++.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 66677777777777764 34 46666666666666666663221 2455555555555555555443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=9.3e-15 Score=160.92 Aligned_cols=201 Identities=10% Similarity=0.120 Sum_probs=112.4
Q ss_pred cccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCccccccccc
Q 038003 331 EAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSS 410 (848)
Q Consensus 331 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 410 (848)
.+|.++++|+.+++++|+++.....+|. ..+|+.+.+..+ +..+....|.++++|+.+++..| ++.+...+|.+ .+
T Consensus 174 ~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~ 249 (401)
T 4fdw_A 174 DIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SG 249 (401)
T ss_dssp STTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CC
T ss_pred HHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CC
Confidence 4455555555555555555554444444 245555555432 44344455556666666666543 34344444554 55
Q ss_pred ccEEEccCCcCCCCCCcccCCCCccCeEeccCcccC-----CCCCCcccCccccceeccccCcCCCCChhHHhhhcccce
Q 038003 411 LNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLS-----SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSE 485 (848)
Q Consensus 411 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 485 (848)
|+.+.+ .+.++.....+|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|. |.++.+....|.++.+|+.
T Consensus 250 L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~ 327 (401)
T 4fdw_A 250 ITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQ 327 (401)
T ss_dssp CSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCE
T ss_pred ccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccE
Confidence 666666 33344444556666666666666665543 3445566666666666666 3355555566666666666
Q ss_pred ecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhcccc-CceeecCCCC
Q 038003 486 LDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMR-SLSCIDISYN 539 (848)
Q Consensus 486 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~l~ls~N 539 (848)
++|..| ++......|.++ +|+.+++++|.+....+..|..++ .++.+++..|
T Consensus 328 l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~ 380 (401)
T 4fdw_A 328 LTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAE 380 (401)
T ss_dssp EEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGG
T ss_pred EEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHH
Confidence 666444 544455566666 666666666666655555565553 4555554443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=2e-15 Score=146.75 Aligned_cols=131 Identities=19% Similarity=0.246 Sum_probs=64.6
Q ss_pred cCCCCCCcEEeccCCcccccccccccCCC-CCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCc
Q 038003 75 FSSFPHLANLNLSFNLFFGNIPLQIGNLS-KLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLI 153 (848)
Q Consensus 75 ~~~l~~l~~L~l~~n~~~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 153 (848)
+...++|+.|++++|.++ .+|. +..+. +|++|+|++|++++. +.|+.+++|++|+|++|++++..|..++.+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 344455555555555555 2332 33333 555555555555543 345555555555555555553322333555555
Q ss_pred cEEEcCCCcCCCCCCC--cccCccccceEEeecccccCCCccc----ccccccccccccccccc
Q 038003 154 DKLALCHNNLHGSIPS--SLGNLSNLAVLYLYKNSLSGSIPSI----IGKLKSLLQLDLSENQF 211 (848)
Q Consensus 154 ~~L~L~~n~l~~~~p~--~l~~l~~L~~L~l~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l 211 (848)
++|+|++|+++ .+|. .++.+++|++|++++|.++ .+|.. ++.+++|++|++++|.+
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 55555555553 3443 4445555555555555554 23332 44445555555554444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=3.4e-15 Score=145.02 Aligned_cols=132 Identities=19% Similarity=0.211 Sum_probs=82.8
Q ss_pred ccccccccEEEccCCcCCCCCCcccCCCC-ccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhccc
Q 038003 405 LEMLSSLNKLILNLNQLSGGVPLEFGSLT-KLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHL 483 (848)
Q Consensus 405 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 483 (848)
+..+++|+.|++++|+++. +|. +..+. +|++|++++|+|++. ..|+.+++|++|+|++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 3344455555555555552 232 33333 666666666666643 456666677777777777765555556777777
Q ss_pred ceecccCcccCcCCCc--cccCCCCCccccCCCCcccCCCcc----hhccccCceeecCCCCccC
Q 038003 484 SELDLSHNILQEEIPP--QVCNMGSLEKLNLSHNNLSDFIPR----CFEEMRSLSCIDISYNELH 542 (848)
Q Consensus 484 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~l~ls~N~l~ 542 (848)
++|+|++|+|+ .+|. .+..+++|+.|++++|+++. .|. .+..+++|+.+|+++|...
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 77777777774 3444 66777777777777777765 344 3777788888888777664
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.5e-14 Score=157.47 Aligned_cols=89 Identities=10% Similarity=0.166 Sum_probs=45.8
Q ss_pred CcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCC
Q 038003 426 PLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMG 505 (848)
Q Consensus 426 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 505 (848)
+.+|.++++|+.++|. |.++.+...+|.++++|+.++|.+| ++.+.+.+|.++ +|+.+++++|.+....+..|..++
T Consensus 293 ~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~ 369 (401)
T 4fdw_A 293 PYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFP 369 (401)
T ss_dssp TTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSC
T ss_pred HHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCC
Confidence 3445555555555555 2344444455555555555555333 444444555555 555555555555444445555553
Q ss_pred -CCccccCCCCcc
Q 038003 506 -SLEKLNLSHNNL 517 (848)
Q Consensus 506 -~L~~L~Ls~N~l 517 (848)
+++.|++..|.+
T Consensus 370 ~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 370 DDITVIRVPAESV 382 (401)
T ss_dssp TTCCEEEECGGGH
T ss_pred CCccEEEeCHHHH
Confidence 555666555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.9e-13 Score=149.60 Aligned_cols=330 Identities=11% Similarity=0.023 Sum_probs=166.9
Q ss_pred CCccCCCCCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcC
Q 038003 72 DFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLS 151 (848)
Q Consensus 72 ~~~~~~l~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 151 (848)
+.+|.++.+|+.+.+..+ ++..-..+|.++++|+.++|.++ ++.+-..+|.++++|+.+.+..+ +...-...|....
T Consensus 64 ~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 334555666666666432 43223345556666666666543 33233345555555555544432 2212223333333
Q ss_pred CccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeecc
Q 038003 152 LIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLF 231 (848)
Q Consensus 152 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 231 (848)
.+.......... .-...|.++++|+.+.+.++. .+ .....|.++++|+.+.+.
T Consensus 141 ~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~------------------------~~-I~~~~F~~c~~L~~i~l~ 193 (394)
T 4fs7_A 141 FKEITIPEGVTV--IGDEAFATCESLEYVSLPDSM------------------------ET-LHNGLFSGCGKLKSIKLP 193 (394)
T ss_dssp CSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTC------------------------CE-ECTTTTTTCTTCCBCCCC
T ss_pred ccccccCccccc--cchhhhcccCCCcEEecCCcc------------------------ce-eccccccCCCCceEEEcC
Confidence 222222111111 112334444445554444332 11 223334444444444444
Q ss_pred ccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccccccccccc
Q 038003 232 NNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVI 311 (848)
Q Consensus 232 ~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 311 (848)
.| ++......+.++..|+.+.+..+... +........+|+.+.+..+ +.......+..+..|+.+.+..+...
T Consensus 194 ~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~--- 266 (394)
T 4fs7_A 194 RN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR--- 266 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE---
T ss_pred CC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce---
Confidence 43 22122334444555555554444322 1122223345555555432 22223334455555555554433211
Q ss_pred CCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEE
Q 038003 312 PHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLD 391 (848)
Q Consensus 312 p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~ 391 (848)
+....|..+..++.+....+.+. ...|..+.+|+.+.+..+ +..+....|.++++|+.++
T Consensus 267 ----------------i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~ 326 (394)
T 4fs7_A 267 ----------------IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSID 326 (394)
T ss_dssp ----------------ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEEC
T ss_pred ----------------eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEE
Confidence 22234555555666555544322 334556666666666544 4434456677778888888
Q ss_pred ccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCcccccee
Q 038003 392 LSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYL 462 (848)
Q Consensus 392 Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 462 (848)
|..+ ++.+...+|.++++|+.+.+..| ++.....+|.++.+|+.+++..+ ++ .+..+|.++++|+.+
T Consensus 327 lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 327 LPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred eCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 8644 66556677888888888888766 66566778888888888888765 33 334678888888765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.8e-13 Score=149.72 Aligned_cols=330 Identities=12% Similarity=0.035 Sum_probs=163.1
Q ss_pred CccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCc
Q 038003 144 PPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLS 223 (848)
Q Consensus 144 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 223 (848)
..+|.++++|+.+.|..+ ++..-..+|.++++|+.+++..+ ++......|.++.+|+.+.+..+ +.......|.++.
T Consensus 64 ~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 456777888888888643 55333456777788888877654 44333456677777777666543 3323333444443
Q ss_pred ccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccc
Q 038003 224 SLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELC 303 (848)
Q Consensus 224 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 303 (848)
.+.......... .....|.++++|+.+.+..+. ......+|.++.+|+.+++..| +.......
T Consensus 141 ~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~------------- 203 (394)
T 4fs7_A 141 FKEITIPEGVTV--IGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYC------------- 203 (394)
T ss_dssp CSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTT-------------
T ss_pred ccccccCccccc--cchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchh-------------
Confidence 322222211111 112334444444444444332 1122334444444444444333 22222333
Q ss_pred ccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCC
Q 038003 304 TNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGN 383 (848)
Q Consensus 304 ~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~ 383 (848)
|.++..|+.+.+..+... . ...+....+|+.+.+..+ +.......+..
T Consensus 204 -----------------------------F~~~~~L~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~ 251 (394)
T 4fs7_A 204 -----------------------------FAECILLENMEFPNSLYY-L-GDFALSKTGVKNIIIPDS-FTELGKSVFYG 251 (394)
T ss_dssp -----------------------------TTTCTTCCBCCCCTTCCE-E-CTTTTTTCCCCEEEECTT-CCEECSSTTTT
T ss_pred -----------------------------hccccccceeecCCCceE-e-ehhhcccCCCceEEECCC-ceecccccccc
Confidence 334444444443333211 0 111112233444443322 11122334555
Q ss_pred CCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceec
Q 038003 384 SPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLN 463 (848)
Q Consensus 384 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 463 (848)
+..|+.+.+..+... .....|..+..++.+....+.+. ...|....+|+.+.+..+ ++.+...+|.++.+|+.++
T Consensus 252 ~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~ 326 (394)
T 4fs7_A 252 CTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSID 326 (394)
T ss_dssp CSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEEC
T ss_pred cccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEE
Confidence 556666666555433 44445555566666655554432 334555666666666544 4444555666666666666
Q ss_pred cccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceee
Q 038003 464 LSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCI 534 (848)
Q Consensus 464 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l 534 (848)
|.++ ++.+...+|.++.+|+.+++..| ++.....+|.++.+|+.+++..+ ++. +..+|.++++|+.+
T Consensus 327 lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~~-~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 327 LPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LEQ-YRYDFEDTTKFKWI 393 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GGG-GGGGBCTTCEEEEE
T ss_pred eCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CEE-hhheecCCCCCcEE
Confidence 6533 55455556666666666666555 54444556666666666666543 222 23456666666543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-13 Score=132.34 Aligned_cols=103 Identities=29% Similarity=0.347 Sum_probs=69.6
Q ss_pred EeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcC
Q 038003 84 LNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNL 163 (848)
Q Consensus 84 L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 163 (848)
+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|
T Consensus 14 l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 14 VDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 344444444 3555443 6677777777777776677777777777777777777755555667777777777777777
Q ss_pred CCCCCCcccCccccceEEeecccccC
Q 038003 164 HGSIPSSLGNLSNLAVLYLYKNSLSG 189 (848)
Q Consensus 164 ~~~~p~~l~~l~~L~~L~l~~N~l~~ 189 (848)
++..+..|.++++|++|+|++|.++.
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 75555567777777777777777764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=133.50 Aligned_cols=103 Identities=27% Similarity=0.381 Sum_probs=76.9
Q ss_pred EEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCc
Q 038003 83 NLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNN 162 (848)
Q Consensus 83 ~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 162 (848)
.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4566666663 5676664 778888888888887777788888888888888888886555556778888888888888
Q ss_pred CCCCCCCcccCccccceEEeeccccc
Q 038003 163 LHGSIPSSLGNLSNLAVLYLYKNSLS 188 (848)
Q Consensus 163 l~~~~p~~l~~l~~L~~L~l~~N~l~ 188 (848)
|++..+..|.++++|++|+|++|.+.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cceeCHHHhccccCCCEEEeCCCCcc
Confidence 87544455777888888888888777
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=133.33 Aligned_cols=105 Identities=29% Similarity=0.302 Sum_probs=54.3
Q ss_pred cEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCc
Q 038003 412 NKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHN 491 (848)
Q Consensus 412 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 491 (848)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 34444444444 2333321 44555555555555555555555555555555555555444444555555555555555
Q ss_pred ccCcCCCccccCCCCCccccCCCCcccC
Q 038003 492 ILQEEIPPQVCNMGSLEKLNLSHNNLSD 519 (848)
Q Consensus 492 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 519 (848)
+|++..+..|..+++|++|+|++|+++.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 5554444445555555555555555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.6e-13 Score=132.64 Aligned_cols=104 Identities=24% Similarity=0.323 Sum_probs=72.8
Q ss_pred cEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecc
Q 038003 106 QYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKN 185 (848)
Q Consensus 106 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N 185 (848)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 67888888876 5666554 67778888887777766777777777777777777777544445567777777777777
Q ss_pred cccCCCccccccccccccccccccccc
Q 038003 186 SLSGSIPSIIGKLKSLLQLDLSENQFS 212 (848)
Q Consensus 186 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 212 (848)
++++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 777554455666666777777666666
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=141.90 Aligned_cols=92 Identities=23% Similarity=0.233 Sum_probs=57.5
Q ss_pred ccccccCCCCCcEEEccc-cCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccC
Q 038003 95 IPLQIGNLSKLQYLDLGS-NQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGN 173 (848)
Q Consensus 95 ~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 173 (848)
||. |+.+++|++|+|++ |.|++..|..|++|++|++|+|++|+|++..|..|+.|++|++|+|++|+|++..+..+..
T Consensus 24 ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 102 (347)
T 2ifg_A 24 LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG 102 (347)
T ss_dssp TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS
T ss_pred cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHccc
Confidence 555 66666666666664 6666655566666666666666666666666666666666666666666666433344444
Q ss_pred ccccceEEeeccccc
Q 038003 174 LSNLAVLYLYKNSLS 188 (848)
Q Consensus 174 l~~L~~L~l~~N~l~ 188 (848)
++ |+.|+|.+|.+.
T Consensus 103 ~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 103 LS-LQELVLSGNPLH 116 (347)
T ss_dssp CC-CCEEECCSSCCC
T ss_pred CC-ceEEEeeCCCcc
Confidence 44 777777777766
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.9e-14 Score=156.94 Aligned_cols=182 Identities=18% Similarity=0.178 Sum_probs=91.5
Q ss_pred CCCcEEEccccCCCCCCchhhhcc-----ccccEEEecccCcCCCCCccc-cCcCCccEEEcCCCcCCCCCCCcc-----
Q 038003 103 SKLQYLDLGSNQLSGLIPPEIGKL-----NQLRRLYLDMNQLHGTIPPEI-GQLSLIDKLALCHNNLHGSIPSSL----- 171 (848)
Q Consensus 103 ~~L~~L~Ls~n~l~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~p~~l----- 171 (848)
+.|++|+|++|.++......+..+ ++|++|+|++|.++......+ ..+++|++|+|++|.++..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 445555555555554333333322 455555555555543222222 224455566666665543222222
Q ss_pred cCccccceEEeecccccCC----Cccccccccccccccccccccccc----CcccccCCcccceeeccccCCCCC----C
Q 038003 172 GNLSNLAVLYLYKNSLSGS----IPSIIGKLKSLLQLDLSENQFSGS----IPLSLGNLSSLTMMSLFNNSLSGS----I 239 (848)
Q Consensus 172 ~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~n~l~~~----~ 239 (848)
...++|++|+|++|.++.. ++..+..+++|++|+|++|+++.. ++..+...++|+.|+|++|.|++. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 1235566666666666531 233345556666666666666532 234455566677777777776642 2
Q ss_pred CCcccCcccccccccccccccCcCCCcccCCC-----CCceEE--ccCcccc
Q 038003 240 PPILGNLKSLSALGLHINQLNGFIPPSIGNLS-----SLRVLY--LYNNGLY 284 (848)
Q Consensus 240 p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~-----~L~~L~--Ls~N~l~ 284 (848)
+..+...++|++|+|++|.|+......+..+. .|+.+. +..|.+.
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 23344456677777777777654444443321 155555 5555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=5e-14 Score=153.52 Aligned_cols=165 Identities=19% Similarity=0.186 Sum_probs=78.2
Q ss_pred ccccEeecccccccCCCCCCCC-----CCCCccEEEccCCccCCCCcccc-cccccccEEEccCCcCCCCCCccc-----
Q 038003 361 SKLSTFIVSMNNISGSIPPDIG-----NSPKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLSGGVPLEF----- 429 (848)
Q Consensus 361 ~~L~~L~l~~N~i~~~~p~~l~-----~l~~L~~L~Ls~N~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~~~~~----- 429 (848)
+.|+.|++++|.++......+. ..++|++|+|++|.|+......+ ..+++|+.|+|++|.|++.....+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 4566666666665532222211 12456666666666653322222 234556666666666553322222
Q ss_pred CCCCccCeEeccCcccCCC----CCCcccCccccceeccccCcCCCCC----hhHHhhhcccceecccCcccCcC----C
Q 038003 430 GSLTKLQYLDLSTNKLSSS----IPKSIGNLLKLHYLNLSNNQLSHKI----PTEFEKLIHLSELDLSHNILQEE----I 497 (848)
Q Consensus 430 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~ 497 (848)
...++|+.|+|++|.|+.. ++..+..+++|++|+|++|+|++.. +..+...++|++|+|++|.|++. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 1234556666666655431 2223344555555666665554322 23334445555555555555432 1
Q ss_pred CccccCCCCCccccCCCCcccCCCcchh
Q 038003 498 PPQVCNMGSLEKLNLSHNNLSDFIPRCF 525 (848)
Q Consensus 498 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 525 (848)
+..+...++|++|+|++|.|+......+
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 2223334555555555555554433333
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.29 E-value=9.9e-11 Score=129.18 Aligned_cols=132 Identities=9% Similarity=0.157 Sum_probs=66.8
Q ss_pred CCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCcc
Q 038003 378 PPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL 457 (848)
Q Consensus 378 p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 457 (848)
...|..+++|+.+.+..+..+ ....+|.++++|+.+.+. +.++.....+|.++.+|+.+++..+ ++.+...+|.++.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 344555555666655544332 344455555666666654 3344344555666666666666543 4444455666666
Q ss_pred ccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCc
Q 038003 458 KLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNN 516 (848)
Q Consensus 458 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 516 (848)
+|+.+.+..+ ++.+...+|.++.+|+.+++.+|.... ..+....+|+.+.+..|.
T Consensus 335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC---------
T ss_pred CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence 6666666443 554555566666666666666654421 344555556665555443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.9e-11 Score=132.51 Aligned_cols=130 Identities=22% Similarity=0.157 Sum_probs=93.0
Q ss_pred eecccc-cccCCCCCCCCCCCCccEEEccC-CccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCc
Q 038003 366 FIVSMN-NISGSIPPDIGNSPKLQVLDLSS-NHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTN 443 (848)
Q Consensus 366 L~l~~N-~i~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 443 (848)
++++++ .++ .+|. +..+++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 344444 455 4667 88888888888885 8888777788888888888888888888888888888888888888888
Q ss_pred ccCCCCCCcccCccccceeccccCcCCCCCh-hHHhhhcccceecccCcccCcCCC
Q 038003 444 KLSSSIPKSIGNLLKLHYLNLSNNQLSHKIP-TEFEKLIHLSELDLSHNILQEEIP 498 (848)
Q Consensus 444 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p 498 (848)
+|++..+..|..++ |+.|+|++|.|...-. .+|..+.......+..+.++-..|
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence 88877666676666 8888888888874322 344444433444444444443333
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.5e-11 Score=126.02 Aligned_cols=145 Identities=14% Similarity=0.048 Sum_probs=112.7
Q ss_pred hhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~ 675 (848)
.-..|++...++.|+.+.||++... +..+++|+...... .....+.+|+++++.+. +..+.++++++.+.+..|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 3456888888999999999999764 68899999865321 11234788999998884 677889999999888999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC--------------------------------- 722 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~--------------------------------- 722 (848)
+||||++|.++.+.+... .....++.++++++..||+..
T Consensus 87 lv~e~i~G~~l~~~~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHCCTT--------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEecCCeehhhccCCc--------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999999998764211 123468899999999999810
Q ss_pred -----------------------CCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 723 -----------------------LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 723 -----------------------~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
.+.++|||++|.||+++++..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13689999999999998766667999987753
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.20 E-value=3.6e-10 Score=124.66 Aligned_cols=138 Identities=13% Similarity=0.126 Sum_probs=95.8
Q ss_pred CCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccc
Q 038003 326 SGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQL 405 (848)
Q Consensus 326 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l 405 (848)
+.+...+|..+..|+.+.+.++. ......+|.+++.|+.+.+. +.+.......|.++++|+.++|..+ ++.+...+|
T Consensus 254 ~~i~~~aF~~c~~L~~i~lp~~~-~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF 330 (394)
T 4gt6_A 254 ARIETHAFDSCAYLASVKMPDSV-VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAF 330 (394)
T ss_dssp EEECTTTTTTCSSCCEEECCTTC-CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred eEcccceeeecccccEEeccccc-ceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHh
Confidence 34455678888888888887654 34566778888888888885 4455455667888899999999765 665667789
Q ss_pred cccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCC
Q 038003 406 EMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLS 470 (848)
Q Consensus 406 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 470 (848)
.++++|+.+.+..+ ++.....+|.++++|+.+++.+|.... ..+....+|+.+.+..|.+.
T Consensus 331 ~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 331 AGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp TTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred hCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 99999999999755 666777889999999999999886541 45677788988888877653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.10 E-value=6e-13 Score=136.09 Aligned_cols=149 Identities=16% Similarity=0.128 Sum_probs=70.9
Q ss_pred CCCccCceEEcCCCCceEEEeccc---cCccccccCCccCCCCCCcEEeccCCcccccccc-cccCCCCCcE--EEcccc
Q 038003 40 SPCSWFGISCNHAGSRVISITMST---LGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPL-QIGNLSKLQY--LDLGSN 113 (848)
Q Consensus 40 ~~c~w~gv~C~~~~~~v~~l~l~~---~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p~-~~~~l~~L~~--L~Ls~n 113 (848)
..|.|.|+.|+..+.+|+.+...+ .++.|.+.+..+..++. .|...+|..++.++- .+...+.|+. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 468899999997766776665544 33444443222111111 112222222222221 1333444444 455555
Q ss_pred CCC---CCCchhhhccccccEEEecccCcCC--CCCccccCcCCccEEEcCCCcCCCCCCCcccCcc--ccceEEeeccc
Q 038003 114 QLS---GLIPPEIGKLNQLRRLYLDMNQLHG--TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLS--NLAVLYLYKNS 186 (848)
Q Consensus 114 ~l~---~~~p~~~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~--~L~~L~l~~N~ 186 (848)
... +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.
T Consensus 154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Np 231 (267)
T 3rw6_A 154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNS 231 (267)
T ss_dssp SHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTST
T ss_pred HHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCc
Confidence 322 1112122445666666666666665 3344445555555555555555532 2223333 55555555555
Q ss_pred ccCCCc
Q 038003 187 LSGSIP 192 (848)
Q Consensus 187 l~~~~p 192 (848)
+++.+|
T Consensus 232 l~~~~~ 237 (267)
T 3rw6_A 232 LCDTFR 237 (267)
T ss_dssp TGGGCS
T ss_pred CccccC
Confidence 554443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.3e-10 Score=120.34 Aligned_cols=138 Identities=14% Similarity=0.094 Sum_probs=101.0
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCc--ccceEEEeecCCeeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN--NVKFHGFCYNGPHSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~~~~~~~~l 676 (848)
..+.+....+.|..+.||++...+|..+++|+.... ....+.+|+++++.+.+.. +.+++++...++..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 344443333466779999998777888999996543 1234678899888885444 5568888888788999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC---------------------------------- 722 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~---------------------------------- 722 (848)
||||++|.++. ... .. ...++.++++.+..||+..
T Consensus 93 v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999998873 211 11 2357788888888888752
Q ss_pred ---------------------CCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 723 ---------------------LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 723 ---------------------~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
..+++|||++|.||++++++.+.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=1e-09 Score=119.37 Aligned_cols=143 Identities=15% Similarity=0.227 Sum_probs=106.3
Q ss_pred ccceeccCCceeEEEEEcCCCCEEEEEEcc--cccccCCchhHHHHHHHHHHHhcCC--CCcccceEEEeecC---CeeE
Q 038003 603 EKFCIGKGGQGSVYKAELPSGDIVAVKKFN--SQLLSGNMADHDEFLNEVLALKEIR--HRNNVKFHGFCYNG---PHSF 675 (848)
Q Consensus 603 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~---~~~~ 675 (848)
..+.++.|.++.||++... +..+++|+.. .... ......+.+|+++++.+. +..+++++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3567999999999999876 4678899875 3211 122346778999999886 44578899988776 4589
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC--------------------------------- 722 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~--------------------------------- 722 (848)
+||||++|..+.+.. ...++..++..++.+++++|..||+..
T Consensus 118 ~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999999997764321 134667788899999999999999731
Q ss_pred ----------------------CCCeEEcCCCCCCeeeCCCCC--EEEeeccCccc
Q 038003 723 ----------------------LPSIIHRDISSKNVLLDSNFE--AHVSDFGIAKF 754 (848)
Q Consensus 723 ----------------------~~~ivH~Dlk~~NIll~~~~~--~kl~DfG~~~~ 754 (848)
.+.+||||+++.||+++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.99 E-value=5.6e-11 Score=128.23 Aligned_cols=62 Identities=21% Similarity=0.288 Sum_probs=29.6
Q ss_pred CchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCccc--CccccceEEee
Q 038003 119 IPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLG--NLSNLAVLYLY 183 (848)
Q Consensus 119 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~l~ 183 (848)
++..+..+++|+.|+|++|.-. .+|. + .+++|++|+|..|.+.......++ .+++|++|+|+
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred HHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 3444555666666666655211 1222 2 245556666655554422222222 45566666654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.3e-08 Score=111.53 Aligned_cols=146 Identities=13% Similarity=0.135 Sum_probs=83.5
Q ss_pred CCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccc
Q 038003 379 PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLK 458 (848)
Q Consensus 379 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 458 (848)
..+....+|+.+.+..+ ++......+.++..|+.+.+..+ ++.....+|.+..+|+.+.+..+ ++.+....|.++.+
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~ 287 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN 287 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence 34445556666666543 33244445566666666666554 44344555666666666666543 44344456666666
Q ss_pred cceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhcccc
Q 038003 459 LHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMR 529 (848)
Q Consensus 459 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 529 (848)
|+.+.+.++.++.+....|.++.+|+.++|..+ ++.....+|.++.+|+.+.+..+ ++.+...+|.++.
T Consensus 288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred cccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 666666666666555566666666666666543 44444456666666666666543 4444455565543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.4e-10 Score=125.15 Aligned_cols=161 Identities=16% Similarity=0.200 Sum_probs=86.6
Q ss_pred hhhccccccEEEecccCcC---------CCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCc
Q 038003 122 EIGKLNQLRRLYLDMNQLH---------GTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192 (848)
Q Consensus 122 ~~~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 192 (848)
++..+++|+.|.+..+... +.++..+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.++....
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l 210 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVV 210 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHH
T ss_pred hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHH
Confidence 3455667777766554321 134455667788888888777311 2333 33 6788888888777654333
Q ss_pred cccc--cccccccccccc--cccccc-----Ccccc--cCCcccceeeccccCCCCCCCCccc---Cccccccccccccc
Q 038003 193 SIIG--KLKSLLQLDLSE--NQFSGS-----IPLSL--GNLSSLTMMSLFNNSLSGSIPPILG---NLKSLSALGLHINQ 258 (848)
Q Consensus 193 ~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~l--~~l~~L~~L~l~~n~l~~~~p~~l~---~l~~L~~L~l~~N~ 258 (848)
..++ .+++|++|+|+. |...+. +...+ ..+++|++|+|.+|.+.+..+..+. .+++|++|+|+.|+
T Consensus 211 ~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~ 290 (362)
T 2ra8_A 211 EDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290 (362)
T ss_dssp HHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSC
T ss_pred HHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCC
Confidence 3343 577788887753 221111 01112 2356666666666666533222221 35566666666666
Q ss_pred ccCc----CCCcccCCCCCceEEccCccccc
Q 038003 259 LNGF----IPPSIGNLSSLRVLYLYNNGLYG 285 (848)
Q Consensus 259 l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 285 (848)
+.+. ++..+..+++|+.|+|++|.++.
T Consensus 291 L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 291 LTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 5542 22223344566666666665543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.4e-08 Score=109.38 Aligned_cols=60 Identities=5% Similarity=0.055 Sum_probs=35.5
Q ss_pred hhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEee
Q 038003 121 PEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183 (848)
Q Consensus 121 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 183 (848)
+.+....+|+.+.+.. .++..-..+|.++.+|+.+.|..+ ++..-...|.+. +|+.+.+.
T Consensus 40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~ 99 (379)
T 4h09_A 40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGM 99 (379)
T ss_dssp TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEEC
T ss_pred cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECC
Confidence 3566777888888864 345334456777777777777543 442223455554 45555554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.9e-09 Score=114.33 Aligned_cols=182 Identities=22% Similarity=0.204 Sum_probs=122.1
Q ss_pred cceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCc--ccceEEEeecCC---eeEEE
Q 038003 604 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRN--NVKFHGFCYNGP---HSFLV 677 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~--iv~l~~~~~~~~---~~~lV 677 (848)
.+.++.|.+..||++. ..+++|+.... .....+.+|.++++.+ .+.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999874 45889985432 3456788999999887 3333 345555543333 34899
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC----------------------------------- 722 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~----------------------------------- 722 (848)
||+++|.++.+... ..++..++..++.|+++.+..||+..
T Consensus 95 m~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 99999987764321 23566777788888888888888611
Q ss_pred --------------------CCCeEEcCCCCCCeeeCC--CCCEEEeeccCccccCCCCCCcccccccccc---cCc---
Q 038003 723 --------------------LPSIIHRDISSKNVLLDS--NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGY---AAP--- 774 (848)
Q Consensus 723 --------------------~~~ivH~Dlk~~NIll~~--~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y---~aP--- 774 (848)
.+.+||+|++|.||++++ ...+.++||+.+..-.+. .+......+ ..|
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~----~Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD----NDFISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT----HHHHTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH----HHHHHHHhhccccCHHHH
Confidence 135899999999999998 456889999998754321 111011111 122
Q ss_pred -------------cccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 775 -------------EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 775 -------------E~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
+.... .....+.|++|.++|.+.+|+.||-
T Consensus 246 ~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 22111 1122589999999999999998853
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.64 E-value=4.7e-09 Score=107.25 Aligned_cols=113 Identities=20% Similarity=0.256 Sum_probs=84.9
Q ss_pred cccccCCccCCCCCCcE--EeccCCc---ccccccccccCCCCCcEEEccccCCCC--CCchhhhccccccEEEecccCc
Q 038003 67 NGTFHDFSFSSFPHLAN--LNLSFNL---FFGNIPLQIGNLSKLQYLDLGSNQLSG--LIPPEIGKLNQLRRLYLDMNQL 139 (848)
Q Consensus 67 ~g~~~~~~~~~l~~l~~--L~l~~n~---~~~~~p~~~~~l~~L~~L~Ls~n~l~~--~~p~~~~~l~~L~~L~L~~n~l 139 (848)
++.++-..|...+.|.. ++++.|. +.+.++....++++|++|+|++|+|++ .+|..+..+++|+.|+|++|+|
T Consensus 129 ~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i 208 (267)
T 3rw6_A 129 QQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL 208 (267)
T ss_dssp TTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCC
T ss_pred ccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCcc
Confidence 33444334566667776 7778884 334444444678999999999999998 4567889999999999999999
Q ss_pred CCCCCccccCcC--CccEEEcCCCcCCCCCCC-------cccCccccceEE
Q 038003 140 HGTIPPEIGQLS--LIDKLALCHNNLHGSIPS-------SLGNLSNLAVLY 181 (848)
Q Consensus 140 ~~~~p~~~~~l~--~L~~L~L~~n~l~~~~p~-------~l~~l~~L~~L~ 181 (848)
++. ..+..++ +|++|+|++|.+.+.+|+ .+..+++|+.||
T Consensus 209 ~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 209 KSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp CSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 965 4455555 999999999999987764 255677777765
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.47 E-value=1.7e-08 Score=98.08 Aligned_cols=89 Identities=10% Similarity=0.150 Sum_probs=52.9
Q ss_pred cCccccceeccccCcCCCC----ChhHHhhhcccceecccCcccCcC----CCccccCCCCCccccC--CCCcccCCC--
Q 038003 454 GNLLKLHYLNLSNNQLSHK----IPTEFEKLIHLSELDLSHNILQEE----IPPQVCNMGSLEKLNL--SHNNLSDFI-- 521 (848)
Q Consensus 454 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~~-- 521 (848)
...++|++|+|++|+|+.. +...+...+.|++|+|++|.|++. +...+...++|++|+| ++|.|+...
T Consensus 62 ~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~ 141 (185)
T 1io0_A 62 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 141 (185)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred HhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH
Confidence 3344555555555555432 223334445666666666666542 2345566677888888 777776543
Q ss_pred --cchhccccCceeecCCCCccC
Q 038003 522 --PRCFEEMRSLSCIDISYNELH 542 (848)
Q Consensus 522 --~~~~~~l~~L~~l~ls~N~l~ 542 (848)
...+...++|+.|++++|.+.
T Consensus 142 ~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 142 EIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCcCEEeccCCCCC
Confidence 334455678888888888774
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.44 E-value=1.6e-08 Score=98.38 Aligned_cols=90 Identities=18% Similarity=0.197 Sum_probs=40.4
Q ss_pred CCCCCCccEEEccCC-ccCCC----CcccccccccccEEEccCCcCCCCC----CcccCCCCccCeEeccCcccCCC---
Q 038003 381 IGNSPKLQVLDLSSN-HIVGK----IPVQLEMLSSLNKLILNLNQLSGGV----PLEFGSLTKLQYLDLSTNKLSSS--- 448 (848)
Q Consensus 381 l~~l~~L~~L~Ls~N-~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~--- 448 (848)
+...++|++|+|++| .|... +...+...++|++|+|++|.|.... ...+...++|++|+|++|.|+..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 334556666666666 55522 2233334455555555555554211 11222234455555555554422
Q ss_pred -CCCcccCccccceecc--ccCcCC
Q 038003 449 -IPKSIGNLLKLHYLNL--SNNQLS 470 (848)
Q Consensus 449 -~p~~~~~l~~L~~L~L--s~N~l~ 470 (848)
+...+...+.|++|+| ++|.|+
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHhCCCceEEEecCCCCCCC
Confidence 1223333344444444 444444
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.1e-06 Score=90.72 Aligned_cols=137 Identities=17% Similarity=0.101 Sum_probs=94.3
Q ss_pred cceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCC---cccceEEEee-cCCeeEEEEe
Q 038003 604 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR---NNVKFHGFCY-NGPHSFLVCE 679 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~l~~~~~-~~~~~~lV~e 679 (848)
.+.++.|....||++ +..+++|+... ......+.+|.++++.+.+. .+.+++.+.. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456899999999998 56688888422 23456788999999998652 3556666664 4456789999
Q ss_pred ccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 038003 680 YLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD-------------------------------------- 721 (848)
Q Consensus 680 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-------------------------------------- 721 (848)
|++|..+.+..- ..++..+...++.++++.+..||+.
T Consensus 94 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 94 KVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred ccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 999987765321 1123344444555555555555532
Q ss_pred -------------------CCCCeEEcCCCCCCeeeCC---CCC-EEEeeccCcccc
Q 038003 722 -------------------CLPSIIHRDISSKNVLLDS---NFE-AHVSDFGIAKFV 755 (848)
Q Consensus 722 -------------------~~~~ivH~Dlk~~NIll~~---~~~-~kl~DfG~~~~~ 755 (848)
..+.+||+|++|.||+++. ++. +.|+||+.+..-
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235799999999999987 455 489999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=4.4e-06 Score=86.53 Aligned_cols=135 Identities=16% Similarity=0.160 Sum_probs=95.5
Q ss_pred eeccCCce-eEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeEEEEeccC
Q 038003 606 CIGKGGQG-SVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 606 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
.+..|..| .||+.... ++..+++|+-... ....+.+|.+.++.+. +--+.+++.++.+.+..++|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 45566666 68998665 4667999985432 3456788999888774 2236788999999999999999999
Q ss_pred CCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 038003 683 RGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC---------------------------------------- 722 (848)
Q Consensus 683 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~---------------------------------------- 722 (848)
|.++.+..... ......+..+++..+.-||...
T Consensus 104 G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 104 GKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp SEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 98877654321 1122345556666666666421
Q ss_pred ---------------CCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 723 ---------------LPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 723 ---------------~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
.+.+||||+.+.||++++++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11369999999999999877778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=2.8e-06 Score=91.91 Aligned_cols=83 Identities=5% Similarity=-0.019 Sum_probs=55.4
Q ss_pred ccee-ccCCceeEEEEEcC-------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-C--CcccceEEEeecC-
Q 038003 604 KFCI-GKGGQGSVYKAELP-------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-H--RNNVKFHGFCYNG- 671 (848)
Q Consensus 604 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--p~iv~l~~~~~~~- 671 (848)
.+.| +.|....+|++... ++..+++|+....... .......+.+|+++++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~-~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDV-PVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGC-CSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcc-ccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 4567 89999999998654 2667899986543200 0001134667888888773 2 3467788877655
Q ss_pred --CeeEEEEeccCCCCHH
Q 038003 672 --PHSFLVCEYLDRGSLA 687 (848)
Q Consensus 672 --~~~~lV~e~~~~gsL~ 687 (848)
+..++||||++|..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=2.8e-05 Score=85.33 Aligned_cols=79 Identities=16% Similarity=0.016 Sum_probs=49.9
Q ss_pred cceeccCCceeEEEEEcC-CCCEEEEEEcccccc-cC-C-chhHHHHHHHHHHHhcCCC--Cc-ccceEEEeecCCeeEE
Q 038003 604 KFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLL-SG-N-MADHDEFLNEVLALKEIRH--RN-NVKFHGFCYNGPHSFL 676 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~-~-~~~~~~~~~E~~~l~~l~h--p~-iv~l~~~~~~~~~~~l 676 (848)
.+.+|.|.++.||++... +++.+++|....... .. . ....+++..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999754 468899998654321 00 0 1123456778888887732 33 4456544 3445689
Q ss_pred EEeccCCC
Q 038003 677 VCEYLDRG 684 (848)
Q Consensus 677 V~e~~~~g 684 (848)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.84 E-value=9.3e-05 Score=77.70 Aligned_cols=139 Identities=18% Similarity=0.136 Sum_probs=91.8
Q ss_pred ccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC---CCcccceEEEeecCCeeEEEEe
Q 038003 603 EKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR---HRNNVKFHGFCYNGPHSFLVCE 679 (848)
Q Consensus 603 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~~~~~~lV~e 679 (848)
..+.|+.|.+..+|++.. ++..+++|+.... ....+.+|.+.++.+. ...+++++.+....+..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 346799999999999986 4678899986432 3566888999888873 3568889998888888999999
Q ss_pred ccCCCCHH--------h---HhcCCCC-------------------cccCCHHHHH---HHH----------------HH
Q 038003 680 YLDRGSLA--------R---ILGDDVT-------------------AKELGWNRRI---NVI----------------KG 710 (848)
Q Consensus 680 ~~~~gsL~--------~---~l~~~~~-------------------~~~l~~~~~~---~i~----------------~q 710 (848)
|++|..+. + .++.... .-.-+|.+.. ++. .+
T Consensus 112 ~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~ 191 (312)
T 3jr1_A 112 ALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDL 191 (312)
T ss_dssp CCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHH
T ss_pred eccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 99987541 1 1111100 0012343321 111 11
Q ss_pred HH-HHHHHHhh-CCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 711 VA-NALSYLHH-DCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 711 ia-~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
++ .....|.. ...+.+||+|+.+.|++++.++ +.|+|++
T Consensus 192 l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 192 IVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 11223432 2245899999999999999887 8999984
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.83 E-value=8.2e-05 Score=79.71 Aligned_cols=141 Identities=19% Similarity=0.260 Sum_probs=79.3
Q ss_pred ceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-----CCcccceE-E--EeecCCeeEE
Q 038003 605 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-----HRNNVKFH-G--FCYNGPHSFL 676 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~l~-~--~~~~~~~~~l 676 (848)
+.|+.|..+.||++...+| .+++|+.... .+.+..|.++++.+. .|.++... + +....+..++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP--------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC--------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC--------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 4567788999999977655 4899987542 123334555544442 34433311 1 1234567899
Q ss_pred EEeccCCCCHH-----------h---Hhc---CCCC-c-------ccCCHHH----------------------------
Q 038003 677 VCEYLDRGSLA-----------R---ILG---DDVT-A-------KELGWNR---------------------------- 703 (848)
Q Consensus 677 V~e~~~~gsL~-----------~---~l~---~~~~-~-------~~l~~~~---------------------------- 703 (848)
||||++|..+. + .++ .... . ....|..
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986432 0 011 1110 0 0012211
Q ss_pred ---HHHHHHHHHHHHHHHhh----------CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 704 ---RINVIKGVANALSYLHH----------DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 704 ---~~~i~~qia~~L~~LH~----------~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
...+..++..++.+|+. ....++||||+++.||+++.++.+.++||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01112234456666653 0134899999999999998888999999998864
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.83 E-value=3.6e-06 Score=79.54 Aligned_cols=87 Identities=14% Similarity=0.130 Sum_probs=56.9
Q ss_pred CccCeEeccCcccCCCCCCcccCccccceeccccCc-CCCCChhHHhhh----cccceecccCcc-cCcCCCccccCCCC
Q 038003 433 TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQ-LSHKIPTEFEKL----IHLSELDLSHNI-LQEEIPPQVCNMGS 506 (848)
Q Consensus 433 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 506 (848)
.+|+.||++++.++...-..+.++++|+.|+|++|. |++..-..+..+ ++|++|+|++|. |++..-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357777777777665555566677777777777774 665444445543 357777777763 66655556667777
Q ss_pred CccccCCCCc-ccC
Q 038003 507 LEKLNLSHNN-LSD 519 (848)
Q Consensus 507 L~~L~Ls~N~-l~~ 519 (848)
|++|+|+++. ++.
T Consensus 141 L~~L~L~~c~~Itd 154 (176)
T 3e4g_A 141 LKYLFLSDLPGVKE 154 (176)
T ss_dssp CCEEEEESCTTCCC
T ss_pred CCEEECCCCCCCCc
Confidence 7777777764 443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.67 E-value=6.9e-06 Score=77.59 Aligned_cols=84 Identities=18% Similarity=0.206 Sum_probs=50.0
Q ss_pred CCccEEEccCCccCCCCcccccccccccEEEccCCc-CCCCCCcccCCC----CccCeEeccCcc-cCCCCCCcccCccc
Q 038003 385 PKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQ-LSGGVPLEFGSL----TKLQYLDLSTNK-LSSSIPKSIGNLLK 458 (848)
Q Consensus 385 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 458 (848)
.+|+.||+++|.|+...-..+..+++|+.|+|++|. +++..-..+..+ ++|++|+|++|. +++..-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467888888887775555556666777777777663 553333333333 256666666653 55444444555666
Q ss_pred cceeccccCc
Q 038003 459 LHYLNLSNNQ 468 (848)
Q Consensus 459 L~~L~Ls~N~ 468 (848)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666664
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=9.4e-05 Score=77.15 Aligned_cols=78 Identities=21% Similarity=0.238 Sum_probs=56.3
Q ss_pred CCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCC---cccceEEEeecCCeeEE
Q 038003 600 DFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR---NNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~l~~~~~~~~~~~l 676 (848)
.+...+.+|.|..+.||+++..+|+.|++|+..... ......+.+|.+.|+.+.-. -+.+++++. ..++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA----PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC----CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC----cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 355567899999999999999999999999865432 22334678899988887422 244555542 3479
Q ss_pred EEeccCCCC
Q 038003 677 VCEYLDRGS 685 (848)
Q Consensus 677 V~e~~~~gs 685 (848)
||||++++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.0003 Score=77.69 Aligned_cols=77 Identities=14% Similarity=0.158 Sum_probs=46.5
Q ss_pred CCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCcccccc--cccccCccccccC---CCCccchhhhHHHHHHHH
Q 038003 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAG--TFGYAAPEIAYTM---RATEKYDVYSFGVLVFEV 798 (848)
Q Consensus 724 ~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~---~~~~~~DiwSlG~il~el 798 (848)
+.++|||++|.||+++.++ ++++||+.+..-.+. ........ ...|.+|+..... ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3899999999999998876 999999988753221 00000111 1245666544311 112234455777777777
Q ss_pred HhCC
Q 038003 799 IKGN 802 (848)
Q Consensus 799 ltg~ 802 (848)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.47 E-value=1.9e-05 Score=76.10 Aligned_cols=63 Identities=13% Similarity=0.162 Sum_probs=29.6
Q ss_pred CCCccEEEccCC-ccCCC----CcccccccccccEEEccCCcCCCCCCc----ccCCCCccCeEeccCcccC
Q 038003 384 SPKLQVLDLSSN-HIVGK----IPVQLEMLSSLNKLILNLNQLSGGVPL----EFGSLTKLQYLDLSTNKLS 446 (848)
Q Consensus 384 l~~L~~L~Ls~N-~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~ 446 (848)
-+.|+.|+|++| +|... +...+...+.|+.|+|++|+|...... .+..-+.|+.|+|+.|+|+
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 345666666654 55421 233444445555555555555422221 2223344555555555554
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.38 E-value=3.8e-05 Score=73.99 Aligned_cols=85 Identities=20% Similarity=0.257 Sum_probs=45.0
Q ss_pred cccceeccccCcCCCC----ChhHHhhhcccceecccCcccCcC----CCccccCCCCCccccCCCC---cccCC----C
Q 038003 457 LKLHYLNLSNNQLSHK----IPTEFEKLIHLSELDLSHNILQEE----IPPQVCNMGSLEKLNLSHN---NLSDF----I 521 (848)
Q Consensus 457 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~~----~ 521 (848)
+.|+.|+|++|+|.+. +.+.+...+.|+.|+|++|.|++. +...+..-+.|++|+|++| .+... +
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i 149 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 149 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence 3344444444444321 223334445555555555555432 1223444456778888754 33321 3
Q ss_pred cchhccccCceeecCCCCcc
Q 038003 522 PRCFEEMRSLSCIDISYNEL 541 (848)
Q Consensus 522 ~~~~~~l~~L~~l~ls~N~l 541 (848)
.+.+...+.|+.|+++.|..
T Consensus 150 a~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 150 MMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCcCeEeccCCCc
Confidence 34566778888888887754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00048 Score=72.24 Aligned_cols=139 Identities=14% Similarity=0.060 Sum_probs=75.1
Q ss_pred cceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcc-cceEEEeecCCeeEEEEecc-
Q 038003 604 KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN-VKFHGFCYNGPHSFLVCEYL- 681 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~~lV~e~~- 681 (848)
.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+....+ .++++++. +.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-----~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-----YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-----eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecC
Confidence 678999999999999 55888987543100 0112457777766632222 46665543 3347899999
Q ss_pred CCCCHHh------------------HhcCCCC--cccCCH-HHHHHHHHH--------------HHHHH----HHHhh-C
Q 038003 682 DRGSLAR------------------ILGDDVT--AKELGW-NRRINVIKG--------------VANAL----SYLHH-D 721 (848)
Q Consensus 682 ~~gsL~~------------------~l~~~~~--~~~l~~-~~~~~i~~q--------------ia~~L----~~LH~-~ 721 (848)
+|.++.. .++.... ...... .....+..+ +.+.+ +.+.. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 5544321 0111100 001111 111111110 11111 11111 1
Q ss_pred CCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 722 CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 722 ~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
..+.+||+|+.+.||+ ..++.+.++||..+..-
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 2235899999999999 56677899999988653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0008 Score=71.64 Aligned_cols=142 Identities=15% Similarity=0.108 Sum_probs=72.6
Q ss_pred ceeccCCcee-EEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-C-CcccceEEEeecCCeeEEEEecc
Q 038003 605 FCIGKGGQGS-VYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-H-RNNVKFHGFCYNGPHSFLVCEYL 681 (848)
Q Consensus 605 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-p~iv~l~~~~~~~~~~~lV~e~~ 681 (848)
+.|+.|+... +|+....++..+++|...... .+.+..|+++++.+. + -.+.+++.+..+.+ ++|||++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 4566666555 778875446778887654321 022345666666553 2 22456666643333 7899999
Q ss_pred CCCCHHhHhcCC---------------------CC--cccCCHHHHH-------H-------------HHHHHHHHHHHH
Q 038003 682 DRGSLARILGDD---------------------VT--AKELGWNRRI-------N-------------VIKGVANALSYL 718 (848)
Q Consensus 682 ~~gsL~~~l~~~---------------------~~--~~~l~~~~~~-------~-------------i~~qia~~L~~L 718 (848)
.+..+.+.+... .. ...++..... . ....+...++.+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 776664332110 00 0111111100 0 001112222222
Q ss_pred h---hCCCCCeEEcCCCCCCeeeCCC----CCEEEeeccCcccc
Q 038003 719 H---HDCLPSIIHRDISSKNVLLDSN----FEAHVSDFGIAKFV 755 (848)
Q Consensus 719 H---~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfG~~~~~ 755 (848)
. ......+||||+.+.||+++.+ +.+.++||+.+..-
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1 1123479999999999999875 68999999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00068 Score=74.81 Aligned_cols=72 Identities=13% Similarity=0.155 Sum_probs=50.0
Q ss_pred cceeccCCceeEEEEEcCC--------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCee
Q 038003 604 KFCIGKGGQGSVYKAELPS--------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~ 674 (848)
.+.|+.|....||++...+ +..+++|+.... ...+.+.+|..+++.+. +.-..++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~------~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP------ETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC------CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC------CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 4578899999999997653 578999987332 11244567888888874 3334677776543
Q ss_pred EEEEeccCCCC
Q 038003 675 FLVCEYLDRGS 685 (848)
Q Consensus 675 ~lV~e~~~~gs 685 (848)
.+||||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999998744
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.002 Score=68.05 Aligned_cols=157 Identities=13% Similarity=0.160 Sum_probs=84.3
Q ss_pred HHHHHHhhcCCcc-----cceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCc--ccc
Q 038003 591 HEEIIKATDDFDE-----KFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN--NVK 663 (848)
Q Consensus 591 ~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~ 663 (848)
.+++.....+|.. .+.|+.|....+|++...++ .+++|+..... ..+.+..|.++++.+.... +.+
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 3444444444544 34577899999999987655 58899876521 1123455777666653211 233
Q ss_pred eEEE------eecCCeeEEEEeccCCCCHHh--------------HhcC---CCCcc---cC---CHHHHHH--------
Q 038003 664 FHGF------CYNGPHSFLVCEYLDRGSLAR--------------ILGD---DVTAK---EL---GWNRRIN-------- 706 (848)
Q Consensus 664 l~~~------~~~~~~~~lV~e~~~~gsL~~--------------~l~~---~~~~~---~l---~~~~~~~-------- 706 (848)
++.. ....+..++||+|++|..+.. .++. ..... .. .|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 122356789999999864311 0110 11100 01 1221100
Q ss_pred ----HHHHHHHHHHHHhhC----CCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 707 ----VIKGVANALSYLHHD----CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 707 ----i~~qia~~L~~LH~~----~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
+...+...++++++. ...++||+|+.+.||++++++.+.++||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455555532 124799999999999998876668999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0011 Score=71.41 Aligned_cols=142 Identities=15% Similarity=0.231 Sum_probs=85.2
Q ss_pred cceeccCCceeEEEEEcC--------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCee
Q 038003 604 KFCIGKGGQGSVYKAELP--------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~ 674 (848)
.+.+..|-...+|++... +++.+++|+.... ........+|.++++.+. +.-..++++++.+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence 356888999999999764 2478999986331 123455678999988873 3334677777654
Q ss_pred EEEEeccCCCCHHh--------------H---hcCC-CC-cccCC--HHHHHHHHHHHHH-------------------H
Q 038003 675 FLVCEYLDRGSLAR--------------I---LGDD-VT-AKELG--WNRRINVIKGVAN-------------------A 714 (848)
Q Consensus 675 ~lV~e~~~~gsL~~--------------~---l~~~-~~-~~~l~--~~~~~~i~~qia~-------------------~ 714 (848)
.+||||++|..+.. . ++.. .. .+... +.++.++..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 39999999865421 0 1111 11 12222 3455555544422 1
Q ss_pred HHHHh----hC-CCCCeEEcCCCCCCeeeCCC----CCEEEeeccCccc
Q 038003 715 LSYLH----HD-CLPSIIHRDISSKNVLLDSN----FEAHVSDFGIAKF 754 (848)
Q Consensus 715 L~~LH----~~-~~~~ivH~Dlk~~NIll~~~----~~~kl~DfG~~~~ 754 (848)
+.+|. .. ....+||+|+.+.||+++.+ +.+.++||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 23332 21 12368999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0029 Score=66.97 Aligned_cols=143 Identities=13% Similarity=0.113 Sum_probs=81.0
Q ss_pred ceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCc--ccceEEE-----eecCCeeEEE
Q 038003 605 FCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN--NVKFHGF-----CYNGPHSFLV 677 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~-----~~~~~~~~lV 677 (848)
..++ |....||++...+|+.+++|+..... ...+.+..|..+++.+.... +++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88899999987778789999975331 12345667777777663212 3344432 1224566889
Q ss_pred EeccCCCCHH-----h------H---hc---CCCC---cccCCHHHH----HH---------------HHHHHHHHHHHH
Q 038003 678 CEYLDRGSLA-----R------I---LG---DDVT---AKELGWNRR----IN---------------VIKGVANALSYL 718 (848)
Q Consensus 678 ~e~~~~gsL~-----~------~---l~---~~~~---~~~l~~~~~----~~---------------i~~qia~~L~~L 718 (848)
|++++|..+. . . ++ .... ....++... .. +...+...++.+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885421 0 0 11 0000 011122110 00 111111223333
Q ss_pred hhC----CCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 719 HHD----CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 719 H~~----~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
... ....+||||+++.||+++ + .+.++||+.+..-
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 221 233689999999999999 4 8999999887643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0028 Score=67.46 Aligned_cols=32 Identities=22% Similarity=0.294 Sum_probs=28.3
Q ss_pred CCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 724 ~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
..+||+|+.+.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 37999999999999998888999999887654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0023 Score=70.80 Aligned_cols=74 Identities=16% Similarity=0.063 Sum_probs=47.5
Q ss_pred cceeccCCceeEEEEEcCC-CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcc-cceEEEeecCCeeEEEEecc
Q 038003 604 KFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN-VKFHGFCYNGPHSFLVCEYL 681 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~~lV~e~~ 681 (848)
.+.|+.|-...+|++...+ +..+++|+..... . ...+ ..+|..+++.+...++ .++++++.. .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~id---R~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EIIN---REREKKISCILYNKNIAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCSC---HHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhcC---HHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence 4578999999999998764 4778899864321 1 1111 2478888888854444 577777632 3699999
Q ss_pred CCCCH
Q 038003 682 DRGSL 686 (848)
Q Consensus 682 ~~gsL 686 (848)
+|.++
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0014 Score=58.86 Aligned_cols=56 Identities=20% Similarity=0.277 Sum_probs=29.4
Q ss_pred eecccCcccC-cCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccC
Q 038003 485 ELDLSHNILQ-EEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELH 542 (848)
Q Consensus 485 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~ 542 (848)
.++.+++.|+ ..+|..+ -++|++|+|++|+|+.+.+..|..+++|+.|+|++|++.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 3444555553 1333322 124556666666666555555666666666666666553
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0025 Score=57.20 Aligned_cols=54 Identities=22% Similarity=0.222 Sum_probs=33.8
Q ss_pred eccCCccc-ccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcC
Q 038003 85 NLSFNLFF-GNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLH 140 (848)
Q Consensus 85 ~l~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 140 (848)
+.+++.++ ..+|..+. ++|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 14 ~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 14 DCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp ECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 44444443 24554322 45777788877777666666777777777777777654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0024 Score=68.96 Aligned_cols=73 Identities=11% Similarity=0.089 Sum_probs=43.5
Q ss_pred cceeccCCceeEEEEEcCC---------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCc-ccceEEEeecCCe
Q 038003 604 KFCIGKGGQGSVYKAELPS---------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRN-NVKFHGFCYNGPH 673 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~~~~ 673 (848)
.+.++.|....+|++...+ +..+++|+..... ........|.++++.+.... +.++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF--N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence 3568889999999997653 2688999865431 11111356777777774223 44666554 2
Q ss_pred eEEEEeccCCCC
Q 038003 674 SFLVCEYLDRGS 685 (848)
Q Consensus 674 ~~lV~e~~~~gs 685 (848)
-++||||++|..
T Consensus 109 ~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 GGRIEEWLYGDP 120 (369)
T ss_dssp TEEEEECCCSEE
T ss_pred CcEEEEEecCCc
Confidence 378999998854
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.44 E-value=0.028 Score=61.33 Aligned_cols=141 Identities=10% Similarity=0.072 Sum_probs=84.3
Q ss_pred cceeccCCceeEEEEEcCC--------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCee
Q 038003 604 KFCIGKGGQGSVYKAELPS--------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~ 674 (848)
.+.+..|-...+|++...+ +..+++|+..... ...-...+|.++++.+. +.-..++++.+. -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-----GKFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 3568889999999997653 5789999864421 11111346888877773 333456666442 2
Q ss_pred EEEEeccCCCCHHh--------------H---hcCC-C---------CcccCCHHHHHHHHHHHH---------------
Q 038003 675 FLVCEYLDRGSLAR--------------I---LGDD-V---------TAKELGWNRRINVIKGVA--------------- 712 (848)
Q Consensus 675 ~lV~e~~~~gsL~~--------------~---l~~~-~---------~~~~l~~~~~~~i~~qia--------------- 712 (848)
++||||++|..+.. . ++.. . ...+..+.++.++..++-
T Consensus 146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~ 225 (424)
T 3mes_A 146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY 225 (424)
T ss_dssp EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence 78999999865311 0 0110 0 111112444444443321
Q ss_pred ----HHHHHHhh---------------------CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 713 ----NALSYLHH---------------------DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 713 ----~~L~~LH~---------------------~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
..+.+|.+ .....+||+|+.+.||+ +.++.+.++||..+..
T Consensus 226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11236899999999999 7788999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.21 E-value=0.23 Score=53.91 Aligned_cols=30 Identities=23% Similarity=0.413 Sum_probs=25.6
Q ss_pred CeEEcCCCCCCeee------CCCCCEEEeeccCccc
Q 038003 725 SIIHRDISSKNVLL------DSNFEAHVSDFGIAKF 754 (848)
Q Consensus 725 ~ivH~Dlk~~NIll------~~~~~~kl~DfG~~~~ 754 (848)
.+||+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567899999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=91.74 E-value=0.31 Score=47.05 Aligned_cols=102 Identities=16% Similarity=0.136 Sum_probs=67.4
Q ss_pred CHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCCccc
Q 038003 685 SLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE 764 (848)
Q Consensus 685 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~ 764 (848)
+|.++++.. ..++++.+++.++.|.+.+|.-.-... .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 788888754 468999999999999999987762110 111334567899999999888864 1110
Q ss_pred ccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 038003 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804 (848)
Q Consensus 765 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 804 (848)
.....+.|||... ...+.+.=|||+|+++|.-+-=..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123567888763 3446778899999999999986665
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.21 E-value=0.97 Score=43.56 Aligned_cols=116 Identities=9% Similarity=0.050 Sum_probs=79.1
Q ss_pred CCCcccceEEEeecCCeeEEEEeccCCC-CHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCC
Q 038003 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRG-SLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 735 (848)
Q Consensus 657 ~hp~iv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 735 (848)
.||+.++. .+-.+.+.+.+.++.-+.+ ++.+ .+..+...+.+++.+|+....+++.. +|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-------ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-------IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-------GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-------HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 68888876 4556666655555554322 3322 24577788999999999988777655 788999999
Q ss_pred eeeCCCCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 736 VLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 736 Ill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+++.++.+++.-.|....+.+ .. .++..=.-..=|++..++++++.|+.
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P-----------------~~-----~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDP-----------------LP-----VSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSC-----------------CC-----CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEcCCCCEEEEEccCccCCCC-----------------CC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999987776443322 21 11112233455678889999998754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.96 E-value=2.8 Score=40.46 Aligned_cols=115 Identities=10% Similarity=0.079 Sum_probs=77.5
Q ss_pred CCCcccceEEEeecCCeeEEEEeccCCC-CHHhHhcCCCCcccCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEEcCCCCC
Q 038003 657 RHRNNVKFHGFCYNGPHSFLVCEYLDRG-SLARILGDDVTAKELGWNRRINVIKGVANALS-YLHHDCLPSIIHRDISSK 734 (848)
Q Consensus 657 ~hp~iv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~-~LH~~~~~~ivH~Dlk~~ 734 (848)
.||+. -..+-.+.+.+.+.++.-+++ ++..+ +..+...+.+++.+|+.... +++.. +|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 68888 555556777777777765443 33332 34677888999999988877 66644 78899999
Q ss_pred CeeeCCCCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 735 NVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 735 NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||+++.++.+++.-.|.-..+ +|.-+ ++..=.-..=|++..++.+++.|+.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l-----------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL-----------------PPDEW-----DDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB-----------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred eEEEeCCCcEEEEEcCCcccC-----------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999999877764333 22211 1111122455677788888887654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 848 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-11 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-08 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 7e-53
Identities = 59/251 (23%), Positives = 104/251 (41%), Gaps = 13/251 (5%)
Query: 597 ATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKE 655
DDF++ +G G G V+K PSG ++A K + ++ A ++ + E+ L E
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHE 60
Query: 656 IRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
V F+G Y+ + E++D GSL ++L A + V V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGL 117
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
+YL I+HRD+ N+L++S E + DFG++ + + F GT Y +PE
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE 173
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSP 835
+ + D++S G+ + E+ G +P + M + P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP--IPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 836 SVMDYGGCHFM 846
+ + M
Sbjct: 232 TPGRPLSSYGM 242
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-51
Identities = 61/245 (24%), Positives = 112/245 (45%), Gaps = 16/245 (6%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+D++ + IG G G K G I+ K+ + ++ A+ ++EV L+E++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELK 61
Query: 658 HRNNVKFHGFCYNGPHS--FLVCEYLDRGSLARILGDDVTAKE-LGWNRRINVIKGVANA 714
H N V+++ + ++ ++V EY + G LA ++ ++ L + V+ + A
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 715 LSYLH--HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYA 772
L H D +++HRD+ NV LD + DFG+A+ + +S F GT Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPT 832
+PE M EK D++S G L++E+ P F++FS + KI + +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-------FTAFSQKEL-AGKIREGKFRR 233
Query: 833 PSPSV 837
Sbjct: 234 IPYRY 238
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 63/246 (25%), Positives = 107/246 (43%), Gaps = 18/246 (7%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
IG G G+VYK + VAVK N + F NEV L++ RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRH 63
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL 718
N + F G+ P +V ++ + SL L + + + I++ + A + YL
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEI 776
H SIIHRD+ S N+ L + + DFG+A S + + + +G+ + APE+
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 777 AYTMRA---TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTP 833
+ + DVY+FG++++E++ G P + +IN ++ L P L
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVG-RGYLSPDLSKV 234
Query: 834 SPSVMD 839
+
Sbjct: 235 RSNCPK 240
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-48
Identities = 64/259 (24%), Positives = 116/259 (44%), Gaps = 23/259 (8%)
Query: 595 IKATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNE 649
I + D +K+ IG+G G+VY A ++ +G VA+++ N Q + +NE
Sbjct: 12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINE 67
Query: 650 VLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIK 709
+L ++E ++ N V + G ++V EYL GSL ++ + + + V +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCR 123
Query: 710 GVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTF 769
AL +LH + +IHRDI S N+LL + ++DFG + P S + GT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 770 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPR 829
+ APE+ K D++S G++ E+I+G P + + + + +
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-------YLNENPLRALYLIATNGT 233
Query: 830 LPTPSPSVMDYGGCHFMLR 848
+P + F+ R
Sbjct: 234 PELQNPEKLSAIFRDFLNR 252
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 6e-48
Identities = 59/236 (25%), Positives = 102/236 (43%), Gaps = 12/236 (5%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
+ IG G G V+ + D VA+K +S ++F+ E + ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSH 59
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL 718
V+ +G C LV E+++ G L+ L + + V ++YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYL 117
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE-FAGTFGYAAPEIA 777
C +IHRD++++N L+ N VSDFG+ +FV + +A+PE+
Sbjct: 118 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTP 833
R + K DV+SFGVL++EV + + + S I ++ PRL +
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKI-PYENRSNSEVVEDISTGFRLYKPRLAST 229
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 7e-48
Identities = 49/231 (21%), Positives = 97/231 (41%), Gaps = 12/231 (5%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
+ +G G G V+ VAVK L D FL E +K+++H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-----LKQGSMSPDAFLAEANLMKQLQH 67
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL 718
+ V+ + P +++ EY++ GSL L + +L N+ +++ +A ++++
Sbjct: 68 QRLVRLYAVVTQEPI-YIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW-TEFAGTFGYAAPEIA 777
IHRD+ + N+L+ ++DFG+A+ + + + APE
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDP 828
T K DV+SFG+L+ E++ + + + +++ P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMVRP 232
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-47
Identities = 69/234 (29%), Positives = 103/234 (44%), Gaps = 12/234 (5%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+DF+ +GKG G+VY A S I+A+K L + EV +R
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLR 64
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H N ++ +G+ ++ +L+ EY G++ R L + R I +ANALSY
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSY 121
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
H +IHRDI +N+LL S E ++DFG + SS T GT Y PE+
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMI 176
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLP 831
EK D++S GVL +E + G P F + + I V +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISRVEFTFPDFVT 228
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 2e-46
Identities = 54/251 (21%), Positives = 106/251 (42%), Gaps = 17/251 (6%)
Query: 595 IKATDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL 653
+ D ++ +G G G VYKA+ + + A K +++ + + ++++ E+ L
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDIL 63
Query: 654 KEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN 713
H N VK Y + +++ E+ G++ ++ + + L ++ V K +
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLD 121
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
AL+YLH IIHRD+ + N+L + + ++DFG++ F GT + A
Sbjct: 122 ALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178
Query: 774 PEIAYTMRA-----TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDP 828
PE+ + K DV+S G+ + E+ + P +N I
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEPPTLA 236
Query: 829 RLPTPSPSVMD 839
+ S + D
Sbjct: 237 QPSRWSSNFKD 247
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-46
Identities = 54/238 (22%), Positives = 99/238 (41%), Gaps = 14/238 (5%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
D +G G G V + VA+K +S DEF+ E + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSH 58
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL 718
V+ +G C F++ EY+ G L L + + + K V A+ YL
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH-SSNWTEFAGTFGYAAPEIA 777
+HRD++++N L++ VSDFG++++V ++ ++ PE+
Sbjct: 117 ESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 778 YTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
+ + K D+++FGVL++E+ G P + S + I ++ P L +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTNSETAEHIAQGLRLYRPHLASEK 229
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-46
Identities = 57/254 (22%), Positives = 95/254 (37%), Gaps = 24/254 (9%)
Query: 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHR 659
FD + IG+G +VYK + VA + + L+ + + F E LK ++H
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHP 68
Query: 660 NNVKFHGFCY----NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANAL 715
N V+F+ LV E + G+L L K + + + + L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGL 125
Query: 716 SYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
+LH P IIHRD+ N+ + + D G+A + GT + AP
Sbjct: 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAP 182
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
E+ Y + E DVY+FG+ + E+ +P +S N ++ P
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASF 234
Query: 835 PSVMDYGGCHFMLR 848
V +
Sbjct: 235 DKVAIPEVKEIIEG 248
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-46
Identities = 57/251 (22%), Positives = 104/251 (41%), Gaps = 19/251 (7%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
+ + +G+G G V+ VA+K + FL E +K++RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-----GTMSPEAFLQEAQVMKKLRH 71
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL 718
V+ + P ++V EY+ +GSL L + T K L + +++ +A+ ++Y+
Sbjct: 72 EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV 129
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH-SSNWTEFAGTFGYAAPEIA 777
+HRD+ + N+L+ N V+DFG+A+ + + + + APE A
Sbjct: 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSV 837
R T K DV+SFG+L+ E+ + N +V ++ P P
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRV------PYPGMVNR--EVLDQVERGYRMPCPPE 238
Query: 838 MDYGGCHFMLR 848
M +
Sbjct: 239 CPESLHDLMCQ 249
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 3e-45
Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 27/258 (10%)
Query: 599 DDFDEKF----CIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL 653
DD ++ F IG G G+VY A + + ++VA+KK + N + + EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDIIKEVRFL 69
Query: 654 KEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN 713
+++RH N +++ G ++LV EY + + V K L V G
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQ 126
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
L+YLH ++IHRD+ + N+LL + DFG A + P +S F GT + A
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMA 179
Query: 774 PEIAYTM---RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRL 830
PE+ M + K DV+S G+ E+ + P + + M + I
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-------LFNMNAMSA-LYHIAQNES 231
Query: 831 PTPSPSVMDYGGCHFMLR 848
P +F+
Sbjct: 232 PALQSGHWSEYFRNFVDS 249
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-44
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 20/254 (7%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+D+D +G+G G V A + + VAVK + + + + E+ K +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKMLN 61
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H N VKF+G G +L EY G L + D + + + Y
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 118
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPE 775
LH I HRDI +N+LLD +SDFG+A ++ + GT Y APE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 776 IAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
+ E DV+S G+++ ++ G + S+ + + + +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGEL-------PWDQPSDSCQEYSDWKEKKTYLNP 228
Query: 835 PSVMDYGGCHFMLR 848
+D + +
Sbjct: 229 WKKIDSAPLALLHK 242
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 3e-44
Identities = 62/262 (23%), Positives = 113/262 (43%), Gaps = 34/262 (12%)
Query: 592 EEIIKATDDFDEKF---------CIGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSG 638
E+ +A +F ++ IG G G V L VA+K S
Sbjct: 10 EDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK 69
Query: 639 NMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKE 698
+FL+E + + H N + G ++ E+++ GSL L + +
Sbjct: 70 ---QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQ 124
Query: 699 LGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758
+ + +++G+A + YL +HRD++++N+L++SN VSDFG+++F+
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 759 SSNWTE-----FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINF 812
+S+ T + APE + T DV+S+G++++EV+ G P ++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTN 239
Query: 813 SSFSNMIIDVNKILDPRLPTPS 834
N I D RLP P
Sbjct: 240 QDVINAIEQ-----DYRLPPPM 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 6e-44
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
+ IGKG G V + G+ VAVK + A FL E + ++RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRH 59
Query: 659 RNNVKFHGFCYNGPHS-FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
N V+ G ++V EY+ +GSL L LG + + V A+ Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
L + +HRD++++NVL+ + A VSDFG+ K SS + APE
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEAL 172
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHP 804
+ + K DV+SFG+L++E+
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRV 199
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 160 bits (405), Expect = 7e-44
Identities = 54/264 (20%), Positives = 110/264 (41%), Gaps = 22/264 (8%)
Query: 588 KIMHEEIIKATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF 646
+I H+ ++ D +D +G G G V++ E +G+ A K +++ + +D +
Sbjct: 18 EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKF----VMTPHESDKETV 70
Query: 647 LNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRIN 706
E+ + +RH V H + ++ E++ G L + D ++ + +
Sbjct: 71 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVE 128
Query: 707 VIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWTE 764
++ V L ++H + +H D+ +N++ + + DFG+ + P S
Sbjct: 129 YMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV- 184
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNK 824
GT +AAPE+A D++S GVL + ++ G P F N + K
Sbjct: 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNV----K 238
Query: 825 ILDPRLPTPSPSVMDYGGCHFMLR 848
D + + S + G F+ +
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRK 262
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-43
Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 23/235 (9%)
Query: 607 IGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK 663
+G G G+V K VAVK ++ + DE L E ++++ + V+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL--KDELLAEANVMQQLDNPYIVR 72
Query: 664 FHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL 723
G C LV E + G L + L + + + I ++ V+ + YL
Sbjct: 73 MIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 724 PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP---HSSNWTEFAGTFGYAAPEIAYTM 780
+ +HRD++++NVLL + A +SDFG++K + + T + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 781 RATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
+ + K DV+SFGVL++E G P + + R+ P+
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP-------YRGMKGSEVTAMLEKGERMGCPA 233
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-43
Identities = 56/250 (22%), Positives = 97/250 (38%), Gaps = 21/250 (8%)
Query: 596 KATDDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALK 654
K +DF +G+G +V A EL + A+K + + E +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMS 63
Query: 655 EIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA 714
+ H VK + + + Y G L + + + +A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSA 120
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW--TEFAGTFGYA 772
L YLH IIHRD+ +N+LL+ + ++DFG AK + P S F GT Y
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPT 832
+PE+ A + D+++ G ++++++ G P F + + +I KI+
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP-------FRAGNEYLI-FQKIIKLEYDF 229
Query: 833 P---SPSVMD 839
P P D
Sbjct: 230 PEKFFPKARD 239
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 2e-43
Identities = 51/270 (18%), Positives = 102/270 (37%), Gaps = 42/270 (15%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLA 652
++ + IG+G G V++A P +VAVK + + +F E
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD---MQADFQREAAL 69
Query: 653 LKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL---------------------G 691
+ E + N VK G C G L+ EY+ G L L
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 692 DDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751
L ++ + + VA ++YL +HRD++++N L+ N ++DFG+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGL 186
Query: 752 AKFVGP--HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809
++ + + A + PE + R T + DV+++GV+++E+
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP---- 242
Query: 810 INFSSFSNMIIDVNKILDPRLPTPSPSVMD 839
+ ++ + + + D + +
Sbjct: 243 --YYGMAHEEV-IYYVRDGNILACPENCPL 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-43
Identities = 54/254 (21%), Positives = 101/254 (39%), Gaps = 25/254 (9%)
Query: 592 EEIIKATDDFD-EKFCIGKGGQGSVYKAEL---PSGDIVAVKKFNSQLLSGNMADHDEFL 647
+++ D+ +G G GSV + VA+K D +E +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA---DTEEMM 57
Query: 648 NEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINV 707
E + ++ + V+ G C LV E G L + L +E+ + +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAEL 114
Query: 708 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE--- 764
+ V+ + YL + +HRD++++NVLL + A +SDFG++K +G S +T
Sbjct: 115 LHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 765 FAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSINFSSFSNMIIDVN 823
+ APE + + + DV+S+GV ++E + G P + + +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-------YKKMKGPEV-MA 223
Query: 824 KILDPRLPTPSPSV 837
I + P
Sbjct: 224 FIEQGKRMECPPEC 237
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (390), Expect = 1e-42
Identities = 59/252 (23%), Positives = 107/252 (42%), Gaps = 19/252 (7%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
D K +G G G VY+ VAVK L + + +EFL E +KEI+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKEAAVMKEIK 71
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H N V+ G C P +++ E++ G+L L + +E+ + + +++A+ Y
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEY 130
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN-WTEFAGTFGYAAPEI 776
L + IHRD++++N L+ N V+DFG+++ + + + APE
Sbjct: 131 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 777 AYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPS 836
+ + K DV++FGVL++E+ + + V ++L+ P
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMS--PYP------GIDLSQVYELLEKDYRMERPE 239
Query: 837 VMDYGGCHFMLR 848
M
Sbjct: 240 GCPEKVYELMRA 251
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 9e-42
Identities = 57/261 (21%), Positives = 102/261 (39%), Gaps = 40/261 (15%)
Query: 606 CIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IGKG G V++ + G+ VAVK F+S+ E+ +RH N + F
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFI 63
Query: 666 GFCY----NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
+LV +Y + GSL L + I + A+ L++LH +
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHME 119
Query: 722 CL-----PSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW----TEFAGTFGYA 772
+ P+I HRD+ SKN+L+ N ++D G+A + GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 773 APEIAYTM------RATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMI------- 819
APE+ + ++ D+Y+ G++ +E+ + + +++
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 820 ----IDVNKILDPRLPTPSPS 836
+ + L P +P S
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQS 260
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (389), Expect = 1e-41
Identities = 53/254 (20%), Positives = 99/254 (38%), Gaps = 21/254 (8%)
Query: 599 DDFDEKFCIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
D +D +G G G V++ E +G + K N+ D NE+ + ++
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLH 84
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H + H + L+ E+L G L + + ++ IN ++ L +
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKH 142
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWTEFAGTFGYAAPE 775
+H SI+H DI +N++ ++ + V DFG+A + P T +AAPE
Sbjct: 143 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPE 198
Query: 776 IAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNM-IIDVNKILDPRLPTPS 834
I D+++ GVL + ++ G P F+ ++ + K D +
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSP-------FAGEDDLETLQNVKRCDWEFDEDA 251
Query: 835 PSVMDYGGCHFMLR 848
S + F+
Sbjct: 252 FSSVSPEAKDFIKN 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 56/258 (21%), Positives = 110/258 (42%), Gaps = 24/258 (9%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNMADHDEFLNEVLAL 653
+ IG G G VYK L + VA+K + +FL E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK---QRVDFLGEAGIM 63
Query: 654 KEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN 713
+ H N ++ G ++ EY++ G+L + L + E + + +++G+A
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAA 121
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP---HSSNWTEFAGTFG 770
+ YL + + +HRD++++N+L++SN VSDFG+++ + + +
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRL 830
+ APE + T DV+SFG++++EV+ + N +V K ++
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGF 230
Query: 831 PTPSPSVMDYGGCHFMLR 848
P+P M++
Sbjct: 231 RLPTPMDCPSAIYQLMMQ 248
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 4e-41
Identities = 64/261 (24%), Positives = 108/261 (41%), Gaps = 24/261 (9%)
Query: 596 KATDDFDEKF----CIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEV 650
K +D + + +G G V AE + +VA+K + L G NE+
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEI 58
Query: 651 LALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG 710
L +I+H N V +G H +L+ + + G L + V +I
Sbjct: 59 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQ 115
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLL---DSNFEAHVSDFGIAKFVGPHSSNWTEFAG 767
V +A+ YLH I+HRD+ +N+L D + + +SDFG++K P S T G
Sbjct: 116 VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACG 171
Query: 768 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILD 827
T GY APE+ ++ D +S GV+ + ++ G P F+ N + I+ +
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKA----E 225
Query: 828 PRLPTPSPSVMDYGGCHFMLR 848
+P + F+
Sbjct: 226 YEFDSPYWDDISDSAKDFIRH 246
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 8e-41
Identities = 61/266 (22%), Positives = 106/266 (39%), Gaps = 20/266 (7%)
Query: 580 LSVLNFDGKIMHEEIIKATDDFDEKF--CIGKGGQGSVYKAELPSGD----IVAVKKFNS 633
LS LN + + ++ F IG+G G VY L D AVK N
Sbjct: 6 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN- 64
Query: 634 QLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS-FLVCEYLDRGSLARILGD 692
++ + +FL E + +K+ H N + G C S +V Y+ G L + +
Sbjct: 65 --RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122
Query: 693 DVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752
+ + + + +HRD++++N +LD F V+DFG+A
Sbjct: 123 ETHNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 753 KFVGP----HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808
+ + N T + A E T + T K DV+SFGVL++E++ P +
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YP 236
Query: 809 SINFSSFSNMIIDVNKILDPRLPTPS 834
+N + ++ ++L P
Sbjct: 237 DVNTFDITVYLLQGRRLLQPEYCPDP 262
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 52/279 (18%), Positives = 95/279 (34%), Gaps = 42/279 (15%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGD------IVAVKKFNSQLLSGNMADHDEFLNEVLA 652
++ + +G G G V A VAVK + S + + ++E+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS---EREALMSELKM 93
Query: 653 LKEI-RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL--------------------G 691
+ ++ H N V G C +L+ EY G L L
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 692 DDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751
++ L + + VA + +L S +HRD++++NVL+ + DFG+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 752 AKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFS 809
A+ + S+ + APE + T K DV+S+G+L++E+
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN----- 265
Query: 810 INFSSFSNMIIDVNKILDPRLPTPSPSVMDYGGCHFMLR 848
+ K++ P M
Sbjct: 266 -PYPGIPVDAN-FYKLIQNGFKMDQPFYATEEIYIIMQS 302
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 25/247 (10%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGD---IVAVKKFNSQLLSGNMADHDEFLNEVLALKE 655
+D + IG+G G V KA + A+K+ + DH +F E+ L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCK 66
Query: 656 I-RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL-------------GDDVTAKELGW 701
+ H N + G C + + +L EY G+L L + TA L
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 702 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN 761
+ ++ VA + YL IHRD++++N+L+ N+ A ++DFG+++ +
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 762 WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIID 821
+ A E T DV+S+GVL++E++ + + + +
Sbjct: 184 TM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQ 241
Query: 822 VNKILDP 828
++ P
Sbjct: 242 GYRLEKP 248
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 5e-40
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 9/234 (3%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+DF +GKG G V+ AE + A+K ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H + F V EYL+ G L + + +R + L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQF 118
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
LH I++RD+ N+LLD + ++DFG+ K + F GT Y APEI
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLP 831
+ D +SFGVL++E++ G P F + + I N L
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSIRMDNPFYPRWLE 227
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-40
Identities = 58/257 (22%), Positives = 97/257 (37%), Gaps = 21/257 (8%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALK 654
D +G G G V + E + VAVK +LS D+F+ EV A+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMH 66
Query: 655 EIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA 714
+ HRN ++ +G P +V E GSL L VA
Sbjct: 67 SLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEG 123
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW---TEFAGTFGY 771
+ YL IHRD++++N+LL + + DFG+ + + + ++ F +
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 772 AAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLP 831
APE T + D + FGV ++E+ + + I ++KI
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE------PWIGLNGSQI-LHKIDKEGER 233
Query: 832 TPSPSVMDYGGCHFMLR 848
P P + M++
Sbjct: 234 LPRPEDCPQDIYNVMVQ 250
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (368), Expect = 1e-39
Identities = 64/251 (25%), Positives = 105/251 (41%), Gaps = 18/251 (7%)
Query: 598 TDDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI 656
+D ++ +G GG V+ A L VAVK + L + + + F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAAL 64
Query: 657 RHRNNVKFHGFCYN----GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVA 712
H V + GP ++V EY+D +L I+ + + R I VI
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADAC 121
Query: 713 NALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTE---FAGTF 769
AL++ H IIHRD+ N+++ + V DFGIA+ + ++ T+ GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 770 GYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILD-P 828
Y +PE A + DVYS G +++EV+ G P F + S + + + I
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPIPPSA 236
Query: 829 RLPTPSPSVMD 839
R S +
Sbjct: 237 RHEGLSADLDA 247
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 52/274 (18%), Positives = 96/274 (35%), Gaps = 37/274 (13%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA 652
+ +G G G V +A + VAVK S ++ + + ++E+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 653 LKEI-RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL---------------GDDVTA 696
L + H N V G C G + ++ EY G L L +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 697 KELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756
L ++ VA +++L + IHRD++++N+LL + DFG+A+ +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 757 PHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 814
S+ + APE + T + DV+S+G+ ++E+
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP------- 249
Query: 815 FSNMIIDVNKILDPRLPTPSPSVMDYGGCHFMLR 848
+ K++ SP M
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 283
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (367), Expect = 2e-39
Identities = 60/255 (23%), Positives = 108/255 (42%), Gaps = 23/255 (9%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDE-----FLNEVLA 652
++++ K +G+G V + P+ AVK + A+ + L EV
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 653 LKEIR-HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGV 711
L+++ H N ++ FLV + + +G L L + VT L +++ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGY 771
+ LH I+HRD+ +N+LLD + ++DFG + + P E GT Y
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSY 175
Query: 772 AAPEIAYTMRA------TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVN-K 824
APEI ++ D++S GV+++ ++ G+ P F+ MI+ N +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMIMSGNYQ 233
Query: 825 ILDPRLPTPSPSVMD 839
P S +V D
Sbjct: 234 FGSPEWDDYSDTVKD 248
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 53/263 (20%), Positives = 107/263 (40%), Gaps = 25/263 (9%)
Query: 593 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGD-----IVAVKKFNSQLLSGNMADHDEFL 647
I+K T+ F + +G G G+VYK VA+K+ + + + E L
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEIL 59
Query: 648 NEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINV 707
+E + + + + + G C L+ + + G L + + +G +N
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH--KDNIGSQYLLNW 116
Query: 708 IKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNW--TEF 765
+A ++YL ++HRD++++NVL+ + ++DFG+AK +G +
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKI 825
+ A E T + DV+S+GV V+E++ + +++ I
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------PYDGIPAS--EISSI 225
Query: 826 LDPRLPTPSPSVMDYGGCHFMLR 848
L+ P P + M++
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVK 248
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 51/248 (20%), Positives = 94/248 (37%), Gaps = 21/248 (8%)
Query: 600 DFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALK 654
+ EK+ +G+G G V++ E S K + D E+ L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILN 56
Query: 655 EIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA 714
RHRN + H + ++ E++ + + A EL ++ + V A
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEA 114
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHV--SDFGIAKFVGPHSSNWTEFAGTFGYA 772
L +LH +I H DI +N++ + + + +FG A+ + P + Y
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYY 170
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVN-KILDPRLP 831
APE+ + D++S G LV+ ++ G +P F + I++ +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFK 228
Query: 832 TPSPSVMD 839
S MD
Sbjct: 229 EISIEAMD 236
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (369), Expect = 2e-39
Identities = 54/242 (22%), Positives = 96/242 (39%), Gaps = 13/242 (5%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
DF +G G G V+ +G A+K +++ + + +E L L +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVT 62
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H ++ G + F++ +Y++ G L +L +
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLA 116
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
L + II+RD+ +N+LLD N ++DFG AK+V GT Y APE+
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVV 173
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSV 837
T + D +SFG+L++E++ G P F+ N I++ P +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231
Query: 838 MD 839
+
Sbjct: 232 LS 233
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-38
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 15/219 (6%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALK 654
+ + CIG+G G V++ S + VA+K + + ++FL E L ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMR 63
Query: 655 EIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA 714
+ H + VK G +++ E G L L L I ++ A
Sbjct: 64 QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTA 120
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS-NWTEFAGTFGYAA 773
L+YL +HRDI+++NVL+ SN + DFG+++++ + ++ + A
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 774 PEIAYTMRATEKYDVYSFGVLVFEVI-KGNHPRDFFSIN 811
PE R T DV+ FGV ++E++ G P N
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 2e-37
Identities = 56/244 (22%), Positives = 102/244 (41%), Gaps = 11/244 (4%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
++F + IG+G G VYKA +G++VA+KK + + + E+ LKE+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--PSTAIREISLLKELN 59
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H N VK + +LV E+L + + D + + + + L++
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
H ++HRD+ +N+L+++ ++DFG+A+ G +T T Y APEI
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 778 Y-TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPS 836
+ D++S G + E++ F + I D + S
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRAL--FPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 837 VMDY 840
+ DY
Sbjct: 233 MPDY 236
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 51/256 (19%), Positives = 104/256 (40%), Gaps = 28/256 (10%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA 652
+ +G+G G VY+ VA+K N + +M + EFLNE
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASV 76
Query: 653 LKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL-------GDDVTAKELGWNRRI 705
+KE + V+ G G + ++ E + RG L L ++ ++ I
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS--NWT 763
+ +A+ ++YL+ + +HRD++++N ++ +F + DFG+ + +
Sbjct: 137 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 764 EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVN 823
+ + +PE T DV+SFGV+++E+ + SN + +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP------YQGLSNEQV-LR 246
Query: 824 KILDPRLPTPSPSVMD 839
+++ L + D
Sbjct: 247 FVMEGGLLDKPDNCPD 262
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (347), Expect = 8e-37
Identities = 55/243 (22%), Positives = 106/243 (43%), Gaps = 11/243 (4%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH 658
+ + IG+G G VYKA+ G+ A+KK + + + E+ LKE++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKH 59
Query: 659 RNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYL 718
N VK + + LV E+LD+ + DV L + + + N ++Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 719 HHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAY 778
H ++HRD+ +N+L++ E ++DFG+A+ G +T T Y AP++
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 779 -TMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSV 837
+ + + D++S G + E++ G F ++ + I + + + +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 838 MDY 840
Y
Sbjct: 232 PKY 234
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-36
Identities = 55/253 (21%), Positives = 94/253 (37%), Gaps = 21/253 (8%)
Query: 599 DDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLL--SGNMADHDEFLNEVL 651
++ D+ + +G G V K E +G A K + S ++ EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 652 ALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGV 711
LKEI+H N + H N L+ E + G L L + + L +K +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQI 122
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSN----FEAHVSDFGIAKFVGPHSSNWTEFAG 767
N +++ I H D+ +N++L + DFG+A + + + G
Sbjct: 123 LNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFG 178
Query: 768 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVN-KIL 826
T + APEI + D++S GV+ + ++ G P F + VN +
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFE 236
Query: 827 DPRLPTPSPSVMD 839
D S D
Sbjct: 237 DEYFSNTSALAKD 249
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 5e-36
Identities = 56/251 (22%), Positives = 98/251 (39%), Gaps = 25/251 (9%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEV-LALKEIRHRNNVKF 664
+G G G V + + + A+K D + EV L + + + V+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRI 70
Query: 665 HGFCYN----GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
N +V E LD G L + D + ++K + A+ YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 721 DCLPSIIHRDISSKNVLLDSNFE---AHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
+I HRD+ +N+L S ++DFG AK H+S T T Y APE+
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVL 185
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSV 837
+ + D++S GV+++ ++ G P F+S + + S + ++ P P S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 838 MDYGGCHFMLR 848
+ +
Sbjct: 244 VSEEVKMLIRN 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (346), Expect = 6e-36
Identities = 51/247 (20%), Positives = 95/247 (38%), Gaps = 18/247 (7%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLA---LK 654
+DF IG+GG G VY +G + A+K + + + LNE + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLALNERIMLSLVS 62
Query: 655 EIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA 714
V + + + ++ G L L +
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILG 119
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAP 774
L ++H+ +++RD+ N+LLD + +SD G+A + + GT GY AP
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAP 174
Query: 775 EIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTP 833
E+ A D +S G ++F++++G+ P F + + + I + + LP
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTMAVELPDS 231
Query: 834 -SPSVMD 839
SP +
Sbjct: 232 FSPELRS 238
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 11/237 (4%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMAD-HDEFLNEVLALKEIRHRNNVKF 664
+G+G +VYKA + IVA+KK S + L E+ L+E+ H N +
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
+ + LV ++++ I + L + + L YLH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 725 SIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA-T 783
I+HRD+ N+LLD N ++DFG+AK G + +T T Y APE+ + R
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 784 EKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVMDY 840
D+++ G ++ E++ + I + S+ DY
Sbjct: 180 VGVDMWAVGCILAELLLRVPF--LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 4e-35
Identities = 42/245 (17%), Positives = 84/245 (34%), Gaps = 29/245 (11%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG G G +Y + +G+ VA+K + H + E K ++ +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 666 GFCY-NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
+C G ++ +V E L ++ + + + + + Y+H
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---K 122
Query: 725 SIIHRDISSKNVL---LDSNFEAHVSDFGIAKFVGPHSSN-------WTEFAGTFGYAAP 774
+ IHRD+ N L ++ DFG+AK ++ GT YA+
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 775 EIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
+ + + D+ S G ++ G+ P +I + ++ TP
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-----TKRQKYERISEKKMSTPI 237
Query: 835 PSVMD 839
+
Sbjct: 238 EVLCK 242
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-35
Identities = 54/254 (21%), Positives = 102/254 (40%), Gaps = 31/254 (12%)
Query: 599 DDFDEKFCIGKGGQGSVYKAELPSGD--------IVAVKKFNSQLLSGNMADHDEFLNEV 650
D +G+G G V AE D VAVK S ++ + ++E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---SDLISEM 69
Query: 651 LALKEI-RHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARIL-------------GDDVTA 696
+K I +H+N + G C +++ EY +G+L L
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 697 KELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756
++L ++ VA + YL IHRD++++NVL+ + ++DFG+A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 757 PHSSNWT--EFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSS 814
+ APE + T + DV+SFGVL++E+ + +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-PYPGVPVEE 245
Query: 815 FSNMIIDVNKILDP 828
++ + +++ P
Sbjct: 246 LFKLLKEGHRMDKP 259
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-34
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 16/247 (6%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G V A + + VA+KK + + L E+ L RH N + +
Sbjct: 16 IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 666 GFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS 725
+ YL + L + + L + + + L Y+H +
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 129
Query: 726 IIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP---HSSNWTEFAGTFGYAAPEIAYT-MR 781
++HRD+ N+LL++ + + DFG+A+ P H+ TE+ T Y APEI
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 782 ATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSVMDYG 841
T+ D++S G ++ E++ F ++ N I+ IL +++
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPI--FPGKHYLDQLNHIL---GILGSPSQEDLNCIINLK 244
Query: 842 GCHFMLR 848
+++L
Sbjct: 245 ARNYLLS 251
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 53/237 (22%), Positives = 89/237 (37%), Gaps = 16/237 (6%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+DFD +GKG G V +G A+K +++ + + E L+ R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTR 63
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H V EY + G L L + E R A +S
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFY--GAEIVSA 117
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
L + +++RDI +N++LD + ++DFG+ K + F GT Y APE+
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPS 834
D + GV+++E++ G P F + + + IL + P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP-------FYNQDHERL-FELILMEEIRFPR 226
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-34
Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 21/232 (9%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+ + IG G G VY+A+L SG++VA+KK D E+ ++++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLD 71
Query: 658 HRNNVKFHGFCY------NGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGV 711
H N V+ F Y + + LV +Y+ + L + +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 712 ANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH-VSDFGIAKFVGPHSSNWTEFAGTFG 770
+L+Y+H I HRDI +N+LLD + + DFG AK + N + +
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 771 YAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDV 822
A I T DV+S G ++ E++ G F + II V
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQLVEIIKV 238
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 128 bits (323), Expect = 2e-33
Identities = 42/247 (17%), Positives = 86/247 (34%), Gaps = 31/247 (12%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV-KF 664
IG+G G +++ L + VA+K + +D + +E K + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 665 HGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLP 724
+ F G H+ LV + L + D+ ++ K + + +H
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 725 SIIHRDISSKNVLLDSNFEAH-----VSDFGIAKFVGPHSSN-------WTEFAGTFGYA 772
S+++RDI N L+ + V DFG+ KF + +GT Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 773 APEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPT 832
+ + + D+ + G + ++G+ P + +I + + T
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-----KAATNKQKYERIGEKKQST 235
Query: 833 PSPSVMD 839
P +
Sbjct: 236 PLRELCA 242
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 57/273 (20%), Positives = 96/273 (35%), Gaps = 36/273 (13%)
Query: 599 DDFDEKFCIGKGGQGSVYKA------ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLA 652
D +G+G G V +A + + VAVK +H ++E+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRALMSELKI 69
Query: 653 LKEIRHRNN-VKFHGFCY-NGPHSFLVCEYLDRGSLARIL-------------GDDVTAK 697
L I H N V G C G ++ E+ G+L+ L +D+
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 698 ELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757
L I VA + +L IHRD++++N+LL + DFG+A+ +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 758 HSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSF 815
+ + APE + T + DV+SFGVL++E+
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-------PYPG 239
Query: 816 SNMIIDVNKILDPRLPTPSPSVMDYGGCHFMLR 848
+ + + L +P ML
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 272
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-33
Identities = 58/244 (23%), Positives = 94/244 (38%), Gaps = 18/244 (7%)
Query: 599 DDFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALK 654
++F+ +G G G V+ +G + A+K + + E L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 655 EIRHRNN-VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVAN 713
IR V H L+ +Y++ G L L E +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 714 ALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWT-EFAGTFGYA 772
+ L H II+RDI +N+LLDSN ++DFG++K + +F GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 773 APEIAYTMRA--TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRL 830
AP+I + + D +S GVL++E++ G P F + I +IL
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEIS--RRILKSEP 253
Query: 831 PTPS 834
P P
Sbjct: 254 PYPQ 257
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-33
Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLS--GNMADHDEFLNEVLALKEIR--HRNN 661
+G GG GSVY + VA+K +S G + + EV+ LK++
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 662 VKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHD 721
++ + L+ E + + L + V A+ + H+
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN- 128
Query: 722 CLPSIIHRDISSKNVLLDSN-FEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPE-IAYT 779
++HRDI +N+L+D N E + DFG + + +T+F GT Y+ PE I Y
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 780 MRATEKYDVYSFGVLVFEVIKGNHP 804
V+S G+L+++++ G+ P
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 47/208 (22%), Positives = 94/208 (45%), Gaps = 10/208 (4%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
+++ IG+G G+V+KA+ + +IVA+K+ + L E+ LKE++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELK 59
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
H+N V+ H ++ LV E+ D+ + G V + L
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKG 113
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
L +++HRD+ +N+L++ N E +++FG+A+ G ++ T Y P++
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 778 YTMRA-TEKYDVYSFGVLVFEVIKGNHP 804
+ + + D++S G + E+ P
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 49/219 (22%), Positives = 90/219 (41%), Gaps = 18/219 (8%)
Query: 596 KATDDFDEKFCIGKGGQGSVYKAE--LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLAL 653
+A ++ IG+G G V+KA G VA+K+ Q M + EV L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM--PLSTIREVAVL 61
Query: 654 KEI---RHRNNVKFHGFCYNGP-----HSFLVCEYLDRGSLARILGDDVTAKELGWNRRI 705
+ + H N V+ C LV E++D+ + D V +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIK 119
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765
+++ + L +LH ++HRD+ +N+L+ S+ + ++DFG+A+ + +
Sbjct: 120 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-V 175
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHP 804
T Y APE+ D++S G + E+ +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 3e-32
Identities = 54/242 (22%), Positives = 90/242 (37%), Gaps = 13/242 (5%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
D FD +G G G V + SG+ A+K + Q + + + LNE L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVN 99
Query: 658 HRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
VK + + ++V EY+ G + L + Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEY 156
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIA 777
LH +I+RD+ +N+L+D V+DFG AK GT APEI
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEII 210
Query: 778 YTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPTPSPSV 837
+ + D ++ GVL++E+ G P FF+ I+ + +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 838 MD 839
+
Sbjct: 269 LR 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-31
Identities = 52/246 (21%), Positives = 91/246 (36%), Gaps = 15/246 (6%)
Query: 592 EEIIKATDDFDEKF----CIGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEF 646
+E+ K + + +G G G+V A + +G VA+KK S A
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR--A 64
Query: 647 LNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKE-LGWNRRI 705
E+ LK +RH N + ++ + E LG +R
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124
Query: 706 NVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765
++ + L Y+H IIHRD+ N+ ++ + E + DFG+A+ + +
Sbjct: 125 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT 181
Query: 766 AGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKI 825
+ A I MR T+ D++S G ++ E+I G F + I+ V
Sbjct: 182 --RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL--FKGSDHLDQLKEIMKVTGT 237
Query: 826 LDPRLP 831
Sbjct: 238 PPAEFV 243
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-31
Identities = 49/254 (19%), Positives = 94/254 (37%), Gaps = 24/254 (9%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG+G G V+KA +G VA+KK + L E+ L+ ++H N V
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF--PITALREIKILQLLKHENVVNLI 75
Query: 666 GFCYNGP--------HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSY 717
C +LV ++ + + + + V++ + N L Y
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYY 132
Query: 718 LHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS----NWTEFAGTFGYAA 773
+H + I+HRD+ + NVL+ + ++DFG+A+ + +T T Y
Sbjct: 133 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 774 PEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLPT 832
PE+ R D++ G ++ E+ + +I + + P +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPI--MQGNTEQHQLALISQLCGSITPEVWP 247
Query: 833 PSPSVMDYGGCHFM 846
+ Y +
Sbjct: 248 NVDNYELYEKLELV 261
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 9e-29
Identities = 54/232 (23%), Positives = 92/232 (39%), Gaps = 21/232 (9%)
Query: 607 IGKGGQGSVYKA-ELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFH 665
IG G QG V A + VA+KK + + A E++ +K + H+N +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR--AYRELVLMKCVNHKNIISLL 82
Query: 666 GFC------YNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLH 719
+LV E +D I EL R ++ + + +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH 136
Query: 720 HDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYT 779
IIHRD+ N+++ S+ + DFG+A+ G T + T Y APE+
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILG 192
Query: 780 MRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILDPRLP 831
M E D++S G ++ E+++ F ++ N +I+ P
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKIL--FPGRDYIDQWNKVIEQLGTPCPEFM 242
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 5e-28
Identities = 53/267 (19%), Positives = 98/267 (36%), Gaps = 23/267 (8%)
Query: 592 EEIIKATDDFDEKF----CIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEF 646
+E+ K + E++ +G G GSV A +G VAVKK + S +
Sbjct: 7 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRT 64
Query: 647 LNEVLALKEIRHRNNVKFHGFCYNGP-----HSFLVCEYLDRGSLARILGDDVTAKELGW 701
E+ LK ++H N + + + +L L I V ++L
Sbjct: 65 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKLTD 120
Query: 702 NRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN 761
+ +I + L Y+H IIHRD+ N+ ++ + E + DFG+A+
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--M 175
Query: 762 WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIID 821
A + A + M + D++S G ++ E++ G F + +I+
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLILR 233
Query: 822 VNKILDPRLPTPSPSVMDYGGCHFMLR 848
+ L S + +
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQ 260
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 112 bits (281), Expect = 1e-27
Identities = 40/212 (18%), Positives = 82/212 (38%), Gaps = 23/212 (10%)
Query: 599 DDFDEKFCIGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR 657
DD+ +G+G V++A + + + V VK + E+ L+ +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLR 87
Query: 658 -HRNNVKFHGFCYNGPHS--FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANA 714
N + + LV E+++ ++ + L + + A
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKA 141
Query: 715 LSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAA 773
L Y H I+HRD+ NV++D + + + D+G+A+F P + + +
Sbjct: 142 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 197
Query: 774 PEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHP 804
PE+ + D++S G ++ +I P
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 104 bits (259), Expect = 2e-24
Identities = 77/387 (19%), Positives = 131/387 (33%), Gaps = 43/387 (11%)
Query: 173 NLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFN 232
L+ L K +++ ++ L + L SI + L++LT ++ N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 233 NSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIG 292
N L+ P L NL L + ++ NQ+ P + N +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTN---LTGLTLFNNQITDIDPLKN 130
Query: 293 YLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGE 352
+ + + + + L LD+S+N
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS-- 188
Query: 353 ISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLN 412
+ L + I + N IS P I L L L+ N + L L++L
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLT 244
Query: 413 KLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIP--------------------KS 452
L L NQ+S P LTKL L L N++S+ P
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 453 IGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNL 512
I NL L YL L N +S P L L L ++N + + + N+ ++ L+
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 513 SHNNLSDFIPRCFEEMRSLSCIDISYN 539
HN +SD P + ++ + ++
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.8 bits (242), Expect = 2e-22
Identities = 84/395 (21%), Positives = 144/395 (36%), Gaps = 35/395 (8%)
Query: 101 NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160
L++ LG ++ + L+Q+ L D + + L+ + ++ +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 75
Query: 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLG 220
N L P L NL+ L + + N ++ P + L L ++ +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK---- 129
Query: 221 NLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYN 280
NL++L + L +N++S + NL++L L + +
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQ-----LSFGNQVTDLKPLANLTTLERLDISS 184
Query: 281 NGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVL----LNQNNLSGKMYEAFGDH 336
N + L +L L N + + P I L LN N L
Sbjct: 185 N--KVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASL 240
Query: 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396
NLT LDL+NN +KL+ + N IS P + N
Sbjct: 241 TNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNL----ELNE 294
Query: 397 IVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNL 456
+ + L +L L L N +S P SLTKLQ L + NK+S S+ NL
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 457 LKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHN 491
+++L+ +NQ+S P L +++L L+
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.0 bits (240), Expect = 4e-22
Identities = 69/390 (17%), Positives = 133/390 (34%), Gaps = 27/390 (6%)
Query: 126 LNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKN 185
L + + L + T+ L + L + SI + L+NL + N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNN 76
Query: 186 SLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGN 245
L+ P + L L+ + ++ NQ + PL+ + + + + +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 246 LKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTN 305
+ N ++ S L +S ++
Sbjct: 135 NRLEL----SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190
Query: 306 LLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLST 365
+ + + + N N +S G NL L L+ N + + + L+
Sbjct: 191 SVLAKLTNLESLIATN-NQISD--ITPLGILTNLDELSLNGNQLKDIGTL--ASLTNLTD 245
Query: 366 FIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGV 425
++ N IS P + KL L L +N I P+ + +L N +
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE----D 299
Query: 426 PLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSE 485
+L L YL L N +S P + +L KL L +NN++S + L +++
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 486 LDLSHNILQEEIPPQVCNMGSLEKLNLSHN 515
L HN + + P + N+ + +L L+
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.2 bits (238), Expect = 9e-22
Identities = 77/406 (18%), Positives = 134/406 (33%), Gaps = 51/406 (12%)
Query: 63 TLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQ-IGNLSKLQYLDLGSNQLSGLIPP 121
LG S + + L G + + L+ L ++ +NQL+ + P
Sbjct: 28 VLGKTNVTDTVSQTDLDQVTTLQADRL---GIKSIDGVEYLNNLTQINFSNNQLTDITP- 83
Query: 122 EIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLY 181
+ L +L + ++ NQ+ P L + +
Sbjct: 84 -LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL----E 138
Query: 182 LYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP 241
L N++ S I L L L + L NL++L + + +N S
Sbjct: 139 LSSNTI-----SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVSDIS 191
Query: 242 ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELE 301
+L L +L +L NQ++ P I ++L L L N L + L +L++L+
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 302 LCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFS 361
L N + + P LT L L N
Sbjct: 248 LANNQISNLAP--------------------LSGLTKLTELKLGANQISNISPLAGLTAL 287
Query: 362 KLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQL 421
+ I N L L L N+I P + L+ L +L N++
Sbjct: 288 TNLELNENQLE----DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV 341
Query: 422 SGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNN 467
S +LT + +L N++S P + NL ++ L L++
Sbjct: 342 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 82.0 bits (201), Expect = 4e-17
Identities = 76/348 (21%), Positives = 136/348 (39%), Gaps = 25/348 (7%)
Query: 198 LKSLLQLDLSENQFSGSIPLS-LGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHI 256
L ++ L + + ++ + L +++L L S+ G + L +L+ +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 257 NQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIE 316
NQL P + NL+ L + + NN + P + L + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 317 RVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGS 376
L ++ + A +L L N + N + +++ S
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL-----ERLDISSNKVS 188
Query: 377 IPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQ 436
+ L+ L ++N I P+ +L++L++L LN NQL SLT L
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLT 244
Query: 437 YLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEE 496
LDL+ N++S+ P + L KL L L NQ+S+ P L L+ L+L+ N L++
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 300
Query: 497 IPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGP 544
P L L L NN+SD P + L + + N++
Sbjct: 301 SPISNLKN--LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV 344
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 1e-07
Identities = 29/129 (22%), Positives = 50/129 (38%), Gaps = 5/129 (3%)
Query: 10 LKWKTSLQNQNLNSSLLSSWT-LYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNG 68
L T L L ++ +S+ + L A + + S + ++T TL N
Sbjct: 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQ 128
SS L L + N + NL+ + +L G NQ+S L P + L +
Sbjct: 319 ISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTR 374
Query: 129 LRRLYLDMN 137
+ +L L+
Sbjct: 375 ITQLGLNDQ 383
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (253), Expect = 8e-24
Identities = 58/261 (22%), Positives = 100/261 (38%), Gaps = 28/261 (10%)
Query: 607 IGKGGQGSVYKAE-LPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVK-- 663
+G G +V+ A+ + + VA+K + G+ + +E+ L+ + +N K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKI-----VRGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 664 -------------FHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKG 710
F+ NG H +V E L LA I + L + ++I K
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQ 133
Query: 711 VANALSYLHHDCLPSIIHRDISSKNVLLDSN-FEAHVSDFGIAKFVGPHSS--NWTEFAG 767
+ L Y+H C IIH DI +NVL++ ++ IA ++T
Sbjct: 134 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 768 TFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSINFSSFSNMIIDVNKILD 827
T Y +PE+ D++S L+FE+I G+ + + + + I L
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 828 PRLPTPSPSVMDYGGCHFMLR 848
LP+ Y F R
Sbjct: 252 GELPSYLLRNGKYTRTFFNSR 272
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.3 bits (246), Expect = 2e-23
Identities = 62/306 (20%), Positives = 113/306 (36%), Gaps = 31/306 (10%)
Query: 238 SIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSL 297
+P L + L L N++ NL +L L L NN + P L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 298 SELELCTNLLRGVIP---HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSN--NNFCGE 352
L L N L+ + +++ + +++N ++ F + ++L G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 353 ISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLN 412
+ + KLS ++ NI+ +IP G P L L L N I L+ L++L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 413 KLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHK 472
KL L+ N +S + L+ L L+ NKL +P + + + + L NN +S
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAI 257
Query: 473 IPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDF--IPRCFEEMRS 530
+F + + S ++L N + + P F +
Sbjct: 258 GSNDFCPPGYNT------------------KKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299
Query: 531 LSCIDI 536
+ + +
Sbjct: 300 RAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.6 bits (226), Expect = 1e-20
Identities = 60/270 (22%), Positives = 98/270 (36%), Gaps = 17/270 (6%)
Query: 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQ 138
P A L+L N NL L L L +N++S + P L +L RLYL NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 139 LHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKL 198
L L + + S+ + L + + L SG +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGM 149
Query: 199 KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQ 258
K L + +++ + + G SLT + L N ++ L L +L+ LGL N
Sbjct: 150 KKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 259 LNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERV 318
++ S+ N LR L+L NN L VP + K + + L N + + +
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 319 LLNQNNLSGKMYEAFGDHPNLTFLDLSNNN 348
N + + + L +N
Sbjct: 266 GYNTKK------------ASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.8 bits (203), Expect = 8e-18
Identities = 53/279 (18%), Positives = 99/279 (35%), Gaps = 36/279 (12%)
Query: 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396
P+ LDL NN ++ N L T I+ N IS P KL+ L LS N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 397 IVGKIPVQLEMLSSLNKLILNLNQL-----------------------SGGVPLEFGSLT 433
+ + L L + ++ SG F +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNIL 493
KL Y+ ++ +++ G L L+L N+++ + L +L++L LS N +
Sbjct: 151 KLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 494 QEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKD 553
+ N L +L+L++N L +P + + + + + N + I ++
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISA-IGSNDFCPP 265
Query: 554 GLMEGNKGLKRVS--------QEEQSNSMNRLRLLSVLN 584
G VS E Q ++ + + + +
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 26/125 (20%), Positives = 51/125 (40%), Gaps = 2/125 (1%)
Query: 447 SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGS 506
+PK + L+L NN+++ +F+ L +L L L +N + + P +
Sbjct: 23 EKVPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 507 LEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNSTAFKDGLMEGNKGLKRVS 566
LE+L LS N L + + + ++ L + ++ + N + G LK
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140
Query: 567 QEEQS 571
E +
Sbjct: 141 IENGA 145
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 2e-08
Identities = 38/230 (16%), Positives = 72/230 (31%), Gaps = 16/230 (6%)
Query: 14 TSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDF 73
L+ L+ + L + I+ M + L
Sbjct: 79 VKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 74 SF---SSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLR 130
S +F + L+ + G L L L N+++ + + LN L
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 131 RLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG- 189
+L L N + + + +L L +N L +P L + + V+YL+ N++S
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257
Query: 190 -----SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234
P K S + L N P+ + T ++ +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSN------PVQYWEIQPSTFRCVYVRA 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 93.7 bits (231), Expect = 2e-21
Identities = 83/311 (26%), Positives = 122/311 (39%), Gaps = 37/311 (11%)
Query: 4 EEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGS--RVISITM 61
++ ALL+ K L N + LSSW T +W G+ C+ RV ++ +
Sbjct: 6 QDKQALLQIKKDLGN----PTTLSSWL----PTTDCCNRTWLGVLCDTDTQTYRVNNLDL 57
Query: 62 STLGLNGTFH-DFSFSSFPHLANLNLSFNLFF-GNIPLQIGNLSKLQYLDLGSNQLSGLI 119
S L L + S ++ P+L L + G IP I L++L YL + +SG I
Sbjct: 58 SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
Query: 120 PPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAV 179
P + ++ L L N L GT+PP I L + + N + G+IP S G+ S L
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177
Query: 180 LYLYKNSLSGSIPSIIGKLKSLLQLDLSEN-----------------------QFSGSIP 216
+ +L +DLS N
Sbjct: 178 SMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 217 LSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVL 276
+G +L + L NN + G++P L LK L +L + N L G I P GNL V
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVS 296
Query: 277 YLYNN-GLYGF 286
NN L G
Sbjct: 297 AYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.0 bits (198), Expect = 4e-17
Identities = 60/277 (21%), Positives = 101/277 (36%), Gaps = 23/277 (8%)
Query: 196 GKLKSLLQLDLSENQFSG--SIPLSLGNLSSLTMMSLFNN-SLSGSIPPILGNLKSLSAL 252
+ + LDLS IP SL NL L + + +L G IPP + L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 253 GLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP 312
+ ++G IP + + +L L N L G +P I
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS------------------L 148
Query: 313 HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNN 372
++ + + N +SG + +++G L + N L+ +S N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208
Query: 373 ISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSL 432
+ G G+ Q + L+ N + + + + N N++ G +P L
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRN-NRIYGTLPQGLTQL 267
Query: 433 TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQL 469
L L++S N L IP GNL + +NN+
Sbjct: 268 KFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 80.6 bits (197), Expect = 6e-17
Identities = 61/268 (22%), Positives = 97/268 (36%), Gaps = 11/268 (4%)
Query: 244 GNLKSLSALGLHINQLNGF--IPPSIGNLSSLRVLYLYNN-GLYGFVPEEIGYLKSLSEL 300
++ L L L IP S+ NL L LY+ L G +P I L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 301 ELCTNLLRGVI------PHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEIS 354
+ + G I ++ + + N LSG + + PNL + N G I
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 355 FNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKL 414
++G+FSKL T + N + + S +++ L +
Sbjct: 167 DSYGSFSKLFTSMTISRN-RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 415 ILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIP 474
I + G L LDL N++ ++P+ + L LH LN+S N L +IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 475 TEFEKLIHLSELDLSHNILQEEIPPQVC 502
+ L ++N P C
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.0 bits (167), Expect = 3e-13
Identities = 59/286 (20%), Positives = 97/286 (33%), Gaps = 25/286 (8%)
Query: 266 SIGNLSSLRVLYLYNNGLYGF--VPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQN 323
+ + L L L +P + L L+ L + N
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIG-----------------GIN 87
Query: 324 NLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGN 383
NL G + A L +L +++ N G I L T S N +SG++PP I +
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 384 SPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNL-NQLSGGVPLEFGSLTKLQYLDLST 442
P L + N I G IP S L + N+L+G +P F +L
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRN 207
Query: 443 NKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVC 502
+ + N+ K ++ DL +N + +P +
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLT 265
Query: 503 NMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELH--GPIP 546
+ L LN+S NNL IP+ ++ + N+ P+P
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 66.7 bits (161), Expect = 2e-12
Identities = 62/258 (24%), Positives = 102/258 (39%), Gaps = 29/258 (11%)
Query: 334 GDHPNLTFLDLSNNNFCG--EISFNWGNFSKLSTFIVSMN-NISGSIPPDIGNSPKLQVL 390
+ LDLS N I + N L+ + N+ G IPP I +L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 391 DLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIP 450
++ ++ G IP L + +L L + N LSG +P SL L + N++S +IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 451 KSIGNLLKLHY-LNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMG---- 505
S G+ KL + +S N+L+ KIP F L + + + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 506 ------------------SLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPN 547
+L L+L +N + +P+ +++ L +++S+N L G IP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 548 S---TAFKDGLMEGNKGL 562
F NK L
Sbjct: 287 GGNLQRFDVSAYANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.5 bits (150), Expect = 5e-11
Identities = 18/61 (29%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 158 LCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPL 217
L +N ++G++P L L L L + N+L G IP G L+ + N+ PL
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPL 309
Query: 218 S 218
Sbjct: 310 P 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 5e-10
Identities = 25/135 (18%), Positives = 45/135 (33%), Gaps = 1/135 (0%)
Query: 10 LKWKTSLQNQNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNGT 69
L ++ L + ++ +S G + GS + + +
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 70 FHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQL 129
F +L L+L N +G +P + L L L++ N L G I P+ G L +
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRF 293
Query: 130 RRLYLDMNQLHGTIP 144
N+ P
Sbjct: 294 DVSAYANNKCLCGSP 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 8e-19
Identities = 26/165 (15%), Positives = 49/165 (29%), Gaps = 18/165 (10%)
Query: 607 IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADH------DEFLNEVLALKEIRHRN 660
+G+G + +V+ VK S F + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 661 NVKFHGFCYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH 720
K G +++ + ++ L D + V+ + ++ +H
Sbjct: 68 LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 721 DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSNWTEF 765
I+H D+S NVL+ + DF + V W E
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQS--VEVGEEGWREI 160
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (209), Expect = 1e-18
Identities = 65/265 (24%), Positives = 106/265 (40%), Gaps = 13/265 (4%)
Query: 142 TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSL 201
+P I + ++ L N + +S NL +L+L+ N L+ + L L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 202 LQLDLSENQFSGSI-PLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN 260
QLDLS+N S+ P + L L + L L P + L +L L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 261 GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSI----- 315
+ +L +L L+L+ N + L SL L L N + V PH+
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 316 -ERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNIS 374
+ L NNLS EA L +L L++N + + ++ L F S + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP-LWAWLQKFRGSSSEVP 261
Query: 375 GSIPPDIGNSPKLQVLDLSSNHIVG 399
S+P + + L++N + G
Sbjct: 262 CSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (203), Expect = 5e-18
Identities = 59/239 (24%), Positives = 91/239 (38%), Gaps = 2/239 (0%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
IP + +R+ L+ N +S +F NLT L L +N + + + L +S
Sbjct: 30 IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89
Query: 371 NNISGSIPP-DIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEF 429
N S+ P +L L L + P L++L L L N L F
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149
Query: 430 GSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLS 489
L L +L L N++SS ++ L L L L N+++H P F L L L L
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 490 HNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNS 548
N L + + +L+ L L+ N R L S +E+ +P
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPW-VCDCRARPLWAWLQKFRGSSSEVPCSLPQR 267
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (188), Expect = 5e-16
Identities = 47/243 (19%), Positives = 84/243 (34%), Gaps = 4/243 (1%)
Query: 19 QNLNSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSF 78
++ ++ + + + + + + + +S + +F
Sbjct: 45 SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL 104
Query: 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQ 138
L L+L P L+ LQYL L N L L L L L+L N+
Sbjct: 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164
Query: 139 LHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKL 198
+ L +D+L L N + P + +L L LYL+ N+LS + L
Sbjct: 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224
Query: 199 KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQ 258
++L L L++N + + L ++ + S+P L L N
Sbjct: 225 RALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAAND 280
Query: 259 LNG 261
L G
Sbjct: 281 LQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (187), Expect = 8e-16
Identities = 55/254 (21%), Positives = 84/254 (33%), Gaps = 5/254 (1%)
Query: 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMN 137
+ L N L L L SN L+ + L L +L L N
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 138 QLHGTIPP-EIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIG 196
++ P L + L L L P L+ L LYL N+L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 197 KLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHI 256
L +L L L N+ S + L SL + L N ++ P +L L L L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 257 NQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIE 316
N L+ ++ L +L+ L L +N L + ++ + +P +
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 317 RVL---LNQNNLSG 327
L N+L G
Sbjct: 270 GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 7e-06
Identities = 32/134 (23%), Positives = 51/134 (38%), Gaps = 3/134 (2%)
Query: 425 VPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS 484
VP+ + + Q + L N++S S L L L +N L+ F L L
Sbjct: 26 VPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 485 ELDLSHNILQEEIPPQV-CNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHG 543
+LDLS N + P +G L L+L L + P F + +L + + N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 544 PIPNSTAFKDGLME 557
++ L
Sbjct: 144 LPDDTFRDLGNLTH 157
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 61.6 bits (148), Expect = 3e-11
Identities = 37/222 (16%), Positives = 69/222 (31%), Gaps = 12/222 (5%)
Query: 245 NLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCT 304
L + + + + + + +L + L + G+ E + YL +L LEL
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 305 NLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS 364
N + + P L + + + L
Sbjct: 73 NQITDLAPLK----NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 365 TFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGG 424
+ + + I + + LS + L LS L L + N++S
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 425 VPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSN 466
P SL L + L N++S P + N L + L+N
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 57.3 bits (137), Expect = 1e-09
Identities = 45/223 (20%), Positives = 80/223 (35%), Gaps = 13/223 (5%)
Query: 198 LKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHIN 257
L + +++ ++ + ++ + +L +T +S F ++ +I + L +L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGV-QYLNNLIGLELKDN 73
Query: 258 QLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIER 317
Q+ + NL+ + L L N L +L +
Sbjct: 74 QI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 318 VLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSI 377
+L + NL +L + N N SKL+T N IS
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPL--ANLSKLTTLKADDNKISDIS 189
Query: 378 PPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQ 420
P + + P L + L +N I P L S+L + L NQ
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 6e-07
Identities = 29/221 (13%), Positives = 65/221 (29%), Gaps = 12/221 (5%)
Query: 173 NLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFN 232
L+N + K++++ ++ L + L + +I + L++L + L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 233 NSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIG 292
N ++ P + L + + I + + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 293 YLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGE 352
L + L G+ + N + LT L +N
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYL----SIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 353 ISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLS 393
+ L + N IS P + N+ L ++ L+
Sbjct: 189 SPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 39/222 (17%), Positives = 71/222 (31%), Gaps = 22/222 (9%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
F + + + + + +L + L ++ + + LN L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGL 68
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
L NQ+ P + +L+ +I + + +
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 193 SIIGKL--------------KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGS 238
S + L LS S L NLS LT + +N +S
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 239 IPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYN 280
P L +L +L + L NQ++ P + N S+L ++ L N
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 6e-06
Identities = 34/225 (15%), Positives = 68/225 (30%), Gaps = 20/225 (8%)
Query: 294 LKSLSELELCTNLLRGVIPH----SIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF 349
L + ++ + + + I + ++ E NL L+L +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI 75
Query: 350 CGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLS 409
+ +I ++ L++L
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135
Query: 410 SLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQL 469
I N++ L+ LS S + NL KL L +N++
Sbjct: 136 LDLNQITNISPLA----------GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185
Query: 470 SHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSH 514
S P L +L E+ L +N + + P + N +L + L++
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 28/214 (13%), Positives = 67/214 (31%), Gaps = 22/214 (10%)
Query: 338 NLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397
N + +N ++ + ++T ++ + L L+L N I
Sbjct: 20 NAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQI 75
Query: 398 VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL 457
P++ + +L N + + T T+ + ++ L
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135
Query: 458 KLHYLNLSNNQL--------------SHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCN 503
+ + L T L L+ L N + + P + +
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LAS 193
Query: 504 MGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDIS 537
+ +L +++L +N +SD P +L + ++
Sbjct: 194 LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 16/69 (23%), Positives = 26/69 (37%), Gaps = 5/69 (7%)
Query: 70 FHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQL 129
++ L L N PL +L L + L +NQ+S + P + + L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 130 RRLYLDMNQ 138
+ L NQ
Sbjct: 220 FIVTLT-NQ 227
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (147), Expect = 9e-11
Identities = 40/279 (14%), Positives = 81/279 (29%), Gaps = 16/279 (5%)
Query: 155 KLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSG- 213
L L NLH + L + + ++ + + + + +DLS +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 214 SIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSL 273
++ L S L +SL LS I L +L L L S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 274 RVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAF 333
R+ L + + F + + + + L G + S
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN---------LQKSDLSTLVR 172
Query: 334 GDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVS-MNNISGSIPPDIGNSPKLQVLDL 392
+ + + + + L +S +I ++G P L+ L +
Sbjct: 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQV 232
Query: 393 SSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGS 431
G + + +L L +N + + G+
Sbjct: 233 FGIVPDGTLQ---LLKEALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 36/162 (22%), Positives = 61/162 (37%), Gaps = 5/162 (3%)
Query: 388 QVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPL-EFGSLTKLQYLDLSTNKLS 446
Q LDL+ ++ + L S + + PL E S ++Q++DLS + +
Sbjct: 3 QTLDLTGKNLHPDV---TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 447 -SSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMG 505
S++ + KL L+L +LS I K +L L+LS E Q
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 506 SLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPN 547
L+ + DF + + + I+ L G N
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 3e-08
Identities = 33/290 (11%), Positives = 75/290 (25%), Gaps = 37/290 (12%)
Query: 180 LYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG-S 238
L L +L + + ++ + + + M L N+ + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 239 IPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLS 298
+ IL L L L +L+ I ++ S+L L L + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS--- 119
Query: 299 ELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWG 358
C+ L + + + + E + N +
Sbjct: 120 ----CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK--NLQKSDLSTLVRR 173
Query: 359 NFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNL 418
+ + + + + LQ L LS
Sbjct: 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS-----------------------RC 210
Query: 419 NQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNL--LKLHYLNLSN 466
+ LE G + L+ L + ++ L L+++ + +
Sbjct: 211 YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTT 260
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 9e-08
Identities = 40/267 (14%), Positives = 82/267 (30%), Gaps = 15/267 (5%)
Query: 297 LSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGE-ISF 355
L+ L ++ ++ + ++ + + E F + +DLSN+ +
Sbjct: 7 LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHG 65
Query: 356 NWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLI 415
SKL + +S I + + L L+LS + +Q + S
Sbjct: 66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125
Query: 416 LNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSS---------SIPKSIGNLLKLHYLNLSN 466
LNL+ ++ LS +H +
Sbjct: 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS 185
Query: 467 NQLSHKIPTEFEKLIHLSELDLSH-NILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCF 525
L + EF +L +L L LS + E ++ + +L+ L + +
Sbjct: 186 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK 245
Query: 526 EEMRSLSCIDISYNELHGPIPNSTAFK 552
E + L I+ + + K
Sbjct: 246 EALPHL---QINCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 7e-07
Identities = 47/259 (18%), Positives = 84/259 (32%), Gaps = 41/259 (15%)
Query: 55 RVISITMSTLGLNGTFHD---FSFSSFPHLANLNLSFNLFFGN-IPLQIGNLSKLQYLDL 110
R++S + +F D S + +++LS ++ + + + SKLQ L L
Sbjct: 19 RLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78
Query: 111 GSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLI----------------- 153
+LS I + K + L RL L + S
Sbjct: 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH 138
Query: 154 --------------DKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSL--SGSIPSIIGK 197
L+ NL S S+L V +S+ +
Sbjct: 139 VQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ 198
Query: 198 LKSLLQLDLSE-NQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHI 256
L L L LS L LG + +L + +F G++ + ++L L ++
Sbjct: 199 LNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINC 255
Query: 257 NQLNGFIPPSIGNLSSLRV 275
+ P+IGN + +
Sbjct: 256 SHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 4e-06
Identities = 34/247 (13%), Positives = 80/247 (32%), Gaps = 15/247 (6%)
Query: 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEI-GKLNQLRRLYLDMNQ 138
+ F + + ++Q++DL ++ + I + ++L+ L L+ +
Sbjct: 24 GVIAFRCP-RSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 139 LHGTIPPEIGQLSLIDKL--ALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSII- 195
L I + + S + +L + C ++ + L + S L L L +
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 196 ------GKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSL 249
+ L Q S L + + + + L L L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 250 SALGL-HINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308
L L + +G + +L+ L ++ G + ++L L++ +
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK---EALPHLQINCSHFT 259
Query: 309 GVIPHSI 315
+ +I
Sbjct: 260 TIARPTI 266
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.8 bits (148), Expect = 1e-10
Identities = 58/333 (17%), Positives = 114/333 (34%), Gaps = 21/333 (6%)
Query: 199 KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQ 258
+ +L+L+ S S+P +L SL NSL+ +P + +LKSL ++
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 259 LNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERV 318
L+ P L L + NN L + + +++ + +P S+E +
Sbjct: 93 LSDLPP-------LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFI 145
Query: 319 LLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIP 378
N L + D ++ ++ + + + + + +
Sbjct: 146 AAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPF 205
Query: 379 PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYL 438
+ + L + + + + F L++L
Sbjct: 206 LTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 265
Query: 439 DLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIP 498
N S+ I L LN+SNN+L +P +L L S N L E +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHLAE-VP 320
Query: 499 PQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSL 531
+L++L++ +N L + P E + L
Sbjct: 321 EL---PQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.4 bits (147), Expect = 1e-10
Identities = 55/332 (16%), Positives = 109/332 (32%), Gaps = 22/332 (6%)
Query: 127 NQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNS 186
Q L L+ L ++P L L N+L +P +L +L V
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNN---- 88
Query: 187 LSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNL 246
++ ++ L L +S NQ L + + + + +PP L +
Sbjct: 89 ---NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFI 145
Query: 247 KSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNL 306
+ + + +L + + + L + L +
Sbjct: 146 AAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPF 205
Query: 307 LRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTF 366
L + + L S + ++ + F + S+L
Sbjct: 206 LTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 265
Query: 367 IVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVP 426
+ +N S I P L+ L++S+N ++ ++P + L +LI + N L+ VP
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVP 320
Query: 427 LEFGSLTKLQYLDLSTNKLSS--SIPKSIGNL 456
L+ L + N L IP+S+ +L
Sbjct: 321 ---ELPQNLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.0 bits (146), Expect = 2e-10
Identities = 53/326 (16%), Positives = 97/326 (29%), Gaps = 31/326 (9%)
Query: 175 SNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234
L L LS S+P + L+SL S N + +P +L SL + + +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 235 LSGSIPPILGNLKSLSA---------LGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYG 285
LS P + S + + ++
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 286 FVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLS 345
E+ L L+ + N L+ + + + N + + P LT +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 346 NNNFCGEISFNWGNFSKLSTFIVSMNNISG--------SIPPDIGNSPKLQVLDLSSNHI 397
NN + + +L N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 398 VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL 457
+I ++ SL +L ++ N+L +P +L+ L S N L + +P+ N
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHL-AEVPELPQN-- 325
Query: 458 KLHYLNLSNNQLSHKIPTEFEKLIHL 483
L L++ N L + P E + L
Sbjct: 326 -LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 8e-08
Identities = 25/95 (26%), Positives = 39/95 (41%), Gaps = 9/95 (9%)
Query: 181 YLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIP 240
Y N+ S I S+ SL +L++S N+ +P L L N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP 320
Query: 241 PILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRV 275
+ NLK L + N L P ++ LR+
Sbjct: 321 ELPQNLKQLH---VEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 9e-07
Identities = 23/156 (14%), Positives = 41/156 (26%), Gaps = 9/156 (5%)
Query: 22 NSSLLSSWTLYPANATKISPCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHL 81
L + + T + + FS L
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262
Query: 82 ANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHG 141
N I L+ L++ +N+L +P + L RL N L
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHL-A 317
Query: 142 TIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNL 177
+P L + + +N L P ++ +L
Sbjct: 318 EVPELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 9e-06
Identities = 21/98 (21%), Positives = 40/98 (40%), Gaps = 12/98 (12%)
Query: 320 LNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPP 379
N S ++ P+L L++SNN + +L I S N+++ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNK----LIELPALPPRLERLIASFNHLA-EVPE 321
Query: 380 DIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILN 417
N L+ L + N + + P ++ S+ L +N
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFP---DIPESVEDLRMN 352
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 3e-10
Identities = 44/181 (24%), Positives = 62/181 (34%), Gaps = 4/181 (2%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
+P + L++N L + LT L+L + +
Sbjct: 29 LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT---KLQVDGTLPVLGTLDLS 85
Query: 371 NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFG 430
+N S+P P L VLD+S N + L L L +L L N+L P
Sbjct: 86 HNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLT 145
Query: 431 SLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSH 490
KL+ L L+ N L+ + L L L L N L IP F L L
Sbjct: 146 PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHG 204
Query: 491 N 491
N
Sbjct: 205 N 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 4e-10
Identities = 44/187 (23%), Positives = 66/187 (35%), Gaps = 6/187 (3%)
Query: 95 IPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLID 154
+P + L L N L + +L +L LD +L +
Sbjct: 25 LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 155 KLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGS 214
+N S+P L L VL + N L+ + L L +L L N+
Sbjct: 83 D---LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 215 IPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLR 274
P L L +SL NN+L+ +L L++L L L N L IP L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 275 VLYLYNN 281
+L+ N
Sbjct: 199 FAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 6e-09
Identities = 44/208 (21%), Positives = 71/208 (34%), Gaps = 7/208 (3%)
Query: 98 QIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLA 157
++ ++ ++ L+ +PP++ K L+L N L+ + + + +L
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 158 LCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPL 217
L L L L L L N L + D+S N+ +
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 218 SLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLY 277
+L L L + L N L P +L L L L N L + L +L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 278 LYNNGLYGFVPEEIGYLKSLSELELCTN 305
L N LY +P+ L L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 47/183 (25%), Positives = 68/183 (37%), Gaps = 4/183 (2%)
Query: 78 FPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMN 137
L+LS NL + + ++L L+L +L+ G L L L L N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDLSHN 87
Query: 138 QLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGK 197
Q ++P L + L + N L +L L L LYL N L P ++
Sbjct: 88 Q-LQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 198 LKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHIN 257
L +L L+ N + L L +L + L NSL +IP L LH N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
Query: 258 QLN 260
Sbjct: 206 PWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 4e-07
Identities = 45/190 (23%), Positives = 71/190 (37%), Gaps = 28/190 (14%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKL 435
++PPD+ +L LS N + L + L +L NL++ G+L L
Sbjct: 24 ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL--NLDRAELTKLQVDGTLPVL 79
Query: 436 QYLDLSTNK-----------------------LSSSIPKSIGNLLKLHYLNLSNNQLSHK 472
LDLS N+ L+S ++ L +L L L N+L
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 473 IPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLS 532
P L +L L++N L E + + +L+ L L N+L IP+ F L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLP 198
Query: 533 CIDISYNELH 542
+ N
Sbjct: 199 FAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 7e-07
Identities = 40/196 (20%), Positives = 65/196 (33%), Gaps = 10/196 (5%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218
C ++P L + +L+L +N L + + L QL+L + +
Sbjct: 17 CDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74
Query: 219 LGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYL 278
L L + L +N L + N+L ++ L L+ LYL
Sbjct: 75 --TLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQELYL 131
Query: 279 YNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIE-----RVLLNQNNLSGKMYEAF 333
N L P + L +L L N L + + LL Q N + + F
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGF 191
Query: 334 GDHPNLTFLDLSNNNF 349
L F L N +
Sbjct: 192 FGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 7e-04
Identities = 27/163 (16%), Positives = 53/163 (32%), Gaps = 6/163 (3%)
Query: 425 VPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS 484
+P + L LS N L + ++ +L LNL +L+ ++
Sbjct: 25 LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 485 ELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGP 544
+ + + +P + +L L++S N L+ + L + + NE
Sbjct: 83 D---LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE-LKT 138
Query: 545 IPNSTAFKDGLMEGNKGLKRVSQEEQSNSMNRLRLLSVLNFDG 587
+P +E E + +N L L L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.002
Identities = 24/96 (25%), Positives = 33/96 (34%), Gaps = 1/96 (1%)
Query: 69 TFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQ 128
+ + L L L N P + KL+ L L +N L+ L + L
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 129 LRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLH 164
L L L N L+ TIP L+ L N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 2e-08
Identities = 27/109 (24%), Positives = 44/109 (40%), Gaps = 6/109 (5%)
Query: 436 QYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQE 495
+ L L+ L+ + LL + +L+LS+N+L P L L L S N
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--AL 55
Query: 496 EIPPQVCNMGSLEKLNLSHNNLSDF-IPRCFEEMRSLSCIDISYNELHG 543
E V N+ L++L L +N L + L +++ N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 2e-08
Identities = 29/120 (24%), Positives = 48/120 (40%), Gaps = 7/120 (5%)
Query: 84 LNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTI 143
L+L+ + + L + +LDL N+L +PP + L L L +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLE--VLQASDNALEN 57
Query: 144 PPEIGQLSLIDKLALCHNNL-HGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLL 202
+ L + +L LC+N L + L + L +L L NSL I +L +L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 1e-07
Identities = 36/125 (28%), Positives = 52/125 (41%), Gaps = 9/125 (7%)
Query: 414 LILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKI 473
L L L+ V L + +LDLS N+L + P ++ L L L S+N +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57
Query: 474 PTEFEKLIHLSELDLSHNILQE-EIPPQVCNMGSLEKLNLSHNNLS---DFIPRCFEEMR 529
L L EL L +N LQ+ + + L LNL N+L R E +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 530 SLSCI 534
S+S I
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 5e-07
Identities = 25/116 (21%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 369 SMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLE 428
+ +++ + + + LDLS N + P L L L +L + +
Sbjct: 6 AHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALENVDG 60
Query: 429 FGSLTKLQYLDLSTNKLSS-SIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHL 483
+L +LQ L L N+L + + + + +L LNL N L + E+L +
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 3e-06
Identities = 30/126 (23%), Positives = 49/126 (38%), Gaps = 9/126 (7%)
Query: 179 VLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGS 238
VL+L L+ + + +L + LDLS N+ P +L L L ++ +N+
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LE 56
Query: 239 IPPILGNLKSLSALGLHINQLNGFIPP-SIGNLSSLRVLYLYNN---GLYGFVPEEIGYL 294
+ NL L L L N+L + + L +L L N G L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 295 KSLSEL 300
S+S +
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 5e-06
Identities = 32/121 (26%), Positives = 46/121 (38%), Gaps = 7/121 (5%)
Query: 130 RRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG 189
R L+L L T+ + QL L+ L L HN L P +L L L VL N+L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 190 SIPSIIGKLKSLLQLDLSENQF-SGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKS 248
+L L N+ + L + L +++L NSL I L
Sbjct: 58 VDGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 249 L 249
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 3e-05
Identities = 26/109 (23%), Positives = 39/109 (35%), Gaps = 8/109 (7%)
Query: 252 LGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVI 311
L L L + + L + L L +N L P + L+ L L+ N L V
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 312 PH----SIERVLLNQNNL-SGKMYEAFGDHPNLTFLDLSNNNFCGEISF 355
++ +LL N L + P L L+L N+ C E
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 108
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 3e-05
Identities = 25/142 (17%), Positives = 48/142 (33%), Gaps = 24/142 (16%)
Query: 274 RVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAF 333
RVL+L + L V + L ++ L+L N LR + A
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-------------------LPPAL 39
Query: 334 GDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNI-SGSIPPDIGNSPKLQVLDL 392
L L S+N + ++ N + + + + P+L +L+L
Sbjct: 40 AALRCLEVLQASDNALENVDGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNL 97
Query: 393 SSNHIVGKIPVQLEMLSSLNKL 414
N + + +Q + L +
Sbjct: 98 QGNSLCQEEGIQERLAEMLPSV 119
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (124), Expect = 2e-08
Identities = 30/134 (22%), Positives = 59/134 (44%), Gaps = 6/134 (4%)
Query: 391 DLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIP 450
+L + ++ + + ++ L+L L + + L+ + +++++
Sbjct: 3 ELKPEQV-EQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLR 58
Query: 451 KSIGNLLKLHYLNLSNNQLSHK--IPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLE 508
N+ +L LNLSNN+L + + +K +L L+LS N L+ E LE
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 509 KLNLSHNNLSDFIP 522
+L L N+LSD
Sbjct: 119 ELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (117), Expect = 2e-07
Identities = 34/163 (20%), Positives = 64/163 (39%), Gaps = 7/163 (4%)
Query: 109 DLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIP 168
+L Q+ + + K + LD+ L P++ ++ L +++ ++
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLR 58
Query: 169 SSLGNLSNLAVLYLYKNSLSG--SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLT 226
N+ L L L N L + SI+ K +L L+LS N+ L L
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 227 MMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNG-FIPPSIG 268
+ L NSLS + + ++ + +L+G +PP I
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 5e-06
Identities = 33/135 (24%), Positives = 49/135 (36%), Gaps = 16/135 (11%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSG--GVPLEFGSLT 433
PD+ VL+ S+ + + E + L L L+ N+L +
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91
Query: 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE-------FEKLIHLSEL 486
L+ L+LS N+L S LKL L L N LS + E+ L L
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
Query: 487 DLSHNILQEEIPPQV 501
D E+PP +
Sbjct: 152 D------GHELPPPI 160
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 7e-05
Identities = 29/142 (20%), Positives = 55/142 (38%), Gaps = 5/142 (3%)
Query: 287 VPEEIGYLKSLSELELCTNLLR---GVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLD 343
+ + S+ L LR ++ +I+ VL +++++ + + P L L+
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLN 71
Query: 344 LSNNNF--CGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKI 401
LSNN ++S L +S N + D KL+ L L N +
Sbjct: 72 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131
Query: 402 PVQLEMLSSLNKLILNLNQLSG 423
Q +S++ + L +L G
Sbjct: 132 RDQSTYISAIRERFPKLLRLDG 153
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 6e-04
Identities = 24/117 (20%), Positives = 46/117 (39%), Gaps = 3/117 (2%)
Query: 63 TLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL--IP 120
L L G D + LN + + + N+ +L L+L +N+L L +
Sbjct: 26 ALDLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRLYRLDDMS 84
Query: 121 PEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNL 177
+ K L+ L L N+L + + +++L L N+L + +S +
Sbjct: 85 SIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.2 bits (124), Expect = 2e-08
Identities = 21/154 (13%), Positives = 53/154 (34%), Gaps = 5/154 (3%)
Query: 427 LEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSEL 486
++ + + + LDL K+ I L + ++ S+N++ F L L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTL 68
Query: 487 DLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIP 546
+++N + + L +L L++N+L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 547 NSTAFKDGLMEGNKGL--KRVSQEEQSNSMNRLR 578
+ + + + L ++V +E+ + +
Sbjct: 129 HYRLYVIYKVPQVRVLDFQKVKLKERQEAEKMFK 162
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (103), Expect = 1e-05
Identities = 24/139 (17%), Positives = 50/139 (35%), Gaps = 7/139 (5%)
Query: 74 SFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLY 133
+++ L+L I L + +D N++ L L +L+ L
Sbjct: 13 QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 69
Query: 134 LDMNQLHGTIPPEIGQLSLIDKLALCHNNLHG-SIPSSLGNLSNLAVLYLY---KNSLSG 189
++ N++ L + +L L +N+L L +L +L L + +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 190 SIPSIIGKLKSLLQLDLSE 208
+I K+ + LD +
Sbjct: 130 YRLYVIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 19/92 (20%), Positives = 32/92 (34%), Gaps = 3/92 (3%)
Query: 97 LQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKL 156
Q N + + LDL ++ I L+Q + N++ L + L
Sbjct: 12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 68
Query: 157 ALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLS 188
+ +N + L +L L L NSL
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 26/135 (19%), Positives = 42/135 (31%), Gaps = 7/135 (5%)
Query: 359 NFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNL 418
N + + I I + +D S N I +L L L++N
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKTLLVNN 72
Query: 419 NQLSGGVPLEFGSLTKLQYLDLSTNKLSS-SIPKSIGNLLKLHYLNLSN---NQLSHKIP 474
N++ +L L L L+ N L + +L L YL + H
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 475 TEFEKLIHLSELDLS 489
K+ + LD
Sbjct: 133 YVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 23/139 (16%), Positives = 35/139 (25%), Gaps = 13/139 (9%)
Query: 217 LSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVL 276
N + L + I + L A+ N++ L L+ L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 68
Query: 277 YLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVL----------LNQNNLS 326
+ NN + L L+EL L N L + L N
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 327 GKMYEAFGDHPNLTFLDLS 345
P + LD
Sbjct: 129 HYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 21/139 (15%), Positives = 42/139 (30%), Gaps = 7/139 (5%)
Query: 379 PDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYL 438
N+ + + LDL I I L + + + N++ F L +L+ L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTL 68
Query: 439 DLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIP 498
++ N++ L L L L+NN L + +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 499 PQ----VCNMGSLEKLNLS 513
+ + + L+
Sbjct: 129 HYRLYVIYKVPQVRVLDFQ 147
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.8 bits (117), Expect = 3e-07
Identities = 48/175 (27%), Positives = 69/175 (39%), Gaps = 7/175 (4%)
Query: 376 SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLE-MLSSLNKLILNLNQLSGGVPLEFGSLTK 434
IP DI L L+ N + L L L KL L NQL+G P F +
Sbjct: 22 EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 435 LQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQ 494
+Q L L NK+ K L +L LNL +NQ+S +P FE L L+ L+ +
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPF 138
Query: 495 EEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIPNST 549
L K +L+ P ++R + D+ ++E NS
Sbjct: 139 NCNCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFKCSSENSE 190
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 2e-05
Identities = 40/157 (25%), Positives = 61/157 (38%), Gaps = 5/157 (3%)
Query: 105 LQYLDLGSNQLSGLIPPEI-GKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNL 163
L L N+L + + G+L L +L L NQL G P S I +L L N +
Sbjct: 31 TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90
Query: 164 HGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLS 223
L L L LY N +S +P L SL L+L+ N F+ + L+
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAE 149
Query: 224 SLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN 260
L SL + P + +++ L ++
Sbjct: 150 WLRKKSLNGGAARCGAPSKVRDVQIKD---LPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 38/163 (23%), Positives = 62/163 (38%), Gaps = 5/163 (3%)
Query: 190 SIPSIIGKLKSLLQLDLSENQFSGSIPLSL-GNLSSLTMMSLFNNSLSGSIPPILGNLKS 248
IP I +L L++N+ L G L L + L N L+G P
Sbjct: 22 EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 249 LSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308
+ L L N++ L L+ L LY+N + +P +L SL+ L L +N
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 309 GVIPHSIERVLLNQNNLSGKMY--EAFGDHPNLTFLDLSNNNF 349
+ L + +L+G A ++ DL ++ F
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.6 bits (88), Expect = 0.001
Identities = 26/168 (15%), Positives = 47/168 (27%), Gaps = 8/168 (4%)
Query: 33 PANATKIS----PCSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSF 88
P + T++ + +F H+ L L
Sbjct: 28 PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87
Query: 89 NLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIG 148
N L +L+ L+L NQ+S ++P LN L L +
Sbjct: 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHLAW 146
Query: 149 QLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIG 196
+ K +L PS + ++ + L + S + G
Sbjct: 147 FAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 7e-07
Identities = 16/93 (17%), Positives = 32/93 (34%), Gaps = 5/93 (5%)
Query: 384 SPKLQVLDLSSNHIVGKIPVQL-EMLSSLNKLILNLNQLSGGVPLEFGS----LTKLQYL 438
S +Q LD+ + +L +L + L+ L+ + S L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 439 DLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSH 471
+L +N+L + L+ + L +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 18/81 (22%), Positives = 30/81 (37%), Gaps = 9/81 (11%)
Query: 458 KLHYLNLSNNQLSHK----IPTEFEKLIHLSELDLSHNILQEEIPPQVC-----NMGSLE 508
L L L++ +S + L ELDLS+N L + Q+ LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 509 KLNLSHNNLSDFIPRCFEEMR 529
+L L S+ + + +
Sbjct: 430 QLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 22/99 (22%), Positives = 36/99 (36%), Gaps = 15/99 (15%)
Query: 429 FGSLTKLQYLDLSTNKLSSSIPKSIGNLLK----LHYLNLSNNQLSHKIPTEFEKLI--- 481
+ L+ L L+ +S S S+ L L L+LSNN L + + +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 482 --HLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLS 518
L +L L EE+ + L+ L +L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 17/86 (19%), Positives = 29/86 (33%), Gaps = 9/86 (10%)
Query: 404 QLEMLSSLNKLILNLNQLSGGVPLEFGS----LTKLQYLDLSTNKLSSSIPKSIGNLLK- 458
+ S L L L +S + L+ LDLS N L + + ++
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 459 ----LHYLNLSNNQLSHKIPTEFEKL 480
L L L + S ++ + L
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 21/98 (21%), Positives = 34/98 (34%), Gaps = 9/98 (9%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSG----SIPSIIGKLKSLLQLDLSENQFSGS 214
+ S L VL+L +S S+ + + SL +LDLS N +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 215 IPLSLG-----NLSSLTMMSLFNNSLSGSIPPILGNLK 247
L L L + L++ S + L L+
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 7e-05
Identities = 16/90 (17%), Positives = 26/90 (28%), Gaps = 5/90 (5%)
Query: 153 IDKLALCHNNL-HGSIPSSLGNLSNLAVLYLYKNSLSG----SIPSIIGKLKSLLQLDLS 207
I L + L L L V+ L L+ I S + +L +L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 208 ENQFSGSIPLSLGNLSSLTMMSLFNNSLSG 237
N+ + + SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 12/92 (13%), Positives = 30/92 (32%), Gaps = 5/92 (5%)
Query: 176 NLAVLYLYKNSLSGS-IPSIIGKLKSLLQLDLSENQFSG----SIPLSLGNLSSLTMMSL 230
++ L + LS + ++ L+ + L + + I +L +L ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 231 FNNSLSGSIPPILGNLKSLSALGLHINQLNGF 262
+N L + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 19/109 (17%), Positives = 36/109 (33%), Gaps = 23/109 (21%)
Query: 356 NWGNFSKLSTFIVSMNNISG----SIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSL 411
S L ++ ++S S+ + + L+ LDLS+N + +QL + S+
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL--VESV 421
Query: 412 NKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLH 460
+ L+ L L S + + L K
Sbjct: 422 RQ-----------------PGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 12/88 (13%), Positives = 29/88 (32%), Gaps = 6/88 (6%)
Query: 338 NLTFLDLSNNNFCGE-ISFNWGNFSKLSTFIVSMNNISG----SIPPDIGNSPKLQVLDL 392
++ LD+ + + + ++ I + +P L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 393 SSNHIVGKIPVQL-EMLSSLNKLILNLN 419
SN + + + L + + I L+
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 21/91 (23%), Positives = 32/91 (35%), Gaps = 13/91 (14%)
Query: 199 KSLLQLDLSENQFSG----SIPLSLGNLSSLTMMSLFNNSLSGSIPPILG-----NLKSL 249
L L L++ S S+ +L SL + L NN L + L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 250 SALGLHINQLNGFIPPSIGNLS----SLRVL 276
L L+ + + + L SLRV+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 8e-07
Identities = 44/223 (19%), Positives = 72/223 (32%), Gaps = 15/223 (6%)
Query: 263 IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIER----- 317
IP + + L L L ++E+ N + VI +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 318 ---VLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI--SFNWGNFSKLSTFIVSMNN 372
+ NNL EAF + PNL +L +SN L ++N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 373 ISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSL 432
+ +G S + +L L+ N I + + N L F
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 433 TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPT 475
+ LD+S ++ S + NL KL + N + K+PT
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 5e-06
Identities = 29/239 (12%), Positives = 60/239 (25%), Gaps = 18/239 (7%)
Query: 190 SIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSL 249
IPS + ++ ++L + + L + + N + I + +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 250 SALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRG 309
N + + YL + ++
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK--------------IH 125
Query: 310 VIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVS 369
+ + + N N + + G L L+ N + + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 370 MNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLE 428
NN+ + +LD+S I LE L L + L LE
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR--ARSTYNLKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 6e-05
Identities = 26/238 (10%), Positives = 61/238 (25%), Gaps = 16/238 (6%)
Query: 272 SLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYE 331
S RV + + +P ++ ++ EL LR + + + +
Sbjct: 9 SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 332 AFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKL---- 387
++ + E + N + + + I + P +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 388 ------QVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLS 441
+ + N + + + L LN N + F +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 442 TNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPP 499
N L L++S ++ E L L + +++P
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 38/214 (17%), Positives = 64/214 (29%), Gaps = 6/214 (2%)
Query: 311 IPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSM 370
+P + + L AF +L +++S N+ I + + I
Sbjct: 27 LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86
Query: 371 --NNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPV--QLEMLSSLNKLILNLNQLSGGVP 426
NN+ P N P LQ L +S+ I V + L + N+N +
Sbjct: 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN 146
Query: 427 LEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSEL 486
G + L L+ N + + NN L F L
Sbjct: 147 SFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 206
Query: 487 DLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDF 520
D+S + + N+ L + NL
Sbjct: 207 DISRTRIHSLPSYGLENLKKLRARST--YNLKKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 34/231 (14%), Positives = 58/231 (25%), Gaps = 15/231 (6%)
Query: 159 CHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLS 218
C + IPS L N L L L ++++S+N I
Sbjct: 15 CQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 219 LGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYL 278
+ + + + + L I+ P + + SL+ + L
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 279 YNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKM--------- 329
E LS + L + I +
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192
Query: 330 -YEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPP 379
+ F LD+S S+ N KL S N+ +P
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR--STYNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 28/244 (11%), Positives = 59/244 (24%), Gaps = 20/244 (8%)
Query: 42 CSWFGISCNHAGSRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIPLQIGN 101
CS C + I + + L
Sbjct: 8 CSNRVFLCQESKVTEIPSDL----------------PRNAIELRFVLTKLRVIQKGAFSG 51
Query: 102 LSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHN 161
L+ +++ N + +I ++ + +L + L +
Sbjct: 52 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 111
Query: 162 NLH----GSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPL 217
N + L + N + S +G + L L++N
Sbjct: 112 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNC 171
Query: 218 SLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLY 277
+ + NN+L + L + +++ + NL LR
Sbjct: 172 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 231
Query: 278 LYNN 281
YN
Sbjct: 232 TYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 11/78 (14%), Positives = 20/78 (25%)
Query: 460 HYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSD 519
L L+ N + F +N L+E L++S +
Sbjct: 156 VILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215
Query: 520 FIPRCFEEMRSLSCIDIS 537
E ++ L
Sbjct: 216 LPSYGLENLKKLRARSTY 233
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 35/222 (15%), Positives = 69/222 (31%), Gaps = 34/222 (15%)
Query: 245 NLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCT 304
L + + + L+S+ + N+ + I YL ++++L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 305 NLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS 364
N L + P + NL L + + K
Sbjct: 78 NKLTDIKPLA-----------------------NLKNLGWLFLDENKVKDLSSLKDLKKL 114
Query: 365 TFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGG 424
+ +N I + + ++ + +L L +L+ ++ +
Sbjct: 115 KSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-- 172
Query: 425 VPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSN 466
LTKLQ L LS N +S +++ L L L L +
Sbjct: 173 ---PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 3e-06
Identities = 37/208 (17%), Positives = 68/208 (32%), Gaps = 16/208 (7%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
FS +F NL + L+ + + ++ + + I L + +L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
+L+ N+L P + L + + I
Sbjct: 74 FLNGNKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSAL 252
I G + L + L L+ L +SL +N +S +P L L L L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183
Query: 253 GLHINQLNGFIPPSIGNLSSLRVLYLYN 280
L N ++ ++ L +L VL L++
Sbjct: 184 YLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 7e-05
Identities = 38/222 (17%), Positives = 69/222 (31%), Gaps = 34/222 (15%)
Query: 173 NLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFN 232
+ L K S++ ++ +L S+ Q+ + + + L ++T + L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77
Query: 233 NSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIG 292
N L+ L NLK+L L +++ S+ +L L+ L L +NG+
Sbjct: 78 NKLTD--IKPLANLKNLGW--LFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 293 YLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGE 352
L V+ + L+ + L L LS N+
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI--- 190
Query: 353 ISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSS 394
S + L VL+L S
Sbjct: 191 -----------------------SDLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 28/200 (14%), Positives = 62/200 (31%), Gaps = 16/200 (8%)
Query: 338 NLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHI 397
+L + ++ N + + I + ++I I P + L L+ N +
Sbjct: 25 ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKL 80
Query: 398 VGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLL 457
L++L L + L K + S I +
Sbjct: 81 TDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 458 KLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNL 517
+N + + + + +I P + + L+ L LS N++
Sbjct: 136 LESLYLGNNKITDITVLSRL----TKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 190
Query: 518 SDFIPRCFEEMRSLSCIDIS 537
SD R +++L +++
Sbjct: 191 SDL--RALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 33/213 (15%), Positives = 62/213 (29%), Gaps = 24/213 (11%)
Query: 287 VPEEIGY------LKSLSELELCTNLLRGVIP----HSIERVLLNQNNLSGKMYEAFGDH 336
VP I + L + + +SI++++ N +++
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ--GIQYL 67
Query: 337 PNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNH 396
PN+T L L+ N + L + + K ++
Sbjct: 68 PNVTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122
Query: 397 IVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNL 456
+ I + + + + N V L L D + + + L
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-----LAGL 177
Query: 457 LKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLS 489
KL L LS N +S L +L L+L
Sbjct: 178 TKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 46/335 (13%), Positives = 94/335 (28%), Gaps = 48/335 (14%)
Query: 199 KSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG----SIPPILGNLKSLSALGL 254
KSL ++ S+ L S+ + L N++ + + + K L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 255 HINQLN----------GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCT 304
+ ++ L + L +N E + S
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL-EH 125
Query: 305 NLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS 364
L + + + + + P L + N W +
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185
Query: 365 TFIVSMNNISGSIPPDIGNSPKLQVLD-------------LSSNHIVGKIPVQLEMLSSL 411
+ ++ + I P+ L+ L ++ + + L+ +L
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245
Query: 412 NKLILNLNQLSG------GVPLEFGSLTKLQYLDLSTNKLSSSIPKSI-----GNLLKLH 460
+L LN LS LQ L L N++ +++ + L
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 461 YLNLSNNQLSH--KIPTEFEKLI------HLSELD 487
+L L+ N+ S + E ++ L ELD
Sbjct: 306 FLELNGNRFSEEDDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 3e-05
Identities = 45/336 (13%), Positives = 103/336 (30%), Gaps = 45/336 (13%)
Query: 224 SLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNG----FIPPSIGNLSSLRVLYLY 279
SL + ++ S+ +L S+ + L N + ++ +I + L +
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 280 NNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNL 339
+ E L+ L + L + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLK---------------CPKLHTVRLSDNAFGPTAQEP 112
Query: 340 TFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVG 399
LS + + + + ++ ++ N+P L+ + N +
Sbjct: 113 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172
Query: 400 KIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLD-------------LSTNKLS 446
+ ++L+ + + G+ E L+ L T+ S
Sbjct: 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 232
Query: 447 SSIPKSIGNLLKLHYLNLSNNQLSHKIPT------EFEKLIHLSELDLSHNILQEEIPPQ 500
S++ ++ + L L L++ LS + + I L L L +N ++ +
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292
Query: 501 VC-----NMGSLEKLNLSHNNLSDFIPRCFEEMRSL 531
+ M L L L+ N S+ +E+R +
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 38/351 (10%), Positives = 79/351 (22%), Gaps = 35/351 (9%)
Query: 81 LANLNLSFNLFFGN----IPLQIGNLSKLQYLDLGSNQLSG----LIPPEIGKLNQLRRL 132
+ +L + + + ++ + L N + + I L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
++ + +L L + L N+ +
Sbjct: 65 EFSDIFTG--------------RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 110
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSAL 252
+ S++ + L L + ++ N L ++
Sbjct: 111 EPLIDFL-------SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 163
Query: 253 GLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIP 312
N+L L + + E L L C L +
Sbjct: 164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 223
Query: 313 HSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEIS-FNWGNFSKLSTFIVSMN 371
+ L + L LS + F+ L T + N
Sbjct: 224 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 283
Query: 372 NISGSIPPDI-----GNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILN 417
I + P L L+L+ N + V E+ +
Sbjct: 284 EIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.004
Identities = 15/104 (14%), Positives = 29/104 (27%), Gaps = 8/104 (7%)
Query: 410 SLNKLILNLNQLSG----GVPLEFGSLTKLQYLDLSTNKLS----SSIPKSIGNLLKLHY 461
S+ L L+ ++ V ++ + LS N + + ++I + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 462 LNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMG 505
S+ E L L + L L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 107
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 3e-05
Identities = 38/194 (19%), Positives = 70/194 (36%), Gaps = 10/194 (5%)
Query: 245 NLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCT 304
L L + S +L + L G+ + + YL +L+++
Sbjct: 16 ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 305 NLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLS 364
N L + P L++ + ++ + L+ N N + L+
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 365 TFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGG 424
+S N I S + LQ L+ SSN + P L L++L +L ++ N++S
Sbjct: 132 RLELSSNTI--SDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD- 186
Query: 425 VPLEFGSLTKLQYL 438
LT L+ L
Sbjct: 187 -ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 32/204 (15%), Positives = 66/204 (32%), Gaps = 16/204 (7%)
Query: 73 FSFSSFPHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRL 132
F+ ++ L + +L ++ L + + + LN L ++
Sbjct: 12 FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQI 67
Query: 133 YLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIP 192
NQL P + L + L + + + I
Sbjct: 68 NFSNNQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 119
Query: 193 SIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSAL 252
I L + + S +L L+SL ++ +N ++ P L NL +L L
Sbjct: 120 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERL 177
Query: 253 GLHINQLNGFIPPSIGNLSSLRVL 276
+ N+++ + L++L L
Sbjct: 178 DISSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.0 bits (84), Expect = 0.004
Identities = 31/197 (15%), Positives = 64/197 (32%), Gaps = 18/197 (9%)
Query: 294 LKSLSELELCTNLLRGVIPHS----IERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNF 349
L + L + + + + + ++ + K + NLT ++ SNN
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQL 74
Query: 350 CGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLS 409
+ + + + ++ K L L
Sbjct: 75 TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 134
Query: 410 SLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQL 469
+ I +++ LSG L+ + + Q DL + NL L L++S+N++
Sbjct: 135 LSSNTISDISALSGLTSLQQLNFSSNQVTDLK----------PLANLTTLERLDISSNKV 184
Query: 470 SHKIPTEFEKLIHLSEL 486
S + KL +L L
Sbjct: 185 SD--ISVLAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 21/113 (18%), Positives = 36/113 (31%), Gaps = 3/113 (2%)
Query: 431 SLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEK-LIHLSELDLS 489
L + + + L L + N Q + + L L L +
Sbjct: 6 CPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 490 HNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELH 542
+ L+ P L +LNLS N L + + + + +S N LH
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL-QELVLSGNPLH 116
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 848 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.38 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.65 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.8 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.71 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.67 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.23 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.8 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.9 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=381.17 Aligned_cols=241 Identities=25% Similarity=0.335 Sum_probs=194.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|.++ +++.||||+++.... ....+.+.+|++++++++|||||++++++.+++..|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 467999999999999999999764 799999999976532 2334568899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.++++.. ..+++.++..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+|+...
T Consensus 81 vmEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEeccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 99999999999999754 5789999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC--CCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCccccccc----------------cccch
Q 038003 757 PHS--SNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSINF----------------SSFSN 817 (848)
Q Consensus 757 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~----------------~~~~~ 817 (848)
... ......+||+.|||||++.+..+ ++++||||+||++|||+||+.||....... ..+..
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCH
Confidence 322 22355789999999999988776 678999999999999999999996533211 12222
Q ss_pred hhhhhhhhcCCCCCCCCCCcccccceeecc
Q 038003 818 MIIDVNKILDPRLPTPSPSVMDYGGCHFML 847 (848)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (848)
...++...+-..-|..||.+.+....+|+.
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 264 (271)
T d1nvra_ 235 APLALLHKILVENPSARITIPDIKKDRWYN 264 (271)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 333333334444466667666666666654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=379.84 Aligned_cols=237 Identities=26% Similarity=0.389 Sum_probs=197.8
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc----ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 4799999999999999999975 479999999987653 23457789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++||+|.+++.. ..+++.++..++.||+.||+|||++ |||||||||+|||++.++.+||+|||+|+....
T Consensus 96 mEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 999999999998754 3589999999999999999999999 999999999999999999999999999998866
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcccccc----------------ccccchhhhh
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFFSIN----------------FSSFSNMIID 821 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~----------------~~~~~~~~~~ 821 (848)
........+||+.|+|||++.+..+++++||||+||++|||+||+.||...... ...+.....+
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHH
T ss_pred ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHH
Confidence 555556778999999999999999999999999999999999999998532210 0122233334
Q ss_pred hhhhcCCCCCCCCCCcccccceeec
Q 038003 822 VNKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
+...+-..-|..|+.+.+...+.|+
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCHhh
Confidence 4444444445566666665555554
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=6e-45 Score=389.53 Aligned_cols=296 Identities=30% Similarity=0.493 Sum_probs=272.0
Q ss_pred ChHHHHHHHHHHHhccCCCCCCcccCCCCCCCCCCCCCCCC--ccCceEEcCCC--CceEEEeccccCcccccc-CCccC
Q 038003 2 LNEEAYALLKWKTSLQNQNLNSSLLSSWTLYPANATKISPC--SWFGISCNHAG--SRVISITMSTLGLNGTFH-DFSFS 76 (848)
Q Consensus 2 ~~~~~~all~~k~~~~~~~~~~~~l~sw~~~~~~~~~~~~c--~w~gv~C~~~~--~~v~~l~l~~~~l~g~~~-~~~~~ 76 (848)
.++|++||++||++++++ ..++||. .++||| .|+||+|+..+ +||++|+|+++++.|..+ +.+++
T Consensus 4 ~~~e~~aLl~~k~~~~~~----~~l~sW~------~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~ 73 (313)
T d1ogqa_ 4 NPQDKQALLQIKKDLGNP----TTLSSWL------PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73 (313)
T ss_dssp CHHHHHHHHHHHHHTTCC----GGGTTCC------TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGG
T ss_pred CHHHHHHHHHHHHHCCCC----CcCCCCC------CCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHh
Confidence 579999999999999775 4799996 367999 49999998754 489999999999999643 34799
Q ss_pred CCCCCcEEeccC-CcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccE
Q 038003 77 SFPHLANLNLSF-NLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDK 155 (848)
Q Consensus 77 ~l~~l~~L~l~~-n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 155 (848)
+|++|++|+|++ |.++|.+|++|++|++|++|||++|++.+..|..+..+.+|+++++++|++.+.+|..++.++.|++
T Consensus 74 ~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~ 153 (313)
T d1ogqa_ 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153 (313)
T ss_dssp GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCE
T ss_pred cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccce
Confidence 999999999997 8999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEcCCCcCCCCCCCcccCcccc-ceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccC
Q 038003 156 LALCHNNLHGSIPSSLGNLSNL-AVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234 (848)
Q Consensus 156 L~L~~n~l~~~~p~~l~~l~~L-~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 234 (848)
+++++|.++|.+|+.++.+..+ +.+++++|++++..|..++.+..+ .++++++.+.+.+|..+..+++|+.+++++|.
T Consensus 154 l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 232 (313)
T d1ogqa_ 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp EECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSE
T ss_pred eeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence 9999999999999999998886 899999999999999998887655 69999999999999999999999999999999
Q ss_pred CCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccc-cccc
Q 038003 235 LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNL-LRGV 310 (848)
Q Consensus 235 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~ 310 (848)
+++.+| .++.+++|+.|+|++|+++|.+|.+|+++++|++|+|++|+++|.+|+ ++.+++|+.+++++|+ ++|.
T Consensus 233 l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 233 LAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp ECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred cccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 997654 688999999999999999999999999999999999999999999985 6889999999999997 5665
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=376.55 Aligned_cols=200 Identities=32% Similarity=0.475 Sum_probs=180.0
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|.++ +++.||+|++.+.... +....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999764 7899999998765432 233467789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. ..+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 85 mEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999998754 5689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. .....+||+.|||||++.+..+++++|||||||++|||+||+.||..
T Consensus 159 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 159 S--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp C--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred C--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 2 33557899999999999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=375.11 Aligned_cols=208 Identities=26% Similarity=0.437 Sum_probs=167.5
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec--CCee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN--GPHS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~ 674 (848)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+.+|++++++++|||||++++++.+ .+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 36799999999999999999965 4799999999977542 23456778999999999999999999999865 4568
Q ss_pred EEEEeccCCCCHHhHhcCCC-CcccCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 675 FLVCEYLDRGSLARILGDDV-TAKELGWNRRINVIKGVANALSYLHHDC--LPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
|+||||+++|+|.++++... ....+++..+..++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 99999999999999986432 2356899999999999999999999871 01399999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+............+||+.|||||++.+..+++++|||||||++|||+||+.||..
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 99876655555668899999999999999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=376.16 Aligned_cols=202 Identities=23% Similarity=0.365 Sum_probs=177.9
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|.. .+++.||||++++.... .....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 5799999999999999999976 47999999999765432 223457789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... +.+++..+..++.|++.||+|||++ +||||||||+||++++++.+||+|||+|+.+..
T Consensus 87 mEy~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999988654 5789999999999999999999999 999999999999999999999999999988754
Q ss_pred CC--CCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HS--SNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.. ......+||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence 32 223456899999999999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=375.71 Aligned_cols=200 Identities=25% Similarity=0.380 Sum_probs=176.0
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+.|++.+.||+|+||+||+|.+ .+++.||||+++.. .....+.+.+|++++++++|||||++++++.+.+..++|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 4689999999999999999976 47899999998764 234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... .+.+++.++..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+....
T Consensus 88 mEy~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 88 IEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999999987543 24689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCcccccccccccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAY-----TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........+||+.|+|||++. +..|+.++||||+||++|||+||+.||..
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 322334578999999999984 45678999999999999999999999854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=380.79 Aligned_cols=203 Identities=25% Similarity=0.332 Sum_probs=184.3
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|+. .+++.||||++++..... ....+++.+|+.++++++||||+++++++.+.+..|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 36799999999999999999965 589999999998764332 2346778999999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||++||+|.++++.. ..+++..+..++.||+.||+|||++ |||||||||+|||++++|.+||+|||+|+...
T Consensus 83 v~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ceeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999998755 5688899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........+||+.|+|||++.+..|++++||||+||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~ 207 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC
Confidence 555556678999999999999999999999999999999999999999854
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=385.35 Aligned_cols=200 Identities=28% Similarity=0.403 Sum_probs=178.3
Q ss_pred hhcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||+||+|.+ .+|+.||+|+++... .....+.+.+|++++++++|||||+++++|.+.++.|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357899999999999999999975 478999999987653 3345677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
+||||++||+|.+++... +.+++..+..++.||+.||.|||+ + ||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 iVmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 999999999999999754 568999999999999999999996 6 899999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.+. .....+||+.|+|||++.+..|++++||||+||++|||+||+.||..
T Consensus 155 ~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 155 LIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred cCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 6432 22457899999999999999999999999999999999999999854
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.7e-44 Score=375.72 Aligned_cols=200 Identities=28% Similarity=0.409 Sum_probs=161.9
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|..+ +++.||||++...... ...+.+.+|++++++++|||||++++++.+++..|+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 467999999999999999999764 7899999999776432 234567899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC---CCCCEEEeeccCcc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD---SNFEAHVSDFGIAK 753 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfG~~~ 753 (848)
||||++||+|.+++... ..+++..+..++.||+.||+|||++ +||||||||+||++. +++.+||+|||+|+
T Consensus 85 vmE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 99999999999999764 5699999999999999999999999 999999999999994 57899999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
...... .....+||+.|||||++.+..|++++||||+||++|||+||+.||..
T Consensus 159 ~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 159 MEDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EccCCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 765433 33557899999999999999999999999999999999999999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-43 Score=373.02 Aligned_cols=199 Identities=28% Similarity=0.433 Sum_probs=179.5
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|+. .+|+.||||++++.... .....+.+.+|+.++++++|||||++++++.+.+..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 5799999999999999999976 47999999999765432 234467789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||++||++.+++... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999988755 5678888999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. ....+||+.|||||++.+..|++++||||+||++|||+||+.||..
T Consensus 157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred c---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 3 3457899999999999999999999999999999999999999854
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-43 Score=371.92 Aligned_cols=198 Identities=28% Similarity=0.416 Sum_probs=174.2
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
+.|+..+.||+|+||+||+|.. .+++.||||+++..... .....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 3599999999999999999965 57889999998765322 234456789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|++..+.... ..+++..+..++.||+.||.|||++ |||||||||+|||++.++.+||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987766443 5689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcccccccccccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYT---MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
....+||+.|||||++.+ ..|+.++|||||||++|||+||+.||..
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 234679999999999864 4589999999999999999999999853
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=366.77 Aligned_cols=200 Identities=29% Similarity=0.482 Sum_probs=169.6
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||+||+|+++ ..||||+++.... +....+.+.+|++++++++|||||++++++.+ +..++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 467999999999999999999875 3599999976532 34556789999999999999999999998755 568999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.++++.. ...+++..+..|+.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999999999654 24689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--CcccccccccccCccccccC---CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSS--NWTEFAGTFGYAAPEIAYTM---RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~--~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ......||+.|||||++.+. .|+.++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 322 23456899999999998643 478999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=359.60 Aligned_cols=196 Identities=26% Similarity=0.358 Sum_probs=170.0
Q ss_pred CcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec----CCeeE
Q 038003 601 FDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN----GPHSF 675 (848)
Q Consensus 601 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~~ 675 (848)
|+..+.||+|+||+||+|.+. ++..||+|++..... .....+.+.+|++++++++|||||++++++.+ ....|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 356678999999999999654 788999999876542 23456778999999999999999999999865 34679
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEcCCCCCCeeeC-CCCCEEEeeccCc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPS--IIHRDISSKNVLLD-SNFEAHVSDFGIA 752 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~kl~DfG~~ 752 (848)
+||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+|
T Consensus 89 ivmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 999999999999999654 5689999999999999999999998 7 99999999999996 5789999999999
Q ss_pred cccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.... ......+||+.|||||++.+ ++++++||||+||++|||+||+.||..
T Consensus 163 ~~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 163 TLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp GGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 86543 23356789999999999876 599999999999999999999999853
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-42 Score=371.66 Aligned_cols=200 Identities=23% Similarity=0.340 Sum_probs=179.3
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++|||||+++++|.+++..|+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35799999999999999999965 579999999987652 3445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC--CCCCEEEeeccCccc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD--SNFEAHVSDFGIAKF 754 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DfG~~~~ 754 (848)
||||++||+|.+++... ...+++..+..|+.||+.||+|||++ |||||||||+|||++ .++.+||+|||+|+.
T Consensus 104 vmE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccccee
Confidence 99999999999887654 34689999999999999999999999 999999999999998 678999999999998
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 179 LNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp CCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCCCC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 86533 34557899999999999999999999999999999999999999854
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-42 Score=372.12 Aligned_cols=199 Identities=22% Similarity=0.398 Sum_probs=178.7
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5799999999999999999965 47999999998764 234567789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeC--CCCCEEEeeccCcccc
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLD--SNFEAHVSDFGIAKFV 755 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DfG~~~~~ 755 (848)
|||++||+|.+++... ...+++..+..|+.||+.||+|||++ |||||||||+|||++ .++.+||+|||+++..
T Consensus 102 mE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999999998644 24689999999999999999999999 999999999999995 4678999999999987
Q ss_pred CCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 756 GPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 756 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... ......||+.|||||++.+..++.++||||+||++|||+||+.||..
T Consensus 177 ~~~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 177 DPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp CTTS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence 6533 34567899999999999999999999999999999999999999853
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=362.21 Aligned_cols=198 Identities=27% Similarity=0.415 Sum_probs=166.4
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||+||+|.+.+++.||||+++.. ....+++.+|++++++++|||||+++|+|.+.+..++|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-----cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 3579999999999999999999988899999998753 23456799999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... ...+++..+..|+.|||.||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 79 ~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccC
Confidence 9999999999998654 35688999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 758 HSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 758 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
.... .....||+.|+|||++.+..++.++|||||||++|||+|++.|+
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~ 202 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 202 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCC
Confidence 3322 23467899999999999999999999999999999999965553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=363.12 Aligned_cols=203 Identities=25% Similarity=0.351 Sum_probs=180.8
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCC--chhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGN--MADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
.++|++.+.||+|+||+||+|.+ .+|+.||||++++...... ....+.+.+|++++++++|||||+++++|.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999976 5799999999977643322 23467899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC----CEEEeecc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF----EAHVSDFG 750 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG 750 (848)
|+||||+++|+|.++++.. +.+++..+..++.||+.||+|||++ +||||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999998654 5699999999999999999999999 999999999999998776 49999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+|+..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 163 ~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 163 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp TCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence 99887543 334556899999999999999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-43 Score=367.75 Aligned_cols=201 Identities=27% Similarity=0.454 Sum_probs=177.8
Q ss_pred hhcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeE
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 675 (848)
..++|++.+.||+|+||+||+|.++ +++.||||+++.. ....+++.+|++++++++|||||+++++|.+++..+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-----cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 3467999999999999999999765 6889999998654 234678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcccc
Q 038003 676 LVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFV 755 (848)
Q Consensus 676 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~ 755 (848)
+||||+++|++.+++... ....+++..+..|+.|||.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999998654 235789999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCC-cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 756 GPHSSN-WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 756 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
...... .....|++.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 544332 233567899999999999999999999999999999999877753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-42 Score=372.10 Aligned_cols=199 Identities=26% Similarity=0.332 Sum_probs=179.9
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|.+ .+|+.||||++++.... .....+.+.+|+++++.++|||||++++++.+....++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 5799999999999999999966 47999999999765432 234467789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+.+|++.+++... +.+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999998654 5689999999999999999999999 999999999999999999999999999998753
Q ss_pred CCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
. ....+||+.|||||++.+..+++++|||||||++|||+||+.||..
T Consensus 194 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence 2 3456899999999999999999999999999999999999999854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=360.51 Aligned_cols=199 Identities=23% Similarity=0.405 Sum_probs=174.5
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||+||+|.+++++.||||+++... ...+++.+|++++++++|||||++++++.+ +..++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 46789999999999999999999888899999986542 345679999999999999999999998765 567999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|+|.+++... ....+++..+.+|+.|||+||.|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 86 ~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999987654 234689999999999999999999999 999999999999999999999999999998754
Q ss_pred CCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.|+.
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 332 2244678999999999998899999999999999999999766643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-42 Score=362.61 Aligned_cols=201 Identities=26% Similarity=0.481 Sum_probs=164.4
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCC---EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGD---IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
++|++.+.||+|+||+||+|.++ +++ .||||++.... .....++|.+|++++++++|||||+++++|.+.+..
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 56788899999999999999765 332 58899886543 345567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
++||||+++|+|.+++... ...+++.++..|+.|||+||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999999988754 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc-----ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 755 VGPHSSNW-----TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
........ ....||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 75433221 22457899999999999999999999999999999998 8999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=355.74 Aligned_cols=202 Identities=25% Similarity=0.440 Sum_probs=180.2
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||+||+|++++++.||||+++... ...+++.+|+.++++++||||++++++|.+.+..++|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-----CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 36899999999999999999999888899999987642 3456799999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|++.+++... ...+++..+.+++.|||+||+|||++ ||+||||||+||++++++.+||+|||+++....
T Consensus 78 ~Ey~~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 9999999999987654 35688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcccc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFFS 809 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~ 809 (848)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||+...
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 332 2234678999999999999999999999999999999998 899986443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=366.86 Aligned_cols=202 Identities=27% Similarity=0.387 Sum_probs=179.7
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHh-cCCCCcccceEEEeecCCeeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALK-EIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~l~~~~~~~~~~~l 676 (848)
++|++.+.||+|+||+||+|..+ +++.||||++++..... ....+.+.+|+.++. .++|||||++++++.+++..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 57999999999999999999664 79999999997654321 234556677777655 6899999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.++++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||.++...
T Consensus 81 vmEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999999754 5688899999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
..........||+.|+|||++.+..+++++||||+||++|||+||+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~ 205 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence 555555667899999999999999999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=359.51 Aligned_cols=201 Identities=26% Similarity=0.409 Sum_probs=173.3
Q ss_pred cCCcccce-eccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 599 DDFDEKFC-IGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 599 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
++|.+.+. ||+|+||+||+|.++ ++..||||+++... .....+++.+|++++++++|||||++++++.+ +..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 45666664 999999999999654 34579999987643 34556789999999999999999999999875 468
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
|+||||+++|+|.+++... ...+++..+..++.|||.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999999987544 25689999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCC---cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 755 VGPHSSN---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 755 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 7543322 234568999999999999999999999999999999998 99998643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8e-42 Score=369.67 Aligned_cols=200 Identities=21% Similarity=0.276 Sum_probs=173.2
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHH---HHHHHHHhcCCCCcccceEEEeecCCee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEF---LNEVLALKEIRHRNNVKFHGFCYNGPHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~---~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 674 (848)
++|++.+.||+|+||+||+|+.. +|+.||||++.+..... ......+ ..|+++++.++|||||++++++.+.+..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch-hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 67999999999999999999764 79999999987653321 1222233 3457778888999999999999999999
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
|+||||++||+|.+++... ..+++..+..++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998654 5678899999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCCcccccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... .....+||+.|+|||++. +..|++++||||+||++|||+||+.||..
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 7543 234568999999999986 45689999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.1e-41 Score=349.26 Aligned_cols=203 Identities=24% Similarity=0.395 Sum_probs=178.0
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCc-----hhHHHHHHHHHHHhcCC-CCcccceEEEeec
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNM-----ADHDEFLNEVLALKEIR-HRNNVKFHGFCYN 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~ 670 (848)
.++|++.+.||+|+||+||+|+. .+++.||||++++....... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999975 47899999999775432211 12346789999999996 9999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
++..|+||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999754 5789999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCcccccc------CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYT------MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+++...+.. .....+||+.|+|||++.+ ..+++++||||+||++|||+||+.||..
T Consensus 156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence 999876533 3455789999999999863 3468899999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=363.87 Aligned_cols=203 Identities=25% Similarity=0.395 Sum_probs=172.1
Q ss_pred cCCcccceeccCCceeEEEEEcCC-C-----CEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecC
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPS-G-----DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNG 671 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 671 (848)
++|++.+.||+|+||+||+|.+.. + ..||+|++.... .......+.+|+.+++++ +|||||++++++.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 679999999999999999997642 2 268999886653 234456788999999998 899999999999999
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCC--------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVT--------------------AKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDI 731 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl 731 (848)
+..++||||+++|+|.++++.... ...+++..+..++.||+.||+|||++ +||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999965421 23588999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCCEEEeeccCccccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 732 SSKNVLLDSNFEAHVSDFGIAKFVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 732 k~~NIll~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||+||+++.++.+||+|||+|+........ .....||+.|||||++.+..+++++|||||||++|||+| |+.||..
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876543332 234568999999999999999999999999999999998 8999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=354.11 Aligned_cols=194 Identities=28% Similarity=0.434 Sum_probs=166.0
Q ss_pred ceeccCCceeEEEEEcC---CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEecc
Q 038003 605 FCIGKGGQGSVYKAELP---SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEYL 681 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~~ 681 (848)
+.||+|+||+||+|.++ +++.||||+++.... +....+++.+|++++++++|||||+++++|.+ +..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC--CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 46999999999999654 356899999976532 34556789999999999999999999999865 4578999999
Q ss_pred CCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCCC
Q 038003 682 DRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSSN 761 (848)
Q Consensus 682 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~~ 761 (848)
++|+|.++++.. ..+++..+..|+.|||.||+|||++ +||||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 90 ELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp TTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999998754 5689999999999999999999999 9999999999999999999999999999876543322
Q ss_pred c---ccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 762 W---TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 762 ~---~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
. ....||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~ 213 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC
Confidence 1 23578999999999999999999999999999999998 8999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-41 Score=356.29 Aligned_cols=203 Identities=27% Similarity=0.379 Sum_probs=171.2
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
.++|++.+.||+|+||+||+|.+ .+++.||||+++..... +....+.+.+|+++++.++|||||++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 46799999999999999999965 58999999999876432 3445677899999999999999999999987644
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..|+||||++|++|.+++... +.+++.++..++.||+.||+|||++ |||||||||+||+++.++.++++|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 478999999999999988654 5789999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC---CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSS---NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........ .....+||+.|+|||++.+..+++++||||+||++|||+||+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 76543222 23456899999999999999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-41 Score=357.21 Aligned_cols=199 Identities=22% Similarity=0.298 Sum_probs=177.3
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 676 (848)
.++|++.+.||+|+||+||+|.+. +++.||||+++... .....+.+|++++++++|||||++++++.+.+..|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 467999999999999999999664 78899999997642 334568899999999999999999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCC--CCEEEeeccCccc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSN--FEAHVSDFGIAKF 754 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DfG~~~~ 754 (848)
||||++||+|.++++.. ...+++.++..|+.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+++.
T Consensus 79 vmE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 79 IFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999999999754 24689999999999999999999999 99999999999999854 4899999999987
Q ss_pred cCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 755 VGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 755 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.... .......+++.|+|||...+..+++++||||+||++|||+||+.||..
T Consensus 154 ~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 7543 334556789999999999999999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-41 Score=351.61 Aligned_cols=201 Identities=25% Similarity=0.448 Sum_probs=167.2
Q ss_pred hcCCcccceeccCCceeEEEEEcCCC-----CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSG-----DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 672 (848)
...|+..+.||+|+||+||+|.++++ ..||||+++... .....+++.+|++++++++|||||+++|++.+.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 35688899999999999999976532 369999986543 3345667899999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..++||||+.++++.+++... ...+++.++..++.|||.|++|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ceEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence 999999999999999887644 35689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 753 KFVGPHSS---NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 753 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 87654322 2234568999999999999999999999999999999999766653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=355.11 Aligned_cols=200 Identities=26% Similarity=0.426 Sum_probs=169.4
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
.++|++.+.||+|+||+||+|.+++++.||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-----CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 46799999999999999999999888899999986542 335779999999999999999999999865 567999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+++|++..++... ....+++.++..++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999999888654 234689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 332 22446789999999999999999999999999999999997777543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-41 Score=357.64 Aligned_cols=196 Identities=26% Similarity=0.326 Sum_probs=170.0
Q ss_pred hcCCcccc-eeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhc-CCCCcccceEEEeec----
Q 038003 598 TDDFDEKF-CIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKE-IRHRNNVKFHGFCYN---- 670 (848)
Q Consensus 598 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~---- 670 (848)
.++|.+.. .||+|+||+||+|.+ .+++.||||+++.. +.+.+|++++.+ .+|||||+++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 35788864 699999999999965 57999999998542 346789988655 589999999999875
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---CCCEEEe
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEAHVS 747 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~ 747 (848)
....|+||||++||+|.++++.. ....+++.++..|+.||+.||+|||++ ||+||||||+|||++. ++.+||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 35689999999999999999754 235689999999999999999999999 9999999999999985 5679999
Q ss_pred eccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 748 DFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|||+|+...... .....+||+.|+|||++.+..|++++||||+||++|+|+||+.||..
T Consensus 157 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 157 DFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp CCTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred ccceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 999998876533 34567899999999999999999999999999999999999999854
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=350.66 Aligned_cols=199 Identities=25% Similarity=0.291 Sum_probs=168.4
Q ss_pred ccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCc-hhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEEec
Q 038003 603 EKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNM-ADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVCEY 680 (848)
Q Consensus 603 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~e~ 680 (848)
.++.||+|+||+||+|.++ +|+.||||+++........ ...+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999765 7999999999765432111 1235688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCCCC
Q 038003 681 LDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPHSS 760 (848)
Q Consensus 681 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~ 760 (848)
+.++++..+.... ..+++..+..+++||+.||+|||++ ||+||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998877766543 5678889999999999999999999 999999999999999999999999999988766555
Q ss_pred CcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 761 NWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 761 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.....+||+.|+|||++.+. .|+.++||||+||++|||+||+.||..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 55667899999999998754 579999999999999999999999854
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=349.50 Aligned_cols=202 Identities=24% Similarity=0.357 Sum_probs=173.4
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|.+ .+++.||||+++.... .....+++.+|++++++++|||||++++++.+.+..|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 6899999999999999999965 5799999999976532 223456789999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
|||+.++.+....... ...+++..+..++.||+.||+|||++ |||||||||+|||++.++.+||+|||.|+....
T Consensus 80 ~e~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp EECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred EeecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC
Confidence 9999875444333322 35689999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.........||+.|+|||++.... ++.++||||+||++|+|+||+.||..
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 555566678999999999877665 47899999999999999999999854
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=343.49 Aligned_cols=196 Identities=30% Similarity=0.467 Sum_probs=164.1
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-CCeeEE
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN-GPHSFL 676 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~l 676 (848)
.++|++.+.||+|+||.||+|+++ |+.||||+++.+ ...+++.+|++++++++||||++++|+|.+ .+..++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 467889999999999999999885 788999998654 235678999999999999999999999865 456899
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVG 756 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~ 756 (848)
||||+++|+|.+++... ....+++..+.+|+.|||.|+.|||+. +|+||||||+||+++.++.+|++|||+++...
T Consensus 79 v~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence 99999999999998654 224589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 757 PHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 757 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
.. .....+++.|+|||++.+..+++++|||||||++|||+| |+.||..
T Consensus 155 ~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 155 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 32 234568999999999999999999999999999999999 6888654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-41 Score=347.69 Aligned_cols=241 Identities=21% Similarity=0.283 Sum_probs=190.3
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCc--hhHHHHHHHHHHHhcCC--CCcccceEEEeecCC
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNM--ADHDEFLNEVLALKEIR--HRNNVKFHGFCYNGP 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~ 672 (848)
.++|++.+.||+|+||+||+|.. .+++.||||++++....... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999965 57999999999765433211 12234668999999986 899999999999999
Q ss_pred eeEEEEeccCC-CCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-CCCEEEeecc
Q 038003 673 HSFLVCEYLDR-GSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-NFEAHVSDFG 750 (848)
Q Consensus 673 ~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG 750 (848)
..++||||+.+ +++.++++.. ..+++.++..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 99999999976 5777777544 5689999999999999999999999 9999999999999985 4799999999
Q ss_pred CccccCCCCCCcccccccccccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCcccccc-------ccccchhhhhh
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRA-TEKYDVYSFGVLVFEVIKGNHPRDFFSIN-------FSSFSNMIIDV 822 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~-------~~~~~~~~~~~ 822 (848)
+|+..... .....+||+.|+|||++.+..+ +.++||||+||++|||+||+.||.....- ...+.....++
T Consensus 157 ~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 157 SGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHL 234 (273)
T ss_dssp TCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHH
T ss_pred cceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHH
Confidence 99876432 3356789999999999987765 67799999999999999999998653210 11333444444
Q ss_pred hhhcCCCCCCCCCCcccccceeec
Q 038003 823 NKILDPRLPTPSPSVMDYGGCHFM 846 (848)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~ 846 (848)
...+-..-|..||.+.+...+.|+
T Consensus 235 i~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHccCCHhHCcCHHHHhcCHhh
Confidence 444444445556666665555554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.1e-40 Score=344.10 Aligned_cols=201 Identities=25% Similarity=0.345 Sum_probs=174.1
Q ss_pred cCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLVC 678 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV~ 678 (848)
++|++.+.||+|+||+||+|++++|+.||||+++..... ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 689999999999999999999889999999999765322 234577899999999999999999999999999999999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+.++.+..+.+.. +.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+|++|||.+......
T Consensus 80 e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp ECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 999988777776544 6799999999999999999999999 9999999999999999999999999999887665
Q ss_pred CCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
........|++.|+|||.+.+. .+++++||||+||++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 5555666789999999998754 468999999999999999999999853
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=344.29 Aligned_cols=202 Identities=26% Similarity=0.387 Sum_probs=163.0
Q ss_pred hcCCcccceeccCCceeEEEEEcCC----CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPS----GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||+||+|.+.. +..||||+++... .....+.+.+|++++++++|||||++++++.+ +.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-Ce
Confidence 3679999999999999999997642 3468899886542 34456779999999999999999999999864 67
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++|++.+++... ...+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 89999999999999887543 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 754 FVGPHSS-NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
....... ......||+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence 7654322 2234568999999999999999999999999999999998 88897643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=351.32 Aligned_cols=201 Identities=24% Similarity=0.452 Sum_probs=167.9
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCC----EEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGD----IVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.+|++.+.||+|+||+||+|.+. +|+ +||+|+++... .....+++.+|++++++++|||||+++++|.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 46999999999999999999764 454 57888876542 334567899999999999999999999999875 5
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.+++|||+.+|+|.+.+... ...+++..+..++.|||.||+|||++ +||||||||+||+++.++.+||+|||+|+
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 67889999999998887654 35689999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCC--cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCccc
Q 038003 754 FVGPHSSN--WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 808 (848)
........ .....||+.|+|||++.+..++.++|||||||++|||+| |+.||+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 87543332 234568999999999999999999999999999999999 78887643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-40 Score=349.67 Aligned_cols=204 Identities=25% Similarity=0.426 Sum_probs=174.4
Q ss_pred hhcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec
Q 038003 597 ATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN 670 (848)
Q Consensus 597 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 670 (848)
..++|++.+.||+|+||+||+|+++ +++.||||+++... .....+++.+|++++++++||||++++++|.+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3567999999999999999999753 45789999987643 33456789999999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCC---------------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEc
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDV---------------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHR 729 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~ 729 (848)
....++||||+++|+|.++++... ....+++..+..|+.|+|.||+|||++ +||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence 999999999999999999885321 123488999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCC-CCc
Q 038003 730 DISSKNVLLDSNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH-PRD 806 (848)
Q Consensus 730 Dlk~~NIll~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~-P~~ 806 (848)
||||+|||++.++.+||+|||+|+....... ......|++.|+|||++.+..++.++|||||||++|||+||.. ||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999986643322 2234678899999999999999999999999999999999965 554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=343.40 Aligned_cols=203 Identities=28% Similarity=0.399 Sum_probs=164.2
Q ss_pred hcCCcccceeccCCceeEEEEEcC--CC--CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP--SG--DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||+||+|++. ++ ..||||++++.... .....++|.+|++++++++|||||+++|+|.+ +.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 467999999999999999999653 22 36899998776433 33456789999999999999999999999976 46
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+++|++.+++... ...+++..+..++.|||.||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred hheeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 78999999999999887654 35699999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCC---cccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 754 FVGPHSSN---WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 754 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
........ .....|++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 87554332 223467889999999999999999999999999999998 8999853
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=342.59 Aligned_cols=204 Identities=25% Similarity=0.365 Sum_probs=163.1
Q ss_pred hcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 670 (848)
.++|++.+.||+|+||+||+|.+. +++.||||+++... .....+.+.+|..++.++ +||||+.+++++.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 467999999999999999999653 34689999987543 334566778888887776 78999999999866
Q ss_pred C-CeeEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCe
Q 038003 671 G-PHSFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNV 736 (848)
Q Consensus 671 ~-~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NI 736 (848)
. ...++||||+++|+|.++++... ....+++..+..++.|||+||+|||++ +||||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence 4 46899999999999999986431 123588999999999999999999999 999999999999
Q ss_pred eeCCCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCC-CCCcc
Q 038003 737 LLDSNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN-HPRDF 807 (848)
Q Consensus 737 ll~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~P~~~ 807 (848)
|+++++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. .||..
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999987654332 224567999999999999999999999999999999999975 56643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=344.02 Aligned_cols=202 Identities=28% Similarity=0.411 Sum_probs=169.7
Q ss_pred hcCCcccceeccCCceeEEEEEcC-CCC--EEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeecCCe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELP-SGD--IVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYNGPH 673 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 673 (848)
.++|++.+.||+|+||+||+|.++ ++. .||||+++... .....+.+.+|+++++++ +|||||+++++|.+.+.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 367999999999999999999765 444 46778775433 223456799999999998 79999999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCC-------------CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC
Q 038003 674 SFLVCEYLDRGSLARILGDD-------------VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS 740 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 740 (848)
.++||||+++|+|.++++.. .....+++..+.+++.|||.|+.|+|++ +|+||||||+|||++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcC
Confidence 99999999999999998754 2345789999999999999999999999 9999999999999999
Q ss_pred CCCEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCC-CCc
Q 038003 741 NFEAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNH-PRD 806 (848)
Q Consensus 741 ~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~-P~~ 806 (848)
++.+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||+||.. ||.
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp GGCEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 99999999999986644322 244578999999999999999999999999999999999765 554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-39 Score=339.57 Aligned_cols=196 Identities=28% Similarity=0.448 Sum_probs=168.8
Q ss_pred cceeccCCceeEEEEEcCCC----CEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec-CCeeEEEE
Q 038003 604 KFCIGKGGQGSVYKAELPSG----DIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN-GPHSFLVC 678 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lV~ 678 (848)
.++||+|+||+||+|.+..+ ..||||+++... +....+++.+|++++++++|||||+++|++.+ +...++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 46899999999999976532 258999986532 44566889999999999999999999999875 45889999
Q ss_pred eccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCCC
Q 038003 679 EYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGPH 758 (848)
Q Consensus 679 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~~ 758 (848)
||+++|+|.++++.. ....++..+.+++.|+|.||.|+|+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 109 E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp ECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999999988755 34577888999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC----cccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 759 SSN----WTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 759 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
... .....||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 221 2335689999999999999999999999999999999998888754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-39 Score=341.74 Aligned_cols=204 Identities=23% Similarity=0.328 Sum_probs=169.2
Q ss_pred HhhcCCcccceeccCCceeEEEEEc-CC-CCEEEEEEcccccccCCchhHHHHHHHHHHHhcC---CCCcccceEEEeec
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAEL-PS-GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI---RHRNNVKFHGFCYN 670 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~ 670 (848)
+..++|++.+.||+|+||+||+|.+ ++ ++.||||+++...... .....+.+|+.+++.+ +||||++++++|..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 3457899999999999999999976 44 5679999997654322 2223455677776655 89999999999853
Q ss_pred -----CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEE
Q 038003 671 -----GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAH 745 (848)
Q Consensus 671 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 745 (848)
....+++|||++++.+....... ...+++..+..++.||+.||+|||++ +||||||||+|||+++++.+|
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCee
Confidence 34679999999998765444332 35688999999999999999999999 999999999999999999999
Q ss_pred EeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 746 VSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 746 l~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+|||.++.... ........||+.|+|||++.+..|++++||||+||++|||+||+.||..
T Consensus 157 l~dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 157 LADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp ECSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ecchhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 999999986543 2334567899999999999999999999999999999999999999854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=342.49 Aligned_cols=202 Identities=23% Similarity=0.378 Sum_probs=174.6
Q ss_pred hcCCcccceeccCCceeEEEEEc------CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEeec
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL------PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFCYN 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 670 (848)
.++|++.+.||+|+||.||+|.+ .++..||||+++... ......++.+|+.+++++ +|||||+++++|.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 36789999999999999999964 245789999997653 345567789999999999 79999999999999
Q ss_pred CCeeEEEEeccCCCCHHhHhcCCC---------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCC
Q 038003 671 GPHSFLVCEYLDRGSLARILGDDV---------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 735 (848)
Q Consensus 671 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 735 (848)
.+..++||||+++|+|.++++... ....+++..+..++.|||+|++|||++ +||||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 999999999999999999986432 123588999999999999999999999 99999999999
Q ss_pred eeeCCCCCEEEeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 038003 736 VLLDSNFEAHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPR 805 (848)
Q Consensus 736 Ill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 805 (848)
|+++.++.+|++|||.++......... ...+||+.|+|||++.+..+++++|||||||++|||+|++.|+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence 999999999999999999775433322 3467899999999999999999999999999999999955553
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-38 Score=333.65 Aligned_cols=204 Identities=27% Similarity=0.413 Sum_probs=171.4
Q ss_pred hcCCcccceeccCCceeEEEEEcCC--------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcC-CCCcccceEEEe
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPS--------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEI-RHRNNVKFHGFC 668 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 668 (848)
.++|++.+.||+|+||.||+|+... +..||||+++... ......++.+|...+.++ +|||||+++++|
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 4679999999999999999996532 2479999997653 334567788999998888 899999999999
Q ss_pred ecCCeeEEEEeccCCCCHHhHhcCCC-------------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCC
Q 038003 669 YNGPHSFLVCEYLDRGSLARILGDDV-------------TAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKN 735 (848)
Q Consensus 669 ~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 735 (848)
.+++..++||||+++|+|.++++... ....+++.++.+++.|||.||+|||++ +||||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence 99999999999999999999996542 124689999999999999999999999 99999999999
Q ss_pred eeeCCCCCEEEeeccCccccCCCCC--CcccccccccccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCcc
Q 038003 736 VLLDSNFEAHVSDFGIAKFVGPHSS--NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIK-GNHPRDF 807 (848)
Q Consensus 736 Ill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 807 (848)
||++.++.+||+|||.++....... ......|++.|+|||++.+..|++++||||||||+|||+| |+.||..
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 9999999999999999987644322 2244678999999999999999999999999999999998 6888753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=343.27 Aligned_cols=204 Identities=26% Similarity=0.378 Sum_probs=176.0
Q ss_pred cCCcccceeccCCceeEEEEEc----CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC-CcccceEEEeecCCe
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL----PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH-RNNVKFHGFCYNGPH 673 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~ 673 (848)
++|++.+.||+|+||+||+|.. .+|+.||||++++.....+....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999964 25899999999876544344455678899999999966 899999999999999
Q ss_pred eEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCcc
Q 038003 674 SFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAK 753 (848)
Q Consensus 674 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~ 753 (848)
.++||||+.+|+|.++++.. +.++...+..++.||+.|++|+|++ +||||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998755 4567888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CcccccccccccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 754 FVGPHSS-NWTEFAGTFGYAAPEIAYTM--RATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.+..... ......|++.|+|||.+.+. .+++++||||+||++|||+||+.||...
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 7643322 23456789999999998754 3688999999999999999999998543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-39 Score=340.51 Aligned_cols=205 Identities=24% Similarity=0.395 Sum_probs=176.1
Q ss_pred HhhcCCcccceeccCCceeEEEEEcC------CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEee
Q 038003 596 KATDDFDEKFCIGKGGQGSVYKAELP------SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCY 669 (848)
Q Consensus 596 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 669 (848)
...++|++.+.||+|+||+||+|.++ +++.||||+++... .......+.+|++++++++|||||+++++|.
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34578999999999999999999653 35789999997542 3345667899999999999999999999999
Q ss_pred cCCeeEEEEeccCCCCHHhHhcCC-------CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC
Q 038003 670 NGPHSFLVCEYLDRGSLARILGDD-------VTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF 742 (848)
Q Consensus 670 ~~~~~~lV~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 742 (848)
..+..++||||+++|+|.+++... .....+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 999999999999999999987532 1223578899999999999999999999 999999999999999999
Q ss_pred CEEEeeccCccccCCCCCCc--ccccccccccCccccccCCCCccchhhhHHHHHHHHHhCC-CCCc
Q 038003 743 EAHVSDFGIAKFVGPHSSNW--TEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGN-HPRD 806 (848)
Q Consensus 743 ~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~P~~ 806 (848)
++||+|||+++......... ....|++.|+|||.+.+..++.++|||||||++|||+||+ .||.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence 99999999998765433322 3346899999999999999999999999999999999985 6654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-38 Score=334.09 Aligned_cols=198 Identities=27% Similarity=0.403 Sum_probs=163.2
Q ss_pred hcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHH--HHHHHHhcCCCCcccceEEEeecCC---
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFL--NEVLALKEIRHRNNVKFHGFCYNGP--- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--~E~~~l~~l~hp~iv~l~~~~~~~~--- 672 (848)
.++|...+.||+|+||+||+|++ +|+.||||+++... .+.+. .|+..+.+++|||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 35688889999999999999986 58899999986532 23333 4555566789999999999997653
Q ss_pred -eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEcCCCCCCeeeCCCCCEEE
Q 038003 673 -HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDC-----LPSIIHRDISSKNVLLDSNFEAHV 746 (848)
Q Consensus 673 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl 746 (848)
..|+||||+++|+|.+++++. .+++..+.+++.|+|.|++|+|+.+ ..+||||||||+|||++.++.+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred eEEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence 579999999999999999653 5889999999999999999999631 139999999999999999999999
Q ss_pred eeccCccccCCCCC----CcccccccccccCccccccC------CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 747 SDFGIAKFVGPHSS----NWTEFAGTFGYAAPEIAYTM------RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 747 ~DfG~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||+||..||+.
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 99999987754332 22346799999999998754 257789999999999999999988754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=336.05 Aligned_cols=200 Identities=24% Similarity=0.349 Sum_probs=167.8
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
.++|++.+.||+|+||+||+|.. .+|+.||||++++.. .....+++.+|++++++++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 46799999999999999999964 589999999987542 3455678899999999999999999999987643
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCc
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIA 752 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~ 752 (848)
..+++++|+.+|+|.++++. ..+++..+..++.||+.||+|||++ |||||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 34555667779999999854 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---CcccccccccccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 753 KFVGPHSS---NWTEFAGTFGYAAPEIAY-TMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 753 ~~~~~~~~---~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+....... .....+||+.|+|||++. +..+++++||||+||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 87644322 224467899999999985 45578999999999999999999999853
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=326.58 Aligned_cols=200 Identities=23% Similarity=0.370 Sum_probs=178.9
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCCeeEEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGPHSFLV 677 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lV 677 (848)
++|++.+.||+|+||+||+|++ .+++.||||+++.... .....+++.+|+.+++.++||||+++++++.+.+..++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 5899999999999999999965 5789999999976532 345567889999999999999999999999999999999
Q ss_pred EeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccccCC
Q 038003 678 CEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKFVGP 757 (848)
Q Consensus 678 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~~~~ 757 (848)
+|++.++++..+.+.. +.+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.++....
T Consensus 80 ~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eeeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999999998887654 6788899999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCc
Q 038003 758 HSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 758 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
.........+++.|+|||++.+.. +++++||||+||++|||+||+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 555555667889999999987665 6899999999999999999999973
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=335.30 Aligned_cols=196 Identities=27% Similarity=0.329 Sum_probs=164.4
Q ss_pred CCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC------C
Q 038003 600 DFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG------P 672 (848)
Q Consensus 600 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~ 672 (848)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|++++++++||||++++++|... .
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 6899999999999999999764 799999999866421 124699999999999999999998543 3
Q ss_pred eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-CEEEeeccC
Q 038003 673 HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-EAHVSDFGI 751 (848)
Q Consensus 673 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~ 751 (848)
+.++||||++++.+..+.+.......+++.++..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence 5789999998765444333222345799999999999999999999999 999999999999999775 899999999
Q ss_pred ccccCCCCCCcccccccccccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYT-MRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
++...... .....+|++.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 170 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 170 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CEECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred hhhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 98775433 3355789999999998775 4689999999999999999999999854
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-37 Score=333.40 Aligned_cols=197 Identities=25% Similarity=0.393 Sum_probs=166.0
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecCC----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNGP---- 672 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~---- 672 (848)
.++|++.+.||+|+||+||+|.+ .+|+.||||+++.... .....+.+.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 56899999999999999999965 5799999999976432 3345677899999999999999999999997654
Q ss_pred --eeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeecc
Q 038003 673 --HSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFG 750 (848)
Q Consensus 673 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG 750 (848)
..|+||||+ +.++.++.+. ..+++..+..++.||+.||+|||++ |||||||||+|||++.++.+|++|||
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 569999999 5578777643 4689999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 751 IAKFVGPHSSNWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 751 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.|+..... .+...||+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus 167 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 167 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 99876542 3556899999999998764 468999999999999999999999854
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-37 Score=323.93 Aligned_cols=197 Identities=20% Similarity=0.264 Sum_probs=169.9
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC-CcccceEEEeecCCeeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH-RNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~~l 676 (848)
++|++.+.||+|+||+||+|++. +++.||||+++... ..+.+.+|++.++.++| ++++.+++++.+....++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc------CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 57999999999999999999754 78999999876542 12346678888888865 899999999999999999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC-----CCCEEEeeccC
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS-----NFEAHVSDFGI 751 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DfG~ 751 (848)
||||+ +++|.++++.. ...++..++..++.|++.||+|||++ ||+||||||+||+++. ++.+||+|||+
T Consensus 79 vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 99999 67998888654 34689999999999999999999999 9999999999999974 57899999999
Q ss_pred ccccCCCCC-------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSS-------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
|+.+..... .....+||+.|||||++.+..+++++|||||||++|||+||+.||..
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCC
Confidence 987643221 22346799999999999999999999999999999999999999964
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-37 Score=325.91 Aligned_cols=202 Identities=22% Similarity=0.317 Sum_probs=168.3
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec------
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN------ 670 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 670 (848)
.++|++.+.||+|+||+||+|.+ .+|+.||||++...... ....+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 47899999999999999999975 58999999998765422 3345678899999999999999999999865
Q ss_pred --CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEee
Q 038003 671 --GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSD 748 (848)
Q Consensus 671 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D 748 (848)
....++||||+.++.+....... ..++...+..+++||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred ccCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence 34579999999987776555433 5688899999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCC----CcccccccccccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 749 FGIAKFVGPHSS----NWTEFAGTFGYAAPEIAYTM-RATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 749 fG~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
||+++....... .....+||+.|+|||++.+. .+++++||||+||++|||+||+.||..
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 999987653221 22346799999999998765 589999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-36 Score=325.73 Aligned_cols=194 Identities=21% Similarity=0.330 Sum_probs=168.6
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeec--CCee
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYN--GPHS 674 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~--~~~~ 674 (848)
++|++.+.||+|+||+||+|+. .+++.||||+++.. ..+++.+|++++++++ ||||+++++++.. ....
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 5799999999999999999966 57899999998643 2467889999999995 9999999999874 4568
Q ss_pred EEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCC-CEEEeeccCcc
Q 038003 675 FLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNF-EAHVSDFGIAK 753 (848)
Q Consensus 675 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG~~~ 753 (848)
++||||+++++|.++. +.+++..+..+++||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+
T Consensus 108 ~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence 9999999999987654 4588999999999999999999999 999999999999998655 69999999998
Q ss_pred ccCCCCCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcccc
Q 038003 754 FVGPHSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDFFS 809 (848)
Q Consensus 754 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~ 809 (848)
...... .....++|+.|+|||.+.+.. ++.++||||+||++|||++|+.||....
T Consensus 179 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 179 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred eccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 875433 345678999999999987654 7999999999999999999999986433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-37 Score=323.73 Aligned_cols=198 Identities=20% Similarity=0.292 Sum_probs=164.4
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCccc-ceEEEeecCCeeEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNV-KFHGFCYNGPHSFL 676 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~l~~~~~~~~~~~l 676 (848)
++|++.+.||+|+||+||+|.+ .+++.||||++.... ..+++.+|+++++.++|++++ .+.+++.+.+..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT------TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc------cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 5799999999999999999965 578999999876542 123467899999999877655 55556677888999
Q ss_pred EEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCC---CCCEEEeeccCcc
Q 038003 677 VCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDS---NFEAHVSDFGIAK 753 (848)
Q Consensus 677 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfG~~~ 753 (848)
||||+.+ ++.+.+... ...+++..+..++.|++.||+|||++ ||+||||||+||+++. +..+|++|||+|+
T Consensus 81 vme~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELLGP-SLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECCCC-BHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEcCC-chhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 9999954 665555432 35689999999999999999999999 9999999999999864 4579999999999
Q ss_pred ccCCCCC-------CcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCccc
Q 038003 754 FVGPHSS-------NWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDFF 808 (848)
Q Consensus 754 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 808 (848)
.+..... .....+||+.|+|||++.+..+++++|||||||++|||+||+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccccc
Confidence 8754322 123467999999999999999999999999999999999999998653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-36 Score=325.64 Aligned_cols=196 Identities=25% Similarity=0.356 Sum_probs=160.3
Q ss_pred cCCcccceeccCCceeEEEEEcC-CCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeec------C
Q 038003 599 DDFDEKFCIGKGGQGSVYKAELP-SGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYN------G 671 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------~ 671 (848)
++|++.+.||+|+||+||+|.+. +|+.||||++..... .....+++.+|+.++++++|||||+++++|.. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 67999999999999999999765 799999999976542 34456678899999999999999999999864 3
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
...|+||||+.++.+. .+. ..+++..+..+++||+.||+|||++ ||+||||||+|||++.++.+|++|||.
T Consensus 95 ~~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp CEEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ceeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 6889999999876554 442 3478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCc
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRD 806 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 806 (848)
++..... ......++|+.|+|||++.+..+++++||||+||++|||++|+.||.
T Consensus 166 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence 8876543 33355689999999999999999999999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-36 Score=326.10 Aligned_cols=198 Identities=24% Similarity=0.352 Sum_probs=167.7
Q ss_pred hcCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcccceEEEeecC-----
Q 038003 598 TDDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNNVKFHGFCYNG----- 671 (848)
Q Consensus 598 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 671 (848)
.++|++.+.||+|+||+||+|++ .+|+.||||++++.. .+....+++.+|++++++++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 56899999999999999999965 589999999997653 2334566788999999999999999999998643
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEeeccC
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVSDFGI 751 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~ 751 (848)
...++||+|+.+|+|.++++. +.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence 345677788889999999854 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 752 AKFVGPHSSNWTEFAGTFGYAAPEIAYTMR-ATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 752 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
+..... ......|++.|+|||+..+.. ++.++||||+||++|+|+||+.||..
T Consensus 168 a~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 168 ARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp --CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hcccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 976543 234567899999999877654 58899999999999999999999853
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=7.8e-33 Score=294.94 Aligned_cols=249 Identities=33% Similarity=0.491 Sum_probs=226.5
Q ss_pred CCCcEEeccCCcccc--cccccccCCCCCcEEEccc-cCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccE
Q 038003 79 PHLANLNLSFNLFFG--NIPLQIGNLSKLQYLDLGS-NQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDK 155 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~--~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 155 (848)
.+++.|+|++|.++| .+|++|++|++|++|||++ |+++|.+|++|++|++|++|+|++|++++..|..+..+..|++
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 478999999999998 5899999999999999997 8999999999999999999999999999999999999999999
Q ss_pred EEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccc-cccccccccccccCcccccCCcccceeeccccC
Q 038003 156 LALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSL-LQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNS 234 (848)
Q Consensus 156 L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 234 (848)
+++++|.+.+.+|..++++++|+++++++|.++|.+|..++.+.++ +.+++++|++++..|..+..+..+ .+++++|.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 9999999999999999999999999999999999999999988886 889999999999999988887654 69999999
Q ss_pred CCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCc
Q 038003 235 LSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHS 314 (848)
Q Consensus 235 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 314 (848)
+.+.+|..+..+++|+.+++++|.+.+.+| .+..+++|++|+|++|+++|.+|+.++.+++|++|+|++|+|+|.+|.
T Consensus 209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~- 286 (313)
T d1ogqa_ 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ- 286 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred cccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-
Confidence 999999999999999999999999988765 588889999999999999999999999999999999999999888774
Q ss_pred cceeeccccCCCCccccccCCCCCccEEEccCCc
Q 038003 315 IERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNN 348 (848)
Q Consensus 315 l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 348 (848)
++.+++|+.+++++|+
T Consensus 287 ------------------~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 287 ------------------GGNLQRFDVSAYANNK 302 (313)
T ss_dssp ------------------STTGGGSCGGGTCSSS
T ss_pred ------------------cccCCCCCHHHhCCCc
Confidence 2345677777777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=1.7e-29 Score=277.14 Aligned_cols=356 Identities=25% Similarity=0.327 Sum_probs=191.0
Q ss_pred eccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCC
Q 038003 85 NLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLH 164 (848)
Q Consensus 85 ~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 164 (848)
.++.+.+++.++ ...+.+|++|++++|+++.. +.+..|++|++|+|++|+|++ +| .++++++|++|++++|+++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccccc
Confidence 444455554443 23556666666666666532 346666666666666666663 33 2666666666666666666
Q ss_pred CCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCccc
Q 038003 165 GSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILG 244 (848)
Q Consensus 165 ~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~ 244 (848)
+. + .++++++|+.|++++|.+++..+ ......+..+....|.+....+................. ....+.
T Consensus 102 ~i-~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 172 (384)
T d2omza2 102 DI-T-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLA 172 (384)
T ss_dssp CC-G-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGT
T ss_pred cc-c-ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc-----hhhhhc
Confidence 32 2 25666666666666666654322 223344455555555544222222111111111111111 111122
Q ss_pred CcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccC
Q 038003 245 NLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNN 324 (848)
Q Consensus 245 ~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~ 324 (848)
............|... ....+..+++++.+++++|.+++..| +...
T Consensus 173 ~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~------------------------------ 218 (384)
T d2omza2 173 NLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGIL------------------------------ 218 (384)
T ss_dssp TCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGC------------------------------
T ss_pred cccccccccccccccc--cccccccccccceeeccCCccCCCCc--cccc------------------------------
Confidence 2222222222223222 12223344444444444444443222 1222
Q ss_pred CCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCccc
Q 038003 325 LSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQ 404 (848)
Q Consensus 325 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 404 (848)
++|+.|++++|+++.. ..+..+++|+.+++++|.+++.. .+..+++|++|++++|++++.. .
T Consensus 219 ------------~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~ 280 (384)
T d2omza2 219 ------------TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--P 280 (384)
T ss_dssp ------------TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--G
T ss_pred ------------CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--c
Confidence 3444444444444432 13344445555555555554332 2556667777777777776433 2
Q ss_pred ccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccc
Q 038003 405 LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS 484 (848)
Q Consensus 405 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 484 (848)
+..++.++.++++.|.+++. ..+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .|.++++|+
T Consensus 281 ~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~ 354 (384)
T d2omza2 281 LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNIN 354 (384)
T ss_dssp GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCC
T ss_pred cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCC
Confidence 56667777777777777642 34666777777777777777543 36777778888888887764 33 577777888
Q ss_pred eecccCcccCcCCCccccCCCCCccccCCCC
Q 038003 485 ELDLSHNILQEEIPPQVCNMGSLEKLNLSHN 515 (848)
Q Consensus 485 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (848)
+|+|++|+|++..| +.++++|++|+|++|
T Consensus 355 ~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp EEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred EEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 88888888776543 777788888888776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=1.3e-29 Score=278.00 Aligned_cols=357 Identities=24% Similarity=0.325 Sum_probs=240.1
Q ss_pred EEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccc
Q 038003 108 LDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSL 187 (848)
Q Consensus 108 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l 187 (848)
.+++.+.+++.++ ...+.+|++|++++|.|+. + +.++.+++|++|+|++|+|++ +| .++++++|++|++++|++
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccc
Confidence 3555666665543 3466677777777777663 3 245566666666666666663 33 255666666666666666
Q ss_pred cCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcc
Q 038003 188 SGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSI 267 (848)
Q Consensus 188 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l 267 (848)
++.. .++.+++|+.|++++|.+++..+ ......+..+....|.+....+...
T Consensus 101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~~~~~~~ 152 (384)
T d2omza2 101 ADIT--PLANLTNLTGLTLFNNQITDIDP--------------------------LKNLTNLNRLELSSNTISDISALSG 152 (384)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCCGG--------------------------GTTCTTCSEEEEEEEEECCCGGGTT
T ss_pred cccc--ccccccccccccccccccccccc--------------------------ccccccccccccccccccccccccc
Confidence 5322 14555555555555555543221 1222333444444444433222211
Q ss_pred cCCCCCceEEccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCC
Q 038003 268 GNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNN 347 (848)
Q Consensus 268 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 347 (848)
.............. ....+.............|... ....+..+++++.+++++|
T Consensus 153 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~l~~~~~l~l~~n 207 (384)
T d2omza2 153 LTSLQQLSFGNQVT-----DLKPLANLTTLERLDISSNKVS--------------------DISVLAKLTNLESLIATNN 207 (384)
T ss_dssp CTTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSCCC--------------------CCGGGGGCTTCSEEECCSS
T ss_pred cccccccccccccc-----hhhhhccccccccccccccccc--------------------cccccccccccceeeccCC
Confidence 11111111111111 1112222233333333332221 1123456678899999999
Q ss_pred ccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCc
Q 038003 348 NFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPL 427 (848)
Q Consensus 348 ~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 427 (848)
.+++..+ +...++|+.|++++|+++. ++.+..+++|+.|++++|++++..+ +..+++|+.|++++|++++..
T Consensus 208 ~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~-- 279 (384)
T d2omza2 208 QISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS-- 279 (384)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--
T ss_pred ccCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--
Confidence 9987654 5667899999999999985 3467889999999999999996543 788999999999999998654
Q ss_pred ccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCC
Q 038003 428 EFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSL 507 (848)
Q Consensus 428 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 507 (848)
.+..++.++.++++.|++++. ..+..+++++.|++++|++++.. .+..+++|++|++++|+|++ + +.+.++++|
T Consensus 280 ~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l-~~l~~l~~L 353 (384)
T d2omza2 280 PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-V-SSLANLTNI 353 (384)
T ss_dssp GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-C-GGGGGCTTC
T ss_pred ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-C-hhHcCCCCC
Confidence 377889999999999999863 45888999999999999999754 38899999999999999975 3 369999999
Q ss_pred ccccCCCCcccCCCcchhccccCceeecCCCC
Q 038003 508 EKLNLSHNNLSDFIPRCFEEMRSLSCIDISYN 539 (848)
Q Consensus 508 ~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N 539 (848)
++|++++|+|++..| +.++++|+.|++++|
T Consensus 354 ~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 999999999998654 899999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=5e-31 Score=286.98 Aligned_cols=198 Identities=21% Similarity=0.227 Sum_probs=159.6
Q ss_pred cCCcccceeccCCceeEEEEEc-CCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-----------CCcccceEE
Q 038003 599 DDFDEKFCIGKGGQGSVYKAEL-PSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-----------HRNNVKFHG 666 (848)
Q Consensus 599 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~l~~ 666 (848)
.+|++.+.||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+++++.++ ||||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 4599999999999999999975 579999999987642 33466778888887775 578999998
Q ss_pred Eeec--CCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEcCCCCCCeeeCCCC-
Q 038003 667 FCYN--GPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHH-DCLPSIIHRDISSKNVLLDSNF- 742 (848)
Q Consensus 667 ~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~- 742 (848)
++.. ....+++|++...+..............+++..+..++.||+.|++|||+ . ||+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence 8764 34566777776555433322222234678889999999999999999998 6 999999999999998665
Q ss_pred -----CEEEeeccCccccCCCCCCcccccccccccCccccccCCCCccchhhhHHHHHHHHHhCCCCCcc
Q 038003 743 -----EAHVSDFGIAKFVGPHSSNWTEFAGTFGYAAPEIAYTMRATEKYDVYSFGVLVFEVIKGNHPRDF 807 (848)
Q Consensus 743 -----~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 807 (848)
.++++|||.+...... ....+||+.|+|||++.+..++.++||||+||+++||+||+.||..
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ccccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 3999999999865432 2456799999999999999999999999999999999999999853
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=2e-26 Score=243.88 Aligned_cols=81 Identities=26% Similarity=0.323 Sum_probs=39.3
Q ss_pred cceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccc
Q 038003 225 LTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCT 304 (848)
Q Consensus 225 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 304 (848)
++.++.++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|..+++|+.|++++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 344444444444 3444332 3455555555555443334455555555555555555544444555555555555555
Q ss_pred cccc
Q 038003 305 NLLR 308 (848)
Q Consensus 305 N~l~ 308 (848)
|+++
T Consensus 89 n~l~ 92 (305)
T d1xkua_ 89 NQLK 92 (305)
T ss_dssp SCCS
T ss_pred CccC
Confidence 5444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.1e-25 Score=238.18 Aligned_cols=199 Identities=23% Similarity=0.324 Sum_probs=99.6
Q ss_pred CCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEee
Q 038003 104 KLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLY 183 (848)
Q Consensus 104 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 183 (848)
++++|||++|+|+...+.+|.++++|++|++++|.++...|..|..+++|++|++++|+++ .+|..+. ..|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~ 108 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVH 108 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECC
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccchh--hhhhhhhcc
Confidence 4555555555555333334555555555555555555444445555555555555555555 3443322 345555555
Q ss_pred cccccCCCccccccccccccccccccccc--ccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccC
Q 038003 184 KNSLSGSIPSIIGKLKSLLQLDLSENQFS--GSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNG 261 (848)
Q Consensus 184 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 261 (848)
+|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.++ .+|..+ .++|+.|++++|...+
T Consensus 109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~ 185 (305)
T d1xkua_ 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK 185 (305)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCE
T ss_pred ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCC
Confidence 55555443344444444555555544322 222334455555555555555555 233322 3455555555555555
Q ss_pred cCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccc
Q 038003 262 FIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308 (848)
Q Consensus 262 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 308 (848)
..+..+.+++.+++|++++|.+.+..+..+..+++|++|+|++|.|+
T Consensus 186 ~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred CChhHhhccccccccccccccccccccccccccccceeeeccccccc
Confidence 55555555555555555555555554555555554444444444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.2e-25 Score=231.89 Aligned_cols=267 Identities=22% Similarity=0.196 Sum_probs=138.6
Q ss_pred eeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccc-ccc
Q 038003 228 MSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELC-TNL 306 (848)
Q Consensus 228 L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~N~ 306 (848)
+++++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|++....+..+..+..++.+... .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 445555555 4554443 345666666666665555566666667777777666666555555555555544332 122
Q ss_pred cccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCC
Q 038003 307 LRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPK 386 (848)
Q Consensus 307 l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~ 386 (848)
++ .+....|.++++|++|++++|.+.... +..+...++
T Consensus 93 ~~------------------~l~~~~~~~l~~L~~L~l~~n~~~~~~------------------------~~~~~~~~~ 130 (284)
T d1ozna_ 93 LR------------------SVDPATFHGLGRLHTLHLDRCGLQELG------------------------PGLFRGLAA 130 (284)
T ss_dssp CC------------------CCCTTTTTTCTTCCEEECTTSCCCCCC------------------------TTTTTTCTT
T ss_pred cc------------------cccchhhcccccCCEEecCCccccccc------------------------ccccchhcc
Confidence 22 222233445555555555555554433 344444455
Q ss_pred ccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceecccc
Q 038003 387 LQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSN 466 (848)
Q Consensus 387 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 466 (848)
|+.+++++|+|++..+..|..+++|+.|++++|++++..+..|.++++|+++++++|++++..|..|.++++|++|++++
T Consensus 131 L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~ 210 (284)
T d1ozna_ 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210 (284)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred cchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccc
Confidence 55555555555544444455555555555555555544555555555555555555555555555555555555555555
Q ss_pred CcCCCCChhHHhhhcccceecccCcccCcCCCccccCCCCCccccCCCCcccCCCcchhccccCceeecCCCCccCC
Q 038003 467 NQLSHKIPTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKLNLSHNNLSDFIPRCFEEMRSLSCIDISYNELHG 543 (848)
Q Consensus 467 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~ 543 (848)
|++++..+..|..+++|++|+|++|.+...-+. ..-...++.+....+.+....|..+.+ ....+++.+.|+|
T Consensus 211 N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp SCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred cccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 555555555555555555556655555432110 001123444555555555444444432 2334445554443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.8e-25 Score=233.87 Aligned_cols=206 Identities=24% Similarity=0.227 Sum_probs=128.1
Q ss_pred CCCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEec-ccCcCCCCCccccCcCCccEEE
Q 038003 79 PHLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLD-MNQLHGTIPPEIGQLSLIDKLA 157 (848)
Q Consensus 79 ~~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~-~n~l~~~~p~~~~~l~~L~~L~ 157 (848)
+.+++|+|++|.+++.-|.+|.++++|++||+++|++.+..+..+.++..++.++.. .|.++...|..+.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 356677777777764444556677777777777777766666666666666666554 4445544455666666666666
Q ss_pred cCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCC
Q 038003 158 LCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSG 237 (848)
Q Consensus 158 L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~ 237 (848)
+++|.+....+..+....+|+.+++++|++++..+..|..+++|++|+|++|++++..+..|.++++|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 66666665445555666666666666666665545556666666666666666665555556666666666666666665
Q ss_pred CCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCcccc
Q 038003 238 SIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLY 284 (848)
Q Consensus 238 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 284 (848)
..|..|..+++|++|++++|++.+..+.+|..+++|++|++++|.+.
T Consensus 192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 55556666666666666666666555555556666666666666554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.5e-23 Score=216.52 Aligned_cols=196 Identities=26% Similarity=0.276 Sum_probs=125.8
Q ss_pred cEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCC
Q 038003 82 ANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHN 161 (848)
Q Consensus 82 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 161 (848)
.++|.++++++ .+|+.+. ++|++|||++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|
T Consensus 13 ~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N 87 (266)
T d1p9ag_ 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHN 87 (266)
T ss_dssp CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSS
T ss_pred eEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccccc
Confidence 34455555565 4565543 46677777777777655566777777777777777776 333 2456666777777777
Q ss_pred cCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCC
Q 038003 162 NLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPP 241 (848)
Q Consensus 162 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 241 (848)
+++ .++..+.++++|+.|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|++++..+.
T Consensus 88 ~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~ 166 (266)
T d1p9ag_ 88 QLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166 (266)
T ss_dssp CCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred ccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcc
Confidence 766 3455666677777777777776655556666666677777777766655555556666666666666666655555
Q ss_pred cccCcccccccccccccccCcCCCcccCCCCCceEEccCcccc
Q 038003 242 ILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLY 284 (848)
Q Consensus 242 ~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 284 (848)
.|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 167 ~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 6666666666666666666 45555556666666666666653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=2.3e-23 Score=215.08 Aligned_cols=202 Identities=24% Similarity=0.246 Sum_probs=182.6
Q ss_pred cCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccce
Q 038003 100 GNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAV 179 (848)
Q Consensus 100 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 179 (848)
.+...+.+.|.++++++ .+|+.+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|. ++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccc
Confidence 45667788899999999 5787664 58999999999999766688999999999999999998 5553 578999999
Q ss_pred EEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccc
Q 038003 180 LYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQL 259 (848)
Q Consensus 180 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l 259 (848)
|+|++|+++ .++..+..+++|++|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.+++++|++
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 999999999 5677899999999999999999988888899999999999999999977777888999999999999999
Q ss_pred cCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccc
Q 038003 260 NGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308 (848)
Q Consensus 260 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 308 (848)
++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|.+.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 9988889999999999999999999 68888889999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=8.2e-23 Score=199.47 Aligned_cols=169 Identities=18% Similarity=0.156 Sum_probs=122.0
Q ss_pred cccceeccCCceeEEEEEcCCCCEEEEEEcccccccCC--------------chhHHHHHHHHHHHhcCCCCcccceEEE
Q 038003 602 DEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGN--------------MADHDEFLNEVLALKEIRHRNNVKFHGF 667 (848)
Q Consensus 602 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 667 (848)
.+.+.||+|+||+||+|...+|+.||||+++....... ........+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999888899999998764321100 0112334568889999999999998876
Q ss_pred eecCCeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEcCCCCCCeeeCCCCCEEEe
Q 038003 668 CYNGPHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCLPSIIHRDISSKNVLLDSNFEAHVS 747 (848)
Q Consensus 668 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~ 747 (848)
. ..++||||+++..+.+ ++...+..++.|++.|++|||++ ||+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 3 2379999998865433 23344567999999999999999 99999999999999865 49999
Q ss_pred eccCccccCCCCCCcccccccccccCcc-----ccccCCCCccchhhhHHHHHH
Q 038003 748 DFGIAKFVGPHSSNWTEFAGTFGYAAPE-----IAYTMRATEKYDVYSFGVLVF 796 (848)
Q Consensus 748 DfG~~~~~~~~~~~~~~~~g~~~y~aPE-----~~~~~~~~~~~DiwSlG~il~ 796 (848)
|||.|+........ .|.... .+..++|+.++|+||+.-.+.
T Consensus 145 DFG~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 99999766432211 111110 012456788999999765443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=4.8e-20 Score=198.33 Aligned_cols=199 Identities=29% Similarity=0.347 Sum_probs=118.1
Q ss_pred CCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcC
Q 038003 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALC 159 (848)
Q Consensus 80 ~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 159 (848)
++++|||++|.++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 5778888888886 57753 467888888888887 567543 46788888888877 34321 1357788888
Q ss_pred CCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCC
Q 038003 160 HNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSI 239 (848)
Q Consensus 160 ~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 239 (848)
+|.++ .+|. ++.+++|++|++++|.++. .|..+ ..+..+.+..+... .+..+..++.++.|++++|.+.. +
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~-~ 177 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-L 177 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS-C
T ss_pred ccccc-cccc-hhhhccceeeccccccccc-ccccc---ccccchhhcccccc--ccccccccccceecccccccccc-c
Confidence 88877 5664 5677888888888877763 33332 34445555554443 23456667777777777777663 2
Q ss_pred CCcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccccccc
Q 038003 240 PPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTNLLR 308 (848)
Q Consensus 240 p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 308 (848)
+... ...+.+....+.+. .++ .+..++.|+.+++++|.... .+. ...++..+.+.++.+.
T Consensus 178 ~~~~---~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~ 237 (353)
T d1jl5a_ 178 PDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLT 237 (353)
T ss_dssp CCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCS
T ss_pred cccc---cccccccccccccc-ccc-cccccccccccccccccccc-ccc---cccccccccccccccc
Confidence 2221 12234444444443 222 24556667777777666543 222 2233444444444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=6.6e-20 Score=197.23 Aligned_cols=138 Identities=30% Similarity=0.378 Sum_probs=95.0
Q ss_pred ccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCccccccccccccccc
Q 038003 127 NQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDL 206 (848)
Q Consensus 127 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 206 (848)
.+|++|||++|.++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 46889999999998 67764 467888999999998 778764 46888889988887 44432 135888888
Q ss_pred ccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEEccCcccc
Q 038003 207 SENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLY 284 (848)
Q Consensus 207 ~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 284 (848)
++|.++ .+|. ++.+++|+.|++++|.+.. .+... ..+..+.+..+... .+..+..++.++.+++++|.+.
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred cccccc-cccc-hhhhccceeeccccccccc-ccccc---ccccchhhcccccc--ccccccccccceeccccccccc
Confidence 888887 5553 5678888888888887763 33333 33444445444443 2334566667777777777655
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.3e-22 Score=227.15 Aligned_cols=110 Identities=21% Similarity=0.225 Sum_probs=73.4
Q ss_pred ccccEEEecccCcCCC-CCccccCcCCccEEEcCCCcCCC----CCCCcccCccccceEEeecccccCC----Cccccc-
Q 038003 127 NQLRRLYLDMNQLHGT-IPPEIGQLSLIDKLALCHNNLHG----SIPSSLGNLSNLAVLYLYKNSLSGS----IPSIIG- 196 (848)
Q Consensus 127 ~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~- 196 (848)
.+|++||+++|++++. +..-+..+++++.|+|++|.++. .+...+..+++|++|+|++|.++.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3688899999998752 23345667888888888888762 2344556777888888888877521 112222
Q ss_pred cccccccccccccccccc----CcccccCCcccceeeccccCCC
Q 038003 197 KLKSLLQLDLSENQFSGS----IPLSLGNLSSLTMMSLFNNSLS 236 (848)
Q Consensus 197 ~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~n~l~ 236 (848)
...+|++|+|++|+++.. ++..+..+++|++|++++|.++
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 224678888888877643 3445667777777787777765
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=1.6e-19 Score=181.22 Aligned_cols=205 Identities=22% Similarity=0.274 Sum_probs=136.2
Q ss_pred CcEEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCC
Q 038003 81 LANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160 (848)
Q Consensus 81 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 160 (848)
+..++++.+.+++.+ .++.|.+|++|++++|+++. ++ .+..+++|++|++++|++++..| +..+++|+++++++
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 344555666665543 34566777777777777764 33 46777777777777777764332 66777777777777
Q ss_pred CcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCC
Q 038003 161 NNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIP 240 (848)
Q Consensus 161 n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p 240 (848)
|.++ .++ .+.++++|+.+++++|...+. ..+...+.++.+.++.+.+.... .+..+++|+.|++++|.+.+.
T Consensus 95 n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~-- 166 (227)
T d1h6ua2 95 NPLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL-- 166 (227)
T ss_dssp CCCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC--
T ss_pred cccc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccc--
Confidence 7766 333 466777777777777776643 22455667777777777766332 356677777777777777643
Q ss_pred CcccCcccccccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccc
Q 038003 241 PILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELC 303 (848)
Q Consensus 241 ~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 303 (848)
..++++++|+.|+|++|++++. + .++++++|++|+|++|++++.. .+..+++|+.|+++
T Consensus 167 ~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 167 TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 2367777888888888877753 3 3677788888888888877543 36777888887775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=8.4e-19 Score=177.93 Aligned_cols=200 Identities=15% Similarity=0.089 Sum_probs=96.1
Q ss_pred CCcEEeccCCcccccccccccCCCCCcEEEccccCCCCCC-chhhhccccccEEEecc-cCcCCCCCccccCcCCccEEE
Q 038003 80 HLANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLI-PPEIGKLNQLRRLYLDM-NQLHGTIPPEIGQLSLIDKLA 157 (848)
Q Consensus 80 ~l~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~ 157 (848)
++++|+|++|.++..-+.+|.++++|++|+|++|.+...+ +..|.+++++++|++.. |.+....+..|..+++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 4555555555554333334555555555555555554332 23445555555555432 344444444445555555555
Q ss_pred cCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCc-ccceeeccccCCC
Q 038003 158 LCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLS-SLTMMSLFNNSLS 236 (848)
Q Consensus 158 L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~l~~n~l~ 236 (848)
+++|++....+. ..+..++.+..+..+++.+....+..+..++ .++.|++++|+++
T Consensus 110 l~~~~l~~~~~~-----------------------~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 110 ISNTGIKHLPDV-----------------------HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp EESCCCCSCCCC-----------------------TTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cchhhhcccccc-----------------------cccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 555544421111 1122333333334444444433333333332 4555555555555
Q ss_pred CCCCCcccCccccc-ccccccccccCcCCCcccCCCCCceEEccCccccccCcccccCCCCCcccccc
Q 038003 237 GSIPPILGNLKSLS-ALGLHINQLNGFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELC 303 (848)
Q Consensus 237 ~~~p~~l~~l~~L~-~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 303 (848)
. ++.......+++ .+++++|+++...+..|.++++|++|+|++|+++...+..|.++++|+.+++.
T Consensus 167 ~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 167 E-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp E-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred c-cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 2 232222233332 33455556654444456666667777777776665545556666666665553
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.2e-21 Score=219.20 Aligned_cols=378 Identities=19% Similarity=0.104 Sum_probs=199.7
Q ss_pred CccEEEcCCCcCCCCC-CCcccCccccceEEeecccccC----CCcccccccccccccccccccccccC----cccccC-
Q 038003 152 LIDKLALCHNNLHGSI-PSSLGNLSNLAVLYLYKNSLSG----SIPSIIGKLKSLLQLDLSENQFSGSI----PLSLGN- 221 (848)
Q Consensus 152 ~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~- 221 (848)
+|++|++++|++++.. .+-+..+++++.|+|++|.++. .+...+..+++|++|+|++|+|+... ...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5788888888887531 3335567888888888888762 23445667788888888888876321 222222
Q ss_pred CcccceeeccccCCCCC----CCCcccCcccccccccccccccCcCCCccc-----CCCCCceEEccCccccccC----c
Q 038003 222 LSSLTMMSLFNNSLSGS----IPPILGNLKSLSALGLHINQLNGFIPPSIG-----NLSSLRVLYLYNNGLYGFV----P 288 (848)
Q Consensus 222 l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~~~----p 288 (848)
..+|+.|+|++|++++. ++..+..+++|++|++++|++.......+. .......+......+.... .
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 24678888888877643 334556677777777777776543222111 1122333333333322111 1
Q ss_pred ccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCcccccc----CccccCccccc
Q 038003 289 EEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEI----SFNWGNFSKLS 364 (848)
Q Consensus 289 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~ 364 (848)
..+.....++.++++.+......-. ...............+++..+.+.... ...+...+.++
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~-------------~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~ 229 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVR-------------VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLR 229 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHH-------------HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCC
T ss_pred ccccccccccccccccccccccccc-------------ccccccccccccccccccccccccchhhhccccccccccccc
Confidence 1223345555555555544311000 000000001123334455544443211 11122334455
Q ss_pred EeecccccccC-----CCCCCCCCCCCccEEEccCCccCCC----CcccccccccccEEEccCCcCCCCCCccc-----C
Q 038003 365 TFIVSMNNISG-----SIPPDIGNSPKLQVLDLSSNHIVGK----IPVQLEMLSSLNKLILNLNQLSGGVPLEF-----G 430 (848)
Q Consensus 365 ~L~l~~N~i~~-----~~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~-----~ 430 (848)
.+.+..|.+.. ..+........++.+++++|.+... ....+...+.++.+++++|.+++.....+ .
T Consensus 230 ~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~ 309 (460)
T d1z7xw1 230 ELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE 309 (460)
T ss_dssp EEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTS
T ss_pred ccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccc
Confidence 55555554321 1122233445677777777776522 22334556677777777777652211111 1
Q ss_pred CCCccCeEeccCcccCCCCCCcc----cCccccceeccccCcCCCCChhH----Hh-hhcccceecccCcccCcC----C
Q 038003 431 SLTKLQYLDLSTNKLSSSIPKSI----GNLLKLHYLNLSNNQLSHKIPTE----FE-KLIHLSELDLSHNILQEE----I 497 (848)
Q Consensus 431 ~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~p~~----~~-~l~~L~~L~Ls~N~l~~~----~ 497 (848)
....|+.+++++|.++......+ ...++|++|+|++|+|++..... +. ..+.|++|+|++|.|++. +
T Consensus 310 ~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l 389 (460)
T d1z7xw1 310 PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL 389 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred cccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHH
Confidence 23567777777777764433333 33456777777777776432222 22 244577777777777642 3
Q ss_pred CccccCCCCCccccCCCCcccCCCcchhc-----cccCceeecCCCCccC
Q 038003 498 PPQVCNMGSLEKLNLSHNNLSDFIPRCFE-----EMRSLSCIDISYNELH 542 (848)
Q Consensus 498 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~l~ls~N~l~ 542 (848)
+..+..+++|++|+|++|+|+......|. +...|+.+++++|.+.
T Consensus 390 ~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 390 AATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 34455567777777777777654333332 2335777777777664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=7.7e-19 Score=171.05 Aligned_cols=109 Identities=31% Similarity=0.403 Sum_probs=49.0
Q ss_pred CCcEEEccccCCCCCC-chhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEe
Q 038003 104 KLQYLDLGSNQLSGLI-PPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYL 182 (848)
Q Consensus 104 ~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l 182 (848)
++++|+|++|+|++.+ +..|+++++|++|+|++|++++..+..+..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 4444444444444322 233444444444444444444444444444444444444444444333344444444444444
Q ss_pred ecccccCCCccccccccccccccccccccc
Q 038003 183 YKNSLSGSIPSIIGKLKSLLQLDLSENQFS 212 (848)
Q Consensus 183 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 212 (848)
++|+|++..|+.|..+++|++|+|++|.+.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCccccccCHHHhcCCcccccccccccccc
Confidence 444444434444444444444444444443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.8e-18 Score=173.49 Aligned_cols=208 Identities=24% Similarity=0.340 Sum_probs=115.7
Q ss_pred cccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccCcCCCcccCCCCCceEE
Q 038003 198 LKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNGFIPPSIGNLSSLRVLY 277 (848)
Q Consensus 198 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 277 (848)
+.++..++++.+++++.+ .+..+++|+.|++.+|.++. ++ .+..+++|++|++++|++++..| +..+++|++++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 444555666666666432 34556667777777777763 33 46667777777777777665433 66677777777
Q ss_pred ccCccccccCcccccCCCCCccccccccccccccCCccceeeccccCCCCccccccCCCCCccEEEccCCccccccCccc
Q 038003 278 LYNNGLYGFVPEEIGYLKSLSELELCTNLLRGVIPHSIERVLLNQNNLSGKMYEAFGDHPNLTFLDLSNNNFCGEISFNW 357 (848)
Q Consensus 278 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 357 (848)
+++|.++. + ..+..+++|+.++++++...+.. .+...+.++.+.++++.+....
T Consensus 92 ~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~--------------------~~~~~~~~~~l~~~~~~~~~~~---- 145 (227)
T d1h6ua2 92 LSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDVT--------------------PLAGLSNLQVLYLDLNQITNIS---- 145 (227)
T ss_dssp CCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCCG--------------------GGTTCTTCCEEECCSSCCCCCG----
T ss_pred cccccccc-c-ccccccccccccccccccccccc--------------------hhccccchhhhhchhhhhchhh----
Confidence 77776653 2 24556666666666655544321 1334455566666665554321
Q ss_pred cCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCe
Q 038003 358 GNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQY 437 (848)
Q Consensus 358 ~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 437 (848)
.+..+++|+.|++++|.+.+.. .+..+++|+.|+|++|++++. + .++.+++|++
T Consensus 146 ----------------------~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~ 199 (227)
T d1h6ua2 146 ----------------------PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIE 199 (227)
T ss_dssp ----------------------GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCE
T ss_pred ----------------------hhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCE
Confidence 1333445555555555554222 245555555555555555532 2 2455566666
Q ss_pred EeccCcccCCCCCCcccCccccceeccc
Q 038003 438 LDLSTNKLSSSIPKSIGNLLKLHYLNLS 465 (848)
Q Consensus 438 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 465 (848)
|+|++|++++.. .++++++|++|+++
T Consensus 200 L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 200 VHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp EECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred EECcCCcCCCCc--ccccCCCCCEEEee
Confidence 666666665432 25566666666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.9e-18 Score=175.19 Aligned_cols=213 Identities=20% Similarity=0.161 Sum_probs=158.7
Q ss_pred CccCceEEcCCC---------CceEEEeccccCccccccCCccCCCCCCcEEeccCCccccccc-ccccCCCCCcEEEcc
Q 038003 42 CSWFGISCNHAG---------SRVISITMSTLGLNGTFHDFSFSSFPHLANLNLSFNLFFGNIP-LQIGNLSKLQYLDLG 111 (848)
Q Consensus 42 c~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~~~~~~~~l~~l~~L~l~~n~~~~~~p-~~~~~l~~L~~L~Ls 111 (848)
|.++.|.|.... ..++.|+++++.+. .+++.+|.++++|++|+|++|.+...+| .+|..++.+++|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 789999997431 25888999988875 5777789999999999999999987665 468899999999987
Q ss_pred c-cCCCCCCchhhhccccccEEEecccCcCCCCC-ccccCcCCccEEEcCCCcCCCCCCCcccCcc-ccceEEeeccccc
Q 038003 112 S-NQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIP-PEIGQLSLIDKLALCHNNLHGSIPSSLGNLS-NLAVLYLYKNSLS 188 (848)
Q Consensus 112 ~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~l~~N~l~ 188 (848)
. |++....|..|.++++|++|++++|++....+ ..+..+..+..+...++.+....+..+.+++ .++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 5 68887888889999999999999999975433 2455677777778888888755556666654 7888888888888
Q ss_pred CCCcccccccccc-cccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCccccccccccc
Q 038003 189 GSIPSIIGKLKSL-LQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHI 256 (848)
Q Consensus 189 ~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~ 256 (848)
...+..+. ..++ +.+++++|+++...+..|.++++|++|++++|+|+...+..|.++++|+.+++.+
T Consensus 167 ~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 167 EIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp EECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 44444443 3444 4446677778743344577788888888888888744444567777777766543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=2.8e-18 Score=169.55 Aligned_cols=179 Identities=26% Similarity=0.348 Sum_probs=91.0
Q ss_pred eccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCC
Q 038003 85 NLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLH 164 (848)
Q Consensus 85 ~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 164 (848)
++..+.+++.++. ..|.+|++|++++|.++.. + .+..+++|++|+|++|++++ ++ .++.+++|++|++++|+++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc
Confidence 4444555444432 2455666666666666543 2 35566666666666666653 22 2455666666666666655
Q ss_pred CCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCccc
Q 038003 165 GSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILG 244 (848)
Q Consensus 165 ~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~ 244 (848)
+ +| .+.++++|+.|++++|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+.+++++|++++. + .+.
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~ 175 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLA 175 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGT
T ss_pred c-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccccc-c-ccc
Confidence 2 33 35555666666666655542 2 234455555555555555542 12344455555555555555432 2 144
Q ss_pred CcccccccccccccccCcCCCcccCCCCCceEEcc
Q 038003 245 NLKSLSALGLHINQLNGFIPPSIGNLSSLRVLYLY 279 (848)
Q Consensus 245 ~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls 279 (848)
++++|+.|+|++|+++. +| .+.++++|++|+|+
T Consensus 176 ~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp TCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred CCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 44555555555555442 22 24444455555443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=7.5e-18 Score=164.95 Aligned_cols=164 Identities=25% Similarity=0.380 Sum_probs=82.5
Q ss_pred EEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCc
Q 038003 83 NLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNN 162 (848)
Q Consensus 83 ~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 162 (848)
.+.++.+.+++.++ ...+.++++|++++|+++. + +.+..+++|++|+|++|++++. ++ ++++++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-cc-ccCCcccccccccccc
Confidence 33455555554332 2345566666666666653 2 2355666666666666666542 22 5556666666666665
Q ss_pred CCCCCCCcccCccccceEEeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCc
Q 038003 163 LHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPI 242 (848)
Q Consensus 163 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~ 242 (848)
+. .++ .++++++|+.|++++|.+... ..+..+++|+.|++++|++. .++ .+..+++|+.|++.+|++++. + .
T Consensus 96 ~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~ 167 (199)
T d2omxa2 96 IA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-P 167 (199)
T ss_dssp CC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-G
T ss_pred cc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCC-c-c
Confidence 55 222 255555566666655555432 22445555555555555554 222 344455555555555554431 1 2
Q ss_pred ccCccccccccccccccc
Q 038003 243 LGNLKSLSALGLHINQLN 260 (848)
Q Consensus 243 l~~l~~L~~L~l~~N~l~ 260 (848)
++++++|++|++++|+++
T Consensus 168 l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 168 LANLTTLERLDISSNKVS 185 (199)
T ss_dssp GTTCTTCCEEECCSSCCC
T ss_pred ccCCCCCCEEECCCCCCC
Confidence 344444444444444443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=8.9e-18 Score=163.39 Aligned_cols=128 Identities=24% Similarity=0.291 Sum_probs=59.0
Q ss_pred cEEEccCCccccccCccccCcccccEeecccccccCC-CCCCCCCCCCccEEEccCCccCCCCcccccccccccEEEccC
Q 038003 340 TFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGS-IPPDIGNSPKLQVLDLSSNHIVGKIPVQLEMLSSLNKLILNL 418 (848)
Q Consensus 340 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 418 (848)
+.++.++++++.+ |..+ .+++++|+|++|+|++. .+..|..+++|+.|+|++|++.+..+..+..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~i-P~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKEI-PRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSC-CSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCcc-CCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 4566666666532 2111 13344444444444332 223334444444444444444444444444444444444444
Q ss_pred CcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCC
Q 038003 419 NQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLS 470 (848)
Q Consensus 419 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 470 (848)
|+|+...+..|.++++|++|+|++|+|+++.+.+|..+++|++|+|++|.+.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 4444444444444444444444444444444444444444444444444444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=7.4e-18 Score=166.47 Aligned_cols=187 Identities=28% Similarity=0.406 Sum_probs=157.3
Q ss_pred CCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEE
Q 038003 102 LSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLY 181 (848)
Q Consensus 102 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 181 (848)
+.++...+++.+.+++.++. ..+.+|++|++++|.+++ ++ .+..+++|++|+|++|+|++ ++ .++++++|++|+
T Consensus 23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~ 96 (210)
T d1h6ta2 23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLF 96 (210)
T ss_dssp HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEE
T ss_pred HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccc
Confidence 34445567888888876653 568899999999999985 33 48899999999999999996 44 378999999999
Q ss_pred eecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCcccccccccccccccC
Q 038003 182 LYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLNG 261 (848)
Q Consensus 182 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 261 (848)
+++|++++ +| .+..+++|+.|++++|.+. .+ ..+..+++|+.+++++|.+++ +..+..+++|+++++++|++++
T Consensus 97 l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 97 LDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp CCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred cccccccc-cc-ccccccccccccccccccc-cc-ccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999984 55 5889999999999999987 33 468889999999999999985 3467889999999999999986
Q ss_pred cCCCcccCCCCCceEEccCccccccCcccccCCCCCccccccc
Q 038003 262 FIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCT 304 (848)
Q Consensus 262 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 304 (848)
.. .+.++++|++|+|++|+++. ++ .+..+++|++|+|++
T Consensus 171 i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 171 IV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 43 38899999999999999985 44 589999999999864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=3.2e-18 Score=167.65 Aligned_cols=184 Identities=26% Similarity=0.370 Sum_probs=151.9
Q ss_pred CCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceE
Q 038003 101 NLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVL 180 (848)
Q Consensus 101 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 180 (848)
++.++..++++.+.+++.++ ...+.+|++|++++|.++. ++ .+..+++|++|++++|++++..| ++++++|++|
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L 89 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 89 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence 34555566788888887544 4678999999999999984 43 58889999999999999996433 8999999999
Q ss_pred EeecccccCCCcccccccccccccccccccccccCcccccCCcccceeeccccCCCCCCCCcccCccccccccccccccc
Q 038003 181 YLYKNSLSGSIPSIIGKLKSLLQLDLSENQFSGSIPLSLGNLSSLTMMSLFNNSLSGSIPPILGNLKSLSALGLHINQLN 260 (848)
Q Consensus 181 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~ 260 (848)
++++|.+.. ++ .++++++|+.|++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|+++
T Consensus 90 ~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 90 LMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp ECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC
T ss_pred ccccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-cccccccccccccccccccc
Confidence 999999884 44 488999999999999998753 357889999999999999973 3 46889999999999999998
Q ss_pred CcCCCcccCCCCCceEEccCccccccCcccccCCCCCccc
Q 038003 261 GFIPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSEL 300 (848)
Q Consensus 261 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 300 (848)
+.. .++++++|++|++++|++++. + .++.+++|++|
T Consensus 164 ~l~--~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 164 DLK--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred CCc--cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 653 488999999999999999863 3 57888888765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=2.9e-15 Score=140.30 Aligned_cols=128 Identities=19% Similarity=0.144 Sum_probs=82.0
Q ss_pred ccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccc
Q 038003 405 LEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLS 484 (848)
Q Consensus 405 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 484 (848)
+.++.++++|+|++|+|+. ++..+..+++|+.|+|++|+|+.. +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 3444555566666666653 344445566666666666666633 2466667777777777777665555666677777
Q ss_pred eecccCcccCcCCC-ccccCCCCCccccCCCCcccCCC---cchhccccCceeec
Q 038003 485 ELDLSHNILQEEIP-PQVCNMGSLEKLNLSHNNLSDFI---PRCFEEMRSLSCID 535 (848)
Q Consensus 485 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~l~ 535 (848)
.|++++|+|+.... ..+..+++|++|++++|+++... +..+..+|+|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 77777777754321 35677788888888888876532 23567788888876
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=8.8e-15 Score=130.19 Aligned_cols=101 Identities=29% Similarity=0.395 Sum_probs=48.8
Q ss_pred EEeccCCcccccccccccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCc
Q 038003 83 NLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNN 162 (848)
Q Consensus 83 ~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 162 (848)
.|+|++|+++ .+| .++++++|++||+++|+++ .+|+.++.+++|++|++++|+|++ +| .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4555555554 233 2555555555555555555 344455555555555555555552 22 24445555555555555
Q ss_pred CCCCC-CCcccCccccceEEeeccccc
Q 038003 163 LHGSI-PSSLGNLSNLAVLYLYKNSLS 188 (848)
Q Consensus 163 l~~~~-p~~l~~l~~L~~L~l~~N~l~ 188 (848)
|+... ...++.+++|++|++++|.++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 44211 123444444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=1.4e-14 Score=128.91 Aligned_cols=118 Identities=24% Similarity=0.325 Sum_probs=97.5
Q ss_pred cEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecc
Q 038003 106 QYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKN 185 (848)
Q Consensus 106 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N 185 (848)
|+|||++|+++. +| .+.++++|++|++++|+|+ .+|+.++.+++|++|++++|.|++ +| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 689999999984 45 5899999999999999998 688889999999999999999994 55 4899999999999999
Q ss_pred cccCCC-cccccccccccccccccccccccC---cccccCCccccee
Q 038003 186 SLSGSI-PSIIGKLKSLLQLDLSENQFSGSI---PLSLGNLSSLTMM 228 (848)
Q Consensus 186 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~---p~~l~~l~~L~~L 228 (848)
+++... ...++.+++|++|++++|+++..- ......+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 998543 256889999999999999997421 2223445666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=4.9e-15 Score=138.77 Aligned_cols=110 Identities=22% Similarity=0.203 Sum_probs=61.8
Q ss_pred ccCCCCCcEEEccccCCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccc
Q 038003 99 IGNLSKLQYLDLGSNQLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLA 178 (848)
Q Consensus 99 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 178 (848)
+.++.+|++|||++|+|+. +|..+..+++|++|+|++|+|+ .++ .+..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 4555666666666666663 3555556666666666666666 232 355566666666666666532233344556666
Q ss_pred eEEeecccccCCCc--cccccccccccccccccccc
Q 038003 179 VLYLYKNSLSGSIP--SIIGKLKSLLQLDLSENQFS 212 (848)
Q Consensus 179 ~L~l~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~ 212 (848)
+|++++|+++. ++ ..+..+++|++|++++|.++
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccc-cccccccccccccchhhcCCCccc
Confidence 66666666552 22 23455555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=5.3e-16 Score=160.61 Aligned_cols=199 Identities=16% Similarity=0.161 Sum_probs=104.7
Q ss_pred cEEeccCCcccccccccccCCCCCcEEEccccCCCCC-CchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCC
Q 038003 82 ANLNLSFNLFFGNIPLQIGNLSKLQYLDLGSNQLSGL-IPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCH 160 (848)
Q Consensus 82 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 160 (848)
..+.++.......+. ......+|++|||+++.+++. ++..+.++++|++|+|++|.+++..+..++.+++|++|+|++
T Consensus 26 ~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 26 IAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp SEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred eEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 344555444432222 233455777777777766543 334456677777777777777666666677777777777776
Q ss_pred C-cCCCC-CCCcccCccccceEEeeccc-ccCC-Ccccccc-cccccccccccc--ccccc-CcccccCCcccceeeccc
Q 038003 161 N-NLHGS-IPSSLGNLSNLAVLYLYKNS-LSGS-IPSIIGK-LKSLLQLDLSEN--QFSGS-IPLSLGNLSSLTMMSLFN 232 (848)
Q Consensus 161 n-~l~~~-~p~~l~~l~~L~~L~l~~N~-l~~~-~p~~~~~-l~~L~~L~L~~N--~l~~~-~p~~l~~l~~L~~L~l~~ 232 (848)
+ .++.. +..-+.++++|++|+++++. ++.. +...+.. .++|+.|+++++ .++.. +...+.++++|++|++++
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~ 184 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccc
Confidence 4 34421 11223456667777776642 3211 1122222 245666666643 23321 222233455666666665
Q ss_pred c-CCCCCCCCcccCcccccccccccc-cccCcCCCcccCCCCCceEEccCc
Q 038003 233 N-SLSGSIPPILGNLKSLSALGLHIN-QLNGFIPPSIGNLSSLRVLYLYNN 281 (848)
Q Consensus 233 n-~l~~~~p~~l~~l~~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~Ls~N 281 (848)
| .+++..+..+.++++|++|++++| .+++.....++++++|+.|+++++
T Consensus 185 ~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 4 344444445555555555555553 444444444555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.6e-15 Score=156.86 Aligned_cols=215 Identities=17% Similarity=0.143 Sum_probs=110.8
Q ss_pred cccccccccccccccCc-CCCcccCCCCCceEEccCccccccCcccccCCCCCcccccccc-ccccccCCccceeecccc
Q 038003 246 LKSLSALGLHINQLNGF-IPPSIGNLSSLRVLYLYNNGLYGFVPEEIGYLKSLSELELCTN-LLRGVIPHSIERVLLNQN 323 (848)
Q Consensus 246 l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~L~~n 323 (848)
..+|++||+++|.++.. ++..+..+++|++|+|++|.+....+..+..+++|+.|+++++ .++.. .+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~---~l-------- 113 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF---AL-------- 113 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH---HH--------
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccccc---cc--------
Confidence 34556666665555432 2233455666666666666665555555555566666666553 22210 00
Q ss_pred CCCCccccccCCCCCccEEEccCC-ccccccCccccCcccccEeecccccccCCCCCCCC-CCCCccEEEccCCc--cCC
Q 038003 324 NLSGKMYEAFGDHPNLTFLDLSNN-NFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIG-NSPKLQVLDLSSNH--IVG 399 (848)
Q Consensus 324 ~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~-~l~~L~~L~Ls~N~--l~~ 399 (848)
...+..+++|++|+++++ .+++.... ..+. ..++|+.|+++++. ++.
T Consensus 114 ------~~l~~~~~~L~~L~ls~c~~~~~~~~~-----------------------~~~~~~~~~L~~L~l~~~~~~i~~ 164 (284)
T d2astb2 114 ------QTLLSSCSRLDELNLSWCFDFTEKHVQ-----------------------VAVAHVSETITQLNLSGYRKNLQK 164 (284)
T ss_dssp ------HHHHHHCTTCCEEECCCCTTCCHHHHH-----------------------HHHHHSCTTCCEEECCSCGGGSCH
T ss_pred ------chhhHHHHhccccccccccccccccch-----------------------hhhcccccccchhhhccccccccc
Confidence 001223456666666664 23221100 0011 12456666666542 321
Q ss_pred C-CcccccccccccEEEccCC-cCCCCCCcccCCCCccCeEeccCc-ccCCCCCCcccCccccceeccccCcCCCCChhH
Q 038003 400 K-IPVQLEMLSSLNKLILNLN-QLSGGVPLEFGSLTKLQYLDLSTN-KLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTE 476 (848)
Q Consensus 400 ~-~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 476 (848)
. +......+++|++|++++| .+++.....+..+++|++|+++++ .+++.....++++++|+.|+++++ ++...-..
T Consensus 165 ~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~ 243 (284)
T d2astb2 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQL 243 (284)
T ss_dssp HHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHH
T ss_pred ccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHH
Confidence 1 2223345677777777764 456555666667777777777774 566555566677777777777776 33222222
Q ss_pred HhhhcccceecccCcccCcCCCccccC
Q 038003 477 FEKLIHLSELDLSHNILQEEIPPQVCN 503 (848)
Q Consensus 477 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 503 (848)
+. ..+..|.+..+.+++..++.++.
T Consensus 244 l~--~~lp~L~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 244 LK--EALPHLQINCSHFTTIARPTIGN 268 (284)
T ss_dssp HH--HHSTTSEESCCCSCCTTCSSCSS
T ss_pred HH--HhCccccccCccCCCCCCCccCc
Confidence 21 12334445666666555555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=9.5e-16 Score=163.78 Aligned_cols=235 Identities=18% Similarity=0.147 Sum_probs=158.6
Q ss_pred cCCCCCCcEEeccCCcccc----cccccccCCCCCcEEEccccCCCCC---Cc-------hhhhccccccEEEecccCcC
Q 038003 75 FSSFPHLANLNLSFNLFFG----NIPLQIGNLSKLQYLDLGSNQLSGL---IP-------PEIGKLNQLRRLYLDMNQLH 140 (848)
Q Consensus 75 ~~~l~~l~~L~l~~n~~~~----~~p~~~~~l~~L~~L~Ls~n~l~~~---~p-------~~~~~l~~L~~L~L~~n~l~ 140 (848)
+.....|+.|+|++|.+.. .+...+...++|+.|+++++..... .| ..+..+++|+.|+|++|.++
T Consensus 27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 106 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 106 (344)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccc
Confidence 5557788899999988754 2445677788999999987754321 12 33456788999999999887
Q ss_pred CC----CCccccCcCCccEEEcCCCcCCCCCCCc-------------ccCccccceEEeecccccCC----Ccccccccc
Q 038003 141 GT----IPPEIGQLSLIDKLALCHNNLHGSIPSS-------------LGNLSNLAVLYLYKNSLSGS----IPSIIGKLK 199 (848)
Q Consensus 141 ~~----~p~~~~~l~~L~~L~L~~n~l~~~~p~~-------------l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~ 199 (848)
.. +...+...++|++|++++|.+...-... ....+.|+.|++++|.++.. +...+...+
T Consensus 107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~ 186 (344)
T d2ca6a1 107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186 (344)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred cccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhh
Confidence 54 3344556788999999988775211111 12356788888888887632 223345667
Q ss_pred ccccccccccccccc-----CcccccCCcccceeeccccCCCCC----CCCcccCcccccccccccccccCcCCCcc---
Q 038003 200 SLLQLDLSENQFSGS-----IPLSLGNLSSLTMMSLFNNSLSGS----IPPILGNLKSLSALGLHINQLNGFIPPSI--- 267 (848)
Q Consensus 200 ~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p~~l--- 267 (848)
.|++|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.....+
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~ 266 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 266 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHH
Confidence 888888888888642 234466778888888888887532 33456677888888888888865433322
Q ss_pred -c--CCCCCceEEccCccccccC----ccccc-CCCCCcccccccccccc
Q 038003 268 -G--NLSSLRVLYLYNNGLYGFV----PEEIG-YLKSLSELELCTNLLRG 309 (848)
Q Consensus 268 -~--~l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~L~~N~l~~ 309 (848)
. ..+.|++|++++|.++... ...+. ++++|+.|++++|++..
T Consensus 267 l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 2 2356888888888876432 23332 46778888888888753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=7.9e-16 Score=164.45 Aligned_cols=249 Identities=20% Similarity=0.236 Sum_probs=145.9
Q ss_pred CCCcccCCCCCceEEccCcccccc----CcccccCCCCCccccccccccccc---cCCccceeeccccCCCCccccccCC
Q 038003 263 IPPSIGNLSSLRVLYLYNNGLYGF----VPEEIGYLKSLSELELCTNLLRGV---IPHSIERVLLNQNNLSGKMYEAFGD 335 (848)
Q Consensus 263 ~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~---~p~~l~~l~L~~n~l~~~~~~~~~~ 335 (848)
+...+.+...|+.|+|++|.+... +...+...++|+.++++++..... .|..+. .....+..
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~-----------~l~~~l~~ 91 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR-----------LLLQALLK 91 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH-----------HHHHHHTT
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHH-----------HHHHHHhh
Confidence 345577788999999999988643 234466678888888877654322 111111 11234556
Q ss_pred CCCccEEEccCCccccccCccccCcccccEeecccccccCCCCCCCCCCCCccEEEccCCccCCCCcc------------
Q 038003 336 HPNLTFLDLSNNNFCGEISFNWGNFSKLSTFIVSMNNISGSIPPDIGNSPKLQVLDLSSNHIVGKIPV------------ 403 (848)
Q Consensus 336 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~------------ 403 (848)
.++|+.|+|++|.++......+. ..+...++|+.|++++|.+......
T Consensus 92 ~~~L~~L~L~~n~i~~~~~~~l~--------------------~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~ 151 (344)
T d2ca6a1 92 CPKLHTVRLSDNAFGPTAQEPLI--------------------DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN 151 (344)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHH--------------------HHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCcccccccccccccccccchh--------------------hhhcccccchheecccccccccccccccccccccccc
Confidence 77888888888887653222111 1122234555555555554311000
Q ss_pred -cccccccccEEEccCCcCCCCC----CcccCCCCccCeEeccCcccCCC-----CCCcccCccccceeccccCcCCCC-
Q 038003 404 -QLEMLSSLNKLILNLNQLSGGV----PLEFGSLTKLQYLDLSTNKLSSS-----IPKSIGNLLKLHYLNLSNNQLSHK- 472 (848)
Q Consensus 404 -~l~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~- 472 (848)
.....+.|+.+++++|.++... ...+...++|+.|+|++|+++.. +...+..+++|+.|+|++|.++..
T Consensus 152 ~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g 231 (344)
T d2ca6a1 152 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG 231 (344)
T ss_dssp HHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH
T ss_pred cccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccc
Confidence 0123445666666666665221 12233456677777777776531 234456667777777777777533
Q ss_pred ---ChhHHhhhcccceecccCcccCcCCCccc----c--CCCCCccccCCCCcccCCC----cchhc-cccCceeecCCC
Q 038003 473 ---IPTEFEKLIHLSELDLSHNILQEEIPPQV----C--NMGSLEKLNLSHNNLSDFI----PRCFE-EMRSLSCIDISY 538 (848)
Q Consensus 473 ---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~--~l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~l~ls~ 538 (848)
+...+..+++|++|+|++|.|++.....+ . ....|++|++++|+|+... ...+. ++++|+.|++++
T Consensus 232 ~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~ 311 (344)
T d2ca6a1 232 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311 (344)
T ss_dssp HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTT
T ss_pred cccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCC
Confidence 23445566777777888777765422222 2 2356888999988886543 23332 567899999999
Q ss_pred CccC
Q 038003 539 NELH 542 (848)
Q Consensus 539 N~l~ 542 (848)
|++.
T Consensus 312 N~~~ 315 (344)
T d2ca6a1 312 NRFS 315 (344)
T ss_dssp SBSC
T ss_pred CcCC
Confidence 9885
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=8.4e-15 Score=142.19 Aligned_cols=143 Identities=23% Similarity=0.284 Sum_probs=108.3
Q ss_pred ccEEEccCC--ccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcccCCCCCCcccCccccceecc
Q 038003 387 LQVLDLSSN--HIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNL 464 (848)
Q Consensus 387 L~~L~Ls~N--~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 464 (848)
++.++++++ .+. .++..+..+++|++|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 344555543 233 456778888899999999999884 33 4788889999999999987 45655666778999999
Q ss_pred ccCcCCCCChhHHhhhcccceecccCcccCcCCC-ccccCCCCCccccCCCCcccCCCcch----------hccccCcee
Q 038003 465 SNNQLSHKIPTEFEKLIHLSELDLSHNILQEEIP-PQVCNMGSLEKLNLSHNNLSDFIPRC----------FEEMRSLSC 533 (848)
Q Consensus 465 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~----------~~~l~~L~~ 533 (848)
++|+|+.. ..+..+++|+.|+|++|+|+.... ..+..+++|+.|+|++|++....+.. +..+|+|+.
T Consensus 101 ~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~ 178 (198)
T d1m9la_ 101 SYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKK 178 (198)
T ss_dssp SEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCE
T ss_pred cccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCE
Confidence 99999853 458889999999999999975322 46788999999999999886543332 567888888
Q ss_pred ec
Q 038003 534 ID 535 (848)
Q Consensus 534 l~ 535 (848)
||
T Consensus 179 LD 180 (198)
T d1m9la_ 179 LD 180 (198)
T ss_dssp ES
T ss_pred eC
Confidence 77
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.38 E-value=7.1e-15 Score=142.71 Aligned_cols=112 Identities=22% Similarity=0.258 Sum_probs=50.8
Q ss_pred chhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCccccceEEeecccccCCCcccccccc
Q 038003 120 PPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNLSNLAVLYLYKNSLSGSIPSIIGKLK 199 (848)
Q Consensus 120 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 199 (848)
|..+..+++|++|+|++|+|+ .++ .+..+++|++|+|++|.|+ .+|.....+++|++|++++|+++. ++ .+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHH
T ss_pred hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccc
Confidence 344444444444444444444 222 2444444444444444444 333333333445555555555542 22 244455
Q ss_pred cccccccccccccccCc-ccccCCcccceeeccccCCC
Q 038003 200 SLLQLDLSENQFSGSIP-LSLGNLSSLTMMSLFNNSLS 236 (848)
Q Consensus 200 ~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~l~~n~l~ 236 (848)
+|++|+|++|+++.... ..+..+++|+.|++++|.+.
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccc
Confidence 55555555555542111 23445555555555555443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=5.4e-12 Score=116.84 Aligned_cols=136 Identities=20% Similarity=0.117 Sum_probs=85.8
Q ss_pred eecccccccCCCCCCCCCCCCccEEEccCC-ccCCCCcccccccccccEEEccCCcCCCCCCcccCCCCccCeEeccCcc
Q 038003 366 FIVSMNNISGSIPPDIGNSPKLQVLDLSSN-HIVGKIPVQLEMLSSLNKLILNLNQLSGGVPLEFGSLTKLQYLDLSTNK 444 (848)
Q Consensus 366 L~l~~N~i~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 444 (848)
++..++.+. ..|..+..+++|++|++++| .|+...+.+|.++++|+.|+|++|+|+...+..|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 444444443 35666777778888888655 4776666778888888888888888887777778888888888888888
Q ss_pred cCCCCCCcccCccccceeccccCcCCC-CChhHHhhhcccceecccCcccCcCCCccccC
Q 038003 445 LSSSIPKSIGNLLKLHYLNLSNNQLSH-KIPTEFEKLIHLSELDLSHNILQEEIPPQVCN 503 (848)
Q Consensus 445 l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 503 (848)
|+...+..|..+ +|+.|+|++|.+.- -...+|..+.......+..++++-..|..+.+
T Consensus 92 l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~ 150 (156)
T d2ifga3 92 LESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAH 150 (156)
T ss_dssp CSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSC
T ss_pred CcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCc
Confidence 875555555444 68888888888752 12233433333333333444444444444433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=5.6e-12 Score=116.73 Aligned_cols=92 Identities=22% Similarity=0.194 Sum_probs=50.9
Q ss_pred cccccCCCCCcEEEcccc-CCCCCCchhhhccccccEEEecccCcCCCCCccccCcCCccEEEcCCCcCCCCCCCcccCc
Q 038003 96 PLQIGNLSKLQYLDLGSN-QLSGLIPPEIGKLNQLRRLYLDMNQLHGTIPPEIGQLSLIDKLALCHNNLHGSIPSSLGNL 174 (848)
Q Consensus 96 p~~~~~l~~L~~L~Ls~n-~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 174 (848)
|..+..+++|++|++++| .++...+.+|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+ .+|......
T Consensus 24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~ 102 (156)
T d2ifga3 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQG 102 (156)
T ss_dssp TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCS
T ss_pred cccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhcc
Confidence 344445555566666543 355444455566666666666666665544555556666666666666665 344333233
Q ss_pred cccceEEeeccccc
Q 038003 175 SNLAVLYLYKNSLS 188 (848)
Q Consensus 175 ~~L~~L~l~~N~l~ 188 (848)
.+|+.|+|++|.+.
T Consensus 103 ~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 103 LSLQELVLSGNPLH 116 (156)
T ss_dssp CCCCEEECCSSCCC
T ss_pred ccccccccCCCccc
Confidence 35666777666664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.65 E-value=2.4e-09 Score=99.38 Aligned_cols=106 Identities=29% Similarity=0.211 Sum_probs=68.9
Q ss_pred CccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCC--hhHHhhhcccceecccCcccCcCCCccccCCCCCccc
Q 038003 433 TKLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKI--PTEFEKLIHLSELDLSHNILQEEIPPQVCNMGSLEKL 510 (848)
Q Consensus 433 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 510 (848)
..+..+...+|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+-.+.....|+.|
T Consensus 42 ~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L 120 (162)
T d1koha1 42 NIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120 (162)
T ss_dssp TCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSC
T ss_pred cchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccccee
Confidence 33444444444333 33444456778888888888887643 3567778888888888888876444344455678888
Q ss_pred cCCCCcccCCCcc-------hhccccCceeecCCCCcc
Q 038003 511 NLSHNNLSDFIPR-------CFEEMRSLSCIDISYNEL 541 (848)
Q Consensus 511 ~Ls~N~l~~~~~~-------~~~~l~~L~~l~ls~N~l 541 (848)
++++|++...... .+..+|+|+.|| |+++
T Consensus 121 ~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred ecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 8888888765432 256688888876 5555
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=1.1e-08 Score=94.86 Aligned_cols=108 Identities=22% Similarity=0.067 Sum_probs=80.9
Q ss_pred ccCeEeccCcccCCCCCCcccCccccceeccccCcCCCCChhHHhhhcccceecccCcccCcCC--CccccCCCCCcccc
Q 038003 434 KLQYLDLSTNKLSSSIPKSIGNLLKLHYLNLSNNQLSHKIPTEFEKLIHLSELDLSHNILQEEI--PPQVCNMGSLEKLN 511 (848)
Q Consensus 434 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~ 511 (848)
..+.|+++++... ..+..+..+..++..+|..+ .++..+.++++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4556777665532 23455566666777766654 45667788999999999999998653 35577899999999
Q ss_pred CCCCcccCCCcchhccccCceeecCCCCccCCCCC
Q 038003 512 LSHNNLSDFIPRCFEEMRSLSCIDISYNELHGPIP 546 (848)
Q Consensus 512 Ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~~ 546 (848)
|++|.|+...+-.+.....|+.+++++|++++...
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence 99999998655455566789999999999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=1.1e-06 Score=88.26 Aligned_cols=149 Identities=15% Similarity=0.072 Sum_probs=100.1
Q ss_pred HHHHhhcCCcccceeccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecC
Q 038003 593 EIIKATDDFDEKFCIGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNG 671 (848)
Q Consensus 593 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~ 671 (848)
++.+.-+.|+..+..+.++.+.||++.. ++..+++|+...... .....+.+|...++.+. +--+.+++.+..++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc----cchhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 3444445666666655566678999865 466688888755421 12234567888777663 33356788888888
Q ss_pred CeeEEEEeccCCCCHHhHhcCCCCcccCCHHHHHHHHHHHHHHHHHHhhCCC----------------------------
Q 038003 672 PHSFLVCEYLDRGSLARILGDDVTAKELGWNRRINVIKGVANALSYLHHDCL---------------------------- 723 (848)
Q Consensus 672 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~---------------------------- 723 (848)
+..++||++++|.++.+..... . ....++.++++.+..||+...
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CceEEEEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 8999999999998876654222 1 122345566666666664321
Q ss_pred ----------------------------CCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 724 ----------------------------PSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 724 ----------------------------~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1268999999999999877677999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=1.1e-05 Score=79.95 Aligned_cols=74 Identities=14% Similarity=0.087 Sum_probs=52.7
Q ss_pred eeccCCc-eeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCC--CcccceEEEeecCCeeEEEEeccC
Q 038003 606 CIGKGGQ-GSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRH--RNNVKFHGFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 606 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~~~~~~lV~e~~~ 682 (848)
.+..|.. +.||++...++..+++|...... ...+.+|.+.++.+.. --+.+++.+..+++..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4555554 67899988888889999865432 1235667777766632 235678888888888999999998
Q ss_pred CCCH
Q 038003 683 RGSL 686 (848)
Q Consensus 683 ~gsL 686 (848)
|.++
T Consensus 90 G~~~ 93 (255)
T d1nd4a_ 90 GQDL 93 (255)
T ss_dssp SEET
T ss_pred cccc
Confidence 8654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.80 E-value=3.4e-06 Score=77.83 Aligned_cols=88 Identities=20% Similarity=0.240 Sum_probs=50.6
Q ss_pred cCccccceeccccCcCCCC----ChhHHhhhcccceecccCcccCcCC----CccccCCCCCccccCCCCcccCC-----
Q 038003 454 GNLLKLHYLNLSNNQLSHK----IPTEFEKLIHLSELDLSHNILQEEI----PPQVCNMGSLEKLNLSHNNLSDF----- 520 (848)
Q Consensus 454 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----- 520 (848)
...+.|++|+|++|.++.. +...+...+.|++|+|++|.|+... -..+...++|++|+|++|.+...
T Consensus 41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~ 120 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE 120 (167)
T ss_dssp TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHH
Confidence 3344455555555555421 2233444555666666666665421 22455567788888888766543
Q ss_pred --CcchhccccCceeecCCCCcc
Q 038003 521 --IPRCFEEMRSLSCIDISYNEL 541 (848)
Q Consensus 521 --~~~~~~~l~~L~~l~ls~N~l 541 (848)
+...+...++|+.|+++++..
T Consensus 121 ~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 121 MDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHhCCCccEeeCcCCCc
Confidence 234456678888888877643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.71 E-value=4.6e-06 Score=76.91 Aligned_cols=87 Identities=13% Similarity=0.116 Sum_probs=41.1
Q ss_pred CCCccEEEccCC-ccCCC----CcccccccccccEEEccCCcCCCCC----CcccCCCCccCeEeccCcccCCCC----C
Q 038003 384 SPKLQVLDLSSN-HIVGK----IPVQLEMLSSLNKLILNLNQLSGGV----PLEFGSLTKLQYLDLSTNKLSSSI----P 450 (848)
Q Consensus 384 l~~L~~L~Ls~N-~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~----p 450 (848)
.++|++|+|+++ .++.. +...+...++|++|+|++|.++... ...+...+.|+.|+|++|.|+... .
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 355666666653 34321 2223444455666666666554211 122233455555666655555321 1
Q ss_pred CcccCccccceeccccCcCC
Q 038003 451 KSIGNLLKLHYLNLSNNQLS 470 (848)
Q Consensus 451 ~~~~~l~~L~~L~Ls~N~l~ 470 (848)
..+...+.|++|+|++|.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSC
T ss_pred HHHHhCCcCCEEECCCCcCC
Confidence 22334445555555555444
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.67 E-value=5e-05 Score=80.28 Aligned_cols=80 Identities=16% Similarity=-0.008 Sum_probs=49.5
Q ss_pred cceeccCCceeEEEEEcCC-CCEEEEEEcccccccCC---chhHHHHHHHHHHHhcC-CC--CcccceEEEeecCCeeEE
Q 038003 604 KFCIGKGGQGSVYKAELPS-GDIVAVKKFNSQLLSGN---MADHDEFLNEVLALKEI-RH--RNNVKFHGFCYNGPHSFL 676 (848)
Q Consensus 604 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~---~~~~~~~~~E~~~l~~l-~h--p~iv~l~~~~~~~~~~~l 676 (848)
.+.||.|....||++...+ ++.+++|.......... ....++...|.+.++.+ .+ ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999997654 67899997544221111 11234455688877766 22 345566654 4455689
Q ss_pred EEeccCCCC
Q 038003 677 VCEYLDRGS 685 (848)
Q Consensus 677 V~e~~~~gs 685 (848)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998753
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.23 E-value=2.9e-05 Score=71.28 Aligned_cols=88 Identities=10% Similarity=0.141 Sum_probs=51.3
Q ss_pred cCccccceeccccCcCCCC----ChhHHhhhcccceecccCcccCcC----CCccccCCCCCcc--ccCCCCcccCC---
Q 038003 454 GNLLKLHYLNLSNNQLSHK----IPTEFEKLIHLSELDLSHNILQEE----IPPQVCNMGSLEK--LNLSHNNLSDF--- 520 (848)
Q Consensus 454 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~--L~Ls~N~l~~~--- 520 (848)
...+.|++|+|++|.++.. +...+...+.++.+++++|.++.. +...+...++|+. |++++|.+...
T Consensus 43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~ 122 (166)
T d1io0a_ 43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 122 (166)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH
Confidence 3445555666666655432 222344456666666666666432 2245556677775 45566777542
Q ss_pred -CcchhccccCceeecCCCCcc
Q 038003 521 -IPRCFEEMRSLSCIDISYNEL 541 (848)
Q Consensus 521 -~~~~~~~l~~L~~l~ls~N~l 541 (848)
+...+...+.|+.|+++.++.
T Consensus 123 ~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 123 EIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCCCcCEEeCcCCCC
Confidence 344556788888888877654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.01 E-value=4.4e-05 Score=70.07 Aligned_cols=39 Identities=15% Similarity=0.180 Sum_probs=17.7
Q ss_pred CCCccEEEccC-CccCCC----CcccccccccccEEEccCCcCC
Q 038003 384 SPKLQVLDLSS-NHIVGK----IPVQLEMLSSLNKLILNLNQLS 422 (848)
Q Consensus 384 l~~L~~L~Ls~-N~l~~~----~~~~l~~l~~L~~L~L~~N~l~ 422 (848)
.++|++|+|++ +.++.. +...+...++|++|++++|.++
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 35555666654 334311 2222334445555555555444
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.80 E-value=0.0016 Score=66.32 Aligned_cols=138 Identities=13% Similarity=0.118 Sum_probs=78.3
Q ss_pred CCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcc--cceE-----EEeecCCeeEEEEeccC
Q 038003 610 GGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN--VKFH-----GFCYNGPHSFLVCEYLD 682 (848)
Q Consensus 610 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i--v~l~-----~~~~~~~~~~lV~e~~~ 682 (848)
+....||++...+|+.|++|+.+... ...+++..|.+.+..|....+ +... ..+...+..+.|+++++
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~-----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER-----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCC-----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 44568999999999999999976532 235667778887776642222 1111 12234567889999998
Q ss_pred CCCHH------------------hHhcCCC--CcccCCH-------------------HHHHHHHHHHHHHHHHHhh---
Q 038003 683 RGSLA------------------RILGDDV--TAKELGW-------------------NRRINVIKGVANALSYLHH--- 720 (848)
Q Consensus 683 ~gsL~------------------~~l~~~~--~~~~l~~-------------------~~~~~i~~qia~~L~~LH~--- 720 (848)
|..+. ...+... .....+. .....+...+.+.++.+..
T Consensus 108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 75321 1111100 0011111 1111122222333333322
Q ss_pred -CCCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 721 -DCLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 721 -~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
....++||+|+.+.|||++++ ..++||+-+..
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 223479999999999999743 56899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.80 E-value=0.002 Score=67.74 Aligned_cols=72 Identities=14% Similarity=0.183 Sum_probs=49.5
Q ss_pred ceeccCCceeEEEEEcCC--------CCEEEEEEcccccccCCchhHHHHHHHHHHHhcCC-CCcccceEEEeecCCeeE
Q 038003 605 FCIGKGGQGSVYKAELPS--------GDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIR-HRNNVKFHGFCYNGPHSF 675 (848)
Q Consensus 605 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~ 675 (848)
+.|+.|-.-.+|++...+ .+.|.+++.-.. .......+|.++++.+. +.-..++++++.+ +
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~------~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP------ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC------CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc------chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 578999999999997643 355777765421 12233457888888874 5445678887753 6
Q ss_pred EEEeccCCCCH
Q 038003 676 LVCEYLDRGSL 686 (848)
Q Consensus 676 lV~e~~~~gsL 686 (848)
+||||++|..+
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.90 E-value=0.023 Score=57.08 Aligned_cols=159 Identities=12% Similarity=0.100 Sum_probs=83.1
Q ss_pred ccHHHHHHhhcCCcccce-----eccCCceeEEEEEcCCCCEEEEEEcccccccCCchhHHHHHHHHHHHhcCCCCcc--
Q 038003 589 IMHEEIIKATDDFDEKFC-----IGKGGQGSVYKAELPSGDIVAVKKFNSQLLSGNMADHDEFLNEVLALKEIRHRNN-- 661 (848)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-- 661 (848)
.+.+++.....+|.+.+. |..|--.+.|++...+|+ +++|++.... ..+++..|++.+..+...++
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~------~~~~l~~~~~~l~~L~~~g~pv 75 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSC 75 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---------CCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC------CHHHHHHHHHHHHhhhhccccc
Confidence 345677777778877543 456777889999877665 9999975532 12234445666665532222
Q ss_pred cceEE------EeecCCeeEEEEeccCCCCHHh-----------H---hc---CCCC---cccC----------------
Q 038003 662 VKFHG------FCYNGPHSFLVCEYLDRGSLAR-----------I---LG---DDVT---AKEL---------------- 699 (848)
Q Consensus 662 v~l~~------~~~~~~~~~lV~e~~~~gsL~~-----------~---l~---~~~~---~~~l---------------- 699 (848)
..... +.......+.++.++.+..... . ++ .... ....
T Consensus 76 p~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (316)
T d2ppqa1 76 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA 155 (316)
T ss_dssp CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred cccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhh
Confidence 11111 1122345567777776642210 0 00 0000 0000
Q ss_pred --CHHHHHHHHHHHHHHHHHHhhC-CCCCeEEcCCCCCCeeeCCCCCEEEeeccCccc
Q 038003 700 --GWNRRINVIKGVANALSYLHHD-CLPSIIHRDISSKNVLLDSNFEAHVSDFGIAKF 754 (848)
Q Consensus 700 --~~~~~~~i~~qia~~L~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DfG~~~~ 754 (848)
........+..+...+...+.. .+.|+||+|+.++||+++++...-++||+.+..
T Consensus 156 ~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 156 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0011112222223333333321 234799999999999999888778999998864
|